>SEQF1602_00001 Internalin-J
MREIVTLRKGAFVLFAAATAMVGCSKSDSNSNPTPPTPPAPQAKVETPTHLKGWAIQPKV
DTQQPYMVFSTEKEGEQALMLTLAEGKDNKVWIDTNNNGILDKEDVKVTDPAKSMALASK
PNVYAVYSKAVRVVASGNALAKAITFTPKQKVYAVYGKVASVVASGNALTAADVRANPAL
TELNVANNKLSEAALTSLVQHLPTPGNGETAAVVLRNKDLGTKEGNVVNATVLAEVKKKG
WAPQAIQDKETVADQEGAKPEPKNPEDYYIELTTEKAIGEKVKLYINAAKEDQPGVWIDL
NSNGQWDEGIDQKPEVFGNIIRCSFQTQIFRIYGKVSSLDCEDNELSAIDISHNDVLTKL
LAKKNKLSSITHLEHLTTISLDTHTLQSSNLPDGLISLDINETSPLATIDTKPFTKLKFL
SIIDCKSIKSLDLSLNTDLRSLRAIQSGLTELDLSYQPYLSFLSASHSPFTKLNITGNKA
LGFVYIELTSEGEGLKGEALMQFIEQLPKKEAGKEGKIRLSPEQASEAVKELLQKKYWSF
SIK
>SEQF1602_00002 hypothetical protein
MARNATNKLLHKAKKSKSDEFYTQYCDIENELQYYREHFSDKVVYCNCDDPRVSNFFKYF
AVNFDNLGLKKLIASCYVENKEGFSSSEAAKNGFYYEYHKENGKKLVFDDISVSSFCGDG
DFRSSESIDLLKKSDIVVTNPPFSLFREYLDQLIKYDKKFLIIANVNSITYKEVFNLIKE
NKIWLGVHLGRGVSGFIVPEHYELYGTEARIDSNGNRIISPNNCLWLTNLDVFIRHKDLP
LTRKYFGNESSYPKYDNYDAINVNKTKDIPLDYNGVMGVPITFLHKFNPEQFELIKFRKG
VDEKDLSINGKCPYFRILIKNKRLQK
>SEQF1602_00003 Type-2 restriction enzyme EcoRI
MVLSRGSLLNTRPRITSGSHKNISEIANFMLSESHFPYVLFLEGSNFLTENISITRPDGR
VVNLEYNSGILNRLDRLTAANYGMPINSNLCINKFVNHKDKSIMLQAASIYTQGDGREWD
SKIMFEIMFDISTTSLRVLGRDLFEQLTSK
>SEQF1602_00004 hypothetical protein
MDAQTRRRERRAEKQAQWKAANPLLVGVSAKPVNRPILSLNRKPKSRVESALNPIDLTVL
AEYHKQIESNLQRIERKNQRTWYSKPGERGITCSGRQKIKGKSIPLI
>SEQF1602_00005 hypothetical protein
MRNRIMPGVYIVIIPYVIVSICYLLFRHYIPGVSFSAHRDGLGATLSSYAGTMIAILIAA
LTFLIGSRTRRLAKIREYGYMTSVVIVYALSFVELGALFFCGLLLLSSISGYMIPTIAIG
IASASFIHICILVFQLYNLTREQE
>SEQF1602_00006 hypothetical protein
MKNGFYATYRSKNKGKDKRSINLSVFLNSLLADNHHLQVGSNYLYIHKIDGKTFLFTKTN
DKSLVQKINRSKASVEDIKNSLADDESLGFPSFLFVEGDTIGFARTVFGPTTSDLTDFLI
GKGMSLSSGERVQIEPLMRGTTKDDVMHMHFIGRTTVKVEAKLPVFGDILKVLGATDIEG
ELFDSLDIVIKPKFKRDIKKVAKDIIFNPSPQFSDISLRAKDEAGDILTEHYLSEKGHLS
APLNKVTNAEIAEEMAYCYARMKSDILECFKRQVGKVKD
>SEQF1602_00007 putative HTH-type transcriptional regulator
MSTKKKPLTQEQLEDARRLKAIYEKKKNELGLSQESVADKMGMGQSGVGALFNGINALNA
YNAALLTKILKVSVEEFSPSIAREIYEMYEAVSMQPSLRSEYEYPVFSHVQAGMFSPKLR
TFTKGDAERWVSTTKKASDSAFWLEVEGNSMTAPTGSKPSFPDGMLILVDPEQAVEPGDF
CIARLGGDEFTFKKLIRDSGQVFLQPLNPQYPMIPCNESCSVVGKVIASQWPEETFG
>SEQF1602_00008 hypothetical protein
MEQRITLKDYAMRFGQTKTAKDLTKRQFKVLLAILRKTYGWNKPMDRITDSQLSEITKLP
VKRCNEAKLELVRMNIIKQQGGMFGPNKNISEWCIPQNEGKSPKTRDKTSLKLGDCYPSK
QGDTKDTITKEKRKDYSSENSHV
>SEQF1602_00009 hypothetical protein
MKKQITDTVLMVRPVRFRTNEETIVNNYFQKGINITQEEINRKAQQEFDMLVQKLKEVGV
HVIQVEDIYEQDTPDSIFPNNWISFHNNGDVAIYPMFAENRRRERREDILDIVEEAGFEI
ENVFDYTEAEDEGIFLEGTGAMVLDRIHRKAYCALSPRASEELFIEFCEDFEYTPVIFRA
FQKTDGELKPIYHTNVMMALGRTFAIVCLDTIEDKKERKNVLNHLKEDKKEIITISREQV
DYYAGNMLEVKGKEHSYLVMSQTAYESLTPQQIEAIERHTQILYSDLSTIEICGGGSARC
MLAEVFLPHSK
>SEQF1602_00010 Deoxyhypusine synthase-like protein
MNKGPISQFIEKNFLHFNAAALVDAAKGYEAHLQGGGKMLVALAGAMSTAELGISLAEMI
RQGKIDIISCTGANLEEDVMNLVAHSHYKRVPHYRDLTPEQERELLDSHYNRVTDTCIPE
EEAFRRLQKHLEEVWHKAEEKGERYFPHEFLYQVVRSGVLEQYYEIDPKNSWILAAAEKN
IPIICPGWEDSTTGNIFAANVIKGNLKASTVKTGIEYMIYLTEWYRNNSSGKGVGFFQIG
GGIAGDFPICVVPMMYQDLEWEDVPFWSYFCQISDSTTSYGSYSGAVPNEKITWGKLDID
TPKYIVESDATIVAPLIFAYILNQ
>SEQF1602_00011 Outer membrane protein assembly factor BamA
MKCNFFIKALLLLCLFSLSGCSPTKKVPEGAYLLRKNDINVDGKAPKNSHVYGYLRQEPN
SRLLGIPIGLLIYNLADDQSEENYQKWLERHPRWHRFLDGFLSKKQTQRLGKSFLVSGKD
RLLQRMGQPPAILDTAQVNKSTKVLKAYYNSVGYYNSKVEHDILPLEKKKEAAVVYSIEK
GMRYYIDSLDTRILSPEIDTLYKKHIGERLIKNHTHYSLEKFTNERSRITTLLRNNGFYN
FQQSAIDFTIARDTVAYNNDSLINVTTTIANYTDRSTDPPTEKTYKKHLIKKVYLYTDYD
SSLQTTIYDSVEYKGITYYYRNKLHYRKQTLYDAIALRPNTLYRDIDRNNAYRQINNLRA
FKYPNIQYRYAKKDSLERTLEADIFLEPLSRFSIETNLELSRSSIQEFGIGFNTSLIARN
VFRGAETLEITPRVTLGAQQFPDGTSAFFNIFEYGGGLRLTIPRIWFFGSIESLIPYSKT
PQTILQFTTSTQQNIGLDKQKTSGVLRYTWSPNTQNRNILELLDVEFVRNKNPENYFRLY
RSSYNALNDLAKKHNAPAAVMDNDGNLNDREGAIAYVIWASKQGGYAGYPQDTKDLYNIF
QRYYRMTKNDLIMATSFTYMSNNTFNYYEPDYEQFRVKVETAGNIPQLLSIVRKLPKDDQ
GQRKFLDVTYAQYAKAELEYIKHIPLTIRKNGGEVFAFRTFIGFAMPYGNGKSIPFSRSY
FAGGSNDNRGWRAYSLGPGSSGSPLEFNEANFKFTANAEYRFTIANALKGALFLDAGNVW
HLMDDEENTDYKLDSFSDIADVALATGFGLRYDLNYFVIRGDFGMKLYDPSKYATHHWTN
ELKLSNFVFNIGINYPF
>SEQF1602_00012 hypothetical protein
METEEILLDYIHRWFMIYRPELDLRKNEAERIFNEIQQELNLDEVDKQFTQEIDGKVYSI
EGAREAKYSMIREYLDEVYFSPTNQVCMEVAEEREFYHATEYMKDLGFLYYEEMEMFIEV
VKKSEWYKEYEDTKELLTNEEFRNKIRQLFRDRKWNNFLPVREEEPFDPTIISAYPPRKD
>SEQF1602_00013 Aerobic cobaltochelatase subunit CobN
MRKKIVWLFLALFLCGGGYFLWRKYVAPTRIALVNFLSYQSSNVILSNKDRFIRFDEVPL
EELDRLRGYDFVLIWGMGMKITQEQRELLQEISQRVPFHSFAVTNPDNDINSLGATDSQR
ISEYLESANRDNYQNLARYVRKYIDKKWFAQEPAPAIERKENVYFHLDDDLSFDSRQAYE
KYIREHNFYKEGAPRIAIVAGLHEPFGGNKEHLNGVISALEQEGMNVYPFTAQSKRIEFL
EEINPDAIVYFPHGQMMMGAPETFINWIKQKNIPFFTGLSVLSLQEDWEKDPMGMAGGFL
GQTVVMPELDGALYPYVVIAQQKNKDGYYYLDAIKNRAAKFAKIIHNFTQLKKQANQDKK
LAIVYFKGVGLNPPVAQGLEVVESLYHFLQELKKEGYRVEGLPATVAEFNTLLVNHANTY
RAGAKGEIERFLSQGNPALVEAAELDSWLKQALPTSLYKEVITRNGAVPGTYLSTEKGGK
EYLAVAQLTFGNVTILPQPPAAISTEDDFKVQHGVKEIPPYAYIGAYLWIQHGLKADALI
HFGTHGSLEFTPNKQVTLSDYDWGDILVGTVPHFYYYTIGNIGEAMTAKRRSYGSLVSYL
TPAFTESDMRNTFNELENAILAYQKSKQEADKNTISLHIKKLAVGMGLHRDLRLDSILSK
PFTEEEIDRLSNFAEEIATEKINGELYTMGIPYAPDKILSTVMAMSADPIAYSIAALDKL
EGKVTEKELKRKVFFSEKYLNPAKALVRQILSGKPVTTELICNYAHIVPKDLEKAKELLA
KEAESGMPYFLKKQMEKKATPSSQGQGKKPDAVGKPTKTKKAPANKVESKPLTPEELAEI
AAKKAKLNRAQAIVDIEKSILSVATYREGLQNSPQAEEKAFFNALKGGYTPPSSGGDAVA
NPKGVPTGHNLYAVNAEATPSKLAWDRGVTLAQNVLKEYKDKHGDFPKKVAYTFWSSEFV
ETEGVSIAQALYMLGVEPVWDTFGRVGDIRLIPSDELGRPRIDVVIQTSGQFRDLAASRL
FLITKAIEMVSALPEETYTNEVSAGSVDIEKELVAAGVPPKQARQMATQRIFGGLQGRYD
TGIKELINAGDKWETQKDIAQVYMHNMGAFYGSKDNWSQFQEGMFRAAIKNADVLIQPRQ
NNTWGALSLDHVYEFMGGMNAAIKEVTGKDPDAYLADYRNHKNMHMQELKEAIGVEARST
ILNPKYIKEMMKGKAAAAGQIQEIVTNMHGWEATRPELIDDALWEEVYLTYIEDKQQLGV
TDFIRRENATALEEVTAVMLEATRKGMWKASQAQISKLATLHTDLVKEFGVTSSEFSSEN
KKLQAYISQKAPQANAEAYQKQLKQAKESSTQLQDSKDGKLLKKEETSTAQEKKKVSLNI
LWVGLAALVALIALVIFVKKRRK
>SEQF1602_00014 D-cysteine desulfhydrase
MINIPPIETQKVPIDYPHGIELYIKREDKTHIHVSGNKYRKLKYNVQEALSKGYKRLITF
GGAYSNHIAATAYAGKMIGIETIGVIRGDELASAIATNPTLHFAQECGMQFHFVTREDFR
LKHTESFKEALFERFGDYYYVPEGGTNPLAIKGTEEILTPEDTIYDFITTAVGTGGTIAG
LINSAAPHQRVLGFPALCGRFLEEEIKKWIHPNDHWQLIHDYNLGGYAKVNDDFIRFLND
FFRQTHIPLDPVYTGKMIYGVTCLIEKGFFPDNSKIMAIHTGGLQGIYGMNQKLNKKKKE
ILDYEKEIT
>SEQF1602_00015 Exo-glucosaminidase LytG
MKKKLLSLLALVALVSSCGTTQKTVSSHKPIVSRVPEKVLTESKRSETYINKEVPETPEE
LKATSAVKVTPALIREYINTYKDIAMVEMQRYGIPASITLAQAILESGSGQGRLARHARN
HFGIKCHYGWEGDTIIHDDDAKGECFRKYEHAEASFEDHSQFLVNRSRYASLFELKAGDY
KGWAHGLKKAGYATDPGYAQKLLLLINKYELHQYDTEVLGYAYKEEKSLSPIPNTPPLPI
GAKKEIAKTAPAKTNSTVAKSTTTVVPTGEKSVAKRENTQKKDTTALTQKVDSTQVTPKE
KAIVRKDSTEVNNTSVTKPNTQAKPEEVAMELIKMYIVKKGDTLYNISRRSGVSVEQLMS
LNNMNNSNINLGQVLVIRE
>SEQF1602_00016 hypothetical protein
MKHIWSALSWVEKIIFIINGGIGVILLFAYLLPFIPPRYFEYASLSVFTPILMLLNIVFI
GIWIARGKWIFLFSGILFCIGLPFIHRFVQLPKNNVTSPEQLSVMSFNVRLFNHYKWSSD
TLLREKILTFVKEEHPKILALQEFYYKEKESFPFYKYKKFIYKHKKDKIGQAILSDYPII
NSGSLDFPHTGNNGVYADIVVNGDTLRLYSLHFESFHIEDTDISQENSKRIFLKLPRRFA
IQQAQVELFNAHADSCPYPIVVCGDFNNTAFSYLYQKFQDRGLVDSFEEAGSGFGRTYDF
PYFPFRIDYILADPYFKITSHKVYTGRDYSDHFPIRATLKKRQ
>SEQF1602_00017 Prolipoprotein diacylglyceryl transferase
MDWNPNQVLFDLHFIQIRYYSLMFVIAFSLGFYIMKKIFIAEHKSLDKLDALVIYVAIAT
LLGARLGHVFFYDWDYFKEHPLEIILPFRFSPSFEITGFSGLASHGAAVGIILAMVLYIR
KYPEFKLSWILDRIVIPITIGGMFVRFGNFMNSEIVGKVVDKSFPLGVKFLQSGDFPINQ
AMQLTGENTPQKAFAMIAHNPQFVEIYNQIPYRHPVQLYEAICYFFLFWLLYYLYWKTNK
KNQPYFIFGVFLIALWTIRFFTEYVKDSQGGIENTLGIFSTGQWLSIPFILAGVFLLFFK
KRNV
>SEQF1602_00018 hypothetical protein
MLKKLFYNERFAAILWAGLALATILQNVVIRGKYNNYLIFEGVFNHTLKQLPLFIPYPEE
YGDMNHYGVFFSAIIAPFALLPSSLGCALWILVNVAFLYWAIRQLPLSKGAIIGILLIAA
HDMYTAAAMQQFNISVIALLVVAFVFVEKGESHWATLFIVIGALTKLYGIVGLAFFFFAK
DKGRFVWSGLLWAALLFCLPMLYSSPEYVLSQYHDWYISLSQKNGENMDASHYNLQNLSF
LGFLQRTRLFNNNLIVIAIALVLFALPYLRIGQYKHLRFRLMFLASVSMFLCLFSTGTEN
STYIIAYVGIGIWFMASPNENKALKITLLILAFLASLSPTDLFKPLKEPYIIRYSLRAVP
VVLIWLTLIGEMCRLDYGKQETNLKEIAS
>SEQF1602_00019 Prophage bactoprenol glucosyl transferase 
MKKIDIVVPCYNESENIRPLYEAIKEVFAKELPEYDFNLLLVNDGSVDSSLLTLEQLAKE
DERVKYLSFSRNFGHQLAVKAGLDHAFSPAVISMDADLQHPPALIPTLIHKWEEGAQVVA
TLRTYPPEISKKKRKSSQQFYKLLNLLSDIEIKEGSADFRLLDQAVVEVIRQMKENEPFL
RGMVPWVGFNQVYVPYTAQARHSGETKYTIKKMFQLALSGVTSFSVKPLYFAVFLGFFFS
LLSVLYIPYVIYSFLNGSEISGWASLIMTIVFFGGLQLIILGIIGVYIGKIFTQTKERPA
YIIQEAHL
>SEQF1602_00020 Peptidoglycan-N-acetylmuramic acid deacetylase PdaA
MIYLSFDIEEFDMPKEYGFDIPFERQMSISREGLTAILDLLQKHEAKATFFSTVVFAQNA
SDLIQRLLSEGHELASHTYYHSDFAIEHLRSSKEALESQFGVSIEGLRMPRMLEVSATDV
KEAGYLYNSSINPTFLPGRYNKLHVPRYMFREEDLWQIPAGVSPWRIPLFWLSFHNFPLW
YYKHLLSRTVGSLGYAALYFHPWEFTDLHQKEFNFPFYVMRNTGDAMIARFDKLLSFAKK
KNWKVERYKKLIEKTDD
>SEQF1602_00021 Phosphoethanolamine transferase OpgE
MIKLKTYLFEILLLCFTIGIPYTLDASETVGGMIASFLILIVLRYINYWLFAIFFSFIAL
TCALLLPATIWFGYPTITMISAFLETNFQEAKEFTQSLPLYAYMLSIAVLFFAGYILYLG
KKKRYIYNKKSILINTLIAVVAIVLTIERPIRKMNEKQGFEFRHSHTLIFSFYDSLYKDI
TAYYELHKNIGINVDLPPSWKINAVTPRYQDYVLVIGESVRRDYMSLYGFPVENSKFLKT
VKGTVLEGFTAAGANTTASLLRTFIQMKGTDFIYENNIISLAKQAGFETFWLSNQGLVSE
WDTPIAKLASLADHRKFMKLGHYESKPIYDSALLPIFKEYLALPATHNRLFVLHLIGSHP
LFENRLETPLHYDYYNANLSSYIQSIEQTDIFLEQIYKTLQEQAHSFSLIYFSDHGLETK
DRNSPNVSFAHGVSKANFCVPFVRINSDDSLHNEVHISKSGYHFIDGFAQWLGIKEKGLD
KTYNFFSPPMDSLKVFTGEYLPFNSLPEDTVILNNKK
>SEQF1602_00022 hypothetical protein
MNIISKNINKYWLSALPLIIILATFLLAYWQPLLWEKDGFKMIFFKVGFYFCGIISALWM
FQHHTLLFRKGEYLRSLIICVGATTVFLWTYKHKITFRMDILLLLLCFIYGIIHRKWIKP
DGTIISFFLLAIFRFLAVFWNKDQTFAWENMNEDMLYLLLILPIICLGFRTREQESFAFI
TLCFKIFLFLLTLNITAYILISKNWNIPFFSFFTLNKGYMSYYEVLKWSAFHHPSFIAWV
ILLIWGLGAFVWKKNKKLISSMEFFLYGVLLLCFAFIVQARVVIVAFPLTILLLIWFSIA
NKWGYHKRIFIEMGILLIGLLSIFFLVKKTTYFSDPIREQLLNKAFDNIHKHPILGSGYG
AQKIIAKEMGYYHIHNDFLAFIIDFGIIGFLLFLFWIISTYYKSISTKDNRIIYTLVIFL
LLMNTDVLLNFHQGIYILFPFLIFIIFKDNKSSIT
>SEQF1602_00023 Alpha-1,6-glucosyltransferase
MKKIYFVCPNTTHITGGVKQIYKQVEILNRNGISAYVLLEKKKQSNIWLTSYNIPIKYSS
YLFKRLRYFFGGKKINIKRKLKLYYLQRKSEKIDDTVILVFPEIYGIYIKDVFPDTPKVI
FNQGCYMTFSGFSIDKDYPITPYNDRKTLATIVASEDAFSYLSYTFKGLNIYRMILGIDN
TIFNYSAEKSKQICFMPRKMEEDIIQVIHILKQRGRVQNWDFVSIDNKTEKEVSEIMKKS
IFFLSFNRNEGFGLPAAEALACGCYVIGYHGQGGKEYFKPEFSTIIEAGNIIEYVKEIEE
KIVLYEKDSFAFLEKGKRASQFILSNYSIEKEEESIVKIWNQILCNT
>SEQF1602_00024 hypothetical protein
MDNTNKYKDISKLKGKTILLCMPNYFNIYELFAADIKALGMELILIVPPVFYYKRSKDRV
INFFRKLFLGDKQYKNKLIKQFNIEYFLDKTTNIESKSIDYMLFVQPDLVTDNQIGKLLR
IGKKNIAYHWNGLEQYPDMEVFDNIGQFDTFYVFDPKDYQKYKEIYPNIKLSHNFFFENI
ENITTVDNIEKKALYVGSYFEDRIKNVIFVEKLLDKYNIPTDIELVYKDKRPFLSNKNIK
ITSEKINFIDYLKKVQRSKILLDFKLGHNGLSFRFFEALKYEKKIITDNFSVKEYDFYNP
NNIFILHKDNLENLETFLHSDYQKLPPELVEKYSFSSWIYDCLCK
>SEQF1602_00025 O-antigen biosynthesis glycosyltransferase WbnK
MKQKHYIYQQGGLGNQLYILAYAFYLKEKGVGPLCMYSADRQKKDTKDKKKRNVYSQITE
KLGFPISGLSYFFFSMAKKMAKKSFFKNYIALQVEKEGQFAVFQEPATQYESKIYLHMGW
YQSYLYQTPEFIERLYKIIEELAGNTRQFSITENDVVLHIRRGDFLKEKNRALFHIIETP
HYLEGLAKLSQGINLEKVYILSDDFEGIEDIITTLSKQYEVVLVKGNTVLQDLYLLTQFK
NYVIGNSTFSWWGAYLSKYKERANIIVPKEPWKIPMPEKSPYPPYWVQI
>SEQF1602_00026 Putative glycosyltransferase EpsH
MNNPLISIIVPVYNGETYLARCLDSLLDQTYAPIEILVVNDGSQDRTAEILSQYEQYPQI
KVFYQENKGLSGARNLGLKHFEGDFVCFVDSDDYVTPTYCEELYKALIDNNADISVCQYT
LIDTKGKEIPQEKDKKIQLFSHIEALALLLEDGQLKSYAWGKLFKKELLENFSFPMGRIF
EDYASMFFLFDKATKVVMINNCLYNYIQYPNSLSNKKGGEKFFHFFLGVMEMYDFACQYK
EKFPNWNRIVEKTAKQSLFAIKRFYLFSKEVEKSIEQAMKERLTSFYSNEYKKIPFKYRW
KIFSFLKLPFLYNTYIQFKKR
>SEQF1602_00027 Hyaluronan synthase
MKTTLLITTYNRPDALELCLMSVLRQTHLPDEVLIADDGSTADTKELIDTYRTKFPIPVI
HIWHEDKGFRRTVILNRAFLVAKGNYIIQVDGDLILGRHFIADHINFAKEKCIAKGRRVC
LSQKETDRLLKEKSLKVSIFLQGTTMREHGIRIPLYNQLFSPKEKATGDGVGGGNMAYWK
ADALAINGYNMDIQGWGPEDWEFAQRLVHFGCKQRKLKFGAIQFHLEHNTYPKQPTEAHL
RMVEELKKNKNIRCTNGMEQINNLIEQVKIYE
>SEQF1602_00028 hypothetical protein
MQGLFSMKISVIINTYNAEKHLATVLETVKDFDEVVICDMRSSDRTIAIAEQYGCKIVYC
ERYPYVEPARNFAIAQAQYPWVLVIDADETIPTKLREYLYQITENPTIGGVYIPFKNYFI
DQYMRSAYPDFKLRFFKKEGADWPKEIHSTVKVQGQVIKIPRHRTDLASEHLANDSVTTI
LSKNNNYSTQEVERRKGKRIGWGKLLFSPFFWFIKYYFIKKGCLDGKRGFIFAVLKAQYK
FSCLAKIYEYQQLHR
>SEQF1602_00029 Malonyl CoA-acyl carrier protein transacylase
MKKAYIFPGQGSQFVGMGKDLYESSPLAKSLFDEANHILGFAITDIMFAGDEEALKQTRV
TQPAIFLHSVIQRQVLGEAFTPDMVAGHSLGEFSALVASGVLTFEQGLRLVAKRAEAMQK
ACELERGTMAAILGLDDAVVEQVCKDTEGVVTPANYNCPGQLVISGAYEAVEQACETLKA
AGAKRALILPVGGAFHSALMKPAEEELAKAIGEITFQKPLCPIYQNVTTTAMTDPETIKK
NLIAQLTAPVKWTQSVQQMIQDGATTFVELAPGKVLQGLIKKINKEVEAISA
>SEQF1602_00030 hypothetical protein
MELIREKLVLPNGGKKLLLHSCCAPCSGEVMEAISASGIEYTIFFYNPNIHPKKEYEIRK
NENIRFAEKLGIPIVDADYDVDNWYERAKGMEYEPERGKRCTMCFDMRFERTALYAYEHG
FDTITSSLGISRWKNFDQINDSGLRAVAPYEGLTYWTHNWRKKGGSARMLEISKREHFYM
QEYCGCAYSLRDTNQWRLANGRERIQIGVKFYGVDDNDNDKQ
>SEQF1602_00031 Heptaprenyl diphosphate synthase component 2
MQLITDYQNEFVAFMQEHLKERDPKNLYDPIHYILNVGGKRLRPTLTMLSADIFGTDYHK
ALYAALAVEIFHNFSLVHDDIMDAAPLRRGHPTVHTKWNLNTGILSGDTMLILAYQYFEQ
YEPNIFQELAKIFSKTAIEVCEGQQYDVDFEQQAQVSTDQYLKMIAYKTAVLVGAALQMG
AIIAQTTEENKQKIYDFGLALGIAYQLQDDYLDTFGDASFGKKIGGDILQNKKTLLYLKA
LEKGTPEQKQELLTLYSTEPKSEEEKITRVTELFIATESHTFLRAQVETYTLKAFAILDT
LDIPEEKKNILKEFGGSLMNRTI
>SEQF1602_00032 hypothetical protein
MKVFDELRKAGIDSHDIEQLEKFYGEERFIRGRDGFIAVEDEDFEGMQDFFDDYTLFNDL
KVILTDENSNYWCVFVGGARKGMVCHLDHEEQDQQQPRFKSISRLLEVIEQHEEAYDFDE
LRELPENVFDFPSKTLEDFQGRKQIIEQLYQEIDSLDTEDESYDQNRSSRIYSIIVLSIA
SEVETHIKPFLDDEDDYVREFAETAMKFWRGKIVTF
>SEQF1602_00033 hypothetical protein
MEWVTYHRLLIIPSGVRGIICLFFLFGFCVRAQEADSYEEFESLKGKVLSVEENCYTSLE
HYRNRTYETAYKTLEVVKRRITFDEKGRKQTYEEYDTPTHCIVKTSFLYDKLDRPTGYTK
IYDTEELPYKERDHCWSVIYQYDPMDNDPKARKTSALTYQGNLLKEYRTYSYDSLGQLTE
EKISSIQQNQGKIYASTTHLTFTYDKEGKVTSLKWAAIPSGDVQYHDVFVYDTQGKISKK
EHWWDNTSFIKYSYEYNEKGDIAIEQKKEGDVLETPKVKCNNSYHYTYTYDTFGNWTQRI
STADDEVFLVTERIIKYKEP
>SEQF1602_00034 hypothetical protein
MRKYLLLLVSLYSLFCWGQRKTHLQEMKLNGEVKYLKVYEYNDKELNFVKEYFFNRQGNI
ERNNNYQKGQLNSEFIYHYDDQGRFSFYEMNFYGDYAKEGKIVFSYNRKRDAIQEEYYEN
DKLIQYTQNKYDNKHHIILSTIYREEKELSHTEFVYNDIDQLVEVSNFNNKNELQSTLKN
YYDSLGNLSKSDTYNAKGDKTTSREMEYDAYNNVIKDKIILESKHSLEYNYRYKYDSHQN
YIMKEDSNTKVKKGNFESVYLKEERQIEYY
>SEQF1602_00035 Short-chain-enoyl-CoA hydratase
MDYVYTTTTDSIATVEFASEQANALSMELLQRLAKELDTLSADKEIKVVILRSKGEKAFC
AGAFFDELVQVDSLESGQRFFSGFAHVLCAIRRCQKPVIGRAHGKAVGGGVGILAACDYV
FATEAASIRLPELSIGIGPFVIAPAIERKMGVGALAELSLAPDLWKNAYWAERKGLYACV
FENIADMDKEIGYFSQRLASYPTESLVAIKQILWKDTPSWEPLLFENAEITGRLALSPYT
KEKLKPKNK
>SEQF1602_00036 hypothetical protein
MISLQQNIAEIQEKIANAPDNSYAIGVLIGSLLPFVVLVILGYLLYSYYKNKKQS
>SEQF1602_00037 Alanine racemase 1
MSVQETTLEIHLDNLQHNVRQLKKHLKEGTRFLAVVKANSYGNSSVAVAQYLEKKDLADE
FAVAFTSEGIELRKAGVTRPILIFHPQLVDFEDIVRYNLEPTLYSKRLITHFIDFAKEKQ
LNQYPFHLKCNSGMNRLGFSVEEIDEACELLKGHEELKVRTAFSHLLASEDLQARPFMEK
QIALFKAFQKKLENHFSHKIIYHNCNTSGILNYPEAHFDMVRSGIGMYGFANDPRLQKDF
KPITTLKSIISQIHTIQKGDYVGYNFGFQAQKPMEIATISVGHADGLNRIYGKEVGFVFI
KDKKCPIVGNVCMDMIMVDITGLGCEEGEEVVIFDERHTSETLAETAKTISYELITSLSR
RIKRVFIED
>SEQF1602_00038 hypothetical protein
MKRYIILTILLISSFTITNCQKETVVERTEVQKGNLIHSGTGAPDASLGSIGDYYLDLST
SNLYGAKTAQGWGNPISLRGLQGEKGEKGDKGDKGNKGDQGNKGDQGERGEQGVKGDKGE
KGDRGLKGERGKQGFKGEQGPKGEDGKQGPKGEDGKQGPKGEDGKQGPKGEDGKQGPKGE
DGKQGPKGEDGKQGPKGEDGKPGSNGKDGQAGIPDKGVGRLFSGTGAPKKEIGQDGDFYI
DILHKRLYGPKEGGNWRDNFISLIPPEIRSSDYEIGNDEETGEQSLTKWFLKTIRKLDMN
SVEELRNVRGIGHGAFKDCNKLESIIIGENVKIIGLRVFNGMMGLKEVILNKNLEKIGRY
SFAGAGISSIIIPKNVAEINYAAFYGCQNLKTIIMESQNPPILIKDNTEPDAFKDTPQTK
IIYVPDNSVDTYINDSQWSKYERYIKPISEKPKD
>SEQF1602_00039 hypothetical protein
MNIEFFIARRLVHNSGGKSSISSPIIKIAISAIALGVVMILIAIATGRGLQERIRQKIAS
LNGHIQIFNYDTNRSEVSIVPISNQEDFYTDPQFFNREGKKVLHLQGVITKGGIIRTEKT
FEGIIAKGVGKDFDAQYMKAYLKAGKFPDFSSDTLSNEVLISEYLANRLELSVGDTCNTL
FLREESEGIPNQRNFTIAGIYASGFQQFDATYILVDIRQLQKINKWTPQQVGLFEVFIKD
FDQMDSVGEYVYNHIPTTYDSQTIAQKYPTIFEWFHTFDLNIFIIIAIMVIVGGVNMITA
ILVLILERTPMIGTLKALGATNWNIRKIFLYNAAYLIGLGLFWGNLIGLSLLCIQYYFAP
LKLDPTVYYVTEVPIYLHMGYIIALNIGILITCLLMLLVPSYIVSRISPIKAIKFE
>SEQF1602_00040 hypothetical protein
MSKITLFLLLIGVFGQLSAQNISIKKYEYVGTGANQSYQYLPMLAGKRIGVVTNHTGIIQ
KIAHEKDSTITVQNEHLVDFLLAKKINISKVFAPEHGFRGTADAGEVIKDGVDPKTKLPI
ISLYGKNKKPTAEQLKGIEVMLFDLQDVGVRFYTYISTLHYVMEACAENYIPLVILDRPN
PNGHYIDGPVLESSYKSFIGMHPVPVVYGMTIAEYAQMINGEKWLKNGIQCTLKIVPLKS
YDRKAIYPLPVAPSPNLPNMTAVNLYPSLCFFEGTNISMGRGTQWQFQIYGSPYLEKTAF
TFTPKPNAGDKNPKYNGKVCYGEDLSHTPTLSTLNLSWLIKTYEQTSAVKVNFFSSSFDK
LAGNKTLKEQLLQHKSEKEIKASWQDALEKFKKTRKKYLLYPSDF
>SEQF1602_00041 UDP-3-O-acylglucosamine N-acyltransferase
MLHKVTASQIAQVLNGTVTGDPEVEVYKLSKIEEGCPGTITFLSNPKYKHFIYTTEASVV
IVKDDFHPEQPIKSTLIRVADPYLAFTQLLEYYNQMRIATKVGIEEPVFINSSSTLGENV
YIGAFTSIGAHCKIGNNVKIYSNTNIGDNVTIGDNTIIFSAVTLCADSVIGANCILHSGV
VIGADGFGFAPQEDGSYKKIPQIGNVVIEDEVEIGANTTIDRATMGSTIIRKGVKIDNLV
QIAHNVEIGAHTVIASQAGVAGSSKIGAHCSIGGQVGIAGHFTIGNNVKIQAQSGIGRDV
KDNEVIQGSPAFTYMDYNKSYVVFRKLPELFKKIGELEKKIDS
>SEQF1602_00042 hypothetical protein
MNIELLKESLNLLNDFPEHIYYINSGAEYLSIYKRCLKDIEQIAQERGSAYIKGKLKEYP
TLTSKEVDEYIRLKSDDKSLLSLFFERIYIENIICLFRTGSFPHSIKKKICKVANINQEI
FRVIEKPILETIL
>SEQF1602_00043 UDP-3-O-acyl-N-acetylglucosamine deacetylase
MKQYTLAAPVTLQGKGLHTGKNVTLTLKPANENTGFVFVRVDLEGNPVIEAEASYVTSTE
RGTVLEKKGVKIQTCEHILAALVGMNLDNVIMELDAPEPPIMDGSAKYFVEAIEKVGIVA
QEAERHEYIVHEVISYKNEETGSEITLIPADEYQVTTMVDFGTKILGTQNAYMHSLSEFK
DDIANARTFSFLHELEVLLDKGLIKGGDLNNAIIYVDKEPSKETMEKLKKVFNRDNVTVK
PNGVLDNIDLHYSNEAARHKLLDVVGDLALVGVRIRGKVITNKPGHFTNTQFAKKLSKII
ANERKNDIPKVDINQAPLIDTVGIMKLLPHRPPMLLVDKVFELSDKHVIATKSVTMNEPF
FVGHFPGAPVMPGVLQIEAMAQAGGVLILSTVPDPENYLTYFMKIDNVKFKNPVLPGDTL
IFKLELLTPIRRGICHMQGYAYANGKLVTEGELMAKIVKRDDNQE
>SEQF1602_00044 Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase
MMYPLVNIHPEAKIAQNVVVEPFSTICRNVEIGEGTWIGPNVTIMEGARIGKNCKIFPGA
VISAIPQDLKYKGEETTTHIGDNTTIRECVTINKGTVDRMRTVVGNNCLIMAYSHIAHDC
IVGDNCIFSNGTTLAGHVTVGDCAVMAGMTAVYQFCSIGSYAFVTGGSLVGKDVPPYVKA
ARNPLSYVGVNSIGLHRRGFSTEKIREIQNIYRILFQKKLSTSHALEYIEAEMEATVERD
EILQFVRRSQHGIMKGYAGILPDEGNV
>SEQF1602_00045 Oligopeptidase A
MFQTPYNAAPFSRFTPTDYLPAIEKAIAESLAQIDSITQNPEPASFKNTIEALAYTGLEL
DRLTAMFFNLNSAETNDTLQAEAQRISPLLTDYGNDIRLNEALFKRVKTVYDQRENLSLT
AEQQTLLEKTYKSFTRNGANLSLNDKESLRKIDKELATLKLKFSENVLAETQHYQWVITD
KEQLSGLPDFVLEILAQEAQKRHTQGWVITLDMPVYTAVMKYADNRDLRQKLFTDYHSRC
AGESAFSNEANVLRIAELRQARATLLGYPSYAAFALEERMAETPEKVMNFLSELLSKAKP
QALKELEQLKTFSGLADFQQWDFAYYAEKLKQECYQIDDSLLKPYLSLDKAVEGMFAVAH
KLYGLCFSLTEEVEKYHPEVQTYKVTDEDGNYLALFYTDFFPRAGKRNGAWMTSYKEQYT
DKQGNDSRPHISIVCNFTRPTDTAPSLLTFNELTTLFHEFGHALHGMLSKVTYPSLSGTN
VARDFVELPSQLMENWCYEEETLRLFATHYETGAPLPIEWVQKIKEASAFMEGILSVRQL
NFGFLDMAWHTYPHLERLESVDLFEQEATKVTQLYPPIDVMCISPAFSHIFSGGYAAGYY
SYKWSEVLDADAFEAFKEVGIFNAEVATRFRKEVLEKGSSEKESLLYKRFRGQDPTPDAL
IRRAFGEVKGE
>SEQF1602_00046 hypothetical protein
MKKLIFLALVATALFVSSCGKDDDNGGGSTSLNGDWYFHTVYSNDNNKGLRWITLDNCSQ
QSYWSISDKKINYERHHLEGSDCKYTPTYYNYTINNGVINAIVAEDSPNHRIGSTFSIKY
EMKGKELIFRFKSGAYDIISVLHKKGEDYSYLDPFVGRWQMTKYVVGQQEFIVQDGKCLY
GSIVASSLGATLYLNYPENGQCNKTINSYEWVKEGGKYYNVSNPAKKTLWDINFSNNNRY
MTFAIDNGRTVMHFTKEK
>SEQF1602_00047 hypothetical protein
MKENLLSAIKAHDFTAIRNICFGLSEEERQELKSYFARKNFNFIFREILEKEKRYHFSNK
ELAIISYTIMCVCNTLEEVRKIELFQNIEPYVKGNYYYFLSSLEDEVLLDFVQTPQGAYM
IEGIQLMYKDNPLEMSFQILWSVYKAGYIPLNEGVFIQKMYDLNWFKADEHLTKYLLKHP
ETVVLFPSVPAYIQDTIFTTEEWKKIYHTLNKKGYLTNKNAILHSFIEALLNPWKKTVLD
MYCRWIETFEPSHQELLSNQHTLFALLSSDKTSVVNFVMKLIKEIASEKDFDFQAFADNF
SLCFTTQKIAKSQLVGLDILEKHYKKQAPTNPDYREQLAVLFTVPDAQLQEKVANLLTTY
FSGEGLAEVVAPYQDYLKGKAQDLLATLSPSENSENSENSQIACAARTSQTACVAHTPKI
AYAARTPRTWDDLLFLIGDCIRERSPLVLDLFFEGLNQLQAQIPADYPEQVKPYLKQLLS
NERAVTSLFYQFLDSWCSQSPIPLVYNTNKEWNELQELYNEKKYSQAEKFNKLREIHVSA
NKAKKIFPFFFNKIACALQKLKEKDTLPFISTPTHAPFYIEPLTFLERVIQYEKAGKTPM
QEDVIIGLNRLLPTEITEAQKQLALSLTGDYTPALQYYFEVNKQIAVTDATRVLWGQVLR
LKDIDGVFPELEIPQKSNLQGLVRPFYLKYEVELTKINGVERNKIILEDNWDKKHSTYSY
YNELGANYYNVSPMGKVIDEDIDYELSLNPRYIDGWLCKYLLTYTQGMDSESLSEATRVM
SLLLQYNLPIYHGGWLMVATCLLAERKPLRDLAAEYILLSLQREKTLSYLAEAIGTLLAH
KYAPIARFVEFLDLPTRDPKVKGFQKAVVEAYLPLAEKQEKKPTNHKKLASFLIN
>SEQF1602_00048 hypothetical protein
MNKELISALKNENWVEIRRIAFALPEQKKTQIKKQTHNKDWENIFEEKHLSYKIEYVITY
LMMCVCHSVEELLSVEKQLDFTSVKSYHTRIKYPLFFLNSQHTQAFMDFIHTPEGAYMIA
GAQQVFEQSPRSFSIEILLALYTEGIIPFNEEIFVKNLYDIEYYRTQETEVAEVLLQYPE
LATRVIPHTAKYIDYVISSSLEWQKVFTLLCKKNYFPDKSFITSFIEILLNPWKKNVLDM
YCRWIEGLVPTEEELLPSQHTLFALLTLDKSSLINFAMKRIAQISTHPDFDFQSFADNFA
LCFTVQKIAKSQLIGVEILEKYYQKQAPTNPDYREQLAVLFTVPDVKLQEKVASLLTSYF
NQEGLPKVIAPYRDYLKGKAQDLLATLSPSENSENSENSPTACAARTLTPITYPLKPEDL
LFLLGDCLREPAAHTIDVFLEGLITIQDNFSADWAKSLSPYIKQLTKRVDKEEIPTDAIL
LGVLRALIDRRPLALDPKCSYTWEELCKKRKKLSEKEFEAYTQDYYLGNARQVLPFLFRK
GQMVIDAILQHCHLPLLSTPTHLPFYIEAEVLVDKLLQYEAQGVQPDIDDLIVACNRLLF
REVSATAKEKAKQLKGNYALAIQYYLGLTDKIQLTEELLPLWAQITRIKHPDRAFPEFEN
TSAKDILGVVKPYLIGYGWQENKSHKSFVFEHHTEWVGVSYTDLKNAFPYRYYNANGGSS
PISTIFEYKLSLNPHYPDAMLCDYISTWVTGNEVREIRNMSVPLEVLLRYDIRVRHSGWL
YIGTALLFEKRPSRDLAYEYICQAITRGEDLTYLKTYLAQVLAWDFLPIPRFIEFLDRPT
HDAKLKAFGKEVIQLYLKEVEKQNKLPRNHKKLAQLTN
>SEQF1602_00049 hypothetical protein
MKKELITAIAEGNFSAILSITSQLTDSERYSTIAAIKDLNPYSETDFPQKNVDKKDTYRH
KDSVFQALNYALITMVREESDIAKVMINKENYYGEIYQVTPYVILGSYYFEPVIKYFTKF
PPDYYIKEVLKERYNKEINGLSFGFQWYFYKKGWIPFEEERFVKNLLEVSMFNRYVTADV
NFLLQNPEAIEKVLLQLYRIETKVLDLSKWKSDNTLRKTNDLGSAKVTTYWDEVFELLVH
YGYQIPRSFVGQLLESLLNQWKKPHLDWHCRLLKWLAPTQEELLAHQQTLFAVLGTGVGS
VVKTVMEYIVSIANAQKFDFEGFRVQFPLAFTVEKQPKALLQGVEILAKEFKKHTPTDVS
YREQLAVLFTQPDIKLQEAVAELLITYFNQEGLPEVIAPYRNYLKGKAQDLLATLSPSES
SAPSDLSDRSASSENSQTACAARSACAARTLTPIIYPLTPNETLFLIGDCIREKAAATID
VFFDALVRLQDQIPADYAEQVKPYLKQLLAREWFVGTMPLLYLFLDSWSNQSSTPLVYDT
DKEWKEIQKLYKEDKYTQADKLDKPRVMHIAANQAQQTFPYLFNKIARTLQKLKEKDTLP
FLSTPTHEPFYIEAEVLVDKLLQYEAQGKSPDLDDLIVACNRLLFKEVSAAAKEKAQQLK
GDYAPAIQYYLGLTDKIQLNEALLTLWTQITRLKHPDEEFKVFETTQAKNILSVVKPFYI
RYGWEKRTYANGEVGEEFTYHCNHYYKYGKDKSRPTLYNYYNANEGKCISAQEAEYKLSL
NPHYPDAILCAHIALWATMNEADQVRDMSLPLEAVLRYDLRVRHSGWLYIGACLLFERRP
SRDCWNRKGLNSQYVSAFGSALRYDIRVRHSGWLYIGACLLFEKRPSRDLAYEYICQAIA
RGEDLSYLKTYLAEVLAWDYLPIPRFIEFLDRPNPPAVKAFGKEVVQLYLEEVKKQDKLP
RNHKKLAQLVD
>SEQF1602_00050 hypothetical protein
MAKKNTRTLKFEALDKELQNLLYSRDISELISVLKEGKNPLFLEQLTQLDVKSCKHLGFL
VLWSLYENDFIPFEEDFLIEKLCDALFLMSKHKEIESFILKRPRIAKEIGEKLPFYFLEK
RHIYVTEYEKLLDFGAKGFFKGTQVVPNFLEALLSPMKTYTANTYCCIIESCKPTTEELL
PSQQTLFALLSSDKTSVINFVMKLIKQIADEKAFDIQAFADNFALCFATPKIAKSQLIGL
DILEKYYKKQAPTNPDYRKQLAVLFTVPDVKLQEKVANLLTTYFNHKGLPEVIAPYSDHL
KCKAQDLLATLSPSENSENSENSHSSQNAYAACTSQPQKTARTLTPISCPLTPEKLLFLL
GDCLRERTAATIDLFFEGLVQLQDQLPENFKEQLAPYIAQVNGMYYTNVQLAALQLLLAG
WVENRPLESPEDWKKMNTQVRRLNTNEEEPFKQACVLHNVWYLRDEIPYLLYKVKATLDK
LKTGSKLPFLSTPTHAPFYIDAETLADRLLAYQTAGKEVDLDDLVVACNRLLLSTITPKA
HEKVRSLSGQYASALGYLFGLSDVVTPTEELLPLWTQITRLKHPDKVFTEFEVTAAKDYL
SAVKPFFLSYEIDSELKWFYLEKKYINSPYNDYQRGTFEKEEDRLPYNYYNAGAFQIFDV
DTLRYTISLNPQYVDVLLGKYTPPWVGVSDAETYRNLQVPLQLLLEYDLPVHHSGWIFVG
MALLHDKKETRDLAAEYILRAISRDEDLSYLQHFIADILAQKLTPINRFVEFLDMPTRDP
KIKAFQKAVVEAYLPLAEKQEKKPTNHKKLANWLIS
>SEQF1602_00051 hypothetical protein
MFEHLKKLITTHDLDTLFSFCSNLADNERLALLEEFQQSKWGLKESFGDKGMFELQPPNN
SDYEFIIALFLLTRSVEEYQALSIHEICGYYVASSRFFSDSKALHILPKILREEKYRFIL
DFYRALKPYEKEFISFETYWALYKAGEIPFDEALFTKNITATYLYDDKKVRYTDLVLHDQ
EFHDKIFRRLHLYENQMFHDAKPWEDFFVHLQRQGYVFDRKYIPELLESLLNPWKKPHLN
WHCRWIEFLEPTTEELLACQQTLFALLSTGNTNLINFALKHIQRITNEKDFDFQSFANNF
TLCFATQKIAKSQLIGLHILEKYYKKQAPTNPDYREQLAVLFTVPDAKLQEKAASLLKTY
FGGEGLVEVVVPYQDYLKGKALELFSTLSPTPIQNDNLSCQLTDCSPSEKSVRVGYVTEL
ETPTTPEALLFLLGDCLRERTPQTIDLFFEGFNQLQDDFPTDFKEQLAPYLKQLERHWNG
IASVPILRWFLQRWTGDKKKLIEEDETFFLTTLPYLYHKAQHLLKNRKKKNRLPFLSTPT
HAPFYIEVEVLMDRLLQYERQGENPDLHDLVVACNRLLFKDISAVAKEKAQQLKGAYAPT
IQYYIGLTDKVQPTEELLPLWTQITRIKYPDGEFVEFGNTSAKDIPCVVKPFETGFGVLT
RKQSTVTFHYLSIHDNWNNNFDARKKPTEYPVLYYNAGNSRKGWSTDILYQCSLNPHYPE
AQILRYIASYAKGNESYDIEYMQTSMQVLLENHLPIYHSGWLFVAAALLFEKKPTRDMAA
AYILECLESGTNLNLLAQYIGKLLAEQYAPIARFVEFLDIPTRDPKIKAFQKSVVEAYLP
LAEKLDKKPTNHKKLATFIN
>SEQF1602_00052 hypothetical protein
MKENLLSAIKAHDFTAIRNICFALSEEERNDLIHTLQTARWEQLYHNTDKRAPRLQSLDI
VCFSYIFLCVSRSSESLKKAVKGCYSSDKDIVAEFLQFYFPHLLDLLTTQEGQYLITTLQ
SLRKNHFLQDTTFQNLWTLYQKGFIAFDEDLFIEKFFFWNNKHITDEPFVDFLLENKQIS
EKIFAIVPQHITQEVPYPSEAWKELYSILQAKGYFADRSIVGSHIEALLNPYKKNILDFF
CRIIETFEPTRQELLSHQSTLFALLSSDKTSVVNFVMKLIKEIASEKGFDFQSFADNFAL
CFATQKIAKSQLIGLDILAKHYKKQPPTHIESREQLAVLFTVPDVKLQEKVASLLTTYFG
GEGLAEVVAPYQDYLKGKAQELLQSLPSPNSSETSETACAARTPKIAPAARTPHTWDDLL
FLIGDCIRERSPLALDLFFEGLNQLQAQIPADFSRQISPYQKQLGEQPFEFTTYRKCMRW
VIDVWEGKASLSDDIFGGKLYNPTPFLREKTKRLLLKLKQGNSLPFVSTPTHAPFYIDPL
TFLERIAQYEKTEKSPMLEDVVVGLNRLLPTEVTEEQKQLARSLTGNYAPALQYYFEVNK
QIAVTDATRVLWGQVLRLKDLDGVFPELEIPQKTNLQGLAHPFYLKYEVKPTKIKGVELN
KIILEDNWDKKYSAYSLYNDLGANYYNVSPMSRATDEDIDYGLSLNPRYIDGWLCKYLLT
YAQGVEGESLTEATRVMSLLLEHHLPIYHGGWLMVATCLLAERKPLRDLATEYILLALQR
GETLTYLAEAIGTLLAHKYAPIARFVEFLDLPTRDPKVKAFQKSVVEAYLPLAEKLEKKP
TNHKKLAAFSD
>SEQF1602_00053 hypothetical protein
MNDFEYAYPFASVIEEANAHEKNFIFSHCSELKEDNAVPCFFWGNITQPFVVAKCLATLA
KTVASQFAIAPGVLAKLRDPIISVGNGELLFEGFSSCNSVYARVGLRNDVLDGDFLQSGC
TNIDFNDVTVRAFNAVTASEKMILGIGQKQTHFITEKHKSVEKKVTLPNRWIKGLGNVQV
YLSEMDLAYRLNKAEAIQLFRSLPKQAVKNDYYLVKRGVGYTFAPTATAGAIKIGGVHRL
NLLQGLLLLADSLYVYRSSSEQSVAFVLHFKGVEMLFLLSDNVYRGFSGEGKYLENMIEE
VPMEWLVGINNFFKTNEVFSPTMVAIENDVNMGTMATLQASLSSIGLLGYNLTDSNYFYR
RLPFKPQRLISLNPRLQNAKKLTENNEVQIVEQRGDYVKANVKGTGGVTHTVILDGEKAQ
CTCNWYTNHQTNRGLCKHILATKMISQQLDN
>SEQF1602_00054 1-acyl-sn-glycerol-3-phosphate acyltransferase
MPKYLFWLLWRTWFYILVGTLIVLLLPVLLLLTTHKKWYRSLYWVMRYLWATPILYAMGF
LPKIKREYTVPNDHHSYMLVANHYSMMDIMLMLYCSKNPFVFVGKKELSKLPLFGYFYKR
VAIMVDRKSPQSRREVYTQAMERIGEGLSICIFPEGGVPDDESIVLDSFKDGAFRIAIEC
QIPIVPMVFYDTKKRFPFRFFSGSMGVMRVDVLPPVYTHGKTLQDKDTLREEVRSLILQR
LMG
>SEQF1602_00055 Di-/tripeptide transporter
MSETKKTYTQTLKSFSSTFWIGNFLQLTERWAYFSIFSLLALYLVAGTDEGGLGLTHTQK
GNIMAQITAILFLLPLFFGVIADRIGYKLSLLISCLIMGVGYYLMGTAVSYWDIYLAFLL
AAVGCSFFRPVVQGIIARHTTEENSTLGFGFFYMVGNIGGLLGPAMSSYLRTTMGWKVIF
VQAMVVIVFNLLVVVFFYKEPKAERKYNIPLLTEIKGSVQNIVGALKDKKLTILLLLMVG
FWTVFNQLFYTLPNFIEDWVDSSQQSDWINRNIPFFGSTFTEHGQIKAEWFGNIDCVMII
LTQMVISYFVMKMDQVSAMIRGTIVMTIGVTLTFMFKEVIFTVLGTAIFAIGEIAVGPTI
SAFIAKITPKGKEALYQGTYFLPMAVGSYLTGFFSGDLYDKWSDKHSLLKMELEKRAITL
PESLNKKQYFELAQEKLHLSATELSDLLWNTYHPNKFWYIIFGLGVLTAFSIFLFNRYLK
KSAH
>SEQF1602_00056 Multidrug resistance protein MdtH
MQENKPSFSQTIKSFSPTFWVANFLQIMERGAWFGIFSVLGLYLVASTDEGGLGLSHVEK
GNILANVTAIQFFLPLFFGVIADRIGYKISLIIAFVIIGVGYYLMGTVSSYWAVYLAFLF
AAIGGSLFKPVASGIIARTTDEQTNTMGFGLFYLMANIGGFFGPSFSSYLRTTMGWRIIF
LQGAIIIFINLLVVLFFYKEKKINREYNVPILQEIKGSFGNIIEALRDKKLSILLFLMVG
YWMVYNQLFYTLPNFIEDWVDSAPESAWINKYIPFLGTTLTEKGQIKAEWYGNIDCVMII
LFQVSISYMVMRIRQISALIRGTLIATLGVVLTFVFNNVWFTIIGTVIFAIGEMIAGPTL
YAYVAQITPKGKEALYQGTLFLPVAVANYLTGFVTGDLYQKWSDKYSLLKVELLQRQLSL
PEGLSKKQFFEQAEQQLHMSPAELTEFLWNTYQPNKLWFLVLAMGAFTIISVYIYNKMMI
KTKER
>SEQF1602_00057 hypothetical protein
MKKAQKILLFLTVTLLGEVLNAQSTDFIFYDQLKNINNPAAVGEEKGHTISLNLRSQWMQ
SLNADAPQVQTLNTTHRITNRIGLAGSVVSDKVFLQRQTAFFADFSYSLPLTESSTIYLG
LKAGGNLYYLDGTRFKTYNKEYDPYLQGISGKFQPNVGVGVYYTRPQFYIGVSAPNLLAS
DKTKLVEDRVTTVSERMLLYSTGGYYFPLTDDFTVKPSYLFYVSKGSQYQLSATASVIYR
GFLEAGATYRTTQAANGYILFNIPKFYLSVGYGFESTLQPKASASIRNIHELMVKFNW
>SEQF1602_00058 Alpha-agarase
MFTIKLRSLVLLLLLFSWPKLYAQSYWKENNTQRSTAQEKTYTYYTLERKAFEKALHNTS
ARSSQDYTYIDIPDGTSVKTYKVRRTAVLSPELAQRYPQIETYSGYALDNSDQLVSFTWS
PAGLSAIFQQDFSYTFVQPTDKRGKNHKVYQRSDVLESVHFDCTTQGAAKKTPTSSATQR
NSYESEHTLRTIRIAVAATSSFTQYFGGKIQTLAQIASTIQRANQVYRSQMSVQFQLVSG
EETLIEHRRDDNLSNYINQNWTGSQLQKFLDDRVGTANYDVGHLFHNTTNPNGNAGCIGC
VCDDNSKGKAFSAGNLGSMDIDRFDIDFFCHELGHQMGANHTHNLQNEGYGVQVEPGSGS
TIMGYAGITGNNDVQSRTDPYFNHISVRQIVDYIKKQSCPTTENVSNTPPQIADLPNYTI
PKGTAYVLDGTATDPDGDKLYYTWEQADNLGSITYDRFSPNIPRGPMARSLPPTESTQRY
IPRMSRILQGTLTERNPTRRSAWETVSNVKRKLTWAFVVMDKKVGARNDREHDRVTGNTS
YALMEINVASDAGPFKVTSDKNRAYWFVNKPHTITWDVADTDKGSVNTQKVSIYFSLDEG
ATFPIVLARNIPNNGSYTFTVPTSLATTQGRFMIRAEENIFLAVNLAPITVREDGDMDGD
GILDSQDNCVETPNADQKDTDLDGIGDVCDDDLDGDGVLNTYDNCPNTPNADQKDTDGDG
IGDVCDEDIDGDGVPNGRDNCPYKPNPDQKDSDGDGKGDICSGDRDNDKVLDEVDNCPDT
PNPDQVDTDGDGIGDACDEDIDGDGVLNAQDNCPKTSNPDQTDTDGDGVGDVCDEDMDND
GIPNSRDNCPYVANPDQVDTDGDGIGDVCDDDIDGDGVPNEKDNCPAKANPDQKDTDKDG
VGDVCDTDADGDGIADEEDNEFDIVLIPNAFTPNGDGINDSFYIQRISLYPQNTLQIFTR
QGQLIYQANGYKNQWQGIGTDGMKVPQGFYYYILTLKKAKETKEGWLYINY
>SEQF1602_00059 hypothetical protein
MRKIIICSVMLLSLTTTVQCTKQTTEEREVEQAGSAILRGETPPVDSVGKVGDYYINEKT
AEFYGPKKSAEEGGWGAPVRFGKDISSKARILSGTGMPKNTDGNEGDWYLDKETKKLYGP
KTKNQWGNGIVLGGNPNNGSNQDNDASLPNYRLGDEGKTLLAWTNPKTQVIDMRKDAKLN
QVEKLEIGAVSEQRALQKFVLGDQVGIIGASAFKNCFYLEEFVFNRKLTTIEETAFQYCL
YLETMELPEGLEVLGQQAFVSCVKLKKVVVPSTCKNIHGAAFEKCEALEEVVLKEGIENI
YTNAFQGCKTLRKVVFPASLKGLGAGIFKDSGVTEVTFKGNVPESGLGQGTGSPFEGVAT
LEKIYVPEQFIEDYKAQLSDYKNIIHPIK
>SEQF1602_00060 hypothetical protein
MGNLIKSIVISTLGLFTIAFISTSCNKETVEQLKVKKASRIYIGDGTPLLDKGEAGDYYI
DKLTGLLYGPKSEENGWGKNPIKLLDDKQLSGNTFVSGQGAPSADQGKIGDLYIDKQNLK
MYGPKSEQGWGNPYELGDRTPHTPKDEWPDYRLSKDGKTLLAWVNQRTIHIDMRTDSKLN
QVTTIAKEAFTPSYGLTSIIISDNVTKIEESAFSALPFLEVVTLPGSIKEIVRGLFNQCP
RLRVINLNEGIQSIGDFSLSDASFEEINLPSSVRKIGGYAFANNEKLLKIKLREGLKEIG
SSAFAHCTELTHFEIPASVERIGEGAFSDCHNVNTLVLHSKEIPKWPNYHLADFEELVDI
YVPDESVTLYKNDPEWEPDWGKIKPISKMPKQ
>SEQF1602_00061 hypothetical protein
MKKVFLASLAIFTAILILNCSKEESKNNASLKPFELTPTEVKVPIGETTTLTISSGNGSY
RINQSTESKEIVEITLNNENQNILIKALKSGTTTASVTDLLSKTDLTISIQAIIPPSYYT
LSEDKKTLLKWNDTHLEELDLSSDPILKEITSIGQGAFKENSTLKKITLHEKIVFLSKES
FAKVSKLETIKLPNSITSIGEGAFAGCTALKEVTLPENDSFTSIPKRAFEECKSLSTLHL
PNTINEIGILAFADAGLKEIHFPENLLTINQQAFAGNKELTEITIPKNVTLISLAAFQET
ALKTIKIEATLPPALKFGIDSQTQQAIEPFPSSTLQNIFVPEHVTQTYRDKEGWHNYATI
INKNREFKHLIIRPTEVTLFVEEVKQLEIVSGNDDYDLERSESSKEIAFIGITNNQKILG
IRGKKVGAFKATIVDKITKEKVEISITVLNSFTLSPKQLTLTVGQSKEVIIDGNGDYEIP
TNTHVTLSLSGDKKKLIVKGLQEGDTQVVIKDKKANLSATLSIKVMAAAPSIKEFSLSAS
QLTLKMNEEKRVILQGNEDYEIGNCQIAQLTLSDDKKTLTVKAVKAGEETIKIKDKKANK
ELPLHIAVLRPFSINPSTLNIKVGQTQSIAIEGGGRYQISQNSLVEVVSQSEHLITFKGK
TVGSGSISIKDERANKTLELTVKVTQALVPFHISPSTIHVKVGETKTVTITGNGKYELSK
TSSPYVELTLNQAGTLTIKGKAKGEETLYVRDLNSVSEEKDKNDDKDHDSEDNEEAKNYE
SRKLTITILPATMEKQFEADGYTLNKWLDMSTEEVDFTQIPALKNIGMIGEGAFKGLTQL
KKIVLPSSLEYIDSDAFAHCSLLESVKLQGNNLDEIARGAFSDCRNLRRLDIPSSVRKIN
GEAFNGCTSLRTIILRHTSVCSLHMAMGYIENLVAIYVPDSLVESYKNDMDWELYKNKIK
PISELTNRKIRK
>SEQF1602_00062 hypothetical protein
MKKIYILPLLSLLLFACQKENSQGKENPGKPTPEKPQPTPIPPTPPTKEKTPEELLEGEW
RLLSIKDSNDPLERELSNCKRQSSITFSKEYKASEVSYYLDKELGECKHNSHQYTVSIQK
DQLTLTEGTQKETYTYQIQENILTLSFPLKQKDGKTITVTTTYKKHYLYNPKKELVGTWY
IHHLKRAGYDYNDILENGQCMTKEKIIFTDTDIKIYQYDLGSLQCKEVIYQGAYEISEDL
SKIIVTSKRNGFKGNREFFLNDGTLELFGYIANGDLEQKFYRKEKKYTDE
>SEQF1602_00063 Colicin I receptor
MSNRIFFTLFFSLFPYILLSQEEKDKMYSLDSVVVSAQIEPQSIKKSVKNVQVISKEQIQ
KMGAVNLADVLNQYVNITVLPNVNTGKQTVSMMGLGENYFKVLVDNIPLVSENGFGNNTD
LSQVNLDDVERIEIVEGAMGVTHGANAVTGILNIITKKSNKHRWEVGYTIQEESIGSEYN
LSNKGRHIQTFKASHSLNDSWFFSLGSTHNKYQGFWNGYHGKNYFQTDGKRGYRTSPYES
LQSNALLSYRKDKLKLLYKFEYMNERFEAYDRTAESTFSPLYRSYHFGDDRRDFYLRYFH
HLNLNGALSKWLYNVSFSYQYQERKEEEFRYMIEYQKEINNKERKTHSMRVFYSTGSVSR
PLAHKKLLWQMGYELTRNTGFSLITDQGQTLKEVERQVDNYDLYSVLEWHLSDHFSLRPG
GRVSFQRLFQNQYAYSLGSRWTLDNHWEWRASVGKSYRTPSFEELYTKSVFLGHAFLGNE
NLLPEKGLSAETSIKKTSLIREEGVLTQSLGLDYNNIKDKIHSVLLDMTNGMPHTQYINI
SKYTSYNLSTSHSLKLSAWEASLRGAFTWISQKIDTERYRTDDRYLLNINANASLSYTVE
KWNTSFSAYYKFVGKSQMWQMSSTGYVIADLDPYGWLDVSIQKRCFQRKLEITLGSRNVL
NTMDVGLYQKTMAGEKVRLNFPMGNGRNYFLKLTYNLNIN
>SEQF1602_00064 hypothetical protein
MRKYFLMLSLIGGLLVNCSKADETEKKPLPPTPSPAPTPSPEKNLIEAGKAYTLLPEVGG
ANEPNQVYVDLSSGKMTSIRRDAWDLAFYCGDDFRVILNPSIAMTVKETPFTDIHKFVAP
VSEILFDDDPKLPSRKPIADHLIDDPRGILQEEAGLKGTGTAIAQISEKEEENKVYLLNL
GNEISTTTPETGGINLQGAHRGFMKIRVKRSGNGYEISYAKNDELKDIKTVTISKNADYN
FVFLNLSTGKTVQVQPKKKDWDLCFTPSTSWFSTEKEKIGSPFNSTTFFPDMIISNLHGQ
TKATIFQSSDKSEEKRNVEYSAYTKEKALKINFSLEKYNNQMIIGRNWRDNQLGALIRNE
LFYLIKDGDGNYFKLKILSMKNDKGERGYPAFEYELLK
>SEQF1602_00065 hypothetical protein
MKRILVIYYTQSGQLKEIADNFVAPFQKQGILVDFYEIQMETPYPFPWTNESFFGAFPES
FLELPQPIKAMPPDIETQEYDLVVLAYQVWYLSPSIPVTSFLKSEQARALLEGKPVVTLS
GTRNMWIKAQEKVRSMLVKKGACIVANIALTDRHYNHISVLTIVHWLFTGKKDKYLGVFP
LPGVSQKDITNATQYGELVLNHSQKGEYQQSLQKEIVAQGGVQVKPFLLSAEKKANRLFR
IWARAIYQSPRRKFLLKCFHAYLYFAIWILMPIVWLFYWLTYPLFYKKIRRDCKEVAERC
>SEQF1602_00066 Phosphoribosylformylglycinamidine synthase
MLLFFKNPKNTIYVVATEAALTETDLNKLKWLFGNAEQLDQQTLQGTFIGPRAAMITPWS
TNAVEITQNMDIHGITRIEEFREVAEPNTPFDPMLFERYNGLTQDSFTIDIQPQTTLEID
DIEAYNQQEGLALSAEEVAYLENLSKQLGRKLTDSEVFGFSQINSEHCRHKIFNGTFVID
GEEKPSTLFKLIKKTSQEHPNSIVSAYKDNVAFIQGATVDQFAPKSADKPDFYEVKPFEA
VLSLKAETHNFPTTVEPFNGAATGSGGEIRDRLAGGQGSLPLAGTAVYMTAYPRLEEDRP
WEKGMAERKWLYQTPMDILIKASNGASDFGNKFGQPLITGSLFTFEHEEGGRKLGFDKVI
MRAGGVGYAKASQAIKHTPKEGDKIVILGGENYRIGMGGAAVSSANTGAFGAGIELNAVQ
RSNPEMQKRTANAIRAMVESDENPIVSIHDHGAGGHLNCLSELIEETGGKIDLDKLPVGD
PTLSDKEIIGNESQERMGLVLPEKAIAKLKTIADRERAPMYEVGVVTSDKHFSIASAKKG
THPMDLDLSALFGSSPKTVMTDETVITNYQELHYYASQLQNYLVQVLQLESVACKDWLTN
KVDRCVGGKVAKQQCAGALQLPLNNVGVMALDYNGKEGIATSIGHSPLTALISPTAGSRN
AIAEALTNIVWAPLKDGLQSVSLSANWMWACRNKGEDARLYEAVEAASNFAIELGINIPT
GKDSLSMKQKYPEGGDVIAPGTVIISAAAHCNEVQKVVEPVLKRNGGNIYYINFSGAHFE
LGGSAFAQVLNKIGDKAPTVTDAEGFKTAFNVVQSLIKEGKIQAGHDIGSGGLITTLLEM
CFAENDLGATIDLSGLSADEDLVKTLFAENAGVVIQADSSIEAILEAHFLEWANIGEVTT
SQELTIHHFGRDYHFNIPELRDVWYLTSYLLDKQQTQNDKATERYQNYSEQPLQYTFPAH
FTGEKPARPAGKRPVAAVIREKGSNSEREMANALYLAGFDVKDVHTTDLISGRETLEDVQ
FIGAVGGFSNSDVLGSAKGWAGALLYNEQAKKALDNFFARPDTLSVGICNGCQLFMELEV
INPEHTEHGKMWHNDSGKHESGFVSVTIPENNSVMLSTLAGSTLGVWISNGEGKFHLPLA
ETEYNIVGKYAYQEYPANPNGSDYNTAMLCDKSGRHLVTMPHIERSLFPWQWAYYPSEKT
AVSPWLEAFINAREWIEARNAEK
>SEQF1602_00067 hypothetical protein
MKATFLLPIIAVSFAACNNATPNQSENTTETPEVTQEVPVVGGDRDEHGCIGSAGYTWSV
LRGECIQVFEVGTRLNPVDVKEEEAVISAFIVSKEGDNSQVELFITNENQNPILKHEADG
TYKGGKYLYNPKKQELSIDGRVTYTAKN
>SEQF1602_00068 3-deoxy-D-manno-octulosonic acid transferase
MNILYTLITRLVACALPLLSLFSKKIKLFYRGRKESFHILETHIQEDDQVIWLHAASLGE
YEQGLPIIKKLKEVFPEKKIAVTFFSPSGYEAKKHSKDADVILYLPMDIPKKVNRFLDLL
HPQMAIFIKYEFWQNYLFALKNRHIPTYLVSGVFRKDQLFFKKRSYGMRAVLPCFTYFFV
QNENAKLLLQSIGFTNVMVSGDTRFDRVMEILSRDNKLSFVEEFLSGAPCMVFGSSWKAD
EDVYIPFLNSYKGNMKFIIAPHEVGNKDKILSLKERIHKYVGILSEVDKQKLPSYEVLIV
DKIGLLTKIYSYASIAYVGGGMGKKGLHNILEPAVFSIPVVIGKNYEKFNEAKDLIEREG
VFSIKDTDEFTKIASFLFTNVIQRKKAGVLNYNYIISNTGATNAFVDFVNK
>SEQF1602_00069 hypothetical protein
MAKKTVATLQGKSKRLTKVIKMVKSPKTGAYTFVEGVMAPELAEEFLKKK
>SEQF1602_00070 50S ribosomal protein L33
MAKKGNRIQVILECTEHKDSGMPGTSRYITTKNKKNTPDRLELKKYNPILKKVTVHKEIK
>SEQF1602_00071 50S ribosomal protein L28
MAQVCELTGKKAMGGNNVSHAMNKTKRKFKVNLTTKRFYIPEEDRWITLRVSTNAIKTIN
KKGISAVLKEAKKQGFIK
>SEQF1602_00072 Lipoprotein-releasing system ATP-binding protein LolD
MIKATNIHKKFGQVDVLKGVDIQVDKAQVVSIVGASGAGKTTLLHILGTLDTMTKQEGSS
LLINDIDVTKLSAKKLAQFRNEQIGFIFQFHQLLPEFTAIENVCIPAFIKGLSKRQAEAR
AKELLGYLGLSHRITHKPQALSGGEQQRVAVARALINQPSVIFADEPSGNLDSESAQQLH
QLFFDLRDTFSQTFVIVTHNTELAQMADKVFTMQDGRIKSEE
>SEQF1602_00073 Membrane-bound lytic murein transglycosylase D
MKKVCSICQEVFSGIGVAAVALLLINAVAAPTEVAVPTLSEDDPLMLAASGERDTLPTYQ
IKAWDLPKKMDFAGESVPLQISDVRERLDRELLVNVYWQSNGLLLIKRAHKFFPIIEPIL
AKYDVPNDFKYLALIESGLQNVVSPSGAAGFWQFMKGTAKEYNLEMENTVDERYHLEKAT
EAACLYLKKAKEEMGSWTLAAASYNAGKSGIRTQLNKQQVNDYYDLHLNNETSRYVFRIL
ALKEIMKNPKKYGFIYKKSQLYDLEPVQYVTVDSTITNLANFAKLYKTNYKTIRLLNPWI
RDFTLENKTGKTYVIKVPKQ
>SEQF1602_00074 hypothetical protein
MNKLFFLGAFLLLASTQAFAKVGIPIGSREVLEKVHDLPDTDEYKNGSTYVDIGRLHKEF
NVAYFLPLWIQEEPKLVLIEANNKDAYYDIKKEDMDAILKENNLDGEKLNKLDFYTRYGG
KLVAVAIIGVLVWSGLSRKGKNED
>SEQF1602_00075 Phosphoribosylformylglycinamidine cyclo-ligase
MDSRYTMRGVSATKEEVHNAIKNIDKGLFPKAFCKIIPDDLTGDENYCLVMHADGAGTKS
ALAYMYWKATGDLSVWKGIAQDALIMNIDDLICVGAVDHIMLSSTIGRNKNLIPQEVIST
IINGTEELIAELKTFGINIHSTGGETADVGDLVRTIIVDSTVIARMNRREVIDNANIREG
NVIVGLASYGQATYEKEYNGGMGSNGLTSARHDVFAKDLAHQFPESFDPSVPNELVYAGS
KQLTDRVTNSPLDAGKLVLSPTRTYAPIIKEILRHYNNTQICGMVHCSGGAQTKILHFID
NLHIVKDNLFPVPPLFQLIQKESNTGWKEMYQVFNCGHRMELYVPEKVATDIIAISESFG
VPAQVIGHVENSDKKRLTIKSEYGTFEYC
>SEQF1602_00076 DNA translocase SpoIIIE
MSKTKSTPAKKETKKNSTSFLERKVSIGVVLLFVCFILCVSFISFIFSWQADQSILSELA
DRNIQSQNIFNKVGAYIGNLFIYKGFGIAVFIPLAILSLTALKLILSTKTKLLNKWFWGI
LWMLFISISLGFFSSDATILSGIGGYEINAYLRDYIGRLGTALLLLLILCLYLIGKLHLT
PEKIKNSFSSGELWLKNKKTIWKSSEKITKEDDKTAEKPSDLPEEEIFTMPSTEREEERK
EEENNAIDIYTHRKDIPLLYDQEESQDTTIEDKEFKVEIKQEEMVNPEDVARRLVEDFGE
YDPTLELKSYQFPPIDLLKEYKEAGVVRNDEELEENKNTIIQTLRDYKIEISRITAVIGP
TVTLYEITPAPGVRISKIKSLEDDIALSLAALGIRIIAPIPGKGTVGIEVPNKNAAMVPM
RSVISSVNFQKAEMELPIAFGKTISNETFVVDLAKMPHMLMAGATGQGKSVGLNAVLTSL
LYKKHPAEVKFVLVDPKKVELTLYNKIERHFLAKLPDNEEAIITDTTKVVNTLNSLCIEM
DNRYTLLKNAMVRNIKEYNAKFKARQLNPNDGHQFLPYIVLVVDEFADLIMTAGKEVELP
IARLAQLARAVGIHLIIATQRPSVNVITGLIKANFPARVAFKVSQSIDSKTILDGPGAQR
LIGKGDMLYTQGNDLIRIQCAFVDTPEVERIANFIGSQRGYPDAFLLPEYVGEEGGGSSP
EVDMSKKDSLLREAAEVIISAQQGSTSLLQRKLEIGHARAGRIMDQLEVLGVVGPFKGSK
PREIFFADTMSLQEFLDEKGI
>SEQF1602_00077 UDP-N-acetyl-D-glucosamine 6-dehydrogenase
MNTIKIAVIGLGYVGLPLARLFATRYPVVGYDKKQSRVDSLKKGEDITLEIDSSLLQEVL
SEKNPTTTEGEKGLFCTDNSDELKDCNYFIITVPTPVDIHHRPLLTPLYSASEVAGKYLK
KGDIVIYESTVYPGCTEEECVPILEQVSGLKYNEDFFVGYSPERINPGDKLHTVAHILKI
TSGSTPEVAQKIDALYQSVLEAGTHLAPTIKVAEAAKVIENSQRDINIAFVNELAKICNL
LEIDVRAVLEAAGTKWNFLRFSPGLVGGHCTGVDPYYLAQKAQEVGYHPEIILAGRRMND
SMGKYVADQVIKLMIARNITIHKAHILVLGITFKENCPDVRNTKVTDVVRQLESFHTQVT
VYDPWANPKEVWEEHQIHSVTTLPIEKYDAIVLAVAHKEFLDLPWKELRKTHSILYDVKG
ILPEADGHL
>SEQF1602_00078 Cytidylate kinase
MKKIIIAIDGYSSTGKSTTAKLVANALQYVYIDTGAMYRAVTYLALQQKFLSSSEEGKEK
QSIDEQGLLRALEQSAISFRYNSQRGASELYLNGENIEKEIRSMTVATYVSEVAKIPQVR
AYLVNLQRQMGEQKGIVMDGRDIGTVVFPEAELKIFMTASEQIRAQRRFEELQQKGEQAS
YEQVLKNIQERDYQDTHRTESPLQKADDAIEIDNSDTTVIEVVSQIVQLAQEKIKA
>SEQF1602_00079 hypothetical protein
MEQFLNGYVEELFSNISGTISVSLVSTLDGSILAYKARLGVDNRLASSYQVEIFRNAVLS
FENTEGLADKSVDDVCLVYEGQTHLIGLLQSRKILHHIILDDTANIGMAKLLIRKIRTEA
EAKSF
>SEQF1602_00080 hypothetical protein
MILEEFKKYADQMGAQLSGILSVSFIGTEHGEVLYNQSFSGLDYTATAKFEAEIAKNALQ
EIKYIDNIHEDSLREITISNSQQIHVIYVSKDFDYLIHLITDAKKVNYGILSIIHKKCYE
AMTKVVTFDSVQTELYPKITQEAPKKESHFRKLFFS
>SEQF1602_00081 hypothetical protein
MKKGLFSFFVLLAITAHAQYTDIINSNKPGRSMGAYSVGQKVAQAEADVYYETNKHEALN
LSQENIGLNYMVRYGVWRNEFEIIGDGTFLYSNRTADGLSSSKLGFQRNTIGAKYLFYDP
VFLSKSNVYSWKANADFSWRKMIPAISLYLGFNILEKNRYLYELNNEDYKIITPKAIIAL
QSHPLNEVALVLNLVGNNMASKHAQYSYIFTLTHNLYDDRWSIFLESEGITSDYYKDSLL
RMGASYLIDENFQINASIGASWKTTPTRYLGGVGVSYRFYDRYRDIEYIEKKKARDKQNK
EDAQIFGF
>SEQF1602_00082 Outer membrane porin F
MLLLFPFSTIFAQVDDKQKEENEKKAQKANELYSKYAYVDAIKIYERIAEQGYVDQTILQ
NLGNSYYFNADYTNALKWYDQLFKNAQKDNYTLTPEYYYRYAQTLKSAERYQEATAILQQ
FMKLTGREDIRARKLEENTDYLKVIKDNSGRLTIKPVDINTEYSEYGTAFYGPDAVVFTA
SRKPSLFREASKWTGEGYYDLFKTSLKDGNLHGEERFSSVLNTSLNESSPIFTKSLDTIY
FTRNYLVPLTKEEKKKKNRDEKILLELYRSVKKGDNTWAEPVRLPFNVTGYSVAHPALTP
DGKYLYFAADIVGTHGKSDIFRVKINHDKGTYGKPENLGEIINTEGRETFPFISQNNVLF
FASDGLPGLGGLDIFAVKINQDGSLKGLQNIGRPGNTPDDDFAFILDEQKSMGFLSSNRP
GGKGKDDIYSFIQNRPLEFDCYKVIKGVVKDADTHETLSDVLLTLSDSQQKEITRKTNEA
NGTFDFGKNPVDCDDTFVFVRAQKEDYAVAEEQINIRQNGEIHQEIFLKSIKKKVTVGDD
LAKFFNIEIIYFDFDKSNIRPDAAVDLAKIVEVMKEHPTIKIAIKSHTDSRGSDAYNLAL
SDRRAKSTLEWMVQQGIDRSRLTAKGYGETQLVNGCSNGVPCSEEEHQKNRRSEFIITEM
>SEQF1602_00083 hypothetical protein
MDGAPKTASLSIHTPIEGKHVGLGGAIYHESIGPQSTNMIDVDFSYTLEFEESKLAFGLK
AAGAFYRFDRSKMNLVDADDYAFQGKETSFLPNIGAGLYYYGEKYYVGFSIPYLLDTKTF
SRSDERKIISDINEKPHYNIMGGYVFDLSENTKFKPAALMKIVSGSPLQLDLSGNFLFNE
RFVLGAAWRWSAAVSAMAGFQIDRNWFVGYAYDWETTELRKYNSGSHEIFLRYEFYRDIK
KIISPRFF
>SEQF1602_00084 hypothetical protein
MLKKGTQLIVLFVLILFADQAKAQQDSQYTQYMYNTMMVNPAYTGS
>SEQF1602_00085 Di-/tripeptide transporter
MNTEKKGHPAGLYLVFFTGMWERFSYYAMRGILVLYLTATWLNGGLGYDEKFSTTLYGIA
TGLCYFTPLFGGWLSDRYLGQRKSILIGGFIIVLALFVLFVPELFTSTASTLSAEDIQSN
QLIGRIGLYGGLFLLVIGNGFFKPNISSIVGDLYEPGDKRLDSAFSIFYMGINLGSVLAP
LIVGLLADNIFATTYTDANGVVQITHGYRYGFLAASIGALLGQLLFVFLSNKYLGDIGIK
PKNANVHSLEAGEKQEEKTPLTRVEKERIAVIFIFFFFAVFFFAGMEQAGASFNLYANKY
IDRNVFGFEVPTAWLQMVNPFFVILLAPVFAYFWNTRLGQALNTPLKMGFGLIVLGIGFW
FMLIAGFQRGAVWEGGLNIVDNSNEMVKASMIWMILTYLMHTIGELSLSPVGLSIVTKLS
PARFASLFMGVWIMAAAFANMLAGLISSYVVELGASTVFASISTFVLILGILMVSLNRLI
ERMMHGIR
>SEQF1602_00086 Prolyl tripeptidyl peptidase
MRTKMNYFWLFLLAISLNVSAQNKQITLKDIWIDYAFYPKGMTNLSALKNTNQYTVLNYD
YTNLNYTIDLYNFSTLEKEKTLFDTKKFPQIKRINSYTFNKQEDKILIATNKEPIFRRSF
SADFYVFDLKKQELAKLTDKKIQEPLFSPQGDKVAYVYKNNIYIYDTQSKKEQQVTFDGE
KNKIINGTSDWVYEEEFAIVRTFDWNADGTQLAYIRFDEHEVPEFSMDIYGTTLYPTKDT
FKYPKAGEKNSVVSLYLYDVKAGKPTQIPLDAYYIPRLQWTKEANILSVQTLNRHQNDFN
IIFVDASTKKFKSVYHEVDKAYVSITDDLTFLDDNSFIISSEKDGNNHLYHYDKNGKLIK
QITQGKWEVTEYYGYNPKAKQIYYQSTEPGSINRGIYSIALSGKNKKGLATTEGTNEATF
SPDFSLFINEYSSAQKPNFYTLNDSKTGKVVKEILNNKELEDKIATYNTGKKEFFELTTK
NGDKLNAWMIKPSDFNENKKYPLLMFQYSGPGSQQVHNSFSGFDTFWYYMLAQKGYIVLC
VDGRGTGYKGAAFKKCTYKQLGKYELEDQVEAAKIVGNYKYIDKDRIGIWGWSFGGFMAS
NCILRGEVFKMSIAVAPVTNWRFYDTVYTERYMQTPQENPEGYDNNSPLTYAKNLNKKFL
LVHGTADDNVHVQNSMRLIESFVQYDKQFEWAIYPDKNHGIYGGNTRHHLYEKLTNFVLN
NL
>SEQF1602_00087 hypothetical protein
MTSFFRGIKYFFEQYAFAPYDYLRKLELSSWWGANIATWIMLVVLFGFFFYWVKQLVKFS
KEGTERMDVTAHSFFK
>SEQF1602_00088 Fe(3+) ions import ATP-binding protein FbpC 2
MLIVENLSYTYTDTQVLENIHFTLSQGEVLSIVGASGSGKSTLLKALYGLFDLSQGKIFW
KGTPVLGPSHNLVPGFPKMKYLAQDFGLMPYMTVEENVGKFLSNLDLPKKRARVAELLEM
TLMQDYAKVKPLFLSGGQKQRVGLAQALAQAPELLLLDEPFSQTDSFLKNRIRQNLFTFL
KDHKITTLIATHESQEALGFSDRIMIIKDGKQLLIDTPEKVYYSQNEYIATLFDEVNKVQ
VEGKEHLYYPHQIHIVNQSPWQTEVENCFFQGGDYLILCRSDKQLFYIKHNEKIEKGKKV
FLKVGK
>SEQF1602_00089 Lipoteichoic acid synthase 2
MKALLSRLKPFLYVGGLYIVISFVLRIIFMGHPITTTSFSLGQVLGMLLVGSFNDIFITI
LALSILVIYFLFIANVKYQKPYGYIILGAMLLLLCYIQFVPNNIFYQYGGSVEEIALFFF
GAKTLCFAAMLFAGKWRRQVRQVLYFITLFIYTFAIVMNAVSEYFFWNEFGIWYNFIAVD
YLIYTTEVIGNIMESYPVVPLFSGVFVVVLALTIFLYKKTKSTLETIPNLKEKGLFLGGY
VVLFLLSLWVTPKFDNIKSNNVFVQEIRANGVYKFYYAFTHSELDFFQFYPTLPEEEARS
TFFSNFMIPYPGFGECGFRNFAPIRELPYPVEGEDDEQHKNVVLISVESLSAEFMAAYGN
TEGITPFLDSLAQKSIFLTNLYATGNRTVRGLEALTLCVPPTPGESIVKRKDNKNKFTTG
SVFKSKGYSVKYLYGGYSYFDNMKDFFGGNGYDIIDRDNFTPEEITFANIWGVSDEDMAR
KAIKEMNAQAKTGKPFFNHWMTVSNHRPFTYPEGRIDIPGTAKSRQGGVKYTDYALKLFF
ELAKKESWFKDTVFVIVADHCASSAGRTELPLDRYRIPCLIYADFLEAEQIDKLASQIDV
MPTVMELLNFSYESKFLGQDIFSRFYKPRAYIATYRELGYLTPDTLSIIKPLREQIQYKI
VPEAEQPKVELPIFYQQLKVAQPDGKLMKKCISAYETTYFLLKNGELDK
>SEQF1602_00090 hypothetical protein
MALELSTFIPIIKELVYHISIDDYASIERKGQNGDILVEDLAEVIHWYPYKIIPLPDEAF
DLAESCFIEEKKSLDVYIPFWTKEEGRSDLMLALSCYMNDGAEEVVIYDVFVP
>SEQF1602_00091 hypothetical protein
MIDVEPFIKEVLEKKIPEENLRFFGEDNEGIVVDFETETHLKRFTVWRNYLRCDYEALCI
ATDKLSVYESKEFDNMSQLISIFNRFYHTAYSEVDTFINQLYEDYRARLTDREEIANIIR
EDHYSKYKGDNYPYEKYLSLLWKEEYLNEKDIDLLDLCLFYQYIGEEIEVLGYWVTGHGG
GTYEEFEATKGTLEVLKPKMQAFVNRCYERYEEVMQEYIEAPERFKKK
>SEQF1602_00092 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase
MPIIREIRGKAPIIGKNVFIAETAVLIGEVTLGEDCSIWYNAVLRGDVNAIVIGNKVNIQ
DNVMVHCTYQKTSTTIGNNVSIGHNAIIHGCTLKDNVLIGMGAIVLDGCVVESNSIVAAG
AVVTKGTHIGAGEVWAGIPAKKIKDISPELTEGEINRIANAYVKYAQWYQESEK
>SEQF1602_00093 UvrABC system protein A
MKEEQILIKGAKLHNLKNISVAIPKGKLVVVTGLSGSGKSTLAFDTLYAEGQRRYVESLS
SYARQFLGRLDKPKVDFIENISPAIAIEQKVNTSNPRSTVGTSTEVYDYLKLLFARVGHT
FSPISGREVKKDTVSDVVDFILSFPDEHKLLLLSPITLSAGRTYEQTLRLLEEQGYARIK
YQGKVERLSDLDFKKVKGDFSLVVERIVVDHEEETTQRLADSVSTAFFEGKGVCFVEDLT
TGEVHHFSNQFEADGITFLEPNVHLFSFNNPYGACPVCEGYGDTIGLDETLIVPNTSLSV
YDNAIYPWRGETMSWFRDQLVNNAYKFDFPIHRPWYELTEAQKQLVWDGNEYFTGLTAFF
QELEEKNYKIQNRVMLARYRGKTTCYACGGKRLRPETNYVRVGGKSISDLVSMPISDLVV
FFDNLSLNTYEQKVAERLLREIHNRLHYLLDVGLGYLTLNRKSNSLSGGESQRINLATSL
GSSLVGSMYILDEPSIGLHPKDTERLIHVLESLRDLGNTVIVVEHDEDIMKAADYIIDIG
PEAGTLGGEVVATGTYEEILKAPTLTGEYLSGRRTIEMPKKARTSKHFIEIKGARANNLK
NIDVTFPLDMLTVVTGVSGSGKSTLVKNILYPALLRKLDQPTDKIGEYSSMDGKFSYIKR
VEFVDQNPIGKSTRSNPVTYIKAYDDIRQLFASQKLAKMRGYTAKHFSFNTEGGRCETCK
GEGEVTIEMQFMADVHLTCEACDGKRFKPEILEVTFQGKNIHDLLETTIDDAVAFFTQHK
QEKIAQKLLPLQEVGLGYVTLGQPSSTLSGGEAQRIKLASFLVKSYQETPTLFIFDEPTT
GLHFHDIGKLLRSFNALIERGHSIIVIEHNVEVIRRADYIIDLGREGGAQGGNLIATGTP
EEIRKNKNSYTGQYI
>SEQF1602_00094 5-formyltetrahydrofolate cyclo-ligase
MNKKALRSLYRQKRAAIPPEQQALLSQQIAQQALRLPIWDKQVFHSFLSIISFGEVDTSY
LIHLLQEHEKTLVVSRTLMETVRMEHFLYDPTQIDTNNKWHIPEPQGGIPIKSEEIEVVF
VPLLAYDTKGNRVGYGKGFYDNFLEECKADTLKIGLSFFPAEPHIEDVREGDIPLDYVVT
PEGVFKF
>SEQF1602_00095 hypothetical protein
MKKHLLEGKVIGLPLKEHLFLTGLVTRQNKDILLGYFFRQTYRNLPTITEWKPSEVCLIC
LFSALGIKNKEWEIIGDFPMWNRQEWEVPTFKLRDPINESVCYAIVHDDDIISSKRYCIT
EEEAEKYYSDGIYGYKAVEAVLSNKIDLMIH
>SEQF1602_00096 hypothetical protein
MKEIELFKHIKDRLGLFVPNSSYDNYVSLIIGYDLAKEHTLLKGFNEWLASKYKLPPNFV
FSQQIKYYLFEKEFAKTLTKEDEILLINCLYEKLVEFCLDKALFDSSIPKN
>SEQF1602_00097 hypothetical protein
MSKIDTFTVEKFIDRLEKFVKPNLPTNELISYVTAIIKDARELISFGKKRLALDILLENL
IEEKIIIDKKTLSLLATIEDEEIRSSISYLYSLSDKG
>SEQF1602_00098 hypothetical protein
MNNIIKKGIIFILVFIPTLICAQDKLYNQQKDIVLSKEELQLLLQKVAEAKLRKIRGEKL
ANLHKSQQKKALSNIYESNEVKNFYYLAQNADSAYTDIEQVNRKLDILLAYMMKKDSVSV
IHLTDTVKYVANSNLNRAKYAANNPNAARYVAGNAPNSAKYVAKSSPNAVKPVANNSNKD
ISLQKQLDMIDKSIKDLSNQQKLLAAAVVPLATLNNKDKLDKIQQRTDSILLLSKKQMDH
NNVQDQKESSIAVQNVKTPEHKGDNLVISEERRRTLEDLLAKYGNKKTPIYFANNAYVPL
PHDTEAMDQIVAMLRDNPELSILLEGYASNVGTAEYNNQLSMKRSESVARLLQKQGISLQ
RILTAFRGIDDSVDKEKARRVDISVIIR
>SEQF1602_00099 hypothetical protein
MKRKIFTSFFAITLGFNAVAQVKDISFAIAPTAEYVLWNKKSAIENGFMVGGYVGFGFGK
NLELLGSYSQSLGLKSRIDGFSAPDNIKAVFTPTDVNVHSWGGELKGNIPMTYSFQPYIT
LGSGIQTVKANQTTQDAIYFAFGLGSKFNLTRRLTLNVQARGTHFNSDASNILHNPSEAK
TSTYNQWITDNVSNKNMLNWSLQAGLQLYLGGRNPDELTELDNSYTNLKNFKVVVAPAIG
YIDFDSDNNFRNTYLAGASLGFDFTEYIGVRGFYYQAMKDEKVSLDFDKLSLYGADFLAR
LNVSNGVVPYITVGAGYLNVGNGYQGKVATVENKSSIFAKGGIGLAIPLSKHLELFGVAN
LLYTTGNESASNALKSPNKLQSNVFYNAGIRIKFAKENEKYTYQDLANEIHTSEIKEGKE
QVKVQNNTKTTPISQKQKDIDYYNAQIATVEKQIQLAYRQNDINNASLLLKEKEKWEKLR
NNYVAEHIPYPSENQTNLVRMTPEQLQTLISEIVNKIEEGEGKTPDQRIDRLEKLLLEIN
KDNQKIEEQQKINQSILDSVKNLEENIQKTNVVVPVRKKTTTTINRSK
>SEQF1602_00100 hypothetical protein
MLLDDLKKRSGNCCELCGSTASLSIYQVPPSKVGGVDDSLLACETCISQINNPETMDSNH
WRCLNDSMWSEYLPVKVVAWRMLNRLKGEGWSLDLLNMLYLTDKELAFAQALNDHLEEGE
KIIHKDSNGAVLSAGDNVVLIKDLKVKGSSMVAKQGTVVRKIALDPENSQYIEGKVEGQQ
IVILTQYVKKTT
>SEQF1602_00101 hypothetical protein
MSKQVELIELYTADLKEKCGVAEPDVELLTKVTKGLGPSIYNNDASKVSGSDQKELDLVK
NNFLIKKLGLKDSPELDTAINTVLEQYGKSNKNKYRAVVYYLLTKHFKKESVYNN
>SEQF1602_00102 hypothetical protein
MKRIILCLLPLLIVGCQSQQKEKKEEKKEAKSVYIKNYTYPELSKEAAENIRNWYELKTI
YQILLSISPERQAVSILQNTNPDSLYVYKRLYPNTNENIHINGNIQQDWGIIESPSDTIY
KFVKQKAEESALFAWQEILLKDIPYTFSLRVRPSSGIKHIQLEITRQKDKKAIREQALRL
DSLSLNTLEPYTKVTPLEDGWVKVDMQVETPLYGEYTFGFAYQDKEVANDYVSFYRSELL
LPIKYQEEIEKSAEKLLGKEKNIKSSYNSIYFWLFQLEDELRQLWAKNNFPEKLQRDEIK
ARLKLFETYVRNLSSEVKENPNLNKEEVQQGILNIRNAFASVLRYINFLNEENLDDKLGT
LLRSPDTLTITPAKPTPSQE
>SEQF1602_00103 DNA repair protein RecO
MIRTKAIVLSHLKFRDTSLIVRCYTLEGVRSYLLKGVLSQKKKALSPAYFEPLSQLELVT
TERNDGSLEYIKEAKVCFPYKKLQQSVIRSSVLFFLSEIGCSVLQEEHPNPSLFSFWEES
LQWYDRAEYFANFHLKFLVDLTLYLGVLPNTSAMELPYFDLEAGVFVAMHNGHSLMSEQD
SLLLKFFLSHSLEEVCLLKISREERNGLLEQLLNYYLWHLPNFKIPKSWEVLKSVL
>SEQF1602_00104 Holliday junction ATP-dependent DNA helicase RuvB
MNANLNPDKSNLSPQELDIERALRPLSFDDFTGQEAILENLKIFVKAANLRGEALDHTLF
HGPPGLGKTTLANILANELGVGIKITSGPVLDKPGDLAGLLTNLEPRDVLFIDEIHRLSP
IVEEYLYSAMEDYKIDIMIESGPNARTVQISLNPFTLIGATTRSGLLTAPMRARFGIQSR
LQYYTTELLANILQRSAQILGVPISEEAAIELAGRSRGTPRIANALLRRVRDFAQIKGNG
KIDIEITRFALKALNVDAHGLDEMDNKILLTIIDKFKGGPVGITTLATAVSENAETLEEV
YEPFLIQQGFIIRTPRGREVTDLAYKHLGKVRFKDGQPTLF
>SEQF1602_00105 hypothetical protein
MQSNIKVVTENFRAIGHAAIQINGITVVAGENSSGKPTFRKRFLP
>SEQF1602_00106 Lysine--tRNA ligase
MTEQEIIRREKLTKLRELGINPYPAELFPVNFLAKDIETQYEEGKDVVVAGRLMSFRIQG
KASFATLQDSSGRVQLYFKRDDLCPGEDKTLYNEVFKKLLDLGDFIGVEGTLFTTNMGEK
SIEVKQFKVLCKTLRPLPLPKVDAQGKVHDEFNDVEQRYRMRYVDLVVNPQVKEVFLKRN
RLFNAMREYFNNHGYIEVETPILQAIPGGASARPFITHHNALDIPLYMRIANELYLKRLI
VGGFDGVYEFAKNFRNEGMDRTHNPEFTGMEIYVAYKDYNWMMEFTENLLEYCAKAVNGT
TKTTFGKHEVDFKAPYPRVTMTEAIKRFTGFDITGKSEDELRTFAQSIGIEVDDTMGKGK
LIDEIFGEKCEGNFIQPTFITDYPKEMSPLTKEHRSDKNLTERFELMVCGKEIANAYSEL
NDPIDQRERFEAQMALSERGDDEAMFIDQDFLRALEYGMPPTSGLGIGMDRLIMFLTNNE
TIQEVLFFPQMRPEHKEVELSEDEKLILDLLKKDNKLPLEDLKAKTEFSNKKWDKAIKGL
TAKKVAAVSKEGETLFVSINS
>SEQF1602_00107 Antitoxin YokJ
MRKINEIIVEIERDKECMVQKLSIPHKNVPSGLPEDLTFYLENYHSIVFFPKAPYSIKIV
GLTEFERANKVLIGEEHKEDISHNWFLIADDSNSQYITIDLSKDRWGYCYDSFWDCYGVV
GEQAIIAKSFTELLERIYACKGQQWYWLQEDFISYGDAYDSI
>SEQF1602_00108 hypothetical protein
MIIDVYKNILTISIKETYIDQFYNFSQKVYEKYSVVVPFDFNDYNNLSQYIVDSSKRLIG
ISLERTYTLKGKKIKLGK
>SEQF1602_00109 hypothetical protein
MQRVKLTIKQYYFLQDLIKQSIITNVFYKDNHIVIIELSEDDMDKIRDLALDYLDIYGFD
KDYELTESGILAEELVDKLYI
>SEQF1602_00110 hypothetical protein
MTEEARTEVLSQLIYKCAKEAFLELFKNKEHYYNCVLLAPAEGYAPILSAWSFEALEREI
PKHPKEEIWLYKWNFADSPYYAFGEEYFEPVQTLLDTYPSILNMEDEDEIEREFELRISA
MVQAMQKLDQEGIFSINQPREQVYINVECIPNDNSDVDRAFLLNEAKNIKNG
>SEQF1602_00111 hypothetical protein
MRIEAINKGSEAKTLAFQEFLGFTLPDDYFNFLTQNDGAIIDEAYFYVKDIEEYIMFDLF
YDIKECIETYEEFSEDFPSKSLVIGTDPGGGMLLLVTTDVGDFSKGIYFYDHSHFFEASN
SDCNTYFVCDTFTEFITILEHTTLP
>SEQF1602_00112 hypothetical protein
MSYYYFNNGVKWQLSVNIVGSIKQEEIRLSLRSIGWKP
>SEQF1602_00113 hypothetical protein
MKNIILSLLLIISATTAAQTTFRGTLVNPDQKPVSDANIILMSLPDSTLVKGVISNGHGS
FELPNPANSKKVLIKITHLEYQGEVFPPTSSNLGTIVLIPTSNELDAVVVTARRRPILEQ
KGTRISTNVAQSTLQKLPTTDMLLNFLPGVSTSYTGGGFEVFGKGNPIFYINNRRVRNLD
EVYQLSPKDIERIEMETQPGAAFDNTVGAVIYIILKKKPGDGLSGAAENTFYFFKKGIMD
ETWLSLNYRKGKTDWFTSISNDNHFNQEDYNVAQDLQVFTQNNQWRVLNDETRQNQHKNI
KTKIGFAHEFSEEHSLGMSIRGSIIPFIGHNFSTQETTTYKNQLLTARGRNEYDQFEQDK
KLSVNAYYEGKLTDVLKMQTDVDYIGLRSDNTSDIVEHNLLNTTSRNVHTHSDVISDWWG
LKTTFFQQLGKGTLGYGVEVSNLHRTENYQDNVLSAFNVKNTETRSDAFLSFSYPIKKVN
LKLGTRYEYADFDYYENEQKSEAKSKTYRDWLPNVSVAFPWEKTQITFSYARKIKRPAFH
DLSDYNSYVSSFLYNRGNPYITPQLTDEWNTLATYGPISASVTYSHIHKGIYADYQLSSI
NSDAVEKILHNYDDFSLLKCALNAQKQIGKWMPKLTLTYEKPFADKVFYKSEGLFSVEWM
NQITPSENWLFLVMLLYKSKGSMQEAYIYKPGSGVFVGVGRAFFHQSLSVYAVASDFYNG
LNRHARIQNSYISNSTAYSYSNFSFKIGISYNFNTTQSKYKGKEISEEENNRM
>SEQF1602_00114 hypothetical protein
MNTYQTVLRKMRTEVQTPIQYYLSLEEGELPMNDLLGQQLSLRFAGYHCLHCGQSKEIYR
QGLCKKCFFEAPEVGEWIIRPELSKAHLGIEDRDLAYEQQVQLQPHLLYLANSSEVKVGV
TRKTQMPTRWIDQGAHEALVMLEVPNRYLAGIGEVALKAHISDKTNWRKMLTNTLQVVDL
NTIKQGLKAFLPQETLSYFSEEVPIYHINYPVLRYPTKVTSLTMPKTLQYQGRLMGIKGQ
YLLFEDNTVFNVRGHEGFVVEISFS
>SEQF1602_00115 hypothetical protein
MALTIIHSIASWFLRKRIDQIEEFIKRPHEVQENVCAKLLEAAQSTEMGKQYDFISIRNY
EDFASRIPISIYEDIEPMIERARRGEQNLFWRTPIKWFAKSSGTTNAKSKFIPVSEEALQ
HCHYKAGKDMLCLYLNNNPDSNLFTGKSLRLGGSKELYEENGTIFGDLSAILIDNLPFWA
EFSCTPSTKVSLMSEWEAKMKAIIAESSRENVTSLVGVPSWMMVLLRQALAYTGKENVLE
IWKNLEVYFHGGVSFVPYREQYKQLIPSDSFRYYETYNASEGFFAIQDRNNSDEMLLMLD
YGIFYEFISMDSFGTPAQKAIPLWEVEVGKNYAMVITTNAGLWRYQIGDTVRFTSTSPYR
IKITGRTKHHINVFGEELIIENTEEALKKACHEHHCSVIEYTVAPIFMQGNKSGGHEWII
EFETAPEDIEAFTRSLDTALKELNSDYEAKRYNDMTLAMPKIHIARKNLFHDWLKENDKL
GGQHKIPRLSNTRDYLEAIWKLKDNNANQ
>SEQF1602_00116 hypothetical protein
MKKNSIKILITLGLLLFIVFDIMHLMGCYVSVKFLIEDNVDSKTIDVIYNFVDKVAFFSI
INILIIFLGGYILLLNKRTIVERKNKPITIFVCTYIVLQLSVILYNYYGLKSNSKQDIIE
TNVMKSINDMTIGLFAFLIFSLIICCLMALFIHKRPITNDK
>SEQF1602_00117 hypothetical protein
MEWRKEIKIKNMTKYLYLPLIPFFLGYQQRTKIVKNTPLLPKKEVIVPKKDSLPTIDSLA
KYYSYSSENINQENFEAVVYEIIQCYNKKDTTALNKLIHPDIGLYFLYKPGGNIYWANQK
RIYLDTLYHEKEKTFIDGYNRKVLATGKIGVGKVPIEKITENIAPDEYSSLIGIFLVAHP
EAQKKLSYYITSSLSTFPFSPKEKQEAQRTLKKAKEIEKTTRCIMTAWKEVSSFSNSTYT
NHFIFYVTKIKEKWYLTMIDFSWIA
>SEQF1602_00118 hypothetical protein
MLPKRRIKHYIFVFLFSLVLFSCKRTISDTTSDENVFRKDTIITNILANEKEKEDKITTE
EKINDTELSSFLKELQVCLSQGQVTKIADTMVHYPLKDEGPLYEMLYGDIVYQDDFTTED
KPIVRKDFIKIYHQLFPKQYIALFERLNIEKIAKEKKFEWWNKEKTTLIDFSFLSEDSFQ
ISISFMEKDVVGGYSITYLFKKINGNILLYLVRSI
>SEQF1602_00119 putative deferrochelatase/peroxidase YfeX
MKNYQNVTDLPNNNTVFLVWVFKKDLDKAQLTATFAKICALIGNLNHSVADRFPDARASV
TLGISHSGWLTLGLPKPLPKELKDFKPIKGSKHTAVATQGDLHFHIRAHNPSLAYDMAAT
IEDVLRSVADCIVNVQGFRYWDGRAIIGFVDGTENPQGEEREQFAVVGDEDPHYQGGSYL
FVQKYVHDMNAWRALPVSEQEKVIGRSKEMDIEMDDDTKPSNAHSALANVGDDLKVVRDN
MPFHDPTSHQMGTYFICYANTFSTVEKMLTNMFVGNPVGNYDRILDFSTAETGTLFFVPS
LDMLDDFSEL
>SEQF1602_00120 Threonine synthase
MNYYNINHKDEIVSFKEATLRGLGKDKGLFVPDHIPTLPTSFFEEIAQKNNIEIAIEALY
PYVNDSFSREELQRILKEVFVFDTPVKELLSNTSVLELFHGPTMAFKDVGARFMARCLGK
FSDKDNPTTVVVATSGDTGSAVANGFYKVEGVRVVILFPKGKVSPFQEYQMTSLGANIQA
VEVEGTFDDCQALVKQALSDASLKGERVLSSANSINVARFLPQMLYYFFAYKQVKDLLGG
KDWVVAVPSGNFGNLTAGLYAHAMGLPVSKFVAANNANDTFALYLQTGNYQAKPSVATLS
NAMDVGDPSNFVRIRELFDNNLEAIRKMITAVVISDKETLDEIAYLHNTLGYTLDPHSAV
GHLALQKALLPSQYGTVLSTASPKKFDEVIRQVIPSFPVPEVDLSTCHKKSIGNSYEAYK
EILLS
>SEQF1602_00121 hypothetical protein
MAVLFPKYCLGCTQIIGDNLPFLCVNCRHELRQTHFDTLPDSENPMIKKFWGKVSVEKAA
ALLYYEKGTVSQRLIHALKYHNREQVGLWLGQWYAYELAQSHYFQGVELVIPVPLHPKKK
KKRGYNQVTLFAREIATQLQVPYMEDILIKQQYNSAQAKKHWLERQKSSKEQFVLKDTTT
IAGKHILLVDDIVTTGATLTQCATLLIGAGAKVSFACMAYSNDE
>SEQF1602_00122 50S ribosomal protein L9
MEIILKNDVPNLGFKDDIVTVKNGYGRNYLIPQGLAILATPSAKKILAENLKQRAFKEKK
IIEDAKELAKAIQQLEIKILAKAGAGNKLFGSINHDDLAEELLKAGHQVDKKYIYIAGGN
IKQTGKYEASVRLHREVIVSLPFEVVAEN
>SEQF1602_00123 30S ribosomal protein S18
MSIEQQAKGKKEGDIRYLTPLNIDTNKNKKYCRFKKLGIKYIDYKDPDFLLKFINEQGKL
LPRRITGTSLKFQRKIAVAVKRARHLALLPYVADLLK
>SEQF1602_00124 30S ribosomal protein S6
MNHYETVFILNPVLSEAQIKEAVEKFENFLTSKGAEMVAKEDWGLKKLAYSIQNKKSGFY
HLFEFKAPGDIIESFEVEFRRDERVMRYLTVRLEKEAIAWAEKRRAKLNSKKA
>SEQF1602_00125 hypothetical protein
MKKFLLILLSAYMTNVWAQITTENLGSKSLDGTRKVTIVLPDGYDKRERYPLFVVLNASS
LLEPTVSSMRYFNKTGEVPPAIVVGIYNTESDVTIPEETGIPFNDTANFFEFVGQVVVPH
VQSKYAVNSFKGIIGDGEAGNFINYYLLKENALFDAYISLSPNLTEKIIPSMPEQVDSFK
RPIFYYLGWAQIDDNAKLKKVKELHNLMNTKEYTNGFYYYQEFPRVSISAVPVSGIPEAL
NLFFELYRPITMREYAEKVVRVQTNTTQYLQDKYKSIRDLYGIDKAPLLEDVKSIYAAIL
KNADFESIPILVKYIKPYYKDTALPDYLEGDYYLRIQEPQKAFRALQRAYGAKEIDFVTK
ELISQTLERLQKEARGKLKTKKGDVVIPEKTEQSAEGNSAENAKDTENNTSKTE
>SEQF1602_00126 Dihydrofolate reductase
MSLTLIAALDLENGIGKNNQLLWHLPDDFARFKQLTMGHCVIMGRKTWESLPKLLPKRTH
IIISREELPQREHCVVTSSIEEAIIEAKKRDASPFVIGGGEIYRQTISLATTLELTRVQV
HIEADTFFPEIDLTQWELIERVFHPKDERHAYDFYFETYNKHL
>SEQF1602_00127 hypothetical protein
MIQSIIEKYKDRIAVGTKDFINITWIEQTEKKLGFSLPDSYKEMLLNYEFISVCGIDFKT
IAPPEYQEDADIDIYYTYQVNLQNNLFQKDELAFLEMDEETYFFKIEEAGQANEYPVYIR
DYMMNEDRLYANNFQEFLEHFFGILLK
>SEQF1602_00128 Thiol-disulfide oxidoreductase ResA
MKKIFITSIAAFSLLSACKDKTAQGNVDYAVISGKVFLPGESQKIVLAHNDEIYKEIPVL
SDGTFRDTIRPITDNHFFYLIENMTVQVPLYLDKGTNIELSLNEDMTKTTVSGTETKKTQ
YLIEKENFINEKINGADSNLFGQKPQEFKENIKSIFNELDSKLKAYNFDNDFVENQQKWA
KYKYVEYLIAYPTYHAYSMGKEAILPDGFYAERDQIDYDNAQEYAAVDSYRDLVRSKYFE
MLGDASNPEQIEGFLKVASSIKSDNIRTDLAKAVVSLIAPGNSKNKEILDFVLKNVKEDD
LKQVAQKSFEVASRLVAGKDSPVFTNYEKIDGGTASLADFKGKLVYIDVWASWCKPCVGE
IPHLKELEAKFHGKNIEFVSISIDEDKEAWKSAVKAHDLKGVQLIADNAFKSQFILDYDI
NQIPTFLLIDKNGKIVDPNAPRPSDPRLAEVLEKLLK
>SEQF1602_00129 hypothetical protein
MDTLWEELTTKLLKDFPIGRTLSIDSILYLIGLQEVGKFHDTFSRDDKINLIHVGTCKVL
EPYGYYFFEYKDKEGWPFYRRTKDHLSLSEQQQKSLLKEAILSYFIKMDYLPTKP
>SEQF1602_00130 Bifunctional NAD(P)H-hydrate repair enzyme Nnr
MKILTNEQMHAADQQTIEEQQITSWDHMEKAASNILAWIKKNLPGDNPYHIYAGVGNNGG
DGLALGRMLAQMGKKVKVTIVPFSEIHSEDFIKNLNLLKEIPSIEIHTLSQPETSEDFLQ
ANEKPFPTLKGKPAKGFEEFVANKYNGTQPITIDAIFGIGLSRRVSPWVQRVFEEVNRQK
GLIISIDTPSGLYLGEDRHEKDLFVTPHVVLTFFAPKLPFLLPQTGRYIPYWEVLPLPLS
FDYLKDVATEYDYTTDKEIKRLLRTRHRFTNKGTYGHALLVGGSYGKIGAPILSGKATLR
SGAGMLTLLLPKCGYNIAQTALPEAMVLTSSQEEALSPTEIPFQPSAIGIGVGMGTSAYA
QGTLASLLRTFANVPFVIDADALNLVASSEDLQRSLPKNTILTPHPKELERLIGKWANDL
ERQEKVKQFAKKHKVILIVKGAFTMITDGDHFWVNSTGNPAMATAGSGDVLTGVLTGLLS
QGYTPLNAAIVGTYIHGKAADTYVRNTKKNTMIASDIIDYLQF
>SEQF1602_00131 Rod shape-determining protein MreB
MGFFDFLTEEIAIDLGTANTLIIHKDKVVVDSPSIVARDLSSNKIIAVGKEAQLMQGKTY
ERIKTVRPLKDGVIADFDASEQMINAFIRSIPPLKRRFFSPSLKIVVCIPSGITEVEMRA
VRESCERVNGKEIFLIYEPMAAAIGIGLDIMQAKGNMIIDIGGGTAEIAVISLGGIVCDK
SVKIAGDVFTNDIIYYMRTRHNLYIGETTAENIKINTGAAIEEIDSPPDPMLVQGRDLLT
GKPKQVEISHREVAKALDKSILRIEDAIMETLSQTPPELAADIYNTGIYMAGGGSMLRGL
DKRISMRTDLPVYVAEDPLRAVVRGTGITLKNIDKFKTILMK
>SEQF1602_00132 Cell shape-determining protein MreC
MRLILLFFKRQKDFLVFLLLFIFSFTLVLDRNSFQKSKFLYVATGVMGDVYMLRSGIEGY
FNLRQQNELLTQENERLHKELLSVKAKKLEELSQDPILLFSPESYSVYRGEVIKNSYNLS
KNYLIIDKGTRDSIHEDMGVVSPQGIVGIIDKGSERFSSVQSVLNTLSKISATHQKSGYY
GTLSWDGKDPTVVQLSDIPSLATISVGDSIVTAGHSSIFPKGIPIGKVKSVNANTRDNSL
LSQVKLFTNMQQLQHIYIIKNKEQVPIKQIEEQIQTQVDE
>SEQF1602_00133 hypothetical protein
MNSLTYIFQLTGWVLLQGIVLNNINLFGYADPALYLLFFMTYPSMENKTPLLVLATLSGL
VIDIFSQTGGIYTCATLCVVFLRPLLIRLFFGQNFDEQPIKLLQVSFTLRLLYILSFTFI
FHIIFSILETFQWELWIFTLHKTLITILLSTIVCLLVEQLIGNRKEEKY
>SEQF1602_00134 hypothetical protein
MSAKNNTHHFPKLLILVGAPGSGKSTFARYFIRTEDNWVRVNRDDFRLMQFGDSLMSPFY
EERITKMVEASVIALLKNRTNVIIDATNSSLRSLQDMVHTYTEYADISFKVFDLPVEELV
KRCDKRCEQTGKFIPKSAIEKHVTQLQYTKEKFDFKPIPRALKETSLTYADQDTSLPKAV
ICDLDGTLSLLNGRDPYNASTADQDLLNTPVAMVLKMAKQQGYKVILLSGRENAYREPTE
RFLAKYQIDYDLLLMRDTNDYRKDNIIKKELFLEEIQGKYFVEFLLDDRNQVVDMWRREL
ALPCFQVNYGDF
>SEQF1602_00135 hypothetical protein
MEDKTLIKKRIDWFCKNKINAFSPTISPAPKSVERNEIESLYEGILWFVLNGVKEIVIEK
KYMGSYCDIYLHRRLEDTYLVSRNGYKINHLDQEQCLRALQGLHDRFSWDGVELRIIQSE
LMPWSILGKGLINNEFSAYYISHEIHAEYLVQSSLYEKLQKIQQEPAYLSFVADAKVLSA
KELKDKYPMHIIRQYQSIRDFKFLDLPHYQQNIQLFKRQLDIFGKEAAPFFKPFNILKEV
YTDGREHFVNDNLSFQQINDDDFLHYQFADREDFEAKYPQIRAWVDQVNQSDEEGVVIKP
RTAFLPGMPPAFKVRNNDYLTLVYGVDFQDRLQEQIAKRNIKGKLRCSINDWAINAKLLA
IPYSELGEENYELKNLVLDRILGEEIENQLDSRL
>SEQF1602_00136 hypothetical protein
MDERRLISQAFPSYLIQEATALADFLLKREACFHEMVGQERVVLSGESLVIPKRVYFGKY
NPKSLTFQEELMLYCLYLCHDNGHFREQYLQEVLQSKEDFVLPYVALLLGDYVYEILEVL
AKNLTKEMKGRLKSFLAENPQLKMRIESRIVSYWDCYYRGACPDLKQYIGYQLFKNIDKY
GR
>SEQF1602_00137 hypothetical protein
MRQSKIHIHFFAFLLLVCMLKVAFPVGEFFHNHLSEKEVCAHVNGKKCDHSTHISQAEKH
HDCVYLQLHHSFVLSTFSYHLLEVNDSFVFFFSEKTTVLTSSTTLSRGPPTTSIHC
>SEQF1602_00138 putative TonB-dependent receptor
MRKILCLFLFVSVFSLYGQETLHLSIEDSQKQPLPSAVVHFMGKHYVSDNNGRVSIPKLS
KGKYPIKVNYLGFLDYEATISIPAANPYIITLQEEVNLLSGTTLLGKASQPLKATATLDK
AQLQENSGEQLAKVLTSVSGVSMIQTGATIAKPVIHGLHSNRILILNNEVRQEGQQWGAD
HAPEIDPSVADKITVIKGADAVRYGSDALGGVIVIAPNKLPYGDGLHGEIAPSFASNGRK
TATSVKLESSVPKLHDWAWRIQGSLKRSGDIQTADYVLNNTAAREANFAIATGVQKEVGA
VEAFYSRYENESSVFYGSHIGNLDDLLARFEIGRPLTTYPFSYNIEAPKQKVIHHLFKAK
AYYLAPFGGKFTTQYAFQKDIRQEFSLRRLDRTRIPALNMWLTTHLVEAYWESIDSPLWK
TTIGGSFSHQDNYNQPGTGVVPVIPNFASISYGAFAIEKYHKGKWTGEAGIRYDYKYLNA
DGYDMYSQRYGGEHNFHNITYSLGGSWEASDKLSLSSNIGVAWRAPQVNELYSSGLHHGA
GTYNLGDPSLHPETGVKWITALDYKNPDKGIDLSVDAYAQVIKGYIYDYPTGETRTLFSG
VYPIFQYTQADAFFRGADLEALIRLAQWHDHSQSLSYEFRGALVFANELKTGRYFPFIPA
PRLSQSLLWKSAPRGIFQSLEASIGHTFVAKQTRFEPSQELVATTPEAYHLFEAAIGGTI
NIGPHQSLGIRLSGENLLNKLYKEYTNRFRYYAHDLGRNIYLRLNYNF
>SEQF1602_00139 hypothetical protein
MKKITNLLKNISLAMFSSVLLFSCSKDENTSPDTSAPTIEGVELGEANSKIGYIGDELHV
EATLTAEGTIQQAKLQITYQNGESSFKIEEAFADFVGKKGGKIHKHVDIPTDAKEGNYDF
QLFVTDQNNKTTSIKETLKVVKKRIFTENEALPLSSLQLGILNKYIGLKKEDFIAKFSNG
NVTYEQDSPFDPLVYYATNKEAPFQRYKIQVSFGNVFDLDKLPYESYEGVDSITIIPVDA
NGQEVTNNQPKEVFEYFEDYISSFSKKPYQYIREDDDKGYSEKRFKKEEFYNTFSNAELK
ETDASILWNANPNKPASESSKAKNTPIVKIKYKRENHTYEISLEFNRPNDYNNNLKQN
>SEQF1602_00140 hypothetical protein
MKRITNTFKTLLATAALGFVLTSCSKEAATPTNEKEDKGHEDPAKVEFVIRRGHLHGVRF
HGDPESIIAPIQKFKFELDEQTKNWVRKDMDGKILTQENPVVMIEGAHYAMEIIYYNSKG
QRMNYEFTSEQMLPIHQHFFEVREYTNTKTTKKDTDTGSLFSYTYRDTNPENVPVGDFID
SKNSTKKSELTDNPLGLKGYFSPTKAYAKYDIRVSLFHVLRGTKNKNNEKGVFYPFNAPG
SELIARSTTDFSQKIPVYVITSIASGGGEEENRYYKDVADYYGITPERVKQLIDEARDKH
DEATYWM
>SEQF1602_00141 Glucose-1-phosphate thymidylyltransferase 2
MKGIILAGGSGTRLYPITKGISKQLLPIYDKPMIYYPLSVLMLSGIREILIITTREDADS
FHRLLGDGSQFGVQLSYAVQPSPDGLAQAFIIGEEFIGEDDVCLILGDNIFYGQSFSKML
SQAVANVKEERKATVFGYYVKDPERYGVAEFDPEGNVLSIEEKPKDPKSNYAIVGLYFYP
NKVVEIAKKIKPSQRGELEITSVNQEFLSSKELKVQLLGRGFAWLDTGTHDSLTEATNFV
ETLEKRQGLKISCLEEIAYHRGWISKEQVTKVGQELFKNGYGQYLLELVK
>SEQF1602_00142 dTDP-4-dehydrorhamnose 3,5-epimerase
MNTIKTAIEGLVIIEPKVFSDERGYFFESFSQQKFVEEVCNTTFVQDNESKSSYGVLRGL
HFQRPPYAQSKLVRVVKGIVWDVAVDIRRGSPTFGQYIGVELTEQNKRQFFIPRGFAHGF
VVLSPEAIFQYKCDSFYAPTHEGSVLWNDPTIGIDWKIPHNDIILSQKDQQGPLLQEVWE
FDYKEKLY
>SEQF1602_00143 dTDP-4-dehydrorhamnose reductase
MKNILVTGASGQLALEIKQELHNSVSNHYIFTTKNELDVTDAAAIKAFFKKNEIELVINC
AAYTNVNGSEIDKETANLVNHLAVKNIANACTEQGSACIHLSTDYVFAGEKNTPYTETDA
TSPLGAYGQTKLLGESALQHSDIDFLILRTSWLYSAFGNNFVKNILRLSKERKEIKVVFD
QVSTPTYAKDLARFIIFVIENKLYRGRQDVYHFSNEGVCSWFDFAVETLRLAGSDCKVIP
CKTHEFPTPAARPAYSVLDKSKIKTDFNFPIPYWRDSLIALMTNNTSLV
>SEQF1602_00144 dTDP-glucose 4,6-dehydratase 2
MKHILITGGAGFIGANFVVYFANKYPDYHLVNLDKLTYAGDLSNLVEVEKASNYTFVQGD
ICDRALVESLFEKYHFQGVIHFAAESHVDNSIANPDAFITTNIHGTFTLLDVARHHWMEA
PFVVKEAYKEARFHHISTDEVYGTLGETGLFTETTPYAPNSPYSASKASSDMIVRAYFHT
YGMNVTTSNCSNNYGPKQHKEKLIPTIIRKALQGEAIPIYGDGKNVRDWLYVLDHCIGID
LVFHQGKAGETYNIGGRNERNNLFIAGHICEILDQKRPLPNGKSYKDLISFVQDRAGHDR
RYAIDATKIETQLGWRAQENFETGIVKTIDWYLSYFKDLL
>SEQF1602_00145 hypothetical protein
MKDIVKGYLCAFISAFTYGLIPLFMIPIKKEESFSVDATLFYRFLIASGAIVFFLFYQKE
RLRISFREGLIMSLLGILYALSAEFLFLAYDYLSPGIASTIFFSYPIIVALVLILFYKEK
LTIPTLLSLLLVVVGVGVLSIKKGEALNYIGLGISLLGALVYALYILIVNKVRIESSGVK
ISFYSMLFSSLYFLIKSLLLRESIIISSWVLAGDLTLFAIITTSLSLVTLVYAVRYIGST
PTAIMGAFEPIVAVLISVGLFGEQLTPSLVIGGMVIITGVLIDILFRKHPK
>SEQF1602_00146 SusD-like protein
MKKILYTSIFLMGGLALISCSKDFTETKFYQSKNAEPLTSVEELTSFVNGAYAGMRNMNY
LGAYYLAYGEVRSDEMYNNLAVGRFRGESTYTMDANNGNARGTWDAIYRVVANANIVINS
ANNLTWLQSNDATKIANEVKSLKAQAYAIRGLAFFDLLRLYGQKYAGGDLGVPLPLEYNP
TASSSRATIAQTEAQIEADWKKALNLFQEVADSQGTTLVDLVDTTNKTQLSPLSVKAYQS
RFYLYKENWDKVISLSQEIITSEKYSVVPAADLETSFTKPSATNSVFELAVGVNGSLGAE
SYEYLFNSSGYGTILLTDYAYGLYEDDDVRKGLVVGSSDDGYYLDGKFSDLQSKSNVKLV
RYEEVLLNATEAYLKKGNAGSALTYYNKLRTQRGLTAAATVTLDELKKERLRELLGEGLR
YWDLLRWGDPVPYYSRTGATNPANNRTVPNNLFVFPIPQLERNSEYSNVTQNAGY
>SEQF1602_00147 TonB-dependent receptor SusC
MKTNVVYFMLFFIGVLQVSFAQKKTLTGVVKDENQEPMLGVSVIIKGTSEGVSTDEKGVY
ALKVKDGDEVEVSAMGYKTQVHKVTAKTKKWDVLLALDVEEIPEFVFVGFGQKQAVKEAT
GSIGKVDNLSNSASASVDKALTGKVAGVQGGVTTGQPGGAANIRIRGIASVNGRTNPIYI
IDGVRVNQGSLTSGATSSNILANLNDDDIESITVLKDAVSTAAYGADAGAGVIIITTKSG
KKGEAKYNFNSEVGVVSRALKGEENLSTSEWFGLLYDAYLNTREGTRLFPNNDKAALLAA
LEAGTLSTAATGRSLQALYKNRNISTDWRKESENSMALVQKLNGSVSGGTDRIDYYSSLG
YYKQDGIVKQTGFHRVTNSNKITYRANDRLTLATDIQLSYSQTMTMPSGGDYANPILGQY
LLRPTDRAYKTDGSLNYGGRGGKLSNGFYNVVALQNLNYIQSQTTRAFGNFQADYKILKN
LTYKFVFAPEYVDIMEDKYLTPLHGDGKDEGGLSNWYASRYFSFNVQNILSYDFKYKEKN
NFYVNLIQEAYKSDVRRLSASASNVGPSGLTTLSNFIKPRDASGTKAVSSRGGYALTFHY
DYDKLFLLDLSGRQDRVSNFWEENKTGYFGSVGVGVDFARLEALKKSKALSQLKLSASYG
SVGNMVDVFPYATYSYLLNYNEQVGGNVNGVENRDLRWETLSPLNVGLDIGFLKDRITLS
AAYFYKKTSDMIFAVPLSRAQGSSGGSVYKNIGEMVNKGLELTFNAKVVENEGDGFNWSV
GGNFTTLKNEVTKLYGDKQEIISGSRIIRKGETVNSFWMKKWAGVDPDNGDPLWYINGEG
GETTKDYNKAGYALQGSPMPTFYGGFDTKFSYKNFTLSLDFTYSGGNRIIDVFASYVNSD
GGLLLNYPGYRSQIGNYWTPENKNARDPKPVLNEGNKNATGFSTRYQYKGDFVRLQTLRF
SYKLKPEWLEGTYLRGLEFYVLGNNVWTHNFDKNFKGDPDLNISGETSFALPSLRTYSFG
VNVNL
>SEQF1602_00148 hypothetical protein
MNNIETNTLLSFFLSIIQKKKAIEMIAFFFITKEFLLLF
>SEQF1602_00149 Ribonuclease G
MTKELIIRSGASDVDFALLKNGRLVELHKEEDANGLSVGDIMLAKIHKPIQGLNAAFVNV
GYEKDAFLHYHDLGPQLLSLLKFIKEVSSGKIKDYSLKDFKQEPDINKNGAISEVLKAGQ
PILVQIVKEPISTKGPRISSELSIAGRYLVLVPFSERISISQKIESKAEKERLKRIVQSI
KPKGFGVIIRTVAQDKKVADLDKDLQNSFERWIQMCKKIAQGTFPSKILSEMNRTGALLR
DMFDDSFTGIHVDNESLYTQIRDYLQEIAPDKLNIVKLYKSSVPIFEKFHIERQIKTGLG
RTVSMTKGAYLVIEHTEALHVIDVNSGNHSNKAENQETTAFEVNLIAATEIARQLRLRDM
GGIIVVDFIDMSNGENRQKLFDALREEMKDDRAKHKILPPSKFGLIQITRQRVRPEINIK
TKEENPSKLDEVDAPITLIERMTTDLEEIIYQSNYNGRITLNLHPFIAAYLTKGIFSIRF
KWFLKYKRWVSILPRDAYSYLEYRFKTKEGTPL
>SEQF1602_00150 DNA-binding protein HU
MTKAEIVAKISEKLGIEKTEVQNVVEHFMEGIKDSLEKGDNVYLRGFGSFIVKTRAEKTG
RNISKNTTITIPAHNIPAFKPAKVFVQSVKTKVKVETKAKAKAKKK
>SEQF1602_00151 hypothetical protein
MHIKKLIILPRKHKLIPMKKILLLLVAGLMAVSCKTQGTIAKSTQGTRQANKVIKGEWTL
SSITYNEKGKYEITLLNDTSKECFEGSYWKFVPNNYRGIYTINNTGCASGNRHFIFTVQE
MDKTTGYYDFLLKPTNEKYQSETNAGVRLHLAYLSENEMRWEQTVRVDGKPFVITMNFTK
N
>SEQF1602_00152 putative lipoprotein YiaD
MTKVFKNITLFLVAASLLVSCEAYNNSNKTQRGAVIGAAGGAILGAILGNNVGSGGNSEL
GAVIGTAVGGAAGAVIGNQMDRQAKKIEEEIPGAEVKRVDDGIVVTFDEKSGVTFEFNKA
DLTSEAKTLLTKMAGVLKEYPDTNVIVAGHTDSKGKPAYNMGLSERRAKAVTNFFTASGL
KASRFTTKWFGATQPAYDNSTEEGRAKNRRVNIAIVPNEKMKEDAKKQAQE
>SEQF1602_00153 Phosphoribosylaminoimidazole-succinocarboxamide synthase
MNSITSTDFSFENQKSLYKGKVRDVYSIGEDLLVMITTDRLSAFDVILPKGIPFKGQILN
QIASECMEQTKDIVPNWLLATPDPNVSVGMRCTPFKVEMVIRGYLAGHAAREYQAGKRTL
CGVTLPEGLQENAPFPSPIITPSTKAENGLHDEDISRENILKRGIVSEEDYAVIEKYTYD
LFKRGSQLALQRGLILVDTKYEFGKTKEGTIVLIDEAHTPDSSRYFYADGYEERLKRGEP
QKQLSKEFVRQWLIENGFQGRPGEKIPEMTAAHVASISERYIELYEHLLGKKFIKSDTTN
IQERIYKNVSEYLRSLL
>SEQF1602_00154 Phosphoribosylamine--glycine ligase
MNILLLGSGGREHAFAHSLSQSPLCEKLYIAPGNAGTALVGENLAFAATDFAAIKQCCLD
KQISLVVVGPEDPLVKGIVDFFSQETALSDIAIVGPTQRGATLEGSKEFAKEFMQRHQIP
TARYASFTKETITEGLHFLETMQAPYVLKADGLAAGKGVVILENLQEAQAELKKMLLEEK
FGNASQKVVIEEFLRGIELSCFVLTDGDSYLVLPTAKDYKRIGEGDTGLNTGGMGAVSPV
PFADASFMKKIEDRIIKPTIEGLKKEKITYRGFIFIGLIKVGEDPYVIEYNVRMGDPETE
VVLPRIQTDLVTLLEATAKGKLRDISLSIDPRSATTVVVVSGGYPEEYQKGKMIYGLDTQ
GESLVFHAGTIQKEGKIFTSGGRVLAVTSLDNDFKEALKKSYQQIEKISFEGMYYRKDIG
MDL
>SEQF1602_00155 Colicin I receptor
MKTIVFCICFLFTSTLTLAQQATFKGKISAEGKPVLGADVILRKGQEVKGTSSQASGDYQ
VKVPAGTYKLTISSVGFKTITQDISLTENEVLSKNFSLEKDLLEIDQVVVTATRNIIPQY
KSPVVVSKVTGHIFETTQSLSLAEGLNFTPGLRTETNCQNCGFNQLRINGLEGSYSQILV
NGRPVFSSLAGVYGLEMIPANMIDRVEVVRGAGSVLYGGNAIGGTVNILTKDPTRNTFSV
GNSLSLLKDGSPDNTLFANASVVSDDFDKGLTLFAYQRNRKPYDSNEDGYSEITKLHNTT
FGADAFWNPTENSKVKLNLNSINEFRRGGNKFDLLPHESDITEQLRHRILAGDLAFERFS
DDLAHKFSLYTSAQYTDRDGYYGGGLGYAVNSKADFDNLSADDQEEYFKALAKYGHTTEL
VGVGGAQYAYTITPELNLSLGSEYKYDKVNDNYIGQNRSVDQVVRTYGNYLQVEWNPAKK
LTLLGGSRYDYVDIKGSYRFAGADKDSNKQISKFVPRLTAMYDITETLKLRGSFAQGYRA
PQAFDEDLHTEVLDGDPIFVELDKDLTSETSNSYTASLNYTKREGNTQANLILEGFYTHI
NNRFINQDLTDIGNIKHKLKTNATDHLKIMGVNVEANFAFGSQWIWQTGFTYQQSRFSEQ
QTIWENEDPTDPKKISSDRVMRSPELYGYTTLSYTPIAALKLSYNGVFTGQMYVPHVIEA
QSGEQVIVKSPNFYEQNLRAAYTFSLTDNYKLEVFAGVKNIFDQYQKDFDKGKDRDADYI
YGPQHPRTYFMGLKLSLN
>SEQF1602_00156 LPS-assembly protein LptD
MQKIYYLFITFFLLLHATFAQENPSKKIEIVYAGTLTIDNDKYPGATIFNSDQERKVQFR
HQGMDIWCDVAVLYQKTNQVKAFGEVFIQQGDSLKMNSEFIEYNGDTKVAIAKENVKLRN
EKMTLETQELFFDRNTQQAYYLNYGKIFDEENVLTSKEGRYFVGPKKSQFTTQVKITNAD
FVVNSLTLDYYHATGHIYMFGPTTITGKEYVAYGEKGYYDSKTEKGYFMDHARIDYDNKI
LTGDSLYFDRFKSFASGTNNLIIRDTLNKTLVKGHYGEVYKAQDSMYITKKALVISEVEK
GKDSIYIHAKKILVTGKTGSRIIRAYTGARIYKTDIQGKCDSIHSSQITGLTRMIRNPIV
WSGKSQMTGDNIHILANKQTEKLDSLRVFDNAFLIEKDTLGTGFNQVKGKLLKGKFKENK
LNNVNLYQNTEVIYYAYNDEHSLVGINKSKCSQIRIDFAPTQQIETITFYKDVDGAIYPE
DKISKKELLFPNFNWRGDEMLKSKEDIFPEEEKNIQLVPIRGIKSEEIDLIEEKLQPKIG
N
>SEQF1602_00157 hypothetical protein
MALWKKYLLFLWKSTNQHGVHSPFVYRLVTQCFYNTQKIPCKHYPKGISKRKGQFLLRLI
AYLKPKSLKIYTDIADFSSLFPIDNTEETSKEKDLLLLYQCKEFPCAKELLSQMHNDSLL
VMVAPHQRENEIFYKQLLKNKAFSVVIDTFSFALFFIRKEQEREVFFIRNK
>SEQF1602_00158 Bifunctional protein pyrR
MERKQLLSSRELDVILHRLACQLIENHLDFSDTVIIGIQPRGVLLAQRLVKMLEEEYGAK
GIQYGTLDITFFRDDFRRGEKPLTANTTDIPFLVEDKKVVFIDDVLYTGRSIRAALTALQ
SFGRPSKVELLVLIDRRFSRDLPIQPDYIGKAVDAINKERVVVYWKEQDNEDAVYLIEKV
>SEQF1602_00159 Aspartate carbamoyltransferase
MNQLSVNHLLGIKYLTAEDIELIFTTADQFKEVINRPIKKVPSLRDITIANLFFENSTRT
RLSFELAEKRLSADVINFSAAQSSVKKGETLIDTVNNILAMKVDMVVMRHPNPGAGVFLS
QHVKVPIVNAGDGAHEHPTQALLDSYSIRERLGSVKGKKVVIVGDILHSRVALSNIFALH
KQGAEVAICGPKTLIPKYIHELGVQVETDLRKALQWCDVANMLRIQNERLDIPYFPSTRE
YVQQYGLTQEILDSLGKEIVIMHPGPINRGVEITSEVADSPQSIILDQVENGVAIRMAVI
YLLASQIKMQ
>SEQF1602_00160 4-hydroxy-tetrahydrodipicolinate synthase
MKTMKMLQGTGVALITPFKADKSVDVQALEQLVHYQIDNGIDYLVVLGTTAETPTLSAEE
KELVKQTVKKANAGRLPMVLGVGGNNTQALIEQVQEVSPEDYVAILSVSPYYNKPSQEGI
FQHYKALAQASRVPIMLYNVPSRTGSNIDYHTTLRLAKEVPNIIGIKEASGNIVQIMHLL
QGRPEGFLVISGDDATALPTVLLGGDGTISVLGQAFPKRYSQMIRQGLEENCKEANTIQY
QLLEAMELIFKEGNPVGIKALLSLLGIGSPEVRLPLCTASDSLQQQLRAFLQK
>SEQF1602_00161 hypothetical protein
MKIFKNIAIKNRIRKNLRNRANYLNGNKLQIARIGCIVDIEQVAKVDFLKDFIKGYGINS
ENYVILGYEEKGTDIQIEGIPLFSWQDINYSGNIRNYHADRLWELEYDLLINAFSTPKLP
LLLLSSGVKAKLRIGVSGIDPAFNDIIIDTPLESGTIFIQEAKKLINTLQ
>SEQF1602_00162 Mannosylglucosyl-3-phosphoglycerate phosphatase
MKNFLLRLFLLSAFLSSCKSNGYFPQAIDGEQLQITKDAEEDEQIKDYLSPFRYHLNKYL
DKVLSYNKTPMLKVIDPEVMNMPIGNFFADSQCEQADSYFLKKRKKHIDFAMFNWGGIRT
EVPQGDITIRQVFQIMPFENQLVVVELTGDMLYNMAKYLVESKFPHPLSKQVQLTINKRG
EVVSFLINKKPVQRKKRYFVCTFDYLYNGGDKMNFFKDALSVTNIDYTSRDAIIDFLRKT
DTLDFKTDERFRLKK
>SEQF1602_00163 Trifunctional nucleotide phosphoesterase protein YfkN
MERRNFVKNIGAGALLLGMGGISFALGKKEIPAKNYRKHITILHTNDTHSHIDPLPVDDP
HYPDKGGVARRAVLINQVRKENPNTLLFDAGDIFQGTPYFNYYGGELEFRLMSMLKYDAA
TFGNHDFDNGLEGLLSQLPHAKFDFINSNYDFKDTILEGKAKPYKVFVVDEVRVGVYGLG
VELKGLVTKENYRETKYLDPIELAIDMENKLKKNEKCDIIICLSHLGYQYRTDKVCDITI
AKRTYNTDLIIGGHTHTFLGEPTIVKNKSNREILVNQVGCYGINLGRIDFYLDNKITSSG
TQILV
>SEQF1602_00164 Vitamin B12 transporter BtuB
MSKIYNISLMAFSLFAFGGYAQVKDKDKLETISVDIVKPYTPTIADVHKDREETPKKDSV
TVAKKKVTYTTHSVPVASTFVPEKGKAVRMSVSSVRDTLYQSYAALGLGNYATLFADAFV
ALPISDTDDFLVDFNHHSSRGDVKGITLDNNFANTQLQAGYHSLQKEYQWGLSANVQHRM
LHWYGVEDVSLLPISGSLKQSYLDGGLSGMLTLSKGAFEGLDFFVQGMKDDFKSSELHLN
LRPSMRFALKEGQTIRLKAEADFLQGSFDRGFSTTEGVFYKSALLGLRPSYTYATKEFSL
RVGLGGYYAKENDNSGDKFRIFPDLEFSYDPQGKGVVWYGGITGDLKQVTYREQSVENPY
ISPTQELHPTYTPYDIFAGVRGRAFKSFSYDVKAFYTRIEQMPLFRANEKYTLTTRLPYH
YDNTYRILYQDAMSFGAKASLLGKLSEKFSMDWTLKIATYSFDETDQEAWNLPLFTSSFS
VLYQVLPQWNIGASFFYVGERKDIKHPLAAQPVEEVTMNGFFDLNFSTDYTFLKRWTAFA
SLHNVTGDNYLRWSTYPVQGFQFLIGMKYRFNVK
>SEQF1602_00165 Lipopolysaccharide assembly protein B
MKYKFVSALTIALLSQLSWGQSTAQYTHESKTLQKALSLYYQKQYKASSHFFRKELRRAT
TQAQKEQCSYYIASAALQGRQTGGDVLMQQYLKDYPTSPYATHANFEMGNYYFDKGDTKT
AIAWYDKVQIPTLSAEQHEKFNFQYGYALFAHGDKETAQQYLSQVKDSKEYGKKAAYYLG
YIAYDADDYQQANQFFQQVEQEKELSKNLSYYQADMNFKQGNFQKALEEGLHQLEKTNNP
QYRSEINKIIGESYFNLKQYTKAIPYLEAYKGKNGTYTDTDLYYLGFAYYQQGDYQKAIG
QFNRIINGKNQVAQNAYYHLAQCYLKTGQKQQALNAFRNAYQMNFSSEIKKDAHLNYARL
SYEVGNAYESTPTVIQAYIDTYPNDHTQELKELLLDSYITSGNFPSALNMLEKSTSPDPK
IYQQVAFLYALQLYGDGNFKEALPYFQKAKNSKAQSQVQARATYWSGETHYQLHEYPEAQ
RDFSAFLALKETTLAEYPNALYGLGYALFNQKKYVEAAEYFSKYIQTQPEASRLADANLR
LGDSYFAAGKYWPAMEAYDKVITANVSNTDYAAFQKAISYGIVDRVPKKIEALNAFITHY
PKSNLREDAIYELANTYVGQGKMEKASELYEMLQSQYQEGTYTARAMLREGLMLYNKNEN
QKALAIFKKITQKYPSSPEAMQAVSSAKNIYAEMGKMEEYAAWAKALGYVKVSDSEIDSA
AFDAAERLYVQNKKQEAKVALEKYLKDYPKGTGASQAEFYLAQIYFDENQKDKALPLYEK
VLAQGRNEYSEQVLVRLSNIYLEKEDTDKVLPLLEEIEKTSSVAQNLIFARSNLMKAFYK
KKEHAKAIVYAKKILAEKGADNRLKNDARVIMARAYMATGDEAEAEKQYAEVRKTASDAL
MAEALYYDAYFKNKAGQYKKSNEVVQKLAKEYGGYKEFSAKGLIVMAKNFYGLKDLYQAN
YILNSVLENFKNDPEITAQAKEALAEIKANEKKSNK
>SEQF1602_00166 1,2-phenylacetyl-CoA epoxidase, subunit E
MKSVSLAVSQIERVTADSVKISFVIPQELKFSFDFFAGQYISLEKEIEGKLVRRAYSICS
SPYEDVISVAIKQIPNGLFSTYACEQLQVGDLLEVFPPEGKFAYIPEISPENLGLFAAGS
GITPMLSIIKVALERTTCKILLVYGNRTPQTTMFAPEIEQLHKQYPDRFFVQYVYSKSHE
KNALFGHIDPAMVHHLLESKYQEVDFGRFYICGPQLMVEAVRDELQKNYEKKKIHTELFT
VTEAPKKEYKGTAEITVRLGGKEQILTIERKPTILSELLSKGFDVSYSCLTGACSSCIGK
VTEGSAEMDNNQVLSQEEVEKGMILTCQAHPTSSHIKVEYNY
>SEQF1602_00167 Dihydroorotase
MKTLLKNGKLISDNRIQEADLLIENERIAKIATDISAKEAHRVIDLEGMLVLPGVIDDQV
HFREPGLTHKATIATESAAAVAGGTTTFFDQPNTIPQATTIAALEDKFAIAARTSLANFS
FLLGGTNDNIEELKHINPKNTAGVKLFLGSSTGNMLVDNEKTIETIFRNVSTLIAAHCED
EQTIRQNLAHYLSLYGPEIPVACHPLIRSAEACYLSSSRAIALARQTGARFHVFHLSTAK
ETELLDNTLPLSQKKITAEACIHHLWFTDKDYQEKGVLIKWNPAVKTEQDREGIWQALLD
NRIDVIATDHAPHTLEEKGQKEYQKIPSGAPLVQHALVAALTMFAKRGIPLERLVEKMCH
NPAILFRIQERGFLREGYYADIACVSEHTPWQVSKDNILYKCGWSPLEGTTFDYKVAYTF
VNGHLAYEKGTLHLEEKGQRVLFND
>SEQF1602_00168 hypothetical protein
MKSRNKLKIVNDPVYGFIHIPNEFILDLIEHPYFQRLCRISQMGLSYLVYPGARHTRFHH
ALGCMYLMQQAIQTLRYKQVEITPEEEEGLYIAILLHDIGHGPFSHAMEHSIVEGISHEE
ISLAFMEELNRQFEGKLSIAIEIFQKKYHKQFMNQLISSQLDMDRLDYLKRDSFYSGVSE
GNINSQRIIAMLTVKDDTLIVEEKGIYSIEEFLVARRLMYWQVYLHKTSIGAEFVLIRIL
ARVKELTQQGKKLPMTTALRFFVENHITKETFDRHALHLFAQLDDYDIISGLKEWQYGDD
WVLAKLSQMILNRDLLRVKLYKSPVEKDKVQELLQETAQQLNISEDLAHYFVFTGEISNT
AYRKDEQNILIYTKNNKIVDVTKASDQMNLDALSTKVTKYYLCSLK
>SEQF1602_00169 GTP cyclohydrolase 1
MNHSDDFIGENHISTSAKTPLRADAFSLSDEEKIARIEKSMADIMETLGLDLTDDSLKGT
PLRVAKAYVKELFGGLDPKRCPSSSTFENNYHYGEMLIEKNIVLYSTCEHHFLPIVGRAH
VGYISNGRVLGLSKMNRIVDYFARRPQVQERLTMQIVQEMQRILGTEDVACVIDAKHLCV
NSRGIRDIESSTVTAEYGGKFQDPIVRKEFLEYIKMETKY
>SEQF1602_00170 ATP-dependent DNA helicase PcrA
MNYLNELNEAQRAPVVHKDGAVMVIAGAGSGKTRVLTYRIAYLIQQGVDPFNILALTFTN
KAAREMKERIGRIVGPSEARNLWMGTFHSVFARILREEASKLGFPRDFTIYDQQDSQRLI
SAIIKEMGLDKEVYKYKQIASRISSYKNNLITVKAYYENPELQEADAMAKRPRLGDIYAN
YVDRCFKAGAMDFDDLLLRTNELLNVFPEVLAKYQHRFRYILVDEYQDTNHSQYLIVRAL
ADRFQNICVVGDDAQSIYAFRGANIDNIFNFQKDYPNVGVYRLEQNYRSTKNIVEAANNV
IEHNKARLEKVVWTDNESGNRIKVHRSPTDADEGRFVAGTIFESAMQEQLPYGNFAVLYR
TNSQSRAIEDALRKRDIPYRIYGGLSFYQRKEIKDILAYFRLVINENDEEALQRVINFPA
RGIGDTTMEKLTLCANEFKLPIFEIIKNLEVMDYGLKINSATRVRLLEFANMILSFRIMM
ETQDAFTLAEHIAKRTGILNEFKKDGTPEGVERMQNIEELLNGIRDFVEGQEQVEEEGNS
LAEFLQDVALATDMDKEVEDENRVSLMTIHLAKGLEFPHVFIVGMEEDLFPSALSQNTRT
ELEEERRLFYVALTRAEKQAYLTYTESRYRWGKLMDAEPSRFIDEIEERYLEYLTPKDNY
RYRPLVDIDAFAPVDKSKLRQQKPTNSPPPAYKKPNEDQLKKLRLQKPEQAKPIATGDIP
KVAVGNIIDHERFGKGTVIEVEGSGADRKAKVRFENGGEKTLILRFAKFKIL
>SEQF1602_00171 hypothetical protein
MKDITQEERKIYALYDNNTIRVYQAYNAEIAEEALKLGTFGSHFSLTRMTWIKPSFLWMM
YRCGWAEKENQERVLAIDIKREAFDEIVRKSVLSSYKADLGITEEQWKEDVKNSLVRCQW
DPERDIYGKPIGRRSIQLGIRGAFVEKYVNDWIVKITDITEEVKRIKQHIDKGTFTKDLL
PKEQEYIIP
>SEQF1602_00172 hypothetical protein
MFLQKRKVKNRNFFFYLGLLFCIACQQGKQVGAQELPKDYTTQHSIALAYCKAHKMNEDF
YFLIDLRLHSGKNRFFVYDFKQKKNLYEKLVTHGSCDVFSSNPDKFQKAQYSNQVDSHCS
AKGKYKIGNRDYSSWGIKVKYWLEGLEESNNNAQKRLIVLHSWEAVSDSEIYPHYSPLSW
GCPAVSNAFMELLDTLLQQSKKPVLLWIL
>SEQF1602_00173 hypothetical protein
MKCIYTAIFLCITSIGLAQSLSFSEALDRMRGANQKLKGMEKQAEASQYGEKSYKGLYLP
QLSINASYTRLSDPLSLSFDKYKAPIQAQLGQLANAIPAPLKPTLGPVFAQMAGRFQPLF
AQEWRYEFQEQDIWRLSADLRWVVFAGGKVRVGNKVGQLNHEIAKIETQKTENMLISELA
ERYFQVQLAQQALQVREKALQTAEQHYSNAQKLEKNGMVAPVETMQAKKAVTDAKREVLA
CQKDIELAQTALSGVIGEETSALTTLSSPLFEVAPLQSLDYYQDLAKKNFPSIVQAHLKK
ELTEQNIKAQWAAFLPDVALIGKKYLWSKNLPLTEPDNWAVGVGLQWNIFNGFSDKNKVA
QAKAQRESVEQLTAQAEKYVQTLVKKHYTEIEKQREQLQSLQESLEFARELVRVRNQAFS
EGLSSSTDVADANLYLASIEIKCYQALFEMDKVLAQLLETCELSGEYTNYMKK
>SEQF1602_00174 hypothetical protein
MSLIDYIQQQTQIEKEPLEALDAIFQVREYKKYSLLLKEGSLSQEVFFIEEGIVRQFYTK
EGKDITHAFYAENSFYTSLDNIYFHQPNHFGLEALETCRVRVAEFVQVEAIINNYPKLER
FMRMLLISFLKNLSDRLYAIKFQTAQERYELLLKNYPQILLRVPLGHVASFLGITQQTLS
VIRAGK
>SEQF1602_00175 hypothetical protein
MKKLFVIGSLLSVMSLFSQQKNVFWDRNFWNEHTTIAQVVTEIKNGNSPSELNEAAFDAP
SLAILGKVPTPTAIYLIEQQGNGVHKTTHDGRTYLFWAASQGNVELIHYLLEQGSDIHAK
DSKGYTPITFAALFGVTNPKLYEAFFRAGIDPKATYEQGETLLMKVVPFDDNKLSLTHYL
VEKGLKINQKSLSGATLFDYAAKKGNIDLLKTLRKKVKPTPQALPMAAEGIVRQPNNPIE
TYKYLVEVQKIPANATDYKGANALHYLARRQDLPAIDYLIQRGAATDVVDKQGNTALMNA
CYGTNLEIVKLLEKNKEHLNRANHKGETALLIALQRSNSQVVGFLLEKGADTRATNQKGV
GVIEALIASYNPRKKNNEEDFDQKVALLRKYLVALQAPNSIGDTALHMAVVKGDKALVKK
VLSWASVDINSQNEDGETPLIKAALTAKDTTLLQYLVEHGADKKLTTSLGETAYDLAKEN
EALKKSGANIEFLRE
>SEQF1602_00176 hypothetical protein
MMLHRKIIVITLLLFLGGGLFVQAQTRVSGQVIDEQGEPIPFANVIFKNTHIGTACDENG
KFSLFSQKNYTTIEVSSVGFTTKEVKLKGHDTEKLKIVLAIEELEALVFVEKPKKNLSKK
ENPAYPILQKIWANKHKNILTQTKAYQYKRYETVELGLNNLDSVFLKKALQSEYKEIRNI
LSEKKYKQYFSMPMYLREEVSQVYGDNLRKLQRTDIEAERTQGVIQTGFGLERFTRNFRE
FDVYDNSFYLLDKTFVSPLSEYGYGVYAYVLNDTIRRDGRELYSIYFFPKQDQDLLFKGN
FKVDSKTYAITSIQMYTIKEASLNFVRNLSVEKEYQWVNDSLLLPKRDYYEGDFTVLTKS
EEEKGMYVKKNVTYSDYLLNAPKEEAFYLATIEKYKTNQFFQPQTYWNKMSDGDSLMTKT
QNLIRRVGDNRRIKGISDALNIVTSGYIPIGKYVQFGSLWESFTNNDVEKNRFRFGLRSF
VSNDDRFRTYLYGAYGTLDKKFKYGMSAKYLLFYKPRVVIGGLYQNDYSQLGSMLQKDDA
RLDLKNASNFLLARGENYYLTQNKRIQGVADIGLFKSNLHITLSGTYQQMKSADPDHFSI
GYRSPEGGVFDKYSDANASLTLTYTPTRNVYGYGVEQFYGKNIFPTFRAKYTKGFSGIRN
SQFDYSRLEGMIHYPQPLWSIGILHTVVEGGKVFGAVPLPLLTPTPANQTYATSQREFNR
TFQLLDYYDFVTDAYINVYAEHHFNGFLLNRLPLIKKTKWRSLLLARMAYGTLREENREV
SASNIYYNAPEKLYWEYGFGIENIGIGNFRPIRVDFIWRSSFNDRNGVKNPYFGIRFGIK
PEF
>SEQF1602_00177 Linear gramicidin synthase subunit D
MIVVTGGTGLVGAHLLYELLCAGATTIRALYRKSKNTSLLEKIFQTYNPNALPLIQKIEW
VQADILDVPALERALQGVDFLYHCAGMVSFDDSDAQLLYQNNVEGTANIVNIALYRGVKK
LCYVSTIATFSAKEGTEVTEQTPQELSVANDKAYALSKYSAEMEVWRGVQEGLPAIVVYP
SVVVGVGVEQHSAMNIQKLCRSRYITQGGTGFVAAQDVAHAMRLLMESFVENQGFILSGE
NLSYQQFFQYLSESHPKLPKKKMLSTNALRWLSYADTFLSFFGKKRQLSPKMVQTLQSVS
FYNGEKITHTLPFTYTPIQEVLKRLVL
>SEQF1602_00178 hypothetical protein
MKTIGISKYYHIYQKPGDRRFYVQMPEQTLEFRFCELLEFRGKVQAIDLSAHFDYSQPGI
EILTFCGGKYLCVFTTEQIVDLQKLLFEIFEGVSEKEIFTKYVLL
>SEQF1602_00179 putative oxidoreductase
MCFKKQKYDFFWQVGQELLKKFAYLFFKTTFVLSNKKNMKEIVLITGASSGIGKATAELL
AKAGYIVYGSARNPQEVLQGVTMLAMDVRDTASVQQAIATIIEREGRIDILINNAGVGIT
GAIEETPIEALENAFETNFFGAVRTIQAVLPIMRSQCKGLVINITSVASYMGLPFRGGYS
ASKGALSLLTETLRMETQQFGITFCNLAPGDVATDIASRRFHTPAIEGSPYKQYAEALPL
MNEDVDKGMPAEAIAQKIVQIIRKKNPKGHYVKGKFIERLSLLLKAILPAKCFEKLLKKH
YNL
>SEQF1602_00180 Aspartate aminotransferase
MKEFLSDRVNNMALSATLAMAAKARELKAQGKDIISLSLGEPDFAVPDFVKQAAIEAIEQ
NYNKYSPVDGYMELKEVICEKFKKDNHLNYTPDQIIVSTGAKQCLSNVALVMINPGDEVI
LPTPYWVSYSDITKIAGGVPVDIPTTLEDNFKITPAQLEAAITPRTKMVWLSSPGNPSGT
IYSREELEGLAEVLRKYPHIFFLSDEIYEHINYIGQHTSMAEIEGMYERTITVNGLSKAF
AMPGWRMGYMGAPAWITKACAKMQGQITSGANCIAQRASITALKAPLSKIQYMIDEYRHR
RDIVHELLNEIEGFKTNLPEGAFYFFPDVSYYFGKTLRGKTIHNAGDLALYLLEEAHVAT
VTGEAFGNARCLRLSYATSEKDLREALRRIKEALTL
>SEQF1602_00181 Inner membrane protein YgaP
MTEIQHVTPKEAWELTQQGTLLVDVRETDEVSQKRYDTSRYLHLALSTLPENFSQIPTNE
KVIIGCRSGVRSQKAIDFLLSQGYTHLANLERGILAWEEAGLPII
>SEQF1602_00182 30S ribosomal protein S1
MAEITKEQQEQLDNFNWTKYEQGIDQVDKDKLNEFERLVKDNFVDTQADELVIGTVTHLT
DREAIIDINAKSEGVISLNEFRYNPNLKVGDKVEVLVDIREDKTGQLVLSHKKARTIKAW
DRVNAAFESGEIVNGFVKCRTKGGMIVDVFGIEAFLPGSQIDVKPIRDYDQFVNKTMEFK
VVKINHEFKNVVVSHKALIEADIEEQKREIIGQLEKGQVLEGIVKNITSYGVFVDLGGVD
GLIHITDLSWSRINHPTEVLELDQKINVVILDFDDNKSRIQLGLKQLQKHPWEALSDELK
VGDKVKGKVVVIADYGAFVEVAEGVEGLIHVSEMSWSTHLRSAQDFVNIGDEVEAVILTL
DRDERKMSLGIKQLTVDPWTDITAKYPVGSRHTGTVRNFTNFGVFVELEEGIDGLVYISD
LSWTKKIKHPSEFCAVGDKMEVVVLELDVNTRKLALGHKQLEANPWDKYENEFGVGTIHQ
GTISKITDKGATVPFNEDILAFVPSRHLETESGKKLGKGDTADFKIIEFSKEFKRVVASH
TAIFKEEEEKNVKEAATQATQQVEKSTLGDLDVLQELKDKMEKEQ
>SEQF1602_00183 Lipoteichoic acid synthase
MKHIRTNEYLVFLYRIFLAYAFYMIARVLFFLFNRDIIPIENTSEFLSFLYYGIAFDTTA
ILYVNLLFILLSILPLWINTNKNYQKIVFYIYFITNIIAYSTNFPDMLYYPFSKTRLTTA
SFAVIENENNKGTLLLTFLGMYWYMFILFFLLVAIWVYFYKKIQIRPIKIGKKSYFISSL
FFFIFFGLLTLAGIRGGDLATSTRPINILDASRHVTIAAQADMILNTPFTLIRTIGKNKG
FREYNFVSEDYIEKNIKPIKEYHREVNQKPNIVLFILESFGKEYWGCMNTRENIPNYKSY
TPFLDSLAQHSYVFDNAYCNGWQSIHGMSSMLAGIPTLKVAYTSSPYVKQPTQSLVSIAK
EMGYDTSFFHSAPNGSMGFLGFSNILGIDHYYGKTEYNNEADYDGIWGIWDEPFFQYMNE
ILSKKKEPFFSTIFTVSSHHPFHIPKKYEGKFDKGNLEIHQCIGYTDYALKKFFESAKKE
PWFENTIFAFVNDHPNQTYYDRYKEPITNMGAAIMFFSPNPSLLKPGRSSDIAQQIDIYP
SLVDLMGYNKPFRSWGRSLFSHTEEPKAYITDGHNYRSMQGNYLYILDENGKVNGIYKKE
DRAMKNNLLGKEDNPEIQKGIQDLKAFVQDYMNRIIHHKLDPNNN
>SEQF1602_00184 Ferric uptake regulation protein
MGTNVENQEIVKKVFTKYLEEHAHRKTPERYAVLQEIYDSNEHFDIESLYIKMKNKNYRV
SRATLYNTIEILLDCGLVRRHQFGQNQAHYEKSYFDRQHDHVILTDTGEVVEFCDPRIQA
IKQTIEEVFDITIDNHSLYFYGRRNKKENTNEAQNQ
>SEQF1602_00185 Adenylosuccinate synthetase
MSVDLLLGLQWGDEGKGKIVDVLTPKYDIIARFQGGPNAGHTLEFEGVKHVLHTIPSGIF
RPNVINVIGNGVVIDPIILQKEIEALAPFGIDIKQRLLISRKAHIILPTHRLLDQASELS
KGKAKIGSTLKGIGPCYMDKTGRNGIRIGDLEHPNFPELYRELTDKHLSMIGFFKVSLEY
DLKKLEEEFFAAIESLKQLTFIDSEDYFYHAQKEGKKILAEGAQGSMLDIDFGTYPFVTS
SNTTASGACTGLGIAPNQIKNVMGIFKAYTTRVGSGSFPTELFDETGEKIAQIGREVGAT
TGRKRRCGWLDLVALRYAIRLSGVTQLMMMKADVLSGFDTLKVCTAYLYRGETIEHFPYA
TETEEITPIYTELKGWSSDLSAIKSAHDLPKELLDYIRFIEKEVEVPITLVSVGADRTQT
ILF
>SEQF1602_00186 hypothetical protein
MKHIYTYLLLLSACVLTPSCNTDGDIQQVGSNILGEPLFTPKKDSIPLEFNNIKESAIQT
NDLNNPIFGQLTQGNLGTTNVSIVSQVVLSTANPTFGEKNKTVETSSYNENETVEKVYLY
LPFYATEKTEKDPNDASKTVKTYKLDSIYGNKSAQFSMKVEELNYNLRNIDSNLENQVYY
SNTSLPTATTLAQVTVAGASNQAIVRKKFDDPTTTEDESTQEKDKLSPGFRIELSPTLFQ
SYLLDKEGDSSLSSSASFSQVLKGIVISSSNFSQDLLAQINLKNAKIEVIYTYLYKKDNR
DYTKRNSFELSLNGIYFNKYEVTNQNVTLSDDSIYLKGGQGYTAEITIPENNRIFQMLKT
KKPIINQADLLLYVDTSKVNVSQLPSYVLPYNADKGTILSDYAGELTNKISADISSIGKL
KKDKAGNYYYHIRITDHLTTLIKNNADNVKIGLAVSTHLSQDSRTTISAMKSIKYKDSNN
QEKKTVLGTAENTLYTVLYGNSSSVPEAKKLKLIVYYTLTE
>SEQF1602_00187 Peptidoglycan-N-acetylglucosamine deacetylase
MTKHTYNCLFLALGIGIGYYLHQGWWYYLGVILLFVGILSWGVFDIRLSYFIPTIYHLKN
RKVKQVVLTFDDGPTELTPRFLDLLKRYEAKAVFFCIGYQVEKHPQILQRIKEEGHLIGN
HTYSHIPQNCFASTATMICEIQRVDNILAKERVTTPYFRPPYGITNPHIAKAAIQTNKKV
VGWDIRSLDTVIKDEERLFKRIVSKLSQGNIILMHDTSERTLRVLERLLQYLQGHHYKIV
NQIE
>SEQF1602_00188 Anthranilate 1,2-dioxygenase electron transfer component
MIRYIHLLLAIVASVFFALAAVTGIVIGINNIDRQYPSYRAENLDQITLAQSIVGVKSAY
VDVSSLTIDPRGFAVIKATDMEGKEVNAHIDPLTGKVLGKIEEKSAFVKKMVSLHRSLEL
KNVGRIIMGFIALFLVFSSVSGLILIFKKQNGAKNFFKKTVKDGFSRYYHTLLGKWVLIP
LLILGLTGTYLVYNRFLGAKIEANHQVDYAIEEAYDGEDPMDVQQIAIFKQITLDKVVSV
EFPFDTTPEDTYLVKLKDKELVVSQFTGNVLSEITYSKTQVFARFCKDLHTGRTSVWWAA
VLVFSCVGMLFFIYTGFAITFSRKSVKVRNTCTPTEAEYIILYGSEGGNTLVIAQKVLIQ
LQNLGKKAYLTPLNSYQTYPKGSHLLIFTSTYGVGNPPSNADRFLSLLHSIPQEQMSYTV
VGFGSKLYPDYCAFAKAIDQELKGQSWAQPFLPLYTVNDQSIEEFLEWVKSWNTHSELLL
SEQKSSYEGERAPLFSLKVLNTIKETEEGHIFTLQLQTNKKYTSGDLLAIYPDGKQERLY
SIGKVGGQIQLTVKLHPHGLGSNYLYHLQKGQQLKARIISNPSFHIPKEAKKVIFISCGT
GIAPFLGMVDQNKNKELHIYAGFGHNNDKSKEYSAFFDEQKRKGKLREYHFIFSREQDEK
RYVTDLLKRDAAFVKETLDTGGVIMICGMLSMYKDVAQWIDESMPFSTAYYKASGQFLVD
CF
>SEQF1602_00189 Acyl carrier protein phosphodiesterase
MNFLAHIFLSGEGDDLLKLGNFMGDTVRGKQYLNYPKEVQRGILLHRQIDTFTDAHPLFR
QSKKRLVPFYGHYAGVITDVFYDYFLTKHWKNFSTEDLDGYIERFYTLIQEKKEVLNPQM
QSIASYMMRDNWLKAYQSYSGLAQILYQMDKRTDFRSQMQYAITSLQAEESLFEEEFLPF
FTQLQEFVDKKSDYQFLETQNSKPEIQN
>SEQF1602_00190 hypothetical protein
MRTFLFLFFVFSIQLYGQPEKLSSGKFILVPKKEAPQQPKGSEEKTSEVSSWLKNYQKDH
PTPSFSSEDKGVDFTGQYRKQYDKKEFTLPQSQTDLKLDKEQDLSALRGDKSYGEFNSTA
DAVGIFCRDYADVDGDLVDIYLNDELVISNVYLRGDYQRLHIPLKVGFNKIEIKALNQGL
YGPNTAEFRVIDDNNQVLINQTWALLTGYKARFVIVKDK
>SEQF1602_00191 hypothetical protein
MRRLIGITALLALLSACSDKKGSLSGDWRMESITVNGKQQPLDDCTKKTYLNFGKDSITY
HTFMPQADCKETVFHLAYKATKDSLKVTNETGRIERSYYAVKGDTLTITDTAEMGGQKFT
SNLILIKKK
>SEQF1602_00192 hypothetical protein
MKKVVLLGGGNVAYHLAKKLSQSTEYQLIQIYNRSPLSHEFDTIPVKKTSLMEALLPADI
YILSVKDQAIAPLSSSLPFEGRLVVHTSGSVPMKDLSDRQRRGVCYPLQSFSKEQEIDFS
KIPFCLETEEASDFDLLKGLAKEFSPKCYAIDSLQRQYLHVAAVFLNNFANHMWYLSQQL
CSNQQIPFELLQPLLEETCRKGLQHNFFEGQTGPAKRGDRTVIEKHLQLLQGIEKDIYKD
ISTSILTTYGQ
>SEQF1602_00193 3-deoxy-D-manno-octulosonate 8-phosphate phosphatase KdsC
MDNKNYKELLRDITTFIFDIDGVLTQCQVLVTNEGDLLRSFNVKDGYAIKQAINQGYRIA
IITGGNNIGTRLRFEQLGVTDVYMANHLKIEPLKDYMDKYNLHPKEILYMGDDIPDVAPM
KLVGLPTCPQDAVPEVKAVARYISHLGGGQGCVREVIEQVMKVQGKWLTELTHRL
>SEQF1602_00194 Aminodeoxychorismate lyase
MINYNGEIQQTSPALSAKNRGFLYGDGVFDLVKYVEGKLIFWEEHYLRLMATMRISRMDI
PDSFTLEFLESEIQKTIQGNALSGKPVLVRTTISRKEGGGYTPQSQEVNYCMDIEGITTP
FYQNLNIPYEVELFKDYYTQADLLSTLNTTNRMLHIIGSVFAKENDYQNCILMNTQKNVV
SFLDGNLFLVFGNQIVTPPLSDGAPNGITRKKLIEALGKTEDFSLEERSVSPFELQKADE
LFLTNTREGIQSVTKYRKKEFPNTIAVKLLGKLNTLARLG
>SEQF1602_00195 hypothetical protein
MKHTYFIKALCINILCIACARIGSPTGGEQDKTPPKVLRTTPANGSLHFTGNHIRIYFDE
YVTLKDIRKQLIISPPMEIFPNITPTGNASKYIDIKILDTLKPNTTYTFNFGKSIQDNNE
GNPLNFYTYTFSTGGYIDSLSLKGHIVDAESPKADNYVNVMLYEVGEKFSDSVVYKKPPM
YVSNTLDSLTSFKLTHLKAGKYLLVAMKDKDNNYLFDPKTDKIGFHQEFITLPTTDSSFV
LSLFKEKLPMKVSRPFLSAEKRISIGYQGEKDSIKVQPLDPLPADFKWAITKEPKKDTLW
LWYHPDIKDSLRLQVKGTGKTDIFTVKYRKMKGEKLTISSEHKSLSPTEEQITFLSNIPL
VAFNPKVLQIRDKDSTLVDYKVDFTPNSEKVSLTFPVKEGEKYHLTALSAFEDFYHQKSD
TLKESFSAKRAEDFASLKVSFKDSLSLPFIIELTDKDGKNVLYSQYIEKSSPTYHFPYLK
AGNYLLRIVEDKNHNKKWDTGNFLQRKQPEIIRYFAKEIELRANWEVEQDISFAKQAEEK
PKQPKEKSVKE
>SEQF1602_00196 Multidrug resistance protein NorM
MKQYINEFGYNLRLALPIILSMLGHTLVGVIDTAMVGKVGTLELAAASLGNSYVFLLMSF
GIGFSTVITTLTAESVKKHNTAETKSILTHGLLINTLLGVIIFAGLFLSKPLMVYTQQKE
EVIALAVPYVHMVAVSIIPLMFFQALKQFADGFSITQYSLYVTITANLLNIFLNYLFIYG
NWGCPRMGVLGAAVGTLASRVVMPILLWGILYKDTRMTQYMKNLMPKIDSTVIKKFIHIG
VPSGLQVVFEAGVFIAATWLSGVLGQIYQAANQIALSIATLTFMIANGMSVVAMIRVGNY
KGMEDYISLRRVAISIFLFILLTQVVLGGLIGLLRYQLPEFFLNTEKLDTVDNIALVIEE
SAHLLLIAALFQIVDGLQTVALGALRGLQDAKIPMILSFISYWVIAFPICYYLGLHTSLK
TTGIWIGLLVGLTFSALLQTTRFLILSSRLIRNNQTKN
>SEQF1602_00197 hypothetical protein
MASFPKFLLGDNTDYPDAIFIIHTEFPRFILNLADDEVEWLEEFDKEDEEELEASAESLI
QEAIAFYDREISRYE
>SEQF1602_00198 hypothetical protein
MNSFIDTLNSLDQEMILFLNGLGTPLWDGFWLFVTNKWAAIPLYAWLCWLCYKHHSLKRF
FFILLCVAVMIALTDQLSNLFKVQFHRLRPCHNPLINGQLRFTRCGGQFGYFSAHAANTF
ALAMFLGQVLRPLYPRLLIILLLWAAVVSYSRIYLGVHYPFDVLTGLSIGLAIGYGMYFF
YQKIIVKRVK
>SEQF1602_00199 hypothetical protein
MYLNDFSQEYLVDSLEELEILLKKRFLEEVNFFILTFKENGFPQLSAFVRGNKCVIYYLE
EEVQYISKGKASEGIEVFVEDIHGTEVFLSKDKVLTIDKFYKVAQSFFEIQARPDFIEWE
KI
>SEQF1602_00200 hypothetical protein
MLTIDNQVYMVDSVEELVHHLIPLSNKIEAMLRLSLEDSWDSDALSCQIDKGKYLLLYYT
TDLDNPTEKYPRSYHRGLQTHKKVEIRGNFYDENTICYDYGLVLMLFKEFFQQKQIPLYI
LS
>SEQF1602_00201 hypothetical protein
MAVESFFVIETSFSDLKEKLREEIVRVDKEYDEKTICYEGFFSWMYFYKEGEAYIDEEEQ
AQLFVNIKHESATPPSVITAFREKLLSLGFCEI
>SEQF1602_00202 23S rRNA (uridine(2479)-2'-O)-methyltransferase
MLSKNQLKLVQKLSQKKHRSETGLFVVEGKKSIVEFVEAGYKAEVIYATDTFSASLGQQP
LTLVSKEELSKLSTLKHPDEGVAIFRQPKRKGILQEGLILALDNIQDPGNLGTLIRLCDW
FGIETLLCSEQTVDCYNPKVVQASMGSLSRVEVHYLPLAGFLVTCDLPVYVATLAGEDLY
TTTFPEDCVIVLGNEANGVSPEVAALANGAITIPRFGKRQQAESLNVAMAGAIIVSQIKG
KASEGSQLGM
>SEQF1602_00203 Lipid-A-disaccharide synthase
MKYYLIAGEASGDLHGANLMRALQQIDPKAEFCFWGGDRMEAVGGKLIKHYRDLAFMGFW
EVVTNLRTILRNIDFCKRDIIQFQPDAIIFIDYPGFNMRIAKWAKQRGIPTHYYISPQIW
AWKENRIKAIKRDVDAMYVILPFEKDFYEEKHQYPVHFVGHPLLDAIAARKEVSEEVFKR
ENGLDERPIIALLPGSRKQEIAKMLSVMLSVVGSYHQYQFVIAGAPSLGYDFYKQFIKEE
NVHFVSGKTYDLLSHGHAALVTSGTATLETALFRVPEVVCYRGNWISYQIAKRVISLKYI
SLVNLIMDAPVVTELIQGDLNTRNLKTELNKLLNPDYREKLLNNYEALREKLGKEGASER
TAQAIYTSLQNKRHYNRS
>SEQF1602_00204 Inner membrane protein YohK
MYISLSAKEPNITMTMKIFENPLVLLAITFGVYYGVLMLQQKYKSVFLNPVMLAVSVLIG
YLMIFNISYETYEQNAGMYIDFWLKPSIVAMGVPLYQQLSKIKKQLLPLLVSQFVGSLIG
ILSVCYIAKGLGADEHIIRSLAPKSVTTPIALEVSKTLHGITSLTVAAVIVTGILGSILG
FKVLQWTGIKSPMGRGISLGTASHALGIMAAFNLSEKHAIYASLGMIFNGIFTAVLAPIV
MPFIL
>SEQF1602_00205 Antiholin-like protein LrgA
MLIRYCAIIFGCLALGELIVYLTGIHFPSSIIGMILLTLFLHLGWIKLHWVKAFSDMLIS
HLGLFFVPPSVAILAYFDLIAKNFWSISVAIVVSTIIVMVVTGHVYQFIRKRTKHHHDHE
NI
>SEQF1602_00206 Na(+)-translocating NADH-quinone reductase subunit F
MILASEILTTITVTVVGLLVVILLLVAILLYVKQKLTPSGPVKITINNDKVIEVPLGGSL
LSTLGNEKIFLPSACGGKGSCLQCECHVYEGGGEALPTETPHFTKKELKEGVRLACQVKV
KQDMKIGVPEQVFGIKKWQATVVRNYNVASFIKEFVVEIPEDMDYKPGGYIQIEIPPCEV
KYSDIDITAHPVEHPGEPEKFKMEWDKFKLWPLVMKNPEPAERAYSMASYPAEGREIMLN
VRIATPPFDRAKGGWMDVNPGVASSYIFSRKPGDKVTISGPYGEFFINESNAEMLYVGGG
AGMAPMRSHLYHLFKTLKTGRTVTYWYGGRSKRELFYVEHFRELEREFPNFKFFIVLSEP
LPEDNWKVKKDIHDTEGDGFLGFVHNAVIEQYLSKHEAPEDIELYFCGPPMMNKAVQKMG
QDFGMPDENIRFDDFGG
>SEQF1602_00207 Na(+)-translocating NADH-quinone reductase subunit E
MLEYLTLIFKSVFSENMIFATFLGMCSYLAVSKKVSTAIGLGAAVIFVQTLTVPMNWLLN
QYILKEGALAWLGEEYASYDLSFLTYILFIATVATMVQLVEIIVEKFSPSLYNSLGIFLP
LIAVNCAILGGSLFMQSREETIHTFGLSVAYGVSSGLGWAIAILALAAIREKIRYSHVPA
PLRGLGITFITTGLMAIGFMSFGGMLTGGSSKKEEPKKETTVQQEVKTDKLANNTKDLSN
DFSK
>SEQF1602_00208 Na(+)-translocating NADH-quinone reductase subunit D
MGLTKKDIKLVTDPLWDNNPVTVQVLGICSALAITAQLKAAIVMSLSFTFVLAMGNVAIS
LLRNVIPPKIRIIAQLIVAAALVIVVDFVLKAFVYDLSKQLSVYVGLIITNCILMGRFEA
FALGNPPGKSFLDALGNAGGYSIALLIVAFFRELLGSGTLLGFQVLGDPIKKTGVYALGY
ENNGFMLLAPMALVTYGIVVWVQRSRNKALIEEGH
>SEQF1602_00209 Na(+)-translocating NADH-quinone reductase subunit C
MAIKTESNSYTVIFAIVMVVIVGALLAGVSSALSGQISENKKLEKKQNILYAMGVSHNEG
ALGEGEVAFLTTNEANAEFDKYVKAQYLINPADNSAKEVKGAEDLINFNGHRAGLPLYVG
EKDGKTLYIIPVNGRGLWDAIWGYIAVDKDLIVQGVFFDHKGETAGLGANIKERFFMDDF
IGEHLLDAAGNFQSIQISKSNGDPENTRKEDGKVDAIAGATLTGNGVAEMIQHGLSPYVS
YIKSLNQ
>SEQF1602_00210 Na(+)-translocating NADH-quinone reductase subunit B
MSLKSKLHTLKEKYKGTKWETTFNALHTFLYTPNEVTHGGTHIKAADDLKRTMNTVIMAL
IPCLIFGIFNAGYQHQVAFGTLEPQAGMSFFSGDFWSGANFCIGAMKVLPLVIVSYLVGL
GIEFIFATIRKHEVEEGYLVTGMLVPLIVPIDIPLWMLAVAVAFGVIIGKEVFGGTGMNI
LNPALTIRAFLFFAYPTSMTGDKVWVEGAVARAKEIAGGAQLDAVSGETILGNLAQGQTG
TYQLSDLFYGFIPGSVGETSTLLILLGALFLIYTKIASWRIILSTFVGAFVMGSIFNCLA
PSMEGTQFYALWSLPAYEHLLIGGLAFGAVFMATDPVTAAQTNTGKYIYGFLAGFIAIMI
RCFNPAYPEGVMLAILLMNVLAPTIDHFVVQANVSRRKKRLKLTTKTA
>SEQF1602_00211 hypothetical protein
MARPATKQDLEALAKENYQKLVSLIEALSDKEREKAFPEGTMNRNIRDVIGHLYYWHLLF
LNWYEVGMRGEKPKIPKEGYTFSDTPKLNREIWEQCQKVSLTEILLLFETTHNKVFQLIQ
KHTDEELFTKKKYHWTGSTSLGSYLVSATSSHYDWALKLIRKSIKKK
>SEQF1602_00212 Na(+)-translocating NADH-quinone reductase subunit A
MSSDIRIRKGLDIQLEGKAEAITKVAPLSQVYGLRPAEFHRVIPKLIAREGATVKAGDPV
FYDKRDERVLFPSPVSGTITEIIRGERRKILEIRITPDAQQSFHEYEKKQVDSLSPEQIK
EHLLQTGCWPLIKQRPYDVIASVDSQPKAIFISACKTNPLAPDYDYVLKGKEKELQVALT
ALSKLTTGKVHVSVFKDSSLSPFRNLKDIVLHNVSGPHPAGNVSTQIAKISPINKGEVVW
VVSPQDLVVIGELFLTGHLNLTRTVALTGASMETPHYVTAIAGAQIKGLVGTGVKDPTNT
RIISGDVLTGQKVCENTFLGFYDDQITAIPEGNDYDLLGWAKPISNKISLTRALTFSWLN
PNKKYNLNTNTNGEQRAFVVTGMYEEVFPLDIYPMQLLKACLYKDLDELENLGAYEVAPE
DFALTEFVCVSKQPHQQIIRDGLDLMMDELG
>SEQF1602_00213 hypothetical protein
MKKILLSALAVFAFSFANAQEQEIVSSKGENYLPQQGDWSIGFSANSALSFVGNAFNGST
GNSVAFDKNDATKLPGFANSVSFLGKNFTEDKKADRYTVNLLFSYEKQKDVDATTQFGLL
AGYGKEWRKGSTRLQGFYGFDGLVGFGIPQKNAFSFLIGAQGFAGAEYFVFPKVALGAQY
AYGVFVKHESSEDAQGNKTSKFGFNIGNTNSGFGTASVLLNLYF
>SEQF1602_00214 putative ATP-dependent helicase DinG 
MELNLTRPICFFDLETTGTDVSRDRIVEISILKVWPNGNRESKTYLVNPTIPIPPASTAI
HGISDERVAQAPTFKELAKQIHAMIKDSDLAGYNSDRFDIPLLAEELLRAGVDFDLKNRV
TVDVQTIFHKMEQRTLSAAYKFYCKKELDNAHTAAADTEATYEILKAQLDTYSDTLPNDI
KQLSEFTTRSQIADFAGFIAYNDKGEEIFTFGKHKGRKVEEILEEEPGYFGWILNADFPL
YTKKVLTAIRLRKGLGQ
>SEQF1602_00215 Aminopeptidase N
MKYTKILSLAALSTLGVAQAQNAPYWQQHVDYKMDIDMNVKNYQYTGKQELTYTNNSPDT
LKVVFYHVFLNAFQPGSEMDARLQTILDPDRRMVNKKEVDGKTINESRIASLKPEEIGYV
RVNSLSQDGTPVKYITEGTIVKVDLNKPLPPHSSTVLKMDFAGQAPVMIRRTGRNNPDGV
ALSMTQWYPKLAEYDYRGWNTTEYITREFYGVWGNYDVKITIDKDYIIGGSGYLQNNNEI
GFGYEDAGVKVPKVKGNKRTWHFYAPQVHDFAWAADPKFVHDKIDAGNGLTVHFLYKNYP
ENWKKIQPEMVKTFDFYNKYVGKYPWKQYSFLQGGDGGMEYAMCTLIEGGKEYSSLLGTA
VHELGHSWFQHLLASDETAYPWLDEGFTSYIQDRALAMLGAKEPFSGFHKSYGKYVASKY
EETPTHQSDRFNTNYAYSVTSYSKGALFLRQLEYIIGEKNVEKTLQLYFKKFAFKHPQPH
DFIRCAEKVSGMQLQWYLNEFMQTPDHVDYAVDKVAAKGNKTEITLRRVERMPLPTDVFV
VDKNNKTHYYYIPLRMQFGEKENPYSYERKVLPTWGWAHPTYTFEVDIPFENIQKVVIDP
NHVTTDINIENNTFQK
>SEQF1602_00216 hypothetical protein
MKRFILLAFLALTLPVVAQSKNAKAQLNVEGICNSCKARIEKAALGVKGVKYAQWNVNSH
QLSLILDKRKTSTAQVQEAIAKVGHSNSLVDGTHKVEASEEDYNKVSDCCKYRDEEVVKN
HH
>SEQF1602_00217 hypothetical protein
MKKYIILALLMLPLSLFAQTMVQGKITLKDATETFAEAGVSIYWEGTTIGTTTDDTGHFK
LLYKPELKKLVVSHVGFKTKVITITDPVRFVTSTLLEDANQLDAVEVTIAKRKPTERLQM
NNAGMVNINSGELLKAACCNLSDSFETSSNTEVAVADAVTGTKQIKMLGLASPYLSLTQE
NVPSIRGASQVYGMTFIPGSWVDNIQIIKGAGSVINGYESIAGQINTELVKPILDTPIYL
NVYGSEDGRFELNNHLNTKVSDHWHTGLYLHGNVRNMQMDNNGDGFMDVPTGSQINLMNR
WQYANPNTGWMSNLTLHYLYDARKAGQLSSVSAPTLWQSENKTHQLNASAKLGYIWEDMP
YQSLGFQADYKQYEQDSYFGLNQYDISQKTIYLNALFKSIIGNTNHTFTTGVNSITDIIT
ERVGATSLSDNYDRTDFSAGAFFEYSLSAGDVFGLTAGARADYHNKMGAFITPRFHLRYM
PWKKGTLRLAVGRGERLASIFSENQKLFSTARTIRLGGTQTGKTYGLSPEIAWNYGLSFT
QYLTLGKRDLEIVADLYYTNFTNQVVVDWDNPREVSFYNLIGKSFSTNFQIEANYEILKR
THLKVAYKWFDVQTDYASGRRTQPFQPKERWMVNLSYETVPQEGRQWRMDATFNAIGSQR
LPDTSANPVAYQMGDTAAAYTTTQAQITRVFSPMIEVYLGAENLFNYYQKRAIIAPDQPF
GTYFDASMAYAPLQGRMIYAGLRFKLK
>SEQF1602_00218 hypothetical protein
MNTVFAKICAFVMTLCLLALPLTSEATPHACQKQHTQQHKQAKSCHKDDVPECCKEKQGA
APKHTCCQVAPMSSYARLEKTELEHTLKLVQKQVVPTIISPKVVFLIETISMKGKQPFYS
SSPQLTRNIPILFQQFLC
>SEQF1602_00219 hypothetical protein
MKRTVSFILSLLILLIAFQQTLLIVHYHLNRDFIEKAYCINKDKKEMDCHGKCHLKKNIE
DTSHTSDKLLNLKDIDIVLQQPFSFETAIVHTLEEMPPFFFKEQLLIHKIVKKQMRPPIS
STTYLC
>SEQF1602_00220 hypothetical protein
MRNLKTFLIATTAIVALSSCSKDNNTPQPAKPNPGQEEKPTPELQGNGKIALQFENYVGE
EKLTLGADANAAKAYTSNGQTLKFSEVKYVISNIRLIKTDGKVVDYNSDNLDTGAFVLDQ
SKPTSLKIDLNNLPSGQYKEIQFDYGIRKELNNLDETKFPKFYNAAGKNDTRMHWEWGKG
YRFTKIEGFWGDQDKPLSIHTGSTIKDRDTKKIGVDACRIIKLPFPKEISISNKDTEISI
IADFDKLLNGTKKITLTEDDPDNNPNHSATPSTHSALQMIDFVNNLAGDNQNNTVGMFKI
ATLK
>SEQF1602_00221 Cytochrome c551 peroxidase
MHFYLQNIKINTLKFFIFVLFFSSCKKEETAKIELFNNPVLSLDKPSNFPEFDSYNLRTN
APTLVGVEIGKKLFFDKQLSRNNTISCNSCHTSAYAYGDNKHKAIGIDGRIGLRNTPPIQ
NMIFLNTYMWDGAVIDLKDQPIIPIITHEEMDSSISEVLRKVQKDDTYIKLFKRAYPDGE
ITSKRILECLAQFMFTLISANSKYDKIMRNEGVSFSAEEQKGYLIFQQKCASCHKEPLFT
DQSFRNIGFPKNPNKIEEKGVARVSGEKADLYKFRVPSLRNIEVTAPYGDHGQFTSLEEV
LSYLDQGVENDANLDPYLKENGNRIPLSKEEKKYVISFLKTLTDYTFIKNN
>SEQF1602_00222 hypothetical protein
MKKILLTILVCASLAFTQCKKEDNSDPLKKEETKPSLKDFSLSQNNVSLTKETEQKIEIT
SGNNEYTFEQSEEDKKIAQVSLSSDKKEVVIKALTEGKISIKITDVPSKKEISLVIFVFS
KVTPKDYELSPDKKTLIKWIGSNTKSLDMNIIEALKGVTNIEEEAFSENKNIEQIILPKG
LTSLADKVFVDCINLKTVSIPDTVISIGRGAFGGCTNLEEVQLPKGLTEIKDTFFYGCKS
LTKITIPEGVESVGYNAFEETPIKEIIFPTALKTLDTDVVAWCEKLEKIVFKGTTPPTID
YSSLKRKVENPPLKIYVPKGKKQTYINSSEEWKDLEELIVESNS
>SEQF1602_00223 hypothetical protein
MRNFRTLVIATTAIAALSSCSKDNNTPQPGKPNPGQEEKPTPELQGNGKIALQFENYVGN
EKLTLGADANTAKAYTSNGQTLKFSEVKYVITNIVLVKADGTKVAYHTEDLDKGGFLINQ
ENTASLSPILSKIPQGDYKGIEFGLGVKKELNNLSLQDKFPNFYRLTGSFKQAQIMHWEW
ANGYRFVKLEGWFSNPTPGKNNKGEDLPAITDGELSIHIGSAFKGTKVVDDDQKVKEIKD
EVLNTDRDAFRFVSLEFPKLLSVKENTPAKVTIKADFDKLINGTNKISLTGKIPVVHSLA
NMFPFVNNIGGNQGIDGKQIIIKDIPTKKNPDPKDPQSGLDNSKLDKVGMFSVINVE
>SEQF1602_00224 Cytochrome c551 peroxidase
MKNILTFYLLLFFLYSCSKNSSEEAQQITNPRLSLNIPSNFPPLNPFIESAYPTQYGVAL
GEKLFYDSRLSHDNSISCATCHIPKQAYADKNPRAVGVAGRIGLRNTPPIQNMAFLTEYM
WDGAVTDLKEQPVTPIVTHEEMDSSLLEVIEKLKDDPAYKQALLKAYGDTKFSSERILGS
MAQFMYTLISANSKYDRVTRDHTETFTPVEEKGYTLFKQKCASCHKGALFTDESFRNVGF
PKHPDVVEEAGRGRVTGNNDDLHRFRVPSLRNIEYTAPYGSFGQFASLKDVLDFFSNGVT
DYPNLDPILKNNDKKIPLTEEEKEALIAFMLTLSDKAFVGRK
>SEQF1602_00225 hypothetical protein
MKELPISAPEQIIQLIPQRSPMVMVDTLWEYTPETAVVGLTITQENIFVQEGNLSASGLI
EHMAQSIALHKGYGYYLKALPTPMGYIGAIKHIEIQSLPKKGEDIRTHITILQEFMEVTL
VRMETYIQDICIAQGEMKTVLAK
>SEQF1602_00226 DNA gyrase subunit B
MSEFLVTNIMSEQLDPNKYSADNIQSLEGMEHVRVRPSMYIGDVGVRGLHHLVYEVLDNS
IDEALAGYCDTISVVINPDNSVTVEDNGRGIPVDIHKKEGVSALEVVMTKIGAGGKFDKG
SYKVSGGLHGVGVSVVDALSTHLTATVFRDGKIWEQEYERGIALYQVKEKGKTEKRGTKV
TFLPDTEIFQQTVEFNYDILANRIRELAFLNKGIHITLTDLRHQDEKGAPISQTFYSEKG
LEEFIQYLDGNRTPIIKKIIAMEGEKNEIPVEVAMIYNDSFNENLHSYVNNINTHEGGTH
LQGFRMGLTRTLKNYADKSGLLEKASKDKKNPLEISGDDFREGLTAIISVKVAEPQFEGQ
TKTKLGNREVTAAVSQAVSDMLESYLEENPEDAKTIVNKVILAAQARLAAKKAREAVQRK
SPMGGAGLPNKLADCQDKNPENCELFLVEGDSAGGTAKQGRDQKFQAILPLRGKILNVEK
AMQHRVFENEEIKNIYTALGVTIGTEEDAKALNISKLRYHKIIIMSDADVDGSHIATLIL
TFFFRYMRELIEEGHVYIATPPLYLLKQGKKEQYAWSDEERDAITKEFYEQAQTKVAVQR
YKGLGEMNAEQLADTTMDPRHRTLRKVTIENAVEADRIFSMLMGDDVPPRREFIEKNAKY
ANIDA
>SEQF1602_00227 hypothetical protein
MKWQGRRQSDNVEDRRGVSTTGKIAAGGGLIGIVILLLQMFGGETGQAVAPLLEQFNQTQ
QTSQVANEADLTEEQKQIKAFTATVLADTEDIWEKIFRENNLGTYQKPTLVLFTDAVQTA
CGNASSAVGPFYCPGDHKLYMDMSFFEELRTRFGAKGGDFAIAYVMAHEVGHHIQTLLGT
SQKVRQAQQGLSQKEANKLSVALELQADFYAGVWAHYDKQYLDADDIEEAVSAANAVGDD
AIQKRMQGQVVPDSFTHGTSKQRVEWFMKGYNTGDINQGNTFNNN
>SEQF1602_00231 hypothetical protein
MKSNIRPSFYIGGLAEFAFNDVVLMDAGLTYSNQGAKAKEGDGKYIQHTLNLPVWIKYDF
EGFRPKAGLYAGYILSAQGKSNGKTETIDSNAYNHFDYGIGLGAEYNLPNNGLFFEASYN
WGLANLDKNGDSKNYTNNRVIQIGVGYKF
>SEQF1602_00232 hypothetical protein
MKKYFLFLILSLFTSLAKAQIQSVVLQNYFNDFQKAQLSLQALHEGKKYAEEEQLLLTYI
KKLEEVSLSEKEQKDYKNLIRGVKASMNYNLACVCALQNKKKEAIAALEKAVALGYDDYR
NVKTDKDLVNIRKEKKFVALLQKLKAFDKLALLQQSGAYQKEQRDTLPHFTYQSATDPSL
VQVKNYFKLDSVVGTGDELSKIFKLLHFVHDNIAHDGGNYALCEFDAIDIYNYHKATKKG
VNCRHLAITLNEMYLAMGIPSRYITCMPKNPDDSDCHVINSVYSSQLEKWIWIDPTNNAY
VKDEKGNLLSIAEVRDRLIHNKPLVLNEDANWNNKEKQTKEEYLENYMAKNLYWFSCPLQ
SQFNPESRFRKTATTFVALLPTGFVKPNGKEEYISHDPDYFWEKP
>SEQF1602_00233 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase
MKKFSLFHSSFFTLDFFTQFIFVLFPEIPLAQQILLACKAKGIRHIVLSPGSRNAPLTIG
FASDAFFTTYSIVDERCAAFFALGLAQQLREPVVVACTSGSALLNYYPAVSEAFYSNIPL
VVISADRPASKIDIGDGQTIHQPHALAAHTAYNANLSEENKALSFNEYLLNEALNTAALK
LLPVHINAPFEEPLYRTLPAPTVTFHNEIGIKKQIPLNCEKLLQFTKDWIYPKKMVLIGV
LPPDAMAQKWIDWLQKDPSILVLTESTANVVAESFVGMIDTFLSPIQKRNLQELLQPDVL
ISIGGMVVSKKIKEFLRQYPPRAHYYIDEQVGYDTFFALTHHFKTDINTFLEAVTPELPL
VSFDYKGVWLPIYKETLAKRSAFLAQIPFSDMAVYQAILEQIPTPYHIQISNSAPIRYVQ
LFPAKDGWEIFCNRGTSGIDGSTSTAIGASVVQSLPTLLITGDLSFFYNSNALWCNYIPK
TLKIIIVNNGGGGIFRILPTDKETSFFETFQETTHSLTAEYLCRMYGITYLQAENKESLT
EGLKILFSDHENPILLEVFTPRMLNDTILKDYFNTLS
>SEQF1602_00234 hypothetical protein
MKKIVLLVSSLFCLNSCADLQSIMNNTQQTGALSSLDISNGLKQALELGISQGVDLLSQK
DGYYGSSLAKILFPEPLQKVDKTLRSIGLGSLADEGVKLLNRAAEDAVTQAKPIFINAVK
NLSFSDATAILTGGKNAATEYLKNTTTQSLVQAFSPKIEASLSKVGADQVWNNIITKYNS
IPLVTKVEPNLTSYVTEKAIDGLFLQIAQKEEDIRTNISSRTTPLLQKVFAKQ
>SEQF1602_00235 Peptide chain release factor 3
MSLEQEISKRRTFGIISHPDAGKTTLTEKLLLFGGAIQEAGAVKSNKIKKGATSDFMEIE
RQRGISVATSVLAFTYKDHKINILDTPGHKDFAEDTFRTLTAVDSVIVVIDVAKGVEEQT
EKLVEVCRMRNIPMIVFINKLDREGKDAFDLLDEVEQKLGLRVTPLSFPIGMGYDFKGIY
NIWEKNINLFSGDSRKNIEETIAFDDVSSPELEELISSQSAQRLREDLELVYEVYPSFDR
QAYLNGTQQPVFFGSALNNFGVRELLDCFVEIAPSPLPKASDVRIVQPNEKGFTGFVFKI
HANMDPNHRDRLAFVKIVSGTFERNKPYLHTRLGKKLKFSSPNAFFAEKKEVVDISYAGD
IVGLHDTGNFKIGDTLTEGEVLHFKGIPSFSPEHFRYINNADPLKSKQLEKGIDQLMDEG
VAQLFTLDFNGRKVIGTVGALQYEVIQYRLEHEYGAKCSYENFPIFKACWVEEPENPKDP
DYLDFLRVKQKYLARDKQGQLVFLADSAFSIEMVKQKYPQLKLHFTSEFDK
>SEQF1602_00236 Dipeptidyl carboxypeptidase
MSLLEKTALPYQAPYFSQIKSEDFAPALLEAMALQQQAITAIVQQTAPPSFDNTVLSLEK
SGEALLRVANLFFALAGADTNEVLQQTEKEILPLLAANEDSIYLNDKLFERIEVLYQQRA
SLSLDSESLKLLEHYYDLFSLRGANLSPEKKEALKEINNRLASLENDFNYNTLQARHQAA
LSIEKEEDLVGLSPEEQKMLLQEDGSWKIALTNTTQQPLLSQLEKEETRHRLFQQSWNRA
SQGAFSTENIVLEIIALRQKKATLLGYDNYAQWSLQKSVAKTPQTVMNFFERLLKPTFEK
VAKEVAFLKDFSGKDQIAPHNWDYYAEKVRKAQYDLDENQLKPYFELFNVLEKGVFHAAT
ELYGITFKHRTDLPVYHPDVVVYELFEADGSPLGLYYGDFYTRESKRGGAWMSELVTPSK
LFGQKPVIYNVCNYTPPTQALPCLLSFSEVETLFHEFGHALHAFFAEQQYATLAGTAVAR
DFVEFPSQFNEYWALHPEVLPHYARHYLSQEVITPSLIEKLKASRDFNRGYAFCEVLSSA
YLDMQWHTLPASAQVTEVAAFENEAIKRFPKEVPVRYRSFYFSHIFGGGYAAGYYAYQYS
EILAEDTYHWFESHGGLTRQNGDRFRSLILSRGNTMDYQEMMKLMIND
>SEQF1602_00237 L-asparaginase 2
MRKTFKKIALTLLVMMSVVALAQKPKVRILATGGTIAGVSKSATETNYKAGELGINQLLQ
AVPQVRDLADVSGEQIVKIGSQDMNDDVWLKLAKRINELLNKEGYDGVVITHGTDTMEET
AYFLNLTVHSAKPVVLVGAMRPATGMSADGPLNLYNAVAVAADKNAQGRGVMVCMNDLVL
DAKDVIKSNTTSVDTFKGSIYGPLAYIHNGKIFFGRTPTNKHTTESPFYVDNLKVLPKVG
IVYSYSNASELPMKAFIDAKFDGIVHAGVGNGNFYHTIFDLAVKAQQKGIQIVRSSRVPT
GATTEDAEVDDAKYHFVASQGLNPQKARVLLMLALTKTKDWQQIQQYFNQM
>SEQF1602_00238 Serine/threonine transporter SstT
MKKIYKNLLFRVFCGIVLGILVGKIAPEWFYRILLTFKGIFGNFLGFAIPLIIMGLVMPS
ISALGKSAGKMLLVTVAIAYSFTLFSGFSTYFVSDALFPSLLEGQKMDDIGEGILALPYF
TVPMPPVMDVMTALLLSFVIGIGLSIREHSVFVEVIKEFGEVVSWLIAKAIIPVLPYYIM
SIFAQITFEGKVVAVMGVFFKLIGILFVMHVVLLLLQFAIAGSITKKNPIKALMTMLPAY
ATALGTQSSAATIPITMRQAIQLGVSERVAGFVIPLCATIHLSGSTMKITACAIALMLME
GMPFDIELFAGFIPMLGIIMIAAPGVPGGAIMASLGILSSMLGFSEIQQGLMIALYVAMD
SFGTACNVTGDGAVALIVQKVIKE
>SEQF1602_00239 putative sugar kinase YdjH
MNNKLLTVGTLAFDTIETPFVRVERTMGGAANYSALASAIFDIEQAVVSVVGEDYPASFL
QILSEREIDITQVEKRVGKKTFFWSGRYYENMNERETLETQDGVLQDYIPKLPSHFLDAS
FVLLGNQHPQLQLEVLDQFVAPPSLIVSDTMNYWIDHSFEQLKEVIQKTDVLTVSDQEAF
AITQEKVLLKAVEKLQQMGATYIIIKRGEHGAMLFHEDKSFYTPALPLCKVCDPTGAGDT
FAGGFVGYMAQTGDISFENMKNGLVYATVLASFCVEEVGASKLLTINKEEVLRRLFSLKE
LTQFDIKVV
>SEQF1602_00240 Amidophosphoribosyltransferase
MSDAIKHECGIALLRLLKPLSYYQEKYGTPFYGIHKMYLLLEKQHNRGQDGAGIATVKLQ
MQPGERYIARVRSNDAQPIQDIFKQINQHINDLLEKNPTLKGDVDQLKRLVPYLGEVYLG
HVRYGTFGKNSIENVHPFLRENNWNYRNLILAGNFNLTNVNELFNKLVELGQHPIAKTDT
ITVMERIGHFLDTEVEECYQKLKAEGISKKEASVLIAQQLDMIRVLQRAATRWDGGYAMA
GIVGHGDAFVIRDPAGIRPAYYYKDEEIVVVASERAVIQTAFNVPFERVEELSPGAAILI
KHDATTQIAQILPATERKACSFERIYFSRGSDQEIYRERKKLGALLLPKVLKSIENDLTN
TVFSYIPNTAETSFYGLIEAVSEHLNQQKKQQILQAGNTLSESQLTQILSVRPRIEKVAV
KDVKLRTFITEDSGREDMVAHVYDITYGAVRRNEDNLVIIDDSIVRGTTLKKSILNILSR
LEPKKIVVLSSAPEIRYPDCYGIDMARLEDLIAFDAALELHKDRGTYDIVAQIYHKCIAQ
KHKPDSEIVNYVKELYVPFTSEELAQKIVQLLRPETMTCQLDIIFQSVEDLHKACPKNLG
DWYFTGNYPTVGGNRVVNQAYINFYEGNKERAY
>SEQF1602_00241 hypothetical protein
MENNLKIKGNIWIETDTGLEINAAKALLLEQIDVLGSISEAAKVLNMPYRRAWGMIQEMN
RDSSFEIVAKEAGGKAGGHSILTEEGRNILQLFKDVNESLKQYSKGENGCFTGWKEA
>SEQF1602_00242 hypothetical protein
MGRYQYLFYKLYLFLKDKTIFKEWIFISESHPLEIKLSLLQLYASFQPVKQPFSPLLYCF
RLSFTSLKS
>SEQF1602_00243 hypothetical protein
MQGRSDYAQVTCILMLSMGNTPIFVADCLGIDISTIYRYRSLYLEGGLDKLLENRYRGYQ
GLLNIFQIESLKQELRTHLYTDAKQVSQWVKDTFGVTYTSQGMADLLNRIGFSYKKTTEV
PCEADPLKQKLFVEALSKILQEKEEGDVVYFAGGVHPTHNSRSTYAWIEKGKEFQQPTVS
GRDRLNINGLLNAYDVTDVIALDCECVNAESTKELYELALKKHPNAKNIYIISDNARYYH
NKELQNWVEDNRIKQIFLASILSEPQFNRALVEILTKKSNQYGFLSEQDRIPRCYKEFL
>SEQF1602_00244 hypothetical protein
MKYISKIQIALFLSCLMISCSQRPEPSNPFSDWEKEHLRGRVKQLITYQQYRNDTLPIIS
EYDTLGRLTFRQDHFNDEFFTKETFIYQFPICIWDPPSYSKDSLTGQDQMEYHETHVKDF
LDTPLQGSLDVFFLSENRIITRNDDGQISHIAYQEGKIVYFNYQTKNGKQYCTEVFFNNG
EEVVFSLKIDYDDKGNLQRLRSFGEKNTLSLEIGYTPDRQIKSITNYDKNQLKEGELKEE
KLYHYNDKGQLIKEIRYDQFIAEYQYNDKNQVVEKTEYNTKFPLDQAEKYRYQYTPQGDI
SRRELSYKKEDNTTATSVTTYRYKYDTQGNWTLKQTYRNGKYIEHQSRKIVYY
>SEQF1602_00245 hypothetical protein
MSAEIWNAIAVVKDPRVQGRIDYPLGLILLVSLYATISGCDDWEQIEDYANIHSEDLRNL
YTKLSGKELKVSRMPTHDTFNHVFQVIDPKEFLEVYKKFIISIYETLTGKTIAIDGKTPR
GIKQTANSHPSNIVSAYCTDHHFVIDHINSEVKGHELSSILDLIKLLFLENNTVTIDAAG
TYVEVIEMILSKGGNFVLPVKGNQKKLLEFIEKEFREYRGNTVSADTQEDIGHGRVEKRT
VYCITEIKTDDDIDGCMQKWKGVKTLVKIVREVYKKADKSTRIETVYYITNLIDPKEINR
AIRAHWGIENNLHRSLDVLLNEDHSQKSNHNVVENFHIMSLLALFIIKEISKQRGISMNR
TRKLCGYSSPSKLLVN
>SEQF1602_00246 Lipoprotein-releasing system transmembrane protein LolE
MKASLFIAWRYVRSKSSQNVINIINWMSIFVLIIGGASLMIVLAGFSGLRTFSMSFSNYF
DPDLKVLPKSGKIFSLTAQQEKALSQEKTVAHYSKILEERVFLNSQGKNYIAYIKGVDEN
YPKVNAVDSILVLSPKEWLLSDDYVVVGNIIAETLNLGLFTSTTPLQIIVPKAGKGSITS
TSTPYREETVLLSDYYQVTEDLDSKYVFTTLSLSQRLLGVKENDVSAIEIKLTKGISSEE
GKKRLLSVLGSDFVIKDRMELNEDLYKMFQTENLATYLIFTLVLIVALFNLVGAIIMMIL
DKQKNLYTLFAMGMTLSQIRRIFFLQGAIISLLGAIFGIGLGVGIAWLQKAYPMLYINPN
AMIPIPYPIDIRWSEIVVVFLTILILGIMASAIGASRTKIND
>SEQF1602_00247 Ribosome-binding factor A
METNRQKKIAGLLQQDLGDILGRAVQNGGLTNLILSVTKVAITVDLTLAKVYISVFPSEQ
GKEILKAIQSNSFQIKHEVAQRVRHQLRKMPDLSFFLDDSLEYLSQIEHSLKGEENPIEN
PELLIKRKKS
>SEQF1602_00248 hypothetical protein
MEKLTKLTNSIFSFLSSLSQNNNREWFSDNKKDYEKAKSQADSFFRAVYAAIQEKDHLGA
IKIYRIYNDLRFAKDKPPYKTHFGLYFGRLQPKYRGGYYLHLSPEQSFVGGGFFNPEPKD
LLRIRQEIAQEGEHFSQIMNSEPIRSYFSGQLWGQEVKTTPKGFDKDDPMIDFLRKKQFL
LKRDFTLDQVLADSFFQEVVDTFVAMRPFYDFMTQALTTDANGEPLYN
>SEQF1602_00249 Branched-chain amino acid transport system 2 carrier protein
MKKKITLLRVIVTSFAMFSIFFGAGNFILPPRLGQQAGDHWLLVAIGFCLSAVLIPIAGI
LVQARLQGSVLDFGKKVSPAVALILGCLLYGMCLAFPMPRTASVSYEMVSTSFTGTIPAW
AKYFFYIVYFLLVGYLCYQRNKVLDVLGKYLTPIMVGIIFLLILKAIFSISDIEISSFQK
PLAEGLKEGYQTYDAMSSIIIGGVISASLFMDNSLDKSQVKRLTIYSGIGSGILLFITYT
GFIYAGASQGGYFPAIVERVPLLVAITKHVLGGVGGLLLSIAVGISCFTTAVGIITGGAD
FFKEITKGNERTYRIFVTILCVYCVIVAPYGVEYIIKIAYPVLVLFYPVVIVLVFLHLLP
SYLASKTVFKVVSLVTFVTTIPLFLEQLGYHFFEVPFPLHEYGVSWLFPAFWAWITTVLI
EKTIVKSKK
>SEQF1602_00250 8-amino-7-oxononanoate synthase 2
MSLILPSSLLKAIDQRKKEDAFRSLSLKNYIVDFYSNDYLGLAHNPQQREYAQALLSREP
QHNGSTGSRLLSGNYPLIEQAEEQLAAFHQAPKGLIFNSGYDANVGIFSSIPLKGDVVLY
DQYIHASIRDGLQLTNAQSFKFKHNSLEDLREKLERFSGKYTTIYIATEAVFSMDGDIPN
LKEMVALAKQYHAYLIVDEAHSVGVFGERGEGLCQQLGIADEVFLRLITFGKGIGAHGAI
ALAQEPVIDYLINFARSFIYTTAPSPESIASVMASYKLLPELKERKMLQERITFFREKIP
FFPSTEQVYFMDSQSSIQGLIVKDTQRLRNLSSLLQTQGLGIKPIYAPTVPKGEERLRIC
LHSFNSQADIEQLFSLITQWLESQ
>SEQF1602_00251 Capsule biosynthesis protein CapA
MSYKYFLFISLIFCNLSYGQIRPTLIPVQRDTLASSLSKAPLALSPTKDTLSIVAVGDVM
IGSAFPLGYLPKDDAIESFKQVKPYLKGDIVFGNLEGAILNEGDSDKCKDKEEGSCYAFR
MPDRYGTILKEAGFNLMSTANNHANDFGEKGRLNTARVLNEVGIYHAGPVENKSVVFEKE
GIKYGFCAFSPNSHMISINATEKVINLIQELRPQVDILIVSFHGGAEGASYTRVTRQKET
FYGENRGNVYEFAHTAIDNGADIVLGHGPHVTRAVEVYKGKFIAYSMGNFNTYGRFSLAG
PNGIAPLLDIKINRKGDFLFANVLSVKQTKAKGLELDNNCKVYEELKRLTQLDFPETPLC
FEQDGIYLKEVVPTTAIQAIE
>SEQF1602_00252 hypothetical protein
MKKLFLTFLFFCQFAFVHAQEEAFGVIYDKDGYVNVRKGKSAQSKVLKRLNNKTIVFAYN
YDKAIDGNWIYTDEEGFIYNDRVKWIHEFPIIAKGIAKGNTIVFEGKEIQVVLTSGKFDK
SKHSFEYYKDSPSGVEVIDDKLPYGTDGKMPTTEYKSIVINIHGKQVSLPKDAYSDLYEP
TFSIDHNSVHYDKENDILYIVANNNYAERPYKVCWQIEKGVYKERKVGDLVY
>SEQF1602_00253 hypothetical protein
MKKLVVPFLLLFCQFVVAQAIEGGFAVINDKDGYVNVRKEKSVHSKVLKKLDNNTLIFVF
EYDKAQEGNWIYADNEGYIYNDRVKWIEKLPKIAKGIARGNTIVFEGKEIQVTLATEKFD
KDKHSFKYHKEYRDIIEKIDGKPFWGTDGNIPKKEYKSIEVKIRGKQVSIPKSAYSDLYE
SYLYTEFNSVYYDKDNDILYIVADNGDGAGAYMVCWQIEKGVYKGRKVGIPF
>SEQF1602_00254 Cysteine--tRNA ligase
MNHQLKIFNSLTGEKEIFVPLHANNVGMYVCGPTVYSNVHLGNVRTFMSFDFIYRALRFL
GYKVRYVRNITDAGHLTDDGDVNNDRFVKQSRLEKLEPMEIVQKYTVDFHKVLEIFNLLP
PTIEPTATGHILEQIQLTEKLLKDGFAYESNGSVYFDVLEYNRRGLNYGELSRRNIEELF
ANTRDLDGQGEKRNPQDFALWKKASPAHIMRWASPWGDGFPGWHLECTVMSTKYLGDQFD
IHGGGMDLKFPHHECEIAQGKAGHGQSPVRYWMHANMLTMNGQRMSKSTGNYILPMQLIS
GDNTFFEKPFAPAVIRFCFMQAHYRSVLDISNEAMLAAEKGFNRLMEAVKILNELTSEIE
HPGPLSSEIEQWKQKCYDALLDDFNAPILIAHLFEAVKWIFQVKSGEEKISIQELEELRS
LVNAFVFDVLGLKNEELNAANNDRLDGVLQLLINMRMEARANKDFALSDKIRDELLALGI
QLKDGKEGTSYSLN
>SEQF1602_00255 3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoyl:CoA ligase
MSTNYAYTHGASSIPLLGETIDENLKKTVEKYPDQEALICAHQNYRATYREFYEQVIQVA
KGLIALGVKRGDRVGVWSPNCYQWTLLQYATAKIGAILVNINPAYRTSELIYVINQSGLS
VMFSALQFKSSNYKKMMDDAREFTDTIRKTIFWDKSWDHFLKEGERISDETLRKREGKVQ
FDDPVNIQYTSGTTGNPKGVTLSHHNILNNAYFIGIRMNYSHVDRVCIPVPFYHCFGMVI
GNLACTVHGATMVIPNDSFDPVKTLETVERERCTSLYGVPTMFIAELQEMEQKTYDLSSL
RTGVMAGSLCPPEIMKKVKEQMNMHEITICYGMTETSPVSTQTKIGVPFEKQIYSVGTIH
DHLEIKIIDPETKATLKRGESGELCTRGYSVMLKYWNSPDATHQVLDEQRWMHTGDLAMM
DEEGYLHISGRIKDLIIRGGENISPKEIEDFLYTYKGVMDAQVIGVPSEKYGEEIMAWIK
PKEGVTITEEEIRDFCKDRIAHYKIPKYWKFVSEFPMTISGKIRKVEMREIAARELGLEP
EE
>SEQF1602_00256 hypothetical protein
MIEHLFTADAMIALLTLTFLEIVLGIDNVIFISIVTGKLPEQQRKKATRVGLFLAMFIRI
LLLLCISWLVQLKEPWISFDYGWCRADFNGQALILLVGGIFLLYKSTHEIHSKVNHIEHI
TDSSQAEKSRRSSFWGTIVQILMIDIIFSLDSILTAVGMTNGLEGALLIMIIAVILSVGI
MMLFAVPVGNFVNRNPSIQILALSFLILIGFMLLTESMHLSHAVIFGKEVGAIPKGYLYF
AIAFSLGIEFLNMRMRKKS
>SEQF1602_00257 hypothetical protein
MAIIKIIITFVTLKLLHILLMFDQQKFIARLQKIMNYYEINASTLADSLGVLRSSISHLL
SERNKPSLDFVLKITEKYPEIDLYWLLYGKGSFPKEEPREEPKEKLPPKKVTPITPPEIP
FPPIEPAQEKPIEKNVPLKDIPKKEVQKIIFFYKDNSFEIFENL
>SEQF1602_00258 hypothetical protein
MNFVYTTDTRIKGKYLYSGKLHQILHNYNLWKYQEGTSEEGQPIPLYRIGEGSKRILLWS
QMHGNESTTTRALIDLFKLFATEGYPFDNCQLYIIPMLNPDGADLYTRENARGVDLNRDA
VNLSQKESIFLRKIYQEVKPDFCFNLHDQRTIFGVGQKPATVSFLAPSVDVTRSITPVRK
KAMQIVIKINNCLQLLIPEQIGRFDDSFNPNCTGDQYSLLGTPTILIESGFYPEDYIREQ
TRRYVAEAIFRGIEYINDTEVTGEGYAPYFDIPENKKSFRDYCIVDDKEPTRRVYVQLEE
QLSEGKIVFVPKVVDKSEGEEFYAHTTYKFSEICRYPNNDIYTMIPDILEYIRKEVEKI
>SEQF1602_00259 Regulatory protein AsnC
MASRFKLDEIDHKILDMLIENTRMPFTDIAKALDVSAGTIHIRVRKMEESGIIKSSTLTV
DYDKIGYTFVAYVGIFLEKNHQTQFVIERLTEIPYITQASIISGKYNILCKIRARDTKHA
KEIIFMIDDIQGVYRTESMISMEESISDKKRLLHTVFKEL
>SEQF1602_00260 hypothetical protein
MNMLSFIPLYNHTNGTMMILLFALVCLMLTYAVASIINKNQKRKQ
>SEQF1602_00261 Glutamyl-tRNA reductase
MDMEMTQNTTQKETHFYTIGISYKKADADMRGLFSLDAEHQERILSLSQQEGMEGLAILS
TCNRTELYGFAQHPFQLIQKLCAHSKATLEDFEKVGYIYKNKEAINHLFNVGTGLDSQIL
GDFEVISQLKKSFSLAKKYNLINAFMDRLLNSVIQASKRIKNETELSSGATSVSFASVQY
ILQNVVDISQKNILLFGTGKIGRNTCENLIKHTQNEHITLINRTKEKAQEIAGRFNVLVK
DFALLEEELTQTDVLVVATGSKTPTITKEMLPSDKEMLILDLSIPKNVATDVEELSKVRL
IHMDYLSQMTDDTLERRKAFIPQAQQIIEEIKEEFDQWLQNRRFAPAIQALKQSLETLKE
GEIDFQRKKTTDFNELQASIISDRIIQKITTKFINHLKESSTPEESLLFMKQVFEL
>SEQF1602_00262 Regulatory protein PchR
MREENIARSASLFQEVEEGVFILHKENESNDYKIVSQEIKQHFIQFHFCDRAEVAFVFHG
GNYSLPLKEMESLLLYNPKEILPLQVRLAPGAALFSLFITIGKFHSLFLEESGLIDFLSP
GRQHEKYYTTGTISPHLSVILHQIRTVHLPKSLHLLYLKAKVYELLSLYFNKNQDNEGEA
CPFLSNEDNVQKIRQAKELLLSRMTSPPSLQELSEEVGLPLKKLKSGFKQIYGESVYGFL
FDYKMELARKWLTTEQYNVNELSLKLGYSMPSHFIAAFKKKFGTTPKRYILTKNTLIKQ
>SEQF1602_00263 hypothetical protein
MINYKAFLTYLAAIFCFAPSFFVFYKTITTYQRIDTLEKKTIWVKEVFYPKKRRKGSIKP
IEIHIGNEKEVKAMTIYDKVEKREADIFISREGWLRRSPKIHWKDKVTYYVLNDPYLKYT
SLTQIIGTYSMGGTPNIVGVCTTHYTRSSFQLFLDILHHYVNIGYLILVVALFSFIKESI
VDLDHYNWAKIIWMFSLSIQILIYFLVG
>SEQF1602_00264 N-glycosidase YbiA
MKPTFELMAPLWIAFPAYTEFTIGWRMGAGEDYKSKFWDWYESLTPAQQKEYQALFPYPC
FWHYNRWEEDDQDIDDEEDYYYEGIPVWQPKGAYKYSKATFIHSAKKLKFVFFWKPNAEV
VDESCFSQWQPSPFCVDGDEYYCAEQYMMAEKARLFGDEEVEKEIMNTSDPKLMKALGRK
VRNFDPQVWDKLKYSIVLNGNYYKFTQNKEMMDFLLSTGDKILVEASPLDTIWGIGLGKD
NEKAHNIASWRGKNLLGFALMEVRDEIRKVYQNVHLLK
>SEQF1602_00265 hypothetical protein
MNTTEKYAEEILQGIAKGFGKYIVKPPYQKWYLDEGLADYIVVKQNNNRIEVALDRDGFG
SVATKIEGIERLSGEEIEEILSIVQEKITEMFFDEVHFGKFQYQLTVVLNFKQANKEFYL
VNEPRKVELRERFDSYVQETTIDGSRKVIENEWISFLDKLFDTNLTQYTESQIIAVAEKY
MKSIEAMQNRNFLKEYRSSLIHRAGKWKKAVFMPLYYQVKGNEKCDKEYILKAEIAPEKV
DAEKLKLFVQQALWKIKYKQYSWDVKFACEDLERAANELASGKAKQYLKKGTGELPDNLI
HYKDSDLEADANDVFATISLKIKQETAEAYGKALDFIIALLKAGFSHSYQIKFSSKAPKH
FLDIKGLAKSSTHRFFAQALQYETLHPKLEKYAKVAMKEFEWYTDVEEGEKSCMPGSYAV
FGLGLTDKKYFPLVIEYFKLVDDEHQMVHKNFVSALIEQYGFSAETLPVIYEGVISSQDE
VIFKSLTESMKNPENKALLNDFLKDKEDYYQEAIYYAVYGKNWEKKK
>SEQF1602_00266 hypothetical protein
MKELLTPEALLTNFKDVRALTRKVIEAFPEKDLFEFSIANLRPFSEMVEEFLMITNYIFR
ETLHEKHTPFYTEGEFPTTKEGVLALWDKVTEIIEREWKEIVDYTQSLTIYQMTFTFAQW
ILYAIENESHHRGQGYTYLRALHIDPPFFWGRESFQ
>SEQF1602_00267 Succinate--CoA ligase [ADP-forming] subunit alpha
MSVLVNKNSKILVQGFTGSEGTFHAEQMIQYGTNVVGGVTPNKGGQTHLGKPVFNSVKEA
VEKVGADTSIIFVPPAFAADAIMEAAEAGIKVIITITEGIPVADMVKVAAYIKDKDCRLI
GPNCPGVITPEEAKVGIMPGFVFKKGKVGIVSKSGTLTYEAADQVVRQGLGISTAIGIGG
DPIIGTTTKEAVELFMNDPETELIVMIGEIGGQLEVEAARWIKETGNKKPVVGFIAGETA
PKGRTMGHAGAIVGGSEDTAEAKKRIMRECGIHVVDSPAKIGEKVKEVLK
>SEQF1602_00268 Glutathione peroxidase  BsaA
MKVSKLIFLFLIGIMLGKAQTKKQMNDQTIYQFEVEDITGKAFPLSSLQGKKVMIVNTAS
KCGLTPQYKELEALYQQYKDKDFVIIGFPANNFLKQEPGTNEEIASFCQVNYGVSFPMMS
KISVKGKDMHPLYQFLTQKSKNGVMDSKVSWNFQKYLIGKDGHLEKVIAPKTLPNDAEVI
EWINK
>SEQF1602_00269 hypothetical protein
MKKILIHILIIASAVYISFVFYKTIAIYSQIDTMKKTTALVNACYKQGLKLRAYLEKIDD
IKQKYKITFLYRATGLFSIRQVPQIKDKEEITYYEIEKCYFNKDDVFSTTNKVGISTEKY
QRSDFQLFLDIFSYYKNVLFYALFFLNCAFYCYVDSSDKSIKLFCIIYTIIFLFI
>SEQF1602_00270 hypothetical protein
MNKENIIHEILTGVTTAFDELDLPKKPYGRNELWEGITDYFKIKQRKNKIEFHNNEEEYT
CPSITIKDFEQLPDDFIDNELLPALEEQFTQMFFNPELYYRFQYKLALVLDFLTATGHHA
RKQVRLEHPERKAELKERLDTYVQKVIYEATEKMKEKEVHSFFDKLFDFELTGYSEDKVI
EILDKGITLIDPKWKKTLEEYQWSLLYHTREWKEKVFMKLYYKVEGSDWSKKYTLKEGLK
EKDIDNTKLNLFVAQALWRIKYKKYSWDVEFACEDLERAAKELGSKKAAMYLKEGTGILP
NELIHYKDSEVECDANDVFAQISVKIKQESATAYDKALDFIIALLKADFPASYYIKFSSK
APKQFLDIKGIAKSPTHRFFAQALQYEELRPKLVAYAEVAMKEFQWYNDVEEGEKSCMPG
SYAVFGLGLIGEEYFPLVSQYFSLLDDEHQMIHKYFVSALIDRYGVNEKSLPLICQGITS
AQFDMVFKNLEKEMEKPENKQLLAKFLKEKEAFFIANKEPGFYKYYEEDIYYAIYGKQWK
KKIKD
>SEQF1602_00271 hypothetical protein
MRKILYLHGLDSYLHADREEVLAPYGEILAPVFDYKNNPELFTHLCEEYQNIDVIIGSSA
GGLIGYFLAQKLQKPCALFNPALNYQHEMPFAPFWDKHYKEYMLLVIGMQDEVIPYKESL
PIALTDKAPEQQVDIHLIQNMAHSYPIEIFSQELKFFFDRVCRGELQFAL
>SEQF1602_00272 hypothetical protein
MRLLYFFSLLFLLSCTSTPEKPKAKKPHPDLKRDTLQGSIRTQTQVNYIFIEDTLTKKTL
QQKAYELSITYDPQGYLIENSYQDDSLQEQTRFYYDEEHRVIVENYMHKSLKNNEIKMTL
THYQYDTLGYEVSRLRYDYSDSLPKVTRFDTEYDKDGNIQSVVKSVFEQNDWQLSDREVY
KYNTKGYEQEKESYYYYRALWMLQEKKISRYEKDSLLVEKLFYNYKLHNLPSRVLYRYKG
LLQEVTYINPKDSITSMVSFEYNPQGEITKYVEYTPEGFEKKRIFHLYTPFRERLEDVTY
KNNTEDERTLYRYDVKGNLTEKITYRDQKITSKTEVKYTYYEAIPPVK
>SEQF1602_00273 hypothetical protein
MRIIKILSLVTLFASCDTPLFTPEEDFITPFELTDGGGGTSYEETIDFYKKLATNYSSVS
LKTMSTTDSGLPLYLVIFNSDGIFDFNRIRKNKMILFITNGMNEKAREGVDATMQLMRNL
AQKQIEIPAHTVVVTIPIMNYLGQMEQEALFKGQINTFLERNLNEDFIENKSLNTRSFVE
IFHQVNPHFLVDTYSLAGDVPSQSLFYQTIIPEKLGKVKYYLEENFIPQLSDSLAKHPAE
DTLGRASRKLLAYPSPQSFASTASIVGYASLWNTIGIQVASRMKNPYKNRVEDMYNALKN
ILLLVDSHKELIENLQDLEGKEMLKQQKYILSYRLVSAKDSLPIEKTLYEPKDTIAIAKS
YVIPQLLTKIIDNLKRNHIELHRFEKDSLLSVYAYTLKAPKDSLSFLTKEAMEKKMTLKK
QKIAIRKGDIWVPTGQKGRKYLLETLEPYSENGFMKTNMLPLLPTPKDSLWIYPIFSIEK
>SEQF1602_00274 hypothetical protein
MKIKIQQLLPHGVCLLLFMGIAMAFFYPLLQGKEMQQSDIIQYIGMSKERNDFRSVRESY
WTNSAFGGMPTYQLGAEYPHNYIKKLDKVIRFLPRPADYLFLYFVGFYLFLLVVKVPYRY
AFLGSLAFGFSTYLIIILTVGHNAKAHAIGYFGFVLAGILMAFQRKYLWGFLLTTLALAL
EINANHFQMTYYLLLLVLLLGGIKLYHAWKGGTLRPFFKGVGVLSVAALLAVLMNATLLL
TTKEYERFSTRGNSELTLTAEGTPKTNTHGLSKEYITEYSYGVYESLNLIVPRLLGGSNH
ENIGEKSATYSFLVAQGYDPIVVGQFTRQLPTYWGDQPIVAAPAYIGVVVFFFFVLALFV
VKRRIKWWLLSGVILSLLLSWGKNFALLTDLMIDYFPLYNKFRAVSSVQTILEFCMPALA
ILGLYQYLVHYKKEIYSRYLYYTAGIVGGTLLLLWLAKGGLSFEAPNDAYYAQAYGEDLI
RLIRQDRESMYTTDILRSLLYVVATFAIVYLFSIGKINEKIAFALVSLTLVTDTGNVTYR
YLSEDNYWLPSQTADYFLPSKEETKILEDKGYFRVFSLSEALNGARTSYFFHSPGGYHAA
KPRRIQELFDYQFYRNKNAQVLNLLNVKYILQNDKNGMVVMENPDALGNAWFVKKLSKVS
NADQAMQGMSTLDPKAEAITYDSSLSNKTYQVDSTATIELRSYEPDRLVYSTDNPQEGLA
VFSEIYYPHGWKAILDGSQELTIHQVDYTFRGVEIPAGKHTIEFVFAPTIVKTGGWISLS
ASLAFVVIAVGSVFVHRKKEKA
>SEQF1602_00275 hypothetical protein
MIQQASFMDFLGGLFTVLIVFVIGFWLLALLVPTFLRFWIGRKVDAFQKQFNQEMKEEQR
NTQQRYYNSSTNYTGQTGHSQQSKQSKEKKIVGEYIDYEEIE
>SEQF1602_00276 hypothetical protein
MIFLFSKSFSLENLVGYQKKCTFDENFEL
>SEQF1602_00277 Thiol:disulfide interchange protein DsbD
MKKIFSIFLMLVAVVASAQEIKWMSMNDALAAQKKTPKKIFMDVYTTWCGPCRLLSEKTF
KNKDLVKYINDNFYAVKFNAEGNEEVVYNGTTYKNNNYDPAKANTRNGMHDFAGALGVSA
YPTMLIFDEKGTPVFPITGYLTATQLEPHIKFVGNNTYLTVTTQEAYDKYLKTFKGTFKN
>SEQF1602_00278 hypothetical protein
MRIVFFCVILRVNKNNSKQKNLFSDGKKSSL
>SEQF1602_00279 Ferrous-iron efflux pump FieF
MEKNLPYRTIGFSIFGNILLAIVKIAAGILGNSYALVADGIESVSDVFSSILVLVGLRYA
QEPADKNHPYGHGKIEPLVTFVIVGFLIASSLLIAYQSYQNILTPHQAPKAWTLLLLGGI
ILWKELSYRIVLRNSKLTGSSSLKADAWHHRADAITSVAAFIGIGIALCMGEGYETADDW
AALLASGIILYNAYKIFRPALGEILDEDMYEDISLKIKEVAREVPGVMAIEKCHIRKTGM
SYCVDIHLIVNGNITVKEGHDIAHKLKDTLQRQFPSIASVLIHVEPDYKEIRFRECLQN
>SEQF1602_00280 2-succinylbenzoate--CoA ligase
MHPLVATHCHPLAKINGYSCDSKGLISLITLWAESNEVHLQKTAAFLSQWLDESNTLTLH
TSGTTGVPKEISVKKEHMIHSAQLTGAFLQLQVGDRALCALPTNYIAGKMMLVRTLVLGL
SLEVVAPSSTPFASIDGEVDFVALTPMQAFKSLEQLHRARKIILGGAPISLSMETAFQEV
PSQIYATYGMTETVSHIALRPIAPKKQHSLRYTTIGAITVRQDPQGCLVIDCPEVADMPI
YTHDVVTLYNDRSFQWQGRLDNIINSAGVKIFPESVEERLAAFITDRFFIWKEPDTLLGE
KVILLIEGREEAYRDLLMNLQKETVFSKYELPKKIYYLPHFKTTESGKIQREITAKLVL
>SEQF1602_00281 hypothetical protein
MYIKNGFSVKNKWFYCLPISLFILLNLNAFFSPSQDYSALVAHIGELPFFTFNLLVFLFL
LGVLLLIVMAVHAQPIRALTTGRKKIDYKRIFFSFFLWGSIISLQTLVSYWLTPSDYLWN
FDPVPFFLLVLIALLLIPFQASFEEYFFRGYFLQATALVCKYKWIPLVLSSVFFGLVHVA
NPEIAKLGYGFLFFYISLGLFLGIITLMDNGLELSMGFHIANNFFIAFLSSSSWSVFQTP
SLLKEVSEPAITPSYILLFYLPLVVLLFIFAKKYQWSNWKEKLLGKIEEKDI
>SEQF1602_00282 Endonuclease MutS2
MKKTLEDLEFPALLSLVAAHTHTPKGKERVLALKPLTHRETITSLLFQTNEYLTSLETQN
YIPSHTFDEVDHEIRFLGIENSLLEPHSFAKIRTLSQTVNAHLLFFKKFHDYYPTIAVLS
QDIPYTEEIVRAIDSVLDKFGEIKSEASEKLSQVRTEIGTLKGKINQSFSRALSEYNALD
YLDDIRETVVENRRVLAVKATYKRKVRGTVLGSSKTGSIIYIEPLVTEQYSRELSHLLHE
EREEIRRILLRLTNTLRPFAALLSQEQDYLVAIDVIAAKAYFAKETHALLPELTQERVLE
LRDAYHPLLYLSNTKKGKQTFPQTIRLDDEQRIIVISGPNAGGKSITLKTIGLLQLMFQT
GLLLPVHRLSKVPIFSQILTDIGDNQSIENHLSTYSYRLKNMNYFLRKCNETTLFLIDEF
GTGSDPELGGALAEIFLEEFYHRKAFGVITTHYANLKILANELPYATNANMLFNDKTLEP
IYKLIVGEAGSSFTFEVAQKNGIPYSLINRAKKRIEKGKVRFDATIAKLQKERSQMEKTT
SSLKEEEEKTREEAKRLETLNNKIQSKLTSYQELYDQNQKFIYLGNKINEIAERYFEDKK
RRPLISEFLKIVETENSKRKAKSKKEKQAEEAQKKIAQEQLHKEIEAVRQQKKIEKKARE
HSEIQEKLTLIQSLKVGDRVRIKDSKSVGVIDKIEKDKALINYGVFTTLTALAQLELVEK
VKKK
>SEQF1602_00283 hypothetical protein
MNRYIITIMALLLWGCQKKQMQLPQVEDTKIISVEDYSQVYLPYDPETGQGKLNANGLIS
STNWIFHIDKRNKLSGVAQHFNRLQEKRTNPRNPHSNPDAHLYISLADIPHKRLGFMDVT
NLILLSYDPLKMSEYGNTPIYVYPDGFRLKEDKGEKTPWNKFGMYKNVFYVWIFSGSMTF
QQFVDIYYTRLHQQDDGIISRIMIND
>SEQF1602_00284 Cyclic di-AMP synthase CdaA
MFDFLNFKFVDFLDIVLVGLMLYYIYRLLKGTVAISIFSGIVIIFLFWKLTVIVKMELVS
SILGQFINVGFFALIVVFQQEIRKFLLVLGSTNVLNSKNLLRKLSLKKTSEDTAIVQMCE
TLVSACRKMGAERTGALIILERNQSLEFVRATGDKMNIELNQPILESIFYKNSPLHDGAI
VVQDGFIVATRVILPVVGQSVIPKEYGLRHRAAVSITEKTDALALVVSEETGKVSYINNS
EFVPYNTDSELVALLAEELSK
>SEQF1602_00285 hypothetical protein
MIREDFIQYLWGAHLIPTAPLELSTGEVLDILSYGEVNPYGGPDFFNARLRIGSLQWAGN
VEVHTASSLWYAHHHEQDPAYGNVILHVVWEHDVEVFDFQQNIIPTLELKSLISNDLVEK
YTQLQQAKSTFIPCEREISSLSEGLITNWLDRLYTERLEEKTQTIVALLQESQQDWEAVF
FLKILGSFGGNINGEAFEQAAKQLSFSVIRKQMQDLSQLEALLMGQLSLLEATDLSCPYY
RSLQQEYQYLAHKYALVKPCFRVQFSKLRPPNFPTIRLAQIAALYHQEQSLFDRCMTLAS
YDQALEFFGKVIPSPYWKNHFSFGKESKESHKYLSPMLIANLWINTIVPMQYAYARSRGK
DTLAECKAKLRATPAEHNSILERWEGLLLPNTNAMESQAILQLYKKYCNKHACMACQVGQ
VLLKK
>SEQF1602_00286 hypothetical protein
MNMTFTKIRIFFERNGFNVSTRLAERLGLRVKYVRLFFIYISFIFGAGFGLYFAFAFALK
IKDLIRRKRSSVFDL
>SEQF1602_00287 hypothetical protein
MKRYTEKYIPIWKEPLWVTCPECQAVAHITYTQEGAVVQCSCCSFHSSQEDLQYFEAITV
LNCPNCGTPIRHSQKGLKEKSELIKVSCPHCHEVYEVKPRYETYYESFPTQDSGLQCDDV
FGLPYYFQENVRGHLFWAKNISHLLLMEDYIASDLREREGMTMVAKLPTFIKLRKNRALL
LKILRRWKEQLQLPQRDTPLKPSIMLFFQEKEISITSYFEELDFYGNYRHITIHTFLKKE
TRQWTQFVRNNRLLRALSKEERADIPLENPECFLVEYSNADFGKEVLTHFLQRYLQTNPS
HSLYIDMGDTLYSDQELYDHLLKNPNWDWNEDR
>SEQF1602_00288 Bifunctional aspartokinase/homoserine dehydrogenase 1
MLLIKFGGSSVGSVENLQRVVQIVKKQIEPFIMVVSAFSGVTNTLQSLGENALKNTHQPI
LEALKERHFTMAKSLLPIHRQTNALVHIGKTTLALENLCNSISTLGELSERTQARIMAQG
ELLSSFIIGEYLNQEGVNVSYLPSEDYIVAQGDPLNAVVDFSQTQLRIQQIDTAASYIAP
GYIAANPAGELVVLGRGGSDYTASIYAYCLGAKQVELWSDVNGMQNANPKLVKNTKVISQ
MSYEEAFEMAYFGAKVIYPPAIRPAMEKKIPVLLLNTLAPEEKGTRIHVATQGHTDKVLG
VSTLSDISMITISGIGLAGTKGSARRVFQALEQADVNVILITQSCSEQSICFGIKTSDAQ
NAKEALEREFAQEIGSLINPIERTDNHVILALIGDNMNHQTGLSGKVFSALGANGVNIQA
IAQGASERNISVVIDAHDEHKAVNVVHERLFQEVIKRVHLFIIGAGNVGGQFIDIVYKQQ
EYFRQQYKVDLKVVMVANSRQYVFADEGLSQEALSLLSTAEATPYASAEALAELIIATNR
RNSIVVDNTASAQVAAIYPQLIRKSISVVTCNKIAGSAPLEQYTALMELVKNQNCDFQYE
TSVGAALPIIKTLQNLRLSGDTIHRIDAVVSGSLNFIFNHYNATTPFVEIVKQAQKEGYT
EPDPRIDLSGLDVIRKILILSREAGYRKEMSEVVFESFLPEKSLETPSVEAFYKVLEENE
AFFQDLYHRAQHKGAKLNVVAQLLEGDIKVSLQEIPASSPFYQLDGKDNIVAFYTDMYPT
EPLVIKGAGAGAKVTASGVLSDVMYVANKQK
>SEQF1602_00289 Homoserine kinase
MNQSLRKANPIQETICGFAPATIANVNVGFDVLGISLSSVGDRVEVTPNGSGENKITFIE
SATPLPYAAEKNSCTVVISAMQAQLENPLYVDVRIRKGFASGSGLGSSSASSAAAAFAYN
TLMGNPFTLEELLPFAAEGERAACGSAHYDNVSPAILGGIVLLYQNKPIRLPLPKGLHAV
SFFPNIEVNTASARSIVSRHVSLDIVSKQVSAMGAFVSGLYQEDYDLLRKAAKDFLVEPS
RKILIPYFDEMKEATLSVGGITFGISGSGPSVFALAESRTVAERILTELHKIYAGQGIET
LSFIEDLANGKGCRLSQFDE
>SEQF1602_00291 3-methyl-2-oxobutanoate hydroxymethyltransferase
MSISKKETKRVTVQTLQAMKAQGEKITMLTAYDYTMAKIIDGAGIDIILVGDSAANVMAG
YETTLPMTLEAMIYHASAVVRACSRALVVADLPFGTYQSDPQRALDSAIRMMKESGAQAV
KLEGGREIGEGIRRILEAGIPVIGHLGLTPQSINKFGGYGLRAKEQSEAQKLKDDARYLQ
ELGCSAIVLEKIPSALAKEVTQNLSVPTIGIGAGHEVDGQVLVSQDFFGMFVDYKPKFVR
QYLNLHELMTGAVSQYITDVKAQTFPNESEQY
>SEQF1602_00292 tRNA pseudouridine synthase C
MKTNAQNLQVLYEDNHLIAINKRAGDIVQGDKTGDIPLSEIVKSYLVEKYHKPGEAYLGV
VHRLDRPTTGVVVFAKTSKALPRLNAAFATKEEVSKQYWALVEKKAIPHQGTLTHFLVRN
TSQNKSYAYPEEKPQSQKAVLTYKVLATLTHYLLVEITLLTGRHHQIRAQFAALGCPLKG
DLKYGAKRSNPDGSISLHARALELLHPVRKEPLHIVAPLPESFCKLLKDIQLENS
>SEQF1602_00293 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MILEMKVPSPGESITEVEIATWLVKDGDYVKKDQAIAEVDSDKATLELPAEASGVITLKA
KEGDSVAVGQVVCLIDTDAAAPAQSAAPVAEVPKAEAPAAVVAPVAPAPVATPAAPVAPA
ASNSYATGEASPAAKKILAEKEIPANEVKGTGKGGRITKEDALNAQPARHSMGTPTFGKR
GEKRTKLSMLRRKVAERLVSVKNETAMLTTFNEVDMSAIYEIRNEYKDAFKERHNVNLGF
MSFFTLAVVRALKLFPDVNSMIDDKEKITYEYCDISIAVSGPKGLMVPVIRNAENLSFRG
VEAEVKRLAIRAREGQITVDEMTGGTFTITNGGVFGSMLSTPIINPPQSAILGMHNVVDR
AIVRNGQIVVAPVMYIALSYDHRIIDGRESVGFLVEVKNALENPVELLMDNDLKKALEL
>SEQF1602_00294 17 kDa lipoprotein
MKKMLVAGVALVLASCGQSSSYEGTYTGTFPCADCSGINVTLTLNKDGYTSEEVMEDLTT
KDKGSVAYDAQKKVLTLTSTEEKGKEQQYKVKEDGSIAFLQEGQEVEGELASFYVLKKK
>SEQF1602_00295 hypothetical protein
MKKIFLFLIALVGIVACSKSDSGSSDNGGYALKLLKTEATVGAIVIQYHNRVETQTTPID
LSKGDYILELESKPLQLAVGGTGKSDTTVLIAQFLKNGKVQNETRSKGLILNLSF
>SEQF1602_00296 hypothetical protein
MKKIFLFVVALVGIISCSKSSDDKGNNRTENIDTQETTTYSPPDWIIGTWKGEYVSYVFE
KNRFCVKPKIGLRNCSTTKGYAKGVVQKRIDANNYFIKMQLVENTTTVIGGTFRKISDTQ
IGWLNPNGEVEETYTKE
>SEQF1602_00297 Magnesium transporter MgtE
MHAFKLTEEVITHIRELIASDQKQELKEYLESLHFADIAEITSELELEEAAYLVSLLNRE
KASETLTEVDEEVLEHILENLSNEEIARDLQELDTDDAAYLIAELPEERQTQILSHIEDK
EHAQDIVDLLRYDADTAGGLMAKELVKVNENWGVDTCVAEIREQGQHVTRVHSIYVVDDD
EVLKGRLSLKDLLTAPPEAHIRDIYIPKVDFVFVHDTPEEVAHVMQKYNLEAIPVVDKMH
RLVGRITIDDIVDVIKEEAEHDYQLAAGITEDVEADDTIWKLTRARLPWLLIGMVGGIGA
ASIINGFQEGLTSYPVLLLFIPLIQSTAGNVGVQSSAIVVQGLANKSIDGALLGRLFKEF
LLGLINGLALAFLVLIMSHFIFGSSYWESATVCIALVTVIINAAVVGTFIPIFLDKRGID
PAVATGPFITTSNDILGILIYFMIAKIILGF
>SEQF1602_00298 hypothetical protein
MQIQRSRAQESTDAIEKLYTTMRHLFNRGFYKPMGVSGESLRESLLLLRPEIYGTIAQRQ
TELNGLLYVLERLPIGIEQCRFINMISDEGYRQSHFEPIIPPKRRRNCYRIDEEQMNIEI
TRGRSDIYDILTHLTFLFIESHKIAHSVLDEESDKISRDWEKIELLAQKKKLTQAERELA
LIHIGKVLGRTFEEILPAYHQLSSEKNPERFIQVIYWLGKIALEEILSDNKRVITFSPIL
RERLGHHIYGEIWANTLKKTLKEYNLLERPLHIISANMHSVMNALFAKKALAIKGKEDSP
WDTYASLSEEKNHSQREKVMDYALQHGMIFIKDKSGTNIDVQIVDTALIPENDFFKKTSS
DKAPVLLVMDYAFGEQAYETIDELLKPYKTEGKSHFLNVVSVSIMGKAGILEGEKGDIMI
PTAHIFEGTADNYPFENELSTSDFEGNSLRVFEGTMVTVLGTSLQNKDVLTYFHKSTWNV
IGLEMEGAHYQKAIQSASKIRKSIRRDVKVRYAYYASDNPLETGSTLASGGLGLIGVKPT
YLITYRILEQIGRE
>SEQF1602_00299 hypothetical protein
MEEIKKIAVLIDADNAQAEYLSESIEEVKLYGDPILKWAFGDWTTPQLSSWKQYMASFAI
KPLQSFAHSKGKNSTDISLVISAMEILYNYPYISGFCILSSDSDFTELVVKLKENNKFVL
GIGKRQTPPAFVKACHKFKYTDDYDYTTPIVAELPASSTIVAKEPKIIVITPHKTTTTPP
AGKPANKTDAKLILLKEAVTNMAEADGTAPT
>SEQF1602_00300 hypothetical protein
MTKFITQKDQIITQMRAELLATTEEDRYYTEENITDCNAHLEDFLAKLEKSNQATDKQTY
LAEAIQTLCEQLSTFNNPEEEEMPEFLWGFLYLGYTKELTDFIREAALEYGFKPIPTVID
LYYCWVEIGDFDWFSVVLGGMEEENFACLDYDPDTHQFYYDENPYGDPFPLPLYNVQVKP
DYSELSFEVLSRDKLQHFCFLAQYPSDKVWIKAIYDLHTGQVLLTKREKHWSSITLVTEN
GQLKELRPVLYDENGEAIDIFQENGGFDVFPMGINEEGELQGKHMIANTKIIDEKVFFAD
HRREWQLYELQNINMQKDKITLTSTEKRYTRDQNGKLLIKNITPISLSYELKNSEFVLNF
IQEVLNTTNP
>SEQF1602_00301 hypothetical protein
MDFLTGKPLSDTIYDTLFKAEKELIIISPYIQLGDYLKDNIFKQHLHNSKLHILIGFGKN
ERNKERSFKREEIEYFLNFPNITIVYIPELHGKYYANEKQSVITSMNLMDYSLVNNVEFG
VLAEKALTDLVNKNNFFETSKNTIMSVLDSGYTIFAKRPNYNKKFLGLAKDYVGSTIHLD
LVDDILSNKEVKPIRYSSFVPENYVNAENRQRTEREPAPEKVVEEEAPQVTTQETVQPIA
QATQQEKKGHCIRCNTEIPFNPLMPLCESCYPIWAKYGNRFYEEKYCHCCGEEKKVTVAT
PLCYSCYAKQS
>SEQF1602_00302 hypothetical protein
MKQKLRKLVHKDKEYLYRVDTVYNRKGDHNSLLSVRIFLNGEKNTPLCVDFITIEDDFMG
QPLNGNIKLLNKITQTEDTINLNEPKYIPKLIDWAKTKGWTGSQKITPLNGLLFLQSLGY
DTLPIETQY
>SEQF1602_00303 hypothetical protein
MDFLTGKLLSDTIYDTLSRAKKELIIISPNIQIDSYLRESIFKLHLNNPKLHIIIGFKSY
KDDNIFGFRGSGLEYFLNFPNLTLIYIPQLNAKYYANERQSVITSMGLSGFPLTNSIELG
VFTLRNSNFFGKNNFYETSKNTIMDIIDSGYTVFVKRPYYGTNFLGFGKKYTGDAVYLNL
LDDVMANRSIEHVRYSFLISQFEK
>SEQF1602_00304 Elongation factor 4
MKNIRNFCIIAHIDHGKSTLADRLLDFTQTVSEREKQDQLLDNMDLERERGITIKSHAIQ
MEYMYKGEKYILNLIDTPGHVDFSYEVSRSIAACEGALLIVDAAQSIQAQTISNLYLALE
NNLEIIPVLNKIDLPSANPEEVKDDIVDLLGCSPDEIIPASGKTGLGVEAILEAIIERIP
APTGDPKAPLQALIFDSVYNSFRGVETYFRVMNGEIRKGQKIKFMSNGKTYDADEVGTLK
LNQVPKPVISTGDVGYLITGIKDAREVKVGDTITSAVDGCTEAIDGFENVKPMVFAGIYP
VDTEDYEELRASMEKLQLNDASLVFTPESSAALGFGFRCGFLGMLHLEIVQERLEREFGM
TVITTVPNVSYHAFTKKEPEKPIIVNNPSDLPDPSKIDRVEEPYIKASIITKADFVGQVM
SLCIEKRGIITNQHYLTPERVELNFDMPLAEIVFDFYDRLKTVSKGYASFDYSPIGMRAS
NLVKVDILINSQSVDALSALIHADNAYNIGKKMCEKLRELIPRQQFDIPIQAAIGAKIIS
RETIKALRKDVTAKCYGGDISRKRKLLEKQKAGKKRMRQVGNVEIPQSAFMAVLKLND
>SEQF1602_00305 DNA mismatch repair protein MutS
MISTYQQLLQEATLTHKQLSRKTQMIGSLRLIVAVVLLGAIYFAFSAQRWIIDLVILLLL
VLFLYLVSLHKKTNLLRQIAQAKIILNEKEIAFLEKNEFFTADGKEFQDDSHPYSYDLDI
FGSHSLYQYINRTHTFLGRQVLADHFLNPKTDDITTLQKAIEELSQEKHLRWRQEFMATT
SQIEDTQDFYQQMEQWAKEQEHTFPRALPPLLWGLSFLAILSVIVGYGWEQELFQILFKS
LIVVNLLVFFSFVGKMQKSKLGFENTYRLLHAFQRSITQIEQASGLGSSRFVSLQKQLSA
EQSSASKSISRLSRLLDDLDSVGNILVSIPLNIFTFYHLHAYRKLLDWKRTHAQHITPWL
TVIAEMEVLHSFATFAYNNPTFAYPSLNDQQLISFEGLGHPLIPAKDRIDNSISFAPHRF
VILTGSNMSGKSTFLRALGVNMLLASMGLPVCAQKATIHPMPLLVSMRLSDSLSDGKSYF
FAEINRLRSIMETLAQAPCFVLLDELLRGTNSQDKQSGTFKIIEKMVLLKAIGVIATHDL
EVCALSEKYPEVLQNKCFESQIVDGELYFDYTLKEGICQNKNATFLMEKMGII
>SEQF1602_00306 hypothetical protein
MKHLLILLAMAMAPVAMNAQDNSKQVQPEKATTKACCSKDKKEGAACHKDGKNDEKVCDK
DSKEAKACCKDGKGDKACCKEDKKDGMASDSEKKECKKTGKKGCCSAKKAA
>SEQF1602_00307 hypothetical protein
MEIKLKRIYEPKEEADGFRILVDRLYPRGIKKEDLQVDLWDKEIAPSEELRKKFHLENNF
ESFSKKYLDELSKNPHAADFLQQVKEYPCVTLLTASKEVNYCQLPILKTFIECSLQKKEA
N
>SEQF1602_00308 Phosphoenolpyruvate carboxykinase (ATP)
MSTKNLSVEKYGIKDANVRYQLTADELHAETLAKGLGKEASSGALAVNTGKFTGRSPQDR
FIVEDSITKDRVWWGKINIPFSSEKFDALYEKVVAFLSKKEVYVHDGYVCADPKYRTNVR
TITELPWSNLFANNMFLRIDDSELAGFKEDWLVINAPSFLADPEVDGTRQGNFAILNFTR
KIALIGGTGYTGEIKKGIFSAMNFELPVFRNTMPMHCSANVGKDGDTAIFFGLSGTGKTT
LSADPNRHLIGDDEHGWTPENTVFNFEGGCYAKVIDLTAEKEPEIFGAIKKGAILENVIM
DDKGVVDFSRTDITENTRVSYPIYHIANIQPGSIGHNPKNIFFLTFDAYGVLPPISKLTP
NQAAYQFISGYTSKVAGTEVGITTPQKTFSACFGAAFMPLHPAEYGKMLAAKIKESGVNV
WLVNTGYNGKMKRCSLKDTRALITAALTGALNQVEYKELPIFGFQVPQSCATISDQGILN
PENTWDDKAQFAAKSKELAEAFIENFKKFEAGADAEVLKGAPKL
>SEQF1602_00309 hypothetical protein
MKKLLLFYAALFSLSTTYGQRAHFGVRAGFTVSDLIIDGRGFDTHNRYSNSSRVEYVTDY
LYTGHVGFLVEIPLAKKFYLEPGAQLTFLGTEYRNVKRFYSRDSDYSRDYYYEGDKVHIT
QLNLPLWFKFNAVAGLRPKVGAYVGYLASVRERRRGTSSKIEGRYLNSDFDFGLGAGVEY
HFRTGFFLDTNINIGLANLSARGEVQNIFLQTGVGYKF
>SEQF1602_00310 hypothetical protein
MKNTIYYILPLLPLSFYGQTKSNDSIIKLKEVVVAEKFRKKQIQSEVKLSCTVDEYLSTS
DNISFIKRGAYAWEPMLNNMNTERSSVTIDGMHVFGACTDKMDPVTSYVETNNLSKVDIH
SGQQGGMHGATIAGGIDLQRKRVAFSETPDWGGSTQVGFQHNNAHRFALADLYYSSQRFV
ADGTAAYRKAESYKDGQGEKVKHSQFEKYNTSLGLAYKTSELSALKADAIFDVAKNVGYP
ALPMDTWLARALITSLSFKQLFEEGILKVWDTKAYFNAIEHYMDDTTRPENLVHMDMPGW
STTYGLTSKILLKKNNYTADIQLNGYSNYSLAEMTMYPKDRSKVKGFAFTWPGVTTNYGG
LSLSNQWELSDKEQLTLGGTLGLHHNHIEYLDFIRVFNQNTADSPQERTRFLPSMHASYQ
AKVNPLTFSLGMGYGHRAPSVSEAYGYYIYNSFDRYDYIGTPNLKNEISYELNGSVSFEN
NALIAEVKANYFYIENYILGKILRVAFPMNAASVGVKKYEALEYAKIFNTSLHLSYHFLD
HYRWKGSLNYAQGVDHQGENLPFIRPLSYQSSLQYLRERLAVTFAVNGDFTQTAYAPQYG
EDRTPAYIVYNLSANYLFPLGKNSLRWEVGVENLLNTYYSTYADWGNIPRMGRNIFTSVS
ISF
>SEQF1602_00311 hypothetical protein
MKTIHIFLIFIAIGLSSCTVEKTPFGNRLNFTSRGELQEVGYFKKNNHLISIEAPDGEFL
RGYNKIAVKISTSNEQDVISEVTFSPSHKDTEGNTKSVPHSPILTPSTKNRSFEGFAVFD
TPKDYSVLNATHSGIKTPWDIVLTYKVNGTTYSLETSIEVLDTRNPNLNMTQFVGRDGKQ
YYIALTAPEVPKVAVNELIAGIWVQQSDSTYTVANGYLLELDPRMPGEDMGNHSSPNNQD
LRQGADGFYHGKVNYTMEGYWTLNFILKDATGQVIKGTQVSQRVQMGVFGEQSELHIDIL
F
>SEQF1602_00312 hypothetical protein
MRKRAHISLICLSCMVLLSAIRGGLFFSYYLLSPKEFTALFCENKANVQKHCDGKCFLAK
VSSDNTQEQTNIKFDFTKHQAEVFCMEIPTFEPLYLPVTEKSLIFYYHFSTYETIDSETL
RPPVNC
>SEQF1602_00313 Signal recognition particle receptor FtsY
MNFFKKLFSSDKKETLDKGLEKSKTSFFDKLTRAIAGKSKVDDDILDELEGVLVSSDVGV
DTTLKIIERIEKRVAQEKYLGTSELNRILREEIAALLSQTQRGEEVDFSVPSNKKPYVIM
VVGVNGAGKTTTIGKLAYQFKKKGLKVVLGAADTFRAAAIDQLQVWAERVGVPLVKQQTG
SDPASVAYDTLSSALSQGADVVIIDTAGRLHNKVNLMNELSKVKRVMQKLLPETPDEILL
VLDGSTGQNAFEQAKQFTLATEVNALAITKLDGTAKGGVVIGISDQFQIPVKYIGVGEGI
EDLQVFNKYEFVDSFFK
>SEQF1602_00314 hypothetical protein
MKILESKYYRAINILRVNGDDEIQLYDKHRFASYRNPYRILLSDILCDIYLEDDDLIIYR
DQLQHFEKCSDFYTLSYASKSNRLYEDEECYYHPELEVFLLISYNLSNDYDNELFEEGIC
KVNYVYYENKNPKAKEHLTTLFAEYLQKHQSKKAKVSILLKNQNGFDLKTHMIKPFRIDF
ERMYNDDFLEIHNRVKKSITDENKGVVLFHGIAGSGKTNYIKWLTSQVPNKKFIFVPTSM
IASLTDPSFMGVLIDHKNSVLVLEDCENYIAERTAYNSNTDVVSSILNIADGMLSDVLEC
QLICTFNSDISKIDSALLRKGRLIAEYKFKELTVEKCNSYLRSIGKEPNITSPCSLAELT
NMETKALKEDTNSPKIGFK
>SEQF1602_00315 tRNA (guanine-N(1)-)-methyltransferase
MRIDIIAVVPELLQSPFEHSIFKRAVEKGLATVHFHDLRQYGLGNYKQIDDYSFGGGAGM
VLMIEPIDACISALKAERTYDEVIYLTPDGETLSQPMANALSLKENIIILCGHYKGVDQR
VRDHFVTKEISIGDYVLSGGELAAAVLSDAIVRLIPGVLSDETSALTDSFQDNLLAPPIY
TRPAEYKGWKVPDILLSGNTPLIENWREEQAYKRTEERRPDLLQ
>SEQF1602_00316 hypothetical protein
MFIISLGLLAPFFATAQEEQTTQQTPQENEKQYPATIEGQYDQLVEKAGNWEKYKLIKKE
SIYSFKRFMLDSLKAQKQVLREKLDTISSQSSQIKQLNQKITSLESDLDKEKNRNNSIEF
LGMTIEKGLYSAVVWGIIIILAIFLAVFVSRFSRSNSITRGALKDLESLQNEYEEYRTKA
IEREQKVRRQLQDEINKHRS
>SEQF1602_00317 tRNA dimethylallyltransferase
MNLLINIVGTTAIGKTALAIVLARHFKTEILSCDSRQFYREMSIGTAVPSREELATAPHH
FIQHKSIFDTYSVGDFEREVMELLPKLFARRKLVIMVGGSGLYNDVILKGLDEFPPIKEG
VRESLNALYKEKGIGVLQEQLRALDPTYCLKVDMQNPQRIIRALEVCLSGDYPYSYYLQQ
KSTQRDFSVISIGLTAEREVIYERINQRMEVMLQAGLLQEIERLLPYRHLNALQTVGYRE
FFDFWEGKVSLAEAIENAKMNTRRFAKRQLTWFKKSEDIQWFDYKEDRGKIIERIETQLL
SKA
>SEQF1602_00318 hypothetical protein
MSSISLLLCRALMIEFVVILLSLLGVGSLFFGIEALGIIINFFIFILVGAICCIPIAIGI
GEYLSRSNKFLIKKLPLGILLMLFFYSFGVFSSITIISIGQGKGFVSMEELLEVIAFSLL
LGAFPSFGVGIWLDGKLLAMIKPPEE
>SEQF1602_00319 Transcriptional regulatory protein YpdB
MNCLIIDDEPLARIGMERLIRQYSNLKVVGTFKNAVGVTDFLKKNEVHLLFLDIEMPGIN
GLELAKILPEQTLVIFTTAYSQYALESYEVDALDYLVKPITPERFKKAVAKAESYHQLLS
EQKTDLEATDAQYISIRANRRNYRIAHSDILYIEALKDYVIIHTFTDRYITWINLKNIHS
QLPESVFVRVNKSYVVNTQHITSYTHQFVYIGDTEIPIGRTYEVIEKLTH
>SEQF1602_00320 Sensor histidine kinase YpdA
MNENPYIFLKNNFFLQFLIADRFRIYRHIVACSSLLLFFILGRQWGDYEGMIDYWDWIEK
WLGITATFYLNMYVLIPRFFFKGKLATYIILLTLWVLFMLGSTYYLNFVLWKDYMIGKEI
KIASEIPVSVAIFSSMVYIVPFIMTSTLIKIFQVWVKDSERMQELERQATESELQALRSQ
IQPHFLFNMLNSINTLLYIDPEKASYTITKLSDFLRHLLYQTHEEQVFLSSELRFLNDYL
SLEAMRRDDFTYELTYSEKNLQGIQIPPNILLILAENAVKHSVDTLSPTYIYMKCEEKEG
LLHFSVRNSVPLEPHRKHKCSGIGLPNLNRRLELLYGERFSLSQERLPQEYIVTLTLPL
>SEQF1602_00321 hypothetical protein
MKKIITIIALIALTATATAQVKFGVHAGAGIGLMSKDVHDDRYEGQNKTDKEPFSTSSYG
GFFVEIPASEKLLLDLGAMYTNYSTIGKGKTMLHRIDVPLAIKYDISGLRPKVGGYVSYI
PGVTSFENKYRSLTRKDIEKFDYGALFGLEYNFNEKYFIETNFYLGLANLLTKDPRHSSD
YLRTRSILIGVGYRF
>SEQF1602_00322 hypothetical protein
MGFGIRGGGSITGYNGKTEANYTNVKYKAGYYVGIFSDSQLLPFLDLRTELLFSSYGAKW
EFTQGNEKYSNTLHTQYINLPILARLKIGNLGILAGVQGGILVNKPSLENTFNGRTVKLD
RSDFAKFDFGAVVGAEFNVTDHFLIDIRFNQGLVNALNSSNSSVRNLNISSNNNFLNVSY
TLGVGYRF
>SEQF1602_00323 hypothetical protein
MKKIIILTALIAFTATATAQVKFGVRGGYTLSPVSKSIHTDRYENQAHSESASSCGSAYA
GLTAEVSASEKWFLDIGLIYINQVTIGEGSTMLHNINLPIAVKYDISGFRPKVGIYASYI
PGVTSFEDEHRSLTKNDLKKFDCGATFGLEYNFFDRFFIEANFNLGLANLLKEDPRHSSD
YLRTRSILVGVGYRFN
>SEQF1602_00324 hypothetical protein
MKKTFFFVALLFIVSVSAQISVKTEYISNSKFYDAVSDSNIGDGSAMIYSVGALVPLSMK
APKEDDPYQRPTVWGVSLSGSFVKMNNHNFPIGKELPSQVMNLGATFLHLRPLKERWSML
MALGAGSYTPENRLSSIHIGENVVANGAFVLVWHWRPNIEIGGGVALNNTFGYPMVFPAF
YFKYNGAFSDKFTIEVGSIDGLKVALGYNYRENLDFKLIANMGGYSAYLRRNGEKEIFSQ
QTFVVGLQPEFKIGKHVSIPLTVGGSFIRSGRYRERKLSAMFASEAKNEDGSSRSSQFNP
ALYFAAGVTIK
>SEQF1602_00325 Lon protease 2
MKIGNFDIFSSEEEPEIHMEVIPISLSEMAKDVSEDQEESEEEEDPFPEQLPILPVKNMV
LFPGALSSITIRRDSALELINDARHSRLIGVVSQRSNEEEATPENLYSIGVVAHIIKVLK
TPEGTTHILVQGRDRFQIESFTATTPYIVAKIKEVPEIVPKEDDQEFLSSVEVVKDISLK
LAKELPEGNQEIAFTIQNIENNYFLLNYVASSFPLSVTEKQEILEQDSLLTRAWTIIKYL
GVELQKASLRKEIQKKVHIDFDKQQRDYFLHQQIQTIQKELGNESFEADIEKFKQQAKEK
KWNEKVQKHFDKELAKLQRLNPQMPDYAIQRNYIDLLLDLPWGVYSKDKFDLKKAQKILD
KDHYGLEDVKRRIIEYLAVLKLRNDMKSPILCLYGPPGVGKTSLGRSIAKALGREYVRMA
LGGLRDEAEIRGHRKTYIGAMPGRILQLIKKAGTSNPVFVLDELDKLSIGYGGDPSSAML
EVLDPEQNNEFYDNFLEIGYDLSKVMFIATANDLSTIQPALKDRMEIINISGYTIEEKVE
IARHFLLPKVLKEHGMMDKHIQLGKKEIERIIEGYTRESGVRNLEKQIAKIVRYIARAIA
MKEEYNPKISLEDIRKILGIPSEHDKYEDNEVAGVVTGLAWTSVGGDILFIESAFSKGSG
DLSITGNIGTVMKESATIALEYIKSHAQQFGLDTHIFEQYKIHMHIPEGATPKDGPSAGI
AMLTSIFSVLTQRKVKKHLAMTGEITLRGKVLPVGGLKEKILAAKRAGIKEIILCKENEK
DINEIKTEYLDGLTFYYVTDMQEVLQLALTQEKVKDAKEFSFEKVKS
>SEQF1602_00326 Type IV secretion system protein virB4
MNVLALGGRYYRLIAGEPTGFNPFMLPATKRNVTFVKQLMGLLCTRNGSTLTPRDEQRLS
MAVDRVMYVLKPENRIYGVTRLLENLSEPASNEAQENGLHIRLAKWAQGGDYGWVFDNES
DNFHIGDCDNFGIDGTEFLDNKDICAPLSFYLLYRVTSLLDGRRLVIFMDEFWKWLNDPV
FADFAYNKLKTIRKLNGCIIPLTQSPAEIITNPIAPAVVEQCATQIFSANPNATKEHYVD
GLKVPLEVFEVIKSIDPSRRQYVVIKNQFRRGDLKRFSALVTLDLSGLGGYIKVLSGSAD
NLEIFDSIYRPGMQPSDWLDKFLDKAL
>SEQF1602_00327 hypothetical protein
MATAIATGLLCSSLQVNATGVPVVDVVGNTQELQHWLVKVKQWAETVKHYQSEIQAYKDQ
LAAQTGLRDVMGLVNQGNSLKNDLLNLQKQGISLSELLVSDNAPSGALNSLYDKYKAFDV
CNEKQAVGYSYVCKQETVNKAYAIEQTTEVQGKISETLNDISTLSNRVATAKDSKESMDL
ANSIQLKTVRLNTLTTQWEMNVKASEQRDKLLAQKREKARNEQQLNAPVVQFN
>SEQF1602_00328 hypothetical protein
MKHIKTAVLAVSVCVLLAGCKEDAKSVDWYKQHQSELAKVYQDCKASGDDSDNCKNAKEA
HFDIQQKDAPVTQFH
>SEQF1602_00329 Type IV secretion system protein VirB6
MAGTMEYFDQQAMDGLKEVTSGQMMQYSSWMMGLAGSAVAVYILVKGYQAMAGKLQTPTV
DLIWDMARLAVVFSFVANVNGYLDATINAIDGLKEGFSGGDNIWQQMDTLWAKAQTVAKT
LHDLDDSAVVKDEGMTAQFYVWAGILVVMCTCAFVSLIAEVTILLLSITAPIFIFCLAWG
VFRQMFNNWLQSIIAAVLTIMFAALSLRIVVRIMDAILTQATSSAPNANIVTLGAQVCLS
AILGALLIWISAKIAGGLAGASTAATMQGMASLGLAAAGFGLAKQAAGASKNTANLKKGW
DAAHDGKKKAPKGGETGYKAAQVRMAAIKQMQQRQEQRSAMAAAAQARARFKA
>SEQF1602_00330 hypothetical protein
MNGKLVIQLFFFFLLTPTLTLRAQQDTPQEKVKDTVRTSTSLRRLLLKDSDRISRKYKYN
AALDKYVYTEKVGTYDISTPMFLTPKEYENLVLRERMGLYFREKNAAMQPATNPQSANTQ
RDLLPEFYVKSELFESIFGGNNIDIIPQGNVAFDLGIRYNKNDNPSISPEYRSSYGLDFD
QRISLGIQGKIGTRLSLSAMYDTQATFDFQNVFKLEYTPNEDDIVRKVELGNVSLPLNSS
LITGAQSLFGVKTELQFGRTRVTGVFSEQRSQSQTVTAQGGGTLQDFEIRALDYDENRNY
FLSQFFRDQYDRALENYPYIRSKVQIVRVEVWATNRSNRTANIRNIVALQDLGEAKAENT
RIAGNAPVGFFRGSIGDRPTNEANMYDPTRMDSPQSVLTKNIRDVATIRSGFGSMSSLVN
EGFDYAVLENAQKLEEGRDFKVNKQLGYISLSQRLNNDEVLAVAYQYTYEGNVYQVGEFA
NDGISATTNAYIAGQNKITNNCLVLKMLKSNRLVVGDPIWNLMMKNVYSLNTAQINPENF
RLNIFYNDPSPVNYISPVDETTWNRELTRKILLQLFNFDRLNAYNDPQDGGDGFFDFVEG
ITIDPEYGKIIFTKVEPFGKYLYDKLGGGNRYQDPTAYQSTSTAWNANQKKYVFRSLYTD
IKAKALEDAEKNKFTLKGRYKSKGSRGISLGAYNVPRGSVRVTVGGRILQEGIDYVVNYQ
QGTVQIIDPTIENSNMPIQVSVENNLIFGGQSRRFMGVNIEHKFNDKFIIGGSLINMRER
PYTQKANYGQEPVNNTIFGFGGTYSTELPFLTRLLNKVPSLQSDVPSNISVRGEVAFLRP
SAPKSTDFDGESTAYLDDFEGAQTTVDIRGFRAWSMASTPLRFGQGAYPNQTLYGTAPDD
PENLKNGYGRAKLAWYTIDPVFYTNNKPSDVSATEISKNSTRRIYVKEIFPERELAQGDL
LVQNTLDLAYYPSAKGPYNNNPTAMASVAATDKWGGIMRGVSATNFEENNIEYIQFWVLD
PYTSGEFTPSISGELVFDLGNISEDILKDGRKQYENGLPGLSIQSPTYATTWGKTPVAQS
LLYAFDSNTENRALQDIGLDGLTDAQERAIYANNITEFPNDPAMDNYEYYLSRSGGILSR
YYNYNGTQGNSPVAGNSQAASLTPDVEDINKDNTMSTVDSYYEYRVPIRGNVQRTDRYVS
DIREVYAETPSGQPILARWIQYKIPVKDANRREYGGGGDLRSVTHIRMYLTGFSSDVVLR
FGTLDLVRGDWRHYTKSLKDDLSAPGTGTHTEIGSVSLIENETRQPIPYRMPPGVYREQI
NQNNTIVSQNEQSLSYTVCDLNTGDARGVYKNLNADLRQYKRIKMFVHAERYKNQPLADG
EMVAFVRLGSDLSENFYQVELPLQVTPAGAYLADAIWPTQNRFDIPMDALTQIKAKGINS
GNLANLTYYDAALNLISSPSTTPHVAGQNRYAIKGNPSLADIQVIMVGIKNATSNQVCGE
VWFNELRMAELENKGGWAGIAAVDLNAADFMEMSVTGKISTVGFGTVEQKPNERSRKELR
QLDAMMNINAGKLFPKKWNMQVPIGLNRSSSVATPEYDPQYEDIKLKDRINAAQTQEQKD
LIKRQAEDYTLRRGISLIGVKKNLGEEQKAKFYSIENFTVNYAYNEMDHHDFEIENQREQ
NVRTGVLYAHAFEQVKWTPFKTNQKVNTNKYLKWLSEVNFNLLPNNIYIGPTITRTFARQ
QFREVYPLGVNPNNQVPLPELQQRNYLFDWQYGLNYSLTKSLKLSYDVTNSNIVRNYYTW
ENGQRQTNKELTLWNDFWNPGTPNHFMSAFKLNYELPLDKLPYLSFVKASYSYTGDFDWQ
RGSDALMEVAGHQINKVQNANTHNFTANMTFDRFYTTLGVKNKGLGQKTTLKDHLLRFAT
MIKRVGVSYTETNGTMLPGYLPQVGFFGTSKPSLPFAFGWQDDIRYEAGRHGWLTNFADF
NDQFVRSTNKTLNITAGLQPAYDLQIDLKADREYIDNFTETFNAINGYYNPLIGNTTGNF
VISDNMILTAFTPSDEYSSKTFQTFKENRLTIANRLARQRGIDLSNPNNIDADGFPKGYG
KNSQAVLMPAFYAAYTGRSAEGVSLGAFRSIPIPAWTVRYSGLMRLEFIKHNFRRFSLTH
GYRSSYALSDFRTNLEYYQNPDQLDQGGNFRSEKLFTNVNLVEQFSPLIRIDTELQNSLS
IMGEIRRDRTISISLDNNYLTELMRREYRIGLGYRFKDISFASRFNGRDVIIKSDLNLKA
DIALRSDYTVIRNMELDDNQVTNGQTSWLARFTADYAFSKNLSGIFYFDYSFSKYAISTS
YPMTTIRSGITIRYTFN
>SEQF1602_00331 Holliday junction ATP-dependent DNA helicase RuvA
MITHLQGRLVEKTPTYLVIDCNGVGYWVNISLHTFSQLSDTQQLKIYTYLQIKEDAHTLF
GFFDKFEREIFSLLISVSGVGANTARVMLSSLSPAQLQSAIVNSDVRTIQSVKGIGAKTA
QRIILDLKEKMVKLTGDNASLVAASQSPSNKEEALAALEVLGYPRKAAEAVVNKILTQSG
QEFSVEQLIKQALKQL
>SEQF1602_00332 Ferredoxin
MAIIITDDCINCGACEPECPNNAIYEGADDWRYSDGTKLRGNIILPSGKHANADEVQKPI
SDDYYYIVPDKCTECVGFHEEPQCAAVCPVDCCIPDENCKETQEQLMQKHDFMHNGE
>SEQF1602_00333 6,7-dimethyl-8-ribityllumazine synthase
MATENKNLSTYDKDSLPSVVGKSVGIITSQWNGQITNNMRKGAVDTLLDCGFSPENIIEW
SVPGAFELVNGAKRMIEEAVDAVIVIGCVIQGETKHFDFVCQGVTYGIAHLNAIQDIPVI
FCVLTDNTLQQSIDRSGGKHGNKGIEAAITAIQMIDL
>SEQF1602_00334 hypothetical protein
MSVYKKNNYRPGRQTKKEREQEEPTKELTSEQLSHESTTAEVFQTLDEKAGKTEAWVQRN
QRSILLTVVAVVVVGLGYMLYKQFVSTPRETEASEKLSFALTVFDEALNAPTTAQRDSLF
TLSLNGDKSHGGFLQVIKDYSSSKAANVAYYSAGMAYLQLNKYKEAVTHLDKFSSEDPIL
SALALGNIGDAFVALKQPKEAMDYYKKAIDKSDNTLTAPIYMNKAALVAEEQKNYKEALE
YLEKIKNDYPKSQEATSVDMQISRVKTLMNQ
>SEQF1602_00335 DNA replication and repair protein RecF
MFLKRLYILNFKNIESRDFSFSPSLNCLIGDNGVGKTNSLDAIYHLGMTKSYFSSSTLMN
IRLGEDFYLIEGNFEKEGREETVVCSVKKGQKKILKRNGKLYEKLADHIGAFPIVIISPS
DRDLIHEGSEARRKFLDGLLSQLYPSYLDTLLRYNKVLAQRNTLLKSFHERQYLDPDTLD
IYDDQLSLYGNKIFQVRLAFLESFLPIFQEQYTHLSQGKEEVSIRYESRLLGQDFKNLLK
ESFPQDSAAQYTTIGIHKDDLLLDINGQLVKKFASQGQQKSFLIALKLAQFHCLYKQTNT
TPILLLDDIFDKLDSKRVAQLISLVTRPPFGQVFLSDTDKERTENIVKETTSNYHLFYL
>SEQF1602_00336 hypothetical protein
MKDKKRDLKAYDIHFAGLKDGEHLFEYQVDNHFFELFDYQEFNSVNHLVQVHLQKKSTLL
ELDFSAQGTINVNCDITDEPFDLPTQAQSHLVVKFGEEYNDDNEELLILPQGEHTLNVAQ
YIYEILVLSVPAKRVNPNTQSFAQAMETLEALSPKELDEAEDDSQIDPRWNELRKLLNK
>SEQF1602_00337 50S ribosomal protein L32
MAHPKRRQSSTRRDKRRTHDKAVVPQIAKDVTTGEFHLYHRAHWFEGKLYYRGQVLIDET
PKEAQTETK
>SEQF1602_00338 Pyruvate dehydrogenase E1 component subunit beta
MRTIQFREAVCEAMSEEMRRDPSIYLMGEEVAEYNGAYKASKGMLDEFGPKRIIDTPIAE
SGFSGIGVGSAMNGCRPIIEFMTFNFSLVAMDQIISNAAKMRQMSGGQINIPIVFRGPTA
SAGQLGATHSQAFENWFANCPGLKVVVPSTPYDAKGLLKSAIRDNDPVIFMESEQMYGDK
GEVPEEEYTIPLGVADIKREGKDVTIVSFGKIIKEAFIAAEELAKEGIECEIIDIRTVRP
MDWETIFASVKKTNRLVILEEAWPFGSVSSEITYQVQEHIFDYLDAPIQRITTADTPAPY
SPALLQEWLPNAQDVIKAVKKVMYK
>SEQF1602_00339 UDP-2-acetamido-2-deoxy-3-oxo-D-glucuronate aminotransferase
MKKIQMVDLQGQYEPLKAQIQASFAEVLDSAAFINGPQVQAFQKELETYLQVKHVIPCAN
GTDALQIAMMGLGLKRGDEVITADFTFAATVEVIALLGLTPVLVDVDKDTFNINIEAIRK
AITPKTKAIVPVHLYGRPANMEAIMQIAKEYNLYVIEDNAQAIGADFTWSDGRKQKVGTI
GHVGATSFFPSKNLGCYGDGGAIFTNDDQLAHILRGIVNHGMYIRYHHDVVGVNSRLDSL
QACVLRAKLPHLDSYNQKRREAARLYTEGLQGNPNIITPEIPQGDTSHVFHQYTIRILGG
KRDALAEHLTKHGVPFGIYYPIPLHKQKAYEDSRYREADFPATNELVQEVISLPMHTELD
KEQINFITKLITDFV
>SEQF1602_00340 TonB-dependent receptor SusC
MKCFAIVLFFFFSWSYSQQQLLSGVVQDENKTPLLGVSIIDKNTKKWAITNEKGQFSLPF
LEEYDLDIQLLGMEKKALKGKDTSITITLKEETLSLKEVVVTADKVKDKTSSAITLDKYA
ISQFQSLSLSDVLQQLPGQAIKNIDLTAPKSIQLRSALSSLNNAFGVGFIIDDMYISNDE
NMQSYGYTRIGGSNTAAFSHMNSSIDLRTIPAANIEKVEVISGIADAKYGNATSGLIIIE
RKAGVSPLQLSASMVGGGNTINVQKGFKLPQKWGSLSLSLDYLNSNSDPRNDLMSFNRLS
ATGIWSTFNASQKLKNTLTLSTSRNLDGSKQYQELDEAFRNGSTKKEYSYSLSNRVSWQI
DNSWIDLLSGSVSISYTKTDSSKESYVNGIGNVVPLADRTSFHQGVYTPVSYMSIERTIG
EPLNISASVSASKTLSHGYFRHSLSGGTGFTYSDNIGEGKVFDSNSASIMTSLMPNRSGD
SQQGVRPLNFNRYVIANKLFHFYLQDNISYTFNDRQSLLANIGLRYENQNGFSSLSPRIN
TAFVLSPSVKFRAGVGLSTKAPSLVNRFPGNVFFDVLVKDLRTRDYAVNYIQTHVVERPE
VSLLPAKAWKYEVGADFNLPFVRMNLTGFLNHNFDNFENTPHLGLYPIPELSFTNNPNPT
LPPSYTITGYKDIVLEYQTTGNTKRSKDIGVELMMHFNKIEALNTQFTLSGSYVYSESDS
TLPNREANANVADTEHKYIFYPRDINRADKLSLRLTTSYHLSFLGLLASLTIEQFTFSNA
FASIKDIYPLGYLNDRLEYTEIPPSERTNNQYQALHRVTKEKNRDSRTPIYHNFHLRLTK
ELQNGLSLSFYINNVANYRPTIIINGSERRMNEDISFGATATFKFGKL
>SEQF1602_00341 hypothetical protein
MRKIIFALSLTALLSACRKDDDSFGSGNDNGQVSRIAYTIETTYGDKFNNLKAAGSVVKL
TDTSTGQQYEATTSDEGKAILQLLPGTYNIEVSKSLTKEQNNSLFGFDNEANFAASKQGV
IISSTANSLYFKMSAARMGDLVIKQIYYTGSDIKKAANYHDNFFEVYNNSSDTIYLDGIY
FAKLQGAQKYIASNAGKKGYTANGQYNWAEAQGLEGLGEKANTDYVYAKTVIAFPGTGKD
YPLAPGKSKIVASSARNHKEPLPGKPAVQKPELTIDLSHAHFEVYLDPSFVKDGKSLDTD
NPAVTNMVILHKNGGKDFLLDTQGREAYILFRDTKENFEAYKRVPLPTVTNADSNSAKCV
QIPLDKIIDGVNAQHNNANNSLPHRLPDSIDAGELKAKSAFSSEVFIRKVKEVKNGFTRY
QDTNNSTNDFQLKDNVFDLSALNE
>SEQF1602_00342 hypothetical protein
MKRFLLPLCILFTPILYGQIAPDTDMFAKMYTIYEQTPIFLTEIPVKNFTLSSVYLNHQE
GNLRLGQQPKEQTDFGLQSYGFYKHKEIRFLGRLNMQRIYQRNKAWNLSETEVQANGLMP
DPHYFGVSRPAPWVNQQYNIFGGVSLPLYQQVWSLSLSTHINYEEKFRETYDPRPKTSHN
ELHFAAQTALRIFPKHKIALSGEYGFNKMVDKMKFADENGQKPLNLTKYNRWQLGYGNFQ
LSSSSNNKRKNDYYGFALGYHYTGLQHKFLVEGSYRNTLTHTYLNANDSESDLDIIARLY
EDTFMAKAHYLNQLKEDQVLSLSIIASQREASNRLVMRQGRSYRSYQEDITFSANLLKNI
GTTTRELAFEAVYQGAYQKDIIAKTLTDHSTLALSLLWAKEYEVDTFLVRPTVKGTVIFP
LYNKLINQNTDYHKPYSETDYAARTLRLFYEEVVYPDHEFFHTTRYQFSLGTDLKKRLSK
QTLLITGIHSTYTTSFKGKDRYGAAISISLLK
>SEQF1602_00343 Cytochrome c551 peroxidase
MERLSLFHYSSKNRIFASITIPLKFYNPKMKKILILPLCMGVFFSFTRLKDSLYEPEYIT
QLREAYSSGDTKNWEVPFLDESVKAYYVEIGSLPKLSFPENNPYSDAKKELGKLLFFDPR
LSKSKQISCANCHDPELAWADGRSVSFGHNRKNGVRNSPSVFNMAYHTTFFWDGRASTLE
SQAMFPLTDPVEMASHEAVAVKHIKRIKGYRPYFKEAFGDEKITLTRIFEAIATYERTIV
SGKSKFDRFISGDKNLFTDEEVLGLHLFRTKARCVNCHFSPLFSDQQFHNLGLSYYGRKH
EDLGRFKISKDTADVGRFKTASLREVARTAPYMHNGLIPSLDEVIQMYDAGMAHPKPRKD
QQNDPLFPTTDPLLQKLSLTKEERAALKAFLLTLNSPAKREKMPELP
>SEQF1602_00344 hypothetical protein
MKKLIFSALVATAICISSCSKDGDGGGSGSGLPGTLYVDFATDGIQSYNFSNGKLSKVVK
TMNGPGITGCDITYGSKEIALAISTDRSFGTQDTQTFLLRPWDGGHVWFAYDKLPKTGNT
FSFSFTYDPKEFYKECIIRLSPNKKFIAVDSYEWDERGVLLLNTETGKLIADFTKGLTRD
DLGYQSTPVWTENNEMYSAIKGVLYRWKEGYGDRVEEVLTLNEGKGASYVTVNPQGTRVA
FRYNKHLWVQNIDGSNLHQVTTSQLTGSNKADGEYHPVFSPDGKYIALVGAPTVGRAWTD
YDPLQPSQGGVVVTSGGYGYVFVIRDDGKLYDLENDKSGFIVLRQGGGIHGVPSYFSGMM
WR
>SEQF1602_00345 hypothetical protein
MDKKTTALVSYITLIGWLIAFFTGKDDADDFVKFHFRQSLGLHITSFVFCIVLGIIISIV
PALSFLGLIGLVFFVLMVLGAINANKGEKTPLPIIGQYFLEK
>SEQF1602_00346 hypothetical protein
MFSVAFAWFSTSMLYAQEKTADVLARFSSEAPVHWAISTNEGRLDLEWRPRQNSLSQEGF
RSFVAYHEGVFSGSISLSSNTFSGEIWHEGHTYFLTDEKGLLRVSPSRGATSCATCQEGD
CDIRPSSQVLSRGTILAEESLPSEDKRVLYNVHVLRTFRLAMLIDYSFYKGHCQGSMELA
KAFMVDVQTKLNEVCGRELGYQFELVDDARLIRDTEKKEVYPDKPLVRTVVNTATDTFNK
LIGEENYDAGIVFSVYKDNRGLAHLGEITGKLKGGCVANQEFYIILHELGHLLGSAHTFT
IGGATASSFTEPDRGNSIMSYINDPYGTYFSLPSIYTIHNRTNLHDAYYADKARTQLVGL
PQPNIPYGEPSDNKAPMIDRSKLKKSYALPPNTYFQFTIEASDPDGDPLLYMAHQADFKE
FGKARFPSNRPTTDNKIAFYRPYTKDNNTNEWKEVPYKFTEEYETGDFTFWLGVCDGSVG
AYKAGKPHTPLYDVYQTKVQIKDGTPFRITNIVRSSRSGAYKRGEDVTLHWSVDKKLFAP
DSKVRILFSDNYGKTYDYVLAEGVPNNGEATVTFPQAKGWKGYAGYVEGLFKIEVLDHIA
YAVDLDKLYMKDMVKSDIIFNNLPKPVITVKRTEIPERAEVTARSVYCNDKNTMVSFSEE
TYPDYILRRWVAIDKCKNKATFVQYIYFEKETPTRTLHFVGDLPQDIHVQCRGEIPPKAT
LQAEGSDSVEIEYEEEMTEGDKKAYKLTRVWTAYAADAPAIRHVQQIFLKDTQRPEFSAY
PANLTVKDESEIPFKPTLTATDNCDSRVDVSSSSEPIYDKQGKKIGERNIWFAEDNAHNE
NRYEQIITINPQKSNNPQPISFVAHTLPQSITVDCSGKVPSVQLPLTSGGCSTPQVTYQD
RIKVQHAPNDYEIERTYKAKDNCGEVTHLQLITVKDDKAPVWLGQLPQPKEILQGDPIPE
GAPLAAQDNCEGILTATPTKEETSDHITYQWVVSDSNGNKATHTQVITIKPKKDIPAPTP
EPKPAPAFMPELNNKGIAVYNGISTESGSQNYFKIENTDDNTPIEVVIFNEMGLKVYEST
HYQQGSDVFRGYANVRGVVGSGQRLPTGTYFYVIHYYQQGVSYMKKGYLYVR
>SEQF1602_00347 hypothetical protein
MRNSLLCIFLLFLGLAKVIAQPTISNTQTLRVYRLAIYVTHNAYKSATFAQNTEKVKVFW
QKTEDFLNELYMRDIGVRFEVLRDERLIIKVPAEEVFTRAHNASYVIGLSTETINNRIGS
DSYDVGICISYTSSKGIRGLAHIRGVYQDQYKGAAVAFPTKEVIAHEIGHLFGGRHTFSG
KKFDYASEKTEYDNGQSVMSTGSPRDFFSLSSIQLIREHLVAAVPVGGIPLGTQPPHIDK
TKIKKQYLLPKDTYFQFAISATDPDSPSLTYMAQQRDVRLGEDPSIAQYIIPQRSHSPLI
AFKREYSKQTGAEVSNSWISGQTTGVFTFWLGVSDALETPTVDHIVQYDLAETQVEVRDG
IPFKITTSTAGKTYRGGQRLALTWTVDPELFRDTKVRIRLSEDHGQTFPYTLAEGVDNTG
SYELVLPNLSIGKKNYGNTNLKVGAGVIKIEVMEGIAFTVTAENPQQGGGFTIEKDSSLP
LAFVGVLPQDMTIEEGQPIVEQAHLSAVSSCNNPIVTPSVTEEKKESKLVKRIYQWIATD
DCGGRIAHTQVITINPKKEIPTPEPKPVPTPEPKPVPTPDPKPAPTPEPKPVPTPEPKPV
PTPEPKPVPTPEPKPTPTPEPDPKPVPTPIPELKQKEVVVYNGVSSVEDSQNYFKVENTD
PDAPIEVLIFNEMGIKVYESSHYQEKGAFFRGYANVSSVVGKGQRLPSGTYFYILHYYYQ
GVPYTKKGYLYLR
>SEQF1602_00348 Chaperone protein HtpG
MKGQINVSVENIFPLIKKFLYSDHEIFLRELISNATDATLKLKHLCQIGEAKVPYGNPII
EVKVDKEGKKIHILDQGIGMTEEEVEKYINQIAFSGAEEFLNKYKDSAKDTGIIGHFGLG
FYSAFMVADKVEILTRSYQEGAQAVRWECDGSPAYSIEPIEKEGHGTEIILHIAEDSTEF
LEESKIRELLVKYNKFMPIPIKLGMRKEALPRPENAPEDYKTEYKEVDNIINNPTPAWTK
QPSDLTDEDYKAFYHELYPSQYEDPMFSIHLNVDYPFHLTGILYFPKLSNDMQLQKDRIQ
LYQNQVFVTDNVEGIVPEFLTLLRGVIDSPDIPLNVSRSYLQADGNVKKISSYVTRKVAD
KLQSLFKENREDFEKKWNDIKIVIEYGMLSEEKFFEKAQKFALYPTVNDKYYTFEELLEK
IKPLQTNKDEQTIILYANNKEAQHSYIAEAEAKGYEVLLLDSPLVSHLIQKLETTQEKIS
FARVDADSIENLIKKEDTLISKLSEEETEKLKDFVTTAIENTAYTVQPEALDSEATPFLI
TQPEFIRRMKEMQAVGGGMGFGGFPEMYNLVVNTNSPLASQILSTSDEAARKALISQSFD
LARLSQGLLKGEALTEFVKRSFSLLK
>SEQF1602_00349 hypothetical protein
MKTFFRCLFLWLSVQVVQAQEDVQTIYALFEQTTPKWSPQLPAVKKPLLIRWQERKGAFN
AKGYRTFVGYHQETFVGTLSLAEGLLYGEILYKGKSYQLMTSPKGKLEVILQKNARCGTT
PSQGKEAPKKTIPQGIGFRNMFPQADKDENDPPITQPTIYNSLYPKSLIHTDGVWRLYRL
ALPVDYSYYIMKTPFNKDKNKIRAFWYATETFLNELYGNDIGVHFEVIDDDRLIFTTPQS
ALFPSLISGNEVVDMGTITLNKHYDSKDYDLAVIITDFRQNYNGLAAVYAAYQTHQKANG
AARPKGPSTIAHEIGHMFGADHTLSNGGEYSEKTETDRGQSIMSYGHEYARDFFSLISVQ
IIRAFLGNSMAYYTDQARTQEAGKRVKDTGNNLVYGVKSENKPPILEQARLKREYLIPEN
TYFQFYLTGRDPEGDALTYMAHPADRRFHSSRSNAQFLTYKGTATPHIRFQEEWVEAEHN
TFAPAKGTISYRPGTFTFWIGVADHNPANPYHVPKYDVVETKVKIKKGKPFEIQNFDNGS
YTHNRTYRAGERLALHWQVDEQIFSPESKVRILLSDDSGKSYKYVLVEEAPNNGHCEVTL
PNVAIGTTRGHFGKLKGKGIIKVEVIDGLAYALTTRSPYKQGGFMIEKDQQAPEPLQFVP
ASLPQDISVKEEVAIPPAELPTAVGGCSTPQVSYQDRRNEVSYAPDVAIERIFTAKDSCG
HTIEHIQLIRIGENKIGFPTSTPQEPTSNKEPLTFVATTLPPQYVTLSCKETLPPPASIE
TQGGCDKITFSLSEQMIQKHCPELYTLKRTYTFVDQCQNRLTFEQYITKKDALPPVFVGG
LPQDKTIEQGAAIPQGEVLTAQDDCKGTFQVMPTQQKSEQKIVYQWVAQDDCGNQVTHTQ
TITLLPKKEEPVPAPKPKPAPEPKPAPEPKPMPIPKPDPKPAPEPKPVPKPDPIPAPKPE
PTPDSIEETREIAIYNAVSTQDNSQNYFKVEGYDIPTPMEVMIFNEMGLKVYESNHYQEN
GEVFRGYANVSGVVGKGQRLPQGTYFYILTCSHRGQKEVKKGFLYVK
>SEQF1602_00350 Murein DD-endopeptidase MepM
MFILYKMIKKISFLLLYFSATFLWAQTTHREHPTDYFASPLDIPLSYAGNFCELRPNHFH
GGMDIKTDGKQGLNVYATADGYISCIKVSTYSYGKVMYIDHPNGYTTVYAHLQKFAPEIE
KFVKEQQYKAEKYEMEWDFTPTDFPVKKGDWIAVSGNTGGSAAPHLHYEIRDTQTKNAYN
PLLFGYPCPDDLSPIINQVVAYPLDDAAAIEGRQEKKALYLAKEKNDYHTAKITAQGKIG
IGIKAIDKMTGTYNTFGVYKVTLSVNGTPKFSYTFDELVSGEDTYINTLIDFPLFVKTGA
RVQLLYKEPYNKLSNYTLVENNGVIEIQDGLFYIITVEVEDFAHNKSTITIPIEGKKEVL
SPKAEETLSKGTLLVANRDNMYKTDRASVFFPENTFFHDTYIEVQQKGDTLSVKAPIQPL
KKQYTVVFNGDKYSEAELPYVCIASVRGKGKYYQGSYRKDKILTARVKTLGNFVLTTDKI
PPVIKPLNFSKVKNNINKLDKLKVSVKDNFSGIGKYRATINGQWVLMEYEHKEGLLFFTL
SDKYFTEGEDYLFELTVADKVGNESTLSIPLVYKQ
>SEQF1602_00351 hypothetical protein
MSYQVLTDNISLYMKALLLSIPFLIGIYFFSKKAMSYFIPMSLAMGFALHILYQYLFYIL
FKGDFYRGMLWLYTLFISDFINIGAFLLSILVKVKRRR
>SEQF1602_00352 hypothetical protein
MKLSWGTGILLAILAFVGFIMYFFVITLVDKQYDHELVTENYYAQELDFQKDIDAQKQTL
DAHMQVELSYTKGAKEGIRFDFPSEVAGKSVVGVISFYRPSDSKKDFTLPITSLDNCSLK
VPADLLTEGRWNIRVEYSFEGKNYLTLFDKVNY
>SEQF1602_00353 hypothetical protein
MLVLAFTLGLFGSLHCVGMCGPIALLIPLQRQRKGFRYLQLGAYFIGKTLTYALMGLLFG
LVGEGVFIAEYQQEFSIFAGLLMILMGLFSLLHLRVKGLGNPLLKGFSLLKNALGKQLSK
KTVTSSLSIGFLNGFLPCGLVYTALFGALAMGNWRGSMTYMAVFGVGTIPLMLLLILLGD
FLPLALRRRLNQWLPLVVILVGILFILRGLGLGIPYLSPADTHLILHPKADC
>SEQF1602_00354 hypothetical protein
MKNFCLLLLLLFTSCGIFHKKISPPETSLYSSQTPVVENLHDSLYSFGDNYLIRNKQGIW
ELYLSGNPLQLGLNSGALTQRLYHRQDSLLFTKLKDFVPSERKQRFLYKFLKWFNRDIDK
NILPIYRAELYGQSRYADSLFDYIAPKYERSLYLHSAHDIGHALQDLMLVGCSSLAAWGK
HTEGGKLLIGRNFDFYLSDDFATEKIVRFVRPTQGYPFMSYAWGGMIGVMSGMNTEGLTV
TINAGKSNIPLKARTPISLLCREILQFATTTGEAIAIAKKRKIFVSEAIMVASAKERKAI
LIEVSPKKFGVYEVDNGILLCANHFQSPTYAKDKKNLKQIAQTHTAYRYAKMQELVAENE
QLTPEKIANILRNTEGLQGKSLGYGNEKALNQLLAHHSVIFSPEERIAWVSTAPYQLGEF
VAYDLKEIFKGETYAPHTVYPQTNENIPADPFLYTQAYKDYEAYRQLEQRLSQQLREKTT
IQISDYLSLTSLNPNYWKGYYLLGEAYWANGQYEEAKEQYKIALTKEIPYAVEKERIEKR
LKD
>SEQF1602_00355 hypothetical protein
MYRIFLVFLALLLWGCPKHTPTINDESLTPKVEAALYKLIGCARFDLSELKDIEKNGYYF
ANEACPEEENPFGQVDIFLYPKNEQFDTKVVRAAMYYGDKQDWVDVVFNPIKEMSPQQIA
QNFNVLLAIVDKKYLEPDSVSGYRMKEFAKIIFYKLKDGHWTREEPISITNNPWNIYEYL
KASEGLEEQLIKPNKDQVHITDAAAFVARIESAGFYTKDKEKSADLNGDGYEDHIFVFSP
TNSRMPQQPIIVLLSQEKDQYKVLVNEGLHLKSSLYGGNSYEIVVKGKYFTTEGQGGYSD
GDTQKQVKSYVTFYAQPDAILLHKIGIITLVNGEKQEIQLDTADFGEIFLDEFFYTLPFD
LSSEEE
>SEQF1602_00356 hypothetical protein
MMKICRLLYICCLWGVFSLSYGQHKTDWSRERLQKAIKTLRIKGYHVIENGAMAQKGALI
AEMNLEKTFDSQGNIILEIYFDDKNAETLRYEYVYNAQGAKKYKLHLNPKKEKVGLTLFN
CDAQGNVTKEETYDQNGDLEYSALFIYNDKGLAKESNFLGEDFSMKIHSSYDSKGRLLEQ
EQHIVDKGENIFNKGKYRYNGHGDYDRILSLLKRNFAQKNTFHYKYDKNGNWIERFEYQD
GKPKTIIERQIEYF
>SEQF1602_00357 Na(+)/H(+) antiporter NhaP
MELYYAFSVIIVLAALFSYVNVRYIKLPMTIGIMVVAMMVSVGIRLFGEVIFAGLSHKLE
SLLQGFDFTEILMSAMLNFLLFAAALHINVSDLKEYKLPIFTYATVSVVLSAFIISGLLY
YIAHWVGMDIPYLYCLLFGTLISPTDPIVVLGVLKQANVPKRIETKITGESLFNDGVAVV
MFAVVLKLATDAAFEPSFNAITKLFLLEAGGGIFLGVILGFLASEMMKKADDYHVSVLVT
LAVVMGGFLIAKASHVSSPLAMVIAGLFVGNVGKKASSEENRDYLSKFWAIVDEIMNAIL
FLFIGFEMLLIDNLDKQFLLGAITIIVCLLARALAIYIPAQTILRKVSSYSRGSLITMVW
GGVRGGVSIALVLSIPQDHAGMKETLLQITYIVVLFSILVQGLTVGKVAKKALHQDEVML
RLKRIRAAQQRKIRE
>SEQF1602_00358 Cytochrome c biogenesis protein CcsA
MLKKLTQILISTRLMAVLFLVYGAALAMGTFVETWYNTDTAKIWIYNAWWFELIMVLFVV
NFIGNIGRYRLLKRENWAVFVLHASWIFIIVGAGVTRYISDEGKLALREGEEADFYTSEL
TYITAQVDGIYEGQPLRKAKQTEVLFSEFTSNNYSWASDFKGKDFHIELTRFIANAEESF
VEDPSGEEYLKIVESSGGEGHEHYLKVGSLENFHGLPISLNKPTEGAINLQITPEGSYIS
SPYLGSYMTMTDQKVFTVAKDSMQPLQYRCLYNIGGMRFVLPEPLKKGKMVMASIAANKR
TAADQSALLMKISCGGETKEVEVLGRRDVINPPTSVEVGGLTFHLNYGSVRTPLPFKVKL
DDFIADKYPGTDRSYSSFKSKVTVTAPEESFKYDIYMNNILNYKGYRFFQANFFPDEQGT
ILSVNHDFWGTLLTYIGYTLLYIGLIASMFFGKTRFVQLSQKLKKLSLKRKGTLILLAMF
FWVGGYAQHNSFELTPKQIDSLIKATTVKKEHADRFAHLVIQDEDGRMKPINTFASELLR
KVSKADTFRGLDANQVFLSMLLNRQLWYNVDFFYIKKDNDSLHKILGVEKGLKRVRALDF
LDQEYNNKLNPYLVEAYSTSNPNQFQKEFKEVDMKMHLLERALSGSMLRIFPLKDSPNNK
WISPLDIYENPRYTQDSLEVGFIKHAFRWYLSSVKEATETGDYTEADKILSLLKENQRAV
GKAVIPSERQIDAEILYNKYDVFKSLFSWYLYVGTLMFVVLIARIFRERKVLRIITQVCT
GLLFFLFALHTAGLAFRWYISGHAPWSDAYESMIYVAWATMGIGLCFARRSPLSLASTAF
VTSMILMIAHWNWLDPSIGNLQPVLNSYWLMLHVAVIVGSYGPFTLGMILGAINLLLMIL
TTSKNREKIKGVIDELTIVNELALTVGLIMLTIGNFLGAQWANESWGRYWGWDPKETWAL
VSIMVYAFVIHMRIVPSLRGVWSFNFASVVAFASILMTYFGVNFYLSGLHSYASGEKVIT
PNFVYYAAVLVVILGIVSFIRRKKLKD
>SEQF1602_00359 hypothetical protein
MKPVYLFLSSILLFANCQKNNSEETVLSVPTDYSQMEMKQYTESQADILNPERGFYTHRG
FSANKKETLSVSDIQKYRKEGISLVFTIYYLKEFRDRPISEAFLEQIRHNMRVLREGGNK
AILRFAYTSSRDEKPWDAPWDITQRHIAQLKPILQEYSDVICLMEAGFVGVWGEWYYTDN
YVYKPKEGEYTPRARVLTALLDALPSDRMIAVRTPQAKLLTQGISAKDTLSASTAFQGTP
LSRIAAHNDCFLADNDDRGTFANNLMYRNFWKAESKYVAMGGETCALSSLAICSNALEQL
SQYHWSYLNRDYHQDVFQQWKGGKCLDEIQKRLGYRFSLVKGYFTKTPKIGSPYQIELQL
KNTGWASPFNPRNVELLFVSEENPREKYKITLTDDPRYWFAGKTSTIRTTFLLPNSMAKG
KYTIYLNLPDPRETLYLKKEYSIQLANKDVWNPQKGYNKIQKVTLSEIGENNLGNIRSLA
KFTE
>SEQF1602_00360 Carbamoyl-phosphate synthase small chain
MKYTQKKPAIILLEDGTIFYGKAVGKEGSAFGEICFNTGMTGYQEIFTDPSYYGQIMVAA
TVHIGNYGTFSQENESEGVKIAGLVCRNFSEFGSRPISEETLGNFLEKQGLFVVSEVDTR
ALVSYIRDHGSMNAVLSTEVENIEGLKARLKAQPSMKGLALAPKVSTKEAYFVGDENAPF
RVAALDLGIKRNILRNLAARGAYIKVFPHTATFEQLNAFTPDGFFLSNGPGDPEPLTEVI
ALTQKLIESGKPIFGICLGHQLIALSQGIPTYKMRNGHRGINHPVRNLLTGKSEITSQNH
GFAVNKELAEKNPNIEITHLHLNDGTVAGIRLKNRPVFSVQYHPEAAPGPHDASYLFDQF
IELMTNNK
>SEQF1602_00361 hypothetical protein
MRTLEELINKEEPGWDLVEEWMQEATNPYEVLPRDAKRAEAELLNAQVTTRSPMGAILYE
TGGILINNGWIRILGSGCERLDRGMFQWNKGKTFENYGEPPAYLLVADDILGGLFAINGG
AFGQEGLGQMYYLAPDTLSWEPMNCGYSEFVSWTLGGDIHMFYEPFYWDGWQEEVSKLNG
NQVFSFFPFLWTKEGQQIEAVSRKVVPIEESYRLTMDMQRQLLEKE
>SEQF1602_00362 ATP synthase subunit alpha
MAQIKAAEVSAILKKQLANFDASVSLEEVGTVLEVGDGIARIFGLSKVENGELVHFESGQ
EGMVLNLEEDHVGVVLLGSSTQIKEGDTVKRTKTIASIKVGEGIVGRVINTLGEPIDGKG
PILGELYEMPFERKAPGVIYRQPVNEPLQTGIKAIDAMIPIGRGQRELVIGDRQTGKTTV
CIDTILNQKEFYDAGNPVYCIYVAIGQKASTVAGIAKTLEDAGALAYTTIVAANASDPAP
MQVYAPFAGVAIGEYFRDTGRPALIIYDDLSKQAMAYREVSLLLRRPPGREAYPGDVFYL
HSRLLERAAKVIKDDNVARNMNDLPDSIKHLVKGGGSLTALPVIETQAGDVSAYIPTNVI
SITDGQIFLESDLFNSGVRPAINVGISVSRVGGSAQIKSMKKVAGTLKLDQAQFRELAAF
AKFGSDLDAATSNVIEKGKRNVEILKQSSNTPYKVEDQVAIIYVGSKNLLRQIPVERVRE
FEKEYLENLRTAHENVLLELKAGKINDEITAVLEKVAKEVAQNYVK
>SEQF1602_00363 hypothetical protein
MTNMKKIVSILCGVGLLFATSSCEKDFEEINTNPNKPKTSLPYALFNGANKRLMDYTRYT
TTSGKLIRTWMQYTAQTAYTKESRFLYADTAGDYIWRFCYQVAGIYKEIIELNTDPKTKE
KTALYGDNDNQIAAARIMMNYAMSIVVETFGDVPYYSWHGKDNPKFQALQLEKYISPKYA
SQKDIYMDMLDDLKEAVAQINKSKSNVFTAGDMVFKTPERLEKFGNSLRLRIAIHLSRVQ
DAELKQKAIDVIKEIVQNPAQYPVMASNADTVELPYEKNDINASPIYKNYFVDKRTDYSP
ANTLVDMLKGTRGASLGFGVDPRLQKYVTPKGLKIEQVRDGQYQETTDLTKYVGMPYGIS
ESYSDSQFGSGRIVSLFSQKILSADYAEVFMEYSEVCFLLSEANYVVNGTWDDAKYKEGV
KASMEKWGVESSKITAFVTALPAATEETVMTQKYIALYMNPNEAWTEYRRTGYPSVLIKD
GERGIPMVEPVQDKNGSTITTYSFTSLVDGVPFPERLRYPLTYKNINLANYQEALKNMGM
GSTDVMNKKLIFAKQ
>SEQF1602_00364 TonB-dependent receptor SusC
MNLKKLFLWICFVFTTMTFAQQNLSGSVKDATGKPVAGASVTVFGTTRTTKTSPEGTYTI
MAKEGEVIQFSAAGYKNVEMKVGLSTTMDAVLQLASSQEGEAGALGIKRDKNAVGYATQK
TDADQGLSGNVAGVQTSTTSSMGGNTNVTIRGVGSITGSNQPLIVIDGVPMATVGGADSK
FGDAAGDINPEDIESVTVLSGGAATALYGSRGGNGVIIYTTKSGKSGKTTIDVKSSVAFE
THYIAPKLQNRFGGGRANAFKKYTKNGQTYNIAAYESDESWGPEYDGTPYLPWYAFDEKY
LPQHYLKPVPWQAPKNDVDKLYRTGVNLSNSVSVSRAVGGTNLRFSLGNNEVTGIIPNTK
LEKTNLSISFNSTLSKKLKSEGGFNYIITSRENPENSYTMKNPISKVLYAWTQRQLDLQK
LQDYYKAPDGTHRTWNRKSAEDGTPRYADNPYWTLYENTSNDKRHRFFGNIGFTYNFTDN
LYWVAKAYGDIYALNTEARVAVGSKETASYVVTNYTNSDFNYETRLHYTPKLGKDFTLTG
FIGLARREGRYQWVQGKTNGGLVLPDFYNLENSVETPSSSNYRSWRRTNSIFGMASFGYK
GMAFVEVTGRQDYFSTVSAPVFYPSVTGSFVFTNAWKSKPSWLSYGKIRGAWAQAGNDTG
PYQLLTYPTINLPFNGSPVYLHPFTQNNPDLVPEIKETKEAGLELRFFNDRLSANVSVYD
ILSKNLIIPLPVDGANGYVNKMVNSGEMSNKGIEVSLSATPVKVGNFSWNVSWNFAKNNN
KLLKLYPGTTRYKITNDSSGLVSLYAIEGEAYGQLFGRDFVYDDKGNKLVDKSGKYVTSE
PKALGTIIPDYTMGLRNSFKYGPVSLSFLFDFQKGGKYFANAYMLGMYTGTLRETVDNGM
REKSTQYIDGQKGIVVPGVFAPGTPKAGQPNDARLSPKAYGGLFYRGVDAQNIFDATYFK
LRSVTLSYDVPLTEKKHIKGVNISIFGNNLWTTGLDWDGMDPEIAASNKGIGETSLPSTR
SFGMSLGLKL
>SEQF1602_00365 hypothetical protein
MWVYVKKILNKIVHNSNKKRKFVTLMNIQEI
>SEQF1602_00366 hypothetical protein
MKNILTTIFCGVGLLLSTSCQKDFEKINTNPNRPQKPLSYALFNSSDKLILSNTRVYTTS
GQMMRSWMQYTAQTTYTTESRFLYRDNSGDYLWRYPYKAAGNYKDIIELNTDPKTKNETA
KYGSNVNQIAAARIMMAFTFNLLVETFGDIPYYSWGGRDNPNFQALQMDKYISPKYATQK
EIYMDLLKELKEATDQIDESQPYVFIQGDRIFGTPQKMKRFANSLRLRIAVRVHEVTDSQ
LRSLANETINELKDGTKVMQSNADTVERPFDNDNTNPSPIFRNYYVNNRTDYAPANSFVQ
LLKGQRGNYGVDPRLQKYFAVKGLTKYQARDGYQESTDLSKYVGMPYGMEESMADFQFNS
GRDVSFFGKRILKADYAEVYMEYAEVCFLLSEVNGWDSQWYKKGVIASMEKWEVDPTVAT
NFANGLPTANKENVITQKYIALYMNPNEAWAEYRRTGYPQTLIKVGETVPLNKPTTSGET
TYTFTSTVAELTDLPERLYYPTTYKLINFENYKEALKNMNMSEDSMAKKLIFARH
>SEQF1602_00367 TonB-dependent receptor SusC
MNFKKLWLYLFIAFSATTFAQQKISGSVKDSAGKPLPEASVIVVGTQRNAKTNAEGAYTI
SAKENEVLHFSASGYKSTEVKVGVSTTIDVVLPQAEAAAEEGALGIKRDKNAVGYTAQKA
GASDNLSGSVAGVQTNTTSSMGGNTNVTIRGVGTITGSNQPLIVIDGVPMATVGGTDSKF
GDAAGDINPEDIESVTVLSGGAATALYGSRGGNGVILYTTKSGKAGKTSIDVKSGVTFEK
IYIAPKLQNEYGGGDSQRFETVNIDGRQYKIARYAVDQSWGPKFENQQYLPWYAFDKEYL
PEKYLKTVPWKAPDNDVDKFYTTGVGISNSISVSRSLSGTNLRFSLGNNEVTGIVPTTKL
QKTNFSFNFNSKLSSKLKSEGGVNYVLTERDNPDFSNTVNNPLAIVHYTWSQRQLDMRNL
ERYYENEAGDQRPWNRTAWNNAEPKFVDNPYWELNKNTNNDKRHRFFGNIGFTYEFSSQL
YWVGKIYGDIYSLTKEDRKAVGSFGTPYYTKTVYNNSDFNYETRLHYTPKLSKNFTLTGF
IGLSRRNGKYGWSSGKTVGGLVSPNFYNLANSKETPQASDYASWRRTNSVFGMLSFGYKG
MAFVELTGRQDWFSTVSKPVFYPSVTGSFVFTSALKKKPSWLSYGKVRVAWAQAGNDTNP
YELVTYPTVHNPFGGAPDYSRPDVSNNPELVPEIKETKEAGLELRLFKDRLSANVSVYDI
LSKDLIIPLPVDAANGFISKRVNSGKMSNKGIEVSLSATPVKVGKFSWNVSWNFAKNKNE
LIKLAPGIKRYKVTSDRYGLVSLYAIEGEAFGQLYGRDFKYDDKGNKIIQANGKYAPSEL
KSLGSIIPDYTMGLSNTLKYSHLSVSFKFDFQKGGKYFSAAHMVGMSTGMLRETTENGIR
DLITRNGRVEERGIVLDGVLANGQRNTKVLSPKRYGEGFYRGGIDTQNIFDATYLKLRNV
SISYDVPLPEKKNIKGLNITLFGNNLWTTGLDWDGMDPETAASNKGIGEVSLPTTRSFGM
SIGLKL
>SEQF1602_00368 hypothetical protein
MKRLAIIILGGLALLGTTTSCQKDFEEINTNPNRPQQALPTALFNGSTKLFLKNTRNYTT
SGMMFRSWMQYTAQDTYTKESRFLYRDYAGDYLWRYPYQVAGGYKDIIDLNTDPKTKELM
TTYGKSENQIAAARIMLAYTFALLVETFGDVPYYSYGSPNPERFQALQLEKYISPVYATQ
KEIYTDLLKELKEAAAQIVSDSYVFKEGDYIFETPDKMRRFANSLRLRLAIRLKDVSDTE
LRTLAQQSIDELKAGTAVMQSEADTVELQFDSDDTNPAPIYKEYFVSNRVDYSPSNSFVQ
LLKGQRGNFGVDPRLQKYFAPKGLTKYQARDGRYTESDNLNDYIGMPYGLDESMADFQFK
SGVAVSFFSSRILQPNYAEVFMEYSEVCFLLSEANGWDNTWYKKGVEASMKKWGVADTKI
TNFLNTIPAANEENVLTQKYIALYMNPNEAWAEYRRTGYPHTLIKVNEETDLNIPTEAGQ
TKYRFESLVADLTDIPERLFYPVAYKVINEANYQNALKSMQMTTDILTKRLIFDRGQRRP
>SEQF1602_00369 TonB-dependent receptor SusC
MNLKKLLLLCFLVFTTMAFAQQSVKGSVKDSTGKPVAGATVQVVGASRSATTNSEGAYAI
QAQAEETLRFSAQGYQNVEIKVGLSSVVNAVLLPMENKQEAGALGIERNKDAVGYNTQNT
EGGQNLSGAVAGAQTSSSSSMGGNTNIILRGVGTVTGSNQPLIVIDGVPMATVGDGKNTG
DALSDINPEDIESQSVLSGGAATALYGSRGGNGVILITTKSGKGGKTSIEVKSGVTFETA
YIAPVLQNEYGGGDSQQFERATINGQQYNLARYAVDQSWGPKYDSSKMYLPWYAFDQKYL
PEHYLKPVPWVAPQKGIEKFYRTGVGVSNSFSVTRSLSGTNLRFSLGNNQVNGIVPNTDL
HKTNLAFSFSADLSKKLKSEGGFNYVITSRTNPDYANTVNNDLANVFYAWSHRQLDVRNL
EKYYIDPAGGQRTWNRTAWDNEEPKFANNPYWEVYKNYNNDKRHRFFGNLGLTYHFKENL
YLVGKVYGDIYYYTKENRNAVGAYGVPSYQKTVYNNTDFNYETRLHYTPKLGENFSLTGF
VGMSRRESRYAWSSGKTVGGLVVPNLYNMSNSKQVPQASDYSSWQRTNSVYGMASFGFKN
MAFVEVTGRQDWFSTVSKPVFYPSVTGSFVFTSAWKSKPSWLSYGKARVAWAQAGNDTGP
YRLMNYPLVNTPFRGSPDYIRSNTSNNPDLVPEIKETKEAGLELRFFKDRVSINASIYDI
LSKDLIIPLPIDAANGYNWKYVNSGEMSNKGVEVTLSVTPIQTEKFNWNLSWNFSKNKNK
LEKLAPGIRTYRVNWDKYGQVSLYAIEGRPFGELYGRDFVYDDKGNRIVQSNGKYATSEL
KALGNIIPDYTMGLTNSFRYGRLNFSFVFDFQKGGNYFSAAHMTGMSTGMLRETVAGGIR
EYDPTGPKNQKGIVLPGVTRSGAVNTKRIDPQTYGEGFFQGAVDKQNIFDATYLKLRSVS
LSYDVPLPSTKYIKNVNVSFFGNNLWTTGLDWDGMDPETAASNQGIGEISLPTTRSFGMS
VGLKL
>SEQF1602_00370 hypothetical protein
MSYLLFIIFYTKKGESIATKKEKYTVFYNFIFTRLLRRKKGYLSFFRQKKPSFIKMALKY
DYKFTFTDV
>SEQF1602_00371 hypothetical protein
MKKILIATLGAGLLLGSCTKDFEEINKNPNVPEDYLTYALFNGSNQALMNNTRGYDNMKQ
MRVWMQYAAQPIYTKESRYLLDPNGPSTIYFQGYKRAMDYKTIIDLNTDPKTKELVAAYG
KNENQIAAARIMMAYTFSLLVQSFGDVPYYSALDPDNPKFQALQTDTYVTPVFASQKDIY
LDILKELDQAISEMDTSVSYVFKDGDFIFGTPAKMKKFANSLRLRIANHLKGANATVLGA
ELKQKVTDIINHYTTVGTETELLGEGERVGLSFEDNYTYPAPIYYDYYVGNRVDYLPSSN
FVKLLAGNNKKANDRGLNFGSVDPRMEKYFAPKGMGKWDVYYGYTLDQSNPIDTTSYVGM
PYGMQEGATTDQYNGGDRVSLFSKEILSATATEVLMDYSEVCFILSELRGWDNALYRKGV
EASLDRWDITGTRKSNFMAALPAANEENVLTQKYISLYMDPDEAWVEYRRTGYPKTLIQV
GERVRGNYPEGNPLVYEFKKEPSAKDVSGIPDRLNYPDTYTGLNLNYIEALKNMGNPNDA
RSHKLIFATRQ
>SEQF1602_00372 TonB-dependent receptor SusC
MNLKKLFLLCSLVFTTMAFAQQTIKGSVKDSKGKPVTGATVLVIGTSRSATTNSDGGYSI
EAQAEETLQFAAQGYQNVQKKVGLETTIDIVLPLATEENKKVGALGVERDANAAGYTDTT
LEGGEDLKGKTAGLTATSSGGMQGSKMELRGKGSVTGSNQPLIVIDGVPMVDMGSKYGDS
ASEINKDDIESVTVLTGGAATALYGSRGGNGVILYTTKSGKGGKTAIDINSSVSFDRAYI
SPKLQNEYGGGSSLDFTQQLINGTTYNLPQYEVDESWGPKYDGTPYLPWYAFDKKYLPEH
YLKPVPWQAPKNDIDKFFRTGMNINNSASITRSISGTNLRFSLGNTETTGIVPTTELRRT
SLAFSFTSELSKKLKAEGGLNYSITVRENPNYTYADANDNGGFSTVLYGYTHRQLDMENL
RRFYKSPIGEQRTWNRTSWENPKPNFADNLYWMLYENTQNDKRHRFFGNIGLTYNFTDKL
FLVGKMYGDIYALTTESRTAVGSHDTSQYSRYIYDNSSFNYETRLHYNPDLGENFTLTGF
IGVARAQNKYEYVGAETQGGLIVPNYYSAANSKERPRGVTYSSWTRTNSVYGMASFGYKG
TAFVEVTGRNDWFSTVSTSIFYPSVTASYVFSNSFKNLPSWFTYGKLRAGWAQVGNDASA
YVLKTYPSVYQPFKGAQYYLVPTEKKNPELRPEIKETKEAGIDLQFFNGRLSLGFSYYDI
LSKDLILSMPVDAANGYTYKKVNSGEMVNRGFEITLSATPVQTDKFSWTLDWNLSRNRNK
LLKLAPGLSRYKVTWEYYGNVELYAVEGRPFGEIYGGNYVYDDKGNRLVDEEGNYFISPK
KEVLGNINPDFTTGLTNTLTYGNLSLSFTFDYSHGGSYYAGPYALGMYAGTIRETVENGM
RERDPNGPNGQKGIVLDGVVGHKQADGSIVSTGVKNTKAISPKQHGTTFYKGIDAQAVFD
ATFLKLRSVSLSYDVPLTETRYIKGLNFTLSGYNLWTGALAWDGMDPETAMYNQGMGNSS
LPTIRSYALSVGLKL
>SEQF1602_00373 hypothetical protein
MIYYSDLQVVLQEVPGEISLCVSVTGCPLRCKGCHSPFLWKKGTGSALTDEVFVGALERY
KNMLSCVLFMGGEWEAEALIHKLQIARSYSLHTCLYTGLIEEEVPPAIKQELTWLKTGPW
IASLGGLSCPTTNQRFIKVSTGEVLNKLFYK
>SEQF1602_00374 hypothetical protein
MIRLTQNQIQQKIDFISQYLQASNAATASQVDANANVTSKNIATMEAEINKDINIQINRE
LVRRKIEELFGEELSREYIRQIEAHEIYVHDETSLKPYCVSISMYPFLLDGLMKLGGESR
APKHLESFCGEFVNLVFAISSQFAGALATVEFLLYFDHFAAKDYGENYLETHPKMIENHL
QHVIYAINQPAAARGYQSVFWNISLYDEPYFDSMFGDFVFPDMSKPSFARLFKLQHFFLK
WFNAERLKAILTFPVVTAAMLTSEGKPVDSAFADMCAEELSEGNSFFVYQSESADSLASC
CRLRNEISDHTFSYSLGAGGVATGSINVITLNMNRLVQQNRNLSEEVRKIHRYQVAFRKL
IEEYKAGGLLPVYDAGFISLDKQFLTIGINGMVEAAEYLGIAPTNNEQYKNFVRHHLKII
YEENRKAREVYGYMFNTEFVPAENLGVKNALWDKKDGLFSPRECYNSYFYAVEDTQVNAL
DKIILHGKEIIQYLDGGSALHLNLEETPNKEGFLKLLNATALAGCNYFCFNIRITICNEC
NHIDKRTLFECPECHSENVDHATRVIGYLKRVSCFSTARQKEHALRHYHVQ
>SEQF1602_00375 50S ribosomal protein L19
MESLLKYVQDNLIAKKDFPDFSTGDTITVYYEIKEGEKSRVQFFRGVVIQRRGTGATETF
TIRKMSGEVGVERIFPINMPAIQKIEVNKRGKVRRARIFYYRELRGKKARIKEIRK
>SEQF1602_00376 hypothetical protein
MSKIFINGLSCISPQPTFAEEFPMTLLDHSLENVLCAIEPSYKEYISPAASRRMAKGVKM
GTATAMTALKQAGISLPDAIVVGTGLGCIQDSEKFLKGILDNQEQHLTPTSFIQSTHNTV
AGQIALNLQCKGLNFSYVNGAVSFESALLESILLIQAEGLHHILVGAVDEHAPHTIYLYE
LSGAIKSKEALQQPSPTSGIRMGEGATFFVLSDTFGEETLAELVDVTFCNQLENNSIEHF
THTFLSREGLEFSDIDLIVSGRNENQDDTPYFENFERLFPNATTLIYKHLTGEFFTASAI
GTWLGCQALQGKEIPKAFFLRKNLDKPLQYVLLYNQYLGREHSLVLLRKK
>SEQF1602_00377 Superoxide dismutase [Mn]
MSFTLPQLPYAYEALEPSIDARTMEIHYTKHHKAYTDNLNNAIAGTPLEGKSIEDILLHL
DTENKAVRNNGGGYYNHNLFWEILTPKKGTAPSEELAKAIDEAFGSFEAFKTAFSKAAAT
QFGSGWAWLTVQKGGKVAVLSTANQDNPLMPHVGGGTPILGLDVWEHAYYLNYQNRRADY
IEAFFAIINWEKVSQLYHQHA
>SEQF1602_00378 hypothetical protein
MKPKKNPNADLKKRTGLFFSIGLALATFASLYALNYRSVDKEKGKIEFDKVVDLTEDVKD
FTMEENTPPPAAPPEPPKVEVEPEVIKQVDDKQKVETDFKANDTNKEDNANTVPPKINST
GGVAGGTGTGDEEIENDVQFFAIEQKPMFEQCKGLPKEEQEKCFKKSLDAFVNKNLVYPD
AAIQMGSQGRVVVQFRIKKDGSVEVINTQGKDKILEKEARRVIEKLPKLIPGKQRDRPVA
VIFSYPIVFKLN
>SEQF1602_00379 SCO1 protein 
MHQKLKSVLWIGSCVALIALAAWGIHALRKGQSHGFYIVGKAPAFCLTDQHGQHICNKDF
EGKIWVVDFFFTSCPTICPVMTSHMVAVQDAFADHSIGIASFSIDPEVDTPEVLQTYARE
KGVRSPHWHLLTGDEKEIYRIANEGFNIYAKAGDTPENFEHSGLFALVDTQGNIICRKEK
GKPILFYNGMTPEGIAMLIEDIKKLKQ
>SEQF1602_00380 Ribosomal RNA small subunit methyltransferase A
MKKSPVQPKKHLGQHFLTNLSIAQQIANTLSEVGYDRVLEIGPGTGVLTQFLLGKNIEVF
VIEIDTESVTYLEQHFSKLKGHILGEDFLKFDIVSHFSKKPFAIIGNFPYNISSQIVFKL
LEIRDFVPEFSGMFQKEVAERICEKAGSKTYGILSVLTQAFYDTEYLFTVSEHVFNPPPK
VKSGVIRLKRKENYSLPCEEKLFFQIVKTAFGQRRKTLRNSLKSFLIEKESLKSDPLFDK
RPEMLSVEEFITLAQWLA
>SEQF1602_00381 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKKCAIITGGSRGIGRAICEQLASDTSYHLLINYQSNASAATETLEQVQRLGATAELLCF
DVTDKEQTEQVLSLWQEQNKEALVEVIVNNAGITRDGLFMWMPYDDWEKVLKTTLDGFYN
VTHFFIQKMLRNRYGRIVNVASVSGVKGTEGQVNYSAAKGALVAATKALAQEVAKRNITV
NAVAPGFIQTDMTAALDEKELSRMIPMGRFGKAQEVADLVSFLVSQKAGYITGEVVNING
GIYS
>SEQF1602_00382 Pyruvate dehydrogenase E1 component subunit beta
MDATTSFLQSMPFDELKRQSLEDYTIAVLSRECSLLGRKEVLTGKAKFGIFGDGKEVPQL
AMARAFQKGDFRSGYYRDQTFMLAIGEYTPKQFFAGIYADNDITHEPHSGGRQMGGHFST
HSLDEQGNWKRLVDQYNTASDVSCTAGQIPHLVGLAQASKVYRTLSIEGSEQFSNNGNEV
AWGTIGNASTSEGLFLEAFNAIGVLQVPVVMSVWDDYYGISVPAAYHTVKESISEALKGF
QRDFNHKGFEIYTIKGWDYPALMDTYAKAGHLARTEHVPSLIHVTELTQPQGHSTSGSHE
RYKSSERLEWEKEFDCNVQFRKWLIENGIATSEELSAIEEEAKKQVREARDKAWQEYQTP
IKTAKRELINLLYEMEKECFNSLEISRLKDALAEIETPLYRDVVSTARKVLRWVVGEENE
AVENLKKWLGDLQEKLQEKYSAHLYSETDKNPILVKKVDPEYAPDAPEVDGRIVLRDNFD
ALLAKYPTLLTFGEDTGKIGDVNQGMEGLQEKYGVTRVNDTSIRESTIIGQGVGMAMRGL
RPIAEIQYIDYTPYAIQTLTDDLATLSYRSCGYQRAPLIVRTRGHRLEGIWHSGSPMAGL
LNFLRGVYLLVPRNMTKAAGFYNTLLQGDQPAFVVECLNGYRTKEKMPTNLGEFTTPIGV
VEKIREGRDITVVSYGSTLRIVEQVAKELDRVDISIEIIDAQSLIPFDINHDTVKSVQKT
NNLLIVDEDVEGGASAYLLQEIVENQNAYRYLDSKPQTLTAKSHRPAYASDGDYFSKPNA
EDIFEKVYAMMNEINPIKYPQLY
>SEQF1602_00383 Ribosome-recycling factor
MNEEIDFILESTKEAMQGSLNHLEKSLLNIRAGKASPQMLGSVYVDYYGSQTPLSQVANV
NTPDSRTISIQPWEKNMLSTIEKAIMVANLGFNPMNNGETIIISVPPLTEERRKELVKQA
KGESEEAKIGVRNARQEANKDIKKTEASDDVKKDAEERVQKLTDKYIKQIDEVLAKKEAE
ILKV
>SEQF1602_00384 Levanase
MRKFSLYNFLSLLVLTSCQNQEPDLIIEDFESASFANWTVEGDAFGETPAQGSLSGEQLV
TGFQGSYLANSFHNGDDSRGILTSKPFRIERDFINFLIGGGMSEDTYIELLVGEQRVARS
HSPVESETLQLMSWDVKAYRGQEASLRIVDNQRGSWGHILIDAIEQSNQYKSSIMENYTL
TYDISQKYLLLPIEDSAPETKVQLMVEGKEVGVAMDIRLAKTHIEYWLPLPVDAYRGKKI
SLVFGQAMKGDMGISQIKPSDTFDLNYDEPYRPYYHFTPEYGWMNDPNGMVYHNGEYHLF
YQYNPYGARWGNMHWGHAVSEDMMHWKHLPIALAPDPLGAIFSGSAVVDKDNTAGFGKGA
IVIFYTSAGEQQTQSIAYSLDNGRTFTKYEHNPVIANPNIADFRDPKVFWYAPQRKWILS
LATSQTITFYASKNLKEWERLSEFGQNIGAHTGVWECPDLFPLSYEGKTKWVLFVSINPG
GPNGGNATQYFIGDFDGTTFTPEALPYPLWIDYGRDNYAGVTWNNIPESDGRRLFLGWMN
NWDYGNSVPTKNFRSAMTLPRELRLQHNGSHLVVASFPVKEVGDEQDNQPIIMNKLAENP
LPIGADFYNNGYVVSFTVKLNALKAFRFALQNSKGEKIVYYFDTEEKNFVVDRRKSGLTD
FSNNFADPLIVAPLIPKKSYTIHLWVDKASVEAFVNGGEVVQTNTVFPTEPYNQLWFDLR
GNTVVSVENITLYKIKN
>SEQF1602_00385 Fructokinase
MRHKIVGLGEILWDVFPERKVLGGAPANFAYHISQFGFDGCTVSAIGNDPLGTEILDSLA
QRQLNHLIEKTDFPTGTVKVSIDNWGVPCYEICEDAAWDNIPFTPAIAEIAKETQVVCFG
SLAQRHEVSRATIHAFLDAMPKDSLKIFDINLRLHYYTKEVIERSLERADILKINDEEVV
KIAQLFGWNLSEKEVCKRLLSMYNLDILILTKGTEGSWVLTPKEESFLATPKISIADTVG
AGDSFTAAFIASHLHGRCLSASHQLAVEVSAYVCQQHGAMPRLADAHLELFK
>SEQF1602_00386 Isopentenyl-diphosphate Delta-isomerase
MEEQVILVNEKDEPIGLMGKMEAHQKGLLHRAFSVFVFNSKKEVLLQQRAACKYHSPNLW
TNTCCSHPRAGETNIAAGERRLQEEMGMKVPLQEVFSFVYKAPFDNGLTEHEYDHVLIGC
SDTPPEINPEEVASWKWLSLEAIREDIEQNPQVYTVWFKIIFEKFYHYLLQNTSLK
>SEQF1602_00387 hypothetical protein
MDFFRKHFTNILMGGLLLVGLATILPYFFGRGAEDSLPQQIIPNDEPIREYEPPFTHEGD
LSFYKKDSTLIKTFQIEFARTQQETELGLMYRKSMKDNEGMLFVFHEEQPRSFWMRNTYI
PLDIIYLDKNKQIVSIAKNATPLSEESRPSEGNAMYVLEINGGLSDKLGLTKGDRMSYES
LID
>SEQF1602_00388 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MITFHSLYQSARLRSLPLSLSGILLGSAIAYGQGAFQWPIFLLALLTTVLFQVLSDYAND
YGDAQKGTDNDQRLGPKRAIQTGAMTLLEMKRVVVITAILSAIAALVLIGVSFSEHWVLA
LLFTFLGGGAIFSAIRYTVGKSAYGYKGLGDIFVFIFFGWVSVMGSYMLYTKQFDPWVLL
PASACGMLSMGVLNLNNMRDIDNDRQMGKQTIVVKIGLPLAKYYHYLLIIIPMFLMMLYS
VMNFEFRYKVLYIIAFIPLVFHLFYVKKVENPKDFDSQLKVVALSTFLMCVLFFVGKII
>SEQF1602_00389 hypothetical protein
MKKLALYICVLMGMPSVFGQELQLPSGNQYLADSEFLIMPTYAGIGNNVRVRLSATSQWV
GLKEAPDYQSLSGDMRLGNRSGLGLSLYNDRNGYTKQMGAKATFSHHLTLDSYDSHFVSF
GISYLVNAFRIDIDKFTEAGRPRADAAVTDNRAMINHNFEVGVLYRYKGIFASLAATNIL
NKNKEMFDVKEPTTLRNYNLYAGYRYKRTPNSILEIEPSVFVQYREGDSRSLTDANVKFR
WFDFEDYYWVGATARFVNDQAFKPLSVGPMLGLKKGVFYFAYGYNLNLNTIRSYNSGSHM
ITLGIDMFQGIGGCNCTER
>SEQF1602_00390 hypothetical protein
MNVNKVVKPDPIDFDDPEITMVSCKNERDGKVVVKNARGGAVDDPTATTLTTTYYYELYH
DIEGAIRPLQLSNEFTELPAGNYTLYVRDRWNCEKSVQFTLGTPPEIQVTRVSNSNLVCH
GDTGKVSVSVTGGTQTPDPDAGGALAYIYSLELVEADRDVVVNRLDKVKMADFPKEIAGL
RAGVNYRVRAMDGKRCAGESDLFSLTAAPKLDIKATYEDNCEDNEYQGYVVLTFEDATVD
FTKVQYSFDNGVTKHSFAAGMTSGAQARISRTHSSVRPSSLPQSIKLYYSDAGTNCEGET
NPVVIPVVEKLTLIKDPSRHPDINELPLLGKNGVPDYTYYINGVHQGNNGTYIVRKQDPE
GVDPSDNKLKKRIEARVEDSKGCTAEEVFYVEYYDIEIPRFFTPTGDGENDTWAPRNTQQ
YPNIQTLIFDRYGRLLKELSQGQSWDGTYNGKEMPTGDYWYIITLGEESDGREFKGHFTL
YR
>SEQF1602_00391 hypothetical protein
MVACTGESTGVIGVYDGTAYLPITDAIDRTKGVAPYVIKIYKYATTPGSAETLQSSNTGR
DLSKGWYKVELSDAKGCKTSVDLEIKEIEAPVLTLVRKKDITCTSGASSLGEIELRFTTG
LQGNYYMALYTDSNYTTPAQNHAGTPQVTGENYVNSTGATKIFDHLPPGDYYPAITNMAT
GCKVKLPMVQIGGSQIKANAIPAQQVDCNTAKQKIEFFEDGAEIDETQLKVAIYRDGPLG
SGLLTWIPGTTGTITGTGNNKKVEIEFTLLAKTPYRIAVEYKGCKTLLDGKFTPNIATPG
VTITEKRKPNLCGAGATGSVTLHYELSAFAGSTAPKWELYTYPFDTRPGAQSPIATGTAS
TPSGGKSEIKQTVTGLTENKTYILVVRDGTANNCVMGTEIFTVLRAAQPLAFVQTDLLRN
SACSGSANETAQVKVTIKDGVGPYKYTISQASTEPTDTQWAHAAVLPTNSRDVLLDQTFE
TTFGGKIKGTPTGATWYVHVRDANDCHISQAVTVKEDPAPAATKAEVENPCVVGTEYTVK
VTLSQIGKGQHYYTFKPAGGTEGPQQPIQFTQTGPSVWEGYIYRVYASSVARDITIYDQN
GCKSAAVNFVFQGKISFDLTQSKPITCQPGVAGNGELKIDNIANHNPANPHIYRVLKEDA
GGDIVIVNDTPMSGFGAFTVPITQPGRYRVEIVDTTHGGCPFSRTLTVNDKVLPILSLDN
STDSKCYNANQDLLDVNGGGSATLVAAPESQLPMSYSLKAARYADDNSAVTALATIPATH
TNVTASNTYVDWQNNGRQVTFKGLLGDVRGIIYTVEAKAANGCTATTEFTIYGVKPIEID
MTQEAVTQFQCSGNQEVLAKLSLPKTAITGGSGRYRFTLLKGGTPVQGNIDLTEPTFTIS
DETGGNFTLRVEDAQYQCAEVTKPFPTAIKPFVKLTTVTATEVTDITCRAGEDVKVEATL
APAGGDPIKVSLSLRSVTNSSHQMVQITVPAGATTATHTFTNVPMGNYSVVATNDETGCV
TYGTTYKVQDPNTFSLTATEEKPVKCYGGNDGSITFTLEDLDLENSGGVNQATQGYTLRI
KSLTRPTDPIITVTVPAGSATHTLNTLAYGSYTAEAESTSTGCITKIPANFTIRQADQPI
NMAAKLRVPDDCSATGSAEISIDITGGIAPYKVTMTGDNGHTQTANQVYNRWLFTGVPGA
AAPGLPSPSR
>SEQF1602_00392 hypothetical protein
MGGKDTNYQVVYRGETLPFYRPGGYVFFQRSKESGGGYWLGRTYDDCFIFEIEKPISLAY
GLDYLLCLEEIQRRATEFIDEYDPNYTLF
>SEQF1602_00393 hypothetical protein
MPISLICMIYKKHRQSEVKMTVEKRPTLSDFDFSRVKVNPGPPTENKARILLRIVEGAGV
ALWQSDPESTPTILIQKGNLFPSPGGYTWGYKGGGCKNLAFAMVTVIYQDDHLEKAELSE
RAYKLVEDYISVLQQDQPHDLSVAYIRKFLGDRELPAIYDQHR
>SEQF1602_00394 hypothetical protein
MLDDIKKHVVKFDFVHGIIQGIVYLSMMLVIFKYGDLSNPSMRLGGLLSIISYIIVVGSP
IVSRKSSAWDKDCYEFYILPAIVLITGIVAYLGCSFYYWDLAINTLKVCVFNVIYLCLSP
LMALGIYYARILATWES
>SEQF1602_00395 hypothetical protein
MKDKDIISFDVPDVSEQRIFLLEQGVDEGIKTLKNNLTARRFPKSKQVDYNALSDKFFLT
QDQGWSAPPGTLVDAWFEQFKSSFPEYGSDEKLANLLGIRSKGASRQIRAFRSGEKDIPY
GIWRRFLVITGRASQEIYPVLGIFDIDEGF
>SEQF1602_00397 hypothetical protein
MFVAFARQRGVRHRMPRLDVRKAVESLLQGLCYHYDPLAGRVNVTLTTLAIECGLATESV
NLNLAITRATRTLKLLEVLGLITYKTEFCKDLGCNFPTDITFTNDFFNAIEISERALEGV
VRERAGWKNRERSKRGLPALSIEEHISEAWGAFRKRFYDYRLKRKRQGEKRAKANRDKER
TRQEIENLVRRELSKEIASGAFPAEKNAVFDEVARRVKERLIMSRGNFTRLAA
>SEQF1602_00398 hypothetical protein
MIPKRLRDARKNAGISQEKLAELVDVEGINIRSRISSYEVGRVEPSFNLMVKIAAVLNYP
ECYFYTIDDALAQTILEIHLNKNNSSHNPYLNTIHHAEKLCSELHDLLKKASAK
>SEQF1602_00399 hypothetical protein
MTVVITLMASDNAKNRRRMRRASEREQESDKEREERRNYYLSNKGCVKAAKAVKAVDISG
PIISRQNRANPDASPPRKTNSDRYTRLTCRARQKVKLGEKPLIKY
>SEQF1602_00400 hypothetical protein
MMSSKPTHTAFLTQEYEQAGEKKTMWHRVGSVWPHNAGNGMTLVITPGMSVSGKVVIMPV
KDDEAPINF
>SEQF1602_00401 hypothetical protein
MNFFVTAGICGDTASPAPGTVGVTFRVEVEGEIGTGGYTWFVKKSGGTTYGTQTGHGASD
QMTVHIPVGDVPQGTAITFETEVTVVGTQCKTAAQLTATRPQNINAVSKVLRYMTYCNGE
AQNDAQIGVTSAPTGGWGAPYQYRVVTDGNAGSFTDQMTFTVGVGTHYIEVRDSRGCTRK
LDSFTFVPYHGPSMQLQAPNAPTATKIPSCVGSQDGEIKLTGVIGGSVTATTPSPSGSTP
TLVEGRLSYELFDATTERSLGRILPDDNPTTRGTVTFSGLGAGKYFIRITSDMLCADDKV
DSQPVTVNDPGTIIARAELTKYPGCNTAGDITVQIEGRPNMNPTRGTYKVELYDISAGRP
GTLVPVTPTITGAYQTGVTAVFAAAVTTPVSSDRVYYAKVMDNGGGTGACEGESNEVHVA
KVNPIDGAIDNDKSVTSLKCYGSSYGKIVVTATGGKNDEPYVFTLKRNGSVVPGLSTPNP
NAQGVFEGLDASDDYSVEISQAVGVCIPKVVQVPIKQETKYTVEYEVKQVTCNGDHDGSI
EITTTSGQTKLDGTQRKLTYAISPRLDRFLDNGGKFEGLAPGKYYVIVQDENGCRPNEIK
EKGQPTPLGTDIIEFTITEPDPLSVTVRMDTVEHESCAGSNDGKAYLRVIGGTPLRTVGN
DKVYEYSKDGGTTWVEYHSDGNGTLIDGLAPGDHTIKIRDKNGCQAEATLTIEAGSEVTL
KLSEGKYECVNNVIKYVVEASVEPASAALNVRYLLDGVAHNNTRFELDVDLQTNTTKSYV
ISVIHKVAGHGECRKDSAPILVAPKTPLKAQADKITSVSCHDGADGSFEVVAQGGSGKYE
YGLKQADGSYRWQGTNNQFKDLSVGSYTVGVKDTEYGCIYEVVNTAIIAPTPILITQNSI
THVGCKGEANGEIEYVLKGGNPQYSWEVFFENGESTSKRGTGEREATPFKIQGLKAGKYL
LVVKDAKGCSQKKEFEIIEGVDLKGVITQHYQCNADISENNKVLVVDGSGPNSDTAAEAT
YDVYVSVTTPYLVINPSSGGAINRLRYAITTQGGSPIQRYEFNGTTPTGTDNTHNMYKIA
HASLLAQLNAVRPLQEGLNKYELHLYYFNKDNPAMSDPPLCQEVRELNIEYYPPIKITNQ
SIANDLNLVKVKVEGGKERYTVYFSGAQYHTGEEVKAHYVQKVDDVKAGDEVVYYVQKTD
YEEVNPATGKVEKKVRVYVEDSKGELKQENGGKQVCAHSVFIYKEYMDVVIPNYFTPNGD
GEYDTWAPLNLASYPHAETIIYDRYGRQIATLNNRQEWDGTYGGEPLPTGDYWYVLRLNE
PDDSRTFKGHFTLYR
>SEQF1602_00402 hypothetical protein
MYTANATIDLPAKDVDYTIVVKVTDANGCVLAIPGSFVGTVKTLQKITGATFHRTQQMSC
QPTGTEQVTMTVTRTNGSNTGGYNVYIRKMTGAGAPTEVAGYDSAARTAGTAQIGGTGVG
TITFPQIAEESADYEITLTDKGYGMYFCGTKWI
>SEQF1602_00403 hypothetical protein
MDTIFLKKTIVKKLFHFLCTVTLLLSGITAFAQGAPAYKAVVKGDFELIGNHSDAPYTLN
IPQTDPNCPVNIKWARLYWGGHSGGGNKDQVRLVGPGGLNKSITKGGGNEETNGVVWADA
DYLIYRFYFTSNDGTDLDIAAEITSPVRYRAGYCRGKFSSQDMPIRGAAPSGNFAMWSGD
NTGVGLESIIINVKKIKQTHPSSQDIVMNFYAGWFRRYVSGNMAIKAEAYRGEMINDPAD
RFNWIPAPGAQKVGEATFPIQLAKYNGACNGNKWTNVPTGDMYHFGEFVYNPSDGRILWK
KSSTIGGGQEYLGQSNVVDATKTIVNDGTRVDDDSYYYRWADVTADLQALARAGNLNGQF
QVNDIYNDGGTSWKFQPGWALVVVYEDPKAKGTTVSKWIEVHNPFQRVGAGAPTEFTYNY
SGFVAAAATTPPGAHNNIWPKYGQVALGGEASVSGDKVEVNGTANPYNGRQANNFFKGII
TRENDASQPSVGWDVSVFGAQNPAAGATSTTVKYKASDGGYDAFINIANVASIPTARPAF
EMVTSVKNSAGTDISGQRIALGATAKYEITLRNVGSGNASSTITLEALLPKNLNYVSHEA
LPLGATFAGKTNNYNNTGRSLLKFTIPAAGLPANANAPMSAPITINVKAVSDCGALRDAC
SNKLEFQPVLKYSVVGPNENLEQLSYNKLTDCEPKPTTFFIDDTPCSQSANNTYPYCAAF
ELDGGAGYPSYKWTRQGSTQVLSTERKYRITEAGVYVLERGASACQNPTTLTFNITPRTG
NDALHPLRNNSRVVERQTCNNTGLEYLQVALCGPSVTLSTTGVSLPDSDVIWYRYKGNTS
QLVPSCPPASVAAEPANWERLGTGKTFTINDNQVSNNGTHFAIVLKNPGNCDADYYFRAY
KASGSYTLAKENILSLMCNGATTATSQGWLKITNIPNGQYQYKIDGPSASVGWTDVPGGN
NNFEHQVSARGEYTVTLRPKLAGGSSQFQNNVCTFEQKITVQETTTSGADPTLTLTKKDV
QCVAQTPSGGAIHVMVHGNVTLPVDVIVKKQAGSQIVRVRVDNDSKRDSNNWDNVSKAAI
STLGKGKYEVTVVPNQRNCTTPAQIVEINELPELKLLTVTPEDPSCGPNKKISVTYSGGT
PPYSLEISGIGIATQQPNVGNVTAYTFEINDPTFTSGSKTYQVKVTDTNGCVVTKMVPFQ
LQPKPTFTKASTSADCSTTAGTITMTINNPLFDVTKYSVRYAIEKANAGGTFSGNWMFQD
YPNKTFTGLTSGKYRLRVYYKRGSKECSWPEETYQVMNNGRLEYLTGPDFDDQIVTIDEG
NGPLTGFANVSHLACKVGENPTGHAHASVRVSGLGGGNGTAGGVGPGGKYDVSLNGGITW
NAIPAGTTITWDANDLRWDNVPIGTYNVKVRSHAPAGGVTACEIEYTVKVEAPLLAPEIT
STLTYDCEGSAQATFVTSRSDYSYHVEIGSPLSSLPTEWNGNYEGTGTINKLTIDKSKAG
TTQYARVFYKRTVMPKRELIREDFGVGEPTDIAGLNRVGVSISPLLRYKTPPGHVSWQEY
SITNYKDFYDTGWPGLRLGSPNWIQDAPEDHTGLPNGRYMFIDMYENIPQGMTLYQKEVD
IVPNGPIGFEVYVMNLNRSASRWELPNIRVQVTDLSDNVIGEVTSGDIPYNDIGNTNWVR
ISSDQLGDINPGNNTRVRIKIQNTHNHRMGNDFAIDDIYVFQGPVSCPTLKVDVALPIEA
GKEMKITSHTTIDETCNGSNDGKLTFGVANYGNVAYTWKVVTRGTTTQVQGGTNNTAGLT
VNNLAPGLYTLKITSGHQKKFSNDQACEVTQDFEIKRNAKVTVTQNRTIDYLDCNIDRKQ
MLIFSQNATGTNQGVFNIMGGKQTPSAPLRYTIKVVKIPSGATDILTPDSNGNYRYVVVA
GTYQITITDDNNCNGGHGTFTYKVEARHKIGTVKAEYKNCVVANGIGDMELSHTFIGGAS
NGKPVTYDWKKQGDATWTAVSGNTIPKTTLDGWTKGVTYLIRAKDEYSCEKEIEVSIPVE
IESLTTADYTVVHPTIACGATTVVPGSITVNHVRGGSPNPTYHYAFVPKGSTPQDTDYTA
SNTKSGIITGGEWDIYIKDIAATPPTCGKKVNTQSIKIDNPISTDVEKSGGSLAVDKYSA
ICEDGQGGKLRIKKFWGKGPFRLELKDNTNNTTATYTIPRTAVPGKVTLEASGRMVVENY
EIGNLQTNINYELHIKDEGNGDCDPLGAAGYTFTIDAMTFTFPTGGAVTQSLSGCTTTIA
FALKANNDIQPAAEYEIVYRLVRRNGNAVTGADAQWDTEANRPVQAPYILQGLQGAMYAG
YNLGDRFTAQVGVRRKSDNSVVCTKDIPEFTLTGTPSNVRLTTAPSGTCNYDLKVQFGAS
GVPYDDVEFFLNHDGPTAEAQSPLMASFTGGNTYTFNNLQKGRTYKVYIHYKEHGSTTVC
KQAVDVPEDANNRPNVQVDNNTLSGVACSPGITTTVNFKVTVTSGTALTYKVYTKADSGI
LTQVGNGTISGANPYLLSLPGQTITAPGQRYVLSLIDASGCESFTHDIFVTPPPTNALTA
GTLSVEASTTAMSCQTGAAKLVVKGGATGGTGPFTYSLLMADNAFLRRNIVKRNVPNFNT
NVEFDLRDTDFVPGTVYSGITFTFRITDQATGCEEIVTVTGNNLGKFLNSKHTATATLDI
NKTATGANACDANDVNYKLKITLSNINATVGTALTFADYEYSIDGGGTYTTFPAATVEVD
IPALFDQNKVKVRSKESLCEANITYAGGTPPGANERLTYPKLKFTAEKKTDMACDNAGVY
TATFDLKITSGSDFVTSPTVPAPFTPAGNRYLIKVTEGTGVAAGTRNALTTAPAGTTFTT
AVTPVGTNLHNQEIKVTYTVPPFPTAPITYNVWVKDLGNKYCDEYVASAPIVVNPAEDPN
NLKARHTIDPAKISNVVGCTPGGTTGSFEFTRTITTGRENVSFVYELYYSTTGAASSFIG
SGTVGDGDIIERTTSTVRYKVTGLKAGYYQLRVKSSANGSCGQDVTGFSEG
>SEQF1602_00404 hypothetical protein
MKIGLSYKIWLCFLISAFALAQEQKGYYMPYQMPTHAFVRFNTFVANPAFPLIVNYQEHN
VGLYYRNQWSGYKNDNFSLMGLSYGRNWRETSSMNAMVFKRNATVMTNYGVVLNYGHLIT
LSDQVRIGLGLSVVPSFSGLDKGRIRAADPTDPLLNVGNSFDINVQPGGYIAFGDFYIAG
MAENLIDYSSGAGKAMTEFRDKTFTAHLMYRTALESNNSLLENGYWSAAFRATKEYDGYN
FGGSAMLDLPALGWLNVGYTQRNGLLAGVGVNLRQQWSLGVEYENPIGVKIPQLGSTFGV
YLNVQFGGERQKVAPAPTPRQPSTKRPPIVQVTPEEPKEKEPLVKQPDLTKMPVKPNQAP
ISVKIETMEGVPPGHYVIIGVYAIARNAFNFRQQMAKRYEVGTFVNKKNGLNYVYLGKGS
MSLEEAQNLMRKQMINVDFVGGIWVLEVKAL
>SEQF1602_00405 hypothetical protein
MKKMKYIACLFLLLVTGMIYGQTAREIYSIQTGSSESNNYYCVRNSSGQVKVYFKWRGTK
ANVDNKFIAELSDANGNFGSPIKLGEITERGNQVQVFEILFHLPAGTDGLAYKIRIRSTS
PEVIGVSAPFEAHHLGDATPTQLNNFNNVELCPGAGGRTISVTGGSTAAVYKWYKDGQLI
PGATGSSYTVTTPGVYAVDPDFGRCSTSLRSNQVTATLAGSSGSMVLKIKGASPREICAG
VPTTLETEVENGGSNTFTYQWYKGEVAITGASTATYNVTEAGDYKVTATAAGACPLTSNV
IKVTERNTAGLLTISGGETQVKCPAQTITLTSVLSNPSLTGIYKWYKNNTEISGASTNTY
TVSDTGSYYVTLTETDGCVIKSNTVTVTDRSGVNPGDIKWLGHENNDVIFSFPYRRPVIE
LDIPSTETLTVKWFKENDPSNILQENTTRSFQVPSEGTFVAEVYDACGTKVNTGVLKLQV
KEPSRYIPTIGFKQGNAPCGASQAILELSKLEAVIVIGSEQKKTLVPNADYDQYTFQWKK
DGVAVGSGKELSVTSTNTVSVYHLMVSGAFNSNEIKLMNVDVPTAISITTSTGATELESD
RALELIPTLSGNFQQELFTYKWYHRKDNTQPWEEKKDVTGETDKKYVIPATSQKDPAFRS
LAGEYQFVAKLKEGNVSIGGQSIDLTPYAAACGGTEGVINIRYVLNYDGVEVPNILLLRG
EDLNRKWILPSQWAGAKVTIYKQTGEIVYQANQYNNDFPNFESIPSREGAAIYFFYELEK
NGKTQRGTITIFH
>SEQF1602_00406 Penicillin-binding protein 1C
MFVIEKTFTFVIVKALCRKYLLAAIGYARRHKIRVGIGIILLLWYSLCLPRDLFPQGYAT
IVESSDGKLLGGKIAPDGQWRFPELDSVPHKLKEAILAYEDAHFYYHLGVNPISTGKALL
TNLRYGRTRRGGSTLTQQVIRLARKNKKRTYGEKLIEAIWATRLELRYSKEHILRLYASH
APFGGNIIGAEMAAWRYFGVPVWQLSWAEACTLAVLPNAPGLIYPGKNQTSLKHKRDFLL
GKLYKNHTIDKTTYELALSESLPEKPHELPNMAPHLVERIAKSHRGERKRSTIDYPLQEK
VNQIVEKYYRYYKRFEVHNLCAMVVDIQRQEVLAYVGNSPTDGEHQKDVNIIHRPRSTGS
VLKPFLYAAMLDSGELLPEEFVADVPTHIAGYAPQNFENTYEGVVPAHEALYRSLNIPFV
LLLRQYGISRFYQQLRKHRLYSINRHPDHYGLSLILGGAESSLWELSQAYAHMGFELNHY
NQKHSYLSQSFQPLSYLPRERNYGKEQQEKTHLSAGAIYKTLEALTQVNRPSFDSAWRYY
ASSRKISWKTGTSFGNRDAWSIGMNANYLVGVWVGNASGEGRPELTGVGTASPVMLEIFQ
WLAKNQWFVSPKEDLQQIEVCAISGMLASDICPKKLITTAKASLLGTPCKYHKWVHLSPD
HKWQVTADCQPISAIDSKSWFVLPPLMEWFYRKGHPTYLPLPPLREDCQGGERQAALDFI
YPKDGTVLHQAKGFGGEVQPIVARVAYKHSGKLFWYLDETYLGETLHFHDMQLQLSPGEH
LLRCMDTQGNEKTISIMVND
>SEQF1602_00407 Arabinose 5-phosphate isomerase KdsD
MENFNKILDFARETIETELYSLGKLTNFLDKDFALSVQTILESGGRVVVTGIGKSAIIAQ
KIVATMNSTGTPSLFMHAADAIHGDLGMIQPKDVIICISKSGNTPEIKVLVPLLKREGNP
LIAITANRESFLATQANYVLYAYTQKEACPNNLAPTTSTTAQLVMGDALSVALMRMKSFG
SEDFAKYHPGGALGKRLYLTVGEAIARNQVPSVAPDTDIRQVIVEISQKMLGVTAVLEGD
AIVGVITDGDIRRMLSRYEDIKGLKAKDIMSSHPKTIESSVLAVDALDFMQNHKITQLLV
THSSRYMGVIHLHNLIQEGII
>SEQF1602_00408 ATP-dependent DNA helicase RecQ
MSTTNVELQKALKSIFGFSAFKGKQEEIIRSIMDNHHTFVLMPTGGGKSLCYQLPALLKE
GTAIVISPLIALMKNQVDVIRGISGTDKIAHVLNSSLTKGEIRNVMEDIRNGDTKLLYVA
PESLTKDEYADFLKTINISFVAVDEAHCISEWGHDFRPEYRNIKTIIERLGEGIPIIALT
ATATTKVQEDILKNLGVPEANVFKSSFNRPNLYYEVRPKTKNINSDIIRFVKQRPGQSGI
IYCLSRKSVEELAQTLQVNGITAIPYHAGLDAKTRAKHQDMFLMEEVDVVVATIAFGMGI
DKPDVRFVIHYDIPKSIESYYQETGRAGRDGGEGYCLAFYCYKDIEKLEKFMVGKPIAEQ
EVGQALLQDMVAYAETSSSRRKFILHYFGEEFDEINGEGANMDDNMRYPKTKKEAKEQVT
MLLDVIDKTRQRLKAKDLVNVLTGKYSAIIKSNRFDEQDFFGCGSDLDGHFWMSLIRQVM
VNDYIRKDIETYGVMFLTDKGRAFLKEPHSFMMTEDHNFDEDPDEPAKNTVSALDDTLLK
YLKDLRKKVAKEFGVPPFVVFQDTSLEDMCMKYPINITELTNVFGVGEGKAKKYGKEFVS
LIAKYVEENDIIRPEDLIVKTTGANSALKLFIIQNVDKKLPLPDIAKAKGLSMDEFLKEM
EQIVYSGTKLNINYWIDEILDEEQQEELHDYFLDAETDKISVASKEFGGDYEDDELRLYR
IKFISEVGN
>SEQF1602_00409 DNA topoisomerase 1
MQLAQRLYESGLITYMRTDSVNLSPEALSAAKQEIVKSYGEAYSKTRQYTSHSKGAQEAH
EAIRPTDMAAHTVRAEADQVRLYELIWKRTIASQMSDASLERTQVKVNASTHTEPFIGSG
EVIVFDGFLKVYLEGKDDEEEEDEGMLPAMKVGESLTSKHITATQRFTRPPFRYTEASLV
KKLEELGIGRPSTYAATISTIQNRGYVERSSLEGESRPYLQLSLIKNEIKEKKLTENVGA
DKGKLIPTDIGMIVNDFLITHFATIVDYNFTAKVEEEFDDIASGKEDWAKMVGRFYDTFH
PTVAHVEQNAVRETGERILGTDPATGKPVSVRLGRYGAMVQIGTVEDEEKPRFASLLPHQ
TIDSITFEEAMKLFELPRKLGVYQGKEVESNIGRFGPYIRFGDVFISLDKSLDVFSITFD
EAKEVIDQKQKADAPISVYDGKEVTKGTGRFGPFIKWNNMFISVSKKYDFEHLSQSDIIF
LIEEKLKKESEKVVKEWPEEGIHIEKARWGRYHLLKGKTKVELSKDTNIEAFTLAEAQSL
LATKEKPKKTPATKKAPTAKKAPAKASKTVAKKTVKK
>SEQF1602_00410 hypothetical protein
MKKIVIAMAIIGLLTISSCGKETEKVIERVEVQKGSQILSGEGAPNTSLGSIGDYYLDKN
AMNLYGAKTIEGWGNPISFKGTQGQAGSKILSGTVAPTTQGNIGDWYIDTQNKNLYGPKT
ENGWGSGISLIGSNNIAQKVDFLISDDATTLLEWRNKNVTTIDMTNIPELANITKIGNEA
FRGCRDLTTIKFTEKITTIGHSAFRNCTVLEEIHFTKNITSIGYLVFQNTDIKNVYIEAT
IPPTLLSSRRNDSFGKSDIQNFYVPASALNAYKANAQWKTATDIKEYDPNTHQLVVTGSK
LKAMP
>SEQF1602_00411 Inosine-5'-monophosphate dehydrogenase
MNSHNPKIISEGLTYDDVLLVPHYSEVLPREVSIQSFFSRNIPLNVPIVSAAMDTVTESA
MAIAIAREGGIGVLHKNMTIEEQALQVRKVKRAESGMIIDPVTLSLSSTVGDAKHCMKEH
SIGGIPIVDEQGILKGIVTNRDLRFERDNTRPITQVMTYENLITAPEGISMKDAEKILEN
NKIEKLPVVNKDNKLVGLITFRDIANLQSKSISNKDNIGRLRVAAALGVTADAVERAEAL
VHAGVDAVVIDTAHGHTRGVVTVLKKVKEQFPQLDVVVGNIATAEAALYLAKAGADAVKV
GIGPGSICTTRVVAGVGYPQLSAVMQVAAALKQQNISIPVIADGGIRYTGDIVKAIAAGA
DCVMLGSLLAGIKESPGETIIFEGRKFKSYRGMGSVEAMQHGSKDRYFQDVEDDIKKLVP
EGIVGRVPYKGELQESMHQFIGGLRAGMGYCGAKDIATLKETGKFVRITASGIAESHPHN
VTITKEAPNYSR
>SEQF1602_00412 Phenylacetate-coenzyme A ligase
MSFPIPIIETQSKDAIRLFQEEKLRELLQYLKEKSPYYQRLFRENNIDITQIQHLEDLQR
LPTTSKDDLQRYNDDFLCVPKEAIVDYASTSGTLGKPVTFGLTDRDLERLAYNEAISLSC
AGISQGDVVQLMTTIDRRFMAGLAYFLGIRHLGASIVRIGAGIPELQWDSILSYHPTYLI
AVPSFLLKLIEYAEKNDIDYRHSSVKGVVCIGETLRQQDFSPNLLTDKIMEKWPELRLYS
TYASTEMSTTFTECDAQQGGHHHPELIITEVLDDEGNPLPYGQLGELTITTLGVEGMPLL
RFRTGDMVTLYDTPCSCGRNTLRVSPVVGRKQQMIKYKGTTLYPPALMDLLTEFAQVENY
IIEISSNEILTDEILIKIGTCEPSEALKEEIANHFRAKMRVVPKIEFYPVDTIEQQLYPK
GSRKPVKFIDRRGE
>SEQF1602_00413 putative GTP-binding protein EngB
MEIKQAAFVVSNTQVAKCPTHKLPEYAFIGRSNVGKSSLINMLTNHKGLAKTSSKPGKTQ
LINHFLINKEWYLVDLPGYGYAKVSKQSKKTFQQFITDYFKKRRELVNAFVLVDIRHEPQ
KIDLEFMQWLGENAIPFAIVFTKADKLTEKQIQEHVTSYSEILLQQWEEMPPYFITSSEN
RLGKEDLLSYIETINQSLKA
>SEQF1602_00414 2-hydroxy-6-oxo-6-(2'-aminophenyl)hexa-2,4-dienoic acid hydrolase
MINLFRKKEDKFSYIEKGEGTPIILLHGLMGALSNFESTIDFFSKKYKVVAPELPIYDLP
LLSSTVKSLTNWLARFISYKGFDQVILLGNSLGGHIGLLYTKLHPKKVKALILTGSSGLY
ESAMGDSYPKRGSYEFIEKKCQDVFYDPKTATKELVDEVFAIVNDRTKVIKTLAIAKSAI
RHNMAKDLPKMTLPVCLIWGKNDPVTPPRVAEEFNELFPNATLYWIDKCGHAPMMEHPEE
FNKTLNNWLTDKDL
>SEQF1602_00415 hypothetical protein
MAQDSDTLTTRYKVLSKGNIFITGNNILSRQEGKNNPNTPFNDLVGGVKLNDSQNMQYID
IDKDKKTFSSSSAEVSLPKNSRILFAGLYWAATYPFELGESSGGKIVVKDDKRESVDEVL
LKLPKEKYVPIKGEFVFDGSTDSRYMGKNAPYVMFADVTKLLQDAKRKDGEYTVANVRAA
GGAIEGGSCGGWTLVIAYENPQEPLRKIDIKDGFLSVKGSKNISFTNYKIPSVKEAFPRL
VGGVLDADFNQGENKLGIFSEKVGFYAETKTRSVKNFFNSSITYLEDYVKERKPNSKNTL
GFDIFSIVVPNYDFEVFPVGNEYLRVNFSSTTDTYYAFLLGLAINTEENTTLRDAEVDKL
LGKKPAIKPQTAVTGQATITPQGQVAATQGKTTTTPIQSGQNVTTPQGQVAATQGKTTTT
PVQGGQNTTTSQGQVAATQPTAGVPDNVRKINAENVKKGFYLILGVYSNKQNADKYIFGL
RQKGMRAEGSFLYPAKNLHYAYAAYVTDYETALKKQREINSAKSQNPELQKVKDVWILIV
E
>SEQF1602_00416 Thiamine-monophosphate kinase
MLEDKNTHRTDLSQLGEFGLIDLLTRDFPLHNPSSLKGIGDDAAVIDFGEEKAVVSTDLL
IEGVHFNLAYMPLKHLGYKAIMVNLSDICAMNALPTQVTVSLAVSNRFPVEALEELYEGI
RLACDIYKVDLVGGDTTSSTRGLILSVTAIGKAPLEKIVYRNGAKENDLIVVTGDLGAAY
MGLQILERENEVFKVNPNLQPDLEPYQYLIERQLKPEARKDIISLLEALEVRPTSMMDIS
DGLSSELLHICKQSHVGCRLMEDKIPLDPTLINVCEEFALSSTMVALSGGEDYELLMTIA
PADYDKIKGNPNLTVIGYITDESLGCNLITRANEAIPLKARGWNAF
>SEQF1602_00417 hypothetical protein
MSIEKFKEVIEAGYTVSGKYITLGGAMYEGKAIANLFVNIPLKNLNRHGLIAGATGTGKT
KTLQALTENLSKEGVPTLLMDLKGDLSGIAAIGEEKSFIKERHAQMNLPYTPEAFPVELL
TISKQDGVRMRATVSEFGSVLLSRILDLSDVQEGVLAVVFKYCDDHQYPLLDLKDLKKVL
QYATEEGKSEFESEYGRVAASSTSAILRKIVELENQGAELFFGERSFETEDLLHTDEKGR
GVVNIIRLTDIQDRPKMFSTFMLCLLAEIYNTFPEIGDQEKPKLVIFIDEAHLIFNQASK
ALLNQLENIVKLIRSKGVGLIFCTQTPTDVPDAVLSQLGLKIQHALRAFTAKDRQAIKLT
AQNYPETSFYNVPEYLTSLGTGEAFVTALDSKGRPTPLVATMMRTPMSRMDILTDTEIKA
LLDKSALKTKYNEVIDRESAYEILNAKIANEAPKEEAPKKTETKSTAAPKTSSAPKKSTA
QNPIIKMLTSATFVRGVFGVLSKLMKK
>SEQF1602_00418 hypothetical protein
MKLKKHIFPPAFFLAGITSLLVGCSQVDKKFLITDSSVGLLTRGTKITQLDSLYQKDSLV
KTSLEGEFRYISEERFLIYERGKEKKQLLELTPNIPLDGSTQYIQGVQVLDDRYTTKEGI
SLNSTFGDIKKVYKEFDFEQLLSTVIVMPKGSNLYFAFDQKELLPALDDTYTIESIPDTA
KVKRLLLNWAEGTPPTQ
>SEQF1602_00419 hypothetical protein
MITVKRVDNTKGMLDFVKFPFFLYKDSKTWVPPLISEELATFDPKKNPAFENCEATFFLA
YNEKGTIVGRIAVIINHYEINRGVRKVRFGWLDMIDDLKVTDALLKKALDKAHELGLLYV
EGPMGFSNMDKVGIQTFGFEHIGGMATWTNYPYYAQHLEKLGWVKEKGYIESFFYLKDVD
FEPYKKAGDVVERRYGLSYAPIKTNKDILPYVDEMFNLFNTSYANLSSFIPVSDKQKEYF
KKKYIPFVLPEFIKFILDKEGKIICFAIMIPSFSEALQKAKGKLFPFGFYHLWKARRNPK
VLEFYLIGISPEYQSKGIPAMLFRDCYLLFKEKGVEQCIITPELEDNILVQKLWKNFNPT
TFSRRATYKKTIE
>SEQF1602_00420 Sensor protein ZraS
MSLIGITILSFITIAIVTIYQYRNQSRIYHNERLLRKEQQLAMQLRYVFSQTTFPLEDKY
IPVIFREEIYRIADIENINFNLYTINGTFLISSQAGLRENKELHCIPDSILTALSSSVDK
RLVFQAPEEGGSYQYSYSYVNNLQYKPLLIVHIPHFENDTFNEGFLQDSLYNLGSAYGAI
LLLTIVVALVISRYITRSLKEIQHRLRTTHFLGKNEKINVKNTTTEIGELIFSYNEMVDE
IEKSKKALAKIEREKMWKDMAKQIAHEIKNPLTPMRLSVQNFERRFTPEDPQCREKVANF
TQMLLQHIDTLSDISDAFSSFVSMPAQKKELSDINAIIRRTIAVFDLPYIQFESSQETIE
LCVDRNQMNRMLTNLLKNALYATDSTPTPLIEVTSFTEGNYAYIVVKDNGSGVPIELQER
IFEPKFTTKNTAGSGLGLAMVKHIVSAHAGEITLSSEVGKGASFTIKLSGVRQNTNL
>SEQF1602_00421 Alkaline phosphatase 4
MERRNFLKNSLLAGLGSLLVPSVAQAQASESFGRKRAKNIIYLVSDGMSIGTLVMADLYS
KRILGRSSAWFSLYEQKLAVKASMDMQSASSVVTDSSAASSSWGSGHRIINGMINVGVNG
EQYTPILQKFKKAGKKVGCVTTVPITHATPAGFCTNSKERKAQPKIAENYLDLRFDVMMG
GGDNYFNAEKRKDKQDMYAKYVEKGFTVVKNVSQMNAAPKNVPLLGVFDKDALPYTLDEN
NTTKNATIPTLAQMTQKAIDMMADHKQGFVLQVEGGKVDWAAHGNDIGALLFDQLAFDDA
VRVAIDFAKKDGNTLVVITSDHGNANPGLIYGKECNKNFDNLAHFLHTNDFTLQSINLTD
SVSQVRDLLTHNFGNIPFSQEEAKEILSFYTEGKQEDGLYNYKKLPYRLLAEIQKKHTSV
GWISMDHSSDYTELAMYGPGSQNLPPFIENYKMHNFLLEAAEVDMLEKY
>SEQF1602_00422 Putative phosphatase
MAYKILFSDIDGTLLDAERTLSEKTIKVLSHLKYQFPIVLISSRMPIQMHYLQEKAGILG
MPLIAYNGALVIDKDRKVLRSTEIPFSLCQQIVALNQQYTGGNLHISFYHFNEWYVPKAD
QWAQREERNTCTTPVVKTNQEVLSLWSSQNKGAHKLMLMGEEELVEAMWQALQREMTGQL
QLYRAKNTYIEITLQGVSKLTGIEAFLAHQKGITLGDAIAFGDNYNDQEMLQSVGLGVAV
ANARDEVKAVANDTTHHHKEDGVARYLAKMFDIEL
>SEQF1602_00423 putative tRNA-dihydrouridine synthase
MVKIGNVTLGEFPLLLAPMEDVSDPPFRRLCKKYGADMLYSEFISSEGLIRDAIKSRKKL
DIFDDERPVGIQIFGGDEEAMALSARIVETVSPDVVDINFGCPVKKVVAKGAGAAVLKDI
DLMVRLTQAVVKSTHLPVTVKTRLGWDSETINIEEVAERLQDVGIQALSIHARTRVQMYK
GHSDWSYIAKVKNNPRIHIPIFGNGDIDSPEKALEYKERYGVDGIMIGRAAIGYPWIFQE
IKHYMATRELLPPPTLSERAEAALQHLLWAVEWKGERLGILETRRHYSNYFKGIPHFKEY
KQQLVTLDDLKALKELLIRVKNEE
>SEQF1602_00424 Glucan 1,4-alpha-glucosidase SusB
MRKLGYRINEKFKTNMKSFILTLSVWLFAYTFSPVKAQELASPNGKVVLSFSLTKEGTPS
YKISYKNKSVIKESTLGFLLKKGESLNAHFKVVDSKRTTFKETWRPVWGEESDILNHYNE
LCVFLEQTTTHRKMNLRFRVYNEGVGFRYEFPEQKELTYFVIAEELSQFAMTGDHTAWWI
PGDYDTQEYDYTQSKLSQIRSFMPQAVIKNVCQTPFSPTGVQTSLMLKSQDGLYINLHEA
ALVNYPCMNLKLDEQHLIFQSHLTPDAKGDKGHLYTPCHTPWRTIMVSDDAREILASRLI
LNLNDPCALSDTSWIKPVKYIGVWWEMITGKSSWAYTNDFPTVDLDKVNYTKACPNGTHA
ANNEKVRRYIDFASQHGFDQVLVEGWNIGWEDWFDNSKDYVFDFVTPYPDFDLKGLNAYA
HSKGVKLMMHHETSASLRNYERHMEKAYQLMNDYGYNSVKSGYVGSIIPRGEYHYGQWAV
NHYLYAIKEAAKHKIMVNAHEAIRPTGLCRTYPNLIGNESARGTEYEALETIKPFHTTIL
PFTRLQGGPMDYTPGIFETDISKVNPQNPHKLSSTLAKQLGLYVTMYSPLQMAADLPENY
EKFLDAFEFIKKVPVDWQKSLYLEAEPGQYITIARKDKHSNNWFVGNTSNENGHTSIISL
DFLDKGHVYEATIYADAPEADFQNNAKAYTITKKKVNAKTKLTLKAARGGGYAIMINY
>SEQF1602_00425 hypothetical protein
MLFQGLISVVSGILITQMSLLGRIGIHTMYRQFLVFRSWWKTALLLFAVQCLLLALFYGV
RKAMSLSSAKKVAWILLLVGILGAGATYWDFSHTMHKVMKAKFHFGFYLFWLGWAVSCLY
FISVKDEEIKVTNEEIEKIKEVKNEE
>SEQF1602_00426 hypothetical protein
MRKYIILLVAFLSLTACSDGKLTPSQAKDLVEESLEGKPLYETAYITLGEVKLRTQKDGE
KIKQIKRLENEDYLSLEEIKMKKKWLSNDSVWVVNIKCTDKALPYIIELKETRAKVKTLE
YTLSDEVTVEQKGEKTATITATLLKKETPFSFLNKKAGGQDFIQKKYKAKYREKEGWTLS
K
>SEQF1602_00427 putative multidrug resistance ABC transporter ATP-binding/permease protein YheI
MKHLTYVNKYFYKYRKQLIWGVLITIIARLFSLVMPKSVQYAIKAVEDYLASPTSQKSIG
SDLLLYCLVIIGATLLSGFFTFWMRQLIINVSRYIEYDMKNEVYQKYQVLSQQFYKQHRT
GDLMNRISEDVGKVRMYTGPALMYSVQTITLFLCSIPLMFYTSPTLASYALLPLPILAVL
VYFISRKINVKTLEVQRFLSDISSFSQETFSGIQTIKAFALETPTQERMKALSREGRKKN
LQLLRIQAWFFPIMIFLIGISVIFVIFIGGRLYIKGEIDSIGVITEFTIYVMMLTWPVAT
VGWVSNIVQQAEASQGRINEFLQEKPHIENTCLSSTPIFGDIRFDHVTFTYPDTQVTALK
DISFHIPKGKSIAIIGRTGSGKSTILELITRMYDVEQGQILIDERNIKELNLNDLRKSIS
VVPQDCFLFSDTIAHNIKFGKPQASEAEVIQVAKLAQVHDNIMDFKDNYQTVLGERGITL
SGGQRQRVSIARALLKEAQIYLFDDCLSAVDTDTEEKILQNLSQVAQQTTRIIVSHRVSV
ARNADYILFLDQGQLIGEGTHAKLYQENEQYRNYYDTQVVE
>SEQF1602_00428 RNA polymerase sigma-54 factor
MLKQQLQLKLTQKLSPQQIQLMKLVQLPTVAFEQRVKEELDENPALEPSDNENWDEEEDY
EDPFDTGQEAYEDSQIIQADAINVDEYLSDDEIPDYRLYSNSYNNSDEEYGQPYREELSF
HQYLLDQLSTFRLDDRQHDIAEFLIGSINDNGYIRRSMRDIADDLAFTQNLYTTEEEVER
VLKTVIFQMEPAGIGARNLQECLIIQLKHKPQTAITELAIRILEENFDLFSKKHYDKLTQ
RYDISEEYLKEVIQEIEKLNPKPGSSYSEGGKYSEQIVPDFTITVNDGQLELSLNGRNTP
QLHISQEYTEMFKTYRDSAEKDKQKQKEAVEFIKQKLDAAKWFIDAIKQRQNTLLVTMNA
IMLHQKEYFLTGDETKIKPLILKDIAESIGMDISTVSRVANSKFVSTPYGTKPVKAFFSE
AIKNDEGEDISTHEVKKILQTIIEGEDKRKPYTDDKLMELLKQEGYPIARRTIAKYREQL
DIPVARLRKEL
>SEQF1602_00429 hypothetical protein
MKNFFTLVSILFCFALQAQEAQKASAQRFIEAVINTSEEDYPVLYPMLKISKIIPPEEGG
MAKLSQVFSVLKNQLQNHDFVIYSSEEALDLISRETGNYRASDILTSEKGVVFYVYLPRY
KRFLVRFPIVVNDKNEIIAINIDYCKDNTICLQYL
>SEQF1602_00430 hypothetical protein
MQQELIDSYYHFVREVVAKGVVYCLKDEKEYVASCISSQFTTEDDEEVGVLAFWSDKEGA
ENCKQEEWEGYHLSEIPLAEFMENWCLGMAQEDIVAGIDFDSTLFGYEEAPLRLLSSLIE
EVEANDVKLTFNSFSSLGDIKEYIKELEEE
>SEQF1602_00431 Signal recognition particle protein
MFDNLSNKLEKALHVLKGHGQITEINVAETLKEVRRALLDADVNYAIAKEFTAKVKAKAL
GSNVLTTLQPGQLMVKIVHDELTELMGGDATGVNLSGNPSVILMSGLQGSGKTTFSGKLA
NFLKNKKNKKPLLVACDVYRPAAIDQLHIVGQQIGVEVFSEKENRNPVDIAQKGLAYAKS
NGYNVVIIDTAGRLAVDEQMMKEIADIHHAVTPQETLFVVDAMTGQDAVNTAKAFNDVLN
FDGVVLTKLDGDTRGGAAISIKSVVNKPIKFVGTGEKMDAIDIFYPSRMADRILGMGDVV
SLVERAQEQFDEEQARKLQKKIAKNQFGFDDFLSQIQQIKKMGSMKDLLGMIPGVGKAVK
DLDISDDAFKYIEAIIYSMTPEERSNPAIINTSRKNRIAKGSGRNISEVNQLLKQFDQMS
KMMKMMQGGGAKQMMRMMQSMPRM
>SEQF1602_00432 hypothetical protein
MTKGKPLNEAVEKDFYQSMGAYQLTFLPLKHFPKEQIAPSEDDKSFRQQLLRGYVNDQGA
AMLGGVAGHAGLFGTANDVAKMMQLFLQKGYYGGVRYFSANAFDAFNKSYFISERNRRAL
GFDKPQLPGQGGYTCGCVSPESFGHTGFTGTLAWADPATQTIYVFLSNRTFPTSDNKKLI
TENIRAKIQKVVQESLM
>SEQF1602_00433 Beta-hexosaminidase
MRFFTLLLFIPIFSFSQNIDPLRTKDEQAQTRWVDSIYKTMSLEQKIGQLFMVQAFSSHT
AKQQKPIKELVKKYHIGGIIFSKGSPVAQAKLTNEFQEAAQVPLMIAMDAEWGLAMRLDS
VYAFPWNMTLGALKDNALVEQAGKRIAQHCKRLGVHIDFAPDIDINTNPQNPIIGNRSFG
ESKFNVAQKGVAFTKGMQSVGVLACGKHFPGHGDTEKDSHKTLPTVSFSRERLESTEFFP
FQKLIGAGVASLMVGHLNVPALDEGKPASISYKIVSGLIKQQLGFQGLIFSDALGMKGVA
DYAESSQVDLQAFLAGNDVLLMSSDPIKGIETLKNAYSAGTINEYRLAHSVKKILKAKYW
AGLNKYKPVALTNLTKDLNTKEDDLLTEKIYEKAITLLQNAKNVLPLKNLDTKKTAYIKF
GDDSGWEFFKNLRYYQDVVQLKSGSWESLKKEMAPFDRIIIGLHRSNASPWADYKFNAQE
LALLQKIIGEKKEVILTVFTKPYALLDVPDLSPFAAVVVAYQNAPFAQQKAAQLIYGAIP
FEGVLPVTAHKGVLFGRNLPTKPLNRLAYGLAENAGLNSANFYKIDSIVTDAIQKQMTPS
AQVLVARNGVVVYQKSFGRCTYDKNAEQVTNNTLYDLASLTKILATVPELIDLYDKQKIK
LNASLATLLPMLSGTNKADITVKEALSHYGQLQAWLPFYRKTIDSKTKVLSTDIYNATLT
SKYPTQVAENIFIKENYRDTILQSIAQSDLIKQKNTFIVIFPITFFRNI
>SEQF1602_00434 hypothetical protein
MSSLAIWRIIYCLSEIIKEQIEENTWGELKEIHRVNYKIQREICKNTKERIAKIQKGEL
>SEQF1602_00435 Tryptophan synthase alpha chain
MNNNSINSVFAAKEKVNIGYIVAGYPNVDFTKAFLSQLDRTAIDILEIGIPYSDPLADGK
LISQASFAASQAGVTTDTVFDLLSSVKGQVHKPLVFLVYYNLIFAYGIDAFLEKCVVVGI
RGLIIPDLPYEEAQELVEKLRAHHIAFIPLVSVTSQGRIAPIVSLGEGFVYAIGSLGVTG
SKQVDLPRLKEFITQVRAQTSLPVSLGFGIKTHADVEQMRQYADGVIVGTSIVALTSSGD
LDQTIIQINTLFK
>SEQF1602_00436 Tryptophan synthase beta chain
MTNKAYFGNFGGQYVPETAMFALIELEKEYEKAKNDPCFQAELEDLLKNYVGRPTPLYYA
KNLSAHYGHDIFLKREDLNHTGAHKINNALGQVLLAKRMGKKKVIAETGAGQHGVATATA
AALLGLECEVYMGAVDMERQQLNVFRMELLGAKVVAIEDGLKTLKEATTAAIQSWVAEIE
TVFYVIGSVVGPHPYPTIVRDFQSVIGREARKQLSTQDKHADHVIACVGGGSNAIGIFAG
FLDDPATQLYGVEAGGEGIDTDRHAATLTLGREGIIHGMKTYVLQDKYGQISPVHSISAG
LDYPGIGPEHAHLFQTKRAHYAPITDTEAMEALLLTTRKEGIIPAIESAHALAYLSKLCP
TLPKDKKQTIVVNVSGRGDKDMHTVFSILKGEKYE
>SEQF1602_00437 N-(5'-phosphoribosyl)anthranilate isomerase
MEKTALKICGIRSLEEIQDLKDLPIDYFGCIFAPRSPRCVSVALAKEITEIAHSEGKQTV
GVFVNAPLEQIADTVNLTGIDVVQLHGEESPDICKMLTTKGITVWKVFSIKDKLLPMEDY
LPYMDLPLLDTKGVSEGGNGLVFNWQLLERLTPYSFILAGGISVENVQKALSYQPAIIDV
NSKVEQNNRKSRQLIEKLIKEIEKYRSGIQKYNK
>SEQF1602_00438 Indole-3-glycerol phosphate synthase
MDILSQIKQQRDLQLQRELDSVVRPSFHKALSQEGIRIIGEIKRASPSKGQIALENFDLL
KQATHYVEHGVAAFSILTEEAYFKGDNTFIPQVVEAFPKVPILRKDFIYTPFQVAQAKFL
GASAILLIVRMLSDEQLQALHALAYDLQMDVLVEVHDEAELQRALRIPQLKILGINNRNL
NTFEVSLQTTERLLSLISEEQRTSLLVVSESGYLSKEDLHYAETLGVDALLIGEALMKGL
LF
>SEQF1602_00439 hypothetical protein
MAIFVTDAVFLFLSMKDYKDSMSSSCLECSFWKDIFVFLLIGMGVLAILLTILFRIVKKR
GYLYGLILISLLSIFYSIDYMLFVDRVAAWSTYSLKETWITIFWDSYRYFPMLMLIYVLL
TNRLIKEIESINN
>SEQF1602_00440 Bifunctional protein TrpGD
MILLIDNYDSFVFNVAQYLQELTEEEVKTVRNDAITWEEITALNPSRIVLSPGPKHPKDS
GICLEILQKNTTIPVLGICLGHQAFGLVNGAEINRMEVPLHGKTSALRVTDDNTLLFRGL
PKQFQVMRYHSLYVGKEQLPENIRITALSDDDIIMALEHKEKPIYSIQFHPESFFTEYGK
HIIKNFITYTQKLQPSVADNHAQERARANEVFKTALKKLQENIPLTDGDFKEICAVIHTK
QYDIVQLGALLVLISEKSLYPESLTAFVRNILAYSATFADESPMIDLCGTGGDGLKTINI
STTVAFIVAAMGVKVAKHGNRSVTSQSGSSDVLGRLGIPLESNLLTQLEHLQKEHLAFFH
APFFHLLVGEVKEVRQRLGIRTVFNVLGPLLHPNTKLKYQLVGLYHEPVQRLYAETLQLL
GRKHALVVRGNDGLDEITLCDETKIVEVKDGKILEYTIAPEMFGFKRAFHADIQGGTPEE
NAEILLRTLKGEEQSPKSDIVILNAMFALYTADFVKHPADAKPLIQEAIRSGKVYEHYLK
MINANKE
>SEQF1602_00441 Anthranilate synthase component 1
MFLTAPPLFYYTFIKERYKNSYLAEDVNQVIIGIDCDYLDAYKYSYTSLEQYHQRQKSIA
PFAGLFGVFSYETIHFFEQIPEKSQKQYDFPAFVFANAKAYLHYSKVSKVYSFYGDEQQY
FHFLEEATVQENPTSPEVFYQLHTDLAQERAHFYQMVEKAKEYIRSGDIFQVVLSEQLSL
ESNLDSLDFYRYLSQANPSPYMFHFPTPYGEVVGSSPEILVDIIGSQIHIAPIAGSRPRG
KDANEDLRLEQELLADPKECAEHRMLVDLARNDIGKFAQKGSVVVKDMMHILRYEHIMHI
ESHVYGDKRTEVSPFEVISIVFPAGTLSGAPKIRAMEIINELESFRRNVYGGGIGFLHFN
GNVQLAIVIRSAFFEKANAENEQVSKVFIQAGAGIVYDSVSEKEYDEICHKRASVLNVFT
KNCKEK
>SEQF1602_00442 DNA repair protein RadA
MAKTKTAFFCQNCGAQYSKWQGQCYACKEWNTIVEEVIQKEEKHQWKKDDESDTPRSKKT
NKYIPLHEITTEKEMRLDSGDQELNNVLGGGIVPGSVVLIGGEPGIGKSTLLLQIAMRMP
YKTLYVSGEESQKQIKMRGERITNARNNCYILTETKTQNIFQQIKELDPEILIIDSIQTL
HSDYIEASAGSISQIRECTAELIKYAKLTGVPVIIVGHITKDGTIAGPKILEHMVDTVLQ
FEGDRNHVFRILRALKNRFGSTSELGIYEMLSTGLREVSNPSEVLLSKTDENSSGTAIVA
TIEGMRPLMIEIQALVSSAVYGTPQRSTTGFNAKRLNMLLAVLEKRAGFRLGSKDVFLNI
TGGISVDDPSTDLGVAMAILSSNEDVAIPKTFCFAAEVGLGGEIRPVQRVEQRISEAEKL
GFDTIFISKYCKLTAGKSNINVITYAKVEEVIAHLFG
>SEQF1602_00443 hypothetical protein
MKNYLFPVLFLFSIVIWGQNDPLPRKNRKTHKTIGDFFGKVKSLSSISCKVINNYKGDII
RTTCENYDHEYYYLFDEKGNITQTNKYDNSNKLIEEKKFLYSYNENDLLIKELYYKNNDL
IGSYTYKYDKHANKIEETYEDTQKNYKYIRKYKYDNKNRLIFVKEKNTDREDTLNIFKRT
YKDDLLMEEYYGEKNYSYTHTYFYENKKLKTKKEESSSFEGCYFTNTETIYTHNDKELPI
SCDVYISHKLQNNITYEYDEKGRKIKNVYTFPDDSQYNSYATYQYDKKGNLIEENNSRLS
QKIIYFYDEHNNWIKQEVYYNDKLSHIYERIFTYYE
>SEQF1602_00444 hypothetical protein
MKQLLIPFLFFCITIVTQNTANKDTIPYKTNERYDQFFPKPLRGKIKTIHTVGCRIEYQG
DTPVAVYHLFHKNKINPYTYTYHFDKRGNDIAFYTYDALGNLMDWEIKTFNKADSLTYRK
ISYVIDSIRHSAERFNLYNDKNLLVEREDIDRYGSKVSLYFYNEADNIIKEEDYYKDKLF
YTALYTYDAKGKLLEKKEKEKNPKKHSTTIYEYDTLGNLIRITEKEKGEKTYVLTNRIYE
NNTLIKEYDDHSYLLYTYKEGKLIETESYYTGIGIDYIIDRKVITKYNEKGQIIKKLEYQ
GNILEQETNYFYDENRKEIKGTSYKKGQEKSTWENKYSPEGYLIEKAWKREKGNPKTLYY
YDAIGNCIKIEEYYKGKLTNIYERIFTYYK
>SEQF1602_00445 hypothetical protein
MKHLLIPFLFITTVIVAQNTANKVEKYKIDSDLAYPFEKPLLGKVKKVHTAHYSTVVTVL
KDTIKRGHFVENYTYGFDERGNEIEFIKYDKEGNIWNKEIKKYNEKDRLLYSKETKILGE
DETYIEENSYSYNDKGFLIEEKSYEEDPDTGISHRRELYKYNNDQKLIENSYYSNDSLKR
QVLYWYDNKGNLLRKLFYLDNKPYTDTKFEYNHIGNLIKKTENYIKTDYKHVKQYEYDAK
NRLILFTKEDDDTKEIILKIIYKDDLIIEIYDNRDDEEVHIFYSYKNKKLINKVISKSFF
NGCYYDYIKEKILYDEKGRIKKSFDYKQNKIKKTYTYYYDNKDRVIKTELLYTGDKKEYW
IDNYDTIGNLIETIYKNNDYRDKDSYTYDNNNNLLSKITYKGNKAIEKTFYTYDKYQNII
KIEKYNNGKNYIYKRTFTYYE
>SEQF1602_00446 hypothetical protein
MKQLLIPFLFFCITIVAQNTANKVEKYKINPAINDEFKKPLLGKVKTMHTAHYFIEYNKY
DTIKKELFDNNYTYGFDKEGREILFIKYDMHGNISSKYERRYNEKDSLIYLREFIWGENF
GTYIEEKSYFYNPLGLLQELKGYSLKESDPLSLYRELYKYNDKQQLLESHYYNKDTLTET
AIYSYNNKGKLIKKLDYSKGKLRSEYKLEYDERDNLIKKDYYFTQFSISQKSITKYQYDD
QNRLILATENIDGDENILIKNIYKDNLPIEIYEKNRSGDEIHIFYHYKDNQLIEEKSTRF
FNGHYYSTTKEKIQYDEKCRIKKFYDYEGKEIARTYIHYYDDKDRIIKTELLYSNNKKEY
WTNSYDMANNLTKTIYNNNKEADKDIYRYDKNNNLLSKIIYKGNKEVYKVLYTYDKDNNL
LSKTTYKGNKAIEKTFYTYDSYQNLIKIEKYNNGKNYIYERTFTYYE
>SEQF1602_00447 hypothetical protein
MKHFLFILLFYFSSCFYVSLLSQEDDPNRYTNEHLRNLGITPQGKVKSVEKFIYHYDTKN
GKEAKIFPKNAKVERMPVHSRYVFDKKGNIIEFYNYYTDGKLFQKIFYQYNTDNLLTKAD
EYKYIEENNPQLTEEEIFYEGKVMISKKYKIDGILSKVEMLFDKNKRKKAILEYRNDTLI
NKKKYSYNSKGNITHEKNKSTSLLSDEANETWYKYTKEGTLVAEKKECYSMFCFYTTYQY
LSNGEVYEETTYTTPLHDDKDISDKKTKYYIYDSKGAIVEIQIYKGKEFRSYHCIENDKE
VESYSYFLEGEVRKTLFSYNKDNQLIKEENFDLLNGNFISGTYYTYDEKGNLLQISDKPT
SSPNRTIYHYDKYNNCTEEIYYKNNKRAAVVERIFTYY
>SEQF1602_00448 hypothetical protein
MKFNSKYFFAALIIFLVEVAIATVFKSVPFVRAYLGDILVVILIYCFIRAFFHIKNTKKL
LIGIFCFAVFVEILQYFKLAAFFGFGKGTLGYILLGNYFSFEDILCYATGCFLAFVFDK
>SEQF1602_00449 NADH pyrophosphatase
MENIFTYCPHCGSTDVEFPRLVRFLCHQCGFVYYHNIAAAVAVIFRRKDEILFTVRNIDP
DKGKLDLPGGFIDPDENAEAAVCREVNEELGLQIVSNQLKYLTTQPNHYLYKNIPYRTMD
IFYECPLDVPVSVRAEDEIKSLQWIPISEIDLGKIGFVSVKTVIEKYYLNQ
>SEQF1602_00450 Competence protein ComM
MLVKIYGSAVYGVEAITITIEVNIDKGVGYHLVGLPDNAIKESNYRIEAALHNNQYKIPG
KKITINMAPADMRKEGSAYDLSFAIGILAANGQIQCEEIERYIIMGELSLDGSLQPIKGA
LPIAIQARKEGFKGFILPIQNAKEAAIVNNLEVYGAENIKQVIDFLNGENTLQRVEINTR
EEFFKHVETPEFDFADVKGQESVKRCMEIAAAGGHNIILIGPPGSGKTMLAKRLPGILPP
MTLQEALETTKIHSVVGRVKDNGLICQRPFRSPHHTISDVALVGGGSYPQPGEISLAHNG
VLFLDELPEFKRSVLEVMRQPLEDREVTISRTKFSITYPASFMLVASMNPSPSGYFNDPD
APMTSSPAEMQRYLSKISGPLLDRIDIHIEVNPVPFEKLSQREKAESSTSIRERVIQARE
IQTQRFAQYEHIHYNAQMGSKQIREYCHVEEASLAMLKKAMERLSLSARAYDRILKVART
IADLEGSESIKEYHIGEAIQYRSLDREGWLGGL
>SEQF1602_00451 hypothetical protein
MSPKKIVIFMISVLVSLLWLTFLSHEYMDEENEVAHGIKIGSFQLKYPTFWDIFSHTEAI
KNDKAMAIIQGKSPENTSKKDTLATGQFNTKTFVFPEDMTQLRDSIGVFLEGGNPKLVSN
VEGQIYYPNPPRDFVKKLHQKLSQPSCRILHYGDSKIEGDRITAYLRNGLQLLYGGTGPG
YFPIKMPYGQHSIIEQTSGNWYRYALFNAEQRKNKDLLTNNQYGLYANVCRFAPARGETA
GLKTASFTISPSYSYYPTLSQYTDISVHYGNCTVPVLVTVYENNTEIKKDTLIADGAYHA
YKLHLSATPKKLRFQFSGTKSPDFYGVTVGSAQGVQVDNIPTRGDSGFHFTRIQDTYDAM
SRELKPDIIIFQFGGNLVPYLTKNKVVPSVKRIITNMQWVQKRNPDALFLLIGPSDMLRR
SSKTTYDIIPELVAEMKKQAAENGFAFFSMYEAMGGKNSMKIWYDNRMAASDLVHFSDKG
TERIAQLLFQNLVEDLLSVQPVEMYKK
>SEQF1602_00452 hypothetical protein
MFLEQVIEDYLENYADTPTGEVIFITPHRRSALFLRKIFSEKVHKAAISPEFITLDNLLE
RISGIKKMPDLQGLFQLYKVYKEHTESEVDDFEKFVGWGRMLWKDFSDIDQYLIAYKDIF
PYMEAIKEVEHWSVGEELTPMQQRHLEFWRTLGTYYNAIHKVMYQQKQGYQGFIARIAYE
QIDAYRQANKEKLHLFVGFNALSVAQEKIIQYILEEMQADIYWDIEKHFLNNQHSAGYFI
ENYLKRWKYYQRERKPKWITEEKTLPEIKIYGTPKQVNQIHLLTTLLDEIPEEEWEQTAI
VLSDSDMLLPLLQAIDTNKLPINITMGYPLQQTPVHDLISAYFKLYISGRWYHKEIKALL
EQPFLTNLLSENYKKDTITYINEHNFSYVYKKILDLYVKEEDRELINLLFDDEKDISVSK
LIENVIKLLFFIKESLEKSDKENVLNLEYIYNFYELFNQIHYLQKKYNYIDSVKSLYYIY
NDLLVKQKLSFRGEPLRGLQIMGVLEAQNIHFKNVLITSMNEGIFPKGNAVNSLIPFDVR
ANLGLPTYKESDYMYSYYFYRILQHTHRAILLYNTDTDGLRGSERSRFVLQLLSDYRIRS
QVKFPEVKIIKQNQIEIEKDKNIIEKLVAIATKIDPKHRKGFSPSSLTTYVRNPIDFYQQ
QILDIRDEAEVEEIVEDRSLGTIIHRILELLYTPYVNSIISKKNIDEIRKKVRETTEIVF
KEYQQNDEISGKNIFVQQTIEEYVMKFLAIDEKNVSENVVTLLSVEQKIQIDIKFDEFPF
PICFNGTIDRVERRGNDIYIVDYKSGIVDREDVKLSDKGWENLILDYKYSKAFQLLMYAY
LLFKMGIIQDADNVYVGNYSFRRLKLGFIGFRNQKDKEISLVDSQVREEFEQKLIELLKE
IYDPELPFVEK
>SEQF1602_00453 N(1)-aminopropylagmatine ureohydrolase
MENTYAGIPAENATYENSKVVLVTVPYDGTSTWGKGADKGPELFLDASENMELYDIETDT
EPYLQGVYMAGEVSEKSSPEKMVEAVYQKTKELVKDREKLFTLIGGEHSVSIGSIRAVGE
EYHNLTVLQLDAHTDLRPEYHGSKNNHACAVFEANQKHKLVQVGIRSMDAEEKQYLPHKR
VFFAHEIAKNDNWIKDVLDKVSGNVYITIDLDAFDPSIAPSTGTPEPGGLQWYPTLKLLK
KVFKKCNVVAFDIVELMDSPQAKPTAFLAAKLYYKMLAYYHKYNKNNKEPKNKKRK
>SEQF1602_00454 DNA polymerase III subunit tau
MRFSPLSKERDFLTPLFMDFETVISNSFAVKYLKETIENDRIAHAQLFSGEEGVGTLAMA
IAYATELLSKTGDANTKLKCEHLTHPDLHFAYPTATTIRVKDHPTSSLFLEEWREFVLRN
PYGSLFDWYQFIGIANKQGKIGVDDAKEITSKLSLKSFEGGYKVMIIWMAELMNTECSNK
LLKLLEEPPAQTIFILVVENENLLLDTILSRCQITRFTKLGDEVISDALIKQGIDPSQAQ
KIAIRAQGNYNKALSFLNQNNDNQFEDWFVRWVRMAYSAKGNTEVLPLILAWSEEIAKEG
RETQKLFLEYCLEVFRQALLANYGVESLVYMQFNSNFKIQNFAPFVHQNNIQAIQKNIEE
AIYHVGRNGNSKLILTDLSIKLIRLIHTKG
>SEQF1602_00455 Methionine--tRNA ligase
MSERYTITAALPYTNGPIHIGHLAGVYVPADIFARYQRLKNNDVAFICGSDEHGVAISIK
AKKEGTTPQEIIDKYNKIIKDSLFDFGISFDNYSRTSLPIHYQTASEFFRTLYDKGDFIE
ETSEQLYDEQAGQFLADRFVIGTCPKCGNEEAYGDQCERCGTSLNATDLINPKSTLTGSK
PVLRQTKHWFLPLQDYTEFLEKWIIEGHKNDWKPNVYGQVKSWIDDGLRPRAVTRDLDWG
IPVPVEGAEGKVLYVWFDAPIGYISSTKEWAAREGKDWEPYWKDKKTKLIHFIGKDNIVF
HCIIFPAMLKAEGSYILPENVPANEFLNLEGNKLSTSKNWAVWLNEYLEEFPSQQDTLRY
VITANAPETKDNDFTWKDFQARNNNELVAIYGNFINRVMVLTDKYYKGVVPSVGELTQVD
REVFAQIKELIQKIEQSLERYRFREAQQELMNIARLGNKYLADEEPWKLIKEDPKRVETI
MYIALHIATALAVTSEPFLPFTSEKLKRMLNFSTMEKAPTWQDIPLSDRLIPQGHTIGES
VLLFEKIEDEAIEKQIAKLEKSKQANKQAITNDHTTVVPQKELISYEDFAKMDIRIGTIL
EAEKMPKADKLLILKVDTGIDQRTIVSGIAQSFDPKEIIGKKVTVLANLAPRKLRGVESH
GMILMVENSAGKYVFLNPDAEGIANGTEVK
>SEQF1602_00456 hypothetical protein
MKQLTLPLFLLGSTLVLSCKNNTEEKKISEKENTTISVERLQDSIQKLSDDLAEERYFDI
SFNEDARYFFHENGIDDPKEFVLQQLMATNITKDENHPLISYRPRRNAKFQINKIKLLNH
RWVICDFSDGLDWGELLLKMTLNDNKTLSFEVLDQTLYVSEQKP
>SEQF1602_00457 hypothetical protein
MNIKNAQLAVDNWIKEHGVRYFNELTNMAQLTEEVGEVARIIARRYGEQSEKESDKAKDL
GEELADVVFVVLCLANQTGIDLQEAFDKKMEAKTKRDHDRHQNNPKLK
>SEQF1602_00458 putative NTE family protein
MKQFFLYLLLFFVGNSLYSQEKIRSLTDLKGKDLKVGLVLSGGGAKGLAHIAALEAIEQA
GVKIDYIGGTSMGAIIGGLYAAGYTSHQLDSIFHSVDFERIIQDNVPRSAQNFYEKENRD
RYMISLALRDGKFGLPAGLSQGVNLYNFLSQLTFGVRKIDDFSKLPIPFLCMATDVETGE
EVILEHGDLAQAIMASGSFPTLFAPVEMEGRFLTDGGVMNNYPIDEVRAKGMDIIIGVDV
QSPLKTRKDLRSANSVLLQITSYKIANDMKEKREKTDIYIHPDMSNYNVISFAEGQAIID
SGRVATKKVFPHLQWLGDFLKKEEKPLPKIKVHDSLHIGNISFSGNKHYSDAYLRGKLGF
QWGEKISFKNLRDGVQNIMATQNFKNINYHICSMEEGEELRFNIEEAPAQTWLKMAVHYD
NLYKTGVLLNVSRSSLLQKDDLFSFDFIAGDNIRYKLDYYVDKGFYTSYGFQSRYDRFRR
DIAFTGFSLNTGDTNIALTRLKNQFYIQSIFLRQKFLVGIGGEHELYNIKLQPDNFNGQV
NYYSAFGYLRYDSLDDAHFPTEGIYFNATGHWYLHSQGYGERINPLFLAKADLGGAWRFS
ERLSAKAIFSGGFHLGLPNAPFLQYVFGGQGDNLFGNLLPFYGYDYLSFGNYDFLKGEMT
LSYRFYKRNYIKAIANIANAEDNMFTENKWFSRPKYTGYALGLSSDTIIGPIEIKATYSP
ETNKFLWLFNIGFWF
>SEQF1602_00459 tRNA threonylcarbamoyladenosine dehydratase
MWRERTRLVIKDEGIHKLEQSHVLVVGLGGVGAFVAEFLARAGVGELTIVDGDVVDTTNK
NRQLVALDSTMGKSKAQLMGERLKDINKDLKLTIINEFLTPEMAYQLVSEQTFSYVADCI
DSITPKLNLLRACHDNRMRVISSMGAGGILDPTKVKVADISKTRDCPLARHIRKRLKKEK
INPKFKAVFSLELPAKDMMELTDGANFKRSYYGTMSYMPALFGIHMAGAIIQKLLEN
>SEQF1602_00460 Diaminopimelate epimerase
MINDNNPNIYAIGEFSDIFNDSNSQTSPLYNTFLSSFFILHRILAGKDTIFLLKDKVKNT
LTQNISLSHCISYYFSLLLPLKTYTMRVIHFYKYQGTGNDFILIDNRLNTFPKEDTKLVA
QLCERRFGVGGDGLILLEDDPEHDFSMIYYNSDGNPSSMCGNGGRCIVAFAQKLGVIQKE
ETTFSAPDGLHKALFKNNLIHLQMQDVSHIEKVKKGLFLNTGSPHYVEVVKNLDSMDVKK
KGAEIRYGVPFNIEGVNVNFVEPIDENHFKVRTYERGVEDETYSCGTGATATAIAMYKGG
KTKAEYIILETKGGNLEVTFEVKKEFLGLKIKEYTNVWLIGEANFVFEGTITV
>SEQF1602_00461 Spermidine N(1)-acetyltransferase
MVRLRALEKTDLDFLYQLENDQSLWEVSETQAPFSHETLRSYLENAHLDIYEARQLRFVI
TYKDKAVGCIDLYDYNPKNNRASIGIALMDSFRGKGIAHSALQQLCNYAFSYLNIHQLIA
YIPQDNLPSQKLFKNIGFLCIATLKDWLFFEGKYKNVLMYQYLKT
>SEQF1602_00462 3-oxoacyl-[acyl-carrier-protein] synthase 3
MTKITAAITGVGGYVPDFVLSNSLLEQMVDTTDEWITTRTGIKERRILKEEGKGASFLGK
KAVEDLFRKTGTNPADIDLVIFASVTPDMPVAISGAYLATEIGAVNAFAIDLQAACSSFL
YGMSVAARYIESGRYKKVLLVGADKMSSIIDYTDRATCIIFGDGAGAVLFEPNYEGLGVQ
DEYLRSDGTGREYLKIEAGGSILPTTIETLQEGKNNLYQDGKTVFKYAVSRMADVTDIIL
ERNHLNAENLNWLVPHQANKRIIDATADRMGLTHDKVMVNIQHYGNTTSATLPLALYDYE
KQLRKGDNIIFVAFGGGFTWGALYLKWAYNPIQ
>SEQF1602_00463 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MDLRDIQNLIRFVAKSGASEVKLEMEDIKITIKTSGEEGRPETVFVQQPYVAQGLPPQVP
VAPIPPMPVSDPANIVATKEHDDEENGKYITIKSPIIGTFYRRQAPNKPLFVEVGDNIVQ
GQTLCVIEAMKLFNEIESEVSGKIVKVLVDDASPVEYDQPLFLVDPS
>SEQF1602_00464 Biotin carboxylase
MFKKILIANRGEIALRVIRTCREMGIKIVAVYSTADADSLHVRFADEAVCIGPAPSKDSY
LKITNIIAAAEITNADAIHPGYGFLSENAKFSKICAENGIKFIGASAEMIDKMGDKATAK
ATMKAAGVPTIPGSDGLLKDIAEAKKIAKKMGYPVMLKATAGGGGKGMRAVWKEEDLEKA
FESATQEAAAAFGNDGMYMEKLIEEPRHIEIQIVGDQYGKACHLSERDCSVQRRHQKLTE
ETPSPFMTDELRAKMGEAAVKAAESIKYEGAGTVEFLVDKHRNFYFMEMNTRIQVEHPIT
EQVIDYDLIKEQILVAAGVPISGRNYTPKLHAIECRINAEDPFNDFRPSPGRITAFHAPG
GFGVRLDTHVYAGYTIPPNYDSMIAKLIVTAQTREEAIAKMKRALDEFVVEGIKTTIPFH
KQLMENPDYIAGNYTTKFMEDFVLQPKEEDE
>SEQF1602_00465 Thioredoxin reductase
MSVEKIKCLIIGSGPAGYTAAIYASRANLSPVLYQGEQPGGQLTTTNEVENFPGYPEGIT
GTEMMMQFEQQARRFEADIRSGWVTKVDFSAKPLKVWVEDKEIHADSIIISTGASVKYLG
LPSEQHYLRTGGGVSTCAVCDGFFYRNQEVAIVGAGDSACEEALYLSKICKKVTMIVRRD
AFRASKIMEERVRKVENITILFNTETEEILGDGQVVSAIRVRNNKTQELSEFPITGFFVA
IGHKPNTDIFAPYLSLDKEGYIENVPGSSRTNVEGVFVAGDAADKHYRQAIVAAGSGAIA
AMDAERYLASLEH
>SEQF1602_00466 Uracil-DNA glycosylase
MEVHISPSWKSLLSEEFEKPYFKSLTDFVKKEYKEHTCYPKGKDIFAAFDQCPIDKLKVV
LLGQDPYHGEGQANGLSFSVNEGIAHPPSLVNIFKEIQEDINVPYPESGNLSRWAQQGVL
LLNATLTVRANQAGSHQHQGWETFTDTVIKLVSDNCQGVVFLLWGGFAKKKTSLIDTKKH
CVLTSGHPSPLSANRGYWFGNKHFSQANAYLSSVGKEIIDWK
>SEQF1602_00467 Chaperone protein DnaK
MSKIIGIDLGTTNSCVSVMEGNDPVVITNAEGKRTTPSVVAFVDGGEIKVGDAAKRQAVT
NPKKTIYSIKRFMGNKFSDLGKEIARVPYAVVQGDNDTPRVDIDGRLYSPQEISAMILQK
MKKTAEDFLGQPVSRAVITVPAYFNDAQRQATKEAGEIAGLKVERIINEPTAAALAYGLD
KQHNDHKIVVFDFGGGTHDVSILELGDGVFEVLSTDGDTHLGGDDVDEKIINWLAEEFEK
EEGLDLRKDPMALQRLKEAAEKAKIELSSSMQTEINLPYITATATGPKHLVRTLTRAKFE
QLIEDLVARTIEPCKKALENAGLQVSDINEVILVGGSTRIPAVQEAVEKFFGKKPNKSVN
PDEVVAIGAAIQGGVLTGDVKDVLLLDVTPLSLGIETMGGVMTKLIEANTTIPAKKSQIF
STAADNQPSVEIHVLQGERPMAADNKTIGRFHLDGIPPAPRGVPQIEVTFDIDANGIINV
SATDKGTGKTHDIRIEASSGLTQEEIERMKRDAEANAEADKKAQEVATKMNEADALIFQT
EKQLKDFGDKIPTDKKSAIESALEELKGAYESKDIAAINVALEKINEAWKKASEDIYKAQ
QEGGAAGGHSSYEAQDQQPNNGGGDNNVQDVDFEEVK
>SEQF1602_00468 hypothetical protein
MNPETNRIEYKQELIDDLEKEVVAFLNYQEGGIIYIGIDKKGKAVGVSDIDGDMLKIKDR
LKNNIMPSCMGLFDVSAETIDSKNVIKITLASGTEKPYYIKKLGMSEKGTFIRIGTAAEP
MPIKMIESLFAKRTRNSIGKIKSPNQNLTFEQLKIYYESSEKMLNQQFTSNLELLTEEGL
YNYVAYLLADTNGISVKVAKYDGLDRVDLIENNEYGYCSLIKATKQVLDKIGVENKTLAK
ITPKERKETKLWNPVALREAVINAIVHNDYTSEIPPKFEFFDDRIEITSFGSLPQGMTEK
EFFEGYSVPRNKELMRVFRDLDLVEHLGSGVPRILRSYGKECFKFTENFLRMIFPATEQV
TAQVTAQDTAQDTAQVTAQVKELIEILSKEMDRQEIQDMLGLSHRENFRLKYLKPALEQG
FIEMTIPERPSSKLQKYRLTILGKQLKDKL
>SEQF1602_00469 hypothetical protein
MKKIIVTLLIVLAIVACSKEEIKKLEGKVDVTLYLKDANGNALKNWVVYAYNQWAWENKN
GSRPTFHAQSTATDDDGKAIFTLSVDKFDEREIYHFVVYYTQDKQNLSGDDVTKNTLKTS
KAVTLKSENNDPITLQL
>SEQF1602_00470 hypothetical protein
MNKIINRTLLLEWGKSDTCLEEAGDVFFFDINNHLSGVNITLQHNVGSCILPSLPSFLLK
EQKPTTLTTLSREDFTFEIDDYTHTRSYLCEDNLVFSYTNCNKLLDLVILKITENLYFIL
NEGKVLQYIVVTDISTMLFNDLYYLKEKEVRELYYLAYTLDSYDVVQYVSVLERIQSNKY
YRQQILEDVADDLVNYLDELLED
>SEQF1602_00471 hypothetical protein
MKKYIVKLTIIQIFRADKEVSYTSEISPTNLFSFYVINIYLQKQESMRVIFFTRIILNKV
RITSYFVSSRFFQ
>SEQF1602_00472 hypothetical protein
MGNVLDNDTLAGAKITDPTKVAITLVDNDGLSGVSFAPNGEITVPQGANEGTYRVRYNLC
MAQQLFVCDDAVVTIVITKNKPLTIYNGVSSNSDGKNDGFTIEGIEAYPKNTLKIFNRWG
VLVYQKEGYTNSDPFTGYSNGRSTVEQGKRLPQGTYYYILEYQDSVGQTHNHNGWLYLKK
E
>SEQF1602_00473 hypothetical protein
MKKIYNKMEIKKEIISSVKSLFTVAFFLFFIGSYAQTCDENVLKGLENTHIYYYKEVTKG
SNASFFIKNPLKGTTYSFIDKATGVAYSKLYTGVPEELTIEIPVGKVDEIRRFYLKAENG
ACTLSKPNHFNFEKSILPDKGTTPKLSFSVEEEWCTNAGAIHINIVNGSTSDYKFYAKKG
NGAFVELSQPDYTSLSAGNYTIKAVHKTTNRELTAYPIYLKNEVKPVKFSLKAIPDACSG
RQVIYVDTTKDENGRNVTNTAPLFFTLYDKNNAIVRSAQLSPIFSNLSPDEYSVRVNDNC
GTGTGGNALTRPINLSATLSALNIEKILYFTAKAGCPYMKEINIGFAAKNIENIIKANTL
TYPIEFDLQIESPTGRIYPIHISANNKEEFTEYFWGDGDQLKLISQKVIQNKIPAEAGKW
KVKGTYTLCGRVHNLNEKESDTVYLPLDQVYIMDSNLPNATGCRTKRMMLSANDQALLRN
YYVILEEAPAGFDYEAAGFYKINSTNPLLQNKWVKFFPDTSSQTLLNPEFITEGFTYKFK
IVDECSGKTRELTRPGYKSTANLEVDYKVYASCTDNNGNPDPTALWKNVIFQKRTYTSSL
SKVEILSYTRNSAYPDYKSLVPVTLPFTLTDAYKTGQERWEIKLPPGDYKVRYTDACNLT
EEQKIEVRGTDNTELKWEEQQCQTTVSIIRNTAAYAPSGIVYIIEIYNPKEQVWEPLKTP
GESKTVLTLDNSNNHRFTFFQGGKLRVIRAISRDGGATIDCPRVVEEREITRGEMRVPTI
TRLDCSAVGGAQKYHIVITPQGGTPPYSYVLKSKEEDQIVGGVTSKVTTVIDKVNGNNNF
FINIDETNASARYKFIVKDACNVEKSIDETLSNIQPFKIEKNQQFYCLNAKGILSLPKIE
GLTYAWYRKDNPANILSTSNQLVIEHLTQDDLDKEFAVKLTLTNVTDPLVKNCIESNLSG
MDSIRFNAVPTISQSYQAPTPHDMEVCIVPNSNVTEYDVNQLFSNVPTTPQTGVYTEIVD
KAGLISVSKEGKINLDATHIGKHTFIYRIKTDCGVLKEAEATLDVCAYSTFGDFKIEVCA
PTLTFDELQKLGQKAYPDWFILAKPEQYLFEWYATESDARNRMNKLTATSVTLSEGETKQ
YYLRIRINNEKSCFTPVPSSYKLTRIATGAKPNKTVTLCKGATVGELKQNIDKNNKEKIV
IYNGSQKLTDDYVLQVGTPYTYTYLVGTCETAPANITLTLSERSVAAIETFVTCDYERDW
RGLGVPYKKVEDYLKGKYGATTVVKVYSEGIQGTLNGNTLMYLGSEKYTFTVEAMGKCVS
NQYPIRVYADTSLANFTVAQKTQVLCSGTNQTIASLQPQGTNIVWYATATATTPLASTTP
LVAGTTYYVAQKNGTCESDRVAVAVIQGASGNETLVFSTPFSKTLKCVPSGQLRFQVQNA
VAGQSYVVELTEVPAGYTGSRTFTITKDNKEGNVPFVWLTQNNIPKGTYKARLIKCGVSQ
EIEQTITELTSNFPIRDNFDAGPYLDINDCNYANLRNSQARAGGIDINAYFQNEAIAKQF
FEYTAVSPQDMTDKGWTNASQIPDSYWREVYSLPAGITSSQPKVIYYDLAAFGRNYADLA
IANKKPKFYFRIKGQPSCGVSAPIEFGDTRMLTMKMAYGGSCTAPTIKISLDRTVIVCKP
ITYQVKNEAGQVVASGSTNVANAIIDITTLNGNPINPNEKYSVTVKASAPDTQSVTTIAR
SFNQAKVAYRPDGQYAEIKRCFGHPERTEMYIQGFLRDENGVLLSLKGYKVTLESAPAGY
VNEPNKLKVGESYTITRDASSYNLLSTLNVQNAAGFSSLPEGDYKIKIEDPCGQTYYVEN
GRRKKANILTIEHPQYSEKPLTPEKEVACTGVKVYPFKGNTAQDWLKKNNQNQNLYVWLV
KIPTGVNAADISTTPQQPGTYAGNTYQRAIYSSDNAATLDTYFTLPRNENSTGVYTFAYA
EDEREIYNYIANSPTACVRTFTISVDDVLLNIDRSTYVGYKCEGSTGKIEVKAVNGINDT
NNYTYELYATKTGTPIETKTAAKGTTVTFTNLGTFSAGQNTRWLKLTDASCPTQSMWREL
PIDILEKPTVGQTYTFCQGAKISDLKTQVDTNTNLVKVYKNNTLVTDDNELLTSTDTYTV
SRFSTSCETDKVGVTVSLTQLAKPIVTTEAATCTAPSKAKITNYQAGLTYWEGGTQLTVA
ADGVITTPLIAGNHTVTAKNAAGCASVASDAFTVIAQLPLPTASDVFSITEQPQDGVTCQ
GTNYTLTSKVELKAPYTGNITYQWEFSTNNGGSWSLLGAQGTLTSGGTATIVHSISSGNT
NKYRVKYTYQVPSCGNTVSVLSDIATLSIRTLWISAHPQASTSYCKGATPTALSVSTNGT
DTGITYQWYKNTSNSPSGATLIIGATQQTYTPATDTVGTTYYFVEVKGQGCQRAERSALA
QVKVIQTQDPTVTEKSAANCAAVSVAQVSNHVAGTVYTITDSIGTTVPGASVAADGTING
LTSAGTYKIKATKDGCSSSEVSFTITAQVATPSSPTVTNLTECPTLASTQFDMATLVTVS
AGHTLKWYDAASGGTALAASPKVERQVTVKTVTTKYVSQEKDGCESARVAVTYTVDDIVD
PSLTADDIVLDCTAANFDTLVTTWLTTTAATATDTCTTPVVTNNYSKPTDLCGAGEIEVT
FTAKDSFGNQTQKKAKIRFIVAKDDDYTATPVTPSATEQVVKDGSGTPYNVLNNDKLYGN
GATTSNVTISEVTPNANVKIDTTTGQVKVQSNTPVGTYTVTYRICDKNTPTACSNVATVT
VKVVPATPTIEAKDDPDTNIPRTGGSIDILSNDKLNGGPVTKDNVHITIEDNGGLTTVMI
DPTTGKLVVPNNSTPGTYTVTYKICDKANPTVCDTAKVKIIIAPGTIHNIEAVDDGVWEV
GTQGEFLTPSVLNNDRIGSKTDLNASDVLIERTQGQPAPDSHLVMNDDGRITVKSGIAIG
TYIYYYTIIDRANNNQTSSAKAIIKVVSFVAQQDEYSLTNTKDREQKTPSVITNDEMDGK
KPPVIGTDVTLTPGTPSHPNLHMNPDGTITIAPNTPDGVYTYDYTICRVSNPTDCKTTQA
IINLHSSLVANDDDYSAHPVNVIHQSIVVGNVLDNDTLGGTPITDPTKVTITLIDNDGLS
GVSFASNGEITIPQGANVGTYRVRYNLCMAQQLSVCDDAVVTIVITKDKPLIIYNGISTN
EDGKNDGFRIEGIENYRKNTLKIFNRWGVLVYQKEGYTNADPFTGYSNGRSTIESGKKLP
QGTYYYILEYENSNNQTQTKSGWLYLKRD
>SEQF1602_00474 Cell division protein FtsZ
MGIEFDNLTFDLPKNAENLIKVIGVGGGGGNAVNYMYKQNIKGVDYIICNTDRQALDKSP
IVNKIHLGIELTEGLGAGSNPEVGEQSAMESIEEIKAMLGTNTKMAFITAGMGGGTGTGA
APIIAKICRDMGILTVGIVTSPFKFEGEIRLAQAQKGIENLRKQLDSLIVINNNKLRDTY
GNLGIKTGFAKADEVLTIAAKGIAEVITKDFEVNIDLRDAHTVLSNSGTAIMGTGYGTGD
NRAMDAVKSALESPLLNDNRITGAKNVLLLILYGKEEITMDEVAEINEYIQKEAGNSQEL
AAGYKTNIIMGMGEEEALEDKVMVTVVATGFSTEQQHEIIDVEPKKIVHSLDENTPFVQE
LDTTSSFTDISFENSLKRKQQDQSESVPSFTTPQATVSQPIRSEVGITLHAPEKKTNSIT
IDDSLYRVPVQYEVVERFVAAPQEEFVIYQEKKTTPKPQPVQPLQVEREVIVMEPQRPQA
SVTKQKAVMSAMAEEDAKIVHNLNDYLEVEEMLIHAHSPQPEEKIDEEFRAEIRVKETTS
PKEQPKEENQNAYLAALKENAANRRTTFKNMSHQFSNQNNYRLEDLENTPAYMRKNVDIS
SSSQASAVSRSTISLDSNNVTQIRENNSFLHDNVD
>SEQF1602_00475 Histidine--tRNA ligase
MQKPSIPKGTRDFSPSEVAKRNYIVQTIRKNFEQFGFQPIETPCFEKTETLMGKYGEEGD
RLIFRILDAGDFLSEVPAEVYQSANSAKLAPYISGKALRYDLTVPFARYVVQHQNEISFP
FKRYQIQPVWRADRPQKGRYREFYQCDADVVGARGLWQEVEFVQLYDRVFTDLQVKGVTI
KMNHRKILSGFAEIIGAPDKLIDFTVALDKLDKIGKEKVEEEMIQRGITPEAIAKIQPVF
SLEGDFSQKIAQLKDILSTSPTGLEGIADLEFIYTQTQLLGLQTAALELEVTLARGLNYY
TGAIFEVAAPKEVALGSIGGGGRYDELTEIFGLKGMSGIGISFGLDRIYLVLEQLDLFPK
TLDNTLDVLCINFGEKEALASFKVIQQLRAKGYRAELYPESTKLKKQLSYADSRQVRYVI
LIGEEELSNATAVLKNMLTGEQNTYPLQEIVNHI
>SEQF1602_00476 Ferredoxin--NADP reductase
MKETDIIIIGAGPTGLFAVFEAGLLRLKCHLIDTLPQPGGQLTELYPKKPIFDIPGYPSV
GAGELIDNLMEQIKQFQPEFTLSETAVTLEKQADDTFIVTTDKGTQVKGKAVAIAGGLGT
FEPRKPEISNLADYEDKGVEYFVKNPERFAGKRVVIAGGGDSALDWSIYLSSIAQSVTLV
HRRNEFRAALDSVEKVKELKAAGKINLITPCEVVGLKGEGKLSAVVLEKEGAQEELPTDY
FIPLFGLTPKLGPIADWGLEIERNAIKVNNALDYQTNIEGVYAIGDVNTYPGKLKLILCG
FHEATLMCQGVYNRLYPTKKYVLKYTTVAGVDGFDGSRKEAEKAVIQSIE
>SEQF1602_00477 Bifunctional ligase/repressor BirA
MEIIKLNATNSTNTYLKNLLKEKQVKDLSCIWALSQTQGRGQQGAKWISEPGKNLTFSVL
KKFENLSSEYHFLLNMEVSLAIFRALKKLYIPDLAVKWANDILSSKKKICGILIENTLHK
EQISSSIIGIGLNVNQVFFNDLPNVSSLQKIMGHPFDLEEVLLLICQELEVSLKSLSPTR
FETMLDEYHTHLFRKDKPSTFEYPNGERFMGYIRGVSHNGQLQVEQEDALMSSFSLKEIK
LLY
>SEQF1602_00478 Ribosomal silencing factor RsfS
MSEKNNTEQMLSSILEGILKVKGQDITILDLRSIENAVCSYFVICTGGSNTQVSAISGAV
QRQTPQKPWHVEGEQNAEWILLDYVDIVVHVFQKPIREYYDIEGLWGDAKITHIKTNE
>SEQF1602_00479 ATP-dependent zinc metalloprotease FtsH 3
MNENKPSRFSAFWFYAGLAIILFFILNPLSSSGLWKQPEEIPQTEFEKFLQDGDISKVVV
VNKHQARIYLFPEALEKPDHKSVRPESSLFKGGAESEVPQYKMEVGVLENFENRFNKIVA
ENNLSNTQLIYKTEQNFLGDILITVVLPLVLFVGLWIFLMRRAGGGMGGGQFFNIGRSRA
RLFDGEKDKKITFQDVAGLEGAKEEVQEIVDFLKNPEKYTSLGGKIPKGALLVGPPGTGK
TLLAKAVAGEAKVPFFSLSGSDFVEMFVGVGASRVRDLFRQAKEKSPSIIFIDEIDAIGR
ARGKNNLTNANDERENTLNQLLTEMDGFGTTTNVIVLAATNRADILDKALLRAGRFDRQI
YVDLPDLNERKEIFKVHLRPIKITENLDLDFLARQTPGFSGADIANVCNEAALIAARRGK
TSVDKQDFLDAVDRIIGGLEKKNKIITPEEKKAIAYHEAGHATVSWLLEHAAPLVKVTIV
PRGRSLGAAWYLPEERQIVRTDQIQDEMCAALGGRAAEQIIFGKISTGALSDLEKVTKQA
RAMVTVYGLNEKIGNLTYYDPTGEEYGFTKPYSEKTAQVIDEEINRIIEEQYQRAISILQ
ENREKLTILAELLLEREVIFKEDLENIFGKRPHEEKETY
>SEQF1602_00480 hypothetical protein
MRKLLILASLILAIGSASAQQASLDRGGVQLNGGFGFTGWGIPVYLGLDFGVAPQITVGG
ELFYRTDKIAGVRYNNFGVLANGNYHFDKLFRLPSQVDVYAGVSLGFYSWNNDYSGYNRY
WVSDYDSGLGLRVQTGGRYFFTDNFGVNAELFVENNAGNSITSGGFKAGVTYQF
>SEQF1602_00481 hypothetical protein
MKKIMFSAIALLSLATYAQEETTSTEAPVSTSTDTPAEKTWTRAGIISLLFNQAAFNHDW
TGGGTNNYGGNLNLSYDANYKKGLWTWDNKLLIDYGLTRVDGDAFSKKTNDRFAITSLLG
AQTKEDSQWYYSFFANFQTQLDKGYKYGTDAQGNQTRTEYTRFMAPGYFSFGPGMLWKKS
DNLKVNIAPATSRLIFTAKKFTETADHFGVEKGKTLRYEFGAAVNAYAKFDLMDNMTLEN
TLNLYSNYLDKPGNVDIDYTFNLMMKVNDYISASLVFQAIYDDDAVKAFQIREAFGAGLT
YKF
>SEQF1602_00483 Regulatory protein Spx
MTPSKKIYYLSSCDTCQRILHELRTLEDFIFQDVKEEPICENDLDFLKNFTGKYELLFNK
RAKLYKERNLNQKELTEKDYKDLILEHYTFLKRPIVVIDDHIVLGNATKIIKETRKHL
>SEQF1602_00484 hypothetical protein
MLKKTNKSYFSFLFPKKNYFCRPIQDKMLRKKLYLILLLVAAIAVGVYFLCFPSGKYRFV
NQEIILNDCDGEDCAEVSINYLLCKSPRDFAKIFNDSLQRQLIRKLIAKDTLMDVEEAGN
LFLSQYKSDKQQFEGITPYQIQIVDTITFQNHSLVSLQRSGSEYLGGAHPIDWITYWNFK
PTGEVYTQEDLFTDKRKILDLAEKYFRETFNLSENQELKDGGFVFQNDIFALPKNIGFDK
DNLILLYNPYEIAPYSTGIMEVKIPLNEVIPWLSFNLKDDKK
>SEQF1602_00485 hypothetical protein
MFLVEKLHFSWDEVHEVAEQLEHIQSDKLIEELDKLLLYPEKDPHGDPIPDKRGNMPIFK
SELLSLLKKGESGQCIGVKNTSKEFLQYLNKMEISIGKNIQVTEIHPFDNSIEIQLDNKT
INISAMVAENIYVKKNK
>SEQF1602_00486 Transcriptional regulator MntR
MTFSEENYLKIIYHLSQELQEEVTTNAIAEAMQTKASSVTDMLKKLHEKGWVDHKKYQGV
SLTEEGEKTLFLSFASIAFGKCFW
>SEQF1602_00487 Orotidine 5'-phosphate decarboxylase
MKKFSLDTLKQEIFSKKSFLCVGLDVDLNKIPPFLLKEEDPIFAFNKAIIDATHPYTIAY
KPNIAFYEAYGEKGWQSLRKTIEYLNEQHPKLFTIADAKRGDIGNTATMYAKAFFEDLQF
DSVTVAPYMGQDSVEPFLAFEDKATILLALTSNKGAFDFQTLTTEGTPLYQQVLTRSQQW
HNAQNLMYVVGATKAEYLADIRHIVPRAFLLVPGVGTQGGNLQEVCKYGLNDEVGLIINA
SRAVIYASQGEDFGQKAAEAAHNLQEEMATILQQKYPNL
>SEQF1602_00488 hypothetical protein
MRKKHLIIAFAFMVLAQLAFPLKMILEREFILLKGETFLFQIEPLDPYDAFRGRYVNIRY
HNNKVDLPIELQNLKDIKELYVTVEKDSSGMAFYGKITKEKPTSTNSYLSQKANLFYEYS
YTNMPRNLWIDLPNRYYMNENKAPLAERLMSEAYAEVVIYQGQAILKGIQVKGMPIEKYI
NTLGKDKSH
>SEQF1602_00489 hypothetical protein
MKILNELDELVSAEVISAEVAERIRNYAQERARSSSSHRLLLIFGSLGALLIGLGVIVLL
AHNWDELPRWTKTFISFLPLLAGQAACGYLLFKKGIHLWHAEAVAIFTSLSVGAAIAMIH
QVYNLPESSFANFLSLWLLLALPTLYLMRSRATAVLYFIGCCVLATLGSDKEWTTFFIAL
LAFALALPFYLWHIREKASSYITGIFHWAGAAFVACIVCSFLDNIDFNNDYAFCLVMLAG
AYLIIGKYLQSYIYYNAYKVSAICGLAICFFVKEIFYVNHPPKTIVSTILLFAFVYLPLL
IKYYSLDKKEQTFDLILFYPILYILLAFTQIAYLYDLAILALGSYYLWKGFKSERTLLVN
FGLVVISAQVVYRFFDSSLSFVLKGIVFILLGISFFVVNYLILKQKKNA
>SEQF1602_00490 hypothetical protein
MKQVPTKISPPLSIGQRIIAFNKGLQYTGSLPEGFAVLNPYLDNPETLEVMTAFYNRFYH
DEAPRKFIIGINPSRHGAGVTGVPFTDTKHLESDCGIRMQSARTHEVSSVFVYDMIAQYG
GVEAFYKDYYINSPFPLAIVRRNAQGNWLNANYYDDSELFTLTREYMIETLKKHIALGLD
TQKVYVLGKKNATFLEKLNKEASLFEKMVVLEHPRYIEQYKSKEKQLYIDKFITLLKT
>SEQF1602_00491 Adenosylmethionine-8-amino-7-oxononanoate aminotransferase
MTLTEKDQQYLWHAYTQHKTSDTPIAITKGKDALLWDENGNTYIDAIASWWVNPYGHSNE
RLAKKAYEQLTSLEHVLFGGFTHQPACDLAEALLKILPKNQSKVFFSDNGSTAVEVAVKI
ALQYYYNQGEKRTTFIAFEEAFHGDTFAAMAVSGISLYTTAFQGQLLDVVRIPIPEKGKE
EACKKRLLEVLSQEKCAGFIFEPLVMGAAGMRMYAPEVLDELIQICREHQVLTIADEVMT
GFGKTGKNFACDYLKEMPDMICLSKALTGGTIPLSVTTTTEAIYEAFYSDDISKALFHGH
TFMANPTGCAIALESLKILAEEEMQDNLKRIHAKHVAFAAKMDKHPKVARTRTLGVIFAM
DLKVPDTGEYYGTIRNELYRFYIDHGVILRPVYHTIYILPPYIMTDKQLDRVYEVVEESI
THLSKKGLL
>SEQF1602_00492 Uridylate kinase
MKYKRILLKLSGEALMGSRQHGIDPARLKEYAIEIKQVVAQGAEIAVVIGGGNIFRGVAG
ASNGMDRVQGDYMGMLATVINSLALQSALEDEGVLTRLQTAITMEAIAEPFIRRRAVRHL
EKGRVVIFGAGTGNPYFTTDSAAVLRAIEINADVILKGTRVDGIYTADPEKDPDATKYDH
ITFTEAIDKNLKVMDMTAFTLSQENHLPIIVFDMNKKGNLAKVVAGEAVGTIVN
>SEQF1602_00493 Cadmium, cobalt and zinc/H(+)-K(+) antiporter
MEHHEHDHHGHHHHHVPDLKRINQAFYVGIGANALYTLIEFVIGIRINSLALLSDASHNL
SDVATLIISLLGMKLAQSGATKLYTYGYKKASILASFVNAVILCLIVIKIGVESIERFSH
PPQMQGVMIIITALIGILINGLSAFLFYKGQKDDINIKGAFLHLLVDALVSFGVIVSGAI
ISFTGWNIIDPIISFVIAFVILFSTWSLLKESIKLILDGVPHQLSNEHIQEVLLKHPKIS
SVHHVHIWALSSSENALTAHLVVEEGVSLEDFMEIKKQLKHTLFHEGIQHTTLEIDASTF
CCGDTTCSCYQHKD
>SEQF1602_00494 Thiol peroxidase
MAKITFHNEPATTAGELPKVGSIAANFVAVGKDLKEKSLSDYQGQRIVLNIFPSVDTGVC
AASVRRFNEEAGKLSNTKVLCISKDLPFAMARFCGAEGLTNVEVLSDFRGDFSKKYPVEL
LDTPLKGLLSRAVIVLDEEYRVIYTEQVEEITDEPDYKAALEALK
>SEQF1602_00495 hypothetical protein
MKQLFLIALLCIGQPFIWGQTQAEEVTKEKAALPKPYNTEEDGLAKIEELLVECQKQNKK
LLIQIGGNWCVWCLRFNHLVTTDKELKKILDKKYIYYHLNYSPENKNEKAFAKYGNPGEK
YGYPAFLILDKHGNLLATRKTEDMEESKGYDRIKVKKFLQGRLN
>SEQF1602_00496 S-adenosylmethionine:tRNA ribosyltransferase-isomerase
MKLSSFNFNLPKELLAEYPSENRDEARLMVVHRKTGEIEHRLFKDVIEYFDDGDVFVLNN
TKVFPARLYGHKEKTNAKIEVFLLRELNKEQRLWDVLVDPARKIRIGNKLFFDPEEELVA
EVIDNTTSRGRTLRFLFDGSYEGFRNKLLELGHTPLPKYISRPVEPEDEERYQTIYAKYE
GAVAAPTAGLHFSKQLMKRLEIKGINFAELTLHIGLGTFNPVEVEDLSKHKMDSEEIIIP
QEACQVVNKAKEAGKRVCAVGTTVMRAMESSVSSHNTLNPFIGWTNKFIFPPYDFGVANA
MITNFHTPKSTLLMMVSAFAGHELIMDAYEEAVKEKYKFFSYGDAMLII
>SEQF1602_00497 Shikimate kinase
MGCGKSTIGAHIATSLSLPFQDLDVFIAEQEGKSIPEIFQEKGEIYFRRQEQEHLKRLLA
LPYPMVVALGGGTPCYGKAMELVREATPYSFYLQLPAKELVARLSLQQEQRPLIRGIAKE
NLEEFVNIHLFERAAFYTQAAFVIPCLGLSVEEIGEKIRQKIK
>SEQF1602_00502 hypothetical protein
MKDLLQQDYQLLVAINQTGSITWDAFWLAITNAWHWVPFFALILWANFYFFEKRKAWRIF
GYAIGTLLFTVLITNTTKELVARLRPLHTPELIPQLRILLTERGYSFFSGHTSNSFALTT
FLYLVFRKRMKVAFWLFLWPIPYAYSRLYLGVHFPTDILVGLLVGITTAHIGYWLYRKNE
QRLISKDSPQYTPQPLQK
>SEQF1602_00503 Extracellular ribonuclease
MRLIPLILLTFLNVLSYGQHTLSSYEPIIVPKKLKYYYQNVDFSKRGEALKEELAVLTIV
KHTRILPYSKRHPFLEKANADPKKTGNLLLMYTGESRSKEFVQKRGNPEGTINTEHIYPQ
SYIKRLSHSTEEPLGDLHHLQYADRSKNSSRGNLPFGTGKGQAGRVFQRKAWYPSDDYRG
DVARMVLYMNLRYNLPCEQVSVGGISLLLKWNAEDPISVLEIQRNNEIEAAQGNRNPFID
NPYLATLIFGEVEGYTVENLWR
>SEQF1602_00504 Extracellular ribonuclease
MKKVFIQLSLALALIACSGESIEDRLIEKPQTPQETPKTPETPKKPETPETPKQPETPET
PKQPETPETPKQPDNPSKETGEIKVPLKLKAYYLGVDFTKTGNAFRDELAAHTIKKHHTF
LGYGQRNQYLSKADADPAHRGNAILLYTGESRNYYASTVNTEHVFPQSKLSNAGQQKGDL
HHLRACDKNVNSTRGNLPFTQGSGRARKVGGGWYPSDEFKGDVARMVMYMNLHYNLPWDK
ISTAGVELMLRWNAEDPVSALEQQRNNVIEEAQGNRNPFIDNPYLATKIWGGNPAENTWK
>SEQF1602_00505 Extracellular ribonuclease
MKKILLILSFASLLLSCKGEDLSQNPNDPYKEIETLEREKEKERPHVPQTYQEIRVPNKL
KYYYQSINFSQRGEALKEDLAILTISKHTRILDYLQRHPYLKKADADLNNPENVIVVYTG
ESREKGHINRSVNTEHIYPQSYLKKYSNPERPIGDLHHLRYCDGNINSQRSNLPFGKGEK
EAKIVSNGKAWYPSDAYRGDVARMIMYMYLRYNLPWNHVSNQGVSLFLMWNAQDPVSPLE
LQRNNEIETAQGNRNPFIDNPYLATLIFGEVTGYTPENTWK
>SEQF1602_00506 tRNA(Ile)-lysidine synthase
MINAFETHLQQHFPLLWQKRIILAISGGVDSVVLAHLLHELGISFLMAHCNFQLRGEESE
GDQHFVETLAKELSVPIAIKRFETKTYGKAHGLNTQLAARVLRYEWFEALRQEQGYDYIL
TAHQANDSWETFLINTSRGSGLKGLLGIPAENAHVLRPLLPFSREEILAFAQERGICWRE
DSSNGSDAYTRNKIRHHLSPILKEIHPNFFKNFEKTQNLLQLSYDFLQESVAQYRKEWFI
MGQPIVFEVEKLRDHPHRRFLLYELLSPYGFGDTEILERFLRASTGRQLSSDTHRLLSNR
GQWLISPKEIDTERSYSIAEDMEELSYPIALRIRSTKAIERGLAGTLFLDRDKIQFPLHL
RKRKEGDLFYPQGMGGKRKTLRKYFKDEKYSLYDKENQWLLTDATDQILWVIGKRADERF
LAIEETKNILQISITL
>SEQF1602_00508 Cysteine desulfurase SufS
MKSIAEIRRDFPILERKIGGNPLVYFDNGATCQKPQQVIDSIVQYYTTYNANIHRGVHTL
SQEATEAYETARKKLQKHINAAKPYEVLFTSGTTEGINLVATCLTPFVKAGEEILVLTTE
HHSNIVPWQLLAQRTGAVVRPIPVDKEGMIVMEDFKAMLSERTKVVSCQHVSNALGNVHP
VKEIIHLAHSVGAIVLIDGAQSCPHFSIDVQDLDADFYAASGHKMYAPTGIGFLYGKETW
LEKLPPYKGGGDMIKTVCFEETTYADLPYKLEAGTPNICGGIAYGVAIDYMHSLGMADIA
AHEHNLLKYAHEQIQGLGGITIYGTHDLDRKAGVISFNVEGAHPYDVGTLLDQMGIAVRT
GHHCAQPVMDFYHIPGTIRASFAVYNTLEEVDRLVTGLQKAMKMLL
>SEQF1602_00509 50S ribosomal protein L34
MKRTFQPSKRKRRNKHGFRERMATANGRKVLARRRAKGRKKLTVSSEPRHKK
>SEQF1602_00510 Ribosomal RNA small subunit methyltransferase G
MELLLKYFPELTPTQVAQYTQAVSLYKEWNARINVISRKDMEHFVIHHLLHSLGIAKIHP
LSAGQKVLDVGTGGGFPGIPLAILYPEVSFHLVDSIGKKIKVVEEVASALSLSNVTYQQA
RVETLAGQYDYIVSRAVTQMADFYKLTKHLLKPVTHKGDKRGILYLKGGDLTEELAAFPS
ATVYNLSEVFEEDFFETKKVVYL
>SEQF1602_00511 hypothetical protein
MKLSEIETADLPVREMTITDSQITILYDEVYHIPSKIISRISK
>SEQF1602_00512 hypothetical protein
MNTLEAKREALAKERIKTKYKSHKDCTFIEVVTADKLQEFYDFISKHIRYTEEDYQRYND
RYCIGEKYDKYSIRNWIIEKITKQTKPSDIIILPFLDFGICVELIRVEAFFEAELDEKIS
QHIGLDIGYINLSQQILHYFSDEEYFVFEYYERL
>SEQF1602_00513 hypothetical protein
MIKFVVPILTFDKEQTIDFYNKLGFVVVSKDLLLREPLIYLQLYEGTLESVAHRKEGDAL
DLLFSIQVEEIAPIKQQLQTNNIPIENDYDIPVGEYLYIRDPNGYRICLYELFVP
>SEQF1602_00514 GTPase Der
MSAIVAIVGRPNVGKSTFFNRLVQRREAIVDSISGVTRDRHYGKTDWNGRDFSVIDTGGY
VAGGDDIFQKEIDKQVNLAIEEADAIIFLTDVESGIMGIDEEIAQLLRRSKKPTFLAVNK
VDNTKRAIDANEFYALGFEEIFPISSVNGSGTGELLDAVVKVLPEEEKVEEEPLPRFAVV
GRPNAGKSSFINALIGEDRYIVTDIAGTTRDAIDTRYNRFGFEFNLVDTAGIRRKAKVKE
DLEFYSVMRSVRAIEHSDVCLLLVDATRGFEGQDANIFWLAQRNKKGVVILVNKWDLVEK
DTHTTKHFEEGIRKIIAPFTDVPIIFISALTKQRIYKAIEKAVEVYNNRSQRIKTSVLNE
YMLPIIEATPPPATKGKYIKIKYCMQLPTDLPQFVFFANLPQYIKDPYRRFVENKLREKF
NFEGVPLDIFFREK
>SEQF1602_00515 hypothetical protein
MRNLFVLFFTLCSYVGFAQSDSLAITPPRRYPPSCDCFEGMIDLTPRLAYTYADAKSSHF
AGLMLHNDCIACGGGFYAGVHFASRDSHRVVPEVGAEFYHLLLGYGVSLSTEAITPRVGL
SLFNLLRADVGYAIPWAKAPLFKGFIFSIITDIRLLSYPLPL
>SEQF1602_00516 hypothetical protein
MKTKILLLLAFFSLGGFIIQAQNNQLEGFYQGRKWGLFLLSDKKFLLWNPLAGVKGDYQV
QKDGMIWLQPQKEPLFLVYARNDKDLSKDKIRVELVNFQLGKNYIHLERGRYYSVFNEDN
DLVHTFDRKEVGKSITFIGESLFEEYNKKFVGIKNAYEVGMNPAYNDYIVFCHSYSLYQG
ESIAAFTNKDGMEILLLMNEEETLEKNKEALAKIRSNIEKTPLKEIKNYIYIRKKDENEK
EMLKTVQSQLGIEDSNTIFREKYEREGTSPYEYMGEITYDKEKNIYKEAERDRTYHKYDL
IDTKKSEIDMKKLKIKISPLFPE
>SEQF1602_00517 hypothetical protein
MKTKILLLLAFFFVANSSSAQDRKLIESYKQPESGIMLFPNKTFAAWTYMTVIRGYYQKR
PDGVYLLKPQREPLFLVYGYHNDSIGKDKVRIRFANFEEGKNYIQYENGKTYSVFNDNPN
CFSYKYIHTFDRKEVGSTLTLIHHMGYYDEDVSYLFEGEGIKNTLQFDLGAYNDFLISYE
ELNHLKADMVLVPMELEGEKGAFFHRGKWPEEELKMVKERLKEVPKEDLKRFFTPKEEPE
KINEESISFLYADNIEPPTTLIVSKKENRVVGGSYTSKPIKNKKYRSYLQVKTQGSITDP
KQLKVEPKTIFVSECERPSQRREIMAN
>SEQF1602_00518 hypothetical protein
MKTKILLLLVFFSLGSLVYAQEKDISGNYRGRGGGIMLLPNRLFVLWGYMTAVPGSYEVQ
KDGIIRFKPKKEPLFVVYGQRNDSIGKDKVRIRFANFEDGENFIRFENGKTYSVFNDNPN
CLSSRYIHTFSRKEMGNSFSLITDIQDFSFAPFLGELKNTYQIDLQNNNDFLISYQKPSV
YQIDGVGALVTKEGHECLLFLNWGDVEGSTQYIRELKEKIDKIPIEDLKKIIFAKEKTED
KELNDFLSISNLEEPKAFFMNIKEGTVDPEPVNWEFLVYDKDKNIYKDTLNDIGYYRFDF
VQPKCYQTDLKKLKVEPKTIFVSECEKPSKRRIYQ
>SEQF1602_00519 hypothetical protein
MDEIVFNRIIVLLFLAVSVGITYLIIRKSNRKAQDKNKAKAGCFTAFFIWVPISLLVGLT
PFILLLGAGTVKELYQLASDSDFKPYTAQVVRYENTYMSETKDSNKRTRYVEMGTPVVTF
TIESGRELERALPFAAEVNGESSYNIRYKASTDEIIVTDVFIVVKTIGVIIFLVIAVFAY
WGIYGYLTDKPMKNYGNYLAKGLLYGVFLTMTMGLCAGLIYGALTKDLPLWIQAICIFFA
LSLVIVIVRIFLTMFRSKVRDPLKQRRKTTYRKGY
>SEQF1602_00520 L-lactate dehydrogenase
MRDLTKMTNIEDLRVVCKRNVPKMFYEYVDTGSWTQSTYRENVSDFNPIKFKQRILVDMD
NRTLETTLLGQKVKFPAMTAPVGFMGMMWADGEIHMAKAAQKFGIPFTLSTMSICSIEDL
VEAGVEPFWFQLYVMRDREFMKDLIRRAKEAKCSALMVTVDLQVLGNRHRDIKNGLSTPP
KFTIPNILNLSTKIPWGLRYVFGNRRWTFRNIAGHAKNVSDLSSLSSWTKEQFDPSLSWK
DIAEIKELWGGPIILKGIMTPEDAQEAVKYGADAIIVSNHGGRQMDDTISSIKALPDIVS
AVGSQTEVWIDSGFYTGQNMLKAWALGAKGIMLGRAPVYGLGAYGEEGVTRALQILYDEM
DTTMAFSGHRNIQDVDKSILVEGTYPLPTRK
>SEQF1602_00521 Inner membrane protein RclC
MQTLLEKLAGLQSQFINFIRIAIFIVMAWIGGLKVCQYEADGIVPFVTNSPFMSFFYANS
GKTAIDENGVTGEANKGKEVAEYKLHKNPEGKMVAANIEWHKQNNTYIFSYGLGTVICLI
GLLTLLGIWSPKIGLIGGLLTFGMSIVTLSFLITTPEVYVPNLGGDMPTPNHGFPYLSGA
GRLVLKDIIMSAGGLIAASDAARRLLGKSK
>SEQF1602_00522 Virulence regulon transcriptional activator VirF
MTYQNIHINSAAPGDFAQGEHTTLYYIFLLQGDSHFSVDFNEYHSQGYSLLFLSPYQYFQ
WKERAAKMDFIAFHGDFYCIEYHKKEVACNGLLFNNIYQQPHFEVSQAVFGELESLLKKM
QAIASDSNPYQIAVLKSYLQLILAIGSREKQHFLSHLKEENPLQNPVANFQELLEANFLK
EKDISFYAAVYHLSVSAFSKRIKQYYGKTPSALLRERLVLEAKKLLHLTHKSVKEIAFEL
CFEDAFYFSRYFKKEVGVSPKQFRENVGISIVAK
>SEQF1602_00523 hypothetical protein
MKYVLYGILVLTIMQHSTAQYRKIQLTDAKRVEHLKLESRSARCKYNEGFIYNKDYMIYQ
ACDAAVTFRPDRETFQIKYRGYGFAVDKKGVYYQGQFVKVDTTGLRVLASREVKEIKGYV
NGIAAYYWRTNGGVFFGTKRLSVPDPQTFEALTYCYFRDKNHVYYYDQIIKGVDPNLVNE
KLSRDELLNEGKNVYYKGKRLYYKGEVVEQMTSKIFKTSKYVLGYDGKEDKQTHSILVEL
HSEPFDIPTLRTLSDSYLIDKNHLYYIPSFYSVPDRGFRMPVSKEEFSSIRAFTEFVVVG
STVYHEREPKERYDAATFRVIPGHYYYQYDKNGIYNWRKKLPFRYTKRPEYGKNLFYIDE
KNLFIYEDQAYYRDSGDSIYIKDLSSQQIEILKQGKTSLKDLLPPHKEPPQKKEKYDYNL
YKVDGHIYIGEELQKDIDAATFQYITGYFYKDKNHVYYYDRWRGKEAHFLIVEGYDIATL
RGDPNGFMMDKDYYYYGTTRLFKNKNVELLAVYTGYRQWCSRDNTPTTDYCLFKNAEGYW
LFEFGNENIICFLGKKLKMRKLVN
>SEQF1602_00524 hypothetical protein
MINSKLKTQNLKLKTIMNRLLLCTLLVVACKQKPAEQKDSSEGLTTHIVSITDPDDYQVY
FSDQYGNSYSEKYIVYEDYVLYQGKKATLRLSPDMATFKGKGDGFAMDKNGIYYRGYFFP
MDTTGFKIVGVKDIPLSEENTPIWKTNKKVFFGTQPMEVAHPKSFEMAYDYYTPCYYFKD
KEFLYFCEKKIEGSDSQYIRLSGITYAVADKNHTYYKDKILTYKGEPVELLTEDFFKTSR
HVLALILDVGGDDAPYWKEVSYMDVATLKGLSIDSLSGASSGYLMDKNHVFFREKVLPIK
KRDFDKIQTFGAYSYISDGKTIYHRSDPTPYDAHTFGIVPEYAGDLVYDKNGIYKNGEKL
PFKYTTPPVWGKNAFLEGEKVIYQQQIYDISDQWQLMTDEPTTNDK
>SEQF1602_00525 hypothetical protein
MNRLLLCTLLLVACKQKPVEQLPTTTNEKAVVQDTIAVSDIHRTDSLWHSFWEYKRPYVE
GYIINRDYVIYQEKNTRKIIKPDMASFAILNVSGSAADIILIFAKDKNGIYYQGDFIKID
TTGFRVVGVISHHDKPSDYWEEPIWRTYKQAFRGTKPIAISDPATFESVSTCYFKDKNYL
YYYDRKVEGADVATLQKERADEEFVSDKDNTYYRGKPFIYKGERVQQVSNNIYKTTTHVL
RYNGGDDDKEKEKAKDYFVELPDYFDIPTLRRLNDYYLIDKNHLYYDENSYPLENKDLRV
PIPKENLSKIKLFEVLVTDGNKLYNRKEPLSDYDAATFGVVPGHYYYQYDKNGIYNWREK
LPFHYTNRPEYGKNFFYMDNQSLFVYEDQAYYKTYNDSLYVPHLTPRQLALLKEGNTPLR
ELFPSQDDKQKNKEIDTTGFEELSYFFWRHNGQIYHLIYKEWYDSDQHDWKSERRYVVVK
GYDNASLRVVPNGFLADKDYWYDGTTRLFPSKDVELLAIYEGYEKGWGMDPAPSPNFYLF
KNAQGYWLAELSGEGAMCPLTNEQANKLLNQQ
>SEQF1602_00526 hypothetical protein
MNRLLLLTLLLVACKQKPVEQLPTTTTTNEKAVEQDTILVSDIHRTDSHSLWIWEYKHPY
VEGYIINQDYVIYQEENTRKIIKPDMASFAILGSGLAKDKNGIYYQGDFIKIDTTGFRVV
DVIRDKQSDYREELIWRTYKQAFRGTKPINISDPATFESVSTCYFKDKNYLYYYDRKVEG
ADVATLQKDLANGEFVSDKNNTYYQGKPFIYKGERVQQVSNLIYKTTTHVLRYNGGYDDE
EKAEDYFVELPDYFDIPTLRRLNDRYLIDKNHLYYDESSYPLEDKDLRVPIPKENLSKIK
LFKVFVTDRDKLYRGKEPLSGYDAATFGVVPGHYYYQYDKNGVYNWDYKLPFRYTNRPEY
GKNFFYMGNQSLFIYEDQAYYKTFYDSLYVPHLTPRQLALLKEGNTRLRELFPSQDDKQK
NKEIDTTGFEQLSYSSSRHNPFWRHNGQIYHLIEGWYDNDQHKWRRSERRYVVVKGYDNA
SLKAVPEGFLADKNYWYDGTTRLFQNKDVELLAIIVGRRGGCRVDSAPGTNLYLFKNAEG
YWLAELGREGVMSPLTNEQVSKLLNRQ
>SEQF1602_00527 hypothetical protein
MIKVVYIILFCIGIYPTVAQEDTDTAYIKPAQIQEGLKAEVQLIYNQRYLINDNYVIYQE
GKSREIIHPDMKTFQLDDWNNFMRDKNIIAKDKNGVYFEGKFFPSDSGCHLIAIMDKPIA
QGEYFPSGKDCIWRTHHKVYFNAEEIPEADPHTFKSMKYFNDLYHKDKNYLYYRGKRLEG
ADVQSIRPSYSLSEVVADKNNTYYKGKVFTYKGESLTQLTSNIFKTPHYALIFKNNRDTH
KDEFVELPAYVDVHSLKGLSETYAMDKKNVYYAQTYKADTLLVPIKNKRKIRVFNKYITD
GVDIFRGRNQKINLDAKTFGILGDDYLYDKKGVYKSHDVSEKIPFDYKAPVRLGKNLSYL
NGNIFYNNQVYDNWEDKVYTLTQEQIEEVKRRNIYPHQLWEKTSKKSYPQSADEATFKYL
YTGQYNSLGTDKNRVYFSAQQKITFIEGYDIASLKAAFDRFFLKDKDYVYYLSIRLIKSD
KAELLASYQGHRHYCSHPSMPASDFYLFKNAEGYWLVKIGGGVFVEFLGTEYNLPIIN
>SEQF1602_00528 hypothetical protein
MLCFSLQAQQKRWQLDSIQQIQFYSDKKEYVYKTFHQSYDPKTRTVTMIDETKGEWGDRT
KYICEYSPLDSLLSQTVYTYDEDIKKWEKQEMIHYVYRGAEIQEKMYHKNEIGDWKILRT
SYIENIDGKLYLKKEENGEKTQKGWEVITYDPPKLWHYFSMQELNPKKKVAPQEKYNKKG
EVIEKLYIEMDNYKDKQKFSYDNSGNISEIELYELRDPKVGFTKEEKRVYTYAPDILYEE
VLDKWKQNYENRKPKKAILSEKVYRTQNSGDYKFIYEHRYFYSPIKQ
>SEQF1602_00529 Ferric aerobactin receptor
MKKIAIFAMSFSAISYAQQPKTHGIEKDTLGLEEVVITANRIEEKKTDAVANVTIIDQKK
LQQFIKIAPDMSHLIGMIEPAMALSTNTTNNRYQNLRGRALLVLIDGIPQSTPLRSTDRD
IRSIDPAAVERIEIVKGSTAIYGNGAIGGIMNIVTKKAPKGVAFSGQTSLGASGRDSFME
NRGFGYRFNQQFSGNYKGFSYLLDGALTQTGSAVDGAGEYISPRYGLGDVRTYNGLVKLG
YQFDEDNTVEVMYNFYQSLQHTPLVASGGKYLQSPRIGVYGSKDPAAQDEGMRYNHNAYV
KFNSNNIFAHTDLELSAFTQHQYAIFDYRKHNAKSPRWESSSGQATVKGEKYGIRTQLTT
KLLLGENIFTQLLYGIDALIDKTSQPLVDGRYWMPELTSYNSAPFLQTKTTFFNHYVLKA
GLRYDYIDVAVPDYQVLRLKNTDPRVYVKGGELSYNNLSPNVGIAYNQIKYFQPFASYSQ
GFSIFDLGRTLRAAKADVLSKINTEPVKTDNHEIGAYSEIGKYVHLSGSYFYTYSKLGSD
LKSVSGFWVVDRSPQKVYGFEVNADFFPTDWLTLGGSFISFEGEKKSTEDGPWDGYMSGT
SIPAPKASAYVRVTPTAKSYLQVNYLHTGSRDRFTPNNRGIYEEGEGVVFPIDLFSLSAG
YTFNKNLSIGLGVENLADKVYYTPASMLVARDAEYAHGNGRYFNLNLTYKY
>SEQF1602_00530 TonB-dependent receptor SusC
MKLRIFYAVALLFIAIQGALAQKVTVTGTVKDGQGDPIMGTYILIKGTSKGATTNDKGAY
TIEANVGDVLYYSFLGMKQVEKKVTQKSSVINVVLQDDVQEIDTGLVFTGYGAPKVASKT
VPSVSVVQGKALAETPNANVMDALAGRVAGMVVTTSSGRPGASSNVLIHGFNNFQSALKG
SASGQDPLYIVDGAQVDGDIMSSINPNDIENITVLKDAASTSIYGSRAANGVILITTKRG
KYNQPTNITISHQVGFNAITSASRKFFDNMMSPREYMDFWAQRDPGAIRSAAGVSGDTDA
AIEKILKENPYNTRWDKIFFRDFVPTSRTDVSISGGTANTAYYFSLGYFKQEGSTAPALD
YHRYNVNSNIDTRINKWLKAGLSLSMSYTESEGGRSSVVGGRVLALPLYTPYNPDGSRKN
FIRGLTGRSTGFYHPEYDAEKHPYGSYGVDVMPIAYLTVEPIKNLVFKTQAGVQYSAGES
ESKQLHSFTDYKFGYETTAFTQLSQSKAYKKTFTNTLEYKFLLGDSHSFTALLGQESIEN
IAKTLTNYTAGQPSDGLSMLVHGNKNFAIGDNKSVSTFNSFFSRLEYDYQGRFFLDLSGR
RDGSSNFGRNNRYANFWAVGAMWKLKKENFLKEVKWLTDLNLRFSTGLSGNAGGLNYSNL
NVVSPLAVYQGQTGYTLSRLGNPDIRWEEQTKTSVGLNVVFLYNTSLNVEYYNRRTYDAL
SYRDNNSASGYTQLYGNTGGMQNQGIDLSISSRVYYNEANNLSVRPYFNFNYNQQKIVEI
FDGRQSLVNARDKIGFKVGKALEYTAVLHKGVNPDTGLIEWYKPGEDKMEKQTDDSQVTT
EYNLNLGQTTGKKMHAPVNGGFGWDITYGGFSLDMNFSFSIGRWVENRDMIYTENPNTFA
NGNLSRNVFDYWKQPGDVTRHPKITEATFVQGSDSRLIQNADFVRLKGITLSYRLPKEVI
EQVGFFQGVRLYGTARNVFTITKYEGADPEFTQPISIGGYPPSRQFTFGVELKF
>SEQF1602_00531 hypothetical protein
MKKIYNKLPLFILLALSLQGCAKLDQEPYVDLSDEKAYLNVEDAQYWVNGMYRALRDNTY
GNAMISTDIQADFLNAVRRDNEKLPALHRWGNTFTSSDETTAAIWLAHFKAIQDINLSLQ
RIPSIPIEKDRETTQKAQIKRNMGELYLGRAYFYTYLVTHFCGAYDASSVYGLPILREPK
VADFPAPSSLKETYEFILSDIALAEEYLANTAGEVGSTTFTVDAAKALKARVLLYQGEWA
TAYQTAKALIDTGTYPLATSSATLKNIWAEDAATESIVQIYAAAGSTGNVSIVNELPKAN
DIYIGANNFDRRLRRFLYNPSYIPTQSFVDLFDTADYRKSIYFQKLFVDYGNTVYSNIYL
VTKYPDNSNLKSNPSGLPTYMHKPKLFRIAEQYLIAAEAAYRNGDEANALVYLNRLRASR
GLTTALTATGDALLTEIQNERNRELAFEGFRLHDIKRWGLGVVRGTPQNTDAIFTSPANE
YHQLNISAGYYKMTWPIPATDITYEKGKWKQNPGW
>SEQF1602_00532 hypothetical protein
MKRLGIFLLLASTLAFGQNQNKKTGWDAAKLKGKVKTYIIEDYRIDEKGKPFRGNTELLT
EFDPKGRTTKMQVKNNGMIMSYHDTYNDQGYLIESISKDEDNKKLSSNLYEYDQKGNRTR
HDLLTAEGNLFMSTFSKYNDKNQLIEKSSCVGGVCDEKSIFTYDDKGYLIQEDKYKKDEL
STKTLYKNDAQGNPIERLTYDAEGKLLKKITSTYDKEGNETENIVYKGDGTIAQKKNYVY
QYDKKRNWIKKTESENGELSLIIQQKFEYYK
>SEQF1602_00533 hypothetical protein
MAVSYNATKARKFNRELQRIMDEDTYHELFPQATLARSPSSQAARKSRNYARNADECEIV
GYQGCFKTIGVGGSLTGEPVDILIMDDLYKDAAAAWSPLIRQNIADWYDTVASTRLHNSS
QQLLVFTRWHEDDLAGRLLQKEGLYHPTDNPHGWVLLSFPAVKDSPPTPLDPRAEGEVLW
PERHNLEKLLQIKQRNGAVFESLYQQNPQPSQGLMYEEFQCYTEIPSHTYSVAYIDAADS
GADYLCMLFYKEAQEGNFIVDVLYTKDPMKVTEQEIAHKLLEHQVERCHIESNNGGGLFA
HNLEERAQQMGNNFTRFYPFHQSQNKIARIFSASSLVQQLVHMPLDWKKRFPTFARDLMG
YLKEGTNPHDDAPDALTGSVECRQPPRKIPLSELLQW
>SEQF1602_00534 Phenylalanine--tRNA ligase beta subunit
MKISYNWIKDFLKIDLPAQEVGEILTDLGLEVEGIYSYESVKGGLAGVVVGEVLECTKHP
NADKLSLTKVDLGEGGVVPIVCGAPNVAQGQKVAVATIGTTLYDKQGEPFKIKKGKIRGE
ESHGMICAEDELGLGESHEGIMVLDSSLPNGKPCSEVFHIVSDTIFEIGLTPNRADAMSH
LGVARDLRAGLLQRGTNKEIITPSVTDFFVENRLLKIDVLVDNKELAPRYCGVSISNVKV
APSPAWLQHRLRAIGVTPKNNIVDVTNYVLHDLGQPLHAFDALRISGKKIIVRNASEGEK
FQTLDGVDRTLSAEDLVICDVDKPLCLAGVLGGNNSGVSQDTTHIFLESAYFNPVAIRKT
AKRHGISTDASFRFERGVNADDCKYALLRAAIMIKKLAGGEISSDVIDLYPRKIEDFQVF
LTYEKVDALVGQVIPRDVIKSILHSLGIQINSITEIGMGLTVPSYRVDVQRDVDVIEEIL
RVYGYNNVEAPSKVSASMAHANRYEDFNVQNIIADQLVGQGFFEIMNNSLTTAQYETLSE
DIQPAQRVTLLNPLSQDLAVMRQSMLFSGLETIAYNNNRKRTDLALFEFGKTYHKVEQSY
TEPKHLALFLSGNTYPETWNTPTEKTNFYQLKGYLLAIFSRLGIVDYQEEPTTEGIFQEG
ITLKIGQQTLASLGIVRTSILNHFGIKQAVYYADVRWEVALEHLAKKVVYREIPKYPEVR
RDLALLLDEDVSFRAIYNIAHKTEKELLKKVFLFDVYQGDKLPKGKKSYAVGFLLQDSNK
TLTDKQIDKTMESLLAAFQQEVGAQLRS
>SEQF1602_00535 Recombination protein RecR
MMDFSSKLLENAVYEISQLPGIGKRTALRLALHLLKQPPAQTERLAASLVSLVNEITYCK
QCHNISDTEICDICANIHRDSSLLCVVEDVRDVMAIENTGQYNGLYHVLGGKISPIDGVG
PNELTIASLVKKVKEGSVKEIIFALSNTMEGDTTNFYIYRQLEGLDITTSTIARGISVGD
ELEYTDEVTLGRSILHRIPFQVM
>SEQF1602_00536 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MARYELKLPQMGESVEEATVSSWLKKVGDTIHLDDILVEVATDKVDSEIPSDVEGILTEI
LTPERTVVKVGQLMAVIETIEQNAASEPTIALPEATPSSEELLPIEEPEQENISSFEEPQ
EIALPAATSEEELQEVVPAVPYVPTQVDTSADATSQEDTQKDFYSPLVRTIAKEENISEE
ELASIEGTGAQGRITKYDILRYLENRTRQEGEQAQVAVTSEPATITPASSTPEVLPVAQE
EKEAATEQKVAESHEVKYPDIEDFIKNLAATQSQKEAPAAQATPAPAAQATPTPAAQATP
AASLQIPVSAPEQAPLATTSYTPSPVDDNVEVIEMTRMGKLIANYMSESKHISAHATSFI
EVDVTRIWNWRNKYKKQFESREGEKLTFTPIFIEAVAKALKDFPLMNISTDGERIFRKKN
INIGMATALPNGDLIVPVIKNADQLSLVGLAKSVNDLAKRARENKLKPEEVKGGTYTVTN
IGAFGNLFGTPILNQPEVGILAIGAIQKVPAVVETPEGDVIAIRYKLMLSHSFDHRVVNG
ALGGMFVQRVAKYLEQWDITREV
>SEQF1602_00537 Lipid A biosynthesis lauroyltransferase
MQWLTFYLAYPFLWIISRLPDRLLYGLSDGLCFLIYRVIGYRKRVVRGNLVRVFPEKSLE
EIKEIEKKFYHHFCDIFLEMVRTMSFSQKEMHRRMTYTNKEILEEFHQKGKSFIIMCGHY
NSYEWLLSLASQIPHTSYALYTPITNKYFDRYIRRLRERFHSYLISRYKAIEEIRRQQHQ
GMLCAYGLASDQSPSSSPKNYWRPFMGVTVPVFTGAERIARQFNIPVVFCDIQKVKRGYY
EATFTLISEEPQQTPEHQITDIFTQMLECQIRKAPQYYLWTHNRFKHAK
>SEQF1602_00538 hypothetical protein
MSKYVIFLFVLFVSCSSENHIRITQQKNLPTGLISYTSKDGSFSFYKKITIKNDSFYFVS
LRAKYIKGADIHLSNKAMQLDEKEKKYIPFKKHIIKLYPYQEKEVYLLLSIPTDFVNDRR
QELVPLLEKYVPKDSVIKVENIKKVEIDYDKLKKEYPVITECFLKSYDSIEIKVLKPKEE
VLHFKAEW
>SEQF1602_00539 2-oxoglutarate dehydrogenase E1 component
MDKYSFLNAANTQFFADLYDQYLENPDSVEASWRAFFQGFDFARESYGYDFFQESVPQEV
STVTAPAASSVASTPQAAPVPVFGKVEKELQVLNLIKAYQRQGHLLAQIDPLKERKAPQV
SLSLEKFGLSQADLSTVFDAAKEIHLAPSPLSVILKKLEDTFTKSIAIEFEHLDNEEEKK
WFQEKIYSGDYTTEFSKEQKKRILEKLAESTTLENFFHNKYVGQKRFSLEGNEAVIPALD
ALIEAAADQRGVKEVVIGMAHRGRLNVLINILGKNLQDVFSEFDGKDYLDPEFDGDVKYH
LGLTTHRTTAKGNEVLLNLAPNPSHLETVSAVLQGITRAKQDLHYADNPSQVLPIVMHGD
AAVSGQGIVYEVMQMERLRGYTTSGTVHIVINNQIGFTTNPSDSRSTTYCTDVAKGFQAP
VLHVNSDDTEAVVRAMLLAMEYRMAFGHDVFIDVIGYRKYGHNEGDEPRFTQPALYKIIG
GHNNPTVIYTESLVRQGVITPQEIQAYQETFRNHLDTELEASRLKEFTIITPIMQNEWKG
LEHIASQQDMLLKISTAYEREKLDALAQLITTLPEDKKFINKITKIIKERHNLYFEQNKV
DWGMAEHLAFATLLSEGHDVRLSGEDVGRGTFSHRHAVVKEEESEESIIPLSRIKEQGGG
TFHVYNSLLSEYGVLGFEYGYALTAPQTLTIWEAQFGDFANGAQIMIDQYICCGEDKWKN
QSGLVMLLPHGYEGQGAEHSSARLERYLQLCATQNMYVTNCTTPANLFHLLRRQLKAPFR
KPLVAMSPKSLLRHPLVISSVEELTQGYFQEVLDDSQVNPEEVRTLTFCSGRFYYDLLAE
REKLGRKDVALVRIEQLFPLPIEELKLIIARYPNVTDYVWAQEEPKNMGAYGYMLMNFDI
VKWRLAAANAYSAPAPGSPMRHKARHQEAIDKVFLAI
>SEQF1602_00540 Iron-sulfur cluster repair protein ScdA
MDFTNKTIGEIVAEDFRTAAIFKKHGIDFCCRGGRTIEEACEKKKVMEQQLIDELSALPS
GKGDNVDVSSWPLDLLANYIVKIHHEYVREKTPMLLQFLDKLCKVHGDRHPELFEVNALF
TESAHDLGEHFQKEERVLFPFIEKLAQAAQSGTPLEPSHFGTVENPIEMMKHDHTIEGDR
FAKIAEITQGYTPPADACNTYKVTYAMLEEFENDLHRHIHLENNILFPKAIELEKKIQTA
S
>SEQF1602_00541 Signal peptidase I
MLTYLTIFLGVQLLQGLFLWKGYQKAGYKGWQAFVPVWNMLILLKIIERPWWWVFLVYLP
VIGNIMAVVLAYEWLHVFGYRQKRYTLLAVVTLGLFIAYVMYQPKTQYIGKSEAVIAENV
PSWLNGILYAVVAASTIHTYFIQPYTIPTSSLEKTLLVGDFLFVSKFHYGARLPMTPLAT
PMVHDTLPLVGVKSYLPKPQLPYLRLPALQKIKRNDIVVFNWPTDTVRFFRDPSGYHAYK
PVDKKSHYVKRAVAIAGDTFEIREGNVYINGQKEIYPVRAKLQTSYIVRVSPEFQNYLVS
LYGGQYTAEQLLPAYLFQNFGVTDASGFRSNTEFVVQSATEEVAQKLQKTPHVESVTKMI
SPKEYNPAIFPHSKHYAWSEDNFGPVEIPAEGKTIQLTTENLPLYKRIITEYEGNTLQVQ
GEDILLNGQKVTSYTFRQDYYWMMGDNRHNSEDSRYWGFVPFDHVVGKPVLIWMSWDSNA
SGLNKIRWNRLFTTVNGEGEPVSYLYWVLGLGVLSYIGYEVYKKKYKKGKVKK
>SEQF1602_00542 hypothetical protein
MKALLHPTYFPTIASFSLLVTTPCVLEVSDNYQKQTYRNRTYIYGANGRQILTVPILHTG
GETGRQLYKEVRVDNNVAWQKQHWKTLQTAYRTSPYFEYYEDKIVPIFTQKHTFLLDLNL
KTIEVLLDCLHASVEWEKTTSYKESYPEYEDFRYLTDAKRPYEGTQTPYYQIFSDKHGFI
PNLSILDLLFHEGNHALDYLPQ
>SEQF1602_00543 hypothetical protein
MEVIHLLFVKENKQQSNAWCDSYRSILNHFDTAISSWKGFNYLSFIIMDSKV
>SEQF1602_00544 hypothetical protein
MSVSAKSKTFEFSVLPLWESFIIFGAFAFLFIFPSLYFQKWAGIIIRIYVPLLCFCALGY
CRIRSKKLSIEVIDNEKLNCRINNKSLVVPCNENKIFYIRLYKRRTASMIRIKNELFYIY
TEDFGKEKIKEYDLNIKELQSVIGNNPNRKPIDWIPFLMLWTIYGTLLICLPFALIFFIA
LFTDNLHWFDF
>SEQF1602_00545 hypothetical protein
MSVSAKSKTFEFWSISLWEGIIVFIVFIILFLLPMFYTSELQKWWGIVIRLYLPMVVLCT
LGYVKLRSRKLIIEVNNKNQREFIYTRNNKQLLTEFEKVKIFYLKSSKGKIGRILRIEGT
LYFIYSKNPFSKEVAKQYKSKIEELQDVIGSNTKKEKIDLVPLSINLLIDVVPFIIIPLA
ILYLIAIFTDNTHWFDFLKSLL
>SEQF1602_00546 hypothetical protein
MSVSAKSKTFEFWSISLWEGIIVFIVFIILFLIPMFYTSELQKFWGIVIRLYFPILVLCT
FGYVKLRSRKLIIEVNNKNQRDFIYTRNNKQLLTEFEKVKIFSKKIY
>SEQF1602_00547 hypothetical protein
MFAYVSDTNAWVDLLGLNTNPETAAEWEARLAKIAPNEKYVAASGKLKKVAEKNGWEKDN
KLTKKNNRTVYRDPETGKIYAFDTQHGRFEVLDKNGNHIDEVDIDGKAMGKKTKVEDIIF
TLNNKSNKIQDKMVKLIDFKENNICRGMVLRCKGKYPYEAIVDFLVCETPDSGAKTFQLI
VISGFKAGAKYYQFPEESLPKDRSRYGLSTHWLRDNWYKYGYIDCPLEDVYIYESQVPTK
FEL
>SEQF1602_00548 hypothetical protein
MKYFRVRVSINNRLWKNFFTYMYHFFCKESTTTFVKNYANRQTILELIALNDKREFILSE
KSFEKEEMPFYLTKESILLIRDDFFHEELFTDLIGIDFRNVIVQGEFSHFYVMLSFINIL
DCIHKEKNKKNEVDPFNGLVLDKKKIPLNIDGFFLDKWDRWGEYTPFVSEILKNRLLMLD
KAQKYLLFDEVIII
>SEQF1602_00549 hypothetical protein
MSDTNAWVDLLGLSYDKPIHHIASNKHKTYSSLFRFLFKRYGLGRFKNGRERKDVLNDPK
NKVAVEGHKGPHGEDYHKEIYNRLEAAGARGEEKARKEGITEESKIIEQGAKEFIKELQK
LSKECSTEGKRLNKIITKKI
>SEQF1602_00550 hypothetical protein
MILIEGQKIYCKGCGKIIENIYDSCILLNIEANEKSPLYCLNEAIFHRDCYNNYPLRNMY
EKRVAELEKLSSLNNFDYISKEELSLEKIGHPDNLIRVPFLTEDYNSPLYEYNCIFLNKK
NLDKWRNYKIFLKLIDNLNKSDEWRGKALSFLMSQLNSPVKPDILR
>SEQF1602_00551 hypothetical protein
MELFKGQSLLEFTERFKTDLDCEEYLASLKVGRWILLSQMWS
>SEQF1602_00552 hypothetical protein
MKKKLLFVFIISLLSVSYGFAQENKLKPVDSLTKKDKIKEIPSEKLEGISPDKIYYQHYG
LRIGADISRPIRSLLDKSYQGLELVGDYRLNYRYYLAGEIGKERKVSENNYFDFTTNGQY
IKFGIDYNSYTNWYGMENMIYFGARYGFSIFNQEVTRYSVHTLRNYWNESLIGTQSDILT
SYQGRTAHWLEGILGIKVELFKHFYAGASLRFSFLLYQNKDNFPNFWIPGVQRVWEGSNI
GINYNYTLSYMIPLYKKAKEKTYKNDK
>SEQF1602_00553 hypothetical protein
MKKFALLCSFLALASCENDDICDDSVVTPRLIVRVYDKDTPTRTKTVNSLLVVGNNQNTP
TQPIATTDSLVLPLKLSSGESSFILVKDAAVDSLGRITRGSQVALKIQANASQLFANKGC
GYKVVYDQVSASIDSIAGNTRWIDRVQVMFRKVEDEKKATIRIYY
>SEQF1602_00554 30S ribosomal protein S21
MLIIPVKEGENIDRALKRYKRKFDRVGIVRELRARQHFTKPSVLRRSVIQRAEFIQQLRD
AEEI
>SEQF1602_00555 hypothetical protein
MILQIHSQNPHLLDLLNKNPHTDLGIYAKSLRNGQLIGNAVSAYQYDVVFQDTRYSYLPE
ESNQIDFQSYCSPLVILHICNEFFKELLQEKQTYWSQQIKWLERTRAEVDTYPCTIEVKN
LYANSTWYSKGHFMMERYFKNIHITPIVGNNLSLRVEGKSVFEAMNLLSFIAVTTHITNT
YGEYTYIDDHFAQKYARILTNIPQVPYFVFYLFIKRAIKSERQFAEIKPMFEAYFKEEGL
DIDFQFTDTHGSRMDFIVKELGMEYPILDIGCGELKYYRRFMRRNYNYSHPYFATDTDKS
VGDYAALLKERMEADNLYFFSDWTDYEYKNPVNIILTEVIEHNTPEAAEALVKHCLSLNF
HKMIITTPNSLFNKYYFDEDPESLRHEDHHFEWTPQEFQDFIRHCVGDTSLEVTYCGIGD
RINGETPTQAVVITRK
>SEQF1602_00556 NH(3)-dependent NAD(+) synthetase
MNTPKVTQQIVEWLKDYLLQTGIKGMVVGISGGIDSAVVSTLCAETGKPVLCLEMPIHQA
ANQVSRGRNHIAFLKNKYPNVSSLEMDLTPVFDTFVAQVPPAENNALALANTRARLRMTT
LYYFAGLQGYMVVGTGNKIEDFGVGFFTKYGDGGVDVSPIGDLYKSEVYEVGRYLGVLPE
ILQAAPTDGLFGDDRTDEDQLGATYDELEWAMRLVESGAEETHLTPRQSQVLAIFKRLNR
ANQHKMIPIPVCRVKREE
>SEQF1602_00557 Tail-specific protease
MKKNIFILFFLGIISFASCSFTDKKFEYTGDKEKLLMEIIQYMVSRGHYDPQPLDDAYSK
RVFKGYIQYLDPQKRYFIQEDIDEFKKSETKLDDDLKKMDISFFTLTYNRLRQRIEEANK
LSQELLKEKYEFTKNETIDLDYEKIPYTKNKKQLRERWRKLIKYSILSNLIIKQKEEQDK
KEKDANYTPKGDKELTTEAVEATQKAFEEMFVSYKDLTSDDWFGIYLNSYVEATDPHSSY
MAPDIKERFDRDISGKFEGIGAVLQKKSDGIRISDIIMGGPVWKGKLLEVGDMILKVGQG
SKDPVDVIGMRLEDAVKLIKGKKGTEVRLTVKRLDGSIQVVSIKRDVVEIEETFAKSAII
KQGNHTYGIINLPSFYVNFNNTRERNSASDMALEIAKLKKQNVDGLIVDLRNNGGGSLSK
VVEIAGLFIKEGPVVQVRDAERNIQVLSDTDSSTQWDKPLVILINELSASASEILAAAMQ
DYGRAIIIGSKQSYGKGTVQELIDLNREIRNSSLGDLGAIKLTRQKFYRINGGSTQLKGV
NSDVVIPDRYQYIKVGEREMENPMPWDEIPKANYTRWSENQNFATAIANSKKRIEEGALF
KLIDENARWVQKQRDENTYSLEYNAYKKQIDESEAMIKKFKQLTEYKSSLQFSSLPSEEE
KAKENEDVKIRRDRWHENLQKDIYVEEAVEVLNDLVK
>SEQF1602_00558 Putative penicillin-binding protein PbpX
MSIFTFFQQLFAQPITQKQIFAEDISKINSLEKAIQQSELVVNYLLQEHYTPSMSICVTK
RGFPIWEQGYGYADIENKVGVNPRETLYRIASVSKPLTGMALTKMQEQGWIDWNCSLYDY
VPYFPKKQYDFTVKQLAGHLAGIRAYKGKEVFLNRFMSIKEGISVFAEDPLLFEPGTQYY
YNSYDINLVSLAMQEARKEPFEWYVTHNVLEPIGMKHTFPDMGGLSPNQSIPYSPDKKKQ
FKRSTEVNNFFKLGGGGFLSTAYDVNLMGQAILGKAFLKPEYQEQMLTSQQLNTGKDTGY
GIGWQTTTDWQGRTYYGHIGNGIGGYAWFYVYPEEEVVFTFLFNTTNPSIADYMHRIMDC
MLKGASYKEYTTHNYPVIHNEQ
>SEQF1602_00559 hypothetical protein
MDLNKMLYFSLLRFCGEQQEEKEELLKITNYQNEEGDFLLATLPKKRELDELLYALKNDA
LYDKLQTEISHSCFEDIFSLLEVCLRAFYYYDNYYINDRLQFFSLIQLLKKENTEHAFKY
LLFFNPCGETFIERNQLTKQGYFMDNIATDIKEVFEKLFSAVFELKNKKECYHQIAKKDI
ECLYSLLKEMVYTIFGAQTLTLSQAVKTFFEIDEDREKLYLSLSKAIDLYKLVSFDNEDN
SASHYYMRDYMGEEIPTIENKVSRSAKTKYKSECLIDSYLFKYAKTPNEFIAFLGFLKTH
NFQQYIKFSILLFSHPLIIFDWEFKRALCHSKIREVLPQGGYAMNLLDKLKAILQL
>SEQF1602_00560 hypothetical protein
MNIDKIIEKLGGIVPLYPKKQTCPNEDYWAKVEKLVGEQIPIVYKNFATKYGVSTPNNLL
KAVPFTEEAEYQHPESVGIPNYTFLETSINVFFGKGTDYDLVKTLKEFKNRMPAKFLPIA
DSGVEPNCYLIKFKRLWKSIFLV
>SEQF1602_00561 hypothetical protein
MLHENPKKINGIKTLPQEGYAMNLLDKLKAVFPF
>SEQF1602_00562 hypothetical protein
MRTIRKKNKCHRIRIYPKIWLNINFGEEIFRLLKGEVMLDKTPYSDETLVPIENPTIEGD
IFSYQVGKTLYKMDCSTMEGAIDLALLVEKLKNETKIIENSIDEYFEITLEEKNLSFSIG
DFNRMILIDYNKYRNQFTERFPEPTKRYTMGDYYVENGIIYI
>SEQF1602_00563 hypothetical protein
MYYPRLIDSYLKEWALRPARKPLLLRGARQVGKSTAVRELGKQFENFVEINLEKQPSFIQ
LFQGDLDVKRIVPQLSAMVGKPIVAGQTLLFIDEIQAAGEAIMALRFFKEDMPDLHVIAA
GSLLEFALETLPTFGVGRIHSMFVYPMTFDEFLRACGETLLLEARNSATAEAPLPLPLYE
KLVGLFRSYMLVGGMPEVVAKWVATRDYLACQEVQDDIVLTYQDDFPKYRKRVDPTLLRF
TLQSVALQIGSKFVYSQVGGGGYHSNEVKKALELLILAGIITPVTHTDANGLPLGSEANP
TYRKMLLLDSGLLLRWLDMTGDITELTTQILTQNPTDLVNKGALTEMIAGLELLRYRTPN
MRHELFYWVRRAKNAQAEVDYLIPYESAVLPIEVKAGTQGGMKSLWQFMREKKLKNAIRA
SLENFGTFTYTDTEEGAERTVRVCPLFALSQIAQ
>SEQF1602_00564 Cbb3-type cytochrome c oxidase subunit CcoP
MRNLLALIRILIIVGFAALLLEYIYGTEEASAIVSMVPIQAFLGFLTLILIAIEMIRYRS
EDILDRLLTDSQKQQRELAEQNSWWGRFVAKMLDQKPLEKESEIILDHNYDGIQELDNNL
PPWWTYLFYACIIFAVVYLFKYEVFGGLSQKAEYEQEITDAQHAIEAFKKANPGMIDADS
VTELTDAASLQEGKSIFQANCIMCHAPDGGGGIGPNLTDDHWILGGDIKNVFHTISEGGR
EGKGMVAWKATLTAKQRQQVASYVLSLQGSSPASPKAPEGDIIWKK
>SEQF1602_00565 hypothetical protein
MMKFIKHHMASIEGVSLYPIISLIICFTFFIVLFWWVLSYKKKDLNEISNLPFNDDDQNN
NIL
>SEQF1602_00566 Cbb3-type cytochrome c oxidase subunit CcoN1
MEMEQFYYDNKIVKNFLYATLFWGVIGMSVGLLLAYYFLFPTLTEGISWLSFGRLRPLHT
NAVIFAFVGNAIFAGSYYSMQRLLKARMYSDFLSKLNFWGWQLIILGAAITFPMGISTSK
EYAELEWPFDIAIAIVWVAWGANMIGTLIKRRQRHIYVAIWFYLATFVAVALLHIFNNLE
FPIALTSMKSYSVYAGVQDALVQWWYGHNAVAFFLTTPFLGLMYYFVPKAANRPVYSYRL
SIIHFWSLIFIYMWAGPHHLLYTALPEWAQNLGVVFSVMLIAPSWGGMINGLLTLRGAWD
KVRTEPVLKFLVVAITGYGMATFEGPTLALKNVNAIAHFTDWIIAHVHVGALAWNGFLTF
GMIYYLVPKMWKTNLYSIRLANAHFWIGTLGIVFYTIPLYIAGFTQASMWKQFYPDGNLV
YGNFLDTVNAIMPMYAMRAIGGSLYITGAIMAIINVIQTIRQGQKVTDELAEAPALAPIS
KKRVAGETLHHWLERKPVQMTIWATIAVAIGGAVQIIPTLLVKENIPTIAEVKPYTPLEL
EGRDLYIREGCVGCHTQMVRPFRSEVERYGEYSKAGEFVYDRPFLWGSKRTGPDLHRLGG
KYNNNWHFNHMLDPRETSPGSIMPSYPWLIKNELNTDRLLQKMRTLSKLGVPYNEDDFKF
AQENLAVQARAIANSLLNDPNFVANYEASKKNAEVRGEKFIPIEKREIVAMIAYLQRLGV
DIKAKKENAEK
>SEQF1602_00567 hypothetical protein
MLISISTIVVGLFLFLYLRAIHKGQYDDVESPAIRMLFEDELVESSPKENTLEKTHTSYH
KKDTEKQTTT
>SEQF1602_00568 hypothetical protein
MAIPVYCMPGMAASSRIFEHLEWPEGYQVHLLEWDEPRPKEGLLDYAARIAQQITAHNPI
LIGVSLGGVLMQEVARLLPSYRCVVLISSVASPKELPSWMRRCKKLKLHHILPLARMIRF
DFWKHTKRYKKLYIHYIGLSSPTYLAWCARELLDWEGKPLDKDKIIHIHGDKDLVFPIRY
IGDCIRVKGGTHIMIVNRFRWFREHFLPIINSKISPTEEPTHTPM
>SEQF1602_00569 hypothetical protein
MYRICILSLLLFACKGNNTPENTPTEEPVTEQREQTAQAPKEQDSRQGILYNGILPTSNG
KNVDTTVILGENNTYTKTERYIEDGHSQSEKGRFQWNGEDKTIVLIGENGSKATYRVDAQ
VLILLPDPNKKMSPAEEERYTLHQK
>SEQF1602_00570 Dodecaprenyl-phosphate galacturonate synthase
MQISVVIPLFNEEESLPELHQWIQKVMAKEQFSYEIIFVDDGSTDHSWEVIQNICASDRH
VKALRFLRNYGKSQALNAGFARAEGKVVITMDADLQDSPDEIPALYQMIEKEHYDLVSGW
KKKRYDHKLTKNLPSKLFNWAARKVSGLTLHDFNCGLKAYRKEVIKTVDVRGEMHRYIPV
LAKSAGFDRITEKVVQHQARKYGSTKFGIERFINGFLDLLTIGFLSKFGKRPMHLFGALG
VLMFFIGFCLAFYLGVDKLFIDPTGRLITNRPQFFLSLTAMIIGTQFFLAGFLAELVLRS
RESEPRYHIKETIN
>SEQF1602_00571 hypothetical protein
MKKHRNLMLKYGSMMGGVSIALTLLQHQLQAYNGASLTIFAFGILPILFLTFFIFLGIYL
SKERSFRQMIKIGLGISILFAIIAGVFWVIFIQYIDPNHLDMVNHLQLEAYQKQFPSADP
QSIAQMQQDMERNKLPWIQFNLSVVSNMFFGLVISLLGSSFFKILNRT
>SEQF1602_00572 hypothetical protein
MKITSPTVSVALPIATVYEKLENVSLFQRLMPENLAQFSSSEDNTSFSFSLKGMPEIFLE
KKKLTPTSELVYGAPEGKLPFTLSIALTSTSAQHSEVVYTFEGEFNPMLALVVKSPITKL
LQTMAEKTKTL
>SEQF1602_00573 Orotate phosphoribosyltransferase
MKISATIAKDIAGTLLDIHAIKLSPKAPFTWASGWKSPIYCDNRMLLSYPEARNKVALAM
SEFIKEKYPQVQLIAGVATGAIGIGMLVADRLGLPFVYVRPEPKKHGRGNQIEGSFNPED
KVVVIEDLISTGMSSIGAVRALKAHQVEVLGMVAIFSYLFDIAQENFSQENITLDTLSQY
DALLEEAKDRDYISQQEIETLAKWRLAPDKWN
>SEQF1602_00574 Translation initiation factor IF-2
MAEDKRLNKAAKEYNISTDRVVEFLKSKGHTIEDVNPNTKIPADLIVLLDKEFGSDKKSR
ETSKEITEEQRKEKEAIKQELLEKERKEKERLQKEQEIIRAKASVPGAKIVGKIDLDQPK
KEAPEETLAPSAEEPAPIASTKEKNSQVKVEQSAHEEHPDKHEKNKDKHNHKDKKDSKEP
ISKQEKDFKKKSQELLSGKPVPSSKDAAKKEEKKPQTEPEPGVIETKYTKLTGPKLVGEK
IDLSQFERPKKKKNGKDKNKDGAALDKQAKRKRKRISSEKENPANPNAQKNGNNNAVNNN
KDKNKKKKENKIFVKAEPTEEEVQKQVRETLEKLQGKSIKSKGAKYRKEKRDSHRHKTEE
EQALQEKESTILRVTEFVTVNELSTMMDVPVNKVIGACMSLGIFVTMNQRLDAETLSIVA
DEFGYQIEFSTADIDEAIPVEEDRPEDLVPRAPIVTVMGHVDHGKTSLLDHIRNENVIAG
ESGGITQHIGAYSVTLKRSKQRITFLDTPGHEAFTAMRARGAQVTDIAIIVIAADDDIMP
QTKEAISHAQAANVPIIFAINKIDKPTANPEKIKEHLANMNLLVEDWGGKIQSQDISAKQ
GIGVSDLLDKVLLEAEILELKANPKKHALGTVVEAALDKGRGYVSTVLVQEGTLRVGDYL
LAGTHSGKIRAMHDERGRSVKEAIPSTPVTILGLDGAPQAGDKFYVFEDEKEAKQIAAKR
TQLLREQSVRTQRHITLDEIGRRIALGDFKELNIILKGDVDGSVEALTDSFQKLSTEEIQ
VSIIHKGVGAITESDVLLASASNAIIVGFNVRPMSNARALAEKEEIDIRTYSIIYDAIND
LKSAMEGMLSPEMREEVTGTVEIRELFKISKVGTIAGCMVTDGKIYRNSKIRLLRENVVI
YTGELSSLKRFKDDVKEVSKGYDCGLQIKNYNDIKEGDVIEAFQEVAVKKKL
>SEQF1602_00575 Transcription termination/antitermination protein NusA
MENNLDLIESFSEFRDDKLIDREALMSILDEVFKTALKKKYGSDENFDIIINPDKGDIEI
WRNRIIVDDGMVENPNAEIPLSEALKIESDFEVGEEVSEEVKISQLGRRAILALRQNLIS
KVHEYDNNTVYKKFKELIGTIYTAEIHHIKGKTVILLDDEGNEILLPRDKQIPSDFFKKG
ETTKGIIESVDFKGNKPSIILSRTSPVFLERLFEQEIPEIADGLITIQKVARIPGEKAKI
AVDTYDDRIDPVGACVGVNGARIRSIVRELGNENIDVISYSSNTNLFISKALAPAKITSI
TVNEETKRAEVLLASEEVSKAIGKGGSNIRLASLLTGYEIDVFREGAEEDVELSEFEDDI
EPWVIEEFRRIGLDTAKSVLEYSAEELEKRIDLERETIEEVLRVLREEFEN
>SEQF1602_00576 Ribosome maturation factor RimP
MNLKEKVKELIDKHLEENPSLFLIEYSIGKDNLIKVIVDGDHGVNIDDCVALSRAIEHNL
DREEEDFSLEVSSSGIFAPLTQERQYTKNIGREVEVKTATATHIGVIQEVSDGKVTLQVT
SRQPKPQGKGKITVTEQFSLPIEEIKEATLKIKF
>SEQF1602_00577 hypothetical protein
MPPEYVIIIDRRATGYDISVDHFVRDYYFNSNGKFLRVNDTIVPSDYHIYKWFYIDNKRI
ELECIKIINGYLEGIYTINPDMPLKEIYYKKSKMAGKYIVYNTDRQILYQTYFTNGNGYW
KDYYYKEGKIREEGKVVNHYKYGEWKYYNENGKIDSIKAYQLSDSIDVRFPHCLFNKNEP
CY
>SEQF1602_00578 hypothetical protein
MKLLLISLFLIGTVSSCKNVVNNNTEKDPQNELLSIESDTISDTISNAQEHCDFEDFIKE
EIGYLNGGFGNKGRLDLGNIDISSMLSKPSFPYGVIPYIGFIDIKIKRRLEINFLKIEKS
TTNDSLYIAKGKTKVGKNVRLFEGDIKIKHVYFFAEHSKGLEDDMVGKIKSQGIIIADYY
FREDEKLSATGVFEGKVLLRWYINNKGVFLFDDIEEYSDDYRNNQFVGTWTSYKTGVKKV
ANWGICRIPCSGDLDWGAAEFSPAPEYRKYGWEDY
>SEQF1602_00579 hypothetical protein
MKHIIITLLLFGLTFSVKAQVYLGETDSIIVKRYYYRDKELSEIGSHDRDIFEELSSKKL
THKQEKILRQKLKQKKSFYHQRALLNHFNISVLIYKDGAKVFKINYSSLTNNLTIYKRVD
EDDYEYDYIYKGQATPYLYRLLNKL
>SEQF1602_00580 Thiol-disulfide oxidoreductase ResA
MNKILYIVALSALWVGCQNTAPAGNASTSGDTSEKISIGDHYIIDGTAPVKEGARIFLYQ
YKDRVYTPVDSVALDSQGRFHFEGKTAEPLVYALRLNGSGKRAHLYIENSPISLILNPDW
NFEFLRSSDGTQVFELYNRMALNNALDLPKEIKEAPASPQLAYFLARNAYRYDFPTLSAL
RKSLDKSLDNNPYIKELDLALEQLSKIQPGAEAPEIDLVDAQGKKVSLKDFRGKKLLVDF
WASWCPDCRKASPELVALYKEQKDKGLEILSISLDEDTAAWQAAIAKDQYTWPQALAKGV
WQSDAALTYALRWIPTYMLLDKDGKILSRGIQLSSVISNQ
>SEQF1602_00581 hypothetical protein
MKKIALLLTFILIGMTQAVAQNFGFKGGYNYSSLNGEVANDSSLKGRSGFYVGALLELPL
GDVISLQPELVYSRQGASWEYKTLGTTTTKDLKMDYLNIPVMAKVNLGPLFLQGGVQFGF
LVGKPEVSYTVGNLSNSQKLDKDAYAAFDFGVGAGLGINFNSHFFAEARYTHSLTNSFDN
SNTSLRNARISDTNNFKNAVLSLGVGVKF
>SEQF1602_00582 hypothetical protein
MKKIMTCLAAMAALVGCSKSDDNGGGISISEGTFPKKIVHKAENGNISYEITNNVQGEKV
LSTTSISYKRDGSIESKILISFSYEGDYPKEATYKRSKTNGENENYTETYSFVDGKLKNT
TLKHDTNPRATTTTTYSYHNDGKLAKVLVEEPRKSSLNGQIVEDIYVTETDYTHTGNVIT
ATEKRYFKDTQGNKRDENTSLTTYTYTFENENLIKVTESTTDDESTTEYIYDEKNNPLFQ
NFKKLIDPDYFNDAKNSKNNILTRKITTKYNYNNSTIVKEYVYEYTYADNNYPLTEKVFD
KTTENGVEKKELDETTEYAY
>SEQF1602_00583 hypothetical protein
MKKIMASLVAIAALVGCSKSDDNGGGISISEGTFPKKIVNKGSSGNVTYETIYNLQGGKI
LSTTSISYKPDGSIESKSLISASYEGDYPKEITHTESRSNGEEKNYTETYSFVDGKLKTT
IKKYDNSDRATTTTYSYHNDGKLAKVLFEEPGNAGENGQIEKITFVTETDYTHIGNVTSA
AEKRYTKDAQGNKRDGNTSLTTYTYTFENDNLIKVTESTTDHESTREYTYDGKNNPNLQN
FIKLVKPDYFISASGSKNNILTEKTTYKGSHNASPYVSEYVYEYTYADNNYPLTEKIFRK
TTENGVEKKELVLTKEYTY
>SEQF1602_00584 hypothetical protein
MKKIMASLVAIAALVGCSKSDDNGGGISISEGTYPKKVVNKFGSGSLISETTYNLQGGKI
LSSSYTSYGLGGSVESKILRSISYEGDYPKEVTYTKSRSNGEKENFTETHSFVDGKLKTT
TRKYGTAHRATTTYSYHSDGKLAKVLVESPGYAGQNGQTEEITFVRETDYTHTGNVISAA
EKKYTKDAQGNKRDGDTSLKTYTYTFENENLIKKTEITTNHEYTTEYTYDGKNNPYLQNS
SKLVKPDYFISTEGSKNNVLTRKETRKDNNDSPYVSEHVYEYTYADNNYPLTQKIFYKKT
ENGVEKKDLIEIFEYTY
>SEQF1602_00585 putative metal-dependent hydrolase TatD
MNSNPLFPYPNIHTHKARHSQEVQNCFPEDTYEQGVFSVGIHPCYIKGEGREQWEQVVAR
ATHPLCVAIGECGLDKRASSPLVLQEEIFRWHISLAQELQKPLIIHCVKSYGEIIRLRKE
TGATGLWILHGFRKSEALAHQLLASGIKLSFGTALERDPRLQHLVQTLPREDYFFETDED
NE
>SEQF1602_00586 Regulatory protein RecX
MSDTVKTYTVQEATARMERFCAYQERCHKEVVAKLRQMRMIPEAIDLILTHLIEDNYLNE
ERFARSFARGKFRFKKWGRVRITRELKLRAISRYNIACAMEEIEENYDEVFDTLAQKKAD
TISEKNIQKARRKLADYLLYKGWESARVYAKAVELFPYE
>SEQF1602_00587 hypothetical protein
MYTLLRTTHSLTAYIVLAVLCFAVVNALLGVLQKRKYTKADLRINLFALIFAHLQVTLGL
ILYFVTPLFQSWSAMGAGVMKDAYLRKMLVEHPFGLVAVALITIGWSLHKKQKTDTGAFK
RILVFYALGLLLILGVLPWKTWMSAF
>SEQF1602_00588 Ribonuclease Z
MKLTTLGCHSASPRDKARTTAQLLEMRGHLFLIDCGEGTQMALRQSSAKFARIKHIFISH
LHGDHFYGLAGLISTFQLQGREAELHIYAPKGAKEAMLLLLKVSGAHMVFPLYFHELEGK
ESQLIFEDDKVAVTTIPLDHRIYANGFLFKEKNKERKLNVDAVQQYGIDVCYYQNIKNGK
DILLDSGECIPNELLSFPPAPPESYAFCSDTIYRPEIVPLIKGVQVLYHESTFLEDNRAL
AEKTKHSTALQAAQIAQAAGAQTLILGHYSSRYKDKRVFQEEAQTLFPNTLLSEDGKEFN
FNDQ
>SEQF1602_00589 Biotin synthase
MNEIRHNWTAQEIIDIYNRPLMDLLYEAATVHRQYHDPNTVQVSTLLSVKTGGCSEDCCY
CSQSARYHTEVEIEPMMSLSQVKAQALRAKASGSSRVCMGAAWRNVKDGPEFEQVLEMVR
TINKLDMEVCCTLGMLTENQAKRLSEAGLYAYNHNLDTSEDYYSEIVTTRSYEDRLKTIE
NVRKTSITICSGGIIGMGESLEDRAKMLVALSTLDPQPESVPINALVPIEGTPLEELPPV
DIWEMVRMIATARIVMPQSQVRLSAGRMNMSREGQALCFFAGANSIFAGDKLLTTPNPDI
KEDMHMLEALGMRTQKPFEKHPQPVTVEAADSQIPALGEKPKWSRPNKVNSEK
>SEQF1602_00591 hypothetical protein
MKWFLLLLSTALYANDGAFFGSGNHLVPIRETDISVQKEILYLKKIQNKYIEVSVYYEFF
NPKEDKEIIVGFEAESPSGDVDGAPKNGHHPYMFDFTVNLNNAFLPYQIAYVTDSLYAKG
GKIQSVDLNTFNGNKDGNYIDFRYVYHFKAKFKKGVNILKHTYKYNISGGVAYNYHFDYI
LTAANRWANKRIDDFTLIIDMGDFQTASIERTFFKSGREWLLSGVGKITETALKTPGDGT
DLNTTNFYVQQGLLLFQKKNFTPKGELHICDWALWMHQSAGFPIDYPFTIDLPNFKYETE
PKTEEEKRLLRNLPFARRGYIFKDKTLQAFFNKQDWYQPNPSYIPEVEYLTPKEKELINS
LK
>SEQF1602_00592 hypothetical protein
MKKEILISSDSNYDNLVAEIYIDDKYIALVSYDEDHNFFVETPTTNRSNEEIITHKVEYN
TFIELLGEAKNSLK
>SEQF1602_00593 hypothetical protein
MVKIEKITRGEITISYKGQYYHILGEGLLLTKDNTYSYIIYRNSIDNTLSSVEQETILQA
IIEHFSSKGQKVLIE
>SEQF1602_00594 hypothetical protein
MNHHLENYYSGDWAWNQFVSLYEEFDTSNSLTKELLQQLNYHRDIAQVIWGKFGSSSLSV
ITQPVPALDNLSITDCIAAPNLLQRLKECLMRME
>SEQF1602_00595 Quaternary ammonium compound-resistance protein SugE
MYWILLIIAGLFEVAFTFCLGKGKETQGTTMYLWYGGFLLCTFVSMSLLMKVSQHLPLGT
AYAVWTGIGAVGTALVGIFVFKEPASFWRLFFLSTLIGSVVGLKAVSS
>SEQF1602_00596 hypothetical protein
MKKIVFIASMLCFLSEAMAQIKLPQPSVRGSIEQVVGLTEVEVDYTRPAKRGRKIFGELV
PYGRVWRTGANENTTISFSEDVMITGKVLPKGKYALYTKPEMDKWTFYFYKKNDNWGLPQ
PWEESQIALQAEGKPIPYPMETEYLTIELNPINYNDGKIAIRWDKTLVELPFHTHTQEQS
MDNIADKITAESSARDYYEAANYLLNANGDLSKANEFITKSLSMQEDAPYYMYRAQAIIL
SKLGKTKEAIKAAETSLQKAKKAGNEDYVKMNQDSISQWKKKR
>SEQF1602_00597 Protein YceI
MKTHLFQQLFIGFSLFFATVVTNPLWGQTQTKSFITFSIKKGFLTIKGEFKNYVHDIHLD
RKIFGRVRVASVDTGNKKRDAHLQSEEWFDAATYPYIEMQSTKITGVSERKYLGTFDIKI
KGKTLSKEISFTTEGNVFKMDFELSRKSFGVGSGFLGAIVGDNVKISIHLPIFGYIEAE
>SEQF1602_00598 hypothetical protein
MKHKPTTIRLSFCIYGDYFDVDKVTDIIGLSPTQTAYRGDQLKYRVSEETFWEYNFAPLE
TLLIEDNLQVFAAQVTPCLEELASFIKAFALTSKLLFCVEMSPEESCPAIVFDNKILELL
HRLNAWIDIDMYK
>SEQF1602_00599 hypothetical protein
MKHFIIFFVTLLLAGCNLFQGQQPGEESVAVEEKQQQEEAFVPVQKELYVIDKEEREDNY
LFGEKIKISAEGNEFYKTDRGDYIKKKDVGDWNTLKTKITGDDLTKNVDINGNSNDSISK
YLSIDQISYEEYQEALRNKIDFLIEDTLAIVKKNGKLTFPCEHKTVYLKDQSDSIEDPFS
TTYAYVGNIPILNQYLVFEDSEDFYAYIFIDKTTGKKTDFERFPFLSPDKKYIITIGRAY
EDLVGIISLYRIKSIKPFVIETLVNEDTKWWAAYDFDKEPIFFSKNGFLYAPMNVIPNFF
DEHNNPNKQRMYIKIGIKRQ
>SEQF1602_00600 DNA gyrase subunit A
MEEHPIPPQASQGEPQETITRISGMYQNWFLDYASYVILERAVPALEDGFKPVQRRIMHS
MDELEDGRYNKVANIVGNTMKYHPHGDASIGDAIIQLGQKELLIDTQGSWGNILTGDDAA
APRYIEARLSKFALDVLFSPKVTQWQKSYDGRNDEPVHLPVKFPLLLAQGAEGIAVGLST
KILPHNFNELIDASVLYLEGKPFELYPDFPTAGIMDATGYSDGMRGGRIRVRARIAQRDK
STLVITEIPFGTTTSSLIDSILKANEKGKIKVLKVDDNTAANVEILVHLPKGISPDKTID
ALYAFTDCETSVSPLCCVIEGSRPLFIGVSDILKKSTDRTVEILKKELEVKLDDLEQKWH
NASLEKIFIREEMYIDFKNYSDKESLYAYLYKRFEPFAEQLLRPITDEDLERLTQIPMIR
ITRYDTYKAEENLLKIEENIAEVKDHLANLIAFAIDYFRNLQKKYGKGKDRKTEIRPFDT
IEATKVVVRNLKLYVNREEGFVGTSLKKDEYVADCSDIDDIIVFTADGKMIITKVTEKSY
IGKNIVHVGVFKKNDTRTVYNLVYRNGNDKISYIKRFTVTGIIRDKEYDVVEPHKDSQVL
YFSANPNGEAEVISVILRQAGSVKKLKWDINFADILIKGRSSRGNIVTKYAIKRIELKEK
GVSTLKPRKIWYDPIVHRLNTEGRGELLGSFKGEDRLLLISKDAIVKTVIPDLSLHFDPN
LLIIEKWNPEKPISVIHYEGEKERYFIKRFLVENPNREELVISDHPKSQLLFVSTQWRPM
AEVIFTKTGRERAENQTVNIEEFIAIKGIKAIGNQLSTERIKEIVPLEPLPYEESQEEET
ATEEEETSAPEMIQPDLFSGLDQ
>SEQF1602_00601 Outer membrane protein assembly factor BamA
MEKPVNNLVSMRRTFIYIFGILFLHTAYGQQEETHQATTVRDTLQSVAVIDTLSQEQNLT
ALERGRDFVIGGIEVKGAKHYNAQTIIVASGLKVGDRITIPSERFTRIIHKLWNYQVFND
IDIYIAKTEGDKVFLEFVIQEIPELTEVKVEGIRKRKAEELLKKLELDKTHLESRKKVNE
SLIAKTKSYITDKYRKEGYLNTKVHITTSPADSLGTKERMLIRIDRGNKVKINSISFEGN
EKFADSKLRRKMKKTKQRFFGRFWKRSKYVQDKYNEDLASLIDFYKENGYRDARITHDTL
YDGKENINLKISLQEGKKYYFGDIKFLGNSVYSNQMLDHILGLKKGEVYNGVQLRNRIND
PKDPDANSISNLYQNTGYLFSQINPVETSVVNDTINFEIRIHEGKPAHFNNITVTGNTTT
NDKVIYRELRTRPGYLYSKEDVIRTVRELSQLGIFDAQSINPQIKNPDPNSGTVDLEYVL
NDTSSSSQIQLQGGYGGGGFMGTLGLNFNNFSIQNIFDKKSYKPLPMGDAQKLALNVSVG
RAYRVASFSFMEPWMGGERPVQFSIGFNYSVSYDYNYYTYDVDKSKRFYITGVTLGLAKR
LRVPDDYFQLAQYVSYNYYDLRNYNTTLFTFGNGHSNALAYTVSLSRRSSGPNPIFPLGG
SDFTITAKLTPPYSLFNGVDYKSLMEQRAVAEANKNTNRIGEIDQERFKWLEYYKLRLQG
NWYLNLVDKLVLRPAVDFGYLGYYNRDRGTVPFERFLVGGDGMSYNSLEGREYIQMRGYP
NQSLSSRDGDVIYNKFSLELRYPITLKPMASIYGLVFAEGANSFGSFSQYNPFDIKRSAG
FGVRIFMPMLGLLGFDFGYGYDGINGKTTPHGWETHFIFGQQF
>SEQF1602_00602 Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)
MDIESKMLPRHLAIIMDGNGRWAKQRGKQRILGHEKGAKTVREIIQEVTQLGIPYLTLYT
FSTENWKRPKLEVEALMHLLSRYLKKEVEIMQQNNVRLNAIGDLESLPSKIQKELHKAME
ATKGNTKTVVSLALGYGGQQEILQMVQHIARKVQQGELSLDEITAERVQAALYTKEIPPV
DLLIRTSGECRISNFLLWQIAYAELYFTDVLWPDFSSEELHKALFNYQNRERRFGKTSEQ
LS
>SEQF1602_00603 hypothetical protein
MHKYFLWLILTCCAITKGWGQYNEIGVFFGGVNPIADIGSTYYVFPTKPAIGLLYKRNIR
KQLSLRADIKWFDLWDSDRRATTDARRNRDFAFQNRMVEMGAGVEYDFLHFDTHEPFKLL
FTPYVHTGFYYFKMDRLYFDDITTPSQHAKYQTYPERDESWAIPFTLGVKTRLWGSRFLV
GAEVSMRYTFTNNLDGSKSGKGVHFGNLNTNDWYMVSGLYLTYTFGAKKCNCFEFAK
>SEQF1602_00604 hypothetical protein
MKYIVNLIITSILILGLSKVLPHIQVRDFSDALLFALVVGVLNIFLKPILIVLSLPITMI
TFGLFLIIINTIIIILADRLIEGIHIEGFWYAVLFSLCLSAVQSLLQGNNQ
>SEQF1602_00605 Esterase YbfF
MELINSQIVGEGKPLIILHGFLGMGDNWRTHSLHFAEKGYQVHVIDARNHGHSFHSPEFS
YALMMEDLIRYMDYHQIASAPLIGHSMGGKTTMLLAVTYPERAERIVVVDMSPKYYPVHH
KVILDALSTLDFSQIKTREQADQQLGKFIIDVPIRQFLLKNVYRKTADQLALRINLPVLR
ERVAEIGTALPVGTIYQGKTLFLIGGKSHYVLPEDMPLIMQHFPKAEAVTIPDAGHWVQV
EKPKEFFEITYQFLQK
>SEQF1602_00606 Pyridoxine 5'-phosphate synthase
MTKLSVNINKIATLRNSRGGNVPNLLQVATDLQDFGAEGITIHPRPDERHIRYQDALDLK
EIVHTEYNIEGNPIPKFVDLVLKVKPTQVTLVPDAEDAITSNAGWDTLTHGAYLTEIVAE
FKRHGIRTSLFVDPVERMVEAAAKTGTDRVELYTEAYAREYARGNKEGIRPYVQAAEVAQ
KVGLGLNAGHDLSLDNLQYFKEQIPGLLEVSIGHALISEALYLGLQNVVSMYLYRLK
>SEQF1602_00607 hypothetical protein
MYLCHENSIQMIQDIITYVLVALAIVFLVKKFFFTKKKKCGGGPDCKCGG
>SEQF1602_00608 Serine acetyltransferase
MEYRLTELILAQRNNITNTLPKKKAEDFIDGLYRLLFSLDTEPCQCSYEVEQKLKAKQLE
FSEIIYDYFRDNQRAQQATTTFFSSIEEVYCRLLRDAQAILDNDPAAQNLEEVYIAYPGF
YAIVVHRFAHQLWLQDLKLLARVWSEFAHSKTGIDIHPGAQIGDNFCIDHGTGIVIGETC
VIGNNVKIYQGVTLGALSVAKDKKDTVRHPNIGDNVVIYSGATILGSGHIGHDSTIGGNV
WLTEGIDPYTVIYYKSEMITKGKNLSPEPIFFHI
>SEQF1602_00609 Cysteine synthase
MKYNNILGAIGNTPVIRLAKLFPSHQVWIKLEKSNPGGSIKDRIALAMIEQAEKQGLINK
DTTIIEPTSGNTGVGLALVAAVKGYKLILVMPESMSVERRKLVSAYGASFVLTPKEKGTG
GAVEKAKELAASIPNSWVPQQFENPANPEIHRLTTAQEIVSDFPEGVDYFISGIGTGGHL
SGIGEILKAKFPQTKVFGIEPATSAVLSGNKPGPHPLQGIGTGFIPKTLNTSIYDGIITI
DKDEAYDYTRRLARTEGILAGISTGTSLAAIAKKLPEIKANEVVLTVNYDSGDRYWSVAD
LFEENPN
>SEQF1602_00610 D-aminoacyl-tRNA deacylase
MRLLIQRVKEAQVAIGGRIHSQISQGLLLLLGIEESDSQEDIDFLCKKTTQIRLFNDDNG
VMNLSVQEAGGALMVVSQFTLYAQTKKGNRPSYIRAARPERAIPLYEQFVHTLQQLSGKE
IATGVFGADMQVSLCNDGPVTIFIDSKMRDF
>SEQF1602_00611 Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
MSWFKRKTKGIQTATEEKKDIPQGLWYKSPTGKIVETEELAQNCYISPEDGYHVRIGSKE
YFEILFDGKFSELDKTMKSKDPLDFEDTKRYKDRLKEAQKKTDLYDAVRCAVGESKGREI
VIACMDFDFIGGSMGSVVGEKIARGIDYAIKNRLPFMMISKSGGARMMEAAFSLMQMAKT
SAKLAQLDDAGLPYISLCTDPTTGGVTASFAMLGDINIAEPGALIGFAGPRVVKDTTGKD
LPEGFQTAEFVQEHGFLDFIVNRKELKDKVNLYIDLVMNLPVRA
>SEQF1602_00612 hypothetical protein
MSKVGNALAALLVGAAIGAGVGILFAPDEGKKTRKRIRKSLEGVSDNLRDRLTHLNEDLK
EKKLKFKGTLEENVEKLLSKSSYKAEELINALERKLEDLKKANAKFQK
>SEQF1602_00613 hypothetical protein
MALQQLKETAQTLPDEVQSTLNSHSEYYKLYIFRIIAKSTMGFVSLFVVALFVLIIAFFL
ACASAFALGEWLGSMALGFLIMGSVFLIILFVIYKWRKSFVHKPILGKLSEIYFKE
>SEQF1602_00614 hypothetical protein
MERKYTSLDEIEKDLHALKLKKDVDLMCLKTDYQTLVRNLSVSQLFSDSVSELTQAFVSK
QKSLLSLAAGFLLRRFFR
>SEQF1602_00616 hypothetical protein
MEECEKDNDWDFVNRYKNGVEFVYEIELDGISKQLPELNMAELARRIAVSPVMIRKYATG
KSKASEKRLLEIQNGIREIGKELSQITLL
>SEQF1602_00617 Chaperone protein ClpB 1
MNFDNYTIKSQEAIQRAQQLAQGLGQQDIQVEHIFKGIQEVDNNVLPFVLKKLQVNTATL
SQAVDKALASYPKVQGGQMSLSRAAGEVLLEASNIAKKRNDEYVSIEHLLLAIFKVKNQV
GQALKEQGVTEKEFEKVITELRKGERVTSASAEDTYNSLNKYAKNLTQLAHSGKLDPVIG
RDEEIRRVLQILSRRTKNNPMLVGEPGVGKTAIAEGLAHRIVNGDVPENLKDKTIYSLDM
GALIAGAKYKGEFEERLKSVVKEVTSSDGNIILFIDEIHTLVGAGGGEGAMDAANILKPA
LARGELRAIGATTLDEYQKYFEKDKALERRFQKVMVEEPDTESAISILRGIKEKYEAHHK
VRIKDEAIIAAVELSERYIPNRYLPDKAIDLMDEAAAKLRMEINSKPEELDVLDRKIMQL
EIEIEAIKRENDEEKLRMLNAEVGNLREERNALFTKWQGEKTLVDEIQAAKNNIENYKIE
AERAEREGNYGKVAELRYGKITQEEEKLEALQKEIDKHEMTMIKEEVTREDIAEVIAKWT
GVPVTKMMQGEREKLLHLEEELHKRVVGQEEAIAAVSDAIRRSRAGLQDPKKPIGSFLFL
GTTGVGKTELAKALAEYLFDDENAMTRIDMSEYQEKHAVSRLVGAPPGYVGYDEGGQLTE
AVRRRPYSVVLLDEIEKAHPDTFNILLQVLDEGRLTDNKGRTADFKNTIIIMTSNMGSHL
IQESFEKYKDTEEATEKAKEEVLQLLKQTVRPEFINRIDDIVMFTPLTQDNIKQIVRLQL
GGIIKLVARENITLEATNEAIDYLAKRGYDPQFGARPVKRVIQKEVMNALSKEILQGKIK
AGSLVLIDSFDNGLVFRNKTE
>SEQF1602_00618 ADP-ribosyl-[dinitrogen reductase] glycohydrolase
MLGSIIGDIVGSRYEFANIHTTDFELFTSHNSFTDDTICTIAIADALLHGKSFKDSLLYW
CRRYPSPMGSYGGRFGQWIRSENPQPYNSFGNGSAMRVSPCGWLGSMDQVLSFARESAEC
THNHPEGVKGAECVAYAIALALEGKNKEQIKEKVCWLYGYDLSMTCQELRRTYRFDETCQ
GTVPQAIICFLESHDFESALRLAVSIGGDSDTLAAITGGIAEAYYGIPKEIEQKALTYLP
EEFKDLIREFREKVIRRIKE
>SEQF1602_00620 hypothetical protein
MKCKLLKDFSLFYLMAFLLLVFIIFFIGFFLYGEEELSPTGIRYPVIWGICYAYQEVFYF
VQRYIPLFFPCAFLSVALLAFPLGTLFALIINGLLNKIDLEKK
>SEQF1602_00622 Calcium-transporting ATPase
MSEKHHYKGLTDAQVVESRRKYGENTFTAVEGEPLWKQFLEKFTDPIIIILLVALVFSFG
VSFYEYTVHDTGIHAFLEPVGILFAILLATGVAFYFEQKANKQFEILNQVNDDIYYKVIR
NERITQVLKKDIVVGDIVIIETGEEVPADGELLEAVSLHLNESTLTGEPLIHKSILPEDF
EAEATYPTNYVCRGTSVADGHGIFEVKKVGDATEYGKVFEGVQIDDSVKTPLNEQLDRLA
DLITKVSYGIAALVIVGRLIVYFADPTHSLDNLDWVSFGGYLLNTVMIAITVVVVAVPEG
LPMSVTLSLAYSMRSMMATNNLVRKMHACETMGATTVICTDKTGTLTQNQMTIYETYFNQ
FPDSSFADRLIAESMAVNSTAYLDFSDKEKPSVLGNPTEGALLLWLYGKGINYLPIREES
EVLQQLTFSTERKYMATLIYSPTLKKNILYVKGAPEIVMTFCQEGARLNSNLSQADFEAK
LLQYQNQAMRTIGFAYKEIDDPKAIISENGKLVVKGLHFIGVTAISDPVRADVPAAIEEC
MQAGIQVKIVTGDTPGTAKEIARQIRLWDESCTDRNHITGAEFATMSDADLLERVSDLRV
ISRARPLDKARLVNLLQQKGEVVAVTGDGTNDAPALKAAQVGLSMGDGTSVAKEASDITI
LDNSFSSIGKAVMWGRSLYLNIQRFILFQMTINVAACIIVLIGAFLGVESPLTVTQMLWV
NLIMDTFAALALASLPPSHRVMHDKPRPRKANIISSAMAKGIFGVGGFFVLLLFGFIQYF
KNEDITSLTQFSLGDYMSHFFHFGAPKGSLSAYELSLFFSIFVFLQFWNMFNAKAYRTGR
SAFHNIGKSQGFLMIAAAIVLGQVFITTFGGGMFSVTPLQLVDWAIIIGATSIVLWIGEI
RRSVAKGQ
>SEQF1602_00623 hypothetical protein
MPQESAFVRLLLALQDIPYGDFTHKLIPTLSRERIIGVRLPALRKAAKELTKQQPEEVAR
FLHTLPHYYYEENLLHGFLIEQMKTFDKAIAYTEAFLPHIDNWAVCDTFSPKLFQKHPKE
TYTHILQWLKSPQPYTIRYGIGLLLSNYLDDYFESEMLSLVASIQSDEYYVNMMIAWYFA
TALAKQYEATLPLIQSQTLSPFVQNKTIQKARESRRISQEVKDFLLQYKLPTTMNLWHIQ
LHPTGAADWTAEDTRRIVATGYIGCSGKAVQTFEKLLVGDLVLVRYGAQVVALAAVEDMP
RLLRDYEKHPLHWFTHGCRVKPLAYYDELKIGGRGWYLPTTLQQIKPENEIAYTFVNSLW
EKTNSRLLFSVDFNELMAHDLVLFSQKDARENVCGEPIPLYEGLKVNIYMDDGDEQNNRD
DLIASGYVTANTTEYYPYVKWCCRIDEKGIRCESEGN
>SEQF1602_00624 hypothetical protein
MLTEQELHNLAMNIVGEALQELGWEFLLVNSDRKKNPQFVCIDPQGQKSFIIVRPILQGD
DPDVYDPVLMEAVHRKAQEHKGDAYWAGVGLYDVANPLAPLEHGKSYQVDFRGLLKIE
>SEQF1602_00625 FAD:protein FMN transferase
MKYLYTLCIAVLVTACGTTPKENVYYIKGEAQGTTYSITYIAKAPVEKTAIDSILQVIDL
SMSTYIDNSLISRINRGENLPIDPHFEKVFSASFDIYWQSKGAFDPSIGQLINAWGFGKK
ENHTPPTQKQIDSLLALTGMDKVHYIDTPRGAFIKKDNPNIQLNFNAIAQGYTSDVIAEY
FLSKQISNFIVEVGGELVIHGRNTLKNKPWRIGIDNPLQKPDEDREIVATVELTDCGLAT
SGNYRKLWTDSLTGQKYVHTINPKTGRPQPSNLLSATVIAPSAMLADGYATTLMALGGIE
KAKDFLAQHKELKAVLLYSDEAHKGQIQKYVTENLTVEFESQTLSEN
>SEQF1602_00626 Protein YceI
MKKLLSIVALLVSVVAIGQTKKLHLKGSNLQWEAKKVVAGGHKGTLAFKSGELTYKNNEL
TGGTFVVDMNSLAVTDEGMDAKGKEKLIGHLKSDDFFYVKKFPTATLTLKQVTRTQQGYK
AKGDLTIKGITKPVEVELLRTAVEGYASTLVVNRTEFDIKYGSGSFFSNLGDKAIEDNFT
LYAFVIPEN
>SEQF1602_00627 Protein YceI
MRKIITILSIAAFLLSFTAEGQVKKKKNKAQTVQTDKKPSGAKNTSSLKGKKGKKTSKKM
IAHPIDTESSSIQWTGKKMIGASHQGVLSFKSGELVFSKEGKLKGGSLAVDMSSLRVLDL
TDNRRGKLEEHLKSGDFFSVKEYPLATLLIKQVTEINNKSYEIQADMTIKGTTKPIVFVL
IPAIAQRSFQTALTIDRTAYGVSFAAESFSDYLGDKAIDKFFSLNVTLIY
>SEQF1602_00628 DNA polymerase I
MKKLFLLDAYALIFRGYYAFIKNPRINSKGMNTSAIVGFMNSLLEVIRKEQPHLLAVCFD
KGGSQERSALFPEYKANREETPEAIRFAIPYIHQILHAMQIPVIEKEGYEADDIIGTLAK
QAEKQGYTVYMVTPDKDYGQLVSPNIFMYKPARGGKDTEIWGVEEVKENFQVENPEQVID
LLGMMGDAVDNIPGLPGVGEKTAQKLLKEFGSLENLLDNTDKLKGKLRENIEANKDKGIL
SKTLARIILDVPVTFDEKDFELSSPKMAEIEPLFEELEFRTMLTTLQKAFNVAPISTQPD
LFSLAGQPSPIAGTATPSLFDLAPSKKLQTIKDVPHEYQLLTTQDEVKALLPELLKQKEV
CFDTETTSLDEMEAQIVGLAFSWEVHKGYYILFPEDFSLAKEWLSLLKPFFEAENILKIG
QNLKYDLKILANYDIEVRGQLFDTMIAHYLLNPDMRHNMDLLAEAYLSYAPVAIETLIGK
KGKGQLSMCSVPAELQKEYAVEDTDVTLQLKHTFLPLLEKDKMTPLFTEVEAPLVRVLAQ
MEYEGIAVDTAFLSQLSKEINTDLIALQTAIFEQAGESFNLSSPKQLGDILFEKLKLLSK
PKKTKTGQYATSEEVLSELASQHPIVANVLEFRALQKLQSTYTDALPREVNPRTGRIHTT
FMQAVTATGRLSSNQPNLQNIPIRTPRGSQIRKAFVPRDENYTLLSADYSQIELRIIAAL
SEETHMIEAFLDGQDIHRSTAAKVFGVPLEAVTKEQRSHAKTVNFGIIYGVSAIGLSQQT
SLSRSQSKELIDTYYQTYPKLKTYIEQQIFFAREHGYVQTLLGRRRYLPDIHSRNQVVRG
AAERNAVNAPIQGSAADIIKIAMVRIAERLEKEKLATRMLLQVHDELLFDVPKRELEVVT
PLIREEMGHAYALSVPLIVEIGTGNNWLEAH
>SEQF1602_00629 hypothetical protein
MSHDEQPHPLLRMSLRQLWELFPIILSPFNPLWREWFEEEKSFLLKQLAHEKVLRISHIG
STAIGGIWAKPIIDILVEIPQEASLSQIKEKLLEAGYLCMNETSTRITLNKGYTLQGFAE
KVFHLHLRYGGDNDELYFRDYVQEHLLVARQYEALKISLWKPYEHDRDAYTAHKTDFIKK
YTQIAKKMYQGRYA
>SEQF1602_00630 hypothetical protein
MIVLQDFSFGNFRSFKEIQTLSLSKAPLTSTKDIALESTHTFKYKDSAFLKTKAIYGANA
SGKSNVIKALHAFIKIVSDSVKDNKVLLLMNSFISIETIYQAAFFQMIFYIDEVKYRYGF
EVQTGRITSEWLYGKKGKRELCYFIREGNTITEIDKTNFAEGVIYMNLTQQGGDTGEMLL
STNLFLTVLASFGFGKISKHITSNLSSINIISGLSNPAMMSYAKEALEDTTKKEFIISML
KKGDTSIDDLELREPEKSVDLEKQKKTQLLVSKRKYMGGLAHGVFSFEKYESEGTRKLFE
LSPYIYEALKEGRPLVIDEFDARFHPLLTKRIVQLFNSEENKQTQFIFVTHDTSLLSNNL
LRRDQIEFVEKDEEGASHLYSLAEINGVRAEASFEKDYIHGKYGAIPWVEDFSELVTNS
>SEQF1602_00631 hypothetical protein
MGKKTKAIKVTNQGKPWEKRKNSYQYEAIRRANKTILIVCEGQTEEWYFSKFPVISLSVR
CVNLQGQSKMNLVQATQEIVKNEDFIFDEVWCVFDMDVQNMDKDFTNFDNSIDKAKSLSY
NVAYSNDCFELWLLLHYKDIQSTQNREYYYEQLGKYFKMNYVKEGKRLDFCKRLYTLLQE
DNNSSELQAIARAEKLHLRQKDLPYHQQKPVTLVYQLVQLLNEYKRV
>SEQF1602_00632 Immunity protein RhsIB
MSTFNKTLSLLQDLIKQSGGKPIHFGNETYCFSRQSEVTPEQLTLFEQQYNVQLPEDFKN
FLLTLGACTLFEDERGFSYQFYHPEQWESYAKEVFEGTGVYLFPHILLVCYPTVGHQAGF
VLGEKDQFGIFYSDIPPEYWEEDTELVPFSQWLEEEIEMCKG
>SEQF1602_00633 hypothetical protein
MKIILKTLKYLAYSILGLVAFLLLYLLSAVILSRIEVNAKEVSTEEETIWVLSNGAHTDI
IMPVKNDLFDWQNIVSQQDTRGKGQSPYIALGWGCRKFYLETPTWADLKFTTAFQAVTGQ
GGTLMHATFYEEIPSSDMIAALSVSQAQYKKLAEHISQTFVLEEGKALLVPTDAVYGDTD
AFYEAKGHYQLFFTCNSWTNKMLKNSGIRACVWTPFAFDIIRNYQEKN
>SEQF1602_00634 hypothetical protein
MNISYFKQSFFILLLAALLFVGLRPYLPTRIFPEGNASSTNVVVDSLMLEALSGKDIEEV
LNENKDTLAHGKAPKHTTSDSLKGQTPQQYLQPFFEKLQHLETTGQGHVRIGYFGDSMTD
GDFIVQDLRALFQGAFGGNGVGFLPITSESAASRGSVHHTYSNNWKRESYVNVKRPTRPF
GVAGQVFFVKSPALTWVSYKASAQPHINQMYSPTLFFGQSGNTEAYVEIRHEGDTTHIVK
PLNASKRLNSLTLAKGNVKGVRVNFFKADSIPIYGINSASDGGVHVDNFSSRGNSGLPLS
LFNTALMQDFDTALGNYDLIVLHFGANVLNYGTLDYRWYEKGMTKVINQLRTCFPKASFL
IISTADKSSKYGMEMKTDNAVVPLSLAQESYAKQTHAGFINLYKLMGGEGSMLKWVGATP
PLAGKDYTHFNARGSKKVAQLLYKELMRKYLSFKHPKSSTEKIDELMQTSKDSLLHKDSI
LDFLDPKKKP
>SEQF1602_00635 putative protease YdcP
MTTTGKIELMAPAGSFESLQAALDNGADSVYFGVEQLNMRARSSINFTLDDLDEIARRCK
EKNVRTYLTLNTIIYDHDLSIIKTLLDRAKQAHITAVIAMDQAVIAYARQIGMEVHISTQ
INITNIETVKFYALFADTMVMSRELSLRQIKKICEQIEREQVKGPSGNLVEVEIFGHGAL
CMAVSGKCYLSLHSHNSSANRGACKQNCRKKYTVIDQESGFEIELDNEYMMSPKDLCTLD
FLDQVIDTGAKVLKIEGRGRAPEYVATVIRTYREAIDAYYEGTYTKEKVEKWMEALATVY
NRGFWGGYYLGQKLGEWSGVPGSQATQKKVYIGKAMHFFPKTNISEFKIEAFDIKRGDNL
LITGPTTGVQELILEDMYVNDQLSESAKKGDSCTFRTEFRTRPSDKLYKIVSNQ
>SEQF1602_00636 hypothetical protein
MSDEYSNKLTDDIVKYGFEVIMVPQTNYLPSFAYTVGLWKSYKHPELISLGLPIDTLHTM
LNTVVFEVIKKEKLIEIGRNYHDILEKYPVQFLAVDKRNIPDYFGQAISYYQTVDFPALQ
LIWPDDKGIFPYESDFREDLIYLQPLLDRNADFKFREDKLCPVFTTSAWLENQQPIVEVI
HDKEGHWFFLPSGEPDWKLVSLEELIKVDPTLNDIFDLDYGECANREFVGGRWKRDIYEE
>SEQF1602_00637 hypothetical protein
MPTNHSFGLFSGHMKHASIATLNEKIKVLCQENELTYIDLYKELVTPGSQLLDPAYTNDG
LHLVGAAYFKWRDFVLPFVKE
>SEQF1602_00638 Asp/Glu-specific dipeptidyl-peptidase
MKRFFKMALFLGVSALYGQQGGMWIPSLLEGMNAKEMKTLGMKMTVADIYSVNKSSLKDA
APHFNGGCSSEVISDKGLLLTNHHCGYGQIQAHSTLQNDYLANGFWAKSLAEELPNKNLK
VTFMVRIDDVTKQVLKGTESITDETEKAKLIEKNIAEVIKTAPKEAWQENSVKAFYDGNQ
YILFVTETFKDVRLVGAPPSSIGKFGSDTDNWVWPRHTGDFSLFRIYADKNNRPAEYSKD
NVPYKPKHFFPISLKGVKEGDFVLVFGYPGTTQEYLPSAAVAQIENVINPARIGIRDIVL
KVQDSYMRKDQGIKIKYAAKYARVANYWKKWMGETKGLKKSGAVALKQQQEAKFQQAIQK
ANKQAQYGNLLSDFNRLYKEIEPYTLAANLNSEFIFRNIDLLSNGSRLLQLEKALEDKGE
QSFNDRKKNLLNTFKEIFKDNDKQVDKDVFEKVVVFYAANMPKNLLINSLKNFDAKKLAD
NLYNNSFLTSLSGVESVLNLSAAEFKERMKNDVGIQFVRELKEMNDTQVFPVYDRLNTQI
HALQRTYMKAILEFSKPSDRIFPDANGTLRVTYGKVAGFSPADAVTYSAHTTLDGVMEKY
VPGDYEFDVPQHLRDLQAKKDFGRYGDKNGKMPLCFLSTCHTTGGNSGSPAIDANGNLIG
LNFDRVWEGTMSDIHYDPKLCRNIMVDIRYVLFVIDKYAGAGHLVNEMKLIK
>SEQF1602_00639 hypothetical protein
MTKKRFSGRSFYSNLSLMFSFVFIFAFLIAILAILFFIVGYLHKQNVPLWQYPIAFIYVL
WLLLFLFLSSFFGAEYTAAIDPADGESYTFISVQYWPTFLTYFLLYHIALGTLWVRRAKL
PPLPLVLCLCFLYIGIVVNIGIASQVSSGESGDFVLASFPLFSSLIAILVIGRTLMAVRE
ELSTKTFRNRWLNKLNTLLSSHFTVLTWSVLLIFPVFVLITLLLMLFGQDYDSVAKGFTE
TTTWAFSQKEHPPYLEHTGHYLCTVAACGSPRLVKPLRWGKRGGRPIIVNRQLQIANAFE
ELVADFSPALHRFLRTNYDKYGYDLSQKINTPFASNLTYLLMKPLEWFFLLCLYTFCLHP
EKKIEKQYRSSEQLSVSSEQ
>SEQF1602_00640 Esterase EstD
MKSFIFLFFICFGAFAQEGNYDSQQVVIDAEVQGTLLSPKGSAQPPLAILIAGSGPTDRD
GNQVQFKNNSLKYLAEGLAQKGIATFRYDKRVIAQIKNGTAQEEKMTFEDEVKDALLVVD
YFKKKYKNITLVGHSEGALIGLLVAQKGVISKFVSLSGAGSSSATLIEEQIAKNAPQLKE
ESQKVINQLRKGELVENLSSYLAPVFRKSVQPYLISWFKYEPTKEIAKLSIPILIVQGTN
DLQVESKQAQLLKEAQPKAQLLLIEGMNHVLKKVKTMEENQQSYLNPDLPVPTELVEGIA
SFIK
>SEQF1602_00641 Malate-2H(+)/Na(+)-lactate antiporter
MSSETKKASAIALLPLIIFVAVFLWSGIQYGSFYEFPAPIAVLIGIIAAFFIFRRNGIGG
NVAAFIKGAGNPSILMMCLIALFSGAFSVVTKQIGATDTFVQITKNYLSLQYLYAGVFVI
ASFLSFASGTSVGAIVSLAPIAAGFVSLPNVNVELIAGALLGGAMFGDNLSFISDTTIAA
TQSQGCEMKDKFRMNGKIALPASVLTVLILIVVGVLLHPSGHSLSQEEVSIQWMNLLPYI
AVIILAVAGLNVYVTFLIGTVLSGILGFWYGTFNLLSYSKTIFEGFASMNDIFLVFLFTG
GLAYLIEREGGISFLTQKIGKFITNKGRAATGIGFLVALIDAAVANNTVAIVISAPVAKK
ISEEYKISPIQTASILDISSCVVQGIIPYGAQVLLLIKLLGVDVNYSSMIAQSYYIWLLL
LCTIVFFLKGVKRVKNEESSQVNELGYVVKNKK
>SEQF1602_00642 hypothetical protein
MRKLLLGLLIGIGAAFLLQYFFKKEQDHSSLTEDSALIVQQINNVGKLVVTEGYFSEIMT
YQDAKKYFNNWVSFDKKALVVVNAEATISYDLHQLRYEIDEAHKVVRLTQIPPEELKIYP
KVQYYNIEESSFNPFTAEDHNKINKRVTDLISRKIEQSSLRSNAQNRLLTELSKIFILTH
TMGWKLEYTDIPIEKESDLALPLKK
>SEQF1602_00643 hypothetical protein
MNFTTKIPISPVAEDNQLSYATPVVSMGSCFAAHMQEKFAYYKLPFFSHPFGTLFHPLAI
ERSLERACLGRLFTEEDFFLEEDLWLSFDLHSQWANPSLPTLLEHLNQEVKQVGEALGKA
SFLILTLGTAWVYEHLATGNIVANCHKQPQKIFSKQLLSAQQIQASLEHIVALVRERQPQ
IKVIFTLSPVRHLRDGAVENQLSKSLLLCAIHALLGTGTSQKAEGLFYFPSYEILMDELR
DYRFYKEDMLHPTEQAVQYVWERFVETFFTTEAQSLMQEVGSIQRALAHRPFNPEGEKHL
QFLAALQEKIKKMEEKISKRLE
>SEQF1602_00644 hypothetical protein
MAKVDQIFRLVRIIKELERHKESGGLTYEELKERLENVHDNEYDAGRLQSEELRFSEKTF
QRDRRLLSDLFDVEVVFEDKKWRLEENDFANKYAFFDNLLLMNAYRRSKELSNILLFERQ
QQSSLRFLEDIIEAIQERMLIRFDYTKFWEGVPHSRRVIPYAIKEYKRRWYLVGEDSTGA
EGLKCFGLDRISHLEVLDIPVVRKEVDFEKLFSNAFGISIATDEKPQEIVLSFNYEQGQY
IKSLPLHPTQELLVDNDQEVRIRLRLVPTYDFVMEICARSCYVKVLSPSSLIEEVQNLLK
TGYQQYEQFAH
>SEQF1602_00645 hypothetical protein
MRRLYLDDLRPTPEGFVRVYNYEEFVEYLERKGLPDFISFDHDLGEDLSGYDCAKYLVDY
CLAHQLPLPNYQVHSQNPVGKENIERLLENFRRFEF
>SEQF1602_00646 hypothetical protein
MKIQYFSDLHLEFQDNLNWIDNNTIERVGDVLIIAGDLCPFVKLSNIMYKSEIADLCKGY
KKVFWIPGNHEYYIFTHNYAATRYEQPIKEIRNLFLVDNYTERIGRTQLILCTMWSHIGR
KNADKIKYGMSDFHYITVQNPEKGEEIESLQVTDFNAINKTAVKFLKKAVKAATQAKKAG
EIDHIIVATHYVPTLKYYPEMYLGSVLNEAFVLDLTDFIEKSAIDYWIYGHHHFNQPDFR
LGKTILTTNQLGYVMREEHEGFEWGKYIEVKNEK
>SEQF1602_00647 Glycogen phosphorylase
MKGETTSPNYLFEVSWEVCNKIGGIHTVLATRATILKEQFAQKYITIGPDLWLRKENPEF
VEDTSLFPSWLNRAQQEGLRVRTGYWNIKGKPIAILVDFSHYISEKNEILTYFWNTQQLD
SLDASWDYTESVLFGYAVGKVIESFVHFQVGARERVIAHFHEWMTGTGLLYLKEALPEVG
TIFTTHATVLGRSIAGNGWALYNYLEEYKPEELAYRFSVQHKHFLEQKAAAGADIFTTVS
DITARECKHFLSRNPEVITPNGFDESHIMDRTSYLERHKRASGKLWEVAEKVTGSTFEEK
PFFVAISGRNEFRNKGIDVFIDALEQINKKATLPREIVAFILIPSDYEGVNTISQPYTTH
LVKNEFHNTIFSKLKEAQLFNHVEDKVKVVFCPSYLLGSDGVFNLPYYDLLTGIDLSVFP
SYYEPWGYTPLESLCLGVPTVTTSLAGFGSWALGHFPNENLALRVLNRDDNNYVEVVEGV
TRQIEKIAGLSPTAYEALWEDAQQIGKAALWDKFFAYYQEAYTLTLERMQPRLQDRPIAD
TEASRYWEQSQQINTPFWRSVIVYRSTPEKFKALEEMAKNLWWSWNEEAEQLFKSIDPEE
WHRVHKNPILLLDSISVSQFKALENDTQFMARLHKVYADFLTYMEKKKEMISPSIAYFSM
EFGLHSSLKIYSGGLGILAGDYLKEASDKATKITGVGLLYRYGYFTQKISAFGHQESEYE
AQDFTKIPVSPVTDSEGKWLKISLDLPGRTLYARVWRVDVGRIELYLLDADFEDNSEEDR
TITHHLYGGNWENRLKQEMLLGLGGIKVLRSLGVSYDIYHCNEGHAALIGLERLNKFINE
FHLSFSEAIEVVRASSLFTTHTPVPAGHDAFEEGMLRAFIGDYAEKLHVDWQQILALGKI
NVSDPHEKFSMSFLAANLSQEVNGVSMLHGEVSREIFKDMWKGYFPEELHISYVTNGVHR
PTWTAPLWKEVEQKYFKKEGGAYTAASFEGIYNVPDEKIAHIQQELRTKLVGRIKNNLKE
TLNITYFTPREIVEVSDTLRDDVLTIGFARRFATYKRAHLLFTNLDRLDAIVNNPDRPVQ
FIFAGKAHPADKAGQDLIKHIVEISKQPRFLGKIIFLSNYDMDLARALIQGVDVWMNTPT
RPLEASGTSGEKAAMNGVMHFSVLDGWWVEGYREDAGWMLPQKRTYENQQYQDELDAELI
YNIIEDQIAPAYYNKDSNGISIQWCNFIKNTIGKVAPQFTTYRMLSDYERQYYYPQQKRS
ALLRANGFEKAIELSQWKKRVAHEWPELRVEKVVAPKRDRELISLGNIYEATIDLYLGEL
TPEDVGLELVVTCKEEGQLKVTQLIQAELISFSGRVASYKLSTSTEDAGLFMIALRLYPK
HELLPHRQDFALVKWL
>SEQF1602_00648 Lipopolysaccharide assembly protein B
MFSKNDDLREAVTRYEKMLLEHETIFFDSYQYEDIILYYLEYAKYAKAKQALEVALSQYP
TASALRLLQVEILIYEDNLQQAGEILDDILREEPYNAEIHVQRANLYSKKNDHIKAIELL
KYAASLSEELSDIHSLIAMEYMYMEEYALAKKYFKKCLAKDPEDYFSLQQLLHCFDFLKE
DEQAIAFLTAFLDENPYCEVAWHSLGKQYMVQNNLQEALRAFDFAIISDDTFTGAYFEKG
KVLELLKDYKQAIENYKITLSLDDPSSFAYLRIGICYEKLGESAMAEQYYFKAVHEDPQS
SKAWLALVDYYVRENDYTKAEKYVSKVLLNEGDNPSFLRRCAEVYAHVGRREDAIQIYTQ
AIDLGDYSVEIRNELSDLLLQEKAYERALMLSLSTLHLYPQEVSAYYRIGIAYHMLGEKE
KEYTYLGTALKQGGEWLAYFEKKYPEVFSFCPLVEEIVKNTDKH
>SEQF1602_00649 putative membrane protein
MEHFQSWSDLVNPEFYIKLGGYWLVLFIIFAETGLFVGFFLPGDSLLFISGIYAVPMVRD
TFGITGSDLLDTTIIASSISLAAIIGNMVSYWFGRRSGHGLYERKDSFFFKRKYLLKAHV
FYEKHGAVAVIAARFLPIVRTFAPIVAGIVGMRRGKFMVYNIIGAVAWSFSLVFMGHYLD
KLFIEQFGIDLKKHLELIVLFIVLITTAPILIKLFMPSKENNESNDQ
>SEQF1602_00650 hypothetical protein
MIRKIRNWVMTAAFVLGGTTIAMAQAKIAHIDSQKLLKEMPEMKTAQAQLQKLEQSYTND
IQASVKEYQKKLEDFQRKVSALTEAQLKEKQAELEKEQRALETMQNNIRQAQQTASEEYQ
KKSQALIEPIMEKAKKAVQKVAKTQGYQYVLDSAAGAGVIVSDGKDLFNDVKKELGF
>SEQF1602_00651 hypothetical protein
MNIKAFFLSLSLVATSSLWAQKATRIAYVDMNYILNNMEEYKVASEQLSQKVAQWEKEIE
EKQAEIDTRKQKLEAEKPLLTPQTVKDREEEIQVLEQNLEDYKQKRFGAENGDYITQRWK
LVQPIQDQVFNITQQIGKTKKFDYIFTSDDAASIYADEKNDITKIVLRLLKRKDNAEDRN
KEISTLLKENLSFELKDEKQRKLEERQRAREQELSKRQAEREKIKQKQLEDRQRREQERQ
QALEKKREEKKKAKQ
>SEQF1602_00652 D-alanyl-D-alanine dipeptidase
MFVRISLLVLCSFVSTFSLTAQKKQSAKHPSIEDKFVNIKTLSPEILLDMKYATADNFLG
QVVYDCAECYLRKATAQALVAAQKDFVARGYSLKLFDCYRPLSVQKKMWKILPGTHYVAN
PAKGSKHNRGAAVDLTLVEIATGKEVDMGTPFDTFSPKAHHSYTDLPKEVLAHRQLLREV
LGKHNFKPIFSEWWHYEYRPEMTSPVEDLAWPCPDDKQYNQ
>SEQF1602_00653 hypothetical protein
MKQLRLIIFREYLTKVRNKSFLLMTLLSPLAVVVLSLVIGYLTQVNSNTKRHIQVLDLSG
SFVKAFEADAGITYSYTSEGDLSTLQKQSQKQGDYGLLYIDAQATHFEFFSEDTPSPTFL
EKIQGKVEKALFFRNLQRENIDPSQIDKAQERVKISLTNFSGDKSSEAAGWIKLIFGSMA
GYLLMIFIVVYGNMIMRSVIEEKVNRIVEVIISSVPARTLLLGKIIGTSLVGITQFAIWL
LLGGALLSFLPSLQGSVPATADSHMLSDFITEVNTLPLGKLSVCFLLYFIGGYLVYSAFY
AMIGAAVDNETDTQQFLLPVLTPLILAIYVGIFTVIEAPHGTVSVIFSYIPLTSSVVMLM
RIPFGVSWGELLLSLGLLYAFFFLSIWVAARIYRVGILSYGKKPSYKELFKWLRMSN
>SEQF1602_00654 hypothetical protein
MLNYQLVTPEIQAYLQEHLWEEAPKFALKKSPFSGVSASELSQQLLGRQKARDKLPLWHR
TQGIYYPAKLSLEQASSEATARYKASLVTGHLLDATGGFGVDDYFFAQHCKSVTHCELQE
ELSEIVAHNFAVLGAHIHCVAQDSYAYLSSEGKHYDVIYLDPARRDSHKRKVFFLEDCTP
DVPHSLDFLWQYTDTILLKASPMLDISRALTQLPQTHEIHIVAIEGEVKELLFLLKKTPL
AREVQIKTVNMLPTRTDIFSFFPSEIDQKDIPMTRGYLCRYLYEPNAALVKGKGLFPVGL
AYGLAYLNKDSQLLLGEEYIPDFPGRVFLIDEILPYDRKLLKSGKIDQANITVRNFPMKV
AEIRERFSIAEGGNCYLFFTLGGIGNKLMIICRKPFV
>SEQF1602_00655 hypothetical protein
MTSNTIAQGILKAVGIMVGIVLLALALYKLQNIIIYIVLAAVLALIGRPMVGFLKRRLKF
KNTWATVTAIAIIMSFFAGIISLFVPLLISQGKNLASIDFKALNDNVHRFLDNLLHSLGM
GRIESQVGNIPELLNIEDISSVLNGFIGVISNIGIGLFSVLFIAFFFMKDGTAISEGFLS
LVKPKRLPKVRETLEDIKTILSRYFVGLFLQLSVVFILLTIVLLIFGVKDALIIAFLCAL
LNLIPYVGPMIGAVVISVLTISNFMDADLQSVILPKTLYVLIGFFFTQFIDNVFSQPIIF
SNSMKSSPLEIFIVTLVIGTLFGIAGMVVAIPAYTVLKVILKAVFPNNKLVQLLTAKI
>SEQF1602_00656 hypothetical protein
MNIKKNKLLIYLSLGVLLLLFTHCTTFISDNNMRWTAQYDFIDLYKKRNNGFNPGSDKEL
SVVFSPTKNIIVLGAQKNTHRFDPTIIEDQAVLYISTDRGQSYRELILDGDDVYDAVAYT
KDNSIIYTSDYKYEYVYLFNHKTLKIKEIDKYDRRNKIYYDDFDGRFLKCEKNEIRFLVD
VLAKDSIKLYEIPKKLTAYQYYPIHQNGDILYYDRILELRTYNVVTGEDKLFKQLKHKYD
YFLTEDYSSYNTPLSLQKVENENDEEKEIITIYDLEENFVRKITKENREKYYFYKDFICD
YTNLHSRGNTLRFSFDKGKTWKTHHIPMDGLLVFNKNVGFFEDKYIVFEGIFFRGASTES
GNRIMVGEFIK
>SEQF1602_00657 Release factor glutamine methyltransferase
MTVGDFKRYFVQHFLSYDMAERTSILSIIIEETLGMNQVEAILYHDQEIAQEKKMELQRV
CQELSKNIPIQYIYQKAHFLGLSLYVDSRVLIPRQETEELVDWIVTSYMAAPQLRILDIG
TGSGAIAIALKKHLPQASLTAIDISEGALAVAQQNAKRHGVAITFLQQDILGVEDLGTSY
DIIVSNPPYVRELEKKEMHANVLDYEPSLALFVPDDNPLLFYEKIAEIAARNLTEEGTLY
FEINQYLGQQTLEMLHKKGFKALLRKDLNDNDRMIRAGRAI
>SEQF1602_00658 hypothetical protein
MIGKIFRILKTIIKIGIYTLIFIFLALMIPAVQTKLASWVMERINTDYNVNIHIDKVSIS
LTGMVGLDGVLIRDHHQDTLIAAQSIRTPLLDLKAAMDGNLIFSHIEANELFLNMKTHKG
DTLTNLDVFVSRFDSGTPRSKDPFVMRSNTIKLRDTHFRVSDYNIAQGENPIQTDIKHIA
GTIVDFDIVDSEVKFQMKKGSLLFDNHLKVEELETYFQYTDSLIFLDRVNIRTPSTHIDA
DLAFEPYNNSFADFLNKITVRAELRSSFIGTDDINGFYNGFGKGKTLEVEGKFSGTLNNL
SIKEVHLYHANTNIEGQDILLRNAFSSDKDFVFWGDFSHFSTSYSDLVGLMPELIGESLP
KELRDFGLLEGQAELTYTTRDLLLDADVFTQKGDFILSGSFYGLKDLNKTTYKGTIDTYQ
LQLGNLLEVKDLGKLSAGLQFVGTGLSLKKLQKLSLHGNVREVSYKDYLYKDIKLDAEYF
NKKIKATASIGDDNLQMDFKGMADITSSQRSNYMLSGQMKYIDLKALGLVQKDSIAKVKG
EIDLDITGNTIDNMVGKVVLKNASYQKNSQTYDFADFAINIEKDTTSLRTITLESSDIIS
GKVQGEFKFAEIGKVLVNTLAYGFENYKPFKVMQGQYLTFDFKIYNKIIEIFFPELSFAP
NTFIRGKLVGDDYDFKLNFRSPYINISDYSLRGVNLEYDKKNPVYRSLIQMSSIQNPYYK
ISDLNVLNTSVNDTLFFQTEFKGGKNSEDDYTIKLYHTINERRESVIGMKHSTIYFKGNE
WAFDQRSENQLRINRKLDSITIRPFTLHHKDESITFNGMASKHNNYKDLHLVFDKVDINK
IIPAIDNLDLAGVLNGHLSLMQDRNKYTPEADLTLKSFMLNKYEMGDLQANISGNEDLTS
FKTKLEFLNGLGEGLLAQGNIFIKDANTYLDLRATLTKLNLKPFGPFMQDILSNLRGALS
GEAQITGEVSKPKVEGVLQLSQAGLGVPYLNIDMELSDNAQIFLEDNKFIFKDITLTDTA
YKTKALFNGLISHRRFTDWYLDLKFDTQNKRFLALNTSAKDNDLFYGTGFIVGKANIIGD
VNALTINVNAVTGEGTKFKIPLSDTQTVGDDSFITFVSKEKSKKNLVVKTYQGLELHFDV
DILPSAEVEIIVDPKNNSSLIGRGAGTLLMEINTNGKFNMWGDFITTSGEYNFKYEGLID
KKFKVLPNGSISWNGDPMGATLQNLRAAYTLYANPSVLLNSSQYNRKIQTQVIINLQGDL
AHPETVFDLKFPDSSPSLVSELNYRLESSDKKQLQAFSLLAQGSFLSDAAAGEKLLAYNM
LETAAGIFNQLLSSEDDKLNLGVSYEAGTIDPNRAYNSADRLGITVSTQITDRVLFNGKL
GIPVGGVTQTAVAGDFEVQFLLTKDGRLSAKIFNRENELQQYLIDKIDYSQGVGLTYKVD
FDTFKQLIRDIFTKAKKK
>SEQF1602_00659 hypothetical protein
MMRNILKAAFIVIAILAISCDKSEDLSSKDLVGSWYLESVTYGGQPQGLSSCAKQSNIVF
TETEYTKTEYAGIDGGLCSETHKKTGTYTTSGSKVLVKYKEGNNETVPTIRISGKTLTLS
LVKEQGDKNMPLVMTFVKR
>SEQF1602_00660 tRNA N6-adenosine threonylcarbamoyltransferase
MNDIPYILAIESSCDDTSAAVMQGDKVLSNVIASQKIHQEYGGVVPELASRAHQQHIIPV
VHQALQRAGVGKEQLSAIAFTRGPGLQGSLLVGVSFAKSLALSLGIPLVEVNHLQGHILS
HFIDQEGQEKPSFPFLGMTISGGHTQILKVSDYFTMEVLGETQDDATGEAFDKTAKILGL
PYPGGPLIDKYAQKGNPKAFAFPFPKVEGLNFSFSGLKTAVLYFIQKEVKENPNFVQEHL
ADICASVQYTIIEILMRKLKKAVEQTGIRQIAIGGGVCANSGLRSALKTYGEKYHWRVFV
PAFEYCTDNAAMIGIAAYYKYLQKDFADMHVTAQARYHF
>SEQF1602_00661 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKIAIVCYSTFGGSGVVATELGVALAQKGYQIHFITYGQPVRLSAFHKNIHLHQVYVEEY
PLFRYQPYELALSSKMVEVVREYNIDIIHAHYAIPHAYTAFMAKEILRKEGLEVKIITTL
HGTDITLVGNHPYYKTAVNFSINASDAVTAVSESLRDMTYELFDVQKHINVIPNFINIEK
KKSEPKRCQRAMLAEPDELILTHVSNFRKVKRACDVVRVFHKVLQQKKAHLIMVGDGPDR
ENAQALAHDLEIQNYVNFLGNYLDVNDILCSSDLFLLPSESESFGLAALEAMAEGVPVIS
SNAGGIPEVNKQGVSGFLSRVGDVDDMARNALTILHDRETLARFKEQALERASLFDEKKI
IPMYEAVYHEQ
>SEQF1602_00662 hypothetical protein
MTGSEIQEALDKLCLEMKDSLSGFLFCGILKCSDGTIMAKASASVELLKTAEETSPFFTT
IVTQVKNVVFLSESLQIKEIHSILIETDKVTYVIGVSNKGKFFNLLVLERDKANIGIARA
LIEKSRPLAMALDEQL
>SEQF1602_00663 hypothetical protein
MKSVKLTLAVLATMAMVSCGGGSSNGDNANTDNSTPSTTTETPAATNTPATETPAAPTGG
AGVDLSNKGIGPVKAVNPPLGNTVDQALAAKGQELFKLNCTACHKPTKKFIGPAPKGILE
RRSPEWIMNMILNPEEMIANDPIAKQLLAEANGSPMANQHLTEEQARAVLEYFRTIE
>SEQF1602_00664 Nitrous-oxide reductase
MKTSKLLSLAIAGAFLASCGNGSKSDNNKSGAMGASDAASRVYVAPGQYDEYYAFLSGGF
SGQLATYGLPSGRLLKVIPVFSQDPEKGYGYNEETKPLLQTTHGFIPWDDTHHPDLSQTN
GEVDGRWIFINANNTPRVARISLKTFETEETLELPNAAGNHSSTFVTENTEYIVGGTRFS
VPIPQEDVSIKDYKGKFKGVISFVKINPDSGKMNLEFQVLMPGFNYDLAHSGKGKSHGWV
FFTTYNTEEANTLLEVEASENDYDYVAAINWKVAEDYIKQGKFTEMKAPHYHNTYSDETH
TGKSEVVETVKILDASQLPGLVYLLPTPKSPHGVDVDPTGEYIIGNGKLASELTVHSFTK
MLKAIEDKAFDGEKYGIPTIKMDAVVAGTVKSSGLGPLHTEFDDKGNAYTTFFISSEVVK
WKVDTREVLDRKPTYYAPGHLMIPGGDSRKPYGKYLVAMNKITKDRYLPTGPELCQSAQL
FDISGDKMELLLDFPTIGEPHYAQGIAADKIKSQQTKIYPLKDNHHPYVTRTDADAKVVR
EGNNVHVYMTCIRSHFSPDNIEGVKVGDTVYFHVTNVEQDWDIPHGFAVLGAQNAELLIM
PGQTETLVWKPTKVGVWPFYCTDFCSALHQEMQGYIRVSAANANTPLKWSLGSDAE
>SEQF1602_00665 hypothetical protein
MVVASLLLLLLFIFPIWSIKLDAPQYPEGIKMYIWINDINGKSSFSAQEDELSIHTIENI
NLLNHYIGMKHIHAENFWEFKAFPWVIGSFLVLGLLIAFAGKRILYFAWAALMGVAGVLG
MYDFYKWEYDYGHNLSDTAQIKIPGMAYQPPFFGGKELLNFYAESYPSWGTYAMVLAAVL
ALVAFFISKKKVA
>SEQF1602_00666 hypothetical protein
MKKVLSLLSLGLLMASCAPKAEPIDYGKEECAFCKMTIVSPQFASEVVTQKSKAFKYDAV
ECMLQAPQEDQVALHLVCDYLKEGNLIDATKATYLISKEIESPMGAHLAAFASREDAQKI
QREKGGELYDWQGIQAKFQGHQHPASSDHDNMHDH
>SEQF1602_00667 hypothetical protein
MLKKLLIPFLFLGCLGTFAQTQTITVCPQCPIRTIAQGLAQAKENDTVIVQKGVYGESNL
LIDKPLTLIGKDRPVINGQFKGSILKIRADRVTVKGFRFANVAFKATEEQAAILLDKSKE
FLIEDNVMEQVCFGVLLRKGRDGIVRGNDISSNAKEQYNSGNAIHLWSCKDVKILKNKAK
NCRDGIYIQFSSKCYIEGNYAEGNLRYGLHFMFSDDNEYHKNKFARNGAGAAVMFSKRVK
MTGNTFQDNWGPASYGLLLKELYDSELTGNTFYRNTIGINGENCTRMKYNENIFSENGWG
IRIRGGCYQNDFWDNNFLNNTFDVAYDNNVNDNKFYDNYWSDYTGYDLNKDGIGDVPYRP
VKLFSYISNRTPESIVLLRSLFIDIMNFSEKVAPAFTPENLVDETPRMNPFSKKKN
>SEQF1602_00668 L-cystine import ATP-binding protein TcyN
MIEFKDIHKKYGKLEVLKGVNFTIKDGGIIAILGPNGSGKTTSMKSFLGMVVPTKGDILF
NGKSIKGQWAYREQISYLPQIANFPSNLKVKELISMIKNIKKVPCNDQELIELFGLQKHL
NKSLGNLSGGTKQKVNLVLTFMVDVPVLVLDEPTSGLDPIAVLALKKLILREKEKGKTIL
ITSHILSFLEELSDEILFILEGNIYFRGTPQELLATTQKDNFQEAIAELLKNEKYA
>SEQF1602_00669 hypothetical protein
MLKIIRYTFFDLIRSSWTYFYFGFYLVLSSILLFLNHDISKSVITLMNVIIVLIPLISTI
FGVMYYYNAREFIELLLAQPIPRKHIFLGQYLGISLSLSLSLVIGLGVPFLLYGLFLSSE
IFNFLMLIVTGVFLSFIFVGISYLIGLYHENKIKGFSLAIFIWLFMAVIFDGIFLICFMV
FRQYPLDSFSLAMILANPIDLSRILILLKLDISALMGYTSAFFKSFFGSTTGIAASLGSL
SLWVIAIIFLILRKIKRKDF
>SEQF1602_00670 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
MYKVVLLRHGQSEWNKLNLFTGWQDVDLTEQGVQEAREAGRVLKEEGFRFDVAYTSVLKR
AIKTLNNALEVMGELWVPTYKSWRLNEKSYGALQGLNKAETAAKYGEDQVLLWRRSYDVQ
PPLLEKSDERHPSHDRRYDTLTDAEKTGGESLKDCYDRMLPLWFSDIAPAIKQGKSVIIA
AHGNSLRSLVQYLDSLSEEEILKLNIPTGVPLVYELDADLKPIKHYYLGDQEAIAAAINS
VANQGKKQ
>SEQF1602_00671 Serine--tRNA ligase
MLQISYIRENKEKVLTGLKKRNFGELELVEQAIALDEKRRALQTELDEALSKSNKLSKEI
GALMKEGKKEEAEAAKEQTAQYKELTKRLNAELDETATSLTQVLYRIPNIPNEIVPEGKS
AEDNLNVFQAGEIPALYEGALPHWELAKKYDIIDFELGVKLTGAGFPVYKGKGAKLQRAL
ISYFLDKNTAAGYQEFQVPHMVNEDSGYGTGQLPDKEGQMYHVQLDNLYLIPTAEVPVTN
IFRDVILSEADFPICCTAYTPCFRREAGSYGAHVRGLNRLHQFDKVEIVRIEHPDRSYQA
LTQMVEHVKGILNELKLPYRILRLCGGDLGFTSAITYDFEVYSTAQEKWLEISSVSNFET
FQANRLKLRFRNSEGKTQLVHTLNGSSLALPRVLAGILENYQTPEGILIPEVLRKYTGFD
IIN
>SEQF1602_00672 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MKKILPILLFFAGTAYHQEVQAQNRPSKPLVDNPTYLEGKNDMLIAATDFGNISRYENAV
IDESMPISRRGELLVKPDLEAMGAEERVVALIDAAYSYIGTPYKWSGTTREGMDCSGFVS
TAFSSINVPLSRSSTEMSTQGVDIPLSQAQVGDLLFFKTTRKRNRISHVGIVVGTGDEVK
FIHASTSQGITVSSLSENYWQKAYAKTSRVLK
>SEQF1602_00673 hypothetical protein
MIRLLSTKLLLPQEVEAFAALGFQVESLPLIRVQLSETIEAFPQADFAIFTSGNALEALQ
KHPAAKALAPHRAFCVGAKTRERLESAGWEVIASFGYAQQLANYLVEQYASYSFVFFCGE
SRMETLPKVLAKRGIPCHECLTYTTELTPKKLSKHYDGLLFFSPSAVRSFLAANSFAEEK
IFCIGSTTQSALPEGVSSYIAQSPTLEGMMERCREIFNNRQT
>SEQF1602_00674 Uroporphyrinogen decarboxylase
MIKNDLFLRILQGEKTERPAVWMMRQAGRYLPEFRALRTKYDFFTRCRTPELVAEITTQP
VDIVGVDAAILFSDILVVPQAMGIHIEMKEQVGPYLPHPIRTKADIERVQIPEVSEALGY
VMEGIRLTKERLAGEVPLIGFAGAPWTIFCYAVEGKGSKNFDTAKSFAFSYPEWTAEFLQ
KITDTTIAYLREKVKAGVDALQLFDSWGGVLSAEDYQKYSWPYTRQIVEALSEEVPVIVF
AKGCWYALEEMSQSKAAALGVDWTCSPEMARKLTGGKKVLQGNLDPAWLLAPITQIKEKT
QQMIRAFGKEHYIANLGHGILPEVPVEHARAFVEAVKSFKES
>SEQF1602_00675 NAD-dependent protein deacylase
MQKLVVLTGAGISAESGISTFRDSGGLWEGHDVNQVATPEGFAADPALVLDFYNQRRRQL
SQVEPNEAHRLLAHLEKRYEVVIITQNVDDLHERAGSHNIIHLHGELLKSRGVDNPNVTY
PCTGDIHVGDKSPTGAQLRPHIVWFGEEVPMLEKAIAQVYSADILMIIGTSLQVYPAASL
IDYVKEGTPIFYIDPNPSLHSKGDLTVIAQKASTGVAKAIELMTP
>SEQF1602_00676 hypothetical protein
MKKLLLFFLVFVSLACQRATPVASLAVYYWRTSLSLTPEQEGFLTEQRITKLYVRYCDVG
LRGGEAVPIAPIEMDSLALVGKQVVPVIYLKNEVFLDKQTDSKALAAKVGKYIEQINNSY
HLTVAEVQFDCDWSLSSKERYFAFLEHFRGLYPYHLSATIRLHQVKYQDTTGVPPVERGV
LMYYNMGKITATGSNSIYDREVAKRYLPSLRSYPLPLDLALPLFSWGVHSIAGDVNALIG
GLTSAQMDTLKGVERMGETSSYLVTHQTNYLGRLWQKGDVVKVEEITPENLREMKADLIK
YMKQPPKEIILYDLNKNITTYEKNFLKTCVKLSVLAGIGYGAYLYACAGEGLGDYYNSVF
SPEIAVGNTSYKALFLSEDSFFYGGYIDIDEKKSEQLTADAKEWRTYLAQAKQPNAESWL
SLFFNPKTKLQDAQKALHRIEQKEYPKKTQNFVDFLRIAVGNEGATNMPYDPWNYENRKV
EKVQQLQIQKADNLYASAQKDKDAFFANRMWFQALRLRFYSYDRSAVIAYFEQTHRDQPK
NALYYRALHYVAGAYIAQKNYRKANALLATLFHEVPALRQTVTYEYHPLTDNEVGTIAQE
LPPSQAAALWAMQGYYRNEKEAIEHILALEPRSPYVDFLLTRYINRIEIKTNTYDDKWVI
MASYKGYRSYTHRVVTKDFDTQWVLQTAQKETLANPYLWHIAAGYLSMFRNDFQGAASFL
KKAKAEAKNTAMQDQVRLLETLNEVSSLEQISKEAEDKLLKDIQWLWTHKKNEDMRYNYA
FSFVRAYLSRLYKDTNNTLMRELTSPEQGFYKNTQHSLDMEQFLLKNNKTPWEKFWAEYY
TYTLGDIYESRAIYAFYEDNISKAIAELKKVPFQEENVYNEVTRRMEKKKIKLSDYILPA
NPFNGFIKDCNDCQHAMPQKVKYSKLSFLEKVKEMQGKITKGEDVYNNALLIGNAFYNAS
YFGSIRAFYHNRIIGEYGLGIDPENQEVLLGMGNAKKYYLLAQKHATTDEQRAKMAYLLA
KIERNEFYIEAYFSKPDNYGGAWADDVLVKDWKGFQELRNKYRHTQYYKEVIRECGYFRK
TIK
>SEQF1602_00677 hypothetical protein
MKKTTILFVLLCFSICWGQRKVVLDDVQRIINQRIDDAKLKATTNLFFSNYTTAKPISRA
ELMESKVGICIDVLPQKNSLVYYPAKFDVNYATFDTNVFSIEDNKDKEAQKKYIQWFQKG
ERSKIQKSTYFDHVKYQYLNQKTEKTTIYTDDIFIRNKRYATFLRSQGDYIYGLAVDNKH
DGNFEDAILKLYIFDKKLLSEKDLIEINDKRKEALSATRDDYSLYHEKRINELITLLEKL
FETFPSYKNDPKLVAAYEKLKEQEPLDKGSLWLAKDILPYLADLKIEESQGRMLLYNLQN
IAHLAAHSLADIYYGNKEYDKAEKYFLKALYEAPYEQTSATTVKKDNERIFFDLISIYQG
TTDKTNKIIAYSFPLLVSFYYQKESNELLIAYIPEGKKARVAFKGEVDKALHSAITTDNG
DIEIVFKGEKVRFWYYGIKQFVEGVKGSDFYKKL
>SEQF1602_00678 hypothetical protein
MEKEHLIELVNQLVQQPHESEWLEFKLNFHSVEEIGERISALSNGACIHNQLYGYLVFGV
EDQTHTIKGTSFKAKTYKKGNEDLEHWLLTRLSPRIDFSIYEFDYQKGVHISIFIIPAAK
NQPIEFLHQSYIRVGSITRRLNDFPQKQAKIWNNKEIPFEKEIAKDNLLASEIIQYLSTQ
TYFDLMKIPYPTNQQGVIEKFIEEGFIIKNKQYAITKLGAILLAKQLKDFDGLERKALRI
IVYKGKNKIETQREHIETQGYAVELKTLIEWINSQLPANEEIGKILREDKRMYPEIAIRE
LVTNAVIHQDFSEKGFPMVEIFKDRIEISNPGTPLVTPERFIDAYLSRNEKLADLMRRMG
FCEEKGSGLDKVIFYNELYQLPPINVTIVENRTKVVMYSYKTLNDLDKKEKIQACYQHAC
LKYVSNEKMSNQSLRERFEIDDKNAATASRIIRDALDEKAIKEDDPENKSRKFKYYIPFW
A
>SEQF1602_00679 Large-conductance mechanosensitive channel
MGFLKEFKEFAVKGNVVDLAIGVIIGGAFGAIVSSLVADVITPLLLTPAFKATGAENLQD
LVWNGVAYGKFLAAVINFLCVAFVLFMLVKGINKFKKKEEPAPEAPAGPTQEELLTEIRD
LLKKNN
>SEQF1602_00680 hypothetical protein
MVSYGQSDSLALDNKYLEDQFHIGISYDWVVSRPSGVRQHSFSRSLFGGYQRDIPLNKQR
NIGFAAGVSYSYDLLYLNIQAKEIGGQMSYEIISISDKKVEDSYYEQHSIGFPIEFRWRT
STPYSHKFWRIYTGVKPTYTFASRYKFSGSEGSYSLSDPNLKGYMDAKLYIAVGHNTWNV
YLQYALRPLFKGENSQNGQNLQSNILKIGLIFYIL
>SEQF1602_00681 Delta-aminolevulinic acid dehydratase
MNILRRNRRLRVNETIRALVRETTITPNDFIVPLFVVEGLGIRAEIPSMPNYYRYSLDYL
AQEVKELWSLGIKSVLLFVKVPDHLKDNEGTEAINPDGLMQRAIKTVKEATPDMLVMTDV
ALDPYSIYGHDGIIKNGVVENDTTVSILAQMSLSHVRAGADWVAPSDMMDGRIEQIRLFL
DKYNYTNAGIMAYSAKYASALYGPFRDALDSAPVDEQDIPKDKKTYQMDYANRLEAIKEV
IMDVEEGADMVMVKPGIVYLDVVREVKNAVNVPVSVYQVSGEYAMIKAAAQNGWLDHDAI
MLEQIYAIKRAGADLIASYFAKDVVKLL
>SEQF1602_00682 Guanosine-5'-triphosphate,3'-diphosphate pyrophosphatase
MGGFFYFSIYYCSFAKKIVMNIRKFAGIDIGSNGVRLLIANILEEEGKTPIFSKGSLVRV
PIRLGADVFEQGRISAENASRLSDTMQAYHLLMKVQGVEAYRACATSAMREATNGTEIVR
EIAQHTGVQIEIIGGAEEAAIIANTDLHTLVESDKNYLYIDVGGGSTEFTIYSQGEVRAA
RSFPIGGVRLLKGKADEQVWEELKEWIHIHTKGLKTIEAIGSGGNINKIFKVSGKRKDSP
LSLHFLEDYLKEINSLSYEERIRDLELNPDRADILPLALPIYIKAMKWAKIKHILVPKVG
LADGIVRQLYLSSEQ
>SEQF1602_00683 Hydrogen peroxide-inducible genes activator
MTIVQFQYILAVAQYKNFSVAAQKCFVTQPTLSMQVQRLEEELDVLIFDRAKKPLRVTEV
GEKILQQAESIVSESERIKDIIAQHKGFIGGRFRLGIIPTVAPTLLPMFLNNFTKKYPKV
ELKVEEMTTRECIRELAEGTLDVAIVATPLHEKHLIERPLYYEPFVAYIPNAKYHLTENQ
KIQVSDLHLNDILMLQDGHCFRESVLNICQENGSSDKGRDNSLEIKSGSFETLIKLANEG
MGMTLLPYLHTLDLSEAEKKNLHYFEEPSPAREISLLYHSNELKISIIDALYNVISGVIR
GAITFENLNIIDPILKKKKKQ
>SEQF1602_00684 Cell division protein FtsX
MHTRTERHNRRKLISSYFSVTLSITLVLFLLGLLGFLLINVKNLTDSYKEHLIINVFLKD
TAKEADIEQLQKSLSLASYTKQVEFISKEQAAQSFSEELGEDFISFIGDNPLGNSFDLAL
KADYVTPQKMEEVKESILQNASVKEVNYDKDSVKKIHSNIQSISLVILAVSAIFTVVAML
LINASIRLSVYSKRFIIKTMQLVGATKAFIRRPFIITNIWLGILSAILACAALAFTFYAI
DQSWPEWGLIMHYRDFIWVGAALFLIGVFLSWISTYFAAQRFLNLHTDELYY
>SEQF1602_00685 hypothetical protein
MLPFEKFIGLFSVVRGYNIMMICIAQYLTAIFILSRQPLRQVLLDPRLFAIVLAGALAVA
GGYIINAFYDQEKDLINKPTRTLMERMVGQHTKLSLYFILNFLSVIVASYVSFRAVLFFS
IYIFMMWFYSHRIKKIVLVGNIVSGILSIIPFFAIFVYYHNFQKIIFVHAAFLYYLLLAK
DFVKDLQNIKGDFALGYHTIATDYGERSSKQLITVLIGLTLVCIYFLTAFPDTGSMKYYF
ILTAIILLGGFLPILWKGRTQIHYAFLRNLLKVIIVVGVFCIALIRR
>SEQF1602_00686 hypothetical protein
MIKTMLYLLLFCILINSVLKLSFWKFWQVGIFSLGVGAFLYGVSDFATEQSQLTISQWLS
DTKVLSNMAVLVTIESVIGLFFCFISLKAFYEEKRNRWARILLWFPGVLLFPCLFLGLTE
SFFFFSGVDFGEVTFAFIALTIAGFLLGAWGFRALVPERELRLELHLLMSIWVTLMGLAM
TASGQIVYVPKSEPINLWLIGKVFLFFTSLFFLGWLLSKIRRR
>SEQF1602_00687 Bifunctional protein PyrR
MTIILDATQIEHKIRRIAYQIYEANIHQERFILAGIAENGYILAEKLYEQLQQFCPIPIT
LCKVFVKKTDPLAPVTTSLPEEAYRGESVVLVDDVLSSGATLIYGVRHFLSVPLKQLKTA
VLVNRNHKKYPIKADFKGISLSTSLQEHIEVSFEGDPVAFLQ
>SEQF1602_00688 Heat shock protein 15
MRIDKYLWCVRYYKTRNIATEACKKGHVRIGGEIAKASKEVFPQDKIQVRKGAITYEIEV
LDIPTSRVGAKLVGLYCIDHTPEEAFEQEELRQLAQEYYRKKGEGRPTKKDRRDLDDFFS
SEEDEEWGSEQ
>SEQF1602_00689 hypothetical protein
MLLLSCGAISLFSCKKSGDDSQKLREMSEVVVENDNDIQAYLKSHYCELDADKNIVLGTL
AGNTGKTSLWDSPNLKRKTLKVPDIHGNYINHTMYYLILQEGAGAQATIADRSYVLYKGL
TLKDNVFEDGMRFTQSNWLDLLGTRASAYQGGAIIGFREAVATLKASTAKPTEVGDGTLK
APTDGGMGIFFLPSGLAYFAGTIGLPAYTPLIFEIKLISTANYDHDGDGKPSIQEINHQE
DGTIVFPDCNGNGTVDYLDAYNCN
>SEQF1602_00690 hypothetical protein
MKKQIPNLLTLLNLFCGIIALRYALSQAFDWALFWFFLGITLDFFDGFVARILKVSSPLG
KELDSLADLVTSGLVPGQVMYWLISYSAAHYGQTLHFFLPFAGYLITLASAYRLACFNLD
TRQSDSFIGLPTPANALFIISLGLIVKQAVYLKAISLWGTLLITLASCVLLNSNLRLLAL
KFKDFSIKNNLLKYLLLLISVVLLVLMRESAFPLIILAYILLSVVGNLKKEKS
>SEQF1602_00691 hypothetical protein
MRKTFLKKAFCSILFLAAAMGYSQEAGSIGTLLRNEAKASDINSVRIQVDVQGGAQRKPN
LGDYRTPPSQYTWNPAPYGYSEVFLRIADRGYFTVVLGDQQISSPSGKFRFFDVRSGALP
LSIYLNGFLVYQTTLRTTENQRSVLDYFVQYGLYELERYPIEKDWYGGEWNDIWNNPYRA
GRQLSHAPHIQVMPQEVFANFFAAYKRLTFDNERIGFIRQQQNTAYTAAQIKDLLSRFDF
DNNKVDMGKLLFPLCADRGNFFIVYDIFTYDSYKRQLMDFVASYRQ
>SEQF1602_00692 hypothetical protein
MVFKKKNYLWMALGLALIAIGFITMSGGGSDDPKVFNPDIFSFRRISLAPALVLLGFAVE
VWAILYTDKKEKES
>SEQF1602_00693 Undecaprenyl-diphosphatase
MDLLQAIIIAIVEGLTEYLPVSSTAHMIFTRELMGIAEDDFFKIFALCIQFGAILAVVTL
YWRKFFDFSRWQFFVKLGFAVLPALLLGKLLDDYIDSVMGAPVYIAIMLIIGGVVLLFID
RFFKHPTILQEKDITIKKAVIIGFWQCLAMMPGTSRSAASIIGGMQQKLSRELAAEFSFF
LAVPTMLAVTVYSLFLKEYHGTGTPIKGYTLLAENSDKLSMFLIGNVVAYIVAIIAIKGF
VNLIKKYGFSLWGYYRILAGGLLLLFL
>SEQF1602_00694 hypothetical protein
MKKYLLFLLPILGYSQAIDLSLSLKNKEKYVHKISSEVSSTQQIDGAQVETKALSRMRIR
YTFGKEDKLIYPMTLRYEEASLEVSTKVNGKEMPLEKIPDYTNQAAKELLEQPLKGELST
KGKIVKIEPLQPLVERAMKTLEKKHAKNNPLTSFEKQQIQMQLEAAFSETTLQSNLSNVL
SILPRQRVAIGDSWEISSFLSKEMNVPIKTRYTLVEALNGQLHIQGKSVIATDKQKVILQ
QGQYVFFTMQGQVDIDIWLDAQTKWILKATALQTLKGETEVEGDLSHQKGKVIPFESQSK
IIINEQ
>SEQF1602_00695 hypothetical protein
MNVDISQINEKIERESVFIDTLRAEMSKVIVGQHHMVDALLIGLLGRGHILLEGVPGLAK
TLSINTLSKAVQATFSRIQFTPDLLPADVIGTMTYNVKQNEFSIKKGPIFANFVLADEIN
RAPAKVQSALLEAMQERQVTIGDTTFPLDKPFLVMATQNPVEQEGTYPLPEAQVDRFMLK
VVIDYPKIDEEQYIMRGNLAGERPEVKAVVTTDQILHAQKAASEVYMDEKIEKYILDIIF
ATRYPEKYQLAELSPLIQFGASPRGSINLAIAAKCHAFIHHRGYVIPEDVRSVVFDVLRH
RIGITYEAEAENISSMEIIHKIVNTVEVP
>SEQF1602_00696 hypothetical protein
MYKEVEEKIDKIPILNKLACFLKKISLGKGQQFSLYDLLLLYTIGIVKGALTYRASAISY
SFFVAIFPFLLVVLNLIPYIPIDDFQQDFWVFLDSLLPPGTHGFFEEIFFDIAGKKRAGL
LSTVFVLSIFLTTNGINAVFGGFEYSYHVRATRGALKQYFISMGVAMLLVFLILFSVILW
LAFEYIQGMKIFSFFNSNPYFFPIVKKVFFIFVAYLVVSILFHFGTIDRGRRFFSAGSLL
TLILFILTTYGFGVYIENFAQYNQLYGSIGALLIFLLYIWLNATILLLGFELNASLSNLR
RVKNEK
>SEQF1602_00697 hypothetical protein
MQVDFSFQEYLGFLAFLGIATMGFWLMIFLLTYVVPYWVFGAAIERFKEKRAAKKLQKEQ
AA
>SEQF1602_00698 hypothetical protein
MKRILLAAMASIALLISSCGKSDDSSGDITGIWQLESETVNGQSQTIDDCEKKSALAFTQ
NQITFHDFSDRPGFCKYTKQLLTYKIEGNAIKSDEDASISFPFSVSGNTLTIESVHGQEK
TILKYRKITQAELDAILATINNNNGGGNKNAQNLEGIWQKESETVDGQSQTIDDCEKKSA
VVFTQNQITTHAFIENAGACRYTKQLHTYKIEGNAIKSNEDFSISFPFSVSENTLTTESV
RNGKKTIIKYKKITQAELDAILATVNNGGN
>SEQF1602_00699 hypothetical protein
MIDKYTDTEKEELGGDEITEPFSPNEIDVDIATINLGSLIGQLKYGEIDLEPDFQRASDV
WNNTKKSRLIESILLGLPLPSFYFSEDAQTQKLLVIDGLQRLCAIRDFVLKEEKPLILKK
LQFLKDFEGKRYKDLERPEIRRIDALKITVNILRKSTPSDVKYIIFQRINTEGVTLTAQE
MRHALNQGIAANFIKELSELDSFKKATDNISFKRMQDRDLVNRFIAFYLGYKDYNGALNN
FLNHWMALLNKMTAQERDNIKISFESSMKCCYKIFGTESFRKPNVEGSKRNPISKSLFDC
ISVNIAWLPLKEMALLEQHSQDFKEELYQLLKTNDSFITATSKSTGQKLSVMERFNTIKN
LIKKAIGNDK
>SEQF1602_00700 hypothetical protein
MINRIIIDNFKLHNHTELQIGGLTILSGMNGMGKSSLIQSLLLLRQSFLMNDLEVGLNLK
GDLCDLGMADELPCIVSKKTHLTIDINFLHQKSLNYSFLYGMNSTLLIGEEDNATNKEVL
ATYSLFNNNFQYLSAFRFGPQKGYGRDTSLVDIKRQLSKQAGQCEYTVHFLERYGKEELP
IKALAIEDNNDYRLLNQVEQWLRKISPNIRITIEPQGQDLNLKYKFNRNENTITENFSAL
NVGFGITYVLPILVAILSANKDALILIENPEAHIHPKGQAVLMELIAKAVANGVQVLIET
HSDHIINGSLVAVKEGVISNEKLSVYYFERDEQQHTAIAHHLEVSKNGRIKRPPKGFFDQ
IDIDLRILTGF
>SEQF1602_00701 hypothetical protein
MPKTYGKFTLSLTGKDSHKVNITPGQGRFTIAPKTSGEKADAYVDADTPIQWEVFNDFKV
PAGGNWPRVMDYMGNDTRFIEWTEQREMESFDWRLMAPATVDFSKAKIEYLSVDNNDYPL
DIKLGNKWLRGLSLEGNPHKITLEMAVPLKSISFRISTEKKNNTPVFLPEFEVLKDLTTI
NISTPVGGQPFDCGSLLQFKKLKTVRLYGNMCNMEALGKLNLSGIEVRYCPDMTGLPPLS
TWADFSYCIFWNVEEVRGKALRKELKELEKTRELSEYASVSNLHPKSWFATEFNIPFASW
EGKNGREAMKAYKETLKAVKKAKEEKEVRSLLEGLIAVINGLPNIETTEREDTYEAVCQL
AEVASFAIEEEKITQWFDQAREF
>SEQF1602_00702 hypothetical protein
MFRWICSLFFCIGLQAQSVKTFDHTCADGKVRPYVVYSPQGESKAPKPLLVFLHGAISSP
ELKAHPEEYVQKSPLLSFANAAGCYVLFPFGQQGATWFDHVGQQMVMDEIAQVKKQYAID
PNKVFLSGFSDGGSGVYYFSMTQPEPFAGFIAMNGSLKVASMLGEEALFPCNMNQKPLYI
LNTTEDILYPLDQIIPAVDFLKRDNPHIVFRTPKGNHFLSYLPEEQTSLVTFIKENTRKP
LTHIVWETANISKINSIGWLRLSALSLDQAPASWHVPYPKVRIENNKADLGLKYDYTYQG
KGLKVAGFKNDTVTAKRLGVKQGDILLSLERDSITSPMSPMLYMAKKKAGDPTQISVLRE
GTPLTLKGNFNAGYPYLLLKQPEKTAKIEAELIGRRVYIRTSRVVDYQVDREQAPVKIKG
KIKKLNK
>SEQF1602_00703 Endoglucanase A
MYKSLFFVAFLGLVVACEKSGDNNGSTTQTPTPPVVPPSPPVVTPPAPTQKPAAYDRDFY
LEPSRLNVVKNEHNAELKKLYYQVYGTPCGGWYDGVSPNAAKNEGWLKNFVEGAERAQKT
PIVVLYGIPNRDCGSFSKGGHPTAASYKAWIDRVSAIIGQRRAVVIVEPDAINYCGHKKG
TQAYNERAELLSYVGRILQKNNPNVATYIHAGNAVLTTNHPEAIAQAIIDGGLQYMRGFA
LNVSGLGGTLEEQEGAEKFVAYLASKGFKDKYYVIDTGRSGINRPQHQNANAPYNSCNNF
NAALGPRSTSKTTGAHADAYLWINGGGGSDGECNMGAPAAGKPYPEYTKHLVENAIRVKS
IEILEVPESLK
>SEQF1602_00704 hypothetical protein
MFYKELEVAPGCVGLLFKKNVFQQELSAGIYKFSPWEKVQIISLSQKLRSTRVVNQEVLT
ADNIALRFSFYIAYKLDNAKLFVDNFGVGADNFAIAEQQMVAIAQVLLRQKIAAIHSEKL
NESREDITNFKEEAFCNEVAALGLKIIKAQLIDLTFPRSVQELFSRVLESKIRATSELEN
ARTAVATARALKNASELVKGDENIKFLQYLETITKIADKGKHTFVIGEVPMTKI
>SEQF1602_00705 hypothetical protein
MSRSRKKAIFKDKGIGKRTYHRIVRRHNGTILRTKIKSNILLDDIEIELDLKDSKSIVND
YNYCDYKTNWEQNITLKNLLTKEELKKWQRK
>SEQF1602_00706 Carbamoyl-phosphate synthase large chain
MPKRNDLHCVLLIGSGPIIIGQACEFDYSGSQSLRSLREDGIKTILINSNPATIMTDPSM
ADVVYLKPLTTKSLVEILKAHPEIDAVLPTMGGQTALNLCIEADEKGIWKDFGVEIIGVD
IDAIQITEDREKFRVLLDEIGIPMAPSETATSFLKGKEIAQRFGFPLVIRPSFTLGGTGA
SIVYKKEDFDMLLNRGLEASPIHEVLIDKALLGWKEYELELLRDKNDNVAIICTIENMDP
MGIHTGDSITVAPAMTLSDRTFQRMRDMAIKMMRSIGDFAGGCNVQFAVSPDEKEDIIAI
EINPRVSRSSALASKATGYPIAKIATKLAIGYHLDELQNQITKSTSAFFEPTLDYVIVKI
PRWNFDKFEGSDRTIGLQMKSVGEVMGIGRSFQEALQKATQSLEIKRNGLGADGKGEKNY
EQIIEKLTYPSWDRVFVIYDAVQMGIPLSRIHEITKIDMWFLKQYEELCALEKEISNYKI
DTLPKQLLFEAKQKGFADRQIAYMLGCWESEVHKKREELNIRRVFKLVDTCAAEFKAQTP
YYYSTFEAPIRTADGKEYVANDSVVTDRKKVVVLGSGPNRIGQGIEFDYCCVHGVLAAEE
CGYETIMINCNPETVSTDFDTANKLYFEPVFWEYIYDIIQHEKPEGVIVQLGGQTALKLA
EKLDKYGIKIIGTSFQSLDLAEDRGSFSTLLKENNIPYPRFGVAETADEALKLADELDFP
LLVRPSYVLGGQGMKIVINKEELEAHVVDLLRKIPNNKLLLDHYLDGAIEAEADAICDGE
NVYIIGIMEHIEPCGIHSGDSNATLPPFNLGEFVIQQIKDHTHKIALALNTVGLINVQFA
VKDDVVYIIEANPRASRTVPFISKAYQEPYVNYATKVMLGDKKLTDFHFNPHLEGFAIKQ
PVFSFNKFPNVDKKLGPEMKSTGESILFIDSLKDDAFYEIYTRRKMYLSK
>SEQF1602_00707 hypothetical protein
MKYLSKTPVLLSNYIFLLKSIVISLLFYSCSSNFPENQVYGQDNPHDIKPYLSQSNLKGK
IKTLHYYNGDYSETFHFNKQGLLTHIDNGLHQKLSYNRQGKLTKIYSERDEIIFTYLPNN
TVKQEWKSDFGNSTLYYIYNDKGNLLSEESEGDGNYKYLYEYDSQGRLLVKKYDFAYMKA
LKETETDMGLSERSFMKLYEYDTAGNLRKYTEYDRQGDIEKIDIYKKGLLIETQRYEQNK
LFEKSIFTYDNGKEQETVYNQKGTPIRLATYNTTLDKQGNVILKTEEYEDTSDTIKAQGI
KTIEEREIEYYP
>SEQF1602_00709 hypothetical protein
MDLQKDFHKYNLITGWGVFLIALLTYGLSVEPTVSFWDCGEYIATSAKLEVGHPPGAPFF
QMVGAFFASFSPSPEKTALFVNFISVFSSAFTILFLYFIIVNFTKKIALSSKETLTNAQV
IGLYGSGVVGALAYTFSDSFWFNATETEVYAMAMLFMSAMFWLGLKWTDNLDSPRGDKWL
LLIALVVGLSFGVHFMALLTIPAIGMLYFFKSHFEKNIKNFILANVISISILLLIFKLIL
PYTLALFGYTEVFFVNELGMPFNSGTIFTGISIIALFVFTLWQAQKHQKRLLQTATLCLL
FVFVGFSSWLMIPIRANAGTVINENSPTDARLLLAYYNLEQYQKTYLFKGPMYSDAFAPT
GDDYMDEKPKYERDYKQQKYIIVNQYKDALDAPNPEHVGLLPRMWSSEHAANYMMLTSPL
KYHINPERNDEQTQQLNQALQRTLAAGDYEQYAYLLRRGQGRIIVEKPSFWDNLSFMFSY
QFNYMYLRYLLWNFVGRQDDIQGKIYNNHGNWISGISFIDDWHTGYPQEHLPSDARDNRG
RNTYFFLPFLLGLVGMFFQLSSSKRQWWVAFTLFLFTGLALKVYLNERPFEPRERDYALV
GSFFTFAIWIGMGVYAIYVFLEEKLSFKFKGLAPAVIGVCTLAVPARMLAENWDDHDRSN
RYTARALAKSYLDSVSKDNGAMIFSIGDNDTFGMWYMQEVEHYRTDVRVINTSLLGTDWY
IDQMKCKAYTSDPIPSQLVHSQYAYGVRDAIYFDQKTDKIWNIKDFMKWVSSDDPSTKLE
IEREGAPSQFYSSYPTDRIRIPVNKENVLKSGVVKPEDADKIVDYIDIKLPFGMGKNRLM
MLDIIANNDWKRPIYFTGGSYSDDEYIWMRDYLQLDGLAYKLVPIRTPIDKDNPYDMGRI
DSDLMYKIVKSWDWGNMDDPNIYHDPETRRNSIVFRGNLARLTETLINEGKIQKAKDILD
LATKRIPVSHFGYYFTVEPFITGYYQVKENEKARKLFLEVAKKYQENIEYYLTLSASDFI
NLYEDVSRDLRRYDAMLPILAEDKSFYDQQYKIYEQYIDRLQDKAVSFGLLSQEDIKAQK
QPKDPNPQTPDSTQSQDTAK
>SEQF1602_00712 Thermolabile glutaminase
MNEQTAYAKTITGIYNKVYQGKNVGKIPTYIPELLNINPDKFGIAIHTLQGKKFGIGDYQ
EKFSIQSIAKVLSLSMAYNIFGDSIWERVSVEPSGTSFNSLLQLEANNGIPRNPLINAGA
IVICDILLSHFENAEEEFIKFVRQLANDPTIEYSQTIASSEKEVGYRNFALCYYIKSLGN
IENDPERVLDFYFKLCSIELTCESLAYVFTFLANDGITLHEGNRILPHIYTKRINAIMQT
CGFYDESGEFAFRVGLPGKSGVGGGIVAIMPGHYAIAVWSPRLNEKGNSYRGVKFLEGFT
MQTQISVF
>SEQF1602_00713 2-dehydro-3-deoxyphosphooctonate aldolase
MAGPCAIEGEDMAMRIAEKIVKITTALDIPYTFKGSFKKANRSRIDSFTGIGDEKALKIL
QKVSLTFGIPTITDIHEIKDAEMAAEYVDVLQIPAFLVRQTDLVVAAAKTGKKVNLKKGQ
FMSPESMKHAVQKVLDSGNDQVWITDRGTMFGYQDMIVDFRGIPTMKQYAPVVLDITHSL
QQPNQSSGVTGGRPDMIETIARAGVVNNVDGIFVETHFDPANAKSDGANMLHLDLLEGLL
TRLVAIRKTINTF
>SEQF1602_00714 hypothetical protein
MWIYYVILGAIALVSWLVSNRLQSKFEYYSKVHLRNGMSGAEIAQKMLEDHGIRDVKVIS
TPGRLTDHYNPVDKTVNLSEAVYNQRNAAAAAVAAHECGHAVQHAQAYSWLTLRSKLVPA
VNVSSNLSQWLILGGFLLGAAAKVGFGYWVALIGVILFAVTTAFAFITLPVEYDASNRAL
AWLKNKNIVSQQEYAGAEDSLKWAARTYVVAALGSLAQLLYWVYRLMGSNRD
>SEQF1602_00715 Sulfate adenylyltransferase subunit 2
MNHLKQLEAESIYIMREVAAQFERPALLFSGGKDSITLVHLAIKAFAPMKIPFPLVHIDT
GHNFPEAIAYRDALAKRIGAELIVRQVEDTIKAKGLTEPKGKFASRNWLQTHTLLDTIEE
FHFDACIGGARRDEEKARAKERFFSVRDEFGQWDPKLQRPELWDIYNGRIHKGENVRVFP
ISNWTELDVWSYIEQENIALPSIYFAHDREVIEHEGRLIAVSPFIQIDENDKIVNKRVRY
RTVGDMTCTAAVESDAATLEEVVREIAASRISERGETRIDDRVTEAAMEDRKKGGYF
>SEQF1602_00716 hypothetical protein
MTTAIRYLFLIGMLFGAFSLYAQEEEEVPFFRIEKHPYYVQTDTITRETKEIPFKNFLDQ
LVIKNLRYPQEAVEKKIQGRVIVALRIDKKGILSIKEIIGRNPLLEEEACRIFDGFPQLS
PALLRGKPVNILYNYPIVFRITE
>SEQF1602_00717 hypothetical protein
MRTIRNLFFIGMILGTFSLYAQEEKDIPSTRIDKQPYYLKIDTLTGEKKEIPFSNFAHQW
VTKKLKYPERGIEEKIQGIVIVILTIDEKGILSIKEIREGNPLLQEEACRVFDGFPQLFP
ALQGGKPVSITIGYPIRFKIDY
>SEQF1602_00718 hypothetical protein
MKALIIGATGATGKDLVTLLLNDDTYTEVHCFVRKPLALTHPKLHAHVVNFDTPEAWADL
LQGDVAFSCLGTTLAVAGSKEAQWRVDYDYQYAFAQQCKVNGVPTFVLVSAAGAKAQSKL
FYNRMKGQLEEAVKALEFTRLLIFQPSVLVRKGSDRKGEQFGLKMIVLLNKIGLFKRYRP
MPTNVLAQRMRREVATATEGVHTFTLDEIFL
>SEQF1602_00719 hypothetical protein
MKKINKLVICLAVALVGCNSQKQTSTSPTLPEVSRWTGEYGGFDKSYDDTLFALREEIAP
KFKQLSFNDTLTGRTMQYNLFTPKNYDPNKQYPLVLFMADASTVGKGVIAPLKQGYGGII
WATDETQKEHPCFVLVPSYKGKEAATNDAYEVTDEVPTTYHLLQEILKKYAIDRNRVYAT
GQSMGGMISFYLNVHYPDLFAASLYVGTHWDFQQLKEVLPKQKFFYIASELDKAAPIMQQ
METFFTQENIAYATTKFAANLPEKQKEQAIKELLKKGADKNIVQFIKGTVLPNGFTKKAE
AGEHMYAFDYAYQLKTVRDWLLSQHK
>SEQF1602_00720 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase
MIKHAFVTGATGLLGGQIVRALVARNIEVSALVRSREKAAKMFGNLKINFVEGDILQPES
YRAGLKGCDALFHTAAFFRDALKGGKHWQTLYNTNVVGTKNLLQVAYEEGVRRVVHTSSI
GVLEGKRGQVIDETMLRSSNTSNDYYRSKILSDEAVLSFLDTHPDIFACFVLPGWMFAPA
DMGPTSSGQFILDFLQKKLPGVMKASFSPVDARDVAEHQILAMEKGRRGERYLAAGRHME
MREIMVALAQVSGVPMPTRKIPNALLWTIAYLNEFYHFLTKKPILLSRASVKGIEDEYDC
TRFSHEKSARELGVSFRPFAETLKDTIAWYRENNWIK
>SEQF1602_00721 hypothetical protein
MNIHLLRSHIEKIVPLSDEEFALVASYFVERSLKKHQFLVRENALIPYEYWVVSGLLKVS
QIDSSGKEHILQFAMEDWWVSDYQAFFLHKEATLSITCLEDCQLLAISYEDKEKLCDELP
KINTFVRKKSNMGYIALQKRILSLLSNDARTRYEQFLELYPSLLQRLPKSLIASYLGVSR
ETLSRLYS
>SEQF1602_00722 Sodium, potassium, lithium and rubidium/H(+) antiporter
MLLIMFANRLKVAYPILLVLGGLAISLIPNVPTITLNLDLVLIIFLPPLLYADVFSLSLK
EMWKWRRIIFSFAFIVVFITAAVVAWVANMVFPGFSLALGFLLGGVIGSTDAVSASAIMN
FVKVPKRISTIIESESLLNDASSLIVFRFAALVVTTGQLVWTDMALNFLWVVIGGALIGL
AIAWVMSKMYKYLPTDANMDVILSVIAPYIMYIVANEMGASGVLAVVAGGMYMSLHLTSI
FAASTRNKGVAVWGILGFILNGLAFMLIGLALPEVLEGIEAEGMSLATATNYGLLITGVV
VGVRLLSSYRSYSLLK
>SEQF1602_00723 putative Na(+)/H(+) exchanger
MKHFITVADRRNPSTRVPLVLGWAGMRGVLSLAVALSIPLTLENGEPFPHRSLILYITFI
VILATLLVQGLSLPALIRWAKYPDYEDHIPEAEAESLIRKSLAQAALDYMQKHYKEGITD
SFLLQNQKDIWQYQLDLPKCNTTPEVRKKYVAILHHQREILHQLNKNPRIDEEQIRNFHR
QLNLEEEKWEVWEV
>SEQF1602_00724 hypothetical protein
MLFIIFFSLLAGIALAAFYIFLVSKFTSSYDREISLLFFPVPFLLGVWICYSFAYNQKIV
GAIAVICTIVFFKFMMGTLGVTFSKVYERLTLPKIYKNYHSTSDHRISRIEGSEYLMRLP
EDIHHFARGIYLNPQNELVIYDKSIPMERGELSVINHIEKYNSLGERMQNKDTLEVQQDI
PDIFDGSSQHFLKRETLERKDIKPMYVESYKTKGNKYETILYFEVKTKPHTFRLKTRFSY
IKNQKELSKKPTTYYENDSEIIESFGNISLYTNKHLHYQLLQIKDDIYLGLIYMVK
>SEQF1602_00725 hypothetical protein
MLSLDRLKYIEGIQKYTRFSVVTTIAIAIVVLTIFIVNQTVIKEKTLSDIPSSPFFSVII
IALLLYCFVFYRIKKRIKRLQELIEQMTEEEFQFLLQAQSSLSFYYKYAPTFVICCDRLY
LFTLFEIKEIDPKKVQKVAYHYARGGSFLVEIQSPETTKFEVYTSAYPYLERLIRKYNPN
ADIEVYKL
>SEQF1602_00726 hypothetical protein
MTPELQLLGDAIFEAAKKAFLKLFENGEHYYYCVLLTTGEALPPCIAACSVEALERLVNE
KSIPEEEIPYYKYSFADSPYYAFGYEEYFQQVVQLFEQRDSLMDYNNEEQWNEEYDLRLA
AMVYAMKKLDETGIFALNQPREQVYINVELMPPDDTDLQRALSFNNPDNIEEWLSIFS
>SEQF1602_00727 hypothetical protein
MNEKAIKLYEQAQADYPTLKTQIEAQVVRWFWAAGGVGYFSLEPFYFEEHKFPKSKILKE
TPEKTDDKYLYGVNANDEIILERSYIGYGDECYEDFYFREENQIINYHFNSYVKKECLSV
NIFIYKEGLLQSIHSAYSAFDNSKTWREKIMYYEGDKLIRQEEKGLDYYLKPIDNALLYT
YDMLGKLNSITSGTGYVCYQKKDKKISYKALSEKAAERYYALLVPTIKAYPVKEPLYCIN
LSFDYQNILPTRIGFGTESERQEYQKYGKEAKHYLWNTAEYAHTIDIEPNEEDAALFDLF
NQETEMQEKSSAATKLLVACAKRLKEEWASLGIPSTDDFVVVVSDEEESFLKKV
>SEQF1602_00728 hypothetical protein
MNPIIKQWDTAKSLKRANQYEEALAIYETLCPKVETELSDTFDRAMFFGDYFGVLADVAQ
YDKAEAMAAKALKYITENGYTTLNYIFYNYGNMYLHQAKWEEAIPWLEKALNKNSNGWID
EKQKAYYGTALGGALFHLGRIEEAEEEFLKAVEAGKYTVANKDWEPFSTSKRYTSKKVTR
N
>SEQF1602_00729 hypothetical protein
MKHFFLSVALMSTMLGFGQASGNLNYQNRNQSNRENNNFSLDFPTNYEMVVSAKGLANIK
ADAFVAIFSVVQVGKTAEEATQLMVQRLSSALSALKAKNFEIFVDMISFVPMYEYETEKK
VFSKRTYNEVPMGFELKQNLHIKINEASRLNELITLLANNEIYDLVRMDYYSSQLETIKK
ELKDKVKSAFAEKQKVYETTLGESFASAEKKVVDGFFHIYPTEQYSSYEAYSSASLQGKR
AGNVVQANKSTTQYYQPIANRDFDVVLNPIIVEPMIQVVYEIKMSVNRPDKNKAKEALLL
TPAGELKKINLP
>SEQF1602_00730 hypothetical protein
MKKLFLLLCVWATLPAVAQTSKDKILIIDASYLKQGSSYGQLGVHFTYYDSNKLALFAGL
AGNFRSENGLVAIPEAQLSAWIRADESHGGLVDIPVLLFRPQLNFSPYYFAPEAGFQILF
FYVKAGYGFPWGKMSDNYPFDTGKFRFSVGAIIPLNIK
>SEQF1602_00731 hypothetical protein
MNIGYKYLFLPILLLCIGCTSSRKIKVPDDYCVPPPYTMTKEKEAPIEVDEAKLALGKKL
FEGKLSSRNILIAYASDTDEALLSLIALADDSSEQAQLKRNTLKIEIHSKINAIFSQMNS
VTAELDCEEERIDQIATTLSNINDKNVTRLTVASILVGAASAVAGAYIADDNWNKGVTVG
SGVLGAGLSFLTLNPKGKKVVLQHPRNLLRCFITEKNDIEFPPFVWYMLNEPRFTNSGES
SVLRNTQKRWIRHLFDNDKEKALKAVVFSDGGVYNAGDLHTRAEMFDQMQSVIHSLNQNL
NFFIQEVNILMLKK
>SEQF1602_00732 hypothetical protein
MFTIPYIETREEFFYLDVFLKLLLGLLAIALVINKSGKGNLAPTSAMDQVQNYVLGGIIG
GVIYSPAITLFQFAIVLVIWAFLIIGLRKLKTKILAFRHFIDGTAVIVINRGKIDIAACK
KAKITAHDLAFKLRKEGVYYIQNVKRAVLEQNGELIVVLAGEENPKYPIITDGIIHKGVL
EDVDKTEEWLLEELHKQGYESVPEIFLAEYYGGQVKVVPYNN
>SEQF1602_00733 hypothetical protein
MKKLLYLLLVLLSSVTAYSQMLFSENLTMTIDSTKTLQGSLMPEIDFKTEKENIFTFKNT
ANLNLLINHNRVINVINKFELSTYGKQVILSGGYVHMEYRYLLDHAFEVYPYVESQWAES
RGMIHKISSGLQSRYRLVNTNSSLMFVALGLFFEYEKWQHPTPDANTPEHAYSRSLKTHL
SLSYKLQLAKKWGLTTTAIHQGKPDRTYFKEARFGGALDLNYSITNAIGIRGAYRLIYDT
APIVPIKKDYHSVEVGLTVSF
>SEQF1602_00734 hypothetical protein
MNRILLLIARVARTWTLPFSMGIGAVAYLVFYYVPALEGASQWFAPLFNSILPLFMFLIL
YVTFCKVDFKKLAPVKWHFWTTACQLLFVVSIVGAILFFHISGKQLILLESILACIISPC
AAAAAVVTLKLGGNLEQMTTYTFLSNLLCALLIPVCFPLIEPASQMTFWGAFSLIMQKVC
LVLVVPMLLALLTKSLLQLRRFHQWLIHIPDLSFYLWGCSLMIVTGTTLKNIFHAGTSVL
FLLLIGFSGLVLCLLQYAVGRYIGRFFGTSIESGQALGQKNTAFAIWIAATYLHPLSTVG
PGCYILWQNIINSIEIWKKGKYKA
>SEQF1602_00735 Endonuclease III
MSQKAKVFNKLLAHYGKQHWWNDPNRITDWISMILIQQTTQQNTEKALANLEGNISVEAL
HAMELNTLQEYIRPAGFYKQKSTYIKALMEWYVSHGASLQKFEAIPTEELRKELLSIKGV
GEETADAMLLYIFERKVFIADQYAIRLLNRLNLSTAQTYKALREECMPLVAEIPLETCQE
WHAVIDVHGKAYRKGFTDEQWLIE
>SEQF1602_00736 hypothetical protein
MNDFKLTLLRKWEFDNEFSFVYASTLLPNGTAVILTSDNTDWHKYYVLFLSTEGVKKIPI
EYNPTSNRDYPMLFRYKEGFAIIISAEEVRYYSDMHSSPALIPIKNKSLLRYNIVPEKAE
QRYFQNISDSQTIPVCFENEVYYGNARCFALLEFDEVAKTAKWKSFSKIDKKAFTHCDNR
TSDTPKIDSLKISDKKIYAFIPGESASSVNKWGMDYYALAQISAEGKVIEKIIESDNLHT
DHKKRGVNGCFTDSEYVILTPVFKTDDWKGNQKVFSLTTREYSNIFLPKGMTKHKLQNIT
GKFCLTSLFDRGLKEISLCNYNNL
>SEQF1602_00737 hypothetical protein
MELEVGKNYRIKNDIFSFKAGEVWSLVDEGYQAYFGEHNFVFVNAEKNCHFMVLRNTSDE
DMEIGCHLDRYFEEIEE
>SEQF1602_00738 hypothetical protein
MKLSLSLHPLKKALKKMKKRFLIAALFALFLGGIAVAQSQEQPSTLAELQAEKERLEAKL
VKVLEDKENAKNSLTGKYADVAFAFNRHISKKQKKFAKTVERGAKRQEKQIKKKLKKLNK
RIEEIKKEEIAN
>SEQF1602_00739 hypothetical protein
MEIKVIEHINLTQELVDQKKFFTLGYCKALETYLMAVLVPWIVDYNRYYRISAEEYHLYQ
NDSQAFCQLYEKEISRNEECFTQKFIGAGALRDYDGRVHFTRAYPSKEVNPFVNYIYYEG
VLYARILWDKGIVYVPPYQKVKTPNGDWEYPLRKECYIEKDLEDQNLCFCLDTQKNRKIS
>SEQF1602_00740 hypothetical protein
MNSTKRNYSKQEKEKKPKREPLFGEKLLKIGRIILIVLVGCYLLSFLWTTPHFIFNNDSI
GVMIIFFLPMAVSLGVFFLFHRWVLSKRIHYEQYIRGELPPVIRVKALNDRVFQGIVFVL
IVSFYTLVFWFINKEIRSKETGELLRYFYQFIAISILIGIIVLFAYDLRKKYRDTFYAIE
IRNGILYIFYKETLQQTIDLKSIRYVYFFLKESSRETKIHPRMKVFNGRTFILCIKLSVD
NYLLLKAFFTRNNVKITDNYTIL
>SEQF1602_00741 hypothetical protein
MDKLLKGKQSKKRLNMISFSRIAIACLLVFVVTSFYIIFKDNNQVDEHFSSNSYQYCLED
SFFYKYQGKIYTKIIGKGYKAIPEADAATFQVFPKSLRIQQIGWDKAHVFHNNQIVPLQP
PITPIGNDLFTDGKDTYFCASRPDFKAGTNDYPPIKQVGRNGQKFSALNSSPYLSTDGTY
FYYQGEKIEGAKDTIFPILELRERDKNSKKISFSCYFSDGKHVFYKNHLLDETFTDDLVT
DIFSNHGYFEYLYHLNGGKVFIDGKPFMPNEAHYHLLISDNSYTNHLFFTNENGVYYYDL
EEKEAKKAMDSNPFKGYKKEDNGYFYNEKNILFFRPRTHIARGRRYKGMTGYSTEICLLK
NTSTLEFEDKIKQKVLSSEEYQVLAKAKTRTVSFWERYFVLWLVIIVTILSYIFRFIFRQ
YNITIDPFVLDEKYLRINNLVGKRYLIKDIQEVVFMIHKEKNILGEMRIVTKSKGTSLSY
CVRSGKVTETEAALTEKIKDLQQLLEKQHIKVEIDS
>SEQF1602_00742 hypothetical protein
MRLQVGKSYRVLKDIFNFKTNEIWLLADKGYQIYYGEHNFAFANTEKSCSHIVLRDASEE
DMEIYSHLDRYFEEIEE
>SEQF1602_00743 hypothetical protein
MKKRFLIAALFTLFLGGIATAQSQEQPSTLAELQAEKERLEAKLAKVLEDKENAKNSLTG
KYADVAFAFNRHISKKQKKFAKTVERGAKRQEKQIKKKLKKLNKRIEEIKKEEIAN
>SEQF1602_00744 hypothetical protein
MKRLLPLLLVLLWGQNILWAQKAVLVRTQYESYATDNETDSLLPERKESREYYTFLRFNR
RKDTLFVHKKDTPKDIAQKDAFSYFLTTKKIASDKLQLLIGDRDNTHTFLFYLESPDLIH
INKDRYVLSDEYSHFLRKKIFKKRDIATILDFLDDQFGDYFIDTEVFMISTKDKYKKNLK
MYGGTVLNEADTTVYSTLYAAYDDKGLRMSGKVNTNVPELPFSLDKKRKYIDADKLVLEI
EGQTPKNNTTYTQEIYFSGEKFIEKGEYTQYGLNITTFYTETIEKIKNERCRK
>SEQF1602_00745 hypothetical protein
MKDVENKQVKVYLSRDSVCAADDVNCPNPATFYLPDTIDEFVLIMDKMLPFRKWRCYLGE
YREGIVGAEDGILVWKEIDNHVLISSYKTNNEFIVTHDSDWYETIKSHPYLYFEWCLD
>SEQF1602_00746 hypothetical protein
MTVIDIGNLLDTCKDEYFLVEESTGNIYYQYKGEKKVFINSDKDSFNKCLFAYSNFVKNN
NSTLVTAENIINICKKHIQYTDFIIQTDFLGAKSFFWQEKLYDIAILIEDNHSILSPYND
FFLFYETKMYINSSIAEINTYQEYQNIDKESVIRTIQTIYNDLSIENLHTIQLKVMELVL
VPLYGKARFDDFLLRREKRIKEIMGI
>SEQF1602_00747 putative HTH-type transcriptional regulator
MTSQPSIFNLKAEESSGLLLWQVSMLWQRGIKKVLQPFDLTHPQFVLLASAQWFAQQGKE
ITQVSLANFTKIDPMTTSQVVRTLQSKDLITREEHKTDTRAKVVAITDKGAELIAQAVAK
VEAFDDEFFSILTIEQPSFNAQLHKLLTN
>SEQF1602_00748 hypothetical protein
MKKRPIKYWIVVASRDHVQMGVAAGFAQACHGKAQPLKRMQEGDGILYYSSKRYFGKEDK
CQAFTAIGKVKDEEVYAFQMSENFCPFRRNITFVDCEETPIADLIELLDFIPNKKVWGYP
FRFGILEISENDFKLIASKMLHNDLSALNF
>SEQF1602_00749 General stress protein 14
MKVLIINGHPTMETSNANKAILEEVKRLLPEAEVSNLQALYPNYQIDVTAEQAKLVKADV
IVWQFPVNWYSLPALLKKWLDNVFSHGFAYGDNKLMGKKLILSFTTGAPEEAYQHGGAQN
YPFTDFLNIHRQTANHCKLLFQEPVISYGMKYIPEVMPKEALTTLQQRAKEHAARLVAQI
KELN
>SEQF1602_00750 hypothetical protein
MKLNAGIITEKLAESKAFYTQVLQFGVTFENDFYLLLHTPNQEAEISFLLPNHPSQQPLF
QKPFTQQGVYLTIEVENVDEYYHKLKEQGVPIAIALREEPWGDRHFAIIDPNGIGIDIVT
YSAPE
>SEQF1602_00751 hypothetical protein
MYFCTLSIANNVLSLRPYYHPTQSVIPAEEKEVTYTEFLPCEALRPFIYCYWELKSPPRN
TPFFYRVVADGCIDLFFDCNAPQMSSLMGYCNTYIEFPITGAFHYVGVRFLPSAFPLLFG
QDAFEISAQEIPLCEVVPALATFIAQQLETPLSLATIAQCLDNYFLRHLSQRPLQMDNRF
FSALLQILQSKGSIHISELDTGISPRQLRRLFDYYIGDSPKTFSNIVRFQHILSAKAYHN
HSFLDTYYDQAHFIKSFKTFYGDTPSKVLG
>SEQF1602_00752 UvrABC system protein A
MKKENPKSPKNIEVRGAKVHNIRNIDVDIPLNKIVGIAGVSGSGKSSLALGVLYAEGSRR
YLESLSTYTRRRMTQAERAEVDDVRYVPASLALHQRPTVPGIRSTFGTMTELLNSLRLMF
SRLANHCCPNGHYVKPSFAVAAMQEITCPECHEHFYGPGAEDLAFNSRGACPTCGGIGTV
RMVDESKLVPDENLTIDEGAVVVWGTLMWSLMKDVCREMGVRTDVPFKDLTPEEKEIVYH
GPAEKKHIFYLNPKTGQTAEMDFTYYSAVYSVQNALAKVKDDSGMKRLEKFLKEDVCHDC
HGTRLSPAARAPRLRGIGLDQATAMTLDELMVWVAGVPDSLEEAMRPMAKNICEAFTDTA
HRLIDLGLGYLSLDRAAATLSTGERQRVQLARAVRNRTTGVLYVLDEPSIGLHPHNLKGL
TGVMDDLIADGNSVILVDHDTQVLTHADEIVEMGKGAGTNGGTVIAQGTVDEIAQNKESV
IAPYLSQESKLPAELPKNELFSMGNIHLSTDAIHTVHPLEVEIPKGRLTVVTGVSGSGKT
TLVLESLIPALEANAMGKKLPQHIKLVKAEGIRQVKLIDATPIGINVRSTVATYAGIHDE
LRKIYAKTLDAKQYGYKAGDFSYNTGDLRCPTCDGTGQISLDVQFLPDVDIVCPDCKGSR
YKREAYKVFRTAKNGEKYSLPQLMSMSIDQVIEVTTDLKLVNQKLQVLQQLGLGYLSLGE
DTPGLSGGEAQRLKLASEMGKGQSDTVFVFDEPTIGLHPQDVCVLLGVFQSLLSLGATVI
VIEHDLDVIRNAHYIIDMGPGGGAAGGRIVAQGTPQTVKNNANSITGKYL
>SEQF1602_00753 hypothetical protein
MNIEEFRDFCLSLPDTYEKMPFSGFFKNADSILVFYVGTKMFCFFDINKFDKCTLKWNPD
EIEQLKANYQAVENPFNLSKKYWVGIRFNEDMPDDKIKAYVKQSYDLVASSQKNKLVK
>SEQF1602_00754 DNA polymerase III PolC-type
MNTFVALDFETANQYRSSVCSIGLVFVENNEIVDTYYQLIKPAPNYYSPFCTQVHGLSQY
DTEKAPLFPEVWKEILPKIKDLPLVAHNSMFDEGCLREVLAYYALPQHTNPFFCTLRAAR
KSLPQLVNHKLDTVSAYFGFDLKQHHHALADAEACAHIALELFK
>SEQF1602_00755 hypothetical protein
MIEKISNILGMNTLKKKPTSCWVFYAKEECIGGSPYPLEDFQKIMNNYTQLNDHNTELLL
GTIHEKDTSGIISICLEQNNSLSEDYSYFIPQSIIFEDINENVRYAICRVKDKCEWVRYA
YFISNKKGHRSYDYIGKNDPVTDSSTIERLEKRLAVYIDLQNALLKKQEGKGEIAPQNIQ
ISKKFQKEWLSLADLLSIPSCAANRICMSVLGEENLSDAFLSEMIASNYLQVIDWKTEAE
DVIYNYNLLSKQLKGKEIDLEIDNNTPPDKVFQLLAAKSEFALYDIDIGGDSYIIGLCPK
ENAEAAQRQYGVLFSMLEDEASVLLIS
>SEQF1602_00756 hypothetical protein
MGHDYIATAQTLPIYETAKEYKGPALVIHGTWDVVVPYTYGERYHQGYKNSQLILLPQVD
HSFTSEEARIKTATEITEFIKKY
>SEQF1602_00757 Carnitine transport ATP-binding protein OpuCA
MITFTHIYKSYNGKEIISDFNLTIESGTFLTIIGTSGSGKTTVLKMINGLVLPDKGEIHI
NGKNILAEDLIALRRNIGYVIQGNILFPHLTVAENIAYVLHLKKYSKTDIEHIVTEKLQQ
VNLPPELANRFPHQLSGGQQQRVGIARALAASPFIILMDEPFGALDSITRKQLQRELKAL
HQQTGVTIVFVTHDITEALTLGTKVLVLDKGVIQQYDTPEMIKQHPANEFVKQLAN
>SEQF1602_00758 Glycine betaine/carnitine/choline-binding protein OpuCC
MTNLSTLLRDEAPFFLHLTVEHLLISLSAIVVASLIGVLLGIFISEYRKYAAWLLGAVNM
LYTIPSIALLGFFISITGVGNLTALIALILYALLPIIRSTYTGITHINPLIIEAAEAMGS
TRWQLLWKIKLPLALPVLMSGIRNMVTMTIALAGIASFVGAGGLGVAIYRGITTNNSAMT
LVGSVLIALLALGFDFFLAKIEKRLVNREVAHKRNPLKLVGVGVLALLITLFFVLSPKKT
KDIHIATKPMTESYILGQMLALLIEQDTGLSVRLTNGVGGGTSNIHPAMLRGGFDIYPEY
TGTSWEAVLKHKDPYQDDKFSILEDAYKKQYGLEWANLYGFNNTYGLAVSKQVAQQYQLK
TFTDLAKVSHQLIFGAEYDFFEREDGYKQLQEVYGIHFGRVIDMDIGLKYQAIRDKKIDA
MVVFTTDGQLFVSEVVVLQDDRNLYPSYKAGTVVRTELLTTYPALRTTLKKLNNLIDDAT
MAHLNFLVETERKRPEEVAKNYLLQKGLLHPQQ
>SEQF1602_00759 putative transcriptional regulatory protein
MGRAFEFRKARKFKRWAAMAKTFTRIGKDIVMAVKEGGPHPETNARLRAIMQNAKAANMP
KENVERAIKRATEKDTANYKEILFEGYAPHGIAILIETATDNNNRTVANIRSYFNKCNGT
LGTSGSVEFMFDHTCNFRINAEGIDPEELELEMIDFGAEEVFVDDDGILIYAPFESFGAI
QKELESRNIEILSSGFERIPQITKELTPEEQADVEKLLEKIEEDDDVQNVYHTMKESEE
>SEQF1602_00760 hypothetical protein
MIYNDTPSHNTTAYNYGSVKLSVYDWLSDIPLPAGQEVFDCVEVRFKNSRKEFFRNVHRL
PLQIGDMVATEAISGHDIGTVSLTGELVRIQMRKKKADALSPTLPKIYRKATERDIEIWR
DHRAKEVALQKRSRELAIALGLEMKISDVEYQGDGSKATFYYTAEGRVDFRQLIKDMAKE
FSTRIEMRQIGYRQEAARLGGIGSSGREISCSTWLTEFRSVTTSAARYQQLSLNPQKLAG
QCGKLKCDLNFELDCYLEALRDFPRTDTKLLTEKGIASCQKVDIFKRLMWFTYEGDFINW
HKLTVDQAKEILELNKQKQTVPSLEEYITEEEDTTQKVSPIDNSQEGSLTRFDEKPKKRK
NKKKQGGKNTAANDTAPEANPDKERDDNNKEKVAPVAKEKRNNPEGRKPQPENKKPFNNN
PQKAINNAQKQEKIAPQATNIKKSSRKPFKKPNKTTPKSDE
>SEQF1602_00761 Gliding motility lipoprotein GldH
MNKFFFFLVGALLMASCGENIQYSEYQTLPQGWAANKPIAFRYEATDTLQKHNLFIMLRN
NNDYPYSNIFLITKMEFPNNQVIVDTLEYEMATAEGKWLGEGATIKDSKLWYKEGVTFPT
KGTYTFSIEQADRSLGKEKGVENLQGITEVGFQIEGSGR
>SEQF1602_00762 hypothetical protein
MNLLTKNIKRNGYIVVICYIILVCFYNVFNYIRKPGMPELHSFSWEGIQALVETFAIPIM
LLFESYRHGDWVLNT
>SEQF1602_00763 hypothetical protein
MNAILIEKLQDFFQKNPITMGAPSTASELLFVEQTMQLKLDETHRYLLLHYGGVVIGDIR
IYGLKNAELIGDETFVELTNDFREQMSIEAQQYVISVDDTGNPILVDTATREVILYNHDI
GAYEKLFDSLEDFILSKLVDSK
>SEQF1602_00764 hypothetical protein
MNRIDFIKSLGLASTGLILPTNLLGKSLVKIYDNYIRGVQYYQYSRVKELLKEGDTLLLK
HEKENIYDAFAVEVYYQEYKLGYLPAYENIIIANMLDANVELTTQVSQHNPKDPYQSIAL
EVFAELITPTPQLLTTLQNARASDAEDLYRQGY
>SEQF1602_00765 Putative NAD(P)H nitroreductase MhqN
MLKDILHFRRAVRYYAPTSISEEKVRECLRLATLAPSGFNMQLYEFYHITDKALLEKLAK
ACLGQLSATTAQQMVVFVTRQDKHRQHAKAILEFERDNIQRNSPPERQAKRIKDKEKLYQ
KLIPFVYSRFFGLLGAFRKLSGVIGWFRPMVRELSEGDIRVEVHKSCGLVAQTFMLAMAE
EGYDTCPLGGYDSRRIKKLLHLPCGAEVSMVVTCGIREERGIWGERFRLPFEEVYKHN
>SEQF1602_00766 hypothetical protein
MQKLITPEKSPMFYCDRFDYTLSDNLHLGGGRDVRDYIPEEELLKICRPVFTLLKLVKSE
SYMVDYLYWLKPTDLDEIDEKVRTDTYEDADFKYSVKAYFTPKVWCFHCNQVVGKALVVG
HQIYPYHFDIECEKKKNRQEVSLRNVPSVEEDLPSRHYISFKDD
>SEQF1602_00767 Pantothenate precursors transporter PanS
MKKIFNKQNNFLFVLVGMILLARILPYRDEYNSTFNLNRFIDWGICIIFLLYGLKLNIKE
VFRDIKNWKLHLLVQLGTFVLFPLLVALFYPLAKGTDYQLVWLSIFFLASLPSTVSSSVV
MVSIAKGNITSAIFNASISGLIGIVATPLLMGFFLENTSAEVDQGAIIQQLLLKVLLPIV
LGLLLNPLLKKWVDKYSKWIGQFDRFIILLIVYESFSDAFVKQIFLSVSPMVFVIIAGAS
VALFFIVYEVLKRLSHALGFNREDTITTTFCGSKKSLVHGSLFVMVLGIPETQKVLYLLP
IMLYHSFQLFYVSWLANRIGQQVKN
>SEQF1602_00768 hypothetical protein
MKKYLFYTLALVGCWLLPIGIQTLVSVFYEKYFTYTTIHGVSWGLFVYYVYYYFNSIGLL
LAFSLFQWKKGLFFVPYGLLSLEILQHFPYRPLRTLLIWGSISIGYALLFILLNRIRKIN
HIQNEKDI
>SEQF1602_00769 Multidrug/solvent efflux pump periplasmic linker protein MepA
MKKILTAVIILALVGFMAYRLYANKEKNAQEVAIVAQKEAQVAVRAAKVTQENVSDLFTA
NGTFVAEQDLNVSSETGGQIVKIYVKEGDYVKAGQVLATTKADRTNVQLDNARAVLETAK
SDLKRFESAYQTGGVTARQLEQAQLQVKNAQANYNSAAIISGDTSVRSKISGIVSSKEVE
EGTLVNPGQPLFNVVNIDNLKLKITVDEAQVSKLKVGQTIEVKPSTSSETVEGKIVFIAP
KSNGALKFPVEILVANKDKKLKAGMYASAQFAGQTEATTALVVPHSAFVGSVSQNKIFKI
VAGKDDQGQAVPKAELVTVKSGRNFGDKVEILEGLVAGDQVITSGQINIDNGTAVKIVE
>SEQF1602_00770 hypothetical protein
MRILIPLIITFIFVGCQKDNSPKVAPPPKSTNTLIGYWQREHTASCGEDEILLFTEARIG
WVPLQENTCTLAYPKIIEYTYTPTEVGKLSVEGMSSPWEYSFRNGQLSLKKTATDAAYSY
RRITAEDYEIFIKAHQRKP
>SEQF1602_00771 Inner membrane protein YnbA
MISVYKLKPKFQQLLHPLLVWLHQKKVTANLITVVAIVFSFCIGVLFWEASTVPFFFLAL
PIGLLIRMILNALDGMMAREFGQTSRLGEVLNELGDVISDVFIFFPLLKYHPESLYLIVV
FIVLSVLNEFAGIMGKVLGGQRRYDGPMGKSDRALLVGIYGLLSYFGVGITAYSQVIFSI
IIALLLLSTFIRLKKGLYADAQ
>SEQF1602_00772 Phosphatidate cytidylyltransferase
MPMPNSKYADVPLRIRSWGVMICIFAVAISHLYTMYLFCLWMSFQGMTELGRLFRYETTY
WCIAVPLLQGILLISCPAYPDYMIGAGIFVCIGLILSCSLRQIPLGLPISLLIVLVAYPH
LIFLRMEPQGVLWLIFLVVVTELNDILQYLTGKAFGKRKILPKISPNKTIAGFLGGLLLS
PILSMAIGSLLDLPISLLSLALIGFFLSFWGFWGDVTFSYLKRRAGVKDTSTLIPGHGGL
LDRIDSLLFNCIWFYLWILR
>SEQF1602_00773 hypothetical protein
MDPSISPFSSCLLFSGGGTRFALYNGMYAALCEIGKAPDLLIASCGGAFASLVINAFPTH
EERKAYLQSREFYHFILSLSLTPYSKLHRLGFLALQKRYDKRPAPFVEDVYQRYLVEMAQ
DLSALLPSLSKVSFSATLPTIIIGAKMLFAPHECGSSRGRRKLYQEVLFTDPQTAQKIPP
SALQHTEPNYIHSAVASNILLNTEMPILRAARISISDMFYVAPVAYQDSYYAGGAIDLVP
MELAYTLSAEVIAERKQAYSPTEEALVRAVLGFSGNERLSTVASYPALWVDTRRATSVLK
GFYSEKYIDWKRLSIGIRFPKDYPTYFQQIEKQWDYGYQTILNTFSS
>SEQF1602_00774 putative oxidoreductase
MNVFIIGGTSGIGLALASFYQQKGHRVGVCGRDLSKLSTELPFEKYEADVIDKELLTSVI
HQFINSSALSLLINCAGSYAEDVVGEISYDQAVAMLQTNIIGAINTLEIGRELMRNSGGQ
IVLLASISGILDYPSSSLYTKTKRSVLQIAEAYRRALRPFGIHITTIAPGYVATQKLHDL
NQNNLSKKPFVVSEAQAVAEISHAIAQKKPIHLFPTRMKWLMCLLSFLPKPLLSLIMYRK
AKWMQANN
>SEQF1602_00775 Phospholipase YtpA
MNTGFFKSHEGAEIFFYEWNYKPGQKTLIVIHRGHEYGERLQEFATHPLFASYNIFAFDM
RGHGHTKAGVSPVFMDSVRDLDTFAKFLQQSYAVREEDIFVVANSIGGVITSAWVHDFAP
RIAGMALLAPAFEINLIVPLAKQAIELMLKINPKLIVKSYVKSKMLTRDPEQQRAYDNDR
FITRSINGKLLIDLANAGKRLVEDAAAITTPTLLLSAEKDFVVINRQQKQFYVNLSSYLK
EFITLEGFHHGILFEQGREEVYKILQRFIQKAFQTPLAPPTLAPDLFTQKEFETMQYELI
PNGERWSYRFQKWALSKFGHLSEGMTVGLTHGFDSGASMDYVYKNTPQGKWGIGHWMDKS
YLNAIGWRGVRIRKGHLLEQVEKAIQALQAQGRKVKILDIAGGVGNYLFDIKQRHPEVEI
VINEFLPANIQKGEQIIKERGYQGMRFTNYNCFEADTYRKLDYAPNITIISGIFELFGDN
ALAAEAIKGVVSISDNGYIVYTGQPWHPQLKTIAFVLKSHQEKDWVMRRRSQRELDGLFA
LYGVKKESMLIDDFGIFTVSLGQVKK
>SEQF1602_00776 hypothetical protein
MKIIYAFIIALILSVLAFFLAIRITDSVGAGIFLLGMLPVSFIVIIGYTKLLETFHVKAF
KYVVLYTFIACYVMVFMTVFLLGSDSQWGIWHALRDAFHVMTDVYLLICNIAITLIYSTL
FMLFRSISEKKAKKKTIQTNQT
>SEQF1602_00777 hypothetical protein
MGSRFSIDIFLFVSLWIVFPCIGYTQEKDTIPSMDIEEEESINTTCFPSMEQKPMFVQCK
DVSVRERDSCFYHFFSQYLKQSILKSPYKELEGGATVLFSVEKDGSVVLVRCVTSSLYIR
KEVQRTMEQFPKLIPAQQWGKPVRYFYRCSIRFD
>SEQF1602_00778 hypothetical protein
MRHTSIFVVCFLISKKGKVIEDRIIRKTTGCEECDTFVLKTIKKIRKIKAYSF
>SEQF1602_00779 hypothetical protein
MTLLASLLALFSCKRATEVRKATEAFAIQSLLTYEYCGEKDGFQYFLLGNQWERKVFKIK
SSEIHIDPQYAFYADPSFEPKIPITPVEQERVFAEIPMNGQKLYLYKGDIVLRYFLSCSD
VHKQKTNRSTYLYDEISQQEAEAHQEERAYYIGYYQGEKLIRYQKIYRGEVLMEKRF
>SEQF1602_00780 Internalin-A
MSYITFKSKLIEQKVKQYLKKKHEDLLVKEGRRVLVKEEGASLITKMLIHNDDLHSEDLA
DLQMFPNIKELQLLSDNITHLEALPPLEKLQKLYLNVKATDYTPLAKYKKLKKVEIYDSG
VSDITPFCELTKLKELKLSCNKLFSLKGIAKLQNLTELWLDRNQITDISPLAWLPNLEYL
QLDRNHISDLSPLKALKKLNTLRLYHNEVKDLSPLRNIPLEELDLEQNKVEDLSDLVGIE
TLRNLKICFNPVKDASPLLKMPYLEFVCTDANDIYLPLESYLGKIVVREVFGGQYPNFEE
ADTYIFSRKE
>SEQF1602_00781 hypothetical protein
MFRSFIFLLVSLLLVSCKTSSHREMDWKDQNLHGKVKKLIVTLYRLSNSDFIKREDGTPF
ISQERLTVGIFNNKGFLMEETDSIYNRPKSRTIYNYLKDNVVEIDMYGEGRKVNKTTLKY
NNKGEIIDEEFLEYILVNGQDSTYIKEETYKLVNKYDGKGNIIRKEQLSPYIKDFVRGFT
EFKYDEKGNVIEVIENYRHGIKLKRKFEIDDKGDILSIKMYYLDDELIREYSFTDYVYDK
KHNWISRKIVERDKNNEYIGTKIEKRIISYYE
>SEQF1602_00782 Demethylrebeccamycin-D-glucose O-methyltransferase
MKDISQILKADIKIEDGIFCCMNDHFVSGDNQKYMKMYDWMSFFYDFGEKWIGKLKYGNG
IDRLRTELMSRLEWKNAISVLYVSIGIGADLRYLPQGIDLKTIDLVGADISMGMLKRCKK
QWQKKTNLTLVQCPAEELPFADNMFDIVFHNGGINFFNDKALAMSEMLRVAKPGSKLLIA
DETADFVETQYKKSVFSKSYFEGKTVDLNAIEQCIPASVVEKKTELFWNNKFYGITFRKS
N
>SEQF1602_00783 hypothetical protein
MKTAKQLIEDELHKTIHQLKEVSLLQEEKQALVSYKKELEQLLSLKKLSDTYHLEPVAIE
RIIV
>SEQF1602_00784 hypothetical protein
MAAYKYPITLEAALKEVTEERFCKGNHYKDVTLTDEMVAQIVQVKSLVNMGFINTDITDE
AIKHLATLPKLKLLFLEDNKQVIGEGFKYFADKPIDHISLDGCPVTDETLKIVLQVPRLK
SLSLKRTRVTFEGLMAVANYNKVSFYLDKPFTAEQIKAFEQAQRTAGKKKPAATLTDDLP
VVKQLLLDFFAAMTEWEAFAAKNDDTEEGELLVREKCKALFQKYCTDKRRAGYRPEGIHF
SLNEGGTYRAHQIIDSETVTKNKIYLYTQNDRDDQFRFLIIRKDGEWKIDDCQWHDGGWT
KYGL
>SEQF1602_00785 hypothetical protein
MKINKPLAKKPPFFDIDIHTVADIDKDPRFYMADTQETPCYWTDGKRIYYRYSPIEKANL
ETFVYFNGFFAKDDKHCYIVGRPLKGANPKTFEMLNECYATDYQSVWTSGGRFEPADIST
FEVCDEGIHRTDRDRETSWEFSDGIRRVVRVEIPYGYAKDSQQVYYEDYHGKIKILAKAN
PATFISMNDGDFAKDDRSVYYGKSSLPKANPATWRKISHFYTKDDKRIYYQNKLLKEVDY
DTFEVVLLTSPEGYKLPYGKDKNQYYEYGKPLSEAEALYEVNRPL
>SEQF1602_00786 hypothetical protein
MMNTNKQEKYDEITDFHKGFACVRQGDKWGYINENGTLITPIKYDFVYDFFQGVAMVRIG
AQYGLIDTSGKEITPVKYDLIDDNDFYNHRPAAALLNGKWGFINEKGEEVIPFIYEDTTY
FHKDYVAVKKDGKWGFINQKGEQIIPFLYDDASYFTEGLALVKKGAKYGYINDKNETVFP
FIYDDGALFENGKAWVQIGNKQFEINKLGIEIK
>SEQF1602_00787 hypothetical protein
MFNNYMKYLVTFCMCIISFIAFGQIKNIDMKKEKPKNLTECIQMLDKNLKKQDKEYIKTL
TEEEFFMESHFTLGMGIRNEWIRSGNPELVKFFLDQGVKHPDDMSAMILTSYYRHLLGKE
IDFEGQISAHKKQLK
>SEQF1602_00788 hypothetical protein
MKTDTQIKFDTIIKEGFTPLLKPLSFKKKALNYYRQLSEVGHIINIQKDRYSHRNHIKFR
INIGIFEPKVWLVIYDFKHTGQVPDYPTEPVCLIRKTINDLRGRKDLWYEIHNYTDEQKL
IKEIQEDIQQYILPFFDQLDSVEKILSALEKDSNLLGITFDLLIFYAEHGQKEKVQTVYN
QLLQKVNPLAEPTLEGLAKKYGLNV
>SEQF1602_00789 hypothetical protein
MKNITEILELFVSNLEKYNQLVEKDIIELLQNKGAYYLLEYDYEWFIISAWAMSAKGEYI
SKCTDIPSQKMEKYFPSDAFVDEDIHFEDNLYEEGLEEDEIDSCLEKYDQEKNAIFSKWF
QQRWENALKNAHIQADGYFSPHDSYFYTDLNTGKTINEDQIKAKYQ
>SEQF1602_00790 hypothetical protein
MTTIEIPKFIEKYKAYEREGGMIDFRIFQLDTEQEDTPYQKHLAVAQQTLISVAEEVNTR
LDRIAAKSKINRKKLFTMDYDFGVLKDSDKEISLQDFMGWQYEEVSGRIILSGGKLRNWY
FYYDDKEVPEKAVAMTEEDLKKEVFAYAFFQPPYSFMITKSNFEKGNFFLDFCRLLFTDI
SQIEVYKWSTDSSNYFDEGKDWWGSFFWTVYNPCRDWYIGIIASETD
>SEQF1602_00791 hypothetical protein
MVDITPLLSENVKKHFITLPISHQKEWVNYINEAKKEETRLKRVLKMQMSFCEKYTLEGD
PQVINLLEQIININSQEGNALAEAFINAIGNNHSGVYCVAYKWAIAFLVQLYQNSEPSSL
RAIAIYGILNDLYYFKPIEEQAANADNTTIKEEIKQLLAPFADKN
>SEQF1602_00792 hypothetical protein
MKSIKIFKMTYNKTLIYFFFLLILSACSKQSGEEQQKGYYYTGSLFEPYIAQGSIFTREV
KNMPLATNSAAIAAYMPKMPAEYLPERFKKTVLTTLSTTSYNIPIYVVDSNDPHQEYAYF
ESKDNRVIYRQDLIKYTTGRIPLPKYAQPAGGGDRAFAVYDKATGMMREYFYAVKDEKGT
WRFAASGYFKAKPNFKDLGKDNFAMQHTTGGSAVVCMLNPLSQIGIAEARKGEICHALSF
TIANAGKGFSYPAKQGDGTSTNPNAPLEGQWFRIDPNIDLNKLKLRPFTLLVAKAVQKYG
GYAADKNLFCHTFTAEHPINEMVQGKPNPWEKGGDIYEKYNGIDLNDFPWHLTQWAPVDW
GK
>SEQF1602_00793 hypothetical protein
MEITQSLKTEIYHALTDFLNAYKSQNTQVLAEKFGVSGAFLEEINETLDFVEDKSVLHLF
PIEDIDKEVNKLRELTLYKDKKMNKLVVEACVYDDKNECIGLIVGDYPLFEHSPKFVFSY
FDV
>SEQF1602_00794 hypothetical protein
MEITQALKTEIYHTLADFLEAYKAEDTQVLAEKFDISGEFLEEIYEMLDFVEDKSVLHLF
PIEEMDKEEGGGVNLEVYNFNNDDTAVGIEAHLWDDQEYFAIIKGYYNLSDQFPKFVFHY
FSC
>SEQF1602_00795 hypothetical protein
MIDYTSKEKGWAEVIISNDSAEIAFVASHLHDSRQDLIHSVATLEKYKEATVVFQDEPDG
YVLHLERDDKHCHYTLHSFKDYDPTALCELVLEGNISLASYKNDIAKIK
>SEQF1602_00796 hypothetical protein
MKKLSFEKYGLSPEKVEQLRAYKILPDKQTLKALTQAYETDKITETELTDLQTQLSYPLD
ETYTHFLLEHNGGIPSKNKVKDSKVVIDRFLAFRSAYKFHSLIDLYPDFQKQGIPIARTP
AGDTLLLAEDQQIYLFNHNIQDVEPNPIATSFANLLMKLY
>SEQF1602_00797 hypothetical protein
MNFITENQTEYQALFTFWGDEEVEVVVCFDAKRHFTEEEKQEVFRQVATKVQWLEGNKEA
VLQFLLKNEEVRELFEVAQEDLEEEITEEQFCEAVYFYDLYCEVGDDLVCTFDVDTDPDY
FLGHLVNIRLDDNYRLHLETISG
>SEQF1602_00798 hypothetical protein
MFKHLLNTLLVAVGLLIACYTTACSSNLEKKVALTNIKKEVETISKKLPTMVASGVQMDK
IEMKGEEALSYYFTLLDFDSDNNSFETESAKASIIKELKADQETVKDFLTSQLQIHYYYY
DMNHKLISEIKITPKDIQ
>SEQF1602_00799 Metalloprotease LoiP
MKKIMLTALSLVAMATAQAQINLGKMAGAASKGVQALSFSNADAQKLSKESVDWMDTHNQ
VADANSPYTKRLNRLFGKHKNEDGMTLNYKVYLVTDINAFACADGSVRVFSSLMDLMTDD
ELLAIIGHEIGHVKNEDTKDAIKAAYTRAALQEAGSAASSTVKALSESQIGEMAEAMLDA
KHSKKQESQADEYSYNFMKKHGYNVVGVYTAFKKLALLSGGETQSRFQKMMSSHPDSEKR
AEAAKKRAIKDGLWKDPGEVKLPTTPIE
>SEQF1602_00800 Multidrug resistance protein MdtC
MDIIKLSIKRPSILIVMLSILLLGGFYSYKLLNYELIPKFEVNVVTISTIYAGASPSEIE
STVTKKIEDAVSSLENIKKIQSYSYESLSVVVVQLTNDANVDNTLNEAQRKINAVRSKLP
TDVKEPSLSKFSLSDLPIISLGVTSNLSSQELYDLVDKKIQPELSRVPGVAQINIIGGRK
REIRVNVDAQKLEGYGLTIAQVQQLIAASNIEIPAGKLKTRENSTSIRVLGKIQDVEQLR
NLPLVSQNGIEIRLSDVADVQDTEEDAEKIARINQENTLLLQVLKQTDANAVSVSEQVRK
KMAQIEKTYKNENVKLQLAEDTSEFTLHAANSVMFDLVLAIVLVAVVMFFFLHSLRNALI
VMVSIPTSLIAAFIGMYFFGFTLNLMSLVALSLVVGILVDDAIVVLENIHRHMEMGKNKV
RAAYDGSKEIVLTVMAITMVIVVVFVPISIGNSIVVNIVKEFCMTVAIATALSLLMSFTV
VPWLYSRFGKLEHPDPKSLMGKISIGFEGFIKRMTHLFSDLLVWSFKHKWKTFILVFFLF
AGSCSLIPTGYIGKDFMPNMDRGKFLIQFELNKDASLEQTNFITQKAENYLRNLKVSGTN
KPLVERMITTVGQSTSGMGSSQATAYKSEIQITLVDKKERSESTTVIAAKLKRELSQYLV
DAKVKTVPVGMMGAKQAPIALVVTSDDVKVAQEYAVKTAELLKTIPGATEIKLSSEAGNP
EINVQLDRDKMAMLGLNIATVGTTMRVAFNGNDDNKFRTGDSEYDINILFEEGNRQSIEN
IENMIFINNAGQQVKLSQFADVFYASGPTQLERYDKSPSVTVQAQSVGRPTGTIVSEWKT
KLETLQKPANVQFVFSGDQEMQDEGFGTIFVSLFAAILLVYMVMVVLYNSFSRPFVVLFS
IPLSFIGALVALALANMSLNIFTLLGIIMLIGLVAKNAIMIVDFANHRKEEGEDTVTALI
QANHARFRPILMTTIAMVAGMVPLAVASGAGAEVNNALAIVIIGGLLSSLFLTLIVVPLV
YLIFDNIGKRFGKGTKVDYDRLMIADYEHKEIKGEHEI
>SEQF1602_00801 Dipeptidase A
MSPQEQALYPSECTTIIVGKKMTQDGSMIVARSDDWNAVNAKKFKVHPPQKQGPEEFVSF
NNGFRCKLPKEALGYMGMPPYQYPDQWESAGFNTAGVGLSATESIFSSKKALEADPLVPS
GLGEISITSIVLPYIHTAREGVIRLGKLIEEHGVMEGFGVGFVDQNEIWYLETACGHRWM
AARIPSHTYFVTANQSRLREYDPKDDHHFLGSEDLIEFAIAHQLYDPTQGPFDFHKAYIR
DEKLDTTYNYPRVWALQAFFSPEIQNDVTKNDFPVFVKGEKLISLADVRRAYYHHYQGTE
HDPYFHKNPKEVYRPVAIFRATNTHILQVRPELPKAIGEINYVALGMAALGIFIPLYQGV
TSYPEAYSKGDHHCSEDSAYWILRKVQSLGMVNYNKYAPVIRDVYDRFEEEMHQRQEEME
KDYLALYPTHPIAAQELLQNFSDKLLEDVLQVSRDLLNDLFTRLTIDVQAEYRFAGA
>SEQF1602_00802 hypothetical protein
MKKYITLLIAFSFLTSCSYKEDNTFEQKASNRTTSVIESYKNILEGHDGYWVLSYYPGVT
RSFGGFPAAPRSLGGYTFVVKFKDGKVTASSEISNTNAEEESYYTYSITEGPTISFDTYN
SILDHFRFVSAVFTNARGGDIEFIFLKEENGVVTLRGRTSNNLMTLTKLTGDREALLNKL
RENTQALNSKGLNPITVQGTQVDLTLFPSYRQLVFSYGGNIVQRPFTITEKGIKFYEPAE
INGVKIEELYFNEDKSALATPDGAISTTLVSSPIKITTNSRWVMLQDYYASQTYIDIYNQ
LKHQIENGKWRNYSLNNYLQFRVIQKGNDQPTATAITLSVANINPRTGNRINYVVDYEAD
FVPVPGHPNQLQIFLKDPNFANGWWQYFPYLSPILEEVVNNAPYEISDSFDSYYYQLTSV
KDRNFFISLSK
>SEQF1602_00803 hypothetical protein
MKKLIYICLAAAFGSCSADNDLSSDSVILGGNTPSQEEKTLNPPNALDTYIENHFTNPYN
IRMLYRFLERETTRSWVLTPTKYEKAVQFATMFNYLFMEPYVEATSKQFMKEHSFNTLIL
IGENAYHATRIPMRGLATNGVKIHMMNINNIRPNNIYYLNDNALHTLYHETAHTWHQSID
YPTDYKRISGTDYKSNSWSAAWSGTDYLKAGFISAYGSSNSDEDFVEMISRYIVYFNAKE
DCDCATTDTTLDTDGDGFDDALYTAWKRSFSNYNNGASVTSYESARVWEEQLALADDKIR
PTEQYTGKEKLQQKMAVIRKYLTENWNIDLDALRKKIRVRYPYVAGRTLSGQAVPQKDFS
DLTNN
>SEQF1602_00804 hypothetical protein
MRKIYYTLTALTLSLTSCNDLLDRMPDNRLVIDSPEKVQQALTNAYPQIATTLINEFSSD
NIDDIGADNIYSNFLTRETAYWQPILEYNNVDGLQNIWDYHYKAIGQANAALDAIETTLH
NDASLNPAKGEALVARAYAHFCLVNLFSQAYNPNTSSSDLGIPYITRPEEEMNPQRQRGT
VAQVYQQIAADLEKGLPLIDDSYYQMPKYHFNKKAAYAFAARFYLYYQQWQKALDAANVV
LTTNDATTKNLVREWLDFRDAQKTGTRSITAYAQAYARESEVANLMLQPVYSQLSTNYFI
ETNQRFSHAYRVSEQETLSTTNLWDANAASKNNGYEFYWFMPFTSRADLRDIVLQSKFPT
FKDGSYTRTILVPFTTDETLLVRAEAKIMLNQLDSAVTDLNIWTSKYVRGTVNSNPNGNT
FTKAQIIAFYNNLAYSQSTPSGATQKKRLNPSFTLSAEQEPLIHYVLQCRRILTLHEGLR
WQDIKRYGIEVARYQHTKEERNISTIQGVLAPTDVRRAIQLPGTAIGAGMQPNPR
>SEQF1602_00805 TonB-dependent receptor SusC
MLLLFLGVCYTSFAQEELKVSGVVKDAKSKPLAGVLVSVKGTSSSTHTDFEGMYTLTLTK
GQTLVFSLQGLQTQELMPTSATVDVVLLPQEDKNAKKEAATPMNTNTRGQTSISGETKPL
WVLNGVILQDEIDLKPEDLVSDDAKMLIAAAIPGLTAESIDSFRVLKDASATALYGPRAI
AGVVVVTTKKGTAGSSSITYTNESTFRFIPTYGQYNIMNSQDQMSVIQELMQGGHYEFQT
VVTQKNKGVVGKMYELFYELDQNGNSQVLNTEAGRRAYLQAAERRNTNWFKELFQTSVMQ
NHTLSFSSGSQKSTYYASLSVLTDPGWQKGNSLNQYSGNLNANYNLSSKVRLNVITDLSY
RDQTTPIQDMYNYALTRSRVLDAKQYYTMNYAPYNIFNEKDNAYIDTDIATLRLQAQLSW
KITPKVEAAVMGAIRYQNNTQKTEYKENANWVLSYRAMPNSTVRDNNTNLYKDPNDPFAL
PVVVLPKGGIREKRDRTSSANNFRATLRYNDSFDNGLHAISLFGGFEMDNAKNTNDLNRN
YGVLYNSGNYASFSHLMFKKLQEEFRNYYTIADTENNNQAFFGNASYTYKGRYTANGTLR
YDASNAFGPSRYIRWMPTWNAGVKWDVTQEAFFNHLKPLSHLSFKASFGVTAVAPSVSNS
LAQLYINNPWRNSSQRELGLEIQNIANHDLTYEKNQELNLGTELGLLKDKINLSVEWFNR
RSYDLIGDIVTQGTGGFTTKKGNMAEMRIRGIEVGLETTNIKTPDFSWKTSFIYSRAKNE
ITKLLTTPTIRDMIGYSTSATSQGGFSRAGYPLKSLFSVPFDGLNDRGLPTFLDENNAST
ISGIRFDSRNVDFLKYSGTLIPTDRGSLSNTINYKGLSFGVVFTYSYGNVVRLRKLSNIY
TDYGNIPRELNNRWQYIGDENKTNIPVVYTTYMQNSYGYSEITQAYNTYDYSDIRIAKGD
NIRLKEISLGYTFDKDFLRETRIRQLSLKLQATNVALLYADKRLNGDDPDYLANGYTPIS
PKRLIFTLRVGL
>SEQF1602_00806 hypothetical protein
MKKYITFLLGAFLLSSCEYRQEDVFDKTPAERTADKLNENKKVLEYDGYWLLSCYPEVYR
QGLETTDYVHRGIGGYNILLKLNDGKVVASSEFMTTNEEQQSFYSYQLAENLSISFDTYN
EVLHHFRTTSAQHPNARGGDIFYDIIKKEGDTYTLQGRTSRNLMTLSRFSGNREAYLNKI
REHIQLFVGKALNPITIGGKTVNLNLSPGYRQLLFSYDDQKVQRAYIYTEKGIKLYEPVV
IGGVSIDEFYINDTKTALTTPDGAIAANFVSSPIEINDNTKEIYFNKEYGYVSDGIFAMY
EEAKAEIARQQTWYDLLRDSYLYVKNIKGSDSESTAGFAKYISYVSPYDGGVWTFYEVDF
QGVPQHSDQVQMVLKGPSNNVAYSQGDYQNNIQYFSPLVRLYRRIAEKGPYAVDATQYNS
YYLLTSTKDPNLWFLLSK
>SEQF1602_00807 hypothetical protein
MKKILYILFLLPFTFGCSNDKVSSDSKLGGEEGTEVMDTHTPLDDRLEKDFAKPYGIRII
YRFLEREINRGYTFTPTKYEKAIVFSNVFNYLFIEPYVKITSKQFMKEHSFNTVILIGEP
AFAPNGNKYVGFAVAGVKIHLLEMNHIKTDNIYYLNENVLATLYHENAHTWHQSKLFTSD
YERVSASDYKRDNWSVWAGDDYLKAGFITAYSSFDKDEDFVEMIARYIVYYNASLDCGCD
IASHPGTDSDSDGFNDTLYQAWKAKFVNYGALQNPNNYRNYFSTKVWEEELKAADAKIRS
TEAYTGKQKIEQKIAIIKSYLTNEWNINLDELRAEIRSRYPSVVGKNFDGDQVLRKDFSV
LPNN
>SEQF1602_00808 hypothetical protein
MKKIIYFIIGVSLLTSCNDLLDELPDSQVPVNSPERIKRVLVNAYPGASAMMLDEYSSDN
IADNGTIVTNFNYLTDEVAYWKTINEYGNYEGLEYVWAYNYSAISHANEALEAIAKLGNG
SSLNPAKGEALLARAYGHFELVNTFCKAYNPTTSSTDLGIPYALTSETKLNPQYGRSTVA
QVYQNIAADIEAGLPLIDDSYYQMPKYHFNKKAAYAFAARFYLYYQQWQKALDAANVVLT
TNDVTTKSLLRNWEDFRDVNKAGSTNQGSRALYYTREDIVANLLLLSIQSQLPTAYYTQG
SERRYTHNVFIAETQTIEAKNVWDPNGLSGKNNYGYEFYWFTPIKVDNGRNSTVFFDKFP
IFSTGSSSRTVIVPFTTDETLLVRAEAEIHLGDYQAALKDLNLWTSKFIQQKTILGYSSR
NEVTLDQVKEFYNAMAYSQNTQDGLTQKKHLNPSFTIVNDGVQEPLLHYLLQCRRILTLG
EGLRWQDVKRYNIEVPRFQTDNVDRHLNELKATLPATDQRRAIQLPASSIKAGMQPNPR
>SEQF1602_00809 TonB-dependent receptor SusC
MNTLRLKMLFMLLLFCGVCYTSFGQEELKISGVVRDTKSKPLAGVQVSVKGTSQSTHTDF
EGLYTLTITKGQTLVFSLQGMQTQELTPTSTTVDVILLSLVDQNAKKEAGTPMNTNTRGQ
TSIAKEAKPLWVLNGVILQDNIDLKPEELVSDDAKMLIASAIPGLTAESIESFKVLKDAS
ATAVYGPRAIAGVVEVVTKKGTAGSSSITYTNESTFRFIPTYGEYNIMNSQDQMSVIQEL
IRGGHLTPDFTSIWERKGLIARMYELHNVLDNNGNFTVPNTPEGRLAYMQAAEKRNTNWF
KELFQTSIMQNHTLSFSSGSQKSSYYASLSLLSDPGWQKNTTYSQYSGNLNANYNLSSKF
ALNVITDLSYRSQSTPTIAGTTLYNYALTRPRFLDPKEHYKYRYTPFNALEEMNNSYTDT
NVATLRLQAQLTYKITPKIKATLMGAIRYQSNIANREQNENSNYANSFRYMPNALIRTYN
KYLYKDPNDPFALPISVLPEGGIRRKTESTTTANTFRATINYNDSFANGLHTLALFGGFE
MDNAKYTNDVTDHFGVLYNSGNYGTYSYKWFQFWQEQGYTYYSIGNTITNYQAFFGNATY
TFKNRYTFNGTLRYDASNQFGPSPYIRWMPTWNTGLSWNVTQEKFFEHLKPLSHLSFSAS
FGVTAVAPSVSNSLSQIYTNDPWRNSSQRELGLSISNTANHDLTYEKNQELNLATEFGLF
NDRINLSVAWFNRKSYDLIGGITTQGVSGTIIKKGNMAEMRIRGLEIGLETTNIKTADFF
WRTSFVYSRATNEVTKLLTNPTIQDMVGYNSQNATSQGGFAKEGYPLKSLFSVPFNGLNG
SGLPTFRDQNGETTINGIRFDSQNVDFLKYSGTLIPTDKGSLSNTFHYKGISLGVVLTYS
YGNVVRLRGMRNVYNDYSAVPRELNNRWQYAGDENKTDVPVLYTTYMYQRLFNGWKEMNQ
AYLTYDYSDVRIAKGDNIRLKEISLGYTFDKDFLRETRIRQLSLKLQATNIALLYADKKL
NGDDPDYLANGYAPIPPKRLIFTLRVGL
>SEQF1602_00810 hypothetical protein
MKKYIIASLALLFLTACEYKEDPVFDQNPKERILSSLQNTRKLLEGHDGYWLLTYYPEEY
QEGFWVYPYLNTLFPSTINFPKYHRSLGGYNFILKFSEGKVTASSEVVPTNREETTYYSY
TISEFPILSFNTKGDIIHHFFSSTTNYHDARGGEVDFFIDKVEKETFTLRGKRNGNIMTL
SKLTTDRETFLNKIRENRDKLLGKGLSPISIGGTQVKLELFPTTRQIAFLYENDTKYQQQ
AFIVTEKGIKFYEPVSINNVTLSELYFNEDKTALVSPDGNFSSALVPSPLTITNSTVISF
EDSKASPYLIEKYEAAKGWAENIFSWGTLSKKVKLAPMAGNEGENATGIEIVETTEDGSG
WSGYYLVDFVGVAGAPTQVKFLSKGPQDSKENYLYFFKDPAIWLAEILVRSAPYTVENHS
SEYYRLISVGDANVWFLVKK
>SEQF1602_00811 hypothetical protein
MKKILYSLLAVGLISCTADDKIPDESALTPSVLHDKNINHQSELDNYLYENIEKPYNIRI
LYRFTDEETFRSYTYTPAKYDKSIEFVNIFNYLFIEPYIKVTSKRFLKEHSFNILLLLGD
PAFNADGSKNVGLASAGVKIHLTEIDNIQPNSIYWLNDNFLVTLYHENAHTWHQAIRFSP
AYEQVSANDYKGGNWVSAWGSYGTTDYLKAGFITTYSSFNKDEDFVELLARYIVYFNADL
DGCNCATTDQSKWGKNSTNLDYNNFPDGYDAEAYNTWRNKRYNYVDSEKWDEMNNESAKI
WQEVLKTADEKIRDTEQYTGKEKLEQKIAIMKNYLSTTWNIDLDALRAEIRSRYKYVVGK
DFEGNEVDKKDFTRLNNN
>SEQF1602_00812 hypothetical protein
MKKILLLIGMIAIGLTSCNKLDELSDNRVEQIDTPEKIKNILTSAYPKTTNTYITELASD
NIADNGANVPGIPFFAIEAAYWKPIKEYWDTDGLHNFWQYHYESVSLANEALQAIEKLGN
TQELQPAKGEALLIRAYAHFCLVTTFSKMYNPHTSNTDLGIPYAKTIEENLIVKYPRGTV
AQVYQQIESDLETGLPLIEDRYYQLPKYHFNKKAAYAFAARFYLYYQKWQKALDAADVVL
SGDVSELLRNWKAFRDGANVGSSTKNNFAMYYTKESIEANLMLQPTFTNMLEAYYLDELY
DARFTHNTFVANNQTLGTKNLWDQDAFNANNGYPLYWFTPFVNTTGGKYIDIVNVGKFPR
FRRSSSNYGTIIVPFTTDETLLVRAEAKVMLSDLQGAMDDLNLWTKAYITDYKEQNGVRT
AHINTGFTIQNVKDFYDSIDYATNTPEGVTQKKHLHPSFTLVEGSDQEAMIQYILQCRRV
LTLGEGLRWQDVRRYNIEVPRYQKYGNSGAYQVPDILTSGDNRNTFQLPDEVLGAGMEPN
PR
>SEQF1602_00813 TonB-dependent receptor SusC
MFLKYLQERSEGYYNISNTVNNNQAFFGNASYTYGNRYTLNGTLRYDASNQFAPSRLIRW
MPTWNVGLTWDVSQEKFFTHLTPVFSYLNIYTSLGLTAVSPYATNSYTQLYYDLPWRNSS
VREKGIYRSNLANRDLTYEKTQEINVGTQFGLLNYRLNVSLEWFKRRSYDLIGSVITQGV
GGQISKYGNIAEMQTQGLEAGLETINIKTEDFSWKTSLVYSRAINKITKLNTAPTVGDMV
GYSGSGGFAREGYPQGSLFSVPFNGLDSEGLPTFIGPDGNPTHFGVDMKERNVDFLKYSG
TLIPTDKGSFSNTFNYKGLSFGIVFTYSWGNVVRLRDVSSIYSGLYSDVTTLPNELKNRW
QFAGDEKKTNIPAIYTSAQEYNYDYKNLTEHAYRAYDYSDVRIAKGDNIRLKEISVGYTF
DKNFLQETRIRQLSVKLQATNVALLYADKRLNGDDPDFRATGIYVAPKRIIFTLRLGL
>SEQF1602_00814 TonB-dependent receptor SusC
MKISVSLRKNTEEHMNTSRLKTLFMLLLFCGVCYTSFAQEELAVSGVVKDTKSKPLAGVQ
VSIKGTSQSTHTDFEGLYTITLTKGQTLVFSLQGMQSQEVTPSSATVDVTLLAQGEEGTK
KKAGTPMNTNTRGQTSIVQTVKPLWVLNGVILQGDIDLKPEDLVSDDAKSLIASAIPGLT
AESIESFRVINDASATAYYGPRAIAGVVEVVTKKGTAGSSSFTYSNESTYRLIPSYKQYN
IMNSQDQMSFVQEMMRKGMMPTESYKTYTLKGAVGRMYELYNILDANGNPRVANTEEGRL
AYMRVAEHRNTNWFKELFQSSVMQNHTLSFSSGGEKSAYYTSLSVLSDPGWQKGEELTQY
AGNLNATYNFSSKLSLNVITDISYQEKRSNGKNMYEYALGTPRTMDPKDDYAYYYAPFNI
HRERENNFMTTDLATLRLQAQLSYKISPKVEATLMGAIRYESGVYNTDITENSNIAQSYR
AINESIRENNDYLYKDPNNPFAIPEIVMPQGGKRTKQVTTFNGNNLRATLNYNDSFSDGL
HLLNLYGGFDMDNAKNSNDRIIIMGYFLILVT
>SEQF1602_00815 hypothetical protein
MRKNKILYFAILPIIFFLVCGCTSQEKKNSYEDSPIVNFDRDSVFYRLNIKEDGEWYVFS
TEELKIDYTKKLSYCIDSFSCIPAKYYNTEETMYDNCLDCDNN
>SEQF1602_00816 hypothetical protein
MKLLEINDLKERKIVQDSYEIGLVYKGRRVDILLDKLHYSLEQLLEAANHLLPYLSQLDL
KARKYLAKEELLRFNAYNQTKNKPLVSEECLEKHISLHAVQFFDESIDFFYRLSCDRKYE
LIVEVCVAQGYQYPKFEQWFLGNVKDKGWLHKVSAFLGKMFRLV
>SEQF1602_00817 hypothetical protein
MESKFVRILSIAATITAVCMYVAYIDQIQKTWGDATGPWLQPLVAGINCTLWVAYGFLKR
DRDYPIVFANLPGIILGFLAAYSAAF
>SEQF1602_00818 hypothetical protein
MKEQILQILLRIASGEAIAQGEKTVYPAVREQLAAIKAIMTLQGWDRKETKKKAVAPEQI
PLEATADTTIVGETSLQREQEFTTGEDVTPDAVPYEVAAQEEKITVAATEVTTIPTTVET
HLLQTNRDISLQKRLYKPFKRKKKLLGLK
>SEQF1602_00819 DNA protection during starvation protein
MSFNSLGLKKAEVEKEIHALNILLSNYQTYYQNLRGVHWNIKGKRFFELHIKFEELYNAA
QEQVDEIAERILTLGGVPFNTLASYVKHATIPVGENVFDDDKAVRLVIDSLVALLPLERE
LLELSDKANDAGTNTLINDFVVEQEKNLWMLKSYLNEAI
>SEQF1602_00820 ATP-dependent RecD-like DNA helicase
MDASDIYDLLLSHFSWEPTESQEVVLEELAEFFSQEEEEQKLFLLRGFAGTGKTTLVNTL
VKTLKELSVRVVLLAPTGRAAKVIASYAGQKAFTVHKCIYRPMGEGGDFSFTLRDNKASH
ALFIVDEASMIGEEASFAGRSLLSDLIEFVYTGDHCYLMLIGDSAQLPPVHTSMSPALDY
ERLSSYYCKKVSEGILTDVVRQGKKSGILYNATRLRKRIENFKDNFRIRTSPFTDVIPLQ
TSYDLEEALMDAYAESGVEETCFIVRSNKRAVEYNQQIRKVVFDYEESLCVGDLLMVVKN
NYYWLDNASQAGFIANGDTIEVLEINHVERCYGFTFAHVLIRLLDYPELEPLETILFLDT
LESPLPALSSEEQENLYYAIMQEYNKQTGQVAPLNMKLHPYYNALQVKYAYTITCHKSQG
GQWERVFVEKPFLPEGQSVAYFRWLYTALTRAKKKVYLINFPYEEIISD
>SEQF1602_00821 hypothetical protein
MRRGIQFGLLIISAIGFFLIYKSIQAPIEFEKESKARYAEVIAKLKDIRKSEEAYESIHK
TYTNNFGELEKFIETAHFYITTKKDTSWVQYDPHFKIDVLKQSVKTDTIGKISVKDSLFK
DNERYKQMSSVTIGDRQIPLTIETGVISREGDVKFPVFEVKVPKKDVLKGLDQDEIEREL
QKTGVNDVKGAYISVGSLTEVSTSGNWPSYYNERTDKKGAARK
>SEQF1602_00822 hypothetical protein
MSIQLNLDGLSFCIFNPALSCIESIYHLPLPPSMPALVVEREIQNYLKEERALCQDFDTI
KVLHNNEQFAFVPEKYFVTDHLFEYLKFNVTEYHNQIISHDTLKEEQMVNVYIPNASINR
ILRETYGIFEYEHLTTTLLGVLLMHNPQKKNAVYAHFDKDAFHLVIFKEGQLAFFNRFAF
EEPIDMLYYLLFSLEQLSIDTETTPLYLLGDIIRNSERYYLIYKYVRFIYFLPPQKNNPF
CQNMDPTLARQNFILTHTF
>SEQF1602_00823 Fe/S biogenesis protein NfuA
MNNPDLLQRVETALAEIRPYLQNDGGDISLIGIEDDKIVKVKLLGSCLSCSVNQMTLKSG
VEMTIKKYAPEIEKVVNIS
>SEQF1602_00824 hypothetical protein
MEKGNHFFAHGKLLLTGEYAVLDGALAIALPTQYGQEMHISPSEREGIFFRSLTQEGTPW
YEGQLFVGDTNPITQTLERILSQAQRMQPNFLTGQSVHVETRLDFPREWGLGSSSTLISM
IAQWAEVNPYELLWNSFGGSGYDIACARASSPILYQLTEGKAKVYPIYYSPPFATSLFFV
YLNKKQNSREGIALYQGLKKNKKPLVSQLSQLTEEIYRTHSLDTFSKLLSEHEAVLSSYL
RLPTVKDSLFKDFSGTIKSLGAWGGDFVLAIGEESYIKEYFISKGMQTILPFAQMILPTD
REPILPPVHQDPR
>SEQF1602_00825 Rhodocoxin
MSAEVTLKITDREGTLFEVEAPTDMNMSLMEVIRAYAIAEDGEIGVCGGMAMCGSCQCYI
VSDTPLPEIGAEEEAMLFETSYTKENSRLGCQIPITEDLDGLEVILAPYP
>SEQF1602_00828 hypothetical protein
MQNKGLVKLFALLFGLVSIYQLSFTFVANRQEKKAEQFAAQKVPTSVEDYTHKREKIVSK
YLDSIANEPVYNLLLTNYTFKEVKDRELKEGLDLKGGINVTLQISVHDILRSLAENSKNA
DFEKALDQADKRLRETDQSYIDLFFEAFDATGAKLSAPDIFGNKTLSAQITPQMSNSQVQ
PILRKKIDESIDSAFEVLRKRIDKFGVTNPDIKKLGNSGRISVELPGAKDISRVKNLLQS
TAQLEFWETFKAGDFALYFSQLDAALQAKEGDKTAENTPTTETPKTTTAIDTLSSKRDSL
AHNEVDSLLNKTAQKKDSLAPAQKNPLFDLFQFTNGENSPSIAYFLAADTTKLLSYLKSD
EAKRLQPAELKYAKFVFGKPHKLTDLQQLYRMFWPYEAEQADPANAKKFKERLQSLLRRS
DLVELYALRGNRTNEPPLTGSVVTEAVQTYDNHNQPCVSMNMNREGAKLWENLTGKVFTE
RGNIAITLDNTVYSAPTVTSGPISGGSTQITGNFTVAEAQDLANVLRAGKLPASADIVQS
VIVGPSLGQEAITSGFISFAIAGLIIFLWMLVYYGRAGIFADIALVFNILLMFGILVSIN
SVLTLPGIAGIVLTIGMSIDANVIIFERIREELRNGKSLTQSIHDGFSHAITSVLDANIT
TFLTGAVLFVFGSGPIKGFATTLMIGIVTTIFTAVFITRLLIDWYVAKGKELSFTTSISK
NILVNPNIDFLSKRKVWYSISAIMILISLGSMFTRGFDQGIDFVGGRSYQIRFKNPVKTE
EIASLLKAGKLGSVEVKTFGAANQVRISTKYKYNDESTQTDNEIQEILYNDLQPVMGEKI
SYEEFMSGEGLGVMKSDKTGPSIAEDIKSSAVWAIIGSLIIIFGYILVRFRKWQFSMGAV
AALTHDVIITLGAFSLLYSVMPFSLEIDQQFIAAILTVIGYSLNDTVIIFDRIREEIGLK
GWSANTLNHAVSTTLSRTLNTSLTTLLTLLAIFIFGGETLRGFMFAMIIGVVVGTYSSIF
VATPLVYDTSKNRKEEAPAEEVTHKHKK
>SEQF1602_00829 hypothetical protein
MRQLYDVIILGAGASGLFTAINIAEGAPHKRILILEKGKEALGKVRISGGGRCNLTNGET
NLREFVKNYPRGNRELLSAFSRFSNKDTMKWFETHQVALKEEADGRIFPVSNSSQTIIDC
FLSLAKKYNIEILYKQNVHAFSFEKEQWKVQATEVFHSRNLVVATGSNPKVWQLLSQLGH
TIVPPVPSLFTFATEDSFIEGLAGVSKEVNAKLLATDHSPLKIPLLEKQGLVGALLVTHW
GFSGPVILRLSAFAARILAQLDYKFSLQINWLAEEEILSSEEALSILQEEKQKHPRKELQ
NHCPFNLTKKLWNKLLERSGVLPHQLWAELNKGQLHTLTQTLTASTFLIHDKAPFKEEFV
TAGGVSLKEIDFKNFRSKLFPTLYIGGEALDIDAVTGGYNFQNAWSGGYLIAEGVKSE
>SEQF1602_00830 3'-5' ssDNA/RNA exonuclease TatD
MIDIGLNLTNRQFAHDQEELLLRAEQAGVTQMILTGTSLRSSKESFALAKGYPTLLYSTA
GIHPHDAKTMNEQTIPQLSALLKEKQVVAVGECGLDFDRDFSPRPVQEQCFRAQLALAQE
VQKPLFLHERAAFDRFVGILKDYTLLPKGVVHCFTGSLSEVKTYLDAGYYIGFTGAISDS
RRFAFLEEVVRYVPLERMLIETDAPFMPTKDSISMYLSDNHETKE
>SEQF1602_00831 Modification methylase HaeIII
MLYGIDIFSGAGGLSLGAEMAGIQICYGIEINPSAAKSFTRNHKGAKVLQGDIKDIDPSK
LKEGIDPVFIIMGGPPCQGFSLSNTRTRNMQNENNFLFLEFVRFVQELKPTWFVLENVWG
LTNMEEGKTKNMIEDCFRALGYEVNSQVLWASDYGVPQNRNRFFMVGNRHGIEFEFPEPF
EKKITVEEAIGDLPDLDNGEMLEKGKYKVPCSEASEYAQLMREHSHYPTQNFVSRNNNLV
IQRYTHIKQGQNWRAIPDELMQNYADKGRTHSGIYKRLIADQPSVVISNYRKSMLIHPYQ
DRGLSVREAARLQSFPDDFYFEGPISHIQQQIGNAVPPLLAKAVFDQIIKMSRHDGQR
>SEQF1602_00832 hypothetical protein
MAKDRENIPVAPTLMGSLRSMGYSFESAVADVIDNSISAHATLVKVLFPTTPLEPTAVGI
LDDGEGMSDEKLFEAMRYGSMASEAERDEDDLGRFGMGMKAASLSQCRNLTVVSYSQGKR
SAYTWDYDYIQKKQKWIIQELTSQEIDNLPYVSQITDQAKGTLVIWRDFDVLSKSSDGQV
YETLDNLKNSLDKALALIFHRFLSATGSAKLQIQINNLSVKPLDPFLERHPRTSSKRERT
IAINDSEGMERLIHVKPFVLPFATDLSDNDKKLIGGIENLRAKQGFYVYRNNRLIIWGTW
FGMKQRAELTKNARIRVDIPNMLDDIWGIDIKKQNASIPKRILNQLRKTVFDTLEASVNQ
QTYRGRTAKIDDETDYIWDRKEGRNQMFYYQINRESKLFQFVKDKMSEEDYNYLEMLVTE
IENNIPTQQMYIDRSNEAITVEETDSRFDDVFQIAVTMVSTLKITTKSTTESIINDLMKS
EPFCKYPKLMDKLTDNFK
>SEQF1602_00833 hypothetical protein
MTDDLYLSLRQITFIFIDADKAVGNEVKFENINTYIDRAITSLRITCDEETRKRLFTDVE
YQFKITHAKGNVIFDDYDSRQEWYSNEDIKKPYFWNKYKALLLKNSSFSRKSINLLDEDT
LPNIMNCLGNPNDQFEGKRFRRGLIIGDVQSGKTATYSGLICKAADAGYKVVILLAGITE
SLRQQTQERIDESIIGLTSRRQGRNVASIRVGVGKDNQELRATSFTSCVNDFVGNHDRIA
MSLNSQSSLVVFVIKKNVSVLQRLHKWLKDQNLDPVKGYIDIPMLLVDDEADNASVNTKK
DETDPTKTNKLIRQICTLFKDTTYVGFTATPFANVFIDPESVDSMKNSDLFPEHFIYALE
APSNYVGAQKIFYPEGQYYRNLRYITDIEEPDYTSEEYLDQVDNDIESLNSGGFYCRHKK
EWDGKLPASLTDAIYCFYLANAIRDLRGQHSAPRSMLINMSRFIKVQRVITKHVECIHEE
AFNNIRFNFTNKNTTNRKLPLYQIFEKLWKRHFSHVTDITFDRVIQRETIMNAIEKIKVM
VVNGSKQSNSLDYRTNKSLRVIAVGGLALSRGLTLEGLLVSYFYRNTSTFDVLMQMGRWF
GYRNGYDDIFQIWTSQTSAEWYAEIARSSQELKDNIKNMYDQRLTPKDFGIKVRDNCNEL
QITASNKMRAARGLDLRYSFYGNIYDTPYVSFNIEHNRNNLKESANFIDTLFKGGYTLRY
TDLVGKATKDVNDTSDSSSRFFENVPKKMIIALLKR
>SEQF1602_00834 hypothetical protein
MANGNFNVPNILEFLNDTKNTGIENWDVVIQAGESKENVQFDGLQNMKCVKRSIYYGTNN
VVQISSRRRALSGSSEGKYALTKEQIKCAEDEYRKGNGGENIPLKAYFEFLPTRKPIFII
MPIHPAPAETDKGKEEKQKLTKFREELGSDHIIAFAIGLPGVKGIENAVHYKINKVYQRL
NIEDAEEEEVDDAD
>SEQF1602_00835 hypothetical protein
MMQIKIYTLLSGDFKASHFIRIGENHNISLYVGKDEMGRYAFDFRGQFKAARTKSSEVIS
VTHINSGDENFMRFSLENPALLEYFCTFCEDLITSTQVISDDETAYQTLRARYFSWKQLF
KPNHGNLTEIEVMGLIGELLFLRNEMIPAKGLDAALESWIGPEKTHKDFSYDNDWYEVKT
INFGKESVHISSIEQLDGRIEGYLIVYSMERMSPSFNGIKLNALVNELIAMIKPSHHKET
FLAKLSLYGFDFSPENDNFVYDLKSVSSYRVDNADFPRVTRDLLPDPIIKVQYDIILSEI
EKFKVS
>SEQF1602_00836 hypothetical protein
MGIEEYRQQIIDELRFNAEHEGTEPETQFIEKTLNDLEEIGELYDPIPISVEMRGSRNRI
LAFDAYAYDEADGALVLIASDFTNQRDVAPTLTNTRIEELYGRMVNFVEESIQGNISKYC
DDSDSALLIANEFKKKIGKGMLSTEILRFKFLIISNATLSKQVKNLSKPNLLERPVELNV
WTLERFFQTFASNSSEIIEIDTADFDCQGIQCLKADLGQGSEYDAYLGIVPGKFLADIYL
KYGSKLLQGNVRAFLSVRGKVNKGIRDTIINHPENFFTFNNGIAVVARSVTFSPDGSRIV
RFKDPQIINGGQTTASLANAIIKKEARYGMNTLFVPMKLTVLNVENDMSEEQVEQYNTIT
KTISQCANSQNAVSDADFFSNHPFHVMMEKLSRKVMAPPVGGNP
>SEQF1602_00837 hypothetical protein
MKLTVAQKKKFCEMNPKNQVIKKEKLAKCYNAILMNPNQVCQSSAINFNRFASVIEKIYE
EQRDSINENFFKKCVSYVILFDSLDSLVGKASWYPKGGNKAQIVPYTISKLITLIPKGRD
LDWHYIWQKQSLYPELAEELLKLAYVTHNFLIDQANGGIVRTISRTQTVWKNFQDYKYTL
SDKFIETLASMAANKAVAQSAKKAHKFNSDIDASVEVFKLGAQYWMNVYKDLVKETILSY
GDCSFIKGIADYITRGNLPSSSQCKRLLKIVAKAEDKGYIMPN
>SEQF1602_00838 hypothetical protein
MINDQTLDLVFEFLTSYSQYFQKNLQRKPTIEELQRVLNTSFAVNIDETLFSACEEKAIS
EVKFKIVKRKKQRKYTVGGIGAIRRC
>SEQF1602_00839 hypothetical protein
MIKRILFISLLVISLGVNVVLIRKMFVGNTQVIPNDTRVSIIVSQSNRDFVMHEMRTFVE
ALHQINLGIAQNDPALIAKVARASGGAVAGHAPAGLLASVPVEFKTLGLDTHGKFDQIAE
SAEKNFDPKHTSKQVTELLGNCVACHKMYRMDVK
>SEQF1602_00840 hypothetical protein
MRVISKQEAIQIRMLNQQLLSPLYERPEDIVAWQGAMQAQDYNYFRWAIGIRQRTPQLVG
LQEAFAKAELLRLHLLRCTVQVVSHTDIGWLLPLCKERNLRTLQSWHKSINVSFPESYFE
EITRAMQELLAGGKSLPKKAIAEKLTTLGFLLDDRLLTSLLVRMEIEGLLCSGEMQGREA
TWALLSERVPIICSLTPDEALKQLALKYFRSHSPASLEDFVWWSGLPKAQCRKALTLIAN
EIEETKVEEETMYLYHNTPDCSDYAGMVLLLPPYDEYLIGYKSRWVALEKKHTAKAHNNF
GIFKPVILHEGRVVGNWKASIDKQGENLTIDFFAEKSKIGKQSLQGAVNQFVEFCKVTTA
NGS
>SEQF1602_00841 HTH-type transcriptional regulator GlnR
MAKTEQKEPKELLLDFDFLKKLVVGIGEVSQITGIPTRQIRYWEEKGILKSLTEEEGKNR
RYDYLNIKKILLIKELLDEGYTLDASAEKVKKRMEMIEEMLTKMSQYVS
>SEQF1602_00842 Gluconate 5-dehydrogenase
MKIINKMKVLENKNAVITGGSDGIGLGIAKAFAQNGANLLLIGKDPEKLQKAQKELLDEH
VVQIHTLAADLSAMDSLTQVSQTILSQFPSIDILVNNAGLGKFVPFEQVDNSLYEAHFNL
NVKAPYFLTQGLLPALTRSKGNVINISSYFAHRMLPNRATTVYSATKGALNSFTKALAFE
VGHLGVRVNAIAPGSISTPQFNRNLQALTAEKQAAFQTMVKEIYPLQHIGTAEDIAQAAV
FLASENASWITGTILAVDGGLTTN
>SEQF1602_00843 Regulatory protein SoxS
MLKITVSLPRESVLRHSNLTYMRTITYNDYTQRINKVVAYINDHLDESLDLKTLAEVAAL
SEFHFHRVFKALKGESIGAHISRLRIEAAARLLRYSALSIEDIAFNIGYEAPAALSKAFK
NQYGITPTQYRTNKDIYIMKKEIINPDLALKAPKIIELEPKNLIYVALTGKYGTLDYGKA
YEQLWAVVKSQKLFTKGIESICVSYDDPKITEASLQRSEVSLAIHKPAHPEGEVSCKTLA
GGKYAVFFYQGSYSHLSAVYDVAMRWVIDSEYEVREEPTFEKYLNDSRRTAQEKLKTEVY
ISII
>SEQF1602_00844 hypothetical protein
MRKTEKITGIVLAMLLLLLTLSGSGYFFFTLKVNFVQWLAYNACSPSSLVYLVGFIVFLY
NKNSTWLALAFLPMYYFGTMGLFTFTWSGANIFAQLSHITMTLNLLWAGYILYRIGDYKG
FAQGLLYSIVLFVPYIAFVMYYCRTHAEEINNLLQMTP
>SEQF1602_00845 hypothetical protein
MQTTHICPECYAADKRITPLLNPEDCLLHHRQYICSTCGRCICADVDDKGRFRALFPFKT
LEIAKLYLRAAEIIHRCACSIYEITDGKERKQYKIFPSIVELNDYLQQNKQKNCNLEPLF
TTPKYKNCTSEQLRKLSTEEVSIYIKEKNR
>SEQF1602_00846 hypothetical protein
MKQTFLLLVAALTVVTCGKSDDSNGSKGGNISIGKFSPPKWIQGSWTTANKQYGYAFRAE
DFCQITLGNTNCFNEKNLPVSDIKDEKNDNTYKISYKINTFSHTFLFEKVNEYQIKTTHN
GRIEGTYTKQ
>SEQF1602_00847 hypothetical protein
MHQNLNHYIMNCKKRKIAGYILSGLVTLIFVATGAMKFTGGEQNVKMAELVGGQTTLFIL
GGLQLLFALLFWIPRTAVVGFLLMACYMAGAMATHLVIKESFVLQTGIETLIWVTGFVRF
PELTQRLCPCNNCK
>SEQF1602_00848 hypothetical protein
MDFERIKEKLAILADAAKYDVSCSSSGSTRKGKKGELGNAAPLGICHSFTEDGRCISLLK
ILLTNHCIYDCVYCVSRRSNDIARAAFSVQEVVALTINFYRRNYIEGLFLSSGVFKDPDT
TMERLVRVAKKLREEEHFNGYIHLKTIPGASELLVHQAGLYADRLSINLEIPTKEGLKLL
APEKDHKQMVAPMQQVKNELAITALEQRKFKHTPKFAPAGQTTQMIIGATAETDQKIIHV
ASYMYDKFQLKRVYYSGYVPVLQDSRLPSIYSQVPIVRENRLYQADWLMRYYGFAPGEIL
DPAQPFLDLEIDPKLAWALRNQHLFPIDVNTAPRELLLRIPGVGVRSVQKILSARTFQRL
TYYSLKQMGVLLSRAKYFITCSGAEPLAGTMDSLRLRRLIIANSQSKQKNIYDPEIPFPN
>SEQF1602_00849 hypothetical protein
MIHLLYDSSFEGFLTAVFITFERRYSQVIITPDYRHTPTLWDEEERVYTDTNKAQRVLSK
IKTIWGTEGVAVVLRAFLSEETRIENHLLEAIRLMIQYPEGNVLENYANEAIAHIQKAAK
SVGREVHRVKEFVRFEQVGTLYFAKIVPQYDVLPLVIPHFRARFSDQEWVLFDPKRGYGF
YYDLKEVISFTPTDKNFGKTSQLSDGYEQLWKTYFQHINITERKNTRYQLRSMPKRYWQY
LPETK
>SEQF1602_00850 UDP-N-acetylmuramate--L-alanine ligase
MKYIYFIGIGGIGMSALALYYRFKGKEVRGYDRTPSDITEMLSQKDIAITFSEDLDFIPK
DYTPENTLVVYTPAIPKEHKQLVYFQTHGYKVCKRSEVLGLITEDSFCLAVAGTHGKTTT
SSILAHILVECKAPVSAFLGGICENFQSNFICKGTELTVVEADEFDRSFLRLSPSIACIT
AVDADHLDIYGTAEEFQKGFEDFTHRLKPGGKLIVRRGLPFAGLTYGIADGSDYEISQVR
IQNGGYLFTLSYTDPKTGNREEVKDCTLFRPGEHHLLNALAAVAVAHQAGYPLADLARAL
ASFKGVRRRFSYIINTPEQVFIDDYAHHPTELNALYNGVRTMYPNEEITILFQPHLFTRT
RDFADGFAQSLAQFDRVVLLDIYPARELPIEGITSQWLLNKIDNPNKILVPKDNIINYLQ
SHPSRVLVLAGAGDIGVEVEKIKKFLEKDI
>SEQF1602_00852 3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 1
MKSYIKAISTYFPKNTLTNDTISEQFPEWNSEKILQKIGIEQRYIADKDECASDMAAQAV
LTLIEEHHLDKNAIDFLLLCTQTPDHILPTTACIVQDKVGLPTTCAALDINQGCSGYIYG
LSVASSLITSGNFKNVILVTVDTYTKYVHPKDKGNLSIFGDAATATLISTEGEYLIGKPT
LGTDGTGAENLIIRNGGTRSARNENPDDWDNFIDMKGAKIFNFIVKRTPEVVYNNLEING
LNKEDIDLFIFHQANTHILNKVREDMEIPEEKFVIEMRYYGNTISSSIPIAFLEHLRKYP
EKAKNKIQLIGFGVGYSWGAICIEKS
>SEQF1602_00853 tRNA-specific 2-thiouridylase MnmA
MKRVVVGLSGGVDSSVAAYLLQKQGYEVIGLFMKNWHDDSVTISNECPWLEDSNDALMVA
EKLGIPFQTVDMSVPYKQRIVDYMFREYERGRTPNPDVLCNREIKFATFLDLALSLGADY
VATGHYCRKEEIEVDGKPIYRLLAGKDTNKDQSYFLCQLSQEQLSRALFPIGDLQKNEVR
AIAKELGLVTAEKKDSQGLCFVGKVRLPEFLQQQLSPKEGDIIQIPSTWAGYHNKQILRC
FECYEDELKFLAEKYHYTPQDGKIVGKHEGAHFFTIGQRKGLHVGGTAEPLFVIDTDTEK
NIIYVGEGNTHPGLLRSALFVKKEDIHWVRPDLALSLGQRMGFQVRIRYRQPLQKAHLYL
TNSGLYIHFDTPQSAITSGQFASWYLDEELIGSGEIY
>SEQF1602_00854 hypothetical protein
MSAELQNVGLPEKKKGGGLIIALLSLGLVGAGGYAFYQSNEAKKNEEAILEKRDQVVKEL
EALQKDYDEAVTVSKQNADELADAKARIAQYIDSLKNMKADINVLFKYRDQVNVLKKERN
RLLAINDSLRKYNVKVTQERDSTASALNVRTSQLDSVSQKARELSQVIDEGSILSLKNLT
ANGVKEKSGGRYVEKERSGATDKIKVCYTVGVNRIAPVGNRTFYVQVVSPNGITLGDNET
VTVGDKTINYSAVKRFLYERNPVDVCEYISSVTKKYEGGTYQVYVFDDQLRELGKIDLSL
R
>SEQF1602_00855 hypothetical protein
MTKVLDKFVQDIKANVPGFIAVSVTEVKSGVSYIASSADPNFDPNLDSAYNLEVVKAKMN
ALRVLGLEGKEKIEDILITLTNQIQVIDVAPNGTYFIYLVVDSSKASLGITRSLLARYKK
DLQSIF
>SEQF1602_00857 Dihydroneopterin aldolase
MKSSITLKNVRVYAYHGCLHEEAQIGSWYQVDMTIWADLSQSIESDKLQDTIDYVRLNRI
IEEQMAIRSALLEHVAGRILQVVKTEFQNIISLEIEVAKINPPTGGDVEQVSVKIIS
>SEQF1602_00858 hypothetical protein
MKKLALYICVLMGMPSVFGQELQLPSGNQYLADSEFLIMPTYAGIGNNVRVRLSATSQWV
GLKEAPDYQSLSGDMRLGNRSGLGLSLYNDRNGYTKQMGAKATFSHHLTLDSYDSHFVSF
GISYLVNAFRIDIDKFTEAGRPRADAAVTDNRAMINHNFEVGVLYRYKGIFASLAATNIL
NKNKEMFDVKEPTTLRNYNLYAGYRYKRTPNSILEIEPSVFVQYREGDSRSLTDANVKFR
WFDFEDYYWVGATARFVNDQAFKPLSVGPMLGLKKGVFYFAYGYNLNLNTIRSYNSGSHM
ITLGIDMFQGIGGCNCTER
>SEQF1602_00859 hypothetical protein
MTYGTTYKVQDPNTFSLTATEEKPVKCYGGNDGSITFTLEDLDLENSGGVNQATQGYTLR
IKSLTRPTDPIITVTVPAGSATHTLNTLAYGSYTAEAESTSTGCITKIPANFTIRQADQP
INMAAKLRVPDDCSATGSAEISIDITGGIAPYKVTMTGDNGHTQTANQVYNRWLFTGVPG
AAAPGATFTFQIEDAWGCVVTPTVNVNKVVKPDPIDFDDPEITMVSCKNERDGKVVVKNA
RGGAVDDPTATTLTTTYYYELYHDIEGAIRPLQLSNEFTELPAGNYTLYVRDRWNCEKSV
QFTLGTPPEIQVTRVSNSNLVCHGDTGKVSVSVTGGTQTPDPDAGGALAYIYSLELVEAD
RDVVVNRLDKVKMADFPKEIAGLRAGVNYRVRAMDGKRCAGESDLFSLTAAPKLDIKATY
EDNCEDNEYQGYVVLTFEDATVDFTKVQYSFDNGVTKHSFAAGMTSGAQARISRTHSSVR
PSSLPQSIKLYYSDAGTNCEGETNPVVIPVVEKLTLIKDPSRHPDINELPLLGKNGVPDY
TYYINGVHQGNNGTYIVRKQDPEGVDPSDNKLKKRIEARVEDSKGCTAEEVFYVEYYDIE
IPRFFTPTGDGENDTWAPRNTQQYPNIQTLIFDRYGRLLKELSQGQSWDGTYNGKEMPTG
DYWYIITLGEESDGREFKGHFTLYR
>SEQF1602_00860 hypothetical protein
MVACTGESTGVIGVYDGTAYLPITDAIDRTKGVAPYVIKIYKYATTPGSAETLQSSNTGR
DLSKGWYKVELSDAKGCKTSVDLEIKEIEAPVLTLVRKKDITCTSGASSLGEIELRFTTG
LQGNYYMALYTDSNYTTPAQNHAGTPQVTGENYVNSTGATKIFDHLPPGDYYPAITNMAT
GCKVKLPMVQIGGSQIKANAIPAQQVDCNTAKQKIEFFEDGAEIDETQLKVAIYRDGPLG
SGLLTWIPGTTGTITGTGNNKKVEIEFTLLAKTPYRIAVEYKGCKTLLDGKFTPNIATPG
VTITEKRKPNLCGAGATGSVTLHYELSAFAGSTAPKWELYTYPFDTRPGAQSPIATGTAS
TPSGGKSEIKQTVTGLTENKTYILVVRDGTANNCVMGTEIFTVLRAAQPLAFVQTDLLRN
SACSGSANETAQVKVTIKDGVGPYKYTISQASTEPTDTQWAHAAVLPTNSRDVLLDQTFE
TTFGGKIKGTPTGATWYVHVRDANDCHISQAVTVKEDPAPAATKAEVENPCVVGTEYTVK
VTLSQIGKGQHYYTFKPAGGTEGPQQPIQFTQTGPSVWEGYIYRVYASSVARDITIYDQN
GCKSAAVNFVFQGKISFDLTQSKPITCQPGVAGNGELKIDNIANHNPANPHIYRVLKEDA
GGDIVIVNDTPMSGFGAFTVPITQPGRYRVEIVDTTHGGCPFSRTLTVNDKVLPILSLDN
STDSKCYNANQDLLDVNGGGSATLVAAPESQLPMSYSLKAARYADDNSAVTALATIPATH
TNVTASNTYVDWQNNGRQVTFKGLLGDVRGIIYTVEAKAANGCTATTEFTIYGVKPIEID
MTQEAVTQFQCSGNQEVLAKLSLPKTAITGGSGRYRFTLLKGGTPVQGNIDLTEPTFTIS
DETGGNFTLRVEDAQYQCAEVTKPFPTAIKPFVKLTTVTATEVTDITCRAGEDVKVEATL
APAGGDPIKVSLSLRSVTNSSHQMVQITVPAGATTATHTFTNVPMATTVWWQPMMKLAV
>SEQF1602_00861 hypothetical protein
MYSIGKVRHCSCRSCPCHIRRRYIHKVCISRAFLLYCIWMCSTMCASVSYTDDRSGCHVR
CYTALRRDLHLFYGQGRNIIDTCLYPTCSNLTQGTIWVYHTYFQGMSWIRRRCHWSWYLQ
LICTYQSSTSIRSSVKLVLKGSPSLDVSEFYQ
>SEQF1602_00862 hypothetical protein
MIVAKSDNYIMRSLLYILLFLIPIVGKAQQCRVNYTATAENTACGGTVKVALASADTNCI
SRYWAVLYDNTGAVQARQNFSAAGKAEFTNRSSGTYKVKVEKKDGTDTHPTVLSVTIVST
YKRFSVDMTKATQVAATGECATDGKVALKIKNGSGPFVVAFYKQGSSTPTSVSAPTNKTG
NETTVNISGLSPNTKYNIEVTDQIGGGTCAVTEPRNVRDITTLPTTQSFLRGVTLESCKQ
KGVVRGSRGMITVEINNTYGTGPFEVEVRKKEDNQLIVSASNPDHSFTKGGATGTTQKEI
EPDAGKSLEVGKEYIIKVKDVGTNCVAERVQMNPLRFSAESIRLHLAHTCSDCGEYEFAV
VPKFPNRNSVIPNQVTRDKFYTYNLKVEVKRGGVMLPGFPEQFTNTDALPQTGTNNGIIY
GNNEFRFNNLYDAMVHKSAHKVKGGDVITITYEDCSLATRIVLKHTVVTTPYKPYSEIGV
RKKTGGGDCDREVVLTTTFQHGGSPSYTDFCNFTGMKARVKTSNIWQTATSVTNVMYKFY
DEHDVNRHRMYVPVSTVTDKYQVEYANASTPLNASAPNDCKHYVSPELTLTKPDLIDNIG
IHAYYNGEGILQWEHRGKRVQITNVGGVVTDANPLKVSIRRKDGFQGIKTYTATGPWNLA
GTYKIKFPIERTYKAEDTASGYILIMDVPPGEYMVNIKNNCASRDLPLKVEEADTPTYYD
IDPLKVETECSKNGQTGKGKLIYRSLSGENTSRLGYLHIFRDPGGTEPIYKRANTGTYMR
IVPVAGIPSPSDPTKIEVKAEVPNLPTGNYILGIITASSHYRTAVYKPEENGYTYGYRPE
QQKGKGKLADTFIYKTFTVKEITDVVPISVIGMCDPSNASSGMVRVELPAGSEPQYPITY
TLYKVSGGTKAIATYSDGTQVAPVRVATRPANLEDAYATFSNIPRLSGSDSYEVKFESGC
LDRLVPVPEFGSLQNPQVRTSSATACAGTPLTLSVDLPASLYELEWKSTPATALSGVADK
TRPSITLNPTVDAEYWVTYKMKSGFGCTPVSKDTAKKQVNLIRSNFAASDITGLSDKTGV
LPVNQCAADVSWTSPTINDTAGCGYKLTWEVTKPDGSKYTPTPDANGNTPATSWNGFPVG
ESTVTYKVEGKIAGGTAATKSFKVTVTAPNVNIQITSSFVANVGGTTALTSVAKGSTVYY
KVTLKNTTATSISTGALRITLPDNTNTNYELPAANDPAIVTSQLGGAVNVSYDTGNPRVL
ILANITGGVLAQNAERSAYIPIKIKQDQGCDAYVNACQAILTAQPKLIYSVGGAGCVAEN
TIQGDGIAAEIDSRATCPREELYCGGSFTLTALGTGYTSYKWYSGQPGSLTPLASTTSSQ
AVSAAGYYTVEKIATCSGIEAKTTEVIRLVDKSDTTVDPIRALAGNVGGVCATDNTKWQS
HFYFCGGTGSKVLQVAYHQSGVKWQKEGSGCSNANQPNCYNTSAACWSTVSTDRSFTIGG
TTPGKYRLQVGNGSCTREFYFEVFTTQLSGTLIGTPTPHTALSLGAANFEMGTHGVQYEY
VATRSDGRTFTGNGPASGANMHKVDVTGLEVPNNRSQDTFRIVIKAKGGALNGCTFEQTV
TINRLETMKAEVEYTGEWSTTECNKAKYNFTVYGGVRNYRYLIYKIDGQLAKTEYAGKVF
EQLPDGDFSSAITPTNAVGTVPDVFSSWIEVPREGKYIFLVRDNDDRYALTNEVQVSQAS
RYAVEVTKVDLTCATQHGGSISAKFLESNVPSPSVKLEKYKTDGTMDTSFPAQNNLAGQF
NNLSAGKYRVTLSYLFNSGGGGRRCEIVRDIRIESPAPIEASIGVVSANNCDGNNGKFLL
KVNWVKGGSGSYQFMSTSGTGSYSPDRTLLVDGGSQANPKVKVFVKDSNGCIAEFEVMAK
KDLTKPTLAASTVDYDCGGNGTFTVTPTAPGGATYTYEYSLDGGVRQAPNLGNAMRYTGL
AGRATPYLVRVYYTEPATESVNQLYNETFADMEDLDESDGAPTGVGSAKTTGILSAGVHV
VTKQLPATPTTYRSLAGTGRYYAIHTAPSDNRLYVKDIQNVVPRAKATVKFKYVNLGNDA
NTAASVPLRVTLQVTNPGGAGTTAFVRTLPAAAQGGTWQSGEVTFEDLEGFNQHTQLPLD
YRSGREQCCGGSG
>SEQF1602_00863 hypothetical protein
MNIIHLLFIFHKQNVKFCFVKKKHKKNTCDINNIS
>SEQF1602_00864 hypothetical protein
MEKLIKKEINIEIDDKVATGIYSNLVVVNHSETEFVLDFVSIMPGMPKARVQSRVIMTPS
QAKQLMQNLSTNLYQYEQDKEALSDGEVFASQTHFSGSGEA
>SEQF1602_00865 DNA-directed RNA polymerase subunit beta'
MARVKEKNATLRFDKISIGLASPESILAVSRGEVAKPETINYRTHKPERDGLFCERIFGP
VKDYECACGKYKRIRYKGIVCDRCGVEVTEKKVRRERVGHINLVVPIAHIWYFRSLPNKI
GYLLGLPSKKLDMIIYYERYIVIQPGIAKTIDGDPIEKMDFLTEEEYLDIMESLPIENQY
LEDTDPNKFIAKMGAEALFDLLHDLDLDALSYDLRHKANTETSKQRKTEALKRLQVVEAF
RDSQKNRENKPEWMIMKVIPVIPPELRPLVPLDGGRFATSDLNDLYRRVIIRNNRLKRLI
EIKAPDVILRNEKRMLQESVDSLFDNTRKSSAVKTDANRPLKSLSDSLKGKQGRFRQNLL
GKRVDYSARSVIVVGPEMKLYECGLPKNMAAELYKPFVIRKLIERGIVKTVKSAKRIIDK
KEPVVWDILENVIKGHPVLLNRAPTLHRLGIQAFQPKLIEGKAIRLHPLVCTAFNADFDG
DQMAVHLPLGPEAILEAQMLMLASNNILNPANGAPITVPSQDMVLGLYYITKMRKSTPEE
PIAGEGSVFYSPEEVNIAYNERKVHLNASIKVRTKDLDENGNIVTKLIETTVGRVLFNEV
VPIEAGYINTVLTKKSLRDIIGHVLKKTSIPRTAEFLDDIKSMGYKFAFQGGLSFSLGDI
IIPQEKQAMIADANEQVQGIIGNYNMGLITNNERYNQVIDVWTSTNARLTDLAMKRISED
RQGFNSVYMMLDSGARGSKEQIRQLTGMRGLMAKPKKSTAGGGEIIENPILSNFKEGLSI
LEYFISTHGARKGLADTALKTADAGYLTRRLVDVSQDVIINTDDCGTLRGIEVHALKKNE
EVIETLGERVLGRVALNDIVNPLNEEIIVLAGEEIREDAVDKINQAPIESIEVRSALTCE
AKHGICAKCYGRNLSTGKMVQIGEAVGVVAAQSIGEPGTQLTLRTFHMGGTAGNISEENK
IIAHFDGILEIDDLKTVKGEDYDGNPVEVVISRTSEVKILEPHTRMVLSTSNIPYGSFIF
KKNGDTIQKGEVINQWDPYNAVIISEFSGQIVYENIEQGVTFQVEIDEQTGFQEKVISES
RNKRLIPTLHIQDKSGNILRSYTLPLGAHIMVDDKEKIKEGKILVKIPRKSAKSGDITGG
LPRVTELFEARNPSNPAIVAEIDGVVSFGKVKRGNREIFIESKTGEKRTYLVKLSSQVLV
QENDYVRAGMPLSDGSVTPEDILRIKGPSAVQQYLVNEVQEVYRLQGVKINDKHFEVVVR
QMMRKVEIQDPGDTLFLEEQMVHKDDFIEENDKLFGKKVVIDAGDSENLKAGQIVTMRQL
RDENSLLKRQDKNLVAARDVIPATAIPVLQGITRASLQTKSFISAASFQETTKVLNEAAV
QGKVDSLDGLKENVIVGHRIPAGTGMKRYENIIVGARKDLAKQNINL
>SEQF1602_00866 Dipeptidyl aminopeptidase BI
MKRIHLALPLVATFAAITSCHTTKEEKTTPFNQDQFPPAPVAERISQTFENFGEKRTDPY
YWLKDKTNPKVIEYLKAENAYTDTVMASTKKLQETIYNEILGRIKEDDQTYPTFDNGYYY
YNRSEKGKQYLTYCRRKGSMEAPEEVFFDVNQMAEGKNAFIFEGYFISPDNQKAAYLYNE
TGSYAEYTLKIRDLSTGSDINFRVEGVASVAWANDSKTLFYSTIDKSLRSHQIHRQVLDA
PNSELLYQEDDARFSTYVSADKLKRHIWVFNESSSTSETRYLSADNPTQPLKVFLPRTQG
VEYAVYPHKDYFFLRYKDDKHLNGEMYKLPLVGYTDRTLWKEFLAHDPNTRIEGIDVLKD
YVVVSLRKNGLTQLEALPVAGGEKRVVSFPEPVYSVSLKENPMYDSGSFRYSYTSLNRPT
TLYEYEIAEGKSNKLKEQEVPSGFNPDDYTVERLWATAPDGVKVPMAVVYKKGLKRDGSA
PALLYSYGSYGSNSRVYFSTSYYSLIDRGFVFAIAQIRGGSDLGEQWYEDGKLLHKKNTF
TDFIACSELLINDKYTSADKLAIAGGSAGGLLMGAVTNMRPDLYHTVVAQVPFVDVVTTM
LDDTLPLTTGEYEEWGNPNEEEYFRYMLSYSPYDNIKAQNYPNMLVTGGLNDSQVLFHEP
AKYVAKLRSLKTDKNLLLLHMDMDSGHGGATGRYGRIKDTAFEFAFILKCIGIEK
>SEQF1602_00867 hypothetical protein
MKNFLLLTSIFFMLMGCSKGDGDNNRANSIRSTENYDLSGDGRTLIKWKNPNTTSLDMQA
DNELRKVNTIGEGAFKEHKHLQSITFPDNLKEIEAFAFEEADLSGEVVFNTAAMVDFGEK
AFFNAHLKKVTLPNIRLLSDSAFSFAKLEEIYFNKVNKLGFGAISWNYFKVLHLENTELT
EIQTVGISGCMELESVFLPATLTAIGYDAFWYCNKLKTVTILAVNPPVLVNNPFRSTALQ
KIYVPSSSVERYKRANYWSAFSDKIYPKP
>SEQF1602_00868 hypothetical protein
MKKLFLFLLFILLVGCQKEDSGHSDIPSSYYQLSHDGLTLVKWKDQSSSYIDMQADSKLR
EINTIADEAFKGCKNLKGITLSDNLKEIGTEAFAQTDLSEGLHFYSYSNVVFGEKTFYQS
NLREVMLPNTKALPNRIFADCKQLKKVTFAKTKLIGDGAFYGCEVLEQVDLTQANVEGIG
KEAFANCSQLKKVILSVTMNLKPIGDKAFANCKTLDSFTMLSLYPPYYEGDPFYGISKVT
FPKIYVPSQPEELLSLYKRDYYWKAFADYIQVIP
>SEQF1602_00869 hypothetical protein
MKKIYALCLLLLAIGCKKDDSESLPLNTEKDILSFVFTLEDKPYTALIKGTDITVSLPED
TPVEALSPTITISKGATLSPNTGVAQDFTKPVSYTVTAQDKTTKTYKVVVTVEKTEQPQV
PIAIEPIPQGFAKDKQGGEVVSFNTNTLPVKKEQIKVQLVNRKDFSISYELKVQKIDKKE
RRVDVVLPASYKNGEYRLKATFDKEEASSDFFVLENGIPVLKVLDINRFEDPVTVLATTH
LQKFNTVIYAKEEDLAKYTYYLRKNGQDYPLAVTYTGSYNVHFLMFDTPSTPLIGGKDFD
FVIKGKGKEYVLPFVNSQKEPIEIEVAHAPLIHSLSQTSLRVGDTLTLTGEYFTYTSVGR
TNGDYRYCSLLLIKDGEVKATIDTFIHRDTTATFTIDDSVPAGTYKVVFSSQIRLLSESF
AQEITIH
>SEQF1602_00870 hypothetical protein
MSTYAYLRKNAMEIHIDLRNVRSERAFLNKMKETFSLPDYFGYTLDGLDDCMQSLEWIEQ
KQVLAKFYHLDDVRQNNEALYGQIVDSLNLYKAYWTGNPDKKVSFEY
>SEQF1602_00871 putative propionyl-CoA carboxylase beta chain 5
MQRQISNMDLAFNKNEDYNKLARDQVRQRWEQIKLGGGEKALEKLHSQGKLSARERIDYL
LDKDKPRVEIGAFAGEGMYKEYGGCPSAGVVVEIGYVRGHQVIVVANDATVKAGAWFPMT
CKKNLRAQEIAMENRLPIIYLVDSAGVFLPLQDEVFPDKEHFGRIFRNNAQMSSEGIVQI
AAVMGSCVAGGAYLPIMSDEALIVNKTGSIFLAGSYLVKAAIGEDIDNETLGGATTHCQI
SGVTDYQCENDQDALEVIKNLVDKIGESSKAGFSRIKSVKPKLNPADIYGILPQSRTQPY
DMKEIILRLVDDSEWEEYKEGYGQTILTGYARIDGWAVGIVANQRKVVKTKKGEMQVGGV
IYSDSADKATRFIANCNQKKIPLVFLQDVTGFMVGSKSEHGGIIKDGAKLVNAVANSVVP
KFTIIVGNSYGAGNYAMCGKAYDPRLIVAYPSANLAVMGGVQAAKVLLQIETATLKRKGE
TLSPEREQELLENIQKKYDEQTSPYYAAAHLWVDAIIDPLDTRQWISMGIEAANGAPLKK
AFNMGVLQV
>SEQF1602_00872 hypothetical protein
MVKKFYFLCVVLLALSAQAQNKYKCMVQMTNYSGEAAYMVVSLIDPQGSYLKTLHVFGDN
SKYYDALKKWYDFYTAKKEKVDALTGASITQGDRKTIVLDLDNNLLNQGYKLRFESAVED
QYYYTTDAEVPFTTESLKEKVSGTGYVRYVRLSEVK
>SEQF1602_00873 putative peroxiredoxin
MSLVGKKFPNITVDAMSEMGDNLRINILEEATKKNKKVVLFWYPKDFTFVCPTELHAFEE
LRGEFEKRNTIIIGASVDTCEVHFAWLNTPKDQGGIEGVTYPILADTTRNLSNALGILDA
EHVYNEEQESYLIEGSNVTYRATFLIDENGKIFHESVNDMPLGRNVKEYLRLIDAYTHVQ
KFGEVCPANWEEGKEAMHADRKSTAEYLAKH
>SEQF1602_00874 Thioredoxin
MLVELTSDTLAEVIQANKKVAVQFSASWCGNCRIMKPKFKKLASEKEDIAFVIVDAEQFP
ESRKLANVTNLPTFAIFEDGQLIRDVQTNKQEVLNELIDEITRN
>SEQF1602_00875 hypothetical protein
MKLPVIKHLTQFVEANDEDYLIEAIEVLEYLTELPSLKEEELDVIGELLSNMYGALEVEK
LIKAGTPQKEALNTFMQRVLGAIDK
>SEQF1602_00876 Dihydropteroate synthase
MKSINCRGELLSFDTPKVMGILNVTPDSFFAQSRVQGTEILAKAEQMLALGATFVDIGGY
SSRPNAAEVSAEEELQRVVPIVEALVKHFPEIRISVDTFRAEVARQSLEAGACMINDISA
GQIDPPIWDVVAHYQVPYIAMHMRGTPQTMQSYTEYQNLTADILYYFSEIKDKARQLKIN
DLIVDPGFGFSKTLPQNYQLMQHLAIFDILDCPILVGISRKSMIYKLLETSAEEALNGTT
VLNTFALLHGADILRVHDVKEAMECVRMVEALKGK
>SEQF1602_00877 hypothetical protein
MKCLDFYNSKALKKYLDSVRVVLEKRYKASDEKYCTAATKTDDIYYDTPLLQKKIKNKDD
KLLILKNIAFCNCMEYEYEQIVKENPDLYSLFIDRSREDYITYGGLDANLTKNNLSFDRL
VKEWHKKEYNAYPADDNRGKIYLTIMKCMDFYNSKKLELYIDSLKVKEKEL
>SEQF1602_00878 hypothetical protein
MKYFLFISLSSFLFCCNNKQNSEGKFPKETSSTASTQIKEIKQEKEIDNEVLTMKKDKTL
EDDLLMLKNVAFRKCFGQEVFGIKKKEPNTYKLIPDATTGGYLQCSEYLDIEWIVANPTL
DKLVENWLSKPYYKTFQEKGSPKRYPNLYEVFRFLQ
>SEQF1602_00879 hypothetical protein
MLFFSQAGEMFSQQRKPFSQKECDCDNVDTTDRTSRKVVLTNIQLLKKGANYFIQGNCCD
ILRAFGNDFERESVICISKKIQKFRLLDAIPYSLFYEDKGEKQHIFTEKWAEVKPFFLKE
KAFLATVFIEVGVSNQDNSLLWVYTRNYE
>SEQF1602_00880 D-lactate dehydrogenase
MNTQNLLEKLRQIVGAKYVMTDPGQTERYRTGYRFGTGNALAVVRPATLWEQWQVLEACT
EADVIVISQAANTGITGGSNPFGNDYDRDVVIINTMRNDNIQIILEGEQAVCLPGSTLNH
LEQELKPYNREPHSVIGSSCIGASVIGGVCNNSGGSLVQRGPAYTEMALYAQRNAEGKLE
LINHLGIDLGETPKEILTNLQEGKYQRKDIHQTDKKGHDHDYCNHVRQIDADTPARFNAD
PARLYEASGSAGRLAVFAVRVDTFPAEKHTAVFYIGTNDTKVLTELRRHMLGSFEQIPIS
GEYIHRTAFDIAAKYGKDTFWYIKHVGTEYLPKLFSLKAWADRVAKKLPFMPSHFSEKFL
QGTSKLMPKHLPQIMWDYRNQYEHHLILKMGGKGVEEAREYLKDYFADKSKGAYFECDAD
LAQAAMLLRFAVASAAIRYRSVHEKEVEDIVALDIALKRNEEDWFEQLPPELDNKILHKL
YYGHFMCHVFHQDYVIKKGYNCEEIEEEMLKILDQRGAEYPAEHNVGHLYHAKEPLKNFY
KELDPTNSFNSGIGKTSKKKDWK
>SEQF1602_00881 Thiol:disulfide interchange protein DsbD
MKRYLLTFLMVLLAIPFAKAQISFNSPLAGQQNDNPVEWTFSQEKLSDTEYLLIFKGKIA
PKWHVYSQNNPKGGALPMVITYTTTEGIEMVGESQEEGLQKTFNDVFGVDELFFEKEIKI
TQKVKITDPNVKHIKGNIFCQACIDVCINLKEDFVFSLDGSAAQVEQKQIDSRSEDMAKQ
LEIPLKNKELIGKTEQESNWTVFLLGFLGGFIALLTPCVFPMIPLTVSFFTKQSKTRKKG
IFNAFLYGFFILLIYVLLSIPFHFLDNIDPEILNNISTNVWLNVVFFVIFVIFAFSFFGF
YEITLPSSWGNKMDNASNVGGMIGIFFMALTLAIVSFSCTGPILGSLLAGSLSSGGAIQL
TLGMAGFGLSLALPFVLFALFPSWLNSLPKSGGWMTTAKVFLGFLELAFALKFLSNADLV
QHWGLLKREVFVGLWFVLFALLTLYLFGLIRFPHDEPRKPLLQYSKGRLLIGVLSAAFSI
YLLLGLFGKNSLRVLSGFPPPESYAFFPKEHKNDQIVFKDYYEGMAYAKKHNMPVMLDFT
GWACVNCRKMEEHVWTDPQVKELMKKYVLISLYVDDKEELPKDKQFDFKHRNGRVEYIKT
IGDKWATFQEVNFSSASQPYYVLLSPNTELLSTPVQYVDVETYKEWLRKGVKND
>SEQF1602_00882 hypothetical protein
MKKITLLIFLLPLLAKAQPIINLEDFDYQKFQWGYYFGINTLDFRVDYQALDYTNPPLTD
IQTKRSYGFNVGLTGDLRLIDHLSLRFEPGLIYNKRELEFPFLTQQTDRKREVLSTYIYI
PVLLKYGSKRWDNFKPYITAGTSVGINLSANNKSRSDNSEGKFRTQPIVYFYELGFGIDF
YTPHFRFTPSIRGLFSIDNELIHDSDPASPWTGNLKGIFTRGVMINLTFE
>SEQF1602_00883 Demethylmenaquinone methyltransferase
MQQEEIVTPDKNSNKGKKEQVQEMFDTISPSYDGLNRVMTLRMDISWRKHVREKIAQIKP
GTILDVATGTGDLAIELSKIPSAHITAVDISQGMLSVGEKKVKELGLSERIVMQVADSEN
LPFADGSFDAVTVSFGIRNFENLHKGLSELRRVLRPGGRLVILETSVPTRFPYKQGYKLY
TKFIVPMMGKLLAKNKNAYAYLSESAAKFPFGKKLSGILKDEIGFSKVHFIPQSLGVATI
YIADK
>SEQF1602_00884 hypothetical protein
MKKIFLSLLTLVAYQGIAQQSFTGLRTSTYGGVTTTLSNPAHALGARPWDVNLVAVDANL
GNNDMAFSFNLEKSFNKFTDGLSTSKVINAGLTADVLGPSAIFRINKEHALGLVTRMRVM
ANTTGIDAKVLQGLIGVGDMQLPTDPSQYYKVQGINDMNLLVNAFKEIGAVWSYTVMNDG
YNLIRLGAGVKLVQGTGSYRMGFSGVNQDNVTLRRENGDVIMHIGDGHAEVRSGGLDVLG
SSFNVLETHATTVGFDLGVIYEFNEDGCPNCDGHVPYRFKVGVSLLDLGKLSYTTNSKSY
NYTIHNQDFNLDNMQGSLDKIPSPTPLQGTSFSSSLPTTLNIDLDYRFIDGFYLNLSNQL
NVVSKNEYNARYANDFVLTPRYETRFGPGIFGAFLPISYNQISKLNVGTGFHIGPLVFGS
RSILGNLTGGAKEMNFFFGLRFGGMYK
>SEQF1602_00885 Oxygen-insensitive NAD(P)H nitroreductase
MNFLSLAQNRYTTKIYNGKTLSKETLEQLKEILRLAPSSINSQPWEFILVGDKRKDEVFA
PLSLMNEERVKQASHIVIFRVLESVEHFEEEAPSYISEGGRTFYQQYIKPQGEAHVKAWM
GHQVYVALGYFLAGCAAMGVDSTPMEGILPKEYDQHLPKNGYQTLFAVAIGYRDPEDKNQ
PSITPKKRKESVVREL
>SEQF1602_00886 hypothetical protein
MLYTIGTSNNYPSRAYGAFRSVKGSITDYLMFGDPEPIHLNIRLDFTDFEAIAAKWDCIS
INRVYIYLLNKRAMDFFEKQCPGTFEWIPAKIYSNNSLIETEHKLLHITQHSKEGIFFYN
EDSLRSIWVEEAFMKKYKKEKLKGWTFYSEEC
>SEQF1602_00887 hypothetical protein
MTIESHYKELLTHIEGLDYSDTKAALVYASKELYKQSSDLCLLTMINALIKAPDFLPEKL
TEIVNTYVYYEGTIGIYRYIKTKLQENESNPSFYYADVFEYLLEVLEEKYQKMGVDLKKV
IQS
>SEQF1602_00888 putative ABC transporter ATP-binding protein YheS
MLNVSGLSISFQGETLFSDVAFMLIGGDRVGIIGKNGAGKSTLLKMLSGELPPDTGTIAL
EKNAKIGYLKQDIDFVAGRTVLEEAYQAFTTLMRLEEELDHIHHEMAERTDYESDSYNDL
LIRLHDVTHEYEIHGGYTYKGDTERILSGLGFSREDFSRLTDSFSGGWRMRIELAKLLLE
KNDILLLDEPTNHLDIESIIWFEGFLKSFPGAVVIISHDKMFLDNVTNRTIEIVAGRIYD
YPKPYSAFLELRKEMITQQLAAQKNQEKMIQQTEKLIDKFRAKASKASMAQSLIKKLDRI
ERIEVDEQETAVMSVRFPLSQQPGKVVLEIDHVSKSYDDKLILKDVSLLVERGSKIAFVG
QNGQGKTTLAKMIIGEIPYEGNIRLGHNVEIGYFAQNQAHYLDGELTLLDTMLNAANDSN
RTKVRDILGAFLFRGDEVEKKVKVLSGGERNRLALAKMLLSSFNVLVMDEPTNHLDIASK
NVLKQALQRFEGTLIIVSHDRDFLTGLTDKVYEFKNHTIKEYLGDIDFYLEQRAVSSFRE
IEKGEEVKKEIVVEKEKTLSYEEQKERKKLSNQLSKVERQISDLEKEIAQMNTQIQNTPT
PELMEQYGNKKKQLDNLMEEWEKISLMINN
>SEQF1602_00889 DNA polymerase III subunit tau
MNPFIVSARKYRPQSFVDVVGQKAITDTLENAIANDHLAQALLFTGPRGVGKTTCARILA
KKINEKTTPTDGDNDFAFNIFELDAASNNSVEGIRSLIEQVRIPPQVGKYKVYIIDEVHM
LSNAAFNAFLKTLEEPPAHAIFILATTEKHKVIPTILSRCQIFDFKRITINDAREYLKYI
AKEQGLEAEDEALQIIAQKADGAMRDALSIFDRVVSFCGKTITRQAVSEILNVLDYDTYF
KVTDLIVSNNIPQLLIEFNSILAHGFDGQHFIAGLAEHFRDLMVCKNSQTVSLMEVGEET
QKKYIEQTTKCDFPFLVEALRIATQCDLEYKTSRTPRLLVELALMQLASLTYQGDKKKMM
DI
>SEQF1602_00890 hypothetical protein
MLAILEKRGEHLLISHLGKDSAPTIAEDVILLEVGSELALIETQSQQERLLTYIRKSLNN
YNITLQITVNKEIAPVTAYTPEEKYLALKEQNPLLETFVRELGLQF
>SEQF1602_00891 Peptidase E
MKKILITLWALLITGLVYGQGQSAPKPSQEQAKMKKILLASTSTIYGGTYLSYLKEELKV
FFAGVDEILFIPYARPSGISHDEYTQKAKDFFATIGKKVVGIHTFANPAKAVKQAKAIFT
GGGNTFLLVTQLYENGVMEPLREAVNAGTPYMGASAGTNIAGQSMQTTNDMPIIYPPSFK
TLGVVPFNINPHYLDPDPKSKHKGETRQTRINEFHILNDTPVIGLREGSWLVIENGKLTL
KGKLTARIFQQGQEPYEWDGKTPLPFFK
>SEQF1602_00892 hypothetical protein
MKKETFILLFGLFSSAMAQPCTYKDVLNKMTLFYDKTYPSKIDIQKADFSSVILNQSTDY
LGAIGVHKKRLVVLISSVKRNPQNPLMYEIAGRTRVGKNVRQFKGSITLTQLISGKPEDT
TNDLYTENSGVQEEGVAVGDFILDEYEDLPATGVFKGKVLLWWFLSKKGKIEYNDGYLMA
DPYLNNAYIGTWTSKQTHKSQQVSWGHYHVPCAGDLDMGAGEFSPAPEYYKYGWDEYIQE
IKKKYPDAYKD
>SEQF1602_00893 Triosephosphate isomerase
MRKKIIAGNWKMNNDAGQSAELIAALLQKLPQTKAEVIIAPSFVNLALAVEKTKGSPIVV
AAQNMHFAEKGAFTGEVSASMLEAIGVRTTILGHSERREYFNETDESLAKKVDTALAHQF
RIIFCIGEKLAERKAEKHFEVVQRQIEKALFHLPKDAWKHIVLAYEPVWAIGTGETATPE
QAQEIHAFIRKTVADKYGKEVADNLTILYGGSCNAKNATSLFANPDVDGGLIGGAALVAD
DFISIIQAMK
>SEQF1602_00894 Dipeptide and tripeptide permease C
MEQQKKHYFDTKVLGQPSGLFFLFFTEMWERFSFYGMRVLLVQFLTAEILLGDPKGGWGW
TAEQAASLYGTYAMLLYLTPVLGGIIADKYLGARNAVITGAVIMTIGQLCLFLSIPVMFY
IGLTCLVIGVGFFKPNVPSILSEMFKEHADKKDSAYTIFYMGVNSGSFFGTMLCGYLAMT
HGWSWGFGLAGIFMALGTIQFVFAKNLMGDLGVLKQSLPQQKEEKQVTEVKKEDTDKRNP
FTFTDTILITIVTLLGLTYAFNDPLSKNGMYDVFAWANSSLMRGQTLFIIITLVLFIYVL
FSRIMRYEGVVRSRMLAVVSLAIFIMFFYITFDQAPSSLIIIARDHVDRSLTGNGLFIFN
IINSLIVVVPLIIIFYVLIRLAIATWKHIPITNMILLLCFSLIWVVVVYMLKSEFAKTES
EISVSWFSVLNPFFVITLASSVSKIWESKFNPPAAYKYGFGLFFVAIGYIAIWLGATGLG
EGAKISVIFLILTYLFHTLGELFISPVGLSYVSKLVPARMLAFMFGMWYLGIAIAQKIAA
TLGGQIEYVKQNYGLSTFFLIFAVIAAGAGILVILLHPMIKKLMHGVK
>SEQF1602_00895 Capsule biosynthesis protein CapA
MKKGLLFCFLLISFYSLGQVSINKEKDTLSLLFAGDIMGHSPQITSAYNKTTQRYEYEPV
FAKVAPIFRKNDYVIANLEVTLGGKPYTGYPTFSSPNALAAACYKSGINVMVTANNHSCD
RGKKGITNTLYQLDSLGIKHTGTFYDLIDRARRNLLVLRKNNIRVGILNYTYGTNGLPIP
EPTLVNLLDTLQIKKDLQSAHAHKLDKLIAVVHWGVEYATKPNQAQKDMANFLLRNGVDA
IIGGHPHVLQPMEKNTNDQFVAYSLGNFISNQRKRHTDGGLMVKLSFVKNKEGKTKFLIP
QYYLTWVHIYQQEGKNHYEILPCAQVEKENFEGLDKESIKQIKLFIEDSRKLFLENNIGY
IVEKK
>SEQF1602_00896 Glycine cleavage system H protein
MNLPEELRYTAEHLWVRAEGDLFYAGITDFAQQQLSDIVYVEVETEGETLGKDQVFGTIE
AVKTLSDLFMPLSGEIIAFNKELVRKPEQINKTPYESWIIQIKPTALTELEELLSAEEYA
SMIND
>SEQF1602_00897 putative ribonucleotide transport ATP-binding protein mkl
MIEVQDIKKSFDGVEILKGISATFHKGKTNLIIGQSGSGKTVFLKTLLGLHIPDSGNIIY
DGVKYADMNKEQRRKLRQEMGMVFQGSALFDSMTVEENVMFPLQMFSSLTPAEMKDRVDF
VLEKVNLVNAHHKKPAEISGGMQKRVAIARAVVNSPKYLFCDEPNSGLDPKTSIVIDNLI
HTVTEEFNITTIINTHDMNSVMEIGEQIIFLKNGYKEWEGSKDTIFKTNNEAVTDFVYSS
ELFKKVRQMYLNND
>SEQF1602_00898 putative phospholipid ABC transporter permease protein MlaE
MKHLEAIGRYFLMLYEIFRKRTKWAMMKRLIMKEIDDLMYGSLGIIAFISLFVGAVIAIQ
MALNIDNPLIPKSLIGFATRQTIVLEFAPTFTSIIVAGKVGSFITSSIGTMRVTEQIDAL
DIMGVNSLNYLIFPKIIALLLYPFAITMAMALGIYGGYIAATVGHYATSAEFLEGLKLQF
RAFDITYALIKSVIFAFVLATIPAYHGYYMKGGALDVGKASTISFVWTSVAIIIIDFIIT
QILLT
>SEQF1602_00899 TonB-dependent receptor SusC
MKRKWLYVLLGFLWLTFSGLYAQEQTVTGVVKDQDGRPLLGVSVVEKGTTHGVDTDLDGN
FTIKVSNEKAVLVFSMVGSTPVERVVGNNKVLNIVLKEEVTELTGLVFTGYQEIDKKLFT
GNSQTLKIDNIKQDGVVDVGRMLEGRSAGVNVQNLSGTFGTSPKITIRGGSSIFGDTKPL
WVVDGAVQEEVVNLSFEQLASGDASTLISSAISGLNANDIESIEILKDASALSLYGARAL
NGAVIITTKSGKRNVKTQLSYQLEESVRMIPNYAQFDLMNSQETMSVYRELEQKGYLDRA
TYMAAQQGGAYQIMYRNTDTYDPATGRFLLQNSPEARNAFLRKYEYANTDWFKTLFRPSL
TQNHTLSLSGGGENTTIYSSLGFFVDPGWTIADRVHRITGNIKTTYDLSSKVKIGILAQG
AIRNQKAPGTFSRSSNQVTGEYERDFDINPFSYALNTTRALRPYDDEGNYDYYRMNYAPM
NILKELKNNYIDLKMMEYKLQSDLEIKFTPALKYKFLGSVRYAQSTQEHTISEGSNVVGA
YRANDNMIIGERNPFLYRNPDDPSALPQVVLPNGGIYKLEQNNLQSYYLRNALEYNKAFK
DQDEQDKHTLKLFLGQEFRYTDRDNQSFDGYGYQFNRGGVVFTDPRIIEKVIADNAQYFD
RSTGRERGVAFFSQASYGFRNRYILSGTLNYEGSNQLGRSRKARWLPTWNISGRWNVTNE
HFLPATHALSNLSFRLSYGLIAGLNNIGNALPIMISTITPRFRNQDNERLIRILSLQNSD
LTWEKVYETNFGTDIGFLSNAISLSVDLYQKNSKDLLDIVRTSGMGGELNKYANDASMTT
RGVELVLDTRNFKTEDFTWSTSVNFAYFKQEITSLANASNSVFNLVRETGGNVLGNPRNT
LYSYDFAGLNNQGMPLLNLKGGSRDYKDIDFQDRDNILSYLKKEGAVDPNITGGLSNTFR
YKNWELNFLITMQAGNKIRKAPLYKGAGYDDLSVFPREFKNRWVAPGDEALTQIPGIVSQ
RTLNEENKAYISRAYSAYNHSTARVVDGSFVRMKSISLSYTFDKEVLENLNLGNLTLRLQ
ASNPFLIYAHKDLNGQDPEFFRSGGVAYPITPQYTFTINLGI
>SEQF1602_00900 hypothetical protein
MKRNKYLSLLALALTLVLSACNKILDDLPDSRTEIDSPEKIEELLVGAYPNRFPTYIAEM
MSDNVSEKTSFLGISTLNTDMYFWRDNNEIDGEDNTPTDYWIACYAAIGAANQALESYAE
LGETARYNYIKGEALVARAYAHFMLAYLWCKPYNEATAATDLGLAYITEPEKHVFGHYTR
ISLKDYYNAIERDLTQGLPLLDDSKYKQPRFHFTTAAAHAFATRFYLMKAQWNKVIEHAD
AVLGANAETKLRNIKTLNAVALESRSAYYTESTNPSNILVGTARSALAYRFQTHKYSLTL
QKMAEICSPRNTHPLNFSNISWEAVNSALGDGAGNIVFPKSNYYYKYVNRSAGTRVYYSA
AVLFSYDEVYLNRLEAYLMSGNLDQFRRDLFTYLIPKTHNSSRPNEAYPFPRLTFERYMT
QEALDRRYQGRGVDFDPSYPLTTRQREWLQAVVDIRRVEFVQEGLRWFDNKRLGMKVVHK
VGDGQIELTKGDPRRELQIPNSALEFGMAPNPR
>SEQF1602_00901 hypothetical protein
MKKITYICIALSVAFSSCNKKETLDPQSVIHDDTDTPTTLDTYIRNEYINPYNIEVNYKY
VDINYEMGRYLYPPTESKVQPFLEMIKYVWLGAYQQVAGTTFVSQVAPRQISLIGGRNLD
PQRNPETYLFEETLGQADNGAKITIARVDYYDPAHPNEENIRHIIHTIQHEYCHIINQHK
PFAPEFGKITPDDYSSSWHGKTTAQANALGFITNYAAANPFEDFAEMTSHMLMKSKAQWD
AALNAMPEKGKVALKKKEAFIVEYFRAEWGIDFYQLQGVAYQRMQNYL
>SEQF1602_00902 hypothetical protein
MRKILYLLAIIAVAGCQKNEPDLLMGKNASERIQQNKENLKKTLSEAPYGWKLSYFPKKN
TFGGYTFLMKFTLGGRVTMVADFGSGTTPQESGYQIQEGQGPLLVFTTRNYIHTLLEPLT
YSSDPREHIGKGLEGEFQFVYIGQEGDKLKFKTQRKSTEQFLYFEKATAEDWTTIGTQGE
QLDGIDHTYYLKVTSAQGVENYFVRSAFRMFLFTSMQDSHKASRAGIAVNSNGLTFTPSL
EIAGEKFTHMTAVPGTPPLNYRAQSNGVTIELRHFNNPMDEFESQGDVVTDFIVLLGDQA
HLNLPYMSADFKRDFYTEVGEGKFFSYELLFQSDADTPLLRVGYTPTGNQNDRVYYAYKC
NYEIRDKKIYITFIGEHEDMDEFWIDPNNEEILQMAQERLTHFIQMSSQGIYLWKSSLSA
TLGPVYYMRSISEPKYYFPGTVNQAVEE
>SEQF1602_00903 hypothetical protein
MDQISQILFLVSDSLLIPDIIVLLILFVRALLLSGSFYNQFITKYKNQRQLSPILETLSP
ESLPRLQEALPEKDNSLFVKYLRKILLRPTDGAYADYMISNFENEAEKDIVTSKLLSKVG
PVLGLIGTLIAMSPALTGLSQGDISKMASNMQVVFATTVVGLVVSLVGLITLQFKQRWYA
KEVNQLDYISRIATQQTPEK
>SEQF1602_00904 hypothetical protein
MRNSRRTNPFKDDDADPLSVVVNLFDVAMVFSVALMVSMVMNLNLSAFFTGGDFTIVNKN
GDDMEIIQKKGEKITKYKTAKGASSSSSSKDKGKRLGTLYENEDGENIFVPD
>SEQF1602_00905 Septum formation protein Maf
MLSQSLRGYSLILASASPRRAQFLKDLGLPFEVRIKQTDEHYPKDLKGAEIPLYIAQEKA
HAFSGEIAEKEILITADTLIWFEGKAIGKPKDYADARATLSDFSGKTHEVITAVCLKGKE
QQRAFYESTQVTFSTLTPEMIDYYLTHYQPFDKAGSYGIQEWIGAVGITQIKGSYNNVVG
FPTQLFWEELTEMIASQTI
>SEQF1602_00906 All-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific)
MAKIIEQIKEPIAQEMAAFEDKFRDSMSSRVALLNRITHYIVNRKGKQMRPMFVFLVAKL
VSEGLVQERTYRGAAVIELIHTATLVHDDVVDDSNKRRGFFSINALWKNKIAVLVGDYLL
SKGLLLSIDNGDFDLLRIISVAVREMSEGELLQMEKARRLDITEEVYYEIIRQKTATLIA
ACCAMGACSVAPENSQVIEQMRLFGEYVGMAFQIKDDLFDYTEEAIGKPTGIDIKEQKMT
LPLIYTLNMVTEKDRHWLINSIKNHNTDKKRVKEVIAFVKAHGGIDYTQEKMKEYQAKAL
AILDRFPDSPYKKALLQIVTYVIERTI
>SEQF1602_00907 hypothetical protein
MYSELAEGHPIRTYLHETELIQNLLEEIMQTDPEKDYQKFYNLFNHLSTVEKRFQRKENQ
LFPFLEQKGWTNPSQNMWSFHDTIRDMFRLVRKNLEEKDLAKAKENMVYVEDNLQRLLSV
EYNILFARSLEILSEEDWIKMRQGEDEIGWMLPTPPPTYPNESGYIHPSEDTTLRTDVVF
DENAQHYDEGYLTIEQVNLLLKTLPIDITFVDENDKVIFYNRGEERVFPRSAGIIGREVK
FCHPPKSVGTVLKIVEAFRNGTQNEANFWFNYRGRLIYVRYFAVRDAQKNYRGVIEMSQD
ITDIKTIEGERRLLEWE
>SEQF1602_00908 Inorganic pyrophosphatase
MAKETTFDVLIEIPKGSRNKYEYDFDLGKMRFDRMLHTSMVYPTDYGFIPETLADDGDPL
DVLVISTIPFFPGCVVEVKPVGILYMSDEKGGDEKVLCVPKADPMVKSLNELDQVNPHLT
KEIEHFFKVYKDLENKKVEVRGWGDAQKALEVYEECIARYKGQSAKKFVL
>SEQF1602_00909 Protein RecA
MAKKEKDKVEEIKDKDAKAQALKLALERLEKSFGKGTVMRLGDKVAEKVEVIPSGSLGLD
IALGVGGYPRGRVIEIFGQESSGKTTLTLHAIAEAQKQGGSAAFIDAEHAFDPYYAKKIG
IDIDNLIVSQPDNGEQALEIVDGLVRSGAVDIIVVDSVAALTPKSEIDGEMGDSKMGVHA
RLMSQALRKITGSISKANCVVMFINQLRDKIGVTFGNPETTTGGNALKFYSSVRVDVRRQ
AAPLKNKDGEAYGNLTRIKVVKNKVAPPFQKTEFEIIYGEGISKVSEIVDWGTEFDILSK
SGAWYSYQGTRLANGRDAMKALLLDNPEMAEEIENKIKEAVKEGKVVVKKKTKSSSSKSK
GKSNEDDDDNYDEPEDDDNYPDEEDDD
>SEQF1602_00910 TonB-dependent receptor SusC
MRTKIRQQLLSLAFFLLATVAGAQTLKGKVTDDQKEPLLGVTILVKDSPSRGATTNEKGE
FTLRVSPEETLVFSYIGFKTKEVKVGKHKQLLVSLESEAEELPELLVVGSRAGGRTKIDS
PVPVDVFDVTKTSKTQPQANINQILNSIAPSFTSTTQVVSDGSDHLDPAQLRGLGPDQTL
VLLNGKRRHTSAFINVNGTPGRGTVGTDLNTIPSFALSRIEVLRDGASAQYGSDAIAGVM
NLELKKEKGLSAQVSYGGHLTPKANDHRGDFDGGQGQLDINYGTELGKKGGFLNLTFSAQ
FRNTTHRAGTFDGDIFNAYNAIELRALEHNDNLSGYFSNINVDADSRLLGLIKGYVQEVD
YFDSSYLSQIQGATSIAALQPLLKKDFTEQELAYRGLGRKDFNMHVGQSSLLGTQFFINA
VIPFSKHWELYAFGGQSYRYGEAGGFFRRPNQARTFTGLHPNGYLPKITTDIQDSSISAG
IRGEVGKWHIDLSNTFGRNEFAYTIKNTGNTSLRFASPDSFDAGKLRFLQNTINLDFSRP
LELFEKANISFGLEQRHEAYSTVAGEELSYATYDIHGGVLPLGAPSSQKTTDFFGNALPG
GAQVLPGFRKESALTKTRNVVAGYGEFETDITKWLLANAAVRYEHYSDFGNTFNYKLATR
VKLFPNVNLRGAASTGFRAPSIHQLYYTNINTLQINGVLQETGTFNNISRAAELFGIDKL
REEKSKSVSAGFALKVPKAGLSLSADAYFIRVDDRIILTEAFSRPAGNTTAENELKQIFD
LANVNTVQFFANAVDVETKGIDVVLSHSLQNDKFSLTNDFAFNLTQTKKVGEIHTPRAIK
AAGLEEKFFSERSRVLLEEVIPRFKATLSHNLTIGKWNGYLRNTYYGKATGPDIIRTADQ
VGDFVFDERGHQVIRGKIITDLSIAYNFTPKTSFTLGVNNLFDLYPEKNVKVNNNNDQFV
YSRATSQFGLNGRYVFARATFHLF
>SEQF1602_00911 Gamma-glutamyltranspeptidase
MIVKRIFSFFGALLFLLVSACTTGKVATGQKKGVLAKHAMVVSAKREASEIGLAILKKGG
NAFDAMVATELALAVAYPNAGNIGGGGFMVYRLANGEKGALDYREKAPNKAHRDMYLDAN
GKVIPGKSTLGALAIGVPGTIDALFEVHKKFGKLPMAELIQPAIDLARNGVVITPLQADF
YMGKNVEQIKKANNYVTPFENGWKAGECFKYEELAQTLERIRDNGRAEFYEGETAKRIVS
YVQELGGILSLEDLKNYHSQWRTPITFNYKNYTISSMPLPSSGGLCIAQIIKSIEPYKIG
QYPHNGEKYVQLLVEAERRAYADRAYFLGDPDFVKVPTQTLLSPDYLKQRMSTFSWDKAS
KSSEIAHGKVVGYESDETTHYSIVDSEGNAVAVTTTLNTNYGSKVYVKGAGFFLNNQMDD
FSIKPGEPNTYGLVGSEKNAIAPNKRMLSSMSPTIVEENGKLRMVIGTPGGSTIITSVLQ
CMLNVFEYGMTMQESVSKPRFHHQWLPDDVMFEPKGFDPMVISKLKAKGYVPKEENFVII
GRVDAILVEKDGSLEGGADPRGDDVAVGF
>SEQF1602_00912 hypothetical protein
MKEFLFLPALLVGIFFAAFFIFLVNEFSTSLYSEVWLLFFPIPLILGIWLFYAIYYKQII
LSLGAIGCSIAFFAWIMKELNVSFSKLSSEKNLPITYQNYEDLDYEVSVCAQEKGHCIHE
VPTNESEDLTSCFLNHLNEVVMVQDDRMSSYIVKFDTLGYQQSIEVPTDDDHRKVAYIVD
DYIINIANNTYSSFFLNDDEDFLPMTFVEASKNWTKEEQQTYFENNVKTKATCFKIVKRE
KSKVFFLKDDKWQYFYTDLGKETLKTQYNYPELFDEKRFPIQERSLKRTYIHPQYVQTYQ
DNYGYTTILYYHIIKPFLTYHLKTRFETVKSQEELSALPTYYFKNDTETIEVFGSMRLYS
HKHLQYQLLRIGKKTYRVGK
>SEQF1602_00913 Polyamine aminopropyltransferase
MFRRILSYIFPLSLHQRTSTVSGTLSVTLLNGKKLLNSPNTDYSYGRLQQVLRFGLEQIG
FSAIKKQKKILILGIAAGSVVETLVKEIAFDGEIHGVEIDPEVIAIGKQFFDLDKVKNLQ
LFIQDAQEYVKNTSERYDSIIVDIFQDDQMPSFLFAPPFFLQLNKLLNSNGVILFNTIVK
NKSQAQRNRDFVQYFQNIYQITVFPKVKQENQLLLLAKKNLNSSIKK
>SEQF1602_00914 7-carboxy-7-deazaguanine synthase
MDGTILPLMEDFYTIQGEGFYRGTAAYFIRLAGCDVGCHWCDVKESWDASVHPRVPIEEI
AQRALAHSKTIIITGGEPLMYNLQPLTELLKSKGARTHIETSGAHPLTGVWDWICLSPKK
NKRPLPEVHQRASELKMIIYNHHDFLFAEEMSALTQPDCIRYLQPEWSRRERMVPLIVDY
VMENPQWKISLQMHKYLDIP
>SEQF1602_00915 hypothetical protein
MNIVLQAAPQAGGGNFTFLIIMVVIMCVFMIFPSMRRQRQEKKFYGALKKGDKVIMKSGL
HGRIVELTDTTVVVETLSGKLKFERSAVSMDYSRRVQQEQ
>SEQF1602_00916 hypothetical protein
MKKIFVLAGMAFLASCADKGTDAAGKINQNNLKEAQELAEKANQFPQIKFEETTHDFGEI
KQGVEVQTLFNFKNTGKVPLVITNASSSCGCTVPEYPKEAIAPGATGAIKVVYNGSGNGN
ITKTVTLTTNTEQGTETLTINANVKP
>SEQF1602_00917 N utilization substance protein B 
MLTRRHIRVKVMQAIYALHKEENHNLQRGESFLLSSMDNMYSLYISLMGLWGALQERSSQ
MHALSKSKFIRDENLSHTLFCENKALQLITTNEPLKEAIEAEKKLSWHTYNEYVNILYNK
IVESQVYRRHSTLERSFQADKQLLIDLYMEVIAPNEELFDFLSDREITWDDDFPIINTLI
VKILKGLSEGGVADFLPPLFKDKSDKDFAIELLRKAVLNDEAFHKYLVEKTPKWDADRIA
ELDAIMIKMGIAEFLKFPSIPVKVTLNEYVEIAKEYSTPKSSVFVNGILDTLSKDFQQEG
KLKKIGRGLL
>SEQF1602_00918 hypothetical protein
MTQNEIDHILQHISEGNKLLAVKELMDKAQISLKDSAEIINLITEGKESDLNVCLQRIKG
GGSLEQPSSHIAEGAYISQSKIKEIQEFVHQGYKLAAVKALKDASGVDLKQAKDIIDDLD
LDNTIDLNARIASAKSHYSENYERISATSDANGSNVHFYYQKGNVKEEVTPGHPMWERVK
AQYSHEWKGAPEDIVKAREPFRKAVLEMEAQAGVSGGKREDTLFIKKKSFNIFEGIKWYF
ILALAACIIYMIWSIFNKA
>SEQF1602_00919 Ribonucleoside-diphosphate reductase subunit beta
MGIFDKRENYKPFEYPEVMKFVDMMHQTFWVHSEVEFTADIQDFKSNLSLVEKEAVKRAL
LGIAQVEVAVKTFWGDLYDVFPKPEFNGLGATFAECEFRHSEAYSRLLEVLGYNNEFEAL
LEVPIFKERNTILKEYLAKNRENAMERILFFTLIIENASLFSQFATILSFTRFKGYMKNV
ANIIAWTSVDEQVHANAGIYILKTIFDENPEFRTKAKKEATEFIREYILLEDKMLDWIFE
EGELEFFSKKDLANYMRYRLDDALTQLDLGKPFGITAEEAKPMLWFEEEVFVNELDDFFA
KRPTAYTKHDKSITANDLF
>SEQF1602_00920 hypothetical protein
MNLTKEINQEIHLIDTDYFTLGEYIYMAMGLVKKHRVCIAVAYKIDYCIKKALQFAEVDP
AITFTHINKVKVGETEAQKRFEWKS
>SEQF1602_00921 50S ribosomal protein L21
MYAIVEIAGQQFKVSKDQKIFVHRLDESEGSEVIFDKVLLIDQNGAITLGAPAIDGASVQ
AKVLRHVKGDKVLVFKKKRRKGYKVKNGHRQFFTEISVEEILATGGKKAPAKESKPKKSQ
KDDLTKVEGIGPKAAEALAKAGVDTFEKLSKKSVEEIRTILVEASKTLAHLDPQTWAQQA
RLAADGKWDELKKWQDELNGGIVK
>SEQF1602_00922 50S ribosomal protein L27
MAHKKGVGSSKNGRESHSKRLGVKIYGGQLAIAGNIIVRQRGTVHVAGENVYMGKDHTLH
AAISGIVKFQKKKDNKSYVSIQPLAEA
>SEQF1602_00923 Prolyl tripeptidyl peptidase
MKRISFLLALCLPLIGFCQKQTIATDKATYDGSLWAKRLNYLQWVQGTDNYMYYKDNNLA
IFDSKGTQVGGIDLQKLSQTYSLKGNPTISYIDANQVVIEEGNKFHIYDYVIEKPLFTIT
LPENAQNAEYNHTQRAVAYTLDNNLFLATAEEPRFPIAVFKDENIISGQFIHRNEFGIQK
GIFWSPNGNYIAFYQKDVSQVTDYPLVDINTTPASVKSIKYPMAGGKNEIAKVGVFDVAK
KTTSYLKIDNHDAHYLTNLAWTPDEKQILLAEVNRGQNHCDLNTYNRETGEKNQTLWKES
NSKWVEPETAAIFIPNHPNEFIWLSEKDGFMNLYVCATNSTKSRQLTSFKWVVEEVLGFD
AKGENVFIKGTGEDPRERHLYSVNIRKGTVKKLTTKAGAHSGLLSDGGRYLLDIHSAVTT
PYNVSLIDINKNTSKTFYEAPNPNDKYDLGTIEFLTLKADDGTPLYAKMVKPRDFDPNKK
YPVLVYVYGGPHAQLVINQWNAATYPWMLAMAQNQQYIIFTLDNRGSENRGFAFESVIHR
NLATYAMKDQMVGVEYLKSLPYINSKRMAVYGWSFGGFLTSSLMYRHPGTFTTAVAGGAV
IDWKFYEVMYGERYMDTPEENPEGYQDNLVTNYIKNLQGNILYIHGYIDPIVVPQHMLTI
SQAAIKEGKVIHAMLYPNQEHNVRGGESIHLTKTILDFILKNNVENPVNAAN
>SEQF1602_00924 L-methionine gamma-lyase
MSTFKQSTNALHAGYDPQAHQGAQAVPIYQTSSYVFENADDAAGRFNLSVPGYIYTRLNN
PTNDVLEQRLAAVEGGVGAVVTSSGAAALTTTFLTLLRTGEHIVSSNSLYGGTYNLLNVT
LPRLGITTTFVDPKEVSNFDKAVKDNTRVIFIETLGNPKLDVLDIEEIAKVAQKHRIPLI
VDNTVATPVLLNPIKYGANIVVHSLTKYIGGNGTSLAGAIIDGGNFDWSSGKFPEFTEPS
AGYHGLVLHEALGNLAFIAKVRIEGLRDLGTSLSPFNAFQILQSLETLSIRVKKHSENAL
VLAQWLKVQPEVAWVNYPGLADSPYKALADKYLQGGQSGLVTFGLKGGFEAAKKTVNNVK
IFSLLANLGDTKSLIIHPASTTHQQLSQEAQALTGVTPDLIRLSVGLEDIEDLQKDLKQA
F
>SEQF1602_00925 Fe(3+) dicitrate transport protein FecA
MKKKTQMIAKLLLTTMVALTIPQANAADKVPSYSIMGQQKEIQVEGRVVDAQGNPLLGVN
VLVKGSQRGVATDKDGYYTLRVDENAVLVFKSLGFHTQEIALQGRTVLNVQMKVSQEELP
EVTVTSTGIKRQIKDFAGTVNVVSATQIKELAIPAVGDAVRFMPGVNYIDEDGRGLRPGI
GLRGIDPARNSNTLVVIDGKIPIGQSYSDMGGYYMMPVGAIESIEVIKGASPALYGSGSI
GGVVNIITKKGAAQPYTGLNLQYGNHNALNIGVETVGNTNEGAMNYYAGFHRRQGDGFRK
SRSRYAVNDFTGNATVKVGERNEWRFFVNGFTEYSDTPGGLSQAQWDADPEQSVNPHDFF
EARRFSTAISYKRTFDEDNSLTTSLYGSYLKRDWWLDNRNADATKRKFTSALRDIPSVGL
FSDYERTNTLFGKENKLLAGIRLHTDITHEVSVAGDKMGEKSGKTTANSANTVAVVEGYV
FDEFHITDKFNINPGLRYTFVNYDKEDYFRNQWDNTNEDAFIYSLGLFYKFSENYRAYLT
YSKGYKMPQIRIAFETNGDLDAETSNNYELGLRTTPTDWLEVELAAYILDFDHKIFREGG
VLNNGGKALHQGIEVSGAIYPIEGLKLYGSGAIQKATIEYGMYKGNRVPYAPRYTATAGA
KYQLECAGGVLTLNGYGNFVSTQFSDTKNTEAGSANGNVGAIPRFFLLNATANYSIKKWN
VNLNALNLLNRKYFTTRHSAWGGIMPAATISVLAGVGYQF
>SEQF1602_00926 Ferrochelatase
MNLGSPNSTSVKDVRAYLNEFLMDPRVIDLPYLSRAFLVKGIILRTRPKRSAEAYRKVWT
AEGSPLIVHTRHLREKVQQGTDIPVAMAMRYGKPSIASAIESLYKQGVRELLLIPLYPQY
AMSTTETISVLAEKIIRKHYKDMCLSELPPFYNNPEYIKVLATSIREHHKEDEYLLFSYH
GVPERHIYKSDITKEHCQLNDICCNTLSPAHQYCYRHQCFALTESIARELQLTPAQYGTS
FQSRLGRDPWLQPYTDTTLAALPEKGIKRLAVVTPAFVADCLETLEEIAMEGRETYLEHG
GTHYNYIPCLNDREDWAKTLLSWIEKWQNK
>SEQF1602_00927 hypothetical protein
MRKRFYTLLALSLLSTAILSVSCNKDKIDFGGGSDPNSISQVTTGSGAPTAGQKGDYYFD
STSKTLYKRKGSSWTGIATMNLNGNLLSGQGKAKPSQGNNGDSYIDIKTNTIYEKKNGVW
SASSEGEIVIKDANFKAALLAIVGIDANKNGKISPAEAQAVTGFSVAGKEIASLEGIEAF
TNLESLDANDNKLTTVNLSGLTHLKKLNLTNNLLSGELNLKELKYLANDKVKIVAGNTSI
EKIFVADEAKATALNNFEHTTKYTFSGELERILDLDPVIKAALLADNNRPDRNGDGEITN
KEAERFNKPIRIETPGIKSLKGMEYFKKATSLVIQAPDGQKNVLVDGQVSLADFSEIESL
TIANTKMTKLTLSNFPKLKHLILTGNELTEVVLSGMPELVTLNLERNNLTNLNGITTPEN
TFPKLTALNLIGNNLQGELDLSKITANLRNNANAIQILRGNNNSGVARIKVKDQDTANVL
NTNDAGAGKYQVDGSGGSNPEVPIRDSRLRFLTLEKLQAIMDTREFRGRFPGGKNDTTGK
IYKSDLDRADFPTALELDSSVGDLSGLEYFSKVKKLTIYTSTPTTLNLIGMDSLEEIIST
GSTIEVIQGNAPRLKKIILRNSHRVKKINVVNSSNIEQITIEEDSNIPNHIECIAVPANR
ADTVKQNINLNSPAKTTVYRSKVQSTPCN
>SEQF1602_00928 hypothetical protein
MSNTIPLKEKLDFQQYQLVINALSNIGIEIAIPEDVAHGHENELAGATLGENEQLFKIEL
PVVAPLFLTDKRGGELVLLTKEAYERFSLKEKELQILSTETYDKLLRKEKELEEFTKEAY
NKLSLKEKELEAVSQKLSFKEKELDVLKRDLQENYVEKNSVEPQNTPITIVPQSAPAPMA
AQNTPEPVVAQSTAASLTTTDPLSATDPFVPQIVMKNITFEEVPEHPESTSSYEESTSSY
EESTSSYEESTSSYEESTSSYQEPVARTTPLYQSSNAPVSLQEAVERARSILEKYNK
>SEQF1602_00929 hypothetical protein
MEKDPQEVAEFYAKLKSELEKTTVFPSEYLYKFILPATQEKREAIRAVFKDTQATIEEKP
SSTGKYISYSIRLEVQDPDQVIAYYQKAGEIEGIISL
>SEQF1602_00930 hypothetical protein
MSKLLSITYYLLSIICIGSASAQSNAELFAQAGSAYNRGDWQEAIDNYRRILSKGEASAS
LYYNLANAYYKTEDVAHSIYYYEKALELSPEDKAIQNNLKYAQQMALDEIVPLPKLWSQR
AMEALSRWNSPNGWGVWAVVSMCLFAGFFFCYYFLEKILYKRIFFTLMVVAFLGSVSSFF
LGRTVSHYVHSNHYGILFDKEVRLYEQPNTYSKEVFSLHEGAKVEILDQFKEWYKLKVAD
GRIGWAKKHSLRKI
>SEQF1602_00931 Dihydrolipoyl dehydrogenase 3
MKEVSRVGDSVIVKADAPNGELVLEGDYCLVATGRRPYTEGLGLEKAGVQLNSRGQIEVN
EHLQTSAAHIYAIGDVIRGAMLAHKAEEEGVYVAELLAGEKPHINYNLIPGAVYTTPEVA
AVGKTEQQLQEEGRAYKVGQFPMRALGRARASQETDGFVKVLADASTDEILGVHILGARA
SDLIAQSVVAMEYRASAEDIARICHAHPTYSEAVKEACLDATAKRAIHM
>SEQF1602_00932 Type IV secretion system protein PtlE
MSEKKLIAESKNFEQTGIEREKRIAKASLTVGAAGLFIGGLSIIALIIMLPLKKTDVELY
TVDNQTGRVEHVTSVSKTSLTAQEAVERASVARYIRMRESYNYFELQSNYDQVQLYGTPD
VNNAYLAWYAGAEAPDAVYQKAAYVAKIDIISNVISDATSPDRLATIRFKKTIRKISDNS
LKTEYWDVRMTFHFEPNREMKASEREANELGFTVTSYQRDKEIRGGQ
>SEQF1602_00933 Type IV secretion system protein virB9
MNKDSASFARNTFKGAMLLAGLLSCGMLAEMAHAEAVPHGSRYDARMQQVVYNPRNVSVV
NTSAGFVTTLIFADDEAVSSAEAGFPAAWEVTKEANRVKVRARPIEQGAPGADGNSEKVV
IPPNSHDWRTNLLVVTNKRIYSLDLNVLDDNSRMKPAYVVMFRYPQDEANKTSQEQLKQQ
LALMKQAEEARTEKALEIAQIPRNWDYSMRVGAGSRRITPDFAWDDGRFTFLGFSPQKDI
PSLFELNGGKEQIVNSSVQRKGSYTVLVVHDLTPKLVLRSGNAVVGVDNNGYGKVKATDG
TTVSPNVERVEAFNDN
>SEQF1602_00934 Type IV secretion system protein virB10
MTTENKDDQSFNEQEEKSVAELELEARQRREAELGNDDEEDESATPQRPEVSALNKRKKG
KTAFASLVACLILIVLAWVGTWFYKTYLRAPPQDKQTDTTDNSKPSTSNVRKNLGQDAAP
YEPEEEKKNDVSNSGDAAKSSDTQESVNSAAAPLRLNKALALITTNTANATESAPTMTRQ
QEALNIVGKSSNSTEADSASTTTESDSARTTTQSVDSGTAGIDADNGQGNAEGSDSRSSS
SSTPSPVRRIPFNPDLYVPELTSVPCSMDYRFVSDRSGKLKCTIAKDIYSASGRVKLIEK
GTEAHAEYRSGTLNHGQGSVFIIVNKLRTRQKPYLDIPLTDTNAAGELGEAGVSGWIDQH
WIDRFGGALMVGVIPDGMAAVANTSGKTDRNTDYTENSRQSMAEMAKTTLDNSINIPPTL
YKNQGEIINLIIGQDIDFSKVYKLKVK
>SEQF1602_00935 Type IV secretion system protein VirB11
MSVKNLSLNQYRNDFFGTYLEMPGLTEIAVNRPGELFTKIAGQWKKHDSSISFSHCEAFA
TALAKHHGDHIEDLKPGLSAMLETGERCQVILPPACERDTISITIRKPSNVVIPHQQYID
NGFYDRVTGKEKSDSRDEELLKLYSSGDIPAFMEKAVRYGKTIVVAGETGSGKTTYMKML
VGFIPLHLRVVTIEDNNELRFNGLENYVHLFYPSEAGDDKSAIVTPARLIRWNYRMNPDR
ILLTEIRGAESWDFLKITDSGHEGCMTSIHNGSPHAAIQGIVERCYQHPECTNLPYSVLL
RKVLNCIDIVVSIDVNGDVRRMGDIYYKPVHRDKFMKDFRNEMF
>SEQF1602_00936 hypothetical protein
MPLWKENNLFIQAPKVSGGWNLKVDNFSGDNQVYPEAFWYGLLHSEKITVATGRKTDWFA
VKNWLRQHGARQTIYYGEKKACEYCIDIYMSR
>SEQF1602_00937 hypothetical protein
MAALLCAITFNCLPAKADEPCEMTLCMWGQVSGSSKEGCEGQIKKFFKKQVKKKGSFLPN
HTADAREDMLRDECPASMVPGDFIKKIISKFGKLKG
>SEQF1602_00938 hypothetical protein
MDRKNFIRNPFSELNDSIRIDVLIIRIEKDAAGKSGLHYEVFHQKVMENLSDIVVRLKDE
DAEKLKLAAAMRGYCLDEESLAQTRECYLNKIKQIEDELL
>SEQF1602_00939 Peptide chain release factor RF2
MVTIEQLKELSQRVENLEKYLQIDKKKIEIANEEEKTLAPDFWDSPKQAQLLVQKLQSQK
KWVTDYEKSAEMVEELQIMLDFYKENAISAEEVEDFYGQTLLHIENLEFRNMLSDEGDAL
SAVLQITAGAGGTESCDWASMLMRMYMMWANRQGFSVKELNFQEGDVAGVKTVTLEIDGE
FAFGYLKGENGVHRLVRISPFDSNAKRHTSFASVYVYPLADDTIEIEINPADISFETMRS
SGAGGQNVNKVETAVRLRHHPTGIIIENSETRSQLDNKNKALQLLKSQLYEIELKKRQAK
RDEIEANKMKIEWGSQIRNYVMHPYKLVKDVRSGYETTNVDAVMNGELDDFLKAYLMLMG
QQNNDQ
>SEQF1602_00940 Threonylcarbamoyl-AMP synthase
MAKFIKIYPENPNEREIQKVVDCLREGGVIIYPTDTVYGLGCDITHSKALERIAQLKGIK
LDKANFSFICADLSNLSDYVKQIDTTTFKLLKRALPGAYTFILPGSNNLPKEFKKKKTVG
IRIPDNTIARTLVEKLGNPIVSSSIYDEDEVLEYTTDPELIFEKWQDKVDIVIDGGYGDN
VASTVIDLSSGVPELIRQGKGSIEGLW
>SEQF1602_00941 tRNA pseudouridine synthase A
MVANYIDILVRYFIQLSYNGKNYCGWQRQPHSPSVQEELEEAMSMLLKKEIALVGAGRTD
TGVHARDYYAHFDSDSSLPDRLVEKLNSFLPKEIAIKQIFPVKNDAHARFDACSRTYQYF
IALEKNPFLYEQSYYIHFPLDLSLMNKAGEILLQHTDFQCFSKVNTDVKTYNCQLKEAYW
RKEGNLLIFRITADRFLRNMVRAIVGTMIEIGRGRLSLEDLQQILLSKDRSKAGYSVPGH
ALFLEEIIY
>SEQF1602_00942 2-epi-5-epi-valiolone epimerase
MEIEKIHHIAIICSNYEESKYFYTEILPFTIQAEHYRAERQSYKLDLCLNGEYILELFSF
PTPPKRLSHPEACGGRHLALAVKDLEVSITYLESQGVVCEPIRTDEYTGKRFTFLEDPDS
FPIELYEI
>SEQF1602_00943 DNA primase
MITKESIDKVYDAIRVEEVIGDFIQLKRSGSGYKGLSPFTNERTPSFSVSPAKQIWKDFS
SGKGGNAIAFLMEHEHFSYVEAIRYLAKKYNIELEETQQSEEEKSKANEKEGLYFVSEYA
RDYFHKTLLESEEGKAIGGTYFKERGFTPEMIEVFQLGYSPDSWSAFTDEALKKGMNLSH
LEKTGLTIVKEDNRKIDRFRGRVMFPILSMSGRVLGFGGRILSKEKQKEAKYLNSPESDI
YHKSQILYGIFQAKPFIAKEDSCYLVEGYTDVIQLYQRGIKNVVASSGTALTQEQIRLIR
RLTQNITILYDGDSAGLRAAIRGVDMILAEGMNVRICTFPEGEDPDSFAKSNSLEEIQEY
FKTNTQDFIRFKASLLMSETKDDPLRRADTIRDMIESISKITDPIKSEIYVRECAQIMEI
SEDVLFASLSQINQRELIKAQQELKKAKKETALAPVQPVERVSPIMVLERELIKYLLLYG
TKECVFYENFLYYDKETGEEKNQELSQRMKVYEKLFLELQADEIELTTPEFKEFYDFFIR
KYQEGLEDFSKIVHELSPQIASLVATFQAEEEKIRLHNWGRKDVVVKSIEEDLAVAINSL
ILNFRKMLINKKIEELREKVASIESQGGDPMEELQEVVTYNSLKIIIGKKLGWNL
>SEQF1602_00944 [LysW]-aminoadipate semialdehyde transaminase
MKEDFLQYQAPTSLYPLGLEVARAEGSYIYDTQGKAYLDLVAGVSACTLGHCHPRVVKAI
QEQAAKYMHVMVYGEYAQSPAVEYCKLLAENLPKPLETTYLVNSGTEAIEGSIKLAKRAT
GRSQIIAARKAYHGNTQGSLSIMDYELRKQPFRPLIPDVAWIEFNNEAELQKITHRTAGV
VLETIQGGAGFITPENDYLAKVKKRCEEVGALLILDEIQPGFGRTGTLFGFQNYNVVPDI
IAIGKGMASGLPCGAFVASYELMHLLADKPKMSHITTFGGNPVVAAASLATLRELLSTDL
MAQTLEKEQLFRKLLRHPKIKAVHGKGLMLAAIMEDEDLANHVILYAHEHGCIFFWLLFE
LRAVRISPPLTISYEEIEKACAMIIEAIECYQK
>SEQF1602_00945 Leucyl/phenylalanyl-tRNA--protein transferase
MYLVTQNLYFPPVEQADKTGILALGGDLSVPRLLLAYRSGIFPWYNEDEPIIWWAPPKRM
VVYPEHYSMHKSMRNVFNQHKYTVTFNKAFQQVIIACKDIYRKDQQGTWITQEIIEAYTR
LYELGLARSVEVWKDDQLVGGLYGVDIGNGIFCGESMFTKSSNASKVAFYTLLQELKEKN
YLLLDCQVYNDHLASLGAFEIPRAEFMQILLKGNISLRVKKLKQTK
>SEQF1602_00946 hypothetical protein
MLRKLLFFLSFFFSIGLFAQDSISFKSIRPKPKKKDSITLTSRDYKRISIFRDTTAVDTT
LTLKAMYRQNPVRRDMFAYVPFQNMGQTYTSLAYDYRSVGISSDFGMRGNRFYFSQAQQI
PYFYLPTPMIEFSFKSGISQGQMLQSFFSANLTPEFNLFIRYNALRSLGDYKNILSSVGS
FSAGFSYYSKNKRYLAMAHYANEEVNRQENGGLLYPEQFGQGDDQFRNRARLDVALSGVN
SEENLKRYFLQHQYNFLPASHREGGSEILLKHQVEYQSRNYYHSQSEMASNGVLGQSFTL
KSLQDKHSLRELTNRLGAELSLPYLGKTFLYGKSYFYNYFAKGIFVDNNGNFIPHQIKNT
DYGIGVQWRKNYKGFAINAQGEQMILGKLLGTEIAGDLSYTFDEKNKVIAGVNITSKMPN
FNFLLYQSDYKNYNWYHLDDFSKENIQTIYGSAYTQWGNLSLDITNINNYTYFQLQPASS
REKNQSKPAQYTGNIQYLKLVGEREFRLGKWGLENTLMYQQVLQDNANVFNVPSLTTRNT
LYFTTFMFKKAMFLQTGLTFKYFTNYYAYEYNPLLADFQVQTQEKIGNYSVTDFFLNAKV
RTMRIFFTVEHLEALLGKYNYYAAPNQPYRDWKVRLGIIWYFFK
>SEQF1602_00947 hypothetical protein
MLDFLYPIEDFFTQKNYIPQTIGGRILKHTRKEGLPSLEGVQIAVFSLFNSENILKNSFR
EYFYSLYYGNWDLVLADLGNIPEGTTQEDTFIAIRETVSFLMKQGIIPVFLASGVENTYA
LYRAFDSMEQMVNLACVSPLFGFGDEYEIFSEDSYMSRILMETPTHLNHFSNIGYQTYYN
PQESKDLLDKMFFESYRLGEITSYMEQVEPILRNTDLVSIDMAGVQAADIDMPQGYVNGF
SAREICAISRYGGLSSQTAVLGLFNVPTSVRGRMLIGEVIWYFIEGVNYRIKEFPTIEDK
NYTKHIVLLDDFTIEFYKSNRTGRWWILPSEASKGAFMLPCTERDYQKALEGTIPLRWWN
LHQRSLS
>SEQF1602_00948 TRAP-T-associated universal stress protein TeaD
MKNILVPTDFSEHSIYAVDVAVDLAKKNGATIFLLHCVELPQRFVTESTSVLPEELFFMR
EASNNVKKLSLELQAKGVEVKTVVETSTLTNSVKTLLEKESIDFIVMGSTGATGSKELFL
GSNAEKIVRTSSVPVLVIKDKTNINEVKKIVFACDFSQKYIDAFQKAISFAQVLGAKIDF
VYINTPYHFNSSREIKVLIDSFSTEHKEILSHNIHMYSDFSIEEGIIHFAEDHQSDLICM
FPARQSVLMHLFNGSISEDIVNHSQKPVLTIKL
>SEQF1602_00949 hypothetical protein
MRKYLLFIFFLVSFFSFARVSHTEETDTLSAPSSAQKLLFNFYINSNFSAEKHTHTPSSA
AFRIEDARLNLQGSYDDNLSYRIRMRLNRPFTPTSSDNASVGLDFAFLTYTFGKEHQWEM
RIGRAYGMIGSYELDINPLYEYIFSDHLNYVVNGFVTVLQAGYRINNRHQIGIQGHNTLN
ESFGTHLANNGFVSGDFKASKTPLGVYLYWMGTFFENKLHTYYSYDFSQFVKGYYTHSIS
LGNQLTIGNHLAYLDLIYSHMGADYALLGSKTLNQFEQVVPANYTMRKNMVYKGLISRYQ
YQFTDHWSIAAKVGVEFSGNQNILSEHHRTNYIYSCAGQYEPFRTEDFRFYVAYIGNTID
YKKELNIPLEQLHRVALGMAYTLPLYKK
>SEQF1602_00950 hypothetical protein
MTKKIRNLFFLLFLLGQVLFAKEKKDSLSESLSAKKLNVELYFRGGAISDYHSQEALSGS
HFKIDNARLNVQGDYNEFLSYRVRFRLNKAFSPTSQDNASDALDYAYITYHFDQEHRWEA
TIGKQLSVMGSFEQDINPLYEYIFTDYLNGVYANIFLAGLQLSYQLTPQHKVGIQLHNTL
NESFAKHLENNLFTTEGFTASKAPIGGYLYWNSSLWDGKFKTKYSYNLSQFAKGYYTHSV
SLGNKLQIGKHTAYLDLVYSYMGADFGLTSSKLLSIHKGLAKEAYLMHKNIVYKCAVSRY
DYQITDRWSATTKIGIETTGSRKELSESLRTNYIYFLAGQYAPLLSQDLRFYVAYVGNTL
HYDQALRKDNEQLHRIAIGAYYTLPIFKR
>SEQF1602_00951 Ribosomal RNA large subunit methyltransferase K/L
MVAKTFFGFEEILEKELQILGATQIQKGVRSVSFSGDKGFMYKANLCLRTALKILKPIHS
FRVRNEKDYYQKLYQYDWEQLLSPTQTFAVEVTLATDLFHHSQYMTLRAKDAIVDKLRVT
TGKRPNVDTLHPDLQLFIHIQSDNQVIVSLDTSGASLHHRGYRTQTNIAPINEVLAAGIL
LLSGWKGQSDFLDPMCGSGTFLIEAAMIACNIPASLHRKEFAFEKWTDYDVDLFETIFDS
SLAKAKEFNYHLYGYDKAPSAVTKAKENIKNARLTEYITVIQQDFFKTKKEKETSLFMAF
NPPYGERLEINPQLFYSQIGDTLKQHYPNTEAWFITSNLEALKHVGLRPSHKIKLFNGKL
ESRLVNYSIYEGSKKAKHNLNQ
>SEQF1602_00952 hypothetical protein
MLDLLGRSLLDYQNGDRSSDVYVQTNISHREYLSRAHFFRSFSQMIPIEQQALTLSQGRT
LDVGAGTGSHVLYLQEKGIEAIALDISPSAIEICKQRGVRVAICCDILQYEGQADTILML
MNGIGLCQKLSLLDTYLQKLKTLLTPHGQILLTSTDIIYMFDQDEDGSYLVPVFEDTDYY
GELTYTITYKGEKESFPWLFIDYNTLQNAAHHNGLLCELIAEGEAYNYLARLRRKA
>SEQF1602_00953 hypothetical protein
MKILDRYILSRFIFNFISSFLIIMVIFIFQTIWLYVDELVGRGLSFLVVIKFIALMLPNL
IPLILPLTVVLSSIMTLGAFGESYELAAMKASGVSLLKATRMLILFMVLLSIGVFFTFNN
LQPWSNRKFVALRDSIKNKQPSLAISQGIFNNVQDFSIKVAKKTGENEQYLHDIVIHKVG
INGDTRTVIKAKNGELSGHKKGSDVLQLILKDGSYYEDVYNDKSDITFPFVKAKFETHVL
NIDISALNADITYDENAERDYYKTMNISQLSHALDSIVQNYQQETKDFGENFYRRTGIAY
IAEKPEKEVIPSAPITDMQQLKEAYKTKGSLPQLYSLAKDNIISLVNSLDNNKDNVEYQQ
KLINVYRLTLSDKIALAITCFVLFFVAAPLGAIIRKGGIGMPLVVAIGLFLSYYFSGLLT
KNMATNGNINPYIAPWVPTFFLLPLGVYLTILVNEDKPIGNIAGLFHWIKQKVFRKS
>SEQF1602_00954 hypothetical protein
MIMPSQMLTFYKKDFSYKWDIVQQVKGRKIQYIELKPTKQASDIKLILLGIDTTTKHIYN
LIQIGKNEAKTTITINEFKTNQPLSGNEFIFNEAKYKKLGYYINK
>SEQF1602_00955 hypothetical protein
MKKIFLFIFAFTISFSQAQNADKAKAYLDEVYKKVTSYKNIYIDFRYSFENSKERIKQDT
RGNVTLSGEKYLLNYMGVTKIFDGKKYILSFLKTKRLP
>SEQF1602_00956 hypothetical protein
MNFVKNFFEDHSSGISSYKKVVISKNGKIFVRKKNSCTFDPNFVNSFSRMKALFKKEIRY
FFTSSIGYVVIAAFLLFNNLFLWILSGDYNIFESGFASLQPFFLLSAWIFVFLTPALTMR
IISEEKRSGMFPLLFTYPISTWKIVLAKYLSVLFFIFVLLLFSGIYVYMVWQLGMPKGNM
DMASTIGSYIALFLLGATFVAVGMLSSALSQSQIIAFVIATFLNFFLFFGLDEIITLFSD
NLLFSIGFKAHFEDISRGVIDTRNILYFLCITLFFLYVTQLFLQAEKK
>SEQF1602_00957 hypothetical protein
MKSLKKYTLSLSLVVVVLAAVLFLSQILYKRFDLTADKRYTLSPTTLQVLSQVKTPVNIK
VLLKGNIPVEYKRLQVETLQLLEEYKAKNKNIHFEFLNPLEGKNPDEQLQKLSMEGFTPL
MITSSSQGKTSEEYILPWAILTQGDKQERVSLLRNKLGASSQEKVQFSVQNLEYAFSDAL
YKILLEKQKKIAIIRSNGTLPDIQIADFLRFEQDYYHIAPFVLDSVATSPEKTLKQLSDF
DLCIIAKPTERFTDEQKQVLDQYIMNGGRVLWLLDPVIASMEDIFRQQGHTMAMPQDLNL
TDILFKYGVRLNYDLINDWYFTQIVVAQGSGSQTQYTPIPWVYSPMILSSNNHLINKNLD
GIRMQFVSSIDTLSNGIKKQVLLSSSPLSKQEGTPKEIVLDFPEKTTQGYDKGNFPVAVL
LEGSFTSVYKNRVKPIPQLKEKDESVPTKMIVVSDGDIIRNDVQQGEPIELGYDKWTNQF
FDNKAFLQNCVNYLLDDTAFLQLRNKKVTLPFLNKKTLEKEITYWKLIAFIVPLVLLSVI
GIGLRFWYRKHFS
>SEQF1602_00958 DNA polymerase III subunit beta
MRFIVSSSYLLKKLQIIGGVINSNNTMPILENFLFELSENKLVVSASDLETTIKGVIEVE
STDSISIAVPYKILIDTLKTFSEQALTFIINDNNTIDIVSNNGKYTLAYLDSNEFPSVVE
IENASQVTLMGDILATAIQSTFFATGNDDLRPIMNGVFFNFTEEGLIFAATDAHKLVKYE
RQDIKSDQPAAFVIPKKPLNLLKGILAGSETQVTIEYNESNAKFSFDQLDYVCRLIDGTY
PNYEAVIPKENPNKLIVNRNLILNSTKRISNFASKATHQMRIKIVGNSLQIFAEDIEYNN
RANETIPCNYEGDDMEIGFNSKFFIEMLSNLSSDEILLEMSYSNRPGILTPADGLDEGEK
IYMLVMPTMLSNA
>SEQF1602_00959 Lysine-sensitive aspartokinase 3
MQIYKFGGASVKDADSIRNVASILEKNPRKDILIVISAMGKTTNALEEVVENYFQQNQEG
LAQSIDKVKDFHYQIINTLFENKNHPIYWKIDGLFGEISSFLERNKSPKYSFVYDQIVSF
GELISTQIISHYLNDKGIRNTWLDARNLVKTNSNYQEGEVDWQETERSIRESINPSLMYV
TQGFIGSDPNYFTTTLGREGSDYSAAIFAYCLKGENVTIWKDVAGVLNADPRYFSQTQLL
EKIPYQEAIELAFYGASVIHPKTLQPLQRLDIPLNVRSFLHPEQAGSSVCNVKELSPKIP
CYIRKQHQHLLSLSSLDFSFIAEENISFIFNLLATYQIKVSLLQNSAISFNLCIEDKYKN
LSFLLEDLSKRFKVSCTENVVLYTVRHAQQDSFDFLGQDKEILLEQFAQNTQQKIVRDET
HIL
>SEQF1602_00960 DNA gyrase subunit A
MVEGEKLIPINIEDQMKTAYIDYSMSVIVSRALPDVRDGLKPVHRRVLFGMHELGVRSNT
AHKKSARIVGEVLGKYHPHGDSSVYDTMVRMAQWWNMRYMLVDGQGNFGSIDGDSPAAMR
YTEARMRKMAEDMLIDIDKETVDHSLNFDDTLLEPTVLPTRIPNLLVNGSSGIAVGMATN
MPPHNLAEVVDGIIAYLGNQDITIDELMEYIKAPDFPTGGIIYGYDGVREAFKTGRGRVV
IRAKAHFEEVNGRDCIVVTEVPYQVNPETMREQTSNLVKEGKLEGLADIVDQTGKGGMRI
VYELKKDAIPNVVLNNLFKHTALQSSFSVNNIALVNGRPQQLNLKDLIYHFVEHRHDVVY
RRTEYELKKAKERIHILEGFMKVMATEDTMGKAIEIIRFHDKPKEDLMTEFELTEIQAEA
ILALQLRRINKLLILQTKEEYEQLLAQIIDLEDILARKERRTEIIKEELLEIKSKYGDER
RSVIEYAGGDISIEDIIPDDQVVITISNAGYIKRTSVNEYKTQARGGVGQKASATRDKDF
IEHLFIGTNHQYMLFFTEKGKCFWLRVYEIPEGGKNTKGRAIQNLINIEPDDLVKAVICT
HDLKEKDYTNSHYVIMATKKGIIKKTSLEQYSRPRQNGIVAITIKEDDELLEARLTSGNS
QIMLAVKSGKAIRFPEDKVRAVGRSGSGVRGISLDSDKDEVIGMIAIENPLEETVLVVSE
NGYGKRTFIDEPETGEAVYRITNRGGKGVKTISITEKTGNLVAIKSVLEEDDLMIINKSG
MAIRLPVSGLRVMGRATQGVRLINIKGNDSIAAVAKVMKEDEDENTTEEIENPTEE
>SEQF1602_00961 Beta-barrel assembly-enhancing protease
MKKSVLLIASSLLVATSFAQKKELKEIKKAIEKDNFSEAERLLESNKRVALSTKKSTAEY
YYLKGELGIKKALAGKDVTTSLKEASEALAEARKIEKKTPAELESLTANVARLAADKGQE
YYQNNDFKNAAIAFEQVYRFSPKDTLFLYNAAEYATQAKESEMALQFFLELKDLKYDGAE
TLYTAKNKETGLVEKSVDKNTRDMKMKTGNYTNPSQEKVPSKKGEIIRKIAYLYVEQGNK
EEALKAFAFARKNYPKDPELIIQEANVHYQLGDHAKFESLMREAADLQPENPYVQYNIGV
MSLQQGKPAEARKFFQKTLKLAPDNADAALNYAFTYTEEANGLVDQMNALGNTAEDIKRY
NELKDNKDNLFRLAAESLNEYVKNNAKNPNKEVLENLKNIYLAINDIENYKRIKNILDKK
>SEQF1602_00963 Nicotinate phosphoribosyltransferase 2
MGITDSFTIFNSILDNDFYKFTMQCAVVKLFPAVKGRYEFINRGGHEFPEGFAKAMQEAV
NHMSQLKLSKEEKKFLKASCPYLNPAYIDFLEGYRYDPSEVHISQEGTELKVSVEGYWYR
TILWEVPLLATISELYYKLTHAVAWDDQKIEEVTSHKIHDYESLDVIFAEFGTRRRHSYH
VHDVVMRTLTKSHRHNFSGSSNVHFAMKYQVKPIGTHAHEWFMFHAAEYGFKMSNAMSLE
HWVDVYRGDLGVALSDTYTTDVFFKQFDTKFAKLFDGVRHDSGDPIEFANKTIEHYKKFG
INPLSKYIIFSDGLTPEKVEAITKACRGKIGFSFGIGTNLTNDVGLRPMNIVMKLTEVLT
SDHEWVKTVKLSDEPKKHTGDPRMIELAKELLRIHS
>SEQF1602_00964 hypothetical protein
MSFLKKTNTVAYTLMIIGVTLLYLQSKKEYRYFQEQYVLMAGLILVVIGIYMLSKKLSSR
EHK
>SEQF1602_00965 Glyceraldehyde-3-phosphate dehydrogenase A
MSVLKIGINGFGRIGRLAFRAISKRANVEVVGINDLQEVDYIAYLLKYDSVHGTFPSEVK
TENGNLVVDGKTIRITAEKDPNNLKWNELGVDVVLECTGLFTTLEKAQAHLNAGAKKVVI
SAPSADAPMFVMGVNHKSAKATDTIVSNASCTTNCLAPIAKVINDSFGIEEALMTTVHAT
TATQLTVDGPSKKDWRGGRSALINIIPSSTGAAKAVGKVIPELNGKLTGMAFRVPTADVS
VVDLTVKTKKATSLKEINEAMKKASEGELKNILGYTEELVVSQDFVGCTNTSIYDAKAGI
ELNDHFFKVVSWYDNEAGYSNKLVDLAQHVASL
>SEQF1602_00966 hypothetical protein
MIFIVDSGATKADWTALNEKGMKEFGTQTLGLNPEVLTEEIVMERLTTNEQLNDNRKRAR
HVYFYGAGCGTERLCTFLHAILQRFFSNATIVVKEDTYAAVHATTADGEKAIVGILGTGA
NCSYWDGKKLHQAVDSLGYSLMDECSGNFFGKRLIVDYYFKIMPEHLRNKFEHEYELNSD
VIKSHLYKLPNPNSYLATFARFLVENKNDDYCQKIIREGLQLFIDHWVVQYEARKEVPIN
FVGSIAFYLQDIVKEVFAQNNLKIGKILRKPIDGLVEYHLLHRKIK
>SEQF1602_00967 Glycine oxidase
MKDYIIVGFGFAGSSLVHLLEKNQKSFVVFNDNPAPVTTVAGAMFNPIILKRFTPVWKAQ
EQMTLLLPFFREIEKKLQTSFLYKVRVLRKFTSVEEKNNWFVASDKPILSEYLSTDILQE
VSPYIKTPFGVGEVLHTGMVNTRILIPAYREKLLKEEKLLEEKFDYDALEFLEEGVRYRG
ITAKRIVFCEGYGMVENPFFRALPMVGSKGELLNFEADMLQLEGVVKSDGFIAPLGGNAF
KIGTTYDNDDKDPSPTSGGREILEQKLRQLISCPYHITGQVAGIRPTVRDRRPLVGVHPK
YKNLFILNGLGTHGALLAPYTATALYDFIEEGKPLDKEMNIVRHYHYFE
>SEQF1602_00968 Cyclic-di-AMP phosphodiesterase PgpH
MEIKHFWYKLYAKQGLLYKLFLAIVVVAVIVLLLPKGSKFSYEFQAGKPWLHPSLYAPFD
FTLKKTNEELAREKELIKEQSPTYFFKDTTLLGAARKNYYQKALSYFATVEASQREKLLQ
KGEDFLKKAYHHGVFYSSQEVTDKKIFLVEGNEVFTFSIHDFFFLNQTKDEIHNYFKGAF
YQEHLDTYYAIFSEVILPNIFVNEHFTQRALEENLKRIVHSRGVVKQGQLIIEKGQLVTG
DRLTMLVSLQKEYALNSSENLTIFSLMGYVLIVAMLVSMILLYLYHFKEEMFTNNNIVTL
IFTTVLLFVAGVSWTARINADYINALPICIFPIVMKAFFDQRVGMFLYIITLILIGFIVP
NSFQFIYTNAIVAGVLLLDTKGMHYRINLFMMITYIVVAYIVTYLCQLMISTGSLRDIHY
PTLGLFILNGFLTLFVQPLTYLYEKIFGLVSNVSLLELSDTHNKLLRELSEKAPGSFQHS
LQVSNLAEASALAIGANAMLVRVGALYHDIGKMKNPLYFTENQKTSVNPHDELTPVESAK
IIKNHVIDGIEMARANNIPDRIIDFIRTHHGNSLIYYFYKKQIDSGESFAEEDFRYSGPI
PFSKETAILMMADSVEAASKSLVNPTTDAIDTLVENIVKRQIEERQFLNADITFKDIEKI
KKVLKEKLFNIYHLRIAYPK
>SEQF1602_00969 Arginine deiminase
MIYFCIFAKKLISMKIHITNETNRLRAVVLGTAQSNGPTPTAQEAYDPKSLEHILAGTYP
VEADMVTEMEAFAQVLTKYGVEVYRPELIEDCNQIFTRDIGFVIEDKFIKANILPERENE
FQAIEYIIKQIPAASYVVPPTQVHIEGGDVMPWNEHILVGTYKGSDYQEYKTARTNMAGV
EFLKELFPNKIVKEFDLVKSKDPRDNALHLDCCFQPVGTHQGIIYKGGFRQEADYEYLVE
LFGRENLFHIEREEMYQMFSNVFSIAPDVVVTERNFTRLNEWLQDNGFTVERIPYAEISK
QEGLLRCSTLPLLRD
>SEQF1602_00970 Modification methylase DpnIIA
MSLTDYTAKPFLKWAGGKTQLIEQIKNNLPEIVFKEPFTYIEPFVGSGAVLFWLLSEFPN
MKKAIINDINKELIDTYRTIIEEPDSLIIILERLQREYHALEDQQEAKKAYYYEKRALFN
SRSEDKLRQSALFIFLNRTCFNGLYRVNSKNEFNVPIGSYKRPMICDKENILAVSKALQK
VEIICGDFEQTIHYTEGNTLFYFDPPYKPLSETSNFNAYAKDNFDDNEQIRLRDFCQKLD
NLNHYWILSNSDVRGKDKNNHFFDILYADFEIKRVLAKRSINANSEKRGVLNELLINNYT
NNFLTI
>SEQF1602_00971 hypothetical protein
MIYGGRGGGNTKTGLAFEGKTDLAEFLNSQKGYEVKENNVFYKGELVGRIFKKYGFYDFL
KELDIDWKQLISKRLLPDDSIFVIIANTLFIIECKFQQVAGSVDEKLQTCDFKRKQYQKL
LSKANIEVEYIYLLSDWFRKPEYKDVLDYIHSVHCYYFFEYIPLIKLGLPVPE
>SEQF1602_00972 Modification methylase DpnIIB
MLTPYFKSQDKSFYLLHGDTMELLPQFHRKFDMVFADPPYFLSNGGLTVNNGEIVSVDKG
DWDKSKGIAFVNDFNRQWLTLVREVMKEEATIWISGTMHNIFSVGQILTELGFKILNIIT
WEKTNPPPNFSCRYFTHSTEQIIWARKEEKTPHYFNYELMKQLNGNKQMKDVWRFPAIAP
WEKSCGKHPTQKPLSVLTRLILASTQTNAWILDPFTGSSTTGIAANLLVRKFVGIDKEQD
FLELSKKRKFEIENPIISNNYKKRLNIIPL
>SEQF1602_00973 DNA topoisomerase 4 subunit B
MEPIDFNKPITEYGDDNIQTLEWQEHVRMRPGMYIGKLGDGSSADDGIYILLKEVIDNSI
DEFVMGAGKQIEVRIEDNKVSVRDFGRGIPLGKVVDVVSKMNTGGKYDSRAFKKSVGLNG
VGTKAVNALSSYFYVASVRDGQKKSASFSLGVLQEESPLKASNERRGTLVEFVPDGTIFK
NYKFRSEYVVRMLKNYTYLNPGLVIVYNGEKFFSENGLKDLLLEDNNEEDFAYPIIHLRG
EDIEIALTHSQSQYSEQYYSFVNGQNTTQGGTHLAAYREAIVATLRNYYNKPYDASDIRK
SIIGAISIKVMEPVFESQTKTKLGSTEMGDGLPTVRTYITNFVQKHLDDYLHKQPEIAEE
IQKKILQAERERKELSGIRKLARDRAKKVSLHNKKLRDCRIHLTDSKHEKALESTLFITE
GNSASGSITTSRDANTQAVFSLRGKPLNSFGKTKKIVYENEEFNLLQAALDIEDSIENLR
YNNIVLATDADVDGMHIRLLLITFFLQFFPELIKEGHVYILQTPLFRVRNSKETIYCYSE
EERIAAIEKLKNPEITRFKGLGEISPDEFKHFIGQDMRLDPVMMDKAMNIEKLLDFYMGN
NTPERQDFIINNLKYEV
>SEQF1602_00974 hypothetical protein
MKNLNINIRCNIYIVLLLFLCYNSVFATTAFVAMPGTGGLSISTPHYIIAFFRTIPYSLA
QSLFFEDIDIPFLFKTYFYISILLYILIPYFLYKEKKGKPYFYHYDIEDKTYFILIDVIM
LLLYAPLLLIGCMMFSFFSLFNIIPLFLFVLGVRIYQYRKKLNFIVKFNFFQKHRR
>SEQF1602_00975 hypothetical protein
MSYYIIKSYSKDITEENFMLEMMDLKDNRWLINYGMQLEESFDYINFKMYGEEKLFFDQD
IMTPYFGIYLLSERFQDVILQNSKISEGIQLLSFKLFNTDDKEIKHNYKIINFLQTEECI
NWEKSYFKIRDEAKKSYIFLDTVFDPLKIATLTKDLLCVDSEKSIFVSEEIKKEWEKMNL
NCLTFSPVS
>SEQF1602_00976 Adenylate kinase
MTKKSYLCSFKKIFMLIKILDKEFRPYLSAQRIATEVERLAKEVEEQMQGKTPLFISILN
GSFMFASDFIRAYQGDCQVSFVRFSSYEGLQSTHKVKQLFGLPFDIEGRDVVVIEDIVDT
GNTLEEIYNFFADKKVASLRIVTLFFKPEAYKKDLAVHHIGFSIPNRFIVGYGLDYDELG
RNLPEIYQLNIENMKNLVLFGKPGAGKGTQAAFLKEKYGLVHISTGDLFRHHLKNGTELG
VLAQSYMDKGQLVPDEVTIKILQEEIEKNPNAGGFIFDGFPRTIAQAEALDTFLASKQMS
ISATLALDADDEELIKRLVERGKVSGRSDDQDEGKIRNRFVEYNQKTAPLIDFYKKQGKY
HPINGIGSIEEITQRLSNVIDVL
>SEQF1602_00977 putative ATP-dependent helicase DinG 
MYAIIDIETTGGKMGEEAITEIAIYRFDGQKVTDRFISLINPEKKIDDFVVRLTGISNKT
VRQAPKFYEVAKRIVEITEDCILVAHNASFDYRVLSLEFRRLGFDYQRSTLCTVEMSQRL
LPDEPSYSLGKLTRSLGIPLLNRHRANGDAMATVHLFKLLLDRDTQKIALSEFVKQDLSP
LPMHLLSMLDGLPNQLGIYYLYDKKGKLLYMSKSKNIRKRVNEHFTGEGKRDIFLQQQVG
KVMYELTGTDLIATLKQEEEHKHITVHFKTKKKKKTFPFALVSHKDKRGYLCLSVELRTP
KQEALAIFESQEEGLNLLFEMTERYELCTKLNGFSQARTYCYNHSIGKCAGACMGDEAVE
DYNQRVHQALEHYTLTGRTFVIMDKGRSVQERSVIYIEEGRLRGYGFIELNYQLSKKILQ
KLILPIEHTPEKAHLLEYYLRKHPFAKQIPIKD
>SEQF1602_00978 Thiol-disulfide oxidoreductase ResA
MKKRTILNLLLFAFIASFFVTNLGYESKILLQRLFASSVEILPKDKQYSIDPDWTLKDRD
NKQFPFTRSNGKVKFVYFFSSWRAMSIADLIGVQKLYNKYHQKVDFYIITNELPEPVEQK
QQDRKFTFKVTYLIQEVKMPFDPEKIPSGYIIDQNNKVVAQGFGNTRWNSDKVHECIDHL
LN
>SEQF1602_00979 hypothetical protein
MEKIKAYLSSLMQNKNVRFWGFQLFLAFLLIFALIYITLLSLDSWTRHGEFVVVPDLTPK
MSEKGGKVEKVLTLSEAQELLEKNHLRYEVIDSAAYDPNLPKYAVVSQTPEPNEKVKKDR
KIYLTLNPANYRKITVPNVIQMPLSTAEDNLKSAKFQVGKITYVNNIGKDMVLQMFYRGK
EVKPRTLDKDGKKVLYEGDKLLENSKIDIVCGNGFDASNPDATLPNGDTSNTGDGKDNGG
IDF
>SEQF1602_00980 hypothetical protein
MAAERFEALGKDLDENPSFKECEDIATKDEKLKCFTGNLSKLYQEMLNSQKLAIGDALSD
TVKVTLLINNEGIISVKEVEMSEKTKELLPSLGELLMSETENFPPIIPAKKNQVNVSSEF
VLPLVIDVK
>SEQF1602_00981 Transcriptional regulatory protein ZraR
MPKILLVEDEASIRRVLGSILSEEDKSYEVTEASNGQEAMEKIRETAYDLVLCDIKMPKK
DGLEVLLEAKALYPTLRVVMISGHGDLETAVQAMKMGAFDYIAKPPDLNRLLTTVRNALM
TPQPQEEEKPKATGKTTKKTTASDIMIGESAPIQKIKAMIEKVAPTDVRVLITGPNGSGK
ELVARALHQGSERASQPMVEVNCAAIPSELIESELFGHIKGSFTSAVKDRVGKFEAADKG
TIFLDEIGDMSLSAQAKVLRALQEKKITKVGSEKDISVDVRVIAATNKDLKQEIAEGRFR
EDLYHRLAVILLEVPSLNQRRDDIPLLVSYFTDKINEEQATSKKFQPKAIEQLQQYDWTG
NIRELRNVVERLLILSEGDVTIKDVKAFGGKE
>SEQF1602_00982 hypothetical protein
MKKNILTIGFCLATTFAFAQNHTDGLRYSMEELSGTARFKGMSGAFSSLGGDFSSISQNP
AGSSILTRTELSFSAGTAFTDNKATPLGGTANGKNSISSNDVYFSQFGIVFPIPLGDEGW
RNMTFAFNYQQTNNFNPNDWGYTYTPDKNMGDYFVNRANGITQQNLFLNNYYKSGGQWVR
EFQGLNNIYSRMGRAPQPEKYRDALLGYTAGLIGPKTAPDGIPPTATDSEANAALNEREY
KKNISDGATTMRTINQYSEGGVNKYNFNFGARYDFFSFGINLNSHRVDYRVVSEQREEYL
NNTANIRSAVFQNDLKTTGSGFSMQLGAIAEVYEGVRIGLSYTSPTWYTLQDETSQALWT
NTSDNRTYPATPNVTNIYEKYQFRTPGAWTVGLSWVWNKQLIVSGDYTYKGYGNMRFTTD
NLRSENTVIQDLLGDTSSLRFGAEYRLPVGKTTHLFFRAGTRYEQSPYKRSYFKNLGQDR
PMDDLYGFSGGLGLSFSGLRFDLSYDRATRTHQQGLYYATNSDRVQVDNTLDNLLLTVSF
KLF
>SEQF1602_00983 hypothetical protein
MTVITILIITGITTITLTIMDIIITILTMGITTITLIMDMAIIILLIAMIGKIIITITKT
LMEILLVGTHLLMDVEEIVIVMTTITMIEVLPVLMTTLPDLIMRIITIPQEGITMATITI
IVITIPMIILPALIMKAVAMEEEIVETAGIVEIVEIVATKVQEEIINQL
>SEQF1602_00984 hypothetical protein
MKKTTIINYGVGALIALTGLTSCGGVYTGMGYDDGIYGDKAPRPSYERDDYERTPRTYRE
QLNQKIAEYKDFEHQAQRLSPSYTPLTNVDGYRTDSSSQAPTYNSYGSWGENARPSQVNV
YNYSGWGSPYYWALALGEVIILPPTTLVVAGAGVSL
>SEQF1602_00985 Proline--tRNA ligase
MSKNLTSRAEDYSKWYNELVVKAGLAENSGVRGCMVIKPYGYAIWEKMKDILDKMFKDTG
HQNAYFPIFVPKSYFEAEEKNAEGFAKECAVVTHYRLKTDPNQKGKLMVDPEAKLEEELI
VRPTSEAIIWNTYKNWIQSYRDLPLLINQWANVVRWEMRTRLFLRTAEFLWQEGHTAHAT
REEAVEEAQKMNDVYATFVEKYMGVPVIRGHKTESERFAGADDTYCIEALMQDGKALQAG
TSHFLGQNFAKAFEVKFANKEGVLDYVWASSWGVSTRLMGALIMSHSDDNGLVLPPLLAP
IQVVIVPIYKGEEQLQAIRERITPLMKALKERNISVKFDDDDTQKPGFKFHEYELKGVPV
RLAIGQRDLENNTYEVSRRDTLTKESVSGDNIIAHIEELLKDIQENIFQKALAYRDSHIT
EVNSYEEFKEILESKGGFLSAHWDGTPETEAKIKEETQATIRCIPLDQKEEAGTCIYSGK
PSKGRVLFAKAY
>SEQF1602_00986 Polyprenol monophosphomannose synthase
MTTSLVEIFSDSLVIIPTYNEIENIESIIRVTLLQAPHFDILIVDDNSPDGTADMVRELQ
KEFPDRLFLTVRQEKSGLGTAYIHGFLWGLQSEKRYAYLFEMDADFSHNPADLIRLYRAC
KDEHADMAIGSRYIKGVNVVNWPLRRILLSYGASFYVKLITGMKIQDPTAGFICYRREVL
ENIDFDKIKFVGYAFQIEMKYKAYVKKFCLREISIVFTDRLRGKSKMNLSIIREAIFGVI
SMKIRHLLGR
>SEQF1602_00987 hypothetical protein
MKLRNIAIAFLGSILFATCGKDDEGDKLYTPEESKAIVKSTMDNFYNCLKKANDGGFANF
FYDGLFKGFDRNNPDGEETWFNILGEKFDNQHYADALRDGVNKFKFEALKGTYVWSKNKE
LWEKTANSANITLKFPATKEATTNNGLLIIDQYEDTSVSYEGEESFLPTKAHGVITVDGT
KVFEVTLNKASYKKGTNFTMPTEVNLSIFTNPFTTTIKFREQGAGNFAFDFAFASAEGCT
TALHADVKLNTTDYENLTGMEVIDHISFVATQGELQIKGVVDAKSINKITKDQNHELTPD
EINTFVKADLYRGNGKIADVKYEKENGKGVIYFIYSDGSREKAEQYVSDFGKRVTEIFKR
FDK
>SEQF1602_00988 hypothetical protein
MNIALAQESNVVFSRDSLKRDTLKTKTFYPHQIGIGISRFVNSAFPTDSNSFLLEYRYLK
CPTIAYRIAGDYRAESNKDSTYEIALKVGMDKLFKDYKSWKFYYGIDLWGRYLYYKDRKQ
HFTSIAINPFFGIQYQLNKNFSISTEPGFFIKYNLRKDNNSFDPNAKEQWWESRLAKIGN
IQLNFHF
>SEQF1602_00989 HTH-type transcriptional repressor NsrR
MLSNSSKYAINAVLYLAINSSVDRKKGVKEISEVLHIPTAFLAKLLQILAKKKAICSAKG
PGGGFYITPENLKAPLADIVRYIDGGDKFSICLLGIRSCSEETPCPMHYAVKPFRDEFLQ
ELERHNIEYFADKIKRGEAYLII
>SEQF1602_00990 Mercuric transport protein periplasmic component
MKYFVLSAMLWGLVSCGNSNPKATDTPSPAPQKETVAKENLEEVTLRIEGMTCAHGCAAT
IEKNLNNTDGVQKATVDFDSQTAVVSFDKAKLSKASIISVIEESNGGEAYKVISQ
>SEQF1602_00991 hypothetical protein
MDTNLFETYVKAMHQEVPGFISITVVSTNDGNTIAYEAGSNVDNRLSSAFQVEILRQATK
ALGYVEGLNDKNIDRIEIALKEQLHVLFSSSNRQFLVHLILDGTKYNIAITKMLHEKFFR
SVEESYVPSAEEQQTVRRRLFF
>SEQF1602_00992 Lipoprotein signal peptidase
MLDQSINVFDWFHIRFVENPGAAWGIGIPGKYGKLILTLFRMVAIVGIGYWLWDTIRKKG
SKILIISIALIFAGALGNIIDSVFYGVLFDHSMNNVATFLSDHPYGSLFHGKVVDMLYFP
LIDTTLPEWIPFYGGHRFTFFDPIFNIADTSISVAVGLLIIFNKQAFKK
>SEQF1602_00993 hypothetical protein
MVLTPEEWVRQHTIHFLLKEKHYPQSLMSVEKRIYINHLTKRYDIVIYRSDGSIFLVVEC
KAPQVAITQEVFDQIARYNMQLQAENLMITNGLQHIFYQVDLLKQAYVFLRELPEF
>SEQF1602_00994 hypothetical protein
MNEAEKILADLQAQKYSPIYYLAGEEPFFIDLISNYIEQEVLREDEKAFNQQIVYGKDIS
VDTIIHYAREYPMMAARRVIIVKEAQDLSRTISQLLPYVENPSQTTILVLCYKYGKIDGK
TKLAKELKKYVCLESKKLYESETLKWVDSYLKGFGYSIEPVAAQLLINFLGTDLSRIANE
LNKLKIILPKGTKITPLHIEQNIGISKDFNVFELQNALGKKDFAKAMQIIKYFNENQKDN
PIAMITENLYRYFKNLFIFATNTSKGENELARMMGVNPYFLKDYRQAAANYPLKKISFCM
ETVKNADLKSKGVESGSISYYDILKEMIIMTIS
>SEQF1602_00995 3-hydroxy-3-methylglutaryl-coenzyme A reductase
MIKGFSKLTKEEKRQWICQQYLSDPSQSEVFTSYDLRDENLQKLHDDFIENTIGNYMLPF
AVAPNFLIDGHYYTVPMVLEESSVVAAVSKAAKFWSEQGGFLCQVRSMEKVGHIHLFFEG
DKHELFQFFSTIEPLLYEQTQGITENMRKRGGGISSIILKDMTDSLEHYYQVFVTFLTGD
AMGANFINSCLEKMSQTIEQEAITHLSHGALEVLMSILSNYTPQCLVRAEVSAPVSRMSF
NDIEGKVFATDFTRAIAVANADVYRAVTHNKGVMNGIDAVVIATGNDFRAVEAAVHAYAA
KEGRYKSLTQAYIKEDIFHFSIEIPLAIGTVGGLTKLHPMVKTALQILENPSAETLMKVI
ACVGLAQNFAAVSSLVTYGIQKGHMKMHLANILNQLGATPAQKQEIIAYFKDKTVSHSEV
VQAFNKVAGVVPHQ
>SEQF1602_00996 hypothetical protein
MKKMIILVALLLTVLVQAQSYDAYFTKEALRLDFYLYGTKSTTYASLKGMKKEPLFGGSH
THLIHPNQGEYRVQVLEIGSGKVLFSKGMVTLMEEWQGMETDATKTEFFEIPCQTPFPKG
PVEVTFERRTKEGNFQKIFTTKVDPTDYRIVKEVPVKYPIKPILQNGSPQKKVDIAVIPE
GYTQEQMDKFVADVKRLFDYLFATPPYNKHKKDFNIQAILAPSQESGTDMEGSPTTYKNT
LLDSHFYSFGMDRYLTCPSLFKAADVAAAVPYDQLFVVVNTKEYGGGAFYNVINLNVSDN
KYAEKTFVHEFGHGFVGLADEYYYEGEEGMADRYNLKVEPWEANITTLVNFQSKWKDLVE
KQTPIPTPRTEQYKNKVGAFEGGGYLFKGMYSPMEDCRMKSIQSNEFCPVCSRAIERMIQ
FYTE
>SEQF1602_00997 Limonene hydroxylase
MDIQSVKQRFGIIGNDPKLNLAIEKAIRIAPTDVSVLITGESGVGKEAFARIIHTLSSRK
HGKYIAINCGAIPEGTIDSELFGFKAGSFTHAGKEDKKGYFEEANGGTIFLDEVGELPLS
AQVRLLRVLENGEFIRVGDSTPRKTDVRIVAATNVKMQEALKKGRFREDLYYRLNTVEIY
LPPLRDRKEDIHLLFRKFASDFAQKYRMPTLQLSEGAVRELLRYRWPGNIRQLRNIAEQI
SVVEPKRDISAETLLSYLPQEGGNHLPATVVQAKGETDFTSEREILYKVLFDMRNDLNDL
KQLTFKLIQEGNTPKVQEENQNLIHKIYGSQPVTYSSEENEPAMMLLSPEKTTVSRGHNT
YDFAEEIQEEEPISLQDKELELIQKSLERHKGKRREAAKELGISERTLYRKIKQYDLE
>SEQF1602_00998 hypothetical protein
MYKINLQYTILKDFLPALKIYLLSLPLENTPTMIQSMTGFGKSTLQLENKKITLEIKSLN
SKAIDLNVRIPQAYREKELLLRKVISDRLERGKIDFTLTVENTSQSSATLINTAVVRGYM
EQLQTITPEASSVDLLGIAMRLPEAISTLLEEVNEEEFALIEKQLLIALEHLQDFRSKEG
AILKKDFSLRISNIQDLLQQVEVLDEERFQSIRSRMERAIDEIRERVDENRFEQELIFYL
EKLDITEEKVRLANHLNYFLATLEETQSNGRKLGFIAQEMGREINTLGSKANHAAMQQIV
VLMKNELEKIKEQVLNIL
>SEQF1602_00999 Peptide chain release factor RF1
MHFVNKKSMLARLDIVKQRFDEVSDLIIQPNIIADQKRYVQLTKEYKELKQLMDKRQEYI
TVTRNITEAEEIIKENIDPEMTEMARLQLEEAKERLPQLEEEIKFLLIPKDPEDSKNAVM
EIRAGTGGDEASIFAGDLYRMYSKYCQDKGWSVSVMDMNEGTSGGFKEIILEVNGEDVYG
TLKFEAGVHRVQRVPQTETQGRVHTSAATVMVLPEAEEFDVELNMEDVKIIRTTSTGPGG
QSVNTTYSAIQLQHIPTGIEVRCQDEKSQHKNLDKALKVLRSRLYEMELAKKMEADSARR
KSMVSSGDRSAKIRTYNYPQGRVTDHRIGLTLYDLGNIMNGDIQRLIDELQLAENTEKLK
EGDIF
>SEQF1602_01000 hypothetical protein
MDQTHNISLGGFSFVIENNAAKELSSYLAKVRQFLGESPDTDEILTDVEQRMAELLRVRM
QNTEVVTSSDVAYLIQVMGQPEQYVDTETQEDIPSKKAKFSFSGRRLYRDGEDEKIAGVL
SGVSHYFQIDVTLLRIIYLLLLVANGILFLPSASFWVLLYIIFWVVVPKANTTTEKLEMK
GVEANLDTISSFKTQSPLKQQWCRSQTDKKIAGVLGGLAVYYGIGSTPLRIGYLLFCLLL
VATRSVGMLFPILLYLVLWYLLKKEKGDEEKEEERDLVREKEVKPHKKSFFWSFFGILFK
VIGYFIATIFFVCLFLILVTGLLSIFGVGVAGGITSVFLLDYLPFVFSPIEQVLFYVIWG
MVFVLFFSVLVLFCYKIFSKGHYNTPKAWFLANVLLFVLPLLGGIAFASSVGRKFVSNNT
VENKIVIDSDTDTLFLNEKKTASFSTMNIDSAGNGVSGEVYFIGIYPTQEAHPFLLISTS
SQGKNTDDAQLHAQNIDFPLEIKDNQLWIPDGYFLQKGKPYRFQRVNIRLFVPKGKKVVS
YSMISKRRGLGLPNGTFQVENDSIIKL
>SEQF1602_01001 hypothetical protein
MHSTKKCCNFAASKQMFMEAINLEKIKTQMRKGVLEMCILSIIHKREEAYASDIMEALKQ
ADMIVVEGTLYPLMTRLKNAALLNYSWRESTAGPPRKYYTLTDKGNDFLREALASWNELQ
TMITKLI
>SEQF1602_01002 hypothetical protein
MSKIQAFTALGARLKEYFSIGEKAPIYPRMEAALERASLHNAWFDRDNCLFALQHWAECL
TQEQLQRWLSAYSFEGKTPKRVALILAGNIPMVGFHDLLCVILSGNKAVVKLSSHDTVLL
PFIVQELTEIAPEIGEFISFTQERLTDFEAVIATGSNNTARYFEYYFAGKPHIIRRNRNS
VAILTGKETPKELYRLGEDIFRYFGLGCRSVSKLFVPRDYDFAPFFQAIYPYHTLLDHQK
YINNYDYNKAVYLMSLCPLLENGFLLLKEDEKYASPIATLFYERYDDLTILSQRLEKERE
LLQCVVGSKEIPEAIPFGQTQVPSLTDYADGVDTLAFLNSIN
>SEQF1602_01003 Phosphoserine aminotransferase
MKKHNFSAGPSILPASVFEKASQSILELGNTGLSILEISHRSKEFIAIMEEARALALELS
GLTGKGYQALFLHGGASLHFYASALNLLERKGAYIDTGTWSHKALTEAQFVGATSVVASS
RENGYRNIPTDFALPQDADYLHITTNNTIYGTEYSHYPEVEVPLVADMSSDIFSKEMPMD
KFALIYAGAQKNIGAAGVTLVIVREDILGKVSHKIPTHLNYQVHIKNESMTNTPPTFAVY
TCLLTMQWIKEQGGIKVIEERNKEKARILYEEVDRNPLFKGYAESKDRSRMNVVFNLVDE
TLTDQFNALWTEAGISGIKGHRSVGGYRASIYNAMPIESVQLLVEVMKHFEKTV
>SEQF1602_01004 Hydroxypyruvate reductase
MKILANDGISPEAIKTLKEAGFEVITTKVAQNQLADFINKEGIEILLVRSATQAKKDLID
ACPSLKLIGRGGVGMDNIEVKYAQEKGIKVINTPNASSYSVAELTFAHLFSGVRFLYDAN
RNMPLEGDTHFAQLKKNYAKGQELKGKTLGIIGLGRIGKAVAAIALSLGMKVIAHDPHHE
EATITLSFFDGRTLDFTLQTIGKEELLKQSDFITLHLPTQQEAVIGEKEFQLMKDGVGII
NVARGGIVDEEALLHALEHEKVAFAGLDVFQGEPTPSIRILMHPRISLTPHIGAATTEAQ
DRIGNELAQQIIQIFGK
>SEQF1602_01005 putative undecaprenyl-phosphate N-acetylglucosaminyl 1-phosphate transferase
MRVKNEAIMQYLYSNLSFELLSLLIVLQSFVVSYLIIPRIISIVRTKNLMDNPNQRSSHK
ERTPTMGGVAFFASIVCSLYLLQAHDAYKIGLSLAVGLLILFYIGVKDDLVGVAPSTKII
GQMLAFIFMMDSSELAINSFNGFLGIYELPLWFSYALGAFIIISIVNAFNLIDGINGSAS
MLGIMIFAAFSFIFYQTKDYYFVLLSLSCIGCLLAFLRYNISNNKSKGIFMGDTGSLLIG
LIIGVCTLRFLNLSVEDLLLANVKYYNKFVLIFIILFIPFVDTMRVFLIRILKHRSPFFA
DRNHIHHIMIDYMKLSHIQASLLLAFFNLIVFGLFYVANLYFSTTTLFVLLILFVIGTTL
LVFYYNRSFAVRRNKQKIQKILDNTPIGRKKKRCKS
>SEQF1602_01006 Dihydrolipoyl dehydrogenase
MNKYDVIVLGSGPGGYVTAIRASQLGFKTAIIEKENLGGVCLNWGCIPTKALLKSAQVFE
YLKHADSYGIKVKDKGFDKDFSAIVKRSRDVAGTMSKGVQFLMKKNKIEVINGYGTLKPG
KKVEVKAADGKTTEYSADHIIIATGARSRELPALPQDGKKIIGYRQALTLPEQPKKMIIV
GSGAIGIEFAYFYHSMGTEVTVVEFMPNIVPVEDEEISKQLEKSFKKMGINVMTSSEVTK
VDTKGKGVKAYVKTAKGEEILEADILLSAVGIKTNIENIGLEAVGIKTERDKIQVNEFYQ
TNVPGYYAIGDVVPGQALAHVASAEGILCVEKIKGLHVEPINYGNIPGCTYCTPEIASVG
LTEKQAKEKGYEIKVGKFPFTASGKANAAGTTEGFIKVIFDAKYGEWLGCHMIGAGVTDM
IAEAVVARKLETTAHEILKAVHPHPTMSEGVKEAVAAAYGEAIDI
>SEQF1602_01007 Bifunctional protein FolD protein
MELLDGKKAATKVQEDIAKEVAYLKEKGHRAPHLVAILVGQNGASMTYVNNKVTACERVG
FASSVVNLPESVTQEELIGEIQKLNQDTTIDGFIVQLPLPKHIKEQEVLLAINPDKDADG
FHPTNFGRMALGLEAFIPATPYGILELLSQYQIPTDGKNVVVIGRSDIVGRPISILLSQK
PWNATVTLTHSRTQNLAALTQKADIIIAALGSPNFLKAEMIKEGAVIIDVGITRVADPSS
KKGFRIVGDIDFENVKEKASYITPVPGGVGPMTIAMLMKNTLNAYKRTHKIQ
>SEQF1602_01008 hypothetical protein
MTKIRITKKFEFEAGHALYGYDGKCKNIHGHSYKLWVTVVGSPIEDSSHVKNGMVIDFGD
IKEIVNEHIIKEADHTIFFNGNSPHRALAEKLQGEGHRIVLLPYQPTSEMLIADFAQRLQ
QHLPENISLYSLRLQETESSFAEWFASDNQ
>SEQF1602_01009 Type III pantothenate kinase
MLLAVNIGNSNIRFAVVEGQQVHLSWTIATKPYRTAGEFYMSFQSYKEQYKNAFGKITKI
VVGSVVPQQTQIIAKMLQKTFSLKPFIVNRDTPSEVTHHSNQMGTDLYANAVAAHYLYPE
QKKIIIDFGTALTLTGVAETGQMLGVIIAPGVVTSLQSLVNSTAQLPYIELNEPKSVLGM
DTETCMQSGMIYGYTAMVEGLIERIKQTYQSDFLVISTGGVGHVFSKLTEKIQIDDKYHT
IKGLALLYDLHRK
>SEQF1602_01010 UvrABC system protein C
MMSELALQVQTLPDNPGVYQFYDSTDTIIYVGKAKNLKKRVSSYFNKEHDSPKTRVLVSK
IVRIEHIVVATENDALLLENNLIKKYQPRYNILLKDGKSYPWICISNERFPRVFFTRKML
KDGSTYFGPYTNLKIVRTLIDLIKDLYPLRNCRLDLSQENIDKGKFKVCLEYHIKNCQGP
CEGLQSEEEYNHNIQQIKEILKGNLKEVIAYFKEEMQEHAAALRFEEAHQIKLKLESLEN
YQHKSTIVSTKIHNVDVFSIVSDGEYAYINFLQVAHGAIVRGHTLEVKKKLEETEQELLE
LAIVELRERFHSASKELIVPFPLTMEFAETLTIPKAGEKFQLLQLSERNAQAYRQEKFKQ
VKITDPERHTNRLLTQMQRDLRLSEPPAHIECFDNSNIQGTNPVAACVVFKNAKPSKKDY
RHFNIKTVEGPNDFASMEEVVYRRYRRLLDEDEPLPQLIIIDGGKGQLGAALKSLELLGL
RGKIAIVGIAKRLEEIFYPGDSVPLYLDKKSETLKVIQHLRNEAHRFGITFHRQKRSASA
IHSELEQISGVGKQTQEALLKQFKSVKRLKEASKEEIIACIGHSRAQKVWEYFHP
>SEQF1602_01011 ATP-dependent dethiobiotin synthetase BioD 1
MNHTYFITGISTEVGKTLTSAIVVEALQADYWKPIQSGDKHASDAMKVKELISNSKTHFF
PSSYEFEYPASPHLSAQMEGITIEKDKIVRPVTSRPLVIEAAGGLFVPLNDHDIMMELIA
PSDRVILVSRHYLGSINHTLLSVEALQRRGLSIFGILFSGAENPATESWISSYTKLPILG
RIDEEPYFDKQTIRKYATLFADKLT
>SEQF1602_01012 hypothetical protein
MRKRTKLLRVFALSGAMVTTMLLYSKINHKTLGVPPVSSNEAKAEEAPVEYEYIYNPKAL
DPFFEKLNTLDQHKNKKLNIVHIGDSHIQGDAMTNEIRQQFQSQFGNGGLGIVFPYSLIR
TNGERYVRFSSNITWDSQKNTSRTDTDAIGIAGYSLLTNNKNFVIELNVKNKDYSFNSLR
VLTPHNKHLFEVATNKMGVAIKPAVVSSHISQKMILHKVQKGETLYGLSRKYKTTEKKIQ
EANRIKGNTIKENAILKIPSQEKIVSNTSTEQSVNLNGFEALTNKADTPYGYTYNNLEGF
DKIYLTPNTESSYFALNGIVLENNQNGVIYHTIGVNGARFSDYNKCNLFFEQIQALQPDL
IIVSLGTNETFSRLSAEDYDKQVEIFIQQIRSHYGDCPILLTSPPPSLFKKKLPNPYCEQ
YANILIDNSVKKNYGVFDLYKILGGSEAMSSLIAQNLIAHDRVHYTHAGYVEQGGMLFDA
LMSNYLKYKNQQK
>SEQF1602_01013 Peptidoglycan O-acetyltransferase
MQRWLLDLCSWEQLKSWFLYNKEYPLLFNSSLFLGLFLVFYLIYILTKKHTYFRTLYVVL
FSLFFYYKAGGEYFILLLASSVVNYIIAVLMHRNSENKHVSYFFLVLSVVANLSMLGYFK
YTNFLIENFNQLFNGNLKFQNIALPIGISFYTFQTMSYTIDVYRKEIAPAKNFLDFTFFV
TFFPQLVAGPIVRAKDFIPQIYKKVTLTKEETSYALFLIIGGLLKKAVISDYISINFVDR
VFDAPNSYTPFENLMATYGYSLQIYCDFSGYSDIAIGLALLMGFTLPINFRTPYQSQNIT
EFWHRWHISLSTWLKDYLYIPLGGNRKGSFLGYLFPTLFFAATIWWAYGVSKQSLIPLLA
VFGVIVLFEVSILLSPNKGKSLRSHFNQLTTMLLGGLWHGANIRFIIWGALHGLALAFHK
SFREIFPEKNPEKKTFGKWLFSLVSIIITFHFVAFCWIFFRAKDLSSAMEVITNISKITY
DPHQWWVIIEGYRNICLLLVIGFLWHFLPQKWSNGLCNLFQRMPLLFKSVVLAFVFWLIY
ATASAGPQPFIYFQF
>SEQF1602_01014 hypothetical protein
MVNDLMRCRALAVLPTMKAVQKILFWGGKLQFSPAAPYWHQ
>SEQF1602_01015 hypothetical protein
MKKLLSKAKGLTIVILFLLLSCKTIKEENTEMFKDFLRQEKINYKDIIYSSYYKDFFCKI
GNKTHYKDSTSLKYNRIYIQEEPYPMLSLYIFHPSGKVFRSYIELDNEKLSKPNDEGICY
TKTAIKIHLEGGGFFLLEDNKLIFQDHFFNLGGNLPFGRLHNAGIYTDVIFGNIENDTII
SYKMYRAKKLSFSKKIFEPAVKRVRKIYLEKDLHPALKEDCTNKEVYYLIPEGTKIELFG
YKKQ
>SEQF1602_01018 30S ribosomal protein S20
MANHKSAIKRIRRNEAARLRNRYQHKTTRNAIKRLRTTTDASVAKELLPNVVSMIDKLAK
RNIIHKNKAGNLKSNLMKHVNSLVA
>SEQF1602_01019 Polyphosphate kinase
MNSTTEIPLVSRELSWLSFNERVLQEASDARNPLVERLRFVGIFSNNLDEFFRIRYAIVK
RDFKLIKDKEAASKAQLFLEQINEQVVLLQQKSLAILECIKEELKKEKIYIINEKELLPQ
HVEYVKEYFINTISPALFTIILDEVAALPTLKDDVAYLAVRMLLKTEEKEKTKIQYALIE
LPKTLDRFVVLPKVNGNNYIILLDDIIRFCLTTHFYIFPCEEISAYMIKITRNAELDLDT
DLNKSFIEKISHSVEGRKQAEPVRFIYDKLIDEQMLHFLKEKMGIQATDSIIAGGRYHNR
RDYMSFPACDNQGLLYPPFYPSPIRKLRVEESLFAQIAQRDYLQYTPYHSFSYLIRFLRE
AALDPKVKTIKITIYRLAKQSQVINSLINAVKNGKKVTVQIELQARFDETANIHYAELLQ
REGVRIIFGIRGLKVHSKIGVIEREEAEGIRRYGFISTGNFNEDSAKIYTDYTLFTAHKE
ILEDVDRVFAFFDTPFQIFQYNHLLVSPHYTKNTFLSLIDREIALAQQGKEAFLKLKMNG
LTSKTMIEKLYQASQAGVKIQMIVRGVCSLVPGLKGISEHIEVISIVDRFLEHSRLYIFG
NGGAPIYYISSADWMSRNLNNRVEVSCPIYQEDIQQQLWDTFHLAWEDKVKARVINQAQD
NVYRSKKEGKSSQEAINEYYIGNR
>SEQF1602_01020 hypothetical protein
MRSFLFQILFFSFTTLLSAQGVSFRAEPSRKSLGENERLRVDFIMNREGDNFTPPSFENF
EYSGPTQSVSNSWINGVRSFSKTYTYMLQPKKKGKLTIGAASVIIEGKEYKTKPLTIEVT
NPVANPRSAQTTPPTSPFGNNSPFGNFPFGFDPFGTEEVQPMEIIEPTKEDLFITAEVSS
NHVFVNQPVTITYKMYLSARFGIAGFESIEDPRYANFWSQQLLDKLQVTEVMHNGKLFRC
ITLKQVLLYPQQSGEQEISPLSTSFVLQLPSNQVDFFGNRSYVTRSRRLQSNALKIKVSP
LPEEGKPANFSGAVGKFSLSVNFPTRTVNAGETAQGEVIISGKGNFKLFDMPKLTFPPAL
EVYAPKEEEHLNHSATGVSGDITHTYTIVPQYKGKFPIAPLSFTFFDPETQKYETLTSDP
LTIEVPNGEEYNATSPENTSEVAQEKGQFAPLKTEAKLAPINRAVFFGSGLFYLLWLLPI
VLIPIVLLLRYFYQKRNDDTAENRSRRTNRLAKKYLSAAKKNIHNKELFYESMERGLHTY
LKAKLHIETSELSKDKVRELLEEKQVESSAIARFLQLLSNCEMARYAPYTQADIDNDYEQ
AASIIALLDKQL
>SEQF1602_01021 Photosystem I assembly protein Ycf3
MKKIQLLMILFPIIAFSQKAEKEVSKAELAKREKAQRQSQAFAYQGYQAEKAHKLLDSEM
DYRKAISKNKENAVAQYNMGDVLYSQEAYNEATHYYQEASVNKEASKEDKHKAFHNLGNL
AMQNKKYEEAVQFYKEALRNNPTDEQTRYNLAIAKEKLKKEQQENKKNQNNQNNQQNKDN
KDNKDNKDNQNKDNKDNQNKDNKDNQNKDNKDNKDNQNKDNKDNKDNKNQGSPERDKQEN
NNQDNREGNTPEEGERKELSAEQMNRILNAINNEEKKTQEKLNANKVKGKAKKSNTKDW
>SEQF1602_01022 Dipeptidyl aminopeptidase BI
MNITPPKAPKRQTILEAHSDKRIDNYFWLNERDSPEVLAYLEAENAYFKQQTQHTQALEE
TLFQEMKGRIKEDDQSVPYKYNGYWYFSRFEQGKEYPIYLRQRDEEGAREEVLFDVNQMA
EGHKFYQFAEYSISPDNQWASFSVDTRGRRMYSLFIKNLKIGEILPTEIKNTDGGSCWAN
DSKTLFYTKIDPQTLRSHKVYRHRVGQTSPKDVLVFHEKDETFNTGIFKSKSEQYLIIES
DSTLSTESRFLDASTPEGVFKIFQPRQRGLEYDIAHYGEYFYVLNNADGATNFKLDKTPI
THTELEHWSEVLPHREDTRLEEVDIFKEYLVVTERSQGLSQLRIIRWDGTKDMYLPFDNE
TYTASTGLNLDFDTHWLRYIYNSMTTPYSIIDYNMLTSEQQVRKEQEVLGGKFSKENYHS
ERIWATAPDGVKVPISLVYRKGLTLDGSHPLLLYGYGSYGITIDPSFSTTRLSLLDRGFV
FAIAHIRGGEYLGRPWYEAGKLMQKQNTFTDFIACARHLIGEKYTSAQHLYAMGGSAGGL
LMGAVINQAPELFHGVVANVPFVDVLTTMLDDSIPLTTGEYDEWGNPNDKAYYDYMKAYS
PYDNVQRKAYPHLLVLTGYHDSQVQYWEPAKWVAKLRELKTDNHILLFYTDMSSGHSGAS
GRYEALREIAREYTFLLDLEGIYL
>SEQF1602_01023 30S ribosomal protein S1 
MTNIQFIKAQVSTTEKAIENTLTLLSEGCTIPFIARYRKDRTGNLDEVAIEKIAKAQADY
ENICKRKETILSSVEEQGKLTEELRKRIEASYELTELEDLYLPYKKKRKTKGDVAKENGL
EPLAKQLMSQRVTDMEQLALRYLSDKVATVEDALQGASDIIAEWINENMYVRRTLRRVFQ
RKAQLCTEVAKGKENDEEAQKYAQYFDWSEPLSKAPSHRVLAMLRAEKEGFVRLKVQVET
EDTLPFIEETIIKGNGQTADFLKKAIKDSYKRLLEPSISNETLQEVKDKADAKAIEVFSD
NLSQLLLSSPLGEKRILAIDPGFRTGCKVVCLDEKGDLLHNETIFPHAPQHETAMAMKKI
RTMVEQYRIEAISIGNGTASRETERFIKEISFPHPLQVFVVSEAGASVYSASKIAREEFP
TYDVTVRGAVSIGRRLSDPLAELVKIEPKSIGVGQYQHDVNQTLLEQELDATVIRCVNKV
GVNLNTASGSLLSYVSGIGEKMAENIVAYRSTNGAFRRREDLKKVPRLGDKVYQQAVAFL
RVHNSENPLDNSAVHPEAYPIIKQMAKDLGISVEKLIGNKQAISTIDIKKYKNEEVGELY
LKDVLKELEKPGLDPRKTAKVFEFDPNVKTFDDVRVGMILPGIVNNITAFGCFVDIGIKE
SGLVHISQLKDGYVSEVSEVVKLHEQVQVKVTEVDTARKRISLSMIL
>SEQF1602_01024 Beta-barrel assembly-enhancing protease
MKKILLIGILLVVSSCKTNPFTGKQTLNFMSNSSLFPTSFSQYNEFLSTSKVIKGTPEAE
MIKRVGERIAKASQLWLDRNGYKNYLKDYRWEYNLVENKELNAWCMPGGKIVFYTGILPI
AKNERGIAVIMGHEVAHALADHGAQRMSASTLQQIGALAGNVLLSNSKYLNEFNTAYGLG
TQVGVMLPFSRSHESEADAIGLQIMALAGYDPDEGYKLWERMSAASGGGSSSSLLSTHPS
NQSRIAHLKELAPKVKAEAKKYGVTRFE
>SEQF1602_01025 Aminopeptidase N
MIRKYLLFAMLATSVGAIAQTETSGRSLYHAEATKYSALDHTKLRVSLNFEKKELYGEEW
LTAAPYFYPTDSLMLDAQAMLIHSVNLSDKKGTIGKPLTYKYDKDRLTIRLDKTYQRGEK
YTIYIKYTAQPENVGKHGSLAISDAKGLYFINSNKEDKDRPIQVWSQGETKANSCWFPTI
DETNQKSSQEIYITVPDKFVTLSNGVLSSSKRDGKGMRTDYWVMNQKHAPYLFFLGAGEY
AEVKDKPWRGKVPIVYYVEKEYADVAKRIFGKTSEMIEFYSKRLDYDYPWPKYYQMTAQE
YVSGAMENTTAVLHSSMAQQDAESLNDQNIWEATIAHELFHHWFGDLVTAESWANLTVNE
SFANYSEYLWLEHKYGKDYADYHMNRDITGYKNSGSFDKDLVRFNYKEREDMFDAVSYNK
GGGILHMLRNYLGDKAFFEGISKYLKNNQFGTGEAHQLRLALEKVSGRDLNWFFNQWYFN
HGNVVMTPKVTYDSAKGEAVLEIAQDEKLMFQFPLEVDIYDAGKYVRKEVWVDAKAKNEF
RFKVSPKYSLINIDPRGLIVGDEAAYKTPEQYLFQYQNAKDYKSRNQAIEYAVTTGNSDI
LLLALKDPFFRLRIKAIQGLRPDNVAQWAPVVENLAQNDPENLTKAAAIAQLSRLRDAKY
KSLYEKSVKLPSRAVKIAAASALVALDPSQAGQYIDMIDLKGLSFEQFMPFYPYILKSRN
EKYLPVLLDKVIYYPLYPEQYQAPIKEGFTWLMSVDNTEYTKKVTKSLSNVFGWLNEEQK
KHLHAVAEEGLKIKEDLLKKNPNSQSIKAQVELLKNIKW
>SEQF1602_01026 Tyrosine recombinase XerD
MLYDMWKKLLKDFEHYLKIERGMSPNSVQSYLFDLEKLSDYINLHQIEERPENISAETLR
EFVYQQSKELQARSQSRLISSLKSFFKYLLLENYREDFPMEYIDTPKYGMKLPDTLSVEE
IDALIAGIDLSTSEGHRNRAIIETLYGCGLRVSELVNLHLSDLFFEEGFIRVLGKGDKQR
LVPISEYTQKQINNYIQHQRKEVPQVKEFTDIVFLNRRGKQLTRAMIFTIIKQTAAAIGL
TKTISPHTFRHSFATHLLENGANLRAIQLMLGHESITTTEIYTHIDHSYLSQVVNTYHPR
K
>SEQF1602_01027 Vitamin B12-dependent ribonucleoside-diphosphate reductase
MNQENDIWWLNDESEQILNRGYLLKGESVEGAIERITSAAAKRLYKPELQPAFKEMITKG
WISFSSPIWANMGTERGLPISCFNVHIPDSIEGITHKLGEVIMQTKIGGGTSGYFGELRH
RGSAVTDNGKSSGAVSFMKLFDSAMDVVSQGGVRRGAFAAYLDIDHPDAEEFLQIKDTGY
HIQNLFFGVCVPDYWMQEMIEGDTEKRKLWARVLESRQQKGLPYIFFTDNVNRKRPQVYK
DNNMFIHASNLCSEIMLPSSEEESFICCLSSMNLELFDEWKDTKAVKLAIFFLDAVLSEF
IEKTKGNYYLQSARNFAIRHRAVGLGVLGYHSYLQKNMIPFESFEATQFNARAFQHIQSE
AEKATQELAHIYGEPELLKGYGRRNATTMAIAPTTSSSAILGQVSPGIEPFSSNYYKVGL
SKGNFMRKNKYLTQLLEEKGLNNEDIWRSIRLSDGSVQHLQELTQEEKNVFKTFKEISPM
EIITQAAQRQQYIDQSQSLNLNIPPTMPIRDVNKVLIEAWKLGVKSLYYQRSQSVAKEMI
MNFVNCSSCES
>SEQF1602_01028 Nucleoside triphosphate pyrophosphohydrolase
MQEKREKQLQAFGRLLDIMDELREKCPWDRKQTMETLRPLTIEELYELTDAILADDSQEI
KKELGDLLLHIVFYAKIASEKNLFDIEDVIQSICEKLIQRHPHIYGDVSVRNEEEVKQNW
EKIKLQKGSKGVLSGVPKSLPSLVKAYRIQEKVAGVGFDWSNREEVWKKFQEELSELEAE
IKKGDSQKTEKEMGDVFFSLVNYARFLKINPENALSLTNEKFLQRFDFIESSAKSQGRDI
TDLTLEEMNDLWEQSKVYFY
>SEQF1602_01029 hypothetical protein
MKLRLFLLLLVSGMQVFAQVGNSRESKNHLKDMNLYGKVKTFKITPYKLVDYFGKVTKGD
KQDFWRGDVVIVFDEQGYKAENNTYNKVGQLSQKVVYKYDAKGKRTSRDLYNSYGKLQMK
FLYVYDNKGYKTAYNSYSPTGELNDSYLYKNDDKGRMIEETWIKKDKSFGSKYTYEYDKL
GKLIKMCQYTTSETQVDNCTSYKYDKLGQIVEMEIYSNNALSRRSVITYDDKGNEKEIKY
YDGKGVFLEERAYEYKFDKHGNWIERIEYINQFPKSFLEREITYY
>SEQF1602_01030 hypothetical protein
MLTFNIVLGLILLVSFLLILVVMVQQPKSGGLSSSFGGNAQIVGGVKKTGDFLNTSTWTL
GVSLIVLSLISNLILTNAHPERGGSVLDGVSTPPVSTQQPVQTPPTQQQSNPQK
>SEQF1602_01031 hypothetical protein
MTAAELSLIMKQPNHITLSQVYELENIIHEYPYFQVVKAVYLKILYAQESYRYNKELKIT
AAHIGNRTLLFDFITSSSFKEKKDFFKKSSMPKTYADEAIPSEFTTYVTGDAFERKEYYP
IENRNASSVRTEQGEQTEQNDIKGSFVPTSEQTRGEEEALQMGKPIEFQKADKHSFAQWL
EVTRYKPIDRRVHATASVDLPFVDKNIFEEGDARAKKFDLIDKFLESNPKIEVNKDYDTP
NAVEIVEKKDIGRQFMTETLAKVYLEQGKYSEAIQAYQILMLKNPAKSGYFAEQIAIIRK
LQQNKL
>SEQF1602_01032 hypothetical protein
MKKLILFLCLLCGISSCGIYNFTGGSTGNAKTFQVNFFQNRAPLIEPGMDREFTFYLQDL
INNQTNLSLTNSNGDLVYEGEITNFTVAPMAATADQRAAQNRLTVTVNVRFTNNKEEDKD
FEKQFSHYYDFPANAQLSSVKSAAFEAIFERIGQDIFNASLANW
>SEQF1602_01033 hypothetical protein
METLEKNKENSEGSLELSNELKRLQRSSNPLKIFKEMSVLGIGSGVKSVKNILFFTIVNL
IFFLVGVYLLFSHTFAYKKLFFLLLMIGIGVLFVFIAIRKVFDLLKMEYASYLFNQFQPQ
IQKVFESIFQKAENTTEKIISKGQLQDTFQRFLPKIPKAFQKHLLFVLSFTPMVGFVADI
VATPTLTSPQKQSDVLYEKVQHYMQESVEDERRGYWVLWALIINALLQGFLLYMLL
>SEQF1602_01034 Tryptophan-specific transport protein
MTQKKIPSLLGGAMIIAGTAIGAGMLANPTSTAGIWFVGSAIILFYTWFCMTTSGLMLLE
ANLHYPTGASFDTIVTDLLGKRWNFLNGLSVTFVLYILTYAYITSGGSITENAINSLQGE
VQISRSIGSLLFCLVLGLFVWFSTKAVDRLSTILIGGMIIAFFLSTTGLLSSVSSHILLD
IQNKNTTAHLPYLLTALPVCLVSFGFHGNVPSLVKYYNRDGRRVMQSIFIGTLLALFIYI
LWQMAVQGNLPRDKFAPVIAKGGDVAALLEALSAYIPIQYISIALNFFAYMAIASSFLGV
TLGLFDYIADLLKLPDTPWGRAKTALLTFLPPLLLSLQFPYGFVIAIGYAGLAATLWAAI
VPALLVQASRKKFPESSYKVYGGKGMVYFIIFFGLINIIAQIGIQMGIIPTFK
>SEQF1602_01035 Tryptophan-specific transport protein
MTSKKLPSLLGGAMIIAGTAIGAGMLANPTSMSGIWFVGSLMMFLFTWFYTVVAGLMLME
ANLHFPKGANLNTMVTQLLGKGWNIANGLAVAFTLYILTYAYITSGGGITENLLHRIVPE
LGISHKESSLLFCFALALFVSISTKAVSRLSTILITGMIIAFFLSTTSLLSSVSPSVLFD
TTAQKESSYILYLLSALPMCLVSFGYHVCLPSLVSYYNKKSRLVIQSILIGTGIAFLIYI
LWQMAVQGNLPREQFAPVIAKGGDVAALLAALSTYIPTQTIGIVLDFFAYMAIASSFLGV
TLGLFDYITDLLQWGNSLWGRIKTALVTFLPPLMMSFFYPYGFVTAIAYAGVAVSFSSIM
ISALMVRSSRKKFPEATTYRTFGGTPLIYFIIIIGILNIAIQIGIQTGIIPIFTGNK
>SEQF1602_01036 Tryptophan-specific transport protein
MKQKKLPSLLGGSMIIAGTAIGAGMLANPTAMSGIWFLGSVILFLIIWGITTLSALMLLE
ANLHFEKGANFDTITTQLLGKGWNIFNGISVAFTLYILTYAYITSGGSITKSLLNRFVPE
LPINHTFSALLFCFVLALFVSISTKAVDRMSTILISGMVIAFFLSTTGLLSSAKSEILLN
TVAHTETSYLPYLFSAIPTCLVSFGYHICVPTLVNYYDKKSKKVIYSILIGSLLALIIYI
SWQMAVQGNLPRGEFAPIISKGGDVATLLSALNRYIPVLSISIVLDFFAYMAIASSFLGV
TLGLFDYISDLFKWGNHLGGRIKTALVTFLPPLLLSLFYPYGFVTAIAYAGLAVSFWMII
IPALLACASRKKFPNSNYKVFGGKWMIYVVILFGLLNIFCYIASQLNWIPTFKGE
>SEQF1602_01037 hypothetical protein
MNNIISKITKYFLYSILVVLIGKFIFYIPIFYTINMDNFKEMIQLERVDIISFVVFFALL
LLCEKKKRDTYKFYTLFYICFHLLSVISFVIYQCIEFYIGRDERFEYHFWNELFSQREEI
MQLFLSRFLDTDIISVYIVSSFFILKKYANHKI
>SEQF1602_01038 hypothetical protein
MESTVLYIKKYAIYSLLFLLFFECMMFLPCLGYQNKQEVLILFLIYQFNYLSLVLIFFIL
LILFRKIKKDTYSFYILFYSCFIFIATIVDIIYHFGKQIFNDETISIYSNEEVSKITYIM
DLLYFRFSTTSYFCIIIVSSYIVLKKYIKDK
>SEQF1602_01039 hypothetical protein
MKKETSFLNKLKLALALSTLFLIISMIPFALANKEEVTDSYKIGFILDLIIPFLLSFTFF
LTLLPAEKYIKNGIRFYLKFFVNWFASSFIILFVLKLFFILINYSRSFYNYSQVVKYVKE
TFQLIFVEILSLTNIGIGIICSLPLLYVYRKIILEKK
>SEQF1602_01040 hypothetical protein
MTIREYFYLLSPTVLLYLVSLLITFLFVKKNKFLYFCFINWMLCTVSYIFFFGEMFENIR
MSPSDYSDRMFDISEGFPLIMMDPLHHLLFLIAVFLLIRKIFIKKKKQF
>SEQF1602_01041 putative ABC transporter ATP-binding protein
MSQQKTKANDFSILKKLFSYTKPYKWIFALVAFLSIYISGASSLRAYISKEIINTYIVPK
DYEGLLYASLLLVGILLSEIISQISFAYYSGWIGQMVIYDMRKKLFSLMLRFNMKYHNQS
SVGVLITRAVNDLERIGEIFSAGFFEIISDILKMLLIMSLMLLTDWKLSLLTFLTLPIII
YATHLFQKASKAAFTDIRREVANLNSFVQERITGIKVVQLFTREEQEYKAFQEINEKHKK
AWLRNILQNSIYFPIAEILSSIAIALVIWYGGLQVAHHEMASLGVIFMFVQLVQELYRPL
RHIADKFTVLQMGMVAAGRVFDIMEEGKENQEDAQGGICRDIEGNIQFNKVTFGYKKEEE
ILHGISFSAQQGETIAIVGATGAGKSTVIQLLSRFYKANSGKILIDGVDCNDYNLENYRK
QISVVLQDVFLFADSIFYNITLGDENITLEQVKEAAKEIGIHDFIEQLPNGYLFDVKERG
AVLSAGQRQLISFLRAYVHKPKILILDEATASVDSHSEKLLQQATEKITQGRTSIVIAHR
LSTIRKADRIIVMNKGNIVEEGTHEQLLEIPNGYYKNLYNMQFASE
>SEQF1602_01042 ATP-dependent 6-phosphofructokinase 1
MTNIKKIAVLTSGGDAPGMNAAIRSVVRTSVYHNIEVLGVYRGYQGMIENDFTPLDARSV
RNLINRGGTFLKSARSKDFRTPEGRKKAYENLVAAGADALVVIGGDGSFTGALLFNQEFG
FPVMGIPGTIDNDIYGTTYTLGYDTALNTVVEAIDKIRDTASSHNRMFFIEVMGRDAGFL
ALNSGIGGGAEKILIPEQHSTLEELVSEIEINHNKGKMSNIIVVAEGDTTGKNVFELKKY
VEKQNPDYDIRVTVLGHIQRGGAPTCFDRVLASRMGVKAVESLLEGKSNYMVGINNDKID
LTPLEKAIKGGESKLDPDLIRIAEIMSI
>SEQF1602_01043 UDP-glucose 6-dehydrogenase TuaD
MKIAVIGTGYVGLVSGTCFAEMGNKVTCVDVNKEKIENLKKGIIPIYEPGLEAMVLNNVA
NKNLFFTTEIGEAIKDAEIAFIAVGTPMGDDGSADLQYVLSVAQSIGETMQGKLIIVDKS
TVPVGTADKVHTTVQKALDKRGVSHEFYVVSNPEFLKEGKAIQDFMKPDRVVVGADSDYA
LSQMKALYAPFFMQHDGFIAMDIRSAEMTKYAANSMLATKISFMNEIANICERVGADVNK
VRIGIGSDSRIGYSFIYPGCGYGGSCFPKDVLALKKLAEEVNYKAELIESVDNVNNRQKY
VIAQKVIKKYGEDLTGKTFAVWGLSFKPETDDMREAPAIYIIKELVKRGAKIQAYDPKAV
HEAKVCYLKGVELTYVESKYDALKGADALLLLTEWKEFRVPDFEEIGKLLKEKVIFDGRN
QYNAFDLPNKGFEYIQIGV
>SEQF1602_01044 dTDP-glucose 4,6-dehydratase
MKILVTGGAGFVGSNLCEALAQNPNNQVYSLDNYFTGSRENHVEGVTYIEGSTEHIFELI
DFIPDLVYHLGEYSRVEQSFDDIDKVLLFNKIGTLKVLEFCRKHKCKLVYAGSSTKFGDG
GIGKDQSPYAWSKSSNTELVKNYGNWYGLEYAIVYFYNVYGKREIRTGKYATLIALFTEK
MKKGEPLTVVSPGTQQRNFTHIEDIVSGLLIVGEKGNGDGFGIGSPETYTVLEIAKLFGG
EIQMLPERKGNRMTAEVVTQKTEALGWKAKRHIKEFIEGLRNNIW
>SEQF1602_01045 UDP-galactopyranose mutase
MKEYDYLIVGAGLFGAVFACEMTKKGKRCLVIDKREHLGGNVYCKEIKGIQVHQYGPHIF
HTNDKDIWNYVNQFAEFNHFIYSPVANYKGKLYSLPFNMNTFYQLWGVTTPEKAQQIIEK
QIKESGISSPKNLEEQALSLVGRDVYEKLIKGYTEKQWGRPATELPSFIIKRLPLRYIFD
NNYFNDRYQGIPIGGYNVIIENMLKGIETKTGVDYLKNKSYYDNIANTVVYTGKIDEYFG
YCFGELEYRSLRFETEILEMENFQGCAGMNYTDAETPYTRIVEHKHFEFGKQKHTVITKE
YSQNWDREKEAYYPINNTANQELYNKYKEKASTLTNVIFGGRLAEYRYYDMHQVIASALQ
RVKTINS
>SEQF1602_01046 Putative O-antigen transporter
MVFDKLKQHKKLIENFSYLSFLQILSLITPLITYPYLVKTLGEVMYGTVVFAQAVVTYFN
ILVVFGFNFTAARDVSLHRDSPKKLSEIISAVTIIKTLFLILSLLLISCYMFYTSKMDYS
LYYLSFWICLNEILFPTWFFQGIEEMKYITFINFGIRVLFIGMIFVFIKSPDDYLFFPLL
NGIGALLAGIISFSLLYRKYKLQLIRVPLKTLIEYIKSSYHLFISNISIQIYVNANKIII
GHFLGMREVTYYDLAEKITNMGKVPQGMINQVLYPKISLEKNGSFLRKVLKGSILMNSFL
YLMVFLFSNEIVAYFGGNEIVLRILFLTVPIIGISNVLMILTLLPFGYNKVFTRIVFLSA
FSYSLIVLTLYGFHSISLYTLTATNVVVESLVSIIAYIYIRRKKIIDL
>SEQF1602_01047 hypothetical protein
MSEDKNIKVLVCCHKKDVMATQSPYLPIQVGKAISNTDLGVQGDNTGDNISEKNQSYCEL
TGIYWAWKNLKNVDYIGLCHYRRYFDFHKQGNMIAHSTIIPSKNFAKLDLSVPKNVLKEL
EKGYIFIPKKITYKYPLYIDYSIHHLSEDIRKLEEIINIHCEDKYKEAFSKVIHHNNKLS
HYNMFLMSWKEFDRYCQWLFSVLVIAEKEINITNYNSVQKRIFGYMGERLFNIYIYANQL
KVKELPILKISDEINNTNLIKRIARTQVNSLTALLHKI
>SEQF1602_01048 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MVSIIIVNYNTKQLTLDCLKSIYDHTTEIDFEIIVVDNASSDNSVEAIKATFPLVKVIEP
NENLGFGRANNLGAKYAKGEYLFLLNSDTLLIENSIKKLYDFYIENQGKLHIGVLGCTLV
NKDLNLIHSGGDFPTIWRYIFDNPLRVLNKIFKTNKSTFKKFSYNDTLTKVDMVTGADMF
LSKKSFDKVGGFDERFFLYYEETDMEYKLMKLGCSHYITNITKIIHLEGGSMSYSNWKRK
IVQNSQTLYFKLNHSKFFWLYGLYEFLITPIRFLQFKYSFKDNLDFVRSNMKNIFLN
>SEQF1602_01049 hypothetical protein
MIKKEEAYKGVRVIFYLNVFYILVSYLHAIFVGSYNGDFLNVSVNLDFIFLTLIVFFCIL
PYWVQWKIYKYFKKKEKRRKSIYIDIQYIKNFVYIILLLHVFATIIFDVNRVGAPPYEAP
IVIKFFIQILLRFNSFLWGSFLFFLLPKKNKGALILTIFLMLLIGILRGSFGVIYSVFLL
FLIKYFNSIIRIIKKKIVFVLIGIAFFPAIVEFAYSQRDIIRNSNEKKIENQSLIAGKLI
GRMSSFSNSAILVDNVFTYFLLAQTFDNYFYQKGMLVAISTSYEKRGFKTPEKVLLPDTP
DGSSFMLGTTGILIFSLYNSPIAFILNLFSIIIVSLIIYGILLRIKFEYNKELAYLLLVG
PTLSGVAGEYAFNLIIVVIFFITLFLFRFLQKLIVYEGQIYRHNLHK
>SEQF1602_01050 hypothetical protein
MRVKYIDTICTNKMHAIFNASLLAMLINLYSDIIFSGEKRNMSDVINILKENHIDVKNVR
KRNLYLITTHSGIRAFLTFCLSFFYNLYFIISSRKNDLLVFNYNNLFSVRSINFFNKFFN
RNILIFCHGEMEFLISDTKQYGLLNTILTYFGKNFFLNKQIKMHPKIKFVVMGDSILSNI
KSVIPNNISKSFISIDHSYFFRRKENSELPFNNKKIKIGTVGTFSKIKGGEDFFKLYNLI
GPDKVDFSITGRIFYESYIFDSMKIDIPKNRGKNMIPRNELEERIEKLDIILFFYPKTSY
KLIASGAIMDAINMRKPILAIKNDYFEYIFRKFGRFGFLVNSVEEMATILKTIRKEDLSF
DFDSIQKEMNISKITEQLKRNLIDINLF
>SEQF1602_01051 Glycosyltransferase Gtf1
MLLIDAIYINTGGGKILLDYLIEELEKTDKQIFYLLDKRIQKEKYVVKSTNVILYLKSGF
FDRMNFYKKNKNRFSKVFCFGNIPPPIKLKSDVLTYFQNINYISYSKKDFSLKNRFLFFL
KRKILSVWKNNTNKWIVQSLYVQQKMIEKYGENKNKIEIIPFYKSFKKNEDIGNIEKIPN
SFLYVSNAYPNKNHLRLIDAFCNFYDKYKKGKLIVTVSDNFTEVKNFINIKIAQNYPIEN
LGYVSQEALVKYYKQSEFIIFPSTSESFGLGLIEGIEFDCKIIGANLPYTYAVCEPSIVF
NPLNIESIEESFNYAVHNKVKNSILKAENCISKLINLLKK
>SEQF1602_01052 Putative teichuronic acid biosynthesis glycosyltransferase TuaG
MKQHLVSIITPMYNAEKYVAQTIESVLAQTYSDWEMIIVNDGSKDNCAEIVKEYTQKDKR
IKLINQPNAGSAAARNNALRNAAGQYICFLDTDDLWDNNFLEKQLNFLKEKNAVLVFSSY
RRIDEKGEKKLDPFIVPKTVTYTDLLKTCSISCLTALYDKTQIGEQYFKEELKSLRDDFV
FWLQALKKIKIAYGNKDILASYRVFASSTTGNKKKVIKPQFMVYYKVEKLGLIKSLYYLS
CWAINGFLKYRK
>SEQF1602_01053 hypothetical protein
MDLIIGAGVSGISYATFTKNDYCMVEATNEIGGYCKTIKRGEFVWDYSGHFFHFRDEKLK
ELICKYIDPKTLKKVKKNTKILYKGKYIDFPFQKNIHQLEKDEFIDCLYDLFKADEYGNI
ESFKDMVYAKLGRSIAEKFLIPYNEKLYACDLNSLDANAMGRFFPKANKEEIILNFKEQA
STSYNEYFVYPTGGAIEYINSLYKNVDDTKVSLNEKVIKIDIHNKIAYTNKREIKYDNLI
STIPFPLLLELCDISYTKEYFTWNKVLVFNLGFNKKGSDTESSWVYIPDKEICFYRMGYY
DNILGTSKMSLYIEMGFPNSFIIEDEQKYLHKVLKDLKKIGVVKDEELIDYHSVVMDPAY
VHINQKGIQSVGKYKKQLAQNNIYSIGRYGSWTYCSIEDNIIEAKDLAKNLLINQ
>SEQF1602_01054 GDP-mannose 4,6-dehydratase
MAKKALITGITGQDGAYLAEYLLKKGYEVHGMKRRSSLFNTDRIDHLYQDPHLENRNLIL
HYGDLTDSMNITRLIQEVQPDEIYNLAAMSHVHVSFQTPEYVGNADGLGTLRILEAVRLL
GLTEKTRIYQASTSELYGLVQEVPQSERTPFYPRSPYAVAKLYAYWITVNYREAYKMHAS
NGILFNHESPIRGETFVTRKVTRALSRVALGMQERFYMGNLSSQRDWGHAKDYIKAMYLI
LQQDTPSDYVIATGITTAIRDFIALAGKEIGLTVEFKGEGIEEKGYITAVDKVVFSEKVG
EKYLPHIEEKIAKNEAVVLVDPQYFRPTEVDLLIGDPTKSQTVLGWKPQYDLKSLVEDMM
RSDIKLFKRDAYLKEGGFTIMNYFE
>SEQF1602_01055 hypothetical protein
MELTQKLRHIFISDLEKCSPLMEEDLKGLLTNSTIPYLEGKDETDVRAFCFEYDHDDMSI
SFYALGEKSEIISDICLLLTEREENHFPSDRYASQEEILEDLLYETSLEEAQIEDLLSEY
RKEKLSIFTHWFIARWKNVTEQLNITIDAYFSKINALYKTDLNSLEPISTEEIEEKYNT
>SEQF1602_01056 Bis(5'-nucleosyl)-tetraphosphatase, symmetrical
MYAAAMGLLTLGSNLSVNAQTKVHYSEKRLKADTSKADFDGPYIFYTQTEAVVKQIVEKN
QQATLVSETFKNPIAGKKLTCYVDNKEHFSFKVQELLQNQPSVYQMPEKLIAISDIEGRY
QEFKQFLIANKVMDKNYKWTFGKGHLVTVGDFFDRGLLVNQTLWLIYSLEEQAEKAGGKV
HFILGNHDLMNMKNDFRYTRKKYLENAKLMGVEYYDLYKPNTELGRWLATKNILEKIGDY
IFIHAGISKEVSDLNLGVEGINKFARSFYFDNVEDRAGVDPLRSVVYMRGKSPTWYRGYG
KETIDKNEFAAIAKNMGAKKFVIGHTLHESVTYLMDKQVIDLDVLHAQGTTQGLLIENGQ
EYMVDIQGQKSAIKERAKEVDDD
>SEQF1602_01057 GDP-L-fucose synthase
MNKNAKIYVAGHRGLVGSAIWKNLKNKGYTNLIGRTHTELDLRNTQEVNAFFEKEKPEYV
FLAAAKVGGILANNTYRADFIYENLMIQNNVIHAAYENGVKKLLFLGSTCIYPKEAPQPM
PEDCLLTSPLEYTNEPYAIAKIAGIKMCESYNLQYDTNFISVMPTNLYGPNDNFDLEKSH
VLPAMIRKIHLAKALLENDWQTIKKDLNKRPIEGYITGESKQEDIILALAKYGIFKDKVE
LWGTGTPLREFLWSEDMADACVFIMERINFKDTYTTDNKEIRNTHINIGTGSDLSIKALA
ELIREAIGYKGTIEFDSSKPDGTMKKLTDPTKLHNLGWKHSVSLEKGVKMMYEHYLK
>SEQF1602_01058 UvrABC system protein B
MKFQLVSDFKPMGDQPAAIASLVNGINDQEKYQTLLGVTGSGKTFTIANVVEQVQVPTLV
LAHNKTLAAQLYNEFKAFFPNNAVEYFVSYYDYYQPEAYIPVTGVYIEKDLSINEDIERM
RLSTTSALLSGRRDVLVVASVSCLYGIGNPLEFQKNVISIEEGQTLTRTKFMHQLVQSLY
ARTTADFLHGNFRVKGDVIDVFPGYSETPIRVHFFGNEIELIESFDRETNKTIERLDKLN
IYPANMFVTSPDVLQAAIRDIQDDLVKQIEFFQSVGKTLEAKRLEERTNFDLEMIRELGY
CSGIENYSRYLDRRPPGSRPFCLIDYFPKDFLMVIDESHATVPQVRAMYGGDRSRKENLV
EYGFRLPAAMDNRPLKFEEFEALQNQVIYVSATPADYELQKCGGVYVEQVIRPTGLLDPK
IEVRPSKNQIDDLLEEIQKCVEEDQRVLVTTLTKRMAEELTKYLTKMEVRCRYVHSDVDT
LERIEIMQDLRKGLFDVLIGVNLLREGLDLPEVSLVAILDADKEGFLRSARSMTQTVGRA
ARNIDGRAIMYADKITDSMRVTIEETAYRREKQMNYNLTHGITPQPLHKKIENALSKSPI
TEFHYENTPKKKEHSPTKPMSRGELEKEIQQTRKLMEAASKELDFIQAAHYRDLLKELQE
KLQESSL
>SEQF1602_01059 Chorismate synthase
MAGNTFGHLFRLTTFGESHGEAIGGVIDGCPAGIALDFEEIQRELDRRRPGQSAIVTQRK
EADKVQFISGIFEGKTTGVPIGFIIANTQQHSQDYDHLRELYRPSHADYVYEQKYGLRDH
RGGGRSSARETAVRVVAGAIAKQFLKGIKITAYVSAVGELALPEKDHQLLDFSQIEKNPV
RCPDPVLAEQMEAYIKEVRKDGDTVGGIVSCVIQGVPVGLGEPVFDRLHAELGKAMLSIN
AVKGFEYGGGFASTRKRGSQNNDIFLPDGTTRTNYSGGIQGGISNGMDIYFRVAFKPVAT
LMQEQETINRAGEVVQFQGKGRHDPCVVPRAVPIVEAMSALVLADYLLIHNAYRELS
>SEQF1602_01060 hypothetical protein
MNTQVEDILDRILQSYSQDVFTKNIEFIRKTNANLENVDTIQSIKTLAILLEVLGNAELA
LQTSSIIDKIEFTGDMLIWEKVRDVLILEYFIYQERKEFQKAKALMDKMALVFERGDEAQ
QRKSKRILDRVLNGSLLHTEEIENAIKRNDIKAEIHHHYLQYNILKYMKIRGGSEAYPIE
KLDPMIEEEKQFIAKHIDKAFFN
>SEQF1602_01061 IMPACT family member YigZ
MTDTYKTITQPVTNIIYKDKSSKFIGYLYPITTEEEVKMHLEAIKKEHFSARHWCYAYQL
GKEQFTYRANDDGEPSGTAGLPIYRQIQSFELTNVLLIVVRYFGGIKLGVGGLITAYKTT
AQLTLQEAEIEERTIDLTYQIVFDYKDMNKVMKIIKDRNLTVVSQTLELNCTLLVEVRKA
EASYVEQLFEQLYEVTITPIEG
>SEQF1602_01062 CRISPR-associated endonuclease Cas9
MKYIKYILGLDIGSNSIGWALIQLDLLQKTKRIIAAGSRIIPMDQKVLSDFGKGITISPT
AQRTSYRNARHCRERHLLRRERLHRVLHILGFLPTHYDKQIDFSKRYGKFVDNTEPKIAY
NEGKFLFMDSFQEMLSDFKSHQPDLFYTKKNGEESKIPYDWTIYYLRKKALSQKISKEEL
AWIILNFNQKRGYYQLREEEGNKENDFEIISSKIISVIKKDKDKKYNKYWYDIILENGLV
YQAAFYNDFVYNWINQDREFIIERTSLKNGAEKVKLSYLPTFDEIDKMDKKEQDKYYKKI
KIKTENSIGNKTVGCYIYDHILQNPNEKIKGKLVRTIERKYYKEELKAILEKQIALQPEL
FTDQLLADCIRELYSKNEAQQRNLAARDFVHLLVEDIIFYQRPLRRQKSTLANCSLESRS
YIDKDSHTRKEAPLKVCPKSNPYYQEFRVLQWLQNLKIYEIDSDQEVTHQFIKTLEDKQQ
LFEFLMAQKEIDCEELLKYFLNQTYPNAKEKALKSELKKWKDTYRWNYVYDIGEKSSKKY
PMNETRYELKRHLEKVANLPDDFLSSEVEYLLWHLIYSVKDKVAYEKGLKKFAQKHHLDK
DSFVESFKKFNPYPSEYGSFSEKAIRKLLPLMRFGAHWDFNHIDKNTQKRIEDLITGVEN
EEIRTILREKAEKYQLEKETDFQDLPLWLAQYIVYNRHAEASSLEKWTSVNDLETYLNEF
KQHSLRNPIVEQVVMETLRVVRDIWQQYGQGQASFFNEIHIELGRELKKTAKEREKLSKQ
NQKNEDINLSIKEKLKELEKYNTRAYSITHQEKYKLWLEQKHISPYTGQIISPENLFTDN
YEIEHIIPQSRFFDDSLSNKVVCESIVNKAPYKDRQLGLEFIKNQGGRIVKELSKENKTI
KIFTEEQYRTFIKEHYSNNPEKTKKLLLEEIPEKMVARQMNDTCYISKFISEILSKIVRS
DEQDEGVHSKNVILCTGKITSILRQDWGLNDIWDNLILPRFERMNNLLQKEKFTIYSIEK
QKKIPVVPINDQFKSFQKKRIDHRHHAMDAIIIACTTREHINYINNQHALEKEKDKKEKQ
EERDKLREKLCIKKYNNRSEGNYSWIFKKPWDTFTQEVRVALEDIVVSFKQNLRVINKAT
NYYERWVEENGKYIKKMVKQEGTNWAIRKPLHEETISGKIYLDREKITKNDILTATRKTV
DSSFDDKRIKKITDTGIQKILLNYLKYKGSPEIAFSPEGLEELNKNLSIYNDGKPHKPIY
KVRIYEKGSGRFALGEKGRKYKKYVQGASNLYFGIYQGAKRSFATIPLNEVIERQKQGLP
SVPEYNEKGDLLLFSLSPNDLVYVPIEGEIIENIDFRNLSKEQKERIYNVNDFSSTCYFT
PNRIAKAIFPKEVDLQRKGDKLSGSYDTKTASLEGIQIKEVCIKLKVDRLGNISKA
>SEQF1602_01063 CRISPR-associated endonuclease Cas1
MLYRSIYIGNPAYLKLKDKQLKVTDPETKEEKGSVPIEDIGLLMLDHYQITLSHQLIQEL
MKNNVILISCDERHVPLARRMPRYISTVSSNGYLLMEK
>SEQF1602_01064 hypothetical protein
MQSQIKMKSILKLSLILTFLAGCNGGTPSVFSPSYNSVSDFEGEYIAYDEDGKILYGGKP
FAKVEKFNNDYHFVALADTLKDFNVQPTLSMIEKEVIERSSKKIPRYELNISGVKGNYVF
LCKIKKGEKFYYNKKTAPTNFMLDLNYVDYSKTFFIEKNNTK
>SEQF1602_01065 hypothetical protein
MFQDKLRNDIDTWFYYNRPGFEPSREFIDNIINNELKDELVDLETGNMRIILSEYLRLNY
GSLAFEIIQEVLGEDEFEEYRNFLDNLIPFVKQGDMEMLVNRVAQRRIIEKYGSELKDLL
DNQPLYEEIREVIREVMKTWKDFDV
>SEQF1602_01066 3-oxoacyl-[acyl-carrier-protein] synthase 3
MYNSTIIGTGYYVPENIVTNDDLSKLMDTSDEWIRERTGIEQRRFATRGKDTTTSMGVRA
AERAIEKAKINKEDIDFLIFATLSPDYYFPGCGVLAQKELGLGTIGALDIRNQCSGFVYA
LSVADQFIKTGMYKNILVIASEMQSPALDLNTRGRNMAVLFGDGAGAVVLSRTTQEGKGI
LSSHLHSEGAHAEELAIVTPGVGKKWVTDLIKENDPEDTSYYPYMNGQFVFKNAVVRFSE
VIMEGLKANNLTEGDIDLFIPHQANLRISQFIQQKFKLSDAQVFNNIQKYGNTTAASIGI
ALAEAVEQGRVKENDLLVLAAFGSGFTWGSVVIRY
>SEQF1602_01067 Succinate--CoA ligase [ADP-forming] subunit beta
MNLHEYQGKEILSSFGVRVQRGIVATTADEAVKAAEKLTEQTGTQWYVVKAQIHAGGRGK
GGGVKLAKNLEQVKEISSQIIGMHLVTPQTPKEGKKVHQVLIAEDVFYPGESEPKEYYMS
ILLNRAKGKNMIMYSTEGGMDIEAVAEKTPHLIFTEEIDPELGLLPFQARNVAFNLGLEG
EAFKEMVKFVTSLYKAYITSDANLFEINPVLKTSDNKILAVDAKVTIDDNALFRHKDYAE
LRDTREERPIEVEAKAAGLNYVDLDGNVGCMVNGAGLAMATMDLIKQAGGEPANFLDVGG
TADAARVETAFRIILKDPNVKAILVNIFGGIVRCDRVAQGIVDAYKNMGTDIKVPIIVRL
QGTNAEIAKEIIDKSGLAVHSAIQFQEAADKVKEVLK
>SEQF1602_01068 Ribonuclease P protein component
MVSLKEKRNTFPKAERLCNYHRVNKLFREAKVLKKYPLKLLYTPIEGSTQPTQLLISVPK
RLMKKAVDRNRMKRLIRESYRHQKSLLSTERTYSLALLYMSKEELSYREIYALVGELLKE
LSTQD
>SEQF1602_01069 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
MEAVNKKILLVEDDPNFGTVLKDYLSMSGFDVTLAKNGMEGFDKFRKDPYDMCILDVMMP
YKDGFTLAKEIREKNEKVPIIFLTARTMREDVIKGYKSGADDYLNKPFDSEVLLMKIRAM
LQRKSIDTVIDSKKFEFQIGDFFLNSKLRFLRYRDEEPLKLSPKENELLRLLALHENDLM
PRELALNKIWKDDNYFTSRSMDVYIAKLRKYLKKDENVEIVNIHGEGFRLLTGKEEEEEN
A
>SEQF1602_01070 Alkaline phosphatase synthesis sensor protein PhoR
MNKRSYIVTLILMPIALIGLISIQFYWVKGSIDNKEEAFTHSVKQALNSVSESVELKEIN
KYITRFIELKGKDSLGSLKSSQIRDLVFVQENKNTKETFTYKHQVLEEGYTVPSELFNLP
KGDTTQIRNYVSRQTSRTFGPSKGLDGQRFSSTTIKEKTGRITSFDKAMFEELFREVSVK
LSIENRITASQLEILIERELRNRGLNLDFEFAVYDKSLSVDKEKTSVASSRFNPSARNMY
TIPLFRNQEGESHYELKVHFPDKQRYLLSSVIVMAIWVCIFTAIIIWAFAKTFIQMRTQK
QINEIKTDFINNMTHEFKTPIATINLALDAMKNPVVMKDTEKMSFYLKMLRDENKRMHAH
VENVLQISKLDKNQVEIEKEPLDAHELIDNAIAHVQLLIDDRGGKIKKHLHAENSDILAN
EMHFTNVIVNILENAIKYSPQAPDIDVFTEIAHNKLVIRIQDKGQGMSKAVLKKIFEKFY
REHTGDLHNVKGHGLGLAYVKRIVKYHDGEVYAESEKGKGSTFVIKVPLII
>SEQF1602_01071 Dephospho-CoA kinase
MIATVGLTGGIGSGKTTIANLFALHFSIPIYIADTKAKELVANNKQLQQEIVALLGEEAF
VEGRYNTSFVAQEVFSNKEKLDKLNAIIHPYVQQDFLQWKKSQQAPYVIKEAAILFESGS
YRDCDFIIMVTAPLEERIKRVMLRDKIDRETVEKRIKNQWNDEKK
>SEQF1602_01072 hypothetical protein
MKLNRYFFSKRTIGILFCILLAALTWLVGKLSKEATQQYTIKLRYMEVPTERFVEMEASP
TIKVKLRGVGFSLFKYTFSPPVVSLSVHKLKKVGRDKYVFTENLKQQLNRQYFPDVRIEE
IQPDTIKIYLKKIKQKKVPVRLQFSGTLQEDYQVDSYKVFPDSVVVSGLAADLDTITGVY
LQKKYKRNVTTSYSGEIRITDTPKLHYDTDKVTFSLQMVHVTEQEIKAKVQLIHQPFSVE
VKLFPEEVPLLLTGDVETIRNLKPTDITIVADYNQRKDRYIPLEVRKKPASLNVNFTEQK
EVEYLIIHE
>SEQF1602_01073 hypothetical protein
MKLNQILTISGKPGLYQLQSRTRSGFLALSLLDQKRISIGLRNNVSLLSEIAIYTLEGEK
PLEEVFKAIKEKENGQKTAVSHKATEDELEAYFFSVIPNYDEDKVYPSDIKKIIQWYNIL
IDKGFLEEEAPVASQEAEA
>SEQF1602_01074 Peptide deformylase
MILPIVAYGDPVLRKECMPIAKDYPELPKLIEDMYQTMYHSNGVGLAAPQVGLAIRLFVV
DTEPFCENDDLSDAERDYLKGFKKAFINAKILKEEGEPWPFSEGCLSIPGISEDVLRKPT
IVIEYQDEHFATHTETFSGLVARVIQHEYDHIEGILFTDHLSSFKKQLLKNKLNNISNGK
VKVGYKMRFFETNKKRTR
>SEQF1602_01075 hypothetical protein
MKRNPNIVPLSKDHHFGLLHVWKIRQGLKKEIAPARIAQYVVFHWEHEQKAHFEEEEKYL
FPYITNKLIDQALEEHDLLRDLIAQITTQPTAALLEEYATRLNDHIRYEERVLFPYMEEN
LSEEQLTEIGKNLSADPHTEEESYSDEFWQ
>SEQF1602_01076 hypothetical protein
MKKILFFLLAVTFGFVAQAQNKAEIKFVTEEIDYGTIKQGADGLRVFEFKNTGKAPLVIS
GASSSCGCTVPSYPKDPIAPGGTGKIEVRYDTNRVGAIAKTIMVTSNATDTPNVALRIKG
KVE
>SEQF1602_01077 Valine--tRNA ligase
MPKMEITTKYSPEDFENKWYSYWMENGFFSSTPDERTPYTIVIPPPNVTGVLHMGHMLNN
TIQDVLIRRARLMGLNACWVPGTDHASIATEAKVVAKLKEQGIQKSDLSREEFLKHAWEW
THQYGGVILEQLKKLGCSCDWNRTKFTMDDELYQSVIKVFVDLYNKGLIYRGYRMVNWDP
EAKTTLSDEEVIYKEQNGKLFYLIYKVEDSEEYLTVATTRPETIFGDVAVCVNPNDERYK
HLHGKKVIVPVVGRAVPIIQDEYVDMEFGTGALKITPAHDINDYEIGIKYQLPILDTFTD
DGKLNEQGMHYQGKDRFEVRREIVKELEEKKLLAKTQDYTNNIGTSERTGAVVEQRPLDQ
WFLKMEELVKPALKAVLESEEIKLYPKRFDNTYRHWLENVRDWNISRQLWWGQQIPAYYY
GTGKEDYVVAETKEKALALAKEKNHNPNLTLEDLRQDEDALDTWFSSWLWPMSVFNGVLD
PDNKEFKYYYPTQDLVTGPDILFFWVARMIIAGYEFAGEKPFTNVYLTGLVRDKLRRKMS
KSLGNSPDALKLIKDFGADGVRVGLLLSSSAGNDLLFDEALCQQGSAFANKIWNAFRLIK
GWQVADIPQPDYAKQSILWFKNKFQKILSETEDDFSKYRISDALMKIYKLVWDDFCSWLL
EMIKPAFGSPIDKETYREVISLFEENLKLLHPFMPFVTEEIWQQIAPRSTQEALIVASYP
KEEAFDESLLHTFEFVQEIISGIRTIRKEKNIAFKEEISLSVIDNEHLGNQWDSIIQKLG
NISSISYTEKTIEGAISFRVKSNEYFIPILDKIDVAQEIEKLEKELSYAEGFLKSVRAKL
SNEKFVNSAPAQVVENERKKEADALAKIETIQKSIENLR
>SEQF1602_01078 Negative regulator of genetic competence ClpC/MecB
MNDNFSPRVKNVVNSGKLEAIRLKHSAVGTEHLLLGLLKETEGSAFDILTALHADFSVLK
RKTESLANSVNSYSDTAATQMEKSIPLTLQADKAMKATVLEQKTFKNSQINTAHLLLCIL
RNQSDPTTKLLNLEKINYENVRQQFEVINNEKKQDEKAFSDSYAYEDDEEDAKPDFLSAS
NSKKNNPNQKTNTPVLDNFGKDLTAMAMQGKLDPVVGRFKEIERVSQILSRRKKNNPLLI
GEPGVGKSAVAEGLALRIIERKVSRALFNKRVVTLDLGSLVAGTKYRGQFEERMKAIMNE
LEQNKDVILFIDEIHTLVGAGSASGSLDASNMFKPALARGEIQCIGATTMNEYRESIEKD
GALERRFQKVIIEPTSYEETIEILNNVKGKYEDHHHVKYTPEAIEACVKLTSRYITDRFL
PDKALDAMDEAGARVYISQIKVSKKVEALEEEIAKIQQLKNEAVSGARYEEAARYRDNER
TLYKQLDHEKELWEKESLKNRSEVGFDDIAQVVSMMSGVPITRMEQSEMKKLSSLEQIIT
EKVIGQEEAISKIVKAIKRNRTGLKDPNRPIGSFIFIGQTGVGKTQLAKILARELFDSEE
SLIRLDMSEYMEKFTTSRLIGAPPGYVGHEEGGQLTERVRRKPYSVILLDEIEKAHPDVF
NMLLQVLDDGFLTDSLGRKVDFRNTIIIMTSNIGARQVKEFGQGVGFSTMAKTAQAEEYE
RSVVEGALKKVFAPEFLNRIDDVVMFNALDKDNIKGIVQVELQKLLDRMKGLGYSLRITD
KAKDFIAEKGYDKQFGARPLKRTIQRFIEDEIAEKIVLGEVREGDTISVDYADKDEKLTF
LVSKIKNIPIDEE
>SEQF1602_01079 RecBCD enzyme subunit RecD
MDIAQYVLDFVNQTHRSIFLTGKAGTGKTTLLHQIIATTYKNVMVAAPTGIAALNAKGVT
LHSLFQLPLATFVPTYKEEAAWPGNLNIVTSKTLMKQQKMNTYKRRVLQKLELLIIDEVS
MLRADTLDMINTVLKSIRGSSAPFGGVQVLFIGDLLQLPPVVKQSEWDILQHYYKGISFF
HAKVIEENPPLYLELEKVYRQSDEDFVQILNHLRTNEITQKDIQTLQQYIQPTFKPSYND
GYITLTTHNYKADQLNAAAFSAIKAPVYTYQAEVKDEFPEYLYPLDTQLSLKVGAQVMFV
KNDLEIPKRYYNGKIGEVVYLSKDEIRVRLSGEDTIIEVGKYMWEHVRYKSKTNSEEIEQ
EVLGTFTQYPLRLAWAITVHKSQGLTFDKAVIDLADAFASGQTYVALSRLRSLDGLVLLS
SLNAKEFFTATDVIDYASQKADPDTLADTFSLERKAFLEKEVLKTFSWLDLAVQWGAHVN
SYKVENARSLKSQFRQWAQEQAKTYDTIVQHSEKFLNQLKGILSQPNYDKHYLLERFHKA
YDYFFPQLERLTIETFYTHLQVNGKKQVKAFSEELTQLEDIQIDAITQLLKTKIILESMI
TPSSEQEEKRAFERAKNYRERLIGRALEKWREDSLNGKFSTEEPTLVAEGKKEKKGKKEK
AEKISTYARTLELWREKKNVAEIVAERKLTESTIYGHLTKYVEEGVISIEEVLSSQRLQH
LQETLPTISEEETLNELRARVGEEYSFGEIKLFRAYWFRQNKIKEA
>SEQF1602_01080 hypothetical protein
MENNKLIPYIEEAYRLFAPYNISLPLTVCDCGNCITEKEQKLLITKHLRELSRDLIETYI
SAMFDNEDKAIVELRYFLPRMLELLSVGETLYIDEGFSLSRCHFERTHIWKEGEIAFMER
FAKAFFEEVLEGECPHLYSTAEDWLVCFGLSGLPIAPLLETWLQQSGKVKALYDFQELLT
YSLHHIGIVFKHSYFKDKRPELNEQITTWLTAPHTQRTFLQATENLLLSDVVLEEEVVFA
LETLYNQLRQLSEE
>SEQF1602_01081 hypothetical protein
MEQTHTFLDTTNGDFLLIKGVVITKDTTYSSLRLQFPSHKIWEVGTGYYWIYFDKCLFEG
KLFYVEVCFKGESLSVIEFSMNERQTTWENWSEAYELQTEKYYKQWLTTHIGEERFFDWG
KVGVHYDRKGGSTFMWVNYLS
>SEQF1602_01082 Threonylcarbamoyladenosine tRNA methylthiotransferase MtaB
MKKRVAFYTLGCKLNFAETATIARSFENEGFDKVDFEEPADIYVINTCSVTENADKQFRQ
IVRKALKHNENAFIAAVGCYAQLKPEDLIAVDGVDLVLGAKEKFNITQYIDDLTKLNKGQ
IHSCDINEADFYVGSYSIGDRTRAFLKIQDGCDYKCTYCTIPMARGISRSDTIENILQNA
KKISENNIKEIVLTGVNIGDYGKGEFGNKKHEHTFLELIQALDTVEGIERLRISSIEPNL
LKDETIAFVAQSRSFVPHFHIPLQSGSNDILKKMKRRYLRELYEDRVAKIRELMPDACIG
VDVIVGFPGETDEHFLETYHFLNQLDISYLHVFTYSERANTEAVEMEGVVPSEVRAKRSR
MLRGLSAKKRHHFYEQQLGSTHQVIFESDNKDGFMHGFTENYVKVKTPFAPELVNTLQKV
VLKKIDPDGIVTIDLVND
>SEQF1602_01083 ATP-dependent DNA helicase RecG
MLETPIEYLRGVGPQRALLLKSELQVANFQDLLHLFPTRYIDKTQYYKIQDLRETTTEVQ
VVGRIIHLKTVEGKNKTQQRLVATFTDGTGNMELVWFRPSQWIKDHLLLNVPYVIFGKCT
PFSGVFSMAHPEMETLEEHQHSLQGNIQAVYPSTEKLTKKGITQKVIRKLIESLFQEVGK
NFFETLPPQLLTSLRLLPKGEALFQIHFPQSQELLSKAQFRLKLEELFYIQLQLIQKNYL
NKKLKGYPFPLVGDYFNTFYHKHLPFPLTNAQKRVIKEIRSDMATGAQMNRLLQGDVGAG
KTIVALFAMLLALDNQYQACLMAPTEILAQQHYQSIASLLAPMDIQPALLTGSTKTKERR
KILEELENGQLQIVIGTHALLEDKVKFHNLGLSIIDEQHRFGVEQRSKLWHKNALPPHVL
IMSATPIPRTLAMSLYGDLDVSVIDELPPGRKPIQTLHQYDTHRAKVYQFLHDQIAKGRQ
VYVVYPLIEESEALSFKNLSEGYQQLCSAFPPPKYTIAMVHGQLKPEEKEAQMQLFVEGK
AQIMVATTVIEVGVNVPNASVMLIESAERFGLSQLHQLRGRVGRGAEQSYCILMTDVKLS
HDSRTRMETMVATCDGFQIAEVDLKLRGPGDLMGRQQSGVLSLKIADLVKDSQLLKVARD
YATDLIRVDPELTDPAHLQVAHTLNMLKKNKGIWNLIS
>SEQF1602_01084 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha
MEYLDFEQPIKELEEQLDKCIALGNESNVDVSDTCKKLTKRLEQVKKEIYENLTPWQRVQ
VSRHIDRPYALDYIKALCGDTFLELHGDRTVGDDKAMIGGLGKIGDQSYMFIGQQKGNNT
KSRQYRNFGMPNPEGYRKALRLMKSAEKFNIPVVTFIDTPGAYPGIEAEERGQGEAIARN
LLEMARLQVPIIVFIIGEGASGGALGIGVGDKVFMLENTWYSVISPESCSSILWRTWEYK
ERAADALKLTAKDMKDNGLIDEIIKEPLGGAHRDREAVFESVKKAIEDTFKKLSKLSVEK
LIEKRMDKYTSYGVYK
>SEQF1602_01085 hypothetical protein
MSAKVRAFLFNFLCFGALFILIRLGILYFFPELSYAVTFAITGILSILLSPRFAAFEQEG
KEILLMRWIFLKGIRQL
>SEQF1602_01086 hypothetical protein
MQIQLKRLGKKKVHLVEVTLAHTPHTLRELITECVRSEVERFNESREETSLLPFLSPQEI
GEQAQGGKITFGEKENRTLADLDTALDTALLAFTDGLFTVFINDEEVKSLDAPLTIEADT
VITFIRLTFLVGGYW
>SEQF1602_01087 Regulatory protein PchR
MKRLSILDMQELSVAQVEVPLIKSEQEMEAYYGRLQNKIGTFITQGKEIGQHTYYNWTAQ
VNDNYSFEGRMAIPSVRFYFVTKSQKGIFVDINGQLFSSKQGGHNLFFCKEECLGRDIFL
KNDTLEVITIAVSEAEFSQMAEKYPDTFKNIYERYQKGGNFLLNNRGSFCTSMQMQAILQ
QLDNTQLLGKAAGAYADLKVLELFLLQLQQMEVQKYQAYQYCKTHTDIDKIHEVSELIVS
DLLHTPSISELAREVGMNEKKLCYGFKEVFGNTIFGYLYDYKMNLAQQLLLYTDKSISEI
AFQCGYEYLSHFSTAFKRKFGMTPQGVRGQ
>SEQF1602_01088 Ferric enterobactin receptor
MLFKKIFYLFLLFSPTLIAQNKGVLSGKVLDKSTGEPLINAEIIIKDLNKGTTTDDKGFY
QIHNLPLGSYTVSFYYLGYQSVSKRINITEQTHLSVSLKEEKQEIGEMVFTAKTIAHQKK
EEAMPVTVINLSNMRGTVSSVQDILIKTVGVTIRSSGGVGSSSRLSVRGLEGKRIGFFID
ELPLSEQTDYIDINDIPVDMIDRIEIYKGVVPARFGGSSLGGAVNIVIREYPEKYADLSY
GLESFYTHKLQAVFKRNLKEKGLTFGIGGSYTTADNNYTFESPYRKGLYITRNHDKYQKI
LVGGSFKAHKWWFDEVEVEPVVVKTYKEIQGIEYDIREAHSRSLMTGLATKLTKDHFFLD
GLNFDMLNGLVFTKMNFIDKATRRYEWDGASYPTPSRYGGEVGYNFPSDSDDRKFSFVNK
TNLEYLINQNHSLNFNTVLSVAKGTPKDELKKQSLGKQVNFDSHMLSWVSGLTYDFRTSD
DVFLNSLTGRYYLYTMHTQRAPLFVPGQYNVDLNKSSFGISDALRYRFLPSFMGKLSVGH
DVRIPTESELLGDGIAIVPSGDLLPERNTNINVGCLLDLVGKHPSNAQIELNLFYMHLKD
MIRYTAGLIGAQYQNFGEMRTIGVEFEAKADILPSLYAYVNTTYQDLRDIRDYEPASTIP
NPTKDKRMPNIPYLMGNIGLEFHRENLFGGLGQNTRIFLDYAFVEEYYYDFEMTQLDKRR
IPRSMTFDLGFEHSFLNNKLFISGKIRNLTDQKVLTEFNRPLPGINGGVKLRLIF
>SEQF1602_01089 hypothetical protein
MYSKFFLTLCACAVLGTACKKDEKEEVAAHTSKSSGKYLLETSVKNEDGMSGVSYIQLTD
KLVGDINNSQGEQIEFGSSVQVEGNDVYIFDTMKGVGGITRWSYDSATKKLTKGANLPAP
ANSMVGHLEKVSDTKAYLPLYGQGIVWIINPKTMEKTGEIALNQYAHGDTNPEPAMGLIH
DGKYYLCLTQVDSGKGWQPYADYQQSDVAIIDIQTDKVEKIASEKETKLTFPTRPMSQCS
GMIFTNEAGDIYIATVGYFGFNPANKKCGFICIPKGATEFDTNRSWDISTTAIEGFEYKA
ASVFSAQYVGNNKVVAYVGIHELASQNPYTAKSALAVLIDLHAKTIKKIEGIPLTDGHSI
SINKVGTNAVFGAFGTDKVGLFSFDPATGALQQLLSTQGNPAYFHAFE
>SEQF1602_01090 hypothetical protein
MLITLWAKAEEHHYSPPFLIDKKAEEMIPQIDYDFSKFNKSKFSQAGVCLRASLIDKEAQ
TFISAHPDAVVIQLGAGLDARYERLGSPTMTHWYELDLPEVIELRKKFFEENDRRTFIPL
SLFDYQWIETIKAHQKPILIIVEGVLMYFERAQVKAFFENLCQKCEKATLLFDMLAYSLV
GHAKNHDSLGSMDKEQRPEFRWSERDSHTLEHWHPALHVEREYFMSDYNRGRYPFIFRML
YKIPYFYKRFNQRVVVLGISN
>SEQF1602_01091 HTH-type transcriptional regulator LutR
MKPLKEKTTASENDSLVDRVEKHIIEYIKENALKAGDALPKELEFAETLGVSRTAIREAM
LRLRTLGLVESRKHRGMVILEPDLVHNFEKMLDPALVDVGRLSNLFELRLMLEVGMADFV
FARKTPRQLKDLEDIVKNSEEQRCDSFNFSIEEERQFHGKLYEMAGNDILKKFQDVFMPI
FQYVHDLNRYQAAYILPEGGKQVTHRDLLEELKQGTPFSFRELMREHLNAHYIKVLGISY
>SEQF1602_01092 Periplasmic pH-dependent serine endoprotease DegQ
MKKYFTSVISAIMGGAIALGGYHFITKNQENSTFSFSSQGDSTHVAQTNFRQVANFNFDE
NSFINASKKTVNSVVHVKNMTIAPEITSIFDLFSGNTPQQGGKERLAGTGSGVIISPDGY
IVTNNHVINGASSVQVTLNNNQTYKAEIIGSDSSSDIALLKIKAPEKLPFLSFADSDNTQ
IGEWVLAVGNPFNLTSTVTAGIISAKARNLGNQYNGKIESYIQTDAAVNSGNSGGALVNL
NGDLIGINTAIASANTGTFVGYSFAVPSNIAKKVVEDLIEYGNVQRGVLGIAGTELNSET
AEKLKTKQTEGFYIDSVEDGSGAEKAGIKKGDIITQMDNIKIRSFSDLSGHINTKRPNDN
VNIVVLRDGKEKEITVKLQKNDSFIANDLGIIIKNLSDKDKKDFKLKEGVKITKTSPLYA
ENGINLDGKVLISINGKEVKDIDSAKSILENNKSQRYAIIVQNKNGEKERYFL
>SEQF1602_01093 hypothetical protein
MPSVTTEILSMNTRKDIQWAFLYFIITVLLGFSLRMSYVTNTFFNVRHVTHSHSHVGLLG
WIYTILTSLICQYFLKEEDRKPYRILFLCTQVTILGMLFTFPFGGYYLYSIIFSSLFVLC
TYAFSIFFLKRSKKFVHLRFTLSKSVEPVCEHPLSLRFVRWGIYFLVLSSIGIWLLPVAI
VKTGKGDWYNSALYFFLHFQYNGWFLAVILSLLVGEIEHKSLLINKQLYKAFYCFILGTI
GSVTLSWVGFFDHPLLYIIGNISGFLLLISVFEIYKAYNQLEKPAFLMKAFLLLWAIKTL
LMFLGSFPWIAQVILPNREFIISYLHFTFLGVIAFGVLHFLSKNLHIRFPWWSLSLYTTA
FIGTETLITYKGIAIYAQWFLPNNYPILLVVFSTLFFIAVGNWCYIIFRKTHTSSNQIFS
KK
>SEQF1602_01094 hypothetical protein
MKNFVYFCLISFCLASFSSYSQASKPISPKITKIIKDSLFAPHDNFEYAIKRLYIDIKGS
EHNLDFKAFRYAYIGYQNMKLKNKLNEKRLLSIIDFTKDSDKKRFYTIDLEAKKILYYTY
VAHGKKTGMSSSTYFSNENESHKSSLGFYVTGKTYNGDAGFSLKLYGDERNYNSNAYKRG
IVIHTADYMNEDFFQKNGRYGRSLGCPVLPTDIYKQVIETIKEGTMVFAYYTNKRYLASS
KYLKVSDLTKNNTF
>SEQF1602_01095 GTP cyclohydrolase 1 type 2 
MKIQDVIQYLETLAPLDYAESFDNVGLLVGNAQEPFRGALITLDTLEEVVEEAIQRDCNL
IVSFHPIIFSGLKSLTGKTYVERAVIKAIEHHIAIYSLHTALDNSFWGVNARICDQLRLS
ERKILLPQPHTIEQLITYVPSEHAQTLREKLFEAGGGNIGNYSHCSFNLQGVGTYQGNLH
SHPTIGERGVFQQQEETRISIIFPKHLRTKMLQTLFAHHPYEEVAYEILSLENEHQHIGL
GMIGQLPTPMEEKDFLLYVKERMQTSCIRHSPFLGKKIQTVAVLGGSGASAIGACLKAGC
DAYITADVKYHEFFKAEGRILLADIGHYESEQFTKMLLWEQLTKKFPIFAFYLANTNTNP
INYL
>SEQF1602_01096 hypothetical protein
MTKKEVSVEDKLRTLYALQLIDCKIDELRNVRGELPLEVEDLEDEVAGLESRAERLVNDI
EKINVDISTKKNLIEESKGLIKKYAEQQKNVRNNREFNAISKEIEFQELEIQLAEKHLKE
FKAEIEQKKLSIAKIKDQLEERKKHLQHKKEELSSILEETQKDEETLLKKSLEISSQIEP
RLLSAYQRIRNSVVNRLAIVPVERGASGGSFFVIPPQVQVEISTRKKIITDEHSGRILID
PDLAREEKEKMEEFFQAM
>SEQF1602_01097 Endonuclease III
MNKKEKLHFITETLEKLYPDPPIPLDHKDPYTLLIAVLLSAQCTDARVNQITPLLFAKAD
NPYDMIKLTQEEIQEIIRPVGLSPMKSHGIYHLSHILIDKYGGEVPQSFEALEALPSVGH
KTASVVMSTAFGVPAFPVDTHIHRMLERWEISNGSTVVQSEKDAKKFFPKSKWNKLHLQI
IYYARAYSPARNWDITKDIITSGIKMAKKKK
>SEQF1602_01098 L-serine dehydratase TdcG
MEYVSVFEMLKIGVGPSSSHTLGPWRAAEAFLKELRQRQILEKVQHVRVDLYGSLSLTGK
GHATDLAAMLGLSGTDPEYIPVDSISTIINQIGKDKKLHLAGERFIDFDPATDVVFNKKF
LPFHANGITFTATGEAIEDYASTFYSIGGGFIVKEKSEESAVEKKEDQRPFPYEFESAKE
LLAHCQREEKNISDIIFEDEKTLREESKIHSELLRIWHTMIECAYIGCHTEGTLPGGLNV
RRRAFDIHKKLMGEHLPYTNFEGWLGAIRQKKVDFREILKWVTCFSLAVNEVNASLGRVV
TAPTNGSSGVIPAVLLYYLAIDNPQAGDREIERFLLTSGIIGSLFKKGATISAAMGGCQA
EIGVSSAMAAAGLCELWGGTPEQVMIAAEIAMEHHLGLTCDPIGGLVQIPCIERNAMGAI
KAINAAELALDTDPKNAKVPLDKVIQTMWQTAQDMNTKYKETSEAGLAVAVSMADC
>SEQF1602_01099 SCO1 protein 
MKRFFLLAMGVICLQACKNNTTDTAKEAETPSETVENTATKSQKEEGGATEISDLSIYNL
PDTWTTQNGNQVQWKDFQGNVLVVVMIYTSCKAACPILIADMREIRKTVEASEAPHKEKV
KYILVSIDPKVDTLEHLKKFAQESHMDDDQWVFLRSDEEKTREFAAVLAVNYKQISPVDF
SHSNIISVFNTKGELAAQQEGLGIDRSSIVQQIKEQLEKIN
>SEQF1602_01100 Serine/threonine-protein kinase pkn1
MKKRLLVCLLFLLEGIYAQDPTPMVEIKGGSYIPMYGVKEGQKKTKAVRVASFFLDVYPV
TNAQYRDFLEKNPQWQRSKIKGIFAQKSYLVAWKSDLDFSPLDSEAPVTNVSWFAAKKYC
ECQGKRLPTIDEWEYAARADEASADARKKKSYSDYITHWLQTPNTYANKIGSTQKNYWGV
YDMHGLVWEWVSDFNSVFFSGEARKDNFGDDGLFCGGSALNATDLTNYGAFMRYSLRGSL
KANYTTKNLGFRCAK
>SEQF1602_01101 Copper-containing nitrite reductase
MKKYTKKLTIFLALSLLVGACGGSEPEKTTTPIPTTDISVEGEAVAAELTSPPHVPKPVG
TRKAMKLKVDLEIIEKEGEIMDGTKYLFWTFGGTVPGSFIRTRVGDEVEFTLKNHQDNKL
PHNIDLHAVTGPGGGAEASLVAPGQQRTFSFKCLNPGLYVYHCAQAPVPLHIANGMYGLI
LVEPEGGLPPVDKEYYVMQGDFYTDGSYGAGGTQAFNQDKALAEKPDYVVFNGKVGSLTQ
DGALTANPGETVRLFVGNGGPNMVSSFHVIGEIFDRVHVEGGKLTNENVQTTLIPAGGAA
IVEFKVDVPGSYVLVDHSIFRAFNKGALGLLVAKGEENRKIYGKNEPKPYVSDVTIAVTP
KEDVIVNKTKEQQIADGKVIYTKTCVACHQAQGQGLEGAFPPLAKSDFLNADVDRAIDIV
LHGKQGEVTVNGKKYNNVMTPQPLSVQEVADVLTYVYNTWDNSKKVVTPEMVQKIKK
>SEQF1602_01102 Branched-chain-amino-acid transaminase 1
MDTTNLPISIEKVAKSRLSEVDFSKLNFGKIFSDHMFICDYKNGQWQDARIVPYGPFSVE
PSLSVFHYGQTIFEGMKAYKDDRGEVFLFRPTENYARMNKSCKRMSMPEFPEELFDKALK
TLVDLDRLWIQPGLGNALYLRPFMIATSAGVQANPSTEYRFMIITSPVQSYYKGGELKVK
IADHYSRAANGGVGFAKTGGNYAGQFYPTALAKEEGYQQIIWTDDATHQKLEECGTMNVV
IRIGDTLISPPPTERILDGVTRKSVFAVAEKLGIAIESRSITVTEVLEAASKGTLKEIFG
CGTAAVISPVNAFGYEGKEYRLPDLEDSYAKRIKEFLLNIQYNKSEDPFGWRVRV
>SEQF1602_01103 Transketolase 2
MSDIQQLTDLTTQVRRDILRMVHGVSSGHPGGSLGCAEFLVCLYNEVMDIKLPFTMDGKG
EDLFFLSNGHISPVFYSVLARRGFFPVSELSTFRKLNTRLQGHPTPCEGLEGIRIASGSL
GQGLSVAIGAALAKMLNGDPHLVYTLHGDGELQEGQIWEGMMYAAGKGVDNLIATVDYNG
KQIDGPTDKVLPLGDLKAKFEAFGWSVVTIEKGNDIAAILEGLKVAKALTGKGKPVCILL
HTEMGHGVDFMMGTHAWHGKAPNDEQLAKALAQNPETLGDY
>SEQF1602_01104 Lipopolysaccharide export system ATP-binding protein LptB
MKTLRAENIVKEYKGRRVVKGISLEVKQGEIIGLLGPNGAGKTTSFYMIVGFIKPNAGHI
YLNNTEITKFPMYKRAQHGIGYLAQEPSVFRKMSIEDNILSVLQLTKLSKKEQIHKMESL
IDEFNLGHIRKNRGDLLSGGERRRTEIARALATSPDFILLDEPFAGVDPIAVEDIQNIVF
QLKNKNIGILITDHRVEVTLPATDRTYLMYEGGILKAGLPEELAYDPMVREVYLGNNFEL
KKRN
>SEQF1602_01105 hypothetical protein
MQLRELLRNSKISLRTYSICLQQQWHTLDDIRNYYREQGHFMSVENTDTYIEEELKSIIF
TTFEESFSDIPYEPSHFSIDTLSPAAQEILQEYIGMLTESLSPRLKTVINTYFRQGVPLQ
IFCEYALDPLCKSFKMKGIGRRNGGEFHAYFEHIKKFVTALSTITDPEQLPEFKKKFFIQ
SIYPIEKIPKEVTLLGIFKIVDYFLKTPALFDESKIALFSKAFRIYNQTQGAKLKTIGKQ
MQITHERVRQIRNQAVLDFLSKLIIIQSFETDLFARGQIDISSEVLSLSPEQVQWINQQS
HTDFTENFIYFILHIYLERFSIVGNLADVLYLRFSQKKTRHNWKGIYLVSSEIASVLPWE
KLIESVSELLKEKVEKDYGLPLKEYLLKFRKADAALCERMIPIVAHVLKGEFSLRVEEGM
LIIPRNTYKQIHEYAYEALDILGKPSSVNEITEKVKELYPNTHITHTGVRSALRRAYGFI
PMGRSSYFGLKKWEKSIKNFKGGTIRDIVREYLQDKSLPISLKEIIQYLAPYRPNARSKS
VLTNLKADASDTFVFFQRSYVGLKGKEYPEDYEIIIEKAVKKRTWEENYNSLSDFVQKNG
RLPMSSEKTPQAIILYRWISVQKNLMKNHRLTPEKEKLFQELIKVKYENTKS
>SEQF1602_01106 hypothetical protein
MNFTPDLEQIPHWLTLKKICKAQAVLDLLICGQEFETYHRYAPAIQEEYEGQEARIGFDF
EEEDGPSLHLFFTEKGCIIVPSVCENFQTVSADFEKRIPKEFQAFYRKNYHEQDIPFVIY
AQENKPWELIWQFETEQEIFTLKHLSTDPEFYKDWATIFFGEETEYLNDEASLETIEKLY
KGEVLTEKMVYSIVSNVQDWLFLEEEFNHMPYRFDF
>SEQF1602_01107 Sec-independent protein translocase protein TatCy
MERPQEEMSFLDHLEVLRWHVIRSIVVVITVALLAFFFKSYIFKYVILPHTMGDFPTYKF
FCEIGRFLGSETDFCNDRLPLVIQNRTMTGQFSATLWISFWTGIVVGFPYLMYEMWRFIS
PGLYEKERKMARGFIGVTSVLFFVGVLFGYYVIAPLSIHFFATYSVVGGEQMVKNEIDIA
SYIDMLRSSVISCGLIFELPVIIYFLAKLGIVTPDFMRKYRKHAIIVTLIVAAIITPPDV
ASQVIVSIPILILYEASIFVAKYVQKRQKIKLN
>SEQF1602_01108 hypothetical protein
MKKISVSLVRLLVGVVFIISGFVKLVDPIGFSFKLEEYFEPHVLDMPFFIPYAYPIAIFV
VAFELILGVLLLLGYLRNFTLLSLLGLTIFFGFLTFYSAYYNKVTDCGCFGDALKFTPWG
SFTKDMVLLVLAAALWYARGYISPLFSPQKCLTILVITVLACMGLVYYTHNHLPIIDFRP
YKVGVDINKAKEIPANAPKAVYDYHWKFKVGDKEQIITTQGAYPEVEGGTYISVKTELVS
KGYEPPVHDFVIMKDGEDVTNQILAEPKLLLVTSYDLGKANLEGFRPIKELTDKALKQGY
KVIGLTPSPEKAQELLGQYGLSFDFYAMDVTPLKTMVRANPAVIRLERGTIKQKVNYNDT
QKIDL
>SEQF1602_01109 hypothetical protein
MDKTISQYNKVIAHCQSIFSYKMKDYGSAWRTLRLPSLTDQIYIKVQRIRTLQETKERKI
QEDETTEFVAIVNYSIMALIQIEKSVVNEPDLNYEQALSLYEQMVEETRALMLRKNHDYG
EAWRSMRISSLTDLIFQKVLRIKQIEDNDGKTLISEGVKANYQDMINYAIFALILSQENN
IKSNEKN
>SEQF1602_01110 Ribosomal RNA small subunit methyltransferase E
MQLFYNDSLYPQVQEVTFDKEESNHIHKVLRKKTGDLLFITDGRGYLYEAQIQYITDKKC
TAHILSHSLAPTPAYHLHIAVAPTKMNERYEWFLEKATEIGVHEVTPILCDHSERKTIKT
ERFEKILLSAMKQSLQCYKPQLNPPISLLEWLDTIESNSVGKYVAHCQEGARVLLLDRLE
ELPQETTNLWVLIGPEGDFSQREIQKACSKGFLPISLSPNRLRTETAAIVACSCISDIFQ
RKK
>SEQF1602_01111 hypothetical protein
MSENEKKSINEVSLETPLQEKLENTSLESSPDFLNEIQQENARSAEDAEEKKRHDIPMLN
YENMDLETLQHELKKLIDTEKIPSIKTHVEAIKKAFDNHYAQLIEEKKQQFLSEEGAEEK
DFSFSLPIRDTFYKTYQLYKQQKAAYQKQIEGDLKKNLESKQEIINEIKNLVSLGKDDIA
WDTNTLLRKFLDLKKKWYEIGAVPREHYNDIWNNFNHHTDNFFDYLSLTRNYQENDFKQN
LEKKNKLIARAKELLQEADIQKAFRELQLLHKIWKEETGPVEKEYREKLWEEFSTITKEI
HDKRQAFLKRLEASFVDNKHKKLGVISQIEEINKQQFSSHNDYQKAIARVNELREEFQKI
GRVPQEDSEPIWQRFIEAIRTFSKQKNHFYKENKKTQNENIAKRQELIAIANEHKDSSDW
EVVTPLIQKIQEDWKQIGAIPRKLSNALWEEFRGACNHYFDRLHKERKKQHKEEDAHIEQ
KKALLDQLKAFVLTGNKEEDIKVLEDFQEKWNALGKLPERLRMVDTRFNKIMEAIYKKLN
FDKKQIELIKYNNKLDHLPEGSNSLMREEIFIRKKIEDTRKEILQLENNLQFFTNMDEKH
PLMREAVKSLHDHRESLTLWEEKLKELRLKEAKEEAVTAEEEA
>SEQF1602_01116 Non-canonical purine NTP pyrophosphatase
MKLVFATHNKNKLKEVQSMLPADIELLTLDEIGCFEDIPETSPTIEENALQKALYVKKKY
GYDVFADDTGLEVEALDNAPGVYSARYAGEEKNNEANISLLLKNMEGKGERQARFKTVFA
LCIGEQHYSFEGIAQGEITQERRGEGGFGYDAVFLPKGEKLTFAQMTPQEKNNISHRGKA
LDKLVAFFQKKKL
>SEQF1602_01117 hypothetical protein
MQTKIYLLFLLLPFLSYGQQVKISAAPDRSEMKIGEQIHYKIAVEADSTARVSFPDAQQF
APFEVVSQTPVDTFKERDRFRLIKEYALTQFDSGHYTLPSLRIGVNKDQYQTDSLSFVVH
DVVLDTIKQPLYPIKPAIEVKKAKSDSSFWYWIIGGIVFLAVLFSLYWFFIRKKKGQQLD
TEAALPPFDRALLKLKNLQNSRYLLESNHKEYYSVLTDIIRKYLEEEIHITATESTTDEL
LAKLQVFLDAGKLHLSSQVMDELRTVLKKADLVKFAKSKPEDYEAESDRKAIESIVVKTN
EGLPDMTQEEDMQDEYQRIRLEKQRKTKRRKYIITLSAAVVLLFALLAGTWYAFTIGKEK
TFNTEHWVTSSYGYPAITLSTPEVLKREKKANELDRFTYITSDSPISIMLITNSLKEYLS
EFYTGQEGEASQERTQEELNELVLRMIEKELKKYFKGENILIKDDTYTTAQGVAGHKVFG
SFTQKEKEVRKMRYQSYFFIRGEAIQMILFAYPEDEKTVSSSLVEKIMTTVKM
>SEQF1602_01118 hypothetical protein
MDTKEILKKVRKIEIKTKRLSDNIFGGEYHSAFKGRGMTFSEVRPYQYGDDIRNIDWNVT
ARYNETYVKVFEEERELTLMLLVDVSGSELFGSLQQFKNEILTEIAATLAFAALQNNDKT
GLILFSDQIELYIPPKKGKSHILRIIRELIEFQPKNKQTDIAKAFEFLNKITKKKTITFV
LSDFIGNDYQKPLQIAARKHDLTGIRLYDPREMTLPNVGVILAKDAETEELSYIDTTSSK
VQKAYEAFYKERTNYFETTFRRLGAGILQCRTDESYTKKLLGYFKYRA
>SEQF1602_01119 Phosphoglycerate kinase
MKTINDISCKGKKVLVRVDFNVPVNEQFEITDTTRIEAAKPTIMKIVRDGGSAILLSHFG
RPKGKDDKYSFSHLVKQIGQVLGLPTHFSPDCIGDVAENTAKNLPVGEVLLLENVRFYPE
EEKGDEAFAAKLAKLGDIYVNDAFGTAHRAHASTTILAKFFPHDKYFGYLLAKEIESIDK
VMKSGEKPVTAILGGSKVSSKITIIENILDKIDHLIIGGGMAFTFVKAQGGQIGNSICEE
DKLDLALDILKKAKEKGVQVHLPVDVIAANDFNNNASTQLVPVDQIPNGWQGLDAGEKSL
EIFKKVILASKTILWNGPVGVFEMPNFAKGTIAVGEFVAEATAKGAFSLVGGGDSVAAVK
QFGFENKVSYVSTGGGAMLESLEGKILPGIKAIND
>SEQF1602_01120 hypothetical protein
MLVKIFNFVSKHKFFSLLCLVLWIGIALWGVVRLHFEEDITKVLPQNEKTSLTAKVLKQL
NFSDKVSVIITQEAEGDFATMQSFTDALCDSLRQRVPNYFSDIQGIVPEEEVDEAWGFVY
EHLPLFLEEEDYQYLSRKLEPDSLRALVGAHYRMMLTPAGMVAQQFVRKDPFSLTFRGLQ
KLQQLNVGTELTLTQGYLTTQDQRHILFFLNPTFDGNDTEHNAAFVAALEQLQREFNQQY
VGKASCEFFGAPFISVSNATQIKTDILTTVLISLSALCLLLIFFYRSVTVPVIAFIPSLF
GVLTALAFLYVLKGSISAISISLGAVLLGVTIDYSLHILTHYKATQDTQELYHSVTTPIL
LSSITTAISFLCLLFVHSEVMQDLGIFASVGIMTSALLSLVMIPHFYRKNKNIEARKTIL
DRVGAYPFHRNKWVVAGAFLLIAGSFAAFHDVRFNGDIASVNFLSERYQKAQTHLESLTD
SKYKSLYTTAYGNSLDEALTQNTQLYHALTQLKDQGKLQQFSSLGGIILPLAEQQRRLTR
WRTFWNVERCATIEYTLATLAQEAGFKPAMYTPFFAYLGEPKQPITDLQTYKALSAIPIG
DFITEKDGFYTIANLVKLTERQRTAFIEQIQRQTPTIVIDRKQISETFLGKLKDDVVALA
TYASFAIFFILLLFFRRIELVLLTLIPIALTGVVTTALMNLFGLEFNVFSMIVCTLVLGH
SVDFSIFMTCALQKEYSTGKDELPVYKVSVLLASITTFLAIGTLIFAKHPALKSIASVSL
IGIFSALLLTFVFYPSLFKFFISRRPEKGLSPISLRIFVNTILSITYYVVFSIILSNIGW
LLLKIFPTRKTLWLRTLAAKLTTSVLYSNPFVRKRVENPSEIDFSKPSVMIANHSSWLDT
LAIGMLTPRVSYMVNDWVYHSVVFGRYVQAMDFYPASEGIEKGMPIFAKNFANGYSAMIF
PEGKRSESNVIHRFHKGAFVVAEHFKKPLTLVYIHGNSEVQPKGDFVIYDGSITVVAAEQ
IAPDDPRFGSSPRERAKAIGKYFREQFSLLRQRIEGEDYLKKKLFLSYLYKELYIVDAVR
ADFQKRKGQYHRLSLALPQEGIILHWADDYGQADFLWLLTHPQRTLITIIADDHKRAIAQ
QSYLTRIRKIQYYKELPEGVSYDWEVDTREGKEVVNKMTN
>SEQF1602_01121 Porphobilinogen deaminase
MAVIRKKMKKTLRIGTRDSELALWQAKKVQTLLENFGYTTSLVPVKSQGDLSLDIPLYEM
GITGVFTKVLDVAMLQGSIDIAVHSMKDVPTSLPKGIVKGAVLTRANVQDVLVYKDGLDF
LSQEQATIATGSLRRKAQWLRRYPTHQVENLRGNIATRLHKLHEHSWHGAIFAAAALERL
AQDHLQRLSLEWMTPAPAQGAILAVAMDSDPYTLEALSLINDPKADTETQIERRFLKRLE
GGCTAPIGAKATLEGDTLSFVGNLFSLDGKQAVEVRKSIPTHSIGSFPEDCAQELLHSGG
EGIMQEIRKVMNIQK
>SEQF1602_01122 ATP-dependent DNA helicase RecQ
MHPLALEILKKHWGYEQFRPAQEPIVTSILEGKDTLAMLPTGGGKSICFQVPAMVKKGIC
LVISPLISLMEDQVKNLSEHGIPALALTGSIPYYEIERLMHNVQHEAYKFLYLSPERLAN
EEVIFYLKSTPLNYIVIDEAHCISHWGKDFRPAYLACKNLREWFPTLPIIALTATATERV
QKDIIEHLQIPQAQIIKGSLIRSNLAYMTYCIDDKWERLTRILLKNKESSIVYVRNRRLS
EELAQHLTEEGFTATSFHGGLPVEEKSKRLGMWKLGDVQVMVATNAFGMGIDKADVRTVI
HWDLPSSLEDYFQEAGRAGRDGHKAFAIVLYNDNDVKKLLVDTQRSQVSPEFLKELYPKL
CSHFIIATGEGEGTSHLFNLADFASKTQMDALKIYQGLEVLDRNGVLSLSQAFFRKANVQ
ILLSSREVIDYLDNNTELKELLFFLMRKYSGIHEQVISFRIEKIAGNLHLTSPEIQQKLE
KLQQDGIISYRSENTDAEITFLMPRDDERTINYISPQVRWYNENKVNQCNEVLAYIEQEE
KCNQRFLLEYFSEETKEDCGICSYCIARKQKNLSKASVESISEEILRLVSSHPMSSQELC
RKSSYHEWEILHVLTLLLDKEKIQLLPTNQWSA
>SEQF1602_01123 hypothetical protein
MKKQIIQVLWSIANGVGQKQNEKIVYPSIREQLSAIKTLMSIKGWEEELLVLQQTISVQQ
NSMDNQEILSVKTMDTTSVVNEKTESKEEFIAPSIEKEAVLPLKEKDELPSTLEKNELSS
TLKKDELSTTLKKGELQFAPTVDDPIASLPACWRNAFG
>SEQF1602_01124 Protein translocase subunit SecA
MSFISSLIKIFVGDKAKKDMKEIAPLVTQINAHQAQYKSLTNDQLRAKTTEFKERIATAR
KEYEEKIQSLKAQADTTEDIDQKEDFYTEIDKLTDEAYKAGEKVLNDILPEAFAVMKETA
QRFVDNSTIEVTAAPYDRELASLKDYVTIEGEKALWKNSWDAAGKAITWDMVHYDVQLIG
GIALHQGKIAEMQTGEGKTLVATLPLYLNALTGNGVHLVTVNDYLARRDSAWMAPLFQFH
GLRVECIDNYQPNSPGRRMAYAADITYGTNNEFGFDYLRDNMAHTPDELVQRPHNFAIVD
EVDSVLIDDARTPLIISGPMPRGEFHEFDVFKPAVEALVEKQRKHLTNVLAEAKRLITEG
NTKDGGVLLLRVHRGLPKNKALIKFLSEEGMKQLLQKTENYYMQDNNREMHKIDEDLLFV
INEKNNQIELTDKGINEMSQGEDKNFFVMPDIGAEIANIEKQNLPKEEENALKDKLYQEF
GEKSERIHTVNQLLKAYTLFEKDIEYVVIDNKVLIVDEQTGRIMDGRRYSDGLHQAIEAK
ENVQVEAATQTYATITLQNYFRMYRKLAGMTGTATTEAGEFWEIYKLDVMEIPTNRPIAR
KDQNDQIYRTKREKYNAVIEEVVSLSQAGRPVLIGTTSVEVSELLSRMLKLRNIPHNVLN
AKLHKKEAEIVAEAGKKGVVTIATNMAGRGTDIKLTDEVKEAGGLAIIGTERHDSRRVDR
QLRGRSGRQGDPGSSKFFVSFEDNLMRLYGMERAIKFLDRLGQGLKEGEVLEHPIITRNV
EKAQKKVEENNFGIRKRLLEYDDVMNAQREVIYKRRRHALYGERLQVDIANIIYDTCEAI
LESNKPGNDYKNFEYEHFKYFGIEPKISEEDFHKKPQKELIKVLYPQLLALYKERCDRNA
AIAYPVIKNVYEDQSNQFERIVIPFTDGQKGINITTDLKEAYESEGKQIIVDFEKNISLA
IIDDAWKTHLRQMDELKQSVQLATHEQKDPLLIYKFEAYNLFKDMVDKVNKEIVSFLFHA
QLPTAEPPVQEAHEVRRAPEHLQTSKEEVLNSDELAQRNREVGQQASPAPQVTEPIVREQ
PKIGRNDKVTIQNILNGEIKEMKYKQAIPLLEKGEWVIKR
>SEQF1602_01125 putative lipoprotein YfhM
MKNFFTFFIALFLVASCAKKGGFKDSDPTLFKEYISGFSSGSISADAPIEVVLTQLDSKA
LEGVEVDKLFDFSPKVEGKTTINGNFVKFTPENPLEHNKEYQITFHVDKLFKVKKDLANF
YFHIRTKSLQFEVNVRDLQSYNQNYYFLNASIEASDNLSPEIVSDIVKANINGKSLSVRA
LTNEKNTEIPIIIDSIPTPTDQSQTLIIEWNGSQYDIESSGSSSLNIPTNNDFGVVQLLQ
NEGENNSFNIVFSAPLQKNQEFRGLIAAENYDGDFRFSTSGNTLKVYADSNFENEVKISV
FQGIKSQYGERMKYDFSGKLAFDPIKPQVRLVRNGTILPSSQNLKVNFQTINLKAVEISV
LKIYQNNVLQFLQENDLGGAYRLRRVGATVAQKVVPIQATTKNSLSKWSTHAIDLSKIIT
PEPGAIYRVKIDFKKEYALNCNNDKTPIKEENLLVLEEDGNSDYYDYDDYDYDYDWEERD
DPCKDSYYYRKSVETNILATDLGVVVKRGQNNDYTVVVNNILTTEPVNGAKIALFDYQQQ
KLTEATTNNEGKALMTTQKRAYFAVAYKDNNTTYVKIEDGASQSVSNYEVGGLELEKGRS
GYIYTERGVWRPGDTISVGFIFNDFANKLPESLPIKLTFSDPNGKVVQQLVKNSTTENHY
LFTLHTQPEAITGNWSCQIKVGASTYSKTIKIETIKPNRLKINNSLSEKFISNEGQNASL
QVDWLQGTPASNVKVEITGKLYPKVNPFKGYESYTFNNTSFPSSSEEIPIFEGQTNERGS
ASFFFQPKKLENATQMLRINFLTKANEQGGDFSTDVTSATYSPFATYVGIKAPNDNYYYE
TGKATKFQTIVLSEEGKPVAGHRVKLYAYKIEKNWWWDISEYNISSYNSSDSKSPAFSTE
ATTGQDGKATFNIQIKNGESGRYFLLVEDSQSKHEAGIDARFYSWGESGENTGTEATMLM
LTTNKKDYKVGEKAIVTFPSDANGRALISVENGSKVLRTYWVNTQKGKTTYEVPVSEDMA
PNVYLYVTLLQPHAQTKNDAPIRLYGIAPISVYNPKTKIEPIIEMPEVLRPEKQVTIKVR
EKSGKPMTYSLAIVEDGLLDLTRFKTPNPWNTFFAKAALGVKTWDIYNDVIGAFGGTINQ
IFSIGGDEDLGAGNTKKANRFKALSIVEGPFTLSGGTKTHQIKLPNYIGSARVMVVASDV
KNNAFGSAEKTATIKSPVMVLASLPRKAVPGETITLPVTVFANEKQVKNVSVSVKTNDKF
SLSSSTQQVSFDQPGEKMVYFTLKVKEIGIGKITVEALSGGEKSTYSVDMDVLNPNPKIY
QVKNVILQPNNSQSIAFEVFGEKGTNTSTLELSSFPGVNLSQRLKYLIEYPHGCGEQVTS
GAFPQLYLSDFENLSSKQQQEVQQNVSAAIRKLSQHQLSNGGFSYWQGSDYADEWVTSYI
GQFYIEAEKKGFSLPMGSKSKWLNYQKTMARNWTYNGAHSTFNQAYRLYTLALAKSPDMA
SMNRLRETSSISNEALSRLAAAYAIAGQKNVAASLFSKVTFDSGSEDSYYGYGSPIRNNA
MSLETALYLGKSQIAAELALKISEKLSSSEWLSTQTTAYGLYAMALYVSKNKTGKSWTAT
YQEGKDSGSLTSSSTGYASKALSSQIGNHKVSVQNKSAVTLYARVVSSGILPVGKELVQE
NGLSVSTHYSNKNGSLSVESLPQGTSFTCEISVKNTTQSAVSNIALTQFVPSGWEIVNTR
FTDYDTDSSKWDYADIRDDRAHIYFGLKAGETKKFTLQLNASYKGTYYLPGSFAEAMYDA
KYNTHNKGSWIKVE
>SEQF1602_01126 Leucine-responsive regulatory protein
MISFDQIDLILLDELQRDSKQSVKELAKKVNLSITPVHERIKKLEALNVIQNYVAVVNPD
ALGKTLVAYCQVKLVRHQETLFEEFEQYVRNLDEVQEAYYMAGPYDFLLKLILKDMKDYQ
NFVVHKISKLDIISNIQSAFTIQSIKNTSMIKCILDEENKEN
>SEQF1602_01127 Deoxyadenosine/deoxycytidine kinase
MHFAIAGNIGAGKTTLTGLLAKHYKWEAHYEDVSDNPYLDDFYANMERWSFNLQVFFLNS
RFRQIVDIRQSKKNFIQDRTIYEDAYIFAPNLHAMGLMTERDFCNYRSLFELMESFIQPP
DLLIYLRSSIANLVNQIQKRGREYENSISIEYLNRLNQRYEDWIRSYDRGKLLIVEVDNM
DFVKNPEDLGEVIQRIDTSIHGLF
>SEQF1602_01128 hypothetical protein
MLQMKKKTTIYGKLLYITVFVALYGLFRFQAELTEQWYSTGIYPYIGRTVRFLLGWIPFS
VGDILYTVLPLGAILYIIKYFGKIRKAPLRFLKKVGESLVLVVSLFYFLWGFNYYRQPLS
VQLGWDFSYTESELEAVTKRLIIEANTLHKQLSTADTQAVQMPFAPREVYEKIPQGYSKL
SDKFPRFALYTLSVKSSLYSKALTYMGYSGYLNPFTGEAQVNDLATHYSFPVTAAHEVAH
QLGYASEKEANFIGFLAIYHHREPYFKYSATLFALRYVLKEVRQLSPERHKEYTQQLRAG
VLQNYTEAFEFWSQYENPMEEVFKNSYDTFLKANAQEGGIQNYDYVTGMLIYYLTHIDK
>SEQF1602_01129 hypothetical protein
MKLQATLYIPQDKEDFHIDIYDEQAPDYQIAEIFRKGDKTIIDIYNNPNDTHKELDLKEF
IEVLSKCYNKLKM
>SEQF1602_01130 hypothetical protein
MKQCICNQLADIVEGESIKNFQGKIAYKEIAFYPTQWVTLYKCECCHTFWKEAYKATGHG
EVPFLTKITLPPYATAEDLQKCMVIVREILDSKAITINEEHCQALALEVMGISYAKGGDY
SPEIIKSFAEGYLKIVEI
>SEQF1602_01131 hypothetical protein
MNTITDLTAICAILKEFKVDSVLLTQYTPTFRRVVLYLTEKDTTATLYLIVIGSKYIQGN
FSWHNPSFEITYNEITQEYLIEDKANGFCLICDGGVILVESTKGSSFEIIQ
>SEQF1602_01132 hypothetical protein
MGKQVHFIPFDIEDKFPFRLEFIEKTVFKNTYFQITYLKFKGCINTPDEQQLLSYFIEKN
LDENAKAVCRILDFTELIFNTIPNIREEVIISLQKVFSNPFTSKLDAINFLIEKNIKKFP
NASYKHYEQLPKMEKLERDSQLSKVTIETLLSENDTIGMLKLIGIYPYKGSLEANYIQNN
IDIFVELTPIQALIVDVTDFSLEYDWDNDLCDLKPTHPKYEHIPIYYLDKEKRDFMSEHN
NIIFNLNEINGL
>SEQF1602_01133 hypothetical protein
MKISLQNREFRLWKFSISHSMLLIRSCKNAFFSNNIDLYFADVKLIKFHQFFRAEALTSY
IADEDMDILEDCNKANIPFNEDQIFVFRGEQQKCYIIASTFQMEENTNELMEVSF
>SEQF1602_01134 hypothetical protein
MNIQNLFKIAWRALLPNKTRAMLMMLGIIIGVGSVITMLTIGEGSGVNTEYLSIR
>SEQF1602_01135 hypothetical protein
MKHLLILFFLLTTNAFAQGPFGYYAVVKDKDGYVNIRAKESVKSKIVGTLPNNTLVYGLF
DTTQDETGEEIFFNWIAVDKGYVHKSRLKMIGEFPSIGKGKEQGNSITIAGKGISVTITT
QKFDKTKHKITKKKHKEYSEYIIDGKRAQGLDGGLFLPENHYKSITVTINGKNVPIPKSA
YDDLYEVWVHPYNNMVYYDKEDDVLYIFVRCGDGAFSYEVCWQIVKGEYKTRIIGQPF
>SEQF1602_01136 hypothetical protein
MKRILSKANYHIHTDAVKNYILPTLSELKEAFVYADEADLLNLAMFGCTAKQWKIANPER
ALKGENIRDIASINELAILSNIESLNASLIKHNIAKEERFKILVETIKEQRAVLDKVDYL
KSIKKLSNDTYISMESNKQLDK
>SEQF1602_01137 hypothetical protein
MTPTNNKLKVQDVEISLATIDNQDYISLTDMAKGKNDEARAADIIKNWIRNRSH
>SEQF1602_01138 hypothetical protein
MSCGKIIQNENLMKHLLILFFLLTTNAFAQTPLGDYAVVKDKDGYVNIRAKENVKSKIVG
TLPNNTLVYGFFDKEFNPTNWIEVDKGYVHQSRLKKIFDFRAIEGKVQGNSLVFDDKDVK
VTITKQKFDKTKHKITKKGQGSYEQLIIDGKEIIYGESGSLTQDHYKSITVTMKGKNVPI
PKSAYDDLHGILYDRYLNRFIYYDEEAEALYIYAVNGEAGLAYQVCWQIVKGEYITRIIG
EQL
>SEQF1602_01139 PhoH-like protein
MNQRTLLLEVNPQSFYGEQNSNIELLRSYFPKIKIVARGNEIHIFGEEAILDEFERRVEQ
LTLHLEKYNHLDRNVIERILTSDHGTLLPSTLLDKDFIVHGVKGKIIRAQTPNQQKLLEL
IGKNDMVFAIGPAGTGKTYTSVALAVRALKDKQVRRIILTRPAVEAGENLGFLPGDLKDK
LDPYMQPLYDALMDIIPIDKLNNFIENGTIQIAPLAFMRGRTLDNAFVILDEAQNTTYVQ
MKMFLTRMGRNAKFIITGDPGQVDLPKKVNSGLSEALHIIKGIKGIGTLFLDDKDVVRHP
LVKEIINAYSRAEKEED
>SEQF1602_01140 tRNA-specific adenosine deaminase
MILSDTYFMQKALQEAQIAFEQGEVPVGAVITIGERIIAKAHNLTEKLTDVTAHAEMQAI
TAASEYLGGKYLMDCTLYVTLEPCVMCAGALYWSQIGKVVYGATDSKRGYHLFGNLLHPK
TQVVQGVLEEPCSQIVKDFFLQRRL
>SEQF1602_01141 hypothetical protein
MAEHNDFGKEAEEEATNYLKNSGYEILARNFYWQSAEIDIIAKKDNILVIIEVKARKSAY
FGEPYSFVNPHKIQLLAKATNHYIKINDLDMEVRFDIISIVKNNAEYHLEHIEDAFYPF
>SEQF1602_01142 hypothetical protein
MKVKTILVSQPEQSENSPYHQIIEKYKVKIDFRPFTEVQGVTGKDLRAQKIELQQHTAII
LTSRNAVDHFFRVAEEMRFKVPDTMRYFCLSEAVAFYLQKYITYRKRKIYVGKKDFADLI
PFLKKHKEEKFFFPTSELLSPAIEKSLNDLKINWKRGILFKTAHADITDLKDVKYDVIAF
FSPAGVESLFQNFSDFKQGTTRVAVFGASTLKTAEEAGLRIDIQAPLPETPSMTMALEKY
LEKVNKR
>SEQF1602_01143 hypothetical protein
MKWIPVSFENKDWISFLFVTILALLAFIKTYHVFRFKEFLNLLVNNKYIIIFNKKERSGV
LFTFLLLLVQGGILSVAIWLLLEFFAIKISFYNIPQQYLVMLGVGLFIFLKFIFQRFVSY
VFDFDTFSRSFLFIRLSYSNYAAFVLVFLLFLNIYATGNNIYLLAFSLVIFLYIQILGVI
SFAKLYKNEIKQYWYYFILYLCTFEIAPYVFVNYLIISQ
>SEQF1602_01144 hypothetical protein
MKYCYLNILFLCLIACSQVVTPPKKLLSEEEMEAVFYDLALLNAAKSIDATFYEQSGILT
STMLYKKYGVDSLQLAENISYYSSDPQKCNKILSAVSMRLNKEDSLLQKQLTPPQPPSPQ
EELPSDTLK
>SEQF1602_01145 Ribonuclease Y
MEITTLVVGAIIGVFIGGILVWFVLKKKQEKYAFKVVKDAQEESQNILKQAKVEAENIKK
EKIYQAKEKFLELKSEHEKLILSKEKKISEAEKRIKDKESQVSNELAQTKKLNEELEQKN
QECAHRMSLVDKKQEEVDRLHKSQVKQLEVISGLTAEEAKSQLVDSLKNEAKTDAMAYIQ
TTIEEAKLTARQEARKIIINTIQRIGTEEAIDNCVSVFNLESDDVKGRIIGREGRNIRAL
EAATGVEIIVDDTPEAIILSCFDSVRREIARLSLHKLVTDGRIHPARIEEVVEKTTKQVE
DEIAEIGKRTIIDLGIHGLHPELIKAVGRMKYRSSYGQNLLQHSREVARLCGLMAAELGL
NVKLAKRAGLLHDIGKVPETDTETPHALLGMEWAQKYGEKPEVCNAIGAHHDEIEMTSLL
SPIVQVCDAISGARPGARRQVLDSYIQRLKELEDTAFSFQGVKKAYAIQAGRELRVIVES
EKVSDEKAAELSFNLSQKIQTDMTYPGQVKVTVIRETRAVNIAK
>SEQF1602_01147 hypothetical protein
MSEKLRISLKIADRVYPLKIFPEQEEAYRKATQRINEQIRFFEQNFPVKDRQDSLAMCAI
SLAMPLSHEGLTEEYQTEENIEKLKNIYQTLTELSNKDYCLQE
>SEQF1602_01148 hypothetical protein
MEEWIQKIELLLPQVQLYVRSLEEKNSMLLGQVEALTHMLDKAQSEKQAYEQKYEALKVT
QALLGSDEKRTEAKLKINSLIREIEQCIVQLSQDK
>SEQF1602_01149 hypothetical protein
MLSINDTQLVILDFQGKLSQIVYQSETVLSKASALIKGIRHLEIPITWVEQTPEKLGQTT
PEIAECLSGLSPMEKCTFSAYATEEIAQKIQSHQRKQVLLIGIETHICIWQTTEDLIQAG
YEVFVPCDAVSSRTLENKQIGLQMIEQAQGRLTCVEGALFSLLRTAKHEKFRDIAKLIK
>SEQF1602_01150 Replicative DNA helicase
MENISPQPMEVVTSSRTIPTLERGKIPPQDLELEEVVLGGMLIEKRGVDEVIDILSDEAF
YSPAHQKIYAAIYKLFKDSQPIDLMTVKDQLLKDGTLKEIGGGGYLVYLTERVSSSANIE
FHARILIQKYIQRRLIKMSNEIIEEAYDEETDVFDLLDSAEGKLFSITQGNITRTSESAK
ELVIKARKKIEELHNRKEEFSGIPSGFTKVDELTAGWQPTDLIIVAARPAMGKTAFTLSM
ARNIAVNSKIPVAFFSLEMSSIQLITRLIASETGISSDKLRTGKLNVEDFERLNTKTQEL
LEAPLYIDDTPSLSIFDLRAKARRMVSKYGVKIIFIDYLQLMTANTTNKGAGNREQEIST
ISRNLKALAKELNLPVIALSQLSRNVESRPGHKRPQLSDLRESGAIEQDADIVTFLYRPS
YYNLETWDDSAQTPTENQAEFIVAKHRNGGLDNIRLQFVNGVFSNLKNLLYAEEQTDQVQ
SFSSKYNNQEEEASSTGLPKGNPNNAFGSGSDIPDVPF
>SEQF1602_01151 Long-chain-fatty-acid--CoA ligase FadD15
MREVTRLFDIPYYQLEKYPIENALVTKYNNTWTPISSEEYVKKINQVSRALLRLGVQPHD
KIAMVTSNNRTEWHILDMAIMQIGAHNVPIYPTIPKEDYIYILNHAEVKYCFASDKELFE
KVSSIVSEIATLEEVFTFDAVEGARGWREILSLGEDNTNQAQVDSLKEQIQPTDMATIIY
TSGTTGKPKGVMLSHDNIISNIKNCHERVPVKSGDICLSFLPVCHVFERMLTYLYQYNGI
RLYFAESFEKVAVNIGEVKPRLITVVPRVVEKVYDSIYSKGVALSGIAKSLFFWALRLGY
QYEPYNQKGWWYSLKLKIARKLIFSKWKKALGGQLQMICGSAALQPRLVRVFSAAGIPIW
EGYGLTETSPVISVNCKKGHLWKIGTIGKPIDHIEVKIAEDGEILCKGSNIMLGYYKNEE
QTHNAIDEDGFFHTGDIGFLDKEGFLTITDRKKEMFKTSGGKYIAPQYIENKLKQSRFIE
QAMVVGEGEKMPAAFLQVNFAFVREWLKRHGDKQTLSNEALVKDERVRERITQEVERINK
KLGKWEQIKAFDLTPDEWSIDGGHLTPTLKLKRRIILEKYKDMYNTFYNKES
>SEQF1602_01152 hypothetical protein
MIYRFRVILDVDTDVFRDIEVESHINLEDFHQCISKSFGFNGEEMASFYKSDEDWNQGEE
YSLFDTEGDTPVMADTILESVMDEDNRHFLYVYDFYNMWTFFVDLKEIGHEQEGVSYPHI
LTTHGFVPEDAPEKNFVAEDFNEFDSEFNDFEFDQDEFDEYHGYNDDEFYS
>SEQF1602_01153 hypothetical protein
MPLTDVVFFGILIVTIGISYYGFTHEAFFRRYMFNVKAVKGGDYIRLLSAGFLHAGWEHL
IFNMISLFFFHKVILVGMGVDVFMLIYIGAIVFGNLFCLYIYRHQPYYSAIGASGGVSGI
IFASIALMPHLRVNFIPGWLFGTIYFGYSVYRMLDPRMGDNVGHAAHLGGAIFGISVIAL
LKPLFIVENALYLGIMALPLAYMGYRLLKK
>SEQF1602_01154 hypothetical protein
MLELFNTQIESLSIHQVGNMQKGENLFLSQQPYALDDQITSVLKEYFLKPFREKEENFMR
FVNDTSLEFNEMFAIVTEIFENPSTIHTHSLRIAQLLYEQSNHPHIKSGELYVAYLTHIT
LDNTKVEAIGIFKSEMKQNFLQFEQGQNQLDILLEEGVNVNKLDKGCLIFNVNEEEGYKI
LSVDSNRYDTKYWTEQFLGIDALADDAFFTKKYLKMCQDFAKEVVLPAEGKQEEILFMNR
AVNHFAKNDEFEETHFLNEVLGDKVFKKEYAAHEDDEDQSPKQGYMDLIPEFHNFKETKG
KKYYIEDVSSFPIVNKAVSDMRKKIKNIIDLDTNIQIRMDFINPESAEKFVEKGWDEERG
MFYYLIYFNEEKKS
>SEQF1602_01155 Aminodeoxychorismate synthase component 1
MKTLPTWAEKLNELGAKHTPCFFTINYQGTHGHVFPLTDLPESVRFSFSEKTAPTEAPIT
IEKHPVPYEVFEKSFQKVHAHLEKGDTELINLTLATEISPVSLEEVYQKAKAKYKILYKD
EWVCFSPEIFVKIEDNHIKTYPMKGTISATLPDAEALLLNNPKEIDEHKKVVALLSMDLA
QVASDIHVSRFRYVDVIEKSTGDLLQTSSEIIGTLPNNWQAQLGTLLSKLLPAGSICGAP
RESTMKIIAEAETYDRGFYTGIAGVFDGKTLDTCVLIRFIEHIGEKFYYKSGAGITVQSK
PESEYKEILEKIYIPN
>SEQF1602_01156 hypothetical protein
MEENKFIETLKLLNGEICHLKWHEKRLGDTFSHFFPKEKVFPLTTILKEQELPVEGIYKI
RFVYSSHNYMIEILPYQITPIESISCVSADDVEYSYKYAHREALLQLKKEAKTDEVIFVK
NGLVTDSSYANLVFFDGTEWVTPTTFLLNGTCRQRLLSERKIKERIIHATDIPSFTHIGL
INAMIDLGELCLPLNRIFIDE
>SEQF1602_01157 Riboflavin biosynthesis protein RibD
MTIDQRYMQRCLSLAGKALGYTYPNPLVGSVIVHQGKIIGEGWHTKAGEPHAEVNAIASV
KDSSLLKESVLYVNLEPCAHFGKTPPCADLIIEKEIPKVVIGCMDIFSKVAGKGIERLQK
AGREVVVGVLENECQALNTRFFTFHSKGRPYIILKWAQTRNGLIAPLHQEQQAPVWISNE
FSQQLTHLWRAEEGAILVGRTTVERDNPSLTVRHWVGKNPLRLVIEGEHSLLDTFNVFQG
EPTVVFSSKQSPNTEHVSYQTLSSDLSMPNEVCNYLYDRQIQSLIVEGGAQVLQQFISEG
LWDEARIFVGKSQFSEGIKAPLLHEPWESVHNVEGDYLFIYKNPIQG
>SEQF1602_01158 Ribosomal protein L11 methyltransferase
MNYIEYDFTVSPTEMGAEILTAELAEVGFDSFVDTPTGLKAYISKDLWREDILEDIYLLS
NPEFTISYQVTEIEQVNWNEEWEKNFSPIVVENLCTVRANFHPKPSTPYDIVITPKMSFG
TGHHETTYMMLQQLIPLSLQEVKVLDMGCGTGILAIMAALRGAHDITAIDIDPWCVENAT
ENVQQNNCDFITVKQGEVSAIAGEKYNLILANINRNILLSDIPAYAQSLLPQGVLLVSGF
YLEDLPAIQECSQAAGLHYISHIERNNWVSAKFQRI
>SEQF1602_01159 hypothetical protein
MVGANIGRITITTKYFSCFSTIKIVHLYIFYSVTLPMKKYTSGYRFWTRGQKRGILGLVL
CCTLLQVAYFVINIPTHTTAFSQAQLLSFQERIDSLKSQEQAQKYTLSPFNPNFISDYKA
YLLGLSKEEHARLQAFREGGKYVNSAKEFQKVTKVSDSLLTVIAPLFKFPDWVNRKKMND
SYQSKSPEKIIKKDLNTATAEDLLPIRGIGEKLSERIIKYRERLGGFSHKKQLNEVYGLS
EEVIKEVWKYFDLLTLAQITKLDLNQASKRELAKIPYLGYKEAEALLIFRSEKGNIQSLE
ELQALGYSPEKIEQLSWYLKVEK
>SEQF1602_01160 Alginate biosynthesis protein AlgA
MNKNHYAIIMAGGIGSRFWPVSTWAFPKQFHDMLGTGQTLLQRTYQRLANFIPKENILIS
TNEIYKNLVKTQLSGISDENLVLEPSMRNTAPCILYATMKIQKRNPNAVFIVAPSDHWIE
QEEEFQENVKDCFALCEKQDILMTLGIKPTFPNTGYGYIQYDKTDPQQSKKVLQFTEKPD
YERAKQFLSEGNYLWNAGIFIWHTQSVLKAFEKYQPQMFALFQAGEATYNTSEEWEFIKN
NYGKAENTSVDYAIMEPSDNIYVYPVGFDWNDLGTWGSLHEKLAKDSNNNAVVNALTLFK
NASDNIIRTDTNKVVIVDGIEHYIIVDTASVLMIYPKEKEQSIKELLGEVKEKFGSNLS
>SEQF1602_01161 D-inositol 3-phosphate glycosyltransferase
MRIGFDAKRAFHNFRGLGNYSRDLIRILQERTDTELVLFNPLKRKFLGVKLTPKTTEITP
KGFFWKRFKSLWRLFHITTLARKERLDIYHGLSGEIPIGIYKQVPTVVTIHDLIFLRFPQ
WYSAFDRKIHTLKFRYAAQKSQHIIAISEQTKRDIVDYFHIDPNKISVVYQGCHAAFKQT
YTEEEKTKIREKYALPDRFVLNVGAIEERKNALEIVKALKGIDLPLVMVGKKTAYYEKIA
TYCQENNMESQIRVLSGVSMQELAMIYQEATIFCYPSVFEGFGIPIIEALFSRTPVITSQ
GSCFEEAGGKGSIYVNPTENTAQEIRQAIEQLLASPERIQQMREVGYSYVQKFTDEKVCE
NLLKVYQKMIS
>SEQF1602_01162 UvrABC system protein A
MKKDKNIIVQGARVHNLKDIDVQIPRYQLVVVTGLSGSGKSSLVFDTIYAEGQRRYIETF
SAYARQFLGGLERPDVDKIDGLSPVIAIEQKTTSKSPRSTVGTITEIYDFLRLLYARASD
AYSYRTGEKMVSYTDGQIQQLILEDYRDKTIHILAPVVQSRKGHYRELFEQIAKQGFLKV
RVDGQIREIEYGMKLDRYKTHDIEVVIDRLEIKDNDTTHRRLSESIQTAMRHGNGILMVL
TEKKDTPRYFSRNLMCPTTGISYPLPEPNTFSFNSPKGMCPHCNGLGTVQEVTLSKLIPD
MSLSIKQGAIIAIGAEKKTWIFQQLETILRKFGHKLSDPVEKLPKEAIDMILFGGKEKFS
EKSETMGVTRDFSIDFEGIVNFIEQQYQDSESSSSMQRWAKDFMEEKPCPECEGSRLRKE
ALYFRIADKNIAQLSAMDIGELVQWFDTLPEKLSDRQEKIAHEILKEINERLHFLLDVGL
DYLSLGRSSKTLSGGEAQRIRLATQIGSKLTNVLYTLDEPSIGLHQRDNERLINSLKSLR
DIGNSVVVVEHDADMMLHADYVIDIGPKAGKGGGEVIFAGTPKEMLKAHTLTASYLNGER
EIEVPKQRRKGNGHFIELIGCTGNNLKDVSVKFPLGIMIGVTGVSGSGKSTLINETLYPI
LNAHFYHALKKPMPYKQIFGLEHIDKVIDIDQSPIGRIPRSNPATYTGVFGEIRDLFTHT
PEAMIRGYKPGRFSFNVKGGRCETCEGGGMKVIEMNFLPDVLVECETCHGKRFNRETLEI
RYKGKSIADVLAMTIDEAVDFFEPIPKIYRKLKTIQEVGLGYITLGQPSTTLSGGEAQRI
KLATELSKRDTGNTFYILDEPTTGLHFEDIKILMEVLSKLTEKGNTVLIIEHNLDVIKMM
DYLIDIGPEGGKGGGKVVAIGTPEEVAKNKKSYTAKFLKEVLKTKK
>SEQF1602_01163 hypothetical protein
MNEVISSLSDGFASLSQEMRLIASDPIYLWDLIGTFVFGISGVLLGLERRMDIFGMFILA
FVTGVGGGTLRDIMIGSIPVFWMKNLMYIFMIGVSVVFTLFFKNKFAAHWNYWLLLFDAI
GLGVFTIIGLEKALRFDLSPTIAIVLGTMTGSFGGVIRDVLANRMPAIFQKEIYATACVA
GGTVYFLLNGVMAEYHSWVVFITICVVIAVRMLSLKYHWELPKFLS
>SEQF1602_01164 Thioredoxin 1
MSVFGDIISTNKPVLIVFYAGWHYLAKDATDSIQQVADSLGDAVRVIKIDIDKNKELTQK
LKINGIPTYMIFHKGELVWRIEALQPSANLINAIKSFIES
>SEQF1602_01165 hypothetical protein
MVRKISKASELVFVTILLFLTISFISFFLFIDKNPFWNIQIGFPFPFFQYNFMGDGCQYF
IYTHSDNLLFLLCDLIFPMLISCGMYALYKRTKGKLKQILRLSYNIVFPILIFSSISLLS
FFPFPKQARVYDIHIGFPFTYYQYDYVGENCLGINRLWNNSHLFWNILFVYLLYFIGIVV
QKNFNK
>SEQF1602_01166 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MHHFINYLCIFYVLMVLLGAFCVRKAVKYKIFTYLYYTASAFFFFYFLYFWNESFAGVWD
QHRQFSFGLFLSWLLFVTLISIFFLGETLVRLFCAPFRTKKEKVIPSRRRFVSLIGMGVA
AIPFAGMIYGMLLGRYNYRVVKHTLYFDDLPQAFDGYRVVHISDIHSGSFDNAEKVQYGI
DMINAQQGDVIFFTGDLVNNKAEEMRPWIAHFKQLHAKDGVYSVLGNHDYGDYVQWDSPD
EKAKNLETLKQIHQQLGFCLLNNESVFLSRGQQRIAVVGVENWGQGFIKKGNLKQALSQV
DKKDFKILLSHDPTHWQYEVLKDPNFIHLTLSGHTHGMQFGIEIPGVIKWSPAGWRYKYW
GGVYKEKDRYINVNRGFGYLAFPGRVGMPPEITVIELKKKTKEALSSEGK
>SEQF1602_01167 ATP-dependent RNA helicase DeaD
MHPITISMNLFKTLGLSAPLLEAIDDLGFERPSEVQQAAIPVLLEAPTDMVALAQTGTGK
TAAFGFPLLQLIDPTQRMTQGLILAPTRELCLQIASELKQYAKYMPQVHIVAIYGGASIE
EQARSLKKGAHIIVATPGRMQDMMRREFTSIAQISYCVLDEADEMLNMGFYEDIRSILSE
TPDDKNTWLFSATMPAEVAKIAKEFMHHPKEITIGHKNQASNNVLHECYIVNGRQRYEAL
KRLADANPSIFSVVFCRTKRDTQAVAEKLIEDGYNAAALHGDLSQNQRDLVMKGFRAKQI
QMLVATDVAARGIDVDDITHVIHYQLPDEIETYTHRSGRTGRAGKSGVSMVILTKSEAKR
IKTIEKIIQKTFEYKSIPSGMEICEIQLYHLANTIKDTQVNPAVNEYLPAIYDVLSGLNR
EELIQRMVAVEFNRFYTYYSKSKDLNAESPEGKSYTSEGETRYFINIGERDGYNWQLLKD
FLRENIGLGKNDIFKVDVKDTFSFFNTEAEMTQLVLDTFADFKMDNRAIHIEISQQRSSE
GKGRKDRRDRKEKKESKDKKFSHKEDKKKGGKRKEASNTFSSKRKRRK
>SEQF1602_01168 hypothetical protein
MFSKLAYDIFWESILRYHIADDVNQPFENPYDSKTIEHLLYRKNWIDTVQWHYEDIIRDP
EIDPKEALLLKRKIDASNQDRTDTVEYIDSYFLHKYKDVVPQAGATINTESPAWAVDRLS
ILALKIYHMQQETERTDATPEHIAKCQEKLRVLLQQREDLSLALDQLLDDIAAGRKYMKV
YKQMKMYNDEELNPILRK
>SEQF1602_01169 Uracil phosphoribosyltransferase
MIIHPFDQSPSLFLEFVAELRNVEIQKDRMRFRRNLERIGELLSYEMSKTLPYQTQRVVT
PLGEKDIPRIKDKIVVCSILRAGLALHQGILNFFDKADNAFISAYRKHTSPSEFEILVEY
LASPSLQDNILILADPMLATGRSFVNVYNSLQPLGTPKEIHLFAVIGSKQGLEYVSQHFP
ENAHLWIATIDDHLNENSYIVPGLGDAGDLAFGEKMQG
>SEQF1602_01170 Outer membrane protein assembly factor BamA
MRKLSFFIALIAFFGCQLVLAQDTLRTKIITNDSIRIKSDSLYKRIERKTQKNKLTRKLH
EWLFSSVKTDSPSPTPVKKKEISPWGSYQGKIIRHIHITTYDPLGFNERDSTQEPNKWEV
LGNRFHNKTKNKVVERLLLFSPYTLLDSIKIKESARVLRNQSHIRRVSIEAIPTHSPDSV
DIKVNVLDSWSFYADASGSLREGTVRGFERNFLGLGHQISTRYSQEIRGSARPSFGIDYA
IPNLYATTLNTAVGYSFDFDRYYYKYASVTRPYYSLYTRWASGTNVYVRTFEDGILKNDS
IYRQDFKVAGKNIWGSTSVPILKRHTPANRVTNLVFSLRYYQIDYQKAPDTFLDPDRFYS
DKDTYLASVGINYIGYEQDRYIFRHQDIEDIPIGKSFTLIGGFQENLGQRRPYLGGRLMY
GDYFSLGYFSGDVQIGSFFGHDTHKQSTLRWEFTYFSPLFQIGRWHFRQFGKWRSVIGLS
RKDYVKDRVTLNGSTGIVGFDSPTLTGVHKSIFTLQTQSYSPVSLWGFRISPFLMADIGF
IGDDNHSFWKDQMLTKFGIGFYITNDYVPLGNFQFSFIYMPRIPGVGNHIQKFSGISNTD
FRLPYFNYHTPELIRYE
>SEQF1602_01171 hypothetical protein
MKAPTIKHEDYAVIADFIAVSFERDLDSFSSTYKTMNASYLENFKKAISQLKNNDSTNAI
VIKQKETTANLYKQADELRRNITFLKDYATRSGLDTSLLKVVVTKINGRNIAGVVKAVRD
AIPYYSDNIERIADMPEGFLEKIVEQTKQLDALNVLQNTLMNERKYHTQANKEMYALIKK
YIGDIAKAGKLIFQGQKKEEEYVISKIVTRAKTNKQNKVEELSKQDINPLYED
>SEQF1602_01172 General stress protein 16O
MEEVKVRYSDKDLQEFKAIIEQKLEKAQMDLEFLRNSYLNGADNSVDDTSPTFKAFEEGS
EMMSKESNMAQATRLEKFIRDLKNALIRIENKTYGVCRVTGKLIDKERLKAVPHATLSIE
AKKMQ
>SEQF1602_01173 hypothetical protein
MKTVFLWISFFLVYVLMAQDTISYKHLLESPMILSSGVDFYGKRVSSFAEHWQKKYDSIK
RSGLVDLLIVQDRKTKKYGYVTFKNEVVIPLEYEQAQPFGYPDKIAWVKKNNKWGAITPQ
GKLVIPFVYDQAEEFVSDRALVRLDKVWGFVDAKGNKVIPFLYEEGKSFRYNTPYTEAKK
GGKWGFIDREGKTLIPFEYDRIYTEEYYPKPQEQIRVIKNNKMGLINWQNQVIIPLDYAS
IYQPTEGIYVVVKEGKKGYITETGKVLTPPIYERFALFHPYKSQFHGGTALVMLGGKYGF
INNQGKEIVPCKYEAVKSNYFRDGLIPVQYNGKWGYIDKQDKIVVPFVYDQADYFSANFS
LEELNIARVQRNGKWGYVNKEGKEVIPVIYDQIRDYFFKGICESMREGKYGFVNTQGKEV
IPFIYDFVSLSNSGKGSIMAYLNGKRVYMDLQGNLKAGD
>SEQF1602_01174 hypothetical protein
MIFTEEQIKQLVDSLNAETAREVIRISLSIDENLVLTDSKLGGLPYIPKEGTLPTTSQGE
PLFMLAQINCDQLPENSLYPKKGLLQFWIASDEYYGANFENRCQNDTKRICYFPKIQESL
PVEYIKELYTKISASKRKTNNIFTQENSLELPFNPNQSLTLGFEKSVEGISYTDIHFDDE
MQKIWEAAFSEEFPGLWGLPEEVLKVFYKYLSNGAGHKIGGYPDFAQYDPREDDDFHDTL
LLQIESEWNEQYSVMFGDAGVANFFINREDLAHCKFDDVLYNWDCS
>SEQF1602_01175 Isoleucine--tRNA ligase
MKFTEYKALELTKIAQEILQFWKDNDIFQKSIDFRNGKEPFIFYEGPPSANGLPGIHHVM
ARALKDIFCRFHTQLGAQVFRKAGWDTHGLPVELGVEKELGITKDDIGKKISVADYNKAC
KEAVMRYTDIWNNLTEQIGYWVDLNDPYITYKPKYMETVWWLLKQLYNKGLLYKGYTIQP
YSPKAGTGLSSHELNQPGCYRDVSDTTIVAQFRVKNFAPQATKELGNPEGTLYILAWTTT
PWTLPSNTALAVGKNIDYVLVKTFNQYTFEPIQVILAKALVSKQFAGKFFQTSEEADFVA
YANDENRKKVPYQIVAECKGTDLVGTTYEQLIPWFLPAENPEKAFRVIAGDFVTTEDGTG
IVHIAPTFGADDARVGKENGIPPMLVHDENDNLVPLVDLQGRFLKGDKVPELFAGKYVKN
EYYKSGEAPEKSWDVELAILLKTENKAFKVEKYVHSYPHCWRTDAPVLYYPLDSWFVKMT
AVRDRLVALNQQINWKPKATGEGRFANWLENINDWNLSRSRYWGIPLPIWRTEDTKEEKI
IGSVEELITEINKSVAAGLMQENPFKDFKVGDMSEANYDLIDLHKNIVDTIVLVSDSGKP
MKRESDLIDVWFDSGSMPYAQVHYPFENKDLIDKGKAFPADFIAEGVDQTRGWFYTLHAI
ATSVFDSVAYKNVMSNGLVLDKNGQKMSKRLGNAVDPFETLEKYGADATRWYMISNANPW
DNLKFDVEGIEEVRRKFFGTLYNTYSFFALYANLDGFTYAEAEVPLQKRPEIDRWILSEL
HTLIAKVKEAFLDYEPTRATRLISDFVQENLSNWYVRLCRRRFWKGEYEEDKISAYQTLY
TCLEVVAKLSAPVAPFFMDKLYRDLNGATGKDKAESVHLTDFPQSKSEYIDKQLESKMEK
AQNISSLVLSLRKREMIKVRQPLQKILIPTLSQAERTEILAVANLIKHEVNVKEIEFIDD
ASGILVKQIKPNFRTLGPKYGKQMKDIAVVINDFTQQDIQALERQGTKEITLDGKVLTLT
LDDVEITSQDIEGWLVASSSTGLVVALDATITDELRAEGIARELVNRIQNLRKDTGLEVT
DRIQIFLQKQDTLEKAVRANEVYIKAETLANEILFADNLQGEEVAFDDIVTKIGIQKA
>SEQF1602_01176 hypothetical protein
MNQQPTMRALLQREITEQECYIKKTLTKLGVPFKKSLHFRVNKAYTSFSVKLKKQFSSKE
LLKVQQAFPEEIVVLSDSFMEQITKGKFVEIRIPNQTSHFFHLWELLSSRQFTHYKGVLP
IALGLDDKDLYIIDLATTKHIAIESDEPSYLYKIQQLFLHSLLTLRPFQKRTRIAWIDER
KQHPELLSRIEPFMLTEATQVEEILTLVVKEYEKRKAEGSFENHWVVFVNDAYATYHKYK
EKFNSLEGCEAQGIHLIGSSECLDKDTMTVKEVMEYNSLFNSSLWFDSKQYMHHDRTLIQ
LPFFTEEMKFSHETTLFIQIAELLKNREKNAFEPIDFLQVQRILSSSMYAYSLRSSDERI
KFPLKDIYTILPLRMRKFFDEIFVRLSQNITYFVGNSPKKLTELTELRIDPESRQVYING
EAAYTPTLKGDLIPFVANSQFELELHASPQSVMFLDHLDKATYPQLWLVSEGLQRGETCK
KIAPQLIPIALLSEIEDILSKVEFQLVNKNEFKN
>SEQF1602_01177 hypothetical protein
MNKIFFKKKEFIEFLPKNGVKSIDSYINYVENADKYFRNRLFEIIENIYNAKSLDALDEL
REIGEELFEIIESASKTHYRAGFIKYLDFIEKEIALSEKITHISIPFGNIEEINPKVEVD
NTDGSIYYDYKKVRHTLYNRLTTQSRYNNNGKIIFPIRFIRLVFGRKGKDEVFRNIIKKQ
IDDIIYFVDSIPKKIKDVKELKILKNGSVFINQEKVNTKTDLGELVELKVDRKDNLREIV
IDHIQPISSILESLDKEEYPQFTLITDEFRKRANGNLSDDQISLLSSLIANDDNFINKID
FKEFEKEFEKINAKVELQLMHSSYNSKKGAK
>SEQF1602_01178 hypothetical protein
MEKIVRQFILLRYVQNRNRKGEYPNFIEIARKMSSYIGGEYDRQKFERDKKALLDKNCGL
EYDSKEKGYYYNEEGKNKDNPMVDDLITNYMFLTAQNKEALLPSYVITETRLSTGVEYLL
ECMRAIETSCELQISYYDYRIDKVKSYTIQPYRLKHKDYKWYLLAVDVAHPEVPFKSFAL
ERFRSLDEGKPFRKNEELDFETPYRDAFGMFTDAQAERLVLEFDHRDGNYLIASPIHSSQ
KVIRQTPKHITFELYVKPTLDLIMELMRRSWSLTIIEPEHLREEFLNYWKEAIKRNKKVK
SAK
>SEQF1602_01179 Phytoene desaturase (lycopene-forming)
MRSKYDTIIIGSGLGGLMTALILAKEGKKVAVLEQNKQFGGNLQTFLRQGILFDTGVHYV
GSLDKGQPLYNYFSYAGILPYLDLERMPQEGFDYICFGQEEIAYPHAQGYTSFVRALLPY
FPQEHEALEQYITKIKEVCDAFPLYRFRLEGSYDQSWLEQSLTEYIKSLTANERLQAVLL
GSNFLYGGVGEHTPLYVHALSVNSYIESAWRFRQGGSQITSLLLRELRALGVELFAENKA
LAFEYREGKIYSVITSQQEKYIATDFVSDIDIKQLLSIAGRTHFRPAYYKRIDALIPVAG
VFSLHLVLKKQSFPYLPYNIYWHRDSSQVWQATHYTTDTFPTTYMLSMNPPKDGGGYADN
MTILTYMNAQELSQWESTTHTLTAPQGRGVDYEAFKARKAQQLLEVVYQRFPQLKGCIVA
QYTATPLTYRDYIGNPTGAIYGYEKNILRTRQNHIMPQTHIPNLYVTGQSVNMHGLVGVT
IGAVLTSMALLGGKIKGIGE
>SEQF1602_01180 Protein SprT
MEEILYKYLPHESVIPCFALIKELGIYLKIVNERQSRHGDYQRLPNGQHKITINANLNKY
RFLMTLIHEIAHLVAIEKYGRQIKPHGNEWKLTYQGLMQPFLRPEIFPRELLSYLVIHFQ
NPSASSDTDVHLSLAMQQYDTEERRKHYLFELPTGSFFRTDDGRLFRKGEKKIKRYECTE
VETNRKFVVQPHALVERVELI
>SEQF1602_01181 putative dipeptidase PepE
MTTKEKLSLLRNEMKANGLDAFVVFNADPHMSEYFTPYWEERKWITSFDSSAGYVFITQD
KAVLWTDGRYLVQAKNQLTGTGVDFYIEGTKDAPESDQWLLDELHQGAKVGCNALCTPHN
TWVLLSQTLKRKDITIVDAPLIEKIWKERPKDERQTIYVRPEKYTGESATSKIASLRKIM
QKKGVTHFLVTALDDVAWVTNLRGNDIVFNPVFLAYLSITPEKATLFAELKQCDDSVKAY
LKQHHIELKDYHDFFKEISHINGEKILLSPDANQSIFNTVEPKNTIYTEVSPIQLLKAVK
NETELEGFRKAMIKDGVALTNFFCWLDKNIGKVELTEYSLGKILDKFRAEQEGFLGNSFA
MIVGYLGNGAIVHHHATETPGVSVKAEGTILIDSGAHYTEGTTDITRIIPLGKFSDEFKK
DYTLVMKAMITLSNTLFPTGTRGVQLDAITRAILWRNMRDFGHGTGHGVGSYLCVHEGPQ
SLRKDLRDVALLEHMVCSNEPGLYCEGRYGIRIENLFVVQKKGTSEFGDFYGLETLTICP
LDTRAIDVALLTEEERNWLNNYNKWVEEKISPLVGEEQRAWLKERCKAI
>SEQF1602_01182 hypothetical protein
MVAIGDVVEVIDESIKGKVTKITAQGVCVETSEGLLLTFLPQELIKIDENASLHYHRMTG
IAPKEEKNTKTATLKGKKAKKKVAPAMEVDLHIEKLVATPRGMTNYDILTTQIEEAKHQL
EFAIKRGIPRIVFIHGVGEGVLKAELETLFARYSNLIYQDADYARYGIGATEVFLQTIF
>SEQF1602_01183 putative CtpA-like serine protease
MTFRTYISILCTLILLSCSKVEPESYYLQKATQKALTEDVNYTVKDFIWRGLNQYYLWQP
QQELLSDTRFSPANATNPAYVNFLKSFSSNELLFNSLKYEGDRFSYITDNYEELEEELQG
ALLSTGMEFGIAQLTDMNNIIIGYVRYVIPNSDAEKQGVKRGDIFLEVDGEKLSTENYQR
LLRDNKNKSITFSFYTISDGGFQFSAHKIISQHTLHENPILLHKILQKGDKKIGYLLYNS
FLNRYDKELNEVFGTFKSGGVTDLVLDLRYNPGGSVQTAIYLASMIAGTDTQKLFVRQTS
NPKMKGRWKSDYAFEDNIAGTPIHSLKLSSVYILTSRQTASASELIINGLKPYLKVIQIG
DVTVGKPLASITIKDTKNKDNKWAMQPIVLRSENANGFGAYENGIAPDIFLREQLGRLGI
LGDENEPLLAKAIEEIIGVPRFTASTRSRRSTRTKDLSFKDIDNSRSGAAYYNRMYIPNQ
NTDE
>SEQF1602_01184 1,4-dihydroxy-2-naphthoyl-CoA synthase
MNKEIPWQIAKNYEDITYKKYNGVARIAFNRPEVRNAFRPRTTSELIDALRDATEDTSIG
CVLISAEGPSPKDGVWSFCSGGDQRVRGKQGYVGEDGAHRLNILEAQRLIRFMPKVVIAV
VPGWAVGGGHSLHVVCDLTLASKEHAIFKQTDTDVASFDAGYGSAYLAKMVGQKKAREIF
FLGRNYSAQEAFEMGMVNAVIPHEELESTAFEWAQEILRKSPTAIKMAKYAMNLTDDGMV
GQQIFAGEATRLAYMTDEAKEGRDAFLEKRKPNFEKKWIPN
>SEQF1602_01185 hypothetical protein
MISSLLLTYIGYGQGELQRAKDKLSSPPMSTSSESKEVHTYSTYEDSPQNNSSWDDISFW
PAFLDLTLVLGYNLMVESSYEKSGRMRHAELSPYPYYKDKGDYTYDKHSIEDFSLFRTVL
SNELFVSEHLFQNHLEAKIRFASRFGAKLSYRHFWEKWRGYPTEHLDALSLTAQYYRIRT
EHVSLAWGVGASYVGNQVRQWGFALTSDGEVFIRKPFSLAYALQFTTFDYSDMFSVSVGG
NYYYKNCYMGVKYQYHNIASAKFSGMLLSVGMSF
>SEQF1602_01186 hypothetical protein
MKELTEYDQLLLGEKGIKVSKLQEQVAIFLAGVPPVNLVAPAHVGSGILSFSRDEAIQYV
AIYQKKKNGLDILKFVPASGSATRMFQFLSSFITDFDPEKQTFEAYIKESGNVNAEIFFE
YLSQFAFYDSLQKYIEQHKLLEGLSSDQQKLRIAKLLLEEEPFNYKNKPKGLFPFHKYGE
KVVTAFEEHFREAFLYASQGEIVNIHFTINKEYTSLFLNTLAEIRPNLEKHYGVHFEVSF
SHQSESTDTVALTLDNEYFRDRNNQLLFRPAGHGALLKNLNELNADIIFIKNIDNVVAEA
YTDEAIFYKEVLAGKLEDTRSKVHKILRQIQKEKLKKKDLPEVLKFLPELNIKVPAYVYK
FAKRYMIEYIYQVLNRPIRVCGMVKNEGEIGGGPFWVKDMDGNESLQIIEMAQIDKNNPQ
QWERLKASTHFNPVDIVCCIKNYKGEIFDLEEFQDKKLSFITEKSYDGRPLKALELPGLW
NGGMAGWISIFVEVPQITFNPVKSVNDLLKKNHQGF
>SEQF1602_01187 Trifunctional NAD biosynthesis/regulator protein NadR
MEKEFVQYPSSCKRIVFLGPESTGKTTLSQYMAAAYHTQWVPEYMRLYLQEKWDKFRQLC
TWEDLLPIAKGQVDLENKAVQGAHDYVFCDTCLIELVIYSYIYYGKSDPIIERYAFTHRY
DHYFLTYIDTPWVADDLRDKPTERAEIFAFFKEFLQKKSIPFYVLKGDLDSRIQQINQKL
KA
>SEQF1602_01188 Nicotinamide riboside transporter PnuC
MNHIFDWVFAQYQGVPTHLIYVEVFGVLFGLLSVLFSKKRNIWVYPTGIISTVLFVYLLW
VGRLFGDMLINAYYTIMSVYGWVLWAKNSQDNVHVEIATMGAKDRKITLYLALLSGLFVM
LVYYFKPYINNDFSMEGIALGWGHFVWTDWVDAFTTAIFLVGMWLMAKRKIENWLFWIVG
DVISIPLYTYKGFVVTALQYVIFTIIAILAYREWRKNLYNTPVLVSESYS
>SEQF1602_01189 hypothetical protein
MKVSVELTLSPLQDEFEAPIIHFIKKLRTSGLIVYENPLSTQIYGEYDRVMEVLTNEVKE
VFELLEKGLIYIKIVKSDRHDYEPHF
>SEQF1602_01190 hypothetical protein
MPAVKLILTMMGIKLRFSKKFLKKGMFFILFALLLGIVVIHNANSTIHKNAEGKLYTEVD
SIPKNKVALLLGTGKYLKDGQPNLYFRYRVEAAAALFKAQKVDFILISGDNSRQGYDEPT
DMKEALVAMGIPEGKIYLDYAGFRTLDSVVRAKEIFDLTALTVVSQAFHDERAIYLAEKY
GIKAIGFCARDVDKYSGMKTRLREYFARAKVFWDLSLGVQPKFLGEKIDIH
>SEQF1602_01191 Ribosomal RNA small subunit methyltransferase I
MKKIGDLYLIPNLLGESAVNDVLPLRVTEVVLLCNHFIVENPKNARRFIKAIAPEKSQES
LELFPLNKHTDQADKETYLSHCLEGLPMGIISDAGCPAIADPGSEIVRMAHQHGIRVIPL
VGPSSILLSLMASGMNGQSFAFNGYLPIDKDERKASLKRLEKRAKEERQSQLFIETPYRN
EALLQEMLQVLSPHTSLCVATNVTLPEEAIHTYTIGEWKYRFKELHLEKQPTIFILL
>SEQF1602_01192 GTPase HflX
MLEKKNLEYEKTVLVGVITATQNEEKAHEYLDELEFLTYTAGGEVVKRFTQRLDTPNPKT
FIGTGKMEELTQFVQDNEIGTVIFDDELTPAQQNNIEKILRVKILDRTTLILDIFAQRAQ
TSYARTQVELAQYQYLLPRLTGLWTHLERQRGGIGMRGPGETEIETDRRIVRDRIALLKK
KLETIDKQMATQRGNRGALVRVALIGYTNVGKSTLMNLISKSDVFAEDKLFATLDTTVRK
VVIGNLPFLLSDTVGFIRKLPTELIESFKSTLDEVRDADLLLHVVDISHPNFEDHIASVN
QILGEIKSINKPTIMVFNKIDAYTHLTIEDDDLMTEKTSRHFSLEEWKQTWMNRMNGDAI
FISAINKENIQEFREKVYQKVREIHVTRFPYNNFLYPEIIIEEEANS
>SEQF1602_01193 hypothetical protein
MFLGDKYFFNVLKFNKLKILRNFYMIYELASSSMMISGYRKLL
>SEQF1602_01194 tRNA modification GTPase MnmE
MENKKTPYTDDTIVALATATGVGAISVIRLSGKEAIELADKVFKTLSGKPLSEAPSHTVH
LGTIKSETQVIDECLATIFKGKKSYTGEPVVEFSCHGSAYITQEVIKLCLANGARLAQAG
EFTKRAFLNGKLALNQAEAVADLIASDSKASHQVALQQMRGGFTSEIEGLRQELLNFASL
IELELDFSEEDVAFADRKQLEQLLKRIKTTLQELVQSFSAGNAIKNGIPVAIVGKPNAGK
STLLNTLLNEERAIVSDIAGTTRDTIEETLHIAGVTFRFIDTAGIRDTRDQIEAIGVEKA
KEKIKKAQIVLYLYNEKENTTDEVVQFVGENYRKGLKILLLHNKTDNEYIGLSDFDEEIE
KKLNPEERKYGYGKLRISAKEKINIEALKKLLSFYAKELTSTESATIITNIRHYEALKNA
LEALEKVEEGLINHLSGDLLAIDIREVLYHLGSITGAVSNDELLGNIFSRFCIGK
>SEQF1602_01195 hypothetical protein
MKKKPTISVGIVISLILLLINFCYTIKELLLQWDYLDFNSFNTWMIYFYINLIVVPLFIA
LLFFLFYSFFYKWAKKWLWNIGFLLVIALIVYWFYGATLVF
>SEQF1602_01196 hypothetical protein
MKKKPNVKIGIIINIALTVLSIVYMFVYYIGQNGFEFNYNSLEFFIYFFIFYIFPFILGV
NFLFFLFYSFFYKWARIGLVITLLMAVLFYL
>SEQF1602_01197 hypothetical protein
MPRKNFSTNLAESSVMIDGLKGRNDNLPLGIKAEDITKLEELRKKMETLNSEQEKLKADL
KTKTEELNKAVSEVENKVTFLKKLIKIDIPQTQWREFGIEDKR
>SEQF1602_01198 hypothetical protein
MIYVPSILFIISNSWIDDSSELLFFSIKCAIIVTLLLIIFFLSIYTFYYRELKKFLIIFG
TIFVVCILVFYVISFVIFKKTNLFSV
>SEQF1602_01199 hypothetical protein
MKKPHFFRIMIKVFSILFLLISIYILYIFIREGMNNKFEATSIICSYLFIYSIVVNLLGY
YIYKKNKIGIPLCSIIIPNPFGSNLLGTSRGRTNRRVFANRNTIM
>SEQF1602_01200 hypothetical protein
MKEHTQHKKRFPILVWLPFVTYYVMQYKVYMLNIKNEKVVTFFIYIMVGMIAWLISLANM
LTYVKKYHWLVILLYCIIFVYCSA
>SEQF1602_01201 hypothetical protein
MKSKLSHLFFASLTGIIFLLTYLLIIYWDYEVIFRGKKILLYVFYALFFGIGVFAYYYFQ
KNSITKRFIRIFPICMLVFFLFKHSYSVYSYYKYLVSYREMPKELRKYDLLDNKEIYQRG
KIISPISQSKIPADTDLFLDKEGHLFIYYKFYDDETTFYIDCILKYDTEGNHMETLYLEN
FVNQKRDIVVRKKYLIDIYEKSYSSFLIDGNRDFLPMKELKKEEQPSEKDMEERTFKNSN
NNLIVIIQKDSERDAMVIIKKENKLYYFYTQEFYYLKYMDFPVSDDFNLFNDFIKPPKEK
GIAPQESPIKYMYYLKEYTSNSGLHLFGKEKSFQEDWSQGYVYFNLILDEQELHLKTFYS
QNLFSFNQTSDDIRYYENQNETLEIHNNIRLYRNKYLSYYLLSTGYQYYLIKNKF
>SEQF1602_01202 hypothetical protein
MKKKLLHLFFASLTGIAFAVAYAFIVYKIYTLVTQMGGKFLAKFVLIPFVLGMLVFYSFH
YRWAKRFFFYGIGVFTAFVLFVLYSPNICQEVFLQYSRIGKQEQARSFLSLADTTRVTAN
TRFSLLSPKEGYQIKQCLLNQNHELVVLYTEKYHVENPFYISRKLVGQDSFETPPYMVVY
DTIGKVKYIVFLAHPEEEPIGEFLLKGNYIIDLSTYEYANYTYDGSFIMQPMEYLKGYDP
AHRETRAPISYYETFLSDEGECGGYPAIIGIFIEDDQAYYFFPPTSEKNTQYRDDQDENM
LISNLFSILEEEEEKGAHSFERRNILPQDFYYEYLTMNGFFRNDQGENCELTYSDIQLLF
DLKIGKDTFHFKKGKVSNYKGYNQLKTPTYYIENEEETLEKYKDMFLYTNKHLSYAIFYD
GEYVYMIK
>SEQF1602_01203 hypothetical protein
MINILKNYFILFLILVVLNIILISTTGNGYFMYLFFYLYGFFALLAFANILFHIGIHQKG
SRIYILAFVFLVLIGVFLTYYGGELSSKLLLYNSKRNFPPALEKFVSLGENPISVEGKEI
IPFNSYKWFDLENYTMSEKNELIALYRDSRPQEGDLEVLVRKFDTTGEVIDSLSFHYSKE
KESKVFLIEDCLIDVYSRTYNKSWFVDGNKEFLPMKLVEGSQKWNFQQVKDFHYNRTKDS
PYCHIIKNSYWSLPDKGDFPESGDPQFIIVFLKNNQLYYYITSYDITDDFYFYNEKYVIK
FPEHTSSPLLLAYRNKFLYNEDHLVKGEKSSQRTHIDPVYYLDKMIECRGLEPLHPSWSF
EVGNRYGELYYRLKIEDKILPLKMDYRTYGNHERSIKYPTYYWKNGTETIEECKNIYLYS
NKNLKYYLLHTPLGFYIIK
>SEQF1602_01204 hypothetical protein
MPLALKEKATSFLLKELYNATNYEYDYYGKKITEASKRICLQFQKEEEYLAALDRILSKK
NLSGYDKRIYTAEKISILSQKGDTEGVNKIIDENLEDPELGKIKIQACIEERDLKTAKKL
LEEGIKTLTQKGRNQNMIKEWTAVLIYIAELEKDIPTIRHYAKKIALEDKGNIEYYEKWK
KTYTEKQWKEVIEKEIKELEDDYNQKRKKISSYWNYSIISPTLFFIYEQEDNHEKLWNYV
KELDIQTTLYFLPYLKKYYKEEIIERLAYLVHLFCEEMYTKNDYETIGKAIRYMIKEVPE
KINIIKDLVLELKTIYKRKHNFVEILNQIIVEYKI
>SEQF1602_01205 L-fucose-proton symporter
MEQNQENKNYLLPILMMFALFFMIAFVTNLQSPMGVIIKSQFMASNFQAQLGTLANFIAY
AFMGIPAGQMLQRKGYKKTALTAVIVGFVGVCIIFLSGAMESYAVYLIGAFVAGFSMCML
NVVVNPMLNTLGGEGKRGNQLLQFGGALNSMGGTIVPVFVGYLIGENIEKASIDKANPAL
YLAMGTFALVFIVLSLMKIPEPHIVKKVENKAKESHSALSFRHFVFGIIAIFVYVGVEVG
IPGVENYFMTAQVDKGGLGIDATTAGSVVGTYWFLMFVGRFVGGALGAKFSSKVMLSFVA
SLGLLFVLLAIFLPTDVVVNMPVFNKNISFGLAEVPASVMFLTLCGLCTSVMWGGIFNLA
TEGLGKYTAAASGIFMVMVCGGGILSTLQSYIADLFGYVQSYWVVIIGLLYILYYALVGS
RNVNKDIVVND
>SEQF1602_01206 hypothetical protein
MRATLYTILHFFIRENIIVASAVTALALSTFYIFHQPIAYPYLLSLWAGAILSYSFAKEG
IFKYRDPLWWSCVLIVGYCFFLLNLQGKILLFLSGVLSILYNAPFLSQNLRSIPFLKIAI
VAFCWVLSAVFLPLSESAISFFSWQVWLLSLQYFLWICVLILPFDIRDRVEDRACLHTFP
TVLGVRKTKIIGIITMLCYLLLSFYHTSLPLRLIQIGIACITLLFLLFAREEQSPFYSGL
LVECIPILYFLLLWQYYS
>SEQF1602_01207 Endolytic peptidoglycan transglycosylase RlpA
MKLSSILKLCCFFLLVSCHSSKMTQQRKATHKNSKTVVKKKKTTSEKDKSVADASSTVST
MATTGVASYYHNKFNGRKTASGEVFSNNKLTAAHRTYPFGTYLKVTNVVNGKSVVVKVND
RGPFTKGKELDLSRKAFMDITDNPNKGNLQVNIEVVTP
>SEQF1602_01208 Ribosome maturation factor RimM
MRREDCFFVGTIVSKFSFKGEVLVKTDTDDLSLFENMESVFVELGKELVPFFIEKCNLHK
SDLLRIKFEEVDTERDAEVLLKHHLFLPLTLLPKLTGNKFYYHEVIGFQVFDVNYGAIGT
ITHINDNSSQPLFEIMHEGKEILIPLHDNFLKEVNRKEKKIIVETPEGLIDLYMQE
>SEQF1602_01209 30S ribosomal protein S16
MSAKIFNLFGNNKKYPSFFRINLTKAFTILIIKRIGEGYYFFKKVCLSEEKIVLLRPNYI
TEVENLINCLNMPVKIRLQRHGKKGKPFYWVVAADVRAPRDGKFLQKIGTYNPNTNPAQI
EIDIDEAVKWLHFGAQPTETARRILSYKGVLLKYHLQGGVKKGALTQEQADAKFAAWLSE
KEQKISQKKDALQKGKASAKQESVKAEQAYSQKRKEAIVAKAQATEAPAESSSEETANET
EA
>SEQF1602_01210 ATP synthase subunit beta
MAQYKGKIAQVIGPVVDVMFPSEKEMPKIYDSLEIVGKDGHTLVLEVQSHIGEDTVRAIS
MDATEGLSRGMEVTATGRPIQMPIGHDVFGRLFNVIGDGIDGLGNLPKEGQHGLPIHRKA
PKFEDLSTVTEVLFTGIKVIDLIEPYAKGGKIGLFGGAGVGKTVLIQELINNIAKGHGGL
SVFAGVGERTREGNDLMREMLESGIIKYGEEFMHSMEEGGWDLSKVDREALKESKATFVF
GQMNEPPGARARVALSGLTIAEYFRDGAGDGEGKDVLFFVDNIFRFTQAGSEVSALLGRM
PSAVGYQPTLATEMGAMQERITSTKKGSITSVQAVYVPADDLTDPAPATTFAHLDATTVL
SRKIAELGIYPAVDPLDSTSRILTPEILGKEHYECAQRVKELLQHYKELQDIIAILGMEE
LSEEDKLAVARARRVQRFLSQPFHVAEQFTGIPGVFVDIKDTIRGFNMILDGELDHLPEA
AFNLKGTIEEVIEAGEKMLAEAQN
>SEQF1602_01211 ATP synthase epsilon chain
MVLEIVTPEAVLYKGKVSVVTLPGAKGSFQILENHAPIVSLLEKGTLSFRESEAPTICVQ
ERFAQEKGEYTLPIEEGVVEQQENKIIVLAQ
>SEQF1602_01212 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MGKDKKPLLIENVTITDAGAKGKSIAHAPDGRVIFVDNAVPEDIVDILVTKKKKAFYEGT
AVKFHQESPLRVVPVCEHFTYCGGCQWQHMNYQSQLHYKQKEVENNLKRLGGVTPEEILP
IIGCNKPYFYRNKIEFSFSETRWLTPEEITSKEEIADRQGLGFHITGAWDKVLDIRKCHL
QEDPSNAIRNKIREYALSYGYPFYNPRSHSGWLRTMMIRISSIGEIMLVIQFLEERKEPR
EQLLNYLLSEFPTLTSLQYIINNKPNDTIYDQEVICYHGRNFIYEEMEGLRFKINAKSFF
QTNSTQAYELYKVVRDFAALTGEELVYDLYTGTGTIAQFVAKKAKKVIGVEAVPEAIADA
KENAQNNQISNVDFFVGDMKNVFNEEFITTHGLPDVIITDPPRDGMHKDVVAQILRIAPK
RVVYVSCNSATQARDLALLQEKYKVVRICPVDMFPQTYHIENIALLEAK
>SEQF1602_01213 HTH-type transcriptional repressor CarH
MPTPYKKLYYSIGEVADIFGVNTSKIRFWEKEFEILSPKKSPKGTRRYTDKDIENIRQIY
HLVEEQGHTLEGAKLKLKEKPKELLSTIEIIEKLKKVKQTLLSIKNEL
>SEQF1602_01214 Murein DD-endopeptidase MepM
MAKIKYYYDSETLSFKQINNRKRRLKYLFFFLLSSFLFALIIVLILYNINFMQTPKELSL
RRELKENETQFAILNKKMQQAEEVLDRIADRDNTLYRTYFEMTPIPDAQRKSGFGGVNRY
EYLEKFSNSSMLIDMTKRLETLQKELAVQSKSLDDIAALAKEKEKLLQALPAIQPVQNKD
LKRMASGYGFRTDPFTKVRKFHYGMDFSAPTGTAVYATGDGVVTRADSNSSGYGEHIRID
HGYGYETLYGHLSQYNVRPGQKVKRGDVIGYVGSTGRSEAPHLHYEVKKNGEHLNPINFY
YGSLSAEEYAEMLKKSSQGNQSLD
>SEQF1602_01215 hypothetical protein
MIRTNKIAEANIILKKFLWLDIYMVDFNEEEIILFGTKDASFGKQVEIILKKVCYIDMPT
MWELDLTSENPIVFTAQEEMNEIYKNRFLDNHNGVGDLFTFSAEGVNKGIQYHIVAGGFE
LHFLSYDSYFPWEINE
>SEQF1602_01216 hypothetical protein
MNKNDETPVNAASWDKIFPKSDKVEHKKVSFKNRYGITLIGDLYFPKNTKNKKLAALAVC
GGFGAVKEQASGFYAQTMAERGFVTLAFDPSYTGESGGEPRNVASPDINTEDFSAAVDCL
GIQPFVDREKIGIIGICGWGGFALNATAIDTRIKAVATMVMYDMSRVFSKGYFDANTPEM
RLEMKRSLNAIRWTDAETGTPSPGYPMPNTPSDKVPQFLNDYIEFYKTPRGFHERSVSNH
VWTATTLLSFMNFPLLSYANEIEVPTLMIAGENAHSRYMSEDAYKLVGSEKKELLIVPNA
RHTDFYDNQAGVIPFDKLEAFFSEYLQ
>SEQF1602_01217 hypothetical protein
MRTNKKTLRNVILFSLVAISCGWIGIGVNQLLGEPSNLESLGSGIFIATPILCMILLRLF
DGDGWKDFPLKPCFKQNTRWYIFAIVVYPVVIGITMFVGKLLGWVDVSKFSVAAYFPVFA
AAFLPVFIKNILEETAFRGYLTVKMEQLTKNEWMIYVVVAFVCQIWHLPYNLVFLGDTYQ
ATFFPYSKELFVLVSLVVIAVWTIMYTEIFFLSRSLLLVVLMHSMKDALNPLISEGFTVI
SPDKTLLVSPLFGIIPTFIYLAIGLYLRRIRKSKESLHL
>SEQF1602_01218 hypothetical protein
MPKPTTITQEVIIETAFEMVRKEGFAVLSARNIAKQIGCSTQPIYWSYKNMDELRAEICK
KALPFLQSVVLSYSKTGNTLLDLGLGYVWMAHTEPALFKAFYMDNVTNVKLTDIFPESER
VVEIMKNSEECRSLSDEELKNSIAKGWMLAHGIASLVAVDMLVYDEDKILEILK
>SEQF1602_01219 hypothetical protein
MKSNCEKVVFMIDMNLIDLITDSHNTPFWKITYHWHRTYQAKDIQYQHFVGEITTTYNIP
EALISLLDKQSQLVNEGVFSVDEIIGDKIKAFELKLQNKNVTIVNLYIEGNGVDFCIVDK
R
>SEQF1602_01220 hypothetical protein
MTELEKVLKDIDTTTHPNGLRDGIIYYNEEGDFCVYNHYSACEWLKHLAVHYGGVTMEEA
TQLVENSDWMRMPESINEVAFITHEEQYHWAMLLVKGNMYWLKGYPSDTNNFKEEHSVWE
EQIAKQYQLNHEYRYGDLEPADYESGILDNAIIKREKKSDLPKEESIIQKISKILKNH
>SEQF1602_01221 hypothetical protein
MNKIFQVEKLSTITENTFSLAGRVIAGNSIHKGEAFNLMKIDNNTLVEVNFLLKQIEMYG
RSIDFIDLGCTGVLFLEGECPTTQIKELIIAAQTI
>SEQF1602_01222 hypothetical protein
MSYSSKTISTFTSVEAMEKFINNVNSEEGFTDWNLTEEEFQQLWNSHLFHELNYELDKLI
DDYEWEDIIGVEALQKACEVTEANTISKLPVGQEFLAMLHKAIEYKTGIFFFF
>SEQF1602_01223 hypothetical protein
MNIEEIKKKIQIILELPELKPFGGIYMNPVLEEAKVAQIEKENRITFPADYRTFITQIAN
GCVGPDYGLRSLKEATEDLMWKDRTIDLSTPFPYTEHWNEEEWLNSIDWDGGERPTPEEV
EAYMDTKHISGCLQICHIGHGASYLLVVNGKEKGTIWLDSRQDYGGLSPEFNEKGEKLTF
EMWYTDWLNKVVAPEKVWFEKSLQFIKKAFPKIEETDFRLMTYVLYEHYSDRNLATLIAE
LYGLNSIDIYFEIGKFIQREKYDEQTIQQYEAQLRESGFYDWAAEEE
>SEQF1602_01224 hypothetical protein
MKHLYFLSIALFSLNATAQLKDCATCATQVIDEEQISELSIDELRFLTNDLYARKGYKFK
DYEISNYFNEKPWYKPVSDNSKVKLNAVEEQNVKLFQERTAILKADREKLIEALRSLKAE
VQRGHSPIPKGNYNEHFSKTIAKIDIDDIHWIKNQGYYSVEVDNFKKTHQYYISIEDNEI
LIYWIFLEYSKKAEEEKLPKTFYENEIDSASPLKGAYIWSFTWENSQLVFKGYIPTG
>SEQF1602_01225 Haloalkane dehalogenase
MQVYQTNFGQLRYHDLLGSLIPILFIHGLGCCGSMDYPTVASGSIQAHRRIIPDLLGSGF
SDYSDDFPYTIESHASLLKSFVEDLQLEELVIYGHSMGGAIAIKLAEKLDKKVKLLLLSE
ANLDNGGGFFSKKIANYSYKDFIKFGHEEVIRENIQNNNRLWAKSLSLTNPTAIFKESLS
LVEGQFPTWREILYKLPTTKVFIFGEQSLPDPDWERLQTEHIQVRVIPNAGHSMAWENPQ
GLSDVIYQSIEGR
>SEQF1602_01226 hypothetical protein
MAQLKDCATCTTQVVKEQQISKLSIDELRFLTNDLYACKGYKFKDYEISNYFNEKPWYKP
VSDNSKVKLNAVEEQNVKLFQERTAILKADREKLIEALRSLKAEAQKGNISILKNNGEEY
FNKVITKIDIDNIHWIKNQGYYSAEIDDFKETNRYFIWIEGNKVTIQCDENGHSKKVSED
KIKGVYDTNDFEVMESNIGWEFRWDKQKLVFVRFILAG
>SEQF1602_01227 Na(+)/H(+) antiporter NhaA
MKLITILKEFFLKNQSSGVLLILCVVLSLTIANSPMAESFQALLDQEVGPYSISMWINDA
LMAIFFLLLGLEIKREILKGELSDIRSASLPIVAAIGGMIVPAVIFSLLNYGTPYSKGWA
IPMATDIAFSLAVISMLGRGVPIAIKVFLVALSIVDDLGAIVVIALFYTDAIHWSYLLYS
GGIIAVLCLLNYLKVRKIVFYLLLGVLLWYCMHHSGIHATIAGVILAFTMPANAEKGKKS
PLEKLEHALQIPVGYIIMPVFALANTNITYKSGMIEGLSSSLGVGVVLGLILGKLVGINL
FSFIAVKLKISTLPHASRWIHMIGVGLLGGIGFTMSIFISLLSFKEHELQDAAKFAILTA
SILAGALGYILLRSGTKKENKSV
>SEQF1602_01228 S-adenosylmethionine synthase
MGYLFTSESVSEGHPDKIADQISDALIDHFLAFDPSSKVACETLVTTGQVILAGEVKSKT
YLDVQQIARDVIRRIGYTKSDYMFEANSCGVLSAIHEQSPDINQGVVRHSPEEQGAGDQG
MMFGYATRETDTYMPLPLALSHAIVRELATLRRENNQITYLRPDAKSQVTLEYSDDNKPV
RIDSIVISTQHDPFDTEAKMLAKIKEDMIQILIPRIKEQYPNYAHLFDENIKYHINPTGV
FVIGGPHGDTGLTGRKIIVDTYGGKGAHGGGAFSGKDPSKVDRSAAYATRHIAKNMVAAG
IADEMLVQVSYAIGVAEPTGVYVNTYGTSKVALTDGQIAQKVREIFSLRPYDIEQRLKLR
YPIYSETAAYGHMGRSPEVVKKVFASPYHNTKTIEVELFTWEKLDYVETIRKAFGL
>SEQF1602_01232 ATP-dependent helicase/nuclease subunit A
MGNIQIYNASAGSGKTFTLVKSFLKLILATKNVEAYKTLLAITFTNKAVNEMKERVINQL
LLFSTPDTLVEEGEKKASDDIMFVQLAQELLLSHEELQERSQKVLKHILHNYAGFTITTI
DGFNQRLIRSFAFDLKLNPNFEVFLETDDLLRLAIENLFKKANENQLLTKLLLEFSRDKI
EEDKDWDIETELFDIAKLLTNENHYTYIKELEEKQLSDFQSLKEDLKQQRKGLYTVVEDA
VKHFFAFTQKEGITADHFIRGSLYNFFDKISKNGFFAIDKGVFDRVWFVESGEKPLYSNG
LLKKDPAIAQLLDENQQWISDLLNSIEKSYWWDQFYKRLIKNVTLLAVLKSLQEEIIAIK
EEENILPISEFNSIIHQTIIDEPSPFIYEKIGTRYQHYFIDEFQDTSTLQWENMLPLVAD
AVHSENLSKQQGSLLIVGDAKQSIYRWRGGRAEQFMELYNKEKKPFHLIQEVQNLDYNYR
SRREVITFNNSFFHFVATHPLLFNNTGKHRYGELYLEAEQKIPDREAERGFISIEFIDKN
STQEVNYSEEEATEGENVVEQTDIRIETIEKYIKEAKSYGYLDKDICILSRRNKECIEIA
AQLSEKGYNVISSEALLLKNIPEIQFLIHLISISLYQTNEKEKIALLFSYAKVKQITELH
AFMSQYVHKPVEAFFSAMGFSLSYFHLYSFYEGIGYAIRVFGLAKPSDAYLAQFLNIIYE
YKSVRNGNIADFLTYWEEKKDKLAISAPEGVNAISIMTIHKSKGLEFPVVIYTDVNDSLR
SGKDTLWICVPKEQYHGFEHLLIDDYSGLEKIDAEIVLQQSQVELLDAINTMYVAMTRPK
DLLYILSQRPKEKEQEKISTLSGVLQAYLQAEGRWNPSESHYTFGQLLPIERAALGENDY
IPFKQRSVISPSYTIVTRSGSMWNTSREEAIARGNLLHEILGQLITQEDIPELLHHFFLE
GRISQEQIAPLSHQLEKITTHPLLKEYYTKEYIIYNEREWLDITGEYLRPDRVAYHKPTQ
RAVIIDYKTGEDHPQYQAQLRRYAQTLEQTGWEVTQSFLVFINEEIRVISL
>SEQF1602_01233 Peptidyl-tRNA hydrolase
MKKYLIVGLGNIGEEYRYTRHNIGFLAVEHLAQQKGVSFETVRLGDVATFSHKGRTFILL
KPSTFMNLSGKAIKYWLEKEKIPIENLLVIADDLNIPFGSIRIKKKGSDGGHNGFKNIQE
ELQTTTYARLRFGISANYAKGTQIDYVLGHWSEDEVALLPERLEKISEAILSFGLAGADT
TMNLYNNK
>SEQF1602_01234 Glutamate--tRNA ligase
MTKSVRVRFAPSPTGPLHIGGLRTALFNYLFAKKHGGDFLLRIEDTDQVRYVEGAEAYIM
EALQWCGITYDEGVGKEGGPHAPYRQSERKAIYAEYAQMLLDKGEAYYAFDTAQELDAQR
KAYEERGETFIYNWHNREKLNNAFSLSPEEVKKRIEEGVPYVVRFKMPQETLTLHDLIRG
EVVVDTKLLDDKVLFKSDGMPTYHLANIVDDHLMEITHVIRGEEWLPSMALHVLMYRAFG
WQAPQFAHLPLILKPAGMGNGKLSKRDGDKMGFPVFPLEWVDPVTKNISKGYREGGYLPE
ALVNFLALLGWNPGVEQELFSVEELISLFDLEKVNKAGAHFDIEKIKWFNHQYLQKIPVA
TLVEDFSPIVAEKGVKVSKDKLTEIVSLIRERATFLTDLWDLAHFFFEAPTQYDAKALKK
QWKDNSAEITTQLVTVIEGLTDLTPHHIETQIKDFITQNNLGLGQVMPLIRLSLVGEMKG
PDVFSIIAILGREETIHRLQYLVQYAKEQ
>SEQF1602_01235 hypothetical protein
MKTILLLFLLPLLPLWGQTPATVIHTEANLYQVDSLLYRSEQLVKADKEEILRTPIKTII
NLRYFTRSKDRNVFSPTDGITLINHPLLTWRITPKDIAQVLKRIRRSQEQGAVLIHCYHG
ADCTGIMVAMYRIIYHDWSIAAAKKEMLQGPYGYHSIWKNLEALFTEETVKEVRKLLK
>SEQF1602_01236 hypothetical protein
MKVILLQGKGNSGKTRLSNKIDEWLLQNGFVEEFKKLDPNNENASPYQRDFWAIYYKKIE
GRNVRVLLNSWSDTGDIINAFRDIYKENKKDGYDILITAIRSKSNPRLYEWTREVYIKEF
PKIEENILDLDTRPQDAEYWLGEFIPLFGSLL
>SEQF1602_01237 hypothetical protein
MSSITKRELIGTTDWDRIKKEIKDEFIEFTKKGEFEKTEEYQERMQYIKEAIEMIAQEVF
VKFVSEPIFMEPIKYDADTELYTIRISKNYQLNYQKKDLGYRNLVFPTILRIDRDTAQYY
ISTKYSIRDYYNYTLDFADFIFFEEYILPKRIQIGGKMYETELYESYLKNWNIGKDEIVA
NILKDKSTHNIIISDLELNTNDLGLSKYFPEVYRFKIPKIENE
>SEQF1602_01238 hypothetical protein
MKHILIIVVSFLIGSTFVNAQYKKSDMERFNIKGHYPNSVPFKDFYSTIEGTIPHIPSPY
NIINAQGIGYRAQVKDGFPYEFDENGNVKYCGYANKGAKMTYEGTNEIRRITSDEYGDAI
IEFKYNDKGIIIGKNILREDYMSKEYKIDWESKYIYDNKGNIVIEKFRDYSLNYGEEDES
GEFRFEYDERGNLIKATIQELVEGGIFVYNYKYDKNNNLSEWSSNGDKVELKYDDKGNVI
SVIGQLGYELVEYTFKYAYDGKGNWKTKYAYDGGKLVGKVTRVIWYNE
>SEQF1602_01239 hypothetical protein
MKRIFLTIVAVLGVLAISSCGSNISPNDYELSEDGKTLVKWLNEETVSINMEKDEVLKDV
TVIGGAAFEGKKELVSIIFPKELTDIGGFAFKQCSKLESIEIPEGITVIREETFIDCSSL
SSVRLPNSLIKIEALAFSYCGELSDLVIPKNVEELGSGCFNPCRKLTTITFEGEKPPFIN
GAFRGGILRKVYVPKHSVNLYKFSYRDSYFDKIVREKP
>SEQF1602_01240 hypothetical protein
MKNSVFIAQNDRVQASTFLCSVNNRAHARAYNKIFDISKPAYEFFRE
>SEQF1602_01241 hypothetical protein
MPDIAKITKKTQKQIKTEFYNILEEFVILTSKDITEANLLKAEKITKDIDVDDIPFIVFH
LQYKHKIWSLDKKLISGLTEKGYGHFFISTNEVRKYLYKKKN
>SEQF1602_01242 hypothetical protein
MPYTITVLNDSPQALAYVKEAETFDFVKVTKIKETKKKTATKAKATPAPELLEEDENGIP
LKYKEEILALSQKTKKAATKRFYEKRAEKSIS
>SEQF1602_01243 Polyribonucleotide nucleotidyltransferase
MIPEVKKEIITLADGRTISIETGKLAKQADGSVVVQMGNAMLLATVVANKEAGEGVDFLP
LTVDYREKFAAAGRFPGGFFKREARPSDQEILTMRLVDRVLRPLFPKEYYCEVQVMIQLM
SHDENVMPDALAGLAASACLAVSDIPFDGPISEVRVGRINGEFIINPSAQQLAESDMDIM
VGASKEFVAMVEGEMDEVSEKDMADAIHFAHEAIKVQIEAQERLREKVGKTIRTYEVPQE
NEEVAKKIYDFCYDKCYAIAKENTTKHERSDKFDAVKEACKALFTEEELEEYDKLVSKYF
SKAQKEAVRNLILNEDLRLDGRNTKQIRPIWCEVGYLPSPHGSAIFTRGETQSLTTVTLG
TSREANVIDIPSEQGEERFYLHYNFPPFSTGEARPLRGTSRREVGHGNLAQRALKRMIPE
DCPYTVRVVSEILESNGSSSMATVCAGTLALMDAGIQMKKPVSGIAMGLITDGDKYAVLS
DILGDEDHLGDMDFKVTGTKDGITACQMDIKIKGLTYEILEKALEQAREGRMHILGKITD
TIAVPNPTVKPHAPKIVRLEMPKEYIGAFIGTGGKNIQDLQARTKTTIVVEEVGELGVVE
ILGTDADGIQEAVDAVYHVSFEPVEGEVYKVRVARLVEFGAFVEFVPGKDSLLHVSEIAW
ERVEKPSDVLKEGDIIEVKYLGIDPKTKKTRVSRKALLPRPENLEKREKPHSDKEKKDKP
HFKKDKK
>SEQF1602_01244 30S ribosomal protein S15
MYLTKETKAEIFKKHGGSETNTGSTEGQIALFTFRINHLTEHLRANRKDYNTERSLVRLV
GKRRSLLDYLKEKDIERYRAIIKELGIRK
>SEQF1602_01245 hypothetical protein
MKRTIVDYKKLTKDILALLVEKYPEGYQDRDVIRFKNAKNETVEALEVRTEDTIYLVKVS
TRLATSMERYDEEEDDYYSDTLEMSREDEIALKRKKDISKTSLHIDDDEEEEEEEEHYRD
DYHDQREDDDDDDEEDDEDDEDEEDDD
>SEQF1602_01246 GTPase Obg
MTEGNFTDYVKVYVRSGNGGKGSTHLHREKFVEKGGPDGGDGGRGGDIIIRGNKNLWTLI
NFKFQQHFRAEHGGDGGANRSTGADGNSVYLEVPLGTIVKDALTDEVLFEITEDKEEKIA
LKGGKGGLGNWHFRTSTNQTPRYAQPGIPGEERELLLELKVLADVGLVGFPNAGKSTLLS
VLTSAKPKIADYPFTTLKPNLGIVRYRDFQSFVIADIPGIIEGASQGKGLGHYFLRHIER
NSVLLFLVPADSPNIVEEYHILLKELEKYNPELLDKQRLLAISKTDLLDQELQGLIEKEL
QAASLDLPYLLISSVAQQGITILKDRLWQLLQ
>SEQF1602_01247 N5-carboxyaminoimidazole ribonucleotide mutase
MKVAVVMGSQSDLPIMQEAIDFLKEKQIPVLVDIVSAHRTPEKLISFGKNAHLQGIDVII
AGAGGAAHLPGMLAAVSPLPVIGVPIKSRNSIDGWDSVLSILQMPAGVPVATVALNGAKN
AGILAAQILGVAHKEVQEEISKYKKSLEEAVLMINIQ
>SEQF1602_01248 Undecaprenol kinase
MKKFVIGRIKSTRYALQGFWLLVRTEDAIITHSIGFLVFVGLGFYFELTPTEWMVQLLSF
GVLLAIEGLNTGLEKLCDFVHPDFHTKIGEIKDIAAGAVTMIFFAVVAVLMFIYIPHLVG
>SEQF1602_01249 hypothetical protein
MLREQLQKLFPDHKEEVLPEEPSSNIWLQDEPLLCKYEKRNGKPVTLIEGYTGADADFKI
LAKELKTHLGVGGSVKEEKIIIQGDYRDKIMVFLKGKGFKVKRVGG
>SEQF1602_01250 1-deoxy-D-xylulose-5-phosphate synthase
MKKYTDTGKKDTRSGFGAGLAEVGRKNPNVVALCADLIGSLKMEKFIEENPTRFFQVGIA
EANMMGIAAGLTIGGKIPFTGTFAAFSTGRVYDQIRQSIAYSNKNVKVCASHAGLTLGED
GATHQILEDIGLMKMLPNMVVINPCDYNQTKAATIAIADYVGPVYLRFGRPAVPNFTPED
QTFEIGKGLLLNEGTDVTLIATGHLVWEALQACEVLEQRGISAEVIDIHTIKPLDEEIIL
SSVRKTKAVVTCEEHNYYGGLGESVARVLAQHYPVPQELVAVNDTFGESGTPAELMRKYG
LDKEGILSAVEKVLKRK
>SEQF1602_01251 hypothetical protein
MKLTTLLEIKGIDPLPLQNFKPHGGVILMDENEREAILQWIRQCNLGFEILPLFSNQESD
CVAIYTSGFLKGKVAIVRHDEAVFAPQFKSLDSFLKAYEKAAKQTDFYDWEDIEEEDYPI
TEENEAEPIVLQECWQHIKAADFISDIQKETIQTMAIWLTPPSELDTLLPFVQKEFALKD
NMSVVAYAIDTLGIIHQYAPAKPLIAELLKTRRFANYYRRNELYHGEFELKETLVGKTWN
SFLMVITIPFMLLSLLFVELTNRFRKKK
>SEQF1602_01252 Fe(3+) dicitrate transport protein FecA
MILHKNLLLFVAIFFGLSLQAQQYKIKGKILDEKKEPLSEVLVRTLSSGRQVLTDSKGEY
TLLVEEEHPTLQVSREGYTPLEFPVVLQDNENRVTYVETTLHRGVEETLSGVVELQPVTI
SDNPSLVVNSVGLTKAKLDKVAGGTNLADLRNLNIQRSQTLKDALQREPGIIIQDFFGGN
DQPRLNIRGSGIQSNPQSRGVALSQDGIPINFADGSYIIGVLEPQVSNLVEIYRGANALE
YGGATLGGAMNFVTKNGYNASPLSVKMEAGSFNYFNSTISSGFSSGKSDLFVASSYNHSD
GYRTYNSSKRFNALLNAGHKFSDKFEARLYASFTDLYFDIPGPLTRHQMESDNKQINKAP
KTTFPYAFGPNVLRDKPNRSSKIARFGTKLAYQINANNLILATLYYQYADDAFTYPIANG
IRQDFNNDYGVRLSYTNTTEKNDFSIGLQYSQGLMHQSRFHNDRGSFGALFAKQDLTARH
AIAYVSDTYKITPNFLANVSVQGSYDTRKVEDKFVGARRPFFFVAPNGLQARALPNPNAA
TPVIGDFSYNAINPKVGLIYKLNDHAQVFANFSRSYEPPTFLEIVRLTGSATPNPNRPPV
PPVVYSNSSNVNSGPTTITISDLKAQKASTAEVGTKGNIGQVLLWNVSAYQSWVKDEIFT
IADGSVGVGGNTVNTPYATIHRGVEAGLQSTFLTHVFSAAEDSFTLSINYNYSDFYFDGG
ELKGNQIAGIPTHYLFGALTYRHPSGVFAEVNLESLPQKTPIDHKNTLYQDPYSLVGARL
GYKKGQWTFFVQGNNLADKVYASSYLVQAEVTAPPMRLNPVATPDDKTNFIPGVGRNIIG
GLSFTW
>SEQF1602_01253 Dihydroorotase
MKTLLKSVTIIDKESSYHRKKQDILIEDGIIKQIASQIASLDDCQTIAGGYISQGWADSS
VSFGEPGYEERETLAHGMTVAARSGFTQVMLNPTTHPITDTRSGVNYLKSAIVGAIAEVF
PIGALTTESKGDYLAELYDMQRAGAVAFGDYKRGISQANLLKIALQYTAPFGGIVLSFPC
DASIMGKGVVNEYITSTRLGLKGIPALAEEIIVARDLAILEYAGGRLHIPTISTAGSVAL
IAQAKAKGLDVSCSVALGNLHFTDEILENFDTNYKVLPPLRHEEHVEALREGVENGTIDM
ITSDHYPLDIECKAKEFDLADFGSIGLEATLGILLTHFSVEKTVEMLTNAKKRFSLPSTP
IEIGKKANITLFTDQGDWVMNKKDIISSSKNCAFVGENCKGKVQGVITERGQWLV
>SEQF1602_01254 Carboxylesterase 2
MKGFSLNYLVRPAIIEQENGKSPAIFMLHGYGQNKEEFFSIANELPQEYIVISIQAPYKL
SDSQFFWYAIELVSSKWYDIVQAQATQHKLLTFIEQACDRFNIDMDKVTFMGFDQGGILS
LSLAISFPEKVQRVVAINSYIDKKLLSFNYQKNNFANLRVCLLHGYSNEVVPLEWAEDTM
TFLKNLHIRYDFQTFASGHVFSAEMFYAVKTWIEENSIAENNPS
>SEQF1602_01255 Thioredoxin-dependent 5'-adenylylsulfate reductase
MNTEITNLLTAIETLSETEILALITEKYPGKVVFSTSFGMEDQVITDFILKNSFDVKIFT
LDTGRLFYETYTTWEQTNEYYHTKITPYYPEAQAIEEYVQNNGINAFYNSVALRQTCCHI
RKVEPLRRALAGNKIWITGLRAEQSPHRQQMPMVEWDESNQIIKVHLLLHWKTQEVLSFL
RSHGIPYNPLHDKGYPSIGCAPCTRAVREGEDFRAGRWWWENKTNKECGLHLHK
>SEQF1602_01256 Sec-independent protein translocase protein TatA
MIPLFISTPELLFVLFVAVLLFGTDKIPEIARTLGKGMRQLRDATSEIKNEINKSVDKAG
IDTSLIDEVKEEVEKAKEGLEDPFGSIKRSR
>SEQF1602_01257 DNA mismatch repair protein MutS
MAKASKETPLMKQYNQIKAKYPDALLLFRVGDFYETFREDAIKTSQVLGIVLTNRNNGGE
QTELAGFPHHSLNSYLPKLVKAGYRVAICDQLEDPKLTKTIVKRGVTELVTPGVALNDDI
LQSGQNNFLASIWLDSPENGIAFLDISTGEYYVAQGDNAYTDKLLENFRPNEVLVAKKQR
KDFETLFGTHFHCFSLEDWVYKGDFAYESLTKQFNTNSLKGFAIEELSNGILSAGAILHY
LSETQHHHLQHITSIKRIVSQEAVWLDRFTIQNLELYGGTSNTSVSLLAVIDKTLSPMGS
RTLKRWLALPLTSLEQIQKRHQVVAYLVENSEVREKVREQLQRVNDLERLLSKVVTTKIT
PREVIYLKNSLRAILPIRELALSSPCAALTALAQQIHPLDTLCDRIETMLNEDAPVNILK
GEVFKENFSSELDELRNLSVSGKNYLDQMLEREIQQTHISSLKIDSNNVFGYYFEVRNVH
KDKVPPHWIRKQTLVNAERYITEELKEYEEKITHAQERITALEQEFFSQLITEIIQYISP
IQQTATAIGQIDALCGFSTLAVENHYSCPTLDDSLVIDLKGARHPVIEKQLPPTQPYIAN
DIYLDNESQQIMMITGPNMSGKSALLRQVALIVLMAQIGSFVPATEAKIGIVDKIFTRVG
ASDNISQGESTFMVEMNETALILNNLSNRSLILLDEIGRGTSTYDGISIAWAIAEYLHEH
PTHAKTLFATHYHELNEMQNEFSRIKNFSVSVKEVKGSILFLRKLIEGGSEHSFGIHVAK
MAGMPQYVIEKANSVLKKLERSHQLEDNKKQLTQKEGMQLSFFQLDDPLLEDIKRQILDT
NIDNLTPIEALMKLNNIKRMLQK
>SEQF1602_01258 hypothetical protein
MITNRLKKLLLENNIVIDYKISPTEFSAKKDFIINLYRSKGYEQINDSLILFLGYFLNKS
FSARGNYIDFTLEKVLTSNNKGHYSYIESSFDLKNLIPFAMVYDDYYTLVIGEDNSVYAE
GFELLLYGSDPFEALENLLQGTPIEIFKL
>SEQF1602_01259 hypothetical protein
MIETITELLAYVDGIATFNEQEYPFELFCNGTKVSGSLQEYLLMEIEEGQ
>SEQF1602_01260 hypothetical protein
MDEKLIAQNIKEEIFRKEYERYFHILEEGINKEPYKIFIGKKRKPFINQ
>SEQF1602_01261 hypothetical protein
MTNNFKNTIDSYLSSEIGKLFIRYKNEAKDIDCTEKELGVTIDDALKYVLLTYGGAYIGV
DLLPCSKDPNNKNQETILDYTKSIRDYYKEINVCHSIQSGYVISIEGNGDIIFIDSENKV
KTFYHDTNEEELLAKNFESFIIEQI
>SEQF1602_01262 hypothetical protein
MTPLYAQCISYNESIKGRIGGNPPINIETEIPEGYAFYATLVHPEKEDKMLSILISNDFN
QLIHHQSYPNILIKVVEHNFSYEGDKYNLSLPQIGKTSSISNYSSDKQKFNLVQVGGTPD
FIDDDPVYYEKLLADDYSFYLSIDEEGYDVPSMKMVIFSYGAVYLYKHNKTGEIIAGFWQ
YT
>SEQF1602_01263 hypothetical protein
MNKIINRTLLLEWGESDTCLEEAGDVFFFDINNHLSGVNIILQHNVGSCILPSLPSFLLE
EQKPTTLTTLSREDFTFEVDDYTHTRSYLCEDNLVFSYTNCNKLLDLVILKITENLYFIL
NQEKVLQYIVVTDISTILFNDLYYLKEKEVRELYYLTYTLNSYDVVQYVSILEKIQNNKY
YRQQILEDEADDLVNDLNELLED
>SEQF1602_01264 hypothetical protein
MSSMTDIVFLLLIFFMLTASNNPKVLDMLLPKAHGKTSGIQNVAVSINKDLQYFVNNKHV
TTSDMENELKSALSGVENPTIILRVEESVPIENAVLVMDIANQNQYKLILAVRPK
>SEQF1602_01265 hypothetical protein
MLLLQANTLADAGQPSAEVQEESLSIMDLIFNGGLANSIIIGILFLMLAMSLYIYFERSF
AIGAAKKIDSNFMNVIRDNISSGRIEAAKNLCYQYNNPVARLVAKGISRIGKPIDDIHKA
IENAGSLEVYKLEKNVSLLATLAGVGPMIGFLGTVVGMVMSFHAMATSGGQADMSILAGG
IYTAMTTTVAGLIVGIVAYLAYNHLVMRINNVTQKLEATTVDFLDMLNEPV
>SEQF1602_01267 Transcription elongation factor GreA
MKVAYYTEEGLKALKAELDQLRDVERPRASQAIAEARDKGDLSENAEYDAAKEAQGLLEM
KIAKLEELVASARVIDESQLDTSKVLILSTVKLKNKANNAVMTYTLVAESEADLKTGKIS
VSSPIGRGLLGKSVGDIAEIKVPNGILQMEIIEITR
>SEQF1602_01268 putative HIT-like protein
MASIFTKIINGEIPCYKIAEDEHCFAFLDINPNAIGHTLCIPKKEVDKLFDLDETLYHHL
LEFARKIAIAQEKAIPCERVGMAVVGLEVHHAHIHLIPISRMKEMTFEEKVSLTNEEFQE
VADKIKSYL
>SEQF1602_01269 hypothetical protein
MGLITAKELAKAIKIDKLGFVGTSVGWGLLHLLRLAPLNRIYDRNKHLQGVEFLSALLKE
FKVHYEVPEEDLRKIPKEGPFITISNHPLGGLDGIILLKMLIEQRPDYKIMANFLLSKIE
PLAPYIFQVNPFEDHKEASSSLQGFKQAMAHLAEGKPLGMFPAGEVSTQISGNIYVDKTW
DKSAIKLIKKANVPIIPIYFHAKNSPLFYQLAKQSDILRTAKLPSELLTQKNKSIKIRIG
RPILPKTQDEIEDLYEFSNFLRKKTYLLSNTYEQKKHFRPFASMIKVNTNKDPEEVAPPI
AEELLEKEIEALRQQKGTRLLQHKEYEIFLAKAEYIPNILHEIGRLREITFREVGEGTNL
SIDLDEYDTYYRHLFLWESDTKRIVGAYRMGLGSDFFDMYGVNGFYTHSLFRFDSELHTM
LRQTIEMGRAFVVSEYQQKPMPLFLLWKGIALTTLHFPEHKYLLGGVSISNQFSDFSKSL
MIEFMKSNFYDPYIAQYVKPKKEYKVKLKDADKDFIFDETQSDLNKFDKIIDELEPGDLR
LPVLIKKYIKQNAKVIAFNVDPLFNNAVDGLMYIRIDDLPESTIKPAIEEFQSQLEKGES
>SEQF1602_01270 Pesticin receptor
MKKTLFCGALVLSLPSFAQEMPAIKDSLSEKTISLDEVVVQGIRARENTPISFSNVSKKE
IQQKNTGQQLPILLGNLPNVVSYSEDGAGYGATALFIRGNDTYRTNVTINGIPYNDAESQ
GVFFYNLSDFASSAENIQLQRGVGTSTNGAGAFGASLNILSDASSEKPYAQIANYLGSYM
THKHAIKFSTGKLKEHFELAGRFSKINSDGYIDRASSDLKSYFLQGAYSNSNTLIKGLVF
GGTEKTYLTYKGISAEQLQKDRRYNPAGKYTVGGQTFFYDNETDNYQQDHAQLHWTQKWD
EHWNTNLSLHYTKGKGYWEQMDNWGDSKGNFVIRYQLDNDFYGTVFSANYRKQAIELILG
GAANVYEGNHYNETVWTENATNPYRDISDWVYGNKQEVSAFTKLTWQIAPKLSLFGDIQY
RRVNFRSTLKKTQVNESIPMINPKAGISYFLSPASTLYFSFAHATKEPNRSDYKEYAKNI
KKGAELPRQEKVNDFELGWRYISEKVKLNANVYYMLYKDQLVLTGDISNTGYSLRKNSGK
SYRTGVEIDATVALAPRWEWAPNVSFSKNKNIDYTIQDPNTPTQKINLGNTDISFSPDWV
VGNTISFTPIDNFQISLISKYIGERYLTNENQENALLEDFLVHSLHLSYELLPQKLFKSV
LFSVTANNLLNKKYVAHGRYASGKPLYFPAAELNSMVGITFTF
>SEQF1602_01271 tRNA1(Val) (adenine(37)-N6)-methyltransferase
MSSPFRFKQFSISQEYSPMKVGTDSVLLGAWTPAINPNYILDIGTGTGVLSLMMAQRFPL
SHIHAVELHPLSAKECRLNVSLSPWHQAVEVFEMDIRDFASTSATAYDLIISNPPFFSEN
TLSPDRVRAMARSNEYLPFSDLLSCIPLLLAPQGFFSVIIPYREEESFLQIAMENGLFPT
QILHVQGNSLSPIKRSLLLLRAQESPLPTAEKLIIEKERHQYTQEYQELTKNFYLRF
>SEQF1602_01272 SsrA-binding protein
MQNNVNIQNKRARFEYELLDKYIAGIVLRGTEIKSIRLGKASIAESFCEFNEKGELFVIN
MTIEEYAWGTYYNHKPKSERKLLLKKQELKKLHKEVKNSGLTIVPLRVFLSEKGFAKMEI
ALVRGKKLHDKRETIKERDNKRQLDRIKKAYQ
>SEQF1602_01273 Tryptophan--tRNA ligase
MARVLTGIQSTGTPHLGNLLGAILPALEMAKDTQNDSFLFIADLHSLTQIKDGALLRRNT
YEVAATWLAFGLDYERVTFYRQSDVAQTAELAWYLECFFPYQRLTLAHSFKDKADRLEDV
NTGLFTYPMLMAADILLYDAEIVPVGKDQLQHLEFARDVAGRFNYQMGETFVLPKESIRE
DIMIIPGTDGEKMSKSRRNYINIFLSDKELKKQIMSIQTDSTPLEAPKDPNNCNVFALYK
LLATEAQTAQMAANYRGGNYGFGHAKTALYELILEKFAQPREKFAYYMDHLSQVDEILRE
GAEKASQVAKQTLQRVREKLGYL
>SEQF1602_01274 Muramidase-2
MRKILLFLCVLTGFSLWAQPKQHNSYTVKEGDTLESIAKVFRVSPSDIKSLNPTLEKGLQ
KGMLLIIPGDEISYFNKKQPTGFEKYTVKDKETLYGLAQRFHITQDDLRRYNMVLYKKEL
RKGQEITIPLYRDAPKEISKGKEGLTKYIVKPGEGLWRIAQNYGVTQETLERLNPNLPNP
LKEGMEIWVPAGKSGVPEVTTDKALVLYQVEKGEGFMSLERKFGLSQKELEKLNPELKDG
IKLEAQIWIPKNNFLDYVATLGGASQTDVATGNATDANPKIKSGMNPSNIKTVSFVLPFR
VNGIQAGNIADIKIKLQKEKITAIASDFYSGALMALDSLQKMGFSLTVNVYDSNGNAQGV
KAISSSEGLKNSQVIIGPFSPSAFNALSETITSDNIAILAPLSNRNIELRPNVFQTVPTI
EVQQNSMISFINQKYPDANIVLLSDAKSKDMNEKLLSSFSQAKNVDNIQGIQRALNKEAT
NIVFVSSDDVVFLSDAIRILYNIAGINGKNKNYNIIMATLDKGDAYDHNSISNSQLSALK
FTYPAANRYAGESNPFIKKYLKTYKISPSKYAFRGFDLTMDAVLRTSLVGNFIKEANIGE
TSYQENKFQYVKNATKGGGYENRAVYILRYEDLQISEIY
>SEQF1602_01275 Outer membrane porin F
MRKQILALTALVALGANAQEYNKWSIDVNGGVNKPVREFTSGYATKTPNFFTVNGGVRYM
FNNKFGLRLGGGYDKFEEGDNSPKFNSNLWNVNLQAVANVGRVLSFEDWTRDLGLLVHTG
VGIGQLKSDNFDKADNLGFVTFGVTPQVRLSNRVALLLDGSVYWYARQNKTFDGLSNTTH
DGFKGLNFTGTIGLQVALGRHMIHADWYSEGKELERKLQAAEDRIAKAESDVANLAKKLD
EKEDRMVDTNGNRIPDELENYLNEKYGSNAQNKYATGDAARELIEKGYINVYFDFNSSKP
QKSSLWAVDFVANYLKQNSGASVNAVGYADEKGSENYNQKLSAKRAEVIKQLLVDRGINA
SQLSFEGKGEDKTVNANSSNARQLARRVTFELK
>SEQF1602_01276 Biosynthetic arginine decarboxylase
MKNKYIDLIDQTYYFPQDEFTLEGDELRFHDIDLMELVREYGAPLKFMYLPKISENIQRA
KKWFEKAIKKHKYKGAYNYCYCTKSSHFKHVMVEALKNDIQMETSSAFDINIINNLISEG
LITKENYILCNGFKRDAYIDGIADLINRGYDKCMPIIDNYEEINLFDEKIKENYNIGIRI
ASEEDPRSEFYTSRLGIGYKNIVPFYNKEIKDNKKVTLKMLHFFINTGIKDNAYYWNELL
KCLKVYIQLKKVAPELDSLNIGGGFPIKTSLAFEYDYAYMVDEIIRQIKIACDQEKVPVP
NIFTEFGSFTVGEAGGAIYEIMYQKQQNDREKWNMINSSFITTLPDTWAINKRFVLLPIN
RWNDEYERVLLGGLTCDGDDYYNSEQNMNAIYLPKYNKNKPLYIGFFNTGAYQDSIGGVG
GLQHCLIPQPKIVLIDRNKDGALTTRLFMEQQKAEEMLKILGY
>SEQF1602_01277 Cystathionine beta-lyase PatB
MIYNFDEIIDRRGTDSLKLEALLPRWGREDLIPMWVADMDFKTPPFIVEAVKKRIECEIF
GYTEKPLAWYQSIIDWQKKRHQLSIDKEMICFIPGVVPALVMAIEAFTHVGDNVLIQPPV
YYPFAAAIRNTGRKVVTNPLLLQEGQYHIDFEDFEEKAKTCKLFILCNPHNPGGRVWTKA
ELERLAAICLKYKVLMISDEIHADLTLPSYQHVSLASLSQEVAANCVTFSSASKTFNMAG
LASAYAIIPNPEIRQKFLDKTVGYMLTDGNIFAFQTTVAAYREGEEWLSQLLTYVQGNID
FLIQYIDEHLPKVKYLVPQASYLVFLDFRALGLSQKELVAFCTNQAHLALVDGSVFGKEG
TGFMRINLASPRSVIKKALDQLKEAFSK
>SEQF1602_01278 hypothetical protein
MANFYNESSLKEIIPALFSQYNLNYGLDKVRVKEAWVEIAGMGVVKYTENVRLQGDKLFI
SLNNASLREDLNLRRSELVQLINDFLKKEVVKEIVIS
>SEQF1602_01279 Threonine--tRNA ligase
MIKITLPDGSVKEYKKGITPAEVAQSISEGLARNVISASYNGKTIETVTPLETDGSLVLY
TWDSPEGKKAFWHSSAHILAQALEELYPNIKLTIGPAIANGFYYDVDFNGNTITDKDFPA
IEAKMLEIARGKYEFKMRPVSKAEALSYYKGKNEYKTELIEALEDGSITFCDHSTFTDLC
RGGHLPNTGFVKAVKILSVAGAYWRGNENNPQLTRVYGISFPKQKDLTEYLTLLEEAKKR
DHRKLGKELELFTFSNKVGQGLPLWLPKGAALRERLEAFLRKAQKQAGYEQVVTPHIGHK
NLYVTSGHWEKYGKDSFQPIATPNEGEEYLLKPMNCPHHCEIYNSHPWSYKDLPKRFAEF
GTVYRYEQSGELHGLTRVRCFTQDDAHIFCTPEQLDAEFKHVIDLVLYVFGSLGFDNFTA
QVSLRDPENLSKYIGTDENWAKAENAIINAAKEKNLTYVIETGEAAFYGPKLDFMVKDAL
GRSWQLGTIQVDYNLPERFDLWYKGADNELHRPVMIHRAPFGSMERFVAILLEHTAGNLP
LWLVPEQVNILCISEKYEGYAHKVANLLQEADLRPHVDNRNETIGKKIREAETQKFPYMV
IVGEEEEKNATLSVRRHGGEDLGSMKIADFITLIQEEINKNVRPFSIEV
>SEQF1602_01280 Translation initiation factor IF-3
MRLVGDNVETGVYPTKEALRLAEEMELDLVEISPNAQPPVCKIVDYKKFLYEQKKRAKEL
KAKATKVEIKEIRFGPQTDDHDYEFKKKHGEKFLKEGAKVKAYVFFKGRSIVYKDQGQEL
LLRLAVDLEEYGKVEQMPKLEGKRMTMFIAPIKKK
>SEQF1602_01281 50S ribosomal protein L35
MPKIKTKSSAKKRFKLTGSGKIKRKHAFKSHILTKKAKKRKLALTHATLVHTNDEASVKK
QLGLK
>SEQF1602_01282 50S ribosomal protein L20
MPRSVNAVARRARRKKIMKQAKGYFGRRKNVWTVAKNAVEKALVYAYRDRRNKKRTFRAL
WIVRINAGVRPYGLSYSKFMGALKANKIELNRKVLADLALNHPEAFKAIVEKVK
>SEQF1602_01283 Diaminopimelate decarboxylase
MEIKDLLSIAHTYGCPVYVYDAYKIRSQYERLIKAFAAVPSLRINYAMKALSNGSILKLM
RKLGAGLDTVSIQEVKLGLHAGFAPEQIIFTPNGVSMEEIEEAASLGVQLNIDNLSILEQ
FGSKHPQVPVCIRINPHVMAGGNSKISVGHIDSKFGISIHQVPHILRIVENTKMHINGIH
MHTGSDILDIDVFLYAAEILFDAAKHFRELKFIDFGSGFKVPYKEGDIQTDIEELGEKLS
QRFLEFCKLYGKDLTLAFEPGKFLVSEAGFFLVKVNVVKQTTSTVFAGIDSGFNHLIRPM
FYGATHFIENISNPEGKKRFYSVVGYICETDTFASNRQIAEISEGDILCFRNAGAYCYTM
ASNYNSRPRPAEVLWIDGQAKLIRKAETLEDLLRNQVEIDL
>SEQF1602_01284 hypothetical protein
MKAPTKYILLSLLVEYVLFCLFMHFVINQKSNTYVTTMGTIRTYAAITALYIPTLVLAYF
VGQKVKFHLYSRLKNFILGVLLIFIFYITTFWFTMMSFTYFLCPEDDRRYCMEITQFVVF
GYTIYGIGKWLFVFVALLLGGLLMMINNGKRMTNGNRI
>SEQF1602_01285 Putative metal-dependent hydrolase YfiT
MDEIRYPIGAFELPKEITQKHITIYIEELRRFPYLLEEAVKQCPPNILNLTYREGGWTIA
QIVHHLADVDMNSFIRCKLALTEENPMVKPYEETLWAEIPEAKDFYISPSLRIIEGVHWR
WWKFLRALTPEDFEKTYRHPQSGQTISIKQEIAKSVWHGKHHLAHIELAKKLQISNNKL
>SEQF1602_01286 hypothetical protein
MKRRFVYQDAKSDKFWDIEFEGTTQTVVYGKTGTAGREAVKEFATAEECIKESEKLIAQK
LKKGYTELAEGEAAPEKREYSEEEKADYFFWEAIEKSYKYNKKDWEAYDLDEHIEKLTTY
LSKYSEEKLILFEKTLQQKLISLYTAPIAELSIILENEYEKEGDTYNFDGYISDDGFIYF
RCWLLLKGKEFYDDITKDIESFVSGKYHFDIGDTWGEGLLYVASRANSEARPDSDEDIIR
DTVYEKWPEINYDSGDFAMDREPKSGRELQKMYPKLVAEIMPIR
>SEQF1602_01287 Riboflavin biosynthesis protein RibD
MEKQERYDRAYMRMAQEWAKLSYSQRKQVGAIIVKDRMIISDGYNGTPTGFDNCCEDAQG
DTLWYVLHAEANAILKVAASTQSCAGATLYITMSPCRECSKLIHQAGIVRVVYKDSYRDT
SGIEFLEKAGVEILHLPETSSEGDSL
>SEQF1602_01288 hypothetical protein
MALVLEWDFESYQEEELLVALHARFAPCKMAYWLNTSLHIGLKRERKDLYDKEFDTFFPF
FSYEGEKKWYLITNKVRKEVSVGMFLQVEENQLLIKELPKVDYFLRITPLEEPLSATTLL
KELRWIDFFYEIALFPEGKIPAKEQRKLNEIKSKLIF
>SEQF1602_01289 Pyruvate kinase
MIGRKKTKIVATLGPATDSPEILRQMILAGANVFRINFSHANYDEVKQRIAQVRAIEEEL
KTHVALLGDLQGPKLRVGVMEDDVVVENGDQISFITGEPFVGNKERAYMNYAQFPRDVKV
GERVLLDDGKLIFEVISTNEKDTVVAKVLQGGVLKSKKE
>SEQF1602_01290 Pyruvate kinase
MDWIALSFVRHAKDIEDLKTLIKQHTTENVPIIAKIEKPEALVNIDEIIANCQGLMVARG
DLAVETPAQEVPLRQKELVRKAKEARIPVIIATQMMETMIESLTPTRAEVNDVANSIIDG
ADAVMLSAETSTGKYPVQVIERMSSIINSVEDCEFINVPRIPPVREGNERFVTQSVCLSA
AKLADDMDAKVISTLTGSGYTAFQVSALRPSAHILVFSSNRRLLTKLSLLWGVTTYYYDR
YVSTDETIEDINRIATREGHVQVGDIVISLSAMPISYQGRVNTVRATQILA
>SEQF1602_01291 Ferrichrome-iron receptor
MYKYLLFWGLLLCCIPSLCAQETITVRGRVTDTQGSPLLGVSVILEGTTKGASTNEKGFY
EIHRVPLGSQTFIFSSIGYETVKKAFEVTPNPSGNHTHLDIALQEETQKLQEVEIIGRRE
SSYKNTSSFSGTKTATAIRDIPQTINYVTKEVILDQGASTVNDVVKNISGVSQYTTYNDF
SIRGFRTTGNRNSGNLLNGMRAQTSLWSSSSLANVERVEVIKGPAAALFGNAAPGGIINR
VTKKPLLERQHTISVNTGSWGTLKAYGDFTGPLNESKSLLYRLNLGYETTDGYRDLQGRN
TLTIAPSFSFIPNEKTRFNVDISYQRLDGKVDRGQTIFGDADLYSVPITRSLSATNDFLR
ETQMNITLGLTHKITEDLSFNSTYLNSSYSEDLREHNQANSYYMQQGNKINTGDQSKILM
QALLRERTFRNNSFNNYLNYTFATGALKHTLLVGYDYFQVELLPGASQLTAGGYLLKNGK
TTTTFDPAKINTYVLDANGKPLTNVAVFDLNNPTAGNVMKETNKYIFTSGNTKPSLQTSH
GVYLQEQLEISMVKVLLGLRKEFFVDYTNYKENNEEKIEQQALIPRIGLVVTATDNINFY
STWLKGFEPQSASIQADPDRYGGPFDPVYSELYEVGVKTDWFQKRLSATASVFKIIQQNS
LYPASPAVPGKPDLRMQIGEEESNGFEFDLAGEITPNWSILASYAYIDARITKTASNSEK
DFDMQRPSTPRHSGNIWTKYIITEGSLKHLGFGAGYNFVTERYGQVGRRANTTVYPGYGL
VNAVLYYKINQIQFQANLNNILNKTHWVGGYDKLRSFPGAPRNVNISISYKF
>SEQF1602_01292 Methionine aminopeptidase 1
MIKIKTKEQIEIMYESAQVVSRTLGMLAREIKPGVTTLYLDKLAEEYIRSQDAKPGFLGL
YGFPNTLCVSPNAQVVHGIPNNKPLQEGDIISVDCGALKNGYYGDHAYTFAVGEVSPEVA
QLLKVTKESLYIGIREFRLGNRVEDVGYAIQTYCEKHGYGVVRELVGHGVGTKMHEDPEM
PNYGRRGRGKKFVEGMVVAIEPMINMGTKNINQLRDGWTILTRDGKPSAHFEHDVALVDG
KPKLLSTFKYIYEALGIESHEEDEFLYK
>SEQF1602_01293 Demethylrebeccamycin-D-glucose O-methyltransferase
MRLVKTLLNTIPRPWLIRASYWVRPLLAFYYKGSRYTDPIDGRSFRRFLPYGYGKVREGV
LSPSTLSLERHRLLWLYLKRKTSFFSAPLKVLHIAPEQAFYKRFKRQANLEYITSDLYSP
LADVKADICALPFEDESFDVVLCNHVLEHIPDDTQAMRELYRVLKKGGWGIFQVPQEIER
AETFADDSITDPKERARIFGQYDHVRIYGMDYFDKLRSIGFSVLPLPCTEVASAEEIEKY
RLVKNEILPICSK
>SEQF1602_01294 Aspartate/alanine antiporter
MDWFFNLMTNHESVAYTVIIYSIVIAVGVALGKVRIGGVSFGIACVLFAGIAASHFGFTV
NGEVQHFVKEFGLILFVYTIGLQVGPGFFASFQREGVKFNALAVLVVGLCMLTVIALHYL
TGIDMPTMVGIMSGAVTNTPGLGAAQATLSDLSPTASDSVLSTGYAVAYPFGVLGIILVM
LGMKAFLRINIETEKRLHSFKHRGEHSTIVRIAFQLENPALFGKKLNAIRQTLDFNFICS
RISKNGEVILANDHIILEKGDIILFVVDKQYTEKLNNLIGAVVKTEEYFTEAAKEKKFIS
RRINVTQKEAYTKKLSEMNIYERFGVTVTRVYRAGIEFVASPDTKLQFGDTITIVGDEER
IKTATKEFGNSKKRLSTPHIAELFLGITLGVLLGSIPFNIPGIPVPVKLGLAGGPLIVAI
LISRYGGRLSVTHYVSQSANLMIREIGIVLFLASVGLGAGQNFIKTITEGDGLLWMGLGA
IITLVPLVVTAWISRWRGKLNYLETCGLLAGASTDPPALAFANDSTGSDVPALTYASVYP
LTTFMRIMVAQLLIVFFA
>SEQF1602_01295 4-hydroxythreonine-4-phosphate dehydrogenase
MQINKKMSEKTNIRIGVSIGDLNGVGLEVVMKTFADERMLDFCTPVLFASNKVIAFGKKQ
FGIDFTYNGIVHLNSIIDHKINVMNIWRELPPIQLGVPTPESGQCALESLSAAVAALKEG
LVDVLVTAPINKKNIQSESFHFPGHTDYLAQELEGDSLMFMVSDELRVGLLTDHLPLKDV
VKNLSQELVEKKIRLMEASLRMDFGVIRPKIAVLGINPHCGDQGVIGNEEERIIHPVVQK
LYKEGILVFGTYSADSFFVSDYKHFDGVIAPYHDQGLIPFKMMSFGKGVNFTAGLSKIRT
SPDHGTAYAIADRGIADESSFRQAVYTAIDIFRRRTENEELIANALDVNSLDKGFLSKEK
GD
>SEQF1602_01296 Riboflavin synthase
MFTGIVEKIGRVAKISLQDKNRHFFIESELAPELKIDQSVDHNGVCLTVVGIEGKVYEVV
AIDETLQKTSLGTWQVGDRVNLERAMKLGERLDGHIVQGHVDQTGLCHSIEDAQGSRIFT
FHYDPSVGNMTIEKGSITVNGVSLTVVGSQKGVFSVAVIPYTYEHTSFHTLKVGDKVNLE
FDVIGKYVLAKVGALELKI
>SEQF1602_01297 hypothetical protein
MKRISISLFFLLFSGTMVAQNGFFMGLGVGAAFPLGDNQQAGVMLNPISVSLQLADEGSF
LGLTAGFLMATKRQYPVHYQRDTGEKKYVYDYAKGTFSSTPIYEHFTSEKNSLSGVFVLL
EYSYPFFENDYYHFGALASVGGCGVSFTPKDEGLKDRKDLDKNEKTRMVFALGVQNTFEL
ERHIVQLSLQYFLQNPTLSGVTPSLEGNYFLMRVTFSGGWWQ
>SEQF1602_01298 hypothetical protein
MTNKIPQEWNVYRSWLDDDPAVFRLNLALNEVAPLEGFSYCVRITIELKNPDKNGFSSDE
ERPTIYAIEDKVLCPLQSDKDILVAVLTVQGEVTWYFYSQAPEELQERLSATWDSEIGYT
YQVECSEDKPWNFFLKGLYPNIYEKQTIYNREILSACEKHGDQVEVPRPIEHWLYFDTEQ
DMLSAIEKAATLGFTVYSSEKVVPEEGEESQEDLGYCLILSKENTPMDIDGDTWNLIDIA
LDTHGNYDGWETILVTEKTN
>SEQF1602_01299 hypothetical protein
MKKIIYIVVALCIAGCNFFSKPSSSDSDELKEPPIVAGDYSQEDDGYPQVDTMPDYSPNI
PDGVSDITFKREKGEAILMGDTIATYDKKGKFLEYRMDLDRKFVTIKAISELMYNDTQEY
CNEYHFVKAELPNGEPLILDGRRAYKLLEKPFEKVFGASQAIRIYRTEYYGQPIFTDELT
GCGSPFDPVVLVSIDGFKGLVTLEKNDIAHQVFNYDHSSRGKVDFLEFCNDEGCGEKVLN
AALTSDGIVLKMHRNFQEGYTNYKILLTKEEQGYKATYLDYPEPSYEE
>SEQF1602_01300 hypothetical protein
MHQDTKQKKLQQHKNLALGLLLLMLALYITAVICQRKAPQWSWVGYLKAFSEAAMVGALA
DWFAVVALFRRPMGLNIPHTNLIEERKNDIGENLGAFVVENFLSSGQVRPYIIKIKPSSF
LLEWLSKERTLTQLTTFLESYPLHTKVSALLEQFLEEHKHEGMLTEGLKKVAIYLDTHRK
TLEREIDDQFPLLVPAFIREAIAQKVAEGLYQYILKMAQDTTHPIRAEITQELYRFVQQL
DTPQWQGQLTRLLHKGISHLTEELRANTSLQSQIDTWVQKAAYQFVLRNKQEVGHLISAT
VAQWEGKELSEKLELEVGKDLQFIRVNGTLVGGAVGLIIYFITQLF
>SEQF1602_01301 Queuine tRNA-ribosyltransferase
MNFELQTTDTTTKARAGRITTDHGVIETPIFMPVGTVASVKGVQQRELTEDINADIILGN
TYHLYLRPTTSILEQAGGLHKFMHWDRNILTDSGGYQVYSFSSTRKIKEEGVRFKSHIDG
SYHFFSPEKSMEIQRSIGADIIMAFDECTPYPCEYGYAKRSMHMTHRWLDRCIAYLGENA
PKYGYNQSLFPIVQGSVYPDLRKISAEYIASKGADGNAIGGLSVGEPAEKMYEITEIVCD
ILPKDKPRYLMGVGTPINILENIALGVDMMDCVMPTRNARNGMLFTAHGTINIKNKKWEN
DFSPIDENGYTFVDTYYTKAYLRHLFAAEESLGKQIASIHNLGFYLWLVREARRHIMEGD
FSQWKDQMVRQMNNRL
>SEQF1602_01302 Lipopolysaccharide export system permease protein LptG
MKIIDRYILKRYFLTYSALFLMFIPIGILVDYAEKNQKMTDNHAPTEAIIKYYANFVVHF
ANILFPIFLFLSVIWFTSKLAEKTEIVAMLSSGISYNRFLRPYFYGATILSVFVLLMGMF
VVPYSSGVYNEFYGTYLSKDLYSKGSRLYNQVNKNEYIYVSSFDANTNQGANFVLERFDG
LRMTDKITANSIEWVQNDSVKTYRLYNYTHRKVGDWNDIYEKVYQKDTLLNFKTTDLLPI
EYAAETKNFFELNKFIAEERQKGSPNIRIYELVYYRRWAAIFNVFILTIIGVAVSSVKKR
GGMGVNLAFGVLIGFSYVFFERIFGIMAEKSGITPLMAVIIPNAMFALLAVYMIRKSRR
>SEQF1602_01303 hypothetical protein
MKNYVLFLVSILCTSCLVSRMARPIITGRVLDYQGNPIGKCQVGEVFTDKKGYFRLPEKR
YHEFTFIGFEAPPVYVSEEVKKEGYEPDVIVMMSRYGGGNRRGTLWPANDIYLKRIGEKI
TLKEVLDNTEREVIYTKEGQLMGFLCTDTGDIPATLRVNDRWKMFDSIKKAVYYQQRRAY
YVATKMLFDKGELCFSEYLDDEMIRDTTYYGRYEFLSDSIVQIEMNHPKIKRKYRAEDFD
RYFFSLQPIE
>SEQF1602_01304 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MNLLQGKTAIVTGGSRGIGAGIVKAFIEQGANVAFTFYGTAPEEAEAEIQELKDKGAKIK
SYQSNAADFEACEALVNQVLEDFGGIDILVNNAGITKDNLLMRMSEADFDKVIAVNLKSI
FNMTKAVQKVFLKQRSGNIINMSSVVGVQGNAGQANYAASKAGILGFTKSIALELGSRNI
RCNAIAPGFIETEMTAKLAPEVVQGWRDSIPLKRGGTAQDIANACVFLASDMSSYITGQV
LRIDGGMITA
>SEQF1602_01305 Sporulation initiation inhibitor protein Soj
MGKIIAIANQKGGVGKTTSSINLAAALGVLEKKVLLIDADPQANATSGLGIEVEGVKRGT
YDVLEHSATAESAILPTSSPNLDLIAAHIDLVAIEIELVDKSRREYKLKEALAPIKDRYD
YIIIDCAPSLGLLTLNALTAADSVIIPIQCEYFALEGLGKLLNTIKSVQKLHNPALDIEG
LLLTMYDSRLRLSNQVVEEVQKHFSEMVFETVIQRNIRLSEAPSFGETIISYDAASKGAA
NYISLAEEIIKKNTKA
>SEQF1602_01306 putative chromosome-partitioning protein ParB
MAKSNKTQRLGRGLGALLPSEDIQSATDAHAEKLIGNILELPLDQITENPYQPRTVFSEE
ALEELASSIRELGVIQPITVRKIATDKYELISGERRWRASKIAGLTAIPAFIRIANDEES
LMMALVENIQRQDLDPIEVALSYNRMIEELSLTQEQMSERVGKKRSTITNYLRLLKLDPI
IQTGIRDGFISMGHGRALINIEDKEEQLELYNRIIAQDLSVRDTEQAVQQLKNPQKVAVI
TPKQSKETTASLPPLVAAKVDGLRQRFGKHLSVKMDKTGKGKIEIPFQTEEEFERIQKIL
HGEA
>SEQF1602_01307 hypothetical protein
MRLSFWIVIAFLLTAKSWSQSDTLSVKMKDTIVAAKAIVPKTWNTDPLSPAKAAFYSAIL
PGLGQAYNKSYWKIPIVYLAIGIPTYLYFKNDNELQRYRTAYKQRLDGRTDDEFYQGRTD
GNPRLSTDALRRAQDLYQRNKEMSMLFAIGFYALNIIEANVDAHLKQFNVDENLAIEPFM
QQDIYRVSYVGLSLTYNF
>SEQF1602_01308 hypothetical protein
MKKVVFAFVLLFSFSLQAQVRKVQLQMKPAFIAPKELDFPKEDLDYAFEKIRLQRQRWYS
FNSFGLNMSEAAYSNWNAGGVNSVSFLADVKLRRRYVVEKYFWDNELTANYGVNIQTGEQ
LRKTDDQISLSSAYGYRTGFRDWYYSGKITFNTQFSDGYDYPKKPDADPISRFMAPGYLY
LGGGFEYAPEKTKLTLFISPLTMKATFVMDQKLADKGSFGLDPAEYDPAGNLLKHAKQQV
VEVGFLFSGKHTVDLYENVQMTNQFSFYTQYDKSFGNIDVDWQLAVDMKINNYLQARVGT
HLKYDDIKFKEEVLPNGTKHLYGARVQFKQILGVGLKYTF
>SEQF1602_01309 Oxygen-independent coproporphyrinogen-III oxidase-like protein YqeR
MYSLYIHIPFCRQACHYCDFHFSTTLKRKPQMVKALCKELELRRVEASTPLQTIYFGGGT
PSVLTSVELQEIFSTIHKHYRIASGAEITMEVNPDDFSTPKSELSLELLKELGINRLSIG
VQSFFEEDLLLMNRAHTAEQAKDFIAQAIQYFDNITLDLIYGIPGMTLARWKENILQALS
FGIPHLSAYALTVEPRTALYQFIKKGKIPPTNDGQAKEHFYLLKDLLEAKGFIHYELSNF
GKEGYFSRNNTAYWEQKPYIGIGPSAHSYTGEERMWNISHNIKYIEQISQGILPQERETL
SLKDRYNERIMTGLRIQKGISTEAIERDFGEFFLNYLKKEALPYIEKGLLVYHNGHIITS
EKGLFLSDGIASDLFML
>SEQF1602_01310 Crossover junction endodeoxyribonuclease RuvC
MEKIILGVDPGTTVMGFGIIQVMKNQMKFVQMNELILSKYDDHYLKLKLIFERTTELIDT
YKPDELAIEAPFFGKNVQSMLKLGRAQGVAMAAGLARQVPITEYEPKKVKMAITGNGNAS
KEQVAKMLQQLLHFRELPEHLDATDGLAVAVCHFFNGGKTEKNKSYSSWEAFVKHNENRI
S
>SEQF1602_01311 Putative mannose-6-phosphate isomerase YvyI
MNLYPLTFTPIFKERIWGGEKLEKELHKPIHQPLIGESWEVSTVKGDISIISNGALKGTS
LQTLIEQAPEALLGRAVYKRFGTDFPLLIKFIDAAQDLSIQVHPDDALAKKRHNSFGKTE
MWYIMEADPEASIIIGFNKNVSREEYQTHLADKTLSQLLHYEKVGHGDMFFIPAGKIHAI
GAGVLLAEIQQTSDITYRVYDFDRKDKNGNYRELHTELALEAIDFERKDDFRKSYSKKEN
TVNPAVSSPYFTTDYLKITQETPLELSGDSFHIYMGVEGKGSLHYGDTELILEKGSTILV
PATCTAITLKGEVEVLQVHC
>SEQF1602_01312 hypothetical protein
MKRKLLILFIALLAIACNGQQSSKENVKPLTEQEALEAFKKQKHRFEIKGYKVYYNDQLM
KLDTIANFFDTFGKPSYKEGYEFVYDNIPLWSRISLGEVKDKKGRFIGNVDRFFIYFRPY
AEGREELSDLYPFYYAVKRMPEIDGYMLVEGHPIHKDTTPKELSEILKPIYGEHFVNLMG
TPTIVFELKEDEIKEIIPHWGADKSYKNIFISFDYLIDEQTKKVIGLKSVDYSYFLL
>SEQF1602_01313 hypothetical protein
MKKGIWILLFLYVCLPIRAQNSKELIEILLDFCQQVTQEEPSEEKIYAIFQSISPEKRYL
LLEEKKSSFTGFTQEKVAYIDLDEEKYDNNAKLISYKRAAARTYTLDLSLHSPYSIKAGK
VSYERATYPISFPLLTEKLGRVFYDTIFQAKDTKVSNYIYQNPQTHKKVVFSILSYNPPE
APYNIIYRIEIEDIRFFDEASLSKGKFYMKEKN
>SEQF1602_01314 50S ribosomal protein L13
MDTLSYKTRSVNKQSAEKQWVVVDAEGQKLGRLASKVAKLLRGKYKPSYTPHADCGDNVI
IINAEKIELSGLKTETKEYLRYTGYPGGQRIQSFKQVLSKFPERIIEKAVKGMLPKNKLG
AALFRNLKVYAGSEHNHDAQKPVSINLNDLK
>SEQF1602_01315 30S ribosomal protein S9
MEVIHKIGRRKTAVARIYMKEGSGKITINKRDLANYFTTPTLQYEVKQPFALLGLEDAYD
LNINVYGGGITGQAEAIRLAISRALCEVDIENRAMLKPEGLLTRDPRMVERKKFGQKKAR
KRFQFSKR
>SEQF1602_01316 30S ribosomal protein S2
MANSIEVKDLLEAGVHFGHLTRKWNPNMAPYIYMERNGIHVINLYKTAAKIEEANEALKK
IAASGKKILFVATKKQAKDIVAEKATSVGMPYITERWPGGMLTNFVTIRKAVKKMSSIDK
MKKDGTYDTLSKKEKLHITRLREKLEKNLGSIADMTRLPAALFVVDTLREHIAVKEAQKL
NIPIFAMVDTNSDPREVDYVIPANDDASRSIEKILSYVVEAIKEGLEDKKVEKADEKPAE
N
>SEQF1602_01317 Elongation factor Ts
MSKITAADVNKLRQATGAGMMDCKNALVEAEGDFNKAIEVLRKKGQKVAEKRADRESAEG
AAIAKVNANHTKGAIISLNCETDFVAKNESFVALANQLAELALNYNDKESFLAAPFQGIT
VADKLTEQTGVIGEKIEIGQFEILEGNYVDFYIHAGNKIAALVSLSAATDKAHEVARNVC
MQVASMGAIVLSSKDFDPAYVASETEARIAAIIKDNEELRRLGKTEKHVPKYISALQLTP
EVLKEAEEAAKAELKAEGKPEQIWDRILPGKVQRFIDDNTTLDLEKALLDQYYIKDESKK
VADYVKAYNVEITGFKRVSLV
>SEQF1602_01318 Guanylate kinase
MNSKIIIFSAPSGSGKSTIIRHLLQEADLNLAFSISTTSRAPRGTEKDGVEYYFITAEDF
KRKIAENAFVEWQEVYAGNYYGTYQSEIDRLSSQGKNIIFDLDVFGGINLKKHFGAQALS
IFIQPPTLQELRRRLEHRNTETVEKIEMRIAKAQYEMEQAIHFDKVIINDDLSQSVAEAL
QMVRNFLNQ
>SEQF1602_01319 putative nicotinate-nucleotide adenylyltransferase
MKRKIGLYFGSFNPVHIGHLILANHLVEHSDLDEIWFVVTPQNPFKEKKTLLDNANRLEM
VSLCLEEYEKLRPCDIEFHLSQPNYTIDTLIYMEEKYPQYTFALIMGEDNLKSFTKWKNY
ETILKSYFIYVYPRISEGEVSELLKGNEHIIYVKTPIIEISATDIREDIALDKNVKPLLP
TEVWNYIDKWGFYK
>SEQF1602_01320 hypothetical protein
MKVTYLGHACVNIQIEGAHFLVDPFISANPLAGHIDINSIEATYILLTHAHADHILDAEA
IAKRTGAPLITNPEILGHYRKLGLDGYDMNIGGSHRFLDGKVKIKMVKADHSSSFPDGSY
GGNPAGFLINYKDQTIYISGDTALTMDMKIIPHQYKVDLAILPIGNNYTMGVRDALTAAK
FVETNNVLGVHYDTFDVIKIDKEASKRKFSDAHKRLHLLEIGNSLEVDDLI
>SEQF1602_01321 Putative cysteine ligase BshC
MTQYIPFEDTGYFSKFITDYLAQKEPLKCLYHRFPLTTNFLEQIKDKQAHFPKEHRTLLF
QVLKEQYQNLSISEKTHNHIEALQQEHTFTITTGHQLSLFTGPLYFIYKIVSTIVSCQQL
KQLYPNYTFVPIYWMATEDHDFEEINHFTFQGQKLSWHSKEGGAVGTFSTEGLDKVASVL
NILLGKSHQGESLKRLFEKAYIEHATLAEATRYLVNELFAPYGLVIIDGDNPKLKGCLAP
YLKRELFEQLSQKEVKKTLSYIKQTDKSYPEQVHPREINIFYLSKGIRERIVKENGVYKV
LNTHIEFTPEALEEELTQFPERFSPNVILRPLYQEIILPNLAYIGGGGEIAYWLELKTMF
AVYGVPFPMLILRNSVLLVSDKQRKNIEKLGLSYHNIFLKNNILENKITQKLSEFPIDFS
SQKQMLEKQFADLLEIALHTDKSFLGAVKAQEKKQLKGLEQLEKRLLKAQKKKYKEQLER
ILSLRISLFPKESLQERVDNFSEYMIQTQGQLIEMLIKHLNPFDFRFVILCYDTSCREGE
CIEYFI
>SEQF1602_01322 Cytidine deaminase
MSEKDYQFSYKTYLLSEANEKDKALIESAFQCRTNAYVPYSHFGVGAAILLDNGQIVLGN
NQENAAYPSGLCAERTALFYAKANYPEAKIIKIAISGDHMEHPKGEITTPCGNCRQALLE
YECTQGSPITVLCVSSKGKVLEIPSVKNLLPFCFDFFYD
>SEQF1602_01323 hypothetical protein
MEIFSMMDTYLQGFWFIAIPVSIIFIIQTIMAFVGANASDGLTADFDGDFSGADAPFQLF
SLRNLINFLLGFSWTGISFYEVIDNKITLTIFAVLVGCLFVYIFFLTVQALMRLAEDNSF
KIEETLGKVAQVYVPIPEYLSGTGKITLSIRGSIRELDAMTEGERIPSSAMVQIVKIKDA
IVFVQKIAG
>SEQF1602_01324 Inner membrane protein YqiK
MDFSSPISLIAIFAVVLFVTIVSLTARYKRCPSDKILVIYGRTGGSSARCIHGGGAFVWP
VIQDFAYLDLRPLSIEANLYNALSRQNIRVDVPCRFTIAISTEPENMNAAAERLLGLSPE
QIQELAKDILFGQLRLVIATMTIEEINSDRDKFLDNISKNVDSELKKIGLKLINVNVTDI
KDESGYIEALGKEAAAKAINEAKISVAEQEKIGETGKALADRERDTQIAETQRDRDVKIA
ITQKNKEISIAQAKKDETVGIAEAKKDESIGKAEADRDSRIKISEANASAIKGENEAKIE
IANSDALRREKEAESLRIAISAEKVQQAKALEEAYSAEEKAESARAERERATQQANIIVP
AEIAKQRVIIEAQAEADRLRENAKGEADAIYAKMEAEAKGLFEILTKQAQGYKDVVSAAG
GDPTKAFQLLLIEKLPELVKTQVEAVKNIKIDKITVWDSGQGENGNTSTANFVSGMMKTV
PPLNDLFNMAGLNLPNYLAKANETPQEIPSEEVPTEDK
>SEQF1602_01325 hypothetical protein
MRHLLIILVVLWGFSSCTTNATFTFHKNQTTSLLAEVDMEGILKFTGDSIMKSFTNKELS
KNWKSLYQISKEKGEPITNKDSIELAKRMFLKGLYKGEVPYGFALKADRISQKQWSGMEK
ISKSENTKYGDLFASVFKWDGKTLIFDPQELTKIGKKEKLNCPEEESSETSKEEIKATSD
ETSEAAASSETIQKIESPFQMKINLFCKFDRKIKSIQGNHPYLQQIDEHTLQFSFNALDK
HPKERGDSKIIIITK
>SEQF1602_01326 hypothetical protein
MKKLLSFLVLFGGLSVAMAQKTIIPEVKVVSEDNVHPMQLQDLSVDILVVGQTAVTTMEM
TFYNPNNRVMEGEFEFPLAEGQQVSRFALDIDGKLREGVVVDKSLGRKAFEDIVRRGVDP
GLLEKTEGNNFRARVYPMPRKGSRRILIAFEQELSQKNGQDFYFLPIANAAKLKKFKIRT
EVVSRFVKADIQNSLQLDFIQSRNSYLSEVEKTNFTLNKNIALLFPKIDKPQLLTASQGD
KSYLYGNIALEKQELRAKEAPKTLGILWDVSSSSEKRDFAKEYMLLDSYFKEVKNVKVVL
TTFHIYASKPISFEIKEGNWQALKDHLDKLTYDGATDGNAMTFPAGADEYFLFSNGIFNF
GKEAFQINNLVKRLHAPVCVITSELVANMDKLQYLAGATGGSFINLSSQELLDAVKALRY
QSFQLLGYKVKSGNVTDLYPQKGALVGENFTFSGELNSDEATLVVSLGYSGKVVVEKEVT
FSKNNSASAGEFALLRRIWAEKKITQLQREGAQAKDIDAVGRQYGIVTEGNSLIVLETVA
DYVRYQITPPEEFQREYNRLVNTEKQNKEKTKKAHLDHIVKLSEAQSKWWNTSFPIAGTK
PVKNTADQSSNESTAGINARASASTLVIRGIGSISESSQAELAEVMVGYSRSSRKKRRQN
KNAAKETAQVLNYEEQSEDYEDRSGEPTMNPSKITLNQYNPDTPYLKVMEYADPAKAIET
YYKLKKEYGQTPSFYVDVADYFFKKGDTEQAVLVVSNLAELGLEDAQLLRVLGYKLSSYK
AHKEAIEIFRKVLSIREEEPQSYRDLGQALSQGGEYQQAVETLYKVVERPWDDRFRDIQL
IVMNEINDLVNTQKGIRTSFIDKRLLKKEPVDIRVVLTWDTDNSDMDLWVTDPEDEKCYY
GHRQTYLGGIISQDVTGGYGPEEFMLKKAPKGTYKIAVNYYGNRSQKQLFPVSLRITFFT
HYGTPQEKKQETTVRLSNQREVIEVGSFEF
>SEQF1602_01327 hypothetical protein
MLKHLCFLFFSLLLIGCKEKNSKAVVDEFADREINESYQSVSLQDTAMATLKKVTIKDPL
YKPAIEREVVDFYKKYNYQTRWLYQNKPSPLFTSYIQVLTALSDYGFFPENYRQKELSQK
VDSLYKGRLSLTDLEETDREITASFLLFTRHLTRGRVPKVGDEKRVWKRTRPLLDNVELL
LKLKDNDNLSQIIEALQPQQPFYKAMAQRYRELEKDTAEVLTPFAITDLKSYTIGYADST
ILALRACLKHKGYESPVQENPEQVDSLLVEAVKDFQRSIGIPADGVPGAQTMGYLLMTAK
EKRDLLLLNMERLRWHNKDLGEDYILVNIPEYRLRLFHKDSLVFQTRVVVGNPETPTPIF
SDSLRYVEFRPTWSVPQSIVRKEMIPNIISSRDSLKYAKRGYKLYENNKEIDPAKVNWHD
ERISKRAFYFVEAPSENNSLGLVKFVLYNDMSIYLHDTPSKRLFGNTQRTYSHGCIRVEY
PERLATKLLRGSEEWDAEKVKEAMTTGRDQRRVRPKQHFVIDVSYLTAWVDEEGKLIIRN
DPYQFDKEQLKILNRYKSM
>SEQF1602_01328 Octanoyltransferase
MNKKITLIDWGLKDYKEAWEEQEKLFQSTIDLKVANKNLPLPIETPNYLIFVEHPHVLTL
GKSGVMEHLLMSEEFLKEKHISFYKVNRGGDITYHGLGQVVGYPILDLDNFSPDIHQYLR
SLEEVIILTLADYGIKGERSKGETGVWIEVGTPRARKICAMGVRASRWVTMHGFALNVNT
DLSYFNYIVPCGIADKAVASLEGELGHQVSLQEVRERITQHFLEVFSATLA
>SEQF1602_01329 hypothetical protein
MIEDIRQVSAYARLEKVYKKLGLENSNQLIDCLIIYPSLEENKDLNFNKLETIEGYAKIY
KQSLSIPLIIEH
>SEQF1602_01330 Glycine/sarcosine/dimethylglycine N-methyltransferase
MSQFYNCIAEKYDFIFPLSPAHQTFFADELRGHTVLDVGAATGNLTAYLSSQGYEVTAID
LSERLIAKAAEKGVSVQQRDMLTIDELSTFDNIVCIGNTLPHLDSKVSVQLFLQKAYGQL
TQGGKLVLQLVNFEKYFAQQQGDYLGNLPLITNDKVKFERFYYLNEEGKIRFKTILDDTI
ENEELLQPIFADELTQWLTQIGFQAINLYGNFKKDPFDKGKSMALIITAEK
>SEQF1602_01331 hypothetical protein
MARLGVFYALSDEQVDAIAEQDDDKMYAYMLNTIEENLLGTPKSYQIDKAWEGIHYCLCE
GDWYKEEGIAPNIVFGGYLLLDHNDCVIFVNDLDNIQKIVDYLEENNLQEIIKKNFEKIP
SDYSYTKNKEELNYLLSWSKGVLDFYKYALKNQLNTIFTVDL
>SEQF1602_01332 putative ABC transporter ATP-binding protein YbiT
MLSVSNLSVQFGKRVLFDEVNVTFTQGNCYGIIGANGAGKSTFLKILSGKQEPTSGRVIL
EPGKRMSVLEQDHYAYDDYTVLDTVIMGNKVLSKVKKEMDDLYADYSDEHAERIGELQIQ
FDEMNGWNAESDAAALLSNLGISEDMHYTLMSEMDGKLKVRVLLAQALFGNPDVLIMDEP
TNDLDFETIGWLENFLANYDNTVIVVSHDRHFLDAVCTHISDIDFGKINHFSGNYTFWYE
SSQLAARQRAQQNKKAEEKAKELQEFIARFSANVAKSKQATSRKKMLEKLNIEEIKPSSR
RYPAIIFDRDREAGDQILHVENLAASIDGQVLFKNVDINLAKDDKVAVISKDSRATTAFY
EILNGNLKPDTGTFAWGITTSQSYLPVDNSDFFTQDLSLVDWLRQWAKTEEEREEVYVRG
FLGKMLFSGEEALKNCKVLSGGEKVRCMLSRMMMLRANVLMLNEPTNHLDLESITAFNNS
LKNFKGTVLFTTHDHEFSQTVANRIIELTPSGIIDRYMTFDEYMDDKNIQELREKMYKQ
>SEQF1602_01333 hypothetical protein
MELNQFIWNNYKESKEGQEVIKLFEEGYLEDIISKFVKDGSNKDLEQYLFIIDDIVNSSP
LPENIKYKDFYPYILENGLKILDESEKEYDIFKPEEYDMIIAFIEPFSLCLFSSNEEREE
DFYIPYFFQMNFGNLQKIADTFNIELPKVPLRKDKRERALYYLEFCKLWNEFRKQNNLTI
FELCAFLYDFAPKFIGKEKEQTLPEPTNIWITGGGIKNGDYKFLSEAKSDSTCFWSGNED
AVKGDIILMYCLSPKSSIEFVCRAVTDGIRDPFFWYYGETHIGHIQHIKPITLAEIKADE
HLKGLPIVRKNFQGVNGIRLQNEDYAWILEILQQKGEDISQLPKLSSANFTLNQDCKNER
EVEVKIVEPFLKGLNYSENDWVRQLPVRMGRGERNFPDYVFFAETKKGYERGKMILETKF
YIKSNAELEETFQQAQSYALRLNANRIVICDKDFIWIYMRENNNFDRTKYLKYNWQEMNN
PEIFNTVKKEIGKDFIK
>SEQF1602_01334 hypothetical protein
MTKNITIWIFSVLFLLITCVGINDFCHTMTYNEAYIGSHFGAGGLIYFKNYPLALAILFG
ITVFLPPISVITVLLFRKKVATSIMMCALVAMLLLDVYTFCFRQRWQLLGEQTSIYDVVI
LGIFLLYYLYLLLLKRKNIIK
>SEQF1602_01335 hypothetical protein
MNTNIISQLENFLSKAGEAVQRVLFVADVKNPIYEDSQEVLQLAQKQIVAPLGAMPNEEV
YAFIGVHSKTVLSGKRDSVGFVITNFRVLTQTDVSVISTPKKANSHLFTNKDNPDDLASE
LWQNFITKVDETIPKEYATMLEVPLKTVLTIVLLQLKTEGQLPDEIKNATDLKGRIKQLG
IEDQLKFYAENEKKYKKFANKHKIEGILLGSLAAPLLFGGLYGFVLTKEGLISRDLMEEA
VRSSWQEIKEHPAQKSQEGDAFTIGDKKHFIPAHQKEYIEPFLTLINEIAQEEVSLNS
>SEQF1602_01336 hypothetical protein
MEIIGISVRTTNQNGQAMQDIGNLWQRFFSEQILAKIPNKVSDAIYSIYTDYQKDYTEPY
TCIIGVEVTTLSTIPDGLEGREFPEQTFQKFVAKGAMPQAVGAMWQHIWDNDATLNRTYI
YDYERYTEKSQQGDASEVDIFIGVRENK
>SEQF1602_01337 hypothetical protein
MKNLYNEADKNEILNRLENLKVDAVRQWGKMNIVQMLAHLNVSLETPLGKNFPKRAFIGR
LIGKLVKKKFINDQPMPKNSPTDKMYVITDISMEDFEKEKQRAKELITLFYNNGREKCSQ
HPHSFFGKLTPDEWGILQWKHFDHHLRQFGA
>SEQF1602_01338 hypothetical protein
MNLEAEIDKIIQTDFFTKMGVKEFLGSNVILLKDVEQAFVNPTEEAFAGMYKEVQWLPSA
LTDADPFYKNIQIPENLLPYRKEIVQFFLKEHRNLNKKLFSFGPYDFTEVAKKAIAFAFR
QYLVEKQLTLGLYWENIVNVYYSGHWPIGYYKEKIFAI
>SEQF1602_01339 hypothetical protein
MITTFNFELFKKRLDLFLEKIEDFGGETDPLTIEKPATEDEIKAVEAQLGYTLPPHFREV
LLENTAHLEFYWSIYTDEDEDYEDEENGVFLPDELAEISSGELLFGLDLLLGYEESRKGW
EEDVYPDYNNEYDRVWHNKMAFHQVGNGDYIAIELEPENYGKVVYVSHDGSENHGLYIAD
NFKEFLMNYAAVGCTGSDDWQWEPFYTKGKGIDPTSKNAKTWYKVLGINPKELEG
>SEQF1602_01340 hypothetical protein
MLGNLFKKKPTFTPAMQELFVKISLALPQRFHFLQKQLTEGTIKGIKKPEGQRYQLRLDI
PLLNKYEDKKGRNFLIENIVIQSVETGKSSVVSWNVAYGLLLMYITANNDFLKWQAEAVG
IDTSHIRIKYLDDSPIEKLLSKEERQYITPNDLYEVSLNDKTYYHVQDITDGDGDFIGID
ADKNVYEFRHDPFEITLLTEPLETILKNNK
>SEQF1602_01341 hypothetical protein
MNIPFNFELFKKRLNLFLSKIEALGGATEPLAIEKPATEEEVKAVETQLGYTLPPHFREV
LLENTAHLEFYWDVNDVTIEDESIIPDALAHIYCGELLFGLDLLLDYEEHRKEWAADVFP
NYEDPEDRIWYNKLCFHINVNGDYIAIELEPENYGKVVYLSHDGASNLGTYLADNFKEFL
MNYAAVGCTGGEDWQWEPFYTAGKGIDPTSKNAQAWYKVLGIDSKELEG
>SEQF1602_01342 hypothetical protein
MITKEHLQKILSDTESYHIEKTVATDNMDKFSQAICAFSNDVADSKKKGYLLIGVRDNGE
LAGLQVDDKLLLQISNIRTDGNILPQPVMTVEKFSFAQGDILVVEVTPSQVPPVRYRGRI
WVRVGPRKSIATEAEEKLLTERRLSNIRTFDAMPCLGTTLEDLDITLFKKEYLFKAVAED
ILQEDKRTIEEQMASLGLYDLRYQCPTNAAIVLFGNNPERFLHGAYIQYVRFKGLDRAGD
IINEHKFSGNLCKVLPRIDVFVETSIAQKRPIPISVLREKTVSKYPYWATRELLMNAIMH
RDYESNAPVAFYEYDDHIEIQNAGGLYGKVSANNFPNVSDYRNPFIAEAMKVLGYVNRFS
RGVYRVQKELEENGNGKASFDFSLITAFRVVEPISTTYFEEGFGEEESDNKLGESTNKTP
IKSEELPNKLPNKSGELPNKIEKTPNKSTDKKEGSTNKSTNKSGEIPNKFEQLPNKSEGL
PNKSRGTTQERILVAIQAKPEVTQKELAQTIGITLDGIKYHIKNMTKLGIIKHEGSTKSG
KWIINNN
>SEQF1602_01343 hypothetical protein
MSIEQKDKEQMEQLIASEKYQQILDKLCDIIDMVFEEEMPSFTVLNYTHKALKDAGVTLE
EIAPVALADDHFLNFTILKMDYIKSGKTMHFSKDFLIRNMIEFYFLKTNPKALPDYLKKA
GLKNYMVPLKKWFTEATDTELVTAVSTSLKELKEKRKGAEQTSSQTATFEDWERLSAVYP
KLTKQVLKDFDEYNVVTAGILLAEITQKSQDLGVTFSEELTLFFQHIGELRLEGVEIRFA
DLYTDVFNGKDYLVLGEFWKYGDGDKLLYAPDTQEIFCFAHEYAKPKVIKQADTMTEFVE
KKLVAYLKNY
>SEQF1602_01344 hypothetical protein
MNIEILAPYCKTTKQQKLLEKLRKKFSLKSSKDLQTVTELVERLFVSKQYEGLLAFLPEV
LAVPFAANFNLWYPIEHSLALIAEVPTITPEQRKACFLHFKTVTEYKGLPDFQEIYDYYF
QDYLALCFVNDALEYIQKSIADKETSYEFSYRIYLITAASLVKLINEEVDYKTLEFPKED
RQPTYNSREELQYYMNTLITEQLTALQDKKFVKYY
>SEQF1602_01345 hypothetical protein
MNIEILAPYCTTVKQQKLLEKIRKKFSLKSSKDLQTVYELVGCLFVSKQYEGLLTFLPEV
LAVPFAENFDLWYPIENSFCLIAVIPTISPEERKACFSHFKTVSDFKSTKGAQEAFDYYF
HRYLSLYFVNENLDDLEEIDEYPASSQLWIHIAIIASASAVKLINEEVDYKTLDFPNWLS
KPTYNSREELQNYMNTLIAEQLTALQDKKFVKYY
>SEQF1602_01346 hypothetical protein
MGIVLRQSLKNVVATYLGFAIGALNTLFLFTYFLSKAQYGLVSYVTSTATILSPLIAFGV
SNTWVRYYSAYTDRQEQGRLNLMLCLLPLLVILPATLLGSMAYEQIVQWLSAKNTEVRPY
VWLIFLTAVAMAYFEIAYAWMRVQLKTVFGNFLKEVFHRVGVMLLLVAIYFDVIDFHQLM
WGVFWVYALRMFLMFVSAFYVRRPTFAWGLPQGKKEVFLYSLFVILSGSVASVLMDIDKF
MLNQYLPISEIAVYNVAIFTATVIAIPYRSMYQIVSPLTAQFMNQQKPQELADLYKRSTV
NTYFVSMVICVLIVVNAQQCYALLPDKDYSTGLWVLIIISVVKLSDALVGFSNAVLLNSP
YYRTVLFLGVFLVIGAVLMNRWLIPLYGINGAGVATLIAFTSYNLLKSVFVYRKYGLQPF
YKETLQTTLFGLVAIGGFFFWDFLFHPLVNIGLKSLLVGGMSVLFLLKYKVSEELVRLIS
KFRNRQM
>SEQF1602_01347 hypothetical protein
MTSEEIKAIVYYIQGLQALWKEGYNAEKVALYNYQFSLRAEMDMPDGLLDVIEMLEMWDD
NWIYGAAPLTEKEAAAIIQEELNIDIYHPEKDIMALVTNEFIRQLKEECSSNMIIVKAFE
NAQKLIVYDEYFLALQNILGELLTYHIRIPADTLAIIDVVEDPHIQRLQASLWGI
>SEQF1602_01348 hypothetical protein
MIDITTLDLLKYMGQRPPMYIGEYDIFSLKAFLDGLAFQRKSEDEGLVFLQQVFYPWLKE
KYALEEEQLWAQQLSLLCDTQEEAVHFFFTLFDECYKEYTSGHIKPRSQSPSSKVSYKEM
TTIELMELIRENPSAYLSKYSLRCFNAFLGGWDIHQESDETDEELRDFEHWIQKRYSIFD
SRGTIGILELVTETEGEALDKFFELWDIFRGKIMDAPIELTPKQLEVKRRFIQELQEVFR
KGYDPKEIGHYTRLFSYDNWREAVALRDIVAALYWFSEEKEETFVQLVQKYLGIDIYQSI
TSEKK
>SEQF1602_01349 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKNIIITGTSRGIGFELVQQLASQGHNILALSRHTAPIEALKLPKVRCFSFDITLATDRE
AVAQFVKEQWQKVDILIHNAGKLINKSFESLTETDFLEVYKVNVFGVAHLTQQLLPFMEK
GSHVVSISSMGGIQGSLKFGGLAAYSSSKGALITLSELLAEEYKERGIVFNTLALGAVQT
EMLTEAFPDYKANTSPQQMASYISNFALNGGEVFNGKVLQVANTTP
>SEQF1602_01350 hypothetical protein
MYVIILTYQKDLSEVEKHLEAHRAYLDRYYTSGHFIASGAQVPRKGGVILCKAGSKEEIL
DIIAQDPFHEHRIAAYQIIQFTPTKFSEAFGKVLS
>SEQF1602_01351 hypothetical protein
MDLQQLIKNFPWRRFGTPYETNANIVKQSIVKILDGVATEKDYQNLIYSFESQAWLIKLS
PWGMRFYLALLEEDKADKAILLRDMLTLFEAANYSSQSPQAKDFKATKGKVAKYEAYKEK
LFNDAYDGTMDEEFLKLIKSLDRHYYHVAIMELLEANIPLLQRFTTSEDKTIAQRATSLI
EAIKHPKIYPINQ
>SEQF1602_01352 Deoxyguanosinetriphosphate triphosphohydrolase
MDWQHLLSLRKQGDTKTRSREQEDPTRLSYDVDYDRIVFSGAFRSLQDKTQVIPLSGSGF
VHTRLTHSMEVSVVGRSLGRAIGAKVLQKYPHLQELGYQMNDFGTIVASAALAHDIGNPP
FGHSGEKAIGDFFRYHEGSVLKGQISDREYADLCSFEGNANGFKILTESRAGVQGGLRLT
YATLGTFIKYPKESLPIKPSGAVYDKKYNIFQSDKAFFHEVAQELSLRAIGDGDQARYVR
HPLAFLVEAADDICYTLIDFEDGINLGWIPEEHALEYLIQLIRGSKIKPENITEKYYQLS
HKQDRIAYLRALSIGTLIGETVALFEENEESLLRGDFTTSLLEKSKYKHQIKDIIDLSVS
NIYQSPQVVEKELAGYAILQHLLRVYFTAVYHKWHGTTSSYDHIILKTVPTRYLLEEEKL
YEQILAITCYVASLTDTQTTKLHSKLNGIL
>SEQF1602_01353 Methionyl-tRNA formyltransferase
MKDLRIIFMGTPDFATGVLQRMVEEGLQVVAVVTVADKPAGRGQKLQESSVKKYALSQQI
PVLQPISLRDEAFLATLKEFQADVQVVVAFRMLPKVVWQMPSKGTFNLHASLLPDYRGAA
PINWAIINGETTTGVTTFLIDDQIDTGAILLKKEVTIAPRETAGTLHDKLMTVGADLVVQ
TLALIASGQAVAKPQPKEVMPKEAPKIHKETSRIPWEKSLCEIDRFVRGMAPYPTAWAWL
HHQGEEYAIKIYEATPVDEPHTLKIGSIRLQHKKIEVAVRGGFLQIEILQFPSKKRMTAQ
EFLNGFHFTEGDFFA
>SEQF1602_01354 DNA-binding protein HU
MNKTELIDAIAQEAGLSKADAKKALEAFLATVEKTLKKGDKISLVGFGSWSVTEKAAREG
RNPQTGKTIKIPAKKVVKFKAGTELSNAVN
>SEQF1602_01356 hypothetical protein
MNLENTDVFHKIEMKDITFVNPEFFWLFLLFPLLVGWLWIGRKKEIPSVLFSSLQGVRSV
STWRTRLRPILYILRGLSLVCLIIALARPRSSSEITKTKTTEGIDIILSIDMSSSMLAKD
LKPNRIEALKRVAAQFIQQRASDRIGIVVYSGESYTKVPATTDKSIVLQALKEIRQGEIE
DGTAIGMGLGTAINRLKDSKTKSKVIILMTDGVNNTGVIDPLSAAELAKEYGIRVYTIGI
GTNGKALSPVAYNPDGSFQYDMVPVEIDEKLLAEISKITGGKYFRATDNNKLAQIYTEID
KLEKSKIEELKYYQHQENFRLWAILALVFLVGEFGLRHTIFRSFV
>SEQF1602_01357 hypothetical protein
MIHIEEKIYFYLLLLLPLIVLLYFGVQFWKAKASKHFAQKATFSRLVPQRSFFKPWVKLV
FFALVFVFIVIALANPKVGTKLETVKREGVDIVFAIDVSKSMLAEDVKPNRIEKAKHIIS
QLIEVLHGDRVAFIPYAAQAYPQLPLTSDYSSAKIFLEGINTNMLSSQGTAIGEAIQMAI
NYFEESSQTSKILIILSDGEDHQQGVDTVIQEAKDKGIRLFTIGLGTAQGATIPVSENGQ
IVAKRDNNGQVVITKLNQALLEEIAQEGGGKYFNGANTKEVLDALQKALDTIEKNEYESQ
VFSDYKDQFQWFLAIAFALLAIDIFISYKKTSWVRRLNLFGEREKVEVRRSEK
>SEQF1602_01358 Macrolide export protein MacA
MKRKKILFILALLVLGILAYFWFSQSAPKETTSTTSIENRDIKEEIYIPGNVYPVKEIEL
KSQLSGVLDKIFVKIGDVVQEGSPVASISLVPSTLELERLENNVKMAQINYDAAKLSYER
SQKLFQAQTISQAAMESAQREYGTAREQLLSAQNQLAIQKTGKVVGKKETSNIVKSSISG
TVIDLPLEEGASVIERNTLNSGITVAILAKMGQFIFRTQLAEQYLENIHLGDSISLAFNA
YKDLNTKAKITKISSKGTLENGIMKYTLEAEFPVNSQMPVIRSGYSATAEIVLSSKKNVP
SIEEKYITYRNDSTYVWVKKGEKIEKKYIELGISDGKYTEITQGLTKDDKIVQNDSAN
>SEQF1602_01359 putative ABC transporter ATP-binding protein YknY
MIQLTDIKKAYRTEYDTLQVLKGINLEIEKGEMVSIMGASGSGKSTLMNIIGLLDTYDSG
TYLFDNKDMKNLDSIERSAYRSRNIGFVFQAANLISYKNVVENVALPLFYQNVSKKEREQ
KAMEKLEPLGIANWAKHFPNELSGGQRQRVAIARALIADAPLLLADEPTGQLDSKTTNEV
MQIFKEINQRGTTIVIVTHEEDIAAQTQRIIRIVDGLIQ
>SEQF1602_01360 Adenine phosphoribosyltransferase
MNDIEIEDFVRNVYDFPKKGVVFKDITPLLRNPQITQKVLQQLIEPLKGLKIDKVAGIES
RGFLFGMLLAQALQVGFIPVRKPGKLPAETISESYDLEYGHSSLEIHTDAILQGEKVLVH
DDVLATGGTALAAAKLVERLGGEVVRCSFLMEIAFLKGREKLHKYQINSILNY
>SEQF1602_01361 Aminopeptidase C
MREKILSVLALMSISQAFAQDNLINALANNQGKDVQKYYQIKPVFAVGVTDVKDQGHSGT
CWSYAGSSFLESEMIKKKKQPVDLAEIYTARKVYLEKAINYLRMHGALTWADGGEMHDVI
NMYRKYGAVPQSAYTGLINGATKNNFKEMQKDLEAYLKEIVASEKVPANWKEVFEQKMDS
YLGAVPKTFMYNGKMYTPETFGKEVVGLQDEKYMSLISIESRPKYCNTLMAVPDNWCYEY
AFNVTMEDLIRTIDYALSKGYTVGWGADVSEKSFSWRNGLALVPEKDYKDLSEAEQKDYF
HVYWNEKQITPQMRQEAFDNYETTDDHAMQIVGLAKDQKGREYYIVKNSWGTSNDNKGYL
YVSKNYVRYKTMNIIVNQKGTPKDLVRKFKKAPYIS
>SEQF1602_01362 Aminopeptidase C
MIQRFFSVLVLLGAGQAFAQENLINALANNKGTDIQKYYQIKPILALDATEVKNQGWSGT
CWSYAGSSFLESEALKKKKQPVDLAEIYTARKIYLDKAINYVRMHGALNWGDGGEPHDVI
NSYRKYGVIPQSAYTGLINGATYNNFDEMQKDLKPYLEQLVKMKKLPSDWKEVFEKKMDT
YLGAVPKTFMYNGKMYDAHSFAKEYVGLEDEKYIEMISVEDRPKYQNVLMAVPDNWSYDY
AFNVNMEDFITTIDYALSKGYTVGWEADVSEKFFSWKNGLAIVPEKDFDNLNPAEQENYY
HTYWKEKTITPQMRQQAFDNYQTLDDHSMHIVGLAKDQNGREYYIVKNSWGTENDNKGYL
YASKDYVRYKTIAILVNQKGAPKDLVKKFKKASYLSL
>SEQF1602_01363 hypothetical protein
MIQRIQTIYLLIVSIISGVFSFYSIGDWTTLGLLGVSCLLAITSIFLFKNRQNQFVLNRI
NILCNLILLGVFSWRVLQSSGENSFSEKGVQLVVPFISIVFLYLANRAIHRDEELVKSAD
RLR
>SEQF1602_01364 hypothetical protein
MFEISDLKEKKLPDLQEIAQSLGMKKTKTLKKEELIYRIIDFQAENPSLITPAKESLPKE
KEKKTKTPKNNKEQEAPTPQVTTPQGTPKTKEVHPKKEKSKNNTPLPKENTPKPQDTPAK
DTGAPAPKKKNDAQGKGEGKGKYTPNKDKKGNNNFPKQERKEVTANAPIENSTVSNNNTN
QNNTPYNTSPKVNNGENYDKEKKNRYRSPDFEFEGIVEL
>SEQF1602_01365 Transcription termination factor Rho
MASPDDIYVSPSQIRLFGLRTGDTVLGTVRPPKEGEKYYPLIKVLKINGCDPQSVRDRVS
FDNLTPIFPNEKFNLSGRRSSTSTRIIDLFAPIGKGQRGMIVAQPKTGKTTLLKDIANAI
SDNHPEVYLMVLLIDERPEEVTDMQRSVRGEIISSTFDKEATEHVKIANIVLEKAKRLVE
CGHDVVILLDSITRLARAYNTVQPSSGKVLTGGLDANALHRPKRFFGAARNIEKGGSLSI
IATALTDTGSKMDDVIFEEFKGTGNMELQLDRRIANKRIFPAIDLIDSSTRRDDLLQDEK
TLQRMWIVRKYLSEMNVVEAMEFIHDRVKKTTDNNEFLMTMNE
>SEQF1602_01366 hypothetical protein
MNRFRKMVTVVTALFALQAAMAQDDVQITFDKLPAKAQNFVKTHFPKEEVASVWKDTEML
RVEDYTVALSNGTEVEFLPNGEWKEIKSRGSEIPASIIPSGIRDYVKKNYASSTIKDIKK
KRYGYEVELTGDIDLEFNSKGKFLRVDD
>SEQF1602_01367 hypothetical protein
MKKNQNRKLFFCKFAVLNNNDENTLYYREDENTLQRMRIVRKYLSDMNIMEVVGLIQDRM
KKTKDYEEFLMSMNE
>SEQF1602_01368 hypothetical protein
MNRFRKMVTVVTALFALQATMAQDDVQITFDKLPAKDEGIVKAYSPKDDVQITFDELPAK
AQSFVKTHFPKEEVASVWKDIEIEMLRVEDYTVALSNGTKVEFLPNGEWKEIKKSRGSEI
PAKIIPNGIAQYVSQNYSGHPIKKISKERNGYEVELIGGTYLEFSRNGKFLRIGD
>SEQF1602_01369 UDP-N-acetylmuramate--L-alanine ligase
MKIHFITQGEPFLQALIEGLSPLHEVSESVSGAMPTSDTEVVVIAQDISTSDPQWQKAQE
LQLPIYSYGAFLYQLHKLKTRVVVTGTQGREEIAAMVLHTMEYFSKEIDYFLETPIGDKP
SCRFSTGAEFVLIEGNESYSEVDKAPIFHTYAPTLALVSHIEETSKEVYADFINTITKGG
ILVYNQEDSPLSSIAEATENQLRLMPYVTADYIENGQTTYLVTPEGEMPLMISGKERMNY
LSGAKWLCQNLGIDEQDFYEAMATFESEE
>SEQF1602_01370 Fructose-bisphosphate aldolase class 2
MYYICGNFKSNTMNHNIKPGVAVGKEVQEIFQYAKQKGFALPAANVISSNSINGVLEAAV
AMKAPVIIQFSNGGAQFMAGKGLSNEGQKAAILGAIVGAKQVHQLAEAYGATVILHTDHC
AKKLLPWIDGLLDASEEHFKATGKPLFSSHMIDLSEEPLKENIEICKKYLERMSKMGMTL
EIELGITGGEEDGVDNSDADESRLYTQPEDVAYAYEELLKVSPQFTIAAAFGNVHGVYKP
GNVKLTPKILRNSQEYISKKYNVAHNTIDFVFHGGSGSTLEEIREAISYGVVKMNIDTDL
QYAFTEGVRDYMKNKAAYLQSQIGNPEGADVPNKKYYDPRVWLREGEKTFIARVKKAFED
LNNVNTL
>SEQF1602_01371 hypothetical protein
MITFLFLLYHTMGKTINIQKVALRQNTLYIPDSMVSQRAIQPGTLELVAALRQHGFGVTE
ELLHAINGTTNEYRQSVVKVIKEVLNVKLNWAPLIKNWEVPTGESFIDHLITAFYNQYPD
LIKSDNYVSYWYDYDDYYEANDIKDYNREYFTHKHERFLACGHYIPYGTFPLWRYNGCPF
CGTPFEIGKIEHTEQGSKLKILDLWREAEANTFFQNLLSSKTALDATQADSLKLLLPYFS
VDPQTHIGMKETLVLVVDNYIAQGKEAEAGACFSSPTDILRYLWYKKTSFLQIVEPKTII
KKEALNHSHITKSLDKHLSAKERAQKELKLKYSRQECARVARWLNALPLSAEKACEIMHP
KREMWVRFIRALRLAEYSKKKGFEKLATLLDVFYNERYSVWQAELNTAYLNMDSEKAFSL
LKQRPGVFARSLFACMLWLGADETLEAFKEIIDQVPTRLLFTLNMYADLYFSKEGKRSVQ
TILGTRVEIPKHPLVVGSYNEEQLAEMKAKIEDLCLWSIQRQFAKEENKNQSIYIDPQLY
HIPLPIGDRSNNVHDFNATLMGTHFPLEGNEIRLFMQWGKDLPAQHLDMDLSCRIVYKDR
TDICYFHNLTTLGCQHSGDIRSIPDKVGTAEYINIDVNTLRQHKAKYVLFTCNAYSNGAL
SPNLVVGWMDSKHKMKVSERTGVAYDPSAVIHQVRITQPLQKGLLFGVLDVEAKEIIWME
LPFQGQVVQALSIIGVKTLLEKLNSKLTIGNLLAIKAEAQGLQQVDDPSLADEVYDMQWA
GQGNVSKLFLG
>SEQF1602_01372 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase
MNIKTLQEKIENAWENRRLLSDEVTMNAIDATIDLLDRGELRVATPSDKGWQVHEWIKKA
VILYFPFRKMETKEVGIFEYYDKIPLKHNYEDKGVRVVPPATARRGAFLASGVVLMPSYV
NIGAYVDSGTMVDTWATVGSCAQVGKNVHISGGVGIGGVLEPLQAAPVIIEDGAFLGSRS
IIVEGVRVEKEAVLGANVVLTASTKIIDVTGEKPVAYKGYVPARSVVIPGSYTKQFPAGA
YQVPCALIIGQRKASTDLKTSLNEALRDFNVAV
>SEQF1602_01373 Mycothiol acetyltransferase
MIRTAFPQDAPSVAPLMFQAMSDIVFKLINRNDPKEATRFLERLFIQKNNQYSYENTLVY
EKDNQILGSLVYYNGAHIATLSQTVFDFVHSSYGHHIRLEPETQAGEYYIDTLSVSPKVQ
GKGIGSSLLLHLKEQLKGETIGLLVSMENPQAEKLYQRMGFAYADMKMLAGAPYKHLIYQ
S
>SEQF1602_01374 hypothetical protein
MKLTQFLKREFQSLGMSRQETAFVITLSIMLCILVSFIIVRVNNKPEEIWLEVPSTEEIT
KLLEEQEKLEDPQTEEDKPADNSQVTTRAYNEADSRIKQAEDLETLDDLLAKQEAENASG
EGENSPEEGEGTEPPKVEPHKVNDGMSFKELEKYKAQPKDKKANKRTLISYSLVGRDAVS
ELPNPVYTCDASGKVVINITVDGQGHVIEASYNKSASSTANGCLIDNAIYYARKARFNKD
SKIKQIGTITYLFQ
>SEQF1602_01375 tRNA pseudouridine synthase B
MNTLIEGTTILIDKPLHWSSFQAVNKLKWAIIKKYHLKKFKIGHAGTLDPLATGLLILCT
GKHTKLISSLQDAPKTYTGTIALGATTPSYDLETEIDARFATSHITEELIEQVRMQFTGV
LLQAPPLFSAIKKDGKRLYELARKGEVTEIPEREITIHSLALTPSGENTLSFEVHCSKGT
YIRSLAHDIGKALGSGAHLTSLRRTQIGNHSVADALSPDAFVELLNTNI
>SEQF1602_01376 Cytochrome c-type protein NrfH
MATSSNESNLKKNKIFKYLIPSLVGIVIGLCGYIFYLSKAHSYLSDDPKACVNCHIMEPE
YATWLHSSHGRNTVCNDCHVPHDNVFRKYYFKANDGLRHATMFTFRMEPQVIKMHAPGQK
VVQENCIRCHSTLVSEVRLGKVTAPMAHADNGKLCWDCHREVPHSRVRGLNAAPSSPVPI
IDDMGENTPQWIQDLVKDKK
>SEQF1602_01377 Cytochrome c-552
MKKRNWLLVGILAIVTFLLGLLANSIMNRSHEAEFIAKGGNNLEDQECRNELYAQFYPRQ
YDSWEATADTTFQSKYMSSQDDDLLALRPEMVILWAGYAFSKEYNAPRGHMHAIEDVTKI
LRTGAPTDSTHSPQPGTCWTCKSPDVPRLMKKVGLEEYYSAPWDKWGSEIVNPIGCATCH
NTKTMKLEVHQPALAEAFARQGKDINKATHQEMRSLVCAQCHVEYYFKGDKKYLTFPWDE
GMTVEKMEEYYDKEGWTDYVHKVSRAPIIKAQHPDYELSQLGIHGQRGVSCADCHMPYKT
DGAVKFSDHQISSPLRNISASCQTCHRQSEEELRKNVYDRQDAVYGMRIKLEKELAKVHF
KAKFLWDNGATEEQMKPTLALIRKSQWRWDMVHSSHGAAFHAPIESERLLSDGLIYALEA
EKNLDVLKEKLHIAAEFVMPDISTKAKAQKEIGLDIPKEEAAKKQFLKTIVPKWIEEAKK
EGRLVTQK
>SEQF1602_01378 hypothetical protein
MKSYPFAILFSLTAVVVGLVLQISLGSISKNWFSFPYNVVGGAIFVLLTTLSYFLFRKTN
FILRCSSAPFAIVTVVTLGVLTIGLGSINVKPHQLSGFLGKMGLDDLTKTWYFGLVFVLS
LTNLWFSILKRSMVYQCKNIAFLLNHFGLWLVMFAGVLGQGDIVRLTMDLKKDTPQWQAK
TSDDKVVSLPIAIELKNFSIDIYPNKLFVIDTTGTSLPKEKPIGFMLEREGAQATLLNWK
VTLHKYLEKAIPDTDSTYINHTMWGATNAALVTVEDLRTHQVKKEWISAGNFQLPPRAID
LDKGHTLVMAPPEARKFESEVLIYQKGSNTILQEKIEVNHPISVGGWRIYQLSYDERMGR
WSDLSVVELVSDPWLPVVYTGIFLLIVGGIALLFEVKKS
>SEQF1602_01379 Cytochrome c biogenesis protein CcsA
MWTYFNIITYLTIALWLLAGGLIYSKSKALWSLAVISHLVATMVVGGFIILLWKNLERPP
LRTLAETRIWYAFFMGLIGYAIFLLYRQKWMLSYSSVMGTVFVGLTYTHPDTMNKALMPA
LQSVWFIPHVIVYIFAYAMLGMASLTAFYGIYRYKKGQEIHSVFAITDQLIKIGYVFLTF
GLLFGALWAKEAWGHYWTWDPKETWAFITWLGYLMYLHHKYNHKEKKPLQSFIIVGIAFV
LLLICWFGVNYLPTAQMSVHTYSG
>SEQF1602_01380 Anaerobic glycerol-3-phosphate dehydrogenase subunit C
MNFHVPTMAELSAQGIKPDVLFWIGCAGSFDERARRVTKAFAKILHKAGVSFAVLGAEEG
CTGDPAKRAGNEFLFQMQALTNIETLNNYGITKIVTACPHCFNTLRNEYPSLGGHYEVLH
HTQLIQQLLEEGRLKVEGGMFKGKRITFHDPCYLGRGNGEYEAPRAILEKLEAEILEMKK
SKARSFCCGAGGAQMFKEAEKGTGEINNARAAQALEVRPEIIVTACPFCNTMLTDGVKNQ
QREVVPVTDIALLIEQAEEL
>SEQF1602_01381 tRNA (guanine-N(7)-)-methyltransferase
MGSKNKLKRFKENETFANVIQPSREEVLGGTFPLKGAWAKEAFKNTHPIVLELGCGKGEY
TVNLAKQYPDKNFIGIDIKGARFWRGAKTALEEQIDNAMFLRTQIELIDYLFAAEEVSEI
WITFPDPQIKYKRTKHRLTNEDFLSKYKKILSKEGIIHLKTDSEFLHGYTLGLLHGMGQE
VLYANHNIYRNEGAPSEVLSIQTTYEKQYLAQGKPITYIRFRLR
>SEQF1602_01382 Transaldolase
MKFFIDTANLSQIQEAEHLGVLDGVTTNPSLMAKEGIKGEANILKHYKDICEIVQGDVSA
EVIATDYEGIIKEGEALAALHPQIVVKVPMIKDGIRAIRYFSQKGIRTNCTLVFSAGQAL
LAAKAGATYVSPFIGRLDDVSTDGLGLIADIRLIYDNYGYETQVLAASVRHTMHIIECAK
IGADVITAPLSAILGLLKHPLTDIGLEKFLADAKK
>SEQF1602_01383 hypothetical protein
MGTYIEGDRDFEEIPSLSAKALRINLNKRIYGTFSEIGAGQETVRYFFRAGGASGTIAKA
VSAYDKNFSDALYGAEKDGRYVTEGRLKKMLSHEIKLLEERLPREKYPDKLFFTYANTVT
TIDFAKRYKGHGWVGIRFQTEPEGGYNDIILHIRFHQIETRAQQETLGKLGVNLIHSAFY
KADKPHSIIRYLYDHIDKDLIEIDMINFSGPKFATIDNRLMSLQLIKNGMTEAVMFDAQG
NNLLPAEELYKKNILTIRGSFRPVANVNIDMLERSLELFLKEKGVEKDNTEVIFEITLSN
LLASGELDEQDFMDRARILSSLGYKVLISNFKEYYRLAEYFSNYTKAQMGMVMGADNLIA
IFKEEYYTHLSGGILEAFGKLFYRDIKIYLYPMRDKDTGQIITSNNIQVPPRMKELYKFF
KFNEKVVDIHNYDAKNLEIRSRDIVQKIKNGEDGWQSSLPQGVAEMIETYGYFGWKKK
>SEQF1602_01384 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MKTNVLGYPRIGEKRELKKANEAFWEGNLTEEELLAVAENIRVHNWTLQKEAGIDLIPSN
DFSLYDQVLDLSFTLNVIPERFAPTKSLSELKQYFAIARGYQKDGIDVTASEMTKWFDTN
YHYIVPEFTKDQSFSIKVNKPLNEYNLAKKHGFETKPVLLGLVTYLLVGKEKEAGFHRLD
LADRLLPVYIQIIQSLVDAGAKTIQIDEPYLVLDLPEGAEETYRKVYTEIKQKFANTEFI
LTTYFGALENNTELAVSLPLDVLHIDLVRATAQLDSVLKALPQSKKLSIGIVDGRNIWKN
NFEHSLALIEKVREVISDDHIYIGTSCSLLHSPCNLELENNEKVLTPEIKQWLAFAKQKV
KELATLKAIAIGHDLSPEVKAIFEENKKAAENRRTSALIHNPAVKARVKAITDADSKRKS
AFGTRQKVQEEALHLPLFPTTTIGSFPQTPEVRSWRASFNKGTLSKADYDKKLEKEIEES
IRWQEQTGIDVLVHGEFERNDMVEYFGELLSGYTFSKFGWVQSYGSRCVKPPIIYGDVSR
PEPMTVRWSRYAQSLTKLPVKGMLTGPVTILQWSFVRDDQPRSETATQIALAIRDEVVDL
EKAGIKVIQIDEPAIREGLPLRKADWQTYFDWAIKAFRISASGVEDQTQIHTHMCYSEFN
DMIEAIADMDADVITIECSRSQMELLDVFADFKYPNEIGPGVYDIHSPRVPSEEEMYHLM
KKAIAVVPFRNLWVNPDCGLKTRHWEETKLALEAMVATAKKLREEYKK
>SEQF1602_01385 TonB-dependent receptor SusC
MNTCKHWLCLFAFLMVATLSAQTITGTVIDGELKEPLLGANVLIKGTSHGTSTDENGKFT
LKTTQKKGTLEVSFIGFKTQDVPFTIVKGKASIQITLLPDAQELTGTTVIGNTLMDIAKE
RKTPVAVSTIRAADIVNKIGNQEFPELLNKTPSVHATKSGGGYGDSKINIRGFGNENIAV
MINGMPINDMENGKVYWSNWAGISDVTSSMQVQRGLGASKIAIASVGGTINIVTRASDMQ
EGGTVSASLGNNGFYKVMGAYNTGKSKKGWSSSVLLSRTAGATYVNSTDFESYNYFFALG
YTPNEKHSFQFMFTGAPQWHHQRSTHITIADYLKYGEDGKPNLRYNSDWGNYKGSEFNFR
RNVYHKPVMMLNWDWNIDEQSSISTVAYASFGRGAGTRDAGSAWTGSFQQDGRPTTLTAS
NFRTEDGQIDMERIINYNRGEDVSTPNQTVAVHGTPYVANAYRKVTMPNGRTTGVTEGFA
RKAAVNSHNWFGFLTSFNHKLSEKFSFSVGLDGRYYKGYHYEVPSNLLGAEYFQDNSNKN
LTSPRNISYTLSDKPSFNPFGGSIESLDNQITFSNDGNVRWLGAFGQVEYTTQKLSAFAQ
WSSSIQAFQRIDHFLKPGTLALKNRPETAQPETTTYKSIPGYNMKAGANYNIDEHHNVFV
NVGYYSRQPFFNSVYPNYKNFVNPNLTNEKILGLELGYGFRWQSISANLNVYRTSWKDRY
VRRDNWDGNTRYFAEMLGVTEIHQGVELDAAYRINDYVKVNGMFSLGDWFYQGGARVNTF
LTEDNSEYILSGKSSSQFDVDLDKLKVGESAQMTANLGVVVTPYENFNIDLSWHYVNNLY
ARLDITSLVRSSQISSLKLPQYNLFEGGASYKFVFGKKQKQAVTVLANVNNILDTTYISE
SDTNQVVDNSTRDTYKGIDVRNRVFFGFGRTWNVGLKYQF
>SEQF1602_01386 hypothetical protein
MEVEQGYKITSAPEWANTLTDAQIIEICKDSDFATEQIEEGRDFCYLLNKYYYVDDQKNT
DYALMAYTLTQPENLERASVNDMILEENEYYEINRIAVIREGEYIDKLPDTNIKVLDNEN
NSNGGVISKSKKINVSIRDLRLYDILILEDSRTKVFSEKEFVRRDFVKHIFVTPDTYWAY
GHYHYKFINNREKKVAYKEFFFRDAKGNALDQPTKYLEKGEVLEIKHTDYINPVDPNREI
FPFIDFATESTWKDLSNYIYPLYKDVLEQSDLKSFAPDLIEKLDKLANLDEKIQFAIEYV
QNNIYYTYNADEMNGHKPQEPAITYHNKQGDCKAKCVLLKTILDYLGVEASVVLVNYNAD
FYLKYYLPSLLSFNHVIVKIHYKGEDYFVDATSRNEFGRLEKRTVLSFCHYMEIKENATL
SIRKPAYFALPCIDEHVKVVVQEGKGKITLRTTYRYNRANNMRGYFKQTNKKELIDGWNR
FLFYNLNYVNDRSEQDIREIFKDVSIKIEKDDKEENELVIAYEATILKPYFTNKEGEEFL
MYFDHSVLKKDLIDFRHKDSSYWHNYDSEHYLIELYADKPINTKEKYTIQELELSNEFFS
YSSKKTIDKTSGKVEILYNPLTNIEITLDKIQSIQEAYHSIGDSNFGLGIDILPKGFFGK
IKSWFR
>SEQF1602_01387 Ribulose-phosphate 3-epimerase
MLIAPSLLAADFANLQRDIEMVNESQADWFHLDIMDGLFVPNISYGMPVVKAIKEHAKKP
LDVHLMIVDPDRYIHTFAQLGSSFLSVHYEACTHLHRTVQAIRQEGMKAGVALNPHTPIT
VMEDIITDVDLLLIMSVNPGFGGQSFIENTYKKVSQAKELITKTGSKALIEVDGGVNATN
TPKLVAAGADVLVAGSFVFNAPDPKKTIEALKRSV
>SEQF1602_01388 RNA polymerase sigma factor SigA
MRQLKITKQVTNRETASLDKYLQEIGKVDLISADEEVELAQRIKAGDKIALERLTKANLR
FVVSVAKQYQNQGLTLPDLINEGNMGLIKAAQRFDETRGFKFISYAVWWIRQSILQALAE
QSRIVRLPLNKIGSINKINKMYAYLEQTHERVPSAEEIAKELDMSVNDVKESMKNSGRHI
SMDAPLVEGEDSNLYDVLRSGESPNPDKELMHESLKTEIERALETLTPREADVIRLYFGL
GENYPMTLEEIGETFELTRERVRQIKEKAIRRLKHTSRSKILKTYLG
>SEQF1602_01389 hypothetical protein
MKLHKFFTCILLTALFIGCTTKSDTYYNRQFRMIPTMYNVLYNGNLALEEGKKELSEKLV
ENYFEILPVELEALSEDYQLKGEGNAHFDRAEEKAIKAIQRHSMVFDGKQKNRKIDDAYM
LLGKARYYNGRYLPALEAFNHLLTNYGETNQRYNAAVWREKTHIQLGREQLAISSIEKLL
EEEKPKRKERANLHAILAQAYINLKQYPQAIQALKLASVETRNKAQRGRYLFITGQLFEA
TAQRDSAQVYYQKTIDLNWNIPRRLWVEAQIGKARTQRLSPEEKIAYVEKLRKMEKLYEH
KNLLDLVYFQHALYAEGENKDKEAIDYFLRSLAKNKENEGLKKRTHEHLGELYFKSKKYP
LAYNHYDSTLVYIPKNTLEYLYMRRKRDNLSQITVFENTIAKADSLSHIMKMPQQERIAY
FQKHIDSLQQPENKHTVAITDFGKVVRHQAQPSQDGFYFYSPQTVAYGKQGFKEQFGDRP
LVDNWRWSHQLVVENIAENQKDSLSSKTITPEEYLSNLPSEQQMKQLERDKEMALYGVGE
LYWEKFKDEKLAKDRLTRLLAITHDDKLREKALYQLYKIHQQNHPAQAEAYKNQLLAAYP
TSEYTKVVTGQVSTNEKQLQEQFSQLQQQFDNQQYQEVIAAIDAQKAAFKTSPQAPDWEL
LRAKALGRLEGKETYVRELEAIAKEYPNTKQADYVNESLEVLKKEENKPDFDTDQKASSW
KIVLEHFDNEAQKEQLKNYLEENGFAYISMSNDVYDANEQWTVLHGFMSREMAERFVEKI
NAFFQEKQQEKLPKGKKNKQEEKNEEKDRFFKEFFVISSENYAILQMYKNKEEYLKK
>SEQF1602_01390 hypothetical protein
MFNKENKKNMAVDNSVAGSNRIVAGTKIKGEVNSGADFRIDGEIEGTIQTSGRLVVGKTG
VIKGNIICTNADVEGSINGTLVVKSTLSLKTTAVIEGEVQTDKLAIEPGAVFNVTCKMGV
KGGATFSNEPTKKELK
>SEQF1602_01391 hypothetical protein
MAVIIVLCTYLGTYLDEKFLSISPWGTVLGALFGVFASLYTVIKQVNQMKD
>SEQF1602_01392 hypothetical protein
MRKYFLWCFFCTLLAHAQDPSQAQLLDDEQIQKQFPTKIQRKLGITYPIVKVYTYQDREG
KHFWVFTENKLYDSSSKKEKNYRRNSEGEVINDKIKAFHLIEDKDAFRQVKLLYDYRPEW
EGWEFSIWFWTKFVSFTDLDKDGYVDPVIVYGATPTDGDPDRAKVKILAYHKGEKTAIRH
QDSPDDIGRETQIDASYYSLPKPIRQRIFDTINRLQENQLTLFNPEDFKKLKK
>SEQF1602_01393 Phosphoglucomutase
MNLLEKSKTNAQSWLTPAFDAATQETVRQLLEGNPEELIECFHKNLEFGTGGMRGIMGIG
TNRMNRYTLGKNTQGLSNYLKKVYPNEQVRVAIAYDCRHNSQEFAKIVADVFSANGIKVF
LFSELRPTPELSFAIRFLKCHSGVVLTASHNPPEYNGYKVYWTDGGQLVPPQDKEIMEAI
DKIQFSDIQFVADESLIEKVDKEVDEAFINASLDKANFPIQGKADLKIVYTPLHGTSVTI
IPKLFERAGYTSLYIVEEQATPDGSFPTVKSPNPEEPEALTLALKKAEEVGADIVFGTDP
DSDRIGIAVRDLHGKMVLLNGNQTMLMMTKYLLDKWKEKGEKTGHEFIASTIVSTPLMRG
LAQGYGVEYKEGLTGFKWIAKMIKDFPNQQFIGGGEESFGFMVGDFVRDKDAETSSLLAM
NIAAEAKAKGSSFFKEMLKMYQEFGLYQEHLISVVKKGVSGAEEIAQMMKNLRENPVKTL
VGEQVVRIEDYQTSVSRNLLTGEETKIDIPKSNVLIYYTDKGTKVAARPSGTEPKIKFYF
SVNAPLPSVEAFEQTQKELLDKIQKIVKEWNL
>SEQF1602_01394 hypothetical protein
MLHFFKSIRRSVKHWYIHLILGILFILCGIGVIISPQASYLTLSVLFSLSFLISGITESF
FALQNTKNLNGWGWYLVSGLISLIMGIFLLMYPALSMFILPLVVGFTLLFRSFQLLGFAF
EEKEAGVLNWGNLAIVSVLSIILSFILIANPIFTGISLVVFTGLAFIFTGISSVILSFNL
KKLKGSAQKLSDDLKNRIEDLEKEVKEATK
>SEQF1602_01395 hypothetical protein
MNNFFYFFKSKCTTGGNKIKNNGIDTFIKELERYKIEWNFKKSINDKVIILEVGDLLFHF
NYDIFSYLYKITYSSFE
>SEQF1602_01396 Enoyl-[acyl-carrier-protein] reductase [NADH] FabI
MYNLLKGKKGIIFGALDENSIAWKTAERVHEEGGQFVLTNAPVAMRMGKINDLAEKTGAQ
IIPADATNMEDLQNLVVKAMEILGGKLDFVLHSIGMSVNVRKNIPYTESNYEYYAKGWDV
SALSFHKVCQTLHKNDAMNQWGSIVALTYIAAQRTFPDYNDMADNKAYLESIARSFGYFY
GKDKKVRINTISQSPTATTAGQGVKGFDGFITYANLMSPLGNATAEDCANYTVSLFSDLT
RMVTMQNLYHDGGFSNVGVTPEVIASMNK
>SEQF1602_01397 ATP-dependent RecD-like DNA helicase
MEPFSKEVFDLFQQKLKVGNRRGVHLNAIANNSRYKFDLSRLSAIFKSLPERFVLDLLTL
RNLKFSFSLYDTPSTDIDHRSYNTESQGKKLLEREDDKEQKGSPNEGKDRESLLEKLSTS
MDNLIFQSEAILQERGINALGFGFPILVRRDLTDGQITVAPVLIWSVRIRPSSQMSTWEI
SRTEEDPIYINEVLINHLQNDSHITIPPIPEEMLEDGKIDKNELHKLLTELLAQLKVNQN
LDFLENNYAEISPIRSKAYYEDLLPERGQALIEKAGLFSLFEVQKQNIINDYQTLKESFE
PKEITLKEDFQSFSSVATDPSQQEILEGLRTQSRILIQGPPGTGKSQTLTALLVNALENQ
QKTLVVCEKQTALEVLYNTLKEKGLEKYTILIKDSITDRKLVVDALRNTLDSNTFKNPVE
PYPLSLQKEQVAEISTLKNQINLHHSLLFSPILSQENWTDLAGKILEYEGIKTPIDLSSL
PLTYQGEEYEGIKKMLEKAQERYMPFAPYKESYLYNAKTLIEKSISQSQHYIEEAFASYR
SQWEQILSIYQDYEKEYKRLRQEEFSTQIETLNEYINEIETLTAMLSPDADQYHRERTNS
FFYRIGALFSSSKKQVLKEQKRLLWLFQEIKKISVHPNFSFLFLSDNLYSNKENILSYRG
EIEKAKQNFEANVSQAFEALDVLNFFEKKYTNPTFERLLSAIHALKEQIKKEHYTSFTDV
GTTFFEFRDRIIALLTQHAQYQEDKNNPFMIGYEWFSFYEPLSDLHKKCIGLLESAKANH
WEASFLHAYYKAFLLKKSGENPVFHPSTYDELRKKLRGFALSQTEIIQRYWDSAQRLAVK
NFETLHKDLSVANLYNKRKSEKHNRLPLRQIAQKDIDLLTCFFPIILTTPDTCCNLFQGT
YFYFDYVVFDEASQLKLEDNLPAILKGKTVIIAGDEHQMPPSNYFSKIFEGNYEDEDDME
DDDDLLVKNSLLSVESLLDFAQEYKYDKHYLNFHYRSRHPFLIDFSNVAFYRGKLRPMPS
LAQYTPIEFYQVGGTFHEHINEQEAEKIIDILRNIPEKPDGTYPSVGVATFNITQRNFIR
KRLLSLRNDPREEAFAQKLSLLEEAGLFIKNLENIQGDERDIILLSVTYGKKKDGKFIQS
FGPLNHQKGYKLLNVIITRAKEKIYVCNSIPQEFFMNYAEALAQEQSNNRRAVLYAYLAY
CKAVSENNESERQKILYSLSLYGNIEKEKTSLGQLLFKEEVFLYLQEKFPSLSLSKDKPF
GGYTIDVFIERDKGQPIAIECLSKEIYQNEMGYLEDIHKEQILSKVGVLYMRIHANMPIK
NYLTALEKLLANT
>SEQF1602_01398 tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC
MNRKVILTQDGSSTLEIEGWDEHYHSTHGAITEAYHVFIHNGLALFEGKEIHLLEIGLGT
GLNAFITFLEHERLGQTLFYEGVEAYPLLEEEVQKLNYVERLQVPDKMDIFYKIHQSPWG
TFQKLSDSFSLKKRQQFFQDIDDKEQFDLIYFDAFGARVQPELWTMPLFEKMYQALREGG
ILVTYASKGSARRAMQEVGFQVEKLPGAMGKREMVRAYKK
>SEQF1602_01399 hypothetical protein
MFTYYESAIKNDTLCELAKRKSIYDSAKKTFLLINQYAFRCSDGSVSISCNSLTFDIEVR
DANFKQVLDWFSENRKPQRVFNLNPKHGEYGKGAHSSNKGNKVSLLLCGRDEAEKLLLRA
INTDDRENKTLYFYDTNKKRYIEFKKESKNVYHGFHLDIKDEKRISQELKERIDRLK
>SEQF1602_01400 hypothetical protein
MIYKISIFIILSLALKCAMGKGDNNPKNSMSEATLIEGVNTSESFIKNIELKQYKYKGSY
IEDLKLDDFQKKDFRLEFFKFLKEQEFEKEEYAQVFFIKLLLVRIEQKDEAILYDILNHI
FKDDSLGYYLEDYNVYLYQLFLYKPHFFIKNAYKYADASIIDYINHSLPNALLTDEKTIK
NDMGEIIKDNDNQLLISEQQVDLFSLAALRDKIKKQSVIEVFYAPSLKRGWKEKTAAYYN
IYNYINEEISTSLTVEERKFFEENFYPMFQDYIKRV
>SEQF1602_01401 Ribosome-binding ATPase YchF
MKAGIVGLPNVGKSTLFNCLSNAKAQSANFPFCTIEPNLGVVNVPDARLEKLEELVHPER
VQPATVEIVDIAGLVKGASKGEGLGNQFLGNIRECHAIIHVLRCFDNDNIVHVEGSVDPI
RDKETIDIELQLKDLETVEKRLEKVTRAAKAGDKVAQKELALLGRYREALLKGISARAVE
LSEEEQELSQSYQLLTAKPILYVCNVDEASAATGNKYVEAVREAVKNENAQVIVLAVATE
ADIAELETYEERQLFLQDMGLGEPGASVLIRAAYRLLNLQTYFTAGVKEVRAWTIPVGAT
APQAAGVIHSDFERGFIRAEVIAYEDFISYGSESKVKEAGKMRVEGKEYVVKDGDIMHFR
FNV
>SEQF1602_01402 hypothetical protein
MKISKEAKTAIIILLGVGSFIFGYNFLKSTPLFSSDKNYHAVFTHSGGLQTGTNVTVNGV
TVGAVKKIQIDPATAKIIVSFSCKKDFTFSKNSQAEIYSSLLGNTGLQILPALDGAPQAQ
PGDTLPSHIQASLMDAIGANLEPTAKNLNKVLSSTDSLMTTFSRTLDAKAQQDIKESLAN
LNVTLQQMSRASVSLNNLLASAQAPLHKSLHNVETLSGNFVQLSDSLSKLQVGKLMAHVE
STLTQVDGLLKEVQKGGGTVSKLLTDPKLYNNLQTATSELGLLMEDIRLNPKRYVHISIF
GKKNKEYETPTKVETPISERISEQSSENQ
>SEQF1602_01403 Lactate utilization protein B
MAILLFILILAAGIGFFVRNMLRLRRAIHLGVAQDTTDHPKVRLLRMLRLALGQGKMGVR
PVAGILHLFVYIGFIIINIEVLEILIDGLFGTHRVLHFLGGFYNLLIGSFEVLALLVLIG
VTVFYVRRNILKITRFQKKELQGRPRRDANIILYAEAVMMTLFLVMNACDLLLQERGVTP
YVQAGAFPISQWLSPLFASLSSPTLILIERGAWWGHILGILAFLNYLYYSKHLHILLAFP
YTYFAPIKPKGAMDNLATVTREVQLMLGTIEDTGDTEETTPTFGASDIMHLSRVQLLAAY
ACTECGRCTDECPANQTGKLLSPRKIMMDTRRRAQEVSANILQNKGTFVPDQKALLGDYI
TPEELWACTTCAACVEACPMEISPLSIIVEMRRYIVMEQSAAPASLNKMMTQMENTSSPW
GYNPAERETVLNE
>SEQF1602_01404 hypothetical protein
MDIVPRALGYFLQYGFKTFTMDDLAHNLGISKKTLYEQFASKQILVDACLDYALEMSCCR
TETFFF
>SEQF1602_01405 hypothetical protein
MLVWIMLWRCLAVEQKHFFSKEDKSVIENVFLGQKEVEHLFNMKSARPLWELKRYFPDTY
KRMDKEFAQADALFIDMLFERGWKEGLFRKDINIKFYKQFYTQVQRLRSFEEAFDERDFP
FWETIYTMMEYFFRIIVNEKGMKELERVLSMINDQ
>SEQF1602_01406 Outer membrane protein OprM
MKHIFITILSICVGTSSLWAQEVGRELTLSQAIGYALQHKANAQKAQIEVRKSEYKIKEA
RANALPTIAGSAGLVYNPKLQATYIDGSAFAIPGMPVSNEPKKLEMGQEWASSAEVKLTQ
VIFNQAVFIGLKAARTTREFYQLNEQLTQNDIIEKVAQAYWQVYQGEQALENVRVNLELT
EKTAKIVEGSYKAGLAKKIDLDRVTVALNNLRSAEQQAKSGLQVATLALKYMIGMPMDEP
ISLPKEAFKADYSLVFEKGNASERTEIKVLEKQKELLSLSTKAQRGGLYPSLALQATYGY
LGMGPKTPIFYGKADKVYWSDYSAISLGLKIPIFSGFGTRAKIEQAKMEEEALEATLKDT
RLALDLAQESAQTKLANNLLTIQTQEENVKLANEVLQNTQNNYHEGLASLNDLLESERAL
SDAKNSYTNALLSYKLAEIELLKAQGKLGTMINE
>SEQF1602_01407 hypothetical protein
MKKILSLALIVAAFIGCSKSSDDPKENGIPASYYKLSEDGLTLLKWEDTNTTSLDMQADS
KLQKVNTIAANAFRDSKVENITLPNNLKEIGDYAFINSRLHTITFNTSSSVTFGQAVFED
TQLVSVKLPNTKEIPASSFSGCVNLKEVQFGKTEKIGERAFRGCVALTQINLDNTTLTEI
GERAFAGCENVEKVILPSTIKKIDKVAFFACFRLSTLIVKAIEVPTLVDPNALNNGSSIR
RNILVPSSSVQKYKGAPNWNFYSDEISAILEI
>SEQF1602_01408 hypothetical protein
MKRFLFSAVCIFSLLPPSLARACSPLLLTDSSPLQESVYPLDSLQRDTIAAIAPTDPVVA
KPYVNPWSLAIPAVLIARGAFSIDSHFDHKLQRYVVENVKGKVRADDYVQYLPIASVFAF
PNLGLPPAHSLKERLVIGATAYALTAIFVNATKYTVRHHRPDTSTHNSFPSGHTATVFTG
VEILYQEYKHYDPWIGIGGYAVAAGVGLLRIHNNRHWASDVVAGAGIGILSAKLSYLLFP
YTSRILGKRKQPLPIEKAIPETSSSLSVLPIWEPTHNTFGAALTLQF
>SEQF1602_01409 DNA-directed RNA polymerase subunit beta
MLTNQSSRINFASTKHVPDYPDFLDIQVKSFQDFFQMETKSDARSGEGLYSTFKENFPIT
DTRNQFVLEFLDYFIDPPRYSVEECIERGLTYSVPLKARLKLFCTDPEHEDFETIVQDVY
LGTIPYMTGSGTFIINGAERVVVSQLHRSPGVFFGQSYHANGTKLYSARIIPFKGSWIEF
TTDINNVMYAYIDRKKKLPVTTLFRAIGFERDKDILEIFDLAEEVKVSKTGLKKYLGRRL
AARVLNTWHEDFVDEDTGEVVSIERNEIILDRDTILEKEHIDQIVESNAKTILLHKEDER
SVDYNIIHNTLQKDPTNSEKEAVEHIYRQLRNAEPPDEETARDIIDKLFFSDQRYNLGDV
GRYRMNKKLGLDIPMEKQVLTKEDIITIVKYLIELINSKAEVDDIDHLSNRRVRTVGEQL
AAQFGVGLARMARTIRERMNVRDNEVFTPLDLINAKTLSSVINSFFGTSQLSQFMDQTNP
LAEITHKRRLSALGPGGLSRERAGFEVRDVHYTHYGRLCPIETPEGPNIGLISSLAVYAK
VNNMGFIETPYRKVENGKIKLDELIYMSAEEEEGLKIPQANIQVDDQGNILDERLVVKED
GDFPVISREEVDYIDVAPNQIASISASLIPFLEHDDANRALMGSNMMRQAVPLLRPEAPI
VGTGLEKRVVTDSRVLINAEREGTVTYVDADKIVIKYDRTEDEILVSFDSELTTYDLIKF
RRTNQGTCINLKPIVRKGDRVHKGQVLCQGYATEQGELALGRNMKVAFMPWKGYNFEDAI
VISERVIREDIFTSIHIDEYTLDVRDTKLGVEELTNDIPNVSEDATKDLDENGIVRIGAN
IKPGDILIGKVTPKGESDPTPEEKLLRAIFGDKAGDVKDASLKASPSLEGVVIGKKLFSR
AVKTKQKRAKEKDEMAALDAAFNAKAEALKDVLLEKLFSLVNGKTSQGVFNDLGEEMIPK
GRKHTQRGLKEIEDYTHLLSGGWTTDEHTNELINDLIHNYKIKLNDLQGMLRRDKFTLTV
GDELPAGIMKLAKIYIAKKRKLKVGDKMAGRHGNKGIVARIVRDEDMPFLEDGTPVDIVL
NPLGVPSRMNIGQIYETVLGWAGQKLGKKFATPIFDGASLEQITEYTNEAGVPAFGHTYL
YDGGTGERFDQKATVGVIYMIKLGHMIDDKMHARSIGPYSLITQQPLGGKAQFGGQRFGE
MEVWALEAYGASSTLREILTVKSDDVIGRARTYEAIVHGDTMPEPGLPESFNVLMHELKG
LGLDIRLED
>SEQF1602_01410 hypothetical protein
MLYITIPEESIEESYREVFVHLYTTVQALGGSIRYSFEKAKNPLQERESNGSSSCESASC
PAGLSHERLGQILTKVCRLTGCLAQEICSTSRVPKHLYARLFLVHLACQEGATVSQLCLL
LGRAPSTIYRLRKQYDQEALYNPAFRKIVKSEELRVKSEK
>SEQF1602_01411 hypothetical protein
MWQEDKPQLLLAQISKVGNGLSPVGFVEKLRDFAPLREQPEPVARMAIGLIVTQHAALIG
IKGTIDAMNKEDISNLVCSRFAHLALEELHKAFQLERYGELGEATAHYNLINAPYIAQVL
TKYVSWLRKTRQNHPHLSLERTPREETPPAPPSRERIEALVQQMQQQYLQTGQMPLFCSW
LFDAMRQVGMLPDFSPEEKNSYRLATRRNDSNSVKRTDPDTTPPPPSMRKSP
>SEQF1602_01412 hypothetical protein
MKDSFVFYRDWLNVMEQLPAEIQLELYQAVAQYALNGKTPTLSPMAKIAFGFIQQTLDRD
EDKYHKTVVSSKVSGRMGNLKRWHKDLYQKVLKGALSLEDAEDIAQAMKKSPPDKKNRPP
KNLSLNDNDNVNDNDNDNDLSFLEKKKQKSASVKKSGIEEIDFQELSVETLKEEKEKNSA
QKEKEKSSAKAFTPPSPAEVAAYCRERGNDISPESFCSFYASKGWRVGNQPMKDWRAAIR
HWETRRAHENKQQSFPKNKQSQPLVIDENGNILSAETNNNTTQANTYVAGRQTAASLSAN
LQGW
>SEQF1602_01413 hypothetical protein
MGAIENMGEFEMWANFNSPLQRAQTYSHHARNAFFCVLTCIFTHIYMYIRQRSDNTRVGA
NCNSPFHMGGQLKTWVNLQCGRI
>SEQF1602_01414 hypothetical protein
MNKEEFLSLLTEKFSAMDAAHLETLAASLAAQQPDAHQGQALVNKLTAEQVADYLAATPP
TPTGITPSVAGDTPSAADSLDKRIEESVRKAVLAFEQRLSLFETQQKQQLQHNRLQEVLA
QCQDSNFRMQSLRDFPLMHFATPTDFEQYLQQKKNDVQQANQTLANRSLALQHPPFYTKE
TPRQNVSPAVVSFIQLQANAQQQFKGKQV
>SEQF1602_01415 hypothetical protein
MKLHITESYPSPGLFMHTLADLSGGVTITTEVLGGAKLIAGTPIGKDSLGRYAAVKTART
STTLTSASATEIKIAKGHHFLPGDYIAADTTKGQKIKTVNKQNPEYDLLTLETALGVELP
KETPLFQSKGNDLLPKVTPVALASYTYLVPMRDNLFCAAWVSCVVSEALMPPMPKTIKDA
LKGVIFL
>SEQF1602_01416 hypothetical protein
MNASLMTGLNQTDLQAVVGSYNLEQYYYPTLFPLREASTLSWRMLQGQAGLKVAGDIIAR
GASIPKKNRKGLSKLSGDIPKLSIAREKNEDELTEYDLMVAACGANPDMLSLIEFWADDT
KACWHGIAARAEWMALQQISLGRFSLTTENNASVVSQYDLDYQIPAAQKIGVEASYNNNT
TGKPLSKDFIKALRLGQQLHGVSYKYAFMNVDTFLKFASQEEIGKRCAPYANAPLADAPD
LSTVNAYLAKHAETYRGLQIIVIDQEISLQSISGETRTGNPFEDDVILFSESKVLGNTYW
KAPIDMKMTSSHALKVLHGHTLIKKYSEESPVREVTEGIANLFPAWNLAARSILMQTNST
SWNKN
>SEQF1602_01417 hypothetical protein
MEQELMTNALYLSRTLSPLGIEKETLELLLLKAQLSPQAPVEIARCDRAIYQFFSLILAP
ASLKKSEGAYSQSWNLEALKEYYTALCYELGERNILFPSHAPKLNDQSQIW
>SEQF1602_01418 hypothetical protein
MQLSLVVFLYDGAATGVVAFGVVGNKDKGALGDVWGIAGEVHHIGEAAEGGIGGLYMMVE
AIGQRYFLPLAIGLLQAATGKGAREGTRRPCAIRPLLREGRSKKKKIMRVKHFE
>SEQF1602_01419 hypothetical protein
MTFEIETHLYQLLSTPEVRKRLGLSGGIYLGNDRPNDSQKEDIVIQCLAYRYLRPKGQPP
SEKLPPPSGQAQILLYVPDHYVYMGRIGAQYVSPRYRLKELCQEVISALRASWIQGNIHY
IIDKQTLTSFPKIHQHAATITLRF
>SEQF1602_01420 Peptidoglycan hydrolase FlgJ
MQPLSPYVFKKQYIPYALDSERLTGISALFSLAQAALETGWGAHTPGNMFFGIKATALTP
DHLKQLLRTQEILPKPARKGDFPEILSITPLPNGKYLHVVKDWFRRYDSPAESFLHHARL
LTRNPRYRQALLHREDPLAFAHFIAQAGYATDPDYEGKLRRIIRKINEQ
>SEQF1602_01421 hypothetical protein
MKFFFFSLLLLVSCRSVKKSQEHTQLFQQRDSVEAYHEYRGESLLREWHSQEIALEVVPA
DSLAPAASSSPLPAPPLLLSPERVPSLSLSPKRGYPLQGVVISQQKTAQGQTLSIQGAKV
LKLHFREKALEEQLKQHEQRTTEKQTHQRHIRDTRRETFDLRRHPYFSLFLWGVAMLLLF
LLHPRKQK
>SEQF1602_01422 putative dual-specificity RNA methyltransferase RlmN
MKDIRALKKEELQAFFLSHGEKAFRANQVYEWLWTKGAHSFEQMTNLSKETRQLLSEHFV
INHIKVDTMQRSEDGTIKNAVRLHDGLYVESVLIPTDTRITACVSSQVGCSLNCSFCATA
RLKRMRNLSPDEIFDQVLTIDQQSRLYYGRPLRNIVFMGMGEPLMNYPNVMKAIERITSE
KEGLGFSPKRITVSTSGVSKLIRKMADDKVKFRLAVSLHSAIEETRNKIMPWTVDFPLTE
LRTALQYWYQQTKSRITYEYVVWKGINDSPKDVEALVAFCRFAPCKVNLIEYNPIDEGLF
EQADEKALQLYKRKLEEAGITTTIRYSRGKDIDAACGQLANKNEK
>SEQF1602_01423 UDP-2,3-diacylglucosamine hydrolase
MTTVYCSPLTENMEINLPEGKKLYFASDNHLGAPTYKESRERETRFVHWLDTIKTDAGAL
FLLGDLFDFWFEYKTVVPRGFVRVLGKLAELRDSGLPIFFFVGNHDLWMDDYFPQELDIP
VYRSPQEFTCRGKHFLIGHGDGLGPGDKGYKRMKKVFTNPFCKWLFRWLHPDIGVRLAQY
LSVKNKLISGDEDVHFLGEDKEWLVQYCRRKLQSKHYDYFLFGHRHLPMTIDLGGGATYI
NTGDWIHYYTYAVFDGEFCQLVGKVKNEE
>SEQF1602_01424 hypothetical protein
MKVGTIELWYTICERSIGEVIVNYMIRPEETDEILAVKYDLNGEILAIDWES
>SEQF1602_01425 hypothetical protein
MKKLLLIVMVAAHFVAFGQKKKKSIPPPPEKITKQKVQKSPYRRIFEDNMMLAFQWRMEV
KDSIIANEDRMIYKINLEFLSVKELRSYKKQPISAQKIIYSVEKGAKLDKNLTPRMDYTD
FVDYPSIFESVKIVGDNVELTNDETKEKEIFKIFLDKDKKNIIKLQDLKTKKEFFPTEDF
YSPIISI
>SEQF1602_01426 hypothetical protein
MRVFLVLLYLYASYVIAQPKNETFDFKLAKELKYKRGVLLRDIYMKEGCRVYDIYFDKEE
GGYIEESLPSPSFITRRKDYYPNGKIKSIKHFIGENVLIGKSVYYNKKGVKRIVDEDKKF
KKIKYPYILQFLEKKGHINLKTGEGRIVNIRGTNYFGFEIFYVEEMNMWEAIIKDGYPKD
KCLEKYIELAKKEKQKREKDHLIVCSERNCDLYYFIDAISGKQISKQEYAKRYRAAFGEE
DEGFDYIFTEP
>SEQF1602_01427 hypothetical protein
MKGTYYKTPIDFKALIEKRDLAKTTLETSIDQQLFLLATTAWGECKFDEGFGAGIGISTL
FAC
>SEQF1602_01428 hypothetical protein
MEKIANLYKEVKYHEQAISYQAEYFIGGCNFEILINGFPIERYYGLGNGALSASVPINTA
ILKSGLQSWKIRIFPIHINGIPQKMIEGGARVQLKIQAIRFKDNGDIEKISTPVIDFEVP
LKKEKETGKNIFVDMGKPYVEYCGTFQANVPYQLKGWQDGEKFDLSDSLNLKKEVLNKFN
ELRNMIINKEENKFEESILYKEKEVAQALFINEKESKDIAKFYTAAFDGTLQNFNMTSID
NEELVYYCEDRVVTLLFTAMKCPRCKGEPVLVGRYEEENRKKVRIFPIYLYRPKGKKELE
VIR
>SEQF1602_01429 hypothetical protein
MKNIILTLAILLFNCHNAQNTGEMKIQQIPLEKQITYGISLSMRVPYELYINDIKADCDY
VGANSGVDMNPYILKNGKYKVKLRIFPAFKAGEKLIVSKDIKNSNISFDSYIRNKETNEI
LNYNSIPLPIVAPKEDVPYFEQEWDVELTELPYELEGWSKGQDLRKWDKDKLEKKVVAFH
QKIRKILNDGNSEEWMKLIQKRFDEVCIFDYLSEKRIEKDLEEIKEDVEEYSKGTMIPLE
DYELKLYAEGKLVTLERKTHTKEFNNYSPLDIKGWSPLISKGTTYGAAPYPILLYLPQGS
DEFVIIRR
>SEQF1602_01430 putative peptidoglycan glycosyltransferase FtsW
MERFRRYLKGDISLWGVILFFALLSFLPVYSSSSNLVYLERTGISTRGYLIRHVGLIAAG
LLIIYLIHRFPYRYFRPLARLGLLLSWILLFFALLKGSTIEGANASRWIYIMGISFQPSA
FAMIILLMYVASYLAEVYETKYSFVESILPLWLPVGITLAMVTLPNLSTGAMMYAMVLMV
LYIGRYPIKYILGSSILAVLLFALFMLVVKAFPDAFPHRVDTWKNRIETFMSKDKEENYQ
SERAKMAIVSGGFWGQGAGKSVMKNLLPQGSSDFIFAIVVEEYGLLGGSALILLFIIMLV
RFVVISMKATTIFGKLLVLGVGIPIVFQGFVNMGVSVGLLPVTGQNLPFFTTGGTSIWMT
CMALGIVLSVSSHGVKSDERKVKSEQGSEVSEQGSVNSEQGSEVSEQRSDIDERI
>SEQF1602_01431 UDP-N-acetylmuramoylalanine--D-glutamate ligase
MKLVILGGGESGTGAAVLGKQKGWEVFLSDKSPLKEVYKKELDAKGIRWEEGQHTESEIL
SADCIIKSPGIPHKVPIVQQAKAKGIEIISEIEFASRYTDAKIIAITGSNGKTTTTTLVY
HLLKEAGLSVAVGGNIGYSFARLVAQEPKEYYVLEISSFQLDDITSFHPHIALLLNITPD
HLDRYNYEFQNYIDAKMRITEFQQAADFLIYDADDPVTAQEIGKGQVKAQLLPFSLEKTF
ERGAWSLDEKNMYVNVNQNIFEMSTKDLTIKGKHNLKNAMGATMVAKLLNVRNENIRNSL
MTFQGVPHRLEFVREVEGVRYINDSKATNVNSVYYALDSMEEGLVWIVGGQDKGNDYTPL
IPYVSKKVKAIVCLGLDNQKIIQTFQSIVPTIIETHSMEDAVQVGRGLSQEGDTVLLSPA
CASFDLFQSYEDRGNQFKHYVNML
>SEQF1602_01432 Phospho-N-acetylmuramoyl-pentapeptide-transferase
MLYYLFDYLHRAYNLPGAGMFQYISFRAGIAAILALLIATLSGKRIIGLLYRLQVGETVR
DLGLEGQKEKSGTPTMGGIIIILALLIPVLLLTRLDNIYIILLIITTLWMGLIGFIDDYI
KVFRKNKDGLKGRFKVLGQVSLGIIVGATLYFHPDVTVKNENAQASRMVQTQAQRRPLSE
MAEVKSTKTTIPFMKNNELDYASLIKWTGENYKHWVWLIFIPIVIFIITAVSNGANLTDG
IDGLAAGSSAIIVFTLGIFAWISGNTIFSEYLNIMYIPHVGEVTIFIAAMVGALIGFLWY
NTYPAQVFMGDTGSLTIGGIIAVLAIMVRKELLIPVLCGIFLIENLSVMLQVAYFKYTKK
KYGEGRRIFLMSPLHHHYQKKGYHESKIVMRFLIVGIILALISFITLKIR
>SEQF1602_01433 hypothetical protein
MEEKELQEDKKGILSKKTYNFAIRIVKLSKFLRESNEYVLSKQLLRSGTAIGALIREAEY
AQSISDFVSKLSIALKEANETLYWISLLYDTEHFDEKIKNSFQKDCDEIISILVTSIKTG
KKRINQKGVKSGFV
>SEQF1602_01434 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase
MLLKELLQGVEVLQTIGDTSQEVGNITQSSRDITPNTLFFAIKGAHTDGHRFIPEVIAQQ
GKVLVVEDLPEALAEGVTYVQVTDTSRAMGQIAAHFYGHPSEQLRLVGVTGTNGKTTIAS
LSYQLFRQLGYKVGLISTIAIYIDQEREETHNTTPDVLTLNKVLRRMVGQGVTHCFMEVS
SHGIALHRIEGLVFAGGVFTNLTQDHLDFHETFAQYRDTKKKFFDHLPKTAFALTNIEDK
NGAYMLQNTSAHKSTYALGRAADFKGQLLESTFAGMTLRVGNHEVWTSLIGRFNAYNLLA
IYATAVLLGEEPLEVLTQISTLRSVAGRFQYFVSPSGVTVIVDYAHTPDALQNVIETILD
IKDPSQRLITVVGCGGNRDKGKRPIMAHIATSLSEKVILTSDNPREEDPEEILREMEAGI
TPENQHKSMTVTDRRQAIKVACHLAQKGDIVLIAGKGHETYQEVKGVRTHFDDLEEARGV
KSEERRTKNEECFE
>SEQF1602_01435 Stage V sporulation protein D
MSKEIQRDRIVNLRTILVGIGLFIFAIAIVSKLIGLYFNGQKYRDLIAENTIKEFVIEPN
RGNLYSDDGSLLATSITRYDIHFDAMTPSKKNFDTHLKALSDSLGRFFSRPSSYYQEALR
GARKNKNKYFLIARGLGYDECARIRQFPLFSKGAYKGGLIVEGRSSREYPLGAIAQRIVG
YERTDGQGNTFKVGLEGAFSKYLSGVEGRHLKQKIAQGQWKPIEDSNEIEPKDGYDVVST
ININIQDIAHHALLKQLETYQADHGCAVVMEVATGEIKAISNLGRNKDGSYGERFNYALG
ETYEPGSVFKTVSLVVALEEAKIDTTYTVDTKKGVISFYGREVWDSNRRGYGTINLSKAM
QVSSNTAIVQMVHDLFGKDPKKFVGRINKMHLNRKLGMPILGEGTPFVPQPNQRGWSGIA
LEWMAFGYGLEMTPLQVLTFYNAIANNGMMLKPRMIREVKQWNKSIQKFDVEVLNSSICT
PETAEVVKKVLENTVKYGTGKSLYSPNFSMAGKTGTAQKDYKDKSKLGYISSFAGFFPAQ
NPKYSCIVVIHNPDKQIGYYGADVSGPVFKSIAQKIYTNSLLIDTIDDIETTSPQVAKSY
GQYNDILSKYKTIVPNVLGMEAMDAIAIMENLGLSVTIEGTGRRVTAQSIAGGEYIGGRK
TIRLKFL
>SEQF1602_01436 hypothetical protein
MQRIKEEFVKLFKADFLIGAHAMRNWAVILFVLLIGIIMIYSGHLIDQKIYAIAKLEGEV
KELRSEFVDVRSRLQKVKLESTILSSLKDTGLKQSPTPPNKIKVLVKDE
>SEQF1602_01437 Ribosomal RNA small subunit methyltransferase H
MQENSYHIPVLLQECIEGLSIDPAGTYVDVTFGGGGHSRAILERLSPQGRLFAFDQDPQA
QANAIADDRFTLIGQNFRHIKRFLRFYGVKEVSGVLGDFGVSSHQFDTAERGFSIRMEGE
LDMRMNPEQPLSAKEVVNGYSQEELSEIFFRYGELSQSRKLAQAIVQRRETAPIATTADL
KEVVQKYFPKNQENKHLAQLYQAIRIEVNQELSALEELLLQLPDIVKPMGRIALISYHSL
EDRLIKRFIRDGQFSGEPEKDFYGNIQVPFRKVGKPILPTAEEIARNNRARSAKLRVAER
VLSEE
>SEQF1602_01438 Transcriptional regulator MraZ
MIQTFVTYECKADSKGRVTIPVGLKAVLESELHKGFILKPSIFKGCIELYPQGEWQEIME
KMRSKLNLFSKQHLDYLRKYTAGVKEVEVDGSGRFLIPKPLLEFAKIDKEVVLAPALNFI
EVWDRECYEAEIASIDEEAFMALTEKIMGADAGE
>SEQF1602_01439 Foldase protein PrsA 3
MAVLEKIRKRTVFLILVIGLALFAFVISGIFSRNTTPDQLVIGSVNGDDISYREFSTQVE
NTTRNMGGSIGQGYIVNALWQQAVQGKIIDQQFEKLGISVGKEQIFAMIKRVPQYAQDPQ
FQDEKGQFSIAKFAQVIAQIKKVNPAQYQQWQAEEKSYVDAAKRELYLSLIRAGLGVTLK
DGEDAYHRQADKVTFNYVTLPYTSIPDSEVKVSDAEIDAYVKAHKKQFEQKEMRNIQFVW
VTETASEADIKQVEQSLQALNAPRVVYNSQRQANDTLPGFGALAAKDVPQFVNENSDVPF
DSLYVSKDRLPADHAEALYNLPVGDLYGPYKEANTYRYTRMLSKKPNAQMRASHILIAYK
GSLPGNETITRSKEEAKAKAEDILAKVKAGEDYAALAMVNSDDSSNAPNGGDLDFFSPGM
MVPTFNDYVFHGKVGDIGLVETNFGFHIIKITDQREGVQLATIVRNIEPSKATQNEIYTK
LTAFNEQALQHPKDFASLAAKAGYNVLPANNLDAMAEDIPGLGNNRALVRWAFADDTKVG
DIHREDVKDGYIIAQLTKKISEGVASASDARPIVAPILIKEKKAKQLSEKLKGSTLEQVA
QASGQAGNIQTAENVTQEYPALPGQGSEPSVLGAAFALPQGKVSQPIAGDNGVYVIQVTQ
KDIAPALPNYSSYMAPLRNQKLNRASQDLFSALEATADIKDNRAKFY
>SEQF1602_01440 hypothetical protein
MSSYNSHWGILINKKIKRIIVNFNIPTSKFYSFILLENRIIIKDYYLFRFYDDIFQYIDM
KKSKFILEWRDIIQEFCFTSKDFFKSKKKKTFEDFETELIIKEVYLLNSFPQYDIFHFEG
RNIISEKLLNAFIENNITGYEVSEYDVLKLE
>SEQF1602_01441 hypothetical protein
MKYFTIDESIDLDMIGEYPQVSPTENCVLGSPFSNERLSFGEIPNKIPYLELEFNKKAKK
NRSIELL
>SEQF1602_01442 hypothetical protein
MKLAALDGFHPNMLQNGIGLEKYTELIGNGIHGNHPVYNKYVNSKLDKFLEKIRI
>SEQF1602_01443 hypothetical protein
MKFKKIKEIQKVKAFDPKTEVYSVYEPTKGIFFNEVFIPLENVPLDIIAIDQKIFTVDGA
RCLKIWQDGILLKTIEKADLLSPSNDKWVWKYYLDKKDYKNYFNILDLEINQLIFKEYIP
YKLYVEKNIIIAYDIFEGEIKRINTDIETLWQFTIASLGDSPYPDEEDKIYKMIGIVHGN
LWVYTQQYRLIVLDIETGCVQYHTDCFGVQLDEVTKNIFSIASNGWTVIDTQTLTVKESY
FFSEEDPNMGQYKSIFDPLLQGDYFTFVGSKPKEHWGIGWIGIFDYKARKLVWEHELIPE
EERKNTRNHLAATQPLYMSGNKLYIKDVKDNLYIFEREE
>SEQF1602_01444 Hemolysin C
MLTSIIIILVLLFFSAYFSGMEIAYVSSNKVQLEIEKKQGGVIGSILEKLTRKPSKFIAT
MLVGNNVTLVIYGIEMGKLILSYLPEYFHGILWQTIISTLVIVITGEFLPKVFFQIYSNT
LLRALSPVTYVLYLIFSPITAFVIWLSDNILHVFFNTQGDVTRLTFSKEELENYISEQIE
NMSEDKTMDSEVQIFQNALGFSQVKARDIMKPRTEIIAISIQESVACLRDLFVRSNYSKI
LVYQENIDDIIGYVHAFDLFKKPKTIREFLRPITFVPETIYISKLLDTLTKKHQSMAIVF
DEYGGTSGLVTLEDIVEELFGEIEDEHDQIHTKELPISDKEYVFSARLEVEYLNEKYKLA
LPESENYDTLGGLVTDVHESIPERNEEIEIDRFRFLVEEVSDNRIITVRVFIND
>SEQF1602_01445 hypothetical protein
MIHTYIKVYFLKNIVGLLVLTMFFSCEEAAKKSADSQEKIPNGETYNFRLIYTDSTKVRT
VLESALNKDFSTQKFPYTEFPKGLVLKLYDEQAHENIIKARYGIYYLPTQMVQLRDSVEI
ITYDGKVLKTSELFWQANTDWVFTEQPFEYIDSLQGSITKGIGMDFDKRFTHLKAHKITG
IIPVKE
>SEQF1602_01446 hypothetical protein
MKKKLLYGFLLMGTVTAFAQKQDCPMKASVYVEAAKLKNYDEAYPSWKFVYDNCPELYQS
TFQYGERILRDKISKGVDKDKYIKDLQELYNKYNQYFPQKFSAANNQIHQAYILIEHNKG
TKEELFALLDGVYKQDKDAFADDTAIYQYFATALDLYKANKKPLQEVFDVYDNVSEIIEN
ENNKLSVRMNELLPKEEANTLTEKEKGQLQVARTRVENLKNITESVDNSLGQLADCKNLV
PLYQKVYDANKDNTEWLRRAAAKLSDKECTTDPLFVKIVERLNQLAPSASSALYLGILKE
KQKNTTEAVKYFNQAVDLEKDPLKKSSYLVKIATKYSGSTAVSYAQKALSFNPSNASAYQ
VMAQAYASAANDCGTTAFEKRAVYWLAASTARKGGLEKLAAHYDKLAPSRADIFSSGLAG
KTITFKCWIGQSVKVPQL
>SEQF1602_01447 hypothetical protein
MKIRLILALLMVSFAYGQKGTNSPFSYYGLGDRRYEGNIENALMGGMNAYVDSTSVDVRN
PASLAKLKRTVFSLASSYDIRRMHSQSDSYSERTFLLDYVNLSFPIYKNLGFSVGLRPYT
SVGYRLLSKETVQGREQYYSYEGSGGVNQAYMALGYQVINGLRIGVAGGFNFGRSNLSNL
YSSPVLAYITREDSQSLYRGGSFTMGVQYERALTEKLSLNTGLSYKPQTTLRSDNNLTLY
SLLPNNGNFIIKDSREVTDASLRRTHLTLPSEWAISAGVGNPNEWFVGATANFVQMQDFS
NPFVTSSFVSYENAYKFSVGGFYLPHNTAYTKYWKRVTYRAGFYYERTGIVLRDKSINDY
GMTFGATLPMKGLSNVSFGATWGRKGDTSLLKENYFTLHLALTLSDKWFQRTKYH
>SEQF1602_01448 hypothetical protein
MMTAYTPVLGRQAVIIVTNCKYPTFLAFTQEKRKVSLLNFCLLKNMNFKPLKNNKIEINE
KFFRIFLEKHLQERKKVVPLHPN
>SEQF1602_01450 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MRIILSGGGTGGHIFPAIAIANELKKRFPTAEFLFVGAEGKMEMQRVPQAGYPIVGLPIR
GLQRKASLSTLAFPFKLLSSLWKAYRILKKFRPDMVIGTGGYASAPTLKIAQWLGIPSFI
QEQNSYAGVTNKWVARGAKGVFVAYDHMQRYFPHSPIFLTGNPIREEVIDIKDKNPEAFT
CFSLDPDAFTLVVIGGSLGARKINELVKTHLDFFQEKKVQILWQCGSYYFEEYRQYDSPQ
VRVLPFVEDMKAAFAIADVILSRAGASTVSELAVVGKPVIFVPSPNVAEDHQTKNAQAIA
DQNAALLLREADIDSHFAPMFSTLWSDPAKRKELSDNFRKLARPHATQEIVNIMINEQ
>SEQF1602_01451 hypothetical protein
MKTIFFYLFLMSFTASFGQKQRTDLQEENLKGKVKTTITTYYNAVLRDGKIVRDGYPKYR
YYSKEVVYNKDGNMLNVKEIGKDAFVQQYYFYDKKGRKIKKQESKHHGEPELASKYSYVQ
GKCIEKLYIIGELYCIDTFKYNAQGDPIEKRSIGVGQYRQDYDYRVSLKYDSSRRLIVTN
LSEEQRITKYTYNKEGHLEKEILSEDGDWIETTLYKYISFDSQKNWTERIMYLTDDAGVS
KPFFIETRKLTYYEK
>SEQF1602_01452 UTP--glucose-1-phosphate uridylyltransferase
MKITLAILAAGLGSRFGADKQIVPIHGDSILLDYSIQDAFAAGFDQVVLIVRSEIEEALR
THLEKKFPSEKLAFVCQDKHNPVERKKPWGTGHALLCLKELVDTPFLIINADDFYGRHSF
QMMAEALRTGKEKTFYSAGYRLGNTLSENGTVSRGICTVSADNQLLSIEERTKLLKTSDD
EATDERTGERFALSSFVSMNFWGFTPDIFEMGVPLFQDFIAQYEDDPKAEFYIPTLVSHA
MAQGYVVEVVPTDAVWFGMTYQEDLAVVKREIERLSRGQ
>SEQF1602_01453 3-dehydroquinate dehydratase
MRVIIINGPNLNLLGQREPSVYGADSFEAYFATLQQAYPQLELSYFQSNHEGALLDKLHE
VGFSYDGIILNAGAYTHTSVALHDAIRAITTPVVEVHISNTFAREAFRHHSYIAAVAKGV
IVGFGMESYRLALESFLFND
>SEQF1602_01454 Alkanal monooxygenase alpha chain
MIAMDKLTMGVLFPIEAFEGPIPQMNKEEQIRLAQQAESLGFDTLWVRDVPLFDPNFRDV
GQIYDPWIYMAHIATLTQSIKLGTASMVLPLRHPIHFAKAAASIDRLFPGRLHLGVASGD
RAIEYPAFNKPYDNRSIDFMRQIETIRTFWKDDFPHYNTSFGKMQGETDVIPKPVNKRIP
MYITGHAGGINLNWIAQNGDGWIYYPREFAYTKNIIQNWKEALKKHNQVDKPYIQPLYID
LLEDPSAEPINIELGFRLGRNYLIDLLQTLKFMGVNHTIFIAKFCSRPMAEVLDEIGKEV
LPHMNE
>SEQF1602_01455 Histone deacetylase-like amidohydrolase
MEKYALLHEQLLWEGVAEEEDFFAPAKVSIADASLAHDRGYVEAFVGLHLPERTRIRIGF
VQSPQLVARELTLVQGTIDGAHYALEEGIAFNIAGGTHHAYSDRGEGFCMLNDQAVAAAY
LLKTGRAKRILIVDLDVHQGNGTAEIFAHREEVFTFSMHARDNYPFVKEQSDKDIELPKQ
TTDKEYLSLLEATLPVLFEQHRPDFVFYQSGVDVLGSDRFGLLNLSIEGCAQRDRIVFEE
CQKRGIPVQCSMGGGYSPKLSIILEAHTNTFREAQRIFY
>SEQF1602_01456 Ribosomal RNA small subunit methyltransferase B
MRLHRNLVDAVVDGFMQINNDGLYADKVIERLLKRDKRWGSKDRAFIAETLYELVRYKRL
YTEIAQEKAPFTVQSSRRVFAVWAVLRGITLPEWYFEGTPERRIKGRFDELSRVRALRES
VPDWLDALGVAELGEEAWGEELHALNQQAAVVLRVNTLKIDREALRAQLAKEGYETEPLE
GYPDALQLKKRANVFLSEAFKQGLFELQDASSQRVAPLLLGAWNPSQGSLKVADCCAGAG
GKTLHLAALMGGKGKIVAMDIYPQKLDELSRRAKRNGAYNIETRLIETKYLKRQRGTFDR
VLIDAPCSGLGVLRRNPDTKWKLTPEFLEEIRQTQAQLLAQYSLLVKEGGSLVYATCSIL
PSENEQQVQHFLASEAGKRFTLVEQHKISATQGYDGFYMAALRVKSEE
>SEQF1602_01457 hypothetical protein
MFQQILSFCLPAVIVAVLAYFFFQLYFKNEDKKRNYQLLKDLQREALPLRLQAYERLVLL
LDRTSPQKLALRVAPATADKQAYELLLIEHINAEFEHNITQQIFVSENLWNVILISKNAT
LQIIHRIATDTNIPDAQKLREAIITEFTNKPAPSTNAISHLVNEINTFIGK
>SEQF1602_01458 Fe/S biogenesis protein NfuA
MKLQIKYTADPTIVQLEAPVVLVKGNYQYSKGDNTQDSPLAGELLRLPFIKTVYFSANFI
ALQSTGNIRWEEVAPELVGQIETALSQGEALVYLPGEETQETAPKRIPVTIYVESTPNPM
AMKFVANKKLVSRPYEFKTIEEAENSPLAQALFGFDFVKSVFFDANYVSITRLPRSTPWE
EVMMETREFLRQYLMEGKTVVKVAVSEEDRPKGLPRLGDIYSKKIVALLDQYIRPAVSSD
GGNIEFVSYDKETHKVKVVLQGACNGCPSSRITLKQGIEGLLREQLKDDKLTVEAVDNV
>SEQF1602_01459 Low conductance mechanosensitive channel YnaI
MIFDFVLERYPQIIATVVTLILFFILKRFADSLVNRFGQRAHFPKARVQLVKKYIDFLLA
TLVSVVIVSIWGVKPDQIFLFISSILTVIGVAFFAQWSILSNVTAGIIIFFSFPFKIGDK
IRILDKECPIEAEIKDINSFYTLLITASGEHISLPNNVLLQKAVVIVEPNEV
>SEQF1602_01460 Sodium-dependent dicarboxylate transporter SdcS
MKTEFISAKRVIILLLATLFSGSMLLWLPYEAQTNRGIALLILVAILWLTEVIPITITAL
AVPILSIFLGLVETKPALQHFANPTIFLFFGGFALATSLSVNGLDRYIAHKVLSLARGNL
LVAILLLFLVTALLSMGISNTATAAMMIPLGVGLLKGLPYEENKKAYWFVILGITYSSSI
GGMGTLVGSPPNAIVSSNLHITFQEWLWYGMPVVAGLLPLTIIFLYFFFRPNLKDAIISP
KGEQTHQVATTLGKKQWAAIVIFVLTALFWVFSTQINPVLSGLFGLEKIADFDSVIAMTA
AILVCVFNVVSWKQIQENTDWGVLMLFGGGLTLSAVLTSSGASKAMVDSIVEVIRSQNYF
IIGLLVSTFIVFLTEFTSNTASAALLVPIFISIAEQLGVNPTGLAMIIGIGASCAFMLPV
ATPPNAIAFGTGLLPQRVMLKTGFWLNIISILFISIVGYYFWNK
>SEQF1602_01461 ATP synthase gamma chain, sodium ion specific
MANLKEIRNRISSINSTMQITSAMKMVSAAKSKKAQEVITAMKPYANTLGTLLQSLKDAL
GNENPFLERAEEKRILIVAITSDRGLCGAFNSAVVKHTLSLLQKYPGKEVEVLTIGKKGN
DILKKTDKVSRYCEGFYDHMDFQKTASLAQELIDAYLSGKYDRILLVYNSFKNVATQILT
EEVFLPLQISEQEEAAQSEYLYEPSAQEIVQGLIPKSLKLQIYKVLRDSLAAEHGARMTA
MHKATDNATTLRDELTLTYNKARQTAITNEILEIVSGANALNG
>SEQF1602_01462 hypothetical protein
MYTCKIYQGAIIVNGSFAFEMLGGDFATFAKGAYKHLGIDYPKFFKMDALSKLAFLGMEY
LLPTLPSQDKEDMALLFANHSASLDTDLRHQASIEDPKNYYPSPAIFVYTLPNICLGEVA
IRHNLKTENSFFVFDQYPEDFFDSYSQYLLQEGIAKKVLCAWVELMAEDYKLLINVLG
>SEQF1602_01463 hypothetical protein
MKKMFVLASLALIGVACSKNDDNVAVYNGGGNNGGGNKAISSSTISGDPFITEEPAVFPT
QKEGTDQEYDITTYTLENNKVKSVVIDHYQNGQKVNKKTITTNVTYNDKGLPTKLEQTED
GLTRTIEYIYNAKNQIEEIKATHNNTTARYVHEYDAQGRLSKMTFSATNEQPYTITYEYP
TANTVVEKNSTNTNESLTYTFENGNLTKKVLERFYQGNVVGSAIEEYKYDTTIKNPDASL
EFKLVDLNYFLEEDRYSPERSKNVVTEITKSGTDGQHELPKRISATYTYEKNDKGYPTKR
TTKEGNTSEVTTYTY
>SEQF1602_01464 hypothetical protein
MYSFSGKIKLVAIISMVVGLLGIGYSFIATPSTVEALGAHASHDPAHAEHVLHLLQNKPW
AALYVAALFFMLISLGVLAFYAINRAAQAGWAPILFRVMEGITGYLPIGALIFFLLLVFS
GLHFNHLFIWMDPAVVAHDKVIQGKTGYLNVPFFLVRAAVYMLGWIAYRQITRKLSKAQD
QAHDNRPFVKAFKWSAGFLVFFLVSESMMSWDWVMSVDPHWFSTLFGWYVFGSLIASAIA
AIILVTVTLKSQGYLEHVNDSHLHDLAKYLFGFSIFWTYLWFSQYLLYWYSNIPEEVTYF
VTRLEHYEPIVLSMLAINFLLPLLILVDSDIKRKPWVVGTMAVVILVGHYLDFFNMIMPA
TVGDQWCIGAGEIGSVLFFFGLFTFVTFRTLTKAPLVEKNHPLMHESEHFHY
>SEQF1602_01465 Cytochrome c6
MKKRYILSLLIASCALTSCFHKDKPNYQYMADTDMYFPVGYETYQEAPQGNQALKNGMEA
QLPPEHTIKRGWMPFLYPNTNEGYEQAKANLKNPLLADSLALKDHLKEGAALYNIYCMVC
HGAEGDGQGILVQRDKYLGVPNYKDREITQGSIYYVIYHGRNAMGSYASQITEKERWQVA
LYVEQLRNKLLNK
>SEQF1602_01466 hypothetical protein
MSKKVVHAIYNDDDVLMDAVKKVRAANLKIEEVYTPFPVHGLDKVLGLKHTRLAIASFIY
GCIGLTVATLMMKYIMIDDWPRNIGGKPNFTYITNLPAFVPIMFEMTVFFAAHLMVISFY
MRSKLYPYKKAENPDPRTTDDHFLMEVASDGNEEEVVKFLESTGAVEVKLADKKAIQI
>SEQF1602_01467 hypothetical protein
MASHYEAPIRNPLIVGDKTYHDVTVDVARPVEGKANRLWWIVFSIALTAFLWGLGCIVYT
VSTGIGVWGLNKTVGWAWDITNFVWWVGIGHAGTLISAVLLLFRQKWRMAINRSAEAMTI
FSVVQAGLFPIIHMGRPWLAYWTVPIPNQFGSLWVNFNSPLLWDVFAISTYLSVSLVFWW
TGLLPDFAMLRDRAVKPFQKKIYSLVSFGWSGRAKDWQRFEEVSLVLAGLATPLVLSVHT
IVSFDFATSVIPGWHTTIFPPYFVAGAIFSGFSMVNTLLIIMRKVCNLESYITLQHIELM
NLVVMITGSIVGCAYITELFVAWYSGVEYEQYAFLNRATGPYWWAYWMMMTCNVFSPQFM
WIKKLRRSILFSFCISIVVNIGMWFERFVIIVTSLHRDYLPSSWTMFSPTLIDIGIYTGT
IGFFFVLFLLYARTFPVIAQAEVKSILKSSGEKYKKLRDANPNNSH
>SEQF1602_01468 Menaquinone reductase, iron-sulfur cluster-binding subunit
MSSEKKYWRSVEELDTNNPVIEQIHQNEFVDKLPTLYSGEHEFLGNQEAMEESSTTRRDF
LKYVGFTTAAAALAACEGPVHKAIPYVVLPEQIRPGIPDYYATTMADGFDFASVLVKTRE
GRPIRVENNREAAYRGCGNARVQASVLSMYDSLRAKNPQKGSENITWDTLDTAMVKALND
AQAQGKQIVILTGTLASPSTENLIKEFTEKYPNTKHVIYDAVSEEAAVLAFEKKYGERAL
PDYDFSKAKVIVSFGADFIADWQGGYEEEYAKGRIPTKTGKMSKHYQFESNMSLSGANAD
VRVALKPSELKIALAKFYGYLCGKSVGGSLPERAEAALKKAAEQAMKAGGQAIVVTGIQD
VNAQSLALEINEEVLHSQALNYDNPVYIRQGNTTALKQLLTDMNAGKVGVLITSNVNPLY
TLPAADAMAFESGLSKVGTSVAFTLRADETALKTTYLAAAPHYLESWGDVRMRADYYSLM
QPTIRPLFDTRQLQEALLKWAGKDANYYEYIKAFWKANILAEGYAWEKAQHDGFYYSPKE
RVLAEKSFVQDVAPMLTALTAAPAQGFELTLYTKTGLGDGQQANNPWLQELPDPITRVSW
DNYLTMSAADAKELGIKNWHVANGGLDGDYAEIQVGDVKLKVPVLIQPGQAKGSVGLAFG
YGRKAGMKKEMQVGVNAYALYNNLNPVQPVASIKKTEGTHEYACVQLHNTLMGRGDIVKE
TTLEEFLTKDAHQWNKKPEVSLDHKEVKATSVTLWKEFDNSTGHFFNLSIDLNACTGCGA
CVIACHAENNVPVVGKSEVRRSRDMHWLRIDRYYSSEESFEGDMQKVEGIEGLSASLSTF
GEMETPSDNPQVVFQPVMCQQCNNAPCETVCPVGATSHGLQGQNHMAYNRCVGTRYCANN
CPYKVRRFNWFLYSNNNEFDYHMNDDYGKMVLNPDVVVRSRGVMEKCSFCIQETQAVILR
AKRENRQVKVGEFNDACACASACGTGAMTFGDMNNPEDPIVTLSKDERMYHLLEHIGTRP
NVFYQVKVRNND
>SEQF1602_01469 Menaquinone reductase, multiheme cytochrome c subunit
MKKSKNHKGSKLQKLWLLAAFLPIYLFGQDASGDAAKGKDLFKANCAACHKLDGKLVGPP
LGGITEKKSAEWLHKWIKNSKALIDAGDKDAIAIFEEYNKVPMLAYDGILSDGDIDNVLA
YIADPSKAEAATPAATDTPATATPDTATASADTPAAAPTAPKGKGSLALVLGIASAALLL
IFLAIVFKTNREIKKLAKENNQEEYLKQSKYYPLWNVFVKNKIITVVVGLLLFFTSTYFA
YGYLMQVGVDQGYQPIQEIHYSHKIHAGDNQIDCKFCHSAARTSKTAGIPSLNVCMNCHK
TIDEYTGPVTAQYTKEFYDGEIQKLYQAVGWDPENMAYTGVQKPVKWTRIHNLPDHVYFN
HSQHVTVAGVACQQCHGDVQTMEVVEQHAPLTMGWCINCHRTTEVNDANPYYEKIHEQLA
AKKGKGKLTIAELGGLECGKCHY
>SEQF1602_01470 hypothetical protein
MRLIILTLLLGSYTLAFTQNKIKGEWYLYELFGKKTSMDMYRLERQTKEKRGYKVNFIKN
KIFIASSFTSSKDDCSPSTHGVYEKINRHYVSFHVDFFSVYGIGCGGEDEKIDADLGKFY
IHFPSKGVLYLIKSTGDLDYDKQLAQDAEQINDINSIAKYVFKRNGENISYNPSFKEEVA
TYVAQVLKLPHYRVSLKFSVGRYTGDVALVKDLETGTYFYVVKDNAAQEEATQKENKYFH
FTSEELKK
>SEQF1602_01471 hypothetical protein
MKKILVTFALFYTILSSGQELIGKVWNSNHIFGKNPKENNLYILTKPYDPEGDWGDHIEL
SPDGRFHSWYSAKCGNDCFRDSYGTYEKINAFYIRFHLSKITNSCDVRTQKKKETSLYYI
HKVSERKIYLIKSTGDLIKDQQKAMNSEQ
>SEQF1602_01472 hypothetical protein
MKDPTDEEMMHHFNKHKTDFEMIRQVIAEDTISAFDYPPILVEGKYKNVKDSIYFNQLSI
SKKRKLDSLLQNIQCSGITVLSDNEISFNYYSYGGIGWGVDKNFLYTKKNFSQMSDVEIC
PPEVDMSEKRYDSMKNCYLVKELGDNWYIELNYDR
>SEQF1602_01473 hypothetical protein
MRILLLFLVVFLSCEGGKVQFVESKAIKGVVLVKNLSQSPDKVKKAIIEYIKNQKGKDFM
EFYEYSSSTKVFIESKRVGGYLREYIHHYQEQNGIGVFYIGKCKEDTSEQVGIIRYYEKY
GNFYEPDTIIGECRNKKAF
>SEQF1602_01474 hypothetical protein
MLVEKFIPKAYSERVEAAKVRHRAYSNIALVKYWGKRDEQIPMNPSISFTLSHSYTETVI
EMAPRTDFTSSFQIDFFFDEEPKDNFLPKIETFFTRIRNYIPFLRDYYFVIRSSNSFPHS
AGIASSASAMAALAVCLMKIENLFDPEMTEQFFHEKASFLARLGSGSACRSTYSGVVLWG
EHSAVMGSSDLYGIPMEDVHEVFNTYQDTILLIDKGQKPVSSTKGHQLMIGHPYAEARFL
QAREHIAALKSILKKGDLEGFMDLVESEALALHAMMMTSDPYYLLMRPNTIAAIEKIWYL
RASTQKPLCFTLDAGANIHLLYPKAYKADIIPFIERELKPLCQDQEVIYDEVKSEP
>SEQF1602_01475 Neutral endopeptidase
MNKISLLLSLSLVAACGNPAKEAQNKVEEKGLDLSAMDTLVRPQDDFYNYVNGGWMKTAK
IPADKTSWGTYYMLDEITENNCLSILDDLNKKEYPEGSEGQKIQTLFRQYTDWSTRNAQG
LAPIEGQLKKIDAITSLADLQKYLEEATLTGNNPICSWGAYADMKDSNTNVAYLSEFSIG
MGSDYYQKESPSNTEALQKYEGFVAQVFEAIGEKNPKEKASKQVAFEKSIAKLMLTNEES
RDPNLSYNPQTMTELKALVKNLDLPALLKNVGMTEDKVILSQMRLYKDYDKLINAANLPL
LKDYLKYMLVLSNITNLNEQLDNLSFEFYNKYLRGQQEQRSITKRAFGVIDGSLGEAFGK
LYVEKYFPKESKEQMLTLISYLRKSFVEHIKNLSWMSEETKKKALVKLDKLGVKVGYPDK
WEDYSKLIIDPKASLAENLQHISQWYYQKSLDEVGKPVDKSKWSMTPQTVNAYYNPLYNE
IVFPAAILQAPMFNFEADPAVNFGAIGGIIGHEITHGFDDSGAEFDADGNLQNWWSPADK
ANFEKATQALAKQYDQYEPVKGIFVNGIFTNGENIADLGGANIAFDALQMYLKDHGDVGK
ISGFTQNERFFIAWATVWRSLTTDQNLANQIKTDPHAPDYLRAFAPLTNVEAWYQTFQVK
EGDKLYRKPEERIKIW
>SEQF1602_01476 GTPase Era
MEHKAGFVNIIGNPNVGKSTLLNALVGERLSIITSKAQTTRHRIFGIVSGDDFQVVFSDT
PGIIKPAYQLQNSMMDFVKDAFEDADILIYMVEIGEKELKDADFFRKINQAKVPVLVLIN
KIDRSDEETVKQAVAYWQQQVPKGEIYAISALENFNVAPLFHRILELLPVSPAFYPKDQL
TDKPERFFVNETIREKILLNYKKEVPYAVEVETETFSETDEIIRIRSIIMVERDSQKGII
IGHRGEALKRVGTQARYDLEKFFGKQIHLELYVKVNKNWRSDLGQLRRFGYSN
>SEQF1602_01477 hypothetical protein
MYLIIKSLHIIFVVSYFAGIFYIVRLLIYHTEALQGKSEPERGILHRQYSFMEERLWNII
TVPALVIVVLTGAYMLWATQWAYLLQGWMHIKLLGVVFLLVYHYWSWRTLRELQQGHTRY
SSVKLRMANEVATLLLFAIVFAVVLRGLFLSYWWATLLSFVAMGALIMAVVKIVNRKR
>SEQF1602_01478 hypothetical protein
MFDSQFSSLPPLQAIQFLQSGRDTTAPDPAAARQALDPRQHPVNNPLLRRDKRVSTSEGL
YTEPVARIALPLQQLIIKRSVAFLFGKPVRYEYTKDTQEHEQAFAILENILAQAKENSLN
RRLARAVFSYGECAELWHALPLATPSLAYGIPCAFKLRCSLLSPAFGDSLYPFFDAVGDM
VAFSRAYTADDPSSSLHGKAAYFETYTADFHYLWKNTLGDWTLEEGYPVANPIGKIPVVY
AHQPQRETQIVDPLIERLEHLLSNFAETNDYHASPKIFVTGHIQGWSKKGEAGSIIEGDK
DASMQYISWNSAPESVKLEMDTLLRMIYTLTQTPDISFQNLHSMGTPSGAALKLLFLDAS
LKVQDKREIFDAYLARRLSILKEYLALLHIPLREAAASLQVKAMIQPLIND
>SEQF1602_01479 hypothetical protein
MKRIAIFLTPLVLLYAYDKQIALRDRLYYLWHTLSTCAPIVVLTNYFYAWQQTHQAFIIA
LVVALSVNLVIGALYHIRNHSFSWRALLIKNAQMLGVVAAVYLLLDLLKVPLRETSTGEV
FESTLQMMTLLYPVSKAIKNIFVLTHGKYPPSWVIKALYNYEKEGKLKEFFVNE
>SEQF1602_01480 hypothetical protein
MIKKLLLLSLFCPTLMWGQEYLRKNLNEEGSTYIKASLSATFWARYYEANPHTQINGTEV
SRVTDFSVRRLRINVQGQLTPKLYVYGLFGGNNYNFTSKNEDRIGILDLYADYQLLPELT
LGLGKFGWNGSRNAMKASGSMMGLDAPSFPLFTVNKNDDAVRSLGAFAKGQIQQLSYVFT
IKSPYTVTTEPKEGVVDYAKNAPHKQYSAHLKYDFWELESNKTPYTAGTYVGKKKVLNLA
LGGVYQKDMMSELQNSVVKYYDYKNFSAELFLDTPLSECNDAITINAGYYYTDFGRDHIR
YIGNNNGSPSIMKVSSNEYLNGAGAAYPMMGSGSTYTLLAGYLFGKSEKFDARIQPNISV
QYSKFHGLNDAMVAYDLGANIFFKGHSNKLSFCYQNRPIYNQQKEVAMRKGAFIVQYHIV
LN
>SEQF1602_01481 hypothetical protein
MKKFFILFLLVISFCNCSYKKDSDPCDMGPYKLYIRVKENSPEYSSFFKQGEIDDNAIFL
KIRDKREQHISSIKKGLSWIEGYNANDIMLDGGTLPRDFFKDNSGETLLLKNRTKTYTIL
IKGASQENECGEVYEVQELMVNDGKATFVLGSRYFIIDL
>SEQF1602_01482 Putative 2-hydroxyacid dehydrogenase
MKAVFLDRNTLSSHMELSVPQGVTQWLVYESTSPEQLLTHLAGADIAITNKVKIRREHLE
QLPQLKFIQLTATGMDNIDTEAAKELGVTVRNVVGYSTESVAEHFFMLMLASLRGLKPYH
TAVETGVWQADGRFCLTEPTLLDLHTRTLGIIGVGNIGKAITERAKAFGMRVLWAEREGK
APRNSDYTLFDEVLAQSDILSLNCPLTPETHHLICERTLAKMQQKPLLINVARGAVVDPQ
AVYDALQQDKILGFATDVFEQEPPRKDDPLMQLAQHPRVLLTPHVAWASQYALDKLWKKV
KEQIEQFIQ
>SEQF1602_01483 hypothetical protein
MKNKEQNLTFRSSLFFLCLLLCACKQSKENTPEDSTPAPTPTEEGKITFLSENPSPVVAY
DSIPKPIYTDDIDLYEPNRSFDFKSIYFSLSTIYNNDSLDIPPQYIKEQKKMSREALSYF
PLEGKYRQNIFERMKLTPKDTIFLYSYQENQLRKYPLADTRSVAAVNVYADIENISAWDY
EVGFELKRAKDSIVSPLSDVFFNSFVYIGKESPFSLESGIRQMQWKKVSPKEFPASYKLL
DDNYLVGNTYKYVSAEVICYVQDFDFDSSKSEDTYYGSKRYFVAVDAKSKKILKRAFFEE
GESTSFAPLDNGQMSPFIGRFLKGKPLAIYGLVYESFGCNPIIFLDDAYENIYPRCDNRH
>SEQF1602_01484 3-oxoacyl-[acyl-carrier-protein] synthase 1
MKNRVVITGMGIYSCIGTSLQEVQASLYEGRSGIIYDAERKKYGYRSALTGAVPAPQLKE
LLGRRERISMGEESEYAYMATLEAMATARIDADYLKTHEVGILYGNDSVAESVILTNDRI
REKQDTTLVGSGAVFRTMNSTVTMNLSTLFALRGVNMTISAACASGSHAVGLGYLLLQSG
MQEMILCGGAQETNKYSMGSFDGLGVFSMREDTPEQASRPFDASRDGLVPSGGAATLVLE
TYESAQRRGAPILAEVVGYGFSSNGGHISTPNVEGPAQAMARALANASMQASQIDYINAH
ATSTPIGDANEAKAIHQIFGSQTPVSSTKSMTGHECWMAGASEIIYSILMMQHDFIAPNI
NIERLDEDSQKLNIITHTQERPIKAFLSNSFGFGGTNSALVVKSEK
>SEQF1602_01485 hypothetical protein
MSIRQLFKHTAIYGLATVMPRLLNLVLTPLHTSARTLSQAQYGLYQGLFAYMILGNVLLT
YGMETAFFRFMNREEDPKRVAATCLTSLVVTTLVFLGVGLLLSQSIAVWLSYPAIYIRYA
IWILALDTLVAIPFAWYRYSGQSLHYAFIKIGNVTVNLGLNLLFLLYFPFLESKGYRLPL
MELVSDKTQYIFLANLIASLLTFIYMLPLYKRIGFLWDVALWKRLFQYAFPVLIAGIAFS
INEAFDRVFIRMLYPASQADAVVGLYAGCYKMGVFMTLFITAYKLGVEPFFFSNAADKNA
PQTYAKVTEYFSIFAGGILLFVCVYIDLFKWLLIPNRAYWEGLKIVPFVLMANLCLGLYH
SLSVWYKVTDRTHWGAIISLIGGGITIVANLSLIPLWGYMGAAVATFLAYGGMMLLSLWI
GQRKYPIPYPWQRIGGFLLLSAGLSLAYFYIGERNLFVGSTAVIGYAFLAYKSVKRVKSE
K
>SEQF1602_01486 Deoxyuridine 5'-triphosphate nucleotidohydrolase
MEVKIINHSGHDLPAYQTAQSAGVDLRACLKESVVLHPMERRLIPTGLFIELPDGYEAQV
RPRSGLALKHGITVLNSPGTIDADYRGEISVLLINLSQENFEIANGERIAQMVFAPYTAA
TFVPTEKLSQTERGTGGYGSTGKQ
>SEQF1602_01487 hypothetical protein
MKKSVFKYIIIEDDKNIWKNITARMERYLQWHPVSPTDNLEEAIQLIQTHRPELIFTDWS
IRGGNSYPILSHIHRNMVGYTPYIIFFTGYQGENPEIPQVVFNEFPLVKKYLVKPIFLQL
TENLSQYVSEAEALAEGEKETPVFIENYLKQSVRVFPKQILCFLQDEQNPRLKVLHTLSG
QAIHLKLTWEEIHRFCAEYQLPIFLANARKAIVNRDYIIRTNKPFLWLEGGLRVQVSREQ
WAALEAENKDGKS
>SEQF1602_01488 hypothetical protein
MKRLAHTFLQAFKNGLLSLCVPKVALLCPNHTSLKAFFTLPLRRNVSLLTTLCLLLSVHV
SLSQSLPQWEHRALQYTRYNINKDFFSMNQPLQVGSEGELLFSSEENELYALHNTEVELL
FKGENIGVFHKKYKLLDNYFYGFSKAIYTGISYKNLEQQEIGFPDGEYSHFVLIDKIIYF
TIYSATESLYKLMSYDGKFFQEVERNPDPIFAISVNSVPYRCILSEATTSLRSLTSKEPE
TTFPEPFLPIYMRSLSDFYFIRSDKEGLFQYNHTVITQVLPANKSENKNGGRYYLYNDSN
GLTLYDLEKQLSPVVITTAMKSAAYKAYSEDSHSLYIAGGNQFYRIFTYLKSYPRLYNHT
NTDGLLAIALTPSGKLWAGSYNGGFSVIDSLKIEESPLRNLQCANGALAIGEKVLFNTQQ
KGMYLFRSPTAYQKVSDTIVSTCNFLTSGRVLYTAVQGNGLAYKALEHLEIRTPWRRVTG
KEGLALNHCQGIAEDFQGNIWVISMQGIARYIPKKDKAQTLFFDKKQTPIRGYAILKDSF
GTLWFGTEKGELYRWVPKGTKQLDPTNFQIVNHPLLTGNIRPIVFLHQWRDFLIVGVSNR
ILVLSLSDFYKGKIRVRYLNPYAMNLQSPIEHTCVASRDSDDHIWFASSNMLFQWNIAQW
LSLPDYPVEPTLTINTGKNTYDSRADAPIILGANESSFDIQLHYQSKDNLPRYVNASLRK
ENSDDVIDQGAISIDTEYRYQNLSTGNYVFSLVVCQTDGSFTRYEYPIIIKKYFWQDTFF
WILIILIPILTGGYLLHNMRRMDRQDKEIALLTIGNLGKQFRPHFMLNALNSLGAELYDN
PHAERILSHIGENISIMHRYSQDKTPFIPFEQEWKLTENTIAIQKEIFLPDLEVQVENFG
AIPPDYRLPMGIVQVIVENSLLHGLRHRTEPPYQLRIAFWERPNMYGISISDNGIGVAAS
KKMAGVQRHGTGLKNIERILKILDKHFDDAITITMTERDKDDLKYPGTTTIIHLKKSINY
EKISL
>SEQF1602_01489 hypothetical protein
MGIIATLIIGAIAGWLGGTIYKGSGLGLIGNIIVGILGSGVGYWLLGSVLHISLGEGWIG
AILTGAIGAIVILFLINLISKKK
>SEQF1602_01490 hypothetical protein
MKKLFTLVTLICISLVAFSSISCSKNDDPADNDLFVGTYKGKISFLKGEEKKSFDNGSVT
VVKTGNDYYFRFSDGIEDLKGVSFKKEGDNRLVNIDFEDGVKYIKIDASSLTMLYTTDGK
TWTANAKR
>SEQF1602_01491 hypothetical protein
MSKIANTLLGLAAGTAVGVGLGILFAPDKGKNTRKKIKDSITDKVDELKEQVESLTKNLR
KKTSDLKESLEEKVDNLLAESKDKSEDIISLLEKKIASMKKEAKK
>SEQF1602_01492 hypothetical protein
MAEIYTYESYKELMDNLLKEGKTSGEDQSEFMVSLTKLNRQRIKRLDNTLELTAEQTAFF
ANLIGEQSWVVISECWCADAAQILPVIAKVAEANPHIHLSIVLRDENPELMNQYLTNGGK
AIPILIISDKATGKVLHVWGPRPKTATAMVEAYKKEHGKLSPEFKEDLQKWYNQDKGQSI
IQDLITLFS
>SEQF1602_01493 hypothetical protein
MKILLSPAKRMAASSTSYPMVGVPTQALFQKEIAQVLAPLRALSPRELAPLMDISPRIAE
QSWQHHQEISLPLNEKNAKEALFAYRGDVYDGLDADTLSSEEVLWLQDRLRILSGLYGIV
RPLDLIAPYRLEMGTKLSVAGKATLYEFWEEKLTQALKNELEKDEPVVNLASDQYTKVIN
RKKLPVPVVDIVFKNWKGDTLKTIVLYTKRARGLMVRYIAQERVTTLEQLKGFQKGGYHF
SEELSHENELVFVGG
>SEQF1602_01494 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MLLYEKFQESKGVTTDTRKELKDTLFFCLQGENFDGNTFVPLALEKGAKWVVTSDPQWNS
EPKAIVVKDTLWALQELATYHRQKLGTPIIALTGSNGKTTTKELIYSVLNQSFNALKTEG
NLNNHLGVPLTLLRLTFETDIAIVEMGANHPGEIARLCQIADPDFGYITNFGRAHLEGFG
SFEGVIRAKSELYQYLKKDNKCIFFSEDNSLQRELLEGYEPTYSFSLEGREGANLQLSLL
KSIPTVTLEWAGQEFSSALIGNYNATNIAAAMCIGRYFKLSAEAIRRGVEGYIPTNNRSQ
FVEKTRGNRVLMDAYNANPSSMHAAIEAFQALPSAHKVLILGDMKELGAYSEREHQQLVT
DIATYPWTAVLLIGENFGRTQTDFLKFASPAEANSYLAAHPFSDTLFLVKGSRSMTLEKI
EI
>SEQF1602_01495 Putative metallophosphoesterase MG207 
MKILLLSDTHSYMDQAILQHALWADEVWHAGDFGSLAVAEQLQAVKPLRGVYGNIDGTEI
RALFPERQLFECEGVRVAMTHIGGYPTHYAKGIPQWLVQEKPKIFIAGHSHILKVIYDKK
YELLHLNPGAIGKYGAQKSRTMLRFEITEGNISHMEVVEYDK
>SEQF1602_01496 hypothetical protein
MSAIRLQAIVQEADIPYIERFLKGIATDINFEEEEDYFSILTPEDIENIAISKEQGKLGM
VTKNEDVFNQIRELRERKWK
>SEQF1602_01497 hypothetical protein
MEIVWTDKALENLKENLEFWDTHNETPSYSEKILFEIEKLTYELSNNPLYLGRYNEKLNL
YVRPILKGRFLIFFEVRNKNGEDFIEIQYFRSSKQQPLN
>SEQF1602_01498 hypothetical protein
MSLESKIMEALKEAMKAKDTIALESLRAVKSAILLAKTEASAGDTLSAEEEIKLLQRLVK
QRKESAELYQKQGREDLATPELAQAEIIAKFLPEQLSEEAVETAIRAIVARLGASSMKDM
GKVMGEANKELAGKADGKLIATVVKRVLS
>SEQF1602_01500 hypothetical protein
MDKDWYIQCIFFDPRYEKKYPKGFPYRKKANKPQTIEERKALISFLLKNIPQQFNNGYNP
ITKKYMNLRDEGAVS
>SEQF1602_01501 Tyrosine recombinase XerC
MRGLYPDLLFIEAFKRALEMKRNANNKRHLYDIQCAINRLEKASEALSMQYIKVKNLRRV
DLKIMLDYLQLPDKYYNKFVIYFSSLYRVLIEYECCESNITRDIYPKKTFKEPRLVLEKN
ELEKVKEHLKDTYPDFYRYMMIFLYSGARNTELFRLQRKDVDLDKQEFVILLEKGGQYKR
CIKVILSPALEYWREVCEECQSPDDYLFALNFVPSKKMGNKEIVTRFWKRNVKDKLGIEA
DFYSLKHYMLDNLDSDTAMLLASHTNKNTTAIYQVNKAKKDREMLKQLKIEI
>SEQF1602_01502 hypothetical protein
MKVNHSQLTLAREYRGLTQTELSKAVQGLSQSNLSKFEKGLGGLSDELLGKIFDTLNFPK
EFFAKKINIDLEIANYRKKSSISKTLLQDFETSCKFIGCLIDEMADSVEYPDFSLVTLDL
EEGYTPEKAAIFTRKNFRIAPDEPIHDIFKVIENKGIIIYELNTDEKFDGISFFTPKGFA
VIVINKRFTNDRKRFTLAHELGHLVMHCSPDFPIPIGRNKEQEANDFASEFLMPKSAIIK
SLGNLKVSALSALKNYWLTSKAAIVRRAYSLGAINKDRYQFLNVELSRSGEKKKEKDSVS
IDYPQVFSTSVGLHLKELGYTENELAGAFSLPLDIIQKYLLQQPFAVIKPKLKVVTE
>SEQF1602_01503 hypothetical protein
MKQNDKDPANVRTSVQFCKRKIAKKETFLADCSELVISQFFTAFHKAKGLFKKAMSKYPP
DSRSRGFEASTFQTCIIGELQKAFPSDWKFWKYKRFALSMKGYSFLIKKLDKKEMPMNIR
TQANKSILNQVQTLIFDPTAYENPIIFFGWQKSKFGELMAPHFVYIDEEKIQWRFYEEEL
TSVTIPTISVPNSNDRLLPKVKEQSKKKRVN
>SEQF1602_01504 hypothetical protein
MRKILLLIMSCVPFLGYSQFILTKDGMVDEKDPSKNYLVYNFEGKTANELYISVLTALTN
YYVSAKDVLSKVEGKIISINGIEQNGICYGNFMGGCNHKFDLEYTMSIDFKDNKIRINTP
IIAKTKGDNFNKNHTYSLVGGGGMFGTYSTFNKEGKLKDENSKKSIETFFNVLVQNIVKS
VKSQDKDDW
>SEQF1602_01505 hypothetical protein
MQNNATQQLRHLTGIETNTFQLHDMKKNIANMKAGINEITTKGIKIRS
>SEQF1602_01506 Ktr system potassium uptake protein B
MLRNCSPYTFIILSFLALIMVGTLLLSLPFAHVSGGGFTYFEALFTATSAVTVTGLTVCD
VHSTFSIYGEVIVLLLIQLGGLGILTLSSVIILLITKKISFYTKRLVSEGLNHEAKIDLY
SHIKKVVFVVLLIEAIGAALLFFVFVGKYPWYKALYYGIFHSVSAFCNAGISLFRYSLEG
YTTHWYMNIIISLLVIFGGLGFTAIIELYEYLIGKRRKISVNSKFSTLITLLLLGVGTFL
FFILEYRYTGELTDGSVQQRLLVSFFHSASLRTAGFSTVSIAGISGTTALLCMLLMFIGA
SPNSTGSGIKTTTFGILYLGVRTSLLNKRYIEYSKRRISWQLFNKASTLVFIASSYIMIM
AILMMYFDRDKEPIKVLFELMSAFSTCGLSMGITSWLSTPSQVILLITMFLGRVGPLTIV
LAFSRERNVGKYKYPKENILIG
>SEQF1602_01507 Ktr system potassium uptake protein A
MKKNFLVIGLGEFGKSVAKTLYKNKATVMAIDSNEELIKQALNEGILDEAVILDATDEIA
LKNVVKDDFDMAFVSVGDNIQASILITLHLKELGIDHIICKAVNHTQGKVLEKIGATQVV
FPEELMGEKIAYSMLHPSIIEYFKFSEDYFISEVKIPKSYVGKSLMELNLRHKYEINILA
VKHSDGKMNVTPDPNVRLSQDDLLIVLARENTIGKIM
>SEQF1602_01508 Primosomal protein N'
MYYTDVALPLPLRQAFTYEVNPEQADFLRAGMRVVVPFGKAKIYTGVVIRVHQHKPSYPT
KPIEFILDEQPMLSSRQLQLFSWISAYYLSTFGEVLKMGMPSSLLLESETIVEKTSTPIT
VATLSDEEFLVYEALGQASSLTTKEVGKVLQRKNPIGVLKSLLEKDAIRLSEKIFEKYQP
KVEKYLRLSSTYEDRNALNTLLEGDTLTSKAQEKLLWAFVALRSQKQTSITPQQLLEKAE
VSASVLKKIVEKGILEVYTEAVDRVSFASDSDTWELTPAQEKALEEVQEQFSQKNTVLLQ
GVAASGKTLLYSQLIEQTLAQGKSVLYLVPEVGLSVQLMNRLEHFFGDKMSVYHGKYSSH
ERVEVWNNVLANKPKAQFVLGVRAAVCLPFHDLGLVIVDEEHDLSYKQEQTPPRFQVRDT
ALMLAHLHGAKTLLGSATPSAESYYNAQVGKYGFVQLLERYTGIQAPTIELVDLKEKTKK
KETQGHFSDTLLAAIEQTLAQHRQVILLQNRRGYAPYLQCDKCDTIPQCPNCDVSLTYHQ
LQNQLRCHYCGYTIPTPMSCPACGEHSSLKTKGLGTEKVEEELLQFFPKARIERMDMDTT
KGKYGFEKIIHHFERGETDILVGTQMVSKGLDFPKVGLVGVMNADLFLHQPDFRASERAF
QLLSHIAGRAGRKEQGRVLIQTYNPFQETLQRIQQGEYTAMMTAQLTERSDFHYPPYYRL
VRIIFRHRELERINQAGQWFADGLRTGLTGYPVEVLGAEFPPISRIRNEYIKHILLKIAP
KVPLSVVKDYILRLEQSFYSTALFRPVMLSYNVDP
>SEQF1602_01509 hypothetical protein
MDTIIHNLQHVQARIDKACQAVGRDPKEVKLLLATKTVTPERIQQALAAGYTLIAENKVQ
ELKEKYEALKATPHTNHFIGHLQTNKIKDILKYDVSCVESLDRYDLAEKLHQKLSQAGRE
MDVFIQVNTSGEESKFGVAPEEALALTQQVAQLPTLHIRGLMTIGLFSAEEDKVRKCFQL
LKSIQQQIFALNLPDVQPHELSMGMSGDLEVAIAEGATIVRVGTAIFGQRIYPDSYYWNE
QKA
>SEQF1602_01510 hypothetical protein
METNYNSGYNKGSYNSHYQKDNELVVYSTESERAVFYRKTYTHVALAILAFILVETALLH
LVPVELIEAMFGRRSIWLLIIGGFWLGSVMAAKWSHSLNKNTQYLGLGFYVLLESIIFLP
LIYMALAYVGTEVLWQAAIITLSLFAGLTAVVFMTRLDFSFLRSVLIIGGFLSLGLIVAG
ALFGFELGLWFSIGMVVLAAGGILYETYGIKNEYTTDQYVGAALQLFASVMLLFWYVLRI
LLSRKN
>SEQF1602_01511 Serine/threonine-protein phosphatase 1
MRTLVIGDIHGAHAALLEVLERARVTPDDLLIFLGDYADRGKHTPQVLDYLIALQQTHQV
ICLRGNHDALCCDFLLGKPMSELWRSHGGKATEEAYKDYTKDDKQPHIDFLQSLRNYLLD
GQNRLFLHAGFTDRGGVAHEFFTENFYWDRTLWELALATPEDLPPADPYYPKRLTLYKEI
YIGHTPTLNYGTDQPMCRHHIWNLDTGAGFTGRVTLMDIDTKEYWQSSMIND
>SEQF1602_01512 hypothetical protein
MNIKNLFNSIIKKQVNIDLSDSGLLINNELLLEFSVSRLTEALGKPRITPITDEDSPYSA
MYLWDSLGIYAFEKKDGTLATLACRVAEDKDWQRRVTFDYFALRPKGLFTGDFTIAGKSP
LSYISKERCADPFGLDVALDSWNVSCVYTEKLSEALEDLSKKAIAGRVAQEAMPFRDYEL
SYTPKKGNGDKKKDPNKWKVPQPEEKCLQFKSFNFKLAVVQELMYVQEVLKPKFDVYDFC
ENYTKRDIDPEEYYFEIIPEVKKWFQDLPIPASLAPLVTELYFDGGNEIYAQLIPFWDGE
DDVFDIESLTEEDILQFPNLKVIDGAAIFMSEEVRNLCKSKGISFADEPMS
>SEQF1602_01513 hypothetical protein
MADLIVSKKSIKELFSELKNRKFIIPDYQRPYKWDIDKCRTLWEDLEHFFLTEAKDHSDY
FLGTIVSYTNNDKNPEIIDGQQRITSFMLLLRAFYKKLEMMNEDSNVLGLKNQIAPCLWE
VSRISQQVEDKTKIHIHSEVATEEDNETFHEILKLGEVNKSDRDNYSVNYTFFLEQCNKY
AENNPLHWNDFCITILEQCVVLPIECDTQDTALTIFSTLNDRGMPLADSDIFKAQLYRTY
EGEAKKDFTDKWKELTKICEEGNFTIDDIFKYYTHVLRAEKNDKSREIGLRKFYAEDKYK
KLRRPNLLEDIIDLAVFWKYLNAKYMGTNKAIDPYPYSISEDTRKYIQCLNYYPNEFWKF
PVSVFFIKNRSALNFDAKFNSILKELVAFLFVKFIYAPTVNAIRDDIFDSCIALNAENKL
KYNVDFNKDFLKERLANIGSSTRMTRALLLLYAYLDKGQTSLIDSFDIEHIFPKKWQNTN
YNGWEREDAELYLDKLGNKTVFEKRLNIQAGNQYFAQKKIKYAESMIATVQILSKYPKPD
WVKEDIEKREEEVIDTLLSFFENHLSKQ
>SEQF1602_01514 hypothetical protein
MNIAIVGGRDFSDYTLFKETLLRYISIYGVPENIVSGGAKGADTLAAQFAAEMDIPLLVF
KPDYQKYGRGATLVRNTQIIENADVVFAFWDGQSKGTKDSITKAKKLQKELHIIFYREKI
EEN
>SEQF1602_01515 hypothetical protein
MSLVNNFLRHRFLIERLRTAPHSLEDFEDDLAYSGEYTEVKPFSKRTLQRDIKDIRDIYH
IDIQYNKSIKKYEIVEDNDLYAQNLFEAFDVFRALQNHGNLSKIIAFDHRRPKDTTYPAG
TQHLSTLLQAIKQKKQLQLHYYKFWGSKEVQVRTIEPYLLKESEHRWYVLAMDVEKKALR
VFGLDRISSIEDKDIKRMYAPPRGIERFFDDSFGVWVDNDRTKAEKVVLSFRRNEKDSFF
TPNPAEYLRAMPLHRSQVFLKDSPEEIILSLQIKITPDFVKEILSYGSHVKVISPEHLAE
RILQEIKNTLLLYAN
>SEQF1602_01516 Cytosol non-specific dipeptidase
MSTSIRELEPKEVWNRFADINGVPRPSKKEQKITAFMVDFGKKLGLETTSDAIGNVIIRK
PATAGLENKKTIILQSHLDMVCQKNNDTVFDFDTQGIETYIDGDWVRAKGTTLGADNGLG
VAAIMAILESKTIAHPAIEALFTTDEETGMTGAKELSPKALTGEILLNLDTEEDDEIIIG
CAGAVDVSAYHDYTEEATPSGVVAYQLSVTGLMGGHSGQNIHMGRGNANKVMNRLLLGQY
EKYGLRISQLHGGGLRNAIPRESEALVVVPVEHKAAFEKEFAKNAALIKKELHPVEVDLS
ITFKETTAPSKVMDVKSQLAFVRAVATAHSGVYAMSRSVEGLVEASNNIANVKVENGKIA
ILCMTRSSVDSSKHDLATSLQAAFELAGYRVEFSGSYPAWEPNADSPILHVLTDIYERMF
QEKPKVAAIHAGLECGLLGEHFSHIDMISFGPTILGAHSPIERVCISSVQKFWKYLLEIL
KNTPNK
>SEQF1602_01517 Outer membrane protein assembly factor BamD
MNMKGKVLTFIVVLSFAFSSCGEYQKALKSDDYELKYKVAKALYDKGDYNRSMRLWEKVV
GYYIGRPQGEDALYMYADSFYKRKKYLLAGYQYERFLKNYPRSEKAEEVLFLQGKCNFLE
SPKYSLDQDATYKALDQLQEYIDRYPNGAYLREANNMVLELLNKLQHKSFEIAKGYDKIR
DYQAAIKSFDNFLVENPGSTFREEAMYYRLHSAYELAKNSIKSKEKQRFEEAKSYYELFS
RTYPESNFMTKANRMYQDILKKISEL
>SEQF1602_01518 hypothetical protein
MINLKRIDAPQSTITYDKNKIDAQTGNIYEAISIIAKRASQINAEIKHELEEKLEEFAIN
NDSLEEVFENKEQIEVSKFYEKLPKPQAIAVKEWLDGEIYYRYTDEKNNHEYSSLA
>SEQF1602_01519 Coenzyme A biosynthesis bifunctional protein CoaBC
MNILPSLKGKKILIGVCGGIAAYKLPHLIRLLVKEQASVKVIMTQAAHDFVTPLTLSVVS
KEKVYTDFKTSDAQWNNHVELAQWADVILIAPATANTLAKMATGGCDNLLLATYLSAKCP
VFFAPAMDLDMYEHPTTLHNIDLLTSYGNHLIPSEHGELASGLVGKGRMAEPETIARALS
EFFWKEKHLFQGKKILITAGPTYEMIDPVRFIGNFSSGKMGVALANVATSMGAEVTLVLG
PTPPHEIDPRVRVVSVVSAAQMYEATTTAFTHTDIAILAAAVADYKPQEQAPEKIKKKTD
TLTLTLVKTQDILASLGKSKQQQLLVGFALETENELENARGKLVRKNLDAIVLNSLRDKG
AGFSGDTNQVTFITAQGREIPFPLQSKTSIAEEILKAIHEQLLRETKK
>SEQF1602_01520 hypothetical protein
MRKLILLCLLIFTMTANAQELSCRVTVNTQRINQTNQRAFVTLQRALQEFVNKTQWTDIK
ARENERINCSFVLTLSSYENNNFKADLQVQASRPVYGSTYPTPLLNYQEKDITFSYLENE
PIYFNPNTFTSNLSSIIAYYALIIIGLDADTFAPNGGNPYFEQALAVVLNAQSSSDSAWQ
QNGSNNRWQMVTDLLAEDFAGFHKALYTYHRQGLDLMAQDIQKGKNQIGAALLELNQINN
SRINRFVSQLFFDAKADEISQLLSGGKPLDKKEEVRAVLLKLAPTRAQEWNQIK
>SEQF1602_01521 hypothetical protein
MKNILFILSIFLCVEGFSQEAFAFFTQNGKRTSYRKLLRKSKKADIVLFGEYHNNPIAHW
LEVKLTKDLLGKRSLILGAEMFERDNQDALDGYLQGTIDQKGLDTLARLWKNYKTDYKPW
VDLAKREKLPIVATNIPRKYANLVYKKGLQALDTLPSAERKWIVSLPFPYDGNLSQYEKM
KKMARHNSENLPMAQAIKDATMAESIETHYKKGSLFLHLNGSYHSDFFQGIYWYLRRRNP
NLKILTISTLSQSNLKKLPSEAYGQADFILVVDEDMTGSY
>SEQF1602_01522 hypothetical protein
MSLLSLAAIACQEKKAPTTAAAETPQETQEKAAPTLTYSNLVDTPTQEKVQQALIAAGIS
QAHAAAFLESVALFNQTAGAKANLVPEGFVTIDSLLPKYDEVAIQSDWMSKYPAFQGYNC
RLTSFTLLRDLISFPTGKKFDSKAEDEVLFIDRESLRNAPKKLFTPAEENDFFALFTEVP
TTNTKDINLHLQAMQKAWKARGIAFRYANDPTKASLISVVFHSQLTPEENMIFVGHVGVL
LPFEGKLLFIEKLAFQEPYQAILFANRTELSDYLMNRYDVEWEQPNAIPFIMENDQLMDG
YRPNPYKVGANSNSPSL
>SEQF1602_01523 hypothetical protein
MKRLSLILLALWLFACKQTPPITEQPMSPEIEAKLYELLKRVSYTSHELPDYEFFYSNVA
DIPSHLDPVFGKVDISLLPKTAAFNPYILENFSDDLLLSENLTQAIHKLSPKEIARYFDV
YISAIDNQYFSGEKENETSDEQGAIYVPFKQVTYLLKDGVWSKGASFSASTREEISTLED
NQISYWKGIIAPYKEICQVEKPTDLSESIVRMGKYGLEQQLSSCDLNEDGQGDYLFVFSE
QRNDPNAHQRVVILLSGEGIHKYRLLIAPDFCDKEWPLHQIVCKGDYFTIEFKDNKFVAE
LYITFKYDKHANNFLLHRYGYIDLSGGTQEPKREVQLTTKDFGKILFEDFYAEQLDYLID
DRFSKMEE
>SEQF1602_01524 hypothetical protein
MKRLSLILLALWFFACKQAPPPITEQPMSPEIEAKLYELLKRVPYTSNEYPGLEFFYSNV
ADIPTHLDPVFGKVDISLVWFIHFTR
>SEQF1602_01525 hypothetical protein
MVYPLHQIVCKGGYFTFEFKKDKFVVEEYITFKYNKYANNFLLHRLGCINLGMDKENPYR
EVQLTSKDFGEVFFEYFGEEAFDEIIDRRWSGEEE
>SEQF1602_01526 Neutral endopeptidase
MNKMHLYSCLALMVACGNPAKKDNMKEETTDKGLDLSAMDTSVRPQDDFYNYVNGGWMKT
AKIPADKPSWGTFYMLREETDQQCLSLLDNLLKTSYPDGSDGQKIQAIYKTYMDMDTRNK
AGLEPLQPYLKKIEAIKTLADLQAYLEEATPLGENPVCGWGVYADMKDSNQNAVYLSNFG
LGLGRDYYQKQSQSNTEAINKYQIFVADIFKLLGDAAADEKAQKQVAFEKDLAKLMLTNE
EDRDPNLSYNPQTMEELSKLVKNLNIPALLKKVGVNTDKVIVGEIRLYKEYDKFINEKNL
PLLKDYLRYNLVASNAGYLNGALDELSFNFYSKYLNGQQEQRPMNKRALSLINGVVGEAF
GKLYVEKYFPAKAKEEMVTLVDYLKKSFAEHIKNVTWMSDATKEKALHKLSTFKVKVGYP
DKWKDYSKMSLSADASLFDNLLKVAQWAYQEELDKVGKPVDKTEWGMTPQTVNAYYNPLY
NEIVFPAAILQAPFFSFEADPAVNFGGIGAVIGHEITHGFDDSGAQFDADGNLQNWWTPA
DKENFDKVTKALAAQFDKYEPVKGVFVNGTFTNGENIADLGGVNIAFDALQMYLKDHGAV
ADISGFNQDQRFFLSWATVWRTLSTDQYMTNQVKTDPHTPGYFRAFAPLTNVDSWYKAFD
VKEGDKLYRKPEDRVKIW
>SEQF1602_01527 hypothetical protein
MKSYLISTVTDFIDAPIALVYEIVTDNSNFQWRKEVKDIELLEDDFIEYYKAGGHTRFSN
IQKIENEYYTFTMRHKLFIGEWEGKFESYRGGTKIYFQEKIHIKNFFLRLIAPLFWKLKR
IQQNYIIALKQEVYANK
>SEQF1602_01528 hypothetical protein
MQTNKYLSLWLPIMGLHALHQVEESISFWQWYIDFGDKIPTWLQLPRISDNAHLAHDHPQ
YFVGASIGQLVLVALVAFLCRRSEKATRIALGGYLAGLSFFLVWHILISYFTHSYSPVMV
TCLMGVYLIPKWIYKVVKK
>SEQF1602_01529 Neutral endopeptidase
MGWFVCLSLVVACGNSNKEEAPKVFTEKGLELSAMDTSLRPGDDFYNYVSGSWMKTAKIP
ADKPAWGSFYMLMEKTDKQCLSILDDLLQKEYPKGSEGEKIQTLYKEYISWDKRNADGLK
PLELYFQKIDAIHSLNDLQNYLQEMTSKRANHICPIGVYADMKNSKMNAVYLGNFALGLG
KDYYQKENPSNTEALAKYQDYVADIFKVLKDPLPQEKAKQIVAFEKNIAKYMLTSEEENN
PNLSYNPLTTKELSTLVKNLNLPELLEKVGVHTDGVILTEIGLYKHYDTFINEKNLPLIK
DYLKYKLVTLNSNFLTQELNDLTFNFYNKYLMGQQEQRPMNKRALELINGILGEAFGKLY
VEKYFPEKAKDQMLTLIDYLKKSFAQHIKNVTWMGDTTKEKAMEKLHKFSVKVGYPDKWE
DYSKLTMNPEVSLFENITQVGEWAFQKALDKVGKEVDKTKWVLPPQTVNAYYDPTSNEIV
FPAGILQPPFFSFEADPAVNFGGIGGVIGHEMTHGFDVSGAEFDANGNLQNWWEPADKEN
FQKATEALAKQYDQYEPVKGIFVNGTMTNVENIADLGGVNIAFDALQMYLKDHGSVGKIS
GFTQEQRFFLAWASVWRTLSTDQYITNQIKVDPHSPDYLRAFAPLTNVDSWYKAFDVKEG
DKLYRKPEDRVKIW
>SEQF1602_01530 hypothetical protein
MKKYLYFLLAIATLLSCHKDNKEKEINECCGAPFKYFYLKVNRNLVNEDFTPKFSLTKIT
NVGNEKVELRDFKRFDSAVIFEFAVIYDLERSLIERSEIYDLKTTDLKTAKITITGQFKS
IPNCCNTPQINKVLLNGKEWVPEKDAEHGYNIYTLEENQLSESPANPKSRMIPHFFNAKE
SPKTK
>SEQF1602_01531 hypothetical protein
MINANNDSYKYELLLAFVIDYCSYPFGDEVYSYKAGDHYKEIKRSCPKSLIHEGRFANRP
YNRI
>SEQF1602_01532 DNA ligase
MDSILQQIEALRKELNEHNYNYYVLDTPSISDYEFDQKLKALQDLEAQYPQYKDPNSPTV
RVGGEITKNFPTVTHEFRMYSLDNSYSKEEVEEWEKRVLKGLGTDKVSFVCELKYDGASI
DLTYDHGQLVQATTRGDGVQGDEITANVRTIRSVPLTLKGDYPDHFHIRGEIIILKEGFK
KMNEQRIAEGEDPYMNPRNTASGSLKLQDTAEVAKRPLDCLLYYVVGDNLPVDNQFDSLQ
KARDWGFKVPSQSKLCHSTDEVMEFINYWDTRRHDLPYETDGVVIKVNDYQAQQELGYTS
KSPRWAIAYKFKAEEVTTSLESISYQVGRTGAITPVANLSPVLLAGTIVKRASLHNADQI
AKLGLHIGDQVFVEKGGEIIPKITGVRLEARHEQATPVTFITHCPECGSELVRNEGEAQH
YCPNAYGCPPQITGRIQHFISRKAMNIEGLGSETVELMFRAGLIHNYADLYELKAEQIQN
LERMGTRSAQNIITGIEKSKEVPFERVLFALGIRMVGESVAKKFARIYKTLDAFRTAPYE
QLIQVDEIGDRIAQSVIEFFADDRNKEILERLQGYGLQFALKETAQTSLSEALKGKTLVV
SGVFARHSRDEIKALIESHGGKVGSSISSKTNYVVAGENMGPSKLEKATQLGIPILSEEE
FEKMIQ
>SEQF1602_01533 hypothetical protein
MGHSLSNATAKKQTVTQAVIFGVGLFALLFLVLKFVNGYSAMGALFIFGVTAILAAITWG
IVSHYLKK
>SEQF1602_01534 hypothetical protein
MAIHPYVEELSYFRRNPDISQVGGIYNNIGVGNQVFGFYNRRKCFQGRLFRDRKRKYHLA
AIADT
>SEQF1602_01535 Colicin I receptor
MKNIIILLFVLFGGSILYGQEQKISGHITSATDKTPLLGVSIRIKDTPRGTTTNEQGDFS
IKAASGEVLVFSFIGFRSLEYTITQTNIPLILELEEEETELEGLTITSTRSSRTIEKVPT
RIELITAEELDEKGNMRPSDLRMLLSESTGIQVQTTSPISANAGIRIQGLDGRYTQILKD
GFPAYSGAASGLGLLQTPPLDLKQVEVIKGTSSTLYGGGAIAGLVNLISKTPTPARELLF
HIDVTSAKGLNLNAFYGQKFNHVGTTLFASHSRNQAYAPSDTPFSAIPRFERWVVNPKLF
LYFDEDTSLNIGINAMVEQRLGGHIEYLRGNTDPAYHYFEENNTHRYGGQLTFDHHISED
SRFQLKSSINYFQREIVLPDYRFSGTQLSSFTEGFYGLEREKTDWIIGVTLLDHRFKEQP
LTTFPLRDEQEMIVGGFAQNTWKTAPWLEIESGLRTDFVKDYGWVVLPRLASLFHLSEKL
TSRISGGLGYKTPTLFTEESERFHYQNILPVSSQKNRLEKSYGANFDINYQTLLGEEWTL
SINQLFFYTYLDHPLLLENLSPKKYHLTNIEGHIHTKGLETNVKIGYKDFKLFLGYTLTN
TQLHEGDVFTDNLLTAKHRTNSILFYEVEDKWKIGLEAYYFSSQLLSDGERGHPYWMTGF
IVEKLWKHCSVYINFENFLDVRQTRFGSIYTGSERAPVFKDIYAPLDGFVFNGGIKLKL
>SEQF1602_01536 NAD-specific glutamate dehydrogenase
MPFAPGKAVNAGGVATSGLEMTQNATHLSWTSEEVDAKLHQIMESIHNACLKYGQEEGYI
NYVKGANIAGFMKVAHAMLDQGVI
>SEQF1602_01537 hypothetical protein
MMIEEKYHELVKQCEELDYSDINTIFEYANHKLSKHSWELALVIMVNICIKHPDLPADEL
SDHIFLVMEYEGTETTYKYMRQKYQKTEDIAVKEILSLLMEVLEAKYAKMGIFLKR
>SEQF1602_01538 hypothetical protein
MAYFLYRKDLAFFVSPKIAECIINNVEIEDSEIMAITFTFLGDRYKTIIDREFASKYYIV
NEDVFDLETNHKEELFFELQPVPYSLFKNFISKNNIHW
>SEQF1602_01539 hypothetical protein
MRFLLIYLSFASLFLASCRDASELYPPTSIEIMDPVRHYYPVVQGEKFEININIKNTGKH
FLKITDVQTSCGCMAVDKNAIGLIRAGEIGTIRIVNDSKKNIGYVKHFIKIYGNIPDGEA
EVIFDYNVVPDALYTPDYEEIYSKDNKSRETRRQKYYTDL
>SEQF1602_01540 hypothetical protein
MFRFSIVTLYFLLLGTCQSNAESTAAAAEVPISLRAKGYAISTQLHASDIDEKWAQYFYD
HLRNRVTDRQRVLLASSQKDYLTLKVKVNTALSTDYCLKNDGQQWLLTARTERGLQWLIY
QMIKRISEDDPSVEAPDLNPSIINLGKGCASFAFAYREPHFLPNLNQEYNQIYNTHNVEI
DWGLWGHNLSKVIDKNNKALYATVEGKLNESQLDFASDALYQEVEHYIIDNFGAEPPMKF
VIMPNDNPIVSDTPKNKSLGSTPTNATPSVSYLVNKLAKRFPKHTFYTSGYRTTRTPPTE
RLADNTGVIISTIDLPKGIALPSGKVTETFYHTLSQWKAKTNDLYLWDYACDFDDYFTPY
PILKGFQKQLKVFKEKGVKGVFVNGSGYDYSTFADVQTFVITSLLIDETLSVDELVTRFF
RQYYPVSGAELTAYYLSLENAQQQQSKPLQSYGNFAHAQETYLDPAQFVNFYDKLSTLRF
EAQGEESKALEKLYAALSFTRLQLAYRQGYSSYGFAQRQANTLQPRPEVQQWLAALATSE
KYKEMARYQEEEKGSVKGYIEQWNSLLARADFQNLLLGKPLQVQCTLDEDYQDLSPLTDG
VEGFPLDYHIGWVINSVDDLKVQLPPEAKKAKKIALTFLQDEKSRFYMPTKIEIYKNSKL
YKTMLPPPQAGVLARTLTTDIDLSDSDVTQVRIYRNRTNERNLLATSEIRLIP
>SEQF1602_01541 Beta-barrel assembly-enhancing protease
MKMTKIYSVLLLLLPCISVVAQDKKELKLIDSYFKEGQYEEAKKLLDKNITQYPKNGDIQ
FYMGTYYYQKQDNDKARYHLLRALDELPNHVAAKEILASIETTQKHYSSAICYVNELLET
RPYDAELWRKKIALYRLQGNDIEANRLLKRIRVIYPQDEQFKKDYLYSLQVQSSQEKKKG
NIEEAIKMEQETLRLNPKDEEAYLTLTNTYLLSGDKDKALTYVNRGLQNLPNNQELINRK
IGILSEMNRPVEAVEFIQQEMKKGNKSPQMLKNYNDLLAQAALYQNQSDPYVLYGKLYEN
NPSNAEALDYLINNSLTKGYYTDAAVYIEKGIKSRGRTKDLLSKKYTYLMLSGQDKEAYK
VLEELFSKYPNDADIRNNYLQYRYNRGQQLAQQGRYTEAIPDLQWVAAQPSFEWREDAIA
ALYGAYLNNHQYGKALEQAELLIQQYPQSKGGYLRKAAALSALRQYPQALEIYEKLIGES
DAKDNDFYISGYEETALAYIKYLNEKGDATTAYEQQKKLMTLKENSNQGLRYIVATSSLL
KKEDEVLSYAQKGKALYPDDFYFVEQEAYAYTRTDRPQEGINALEPYLEKYAYNKDLSKA
YAEAAEKQAQKEYKQRDYDQAQHTLLKALQYDPLNKNLQYERGRIFEGQKQYDSAYYYQR
QFNPSLVELAEFKRHLNYLKYKTYKNEIQFSYQQNQLKDTKLPGIFTALYHRYQPKNTYT
LGLSSSGRADKRAFQGQVGWTHILSYKSYFDIDAALSNHYFPEYMGNVTIYRALRNEWEA
QVGVGYKKLRSEDTPQLIQAHLGATKSLEDFSFLVKLTGVSFNNSLYYNTFGRIQYDLLD
KRSFLAIFGGVGSAPVDEILNYQLYGQFSTTNANFGGMAQYMLVDKVALSLSGVWYNYYN
GVDYSDLYNLIFGINVSF
>SEQF1602_01542 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MELLYDIFQISVLIYSIMILLCIGAQVLMARQNLRNNKWKYTDLDLITLRNSPLAPGISI
VAPAYNEQTTIISNVNSLLSLDYPKYEVVIVNDGSKDRTLELLIEEYELEETPFMYIERI
KASPVKRIFKSKNPKYAKLTVVDKVNGGTKADASNAGVNACRYPYMLNTDVDCVLAKDAL
LRMIMPFLKSSVRVIGVGATLRMSNGCEMEDGKLVRVSPPKSFFPAFQEIEYLRSYLVGK
MGWSVINGVPNISGGLGLFDKEILINAGGYDPASFAEDMDMVTRMIVYMRDFNYDYRIVE
IPDTCCWTEGPPNYSVMYKQRTRWARGLFQFFMIYRKYLWNYKYGRLGLVTMPYMFLFEF
LAPLIEIVGWGILIYLLVIGRMNYTNALLIFGTIYLFGLMVSSSAIVFDYVTKQHYKRLR
EYFRLFAITLIEPFTYHLLIVYFSIRGYISFLSKKTSNGEK
>SEQF1602_01543 hypothetical protein
MEKFLMNVEYYYELFQINSLFLKILYTLVFILSCLCAYNILFLIKKHFKRRKTQRRVAYL
RREYFERIKEILLTEQVFSSSEFHNYLGVSSYDNGFKRELTNLILEIIDTYPKANKKNYE
LLMEELKLKKFWEAELLKGSKKRKERALRKIKGLNLVIAESVIIPMTTIKNSILRRKARS
LYIYISKNNPFKFFDNDFDDQFSEWDNIEIHEILSKKPEETIPNFIHWVQNHSAGEALKS
FLVYEMGCYGQKEASPYLLKMIESSGMKLRQQIIRTLGVLQYKEAATFLMGIYPVQPSFI
QEEILKTLGEFAQEDSLPFVENAVVTTHNVETKMQGLYTLLCFGKSGKAIFERLKAQAKP
QELLAFEHVENPLNQRTL
>SEQF1602_01544 hypothetical protein
MKKIWGKSTIIFQERKLKAVKRIVNLSKGFGNKKEAAS
>SEQF1602_01545 NAD-specific glutamate dehydrogenase
MDVQKIMASLEAKHPGEKEYLQAVHEVLESVHDVYNQHPEFAKAKIIERIVEPDRIHTFR
VDWVDDKGEVQSNLGYRVQFNAAIGPYKGGIRFHKAVNPSMLKFLGFEQTFKNALTTLPM
GGAKGGSDFDPTGKSDAEIMRFCQAFMLELWKYIGPDTDVPAGDVGVGGREIGYMYGMYK
KLAHEYNTGVLTGKGINWGGSLIRPEATGYGALYFVDHMLKKLGRDIKGQRVVVSGFGNV
AWGASEKATQLGAKVIGLSGPDGCVEVPGGMTQEMIDYLLELRASNRNIVAPFAEKFAKE
SKFTAGKKAWVIPCDIALPCAFQNELDGDDAKTLIANGVKLVAEVSNMGCTPEAIKAFQD
AKLPFAPGKAVNAGGVATSGLEMTQNAAHLSWTSEEVDAKLHQIMESIHNACLKYGQEEG
YINYVKGANIAGFMKVAHAMLDQGVI
>SEQF1602_01546 Phosphatidate cytidylyltransferase
MNELLKRSITGILYVFLLLTAIMLSNAEAFGFLFLVFGLICLYEFKRLVRLSSSAVYLAF
LCLWWCFNYLIPMEGFSNNFVVYLLLLAVISTDVYLGFYLYRHEAVSYTQWQKFLLALLY
VGGGCLFISLLYKVEIYKNEQEITAASFAFWEFSQWQFSEAFSEAQHTMIALLAIIWASD
SFAYVSGRFLGRTKLFPSVSPKKTVEGFIGGFVGALLVAAWLSLYSNKELWKWLVIAAVL
VVAGTLGDLVESKFKRVAGKKDSGTILPGHGGLLDRLDSLIYASPFAFVTILILSYF
>SEQF1602_01547 hypothetical protein
MKWLEKLFKGAFSEAPSEVYEGKNSDLPIDEAFVNNFKNKGGIFIYIENPIELPNILQTI
LLDKGADSLVFSHNEQVEALFSAVPHTFFTDDDQEATHFLTDCEYLVAEEGSLLFSSRQL
GQKHLDELPQNLVVVAKISQIVATLFDAMGGLNRQTQQNRPNNIRTLRAFLPPKEKDSIL
YENCYRTTYLLLLEDLNTNE
>SEQF1602_01548 3-phosphoshikimate 1-carboxyvinyltransferase
MDIRLKKKRLKNNNQLTLNIGGSKSESNRLLLLKQLFPSLEIENISPSKDTEMMSRGLHL
LGEEINVGDAGTAMRFLTAYYACCTDRKVVLTGSERMQQRPIGILVEALRQLGASIDYLS
TEGFPPLSITGKHIEGGELTIKANVSSQYLSALLLVGSTFPKGLTLHLEGEITSLPYLRM
TLALLNQLGIEAVLEDNIITVYHTPEVEAQTIVVEPDWSSASYFYSMIALSEVGSSLFLN
HYKKESLQGDRILADIYQSFGVKTIFWRDKIQLIKERDDFSTIFSYNLMDCPDIAQTIAV
TCFGLGVECFLSGLHTLNIKETNRLEALRDEITKLGGEVHISQGEIWIGVPRKIARNVSI
ATYGDHRMAMAFAPLCLKVPLTIEKGEVVEKSYPNFWTDFENISE
>SEQF1602_01549 hypothetical protein
MQSEIEKNGDFPVISQSANYIEGFSSDETKVLKVEDFIIVFGDHTRVVKYIDFDFIVGAD
GVKVILPNNNLSKYLYYLILNASYKIENRGYSRHFQFLQKEFFPLPPLAEQYRIVQKIET
YFSFLNTIESNL
>SEQF1602_01550 Tyrosine recombinase XerC
MIKQFKSFLLKSNLAPNTIDSYVWTVRYFLEKYPVINKPNLMAYKNFLLDKYKAQTVNLR
LQAINKYLDFVKRGSLKMSFVKVQQKNFLEHVISHADYLFLKAQLKKDGYQDWYFLVWFL
TATGARVSELIQIKAEHLTQGYLDIYSKGGKVRRLYIPKLLREESSLWLKEKGITSGYIF
LNRFGKRITPRGIAQQLKVFAYKYQLNPKVVYPHSFRHRFAKNFLERFNDLTLLADLMGH
ESIETTRIYLRRTASEQQAIVDTIVNW
>SEQF1602_01551 hypothetical protein
MDTIEQLQEELKALVKQTKNQVLNYAIAGKLTQQDPNDEPAEELLKRIGKTTAADTPYEK
LPEGWVWCQGNQILNTMKSQKPSGEKFNYIDIASIDNRQNKITEVKTIAVTEAPSRASRK
VKFGDTLFSMVRPYLKNIAFVDEEYSNCIASTGFYVCSPNETLFPKYLFYLMVSDYVVQG
LNKHMKGDNSPSINNEDITNFIFPLPPLAEQHRIVEKIESFFASFDQIEKELA
>SEQF1602_01552 hypothetical protein
MNTKQIRQTILDLAIRGELVPQDPTDEPASVLLERIRAEKEQLIKDKKLKRDKKNNEPID
EVPFELPEGWEWCRGYEILNPMETQKPIGEMFGYIDIASIDNKNNRIIDAKFISVSEAPS
RASRKVKFGDTLFSMVRPYLKNIAFVEEEYSNCIASTGFYICSPNKTLYPKFLFYLMLSE
YVVNGLNKYMKGDNSPSINNENITNFFSLSLPLPSNIVLPKK
>SEQF1602_01553 hypothetical protein
MSSPKKPKDMLRASVAEYLTFVTATGESNIQSLYADENVWLSQKMMGLLYGVEIPTINYH
LQKIFSDNELAENSVIRKFLITADDGKTYNTKHYNLSAIIAVGYKVNSERAVQFRKWATQ
IIEEFTIKGFAMDDERLKNDGTLLGKKYFEEQLQRIREIRLSERKFYQKITDIYATSIDY
DPKSSSTQRFFATVQNKLHWAIHGHTAAEVIYERANAKKPHMGLTSWKDAPKGKIYPFDV
VVAKNYLTEDEMAQLQRLVSAYLDMAEDMALRHIPMTMSDWEVRLNRFLEFADREVLQDA
GKITAEIAHTHALAEFEKYRIVQDRLFQSDFDKFLES
>SEQF1602_01554 Type I restriction enzyme EcoKI M protein
MNNQEIVAKLWALCNVLRDDGITYHQYVTELTYILFLKMAKETNSEGEIPEAYRWDTLVS
KDGIPLKKFYEELLEHLGEQCRGRIQEIYAGAKSNIEEPKNLEKIIKTIDALDWYSAKEE
GLGNLYEGLLEKNANEKKSGAGQYFTPRVLIDVMTELTHPQAGERCNDPACGTFGFMIAA
DRYIKDQTDDLFSLSQEMQEFQINEAFSGGELVHETHRLALMNAMLHDIKGPIQLGDTLS
SLGKQMTGYDVVLTNPPFGTKKGGERATRDDLTFPTSNKQLNFLQHIYRSLKRGGRAAVV
LPDNVLFVDGDGERIRKDLMEKCNLHTILRLPTGIFYAQGVKTNVLFFERGLSDKGNTQE
VWFYDLRSNMPNFGKTNPLKREHFDEFVQCYQRDDRHKRQETYSEENPQGRWRRYTYEEI
CARDKTSLDLSWIRQGEETEDIPLSELIATMEEKAAKITEAIAQLKAIMGNE
>SEQF1602_01555 hypothetical protein
MIDKIVKILNKNKSSIKIEDDIISCIYRIDSLEFLRELSDNELITNSFFEDYNTDEDIVL
EFLISRLRSQGFYLSKKSFLTWNQYNYPEKEVYIHEINDFLINNVFFNERFSTIINLIDI
LGQNSKIKYNEDEFLNFLIVREDKSLLLYLKYLPEDLDLIDNTDLNNINNFIQILKEDIA
PDRKNIYINELIDYLLPIEEKNRFSYLIKNFNEFIHRASASYNYYLRNFSYYKLKIELDT
KALDFYQKIQGVVNDSQTKLIAIPTAIVFASTTLDYENINSMKNYLILVGMIMFCIFIQI
FINNQESALEFIERNITIYKQSFSDNKQILENSFIKVDKERNKQKCRLLTIQILLWSSPI
LIFILLFITNIEIKSKYIYKIYKFLFDNSLMRIILQI
>SEQF1602_01556 Nucleoid-associated protein YejK
MKKIGKNLEIKNIIIHQLLKEAGNGIVDAKSADHVLNISDREKLFLGNLDEAYYKKSEII
HGIFSGNFPKFKDLLLEYTEGKNSFYDFSINVMNHYKEILQRTIAATGGYMILCEYTKLK
KELLLVLMINNKEGFVVNETDLSLSNIKKLELHKVDIACSINLTDWKAIENEDLTTDRKT
YLSFVKGLKDISLYFMQFIDVDNKNTSTESTNRLLRAIDEFAKREGWDKERKIQRQDDVC
SYCLDRIDKKQEILLSYISAIMDPDNPEKFQDLATDDEFGVSSVINGNKSKLRLLKRITY
KDDNLRLEFNTKLFLDKTIIYDEKNNKLTIKNIPELLKQQIKKLND
>SEQF1602_01557 Type-1 restriction enzyme R protein
MRSNFEFLKEIEPHILYRIAHLAEMYLYTDPNGCLMKLRQFAEVMVNEVFQIEHIALPYD
NNQANRISVLKREGIIEHQLGRILNELRQRGNEAVHAGFDSLTSAKTLLQMAYHLAQWYA
LSYGEGTGGHTFVMPQEEDIPNAAELQAEKEAQDQQIKALTEQLLGLQKQQSYWEAAQTK
EFINAQKERARRTQQYTKNLQLSEAETRQLIDAQLCEAGWQADTEHLRYSKGTRPEKGKN
LAIAEWPTDKGFADYALFVGLQLVGIVEAKAKHKDISSILSNQCKDYATHIKKEHACYLI
GQWGDYQVPFLFATNGRKYLKQLDTKAGIWFLDVRDNGNISKALQGWKSPQGLLEDLAQD
IAKATQDLAQTPYDLLRDPNGLNLRPYQIRAVEASEKALTEGRRSVLLSMATGTGKTRTL
LAMIYRFLAAKRFKRILFLVDRNVLGRQALDVFKDVKLEDLQTLYNIYPINELGEKTIAK
ETKIQLSTVQAMVRRILYNEAEDMPSVSDYDLVIVDEAHRGYILDKEMSEDEFDFRNQED
FISKYTMVIDYFDAVKIAVTATPALHTTQLFGKPVFEYSYREAVLDGFLVDYNLPHHIFT
QQRIEGIHYAKGDTVQAYDPEKNEVIDLSEIPDELNFEVEQFNRNIIVEGFNRAVLEEIA
QSLDPTGEGKTLIFAVDDAHADLVVKILKEIYAEQGVDNDAIQKITGSIGDKKRVEDAIK
RFRNEINPNIVVTVDLLTTGVDVPEITTLVFLRLVKSRILFEQMMGRATRLCPKINKESF
EVYDPVGVFDFFAEVSEMVPIVVNPNTTLEDIINGFEHTEDPELIAKYTQQLLARLQRRV
KNISQQDFDYFCSLSQGVSPKDFLTTLKNIPSTEVKSFVRENIKAIACLFHSQAKTVKYK
YISDKPDEVREHYVGYGKTQQRPGDYIEQFSAYIAENRNKLAALNLLCTRPSELTRSELK
HLYLEMAQEGYTLKELNKAWNNAKNVEITADLIGMIRTLALGNALVDYKVRLDNAFEKLK
QTHSFNAMETKWLDRIKTFLEKEQYIEKADFDTGAFQNAGGYEKINKVFKNHLGEIVDEL
KEYLFMG
>SEQF1602_01558 hypothetical protein
MLYKLQRKTLPKGQLLGYAFALMVAVVLLGGIWQLYRDVKPLLEEQTDIFSSNYAVVTKP
ISAIGSLQKEMIYFTPAEQESLRQEPFVKSMAPFSVATFKIMAYTRESEGEFPLFATDLF
FESIPDKYIDVKSDQWEWNPSRSFVPIIIPENYLSLYNFGFAQSQGLPVLSKGLIDKFTF
GLRLSGNGKEATFSSRIVGFSAKINSILVPEDFLSWANATYGSPTSQVSRLLVEFHDPSQ
KEILAYFKAHNYTIAKDELELSKMRFFFSSALWVVVGIALLILILSVGVVVLSLHLVLQR
NKEQIHSLLSIGYTPAQIARYYQRAVSLFTIGAIIAALSLCYGLRNLYMAKLSQLFPFTP
TGFTLPLAAFTLAIVLCMLYSVILIRGVRGVKREV
>SEQF1602_01559 Thiamine import ATP-binding protein ThiQ
MGLAHKVDTPLAALSLGQRQRVAFLRALAQPFEVLLLDEPFSHLDEANTHLLCELLQEEC
SQRGATLLMTSLEVNDLLNYDQVLQL
>SEQF1602_01560 hypothetical protein
MELVLRHLKPTYMEEAELHPSDIYLREEVVFAPAKRYLIRAQSGRGKTSLLSFIYGDRDT
YKGTITYDGVACPKDLFSYRRNKLSYLFQDLRLFPR
>SEQF1602_01561 hypothetical protein
MKRFLLGLVLIFLASCPKQPASLALVPSDAAWVVSIDFKSLYQKADIASTEDSAEFKQWI
DSLSLTDKQRDFLRELLRNPRNSGIRFRDPIYLFQYGQQGGNGMENYIGIACVLSDKKKF
ENTLNQLFALAKEEKNLTEEGGYKLLNLSGGKYTLSWDDDKVLFLGAEDDKGESSSGLQT
FLKAKQLRSLEAKKQITALSGFGDFLHDQKDISVWVNVASAYATLDEKLPSTTALSPSLF
NLQQGTYLYATLDFQKEAIALSARTLYNEKYQKLLDKHHIGEASFNKKLFKHFPEKMPMA
ITGALNVKHYYEFLKEAEPELVKEADIKEWLAKKDLQLDNLLNLFGGSFVIALEDFETGM
SIPIPVVGACFEVNDKKILDKMVAEEGSFTKDGDRYSLSFFFVNVYFAYNDKAFFISNSS
DEVDAFLAGKRKNNAYSSSLASQASKNTFYGFFNLNMDDYPSVFKMAMKADERSRNEASL
QWMIDHSKNLEIKADAKKNTATLIYHMRNVKRNSLYSFLQFAKQVDTTKANKEDKAVEDD
STYEDDGVYEEDPATDEDIIIEKDEE
>SEQF1602_01562 hypothetical protein
MVNNLKRIMSAIVWVQLIVLGFFFLCLAGVYWLDPFIWSLTKVEPFTAIAKVVNPPLLSF
LDALIGHRFHYSVIAAFLVGVLLIGISILIGAVVTKIRQLLKKEPLPLTEWMKDILLFEG
IFLGVLAVGALFWTLFTSFDDAQDRDNSSYIFFALLPITAVLFLLGRFLSRKGYRLMGMS
LLGLFGVGLFYGLGVSIYLFFKGELNTDYDYFDLLRRPSAQVVDESEYDGSYIGQEHKTF
SDTDTEDTYQREEVKDPEWDFVAFNKDSLQKLLNNEMYKKVYDLNEFFIKEDGYLYPMSI
YAKGDTLSRKQPTLYHLQRYISRDNNKLLAFWYYFGGSVMEAMYQSGQLGENTYMHRTLN
GQIADLLNVYELQGDNDQLYKDILEVMNRSSYIEDHIKGLKKVFKEYEIPEFERDLTDSN
SPSDGYVRWVYTFWARRFDEDNTAAVLTILRSMQEQ
>SEQF1602_01563 hypothetical protein
MKHSGLIPTEKIIERLQYENPWWTSNEIPTTYALMPRRLYFDQFYPYVADRDIRRAVVLM
GPRRVGKTVMMYHTIARLISEGVPAQKIGFIGVDNPIYINLGLQDILDIYLQAIGNTSLK
DTYIFFDEIQYLKDWERHLKVLVDRYPNTKFIVSGSAAAALKWHSTESGAGRFTDFMLPP
LTFQEFIHLKGKNHLMQKQSIIFAGKEKPYWVSTFLKELNSEFLQYLNFGGYPEVVFSEK
IQQDMGRYIKNDIVDKVLLRDLPSLYGIKDVQELNRFFSYIAYNTGNEFSYEKMAKESGI
NKEMLKKYLEYLEAAFLIKVLNKVDINAKKLKRITSFKVYLTNPSLRTALFSPIKDDDEE
MGNMVETAILAQWLHREQLHLTYARWKEGRGEGEVDLVLIDDKRFKPKWAVEIKWSNRYY
QMPQDLISLISFCKANELTAALITTKDTIGTKTLDELQFTFIPSALYAYNIGANTLKTLQ
>SEQF1602_01564 Inner membrane transport permease YbhR
MKTLSFILQKEFKQIFRDKTILAMMLVAPMMQLIILPLVANFDVKNINLVYIDHDQSPYS
HELIQKITASGYFKLVDAPFSYKEGIALIEDGKADVVLEVPEGFERNLVREGKQTLGLSI
DAINGSKSSLGGVYLLSVIRDFNTQLDINVKTPQRIGNVAKFSVASSHWYNPQMEYRYYI
VPGILAILLTIIGGFLSALNVVKEKEIGTIEQINVTPIKKWQFILGKLIPFLVVGLILFT
LGLTVMYIVYGIFPAGSLFTLYAFAIMYLIAILGFGLLVSTYANSQLQAMFIAYFFIMIF
LLMSGFLTSVDSMPAWSRQVSNAIPVTHFVSAMRLIVLKGSSFAQLSTEFLYLVGFAVLL
NSWAIWNYKKTN
>SEQF1602_01565 Ribosome-associated ATPase
MKQLIAFIRKEFYHVFRDRRTLLILFGIPIAQIILFGQALSSEVKNIGIAVLDEANNTYS
QQITHRLQASPYFKLKEPLLRYDQVEDQFKRGTIKAALIFPPNFGKDLYTPSGTSLQLIT
DGSDPNTAKTVQNYFSAMVASYQQELNPAVQLPYQITVENRMLYNEEQNGSMNFVPGVIA
LVFMIVSTALTSVAVVREKELGTMEILLVSPFNPLKILIAKAVPYLILSLINFTVILLLS
VYMLDVPIRGNLLLLYAESTLFIIICLSLGLLISTVTASQQTAMLIAMMGMMLPTAFFTG
FMFPIENMPLIFQGISKVFPSSYYYAIVKKVMLKGLDFTYVWKETLILIAMAVIFLSLAM
KKFKVRLE
>SEQF1602_01566 putative ABC transporter ATP-binding protein YbhF
MNAIHCHNLTKQFGDFKAVNNISLTVEKGEIFGFLGANGAGKTTAIRIFCGLSYPTSGEA
TVAGFDLYREQEQIKKHIGYMSQKFSLYDNLTVQENITFYGGVYGLSRKEIKTRSTDLIT
KLGLEAEANKLVGSLPLGWKQKLAFSVAIFHHPEIVFLDEPTGGVDPITRRQFWDMIYEA
SAQGITVFVTTHYMDEAEYCHRISIMVDGKVEAMDTPTNLKNQYHTHSMDEVFYQLARKA
KRSE
>SEQF1602_01567 hypothetical protein
MSKIWKNIVAETQEEVKATFSEVYASLDFGAYIAPQDYFVSYIFETEEALNKAKEIGLLQ
KISNYHKQLLRNKEYPEEGIKDCTFASQEDCDKEYNGNWYYYYK
>SEQF1602_01568 putative ABC transporter ATP-binding protein YbhF
MTSITIHNLSKSYGDTHAVQHLSLEVKKGELFGLIGPDGAGKTTVFRMLTTLLLPDEGTA
SIEGWDIVKDYKEIRKHVGYMPGRFSLYQDLTVEENLSFFATVFSTTISENYDLIKDIYE
QIKPFSNRRVGKLSGGMKQKLALCCALIHKPKVLLLDEPTTGVDVVSRKEFWEMLKKLKE
QDISILVSTPYMDEASLCDRIALIQSGKVLSTSTPKQIIAQYPTALYAVKDPNLYALLQH
LREDPHIDSCYPFGEYLHLTLNENTDIPIFEQQLKTTFPHLDWQPITPTIEDSFIRLMEE
KEKI
>SEQF1602_01569 hypothetical protein
MNTTKNKHPGKDLKDQGISPEKLLKIALVVLMIVPLGYFLYITLEEFSPIFSRDTEEIIH
FFFPMIGLMVLFVLFFTMRLKNRTLYNPYAEGELPTVIRIKGVNNKVFQCVSFVCYVCFN
VWILRQITMGKPLLIAILIVGIVLFVYSFIKNYPNTLYTLEIRNESIYFFYKGTLKQTIP
LKGIHHIYFSFVNEGIATRVYPQIKVYTSKKECVLHMKLSRDNYYLLKTFFSQKHIKLID
DYILEK
>SEQF1602_01570 hypothetical protein
MIYIEQFQTLTSIPEKLNSGDKLMTLTDEGLSVKNTKTGKEYFIKGDVLHYEESLNHTYL
WCALYNENETFTLMAIDENGKTIASLEMEDPFGAASLWLTHLPKENEVTISLLDGAGWSE
SYYIALEGNQLKIYQKLPDSYIYMFPLGNRSLLTNFDDRLMLASYPDFEILKEKQLSDTD
GEGILNIWQVDEHFGIFSSTQGIWYAFSLDTLEIISECVIKGYEPIIEGEYYYSHIAALI
PTPDKFLFEHWSYQDKKEESQWFAVDKAYLSALIQKYLN
>SEQF1602_01571 hypothetical protein
MTNINIHNKHFGKVSAILFLLAFILLTNIEYAPQYFNKAFKLSNTIVVVITILFLPICYF
TYKKRLIWGYRCILWGILFSFSSMLFMHFEDSLLEKYERGEISLLDKNASISIGEPILLG
IVFIFFLIYGAIYDIIIAKKNK
>SEQF1602_01572 hypothetical protein
MFDIEECRITLLTEYTYEVAYLGGCMLLRYETEPPHGDEVCSVYFPESNNELPYWCYLRN
IKQISVDKSTKSFFISIEAVKPHQWSGVVTLIIDPKHSRFASLDDWYPSVKAEENKIYFY
NSYTGKEYILDDFQLLKWQSF
>SEQF1602_01573 hypothetical protein
MKLKLIEHIKLTKELVDREHFFSVGYCEAIETHLMKVLVSWAAGYERYYRISADDYALFE
EDRPAFYELYKNELGEDNECFTQKFMGAQALRDYDGRKNFQMCYPSKEMNPFGHYAYCNG
VLYAQILWDKGTVYVPPYQKVKNLNGDWDYPLRKDCYIEKDPEGKDLCFCLDIENGK
>SEQF1602_01574 Quaternary ammonium compound-resistance protein QacC
MHYLYLTLAIVLEVLATALLGKSEGFTKWLFAVGSLLSYGVCFYFLSLALKNIPLGVAYA
IWSGVGIVLTAIISILVFKNKIDLPFVLGSLLIIAGVVVINLFSKANGH
>SEQF1602_01575 hypothetical protein
MIRNYFYLVVGVLCLLSAVTHEMNGFAAVFPALSNTNIDAESRVTFNYLWHIIATENIVM
GIALVLMALRKNDNAGKYIAQFVMALLAVRWASIAFSTLTSDGGNLTKILPESIIMWLLI
FLLWLGARKKEKK
>SEQF1602_01576 hypothetical protein
MKKRLLYLSIAFLSAAILALVIVAMRLLYTNCCDSTFGIILSKVVFMGAYLFFPLFFIYL
VIVEININFMYQHSLRKRLHKRTTSFTLSLITLALVLLSLLARLFL
>SEQF1602_01577 hypothetical protein
MKSYYISIVLFFVSLCGIAQTVDSIRNIQEFDKFEKYTHLAKDSLAIQNIVAHQKFFHSS
RHFTIEKGEKGEAEATHRLLMWSLSSVLSQNKILVRNPQVHYCLTNLYVYTNTELFFDHI
INLYVLSSFSSANKSLMKFVHSLKDKDYIAFDPIMKMSHVCYMFWHEEKLIMVLVPCRVI
SFAKDVNDKIVEVAKEALERYYK
>SEQF1602_01578 hypothetical protein
MKKITLITALAALIACNHKNNFDASGNFTADEVIVSAQQAGQLIAYEVEEGKTLTEGQKV
GQINVEVLKLQKEQVEATISSLKEKTLNPADQVALIRSQYEVQKAQLEQQERELTRVRQL
VAGGAATQKQLDDLTAIVEQLHKQLAVTQNQLRVSLTNINTQNRNVMSQEAPLQKNAEAV
QVQINQGEIINPIAGTVLVNYALKGEMQTFGKPLYKIANMETLTLKAYITGDQLPQIKLG
QQVTVRTDAGEGAQRTYGGGITYIASKAEFTPKTIQTKSERANLVYAIKVKVKNDGYLKI
GMYGEVVF
>SEQF1602_01579 hypothetical protein
MRLFVLFLFLPVVVFAQERLTLERCYELAREHYPTVQQLDLIAKSKDYTLANANKAYLPQ
VSLSAQATYQSETIDFAQSIGRLPLPIALPEVSKDQYKVVGEVSQLLYNGGATRAQKELA
KAQSAVQAQAVETQLYALKQRVSNLYFGVLLIEAQLAQNQLNAETLQSQLEKAQVALKHG
TTLPSNVAELKAELLRLAMQRTEYEATKGMYLKMLSTFIGKNLPEDTALQRPEPRVLSRS
NHRPELRGFDLRQTVLDAQERLLTSEYLPKIGLFFQGAYGRPTLNIIKNEFDWYYIAGVR
LQWNLSPLYSLSNKKQLLRLQGESLLADRKAFLMSTELDLIQQDTQLSKLQRLMEQDKES
ANLRHSVAKAAEVQLDNGVITTHEYLQKVNAWHLAQQTLLLHEIQLLQAQEQQQLIIGK
>SEQF1602_01580 putative HTH-type transcriptional regulator YttP
MYLCPRNQTTMSNTKDTSTEDRIKAAARKVFHQKGYAGTRTRDIAEEAGINHAMLNYYFR
SKEKLFGIVMMETMGQFFKGVGVILNDESTSLEEKIEQVVANYIDLLLEEPDLPTFILNE
VRPNPQFFVEQSPIREVLTNSALTRQYAEAVARGEISEPNLMHAILNVIGLVIFPFVAKP
ILSAITNLPEEQYKALMLERKTLIPQWIKGMLFLPNPS
>SEQF1602_01581 hypothetical protein
MARLTFEERNKNNYTKYSNVSINTINKYKGVLPEELLTIWQNMGYGIYEDGFIQFVDPDE
YEFVFDYIDKLLEPSIVFVVTALGDLLIWEGNDNWTISSDEGNRILFINIRKCTSEILGD
MDFLLNFTLGDETAIIDKEYFDSRPYLNIKGELPTLQYGQCYGYVPALALGGKASSKNLQ
VVDVKSYIDIIGQAVGKFIDLSD
>SEQF1602_01582 hypothetical protein
MGKEERINQITKLAKILERIPRDKRIEVFNRGAKNISLSRSII
>SEQF1602_01583 hypothetical protein
MDIKNILESNGLYEARILSACDYISVPKDWHFILKEDSKKIRKELMLNYWKSFNFLLPKT
MAIFEEYLDDIFVISHYNQVKMVYLFVIDDDYIVYVGNYPSSDTKIAILPEKLREFYMHI
HNGWFESISGGLGLLPIEKIQFLDESEWGLPQEILQSVELSKTYYVFHNGGGGFLCINTE
NAANPKSLVWWTNNRPKLGIDFWSFLDSWIEIGFLY
>SEQF1602_01584 hypothetical protein
MIMNHEEFLSVYNKALETDSFKVHNDFLNILLADHSEIGMERHFAYFNECDNSDLKRILG
NGFLKRGDEGLSFLLKKLDSETDNLIRSNIIHIIGLTHDRKYLPSIIPFLKNEDQEVRYK
AIVVCGWLGDTETINILKVHYQSEQVDILRGFTISAMRQIFFRHKETKDEIVKFIYTKLP
KEIDEEVIAIMIVVLQDLTKIKYGLKEDPYSGEVSGNIVKAKCKILKTPIVLFQ
>SEQF1602_01585 hypothetical protein
MNYKVFILSVVGGLSLTACEKEKGEETILSVTKDVKMLNATSYQKWVYYSFEKGAVVEVS
SPETDLSWDIAFQRWYIKTNSGTSGKGKGGAINTKKTDWNKVVYASPSGYKEDAIGTLNG
WDIIKNVETKKEGSFSQEASLYVTYISGGKYKNRNEVYLLKTAEGKFVKIQFYDYVNERL
KGGYPSFRYKISNDENF
>SEQF1602_01586 hypothetical protein
MRIFNMKYLWTALFWLLTVPSNAHAIWIETNTEAKVGDWHEVRVFFGEPNETNKPTPTER
WYSDLNTLSLLLISPSGKVVTLEKKQAELYYYANFKVEEEGVYTLSINHLVAKVYKRMRL
RYQSVAYVSTHPLKETIIMGDKSFFRLGIVPAEKEGQKYKAFYKKRGLKEENVTFDFSVD
KSVTVRTDKKGAFYFNPDTSDRYVLNLAKKKKHRGKHNDRKYLFDYIWLTFRH
>SEQF1602_01587 Formate--tetrahydrofolate ligase
MSFPTDLAIAQQAKMLPIREIAKKLNITEDDLDPYGKYKAKLPLSLIDPKKIAQNKLILV
TAITPTPAGEGKTTVSIGLTEGLNKIGKKAIAVLREPSLGPVFGIKGGAAGGGYSQVVPM
EDINLHFTGDFAAIERANNLLAAVIDNNIQSKTHSLGIDPRTVVWKRVMDMNDRALRHII
VGLGGTTHGIPREDGFNITPASEIMAILCLAENFSDLKRRLGNIYVGKKYDGTPVFARDL
KVVGAMALLLKEAIKPNLVQTLENNPAILHGGPFASIAQGTNTVVATKMGLSLGEYVVTE
AGFGADLGAEKFLNIKCVSAGLAPNAVVIVATIRALRHHGGATKEEYNTPSLERVKKGIA
NLEKHIENVQCFGLKAVVAINHFPHDSQEEIAYIQAFCKERGVEAIVSRGFSEGGAGTQE
LARAVVAIAESGESHFTPLYDHAASVEEKIKTVATRIYGAKGVNYSTTALSQLKQINKLG
FDKLPICMVKTPKSLSDDEKKLARPTDFEVTVREFEFASGAGFIIPILGDTVRMPGLPSV
PAAEGMDIDDDGIITGLS
>SEQF1602_01588 hypothetical protein
MCKEQWAAFVWAYAQNYHAQQQGFERLSIRTAEGIELIPLASILYLQSDKGYTTFCLESG
ETILISKVLKVYEALLPASQFIRCHQSYLVNARYVRKYYKEGILELTTGEHIPVAERRRE
LVQQWLMKSE
>SEQF1602_01589 hypothetical protein
MNTEIPQNMAAYFQAHPEQFVLKADVAKKSTYGLLFAVCLVLMIKPDLIPVGELWIWRVI
AWIGMGFAGISLFLASDYYNKQTQTKIKQKGHKKFDSGHTTVEELSRLLEQGNYQELANL
PSKNNQPLQMYVYEDTQNKTFYLLLMKYFSPSDFRGVTPVKVVSGADYDRYKMVIRAIDG
Y
>SEQF1602_01590 hypothetical protein
MTTTTLSPSEPHFLTDKQGNTIYAVLPIDQYHQMLDIVRSYEMGDDLLTEEDIKEITISR
EQLKMGLGIKNEDVFKEIEEKRKKGWK
>SEQF1602_01591 hypothetical protein
MEIIWSPKAKDNLLETLEYWEVHNGSPLYSDKIIEEIKSLLQELSNNPYFMGRYIEKLNL
YVRPILKGRFLIYFQLKEDNSIEIQHFRSSKQESLE
>SEQF1602_01592 hypothetical protein
MTLSEAKASVLYEAGREKRITLRNLIIVGVLVLIGIFLGVKYLLPILSQQVTNVPTYVKF
ILPLALLLTIGYPVVRVWKIFKRREQVEEAFSLIAQGEECRITSETDDYLTVIPFGKRSR
INMDPISYLGVTIKNKNYLLPVHYRAGSAEIKRVLTGADDGAYKEVMYELYNKPQANSLF
DKAAEKSEVDKDPITLKPVSEFRSFAQKELAPTLASMEKARSTNQSMFKGQTIIAIAFVV
VMMILVFTGVINFSSQTSVLYFIIGFAVFGFLYSFLSMQHAKKKLAGTEDYTQLKTKIFS
RIVHYISPDFQYIEKGHIGIGDLLASFLFRQERYDLTGGDQIIGRYKGIPFQSCNLTLTY
RPTIRQEKQPDDVAFYGNYFVARSPKTFEHPIVIHPVKSFFGTLNDNDIAAYLNTGGERI
RLEDPEFQKMFEVYCDDQVTARYVLTPAFMERLKKLNERYKGQVYIAINTDNIVIATNRG
NVLSSVDSPIGALFQKIDLNLVTEVYEELVEQLQMIDTLKLSNQ
>SEQF1602_01593 hypothetical protein
MVTYILCGIGVLVVLYVVMAFNRLSTRRNQIQNAISSLDSLFIQRAELIPNLIETTKQYM
QYEQETLTQITELRSPTVTEKQNPYLQPEQGKKVLMNFMARAEEYPELKANTQFIQLQRA
FSDCEEQISAGRRYLSASITDYNDAIVTFPSNIISGLFGFTKYQWQYATEKQRQAIDAKE
LFK
>SEQF1602_01594 hypothetical protein
MALNVSDALIWTKSYCVVLAIIAGLLLPFMFNLTQQERQDAPVWRKFLNLFTLCCFIFGS
ISPLTFYLLGYLLPNLQNKEITSFLLWSMLIVCTLIGFFIHLCLRRFIEPEIQNIKHKAI
KKTKLERDVRTDVRKIKDLLPVTIKYDPLQYIDLSKGVFIGLNDAEKPQYIPLEDWQKQH
ADIIGTTGAGKGVATAILLYQSIIADEGVFVLDPKDDEWAPHLYREACRAAGKPFALIDL
RSKKYQVDLLEGTNSETLEELLNAGFSLAEKGEGADFYRLGDRRASRHVSELYESGMTLR
DLFNTEYIRSIQEDVANFHAKMEEISLLNSVNARGGLSLKDTFDNGGCVYIIGSMRNPKI
ISAQRMILVRLLQIAEARDRIKSKPRPIAIFLDELKYHLSRPALEGLGAARDKGVHIIMA
HQSLGDLEDCPADLKPKAVIGAVVENTKFKLVYRVQDPATAKWVAEMSGSILVDDESRKV
KTNAVLVESVEGDRMIKQSERFYVDTNMLLNLPDFVSFIFTNKHLPRASMISPIKVSKRA
LVIFEADEKKQTEITPVINFSETPPLVPLDENPVQEVEDDNQKNRDDSDDDFAAFKLTEE
DDVFFKVDS
>SEQF1602_01595 hypothetical protein
MNEQLISDYKTRKDRSHEKIRLFLEFLKEETYTDRKNIMRLFSFKDTKSFYSLTNKMVNM
GLIQKYVFTSLLGELPLWGITREGLSMVIRPEDETVPPWFEPSKIKGWGLEHHLFNQNVR
LILEEKSATEWINGDRRTFLTRFPKVKHRPDGLIKLKNGTVVAIETERYLKTPARYTQIM
ISHLMARTAQNWFSVIYVLPDEQKKLLLKKYFDAIKVLSVNSSKVTVEQKHRDIFNFYTL
AELEAADF
>SEQF1602_01596 DNA topoisomerase 3
MRLFIAEKKGLGEVIAQALGNGVNRGGYIECGNDVVTWGSGHLLELVPPESHNPDYAKWN
VAHLPLQLRPHRYQPIARTANQFKTVVSLMQKATEIIHAGDPDAEGQLLIDEILTYTGNK
KPVKRVLINDLNTEKAKRALANLRDNSEFYGLSQSALARSVADQLYGFNMTRGYTLAAQK
KGFSGVLSVGRVQTVILGLIVRRYEAFKNHAEAYYYQVSAGVEIEGGNIPARFIVPDDAP
VDDKKRITDKNYAAVVAETATGKAATVSLVKVEDKTTPAPLPFSLLDLQVKMNRENGLSA
ETTLAVTQSLRDNHKAITYNRSDCRYLSTEQFNDAPKTLQAICSVLNNRFSADVVSSLDS
SLKSRAFNDNKVTAHTAIIPTDTCPDIAKMSRDELTVYTAIAKQYLCQFLPEKKWKQATV
DFGIAGYAFRASARMTTFPGWTSLVEETKEIEVINTDDADDESDILFNRLSSLQQSDTGH
CDAVTVSPKKTKPQPLYTIASLLEDLQRVARYVKDPRIKALLISRDKNAAEGENGGIGTP
ATRGSMFETLEKRGYYTIEKNKLIPTELGISFIAALPPIAYEPDMTALWHEQQQQIEKGQ
LTCAAFLDELELFIADQLKNIDVSNLAALVTSTQSGAQADNRRERLDVPCPACGREIIVT
PKTFSCSGCAFKIWITLAGKALTKTQVQTLIKKGKSSEIKGFTSTKTGKTFSAFVCLADK
KTGKLSFEFPPR
>SEQF1602_01597 hypothetical protein
MAKLPKKITTNETTEKTTLRHFISTATHKPATASAVTRINLTVTHEDLVKTTEFQQEGAI
SRADVFRAALVALDDMPKEARQTLFDEIRKTSPKAGRPPVNK
>SEQF1602_01598 Chromosome-partitioning ATPase Soj
MGKIIVFGSHKGGVGKSTMLVSILAYLLRAGKKCAVLECDDQNSIKDWLAERRDQGITPD
VDYFECYTDIPERARKLAGRFDFVLLDTPGKKSAEFRKALTCADTLLSFIEPGAQVEINT
LSQMVNDVKTAQSALNPTMQPWIVLNRCSTDPRDQDASELRQLLNDDPDWLPVTRQRLYS
RKSYKQAYNAGQGVHEYQDKSGNKGRGEIECLLNEIGLI
>SEQF1602_01599 hypothetical protein
MAIEDEVLKRLLVKGVFDKDDKAEGIAKRGADKGYATLTAPQRYVVDPYMTIPCDGVEDL
GGHHNDCSVQMQGQELVTALDDEGYYEGLLCTDCRSEHFEMYE
>SEQF1602_01600 hypothetical protein
MYSIGKVRHCSCRSCPCHIRRRYIHKVCISRAFLLYCIWMCSTMCASVSYTDDRSGCHVR
CYTALRRDLHLFYGQGRNIIDTCLYPTCSNLTQGTIWVYHTYFQGMSWIRRRCHWSWYLQ
LICTYQSSTSIRSSVKLVLKGSPSLDVSEFYQ
>SEQF1602_01601 Na(+)/H(+) antiporter NhaD
MEYLIVAVFFIGYLFITVEHQVKIDKTISALGMAVMCWTILKTADLSVFEVSETGGLISQ
ADKFQGGNPEAIDSMLLHHLGKVAEILFFLIGAMTIVEIIDMHRGFEIIKKMVKTRKKKK
LLWVLGIVAFFLSALIDNLTTIIIMITILRKLVPFREERIWYASLLIIAANAGGAWSPIG
DVTTTMLWMAGKVSAARLVDYVVLPAVLCFVVPFAIASLMPIFKGRLEIPQMDKTEAYKS
STPILTIGVLAIIFVPVFKSLFHLPPYLGMLFSLATVWFFSELLKPNSELSEEAKPTFSV
HKALGRIEHSSILFFLGILLAVAALESTGSLFHFAGTLKEVVPNTNIVVMILGFASAVID
NVPLVAAAIGMFQEGMDASIWHFIAFSAGTGGSLLIIGSAAGVAAMGMEKIDFFWYVKHI
SWLALLGFLAGSGVLMAVEAIFR
>SEQF1602_01602 Aerotaxis receptor
MRYYKEPKINSMIPNFQYPTPIDREVNWDKSKTIMSRTDAAGVIDYVNQVFCDVCGYSTE
ELLGSPHNIIRHPDMPRVIFKVLWDNIQQGINFHAVAKNLAKSGEYYWVVTDFDIIKDAQ
GKIVSYLARRTSVPTQSVEKYIAPLYAKMLQVEAVGGMEASGAYLANFLKENGYIDYIDY
IENAILEFK
>SEQF1602_01603 Undecaprenyl-phosphate mannosyltransferase
MVRDSKNLVKLNYAILIPTYNNAPTLARVLKGVLSYTQEVWVVNDGATDHTAQVLSEFPQ
VRVITLPKNQGKGNALKIGFRTLLAQGYDYALTIDSDGQHFPEDIPTFLSALQGRTEPVL
LVGSRDMTGESVPKKSSFGNRFSNFWFHLETGIRLPDTQSGYRLYPLSQLPKRYFSGKFE
FEIEVLVRTAWRGVAVENVPVRVLYDPAERVSHFRPLRDFMRISLLNTCLVLIAFLYIKP
RNFFRKFKKKSFSQFLREDLLESNASHSNKACSVALGLFFGIAPFWGFQTLITLSLAALL
GLNKSLAFLCSNISIPPMIPFLGLASLKLGSLFVGGDILPSEGKITQEFLMNNLSQYLVG
SFLLASLTSALLGSMTYLFLKVSSKQ
>SEQF1602_01604 hypothetical protein
MDKKRNTIEYLKSFYIKDYLYMALAIAIYTIGLTGFIMPNQIVSGGLAGAALLLNYATGI
KVSTTILVVNFALLILAFRPLEKKFVINTIIGAGMLTLGVRLGEMYLKPYFLANPVVHDP
FIAIVLGGIFMGVALGMVYSVNGSTGGVDIIGFLVTKYFKIRISRILLLVDVLVVTSSIF
VLKGYTMEKMVLGLILLPVMYQAVDVIMNGAKQAIQVIILSKKYEEIATHINTELKRGCT
VVDGTGWYTKNPQKVIIVFARRGEGTTIFRLVNSIDPDAFVTRTNVEAVYGKGFEKFS
>SEQF1602_01605 N5-carboxyaminoimidazole ribonucleotide synthase
MSFFSTDFTLGILGGGQLGKMLLSQTLKWDIRTLVLDPSAEAPARLGCNAFFQGDLMDYD
TVYRFGKQVDLLTFEIENVNVDALERLESEGVRVFPTPKSLRIIQDKGLQKVFYKEHGIP
TAPFELFSSVALLQEAVKEGRWSFPFVWKSTRFGYDGNGVKIVRQKQDLDTLPDTPCLAE
VCAPIEKELAVIVARRPSGEVALYPVVEMEFHPEANQVEYVLCPARVPSTISEKAQKIAL
QVAEAFGSIGLLAVELFLTQEGEIWVNEVAPRPHNSGHYSIEASYTSQFEQHLRAILDLP
LGSPKSKVAGVMVNLVGAEGYAGDVIYQHIEEVLALEGVTPHIYGKRQTRPFRKMGHITI
THPDIETARAIAQKVKETIAVVSEQ
>SEQF1602_01606 hypothetical protein
MNYLKEIQILKTELALPLQKAKTLLEQTAGDIPAAIAFYHQENITSIMAETECERWEAES
VYERFNYNVEKAVKHIYSTSLTISVNGERDKSERGMGYLISALDGNLNNLPERSIFIPIE
DFDQYLLEDFKSVFPLYQPQWDKVENYFNCTTSNVFDSTTCRKIITQLRQHTFTDDKVKI
FIEKIITDVEEKLSTCAYIEVYGNI
>SEQF1602_01607 hypothetical protein
MKEQLHRIQQKLAQAKEADKNLEVFGADTHQYHLNPPVSEAEVLAFEKKYGVQLPECYRA
FMLTVGDAKAKKSDFIAGPYYGLYAFGTSLDSLLYEKIETYLKAPCNLSPDMTQEEWETL
SDPLLPSEEEEEEEDDDKYFAERAKVFGGLLPLGSQGCTYEHALVLNGKYAGRVVNVDLD
LLQPKFAFETNFLDWYERYLDEVISGQLIDDRPTWFGYHRGEPAEVLLNEYEHTTDRKTQ
TDCLEGVYHKKPPLEPALLDKIEKLIALDNEDRTFLIEILTQSSYERAKPYLQDLVTKDP
KKVFQFVWWYAQDHCADWVSVVKKLLPTITDERTFDFATYLLTEGDDNFEEAILPFTDNV
NPQIRSTAYYTLGESKKREQYLDTFIKGLQETDTGVLCTVMQALSGLEDKRLLPYYKAIA
KRFPEEKDYILSNLEHRLASFGLTIEEARK
>SEQF1602_01608 Methylated-DNA--protein-cysteine methyltransferase
MKNRDKPIFLKYIETPIGTMVTCATDKGICMLEFSDSKMLERELQNISKIEKAPIIEGES
PFFAILERELSEYFVGKRQEFSVSLQPFGSDFQKSVWQVLRTIPYGQTWSYKEQAIALGS
PQSVRAVANANGQNHISILIPCHRVIGSNGTLTGYGGGLWRKKFLLELEGVEEVKNKTL
>SEQF1602_01609 hypothetical protein
MNLKKKIEKSWIVNKTIVLLDKVFAYNEYLGCFLMITFFCIIYVLMFPIMLVTLPIVGLA
NLFKK
>SEQF1602_01610 hypothetical protein
MNLNRIIHSRLLNTTIDKVIKVNAYNPLLGLVVITIALFVFFIAVIFLIIVGLPILGLVN
LFKKLTK
>SEQF1602_01611 hypothetical protein
MYCKIFVNYQGDKTTLLDTLAKELQAKSIDINTLLFPWGDLYIGRNDEYDPKKVQRTDGF
LYYLYLLDMEITTTDYVAITYTILDYFRQQEVEAVAACDYEEKLRKQ
>SEQF1602_01612 hypothetical protein
MKKSLENLLEKQGIVLLNTLSKEERRARTETIKARYREAGYDDLPHELITFLTLFDGKDI
KRRDGYMVFISSQNLPTRQEMLYYESDAGVTELIPFGDVNADEVLCIDSVGSVWGVLDLT
SWVPRKTYHYFYGGDLYTALENMIKGKVEETIIRP
>SEQF1602_01613 hypothetical protein
MELQYLLGRLIHSPEIKEFFAKYHLPQNPEPQYDAYGNLFWVPVNNEEKTIRCLFTGYVR
YAPAYGEPIGNYNKEKDQLILHQITIDSENAPNGKISDINLPFGLNIGDDKTTIEQKIGK
KLTRKEVSDYGSTYDVLFEEFSLLVALNPQEQLDRLMLFKLELYEKERIRLKALLKSQNK
NIDPNRIPEIQAFLSEIPIPEWRQRMAEGDDMFSEESITAVETALTEYVQTLCEAMQKKN
ATTVYNSMGKLVKKLNKINDKYGLIETMEREELCEWLNTLIRKTGLELADNVDITDEYRE
W
>SEQF1602_01614 hypothetical protein
MKKSLENLLAQQGITLLNSLSKEERRARTETIKARYREAGYDDLPHELVTFLTIFDGKDI
KRRDGYMVFIYSQNLPTREEMLYYESDAGVTKLIPFGAINADEILLCIDSVGSVWAVLDL
TSWVPRKTYYHFYGGDLYTALENIIKGKVEETIIRP
>SEQF1602_01615 hypothetical protein
MAIDGVKIIDSDSGYDIYNNITERYKDGEDIEKIRQDWLNEEANFCIDELYTEIYWTAFA
YSLWKIGYPHDEVRAKALQLIEQGATPLWNEIDSKAQKQRQKALNKLKLQLQEDNPRHLV
KPAPKKPKTPYFEVGDVLVVTIDKRYGICFVSAVEVSPRKIEYHLACTRYISEQFPMMTD
FLQSELACGKNNQDFALKTDCWFNHKNLGAILPSLQKIGSVQLKPYSLWTLSPANSIDDI
YEKIIEDKKYFGGKLKKVEELVEKVIEENFLEHAL
>SEQF1602_01616 hypothetical protein
MKNTLWLYKNPYQIEIIDETNLDDNQKALTRYQERQPYDREIGDYDQLIGIRLYENEEPM
GKVLLVADTYNVLNEKGILLDNDRLLVACGYEVFCILLPSLELLWHTQVDMATCFEIAPY
QDDYITHGEVEIVRLNKQGEILWQFSGKDIFVSPTERTPAFTFTPMGIELVDFNYENYLI
DYDGKIIRG
>SEQF1602_01617 Anaerobic C4-dicarboxylate transporter DcuA
MIYMELLVVLAAIFVGARVGGIGLGIFGMLGLGILVFGFGLPPGKAPIDVMLIIVAVITA
AATLQAAGGLDYLVKVAEKILRRNPAMITFLAPVVCYFFTLFSGTGHIAYSLLPIISEIA
TDSKVRPERPLSISVIASQQAITASPISAATAALLSAELLGGKGITLGNILMVCIPATLI
GVIVGAIAVNFIGVPLEKDPEYLRRVQEGLIKTDKDEKEVLTPEQQKRAKLSVIIFLLGV
LSIVLFGSIDALRPVFEIDHKKVTMEMTQIIEIVMMSTAGLMLIFSKADIGKAVKGSVFI
AGMQAVIAIFGIAWMGDTYFNGNMEFFKSHIAEIVTAYPFLFAIALFVMSIFLFSQAATV
RTLYPLGLLLGISPMALIAMFPAVNGYFFIPNYPTVVAAINFDRTGTTRIGKYVLNHSFQ
IPGFVATIVAIIVGYIIIAFM
>SEQF1602_01618 Protease 4
MNFLKTVLAVIVGFFITLSIALFALIGIASTFAPKEEAFVVEDNAILELNFTEPVYEYGA
PMRVKDFDYEIAQENTLQAILRAIKHAQEDPHIKGIVLGSTEGVEGKTHLADIRHAVEDF
KKSGKFVYAFSEGASQYDYYLQSVADSVFVGTLGSVEVQGLSAEVLYYKDLQEKSGVHME
VFRHGKYKSAVEPFLENTMSDANREQITSYLRSLWNSYAEAVSSSRGLSLSELDQVADSL
WGRTPELALQHHLVDRIAFRDQFEESVRKASKCKEVNDLQWVPIEKYTEKVTLDRKKNLY
KEIKNDKIAVIFCDGEIIDGQSTAGRVGHETIIKALRDAREDKRVKAIVLRVNSPGGSGL
ASELIHREIGLTQKKKPVYASMGNVAASGGYYISCNATRIFADRQTLTGSIGVFGVVPNL
SELTQRWGIHSQQVSTHPYALSYSLFEKTPEKTRQVITEGIEAFYKKFVQRVADGRHMSW
EEVDALAQGRVWTGQEALEKGLVDEIGSLRETIAYAAKEQKLSEGKYLPVAYPIIEVNFM
DYMKQRFRASSQAELKMLLQEEIGKELYEQLQHTKQALPTSGAFLQAKMPYQVRIR
>SEQF1602_01619 Glycogen synthase
MKSKKILYVSSEVLPYQAETEVSKLAFDLARALNTTGGQLRIFTPRYGDINERRHQLHEV
IRLSGMNLVINDIDMPLIVKVASIQKERMQVYFIDNDEYFKLEESFDKDGELYADNDERC
IFFAKGIVETVKKLNWSPDLIHIQGWLGALLPLYLQTYCKEEPIFQHTKVITCFLREPFI
GSLDEGILEKIAFDEITPDQAPELKEPNSMNLIKLASRYSDGVTTLRGTLPDEAISYITS
LGKPFLCEENIETTCKSYPQFYKEVMGK
>SEQF1602_01620 Pantothenate synthetase
MEIFNKTLELERFLAPFHQEKKTIGLVPTMGALHQGHLSLMKKALEENEVVVVSVFVNPT
QFNNAEDLEKYPRNLERDAATIATLSDKIILFAPEVSQMYEGTPTSESYDFHGLDKVMEG
SSRPGHFDGVATIVEKLFRLVRPTRAYFGEKDYQQILIIRSMVAQRKLNLTLVPCPIVRE
ASGLAMSSRNERLSPQGKAQAAFIYQVLTEAKERFASHSVEEVTAFVKEQFAEKAAFELE
YFIIADERTLQPATEKEAGVAYRAFIVAYIEGVRLIDNLAF
>SEQF1602_01621 23S rRNA (guanosine-2'-O-)-methyltransferase RlmB
MQQITSTQNSLIKYLYSLSEKSKLRREHQEFLFEGKRELSLAIAAGYHIKQLFFCPAILP
AAEVERSFAGYPLTEISLPVYEKLSYRSSTEGILALAQGKDLSLSALSFNKENPLLLIAE
APEKPGNIGALLRTADAAGVDAVCIANPKTDMYNPNVIRSSVGTLFTVPIATASTEELLH
FLAQEDFTLYCAALSASVPYDSVSYKGRTAIAVGTEDVGLSPLWLEASSQNIIIPMRGKI
DSMNVSVSAAVLIFEAVRQRHSEE
>SEQF1602_01622 hypothetical protein
MLLIYTEKKSPRLMYICEHIFVNMLGLSIEITTDLETFVKSDESKLSYAKSPIGNEFFIK
NFGLLFQKGVQPIELLVDHWEGIPYFFATKKGNLPFDILSAAFFLLTRYEEYLHHEAHPS
TPFAATDSVGYEYHFLELPIVDIWVEKFRNALVEKYPNLTFAPREASTVSVIEVAKAFKY
KHKGILRTLLRGLTYFFTLQWTQLGELLRVVMGRSKDPFDFYEALIDFFQERKLHPTFFF
LLGDYNYYDQGLSYNNVRYKYLIKHIADYAIVSVLGSYDATSREEILLKERERMSNIINR
PVRRFRANNNLLPLPELYQHLAATEFKEDYTMGYLSHIGFRAGTCTPYIFYDIRLEVQIP
IVVHSFALHWQHIEKQCTKETLYLIETIKQQVADLKGDFISIFSPEYLSKAPNRFSLYKK
VVN
>SEQF1602_01623 hypothetical protein
MKIISKFKDYYDYKVAEYGIDENLVYDRRLPPEVGMSLPQRSWLTFDDPTDDEALHSALY
VGTALVHLFATCSKIYTHWDFADPDDWHYNLFDLWYGERYALMNDGKEIRITSYLSSTCD
ILLEQMEAPREQNIFKLEDRPPWLVLKSPLLLIYNKDHRENNRATHYINLQELGIYIDPD
FVWQHIVQYLSDLKTQAEQSPELPNELKIDSKGFDKRRSFRPKMKGQ
>SEQF1602_01624 hypothetical protein
MNNNVITAQERKNRSIAILVSQGVPYIEHLPFRYETEEVTPRDKKEVIERAVCSFASIMC
ALSISEGEYSEEDRVYAEDFLSEKYNALELLTPMEQQVIAGTISEAGAMNASWKYESLWV
LLWALGIVEELSFPNEICDCDLIMDTMDEFEGLDDFMAHTTLRPIEEILQALDLHYRYHW
TTVNARIYGSDLAGLDEDIVMERRAGLEWLCCKGEENDNLTDTYNAWDYPELGT
>SEQF1602_01625 hypothetical protein
MTLAEQYLEGLKAAYIDNGGKEAWQKLMDTAHGATEADLQSLCNCYPQVPESLLDLLCHI
DGTYWREYEKGTICDLILGADEAMGDYPYYLLSAQEIVETQNEAFDFYADYINRKYEEVP
IDERITSDASQLNWLHFSDCMNNGGTSQLFIDFSPSATGKVGQVVRFVHDPDAMDVIANS
FDDYLKMLMDREYCFINETDFE
>SEQF1602_01626 hypothetical protein
MSLIRKKDPKNQFIFAKKLLKIARIILIVSVIFNISYALLKKPFLVFGGNFTGDVIGLFS
PLVFFVLLYVFAYLWALDRHIAYNQYTKAELPSLIKVKAVNDRIIQVFLLIFFWTFLVWL
FWSTIQYFIGQQNGGDRPFMTYIGITLLVGIIVASVYDFIRNYRGTFYALEIRNESLYIF
YKEALTDTIPLNSIHHIHFFAKKQGKSTRIHPRMQVYTSKIERILHIKLSIDNYHLLKTF
FYRKQIKVIDEYSSRSKK
>SEQF1602_01627 hypothetical protein
MNNNTKYLWQKIQQSLLAIAPSIGRSFQKPAQEAQIKALEDTIAQPLPESFKEYLRTFNG
QEQSDSPHYFMGYNLLLPIDEIIETYQMQVEDFEGESIADDINPNKIQPVLWDKGWVPFT
DFEATTRICIDLNPATNGVKGQVIMLYPGIDYQSDEVVLANSFEEFTQKIWNILDSKDYS
FEEGIIEQDFLI
>SEQF1602_01628 Actin-binding protein
MAKKKKTLPANFYELLEAKDLEALKAVFNECELNAYDRRSFNKPTLSFYDVPLELMNWLI
AQGADINVKDEYDRTPLHYHAQVNDVERVTLLLEKGADIEAIAEYDETPLHAAGYYPEVT
ALLIAKGANVKAKDDMKHNPMEAMLYSVQSIDIPKAAKTAELYLKAGVKPTKFAKEQVTR
IGEDFEFHRNNFNPEYLEETDAGLQQLYKLFGVPPVPRRIQHDGKSPIVLTGNTWEARYE
QAWTLLVPSSGSATTVQGEVVRIAGRVNDELLRNAMGNWDKEYRKMLTAISGYLQQGNSL
SESELAEVADIQKHILEDDGTGTQRLCELATAWVVQNPQPIALGKVNYKY
>SEQF1602_01629 RNA-splicing ligase RtcB
MANLKLKGKDLLKLGFPNNQSINVALEVMKRNYATKNLAYVKSVLEDILKNPAQYEGHLT
FGQIAEALLSSTKTEKRQLNATRAPYHIFGDDITEEAKTQLYTALKLPISVGGALMPDAH
SGYGLPIGGVLAVENAVIPYGVGLDIGCRMCLSILDIPVSYLSGARDKYEKALVEHTKFG
MYETHKSHVDHEIFDRDTFSLIPILKRLKDKAIKQMGTSGSGNHFVEFGEVELLADDPQI
GLPKGKYLGILSHSGSRGFGAEIAQYYVRVAAEQCPLPKEAQQFAWLDLSTHLGLEYWTA
MNLAGDYASACHDDIHRRLIKAVGGRLRARIENHHNFAWKEIHDGKEVIVHRKGATPAGE
GVLGIIPASMTDAGYIVRGKGNTESFDSASHGAGRAFSRNESKNRFTNSDIKKALKAKDI
TLIGGNAEEAPMAYKNIETVMASQTDLVDIIGTFQPRIVRMDR
>SEQF1602_01630 hypothetical protein
MKEKTATQIEFDEMVKELYQILKPLGFKKKALHFYRVVEQSLQMISIQKGAYGSADEIYF
TANIKKAPYKEPISFYPDDNTQRIGNIKGNGDIWYEFSGSIIDIFKRKQKIKENREAFLT
DIQQIVLPYLSN
>SEQF1602_01631 hypothetical protein
MKKFEFKYQFEFFCSPIWIEENVKNPTPRNVEIADLDINPYLKEELEELNHLYQEIFNDN
YPPESDFKDVISEYIFVNRVLTSAKLLEKEVGEQYTFVFDYPKWRERKEQLTNLL
>SEQF1602_01632 hypothetical protein
MKNKDIYGVHIFESDLANELDSIVEDAYHYGATEAEIRSLIDTFRKEAVRTTLEKEIFLT
LRLAILWQYGWLRPEEVAPLQQLVQKGVSKKWLQQFGTDTPQMSYAKRQQQVVRLLSRLA
TANTAVPAREHWQKVTDFLFAPYEVLSVPLLGGQYGAVWLLRTDNYEGDGHYTFVELLYK
STEKPTMKSLMEARLQLMGDGEKEVLSDVRRVSHKALLLFAERLERIGTAIPKKSLPAPS
PYIIAYDSFEKFVQRWNSDTGIPDKRKRKKFKSVVAHW
>SEQF1602_01633 hypothetical protein
MKELTCPNCNRTFLPETLSDYDFNFLKEAIGKQMQFMFLHCPHCTAMFDFNPMQWISPSA
LSQSKENHTSSPKSVRSLPGNKEVKSLSPKYRNYLKAQKEIVCFPIFSEQTPFVLYSLEE
LCKEITIDKHQCTIITQLKAYATTLQEVGYEEGSFSLERLSQSLSIGYENERLLFVDSQD
NSSLYIFEVEDGDILKTDYTLTDLIR
>SEQF1602_01634 hypothetical protein
MTNKIIIIDLEATCWEGIPPKGEVSEIIEIGICLLDTLTGEVSDNRGILVKPTHSKISPF
CTQLTTLTPELVAREGVSFEEALQILKKEYQAYQYTWASYGNYDRNMLQKQCALRKLPYP
MRNEHINVKERFQEVTQHPKRLGMHQALNYLKIPLVGTHHRGKDDAYNIAKIMYKLITNP
LEQN
>SEQF1602_01635 hypothetical protein
MEEQIQELLNSIPQGVTYTSFPEELEPEDISQERIDGLKKLLTHEDVFIELCAAKLLCAW
GIDEGFKALIQLYEAGKAEGYFTHRLHGYDETAEQLFWPLLYYQSTKEGISKEAGEKARL
QIRPYVKQLLQKVHNPEQWKKYVKDIIN
>SEQF1602_01636 hypothetical protein
MIRTIIFEKEEGISSTISDILIPSLGATLPIWIYNETGEAGFFSPKQEVAFEQFFYHNSY
REQLKEQLRDFYEELVNEGELERKNTHHFELDFEFVAIPSQCKTSKNVIYVGAFTNWDRE
DSEFPLEVEICFEDGEVMWIDELHGNYIFPH
>SEQF1602_01637 hypothetical protein
MTGRMYQDTHFNLTLLNGLPIEQLKVCVNPDDGNVLIVYLKAEGQPIFHFFLDVGIAFCE
CWNEYEVDEDDDDYRFDDLTEAWQLKGKHISAIFAEKVAGNSEITFLLEEGEKLRLYYCP
TEDKSYFIKDNEAMG
>SEQF1602_01638 hypothetical protein
MVKYIQELLYSIPQEVTYTTIPEELDLEDVPQERIDGVCKLLTHEEEYIQLSAAILLCSW
GIDEGFQALVQRYETGAVEGCYTHRLYGYDETAEHILWALIFYQGNKADISEQAGEKARQ
QIQPYVKELLQKVAHPEDWEKTRVKEILA
>SEQF1602_01639 Peptide chain release factor RF2
MEEKIIQITAGRGPLECQWVVAKVLKTFLQEATQAGISYTILSREEGDANLTVKSVTLQL
KGKELASFLKTWLGTVCWVGKSTFRKFHQRSNWYIGVFELDQLQRQLFSERDVQFQTTRS
QGNGGQNVNKVNSAVRATHLPTGISVLAQDSRSQLDNKKLALARLKEKLAEMELQQLAEQ
AQNHWNNHTQVQRGNPVRTFKGTDFKSTYVEKSYKKERAEAKREIKLVVSR
>SEQF1602_01640 hypothetical protein
MGNLYITPEGVSRLRNLRSRKRIAREDHEKYLRACIKRQKALFKQRRELPLVPLEKPYQK
GYVRFFVLREDVRQGKQADFFETLLEKINTYQYADTRKFQKKKKRRGKRVYIARKQELYT
FSQWEWERALERGKFTQKERAYFAKIECFNRQKDRFEIHYEFTEAWRFELRVKPNMITHY
RPVDVAIERELAELDKIINDYNNWNIITKKIYGHSYRYSWMYYEKRYNPKEKYKRTPLKE
ITALKYHTSAMEIADILLEVNL
>SEQF1602_01641 hypothetical protein
MKKYFLPFILSSFLLLTACNKATYDNQLPMPKKEEGHPSPSKEQSSSKETFLTGTFLQLF
GKDDWTPSQWEQYLSELKELRIHTLIVQYTAFKNAYNDITWFDSANTFTTQKSRLTLARV
LEAAQKKGVEVHIGLHFDDSYWQHQTDRAWLELNAQRCIALAKELHTQFGNHPAFKGWYI
PHEPEPYAYGSDEKIALFREVLVNPIADSIHQWDRKPISIAAFWNSALTSPAQLQHFMAE
LAKSHLQIIMLQDGVGAKHVTLDQLGTYYQSAQKGLFEENKNYKGVFWTDLETFYSPTGE
YPFTPASFDRVKQQLTIETALPKVSKAVSFQYYDDMSTLSPHKAQAQALREAYKKWLNQK
IK
>SEQF1602_01642 hypothetical protein
MTIRILYLFLLLLPQLLQAQTLREKLSLADKE
>SEQF1602_01644 Bifunctional oligoribonuclease and PAP phosphatase NrnA
MYICGMNKQDSKSLQALLDKRPIITIIPHTSPDGDAIGSALGLYHFLKNQGHDVQVIAPT
DFPDFLKWMPEADQILIYPDQESRAEQRIADSSLIFTLDFNNLLRAKPLTPFLQKALATF
VMIDHHQQPDTYATIIYSDEKASSTCELIYNTIVSLGSQEAINQAIAICLYTGIMTDTGG
FRFSMTSPQTHRVAAVLLEKGANCAQIASDVLDSYSIDRLQLLGTVLDGLTYLKEYKTAY
MSVSSKTLKQFNFRKGDTEGFVNYGLRIKEAELAVIFIENEEDNLIKISFRSKTSLDVNL
LARTYFNGGGHINAAGGSMSISLEDTIKYFLEVLPKFLSLSNAYQPMDTL
>SEQF1602_01645 hypothetical protein
MRIIITLLFLVLLSSCANKEARRPVMVKTDTFLKESAKKNRALLQDQEAVMDSIIAKDTL
HTYLKSEDGFKYYYVAENKEATYKPAFGDIVDFTYSLSDIYGKEIYSKEDTKVITYYVDK
QELFQGLRQAIKLLKENEEAVFFFPSEIAFGYHGDKEKIGINKPIRAQVHILKITPAPPP
PPSTSESVGLIKCDF
>SEQF1602_01646 hypothetical protein
MKKVNTKDTFTHYRKIYPKVEDVTKEFLEN
>SEQF1602_01647 putative peptidyl-prolyl cis-trans isomerase
MKKVKFWALLLPLLFVACKSAKYPDLKDGLYADIQTNHGDMLVELFYKATPGTVANFVSL
AEGTNTYVADSLKGKRYYDGTKSHRVIKNFMLQAGDRTATGEGSPGYQFADEFVDSLKFT
KKGQLAMANSGPATNGSQFFITEVATDWLTFRHTIFGQVVKGEEVISKITDEQTSKEDSR
PKNPVIIKKIEIIRVGKDAQKWDAPKAFDAFMKEQDALAKKREEEAQEATKIRMEQAQRN
LSLISEQEKQAKALPSGIKILSLNEGKGVKPQDGQKVLVNYAGYIRDTGMLFDSNIKEVA
QENGVFDPQRAQDPQYGYMPYPWEYSQKVSLIAGFKEALLSMKVGDKLRVFIPAALAYGE
QGIQGLIPPNSDLVFQIEIVDIAK
>SEQF1602_01648 hypothetical protein
MSLTNKKIHNLLQITLFFYALLLTYMLLRPANSLPKDIHWFEGADKVVHFGIFGVLGFLF
EATYPKQDFYKYLAILLLYAIFTEIAQHLMDNGRSGDVMDLLADILGIIIAYILFRYVEK
CQKKKK
>SEQF1602_01649 hypothetical protein
MNILFFFLSLFTLGTVQAQTMFGGAPVADTPVEFANNDYEAGLLEVSITLPSGKTAADVE
ITLPQGIEYLAGSMAKKSGTLSITHEASSPLNKPVFKLTGTGTIIFSIKRKVTKAALSKL
KVQGGGFSDVVKITAGGTTESKNSNAYSLPIPNIVVQLAEPTHNNASGTSIKKFVLRNTG
EGATKEIFFSVKYPTGITGNEISYNGTPLTPEATLPSGEKIYKVTAPTAAGFIKNADVEI
TEKYTVTSCGSKSIVYTGYWGENATTLYEGRDLTRAVNVENGTPNIVLDEDSNHTYFEWG
DGICGNTLGTFTVQYINKGSGNATAYDLQMLITPYVSWRGFKTHKPANFRIVAADGTEIP
ISSMTPNGNEVTERQIAFKDLAPLAEATLGTKDIGLKDIDGDGFRDDLPINAKLKVRFDM
VPNQPIVCLQNDGGIFSVSPHSNFNYKDACGTLRTSAVQAITNNTFRRLISGVADTSKIP
ASLSQNEPVFGYISVGSHTIINQQKLKGGATAGNPTKWKYEIKLPAGVELKNVKFYEGIG
YGQSTKAPANLAPIAPGGTLTYESSTRGYITFDMLLTNPCNSGNVSLQYNIYYLDKVGNT
NTYCELPFICANTEIGTICPGTCAGNGPVMISTKAERADNSYGWTDYTMNTRQTRNNVSI
IDRSRTLYLDDVEIISKGEQNGVLTHNLFYHAQVKSHAELTPKSITIKVGTNSEVTLSAS
SAILAQGTNADGKYFRWNLTSALPAGGIAVGEKFDVVATYQVNNSNPTNRRDYAFDVQVG
DKSFFYMLDNVNDTNINTEGYHVNEKHCGAKQTPAFYIAETYKLIGTNGYDIAACDVTAI
GSQQAYLARRFGTAGTYYTNEFRPSRRIKTLKIIIPSSYNMVKPVDYSYIRAVGTWVEND
VQIPVNQFTVTDDGTYKTYTYVNPPKGSAGYLTPGTVSVENFYGETIRTWLQATCASKVF
VNANQAKTDNQMAKVDIDFEDFYYHYANEATKPIQKEPYEQWLTYTKKPAINLVTQTPVN
ITANKKEQTLDFKLTNTSVSDAPFGWVSVPDVAGITVIGLQEMDATGTTVLRTIAPEASL
TGEKMFFLNQGGGNGVIAMNTERRFRLKYKITNCTQATLNFDLYAGWNCNSNPTQGYTKT
CNDNKLTYTVKIAKSLKQISPDSNNPGENHPDKIGTIEMCKKTKYQYTINSGDEGDLFDV
KLVMMKGNGITFSDVEVEYPLNSGRKYTTTSSPAITVVEASDKYTYDLTNILPNGSLPGS
ITENIDVDKRNFKLSFNIQPGCDFTAGSAFDIDIEANNLCGTLADGDKTKVIIAGIQGVD
ANKYKVNNSLTLVGGNASACATNYAEYKGKHVIIDQTTPKNFVTGTNGRVVVRIPAGFEY
VSGSFSAGAKSQTTFGDPSLAGGTNPKPIAGGDTELSIQIPSGMRDNDFFEYTIKVKQKA
NTPIPQCSTEKKIKYYTTDLVTGVACPSGPANPCPAITIETTTNRGEVNIPVDIAVLSIE
DVQLSSVIQNNKEKVTISYNIKNATTSPITYTGNLKVALFSDTDNNHLIDEATDEKLTDF
TDAITSLAPGASQAVTHTIELTQDKLCRLLLSIRNSQNPCLCSDAVVIPTAPTALTDLVQ
NVTICEGEEKVLTYNTQAPTYEGYTWTAITAGALAYLSPTNIAAPTFKYVGTKLTAEQEF
TYKLTVRRANGCEASQEVKVKVTPATAAGAAQQLLFCGADTDKVSTLEAKLRTALSAPTT
TVIKIYDTATATTAKAATDTITFGTTYYYTLTQGATCESQKATVEAKHIDIPTIAEKTAA
TCTDISVVQITNYDSTLTYTFTKNGVAQTGVQIDTDGTIKNLPVGAYKVTANSTSPSCSS
LPSQEFHINDKLTSAKPIVTVTPATCAEGSKAKITNYTAGYTYWEGTVQLTVNASGEITT
PLTAGNHTIVAKNGTCESLASDPFTMTDQKATPSSPTVTTVTECPTLVSTQFDMATLVTA
SAGHTLKWYDAASGGTALAASPKVERQVTAKSVTTKYVSQEKDGCESARVAVTYTVDDTV
APSLTADDIVLDCTAANFDTLVTSWLTTTAATATDACTTPVVTNNYSKPADLCGAGEIEV
TFTAKDSFGNQTQKKAKIRFIVAKDDDYTATPVTPSTTEQVVKDGSGTPYNVLSNDKLYG
NGATTSNVTISEVTPNANVKIDTTTGQVKVQPNTPVGTYTVTYRICDKNTSTACSNVATV
TVKVTSSIDAVNDPDQTIPTTGGTVDILSNDKLNGNPVTKDQVNISIDSDGGLTGVGIDP
TTGKLVVPNGTTPGTYTVTYKICNKANPTVCDTATVKITVPAITPSIIANDDPDQTIPTT
GGTVDILSNDRLNGNPVTKDNVNITIDSDGGLTGVGIDPTTGKLVVPNGTTPGTYTVTYK
ICDKANPTVCDTATVKITVPATPTIKANDDPDTNIPRTGGSIDILSNDKLNGGQATKDNV
HITIEDNGGLTTAMIDPTTGKLVVSNNSTPGTYTVTYKICDKANPMVCDTAKVKIIIAPG
TIHNIEAVDDGVWEVGTQGEFLTPSVLNNDRIGSKTGLNASDVLIERTQGQPAPDSHLVM
NDDGRITVKSGIAIGTYIYYYTIIDRANNNQTSSAKAIIKVVSFVAQQDEYSLTNTKDRE
QKTPSVITNDEMDGKKPPVIGTDVTLTPGTPSHPNLHMNPDGTITISPNTPDGVYTYDYT
ICRVSNPTDCKTTQAIINLHPSLVANDDDYTTHPVNVIHDAAVVGNVLENDTLGGASITD
PTQVTITLVDNGGLVGVSFAPNGEVTVPQGAPAGTYRVRYNLCMSQQSSVCDDAVVTIVV
SEEDPIEIYNGISTNGDGKNDGFRIEGIENYRKNTLKIFNRWGVLVYQKEGYTNSDPFTG
YSNGRSTIESGKKLPQGTYYYILEYENSNNQTQTKTGWLYLKRD
>SEQF1602_01650 hypothetical protein
MQMKKEIISHVKCLFTVALFLFFRGSYVYALDINIGNEAQGNRVNFSNKYVKEVVVNHKK
EGYHTLISRRKVQGTADEETLNLQSSNNSLNCIPTGQLRIQIQKPKAGQTYKVKLTDFPT
GYTGPTEFPITAGDMDGRITFVKFTDYDMPAGNYKGKIIAPVIPNTQEVPATIGKLVKDF
PAPNRNNNDFGSDQVYREILDASGEKDCNYAAIRFGGNTNSPFYKYFTKPELIALYEYTA
YSDYDLQNVYGGNRDHPNIQWRDLFSLPAGKSSSQKVVYYDMGAHGRTYKDMKEDPNKRP
KFYFRIKGHNGCNNQDAPMEPGDMRFMGASLTFGGTCTAPQMTVRAFNHMFCDPATYVVK
EKVTNIQVATGTIKLDEIKSLSTLDNGQPFDRTKVYEVTVTSRDGQTYTESGSFNNFYNA
LVPNAGFTIATRCYGSSNSTKGYIEVLFRNSQGTGAILPMEGYKVTLLQAPAGYTEEEGK
IKLNETVTISLKNKNKVTTNILATTEQDVLTKYFTLPEGQYKIKVEDPCGRVTYVRNSWA
PITQEVFNLTYPTDYQEKALTPETETECAKVKVYPFRGNPAFDWLKYKNANKAIYVYLFK
RPNGINAGDVTVSSNLSESLGGTNYIKAVYNPSDPTSVNQYFSLPRNQNSDGKYTFVYGG
RINAANNSDASDVIQYIISNGTRGCARTFEVKVDDVLLNFDPNTYIGYRCDNNTGKIVVK
AINGVSGSGNYTYELYDTKEGNLIESKTEAKGTEVTFMNLGTFATGQNTRWVKIIDSACT
AAPVWRELPIANASQAYLLLKNPLRASYCQGESISIELRPIGATKYVWTLPDGSSQETTE
PKLDIASLQATHSGTYAVKAEGLTCGANTLTFSYNVNVLQKPTVGQTYTFCQGAKISDLK
TQVDTNTNLVKVYKNNILVTDDNELLTFTDTYTVSRFSTTCETDKVGVTVSLAQLAKPIV
KVTPATCAEGSKAKIMNYTVGYTYWEGTTKLTLNASGEITTLLTAGNHTIVAKNGTCESL
ASDSFTMTDQKATPSSPTVTTSTDCPTLASTQFDMATLVTASAGHTLKWYDADSGGIALA
ASPKVERQVTVKTVTTKYVSQEKDGCESARVAVTYTVDDIVAPSLTADDIVLDCTAANFD
TLVTTWLTTTAATATDACTTPVVTNNYSKPTDLCGAGEIEVTFTAKDSFGNQTQKKAKIR
FIVAKDDDYTATPVTPSATEQIVKDSSGTPYNVLNNDKLYGNGATTSNVTISEVTPNANV
KIDTTTGQVKVQPNTPVGTYTVTYRICDKNTPTACSNVATVTVKVTPTIEADDDPDQTIP
TTGGTVDILSNDKLNGNPVTKDQVNISIDSDGGLTGVAIDPTTGKLVVPNGTTPGTYTVT
YKICDKANPTVCDTATVKITIAGGTIRDIEAVDDGVWEVGTQGEFLTPSILDNDRIGSKI
GLSASEVRIEKAQGQPAPDSHLVMNADGHITVKEGIAIGTYIYYYTIIDRANNNQTSSAK
AIIKVVSFVAQQDEYSLTNTKDREQKTPSVITNDEMDGKKPPVIGTDVTLTPGTPSHPNL
QMNPDGTLEPKGFEFARYWSNSSYGRL
>SEQF1602_01651 2-iminobutanoate/2-iminopropanoate deaminase
MKRVILSSKAPAPIGPYSQAIEANGTLYVSGQIPINPATGEVVAGGIEPQTQQVMKNIKA
ILEEAGYSFDQVVKTTILLDDLANFNTVNTLYGEYFPGEGAPARETYQVAKLPKGVAVEI
SCIAVK
>SEQF1602_01652 LPS-assembly protein LptD
MHIYKKYTILIGVIACFVGLSAQRPRELKVPQRERIEAFLKDTLVKGKDSLKSASSRAKG
KDLLTKSKDTLGKGKDTLAQLKDSLPKKPAMLTDVVRYHAKDCVVISKPLSKITLYDQTQ
ITYEDTDLKAGISVIDYQKREAYAGRIKDSVGELVQAPVFKQAQQVIEPDSIRFNYVTKK
AIIRNAYTIQDENKIRAQIIKKENDSTYFLKEGMITTAEDLSDPDYYIRLRKAKFVPKKK
IVAGFSNMYISDVPTPIALPFAYYPMVDSRTSGLLFPTFGQVNDRGYYLQNGGYYFVISD
YFDLALTGDYYTNGSYGLRGASTYRKRYKYSGNFGVRYENLIYSQRGFPDYSRNSIYNIQ
WSHSQDSKASPLSTFSASVNLGSSTYYRNSYNQQNSANFLNNTLSSSISYSRTFPSYPSV
NLSLTASHSQNTNTQSIQMTLPAMRVSMERIYPFAKEGTPKKGMIKNINFNYSLQGDNRY
DTSDRDFFSKKMFDKGQTGFRHSIPISTNFKILKFVSMSLNTSLDEVWQFKTVKYHDYDE
LTGKIRKDTINGFSRYMTYNFGTSLGTTIYGTFNFGKDKKIQAIRHVMRPSVSYGYTPSF
DNYYNYYIADAFGTKRDYSRFEGGLYGAPGRNESSSMSFSLSNTFEAKVRNREQDSIDGK
PKKVMLLNSLNFSSGYDLVTKRFSPLNMTGGTQFFDNKLGLNFGATMNPYAIDANGVQME
KFNINNGGSLFRLTNANMTLNYSFSSKNFKKGKNADNTQSGGRSDDLFGSAMNTDLSKPM
KEDDPNDKEKEEKQRLYYASMPWDITLAYSLSYSNTNRNPMISTNSLMVSGNIDLTPKMR
VGASSGYDFKEKGVTYTQLRFERDLNSFRMSFSISPFGDRNSWYFFIGIKASMLSDLKWE
KNKSPDRVLN
>SEQF1602_01653 N-acetylmuramoyl-L-alanine amidase AmiC
MNVFKEILELMKYFYYIFLLFSLSVSAQTERFKVVLDAGHGGKDPGKVHKKIFEKEIALN
ITLLVGKELEKDPLFKVTYTRKDDRFIELYERGAIANKAKADLFISIHCNSSPSKDAHGS
ESYVLGLHANDLNFEVAKGENQVIYLEKDYKERYAGYDINSPESFIGLSIMQEEFLEQSI
QAAKRIQSSLAENPVHRDRGVKQAGFIVLHQTYMPSVLIETGFLSNAEERDYLYSAQGQK
QVAEAIAKAIKNYRYWLKNRNQLSPENATNDLIYRVQIATSNKDLAATPSNFKGLSPILK
EKVGNAFRYYYGKETDLKKIDELLQIAKKKGFTDAFIVSFSTNGKRNVQ
>SEQF1602_01654 Purine nucleoside phosphorylase DeoD-type
MKIQNSELILSGEGRIYHLNIQKENIAPTIILVGDPQRVPVVSAHFDKVEFTAHKREFVT
HTGYYHGKRLSVVSTGIGPDNIDIVLNELDALFNIDLERRVPKEEHTPLTFVRLGTSGSL
QADIPVDSIVLSAYGLGMDNLLHSYKDSPKVREKAMEDAFIAHTQWNMDKGHPCIVQGSE
ALLEKLYSPEVFKGITATAPGFYGPQGRRLRLIPQDEHLNEKLESYAFNGYKVTNMEMET
AAIYGLSKLLGHQALSMNAIIANRPAGTFSADPGKAVEKLIQYALPIICKE
>SEQF1602_01655 Inner membrane protein YccS
MKRLDFSEFLKSYAFVIGVLKSFAILSCAIAGWIFGNVSAGLTAATTIIMIAPSDIPGNR
KHHLGGIVIATLFVAISSVTVNFAHAYGHLWQLLSLMALLTFGYAYISLYGARAAMVSIA
GIFTLTLALVRPQKGIDILYNALYIFMAGAWYIFLVRILMWIRPRQYSEQLLAKCMTLTA
KYLQIRALLIRDTEHRSANKQLLLSLQSSLNEEYEKLRAVLLDSRSKSGKTNYLQRQFLI
FIEMVDIFELAIANPIPYEKVDKYATKNAGFLDQYTHFLEELSQILLKMAEYIGERKKGT
YDISLKSLLEKQLLFKQTYLSISQEGSFSEEQMLLEKMYLYLSKQTQNIYNVQQIFNNYY
TQEVSFRDEKSFRRFVSADNYSIKRLADHFSFQSSFFRHALRLAIVTVIGYLIGSAFEVQ
NPHWILFTVYVIMRPGYGLTLKRSKDRALGTLIGAGFAFVLVYVCQFVLHLDYEVYKYIY
GAAILMSMPFGYGLLQENFSMSAIFLTLYIVLAYALFVPDAMSVVQYRVVDTLIAFVLSV
SANYLLFPSWEHKNYNLLIVKSLRANLGYTNELIKRAEHPEITTEYKVARKKAFLALANL
NAGLQRMLQEPKSQQKNYTQRNEIQVLQQDFLSCVATLSTQLSEHPSPIIKDLFVRAIQE
IQHKLQHCVALLDGKLDEEIRPFDPKVFQEIRQATLELFAQQGKTPPTDNPLATIRPQEM
LFYTEQLNYLRELTENIEKMINTIVTD
>SEQF1602_01656 hypothetical protein
MQKIINVVKDYLTRETNNALLITGQWGVGKTYFFNNTLSEKIKEIKIKGKTNSNYTPIRV
SLFGVANIDDIGRRIFTELFPRLEKGTKIGKGIAKLLLSIPITKAFIPEKIPELISEFEA
DNETKNNIINSMTNRIVICFDDLERASKDFPIENLIGYINNLTENYDLKALIIGNTDEIE
SETFKKIKEKLIGVEIEFDNDIKSIFDDIVKKKFHQDESNRNTYQKFLEKEKDFICSFFS
KDYKNIRTLLIVLECYKHIYSAITGLTSEHLEQYKDDLIKNTLLFTIATTIEFKKGKISK
EDKETMSNEIWATLNFTKNEGEDLFAEPQENENINPNILQKKYYEQNNYKYYETIFDYIV
GIDTFIEKNFTTEVKGKYGISQKENLSECYKALNDISTEVIFKISNQEYKKRLKNVLQYV
DKGEYELDSYLGVYNHIIKYEDPLKIGKENLKKRIIKGIKKGKNNLQYNQELTQMSQYLH
FPNSMDEYAREILQFCLTINEEKKRETHKNESAVLEKLLEANKFEEFKKAAIEKATLPIF
AYIESKLIFDFYDKNIPLREDIASFIKERVITNAPLAVLKLEKNFYIQLQQSIQKKASQL
KSGPEWAVYSKFNELLKSITNHL
>SEQF1602_01657 hypothetical protein
MTQEQIYKEDECMKEEEWNDIDKKIYKFDQYYCAFLDILGYKEKLNQFFQNKYNLYERFK
RAMSSAGAKIGKEYPSGINTYAFSDSIIITAPQKENNLILLIDYVSAIVAYFSYEGLFIR
GGISSGKLMEDREIPFLASEGLVKAYELEKQAIYPMIVVDNELIQNNLDPNSPTLKKYII
KNGNRYIVNHVRYIINESANNEQEAAKELDEMIRTKNNIKDPKVKEKHNWLINYYLWFIE
ESNKKFSKFNQSLFSTFQKERDPRFMFSEI
>SEQF1602_01658 hypothetical protein
MDNSLDALYDISLSTEDRERAWQENRQLSQQVLSEYELDEVEQCIVLATGLLAGIVDAFF
VTDARLLLESESNAIRDANGKSIHVTGSGYINRFVDKRIRNFYTIEETKELEKRFKVPYD
PSTNQKLSIEVSGLHPKTHRLNSFGHDPILGFYYGVKDILNGTFTAINDAGEIIVQARPN
ANTSITLFEAIAIQFGHLRSDLSTKAGLPMPFMGQLMRLKGDMPKILMSMYEKGYNFSHF
IAMGIPCLIIEVIIRVSYFAYSLYKGKTFAESIPINKPKVDKMLFYSYLITSGCNGVKVA
GTRNIFAFNPNLWAMTLRYGISEFKRWITNEKERKRHEYVMNIYQNRIKELDIEIENHLK
FYGYDTRTNI
>SEQF1602_01659 hypothetical protein
MDLFKVLSQLFELSQTNAGKNFTSNALKTVTEIAKNKTVQKVVLAGGGLAAGVVAYKAGE
NKGTKEGHEKGFNEGYTKGGEDTKQKLQNVLSMVRSRDEFMLLAVKIAVHIAKCDGDFSF
EENSEIDRYIGQLNSSPIVPQIIKNRIWEIKNNNLSFDELVTETKSFLRQYCDVQNQNEV
VLCIHDLIINMIYADGKVHPAEEAFLARWQEIFPI
>SEQF1602_01660 hypothetical protein
MALYQVTVSKTVASNGIRLEPGMQVVIPTQTTTNPVSVNGGKDVIAAFQRVFGIDISSIF
HTLGAVLKVG
>SEQF1602_01661 Cytokinin riboside 5'-monophosphate phosphoribohydrolase
MVKKRQFEEIQLKQHDSWGIFKIMSEFVTGYERLSEIGPCVSVFGSARIQPDSKYYNLAT
EIAGRIVEMGFGIITGGGPGIMEAANKGAHQQEGSSVGINIELPFEQHDNPYVDRDKNLR
FNYFFARKVMFVRYSQAFVVFPGGFGTMDELFEAITLIQTTKIEPFPIILVGTEFWSGLV
AWIKEVLLDKFGNISAKDMDIFKIVDTADEVEEIIEKFYLKYSLKPKF
>SEQF1602_01662 hypothetical protein
MKSFLRKDARSFYFVFCLLFFVAVVIYYLVREEKTSLLNTILLLSVALLNVCSAGYSLYD
VRKRESITH
>SEQF1602_01663 hypothetical protein
MKSFFFAFLLLGSIPLWSQNSLERQILQSKYAVDSIIATQKAHLFKQLGSVEDLLEQGKI
SKDEAEQMKKDFKQRAKRRTQQLLYTQAQSLRDQLDKELQSFPADSLLMPADSLNPHLPY
EKTMAQVDSLAQRQEANTYLRRYMNRGDIFSPYLALGILNLHSAGHFGNKRLSPLGSKSF
ELGIYTNYRLRKNDNLLHLNLGLSWLYQSFKIRDGLYYQHQAGNTLLVPYGSELTKSKFR
THYLLLPIDLEWDFSKEGMHRNISYFQTHEHLYLGVGAFVGILLDANQKVNAKRGGNTYK
TLIREDLHTNRWTYGLSAHIGVKEWSLYFRYSLAPLFTGNSKGEYPFMIGIRAGR
>SEQF1602_01664 hypothetical protein
MRFFFLLFTLPLWAQQQVLSSKGTPVEYVNIGIVGTSKGLITNEQGEFTLERLEAAPTDS
IYFSHLSYKRKVLLAKDIEKKIILEETDIKLPEASFTLQKPKYYTLRGKGMPIVFKLYGE
MKDGFEPTSNRKYLNAEIGDFLSLKHDARLTELSIDIDRSDFYMAVLRVVVYQTDREHKA
FTPLLREPIYIEVFPSPQPQTFTRKLSVFAPKGEVWIGVQFVEMRGKDYDRLIFPATVNT
CYIRFADGKIRPLNKHLGIPFSIKGYDYIMVNDQ
>SEQF1602_01665 Bifunctional aspartokinase/homoserine dehydrogenase 1
MKVLKFGGKSLANGKGLETVLSIIIDKVKQGQEISVVVSARDKATDQLESMLERAAGGED
ISDDFSAFKQYQLAGEDIDFSEEFSVLQRIFDGVSLLGDYNDKIKDNTLAQGEVLSAKYV
AHLLRKRGIQAAFADSRQFYVTNSLFGNAQLQEEASHRRTLDYFAQFPKGTTPIVTGFIA
ANELGQTTTLGRNGSNYSASILANILNAEELQNYTHVDGIFTANPELVADAKIIERLSFE
EANELANFGTSILHAKTIIPLLEKKIPLRILNTFKPNDAGTLICEAQDSIGGIRAISVLE
NYALVILEGRGLLGEVGVDARIFRALAQAQISVSIISQGSSERGIGFLVTNKDAHKAKQA
LEKEFESDVYSHDVSGVSLVEEVGVVSIVGQNLADFDKPYNALIRNQIIPLLINNSATGR
NVSVVIHKKDLPKAVNVIHGEIFQISKRINLVIFGRGTVGGTLIEQIFQARADILKRRNI
NLQIVAIANSKEVVFNHKGISPADYTAFDTLKVPYQISELIAQVQQHHLENLIAIDVTAS
KAFVENYLPLVENGFDLVSANKIANTIGYPFYKKLRETLTQYKKQYLYETNVGAGLPLID
TIKLLHHSGENITRIRGIFSGTLSFLFNTYSASDAPFSEILQKAIDSGYTEPDPREDLCG
NDVGRKLLILARELDLENEFEEVSIENLIPPALREGSREEFLSRLKEFDPIYQEIKDKAP
QGTVLRYVGDLHGDLSQTATARLEVKLVSVPVTSALGQVKGADSIFEIYTESYGENPIVI
QGAGAGAAVTARGVFGDILRIIGNK
>SEQF1602_01666 hypothetical protein
MHIHKKDLIATIRLEADEISLDTANVLLKDPTLKPCHIIIDLSALTELDEEQLDALFYLS
EMFRSETEHSFVVVIPSYDPDTFPEEIVACPTLQEALDIIEMEEIERDLFDD
>SEQF1602_01667 hypothetical protein
MLLFIEGYPYTLNHKVKTNLSIKDILEGIVSFPKMEKIQSFDYVGYCYSKKAKDVVFFLP
KVILTGDIDKDNQADTIFGASPLEIIDFEGQYIKEKFTEEGCKEYKDFLSNLSIWIYRTI
SVYQKNHNDNILESREHQKESSGRKQKHNTLLDVIIALRDFNKNNQDYFTFIAKNLHSGQ
NKIQWTKTITHSQAIIQKGKPFYTSPINKKKVINFDEELLIIYFSILNYIRQTHGFSFKI
NIQYPLINPDKLQRLYIGKNMGCRKLKQLKYKYFSDKALHIWDLCYAFFDREYKIAMNQF
ETDYLLTKDFAHIFEVMIDTLVGGNDKRNLPKELLEQKDGKLVDHMFIGHGLIEQSDLTE
ELTYYIGDSKYYKRTKNDTIHLGDNSIYKQYTYAKNVIQWNMNLFLDGDTKGQPQLRDTL
TEGYNPIPNFFISARIPNKRNGGEKFLSFDEGKLNSQESGIQLNRQYENRLFDRDTLLLC
HYDVNFLFIVSLYGRDNKSQQSKWRAYVRDEFRTRIQATLNTLYDFYIIQPRKGMDCYQY
IKDNFHLLNGKLYRPRANSNYLIVALMKEENKDFWNKLKIRTEVIENEIKDNKSLLNSLQ
SHFHISPSFNLNTDIDIPQIDAIGTLSPPLKQKRNVLTGLVRKTDDNFEIFVNHQATSYI
MEKIPTIINLMNIEYFLPMIAGNIDGYYKVEKVYFLFPKDNEIPNLKLKLSTYIPLGDKK
IQIYRIKMQPGELISEEDMKRLYE
>SEQF1602_01668 Type-2 restriction enzyme BsuMI component YdiS
MNLNLSSLSFNLNIEGGGGTPAWGTELGQGAEYKFSDNLQDFLTAMLYKSVSNINDVKCP
LGKGGHQEGGYDFIVASIFDKVFVNGVRIQGARMLLLIVRKIEGNFHVGRMSLKYNPKMT
YQGKFINEDCYRLISIHLGLEANNGAWFAGKMYTLHQDELHLTVYIGDTKPLIFSNSAER
KRFYLEKMKDTLSSKSEVRKEQEEFLPSHQIIYYGAPGTGKSYKIKEYLESQQVSKENIF
RTTFHPDSDYATFVGTYKPTMVEQYRYTDNGTKVKYTEDDNLACAQKSDPIIDKSIEYSF
VPQVFLNAYIRAYQTQENVYLVIEEINRGNCAQIFGDLFQLLDRNAEGKSDYTIKADTDL
RAYLENILGSDNEGIKDGELCLPSNLYIFATMNTSDQSLFPIDSAFKRRWDWEYEPIKYK
NQDWSIIVGSKQYSWVSFQKIVNERIFDSIHSEDKMLGDYFVNPHNGIITEQILLNKVLF
YLWNDVCKEGEGEIFKTSETEEVSFSDLYGQEGQQRIIQMMEYLGVNPFSTEENKNISFT
DSNIVPENEEKE
>SEQF1602_01669 hypothetical protein
MTPPPIESHKRLADFLDPDGYVPKAMYLSEAQIEHLKIKHNIPHFNVDRPLCLDIYNKKI
KYDGYSITITQPEHNSLRIIESHKDKEVVRKMSVTEQFRLMGLEGLQGVGRKVDIDFAGQ
SYSQLSKRAGNGWDVNLVTILLEHIFKQL
>SEQF1602_01674 Ribonuclease H
MAKKYYVIWEGYEVGVFSSWEECKKYTSGYPTAKYKSFPTKEQAEKAFREDYRLYWGKKA
TTTVPLSADYDTNSIAVDAACSGNPGTMHYRGVDLSTGEIIFSQGPFMQATNNIGEFLAI
VHALALMEQTGEQRTIYSDSKIAISWVKQKKCKTKLPASQANKKVFSLIERAEKWLHTHT
YTAPILKWETKIWGEIPADYGNKQR
>SEQF1602_01675 tRNA (guanosine(18)-2'-O)-methyltransferase
MISKEAHLLAYLEEFITQERKERFTQILSQRTEHFTVAIEDLFQVHNTSAVVRTCEVFGV
QTAHIIEEKYGKRLDSKIAMGAEKWVTTIRYPHTQPCIEALRGQGYRIVATVPPPGATPL
QEFDITPKSAFFFGTERDGLSQEVISQADECLTIPMVGFTESLNISVSVAIILQYVTAKL
RASCIPWQLSPQEELLLRLQWTKNSIRSLTDVLSRYESLQ
>SEQF1602_01676 hypothetical protein
MKPTTSRLIFIDIIRAFAICMMLEGHFIDGLLAPEYRDENNLIFSTWLYIRGMTAPVFFT
VSGFIFTYLLIREQNPEKMGWNHVRVQKGVRRGISLVFIAYLLRANIFNLFSDMTDMNVR
KVDVLHCIGFSLLFLIAFYLASYKRKSHYLLPVFLLMITFVLFFFEPIYSHLTYEYLPIF
LANYFTKVNGSVFTLFPWFGYASLGGFMGYMFYKYREHPHLYRNAILLYIVLGIFFLTFP
YWAGEIGKETHYYTLELIAGGDYLIKRIGNVLLFFALFMLLRKVITSTLLQKIGQNTLTI
YVVHYIMLYGSFTGLGLYRFFHDKLNPYEAVIGAVLFVVGTLLVTFAYLNKEAIIDQKID
GIKAKIGQGIGRGFDSIKNTIKRFFS
>SEQF1602_01677 Hydroxyacylglutathione hydrolase GloC
MLTLQQFTFNPFSENTYILYSDKGNAFLIDPGCSTHSEEQQLRTFIAEKGLTIEKILLTH
AHIDHVFGLQWACDTYALPVHLHPYEKEILERNPSDARLFGFTFPEFDGQIVEIDTDTIL
YIDDTPITLRFVPGHSPGSVAFYVEREAFIISGDALFRRSIGRTDLYKGNTEQLLSSIHS
QLLTLPEQTKVYSGHGLPTSIGEEKQHNPFLQ
>SEQF1602_01678 hypothetical protein
MQLEFEHTQSAHCENGVASNLLKYNGLSLSEPMVFGIGSGLLFFYFPWIKVNQAPAISYR
TMPGHIFSKVAKRLGFKVFRKKFSSEKEAQQVLDQTLSKGIPVGLQVGVYHLPYFPEQYR
FHFNAHNLVVYGKQGDSYLISDPVMEFTTELSATELERVRFAKGALAPKGHIYYPTDLPK
SFSLEKAICKGIKNTCDWMLSPVPIIGYRAIIRVSRDILKWQKKLGNKITNHYLANMLRM
QEEIGTGGGGFRFIYGAFLQEAAEVLQEDRLKTLSQEITEIGDRWRDFAVAVARLYKDRN
STPNAYEALSKTLYDIAQSEKNFFKKLKAVISER
>SEQF1602_01679 hypothetical protein
MPNKLKKFHSVQEVFDFHIKEDLLLGHTNLYLLYDIVRYFRPKKASYKISLLELIGYLRE
HPTHCQLFSTYIKELLSNRRFGRMISEVGILQDSSFFYEVKKRLSEKILPYQPEKDTLQY
VLNQVFYLSSDYKWLEKIEHHEYRTLFGLLEFDNIFTCEGAPSYGLNQLCDAIGLITQRM
SGRTMESDIIRMVPQYGYLESPFLSFEREFETVREGILRGESLTEENLNYKQLMVLFQQC
EDFVQQAYKNSSKYGITMRVNQGLLRINQQLTRVKTLLNLLVLRPEKDKIDNTICIALKL
IEYNCYKNNLRSFIRESTQTVTYEITQFNASTGEKYITDTPREYFKMLKASLGAGFIVGF
LCIFKALLHEVHASAFGHAFLYSMNYAFGFILIYLTGSALATKQPSMTATTVARMVEEGM
KKQGKESEKHNEFAEFFARLWRSQFIAFVGNVIMAFGVALLLVWGIEAAWGQNIVSHSWE
KFLSDASPIHSKLIFHAAIAGVFLFISGIIAGDVSNKQKYNQFAYRIMEHPLLKRTLGVK
RTRRLAHWLDHKRPGILSNFWFGVFMGSTASIGSFFDLDLDIRHITFVSGNIAMGLYGAT
FHLVWSMWVWIFVGLVLVGFINFIVSFGLSLWIAFRSRNIPSSEVFALIKAVWRHFKKAP
FSFVLPSHRVKNEK
>SEQF1602_01680 Tetraacyldisaccharide 4'-kinase
MRFLLLPFAILYGLGVRLRHFLYDRGWLSSKRYPFPILCVGNLAVGGTGKTPMVEYLVRL
LGQEQVAILSRGYRRKTRGFILADDSATAMTLGDEPYQYHRKFPRATVTVCESRQEGIER
LLENPHFKYIILDDAFQHRKVQAGTNLLLTSYDKLYTQDFLLPVGSLRDIRSRARKAQII
IVTKCPELTQAEQEKIIQQLKPLPSQKVYFTSIAYSDRVYSHEDSQALKDFIATPFTLVT
GIANPTPLVDFLEKQGASFEHLAYSDHHHFSNRELELLRQKGRILTTEKDYVRLEGALST
LYYLPIETQFLNDQRLIFND
>SEQF1602_01681 Macrolide export ATP-binding/permease protein MacB
MSGFGIMWGIFILVLLLGVGKGVEYGVQNQLKSFASKSIFVWGGETSMKYKNMQEGRRIF
FNKYLLEDIKRRFPEIEGLSPRISVSKNIIFGKRNYYTSVTGITHDYWMFSNFRMIEGSR
PFNLMDDKKVRNVAIIGKKVATKLFLNDNPLDKLINVGGVYYRVIGVMKNDDMMSQRVES
DIFVPFPSFTCNIQDAPDISTFALYLRDDAQISIPDFKKKITNYLARTLRFDENDPNAVY
VHAFEEEISSVNSIFTGISVFIWIVGLCFLISGIVSVTNILFIVVKERTNEFGLRMAIGA
TPRHIIIQVLLEALIITLASGLMGMFLGIGVLKLVNMFLTATGGLGLLKTTEIDMGIASL
AVFIMVLSGIFAGTFPARKASKIEPVAAMRYENRG
>SEQF1602_01682 Macrolide export ATP-binding/permease protein MacB
METLREIIHSIQQNKVRSFMSGFGIMWGIFILVLLLGVGKGVEYGVQDLLKRFAAKSIFI
WSGETSMKYKNMQEGRQIFFNKYLLEDIKRKFPEIEGLSPRTTISKNAIFGKKNYYTSVT
GITHDYWSFSSYKMIEGSRPFNLMDDKRARNVAIIGKKVATKLFLDDNPLDKLINVGGVY
YRVIGVMKNDDMISQQAESEIFVPYPSFTRNIQDTPDISSFGFYLRDDAQISVLDFKKKI
TNYLARTLRFDENDPNAIYVQALEEQLSSINSIFTGISVFIWIVGLCFLISGMVSVTNIL
FIVVKERTNEFGLRMAIGATPRHIITQVLLEALIITLASGLLGMFLGVGVLKLLNILLEA
TGGMGLLKTTEIDMGIAYLAVFIMVLSGIFAGTFPARKASKIEPVAAMRYENRG
>SEQF1602_01683 Multidrug resistance protein MdtN
MKKKNIIGLLVTIAVFAVVLVLSIYFFSNSEPVYLQGQVEAKQINVAPKVPGRVKAIYKQ
EGDQVHKGDLLLELESTELDAKLSQAEAARLAAQAQSDKAQRGARSEQIQGAYNVWQQAQ
AAAELAEKTYQRVSNLYNDKVLPAQKKDEAYTQMVALQKQAEAAKSQYEMAKNGARVEDK
TAAQALVAQAQGVITEVNAYKDGAKVFAPADAEIQTIIPNEGEIVNAGYPVMNLIDSSDE
WVVFNIREDKMADFKIGTKFKGIVPALGNQEIEMEVKHIAVQADFATWTATKSKGDFDKK
TFAIKAYPTQKVKDLRPGMSVLVEDNR
>SEQF1602_01684 hypothetical protein
MKIDHIALYVKNLEVSKAFYETFFGAKSNELYHNPKTGLHTYFLSFDSGARLEIMWRPNL
SKRLDKVMNEGFIHFAFSVGSKEAVDALTQKIIDEGYICFSAPRTTGDGYYESVILDPDG
NMIEITI
>SEQF1602_01685 Acetyltransferase
MRITEGLLPDDKLAIIRWTNSKGADFLQQWAGDALPYPLTIEALNALSHCFRIEAEGSFI
GMIQQIKVEGSNVHIGRFFINPSLTGKGLGTKAMQLFIAMLFEDKSVHSISLNVFDDNPI
AKGLYTKLGFKVVATVEGERKKYKMMKSNSVIN
>SEQF1602_01686 hypothetical protein
MDIKRDESHCYAAVITEDGQWQKGEEYFLEDYTETLIYNEQGKLVEASYGEEYHFLFTYD
SHSNCLSSRLYDPEDEELTDCWEEKQYRYNDLQQKVECITYENDKWKETTTFTYDAYGNN
ISQLTRTADAEYLLQLQYDTQGRCIDRCHTNISTGEKILHDSIEFRSDTEKVDTNLSANG
KPFMFTITRFDEKGNVIYVAHQDIGDPQPYSITETTFDEHNNEIFERISNKEGEVYTRKY
TYRYDNHGNWIEKRIEYSKRYTNLIVERTIEYANE
>SEQF1602_01687 hypothetical protein
MTYDEFYNCIEQLPKEVTNRDLEAYLLALYRIVTPHENTPFSPTLCLELLKEAFSAKTAT
YEEQWTSIRTMPEAEDDHLSAFAYTQAVILFQIAELHRMKDKELHNEMRSFGIASETGYD
WYNFNPLDLLECGARGLCDYIDEDETIPNDWHFLGHLLDLGRYYE
>SEQF1602_01688 hypothetical protein
MKKVTLQESLITDLRTLINEARNKVALMVNKLSHHWRDN
>SEQF1602_01689 hypothetical protein
MKESNIFEQIRTLFGLEEDCGFTDEEMQPFFKVIEKMPTLLYNYYTTLGKHQALNQTQDN
LVTPKDNLTLFSNPNYFVFYTENQNCCLWAIAKEDLDTANPKVYMSTDFTHQHWQVECDT
LAEFLLAIAHLQAVFALPYVYESFKYITPEELAAIKERFPKKPFALHHWLDGADFYGDAT
DSIAILDKGTQLIYASSSKSSFEAIDSFLKDIGEDM
>SEQF1602_01690 hypothetical protein
MNLLQQIEQTYGFQYPKLYHRLYEDGMLDMGAKYPYHSYCPMEYKNGDRLPNKEWLEQEY
PKLKENPPLFLYVDWFQVLTPSQLAKEFEFLNQHLTQYPQNQKFFFAPFARAVVDDYMVY
CFCYNKEKATQEPSVVFIREDGEVDILSRNLQNFIFYQLIKRLVAHFHDISFICYGDFYE
NLRQTLRTHRPYLTEEQAEVLEEIYKREIREYTRKLTSGGCFTFLTLLHEGEEETLLNKY
NPLPKETILLRTL
>SEQF1602_01691 hypothetical protein
MEERNIFAQKKAPFKCPEIVTLLREENFSALEAELAKDWDINQEVRVHERYSQTPFDFAL
SSRKKKLLEFLVDKGAHINKTALIGVCNSGNSDPELIKWLIKQGADVNARTHLTALQATI
YNKNEEIAFLLIENGFKLTPDGTTLRMVASEGMYKLADYLIAHGFDVNYCEPDMVYPYNA
SPLQIAASRGHLALVKRLIELGADLSYKDKYGERAYHYALRNKQKAVAEYIKSVEPAEWH
DEEERLRALKAYKLPEGLIALLRATDRRIPLPECEYTSFVEFAPLSDVKEVKWKNKKFLD
LLSDADRYGAEGFLVWYPKNKKLAFADYEHGTFTELCTFDEFMANPSAQINKIFE
>SEQF1602_01692 hypothetical protein
MVKNGVYVDRYILVDIFSEDFTSQKRLSFFFEEEEICYSSDVYYYWEDEQLFILIEYYKL
GNIFVTNKVFKITENEVIEQSFCVIPQKRILNDAKVYSFGDKEVFMQSPFMMNCRDKQNQ
KTLWKYKLSAYLYTEVEEYKDILYFGTAGKGGYFYGISLNNGQTVFSYNTGQTVRFVRSG
ERIIISDKKQKPILINALTGEIIHSLDIGKNTIDYEQQMLWYKNRFYGIVRNKKKDLSVV
CIDI
>SEQF1602_01693 hypothetical protein
MNLEELRDYCLSLPHVTEDMPFGEDFLVFRICNRIFALTNLERNPVSVNLKCNPERAVEL
REEFPNKIVAGYHMNKKHWNTVFLDGLPPILIKEMIQHSYDQVLAKVPKKEKEELIS
>SEQF1602_01694 hypothetical protein
MFSKLKDLFCKTHTFFRYEFFIPAALYQHIEAAEGEVSLKSIRLFFSKAPYSLSKGQLQI
TQEANKLFFVQIAFYEEDKRETFKKEMEGYKEVFPFWTVFPHSFYGAPRWNQGYQEHYRD
TFLEYWRSLPEEEQEKYMDTYHCPEDWRLWLEEYRQRSKEKETF
>SEQF1602_01695 hypothetical protein
MLNQKILTRIQALGGNTSQVKGSSLADDLLAITFDTVLYPKPQDTPWAKAEDTEPIYGIG
AWVDDHRELYQTDKKDFYDQMIAQFYRLTEEPYGQHFWTVSLFTPFKEGTDDYEEWYDDF
SDEEFTDLSEITKVTGDKTPDLIQLFYTSGYPDHIYIALSDPNGENPTLFGTDHEVFFNE
IDNMGTLEDYLNTLMTPEELIEIVEKALTK
>SEQF1602_01696 hypothetical protein
MRQKFTLITLGVRDFKKALAFYENLGWQKSDKSMEEYALFPLGGIVLGLYPLQELSEDTT
LPYQSSAFAGITISYNAKSEAEVDAVLSKVSELGATIVKPAQKVFWGGYSGYFKDLDGYL
FEVAYNPFWEFDENDNLKL
>SEQF1602_01697 hypothetical protein
MTETEQTLRQRFTAFLQAMYDWETEANRVDEEEVEKKKTLSWEEFCKKQTELRIPIYKEY
ITERERKNGGAQYTSHIFPPNYDPSKDTITEVQITGKKASIFTDRVYAGMNYKREYKYKL
VEGRWLLDTIKEQYLPENRDPEKWKSVIL
>SEQF1602_01698 hypothetical protein
MNIERLQDIDERLFVKNDLNGECIYYTDKDCQTPFNGIVYGMCGRPPRLDYECEIKNGVK
DGMELIYNEDGGIEQASECRHNLMYGVSKEYDEEGNLLTASIVYNNSHLKVVSATTEGTY
KIEKYAPQSTQNLPDDLLSLLALSEQELVKYQFVPRYGMFKNVK
>SEQF1602_01699 hypothetical protein
MYLSSYNTKFGSLAFSQKVGDEYFWEASFQWKSDFYKETLQLPFSVFSNTETLTPDTIAF
IEQILTSADKFIAKALSYFQEQLLICSEGFHLSEEEKQLLSVPLQEVPLQSPQFLFYDNK
EWILHFAGGSFSFCEPYGVSFHFKDEEPILIENLEDAEEI
>SEQF1602_01700 hypothetical protein
MNRITETEQKHSFELPAFYKEILSSFDLYCLYQYKGKDLDIKNRNLLFEKLSRDYQAWQL
LQYLDEPNTENTFVFGSLGDDSRLYFNLSDGSVWDYWLDDKSTHKIANSFDELLSEATLE
EKE
>SEQF1602_01701 hypothetical protein
MKYFKTECKNLFLSPKRLFYVLVFPLVIFGFFAAIFYKGVPRDLPMAYINYDQSQLSENL
LRMLDATPNIDLKIKLTDEKEAQRLIQQQQIMGFIVIPADFQQKLFKGENQSLICYTNSQ
FMLGASLIQKDFQTTVGMFSAGLVMKKKMQKGQQTEKVRAEAQTVKVDDHGLFNPYANYA
YYLLTALLPMMLQMIVMMVTVYVLGIEFRYRRGKQWLKKAGGSPLKALIGKLLPYTLTLL
FVAWWMNYLLFGLIGAPLHIPMFNVVLITFALVIVYQIIGITFVSLLPNFRSALTIGSGF
TAIAFSFAAYTFPMEGLPKSMQYLAQIFPYAHFMKYYVNRAIKGIPVEMTWQPLLALLLF
GLLLIVAYPMFVKKIKSGGYETI
>SEQF1602_01702 Inner membrane transport permease YbhS
MKQFRSYIYQSSADFTRAMLWEAKYIFRDKAVFFSFVIVAVVVSFLYTYLYSEETLQKLP
IGVVDEDNTAQSRQLLRMIDANSGVAIYSSYLNLSEAEKAFQREQIRGIVTIPNGFARDL
QRGEQPSISVYADASYMLYYKQVLTAAKLSATYLNAGVEMKRSSAQGKLPTQAREEAMPV
SAKVVSLYNPSSGYATFLIPVVLVIIFQTTILTAVGILGGTMREGNKLRKIYPNSGNFFG
ALPIVMGKATTYLALAMMILLIILGIVMPLFGIPVRSSMLTTMVFMIPFILSIVFMGLCL
LNFLRRREDAIMLIMYTSLPSVMLTGFSWPSVAMPQWLNVFSYIVPTTLGAKGFISITQM
GASLPTIMPYWLGMWGLCLVYLVLAGFSIKKIINKDQ
>SEQF1602_01705 hypothetical protein
MIFKFSHSTLEGKYPLENVLFLNCWENVGKNHTF
>SEQF1602_01706 hypothetical protein
METAVTFATSDVGKLNSIKDFIRSLNVSIIQEEDIPQPIEMTPRLVAFLDEIETRNTPFE
ECEDFDVMINEVASEYGISL
>SEQF1602_01707 hypothetical protein
MESPYKIKVEPKAKDDLREAVAYYISVAPPKIAKNFLKEYTSIKDFIKNHPYQRKYRGEL
RGVIMKKYPYIVFYKVNDTEKQIIIKGIFNTYQDTSRYPE
>SEQF1602_01708 hypothetical protein
MQNKNYWAPYSYQHSLVPFVVWDHKIIRYQRDNSGNYTVIGQLPATSEIKDLKLCFATKD
KLLIEEKVIENSCDFETMSFVGSTVDVISPCDGGQGQIPIVIEYNYFFKDKNAVYWYHTG
KEKLEKLSYNPQSFTEESLLKLLNKKK
>SEQF1602_01709 hypothetical protein
MNRGIKILLILFFMNISFLQASECYHYHTPTTYEIINEGGKAYWVTIVRDPNGISLVSYS
KKLLPNVGEKARFVTMDDQMRYMVIADKDWYYFINNYALDEKEKMPIRAFSAKGVAHFGQ
RTFRIGGQWYRVSFDPYDKQNKFKKELVEGLPKEVTVISSFRNKWFLVKGDTGVFLYKEE
LHNSVDKYLQKIEGLDPKTVQFKERRDVNFLYDEDTFYTTDDAFNLKDHSKSFQMLNIGN
HKFTEATFGSYGLWEELLDFHDGRIWFYWWQGITAINGQKVYFYPHENFVYLPQMNLVRR
GADEYFTNYERIAWKQKAVDMSAVKDIPRLKYIEDKGYYYDGIDYYRMYHVL
>SEQF1602_01710 DNA polymerase IV
MERKIIHIDMDAFFASVEQHDNPSLRGLPIAVGGGEARGVVAAASYEARRYGVRSAMAGA
MAKQLCPSLIFVKPRFDRYREVSMQIRAIFHEYTDLVEPLSLDEAYLDVTTNKKDLPSAT
LIAQQIRAKIFEQTGLTASAGISVNKFIAKIASDYNKPNGQKTVPPQEILDFLAPLDIKK
FYGIGKVTAQKMYQKGIFTGADLRAKSLEELQTYFGNNGEYFYQIARGIHLSAVQPFRLR
KSIGVEHTFETNITSERFLEKPLKELCEEVALRLKEKKLLAKTVTLKLKYSDFKQQTRSR
SIPEFIGNSTDIYAVVEELLYQEKLYESVRLVGVSLSHFNYPSPENKKPQWIQLQFEFPL
WEEYPKR
>SEQF1602_01711 Glycine--tRNA ligase
MANQEDIFKKVISHAKEYGYIFPSSEIYDGLSAVYDYAQNGVELKKNLREYWWKAMVQLH
ENIVGIDAAIFMHPTTWKASGHVDAFNDPLIDNKDSKKRYRADTLVEDYVAKIEDKIEKE
VAKAQKRFGEAFDKEQFLSTNPKVIEYKERAEAILHRLGKSLEREDLADVKALIEELEIV
CPISGTKNWTEVKQFNLMFGTKLGATSEGAMDLYLRPETAQGIFVNFSNVQKTGRMKIPF
GIAQTGKAFRNEIVARQFIFRMREFEQMEMQYFIKPGTQQQWYEHWKKTRLAWHLSLGLG
EENYRFHDHEKLAHYADAACDIEFRFPFGFKELEGIHSRTDFDLGNHEKYSGKKLQYFDP
DENRSYVPYVLETSVGLDRLFLAIFSHSLQEEVLEGGETRTVLRLPFVLAPTKVAVLPLV
KKDGLPEIALDIFNDLRYDFNVAYDEKDAVGRRYRRQDAVGTPFCITVDHQTKEDNTVTI
RHRDTMEQQRVPISALRELILKEVDMNQWLRKLRLEN
>SEQF1602_01712 1-deoxy-D-xylulose-5-phosphate synthase
MTLLEQIYSPADIRTFSLAELKQLAGELRHFIINEVAAKEGHLGAGLGVVELTIALHYVF
NTPEDILVFDVGHQAYPHKLLTGRRERFTTNRQWGGLSGFPKRKESEYDPFGTGHAGTSL
SAVLGMATAAVLQENFLRKHVAVIGDASFVNGMAFEALSQIGDSKVNVLIVLNDNQIGID
PSTGAFRYYLERLAQGTDLGTFFTDLQIEYLGSYDGHSLEELIPMLREARDFFGVQLVHI
RTTKGKGYQRAEEKQTLFHAPGKFDPATGMLLPKELQQTKFQDVFGHTLCELAAENKTIV
GITPAMITGSSLHYMQQQFPARTFDVGIAEEHAVTFAAGLATQGLLPFLVIYSTFLQRGY
DQLIHDVALQELKVIFCIDRAGLVGEDGATHQGVFDIAYLRCIPNIEIVAPRNEIELRNM
LYTAQLPEQDKALAIRYPRGYGQLTLWQLPFEKVEKKGVLLREGARYAVLSVGTIADEVA
QEISQHPQAEAFAHYDMRWIKPLDEALLHHILSQYEAVITVEEGCKAGGFGESIVVFAKE
KGYSLPIKIVAIADVFIEQGTVALQREFASLTNFLNGAF
>SEQF1602_01713 Putative pre-16S rRNA nuclease
MRILAIDYGTKRCGIAVTDELKLIASALATVETTELLDFLEKYCQAEQVERIIVGLPKQV
SGELSESEQAIAPFIEKLQEKLPKIPVSRYDERFTSKIASHILVQSGTKKKKRQDKALLD
RISATLILQDYLSSL
>SEQF1602_01714 hypothetical protein
MIRDDYKDEEKFEEDDFEEDNKLPYDEEAMWDFLYPNRNDEDFFDYYVKQIFEGED
>SEQF1602_01715 hypothetical protein
MNKIIPIIKEKEEFYGDKPIKNIWLLGEKKGNVGGELMHFLEVQPEGILCIQTPKLTDPK
IINDILKNAEYVHTYLLVDEYTKGLDALNEKVLIRYGVKTKGSMILRNPNSNQPSGIFIT
GELSEENIPQSYLKESSDKKIISALYRHFCYLFWEEAKEEIIEKGKSTTIDSKPMDIFHN
PNQYGDKDFVFATLFESFEEKRREKLSEKVVLPIGKEMDIPIRIFAQNKQDLGAQTFNEL
LPEIELQNNEPIFKDDNCSITIVYFWKNMPFYLPEGGHRHSLYKEWEIVNEKIVNRLKEL
IRRIGFLSDKEELKEDRSFIEKLINNISGKDIELSDKVIKVNYIYRKIILCEKKEKIGDY
QKKLDNLDQEKKTKVDYLADKSRQLGSDEEKNRILNEEISMIGKGIANLNTKIEEVKNEI
EKIEAIEEEKEFIEPITLPFLPIVGELYERERINYLAISFWEEYNTALKEAERLSAVLCA
NKD
>SEQF1602_01716 hypothetical protein
MKIIFSKELTLQKADVYLKIEKKIIRKDIQDYLNGKVYNNPLVENRMKKYLQEQKIYNDL
FSLTSKGEKIRETGETFESEEGKYTIWYVENDSVLGTKILFFERKNVEYNSKERRIEEFP
NNFPRKGHFVLPSINKDIDFLEFNLREQIPYAEKYSTDKLSFKWVWDNLKSSHYEFEGIL
GNNQIRKRDVVVDRDLKQDIQKYFRNWNIENERFTVDFNRTDEEKRSFYFDKRETFEDYT
IDLQQCPIMPKNKEIAEQWRDWLLEKRIQKEYLSINDFEYKAESVQEKEGLIMYKLELPI
ANNFMRERKTDKLIKWHLQAPEDLNPNKEFLKSSFAKTIPIAQGEIFSFREFVSKLNPKE
GDVIIYYDIYALDHCDLVEKFLDEIEISKRIIVSLPFTKNNNNWLSNSYRRCQSKFKIID
VNQNNDRLHDRYIFILKDNRWYILNGSNSLNGYVYYDKQSKNYKTTKPTIYTYIDENMFS
KNTINFLNKLANE
>SEQF1602_01717 ATP-dependent RecD-like DNA helicase
MQHYYLNLQKDKKDLSFETNVKISDGIRYTANEVFSNFENYLKNVLRSLENKEIRAKWRK
INSKNQAKLLLEGKFFEVENKVGLYKITNPINEFDIDFEASLYYWVNNERKEQKISRQEF
DRRVVRLDTKEKISKANWCGDSVSLQPFWNTTTERLKGISVYKNVEKTILYIEDGQKPNN
DYKECNFKSYIDLKSISDIITKDYKGKIEDENNLIFSFLEDGNIPTNISFEGLKFRLEKI
NNSKVEDFHIQLLEMNETSNEDIFSPLRFFFDDDVIIKDGKDRIEYQKIEGSEEECILLL
KKKGENSPSFPVSDLLTIVVNTYQIERQIEAISTLKTMPIGDHRNLIKLFEDKDKVGWDF
PTNQQINEWNILTDENRDGCFEQRDFVRKAINTPDFAILEGPPGSGKTTVILELICQLIQ
RGKRILLCGSTHVAIDNVLERLIEKQPSGKSLIEQFAILPVRIGDAQRISEDVSNYQLDN
FLVNNPDVEQKLLLEMSNLVCGTTIGILQHPKFKNRKGYINKKEGRDKYNYYSNEPIIPD
FDYLIIDESSKTTFQEFLVPALYAKKWILVGDIMQLSPFTDRDEIVSNISHISDREGKRL
VPNELQQAIFYLHQFKRCVNKNSKYILPIDRKVIKKIQEELYAGRIDVFKDKLFYAIMSN
GEDFSEENFIQKHLHDLTKLELAVSDIILIEKNLLEEALKKHLLPETHAILLSKEWNSSQ
QAFTHKSYTSNHPFLYQDKDKEYTDSFEIVEKINQTFKEKGWADEIAWRMDREYQLRASE
KTDKKINYEDFLPRSIDIKEALDRVACMAFPSILESLVQGIKIKGKHIRTDTTISEGFKP
SNLRDRRVQLKYQHRMHPDISIFPREQFYSKEGALQDLSSIEQKRQWGYGKYKRRSIWVD
IEGKVNKNRNEKEVSELIKHLKEFLDFAKNMNPPDGSTEWTIACLTFYRGQETLLREELR
KLTKKYKSMSNFCVQGKYKVNIKLHTVDKFQGQEADIVFLSMVQNRRDGFLDSPNRLNVA
VTRAKFQLVIFGSYKYFRTESRSKELNKLAELTTKY
>SEQF1602_01718 hypothetical protein
MNTEKLNTLLEEYSNKEVSSSKVKEAEGKVKNLGTRIADFKLILRMFKDGISGKYRLSKA
TLAAIGGAILYVASPVDLLPDFLFPIGYTDDIAVIGIVMSRLADEIEKYKIHINYK
>SEQF1602_01719 hypothetical protein
MATNKNAQLRYKILDECFANIDERYYIEDLIYTCEEKLSQKGKKESISKRTILDDIKFMK
SREGYNAPIESIKDEKDKRKSYYRYRDSDFSIFKKELSNSDKETIREALPLLLRMKDMEG
FNWVEEVVSKMELFLEITSQKKIIDFQDNNYLIGIEYLHKLYHYILKEKCLEITYKPFQK
EENKIKISPYYLKQYNNRWFLFGREHISDKLKNLALDRIVSIRTIKGTFVKNTINFEEYF
EEIIGVTNYEDRGEEDILIKLDEKTIPYVITKPLHPSQKIKGDELRLKVKQNPELISIIL
SFGMGMTVIEPRSLRDKIKNIIQDSVNQYNI
>SEQF1602_01720 4'-phosphopantetheinyl transferase sfp
MPFFQQLHITDTYVYTWQLTETVAQLRVGLTLSQGEEERLMTLHSEKKQREFLAIRHLLR
EAQLPTTALYYTSEGKPQLEGQYISISHSHNFVMIALSPHPIGIDIERCTPRILRLAPHF
TPWQAPSDMDELTQIQAYTQLWTIKEALYKVTDLPSVRFYEDLQVPYFEPLAPRQQALIT
HPEGDKAYEVQSFFWEGYVWSVVCEKVTSEKLTINH
>SEQF1602_01721 Deoxyguanosine kinase
MLFLSLGSNLGNRAQYLKHALFLLHREVGEVVSISPLYESPAWGFSSTPFYNICAQLHTT
LPLEALLPKLHAIEARLGRVRSSSPEQGYKARTLDIDILYYGDTLLHTDTLCVPHPHLAL
RRFVLQPLADIAPDFVDPNARQTITQLLQGCPDTATLTVVAQDFSLPVNKANIPYHYITV
EGNIGAGKTSLATRLAEDFSGQLLLEEFASNPFLEDFYKDSQRYALATELSFLKDRYKQL
QQTLSQNKHTLWVADYAFSKSLIFAMETLPLKEYNLYEELFYLLFERMIKPDLYIYLHQN
TDSLLKNIQKRGRSFETPISKAYLERIEQSYLSFLQRNTSLNTLFIDVSYMDFVNNEDDY
QFITALITK
>SEQF1602_01722 hypothetical protein
MRRIYLHTGFFIGLLCLVGLFVLSFFFRMLFPLVQLALFGFASLCLIDFLLVFTTRKGVT
AQRQLPERLSNSDENLIEVYIKNLYSFPVYIQLIDEIPFQFQKRNFEYTFFFKAGQEKCM
QYYLRPTERGEYNFGKLNAFVYTPMRLFMKRYISCENAMVATYPSFIQMKKFELIAFSQR
LFDYGIKKIRKIGHTMEFEHIRDYVQGDDIRTINWKASSKRGQLMVNQYQDEKSQHVYTL
IDKGRSMYMPFEGLSLLDYAINTSLALTNIIIKKQDKAGIFTFSKKVEDRVVADRKASQM
ERIMETLYRIETDFKETDFSRLYSDINNTIKQRSLLMLYTNFETPNSLYRQLPFLKAIAK
KHLLVVIFFQNTELEQMLHKPSEHIQEVYDKVIAEKFSFEKRLIVQELTRHGIQCILTRP
QELTLQSINKYLELKARGMI
>SEQF1602_01723 ATPase RavA
MDENNKLEFASRLDLGQLQSQLNQVRSQLKKVIVGQERMIDYLLVALLSNGHVLLEGVPG
IAKTITVKLLSKALDIGFSRIQFTPDLMPSDVLGTSVFDLKKSEFEFKKGPIFSNLILID
EINRAPAKTQAALFEVMEERQITIDGLRFSMQPPFLVIATQNPVEQEGTYRLPEAQLDRF
LFKIVIDYPTLEDEIQIITREHEAKAKDKTAVVEKVLSAESLVHYQALVKNILIEPQLIE
YIAKITQNTRENSFLYLGASPRASLAMLNASKGFAALAGRDFVTPEDIKQAAYPVLGHRV
ILAPEKEMEGVHSEQIIQQIIESVAIPR
>SEQF1602_01724 hypothetical protein
MGKSIRNYLIFLGVVVLIMSLTVFSPSNRKRDWQWTFDPESKQPYGLYIFGKELKHFFTK
KVIQESYYTPYEYLSVKEEKEEPYNYIFTVGSIDKVSLRKLLAEVERGSQVLFLNDFASL
TDSLEIKTEDKYRAEDLQMQLNSPSFDKKVPIELKQTFLEVNYFTNLDKNRDKALGYMYF
YEEGKTKKELRKKINFVEVSHGKGKLYIHAGPPIAFTNYYLKKDPQVRDYAATILSYLPK
DRPTVWFATPTQDRVSSSDALLFIMSQPQLRIAWWLLLLGFLLYLLFKGKRQQRIIPVIE
KPKNTTVEFAQSVSSLYYQEGNATDMVQKKITYFLDQVRQRYYMDTQQINEDFAQKLYNK
SGKDKTLVENIVQTIVHFRQTQQAQEETLTQMDKWIDEFWKP
>SEQF1602_01725 hypothetical protein
MWKNKWKIIAYGGLLYFFSIGVPLYAQADSLALRGKDSLTYQIPISRERPESLRSFHGVP
HSYDSSAFDYSETSGRNEAFLSGMWKAFIKLITRILEFIYGKGANGMGMREILRMLGAIL
FLVSLFFFGRWILKNKGRWLTDRSSEKLSNISMEEVEKHLHQTDFSVLIQNAEKQNDTRQ
SIRLYYLWLLKVLSDKKQIEWDPKKTNSDYEREIKDPVQKERFVYLSKLYNYIWYGEFLI
SDAQYQEAKADYQNYINTQKAK
>SEQF1602_01726 hypothetical protein
MNDFVFYKKRKFGDLISDTFTFFRKYAGNYFSNYLVINGAAIVSVGILFTVMVFFLPSLF
GGIGTSLLLVLLMLVIVFFLFLFVFCFPIAYTELLEKNPNRTDIASQELLESIKKMMPRA
FLFGFISIFVIWIPYLLVFFGLVSILEDAPLLLQLVNYFLSTLLFLFMQQTMLVYIKDRE
DYFQALGKVVNQLRERFWDKFGATFVMNFICGIIMSAGAIIPIIVYFLTLAVSGFEPGLG
TAILVFVLLLIVVTVIFVSLNLSLFQQILIHLGEKEDQHTDDIDLIGKNVEE
>SEQF1602_01727 hypothetical protein
MREVAFIEQNKDKWLEVEAILNKGQTISPDQMADNYIQLLGDLSFAQTYYPRSNTTIYLN
FLVTQIYQKIYKTKRIDKNRLKFFFTDYVPMLAYKYRKLIYFSFILFFFFVLIGVLSAQY
MPRYIRAILGDYYVNQTLENIEKGNPMGVYGDGSNWGGFIGITLNNIRVAFLCFIYGITA
GVMTFFIALNNGVMLGSFQYFFYEKGLLFLSVRAIWLHGAMEIFSIVIAIASGFILTGGI
LFPKTYSRLLSFKVAFREGVSLLLGTVPFFIAAGFIEGFITRYYNQMPLWLNMLIILGSL
SVISFYFLVYPIVKHTKNKYLKP
>SEQF1602_01728 hypothetical protein
MSKIQIKTTQNILLAFQPASIGERMAAFAIDFVLIMGYGFLANKAFMEISPLSSFSLEEG
IAIYSLLMLPAAFYPLVAESLMQGQTIGKRIMKIRVLKIDGYQASFADFFIRWAFGLFEL
DLFIGSIGIISIISTQHSQRLGDIAAGTAVITERNKLNISHTILEELSLAYQPLFSQTEV
LLFSDRDVQTIKNYFTQALKSKNGEAIIQRLADKITEVSKREHTIYPQKTAFIQQFLKDY
NFYTRG
>SEQF1602_01729 Azurin
MASVALMVASCGDNKKPEESAQTTEQGAVSQDTPAASQDTEAVNVALEGTDQMTFNIKEI
KAKAGQTINVTLKHVGNMPKDKMGHNFVLLKKGVDVAAFGMEAMKAGLDKDYIPNDGADV
IAHTKLLGGGETDTISFKAPEPGTYEYICSYPGHFSLMRGVLIVE
>SEQF1602_01730 hypothetical protein
MKIVHIHFPSSGEPVFYIKPDTAVHNRELPLYIPDFTTDLRGQLVLLAKISKQGKCISER
FASKYYEQVSVGLSLTAYDRWQELQAEGLPWEEATSFDGAMIVGNFIEKSSLEKEMTIIF
SKNNIPFQSIALQDILPKVPLGLSMVSQRVTLRTGDLLAIPLESIFYPLEGETTWIALLQ
EEKLFWVEVK
>SEQF1602_01731 Ribosomal RNA small subunit methyltransferase D
MRIISGSHRGKQLIAPKNLPVRPTTDFAKESLFNILNNYFYLDSIKVLDLFAGTGNISYE
FGSRGCPDITAVDSHAGCVQYIHKTAAALSYPIEVIKSDAFTFLERNLSSYDVIFADPPY
DLPEQDLERLVSLVFERNLLAPDGLLIIEHSAKISMEENPYFDHDRRYGGTAFSLFNNV
>SEQF1602_01732 hypothetical protein
MKLDKTVFALHKCIRERYLQYLEGFSLEQLAVIPEGFRNNLLWNISHAIVTQQLYCYYNS
GLPMYVSEDFIAAYRKGTVPDGHIPTQEEVDTLKKLLISTQEQMEEDYQKGIFTTYTDYL
TGLNYPLRCVEDAIYFNNTHEGMHLGLVIAIKYLI
>SEQF1602_01733 Phosphoribosylglycinamide formyltransferase
MKKLILLASGNGSNAERIVTYFKENALAEVSFILTNNPKAGVIGRAERLGIPCMIFDRKD
FYESTYILELLEREQPDLIVLAGFLWKCPENIIARFPNKIVNIHPSLLPKYGGKGMYGMY
VHEAVIAAQEKESGITIHYVNEHYDEGAIIFQECVPISPEDTPESLAQKIHEVEYRTFPL
IIKQLLQN
>SEQF1602_01734 Phosphopantetheine adenylyltransferase
MKKALFPGSFDPITLGHYDIICRATALFDEIVVAVGENADKRYMFTTEERMAFIEKAFAG
NEKVKVVSYQGLTVDFCKKLDIPFILRGLRNPADFEFERAIAHTNRDLAGVETLFLLTAV
QTSHISSSIVRDVIRNRGDYTLLVPESVRIENIEKYYIH
>SEQF1602_01735 Folylpolyglutamate synthase
MTYLETIDWLWAHLPMYQEKGRAAFRGKLDNILLLCDHLGNPQEHFPCLHIAGTNGKGSS
SHALASVLQEAGYKVGLYTSPHLKDFRERIKINGVDIPEEAVVHFVEENKEYMEGEDLSF
FEVTVGMAFDYFARERVDIAVIEVGLGGRLDSTNIITPIVSLITNIGKDHTEILGNTLEE
IAREKAGIIKRQIPVVISEFHPLTAPVFKQVALEKESEIYFANSLEVPYTMDLKGGYQAK
NIKGIVQTLRVLQQKGWKITEEHIEKGLSHIVANTHLMGRWQLLGEAPKTICDTAHNAHG
FTEILSQLQQEKYDTLHMVLGFVKEKDLSSILPMLPKNARYYFCKPQIDRGLDATVLQEK
AREYGIEGVVFSSVKEALTKAQQEAKVTDFVYVGGSTFVVAEVV
>SEQF1602_01736 hypothetical protein
MIEINDTLISEEIIEKDFVCNLDACKGACCVEGDAGAPVEQEEVAILERIYPKVAPFLSA
AGRQAIEAQGTAIRGIDGEWETPLIGGGECAYVVRDEKGIVLCGIEQAYREGVIDWKKPI
SCHLYPIRLKQYSSFVAVNYDRWSICKDACVLGRKLQVPIYQFVKEALIRKFGEEWYEQL
EAAAKIIND
>SEQF1602_01737 hypothetical protein
MKIKKWIGAFFLWITGWKVVLEGEDKVLNRCVLVVAPHTSNWEFVLGILAYWKLDKPIKL
IIKDAHTKAWYGWLVRKLGGIGINRSQRNHLVEFVTEQFKKEDFSLVVTPEGTRSRVDKW
RMGFYHMALTAQVPIVLGAGDFKKKTIFIGKTIPFTDLQTRSKESIIDEIREYYRDKNPK
YPQQWNPDFSC
>SEQF1602_01738 hypothetical protein
MKSSANGSCGQDVTGFSGGVVQITERPIPAFDANPPANPGIEIVQAGCGAATSYGVTPKQ
SNAQLYLNIKGGTAPYKVEIYEAGNVILTQTVTSTTPPAPYPGPTVYTANATIDLPAKDV
DYTIVVKVTDANGCVLAIPGSFVGTVKTLQKITGATFHRTQQMSCQPTGTEQVTMTVTRT
NGSNTGGYNVYIRKMTGAGAPTEVAGYDSAARTAGTAQIGGTGVGTITFPQIAEESADYE
ITLTDKDTGCTFVVPSGYRVEKAKAPRVNFFVTAGICGDTASPAPGTVGVTFRVEVEGEI
GTGGYTWFVKKSGGTTYGTQTGHGASDQMTVHIPVGDVPQGTAITFETEVTVVGTQCKTA
AQLTATRPQNINAVSKVLRYMTYCNGEAQNDAQIGVTSAPTGGWGAPYQYRVVTDGNAGS
FTDQMTFTVGVGTHYIEVRDSRGCTRKLDSFTFVPYHGPSMQLQAPNAPTATKIPSCVGS
QDGEIKLTGVIGGSVTATTPSPSGSTPTLIEGRLSYELFDATTERSLGRILPDDNPTTRG
TVTFSGLGAGKYFIRITSDMLCADDKVDSQPVTVNDPGTIIARAELTKYPGCNTAGDITV
QIEGRPNMNPTRGTYKVELYDISAGRPGTLVPVTPTITGAYQTGVTAVFAAAVTTPVSSD
RVYYAKVMDNGGGTGACEGESNEVHVAKVNPIDGAIDNDKSVTSLKCYGSSYGKIVVTAT
GGKNDEPYVFTLKRNGSVVPGLSTPNPNAQGVFEGLDASDDYSVEISQAVGVCIPKVVQV
PIKQETKYTVEYEVKQVTCNGDHDGSIEITTTSGQTKLDGTQRKLTYAISPRLDRFLDNG
GKFEGLAPGKYYVIVQDENGCRPNEIKEKGQPTPLGTDIIEFTITEPDPLSVTVRMDTVE
HESCAGSNDGKAYLRVIGGTPLRTVGNDKVYEYSKDGGTTWVEYHSDGNGTLIDGLAPGD
HTIKIRDKNGCQAEATLTIEAGSEVTLKLSEGKYECVNNVIKYVVEASVEPASAALNVRY
LLDGVAHNNTRFELDVDLQTNTTKSYVISVIHKVAGHGECRKDSAPILVAPKTPLKAQAD
KITSVSCHDGADGSFEVVAQGGSGKYEYGLKQADGSYRWQGTNNQFKDLSVGSYTVGVKD
TEYGCIYEVVNTAIIAPTPILITQNSITHVGCKGEANGEIEYVLKGGNPQYSWEVFFENG
ESTSKRGTGEREATPFKIQGLKAGKYLLVVKDAKGCSQKKEFEIIEGVDLKGVITQHYQC
NADISENNKVLVVDGSGPNSDTAAEATYDVYVSVTTPYLVINPSSGGAINRLRYAITTQG
GSPIQRYEFNGTTPTGTDNTHNMYKIAHASLLAQLNAVRPLQEGLNKYELHLYYFNKDNP
AMSDPPLCQEVRELNIEYYPPIKITNQSIANDLNLVKVKVEGGKERYTVYFSGAQYHTGE
EVKAHYVQKVDDVKAGDEVVYYVQKTDYEEVNPATGKVEKKVRVYVEDSKGELKQENGGK
QVCAHSVFIYKEYMDVVIPNYFTPNGDGEYDTWAPLNLASYPHAETIIYDRYGRQIATLN
NRQEWDGTYGGEPLPTGDYWYVLRLNEPDDSRTFKGHFTLYR
>SEQF1602_01739 hypothetical protein
MKTKLFKTKKYTAMRKYLYILFALCMFLSSFGVWGQPNNTPVSLRWNNGGQAVKGDFIQI
GNIRNFSTEAQSSATLKVPTHSSCLRVKWAGLYWSAYVPIGDRHNSRIEQVKFKMPGDTQ
FRDLRADVHMYSNFANSGDSYNCFKDVTSLLQSKGANFNNGEYTVSGIYSPNTIGSWGGW
TLIVVYEDIQAATSKKIYIYDGAEWNFFNYNGTQTKTIPITGFQTPPAPAPIKARMGIFT
GAGDKGTSYTAGDEIRINEVKQGQASNPNAYNDFMDETISFNHSEAAMPRNPSVTNHIDI
DIFDIPNPNNSVIKNGDTSLTIKFVASDAYITYTVALSVDAIAPHIETHKEVLGLENAQW
KDFTGKTTAFGEALKYRLKFRNIGNDNVRDAVLEDLLPKGVTYENFETLPSGVTFVSATP
NYNNTGRTLVKFNVSPSLLQHSSTAPFSASITINVKVQPDCANLIDLCSNEFKNQAEMVY
HAVLDNKEYRTGSSATTGSACDQNNESATIFFVKDDTCQAQDLPYCGNMTLKGGAGFAAW
KWTKEGQTGTIATTEDLQISTPGVYWVERTLPPGGNRCNNQLRIKYNVQTRTGEERHPMR
DASYVTERKVCNNTGIEYLGVSVCNTNVPMAINNATLSDTQVTWYRYKTQRAADDCPPQV
ANTGIQTDSNWEFIHTGKNLNMTPALVKYANGTEFAVRLGHANCPLTYHFRAYKGEVNYN
AIAENIICGTGKIKITGIPTGSFQYKLQGPASSNYTDIPTGQTAIDIPVTQAGHYKVYIR
QKLTGGATPFQNNVCEYIKEVDVYELTTTNAFTLTQVEEVKCVSSNPNTGKMRIVLDANV
TLPVKIEVKKGTTLIHTYTVTNTTQLNSDNIPATKAVLHSLAAGNNYSVTLTPTYKTGCS
VTQSNFEITQIPELKINNGAAKTITCGLEKELTVTVQGGKLNSVNGRYHFIVDGIHNNNV
SEVFENKAGTPEVHTYTLKIKDPWAGPGSKIYKVTVYDENNCAATKNITYTYQEKPTFDL
TKVVDAVCGPATGSLKVDNINANFVTTDYTIKYKLIKKNSNGTWPDWSSPIKDQSDPTFT
GLAPGDYRARIYYTKGTVTCHYPEDCITYQLENGQTRTDCNPPHTDPKEANISEGNGPIR
AFAGVIQLACDTPPNSAEIYVANVTGGTNNIYEYSINGGAWQTTKSFSNLRPDTYIVRVR
NKVAAGQPFCEWSKTLQVEAPIAKPVLSSTIEYDCEGIARMKVTSSRTDYSYLTVHTPTH
GATPGALPTTPPTGTFNNGTVPNVVFPAITTSGTQTVRVFYKQTANPSPIVLIQEDFGQG
ENRCDPNVYSAYACQPNKSSFINDGEYVITSSENGTLVLNNGCWTKPNDHTGLTNGRYLA
MNVGSIGFNRPIYVKEVEDVVPTQPIKFKMYVYNLCHCSSCGSPSFQIRLVNKLTNAVLS
ESTTLAPPINGHDPNAWHEFSGELASPGVTSLRIEIVSKSPVIGGNDLALDDIYVYQEPK
ACPSSYVDLTATIEATDAKKMKITSHTTIDETCNGLNDGKLTFGVANYGNVAYTWKVVTR
GTTTQVQGGTNNTAGLTVNNLAPGLYTLKITSGHQKKFSNDQACEVTQDFEIKRNAKVTV
TQNRTIDYLDCNIDRKQMLIFSQNATGTNQGVFNIMGGKQTPSAPLRYTIKVVKIPSGAT
DILTPDSNGNYRYVVVAGTYQITITDDNNCNGGHGTFTYKVEARHKIGTVKAEYKNCVVA
NGIGDMELSHTFIGGASNGKPVTYDWKKQGDATWTAVSGNTIPKTTLDGWTKGVTYLIRA
KDEYSCEKEIEVSIPVEIENLTTADYTVVHPAAACPPNPVTPGSITVNHVRGGSSTPTYH
YAFVPAGTPPQDSDYTATNAKSGITTGGDWDVYIKDIAATPPTCGKKVTTTPIHIEDPVP
TGGDLDPSGTIKHTSFSATCEDGQGGSLVIERFRGKGGFRVEVTKTAPAALPTVTYRIPK
VAVAGKVTINPTTGEMVVTGYVIDNLSKGTYKVEIYDEGNSNCAVPGMVGKSFTIADMSI
NFSPSGAVTQSNPNCTDTTMAFALKATSTIVPASEYEIVYRLVRHNGAPVTNGDEQWKTE
AQRPIQAPYTGQGLVGAMYGGVAIGDKFTAQIGVRRKSDNAVVCTKDIPEFTLARRANDL
TLTPKVNANCSNFDLDVKFGATGTYHKVTFYLNYDNIAHTAEMTSGPHSNYAAGTTYTFT
GLQKGRNYTVNVVYETSSSSGECNEGLEVPTNSANTPAIQVDNSASRGVACDNASTPVNI
RFHVTLTTGGGGALPYKIYEKTNTGLTQVGTGTANPTPAGSNTYEISYNRPTPLPATGQP
YVISFTAAGCDSYSGDITVTPPAAGRALTPGTLSVVAAKTKPMNCQDGTAKLTVKGGATG
GYGPFTYSLLMEDNITAPSTSFLRRNIVKRNITDLTTDVEFDLRETDFNVTGTNWWSTVF
PTLTFKVRITDQATGCEVTATASGNALGKFLSSKHTATATLDINKTATGANACDANDVNY
KLKITLSNINATVGTALTFADYEYSIDGGGTYTTFPAATVEVDIPALFDQNKVKVRSKES
LCEANITYAGGTPPGANERLTYPKLKFTAEKKTDMACDNAGVYTATFDLKITSGSDFVTS
PTVPAPFTPAGNRYLIKVTEGTGVAAGTRNALTTAPAGTTFTTAVTPVGTNLHNQEIKVT
YTVPPFPTAPITYNVWVKDLGNKYCDEYVASAPIVVNPAEDPNNLKARHTIDPAKISNVV
GCTPGGTTGSFEFTRTITTGRENVSFVYELYYSTTGAASSFIGSGTVGDGDIIERTTSTV
RYKVTGLKAGYYQLRVKSSANGSCGQDVTGFSGGVVQITERPIPAFDANPPANPGIEIVQ
AGCGAATSYGVTPKQSNAQLYLNIKGGTAPYKVEIYEAGNVILTQTVTSTTPPAPYPGPT
VYTANATIDLPAKDVDYTIVVKVTDANGCVLAIPGSFVGTVKTLQKITGATFHRTQQMSC
QPTGTEQVTMTVTRTNGSNTGGYNVYIRKMTGAGAPTEVAGYDSAARTAGTAQIGGTGVG
TITFPQIAEESADYEITLTDKDTGCTFVVPSGYRVEKAKAPRVNFFVTAGICGDTASPAP
GTVGVTFRVEVEGEIGTGGYTWFVKKSGGTTYGTQTGHGASDQMTVHIPVGDVPQGTAIT
FETEVTVVGTQCKTAAQLTATRPQNINAVSKVLRYMTYCNGEAQNDAQIGVTSAPTGGWG
APYQYRVVTDGNAGSFTDQMTFTVGVGTHYIEVRDSRGCTRKLDSFTFVPYHGPSMQLQA
PNAPTATKIPSCVGSQDGEIKLTGVIGGSVTATTPSPSGSTPTLIEGRLSYELFDATTER
SLGRILPDDNPTTRGTVTFSGLGAGKYFIRITSDMLCADDKVDSQPVTVNDPGTIIARAE
LTKYPGCNTAGDITVQIEGRPNMNPTRGTYKVELYDISAGRPGTLVPVTPTITGAYQTGV
TAVFAAAVTTPVSSDRVYYAKVMDNGGGTGACEGESNEVHVAKVNPIDGAIDNDKSVTSL
KCYGSSYGKIVVTATGGKNDEPYVFTLKRNGSVVPGLSTPNPNAQGVFEGLDASDDYSVE
ISQAVGVCIPKVVQVPIKQETKYTVEYEVKQVTCNGDHDGSIEITTTSGQTKLDGTQRKL
TYAISPRLDRFLDNGGKFEGLAPGKYYVIVQDENGCRPNEIKEKGQPTPLGTDIIEFTIT
EPDPLSVTVRMDTVEHESCAGSNDGKAYLRVIGGTPLRTVGNDKVYEYSKDGGTTWVEYH
SDGNGTLIDGLAPGDHTIKIRDKNGCQAEATLTIEAGSEVTLKLSEGKYECVNNVIKYVV
EASVEPASAALNVRYLLDGVAHNNTRFELDVDLQTNTTKSYVISVIHKVAGHGECRKDSA
PILVAPKTPLKAQADKITSVSCHDGADGSFEVVAQGGSGKYEYGLKQADGSYRWQGTNNQ
FKDLSVGSYTVGVKDTEYGCIYEVVNTAIIAPTPILITQNSITHVGCKGEANGEIEYVLK
GGNPQYSWEVFFENGESTSKRGTGEREATPFKIQGLKAGKYLLVVKDAKGCSQKKEFEII
EGVDLKGVITQHYQCNADISENNKVLVVDGSGPNSDTAAEATYDVYVSVTTPYLVINPSS
GGAINRLRYAITTQGGSPIQRYEFNGTTPTGTDNTHNMYKIAHASLLAQLNAVRPLQEGL
NKYELHLYYFNKDNPAMSDPPLCQEVRELNIEYYPPIKITNQSIANDLNLVKVKVEGGKE
RYTVYFSGAQYHTGEEVKAHYVQKVDDVKAGDEVVYYVQKTDYEEVNPATGKVEKKVRVY
VEDSKGELKQENGGKQVCAHSVFIYKEYMDVVIPNYFTPNGDGEYDTWAPLNLASYPHAE
TIIYDRYGRQIATLNNRQEWDGTYGGEPLPTGDYWYVLRLNEPDDSRTFKGHFTLYR
>SEQF1602_01740 hypothetical protein
MIEQEQVNQYLAPFKAKELKKEDLASFSQSYQKLGEYILNKSSSKEQRHLEANFPSLGLP
DKLWETKEGKALATLLFSEVQAPYIQRVWDIAYQFPYSYTYNRRPFRSPNPEDYRAEQLR
TLKRLRSFYNVGVGALSVEEQFQYAFYKGGEEDFFVVVLSENPDAYYPLFEEIFFGEHEI
GGVCESLIKAALMVKDPRYHTLVEKLLLAAQLQEGLRQTILESLDETTIPVLQHFIALIL
EHNLTRFSSVVRAVDVWFGFGWEAPQQAVVKRTLELAQTYLVDLDKAREAVSSKDNVERY
VALWAVAVYNVQEALSLATEALNNTQTSYEACVAVLYFMYQTQKKTSEILPFAEKYFGIE
PAWDYWILQNLPKGEIPQELFEKMRTAAHKLPKDGKNFEGLGFRWLNFTVKPLDIYQSIL
KVANEQQQQILAGELAEIPVDVRHILLDDIFPVLSRGRYSYYSEEEKNLPPEDYPADSWQ
RTLVRTALNDKGPYVVSKAMEVLKKVPLVQDDILALEQVLSRKNKEQRKESVALLVKQPE
AVLKDSTSRMIVSKNADQRLAALEILTILQEEGRLTDYVTEQVEAYKGRKLSKNEQVLMD
KLTYNPETATELRYDLTNGFGVLNLDNLTSFDLPKPQFDKERKEKKVGFLFDKLVNIQKV
GEGVSELLALWRANKDYEYQYEGYQGATETILLGNVIRRQHKGKDDETPMEILEDLPLTD
LWKGWHEKYQFNEVEYYFAKRYCGNLYYENAIPQGLDDYLAMYYPDFKVRFEGQVHSYYG
EARRAESLLGYLMNAYSEDRALLASFKLSVFEDALATFPKEKRGEIYKRGYSSLDWDDVV
TDYAAVVYYGDDGDFPYYTDDQLFRLWQILYYLYIEVKKDLDAQKNTIKDVLPYVRNFVR
REERLPGINEGLLQLTLMLYNKGRLTTDDLIFFCLLNNELFAMAQGAENHFSRRLPKWIK
DTLTFPEILLEEIRTHMLQVELQRGDLPTDASVYISSLSEIEGAQYFFEALERMGKEPFA
KGYGSGVSKRFTFSRILEVSQPSATDTFTAFKKHLDEVKLDKKRLVEAACYAPHWTEWIG
DYLKIKSFREAVWWFIAHTTDYMDAEKETIVSQYSSVPRDDFQRGAIDVDWYHRVHKAVG
KEGWKLIQESAKYLSEGMGYRRVKLYSAVLTGEIKLSEVIQKITEKRDKDYVMALGLVPI
NKKKEEEDLVSRYNLLQTFLKESKQFGQQRQESEKNAVEIGLDNLSRNAGYEDSIRFSWA
MEAKATQQIMEKATLTLDDTTIRLVIDEQGKAELEVTKGDKTLKSVPDKYKKSKEVEALK
EGKTYLTKQYSRTRLSLEQAMLSQTLFTVAELHRIMEHPVVRAMLSKLVLFNPETQASGF
WQDGHLLNAEGEKVALKADDKLLIAHPSHLFYAVQWDLYQKYLFDKELKQPFKQVFRELY
IPTKDELETSNRSERYQGHQVQPQKTVALLRSRGWTVNYEEGLQRVYHKEGFRATIYAAA
DWYTPSDVEAPTLEYVVFYSLKDGKEVPMKEINPVIFSEVMRDVDLVVSVAHVGGVDPEA
SHSTMQMRAALARESARLFKLTNVEVKERHILVKGKLGEYSIHLGSSMVSRGGLQLSILA
VQSQHRGRVFLPFVDDDPKSAEIISKMRLLAEDDKIKDPTILRQIK
>SEQF1602_01741 hypothetical protein
MSTLHNYYGSGVGVLPIAEQFQYVIYREYNVEEFFALVLSENPDAYYALFKDIFSSEHEI
GGVCTVLIKAALMVEDTRYRTLVEKLLLAAQLQEGLRQTILESLDGTSLASLQHFIGVIL
QHNLTRFSSVVRAVDVWFGFGWEAPQQPVIKRTLELAQTFLADHTAAEKAVSSKDNIERY
VALWAVGVHSVQQAISLAVKAIQDPQTSHEGRIVTLYFVRETGRTDWEIATYAENHFGEA
ADLDCWLLQNLPEGSLSPVLFDRMQAVAKALPKEGKHFEGVGFRWLNFTLKSQDIYRFLI
GEANEEQQERLAGELSEIPVEVRQNLLQNVYPVLGRGRYYYESPAEKKKKPEKYPADSWQ
RALVRTALNDKASYVAEIAFEILKKVPLVHDDILAIEQVLSRKNKEQRKESVALLIKQPE
AVLKDSTSRMIVSKSADQRLAALEILTVLQEEERLTDYVTEQVEAYKGRKLTKNEQVLMD
KLAYNPDETGEQRYDLSNGFGVIDFDRLTPFALPQPQFDKERKEKKGFLFDKIIRVEKVR
EALNDLLALWRKNKDYEYACEWYQGETRTQLLGQQIYRMHATKEGETPMEVLEDYPLAVL
WKDWHQKHQLNEIEYQYAIRYCQNLYYENKVPKQLKDYLAGYYPDFKVAFKGDLGNYYDS
EARRLEDLLTPISEAYAQDKAFLASFKLSVFEDVLATYPPEKRHITIERDYEDLSWTDVI
QDYVISIDQDEEGDIEYYTPEQRFKLWQLLYYTYAQKQTKNDLSSYTPQSVLTGLRAKVR
EDERLPGIGGSLMGLTLNLYQKGQLSADDLLFFCLLEDELFTVVQGGENYFYRRLPEALR
ASLIFPDTQLELLKTRMLQLELQRGDLPTDASIYIQYLQEVEGMHYFFEALERMGKEPFT
KGYYYGSSVTKRHTFSHILEVSQPSATDTFAAFKAHLDKTKITDKRLVEVACYALHWADW
IGDYLQIKDFKEAIWWFIAHTTDYMDAEKETIVSQYSSVPRDDFQRGAIDVDWYHRIHQS
VGKEGWKLIQESAKYLSEGMGYRRVKLYSAVLTGEIKLDEVIQKITEKRDKDYVMALGLV
PINKKKEEEDLVSRYNLLQTFLKESKQFGQQRQESEKNAVEIGLDNLSRNAGYEDSIRFS
WAMEAKATQQIMEKSTLVLDDTTIKLVIDEQGKAELEVTKGEKTLKSIPDKYKKDKQVEV
LKDNKSYLTKQYSRTRLSLEQAMLSQTLFTAAELSKILEHPVVKAMLSKLVLFNPETQAS
GFWQDGKLLSAEGTLTPLKADDKLLIAHPSHLFYAVQWDLYQKYLFDKELKQPFKQVFRE
LYVPTKDELETSNRSERYQGHQVQPQKTVALLRGRGWTVNYEEGLQRVYHKEGFRATIYA
AADWYTPSDVEAPTLEYVVFYSLKDGKEVPMKEINPVIFSEVMRDVDLVVSVAHVGGVDP
EASHSTMQMRAALARESARLFKLSNVEVKERHILVKGKLGEYSIHLGSGMVSRGGLQLSI
LAVQSQHRGRVFLPFVDDDPKSAEIISKMRLLAEDDKIKDPTILRQIK
>SEQF1602_01742 hypothetical protein
MIKQEQAEKFLGKHEPKELKEADLASFSAPYQKLGAYITGLMEYEEIGAFEQEFASYNFP
DKLWESKEGKALALLLFGKEIAPYA
>SEQF1602_01743 hypothetical protein
MVVKWLIEAESKYYETLDYWEEHNGSFNYSLKIIQAVENLEDNLAENPYFSAKYSKKLDL
YKRFFLNGRFALYYKVDEENQTVEIRDFRSTKQLPVF
>SEQF1602_01744 hypothetical protein
MNALTPQFLNDEDGNAMYAVLPIAQYNQLLSRAMEEETDFYYELTDEEIAYFERAEQLSK
EGKVVSSEEVRKKVRERYGSKMADRS
>SEQF1602_01745 Glucose-6-phosphate isomerase
MLATQNPTQTKAWAALEAHFAKVKDVTLQQLFAQDATRAPKYTLQWEDFWVDYSKNNWDE
TTRNLLLQLAEECDLKASIEKYFTGDKINATEGRAVLHTALRSAEKEILVDGKNVIPEVA
QVKAKIKDFSQEIISGKRKGYTGKSFTDVVNIGIGGSDLGPVMVTEALKFYKNHLNIHFI
SNVDGDHVHEVIKHLNPETTLFVIVSKTFTTQETLSNALTVKKWFLKHAKEADVAKHFVA
VSTNLKKIDEFGIASENVFPMWDWVGGRFSLWSAVGLTIALSVGYENFEALLLGAQKMDT
HFRTAPFKENLPVLLALLSVWYTNFYGAETEAIIPYTQYLHRFPAYLQQAIMESNGKYID
RSGQRVSYQTSAIVWGEPGTNAQHAFFQLIHQGTKRIPADFIGFKHSLYGDQDHQDKLMA
NFLAQTEALMNGKTPEQVRAEGVAEHLVPFKVFEGNKPTTTLLIDKLTPESLGKLIALYE
HKIFVQGVLWNIYSYDQWGVELGKQLAGTILKDFSAAQPAKHDSSTSQLIERVKSE
>SEQF1602_01746 hypothetical protein
MKKLLLLLLLPICSFAQELSAPDYIRTIEFRGSDDPLMQLPIVSLGSPFTLSFDDLRGQE
ADYYYTLTHCNYDWQPSGLLKSEYLKGMDDVRITQYRNSYGTLQPYTHYDLTLPNNETDF
LITGNYLLTVTDSEQRPIFTRRFVLYTRTALVQLSVHQSREVKYAETRQSVQMKITSKEL
QFQTPNTSVKIAILQNYRWDNAIKNVKPQFILGNDLVYKYDRETSFEGGNEYLYFENRDL
RTPTSGVYATRREGNNYLCQLFTQMPRAGLPYTYNPDIDGAFRITSDQGRNATIEGEYAL
VQFSLAAPKDLQPNDQLYVYGAFSDNALTKEYELHYDEKQKIYIGGVYLKQGFYNYKFAI
KRNGKADYNAIGGNHYQTENTYTVLVYYRSVNDLYDRVIGMGNLQSTQVTR
>SEQF1602_01747 hypothetical protein
MKEKFLLYDGDCLFCNRIAYFLSQKDREGRFLYIANTSQQGMDICKQYHLEELTQKTIVV
KVGENLYTQSQAVYYFLKECKLFPLLRFLIKITPSFIADFVYDYIAKRRKSLGKYCPIPN
R
>SEQF1602_01748 Putative electron transport protein YccM
MEQESFRNSIGTVDTSGKRVWAYPKKPKGRYYRYRKYVSYLLLAIFFISPFLKIDGNQFL
LFNIIERRFNIFGFPFWPQDFYLFVLSLIIGVVFILLFTVAFGRIFCGWVCPQTIFLEMV
FRRVEYAIEGDRNAQMKLDKQEWNAEKIRKKGLKWLVFFMISFVVSNVFLAYIIGSDQLL
VEIKEGPLKHLNTFVALLIFTSVFYFVFAWFREQVCIIACPYGRLQGVLLDNKSIVVAYD
YKRGEGENGRKKFRKNEDRKALGNGDCIDCFQCVHVCPTNIDIRNGTQLECVNCTACIDA
CDEVMVKSGMPKGLIRFASEEEIAKKEPFRFTARMKGYASVLAILVGILIGLLFLRSDVQ
ANILRLPGQLYQKEGEIISNVYTYKIINKTTEDFKHITFKIVEPKQAKIEMVGNPDITLD
KQGIASGTLFIKLHQAFVTDKKLKLKIEVYSGENRIESTTTTFSGPVTF
>SEQF1602_01749 Single-stranded-DNA-specific exonuclease RecJ
MPSKLVWNFLPTPQQNEVETLASALFQVQEILPWHRTIASLLLQRGIATVEQAKTFFNPS
LSDLFNPFLMKDMDRAVERILLAMAHKERILIYGDYDVDGTCSVALLYLFLSKIYPEVAY
YVPDRYREGYGVSCEGIDFAQDNEMSLIITLDCGIKAHDKVFYARERGIDMIITDHHTPD
DTIPPAVAVLNPKRTDCSYPYKELCGCGIGFKLIQALCKSLGYPLETAYAYLDLVALATC
ADIVPITGENRILVSVGLKQINERPSEVMQLLLSTANPPIQVRDLVFVAAPRINAAGRMN
HASRAVDFLIGESMEEATLLEHFNTQRKTADEQITQEALSQILGSHEEDAPATVVFSPHW
HKGVIGIVASRLTEIYYRPTIVFTQSGEVLAASARSVRGFNLYEALCECKDELIQFGGHT
AAAGMTLLPENYQRFKLKFQAVVDRTLPQELRSPTIMISARMPLHVITSSFYRCLQRFSP
FGPKNMTPIFQADEVIAKSVSLVGSDRSHLRMILTDTSLKQEFVAIGFGLGHKKEAVESG
KPFTIAYELSENHWRGTTSLQLVVKMIND
>SEQF1602_01750 hypothetical protein
MHEITAYWEGDMQFTSTNPSGNSFFIDTTPENGGENNGMHPKALMLSALAGCTGLDVLAL
LKKKQIELDNFTLDVKGKLTKNHPRTYEEVTVSYFFEGADLDVEQITHVVSLSVEKYCGV
IAMFRQFATVNIKLFFNSEEHPYNAQ
>SEQF1602_01751 Iron-sulfur cluster carrier protein
MTILKAQVIEALRKITSPGEGGNLIDAGVVKNIVVFGDEVVVDATISNPSLQAKKKVEVE
IMKAIHAEVYEKAKVKVNITVEVAPTSQTNEIKGKPIEGIKNIIAVASGKGGVGKSTVTA
NLAVALRKMGFKVGLLDADIYGPSIPMMFDVQEERPISVEIDGRSKMKPVENYGVKILSI
GFFTHPDQAVIWRGPMASKALNQMIFDADWGELDFLLIDLPPGTGDIHLSIMQALPITGA
IVVSTPQNVALADARKGIAMFRQETINVPVLGLVENMAYFTPAELPQNKYYIFGKEGVKS
LAERTDTPLLGEIPLVQSLRESGDVGRPAALQEGTPLAKAFEDFARNAVAEVVTRNQYLA
PTEAIKITTMAGCSPKKK
>SEQF1602_01752 Sec-independent protein translocase protein TatA
MLANHIFLGVIGAPQVIIIIAVALLFFGGKKIPELMRGLGGGIREFKDAMKDGQEPQQTP
EKREGLTREDLKKLEEKNS
>SEQF1602_01753 hypothetical protein
MKKATQYILIAIAIEVLLALLTYESVSFLITKNHIGFFSDFKGIFFSIGSGILMCVVLGI
LIGEFFPFERQPRALQIYLGIIILFFLLFEGVLTGYFVENAHYSLFYFNWNNLGILFLIF
LIFGGIQTLGVGIWLGMRLRKMKSEG
>SEQF1602_01754 hypothetical protein
MKRSTIYLLTTILFEILLIVIFIKRLISPLSEKGANRGILWIPIPVAAIISLVLGFLAGQ
YIHFEKMIPFFRFLIGVSIFYAIFVISVILGFGFFHLLYSDLPSGIWVAPSMFIFLASVP
ILCIGCVFGLALCLLKNNY
>SEQF1602_01755 hypothetical protein
MKPATRCILRTIGIEIVLIFLALAIYTGGESDIGGEIFLGSLLIILPFALISFVLGYFAG
ERVVPFEELSPLVRFFLGVQLILTVFWASGIFSFTFAYIIFFPEGSEDAWQYIFIILLLG
SIPILVIGIIMGIVLSKMALGNKKIQNSNLKTQNDINECKKEIK
>SEQF1602_01756 Murein DD-endopeptidase MepM
MSVKKKSNKDLRGKWLFKYRVVIMNENTLEDVATFRLNRLNVFIYSSLFAILMIVLTSLV
IIYSPLRQYILGFSEADLRKQIVDLTFRTDSLQQRIGGNDAYFSSLQKILTGDIHPDKVN
KDSLLNAVQQIPVEVDIQASEEEMKLRHEVAEEERYNVFDQASNKAQKSFFPPCQGTLSS
AFKSDKRHYGVDITAPEGTPVRAITNGTIIFSEWSAQTGFVIVIEHPNNFISVYKHNASL
VKKQGDKVSPGEVVAKVGNTGELSTGTHLHFELWHEGYPVDPLNYMTFK
>SEQF1602_01757 hypothetical protein
MSIKSFLARKWAQYIRKKIDLWAKDPIPTQEKILNSLIQKAKNTVFGKEHHFDQIHSYED
FIKQVPIRDYEALSPYIERVKEAQSDILWPGKPLYFAKTSGTTSGAKYIPLTKESMPYHI
QAARDAIMCYIAQTGKADFVNGKMIFLQGSPILEKKNGILLGRLSGISAHYVPKYLQRNR
MPSWETNCIEDWETKIDAIVKETIKEDMTVISGIPPWVQMYFERLQEKSHKPIGELFPHF
QLFIYGGVNYEPYRQKFEHLIGRRVDSIELYPASEGFFAYQDSQNEKGMLLLLNSGIFYE
FVEADTFFSENPKRISLKDVQLGVNYVLIVSTNAGLWGYNMGDTVMFTSLSPYRIVVTGR
IKHFISAFGEHVIAKEVEEALAQAVSKAGGEVSEFTVAPQVNPAPGELPYHEWFIEFEKL
PEDIETFANTLDQGLQAQNSYYKDLIEGKILQRLKITCVPKGTFVEYMKSQGKFGGQNKV
QHLSNDRKIADNLKW
>SEQF1602_01758 Putative NAD(P)H nitroreductase YdjA
MNTTATLIKHIIKSRKSIFPADYTETPIPEEIIEDILDIATYAPNHKKTKPWRLKAFRGE
EKTALGAELQRLYKGHVPAEKFSEDTYNALAQKVAKADTIISIAVEFSGKVSQWEEVAAV
AMAVQNMYLLCTAYELGCYWGTPAFAPKLKDFLHLTENQECYGIFFIGNLQ
>SEQF1602_01759 DNA repair protein RecN
MLQSLAIKNFALIEDIKIHFSKGFTIITGETGSGKSILLDALALVLGRRADLSALRNPEE
KCVVEAEFAIASYGLADFFQQEELDYEPLTIIRREILSSGKSRAFVNDSPVTLDVLSSLG
KTLIDIHSQHDTQQLSEEDFQFFLIDSLAENTSLLEEYQAALKVYKGESKKLQELKTFQE
NTQKEHDYNTFVLSELQEIELEEGMQEELEAFYNQASNSETIRDNLTEAANLLAEEEQGI
MTQMRDLSSLFSTLSSYSPQYSELYERIDAAYIELDDLSREVYDLAENVEFDPKKLARAQ
KKLQKLYDLQKKHKVSTVSELILIKEALEEKVSQMENIEGDIEIAQKEVEKAFQTLSTLA
QKLHKVREKVIPRLTKSLQDSLKDLGMPNAQFQISLTPTEHYQAKGNDSLSFLFSANKGG
NFGLLKKTASGGELSRIMLTIKHILATKIALPTIIFDEIDTGVSGEIAHKMGEIMKQMSQ
SRQVFAISHLPQVASKGDVHIKIYKTDIAGRTTTQFQELSPEQRIEEIAQMLGGKDITES
AREHAKQLLSKS
>SEQF1602_01760 hypothetical protein
MTHLTIQGRSLTAMEWGNRILLLMLTTFFVSGVSHSFLTDTLDPIGFLLRILLVVATASI
IIYILIMIFKEYKYTLYTLVIRGEKLKIHYKEQILYSLDKDAIKMAYFFNLSEERYKMSK
PFLDLFTKEKGRILHLWIEYKDYEALKAYFIEQHIPVKDEVIFLKD
>SEQF1602_01761 Energy-dependent translational throttle protein EttA
MNYLSVENISKAYGERVLFENVSFGINKDQKIALIAKNGAGKSSLLKILIGQDTPDTGQV
VSRKGLKIAFLSQEPALPEELTIEDYIFQEENPILKVIQQYEHALEHPEDEVAYQKAFEA
MERHEAWDFETQYKQILFQLKLTNLHLPIKHLSGGQRKRLALANVLISKPDLIFLDEPTN
HLDLEMIEWLENFFAKEKMTLFMVTHDRYFLERVCNEILELDEGTLYSYKGNYTYFLEKK
QQRLDQEQASQEKAKNLYVRELDWIRRQPKARTTKSKSRIDDFALIKEQAQKRRREHVVE
LEIAMQRLGSKIIELHNVVKKFPEKTILDRFSYVFKRGERVGIIGKNGTGKSTFLNLLTG
KIAPDAGKIIIGETVQFGYYTQQGIEINPQEKVIDVIKKYGEYIPLLKGRTLSAAQLLER
FLFDRKKQYDYVEKLSGGERKRLYLCTVLIQNPNFLILDEPTNDLDIVTLNVLEEFLLDY
EGCLVIVSHDRYFMDKIVDHLFVFKGEGEVQDFPGNYSDYFTYEQSSVRETPKEEKAPAT
KNSWRGANSTLSQNEQRELSRLEKEIAQLEAQKATIEAHFTQEALSSEELQEQSQALSEV
LTLLEEKSDRWLELSIKSEEG
>SEQF1602_01762 hypothetical protein
MKKLVVLAVTALFLGACGGGKSPEMKRLENEQKALSLQSKINDLQMQLVKEQATNEKLKQ
EAESINSLANSSASAFSDAESASASAAKAKKAQRDLKKAQKVNKDLANSNKKVQKLEKEI
SRAQQKLAKTGVQVEFTQPAN
>SEQF1602_01763 L-lactate permease
MDLFLSIFPIVLLIYLMVKRNAFPSYVALPLIAGIVYILQLFYFKNEFILLNANVVSAII
SVFTPISVIFGAVFFNRMMETSGAMNTLRSWLGNISENPVAQLMIIGWAFAFMLEGASGF
GTPVAIAAPILVGIGFKPMQVVMLALVMNSVPVSFGAVGTPTWYGFKTLLDSGTIGGEDV
SSIGKYSALIHFVAAFVIPILALRFIVSWKEIKQNILFILLSVLSCTVPYLLIAQFNYEF
PSLVGGAIGLFVSVLLAGKGIGLAKTEQKKEKQPIAAKTLIKAFTPTLLLIIILVLTRVQ
QLPFKAMLNDSSEWLEFSLGELGIFKVSKGLIFSVENIFKTGVGDSYKLLYTPSLIPFVV
TVVISFFIFALSWNKCKDIYLKSAFQVQKPFLALVGAMIMVKLMMVGDDYSMTQTIGKGL
ADATQQHWVSFASFLGALGAFFSGSNTISNVTFGAVQYSVATATGLSVPLILALQSVGGA
MGNMVCINNIIAGCSVLGIDNAEGTILKKTVIPMLVYGLIAAIVAFFL
>SEQF1602_01764 GTP-binding protein TypA/BipA
MTAIRNIAIIAHVDHGKTTLVDKILHHCALFRDNQETGDLILDNNDLERERGITILSKNV
SVNYKGTKINIIDTPGHADFGGEVERVLNMADGVLLLVDAFEGPMPQTRFVLQKAIEMKL
KPIVVINKVDKENCTPEEVHEAVFDLMFELGAEDWQLDFPTVYGSAKQNWMSEDWRKPTT
SIEPLLDMVVEHIPAPVIEEGSLQMLITSLDYSTFTGRIAIGRLHRGTLQAGMNISLVKR
DGTIVKSKIRELHTFDGLGRKKVEEVQAGDICAIAGLEGFDIGDTIADYENPEALPTIAI
DEPTMSMLFTINDSPFFGKDGKFVTSRHIKERLERELEKNLALRVEATGSADKFIVYGRG
VLHLSVLIETMRREGYELQIGQPQVIIKEIDGVKCEPVEELTIDLPENVSGKAVDFVTLR
KGEMLSMEPKGERMVIKFLIPSRGIIGLRNQLLTATAGEAIIHHRFLEFQPFKGEIAGRI
NGSLISMEQGTAIPYSLDKLQDRGRFFIFPGEDIYTGQVIGENSRSGDIVVNVTKTKKLT
NVRAAGSDEKVKLAPPIKFSLEEALEYIQKDEYVEVTPKNMRLRKIYLDENERKRHEKEF
K
>SEQF1602_01765 H(+)/Cl(-) exchange transporter ClcA
MRTTARWYIKFLQWKTQYLTHRQFILLLCGLVGVATGFAALAMRSLTHFIEEVLVGNIIR
YINYGFYVIFPAVGFLLVYWVKKYIIRKEVSHGIPSILYAVAKQKGIMKRFQAYGSILTA
PITIGFGGSVGLEGPMVVTGAGISSQVARLFHINQSDRMLLLACACAAALAAIFKVPLAG
ILFAIEVFGLDLTLSSLLPLFVASLSGVLTSYIFFGNAALLPIYVGDSFLMHNIPFYLLL
GVVGGFMSAYFTFVYEGVNRFFSKFSSAYLRIVIGGAILGLLVFVMPPLYGEGHEVINHL
KAGHPELSISSNIFGWNLENPWVVILLLGGLVLFKVVATSVTFGAGGVGGIFSPMLFMGG
VMGNCFARIINQIDILPYKLPLANFTLIGMTALMTGVLHAPLTAIFLIAEVTGGYSLFVP
AMVTAVVSFSIAKYFNKYSIYTMELGRKGELVNQDKDQAILTLMDMESVIETNFVPVYTD
MTLKGVVYEAVRESSRNIFPVLDREKGSLEGVILLDDIRHLIFEKELYDKVSVLEMMQPP
PALIQMGQDTMNQVMDKFQNTAAWNLPVVKNGKYIGFISKSKLLTVYRRKLIYFSNNK
>SEQF1602_01766 hypothetical protein
MLSIFTETYKVRSTQVNLNNQLGLYGVLGMLQDIAAEHAASLGFGYKDLVRKGFFWALIQ
QKLKMYEWPQWNERVTIHTWSLPVQGVHAFRQFELYVGDRKIGESSSTWITMDIASRHPI
DMTNSQEMFHPRLDGGIAMQTERVLLPEEMIHICDFKVRISDLDVNSHVNNVKYTQWALD
MMREKDHREWVIQEYDINFLSETFLGDTMQGYKSHGHYLNPEKTLVETFLCAQKEGGTKP
AFIAKWKAKSIVNC
>SEQF1602_01767 hypothetical protein
MALAVRMVNLYKYLTEEKRNMYFLSKSYAVAPLLGLWYMNQSILKAPQILSISLLLLKKK
>SEQF1602_01768 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MYDVIVVGAGHAGCEAAAAAANTGAKTLLITMQLQNMAQMSCNPAVGGIAKGQIVREIDA
LGGYMGIITDQTAIQFKMLNKSKGPAMWSPRAQSDRMRFSEAWRLQLERLPNLDFFQEMV
TEVLIEGGKATGVKTSLGSEIRAKSVVLTNGTFLNGIIHIGLKQLGGGRAGEKAAKGITE
CLVAHGFEAGRMKTGTPPRVDGRSLDYSKMTPQPGDENPEKFSYLPLTQPLTHQLDCYMT
YTSEEVHDILRTGFDRSPMFTGIIHGVGPRYCPSIEDKINRFADKDRHQIFVEPEGWHTV
EMYVNGFSTSLPEEVQYTALRKVAGFEQVKFLRPGYAIEYDYFPPTQLKATLETKIIENL
FFAGQINGTTGYEEAGAQGLIAGINASRKVQEQSPFVLKRNEAYIGVLIDDLITKGTEEP
YRMFTSRAEYRTLLRQDNADMRLTPMGYALGLASEERMRLLEEKQTKTAAFVQFFKETSI
TPEEANPLLEKYDSSPMKQGDKMAKVLARPNITVEDFMELPQVKAFAHAQQLSKEVLEST
EIEIKYAGYIEKEKNNADKLNRLEDIRIPESFNYDKLTSLSFESREKLKKIRPTTLSQAS
RISGVSPADISILLVYMGR
>SEQF1602_01769 hypothetical protein
MKKMVLSAAVVLALIVASCGNNGTTNNQEQTTETPVETAPVTASGTYTAEPTSVIEWKGS
KPTGSHTGTIALQNGTFTVDNGKVSGNFVIDMNSITVTDIKEDEGKLDLEAHLKGTGKEE
GADHFFNVKTYPTGSFKLTGFDGTNVTGDLTLKGKTKTISFPATLTITDSEVTLESQPFN
INRVDYGVNYASKSVFGDLKDKFINDEIELVVKVKAKK
>SEQF1602_01770 hypothetical protein
MHKRNLEILRKMLVSMDSLPQTARVWIYPSNRLLTGEEEAQITADLTAYLSKWASHGTLV
RSAFELRYHQFIVIAADDNQHIGGCSLDELAHFIQALEQKYNLLLLDKMNVSYRHEDKIY
YVPLTDFKKLVQHKKVDGNTIVFNNLVTNLYEYEQVWETPMIDSWHNRFLK
>SEQF1602_01771 hypothetical protein
MKYQEMKRIELIIVVISLLYITIGNAQTNKKIAVKKQILGVLGKNYTIEKYKSYTRNKEY
LTLQVFVDSIHEKELYIAYINGDSFWIKKKESVTFLVNHRQTYEVGASAFVTGILKIPNI
IPRKRDSLVIKANLKSPPKVTPRPKYGKIAILGEEYTMDTYKSQDKKTYLTFQVFVFG
>SEQF1602_01772 Asparagine--tRNA ligase
MSIKELLQEKTNIGEVTLRGWVRTFRSNRFIALNDGSTLSNLQVVVDFEHTPEETLKRIT
TGAAIEVKGKVVESQGKGQSIEVQATEVTILGDCNPDEYPIQPKKHSLEFLREQAHLRVR
TNAFGAIMRVRSTLAYAIHKYFQEKGFFYVNTPIITGSDAEGAGEMFRVTTLDAKNPPLT
ETGEVDYKKDFFGRETNLTVSGQLEGETFAMSLGKIYTFGPTFRAENSNTSRHLAEFWMI
EPEMAFYDLIDNMNLAEDFIKNVLKYTLEVRREDIEFLNQRFLEEEKTKPQQERSEMSLI
EKLEFVIHNDFKRVSYTEAVEILKNCNHNKKKKFQYLIDEWGVDLQSEHERYLVEKHFGC
PVILYDYPAKIKAFYMRLNEDGKTVRAMDILFPGIGEIVGGSQREERYEVLKQKIADLGM
DEQTLWWYLELRKFGTAVHSGFGLGFERLVLFTTGMTNIRDVIPYPRTPQSAEF
>SEQF1602_01773 Glycerophosphodiester phosphodiesterase, cytoplasmic
MKKIIVLFLLLIAGVSCKNASSSGQIVPQKEITNAIYYAQKPIISAHRAGKGIKGYPENC
LQTIQHLSKKGIHSFEIDIFESTDGDLFLMHDDKLGRTATGSGIVSQMSTQELLKVRLKD
DFGQETTFPIPMLKDVLSWSKQHGAYLMLDFKKGISYQKVAELVRAEQMEAQVVLISYNV
EQAKALHKVAPEMLISVTIRNQAELDRILETGIPKEKLLAFTGVHLAEDSLYKTLNEQRI
PAILGTLGNLDKRAAAKGDQLYNQWAEKGIQVFSTDRPFAPRF
>SEQF1602_01774 ATP-dependent Clp protease ATP-binding subunit ClpX
MSTTTEVCSFCGRHSGKDVFLVSSGVESNVYICNYCIEQAGSIWRSEIENNKKKAIMAMN
KDLLLKKPTEIKSFLDQYVIGQEATKKVLSVAVYNHYKRLLQERDEHEVEIQKSNIVMVG
QTGTGKTLMARTIAQMLNVPLAIVDATVFTEAGYVGEDVESILTRLLQAADYDVDRAERG
IVFIDEIDKIARKGDNPSITRDVSGEGVQHALLKLLEGSIVNVPPKGGRKHPDQKYIEVN
TEHILFIAGGAFDGIEQIIAKRMNRQAVGYNTSKETRVDDKNLLQYVTHKDLKDFGLIPE
IIGRLPVLTYMNPLDESTLRMILTEPKNAIIKQYIKLFGMDDIALSFEEEALNFIVEKAL
EYKLGARGLRSLCESILTDAMFQLPGTEEKSLVVTRAYAQEKLTKSGFTQHLLTA
>SEQF1602_01775 ATP-dependent Clp protease proteolytic subunit
MNYSEEFKKYATQHRGVSSTYYDKIISSMTPYIMEERQLNVTQMDVFSRLMMDRIIFLGT
DVNSHVANIIQAQLLFLESLDASKDIQIYINSPGGEVYSGLGIYDTMQFIKPEVATICTG
MAASMAAVLLCAGAKGKRSALPHSRVMIHQPLGGAQGQASDIEITAREILKIKEELAQII
AHHSGKSLAEVIQTGDRDYWMIASEAKDFGMIDEVLTRN
>SEQF1602_01776 Trigger factor
MNISKEQIDALNAVITLEIDKSDYQKKVDEALNSYRKNASIPGFRKGHIPMGMIKKQYGR
AIQVDEVNKLISDSLNKFVSDEKLELLGQPIPKENAPEVDWDSDHHTFVFEIGLAPQFSI
DLSTPIDYYQIKVTDKEVDTQIEHLRTRFGSLVPTEKVAKNSQISGIFFNEAQNIDKEYS
FLAEALTDKAFEVIKDKAVGDQLSFSTKELFKDPHVLMQALGVPHEVVHSLDIEVTFTIE
SIQEVVLATMDEAFFAQLYPNENITTEEDFRKKVEEGIREEFTVNSDTRLLDDATEMLIE
KTSFDLPKEFLIRWIQATSENPITEEQAAEDYKNSEKGLRYQLIEGKIIQENNLQVTYPE
IREFAEKAIRAQIARYGLTDVEQAQIDTFVNNTLKNEQELNRIHRELTGGKLIQFYKEKA
NLNKIEIDVDAFIEKFYSHQHQH
>SEQF1602_01777 Citrate synthase 1
MENVAKLIFEGKEYDFPIVVGTEGEKAMNIEKLRALTGLITLDSGYKNTGSCKSAITFLD
GEKGILRYRGYNIEDLAAKAEFLEVAYLLIFGELPTVEQYDDFKRTIHKYTLVHEEMRQI
LNGFPKAAHPMGVLSAATSALTAFNPIPVNVKCEKDVYQAVCKAIAKVTIIATWVYRRRE
GLPLNYYNNELGYIENLFQLFFSIPTEKYHINPIVVAAMNKLLILHGDHEQNCSTSTVRL
VGSSEAGLFASISSGVSALWGRLHGGANQAVIEMLEEIHADGGDVDKFIRKAKDKDDPFR
LMGFGHRVYKNFDPRATIIKAAADDVLNALGINEPIFAIAKHLEKVALEDEYFKARNLYP
NVDFYSGIIYKALGMQLEMFTVLFAIGRLPGWIAQWKEMRQGGEPIGRPRQVYVGATQRP
FVPLEKR
>SEQF1602_01778 Isocitrate dehydrogenase [NADP]
MESIIYTKTDEAPLLATHSLLPIIERFCASSGVHFELKDISLAGRILATFPEYLRPEQRV
EDALALLGDLTKEPHANIIKLPNISASVPQLKAAIAELQGQGYALPDYPETAKDDKEKEI
KTRYDKVKGSAVNPVLREGNSDRRAPKSVKNYAKKHPHKMGAWSRDSKTAVATMQVGDFF
HNEKSVTLPKADKVRIELVTTQGNTLTLKDGLPLEAGEIIDATFMSRKALLAFYKEQFAK
AKEKGVLLSLHLKATMMKVSDPILFGYAVETFFEELFHKYAEDFKNLGINPRNGFSEVLS
KITELPSEKQEAIGKDISLAFQKDPAVAMVNSDKGITNLHYPNDVIVDASMPAMIRNSGK
MWNAQGDTQDTLAVLPDSSYAGIYQVVIDFCREHGAFDPSTMGSVSNVGLMAQKAEEYGS
HDKTFEVPEDGQIRVVGATGEVYLSHSVEAGDIWRMCQVKDAPVQDWVKLAISRTKASQS
PAVFWLDIHRPHDRELIKKVEKYLAAYDTKDLDIRILSPEEATLFSLERAKRGEDTISVT
GNVLRDYLTDLFPILELGTSAKVLSIVPLMNGGGLFETGAGGSAPKLAEQLLEENHLRWD
SLGEFLALGASLEHFAATYHNNKALVLAQTLDEAIGRVLEEDKSPKSKAGELDNRGSHFF
LALYWAEALAAQGKEAALSQEFTPIAKALRQNETQIVEELMQVQGEKVDIHGYYHPQEEK
TYQVMRPSKTLNSIINVQ
>SEQF1602_01779 Aconitate hydratase A
MAFDIEMIKKVYSRMPERVDQARKLLGRPLTLTEKILYAHLWDALPATAFVRGKDYVDFA
PDRIACQDATAQMALLQFMHAGKSKVAVPTTVHCDHLIQAKEGAEIDLKVATEQSKEVFD
FLSSVSNKYGIGFWKPGAGIIHQIVLENYAFPGGMMIGTDSHTVNAGGLGMLAIGVGGAD
AVDVMAGMAWELKFPKLIGVKLTGKLNGWTAPKDVILRVADILTVKGGTGAIVEYFGEGA
QSLSCTGKGTICNMGAEIGATTSTFGYDESMRRYLKATGREDVVAAADKVAAYLTADPEV
YADPEKYFDQLIEINLSELEPYINGPFTPDRGTPVSQMKEVARANDWPLKVEWGLIGSCT
NSSYEDLSRAVSVVKQAVDMGVTPKAAFGINPGSEQIRYTIVRDGIMKVFEQLNTKVFTN
ACGPCIGQWDREGAEKQEKNTIIHSFNRNFSKRADGNPNTHAFVTSPEIVAALAIAGRLD
FNPITDTLTNDKGEEVKFKPPYGEELPTKGFAVDDPGYQAPAQDGSHIEVVVSPTSNRLQ
LLEPFAPWDGKNITGAKLLIKAQGKCTTDHISMAGPWLRFRGHLDNISNNMLIGAVNAFN
GKTNSVKNQLTGGYDEVPKVQRAYKAAGVPSIVVGDQNYGEGSSREHAAMEPRHLGVKAV
LVKSFARIHETNLKKQGMLALTFANEADYDKIQEDDTINFLDLTDFAPNKPLHLEFVHKD
GSKDVIPCNHTYNASQIEWFKAGSALNLIAKNKK
>SEQF1602_01780 hypothetical protein
MKKYIYMCLAACLLASCSQEEEAVYGKGNSYAKRTGETSTEYVNLLEGATNGWLLSMYVG
TGQQYGGYNYILKFHQGKVTALSEATTEEDTSLYTLNFSEKSILTFDTYNKVLHQFVEPS
ALFPEGKIGDNQLVIQSYENGVFTLKGQRSNNLMTLRKLEGEATAYLTKIRERQSLFRVS
DAYPVTINGKEVDFELQPSNRQFIAREGTTVIKKAYIYTENGFKLYEPITIAGKTFSEFT
LSADNSEITADDASIKTRMVYNNLPFDFYNGNIKINMLDDLCSSNAAFVKIYNLYKTVKS
RNIAPYFYLGKLSPSEDIAMNFTIYYYDNRNYKMRYLLDFLPVAGKSDQVNIVPVEQGFY
WNYYGNYPLVEVLTQNAPYQMTDVNGDGTLYKFTSTKNSEVTFLSHNNATLPYDPSQNEW
KSIDFEYASDALKALYETYKTHTVTKGNASATYRLQDSMSIGYGSLWFTVRRGTSSATVS
YAIDALAVPCDTNQVSFVDKGATHTASSNWTTYNYLSPIVNFFLQNGPFKVEDVGGGWTK
FISAKNSDYWFYTR
>SEQF1602_01781 hypothetical protein
MKKICIIPFLALFLFSCQKDNPDKDNSVVQLTTKEQAKNQSELDRYINQKLTIPYNVNIN
YRYPENDINRNQFTYVTPPSTQKALEMVNLIDYMYYQPYSKVVPKKFMEEYVTKQITLIG
SYAYAREGGTYNGLATAGIRLELLGVNYIEPNTHDDSKRKDMDNNLLRLIYHETSHILEQ
NKQIPPEYEKLCAAEYKGGSWTRSWNLNTQNYLKSGFISPYSSDNVHEDFVEFIAHYIVF
YQKNQCGCETTDATADTDGDGLDDAAYTAWKTQILKRGFIWEEALATADGKNKTDAQYTG
KEILLKKLEIVKNYFSQEFGVDLEKLRKEVQAHHVNLPNLNFSTYNW
>SEQF1602_01782 hypothetical protein
MLLLSVVACDKYLDKDPDSRVTVDSADKVQKLLVSAYPTSTPAVVTEFSSDNIDDIGATN
AKTLSFIEELVYWHKDMHEYKYIDGLRTLWEDHYGAIYHANTALEAITKLGDSPQLRAAK
GEALVARAYAHFVLVNLFGKPYNAQTSTTDLGVPYIDFPINNFRAERPRNTVAEVYQYIE
KDLTEGLPLLDDTYYKVPKMHFNKKAAYAFAARFYLYYTKWAKAEEMATEVLGDTPTNLR
NWIAFQALGNNDPHAKEYTREGVEANLMLASVSSYARRFIDGQTVGRFAHSRGTAVRETF
RDANNLWTNNYKDKQYESFRVDASKYIYTKYPTYTGNNTQIVLFTTDETLLVRAEARILQ
KNYTGAVADLNLFAKAYFMDEPQFTMSQIVSGYQNIPYSSYDPTSKLSHATQKKRLSPEF
TIDNDQENLLHFLLQCRRLLTLGEGLRWYDIRRYGIEIHRHQMDIDGNAHIVEVLTKEDN
RRTLPIPVDVAAAGMTQNPR
>SEQF1602_01783 TonB-dependent receptor SusC
MRIKISICLLFSLLGMIHTFAQEKSISGTVKNSQGLPQQGVVVSLKGDSSRTTQTDAKGG
YTILAKSTDILVFSSLGMATIERTVGEATTIDVVMSSSTAKTTSTPSTTGEAVARTNVRG
PSSIYGESKPLWVVDGIILDDGVELSPDALSSSDAKTLIASALGGLSSDDIDTFRVLKDA
SATSIYGPRAIAGVVVVNTRKGSKGTNSISYTNESTFRLIPSYNNFNIMNSQDQMDVFME
MMRRGNITYKEMGNRRHYGEIGRMYALLNTATPSGYGLANTNEAKEAFLRAAEMRNTDWF
SRLFQTSILQSHSVSISTGTDKASYYASVGIINDPGWMRFSNYNRYTANINANYKLSKSV
SFNLIANGSYRENKTPGSVDGVSGKVSSAFSLNPYSYALNASRTMDPDAVYRYRFAPLNI
FEEMENNYTNTHIGDIKIQGQLSWKISPKVTAVGLAAIRYQNISQELNQTERSNLARAYR
AMDNVTMITNNTYLYEDPYDDFDVKRTVLPEGGIREKSESILNGKDFRGTIDYRDAFSGG
IHKIQVLGGAETSDIYRNKDWNQNLGLLYELGDMSYFSYEAFKQMQENKTNYYTLTRTTT
RNVAFFSNAMYSYKDKYIFNGTLRTDASNKFGASHYIRWMPTWNLALTWNISQEKFFPKL
KPISALSFKGSFGMTPESPSVSNSLAKIIGERPWRSADRFQETALRISEAANHDLTYEKK
EELNLGVQMGLFKNRINLALDWYTRNNYDLIGRVPSQGLNGTVIRSGNVAAMRSSGVDLS
LQTKNLTIGDFSWVTTFVYARNDNKITKLYVEATIEDMVKGTGFSKEGYPVGSIFSIPFR
GLNSEGLPTFADSNGNTTIDGLRLDQRDNLDFLKYSGTTRPTDVGSLGNLFKYKGISLNI
LLTYSFGNVLRLPASFKHSYINDSPTSPSDMVAMPKEFKNRWMQPGDENRTNIPAIASAY
QLYATPTLEYAYTAYNYSDVRIAKGDFIRLKEISLAYDFDKETLRDMKIKRLSFKLQGTN
LFLLYADKKLNGADPEFSASSSFIPTPKQLTFSIRVGL
>SEQF1602_01784 Glutamate-1-semialdehyde 2,1-aminomutase
MLQYKRSSELFHQAQQVLPGGVNSPVRAFNAVGGNPVFVEYAKGAYLYDADGNKLIDYIA
SWGPLLFGHAYAPVIEAVTERAKRGTSFGMPTEVETEIAQKALSMVPHVEKIRFVNSGTE
ACMSAIRLARGYTQREKIIKFAGCYHGHSDSFLIAAGSGATTFGVPNSPGVTQGTAKDTL
LATYNDIDSVKQLFAAHPKQIAALIIEPIAGNMGCVLPKEGFLEALRALCDQEGTLLILD
EVMTGFRLAKGGAQEALGIRADIVTFGKVIGGGLPVAAFAARNEIMDHLAPLGAVYQAGT
LSGNPLAMSAGLAMLTEIEKRSDVFESLGKKTAYLHEGLDRVLTQAGIPHQINRFGSMCS
VFFTEEPVTDFASAQRADHQRFKKYFHAMLSRGIYLPPSGYESYFLNDALSYADLDTTIQ
ALADALEKGEI
>SEQF1602_01785 3-oxoacyl-[acyl-carrier-protein] synthase 2
MQTNISITGMGSISPLGADRANIWRQYLLDKPLLVGQRVGEELLPVGRLQEESHALVREI
RQENARYRSVDPTVLYALYASRQALQEAGWEQGKDFGVNIGSSRGATTLFEEYHQSFLEQ
GKCAPLASPTTSLGNIASWVMQDAKGQGAAISHSITCSTALHALLNGIAWLHADMAEGFL
VGGSEAPLTPFTLSQMKALKIYGSLSDSYPCQPLLLEKLKNTMVLGEGSAVFAIEKGVRP
NALAIVKGIGYATEAITHPVAISAQAEALQLSMQQALQGVAPAEVDVVIPHATGTIKGDE
AEYHALREVFGQDLPRLTSNKWKIGHTFAASGALAIEMAVLMLQNQQFLPLPYLKKEAEA
PLRNILINATGFGGNAVSVLIGLPY
>SEQF1602_01786 DNA damage-inducible protein F
MKRISITEINRLALPALVSGVIEPLISLTDTIMAGHIALNTKEVLGAVGIVSSFLTSLVW
IFIQSSRAITSQVAYAYGQEKLNQLKSLVAQILTLSLGLSLLCSIFAFFNSEVILTNFYD
ADGILLDYCLDYFRIRVWGFPFTLLTLTIHSIFRGMQNTSWSMYISILGGVINLVFNYIF
VFVLHWDIKGLAWASLLAQGVMFAVSLYFLYERTPYRFILTRSLHPKFFQSLRMSFDLII
RSSLLQGVLYFSFLSATKLGGGEDSTIVATHTILNQVWLFSVFLFDGYCNAGGLLSGRLY
STQQYQTIRNLVKDLFYIVLTIGMAILLVYFLFYHQIGIFMTKNKDVQLLFFETFWIVVL
MQPLNAITFLFDGIYKSMGFTAILRNAFIIATFLGFFPTFYVTQSLLEWGLSGIWLTFFV
WMAFRGGILIIHYINFFFNRPLQAG
>SEQF1602_01787 D-alanine--D-alanine ligase
MKNIAILMGGFSQEAAVSLQSAATVAEYLDKSKYTAYRILITKEKWVYTDTLGQEILVDK
NDFSLTLEGKKITFDCAFNAIHGTPGEDGNLQAYFALVGVPITGCSMYASALTFNKRDML
SVLKPYGIPRAKAYYLNQGEPFSTREIIKTVGLPCFVKANRSGSSIGVFKAYDEKDIDQA
IEKAFEVDTEVIIEEFLKGTEVSVGVITYHGKKRVLPITEIVSENDFFDYEAKYQGKSKE
ITPARLSEEERKKVEEVALRVYNLLQMKGFSRSEYILVGGVPHLLEMNTTPGLTKNSILP
QQAKAAGISLTNLFDNAIEEAMNND
>SEQF1602_01788 Cobalt/magnesium transport protein CorA
MSKKRKANRAKKIGLPPGSLVYFGEKEKLIDIDIISYSDSSFYTQKVGSAQEALSFINEG
CITWININGLNNIEEIRKIGAYTHLNNLLLEDVLDTQHRPKVELLEEHLLVIIKMIYHQE
GQLTAEHLALLLGHNYLISFQESEGGDVFDPIRKLLQQPESLLRKSSADYLLFGLLDSIV
DNYLAIVDRVSDTIESMEDEIIARPREDMISEIQLLKKKATFLQKSIVPAREVISRIERN
NHMLIQEGCKPYFRDLNDHIIQIAETLASYRDILWGLTDTYMGAMSNKMNNIMRLLTLIS
TIFIPLTFIVGVYGMNFEHMPELHYPWAYPACWGVMIVITIAMLLYFKKKKWL
>SEQF1602_01789 hypothetical protein
MSRTFYIQNPEAPKVMSTEELLDLVGGNFRQFALREDDEELDEVMQMPLNEFGHMLLGQE
GISGRGFECSYSDENHSYDVRVFTPSTSADWHGALSFIERLASHFGVSVTDEEGEEYEGN
NITYDYRHDIEFGIKSFNKSREGHFIFGVKRPIFLTEENIHQIQSAEDKVKAFDDFVAAQ
LQHEDIYIARPIFMQNDKDEIIGIYVLTKTVQSILPYEYPPFIDITKYNLSQEDVKEWRV
NIGDYDPNLPKEEQFTSMGDVDYQTFLERLPKEKIQKLDGHYMNIRIDTKAEIEALLGKK
KGFLGKIKGLFS
>SEQF1602_01790 NADP-dependent malic enzyme
MKDNKKDALDYHEFPQPGKIAVVPTKKHASQYDLSLAYSPGVAEPCLAIEANKNDAYRYT
NKGNLVAVISNGTAVLGLGNIGADAAKPVMEGKGLLFKIFADIDVFDIEVDTTDVDAFVN
TVKAIAPTFGGINLEDIKSPEAFEIERRLKEELDIPVMHDDQHGTAIISAAALKNALEIV
GKDIHKVKIVVNGAGAAAISCTRLYIALGADPKNIVMCDSKGVIRKDNPSLDALKAEFAT
DRDLHTLEEAMKDSDVFIGLSKGNVVSPEMLLSMAKDPIVFAMANPTPEIAYDLAIQTRK
DIIMATGRSDTPNQVNNVLGFPFIFRGALDVRATKINEEMKIAAVHALADLAKKTVPDQV
NLVYGVNLTFGKEYIIPKPFDPRLIYEVPPAIAKAAIETGVAQKPITDWDAYREQLMDRL
GGSNREIRVLQERARQNPKRVVFPEADILEVLKAAQRVYQEGIAIPVLLGRKDVILGYME
ELGFEADLQIIDPKSDEETQRRHSFADIYWKKRQRKGITQINARRLMRERNYFGAMLVNT
GQADAMITGYSRSYPQVIRPILDLVEKEEGFSRIAATSILITKRGPLFLSDTTMNPNPSS
EDLISISLAVAEKAKMFGLEPAIALLSYSNFGSAPSESTQKLSKTVAYLHKNYPDLIVDG
EVQVDVALNPEKMAAAFPFSKLNGKPANVLIFPNLESANITYKIMKESEGISSIGPIILG
LSKPIHITLMNASVDEMVNLTTFAVVDAQERERRI
>SEQF1602_01791 27-O-demethylrifamycin SV methyltransferase
MNPPITDMAALGRQLRCPEGALAQEVADYIFASNEYMIRQTIDRLFLTSGERILEVGFGN
GGHLPYLFAQGDNLHYTGIERSEEMLLRAREQYMPLIEQGKAVFLKATEGAMPRLPEEAF
EVFFSVNTYYFIQDLRGYFERLYPMLTRGGRLALGYIDKDFGERMPFTKEVFTFYTNEQI
GQWLLEVGFSSFGITSYTEEIFSKNGRTVTRPFHIAMAIK
>SEQF1602_01792 Keratan-sulfate endo-1,4-beta-galactosidase
MRKVFIILSALNILVGCSRDQKEEPAVKEKDVWELVWEDDFNRDDIFSTGIWSKIWGCPT
STADWCKTMNHDPSLFEIKDGNLILLGKPRTDPAKHKTPYITGGVTTQGKKYFEKGRLEI
RCKLEATQGAWPSLWMVPDAPWPTGGEIDIVERLNYEPFVHHSLHSTYTQAGKKDKSKRT
PPSTATAPINPDDYNIYAVELDTDEVRFYVNGKQTFSYARVPGKESEGQFPFARPYMLRI
DMQLGGSWVGEVKPFTDPVRMYVDWVRFYQKK
>SEQF1602_01793 hypothetical protein
MHTDNFDILAQLIDRRLAQVKDEAARALLFFPIQILQRKKDIAGLPQNAHVIKLYQVKDS
QDLLKKRAEITRLCELFEARAMLNLNPKSYKEVAFGMLKKLSELLSQEAYPAVDKLLSSC
INSAGVGSKELKKYWIIDVDEVNEPAPVIATIQEQLTSTNPIGEEKLVSIVPSKSGVHLI
THPFDTNGVCFADIIEIKKDCLTNLLIC
>SEQF1602_01794 Glyoxal reductase
MKNIELNNGVQMPLLGYGVYQVDPKECERCVSDAISVGYRMIDTAQIYKNEEGVGNAIKK
SGIPRKEFFIVTKVWVSNAGYEKAKASIETSLRKLQTDYIDLLLVHQPFGDYYGSYRAME
EAYKEGKVRAIGVSNFYADRYLDLAYHCEIKPAVNQMETHVFYQQQDLQELMKKYDTKLM
SWGPFAEGKNDFFANPTLNAIGEKYHKSAAQVALRYLLQRDIICIPKSVRKERMEQNLNV
FNFNLPKDDMAKIEALDTKQTLFFSHRDPAFVEMILQYGR
>SEQF1602_01795 hypothetical protein
MAKNKKINVQGNEITIIENKGKEYISLTDMLKAKDGDFFISDWLRNRNTVEYLGIWESVY
NPDFNYGEFAIIKSQAGLNSYKISVKEWVEKTNAIGLRATTGRYGGTYAHPDIAFEFGMW
ISPQFKIFLIKEFQRLKEEENSRLKLEWNLQRTLAKVNYHIHTDAIKENLIPKEVTKKQM
QYIYADEADLLNIALFGITAKEWRDAHPNKEGNIRDEATLEQLVVLSNLESINALLIRQG
LSQADRLLELNKTAITQMKTLITHQVKLIR
>SEQF1602_01796 hypothetical protein
MKKVIKKILLTILVIFLLLTILPIAYFFIYGFFLGGDISEEKVNYLKANSIILPPECTIS
DTALFTEVNTPTVFMFGEIHGFSKTQLFDAQLLIYLNKKFGVTDYFNEFFTEDAELLNRY
LNAGTPDETLLKQHFNNLKENIPQRQTQEYLEKWKILYNYNQTLPKDQKIRVYGLLGKQE
AFKHNRDSVMMSNFDSTIIKQLDSVTDTKRNYYCSLGSGHIYQEKYNERKCFAALLKQKD
YTVISVMHRPFDSEMYLPKGLGMPTSPNEMISWANCDGPIFYFTNAENFKEASENPSIVL
YKLNSKDSPYAHCQDVVGFKSPISFLMGKITPEEDKYTTDYFQYVLVTRGWKGPKLP
>SEQF1602_01797 Tetrathionate response regulatory protein TtrR
MTTDKSIEEIAQEYIPHLKILEQAGSFAVFLLDRFGHYYYVTKYVEDIQASDELNIEKLV
HPDDLEVVRRIDKKVWEFLDTLREEEKLTYKYIYEMRVLDRGKYVRMIYQMRMLAFKDDN
FLGMGIIDLAPEQSANTSVRFQIKNCLTDEIVPFAIETATDTLLTPREREILALAKEGMF
SKEISEKLNISVHTVNRHRQNILEKLQVDNMIEAIR
>SEQF1602_01798 hypothetical protein
MKNQSRTIRNLCIFILVALSCGWVGVWVDSLTGETTGDFSDTNNGTTGMGIFIVAPLLTW
LLLRAFMGDGWSDAGLRPLIKKNLRWYGVATLIYPAVITLTLLIGELLGWLKVQIRWTDY
FAGFGIFVVAEFVKNFFEESSWRGYLTARLLSLHIKDVWLYLIVGVVWCSWHWPYFFYFV
KPEQLFAVFPYEKVTFCVVALVCCISWTVIYTELFRLTKSIWPGVWMHAVEDTTINSLIY
DKHILIEAGREILISPVSGMIPCLLYLGVGLWLRKIRIAREAQ
>SEQF1602_01799 Oxygen-insensitive NAD(P)H nitroreductase
MNFLEIAQKRYTTKTYRNEKISETKIKELAEILRLTPSSVNSQPWKFAIIGDEALKADLA
GHSFFNEQKIKEASHLVVFFAKDNVAEFEENFKQVAPQPILDFYAGMKAGDEKNAKTWFQ
KQVYISLGFFLAACGVEGIDATPMEGIDTAYYTEKLQVEGYKAVLAVAVGYHSEADGNHP
SKTPKKRLPLEEVVEIR
>SEQF1602_01800 Organic hydroperoxide resistance protein OhrA
MTALYTAVATATGAPNRKVTSDNGVLSLELRSPKALGGANDDYTNPEQLFAAGYAACFDT
ALNLVIKQTKVTTGVTTVTAHASIGKLDTGGFIFAVTLQVNVPGVSLEQAKELADKAHQV
CPYSNSTRGNIEVTTEVSNN
>SEQF1602_01801 Organic hydroperoxide resistance transcriptional regulator
MIEENLQLGAQVCFPLYAASRKITQQYAKYLTPLDLTYPQYLVLLVLWEEGSLTVNAIGE
RLYLDSGTLTPLLKRMEAKELLTRIRCKKDERIMWIALTEKGQQLQETVKDIPSRLKESI
ALSAQELETLRTLVYKILK
>SEQF1602_01802 hypothetical protein
MKKLVVLLTLIYSVAGVAQNKKELFVVTNHTQLGNTGETTGYFLSEVTHPLEVLTKELQK
SPLRFDASKYTTQQVTQGDQTLTVRAYEGIVYVANPVEEQYQQFNLYIPEAYFNGGTING
FNAQTAPIFLPNGVGGYMPAKPLSLTGGKFKDTNNSLIMALSKGFVVASPGARGRTSATG
KAPAVIVDLKAAVRYLKYNDKEIPGDANKIISNGTSAGGASSALLGASGDQAAYEPYLKE
LGAAPATDAIFAVSAYCPITNLENADKAYEWQFGNLSQYKTMEISMLDYNVQRTYKTGTF
TPEQSKVSADLRKDFPAYLNSLQLKDSKGKRLTLNAKGEGNFKELLKQTVIAAAEKAQKE
GTDLSQYSFLTLRNGKVTAINWEGYITYMERHKSPPAFDALDLSTGENQLFGDSTTDKKH
FTPYAFKNSIVESQMADAHIVKLMNPMSFIGKKNAHLPKYWRIRHGAKDSDTSAAISLIL
ATALQNHHYTVDYALPWDKPHSGDYDLEELFDWAEKISK
>SEQF1602_01803 hypothetical protein
MKTLNDYQIALDDVMEFIDNNLLQAKLSEVEADYKANSSLLSKVRLGIIYHEVALNLGFF
NKYYKGYAQKSLTILSECESAPEASEALQPFILSYKASAMALVAGETFKLSLIGKSFQLF
ETAIQKYGAIHYLPEFMRGSVAENLPWFYFRKRALAKIDFENIIRKQAQHPEYASWKIMS
FVYWAWAKQHPQRKYRSQALVYLQKAIELDPHYLAGRKRSEELMTKLAD
>SEQF1602_01804 hypothetical protein
MYDSLKRHFQQVLPFTEEELSAVDQYFTEHIFAKKAMLLEAPHPCKYLFFIVKGCVRHFH
TKDDGNEKTCDISLENQWTTAFMSFNSGCPSNLSLQALEETTVYRISKEDLISLYAEHHN
FETFGRLMAEQILQRATDTAMYLAADKPEERFEHLLHSRPELFLRVPQKYIANLLGISPE
SLSRLQKRMYSKKS
>SEQF1602_01805 hypothetical protein
MLFLLFPLLGMAQINSTELKTTTEYMVQSPYTFTQTIERLQKVLKSKNITIFATIDHKKA
AEAVGESLPPATVLIVGNPKVGTALMQENPLLAIELPLKILIYEDGKKVNIRYEKIAAIA
EKYHIKQNFSTAEKIDAAMLQLIKSSIGEYPRGTAD
>SEQF1602_01806 hypothetical protein
MNAIINTSAYREWLEALKTNIQQSQIKAAIQVNSELLHLYWRIGKDIVQKQEQTQWGDGF
LQTLSRDLQEAFPTMKGFSYRNLKYIRQWYLFYNQENIIGKQLVSQLEMTLFNIPWGHHI
MIIQRCKNISEALFYVNKTIENHWSRSVLEHQLGLNLYDREGKAITNFKQQLPAIQSDLA
QQLTKDPYIFDFLTLMKPYTEKELQSYLEENMTKFLLELGKGFCFYGKQVHIDVGGDDFY
IDLLFYNVRLHCYVVVELKSVKFKPEHVGQLKFYVTAVDKQMRTEADNPTIGLLICKDKN
DVVAEYTLSDVNSPIGISSYQLYEQLSEGYKSSLPSIKEIEEQLKD
>SEQF1602_01807 hypothetical protein
MKKKMIYILITLVLFLLGSGAYYIFHSTFFAKPMGKYAVGTVTYCVTDPDREEIFITDKH
QARQIPIQVWYPAENTAQPDYAPYIPEATKVSEAISELLHIPKALLYPLQFKRSNALEKA
PISKEKSQYPVLLYLTGLYGHRCISTFQIQELVSQGYIVVGIDCPMAVALATFPDGSTLK
SLPRTLIDPMLNESLTEENPLLSYNGKTFEGGLIAYFAKDVSRVIDFLTALNTNDPNNLL
YNKLNLDRLGAFGVSLGGVIVSEASWKDRRIKASLIMESPIPKKIAQTGLPVPTMVITRP
AEAMRAERKKSGGWTESDIEQHLSTMRALFENTAESEFVQLPDMFHVDFTDVPLWVPFPH
LLGFSGKTPIEQTHDKLNGLTLTFFKEYL
>SEQF1602_01808 hypothetical protein
MPHSQLLSDLFRKEYAKMVAVLCRHFGFSHLEIAEDIASDTFLKAYELWEMQPLPANPTA
WLYTVAKNKARDYEKHVAIFQNKVKKGLTPTEKSEELTFETSEINDSQLEMLFNICDPSI
SVESQISLALQILCGFTVEEIANALLTHTETIKKRLFRAKSKLREHHFQIKTVSPADIQA
RLETVLRCLYLFFNEGYFSETNNQFIRKEFCKEALRLTLLLAEHPQTDTPQVNALLSLMC
FQSSRLEARINTTGENTLYEQQDKSKWDKELIHRGNYYLVKACEDCQISKYHLEAGIAYW
HTTPTDENKWEYILRLYNQLIIIEYSSVIALNRTFAYGKVYGKEKAIVEAEKLGLQNNRY
YHELLGYLYTDINNQKAIAHYQKAITLSKSPNERATLQKQIEQLVE
>SEQF1602_01809 hypothetical protein
MKDFVLIFRLNNIADFKPTPEQMQERMNWLAGIASQNKLADKGNTLLPIAGSAKTIKADK
VVTDGPFTEIKEFISGYVVVKAENIDEAVEMAKANPIFEQVGGSIEVREVLKRD
>SEQF1602_01810 hypothetical protein
MAININPFLQFNGNCRAAFEFYKNAFGGDFTMISTAEENALPIAENEKNLLVYIELPIGD
IKLMGADMFPSMGDKLQLGNQNYVVINTTTQEEANKLFAVLSEGGTIETPIGEQYFGYYG
SFTDKFGIGWMFLC
>SEQF1602_01811 hypothetical protein
MFDFLTELAENNNKEWFDAHKAQYESAKLEATTLFKHIYSILTENDTLASLKIYRIHRDL
RFSNDKTPYKTHFGCYIQRKEPYYLGGYYVCISPQETFIGGGFFEPNKDQLLRIRQEISF
NAEKFRAIMKNEGIQKEFDGQLWGEEVKTVPKGFQKDDPMIDYLRKKQFLLKHDYSLEEA
TATNFTEKAIQGLLAMRPFFDFMTEALTTNLNGELILNN
>SEQF1602_01812 hypothetical protein
MAYSITLANRVREYLAEIPHITVEEKAMFGGLAFLVNDKMCINIGEDSLMCRFDPEQTEE
IAERQGFLPVVMRGKELSGYCYVDPTGYNQKKDFDFWLQLCLEFNSKAKSSKKKNKND
>SEQF1602_01813 hypothetical protein
MTKTKHFDFLLSIRKNLLTYLDNLTPEQLGYIPIGFSNNIFWNIAHCIAVQQFLCYQLSG
NKLLISNDFLEKYNRGTFPQKIAPSKEEIYQVKELLLSTVNQLQEDYQGRPFNEFPTVKV
GLFSIDTIEDAMYVNNMHESRHLGTIVALNYFSSKI
>SEQF1602_01814 hypothetical protein
MPFDDKTLVFSVKGKMFCATDINTYEFVNLKCDPDKAIQLREQYNEVIEGYYMNKKHWNS
VKTKGEITDKQFQEWIKDSYDLVVLALPKKIQKELNDE
>SEQF1602_01815 hypothetical protein
MKITKLTPNFEVTDVKKSVAYYEKNFGFKLIMTVPATQDGIEQSFTEGKEYVYAMMQKDN
VEIFFQRTDTFKEDVVFATGLPIGASVSFYMDIEGIDEFHQQMKAKKLEITELKTTWYGM
KEFYLKDINGYILGFAEKAEQ
>SEQF1602_01816 hypothetical protein
MKYREIKPIGFLTNFIQSFWEYETFSTEFEHTIIPDGYFDLIVEFENNSFKQIKLTGVWI
MPINVVIPKSTKLFGIRFKLLAAEYIFQREIKSILNTNIILHDTFWNISSYQTNDFEIFV
SEISNYLENSIKHFKEIDNRKLKLFELVYQRQNLSVEELSKSVFWSSRQINRYFNQMFGF
SLKLFLNIVRCNTSYKDISKGILYPSENYFDQAHFIKEIKKYTEKTPRELSKNENVRFLQ
LATKRNE
>SEQF1602_01817 hypothetical protein
MTHNLFQNIYKHPLIGAQELQQIQKAHQPIAFRKGDFILRKNEIARGYLILQRGVARAFV
YDYEGNDITTDFFCEGEIIVQELSLFKHLPSAENIQALTDCEGWHIDYEDFQKLYHSLKG
YSEWGRLFMTEKLFEAKRRSLEMITLPAKERYIQFIKKKPSAIKCAPLKHIATYLGITDT
SLSRIRKEVC
>SEQF1602_01818 hypothetical protein
MRVVITTLVILIVTPSLYLAYSLLKEKEFNENVAHYITAEFENNGYTIIYKKIHYNTNPK
SIELAFLDKKFSDEELKTLQSDLKNFKLLNTKLIVRQKESEIDKEILSEINKNKSSLSSK
DVMIKNLTDELEKYKPTDATFAKEMQVLFPSIDDFYFGKLNLLSNKDSLQTATVLLYTLK
KDTIKGKEVTKEIDAARLQQWLAEKFGDKKVICRVAD
>SEQF1602_01819 hypothetical protein
MSFLKKLLNLHQGEEKKEKVIEDILSNISFRGAKLWILACAILIASIGLNVNSTAVIIGA
MLISPLMGPIVGAGFALATYDFDLLKKTGRSLLIATVVSLIVSFIYFYISPFKDVQSELL
ARTSPTIYDVFIAFVGGLVGAISLTRQDKGNPIPGVAIATALMPPLCTAGFGLATGNTSF
F
>SEQF1602_01820 hypothetical protein
MPTLTDIEICSCKKIDNLIATLAQKNNLEKLTLWNQGNLDSIIPLSKLEYLTTLNIWEQT
KIIDGKISFLEEMPNLKKIDIRKYTHYH
>SEQF1602_01821 hypothetical protein
MQIKYFPVNSKNSYVVFENNDKIEELEPFMKENKLSRVIFSGFLGYSKSVLPFNEDIDVI
EEISIQCSNITDFTPLYHLSNIKKISIEENVALAHPFDIRKIAKLTDFFTDDTLKIDGFF
DHPTLKQLHIEPKKTKN
>SEQF1602_01822 hypothetical protein
MDKEKAIMEVLYSKYGSILEKYGYKPNKAQNKYSIKTKNNLSEVSFLFSKRSDILHLVYS
YTDLKAGKLHIDIENQIRMEEGENALKLLRPTFTITDWKDIFTLYGYDYHKMPGWFTLIE
SIDHLEEETKNTFPQALEIIIDLDEKFKTLDGILDVLWKKNNINEYMNVYDAINILVINK
LKSEENLLESYQNIISCSQYKNLSDNAQREITKYFNTLKNS
>SEQF1602_01823 hypothetical protein
MTLETIITHYRNCLAASPDAILIGEIPEGAENISPEVLQLIAPAHCAFLKLCNGGSFGDI
ILWSTEELPDNQYRVPAEQPSWYEIGQLLYEPLFLDKHTQLVIFPADSYEGIEEIDVDFD
TFVSEYILGSKYKEKIIGYANADDDWSVFLNNSSIC
>SEQF1602_01824 hypothetical protein
MKQYKIKDFTQHTDDPTSYDGMVVINGEELRVDIILEDEGETEKIEQQMNSFFSEINTLL
PKAKECIAEKYLDLYNDNWRFGDDDDDDPNKPELTKEEFMESLSLQSLLFYSEDIEVFFD
DKDMFLGHSLIASEFDGMNFNDAQMFG
>SEQF1602_01825 hypothetical protein
MSIITDFTNRRMYFWRGYYFGKEGIWCQDFDKEKAFCVLKDSLYKDYLVRAVADNGKTIA
VSRDINTNEPLLMVDVDKKTITNTIYNHTFIYPSLDREGSKVFSVTKSDIYKNIYGNPFC
VDAETGKVIATLDEKTQWGNTAYHPASNSVYFSAFRQPNLYKFNFDTLTFSAIPTDKKIR
IFDCKVACNNKGYYYLGSNILVYMNNEDKEVWRINFKEKEKLSGKTLFSICLSDHPDYIG
VYLIDGEWLFIINRNDFSYKKYKLGRRVGFSQFLNNSLLLIDKNYNLSTLNLETLEEKPF
LPTTSARCEPHGQNRD
>SEQF1602_01826 hypothetical protein
MKKILFLLKLTLLLCSFTGLAQPKYFIFEEKGKLGLVDLQGKTVLAPTFNSIEEKQPYFF
ACSKAKGCSVYNENLQPILKGDYNSIELGCEGQFIVEKNGKYGVVSEKGTIILPLKYSFI
NSNKNGYTVKLNQKAGLFNSEGKEIIPISYHWVYTDKIDDNIPIVAELNESKAGYINTKN
EWVIPPTYQYAFAFRQGVARVKKGRNYMYINLKGEPVIQDFDNYVIQNFDNYVIQNFDNY
VIEPSDNTYIVGVRKECKYMVYDLNGNLLDTYDGFINNWSGNAIFGVKKGSKWGYIDGYG
KVIVPFEYEEVNNFSEGLASVRKDGKWGYINPKNEIVIPIEFTNKEVGSFKNGGAEYYTD
RGAGLINLKGEIIAEPKYDSIEYVNGNIAIVSFDGYNYLYDFVKEKKLKRLRKVKIHKGF
IAVEPRCD
>SEQF1602_01827 hypothetical protein
MKKIYTIGHSTHTLEEFIKILQSFEIQHLVDVRGLPGSNKYPQFNKENLEVVLPQVGIAY
THLPLLGGRRRVHKDSKNTRWHNVSFRAYADYMETPDFEKGIAELVAIAERETTAYMCAE
ALWWRCHRSMISDYLKAKGWQVDHIMAIGKDEPHKYTAPARIMGDKVVYYDEGAILGL
>SEQF1602_01828 Sodium/glutamate symporter
MNTIIVNPYYTLIAATLVLLIGRLLVGKIKLLQNFNIPEPVAGGLLMAFLIYMLYIGTGL
SFENGIHMGQGLSLDFDKSLQDTFMLIFFSSIGLSADFSRLKSGGVGLFIFLGVVALFIV
IQNLVGVSLATAFGLKPIIGLMTGSITLTGGHGTAGAWGKVLEQKYSIEGATALGMAAAT
FGLVLGGLIGGPVSRRLVNKMGRKPLTESGEESSEAEVGVFEHPEKQRLITAKSAIETMA
LFAACLSFSALMDTDFVKSFFPEKFTLPQFIWALLFGVVLRNVLTSAFKINMFDRAIDVF
GNASLSLFLGIALLNLKLWQIMDLALPMLVILAVQTFVMSTYAYFVTYRLMGKDYDAAVL
AGGHCGFGLGATPTAVANMQSITEKFGPSHKAFLIVPMVGAFFVDFVNAFILTGFVYIFG
>SEQF1602_01830 Ribose-phosphate pyrophosphokinase
MEYSMPAVKIFACTQSTELASKIAQEYGIELGKIIFSHFSDGEFQPSFEESVRGTRVFLI
GSTQPSSENLMEMLLMIDAAKRASAKHITAVIPYFGWARQDRKDKPRVPIAAKLVANLLE
TAGATRVITMDLHADQIQGFFEIPVDHLYASTIFLPYIKSLNLENLCMASPDMGGSKRAH
SYAKFLNSDVVICYKQRKKANVIEKMDLIGEVEGKHVILVDDMVDTAGTLTKASEIMMEK
GALSVRAVCTHAILSGNAIERIENSPMEEIIVTDSIPHNLEGTKKIHVLSCAKLFADVMH
SVHQHVSISDKFIM
>SEQF1602_01831 50S ribosomal protein L25
MQSITIVGSQRESVGKAASKALRNAGKVPCVLYGGNSTIHFSADALAFKKLIYTPNVYTA
TIELGGKTYNAILQDIQFDPVTDNIIHVDFYELHKDKEITLAVPIQIVGTAPGVMAGGTL
RIVNRKLKVKALPENLPDFVPVDISWMEMGNRLYITKIAQEKYKIMHPDNTVVCQVRVSR
AALKAAQEAAKADGKKKK
>SEQF1602_01832 hypothetical protein
MKKLFLLLIFLTFVFNLQAQQTDWKKYDLKGKVKQVKATTTSYSGGCEKAKKYVEWTCIT
EFDSQGNVVKNTWYIWRNKLSQEHFYSYQGEEVTLTICLYKQDKITDTKTYHYKRGEEER
VEKEIERTEQSNNIPYTAQVRTFTSSYKNGILRSSPATTYKYDDQGNWIHKKNTTNPHCV
RHNTRSIVYY
>SEQF1602_01833 hypothetical protein
MRTIQFNKNITFEQYQMAVRVLEAIGLEVKKEELSAEIIEGIEQGWKELHEGKGISSEEV
HKKARLLCTKK
>SEQF1602_01834 hypothetical protein
MYKKVIWSPRAQEEYISTLEYWIEHNDSSTYSNKIIDEVERIEQRILDFPIAHPIVYQTP
EKEIRRVLILHNFSLFYQIFTDRIEIVFFFDNRNDPKKLIL
>SEQF1602_01835 hypothetical protein
MNIQEQNVPQSYRDLFATIPEKSNFFYEYARRKKPTLPKRVYVIQGFFSLTRETDDNGEK
LIPTYRLLAQKDFFYKSIEGNSIDKLPSVEVLKTAFAFGVSDGGILFFHPENHSVWVIYD
DLYTELVADTFDEFLEKATFQRQWDFK
>SEQF1602_01836 hypothetical protein
MQKVPTYLSENASNIKSGDYLSVDIQSKNGNTLFEVYYYGDLFEVKRKKLPCIVDNKTGI
PCKIVAKDTETGEEILLFDGYRHGYNAMFCDEFDPEEVEKRTLVKYNITPCKIHIDFGYS
IDYEEEKEDYEVDEEDRVTLINGENIPWEEVKRNGFDYISIVCETENGEKAEIVSLELA
>SEQF1602_01837 Leucine--tRNA ligase
MTYNHKEIEAFWQEYWAEHQTFKAQNDSTKPKYYVLDMFPYPSGAGLHVGHPLGYIASDI
VARYKRHKGFNVLHPQGYDSFGLPAEQYAIQTGQHPAVTTAQNIARYREQLDKIGFSFDW
SREVKTSDPDYYRHTQWIFIQLFNSWYNNATDKAEPIETLIALFETEGNSKVNADCDDDT
PTFTAAQWHAMTAESKQRHLLKYRLTYLAETEVNWCPALGTVLANDEIVNGVSERGGHPV
IRKKMTQWSMRITAYAERLLQGLDTIDWSESIKESQRNWIGKSVGASIDFVLASGEHKVE
VFTTRPDTLFGAIYLTLAPEHPLVLQITTEEQRAEVEAYIAATAKRSERDRMADTKTVSG
AFTGAYALHPLTGKQIPIWIGDYVLASYGTGAVMAVPAGDDRDYAFAKHFKGAKGMPEVI
NIFDKDISENAFTDKEGMTYQNSDILNGCTNFSEAVAKVLAALEAKGAGKAKVNYRLRDA
VFSRQRYWGEPFPVYYKNGLPQMIGEEHLPILLPEVEKYLPTEEGNPPLGNATAWAWDTA
NHKVVSNELIDNQTVFPLELNTMPGWAGSSWYWLEYMMEKDARADFPTKAVVDYWQNVDL
YVGGSEHATGHLLYSRFWNKFLKDRGFAPTEEPFKKLINQGMILGMSAFAYRLEGTNTFV
SKNQIKGQSVQPIHVDVSLLKDTSDELDIEKFKAWRKEFANAEFILEEDGKYITGREVEK
MSKSKYNVVNPDDICEQYGADTLRLYEMFLGPLEQAKPWNTAGISGVYNFLRKLWRLYFN
DNGWQVTDEAPTPEMLKALHKTIKKVNEDIENFSFNTSVSQFMICVNELSSLKCHHRDVL
APLAVLVAPFAPHIAEELWKRLGNTESVTYAPYPVHEDKYLQEDSKEYPVSFNGKVRFKR
AYATSMSVAEIEQAILADPQTAEQLQGNTPKKVIVVPNRIINIVS
>SEQF1602_01838 hypothetical protein
MNTSMILLIVPILIVIFVLYTFINRKGDFEKRLTYHTPRLLSSQRQEYINGAERYTKKAS
IIIGLFVSFPLMIMFVSLLSQDVSNSLIIFLFIIFIILIECLCAYLMYRFLMKNIKKQRL
LLEQMSDSDFELLLDIQKNTYLFKYFPPFILCKDRLYFFSFVIKEIDPASIKKVSFSYAK
GQNMIVHIKSATSTTISLYRNIYPILVEIIKRYSPDAQIES
>SEQF1602_01839 hypothetical protein
MDSLSFTYFLPLLLFELLFFYLIVVRKNAFEKRLALFSPTRQLSQKRQAYMQKVHNYHKY
FNAILLIIFYLPLCFFITLIIKEKYEETGKLVIPISNNMIMILLVLFLAHYLIIYLKKRK
EKALRMFLEQMSDDDFELLLRVKDSLSFTSKYSPPFVLCNHQLYVFSFFTIKEIDPAKVT
EVNWSRGKDSIFVQLKAPQRITLGLPRGGFSYFLQIIEQYSKLKL
>SEQF1602_01840 hypothetical protein
MIWFVPLFLFLFALFYFVVMRKNDFEKRLAIFYPYRQLPQKREAYMQKVSKYNNIMFALF
LLPFFILVYALFKENYQEISEANTSFSDENLMLILATLLPLFVCYYIIFYMQKRSRKAKR
MLLEQMSDTDFELLLKLRDNLSFPYKYDPPFVLCNNHLYIFLFHTIKEIDPTQITSVKWY
SNRHRFIVRIKDPKAKVTVLSISKSALDIFLQIVEQYTKLNLLTDQKNK
>SEQF1602_01841 hypothetical protein
MDSLYIICFAPLFLFSLVFLYFTVVRKNAFEERLALFSPTRHLSQKREAYRQQVRKYSKY
AHIILLVILYLPLCVFIAILLKEEYEKTGILNILSIYDDTKMTLLSVYVPILLLHYLLFY
VIKRNEKAQHMLLEQMSDDDFELLLKAKDSLSFTSKYNPPFVLCNDKLYIFIFFAIKEID
PTQITDLDWSYRRNGIFIEFKAPEKIIFTLPKKVLPHFLQIIQQYTNQEF
>SEQF1602_01842 hypothetical protein
MNNTIIIPFSKKKMVKLLGLYILVMLGIAAIIFFILSADSINLFYLMLFIVLFIAGTYLF
YKHIQELWRSNKKNEGVILTPDYLKSNATPLGKRVGEIPWSEIASIGKVNYYGQHIHIKL
KHPEKYVNQLKGMRKDFTGIYLNDSELEISFEELEKLIHEYFQKYR
>SEQF1602_01843 hypothetical protein
MNPDILILIVSSLPYLSMGVLLYFVAVRKNAFEERVAHYIPYHALERERSTYMEKVEKYK
RYICIGLGIFLSVFIVLPFVIFFVAISKEGVNFSVPEQLTLLMIPLSLFLMIYYLLSYVV
KRHAKAQHLLLEEMSKEDFAYLLKVQKDLLWLRKYFPFFILCKEKVYFFTFFTLRELDPK
QIKKIRFWNSRRGNRTILIKSSRWFITTMTEIVYPYLRDIVQKYNPTVDIE
>SEQF1602_01844 hypothetical protein
MIESIFVAISLGVMLAFTIGPVFFILIETSITKGIRSALAFDFGAISGDIFFILLAYWGT
SKLSDYIKNNPNLFVYGGILIIIYGLFSFFKERKDYRLHPPQTRIVEIKEGNYFTFFYKG
FFLNIINVGVFFYWVATIATFSSSAGTTTTKVLVFLGTILLTYLLTDIVKILIAKRLRHK
LTPTNIHKIKQGIHIFLVIFGIFLLLNGVFPNALAAVKEAFL
>SEQF1602_01845 hypothetical protein
MNKIILGVALMLSLASCQQGQKIAFVDNSKLLDDYQEKKDLEALLKGKIDKYQHKRDSIS
QAFQVKAQAFEAQAKTLAPAVAQQKYSELAHESQLLQQQLMAEEQAIQEESRTKMDTLLK
KVKNFIKEYGKQHSYDFILGANDGGSVHYGKADKDITADIVKALNEKK
>SEQF1602_01846 Ubiquinone biosynthesis O-methyltransferase
MNIIDYSVSKEEFFLEYDPVYKLYRTTPVPQELGRYYQSDAYISHTDGKKGLFEKLYQWV
KTYTLQQKIKLIERYVPQGKLLDIGAGTGDFLRVAAQRGWSVSGVEPEKKARDRAEEKGI
LLKEDKTHITDTYQVITLWHVLEHVPNLQEQIAFLKDHLTKGGLLVIAVPNYRSRDAQHY
GKYWAAYDVPRHLWHFSQESIRLLFTEKGFQLIGVKPMPFDAFYVSLLSEKYKTGSMNFL
KGGYQGLLSNLSALKTGEYSSLIYLLKLHE
>SEQF1602_01847 DNA-3-methyladenine glycosylase 1
MSEKIRCTWCKDDSLYIAYHDMEWGRLITKDTLLFEFLILESFQAGLSWITILRKREAFR
EAFDNFLIEQIANYSQEKISALLTNEKIVRNRLKIQAAVTNAQAFIRIQKEFGSFVSYLN
TFIPTPIDNHPESLSDIPTHSFLSDSLSKDLKKRGFKFVGTTIVYSFLQATGYINDHVSN
CWVRKELNVPRETN
>SEQF1602_01848 tRNA threonylcarbamoyladenosine biosynthesis protein TsaB
MPTILSIETSGKNCSIALFTDHHLVQLIEERTEQFSHSEHLHVFIEHILEETHTQPKDIK
AVAISMGPGSYTGLRIGTATAKGLCYGWGIPLIALPTLRILAEQVTYEFADIEYIIPMID
ARRMEVFTAVYNRDFSPILKERSEILTESTFDTYLNKGKTIFLGDGITKFQAICKHENAY
FLENKFPSAKQMGRLALEKYQAQAFEDIAYFEPFYLKEFYFNK
>SEQF1602_01849 Beta-glucosidase BoGH3B
MKAKNILLPLSFLVGLSTLAQEADIKYVTNKKGATLGYSTTSGVKILTIGGKSFKDLNKN
GKLDKYEDWRLPVDERAKDLAKQMSIEEIAGLMLYSNHQALPAPPDGYRKSTYGGKPFAE
SGAKPSDLTDQQKTFLDRDHVRHVLITTVSSPKDAAIWSNNLQRTSESLPLGIPVNISSD
PRHTTLVTAEYNAGAGGNISLWPDGLAMSATFDPSIVQKFGEIAAKEYRAMGITTALSPQ
IDLGTEPRWNRMVFTFGESPELTTDMARAYVDGFQTSTGKAEIKDGWGYESVNAMSKHFP
GGGAGEGGRDAHFAYGKYAVYPGKNFEMHQKPFVEGAFKLHEKTKSASAVMPYYTISYNQ
DTKNHENVGNGFSKYIVTDLLRNKYGFDGVVCTDWLIIAKEPGTPGGFAGKPWGVEDLDL
PQLHYKALEAGVDQFGGNNMVAPVVEAYKIGVKEHGEAYMRKRLEQSAVRLLRNIFRLGL
FENPYLNPEESAKIVGNPQFMKAGYDAQLKSIIMLKNKGQVLPIDKKKTVYIPKVYNEPQ
RNWWGVYTEGNISYPVNIENVKKYFNVMDDPNKADLAIVFVKSPTQNHPGYNDELFKAGE
NGYIPISLQYNTYTAEYAREHSIAAGDKVIAPQVTDRSYKGKTANASNITDLYNILETKE
KMKGKPVIVSITASRPMVFHEFEPMVEGILLNFGTSEQALLEILSGKVEPSGLLPTQMPA
NMKTVEQQFEDVPFDMQCHKDTEGNVYDFGFGLNWKGVIKDARTAKYIKHRK
>SEQF1602_01850 hypothetical protein
MERNYFLLLSVLLGVSMFAQEKDSLEMKKKLPDTEENRNVMLNASSNSGPREVNIGLPSS
VGGITVLENDLPVVYHFWPELPIRTWRPSQSLDMKGLISVSESTLTIADFGYAVNSYTKT
GGEKTQLVGTLKGNHHGYYLGDVNLNGRFGQSNWYYALGALVTGDPGEAKHKGSRLIDDT
QIFRGVLTYRFGEKDEINLAYKYSRSKMIGHYAPFIYHTNGVVKEYDGIGIGTDSYMITD
GYLNFKNVLTGEPYRADFTGSDSKLWSSSHTFDLFGKHDLGNDWLLRHSTRFHVAKSSAL
LPLLIGAEKRGNNSYTYLDGTPYTGEYVQRMLAILSPQTPTTTLMTRLWAEKRTERHNWR
LGVLGQYYNVDAYHQDRSFLFHSVEKQPRILRKSSTTDPFFNYNIGGEYHNGYETKITAY
VSDSWNVAHWLDFSYGANFQYQKLEGDYSLQPRGADVVLNQPFTTFNHDWYHFNGDLRAV
VKLNDQFGFLANFTYQEKHGYLEDYSGAYTPDFAKTKTPFLAAGIYYNNKWLSLVSQVST
LTRNNYKTRLSISDPVTRRPEVVSAHYDIQTKGWTTDMLLKPFPNFQLHYLLTLQNPEYS
NYSWVNPFNTAETISYNGNVVTGISKMLMEIDPSYTIKKFRFGLNLRYFSKQYVSLTNQF
FIEPRWESFFSSSYEINKYLNFGFNVVNIFNQTGASTSIADSEFPYANINDADGRLVTGS
YIRPLTFEFQLNFKF
>SEQF1602_01851 hypothetical protein
MKRKLFFLIAFLVGITMYGQTVYEPSGKRSVKTVEVGHYKNIFIDESHFDITLRNSRDRQ
IQIEADDAIHPIIKARVEKDTLKLNIETEGGVVFITTGKINISLPVPEEVQKIHFKMAGN
ISCEKELKLKKAAIEMEYVSNLNLPLRVDDLQLKIELARKGSVSLQSKNCTLYSLGVKDI
AFSGKVGNLEIEGCDGDLNFENVRVENVFFKEVSGIGTMRLWVEDTLKGSISGILTVQYK
GNAANEVTVSGISKVVKQ
>SEQF1602_01852 hypothetical protein
MKKVILAVSVLILSACNLGSTIANTTEEVANKTATKAGEILGGSTRSFADGVGEGLDKAG
NSSIKLSENLSKKGIKLGGHKIETLSGNDNKISIYFIFEEDFTGTITVKAFDKQMQEVGR
VKQELSGKKDDAGYIDFVFDERTNIDPKYTITIE
>SEQF1602_01853 Ribonuclease R
MSRKKIKQKKKKNKDFSRDILVILQKNSNKSFTWKQIAEKLKATSTEMRNDIIASLTKLV
KQSHIQETTQGNYQAQESTYYHKGVVDMASNGNAYVVCEDLEQDVFVPNNLLNKALHGDV
VEVYVFPRRREKLEGEITQIIERKRTTFVGVVQMQKNFAFVVPTDRRMYTDIFVPKTDCN
GAEDGDKVLVRITQWTSRANSPYGVIEKILGKPGEHDTEIHAILAEYGLPHEFPKEVEEY
AQGLDTSIKEEEIAKRRDMREVLTFTIDPRDAKDFDDALSFQVLENGNFEIGVHIADVSH
YVQPNTILDDEAYQRATSVYLVDRVVPMLPEVLSNFACSLRPEEEKYTFSAIFELSPKAE
IRNTWLGRTVIRSDARFAYEEAQAVIEAFDTPYMEVLTDFVMPQEISIRPEGSYTVSKEI
VEAILSLNALAEILREKRMRAGAISFDKVEVKFLLDENNNPLGVYTKESKEANKLIEEFM
LLANRKVAEYASKLQKTFVYRIHDVPDEEKLLQMQGIISRFGYRLNLKDKKNISHSINHL
LEEVHGKKEQNLVDTLAIRSMSKAAYSTHNIGHYGLAFDDYTHFTSPIRRYPDVMVHRLL
QRYLDKEASANEAEYEEKCKHSSQMENLATSAERDSIKYMQIKYMEDHKDQEFLGVISGV
TEFGIYVEIIENKCEGMIRARDIKDDYYVFDEKAYALIGEVSKKHYTLGDEVWIRVKNTD
LIKRHLDFELVK
>SEQF1602_01854 hypothetical protein
MKISNRKIIIALCTLIPFVFLSCAKIYHRDLCKGFINEKSFVLGESTIKDIQKRFDAYKD
LEIFPNNDSLYTTKVEEKDGFIKILSQKRFLF
>SEQF1602_01855 hypothetical protein
MKRIFVMAVAMVSLASCDKSKVENTVINKYYDKINTDTNTRQATLTLKDYLLTAGYDRNN
DGIMQDSELAQIETLMAADKNITSLEGLEKMLTLKKADLSNNKIETATIRNSTLEELNLS
GNKLVKLDISRAPRLTDKLDIRGNTNLNCVQVEIVQLTELRRASNFKTDKGISILSTTCN
>SEQF1602_01856 hypothetical protein
MSIGHKKIASCEAIPFLTNKFQYYETVQRYDFSLNTLYF
>SEQF1602_01857 Miniconductance mechanosensitive channel MscM
MNIRLLLLLSNFFSVAALFGQAQDSLLQLLQRQVRELKVQRSQDSLKVNVLSQELQALLL
LDTKHVDTSKDSLYKKQRQEEIKRIYSKANGAPVCLEKDTLYTVYTSLGLNSPLERSEYT
EKKLQKLVKFPTFKQDSLKIQSHDNLLMITYQGEWIQAVSEEDAIMAHLSQEELAKSLQR
DILRAVTHYRDEHSMQKKLMRIGELVLLVIAIATFFCLLNFLFRKLEKQILKKRLFENGI
KVKNYQILNKEKINYILTRILFLVKLIIFFIVIFLSISVALKLFPSTQLWAERLLNLILD
PLSQVGNAIVNYLPNLVIIGIIALIARLVLNLMRYFLYEIERGALKIKGFYKEWAKPTYK
MVRILFLCFIFIVIFPYLPGSGSSAFQGVSIFLGLLISLGSSSTISNGMAGIFITYMRAF
RENDWIKVGDYIGMVIHKDSLVTRLKTINNEEVTVPNSMILSSSTMNFSSMGRTNGLVVT
TQVKVRYDARLEEVDATLIAAAQATKGVTDKITPYIYHISLNELNATYEINAVTFEPQNM
YIIKSDLIKNIYNAFRERNIELTSIEYVELRKYEKL
>SEQF1602_01858 hypothetical protein
MKNYSILLFFLLFSCGENNPNTNSVTMEEQINSSIDTTLLVKNFRSQLLPDKELSLDHYY
NDVVLIKKITPTTLTVEKNGKETSFPVKAESMTYMDLDYSEGKYVVIRWKIIIDNGKITE
VLENIGKFNRSSNLRRDQVLEIGKIYKDTVVFLENITDYDYFFFLVSKEKDTVGIIYYDE
EIPFRKGDTIALQWKMDTVYIAGEGDILSFEEWYVSGKKIGHKTKK
>SEQF1602_01859 3-oxoacyl-[acyl-carrier-protein] synthase 2
MAYIHSYNCVTPLGITVRENVEALLQGQVGIQFYPHYENFSDIYLSKISMDTIEDSFPYI
SATEQLSFLEKMLLLAVVPLLPTIRITENTAFILSTTKGNISQLNSQMDREHLPYLTRLA
KSIAGLLGIRSEPIVVSNACVSGVMALSVADRLLESGQYDNALVVAADEISSFVLSGFQS
FQAVSPKPCRPYDKARDGITLGEAAAAAFLSMESVGASAQILGSSSINDANHISGPSRTG
EGLYLSVCKALAQAGITPEQLQLINAHGTGTLYNDEMEAIAFSRAGLLGVPINSYKGYFG
HTLGASGLLETLLTIALSKRRKLLQSKGYTTLGVSQPIHVIEQTQEAVVTHFLKTASGFG
GSNTAMVVRIKK
>SEQF1602_01860 30S ribosomal protein S12
MPTISQLVRKGRAKIAKKSKSAALDSCPQRRGVCTRVYTTTPKKPNSAMRKVARVRLTNG
NEVNAYIPGEGHNLQEHSIVLVRGGRVKDLPGVRYHIVRGALDTAGVNGRTQRRSKYGAK
RPKPGQAAAAPAKGKKK
>SEQF1602_01861 30S ribosomal protein S7
MRKRQAKKRPLLPDAKYNDQLVTRFVNNLMWDGKKSVAFKIFYDAIDIVEQKKNNEEKTA
LEVWKDALSNVMPHVEVRSRRVGGATFQIPMQIRPDRKVSMAMKWLIGYARKRNEKSMAQ
KLAGEILSAAKEEGAAVKKKMDTHKMAEANKAFSHFRF
>SEQF1602_01862 Elongation factor G
MSRDLKYTRNIGIAAHIDAGKTTTTERILFYTGKTHKIGEVHDGASTMDWMEQEAERGIT
IQSAATTCKWNFPTENGKPTADAKEYHFNIIDTPGHVDFTVEVNRSLRVLDGLVFLFSAV
DGVEPQSETNWRLADNYKVPRMGFVNKMDRQGSDFLKVCQQVKDMLKSNAVPIVLPIGEE
ADFKGVVDLIKNRAIIWHEETQGATFDIVDIPEDMKADVAKYRAQLIEEVAGYDEGLLEK
FMEDENSITEEEVHKALRAAVMDMAIIPMTCGSSFKNKGVQFMLDAVCRYLPSPLDKEAI
EGTNPETGEPALRKPSVDAPFAALAFKIATDPYVGRLAFFRAYSGHLDAGSYVLNTRSES
KERISRIYQMHANKQNPIEYIEAGDIGAAVGFKDIKTGDTLCDEKYPIVLESMVFPDPVI
GIAVEPKTKADVDKLGMALAKLAEEDPTFQVKTDQASGQTIISGMGELHLDIIVDRLKRE
FKVEVNQGEPQVEYKEAITGKADHREVYKKQTGGRGKFADIVFTMEPAEEGKTGLEFINE
IKGGNIPKEYIPSIEKGFKEAMKNGPLAGFEMDAMKITLKDGSFHPVDSDSLSFELAAKL
GYKEAARAAKAVLMEPIMKLEVITPEENMGDIVGDLNRRRGQVNDMGDRNGAKVIKANVP
LSEMFGYVTTLRTLSSGRATSTMEFSHYAETPSNISEEVIKKARGN
>SEQF1602_01863 30S ribosomal protein S10
MSQKIRIKLKSYDHNLVDKSAEKIVKTVKSTGAGVVGPIPLPTHKKLFTVLRSPHVNKKA
REQFQLSSYKRLLDIYSSSPKTIDALMKLELPSGVEVEIKV
>SEQF1602_01864 50S ribosomal protein L3
MSGLIGKKVGMTSIFDENGKNIPCTIIEAGPCVVTQVRTKEVDGYEALQLGFDDKKEKHT
SKAAAGHFAKAGVTPKKKLVEFQGFESTYKLGDTITAEFFVEGEFVDVTGTSKGKGFQGV
VRRHGFGGVGQSTHGQHNRLRAPGSVGASSYPSRVFKGMRMAGRMGAEKVTVQNLKVLKV
IPEKNLIILKGCVPGHKNAYVTIHK
>SEQF1602_01865 50S ribosomal protein L4
MEVAVVNIQGKETGRKVTLSEAVFGIEPNNHTIYLDIKQYLANQRQGTHKSKERNEVAGS
TRKIKKQKGTGTARAGSVKSPVFVGGGRIFGPRPKDYTQKLNKKVKRLARRSILSQKAQQ
GAIIVLEDFSLETPKTKDFTKILAALGIQDKKSLFVLADTNKNVYLSSRNIPSVNTVTAS
ELNTYDIANAKTVVLLESSVEVIQSNLTK
>SEQF1602_01866 50S ribosomal protein L23
MSILIKPIITEKATNDSEVNNRYTFSVDKKANKIQIKKAVEEAYGVTVEKVRTLNYAPKR
SVRYTKNGLQLSQTNAVKKAVVTVKEGEIIDFYNTI
>SEQF1602_01867 50S ribosomal protein L2
MSVRKLKPTTPGQRFRVVNNYDAITTDKPEKSLLVPLKKTGGRNNQGKMTMRYIGGGHKK
KYRIIDFKRNKFGVEATVVSIEYDPNRTAFIALVQYTDGEKRYIIAPAGLKVGQVIISGD
NVAPEVGNAMPLAQIPLGTVISNIELRPGQGANMARSAGTFAQLMAKEGKYATVKLPSGE
TRMILLTCLATIGAVSNSDHQLVLSGKAGRSRWLGRRPRTRAVVMNPVDHPMGGGEGRAS
GGHPRSRKGIPAKGYRTRSKTKASNKYIVERRKK
>SEQF1602_01868 30S ribosomal protein S19
MARSLKKGPYVHYALEKKVLQNKETGKKTIIKTWSRASMITPDFVGETIAVHNGKQFVPV
YVTENMVGHKLGEFAPTRSFRGHAGAKNKGKK
>SEQF1602_01869 50S ribosomal protein L22
MGVRKREKAIEIKEAKRSVAFAKLNNCPTSPRKMRLVADLVRGISVEKALAILKFNQKEA
ATSLHKLLLSAIENWKVKNEGADIEAAQVFIKEIRVDGGAMLKRLRPAPQGRAHRIRKRS
NHVTIVLGAKNNTES
>SEQF1602_01870 30S ribosomal protein S3
MGQKTNPIGNRLGIIRGWESNWYGGNDYGDKLAEDDKIRKYVHTRLAKASVSRVIIERTL
KLVTVTITTSRPGSIIGKGGQEVDKLREELKKITGKDIQINIFEIKRPELDAPLVAASIA
RQIENRISYRRAIKMAIAATMRMNAEGIKIQISGRLNGAEMARNESYKEGRIPLSTFRAD
IDYATDEAHTTYGRMGIKVWIMKGEVYGKRELSPLVGMTKKNLNGSSASKEGSSDAKRAR
RKK
>SEQF1602_01871 50S ribosomal protein L16
MLQPKRTKYRKDQKGRMKGVSQRGHQLSNGTFGIKSLESAFITARQIESARVAATRYMKR
EGQLWIKIFPDKPITKKPLEVRMGKGKGAVEYWVAVVKPGRILFEVGGVPLEIAKEALRL
AAQKLPVTTKFVVARDYQD
>SEQF1602_01872 50S ribosomal protein L29
MKQSEVKNLSVAELEQKLIELKNTYSGMKMAHAISPIENPLTIRTTRRAIARIESELTRR
KLQ
>SEQF1602_01873 30S ribosomal protein S17
MEKRNIRKERIGIVTSNKMDKSIVVSVVKRVKHPMYGKFVLQTKKFVAHDEKNDCNIGDT
VRIMETRPLSKTKCWRLVEIIERAK
>SEQF1602_01874 50S ribosomal protein L14
MVQQESRLKVADNTGAKEVLTIRVLGGTKRRYASVGDKIVVTIKEATPNGTVKKGQVSTA
VVVRTKKEVRRQDGSYIRFDENACVLLNAAGEMRGTRVFGPVARELRDKQFMKIVSLAPE
VL
>SEQF1602_01875 50S ribosomal protein L24
MIKLKIKAGDTVQVIAGDHKGEKGKVLKVDREKNRAIVEGVNLVSKHTKPSAQNPQGGII
KKEAPIHISNLSLLDPKTGEITRVGYEQRDGKKVRISKKSKQVV
>SEQF1602_01876 50S ribosomal protein L5
MTYIPRLKKEYKERIIAALKEEFGYKNVMQVPKLEKIVVSRGVGSAVADKKQIEYAVEEI
TKITGQKAVATTSKKDVASFKLRRGMSIGAKVTLRGERMYEFLDRLITTALPRVRDFQGI
KATGFDGRGNYNLGITEQIIFPEIDIDKINKIAGFDITFVTSAPTDKEAKSLLTELGLPF
KKN
>SEQF1602_01877 Alternate 30S ribosomal protein S14
MAKESMKAREVKRAKLVAKYAEKRKALKEAGDYEALQKLPKNASPVRLHNRCKLTGRPKG
YMRTFGISRVLFREMANKGLIPGVKKASW
>SEQF1602_01878 30S ribosomal protein S8
MYTDPIADYLTRIRNASSAGHRVVEIPSSNLKKEITKVLFDQGYILSYKFEENDVQGTIK
IALKYDKETKEPVIRKIVRVSTPGLRKYVGASKLPRVLNGLGITIVSTSKGVMTGKQARA
LNIGGEVICNVY
>SEQF1602_01879 50S ribosomal protein L6
MSRIGKAPISIPQGVTITIKENIVTVKGKLGELTQVVKDVAVKQEDGQLIVERQLDTKQG
NALHGLYRALLHNMVVGVSEGFTKELELVGVGYRATNQGQRLDLALGFSHNILMELPQEV
KVETINEKGKNPIIKLTSHDKQLLGQVAAKIRSFRKPEPYKGKGVKFVGEELRRKAGKSA
>SEQF1602_01880 50S ribosomal protein L18
MALSKIERRQRIKFRIKKIVSGTAQKPRLVVFRSNSEIYAQIIDDTKGVTLVAASSRDKD
LKATGTKTEKAKQVGQAIAKKALAAGIESISFDRGGYLYHGRVKSLAEGAREGGLKF
>SEQF1602_01881 30S ribosomal protein S5
MYQNYKNVEYVKPSGLELKDRLVGVQRVTKVTKGGRAFGFSAIVVVGDENGVVGQGLGKS
KEVSEAIAKAVEDAKKNLVRIPLNGTTLPHEQKGKFGGARVYLQPAAEGTGVIAGGVVRA
VLESLGVHNVLSKSQGSSNPHNVVKATFDALLRLRSAKTIAQQRGISLDKMFKG
>SEQF1602_01882 50S ribosomal protein L30
MAKKIIVTQTRSSIKRAKTQKLTLISLGLGTIGKSVTHEATPSILGMINKVEHLVSVQEA
>SEQF1602_01883 50S ribosomal protein L15
MNLSNLKPAQGSVHKDGKRVGRGQGSGKGGTSTRGHKGAKSRSGFSTKIGFEGGQMPLQR
RVPKFGFKNFNRKEYTGINLGKLQELVDKGVVTDTVNLDILVENRLANKNDLVKILGGGE
LKAKLKISVHKFTASAKAAVEKLGGEAITL
>SEQF1602_01884 Protein translocase subunit SecY
MKKFIETLTNVWKIEELRNRIILTIGILLVYRFGAHIILPGIDAKQLSSLTQKTSEGGLL
DILNAFTGGAFAKASVFALGIMPYISASIVVQLMGIAIPYLQKLQQEGESGRRRINQITR
WLTIAICIVQAPAYLYSISALGVPEEAFIQGKGLGFIIPSVIILVTGTIFAMWLGEKITD
KGVGNGISLLIMVGIIARMPHAFFGEMNRVHSPMIVIVEILLWLLVILGCIFLTLAVRQI
PVQYARRTTGGQVEKNIFGARQYIPLKLNSAGVMPIIFAQAIMFVPAALAGLSKSDWALS
IQNAFRSPFEFWYNVLFGFLIIIFTYFYTAITVPSNKMADDLKRNGGFIPGVKPGQETSD
YLDKIMSLITFPGSLFLVAIAVLPAVVNKLPLLEIDQQWALFYGGTSLLILVGVAIDTMQ
QVNSYLLNRHYDGLMKTGKKRR
>SEQF1602_01885 Translation initiation factor IF-1
MAKQAAIEQDGTIIESLSNAMFRVELDNGHVVTAHISGKMRMHYIKLLPGDRVKLEMTPY
DLTKARITYRY
>SEQF1602_01886 30S ribosomal protein S13
MARIAGIDLPKHKRGVIGLTYIFGIGRSRAKEILKTAQVDEDIKVSDWNDEQITRIREAV
SSYKIEGELRSEVQLNIKRLMDIGCYRGIRHRSGLPLRGQKTKNNSRTRKGKRKTVANKK
KATK
>SEQF1602_01887 30S ribosomal protein S11
MAKTNTKVTKKRKVVIESSGEAHISATFNNIIISLTNKKGDVISWSSAGKMKFRGSKKNT
PYAAQVAAEDAAKTAFDAGLKKVRVFVKGPGVGRESAIRSIHNAGIEVTEIIDVTPLPHN
GCRPPKRRKV
>SEQF1602_01888 30S ribosomal protein S4
MARYTGPKTKIARKFGEAIFGEDKSFAKKNYPPGQHGINRKRAKRSEYAIQLQEKQKAKY
TYGILERQFQNMYEKARRSKGVTGEVLLQLCEARLDNVVYRMGIAPSRRAARQLVSHRHI
TVNGEVVNIPSYSLKPGDIVGVRHKSQSLTVIENSLASNSSVYEWITWNPEKLEGTFVAL
PQRIQIPENIKEQLIVELYSK
>SEQF1602_01889 DNA-directed RNA polymerase subunit alpha
MIESSEFEGKFEFRPLEPGYGLTIGNALRRVMLSSLEGYAITSVKIDSVEHEFSTITGVV
EDVTEIILNLKQVRFKLQTEGTDHEKASISVTGKKQLTAGDFQKFITGFQVLNPDLVICN
MEPDVAIKMDITIDKGMGYVFAEENTKPNMPMGTIPTDAIFTPIKNVKYSIENYRVEQKT
DYEKLIFEIKTDGSIHPKDALMEAAKTLIHHFMLFSDERITIEPEEVVQPESYDEESLHM
RQLLKTKLIDMDLSVRALNCLKAAEVDTLGDLVSFTKTDLMKFRNFGKKSLTELDELVES
KGLTFGMDLSRYKLEKE
>SEQF1602_01890 50S ribosomal protein L17
MRHGDKINNLGRTAAHRKSMLANMACSLIQHKRINTTLAKAKALKVFVEPLITKSKEDTT
HNRRIVFSRLHNKYAVTELFKNISVKVANRPGGYTRIIKLGNRLGDNAEMALIELVDYNE
VGYSPKGTAKKKSTRRSRGGKKAAAEQAAPEAKEGNSSEA
>SEQF1602_01891 hypothetical protein
MRKLFLLFGLFFLSQIGFSQNKDWEKIIVTKNPEDVKGLTRLKEVSAEAARFYGKQSKLR
EEATKKLKQEAAKLGATAILLSVDEFAMSPVNNVSMVGMCFTDGSVPVKENTDTETSTAS
NEDIILTKNPDDIKGRTRLGDVKGEASQFFGMQSRLRKDATKKMKEEAAKLGATIILVTT
DSFTMTPVNNVVMEGTAYK
>SEQF1602_01892 hypothetical protein
MENTNSQAPQGQNSGENKQTIIIQQPASKSNGIGTAGFVLALAALVLVWAPILNSILWLL
GLILSGVGVTKQPRGLAIAGLCISLIGLVVLLTIFGLFAASAAAVGH
>SEQF1602_01893 hypothetical protein
MKKILVFLAIGLLLGSCSDKLTSSKAEKLVEKSLEENPMYGKVRLYTGKLRESSFDSKEE
AELYNKLATDEYIKVLTDKQPVLNWRGEPKEGEFKYLYTVSLTEKSKDFLLQSDHYSDDI
YTNTMKSYTAKIDKLADFHIVSEKEAEANVTFLKRDKTPFFPFEKDQTDFFTQKITFIKT
EKEGWKVYR
>SEQF1602_01894 hypothetical protein
MNEIVGEKIKNLRKSKNLSQEEVAEYIHLSQSTYARMESGASNSWAGYILPLCDLFGIQP
EELLKADHIVINNNNTSCQYSGGYVINQLSDKLIEQYEKRLLEKDNLIAYLQKEIQQLKT
ENRGQ
>SEQF1602_01895 Purine nucleoside phosphorylase 1
MYEKYEQTAHYIRQFITEQTPEFAIILGSGLSSLQGEVTPIVEIPYAGIPNFPQSTVEGH
GNKLIYGTLAGKYVLLMSGRFHYYEGYPMQEVTFPIRIFHLLGIKKLIVSNASGGVNPDF
SIGDIMLIRDHINMFPEHPLRGKNLEKFGTRFPDMSEAYDRSMIALAEDIAKEQGTKLQK
GVYVGLQGPTFETPSEYGMVRAIGGDAVGMSTVPEVIVARHQGMKVFALSIISDLGGKDI
APNVSHTEVLNAVNATMPKVLALVREFVKRSE
>SEQF1602_01896 hypothetical protein
MNLHLVAFHWHFEAIHPFQDGNGRVGRLLLFKECLAQGIVPFIITEKLRWYYYRGLQNWP
QVEGYLLDTCLAAQDEYKVLLKYFRVE
>SEQF1602_01897 hypothetical protein
MKVKFLAPVLLTGLVAFTSCSKDDNKTPTPIPPQNTVKEVKNLNASDEQKWVYFSFQTGT
TVEVTNPKTTDNWDIAFNRYNIRTNGGVSGIGEAEVVNTNSKDFAAVTKAPAEGYEKDKE
VTDFGRPHPGQTQPSVTKSEKNPVISGTVNKQDSKGWYNYIPPKQGEKTPNHEITKYVYV
LKTAKGGKYVKIQLTGYTNDKNETGYITFSYDFLTEKETAKPAEKVTLDFSGSEAKEVQL
NATGDWKYFSLKNGEVTPNNPAEDLSWDIAFKGYYVRLNGGTSGKGKAEVVKVEATDFAT
VTEAPKAGFAKDAQGKMSQGYPNITKVDASFSQYMSGGFGTKTGIIGLDPTKAPKVYVPT
NYIYVLKTADGTYAKVQVTDYYKDNTDVLGGTPKLKYQLSKTVSE
>SEQF1602_01898 hypothetical protein
MKVKLFLAALVTGIFTLTSCSKDSNKEEEKKPANVKQEKNLNARQEKWVYYSFEKNAIVE
VADPQNSLDWDIAFFAYYAKLNGGASGKGQAGVAKTENKDFSAPIATLPSEYIQDVKGTM
SYGNYPNLTEKEDTFSTFLSGGFDTPTGYVSLNPNNRQSSGGKWPSVYAPTKWVYVLKTA
KGAFVKFQVTDFYNDKTDANYPSFQYILSEDGKF
>SEQF1602_01899 Colicin I receptor
MSRIFIWLLCFCGVGTLQAQYTFTGTIADCQTRHPLSGATVELASLKKSVQTDTEGRFSF
PDLPKGIHHFYVTKDDYKGHFFKVSLKKDEKNYIFALCKDKEIEVGEVVVTATRTERNLK
NVPITVQVVTAQEIQKAQAPDFQSFLENEFSGINFTYDGGMPNINMMGFGGKYVLFLMDG
ERMAGETFDNIDYDRIDLDNIERIEIIKGASSSLYGSNALGGVINIITKNAQKPLELSAS
YLYNTKKDHKTNFSVATKQKWGSLRLSSFYNFREPYVIVDKEPLKTYKNGSEILSPMGEL
NIAGFTNYGATPKLSFNLSPKWNITLTPSYYFSERNAGTESSKKLRDRYYNYTAAFKSDY
KITDSKTLSLSAAYDRYDKYKYYVLLNEKEKSYENSILRVGAQYNQTLFEKHSLVAGAEG
NSDELLSFRFTNQGTEEKKNAQNYAIFTQQEWALSDAFTLVTGVRMDYHSLFKEYLTYRL
SGMFRVEQFTFRGGFSTGFRSPTLKELYTNWFHPWGGGFQIMGNKDLKPETSRNITLSVD
FNARKWNITAMTQYSKVKDKIAYRWTQASDTIRYVNYGGNTDIMSSEIAATYRPSKYFRL
KGSYAYYTSSNSRSDVRPHTFTAKAEYVEQADMKYLPNIILSGKYVSGSDIYDGENTYTY
YAPYSIWRLQFSKNLPYHFTLNAGIDNLFDYVTPSTSFYSSISPGRTYFVGLKWNL
>SEQF1602_01900 hypothetical protein
MKYIYNLTYHIEEEVYPLWQEWIASRLEPLLRQSKCSAAKLLQIHTDALGSKAFGVQYEA
EKEEDIVHFQEVVEAPHRKELFLQFGEKVLIFGTLLTVEKEWKR
>SEQF1602_01901 50S ribosomal protein L31 type B
MFVNSKKSSTFAPRKNEKKNMKKEIHPSNYRLVVFKDMSNDDIFITKSTVEAKDTIEVEG
VEYPLVKLEISRTSHPYYTGKAKLIDTAGRIDKFKSKYAKFQK
>SEQF1602_01902 Beta-monoglucosyldiacylglycerol synthase
MNLGLIITYVVITIYCLSLLLIFFYSLTILNLSVNYLKNKHQNNEAPKFNLLDPNEIPYV
TVQLPIYNEKYVVPRLLENIAKLEYPKNKLEIQVLDDSTDDSVAETARIIAELQQTGLDI
VHIRRENREGFKAGALKYGTAIAKGDFIAIFDADFLPKPDWLKQTVVYFKDEQIGVVQTR
WGHINRNYSLLTKIQALALDTHFTLEQVGRNSKGHFINFNGTAGIWRKKTILDAGNWEGD
TLTEDLDLSYRAQLKKWKFKYLEDVETPAELPVVVSAARSQQFRWNKGGAEVFRKSVRNI
LASKNIGWKTKFHGVMHLLNSSMFLYVFIVAILSVPMMYIKEAYPDLGWVFKLTSFFIVS
TVILFGCYWITYKNIQGKTFDDFVDYVKLFFSFFSVALGFSLHNVSAVLQGYWGKKTEFV
RTPKFNISSLKDSWKGNKYINKKLSPNMIFEFLLMCYFLFGLYSGIKLNDFGLFPFHLML
TFGFGFVFYKSLIPKA
>SEQF1602_01903 Tyrosine recombinase XerC
MPKNNKQSSIIPMVAFKPAELRIGTDWLIVYYAKDPQSDKLVRFRNRVPKMSNKKERLRF
AQKMIDTLNEQLYSGWSPYMGNLTEVKTIDYCFDYYLKTLSKELSDGVKRKSTCNNYKHF
ITAFTEYLSIYQKNAKFISDISTLICDHFLDRIYIEKEKSARTYNFYLTCMRTFFNFCLS
KGFTKESPVKNTKKKSIKEKTRVVLNEKEKAKLALLKGENFHFYIFCMTTYYCFIRPNEL
KKLKVEHVNIEKSYITIPSSISKNRKTENVTIPNIFIEELKEHIGNASKDLFLFGKKFVP
GKQAITNLFYHWENVRKKYHFRKEVQFYSLKDTGITDMLNAGVPAIKVRDQARHSDLKIT
EIYTARNNSADETVKNIHY
>SEQF1602_01904 hypothetical protein
MATKKVGLKANGRLKKGFRYNENGRIVKAKKATAKKTRKR
>SEQF1602_01905 hypothetical protein
MNKEKQQVFERVRVEYDELREKIGKLKDFLKSEKIKQIDTTQAYLLRIQYDTMTAYANIL
EKRLALYEEESKTTDFN
>SEQF1602_01906 hypothetical protein
MTALEAFNALDNREVSRKEVEQVLTQAKAENNTAIIYRLSRVLNDSPEATHFEITITHYD
SPVGLSGVQHTGDYREALDDCGRLRKGWKFVKGNVVKVEEKPKKEAKPKKEKAPQKEETT
KEVSGPKVKNFEAFDDLQAQLLAENADIPESEVLDFLYNFTDAFEEGKTVFRFWNTPGKK
PTEAVLQYKKPPLLTRLQNPSAKMRAYELTPRGYELLEKFHKGVERIKKTYDLGYIAGIQ
KLYNFLRDRKAYTKKENVEDSSKKKVEKAPAKATKSLKSGKEKGENVANFTLLQEPTKVF
LEFEDEKNQAYYKKSANKQGAVGADFLKKVLKDLKKQNLREEPRGFINTEDFPVSPTISK
VTGIDSLKTVVVKDKNRPTLECVLIEADRYVATDLYNIILLNRSKNDGLKTGALYDPNYK
CTNIGGCSKEEYYRDIEIGYLNYKAVLTENPVYTSDWGAIEPIIQHLKSGLEVIRKIYDW
KKVYLVKITSNVGEGHYNLKYLLNDLQILQSNGAKKIRLYTNKLDEKLNIETDNGNIVVT
MAVYMEDRSNYADVISPLRIAPIQLHFTQNRKEEKGLSGVDYSQGLFGDIGLNAPRHEGI
LKEALNDCGRLKKGWKFEKGKAVKVETKKGKDKEGEQKELDLYMQEMKTAIKESKAGKFD
KKNILSWLSKFPDKVKGLLYNFLYHHYLLDQEEAKLRKSKKLVPFGLISVQAGISEFVSK
LMDLEREDFFDLYFFFRDNMDECIELLEDKEVKKNYYEKKKKGLSGVDYSQGLFGAVPEV
STERFKKMKVNELRTFTLRYYNLFLKGDSVTIERHLKEVVFTNKAGRKIAHGEAMYSEKA
AVIAQLKTLIKNSTYNNWGDRKPQDHPDILGYLNFKSKITIDGEKRHLRISIIVDKDRKL
KLKSYDVGKKKSRDPQGGLPSAEGSQLFKTVQSTQDPVGTLQDGRTEPLSEGKGTKKSLS
RKKKEENFGLNASEAPVTSLPAPRQTLAQQLATCPEVRESFLVADEQMSLFLGALEKKTK
DSLVITLTGKQGSGKTRFAFQFMNALAQRYRVGHASIEEHPESVLYEEKAYQYLNDTALE
HITAQDVRSLAELDTMIRTNEVIVIDSFQKMRELAPHFEIDKDLRKKYDGKLFLVIFQQT
ADGKMRGGSKSQYDGDIILFTETFPDYRENYVYPDKNRYNKRPATELQYSIYEQRMLATA
PEVPALPAHYEPTESEELNFEVL
>SEQF1602_01907 hypothetical protein
MASIYATTKGFNELWQKVTQEKETLDKYKKKIPPFIINNDVALTYTLGIEHYSEILAELN
TIKNEEMEDWVIDVFPSLYASIDSLISDMKSLLANYESELKKNKVIPSEKPSDPPAQTPP
TNTVIPSSTPPVTQAPPTNTTPTISEKNTEGGPKVKDSNTGEPSLAPTEKKEVSPEGTPK
TEAPKKGFFTPTNIVILFLLFGAGVYFYNQKK
>SEQF1602_01908 hypothetical protein
MAQKKTTQKSTSVSQFHLKDILALSLSAAAVFLAGYQVHLAIKHDKQNSKQ
>SEQF1602_01909 hypothetical protein
MTDLRRLTTIRGLRNNNPGNIRMSDTAWQGKISKEFNTDTNKAFEQFESLEYGLRALMKN
AYTWIQRGKNTLEKLISVWAPPHENKTGRYIDYVAAQMQIAKNQPFKKLDRKFFISLAKA
ITEMENGAAAAQSLVPYSAYEKAFSMMGNVSYIPSVEKKNE
>SEQF1602_01910 hypothetical protein
MRTFTTNEYKNSPLYQNNPGNLPNKGEDWGGKVPKALRKGNDKYEEFITVEYGLRALMIN
IRTIMDKGKRNTILEFSHRFHPAAGTQKVALYQSTLSKALGVDKNKRITAFTKDFYIKMA
KAIASIEMGSSAHFIPEDAYDTAYIYMGINMTSGGNPVMPENKKPANTPPNKPSGRNTQQ
NGGNKQGDSTPQQGGGNQQGNTQQGGNNLTDPNLQNPYPTDPNSGQGSNVFLWVGVAIVV
GTGGYLLYDHYAQKGKKK
>SEQF1602_01911 hypothetical protein
MKTRSIVLLGLFGLGIAIYGMAKAKAGQAKRLFEKVMFSFHRYRDSGAKIFQNKIWLRLD
FALTNPTAEDFFIDTNGSIQLKVMRVYLKGKQIGYATLPEFYKLNLRAGGTAYIEDVYIE
LNGISLAGEIWDMIAQNKKDWVKYTDIINKLSFEIDIDGFGQIYTLKQSFS
>SEQF1602_01912 hypothetical protein
MKNILLSLLLSLLAVACKSVKETQQSQEVTQRTRIDSIFVEKQVPLRDTVYINIPEIRTI
KPECDSLCNEEVRKIMQQISVNRQQGEDSQGVYYNRHKGQLVVYQNIGARQSTYQEKFSG
YSHTKAVEQTKIVKQYYVPKLVKILAFIGGGTLLFGVFWIGFRIKEKIRL
>SEQF1602_01913 hypothetical protein
MIALEHVVTILSSLIGGGLLGILFERRKRRAETEAIEADVIEKIQSSYGHFVEDYNKRYE
ELVKENEYLRRKIKELEERLNDLTK
>SEQF1602_01914 hypothetical protein
MIGIPHRMICNCNNQGNNQGNNQGNNQAPKKVTLYAAVLLSGVTGNKEGKITTKEIVFDP
KLPTLQEIELNLPVFDGGVKNVVVWASLPGFRLEGAWKQNNPHQATDLEMLDNPNITGAE
LLQKLDDLPGVEYMSTALGTAPEGEWNLYHKDKSAGYGDVIIKYKFTGHLQALQH
>SEQF1602_01915 TonB-dependent receptor SusC
MKTETRFITGKVTDEKGEPLLGVNVVVKNSQPIQGTATDSHGIYKLTAPVGSQLVFSFIG
RQTMESSPITKTSSKFPTVVLREVAEELDELTFTAPKKEPEKNLPPTQPKKENPIQKYYN
PQTTITQKNSYNQNLKDAKLLMLGGGILLFGLLIATLNNSQTQKVSKKVNL
>SEQF1602_01916 hypothetical protein
MKKKYILWSAFGVGVITITLSLLLKKKPAIPNGGGAYGKYYNKLNDPDYRAFIADFANNR
ELVSEYAQQLHNAMKEEGTNFNKILEIMSNLDETQMKIVSDRFGKRAYYNRLFGKIPMAS
GKMLTLKEWFKEELDKSEYQQVKDRYPNLF
>SEQF1602_01917 hypothetical protein
MPRKKTTALKGVATTVAATSVGKYLDNHPEAIEAAGRKAKTAVNVGLVLISFTVISIGGA
LFYNLYWKNRFRKMDYDPNQKPATISAGLAKSKADMIYRALHGIGANYNTVYNALRGMGH
NNYVAIYNAFGKRTPATSFSMGNKNDMDLSQWIQDQFSGDKLAALRAQVGSAFF
>SEQF1602_01918 hypothetical protein
MEITIKINSNNPIDAQARQAKLQAIALLDDKTLALFHEIATNEKFRKKFVANEKLLRKFV
>SEQF1602_01919 hypothetical protein
MKKELIDIINRLKNSPSILISVINKETGQPLVRSFSADRFVEKYGSVEGFFNSLVSEGIS
QIIVEERRKLGNTTRSFSEPKTFILGPKEEETPPQDTPEVMPATVSPAPLQQPMGQMGLM
GLSFPQMMDLHVKAHDQGRLEVENKFLKEKNEKLEQEIAALKEERLADKFSEAKAKGNNE
MLLGIVQNLPMLMGAFKGGAPTGLQGADGELPQVPEGKGVIIQEFAQTSPEVDSFMLKIL
HLVFESKEFYEEVSKLVSKYETK
>SEQF1602_01920 hypothetical protein
MNKSKWNTQKIYSNSSFLLRGVTSLTLYNSGESKVYFRERTLEKGDYYLLEGDGTASDID
LEISFENGRGEAILDYRALQKCRTE
>SEQF1602_01921 hypothetical protein
MHTKEEVYNIDIKVGEKGNNIFITPVAGRVIGLLIYHNKGDEFVANAGLKADDGTYISKM
QHIRNYRSRESCYFTGCKPVDFQTQGKTYTLEITTEEAVANKDFKGQLILIYEDTRFNNC
GNE
>SEQF1602_01922 hypothetical protein
MDNRQVQLERSNHVLTAMGVDTRNAKVMDRTQYLTFDGKGKSSVVLLIDSNTKKLVGDTS
FDANKFNKGRYFVIDGIRVLIEDKATSLHESDWKGAPNSAILNSELKISQDEDLLVLPVS
DLVYTKISEGEDNGFRSIASAPVIVPEKEINISWQFPQGASVPSSQTQFVRIELRGFEFF
TN
>SEQF1602_01923 hypothetical protein
MNFKKPKMENLTGALVTGGSAVAGAAASNLLVAELTKKPSGDEKKDKSKRQLVKGGAVAA
ALLGLACVDGNDTSANALRGAFVGMAGAQGISLAREFTSATAGTTVKRALGLGCPCQEQQ
EGLGYVDQPEWFTPVYDQVDYSAYDSTSQAQESTQGRNPLAGFTPRESYV
>SEQF1602_01924 hypothetical protein
MIMHPCMPRPTPAKKVEKVDIPAPQEPPKVIYIAVPQRSQKEENEQQTINYKLKWWHVAI
AFVAGYALASSNSKKA
>SEQF1602_01925 hypothetical protein
MANVNIEFQGDFQYLKYEFTPRLRALIKNVHTVMNSYNAAFFERCKGFGDLESIKREALA
TGRLPQGVESAMKAAGAFKPIAATTLLWSIANQIASFANFHFWYWKKNFSDNAPQQNGRN
VNSVYNVMRSEFAYGLTYALSVPFLYRIGQGVNLLYYPRPEFVDFYKAKPFHGTNALTVE
PMRFAQKKRTESGVMTSTFIGFDHSIGIDTSLAERLSTINSGGTRIPFVAGVGSDNPYQT
RQERLSVIFYHYFCLNNRQIAHNQPLKNAGNVSNYFVFSKKDFYTLSEECVIARFWNFFA
KNISLNFDPSGREGDPAFGGKVLIGGGQTTSPVCDYYARFKKQSLQGTFEERLSRFSIPS
TEILQVPELSDAEIQEGLALLEKEKRPFSIGVDLKTMTTGKELTQRSNMLQPNLMEKLLY
YETKARTNHVLLVNKGVNDLFNFNTGIRYLPQL
>SEQF1602_01926 hypothetical protein
MKGVHLFPQEEKQQGLNAPPGRAEIVDTDYDPVINMTFAEYENNLQEHAQLAMSVHEKMS
ALVVGLITVGALSNAWNPVGWVLAAVALVIRVLVELKVFNEKSAWDKDRAEGAWNEISNY
YEYSVLGERTGETDEQGRPKHRGGLASMLSSTHFLDETVQTMMNTALKGLCIYEAVFLKE
RSKDWSSKETKANLDQLRDLGQALKSNFLGKIKTYERVYNIEYQKIPVNLGDSLFSGDLH
DLKVRQAPIDLQDPFTDVTFELIAIKLKRKPEYEGAGITFSDFKDAASPKASFLEKVLND
PNEVKGLFELGKQQISTLKLDGYLTADEADRLLFKNWMNTAPAYDKAEYSYNWNMPFDPK
AAQNRNLTEGDYLSQKCQGMDRVLQDFANKVPPYQNATAQDVIKVLKDAKAHHDKQYKGK
PGSGFCKSVARGGSPGAAYALKKFGINLNDYDEDFNLKKIERSSAFTNAIGETDTRSNRP
IPGVEVPNGYTDERVKAPVPKATPPAPAPAPLAPNATPEQPKPQPAPNTPSAPAPVKPSA
PANTLQAENKTPQKQAPKKKSLWWLWILAIGTGYYMLKDQQPKKKENG
>SEQF1602_01927 hypothetical protein
MNFGGSLYEGYKKYFGNGSGRTNAAPPPVYNDNSDVIRRQQAEYRAALEKEAERLAEIGK
RQEAEKLRMEKEEYERRIADAERRAQGYYPNGNNYNEPNKPKDNTILYVAGGLGLLGILA
IVIMSNKK
>SEQF1602_01928 hypothetical protein
MPNINQALHRKVRSDYPQDIFPKVACKRTVLGDGDTFFSVRQIVTTIDTYYSQCDKIAKA
LKGRTLAITCRNVHNFLYHHFQYKADDEVQQLRSPACSWAQRFSGIDCKSYTILAGAILK
AMGYNSYVRQIKQPFSQYPDEYSHVYLLVPASQKRQ
>SEQF1602_01929 hypothetical protein
MDLRTLYFVGQRVFYVYCGNIIEVKIREIHLQVVDLGKKNLIQIHYNVFNKFFVLKDINE
KELFSSKEELLNALAGDEFAVVPLKN
>SEQF1602_01930 hypothetical protein
MLYSKKRKLLFQQHPLTDTLFLYTMLKQETNPAVVNNSSPSTYCFDVEAVNQFFAEEIHV
QEFTRYMRMLIYETTRLHLRYCDTASGELSEEVLQAYDYLNGLSEVLNPYFTNPKL
>SEQF1602_01931 hypothetical protein
MVICDTNIIGKYLFKDPLVLRQINLLGGMKNIYITPIVYIEIIHWLSSYQKFTREDRKEI
KKFLDELKMLHLNKGISELSIEISKKDNSLDMPDILIGATGVYYDLPVYTHNLKHFKLIK
GITLYKEE
>SEQF1602_01932 hypothetical protein
MPATLTRPRTAMRKPAVSQGLKRVATQKKTATTTKKKTIDELGKRAQDIISKYDIKPFNR
KELYGNL
>SEQF1602_01933 hypothetical protein
MKILKPIKTKKDLFSLYLSQYSEKNIRAYINDIIQQYRPKANAYCKNVSRQEFLTFVELY
GLPNGYTLSEELQNEIKTRNLKV
>SEQF1602_01934 hypothetical protein
MLSRAEFNRNMQLYLDAHRFCVDHGVFVYAGAIPNRINTLYVEVNDHGKIQRGKEYYTNE
EAQLKIYEIYLHIYKKMSNLHAQN
>SEQF1602_01935 hypothetical protein
MKTIKFRAKTKNGEWIYNLAPLVPFSVSDPTDFDRDTLTQFTGLHDCHGVEIYEGDFLKI
NLSEGYKIRLVCYNEDVMGFCLAHLEDWNDPFLYNLYQFSFSWWERFKNDIEVIGNRYDN
PEIFNQYAK
>SEQF1602_01936 hypothetical protein
MKEIYFKRGDKVRLTRLNMEGIIISIAYISYESLSYNVEVCGSTVVVNVNNLEKI
>SEQF1602_01937 Modification methylase BanI
MKIIDLFSGIGGFALGFQRAGYQFTEHYFSEIDKQAIANYKYNFPHAKYIGDITTLQPAD
IAGADIITFGSPCQDFSLAGKRAGLKGNKSSLIQHAIALITHVRPSIFIWENVKGAYSSN
AGADFWAIIKAFAYIDGYRFEQQLLNTKWLLPQNRERIYFIGHLAGRSIPGVFPIGENDF
PFTKETESQLQAPISTTLKASGAMRPDDTYIIPKVAATLTGGGHSGGLHSDMTVIQLNPS
KESNGRQPYQQNRVFDSKGISPALTKHNSDFIIKQRSRGKNKGTDMKICPTISSNAFQEN
NLLNGVRRLTEIECERLQGFPDNWTQYGDYNGAIKPIAKTQRYKLIGNAVTVDIVELIAK
RLKFLEP
>SEQF1602_01938 hypothetical protein
MDINLEQLKQELWNATDYGRQFFEDEFASEIARNRGRLKGFAVRTEDKTGSCHINQKTSD
KGPAPYTFTDFGVENKGMNAIDYVVKRDHCTFWEALKKLCSQYGVPLPEGNKVTPTVEFS
SNVEEDEGFWKVNFSSSYKNKKLLQRLFPFYTEELLKEYVFKEIESYQTVGVNEKGNKYK
KTTIANADFPIFGYDKGDYVKIYQPYAPKGDAFIHKHSFVGDKSGKRIIYGWDRLFEKVE
YETIKQVIKDLKTARNSETKKDLLAQLDALKLETVIIATGGTDGINIASLGYDVIWFNSE
TEVINSQEYYELSQIAKNIYYIPDLDETGVKQAVQIADSFLDIKLVWLPKDLKYSKKKDF
ADWLRREKNAGKEILQAIFAKMLNQALNFRFWTFSDKGTVQFNPTKIIHFLHLKGFYTFA
SNYSEQKEDECEFVSLKQGKLEKILSTDIKKYVLEWIDNKVYNEQVRNRVFSAAAFQPSH
LKMLPIFDKDITNYGRSYQWYFFANEAIKIQKDSIASYKYSGALKVQFWKDEIINHNISL
LTPFFEKYTDEQGRTRIKILNKDSNYFKVLINSSRIYWEKDANEEHKDLNPFGISSENLT
EAENYEQELHLMNKIYCVGYMLHQHKRESESFIVIGTDYKGGNSVKGSYGGTAKSFLVNG
IRKMLKSKYIDGKTLGNNKFPYDKVTEKTRLVFLDDMNFNQDFRDFYNKVTGDFEANHKG
GKIYYIPFERSPKMAATTNYVPDFEESSLVRRLLFYQNGDYYHAKTPKNDYLFSRKISDD
FGGRDIMNSDYSAEEWNADYNFLFNCLQFYLSCDQPIMAPLEALQNRRALLSIGDNCLNF
LNDYFADEAKLNHWINKPEFVREAIGELGNKYTPYQVYKKLQEYCNIHKWELQKAKRKTE
NGNSLEHFYIDTKQLGDIPAIEEPTQPSTPPAPHITDNLSQEIDF
>SEQF1602_01939 hypothetical protein
MIQNNMQEHINELVKILSNTEGITYITQRIVKTQVHFSFIFESYKVLDDLKQKMPEDWFL
FIVGSHNICYLSYKQSDLERYFERLQLVKAAFFIDDFINIFCNKH
>SEQF1602_01940 hypothetical protein
MIKSQKVIVTLKPSIKEKINDIVITNLSLKTSEKYRTIKDWLKKDSEKLTHYSFLLALSE
LLQLPIDQLINIDRC
>SEQF1602_01941 hypothetical protein
MITKDKILENISKIRVNKKITQKTIAEFLEIEQGSYSLLERGERDLTIDRLLQIAIFFKM
DVVDIITYPNKGSYNKENEEDIKAILQIELKKDKKDQVMKLIFGDNSLEILNN
>SEQF1602_01942 hypothetical protein
MKKASISIVLSITAIIICIINFFVFNIRVAPYEFDVYGVLVGILGILVTFLLGWQIFSVF
QMKKEIDKLKADISQEVDTEIEKLREDVKEHTNQMDDELRNLVSGLGFEFYGTILTDHYL
KNSGSFSFFSKFKNLIMFLLYANNVSSPLYEEKVEPVVKLYLRKLIKLCRKHKSKIRNLD
PLIKKELLEKIDIFTEENKKIDFSFLIATLNGTI
>SEQF1602_01943 hypothetical protein
MFLSSTLSFLDSFSIVSATVGVSLIVSFEYYKRKRLSYEDKEVIKKLLQTLDVNNFQENI
YQQNAWYGYSLESIQKTTSFVKESERISNFIAQKKSRRSVEKIRTLLKEFNQLVIEKMNT
KRTSYILPKEPDKYSQSEAIAIVLNEKTKKIFQELEKFVFYIKKEHQLIF
>SEQF1602_01944 Electron transfer flavoprotein subunit beta
MKILVCVNQVPDTTSQINFTSDQSAFDPSGVQFVLNPSDEAALMRALQLKEEVGAELTLV
HVGLSDSEPVLRKAFALGADHMLRIDTFPTDGFFVAEQLAAIAPEYDAIFCGRESLDYNG
GMVGGMLAALLDYDFVDEVTAFSFEGDKAAKITRMTDGGKEHLEVPLPVVVGIQKEIVPE
SEIRIPSMKGIMMARKAPLEVIPPVEASSQPKITALEKPQPKAPVKIIDPNNLDELIDEL
HNKRKLF
>SEQF1602_01945 Electron transfer flavoprotein subunit alpha
MTLVYTEYNDGQFTKKTLEALSYAQAFSDKVIALTINVADPTPLARYGVSKIVKVTAPEL
SSFQAKPYAELLSQVAKREQVSLVVLPSSANTRYLAPMLAVSWQAAYLSNVSSLPKDGQV
QKVIFSSKAISWVPLAPKQVITLAGNTVEIKEAPAQAVVEEYTPQLPKERIKHLGTEKFT
SKISIDDAAIVVSGGRGMQTPDNWHLVEDLADALGAATACTKPVSDMGWRPHSEHIGQTG
KPLACELYIALGVSGAIQHIAGVNASKVKVVINSDPEAPFFKAADYGIVGDLFEVVPRLT
EKIKNLQK
>SEQF1602_01946 Rhomboid protease AarA
MMNITKAVAHLIIANVLFFLLAHFIPMLQDKAALYYIENPNFQWWQVFSHLFMHASVAHI
FFNMFALYSFGMPLESYFGSNRFIVFYFACGLGAAFLHTAVNYYEFHSALDILQSKGFSI
SQAQELLQKGMYNTGWEEALSESDFKDMMSAYMIPAVGASGAIYGILVAFGVLFPNAELM
LMFLPIPIKAKYFIPILIALDLFSGVTGYSIFGSNIAHFAHVGGALIGFILMKLWQKNSF
NDRRLY
>SEQF1602_01947 hypothetical protein
MNRTVKRIWGKHSLSLVYILIVSYLCGYILPQLFAFLWQRTDPFVRDLFALSQDFSQLLQ
QPWTAITYSFFHASFIHCFFNAIMLYFVGILFMNLFTPKRFLGIYIAGVVAGGLFFMLTY
AIFPVFAHREDYLLGGSAGIMAVLIFLTTYTPTLRIYLFGVWAVPLWVLGVLMVATDLLS
IPISNAGGHIAHLGGALVGILYGLFLKGKLSFSLPKRARQAPTSPYTNEHAQERINTILD
KISKSGYDSLTNEEKRYLFLASRENANQ
>SEQF1602_01948 Riboflavin biosynthesis protein RibF
MQLVTDITHFQSPEHTVLTIGTFDGIHIGHQRIITQVVERAKEQDLLPTVLTFFPHPRMV
LDPSAPIALIQTIEERAQLLASYGIAQLVIQPFSKEFAALSAQDYVRELLVGKLRAKEII
IGYDHRFGKNRSAGIEELKAFGEQYHFQVEEIPVQEVDSLSVSSTKIRQALEKGDVQTAN
HYLGYSFSLAGTVVHGQKLGRTLGYPTANLQIENSHKLIPKIGVYAVYMLWEGKKVFGML
SIGKNPTIEGKGESIEVYFFDFSSDLYGKEIRLYFIDFIRDEVKFPSLEALKAQLKKDED
SCKWLIANAQ
>SEQF1602_01949 5'-fluoro-5'-deoxy-adenosine synthase
MRKNNPCLGVFSYICTFFQVFDFAVMNIITLTTDFGEQDYGVGALKGQLYSLIPQARIVD
ISHQVDRYSISEAAYLLEGAYRYFPKGTIHIVGVNNELSPECGLLLLVHERHYFITADNG
FVSLLTHNAPETEVYLLDLPSRVSIFPTLEFSTHIAQKLCEGALPSTLGTPCEKHLYITD
FVPKVRAQRIEGTVIYIDHFGNVVSNITRSLLTQEAKDRRFHVYFRYQSVENITLDSICL
QYNQVEKDSLSAGEVFLLFNHLDYLEMAIYKANPDVSGGSASLMGIQRGDTVSIDLI
>SEQF1602_01950 hypothetical protein
MATNKNALIRYKTIDKCLRDTTRLWTLDDLIAACTEALCEYEGKENVVSKRTIQLDIQNM
RSDKIGYNAPIEVFDNKYYRYADSDYSITKMEIPYEDIKKMRQAVEFLKEFKDFSFFQQM
NGVLHRLEDAVFLTLSHHPVIHLDKNEHLRGLSYIDPIYQAIQQKKPLAIEYKSFKARHS
ATMHVHPQFLKEYNNRWFLVAFYKTSLLTLALDRMENVNILSAPYVDKNIDANEYFKDVI
GVTVSEGNPIEEVVFWVDRNNANYVITKPFHHSQEIVEEREDGVVFRIRVRHNYELERLI
LGFGASIIVLAPSRLRRNISSLLKKAAANYS
>SEQF1602_01951 hypothetical protein
MQKYNKIQQEWGAMLKKLYFYPFKTESVMKSLFSYIFLLAVLFTGCRTAKVTNTQGVADT
SLRGKEILEKHQETFPAFETLAGTLTVTYSRIGKIGQAIPLSFRMKKGETIWISAPLGMA
KALITKDKVQFYNKLDNTYFEGDYTISEKYLGVHLGFEALENLLLGQLLFRDRHTTLTPE
GERYKGALKKDALDLSFFLNAAFRMESLLIVQEKQTERERSLYAAYTYQAVEGQLFPLSL
LLQGSQGGEQVQLSLQFSALQRNVAVRFPYSVPSAYQPLTLRP
>SEQF1602_01952 Murein hydrolase activator EnvC
MHRLVVFICILSFAGAFAQTSQKQKQLEKQKKALLEQIQEMSALRSQQAQERKSLAFQIE
EISEKISARTQLIRLTNHQANLLSQQIKDNQNQISTLKKDLESLKKNYAAVILQSYKSRS
PQSRWMFLLASESFTQGYKRLKYLQQYTQYRKKQAQEIQQKNTLLQQLADSLSSQYNYQR
RIVEENQKEQTRLSQERKEQESLVASIKKKESEYAAEIKKKQAQANKIDREIDRLIRLAI
VEANKKAKPKTSSTGKTTTSAAASDKVFDLTPEGQALSSDFEANKGKLIWPIERGYKSQG
FGTYDDPVYPDLKHYNNGVSLMAPRGADARCVFNGEVSAVISIPGGNKAVQVRHGNFITI
YYNLTQVYVSKGQKVSAKTPLGKIFTDSEGRTEMKFFVYKNTNKLNPEHWLRE
>SEQF1602_01953 hypothetical protein
MSRFKLWKQDPFGHALWIKKFIIRTLGSLTHRRYRGFNDLHIEGSEIIRSLPERGVLFIS
NHQTYFADVIAMYHVFNASLKGRVDSLKNIGYVWQPKLNLYYVAASETMRSGILPKILAY
VGAVKVSRTWREKGKEIHREVNPDDIKNIGVALQDGWLITFPQGTTSPWKPIRKGTAHLI
KTYKPIVVPIVIDGFRRSFDKKGVVVKKKGIQQTMRIKAPLEIDYERESVEEIIEKVAFA
IEQHPTFIKSKEQE
>SEQF1602_01958 Elongation factor Tu
MAKENFDRSKPHLNIGTIGHVDHGKTTLTAAITKVLADAGLSEARSFDSIDNAPEEKERG
ITINTSHVEYQTKNRHYAHVDCPGHADYVKNMVTGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGIPRIVVFLNKVDMVDDPELLELVEMEVRELLSFYDYDGDNGPVIQGSALGALN
GEQKWVDTVMQLMDAVDNWIELPQRDIDKPFLMPIEDVFTITGRGTVATGRIETGIANTG
DAVEIIGMGADKLTSTITGVEMFKKILDRGEAGDNVGLLLRGIDKKDIRRGMVICKPGSV
KPHAKFKAEVYILKKEEGGRHTPFHNNYRPQFYVRTTDVTGTINLPEGVDMVMPGDNLTI
TVELLQPIALNVGLRFAIREGGRTVGAGQVTEILD
>SEQF1602_01960 hypothetical protein
MINYIKESYTELTQNVTWTPFNEAQRLLWVVTIFSVIFSLFIAGVDFLFESFIAQIFKIF
>SEQF1602_01961 Transcription termination/antitermination protein NusG
MAVLEKNWYVVRAVSGQENKVKNYIESEISRLGYGDYVEQVLVPTEKVPQLRNGKKVNVE
KVFFPGYVMIKADLSGEISHLIKGISGVIGFLGETKGGAPTPIRKSEVNRMLGIVDELQE
KVDTVLIPYEVGESVKVIDGPFNGFTGNVDKVNEEKRKLEVIVKIFGRKTPLELSYTQVE
KI
>SEQF1602_01962 50S ribosomal protein L11
MAKELHKVVKLQVKGGAANPSPPVGPALGAAGVNIMEFCKQFNARTQDKPGKVLPVVISV
YKDKSFDFVIKTPPAAVQLLEAAKIKGGSGEPNRKKVANITWDQVRAIAEDKLPDLSAFT
IEKAMSIVAGTARSMGITITGDKPF
>SEQF1602_01963 50S ribosomal protein L1
MAKLTKKYKEALSKIEADKLYSLAEGSKKVKEVSFTKFDASVDIAVRLGVDPRKANQMVR
GVVTLPHGTGKDVRVLALVTPDKEAEAKAAGADYVGLDEYLQKIKDGWTDVDVIVTMPAV
MGKLGPLGRVLGPRGLMPNPKTGTVTMEIGKAVQEVKAGKIDFRVDKTGIVHASIGKVSF
TAEKLTENATELLQTLIKLKPTAAKGTYIKSIYLSSTMSPSVAIDTKAV
>SEQF1602_01964 50S ribosomal protein L10
MTKEEKSVVIEDLTAQLAANHVIYLADLTGLNAKETSDLRRACFKANIKLAVVKNTFLAK
AMEASDKNFGDLPSVLKGNTSVMYAEVGNAPAKLIKNFRKKSEKLLLKGAYIEEAVFIGD
DQLDALSSIKSKEELIGDIIALLQSPAKNVVSALKSGGGKIAGIVKTLSER
>SEQF1602_01965 50S ribosomal protein L7/L12
MADLKNFAEQLVNLTVKEVNELAQILKDEYGIEPAAAAVAVTAGPAAAGEAAAEKTEFDV
ILKSAGDNKLAVVKLVKDLTGLGLKEAKEVVDGAPSKVKEGVSKADAENLKKSLEEAGAE
VELK
>SEQF1602_01966 hypothetical protein
MRKLLFLALLIVGCKPSYVTEIPRDTNLHTGIHLKNPKRVVIFAEDATYYKYAQEHPEYK
KIKARISSLLPAASESCFCGITLRGGIIRIDGEKSWIIDTEKLPYIAALVLYNGKGKPEV
VLDPKQYEKRLRQMWGSKSTR
>SEQF1602_01967 Aspartate 1-decarboxylase
MKIEVLKSKIHRVKVTGADLDYIGSITIDEALLEAANLIVGEKVSIVNVNNGERFETYII
RGERNSGTITLNGPAARKVQKGDIVIIISYALMDFEEAKTFQPTVIFPDEQTNRLMINTN
SN
>SEQF1602_01968 hypothetical protein
MSLFGKIFQGVTEEVKLNEQESFAGIALAMAGADGNVGHGEWDEIVNYMNRLRIYDSYTG
SAFDKLFDKLFRILKKEGPGSLVEKSVQGLPSELRLTAFACAVDIATSDGILEEEEKDMI
NQLAELLTVPEKTAISIIEVMLIKNKV
>SEQF1602_01969 hypothetical protein
MYRLFFDFSFHPDFQLYLPQTLLAQQRSHSWFLLKKASPEVMKNISIPLRASEKEALAIT
YSLQPHVLAQKYNPKNLSIEELFKNKSQKKYIQEQIEEKTNTLLSLIAKEALWLTTHCQK
EQPIERQLIEVSPKELHPILEFEKTPEGIAYHLFLLAEERLVPAEHQITLLSQKKSWIVI
DQKLSLLEDIPAQLVKPFLGKTSVEIPQRMVQEYFDKFLKEVLQRVEVCSVGFDILTKDS
LQGTSLHFVHDFLSGQYKLYVAFDYGGYTFYSNQRRAQQSLLNITPEGDIHIQHFRRNPL
EEARKVQILKDLGLQEVEGFLWVDDPYPFATYLHLLPYGEVLEAQGLPLAPIEIEGKQTC
LQHFDIQLNETTGQQDWFDVDIWITQGDFRLPFASLIKNLRENNPLYPLPDGSWLVIPKE
WFARYERLAKFGQEHQGKIRLARSHYALLDTLAEAKPKEWVSGIHYQPSPRLKASLRPYQ
REGVEWLLEHYHNQMGACLADDMGLGKTLQILAMLIAVHDTYPLKQTDFPTDIFQLGQMQ
REPLKALIVLPSSLIFNWYEEIKRFTPDLRCTQYIGNDRKTKVRRLLNYDIVLTSYPILT
RDIALLEKHPFSFIILDESQRIKNKNSQIFKAIDRLQGTHRFSLSGTPIENSLSDLWAQM
QFINPNILGTFAQFSKYFLPEIQKKHNPIALEELKTIINPFLLRRTKEQVLQDLPDMEEQ
IIYCPMSELQGKWYEQEKSKVRNALLQVAPQGKNIHSLNMLMRLRQISNHPLLADPKSDI
PSGKYEEVVSCLEQLLLSAQKALIFSSFTSHLEIYQRWCDEQKIKYALLTGATALPDRKV
QVERFQKDKEVPFFFISLKAGEVGLNLTAASYVLLLDPWWNPFAERQAIARAHRLGQEQK
VNVIRFVSQHTLEEKIIRLQQHKRELSEHIIEEDTLMKEELLELLE
>SEQF1602_01970 Phospho-2-dehydro-3-deoxyheptonate aldolase
MEITKANRKWLDNLHLPHPVVIAGPCSAETEEQVLKIAHALKDTDVTYYRAGIWKPRTRS
GMFEGVGALGLKWLERVKRETGMKTATEVANKDHVRLALEHDIDLLWIGARSTVSPFIVQ
EIADELKGTDKVVLVKNPVNPDLALWIGAIERLLRADIQNLGVIHRGFSTYEKTKYRNIP
EWQLVIELQNKFPDLPLICDPSHITGKRELIFDVSQTALDLNFNGLMIETHCTPDEAWSD
AAQQVTPQRLVQIMNDLRIRKTSTSEEDYVSQLTGLRSRIDILDDQLLDLLKKRMDISDE
IGQLKKINNVAILQNQRWHEILGKVILEGEQHGLNEEFIIQLFKVIHQESINRQEKIVKA
K
>SEQF1602_01971 hypothetical protein
MQVYTIKGMGCTGCATTVEQRLSKVAGVTAVKVDFNAQKAFVESKEEVSLPALQKALEGT
DYTIKKD
>SEQF1602_01972 Silver exporting P-type ATPase
MTHTYYVKGMSCSGCEMTVKKSLEAIEGVSKVVANAKEKTAVVEMSQHVPFETLKTALEG
THYTLVTSLEEATSAAKPQASTHKGTGVYYCPMRCEGNKTYDHPGHCPVCGMDLVEEVSA
QSLKQGNQEDHKRQELRRQFWGAVAFTLPIFIIAMGGMWHDNPMYKLMPLSYWNWVQFAL
SLPVVFYFGWTYFSRAWVSIKTLRFNMFTLIGIGAAAAWLFSVVALCVPESLPEQFKEHG
SVPLYFEATTVILTLVILGQLLEANAHNRTQQAVRMLLELAPNTAIKLVGDHEVEVPVEE
VVKGDLLRVRPGAKIPVDGRITTGEATIDESMITGEPLPVEKQVGAAVSAGTINGAQAFV
MQADKVGSDTLLSQIVTMVQQASTSRAPIQKLADRISSYFVPTVIAISVLTFILWAVFAK
EHAWEYALVNAISVLIIACPCALGLATPVSVMVGVSQGARQGILIKNAEALERMKQVDTL
IVDKTGTLTEGKPSLRALIPWAGYEEQTLWPILYGVNKASEHPLAKATNAYAVEHGVTPL
PMTDFKALAGRGVVASYEGKHYYFGNDRLMQEIGASLSEEQLSQVAQAQRQGQTLSFLAI
EKEVVAAVAIADKIKDNAAQAVKDLQEQGVTVVMLTGDNPLTAQAVAQQLGITHYKAGML
PEDKQQQVKRFQQQGKVVAMAGDGINDAPALAQADVGIAMGTGTDIAIESAQLTLVKGQL
SGIVKAKKLSEAVVKNIRENLFFALVYNTLGIPIAAGVLYPFFGILLSPMLGALAMSFSS
VSVIANALRLGKRK
>SEQF1602_01973 hypothetical protein
MILCRNIFPLSRISVSINDQKISLAPGGSVEMPLEKSDHYVIEIVSPLLLKKNSKTVSDL
HENSVIEIRTSLPDSYYLLMGGVSLVICVLFFLQMVPAIIFGMVLLLYIFPIVYHTFVKA
DEYFSICVR
>SEQF1602_01974 hypothetical protein
MFRNTILLINFYHFSFACMKLFYIFAVYSKNVKPLSAFGIEEYLVFVVYFKHQSYDIM
>SEQF1602_01975 hypothetical protein
MKKQAESILWEIAKGDAIPQGEKTIYPSVRERISALTTLGKWEGWDKPAQKAAEIIAQDL
QHTHEALKEGDNPFEEVLDEEEDADDTDTEAIAVSAEESPPTCIPIAKPTVKKGLIKKAL
AQKDLLAFTQYTLPYFAPAAFHHSYYRQLTEFAMGRIQKLMITMPPQHGKSEGATRRLPA
FLLGRNPECRIAIVSYNTTKARKFNRELQRILQEESYQQLFPQTFLAGGAPHGMRSNHRA
YARNADECEIVGHRGSFKTLGVGGALTGEPVDVLIMDDLYKDALSAWSPTIRQNIADWYD
TVATTRLHNDSQQLLVFTRWHEDDLAGRLLEQEGHYDAQNNPLGWQVISFPAIQNVPPSP
EDPREMGAALWPQRHDLPKLLSLKERNPQVFESLYQQNPQPNEGLLYQEFAVYESAPVYA
PVVAYIDVADSGNDYLCALIYKEADEGNYILEVLYTQEPMERTECLLSDLLMRHQVERCH
IESNNGGHYFSQNIEELSRNMGNTLTRFLPFHQRENKAARIFACSTSVQRMTLMPMDWKE
RFPAFAHDLIGYLRTGGNAHDDAPDALTGAIECRQPKRKIPLSELLQW
>SEQF1602_01976 hypothetical protein
MSKSIVRDKSKKFAIRIVRLYKYLTQEKNEFVIAKQLLRSGTSIGANLAEQEFAVSEADY
LNKTSISLKECAETAYWLELLYEANYISLKEYENIQKDCSEIIKILIAIVKNLKTKKLKS
DNR
>SEQF1602_01978 Acyl carrier protein
MKRDEIIKTINEVLVEEFEVEGSKIQPAADFRESLGLDSLDYVDLVVVIEEKFGVKLVEA
DFKPIVTFEDFYATLEQKINGK
>SEQF1602_01979 Lipid A biosynthesis lauroyltransferase
MESKEISKTKWQGKSKGNVLGYRIFVFLIKHLGVRSAYLLLVFVALYYFLSQWTSNGYLY
RYFRHRLGYTPLRAVVSVYRNYYVFGQTIIDKIAIFSNLRHRFTYEFDGQEQLHKLLASH
KGGVLISAHIGNFEVAEPFFREIDVECQIHTVTTDMERSAIKEYLESVSLKEYTPKFIFV
KEDMSHIFEIHQALQDNGIICFTGDRYFEGTKHLTASLLGKETLFPAGPFLIASRLGVPV
IFVYVMKEKGLHYHLYARMAQVKSRDPQALLEAFTLNMEQMIHKYPLQWFNYFDFWNEKK
EAQ
>SEQF1602_01980 hypothetical protein
MIDPQYIGYFASVCIVLSFVMKKVQHIRLINLVGCLCFVIYGLMNTPQLWPVIIPNALIC
MVQVYYLWIKKEAH
>SEQF1602_01981 Thiol-disulfide oxidoreductase ResA
MRFFFLTLSLLSFGRGHSQNFTIDGNVSSPYEGKIYLWYGDKVDSTTVVNKEFRFSGEVG
YPTKASLSVSRKFKDTGFFVLEASNLSVDIAIENRHQVYIKSLNGSPSLTQVKDFLVYKY
KNASLSNLPELLVARLETIIKQNPKSQFAGMLLSELITDREIPYKQAQRLYNLLDKKTQD
KEDLQKMDVLLGAMSRTQVGSQLPDISFETEKGTPEKLSSVRKKYTLVLFTASDCIPCVE
NDRQFANLYKEYHRSHGFTIYSVYLDGERNTWLDHIHREGVRWSATIAPKKFKDETLKSL
GITEIPSNFLIDENGKILAVNITPKGVHRGLDPEAAAYVPVPKKDKKGAKKNPPLKPVNK
NKNTKKRK
>SEQF1602_01982 Acyl carrier protein AcpP
MSDIASRVKAIIVDKLGVDETEVVSEASFTNDLGADSLDTVELIMEFEKEFDIQIPDDQA
ENISTVGQAIKYIEDNKQ
>SEQF1602_01983 3-oxoacyl-[acyl-carrier-protein] synthase 2
MLYGEATPRLVYVETTNFNGKTSISMQTRRVVVTGLGAITPIGNTLEAYWDGLLNGVSGA
NLITHFDASKFKTQFACEVKGFEPTDFIDKKEVRKMDRFTQMAIVASDEAIKNSSLDLEK
ENKDRIGVIWGAGIGGLMTFQEEVLAFGKGDGTPRFNPFFIPKMIADIAPGMISIRHGLR
GPNFTTVSACASSANALIDALNYIRLGYADVIVTGGSEAAVIEAGIGGFNALHALSTRND
EYKTASRPFDVTRDGFVLGEGAGALVLEEYEHAKARGAKIYCELAGGGLSADAYHLTAPH
PEGIGAKAVMLNCLADANVAPEEVDAINLHGTSTPLGDIAETKAVKEVFGEHAYQINLNS
TKSMTGHLLGAAGAVEAIASVLAIEHQTIPPTINFVNPDENIDQKLNFTFNKAQKRTVNV
AMSNTFGFGGHNACVLFKKID
>SEQF1602_01984 Ribonuclease 3
MEQLLGFPPKEIHYYEEAFTLGTVRTDSAQPHISYERLEFLGDAILGAVIAHFVFLQAPD
KNEGDLTKMRTRMVRRENLNQIGEDLRLREYLLADKHTLLSGNIAGNLLEALVGAIYLDR
GYSKATEFIHRILIDTNLSMRDLENKVISYKSLMVEWAQKYHKTIAFVSEEDPTYKGRTK
YFQAKVMINDKVFAKAHDTSKKKAEERAAKRAFFRAGDKKKSSKKNNKGKKQ
>SEQF1602_01985 ATP-dependent Clp protease adapter protein ClpS
MPQTQPTPQKESQEELLTQQADNYQIMLYNDDYNTFDYVIELLIEICDHTYEQAEQCAVL
VHFSGKCPVKEGSYEDLLPRCSKLTQAGLTAEILPR
>SEQF1602_01986 hypothetical protein
MSRQLNFYATDADRKIIADILREHFGEMIEVPSPKDSLQPFEDTIDKKLYRLTDVEGKEH
ITYREHTYYDLRKALVLDEYNSSILEYSTAFKNPSGAYVSGRFYTCTNDKDFSAKVAKFF
TKLKKVFIYLKPQRLYISKNIDLDSALFLLSNRIIKLSIDGTEEVIQDVKKTSKKAPSVK
VIPDKMNLFDKK
>SEQF1602_01987 hypothetical protein
MAKQIKQVATTEDYIVARYEDDSIGVYNRYGNTKGALREIAEVQGFEYDPTWTTRQFGKK
LIDAVDNGAPAIANDHYIVYIDTNGTVICGRKTEGSAKGTLRMIAEKYSIIYEEGWNTQQ
FGRKVIEHLLNAKTSTATKEEFLEKIRKDIKEFLEKNDKKDNKLFFNERHLQMNLASFLK
EQHYYDNVFLEYSLPSSFIKDNREEEVEANIRIDIVVEKSNQFCPIELKYKTKLAEGNII
ERFGEEIKTELLKNQAAQNINRYSFWKDVYRVERIKRNFSKVIAGFSIFMTNDESYMNTP
KGASEPFTMEAGVQHSKELDWKGEVAKSTKDKHPKIELEKEYTIGKWYDVTIERIVFHYC
IVEV
>SEQF1602_01988 hypothetical protein
MTQYNNLLIEDIFLSGFVEREGEISVFKPMFWWCFLKLDNGKIIEISSNDGNIKLVETPK
INCNFDLEEEDIFCIMSHSPIENYGRIIDMRYLFDETGNVVALKIETSSHRIQINATTSF
EGLDIFIIR
>SEQF1602_01989 hypothetical protein
MPDSVGSINSLTIVMDPQLWGGVVGDSLREYFASPVEEIAGAREPLFDIQQIPLEVFDGM
TRAGRNILIVSTDTRNGFDIRDSLYAKPQKVAFIIGQTTDDLISEIQKYAPKIIRTFKEN
EMQEVRNRFQNTLNNTKLIENTLGIQLSFPSLYNIVKQENNFFWLERKVKNGTADILIYE
VPKGKICTHSNLCSEDIIQMRDSIGKRYVPGPQEGMYMITSPAFAPTYTKTQLNGYPTIV
SKGLWEVKDFILGGPFSNYIIEDPKRDRCVVIEGFIAAPGTSKRDLLFELETIIKSVRFI
Y
>SEQF1602_01990 Bacterial non-heme ferritin
MAKSTRRETVLNAKVVALLQEQVGMEAHASATYLAMSSWCEANGFPKSAAFFLEHAEEER
GHMLKIFHFLNDNGARAFSPEVKDIPQEFKGLRDVYEKTFDHEIAVTDSINAIVKLARKE
EDYASEHFLQWFVEEQLEEERLVRDILSWFDFVNEKESKFALRLIDERIPVGA
>SEQF1602_01991 hypothetical protein
MRKIFLLLSIFSLHLYTHAQEFDVGVKGGINYVSLRGTTSEVSTFKSKLGVYVGAYGELF
LGRIFSLQPEVLFSREGARWQREGLLPSGDTYKASLNTDYVNVPILANVKLHEKFSLQAG
PQFGFLVVKPEIGSEEPIFGGENYLDKGIYRTFDFAVVLGFKIRFTDNIAGELRYTNSLT
NLFDKKHPALEAANFGNNNNFRHSYFSFGVEYRIKQLTIF
>SEQF1602_01992 Endolytic murein transglycosylase
MIKKILKIFIFSLLLGVLLAGGAIYYVLFSPNTDFKEKKFILYIPTGSSYQTVIDSLYPK
LSHENTFFWVAKYMGYTEHVRPGRYVVHKGMNNLALVRMLRNRSQPIKVSFNNQERLPLL
AARIAQEIEADSASLMKATLNPFFLYEHQMDSLNVLGLFIPNTYEFYWNTSAEEFVHRMG
KEYKTFWNDSRRERADSLGLSPKQVSILASIVQKESYRVSERPTIAGVYLNRLRQRIPLQ
ADPTVIYAIKETSGNYDTIIKRVYLKDLQIESPYNTYLHPGLPPSPICMPDISSIDAVLH
PQQHDYIFFVADTARLGYHKFAKTLQEHNKNRDAYRKWLDRKTMNSKEKGEQ
>SEQF1602_01993 hypothetical protein
MNRLFLLLLLLSCFGWAQEKIYIDNSGNPVSQDKASLYRTISEKQGIYHIKDFYLNGKLQ
MDAFSKNKDFRGIEELVGKFTFYLENGKIEIQGEEKKGELKYKMFDEKGRITTLYSKDAK
DNEISQSYYYPEEKDNFNIVYFQENGEIKKIVLFDKDLSKIRIERFNQENGNILSHYYDE
RGKLIGSRLTKDDDSPAEGTEVEYYFNPAQVRMITQWDNKGNITTKKEFYRSGKVFSERT
VRQKDTIITFLNPKQKKMGELLIKEGHPYQGVAYNLDESGVLQGKEDYKLGILSESTFFY
KNGNIKQKVDNDIHGSISKITYFNKNKSQKGIVSFRNETPYEGYLYDNLEKNESYVFYKE
GEINEIKQLDDTNRLRFYKKVQENGEEVGDIYNKKGEKEFHYIIKKEKDKDRYDIKTTIS
FKQFKNGKEIHSGVIKDGILSQGSIRLNNRYYENADYIYKIVDNKIVKDHFYKDKIFKTE
ILYLDYKKEEDSVFHPYLDGFEISEEDFQPYMNNPTFYQPIMESSNRY
>SEQF1602_01994 Tyrosine 2,3-aminomutase
MPDIVLFTNFAPVRKSRQTYNMEPYSISFEEFAKIVFHHKKVEISTETEKTVRESYEFLK
NFSKDKIIYGVNTGFGPMAQYRIEEEDQLALQYNIIRSHSSGMGAYFSPEVVKSAILCRL
NTLSLGRSGVHPSLIYLMKELINRDITPLIFQHGSVGASGDLVQLAHLALVLIGEGEVFY
KGERRPTQEVFKEEGLEPLKIHLREGIALMNGTSVMTGIALVNIHYATLLLNWSVKLSCA
INELVRSYDDHFSEELNAAKRHEGQQLIARKMRDYLTDSQLTRKRADHLYKGEHKETVFK
DKVQEYYSLRCVPQILGPIYETLSQAKEVATRELNSANDNPIIDMESQQVYHGGNFHGDY
ISLEMDKLKLAITRLSMLSERQLNYLLNPKINEILPAFVNAGKLGFNFGMQGIQFTATST
TAENQTLSSSMYVHSIPNNNDNQDIVSMGTNAATLTHKVIENAFEVLAIEAITIAQAIDI
LGYQDKLSTTTQKWYQEIRQIIPFFKEDITPYPYLAKVKAFLKNN
>SEQF1602_01995 Apolipoprotein N-acyltransferase
MKHLLLALLTGILLALAWPTYGISLLVFVAWVPLLWVEYQLRSTGKASKGKVFLCSYLSF
LVWNTLTTWWIWNSTVVGSLFAFLVNSLLMSLVFLAYHIVAKRNSTKISIIFFITIWIAF
EKFHHHWDFSWPWLSLGNVFSENISWIQWYEYTGIFGGSLWVLVVNVLLFHTLRFFLQEK
DKKLFYKRIAGIGLLLLLPIIISLGIYSHYTEQGKPIEVVVLQPNIDPYEEKYSLTNEET
ITLLQELAEKKITPQTHFVLTPETVISQGVYHLDDISRGKEVASMHPLLEKYPQLNWVMG
AAIYQVLTDENKVGAQSNYNPQQNYWFNDYNSAFLLNTYGIMGFHHKSKLVVGVENMPLQ
SVLRPILGNIMIDLGGTVAVKTTQKIPSVLSSVSQEKVAPVICYESIYGAYVNEYIKQGA
QFLGVLTNDAWWGDTQGHKQLLSYTRLRAIETRKSIARSANTGISAFINQRGEIIQSLGY
GKKGALRGTVLANENITTYVRYGDYIARLSAFIGIGIFLMSFLKKRSEV
>SEQF1602_01996 hypothetical protein
MKRIVILCTCLLLWIGCSHSFPVIKGDNSIISKERNLPSYSQINLECGADIILTKGQVGN
ITLKASQNIEPYVITEVTNGVLTIKLSPDFSFQFTRKLELYIPVDESLSKISVSGSGDIS
SREQLHVKNLTCKVVGSGDIDLSLQADSLSVSIKGSGDMDIKGTTETLDVTIAGSGDFQA
DELITKKATASISGSGDVELYVTELLSAIIRGSGDITIKGNPKKVDVQTKGSGRVRYL
>SEQF1602_01997 Chaperone modulatory protein CbpM
MEQPLRISKTKVIRTYKIKSSFFNALVDNGLIKTEVIDRVTYVHYDQLASLERFVNWHYD
LEINVPSMQIIHRLLEQIKTLQEENQKLRRK
>SEQF1602_01998 Curved DNA-binding protein
MAYIDYYKVLGVDKSASAKEIKKAYRQLARKYHPDMNPNDKSAEQRFKEINEAYEVLGNS
KNRAKYDKYGKDWQHSEAFENAQRQGRNPFEGFEGATYTNENDFSDFFKEIFGKEAGFAR
SNYGSAYGKFKGQDLQTVLSLSLAEAATTHPVTFSVNGKNIRITLPAGVQNNQQIKLKGY
GTEGVNGGPNGDLYITIHIHPDPIFERVGNDLKTKVTIDMYTAILGGEVQVNTLSGKVKL
KVKPETQPGTTVRLKGKGFPVYKEGAFGDLFITYTVELPKNLSDKQKQLLEQMKKLQENG
TTA
>SEQF1602_01999 hypothetical protein
MLNASNKTSAQGKGNGNQGDDNLDGYKGDPKGDPYSNSFYGGDGSGGNGKGWGLNGRRYI
SGEKIFQDCNESGFVVVQIEVDRSGKVIRAKAGEKGTTNKAPCLLEAARKSALTYRFNPD
DKAPQTQIGFISMHFKLGENK
>SEQF1602_02000 hypothetical protein
MRKIILLLVATTFSLIGCSKGEDTLAKSDLKATMSAQLDPVLDGSLYPSAVYSMAQIKSV
DKNTLTYFNLSIESEVEFNGKIRVTNDKFIHETLIEKKFQKGMNNISVNLLWKYDDFIKF
QNPGITHFSFQLLDREGKLVTNTDVEVPYRSVSECVFALKNGNQVLDFRAFFASYVNEDS
KLIDPFLSETLREHNETYKAKPNVQLSSGWAGYQLGSDYADLQVIAIVAQLMRKGMNYSN
ITDTSNSSTKVYSQNVRFINETLAVKNANCVDGSVLLASILEKIGIRCFLVAIPGHMYLA
YSRTGKMQIPSADIQYVETTLIGSGSLEKVFGGKNDQDQKFIGIKAARELGLKPIQ
>SEQF1602_02002 hypothetical protein
MKKTTFTTIIVLLCLCFSCSKDNDSSGAGALGVTGSGIYYKFAGGYGYYDLRSGRNITEI
FKSNIVDKYDVSWDGQKLLVAWAKRPYGQYQTDYLQFTYLPMLEKKSGAATSDDDFEKRK
INSFDFNGYDVGGSGGVGFFLSPDERFVAVQAKKSTGYNNDNPASILDMSSGRLLKEFNI
VGYEPHRINIVGWSSAGELFLSVDNELIKASERNDWSMTYVKKLPFDDIEMLNMNPQGTQ
FVFRRGDKHIWLYDIQEDSHYQVTTSKVDGITDARTYYSGGERLPSFSPDGKYIAFTGQP
RHSAVPYAYDPAVFGTAGVVNMLIIIENNGKTRDLDADNDGTIFYPKDGKYPISAEERLI
WR
>SEQF1602_02003 UDP-N-acetylglucosamine 1-carboxyvinyltransferase
MESFKIEGGHSLYGSITPQGAKNEALQVLCLVLLTQEKVTIHNVPDILDVNKLIELLGDL
GVKIQKLGKGSYSFQADEINMDYLSSEEFAKQSQRLRGSILILGPLLARFGYGGVPKPGG
DKIGRRRLDTHFDGFVKLGATFTYSHENHYYTVTAPQGLKGAYILLDEASVTGTANILMA
ASLAEGTTTIYNAACEPYLQQVCRMLQQMGAQIEGIGSNLLTIRGVKKLGGCTHRILPDM
IEIGSWIGMAAMTQSELTIKEVGWEHLGLIPTIFERLGITLERRGDDIYIPAHTEGYEIQ
NFIDGSILTVYDAPWPGFTPDLLSIILVTAIQARGEVLVHQKMFESRLFFVDKLIDMGAK
IILCDPHRAVVIGNDFKSRLRATTMTSPDIRAGVALLIAALSAKGTSTIHNIEQIDRGYE
CIEERLQAIGARITRV
>SEQF1602_02004 hypothetical protein
MEQSALEYNTERNELIIPEYGRHIQKMVQEAMKIADRTERNNTAKAIIAVMGNMNPHLRD
VPDFQHKLWDQLFKMSDFQIDVDSPFEKPTRESTTPNPQRLSPPQHRMKYRFYGNNILKM
IQICVGWEEGELKEALKFSIANHMKKCFLTWNKEGVEDSIIFAHLYELSNGKIDLGVLEE
NLTSKPTHYQKKNNNPPAVGKKSYGKGKRK
>SEQF1602_02005 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MQYTLSEIDSIAHTFVKEVLPHSHRVILFQGAMGAGKTTFIRSLCKALGVKDIVSSPTFS
LVNEYQGNPERIFHFDLYRIEDEAEALDFGIEEYWQGNDWCFIEWGERIPTLLPEAYSEF
VFTLIDDITRDISIIHHPTV
>SEQF1602_02006 hypothetical protein
MNLLRRFLLFFLGLSVGSIFVMFFFQRKDTEFCYLPNCRVLKSLRAKSLVLTDSLQAQGY
QKEQLLPLLTEGDVDFSRSDTHSACRTYVITGEDTAHTPLEITIKSCEKEAVITSITPLK
>SEQF1602_02007 tRNA (guanosine(18)-2'-O)-methyltransferase
MEMRKLGNEELHRLSVAQYKETPKIPVIVVLDNIRSLNNIGSVFRTADAFCIQKIYLCGI
TATPPHKEIHKTALGATESVEWEYVQDITTLVESLRQRQVEVIAIEQVEDAVSLEHFSPK
KGVTYALIFGNEVEGVQQSVVSLCQRAIEIPQYGTKHSLNIAVSAGILLWDFSYKIRGLH
>SEQF1602_02008 hypothetical protein
MFFFFCIFALKKVVSFTLMKSTLFYSKILLFGEYGIIKDSKGLAIPYNSYNGTLKKVPLS
EQNKEQEQSNSSLAKYFVYLSEITQGEAPLVQFDMERLSEDIAQGMYFDSSIPQGYGVGS
SGALVAAIYDTYAIDKIEATETLTRDKLLRLKEIFSLMESFFHGKSSGLDPLNSYLSIPI
LINSSNLIETTGIPTPYEEGKGAVFLLDSGMIGETAPMVEIFMEKMKNEGFRQMLKNQFA
KYTDDCIENFLQGNFKNLIVNVKKLSRVVLSHFKPMIPQQFHSLWKQGIDSGDYYLKLCG
SGGGGYILGFTPDYERAKKALSDHKLELVYRF
>SEQF1602_02009 Membrane-bound lytic murein transglycosylase D
MKKIQLLVLLCISSYSGISQVRHSVSDTLKNKRNNTQRVQRGTTHDTLSLSNIREGLLQL
KDDNKALKYDKKWLEELSNQSLYSTMQNDVETPPSNVSYDELPTEVLKERLARLDQKTPF
HIEYNPVLENVIKNFLKNRRASLQRLMNISQYYFPLFERELIKNQVPKEVKYLAIVESAL
NPKATSRMGAKGLWQFMYYTGKMYGLEVNNYVDERSQPELSTQAAAQYLKKLYSVFNDWD
LVLAAYNSGPGNVTKAMRRSGGKTNYWNLRPYLPNETAGYVPAFLATLYIFEYAKEHGFQ
VEKRENVFFETDTIQVKRSISFKDIGDVVGMSEQEIEFFNPAYSLNIVPYIEGKKYGVRL
PVEAIGKFVNNEDVIYAYLDQESSKREKPLPEVVAASQSSSSHKITHKVKKGETLGRIAS
RYGVSVSQLKKWNQLRSNSVKVGQRLVIRK
>SEQF1602_02010 Putative cystathionine beta-synthase
MNKIQYHDTILDLVGNTPLVSLQKIASPMLGQFFAKLEAFNPGHSAKDRTALYIINDAEK
RGLLTPGGVIVETTSGNTGYSIAMIAAIRGYRCILAVTDKSSPDKIDMLRALGAEVHVCP
ASVPADDPRSYYEVAKRIHRETPNSIYINQYFNPLNTEAHYQWTGREIWEQTAGEITHLV
ACSGTGGTLSGIARYLKEKKPSVKIIGVDADGSLIKKYFDTGEVDKGELHPYYIEGLGKN
LIPGALDTSVIDEFVKVNDTESALMARKISRTTGIFCGYTCGAAWVATQKYNQEHPFSKE
SVVVVVFPDHGSRYMNKIYNDQWLAEKLNIKD
>SEQF1602_02011 Acyl-CoA dehydrogenase
MDFSYAKELEIIAHAANAFAKQYILAHRQEWDKSQTFPIDVFRKAGELGFMGILVPEAYG
GSGLGYHEYITIVDEISQIDPAIGLSIAAHNSLCVNHLLTFASEEQKKRWLPKLASGEHI
GAWGITEHNTGSDAGGMLTTAVKQGEEWVLNGTKNFITHAISADVVVVIARTGEKGDKHG
MTAFVVERGTPGFSNGKKIDKLGMRASETAELVFQNCRIPDQNRIGAVGEGFIQAMKILD
GGRISIGALSLGTAKGAVKAAIQYAKERSQFGKPIISFQAIGFKLAELSTEIEAAELMLH
KAAHLKETHQPVTQQAAMAKLYASELCVKASNEAIQIHGGYGYTTDYPVEKFYRDAKLCT
IGEGTSEILKLVISRKL
>SEQF1602_02012 putative acyl-CoA thioester hydrolase
MNNLAPKKVSESRSVSTDLVLPNETNHYGNMFGGELLARMDRVGTIAAVRHSGCVVVTAA
VNSVSFNKTIPQGSVVTVEASISRAFTSSMEVYIDVWVEDSVSGERIKSNEAIYTFVALN
AEDKPVAVPEIIPETDLEKERYEGALRRKQLSLVLAGRIKPHEASELQSLFQDLENQ
>SEQF1602_02013 Replication-associated recombination protein A
MFDSRPLAERMRPVHLTDYISQSHLVGEKGALRMQIEKGVTPSLIFWGPPGTGKTTLAHI
IAKESQRAFFSLSAISSGIKDVRDIIEKSKREQGLFTARNPIIFIDEIHRFNKTQQDSLL
EAVERGWVTLIGATTENPSFEVIPALLSRCQVYTLNPFSKEDLLALLTRAIEQDVELKRK
KITLKETEALLRLSDGDGRKLLNTFELIVNTFPEGEEIVITNDKVLEIVQQNTVLYDKTG
EQHYDIISAFIKSIRGSDPNAAVYWLARMIEGGEDVKFIARRMLILASEDIGNANPMAMV
VANNTFQAVTVIGYPESRIILSQCAIYLASSPKSNASYKAINKAQQLVKQQGNLSVPLHL
RNAPTALMKELSYGKDYHYAHDYPHNFVFQDFMPEELQGTTLYEPCDNPKENALRAYLKS
LWGERYGY
>SEQF1602_02014 Putative hydrolase YdeN
MKVYIVHGLNSALDKHWFAYLVGELAKRNISCYCLPMPNPTAPNAQEWLDFLKKEIHMDD
QTVLIGHSVGCVSVLTYLANTGAKALGTILVSGFDEPLKRLPQLDPFIELYRKQPSIAPL
ANSYVFAALDDQSVPYQMIDDLSRHLDSVLIRYPHGGHFKEEDGYDTFPALLHKVEEIFK
K
>SEQF1602_02015 Putative pyridoxal phosphate-dependent acyltransferase
MKDLFEHIKTNKGNIGRWASHAEGYYVFPKLEGELGPHMKFQGKEILNWSINDYLGLANH
PEIRKADAEAAAEYGAAYPMGARMMSGHTTMHEELEQRLAKFVQKEAAYLLNFGYQGMVS
IIDALVTKNDIIVYDADCHACIIDGVRLHFGKRFTYQHNDIESFAKNIERAKRLAETTGG
GILVITEGVFGMRGQQGKLKEILSYKEKYGFRLLVDDAHGFGMLGKTGAGTGEEQGIQDQ
IDLYFSTFAKSMAGIGAFVAGDKEIVEYLKYNLRSQMFAKSLPMIFVKGGLKRLEMLQNM
PELRKKLWDNVHALQNGLRSRGFNIGNTNTCVTPVFLEGSIPEAMAMVNDLRENYGIFLS
IVVYPVIPKGMILLRLIPTASHSMEDIERTLEAFSAIRSKLEGGVYRAQNAALEAEMGTE
K
>SEQF1602_02016 hypothetical protein
MEIELDNSKAAMSKRLNEVFLYIRKNTEYVNQTLFAQKIGEPRSNFSAALNGNEKYMTEG
VVKKVVAAFPEIDKEWLLSGKGSMLVENDGYENDGQFLRTEREKYGLTLTDIYEHTHIPI
KKLKAYEMWEEEMPPRTRALLELYFDQVAFEYDSQEDEDLDIPILKTELVSSSVKVPYYD
VDFAGGWTSTELFSQTKPSFIISSPDFDRADFACNLIGHSISNRIRSGSIIGLKKIEDWQ
TYFPTNELYGVITKNQLRTVKIVKRSKEKGFLELIPDPLPQFNNPPFEPELVPMNYVLEF
YQVVAYAFFERLAM
>SEQF1602_02017 Lipoprotein E
MKKLYILTGLALLLGACQGQKVANTSHDDFLINGKMYAAFFQQQAAEYDALCYQAFNVAR
LRLDEALSHPSDKPIAIVSDIDETFMNTSYYAVECGRKGTEYESKTWEAWTAKGEGTPLA
GSLAFFQYAAEKGVHIFYVTNRKEVERAGTTLNLKRYNFPIQGEDHLIFRTAEKSKENRR
LDIAKNYNIVLLLGDNLGDFDKDFDATTTQGRAQAVNKNHSLFGKKYIVLPNPSYGDWEN
AFFGNKPLSFKERKELILSKLKNKPTE
>SEQF1602_02018 ECF RNA polymerase sigma factor SigW
MKSVTEEVAQWVDCYTQKLLDHAYYLLSDRTEAEDMVQEVFLTALSCFDSFEGKSNPLTW
LKGILHHKVADYYKKKYKAQHVSFDYFFDEDGSWKNNQNLEEWAEEEPDLVALLDDTYFH
DTLEDCLEKLPPKWKILIKMCYLEAKKYSEICQDIYISQTNYWKTLQRSRLQLRECLEIN
WFKE
>SEQF1602_02019 hypothetical protein
MKKILHKFIHFIILPCKDATFLIEKQLHTKLSLKESLQLKAHLQLCKLCLAYSKKAAIIH
QWLRKNLNNEIIRTSKDSDELENFKRNLKEKLHKHS
>SEQF1602_02020 Inner membrane protein RclC
MNHKKNTLVLYRIGYYTILYGTALILLWIGVFKFTQAEANAIKPLLTHHFLFSWLYHLFS
VQGVSNLIGIVEIIVGFSFILGIRFVCFRKIAFIGSTIIFCVTLSFLFTTPGKWRIIEGV
PITDFFILKDIALLATGFISLRKP
>SEQF1602_02021 Hydroperoxy fatty acid reductase gpx1
MKNILTLVLVALCTFVLQGQTSDNTIYSFKVKDLYGKVFDFASLKGKKVMIVNTASKCGL
TPQYKSLEALYQKYKDKDFVIIGFPSNSFEQELNNEAQVAQFCQANYGVTFPMMEIITVK
GEKMHPLYQFLTQKKLNMVTDSQVQWNFQKYLIGKNGMLEKVISPKTLPDTPEIIEWIEK
>SEQF1602_02022 Peptide methionine sulfoxide reductase MsrA/MsrB
MRKNLFLRIACLLIGLLAFPTIAQTNAKKMNTKEIYFAGGCFWGTEHFLKQIRGVVATEV
GYANGNTANPTYKQVCQGNTQFAETVKVVYSPTEVSLSQLIELYLKTIDPTSLNKQGNDK
GSQYRTGIYYTDKADATTIKAHLLALAKEYSKPIVVENLPLKNFYPAEDYHQDYLDKNPH
GYCHLSPALFEMARKANAKKTAPKTSYTTKDKATLKKELSPMQYEVTQNSATEPPFRNAY
WNEKREGIYVDITTGEPLFSSTDKFESGCGWPSFSKPIDKKLVKEYLDKSHNMVRTEVRS
KLGNAHLGHVFTDGPKDKGGLRYCINSASLRFIPKEDMEKEGYSLELLSK
>SEQF1602_02023 Shikimate dehydrogenase (NADP(+))
MKTFALVGRNISYSFSRRYFAEKFAQEQITDCEYINFDIPQIEDLPSLIHTTPTLVGMNV
TIPYKEAVLPLLNWQSEALVAIKACNTIKILPSGELKGYNTDYIGFRDSLVPHLKPHHNR
ALVLGTGGASKAVAFTLSMLEIPYQLVSREATPEAISYQELTREVIESHPLIVNTTPLGT
SPHTEAFPPIPYQWITSRHLLYDLIYNPGKTTFLAKGEAQGATIINGYSMLVLQAEAAWE
IWK
>SEQF1602_02024 Small ribosomal subunit biogenesis GTPase RsgA
MNGIVYKSTGSWYVVKGEDQQFYECRLKGRFRLKEIKNTNPIAVGDRVVFHQEEAPEKGV
ITEIVPRENYIIRKSVNLSKQTHILAANIDVAFLVVTLNNPTTYPAFIDRFLVTAQAYSI
PAVLLLNKVDSYSPDQLAEVKYMAHMYRDIGYECIGISAQTGKNIEQVKARLEGKTAMVL
GHSGAGKSTLINRLSPSLQLKTQPLSEQHAQGQHTTTFAQMYDLDFGARIIDTPGIKGLG
VVDFEREEIADYFPEFFALKHLCKFHNCMHLNEPQCAVKQALDQDKLYWSRYKSYLQLLE
GDDTYREGEK
>SEQF1602_02025 hypothetical protein
MQLLECSAMNGLQKLQQKLKNGDFFMIQKAVSQALTVFFCVKKLLKKDASLPVIFLSLLR
FFYRPPISFLAPRFLSSPPDFFPRPPKNLSLNDNDNVNVNDNVNVNDNDNDLFLFGKKKQ
KARA
>SEQF1602_02026 hypothetical protein
MAIRLVNGCINCENLTAENVCKLHQTKVEVKHTCDSFNMRPSLKDEVDCLSCAKYNTALC
ANRTHAAAGMLCNEWAPETTAEA
>SEQF1602_02027 hypothetical protein
MELFKGQSLLEFTERFKTDLDCEEYLASLKWEDGYCCRKCGHKKYQVRKDFSRTCNICGD
TESPTAGTLFHRLKFGLRKAFFICFEMTTTTKGLSASQVARRYEISRQTAHYFMQKVREA
MKSSESHKMNDRVQVDEFTIGGKEEYSFRINRSQNKDTIFNKLMKRIVERSPVSQSQLVC
S
>SEQF1602_02028 hypothetical protein
MNEKRNIKQKINLFIGSIGAFIGVAVFVAYIPQIMANLEGHKAQPWQPLFAAGSCLIWVV
YGWTKEPKPDYILIIPNLVGVVLGFLTFITSL
>SEQF1602_02029 hypothetical protein
MLLLELLFVYLLPLQFKIIMIKFFLTSFLTIGISLSSFAQWQQHIDYQMDIQMDVKTFQY
KARQVALYENHSPDTLRTVFYHLYLNAFQPGSQMDKNMQQVSDMPARFMHNAGTEAEPKY
ISKLSMLKENEQGFIRLQSLTQNGKTASYKVIGTILQVTLPEPILPHGKATLSMDYTAQI
PNIGVRMGRNSSDGVALSLSQWYPRICVYDAQGWHPYQYIFGEFYGDWANFDVKITLDKN
YVVAGTGTLQNPEQIGFGYNNIKEVKTRQKTRTWHFKAEKVIDFSWAADPAYQHDIVKTK
RGVELHFFYKNFPENWKKLQQIMPEVLDFYEAKVGKYPWSHYSFIQAGQGAMEYAMCTFI
EGGKDPEALIKTACHELAHTWFQHIFAIDEQQYPWFDEGFTCFLQLWADAEVVKKEPVAN
FSEFRHKAFLKYVSENQEEDPSIRADFFERSRSYFSTAYAKGTMFASHLDYIIGRKAMER
TFKRFYKEYAFTHPTPENFVRCAEKESGMQLFWFLKEFMHTTHHIGYCIEKVEAKGEKTL
VTLTKKGRIPMPLDLIVIPNGQKPFSLYIPTDLTFGEKPNPFINMERIVLPIWNWAEKTY
QFELNLPFTQVRNISIDPQEFMADPNPECHNY
>SEQF1602_02030 Cysteine desulfuration protein SufE
MTITEIQNAIIEDFSFLENWEDRYEYMIDLGKSLPLIDPQYKTDEYLIKGCQSQVWLHAE
NQGDIITFTADSDAIITKGIIAILIKALSNQKAADILAADMSFIDKIGLKEHLSPTRANG
LVSMIEQMKLYAKAITLKNK
>SEQF1602_02031 hypothetical protein
MSEEKTPIDTELIGEKIVEVLHTIYDPEIPVDIYELGLIYDVFINENHDVKILMTLTSPN
CPVAEVLPQEVYEKIGSIDEINEVEVELTFDPPWGQEMMSEEAKLELGFL
>SEQF1602_02032 3-deoxy-manno-octulosonate cytidylyltransferase
MKKIAVIPARLQATRFPKKLLEDLGGRSVIEQTYLATVGTDLFDQVWVATDSPEIAEKIK
HIGGEVFLSQIQHNCGSNRIAEAVENLPADIIVNVQGDEPFIQKKSLQPLLEVFDHDPKQ
QIDLASLMMPLTDPEEIANPNNVKVVVDSQSFALYFSRSPIPFARDTEREYTYKKHIGVY
AFRKDALMEFYRLSPTPLEEMEKLEQLRYLENGRRIKMVLSEVENIGIDTPEDLEKARKY
WKNIY
>SEQF1602_02033 hypothetical protein
MKKIVFLTALLSIVSITNAQDRQEAIRTQNVQKSWVKNIPFQALPLTRGAGEIIQIERNP
KDPYQLYVALSQSGVWYSDNNGASFTPTFSETMSPQTMAMAVDWDNRTLWVATYQGVFIK
EYAKDWVTAAPIGNMNVRQIVLTSPTNACLNALGEDGSIAGVLCTSDKGKSWKQTFAQVG
VSELKKVPSADQTLYMTAWDMEKTPYNINPSGKKSGIYKSTNAGDSWELISTAGSGFPQG
NIGKISLAVFSPTSLYALVDNRERVKEPLNEISLQGLSSKDFLELENEKINQYIYNHFLQ
NKYNANSLKEMVRAGIAPNELTKLTDALPAVVGAEIYYSNDGGKSWVKKNNKPLTNVFYT
KGYEVGALAVNPQQENELYLSGVPLLKSNNGGITWTLIKDNPMNQKVYQLSADGKQIILV
TSQGAFQSLDQGRTWAKQEMPQTAYVTSLTIGKPSEGALYANILNGGVVKYTNNQWLMVS
SENGKLITTPENKSFLAQPFGEILPLRQSRIVLPYDKKTKQRYPIETTLSLSPQNNTILY
AGANVLFQSLNEGKAWKAISPDLTNGDKGGNLSYGTISAISESPFQFGLLYTGSDDGMIY
TSDNGGVSWQMIYSSFPAQNRVSCLLASKHKQERVYAILQNSNHQALIFRSNNMGKSWDN
LKANLPEETANVIVEDPSNEQVLYLGTENGLYVSFDMGEKWHVFKQNLPRTSVSAIAINP
QDNQLYIGTKGHGFFTANIASLREIRAAVQDQLFYPLKDTYSIKYSAQWGNAENPWAAPK
VPVLYLESFASMDGTEVKISVVKNKITLSKFSYQTKVGFNFIPFDLVFNEEGRIAYEKKL
LTTFKKADNGKCYLPKGTYQLIFEVEGFEQERTLVIE
>SEQF1602_02034 Diadenosine hexaphosphate hydrolase
MYKVFFDNKKIWVTNNLRKARKKKGKLFSLTTLSVKDFLKKVEKAKSGKFVFYIDKGEDF
FSYFTSALICIEAGGGVVRNPKGRILFIKRKGKWDLPKGKLEAGEQIEECAQREVQEETA
LASLQLLGLRTITYHIYVQDQKYCLKKTSWYNMYSDATENLSPQQEEDIEVCAWKKPKKL
EKLLKNSFSSIQEVFKGEY
>SEQF1602_02035 hypothetical protein
MEIYTSRKKNIFLLFLSLLFLAAGIYFVLHGEEIAAGKRSPLLVQGIGIAAIAFALLALF
FTIKNLLNKRWVLRANPEGLYLRIRNELFIPWQEITGFEVFEVRGSKSVLIMLKDPQAYI
AKEKSPFLRKMMQWNLRLCGTSVSISSSTMQISHKELLALLIEYWNKYKK
>SEQF1602_02036 hypothetical protein
MYWTLELASYLSDAPWPATKEEIIDYALRTGAPMEVVENLEALEDEGEIYESIEEIWPDY
PTEEDYLWNEDEY
>SEQF1602_02037 hypothetical protein
MSNIDIVLGVFLGFGIVQGFLKGFIWGVTSLIAVFVALWGAIHFSAMVAPFISDIFSFSA
KTEQVLAFIITFLIVLVLVGLAGKLLTKILESVSLGFLNRIAGAVFGMLKWSLIVGTALM
YLNEGAMELIPKKTTEESLFYNPIMKTNTWIRTYIFQYKDSFSTESFLPKSPL
>SEQF1602_02038 hypothetical protein
MNWKIMSSFLLVGLLVSSCQWLSSSEKDRTIVAKVGNYYLYQEDIQKLLPKDYTLEDSVQ
IVTPYINNWALKKLLFLKAEENINKEKQEEFEHLVSQYRTDLYTQFYLDLLSQQIDTTIS
RKEREDFYEVNKEVFRLSEDLVQLRYIQLSSTEISPKLSAAFRTYSSKDRHYIDSLAPHF
TSSFLNDSVWVRASEVEEKLPLLKDKLKKSYLHQLIEERDSSSVYLVKINNFLETSDYAP
MEYAYPTLKQIILNKRKSKYINTLEKEIINSAIEKKQLEIYEQN
>SEQF1602_02039 Chaperone SurA
MNRISILCQLFLFSLLSTSALWAQSPKNKIDGVAAVVGDYLILETDIDRALVELKSQNVD
TKNVTRCQLLGKLMEDKLYVSQAIQDSIKISDNDIRDGVNRRIDFLVEQLGDIKKVVDFY
HKDDEQSLRDELFEILRQNELSSRMKAKIVENIEVTPEEVKQFFNKIPKDELPTIGTELE
IAQIVIEPKAPQSEIDKVIEQLKEIKKDVLENGTSFSTKAILYSADRATGGKELTFNRKS
SFAKEFKDVAFSLQEGEISDPFKTDFGWHILQVVKIRGKEVSVRHILMVPQIPQNSLEEA
KKKINDIRDKIINKEFTFAEAAKNFSDEKETREDGGQLLNPEDYSTKFELTRMEPLLYSQ
VASLKDDEVSTPIMDEDRTGRKMYKIYRVTNRTNEHTADFVNDYIRIKDLALKEKQLEAV
QKWIKGAIQKTFVSVKGEYRNCKFSNNWLKK
>SEQF1602_02040 Malate dehydrogenase
MKVTVVGAGAVGASCAEYIALKNFASEVVLIDIKEGFAEGKAMDLMQTASLNGFDTRIVG
VTNDYSKTAGSDVAVITSGIPRKPGMTREELIGTNANIVKSVVEQLVKHSPNIIVIVVSN
PMDTMAYLVHKATKLPKNHIIGMGGALDSARFKYRLAEALGSPISDVDGMVIAAHSDSGM
LPLTRLASYRGVPVSEFLSAERLSQVAEDTKVGGATLTKLLGTSAWYAPGAAVSALVQAI
ACDQKKLFPCSVLLEGEYGQKDVCVGVPVIIGRDGVERIVEVKLNEAEKAKFNESTQAVR
EVNKALEGVL
>SEQF1602_02041 hypothetical protein
MTEQQILKKIDKWNEDDHIQAIVDFIENLPHESKTTEVLSELGRAYNNLYWLDSNKENEK
YLQRAVEVFKYLEPEIGDTESWNYRIGYSYFYLNDMENAKKHLLKATSLSGTQELLDYLS
IAEEKGITLLDAVAGGRGGVEYILENYKRAIAQYAPQMTDRLGAPATEQKIEALEKRLGF
ALSEEFKQLHRTFDGQTGAPFYSAGQRFVSLDEIEAYQDEMEQYLEAHYGKNWQKVRIPE
DEFVEEGYIKNRLYSRKWVPFMVQELEGEDAPSYLCFDFDPDEQEGIFGQLIGVSPAEKI
EDCELDFIYPNIFQWANVMIEGMKKGQLAYSEEKDALEFLSRGNFEPSYYSEEERESLEE
YIQENIGEFDEVLHELVSPDIHCDIYIVKPTPERNYYTLVTGGMGAYAMNVPDGFNGSPY
AEMCINLPPTWNLKSEEEKDYWPIRWLKILSRLPIEQDTFLAWGHTVPTGEPLEGTNFTC
MLLIAADNKDGEDAVAHLAPSGKEVNFYSIVPLYEQEMLYKLENDSGALLELFSEKEIPY
PPVVDVHRQNVCEGYTPTQNSNLLDEVYWAFTQEAYPGLMIFWEAVKTYNSDVENDLEDF
NPFGTIFRSPKVKIMYEAWIKSRKELYDFEILANENLFDEEPDENGLYQALIVAELYSGD
GAAFGALELLWLIHNTLSNKDLGDHIFFEGFDIEGYEEDGTPVIFINCGS
>SEQF1602_02043 Nucleoside diphosphate kinase
MTTNQTFTMIKPNAVEKGHTGAIIDQIIKGGYRIIALKYVWLSQREAEKFYEIHKERPFF
AELVAFMSRSPIVAIALEKENAVEAFREFIGATDPAKAAEGTIRAKYGESVGENAIHGSD
SNENAQREIGFFFSGREVY
>SEQF1602_02044 hypothetical protein
MRKIYLPFTILLILNSLLLQAQNKTYKIRTVAFYNVENLFDTINDPKKFDDDRTPTGKDH
WTSKHYYDHVNKLGQTIAKIGKDVTGQAPDFVGLAEVENREVVEDLVNSEALKDNYYGIV
HYNSPDARGIDVAFIYKQSVFKPTKTSKHFLDIKDAAGKRRYTRDQILISGEMDGEEVHF
IVNHWPSRSGGEAASRPLREAAAALNKRIFDSLTAINPMAKVISMGDFNDDPTNSGFKKI
LKTKADKKKVQQGDLYNPMENMYKKGIGTLAYRDSWSLFDQFVLTYGYLAKEAEGYKYWK
AGVFNSPELANPSGKYAGYPYRSYANGSYTGGYSDHFPVYLYLIKEF
>SEQF1602_02045 hypothetical protein
MFLFLYLQKKPILMKKILLFLLLAIFLTSCFFKTKDNKENKEPQETKEVKETKDDNMKWT
AKYNFMDLYKKRNHGFNPGSDKELSLVFSPMENVIILGAQKDTPNFDPTATEKQAVLYIS
TDRGQSYKELILEGNDVYDMVAYTKDYSIIKTSGDKNKYVYLLNHTTFQFKKIDIYHRGD
ETYYSDFDGRFLKCEKNEIRFLADVLSKDSVKLYEIPKKLTAYQYYPIHQNGDILYYNKI
LELRTYNVITGEDKLFNQLKHKYNYFFPENSSDYNTPLSLQNAKNENDEETYELMIYDLK
ENFVRKITKENREKHYYYKDFICDYTKLHTHTELRFSFDKGKTWKTHKIPMVGLFGFNKN
VGFFEDKYIVFEGIFFRGDSPESGGRIMVGEFLKD
>SEQF1602_02046 hypothetical protein
MRYLIIFLSFLFFYSNAQPLPSIIIVDSISFSKKPLFVKKIKANNIKTTIYFLSLSMKKT
MPIAISNNGKNIFIYKKDTMSIILSLEERKQILIQNLHFQKGEYTINLKDCNFQSDYYIK
NFPCDCLNYRREEE
>SEQF1602_02047 Energy-dependent translational throttle protein EttA
MADDKKIIFSMNKVSKTYSSTNKQVLKDIYLSFFYGAKIGILGLNGAGKSSLLKIIAGVD
KNYQGEVVFAPGYTVGYLEQEPKLDEEKTVIEVVREGVAETMKLLEEFNHINDLFGLEEN
YSDPDKMQKLMDKQAELQDKIDALNAWEIDNQLEVAMDALRTPDPDTPIKVLSGGERRRV
ALCRLLLQQPDVLLLDEPTNHLDAESVLWLEQHLQQYAGTVIAVTHDRYFLDNVAGWILE
LDRGEGIPWKGNYSSWLDQKAKRLAQEQKAESKRQKVLERELEWVRQGAKGRQAKQKARL
QNYDRLLSEDQKQLEEKLEIYIPNGPRLGTNVIEARHVSKAFADKLLYDDLNFVLPQAGI
VGVIGPNGAGKSTIFRMIMGEEKPDSGEFLVGDTVKIAYVDQTHKNIDPEKSIWENFSDG
QDLILMGGRQVNSRAYLSRFNFSGSDQNKKVATLSGGERNRLHLAMTLKEEGNVLLLDEP
TNDLDVNTLRALEEGLENFAGCAVVISHDRWFLDRICTHILAFEGDSQVYFFEGSFSEYE
ENKKKRLGKEVTPTRIKYKKLVR
>SEQF1602_02048 hypothetical protein
MWKSFYIFIFLFFVYLRHKIVFNQKFYIIRQMKVFLTALCCCASFFTFAQPKLEETWKDS
HLNETLETPLGFLRKEKTTVEKVDYFLGVDKSNKIKYIETSSPAFKVSNYNLNTKLFGFK
NYTYTRYFEGWGYYLRINASWCAFFGKAKPTKDTRPVFFFNYNFGAAEGKPIFDANYEEV
LAAQQKAEKEKAEKKAKEKEQQAQKKAEYEKEAARLAKEKAEKEKAELERKQAIQKEVEK
KKAEEEAKKKAEDEAKQQYAREVAAYNAQKEAEKKAKEEEKKRKSEEFRTGQRVVNTELA
QAGSTATTSSTEALQGGEKYLDETLKAKLKKSLRDYQAYINKNQKRTEAYPLVLVNYKDV
MEYSQSELSKITKVNSTTVFKKGAKRTEDFKEKGLNGVVIIKVEFSK
>SEQF1602_02049 hypothetical protein
MQGAAIDTSVKEAYKGASLMIYSKQSGKLRTMLKEGKALIEGAIGKEPQNIELRMIRLSV
QEHLPKIVPYRANIEEDRKFIQDHLAQQPQPLKKYIENYIND
>SEQF1602_02050 hypothetical protein
MLENFYTLNQIESQGEGKYLCRITLNAAHPIFAGHFPDNPVTPGVCMLQIIKNITEKITQ
KKLFLSKTSQVKFMTLINPNTAGELTLQLELAEHPDTIVVKNTTSFGDTVALKLTNTYKL
C
>SEQF1602_02051 hypothetical protein
MKRLLSYSIFLLLLSCGASFSLPEGYQKERAGEKITHPYFGIGEHQLRATIEAYGHSFNG
VLAIKTVTDSYRIALITDFGNTLFQFYYRRGEGWRVEYITEALDRKPLIRLLQRDFEDLL
QADRYADKYTHNQEVAYVATEGKRKVYLFENQDKKIYKQENIKGSKHYTTFAANYKAAGE
LSQIVIEHHTVPVKITLDVL
>SEQF1602_02052 Outer-membrane lipoprotein carrier protein
MREIYILLSLLCTTLLWGQQPLTQVQANAFKEKVVQKNKAIKTMQASFVQKKHLEFMSKD
METKGEMAFSKPDKLNWSYTTPYSYRIVFQGDNIKVDDAGKVSQMKADNKVFKKINQLIT
RSVSGDMFDQKEFAVTFFTSGKETLTKLLPKDKTLLKYIKEIHLFFSPDATVGRVKLIEP
TDDYTEITFTHQQFNTPIDEATFKL
>SEQF1602_02053 Homoserine O-acetyltransferase
MDELKYIEINNFTTLSGKVYPKIKLTYQLFGQPLGEAPVIVVNHALTGNSQVIGKEGWWN
QTVGEGQPFNTLTHTVICFNIPGNGYRKGELLTDYKAWTARDVARIFLLGLELLGVEHVD
ILSGSSLGGGIAWEMLALAPQYVTHFFAVATDWKTTDWVIANCLIQERLLEGNNPLHDAR
MHAMLCYRTPASLKEKFDRSINIERNLFNTETWLLHHGEKLQNRFTLEAYKLMNQLVKTI
DICKDRGGFAQVMAPITTQIHIIATDTDLYFVPEENRLTYEALKQMGKKTTYHEIHSIHG
HDAFLIEFDQLDAFIRPCLS
>SEQF1602_02054 hypothetical protein
MNNLFHDYTSEQFQAQALAVFAFQYQNNAVYQEFCNYFGKTPQSVHTLWEIPFLPIEFFK
SKEVYAATTPFEEVFTSSGTTGSQTSRHLVSSLALYRESFRKGFAYFYGEVEEYIFLALL
PSYLERKGSSLIYMAEDLIGHAQKESGFYLYNQEELAQKLSVWDTQGRKIFLMGVSFALL
DLVEQYQFSLKNTIVMETGGMKGRRKELIREELHSILCKGFGTEVIHSEYGMTELLSQAY
SQGNGLFYPVPWMKILIRDSEDALSPLPYGKIGGINVIDLANYYSCSFIATQDLGKAYPD
GSFEVLGRFDAADIRGCNLLVLQN
>SEQF1602_02055 Ribonuclease HII
MEKWFFSPQEAGTDEAGRGCLAGPVTAAAVILPEDFYHPLLNDSKQMTEKQRNLLRPIIE
EQALSYAVVHLSPERIDQINILNASIEAMHQALDKLTLTPEFVVVDGNRFKPYKEIPYSC
QVKGDGRFMRIAAASVLAKTYRDAYMETLHKQYPMYHWDKNKGYPTREHREAILEYGACE
HHRKTFQLIDIQLKFDF
>SEQF1602_02056 Cell division ATP-binding protein FtsE
MAKPVVELKDVSIFQRKNLILHDINLTIERGEFVYLIGKTGSGKSSLLKILYGDLPLKKG
SGMAVDFDLATLKEAEIPYLRRKIGVVFQDFKLLPDRTVFGNLEFVLRATGWQDAHKIET
RINSVLTKVKMQTKIQKHPHELSGGEQQRVAIARALLNDPDLILADEPTGNLDPETSVEI
MKVMREINDSGRSILMATHDYALILKFPSKTIKCDAGKLFEVVQRTV
>SEQF1602_02057 Long-chain-fatty-acid--CoA ligase FadD15
MDLEKFHLVTRLAYQAAHYKDREAIRYWEEGQWRPMSWTVFYDKIQELAKALLHHKVGVQ
EKVGIFAPNSPQWTMVDMAAAHLRACAVPIYATNTADQAAYIINNAGIRILFVGEKEQYE
KVAQIKEQCPGLQCVILFNETLLDKEDTFVLPLSQFVRTGQEEEYEQLLKERVAQRNMQD
IYTIIYTSGTTGNPKGVLIDYENVAYQFINHDDRLAVVEGNVSLSFLPLSHVYERMWVAY
VLHKGVINCYLDDTNRVAEVLKEVRPHYMCVVPRLLEKIYTKIYENVEKQSVLKRLVFAT
ATRIAKIQLGRKKKGKKPSFLLQKAYNVADRVVFQKLKAALGGNIQMIPCGGALLEPSIG
RFFRAIGVNVTLGYGMTETTATVSCWDDHKFKLKSVGTLVPNMQVKIGENNEILLKGGSI
TKGYYNNPEENAKAFTEDGFLRTGDAGYIDKEGNLFITERIKELMKTSNGKYIAPQQIEG
KVGKDSFIEQIAIIADARKYVSALIVPNYDALAEYAKSLNLKYKNYAELIKNSQIVEFFQ
KRLQNLQQELASYEQIKKFTLLTTPFSINNDELTPTLKLKRKNIYKNYFREIEAMYA
>SEQF1602_02058 Succinyl-diaminopimelate desuccinylase
MDIKNYIEENKERFLSELFALLRMPSVSADSAYKSSIEDTARWIKEALLAAGCDKAEVCE
TPGNPVVYGEKHVGDNLPTVLVYGHYDVQPADPVALWDTDPFEPVIKKTELHPDGAIFAR
GACDDKGQMFMHVKALEYMVKEGKLPCNVKFMIEGEEEVGSKNLGWFVERNKEKLKNDII
LISDTGIIAKDTPSITTSLRGLSYMEVEVTGPNKDLHSGVYGGAVANPVNVLSKMIAQLH
DENNHITIPHFYDKVKEIPAEERALFAEIPFSLEEYKKDLGVADVQVEKGYSVIESSAIR
PSLDVNGIWGGYIGEGAKTIIPSKASAKISMRLVPDQDNKEIEALFTKYFTELAPEGVTV
KVTSLGGGPAYAMTIDNDGYRAAEKAMEKTFGKRPIPSPEGGSIPIVALFEKELGTKSVL
MGFGYDSDLIHSPNEHYGLFNFFKGIETIPYFYEYFVEIHKK
>SEQF1602_02059 GMP synthase [glutamine-hydrolyzing]
MDKVLILDFGSQYTQLIARRVRELNVYCEIHPYNHLPEGVEDFSAVVLSGSPYSVRASDA
PHPDLSLFRGKKPLLAVCYGAQYLAHFFGGEVAPSDVREYGRAHLVYLKDNEPFLSGVPA
NSQVWMSHSDTIKQLPTGAVRLASTPDVENAAYRIEGEDTYAIQFHPEVYHSTDGKQFLA
NFLFKIAKLTPSWTPDNFIETTVAALREQVGKEKVVLGLSGGVDSTVAAVLLNRAIGDQL
HCIFVNNGLLRKGEFQSVLAQYQGMGLNIKGVDASGEFLSALAGITDPEAKRKTIGRVFI
EVFDKEAHQITDVTYLAQGTIYPDVIESVSVKGPSATIKSHHNVGGLPDYMKLKIVEPLR
TLFKDEVRRVGASLGIPAELLGRHPFPGPGLAIRILGDITPEKVATLQEVDAIFINSLKD
NGLYDKVWQAGAILLPINSVGVMGDERTYEKCVALRAVESTDGMTADWVHLPYEFLQKVS
NEIINKVKGVNRVVYDISSKPPATIEWE
>SEQF1602_02060 hypothetical protein
MRIFVFLLSLLPLSTVTAQESNVRIGAKAGLSLSTFSRGFLYQQNDFSYVSSFYVGAVLG
VRTDRNISGKLELMYSGQGSHYKDSYNAQYGGRYSLGYLSMGYIIHFRLLEFLYLDAGLT
TDLLVKKDSKVPSPRTFDVAGLVGVEAPILPSLSLEARVKSGQGNINNYTNYYGGQAPFN
TDLKNLVVQMGVIYYF
>SEQF1602_02061 Fosmidomycin resistance protein
METKQRTQYLIIILISLSHCLNDLLQGVLPSIYPALQSKFALSMAQIGLITFCYQIAASI
LQPIVGAYTDKHPKPYAQVVGMAFSALGIGLLSWVDSYTLVLCSVVFVGIGSSIFHPEAS
RISFLASGGKRSFAQAVFQLGGNAGAALAPLLVIWIIFSKKVVEGKLVEESHLERLLWFV
LFPMIAIVILFFIGTWRKKLLKQAQTVKKKEIPLPDLTHAQVRNSMIILMFLVFSKNFYT
SSINNYLQFYTIKTFGFSDTQAQLYLFYYLGAAAAGTLIGGFFGDRVGRKFIIWFSILGA
APFALWLPYADAQTTAILIVLIGFIISSAFASILVYAQELLPKKIGMISGVFYGFAFGMG
ALGSAVLGKLIDMTSITFVYKVCSFLPLMGLIAYFLPNLKKVKMRE
>SEQF1602_02062 hypothetical protein
MNLFLVDSKKNINFVAPNFLRMLKRNLFLGISAIATSLTGNAQDYQWKEAQSGGYTYRYV
TNDPTNARFYTLKNGLTVILSPTNKEPRVQCYVAVRAGSKTDPATNTGLAHYLEHLLFKG
TDKYGSLDWAKEKVELDKIDALYEKYNKTKDPAQRKEIYKEIDRVSGIASKYAIANEYDK
MMSAMGAQGTNAFTSFEQTVYTDDVPANALDKYIAVQAERFRNPVLRIFHTELEAVYEEK
NRSLDNDGSLVLETLLANLFKKHNYGQQTTIGTVEHLKNPSLIEIRKYFNTYYVPNNMAV
ILSGDFNPDHAIAKIDKAFSYMKEKSVPEYTFAPEDAITSPVIKEVVGPDAESVTIAFRL
PSNQDKDAALANLVGSILTNGKAGLIDLNLVKKQKLLKASAYSYLLVDHGLLYISASPSQ
GQSLEDVKKLVLNEIENLKKGNFDDDLIPSIVNNIKKHKIQQTESYGDRAYMLMDAFTGK
LNWRDQVAYVNDLSKVTKKDIMDFANKYFGNNYVAVLKHKGERTDIEKIEKPTITPVETN
ADKQSAFVKMINQMPSTPVAPVFLDYNKDLQRSKLGKAEVYYVQNKENQLYRLNFRYKIG
TLNDLKMGLAAQYIQFLGTDKKSAEQISKEFYKIASSFRVHTADEYTFVTIEGLQENFEA
AVTLYENLIQNLKADDQALEALKARIQKYRSDVKANRNQIMQALTSYALYGPKNKYNHAL
SNAEIASTTSQELVERLKKLNDVEQIVIYYGPATMGELTSKLSSLHKVPATFAKVAPAKV
FKQVEQTKNQVLFTDYEMVQAETRWIRNTVPYNPAESTVIKVFNNYFGGSMGSLVFQTIR
ESKALAYSTYGMYRTPRKKDEKYYMLAYVGAQADKLKEAVSTMDDLLTTMPELPANLDLA
KAQLKKDIQTERISQDDIIYNYLNAKELGLTKDIRKEIYQNLDKITMSQVKAFHDKYLSK
KPYTYVILASEKKLSKEELQKIGEFKKLTLEELFGY
>SEQF1602_02063 Outer membrane porin F
MKKMVLFLLGGLVMTSCVSNKKFRAVQEQLKTTEDLLNTATIKLNSCLKDKELLQSKNEM
LAKNNEGLMTNLGNMTILTQKGADNLERSLESLKEKDLTIKNLRDAVTRRDSINLALVQS
LKGVLGNLDDEDITVQVDKGVVYVSISDKMLFSSGSYNVTPRAREVLGKVAKVVNNKPDF
EFMVEGHTDNVPIKNTCIKDNWDLSVLRATAVVRILQNDFGVTASRMTAAGRGEYVPVTS
NASADGRALNRRTRIVVLPKLDQFYNMIEQGMKDPKIN
>SEQF1602_02064 Peptidase T
MEEKKIIDRFIRYVKVDSQSDPEGTETPSTQKQWDIVHLLVEELKEIGLSEVEVDQYGYI
MATLPSNVSHTVPTIGFIAHYDTSPDFSGANVNPQFVHNYDGGDIVLNAKENIVLSSSYF
PDLKKYIGQTIITTDGLSLLGADDKAGVAEIVSAMEYLLAHPEIKHGKIRIAFTPDEEIG
KGPHKFDVPKFGAQWAYTMDGSHIGELEYESFNAAGAKIHIKGKSVHPGTAKGRMVNAVL
LASKLIEALPENEIPERTEGREGFFHVMNIKGDVENVYINLIIRDHDRNKFNARKELLST
IVKDFQQKHKDAVFELEVEDQYYNMREKIEPVMHIVEIAEQAMKDAGVTPVIQAIRGGTD
GAQLSFKGLPCPNIFAGGVNFHGKYEYLPVPSLFKAIDVILKIVELTAKRSEQ
>SEQF1602_02065 hypothetical protein
MRKAKYGSYVIGLWFVLLIVACHHQRDKIITLQEAEEKVLSLPLTQKINEYIDKFSDGKH
GVSILSDSLLIDNKYFYELQIGYNSPIRYETYYTLYVNKSNEEDIRIMEPISGEIIPLSQ
WREDTSSYENPSEEVSDNLSCDELLTQIVQSSNITLIVKSSDCYVVQDRVEKDAIYAGVY
TPTEGESKTMVLAWIKYNVREAKLYDITKDPDQPIELDFDKKLPVGYDFESQCGANSQRE
>SEQF1602_02066 Tyrosine--tRNA ligase
MRNFVEELRWRGMIQDIMPETEQHLLEGLRAAYVGIDPTADSLHIGHLVGVMMLRHFQNC
GHKPYALVGGATGMIGDPSGKSTERNLLTEEALAHNIAGIKKQLAKFLDFESTASNRAEL
VNNYDWMKGFSFLSFIRDIGKHITVNYMMAKDSVKKRFDPNENTEGMSFTEFSYQLLQGF
DFLHLYQEKGVTLQMGGSDQWGNITTGTELIRRKASGKAYALTCPLITKADGTKFGKSEG
GNVWLDPEKTSPYKFYQYWINTSDADAQRYIKIFTMLPKEEIETLTAEHLQAPHLRILQN
KLAEELTLLVHGKEEWEKAVQASGILFGNSTSEDLKKLDAKTFLEVFDGVPQAEIALDDL
KNGLDMIAALSAKTGFIKSNSEARRALGENSISVNKEKVTEGYCLSEKDLLNQRFILLQR
GKKNYFLIIVK
>SEQF1602_02067 Inner membrane protein YjjP
MKEIERVAQLLADINFVLITGGANTRRVLRNVNRIAGALNYRCDIFYSFSAIILTLYNNT
TGEKETVVKSIPHHGVNFNAISDISILSWRILEKKLPINVIEREVAYIKGKSHYNMYLMW
FFVSLAGGSLAYIFGGDHHNSYLEFGMSFLATLLGLAGRRILQLRKFNIFICWAWAAFIS
VSVVNGFRLLGVEEYKNALASCVLWLIPGVPLINGFIDLLTGYVVAGIAKLAYAMMLIFM
ISIGFYLSLFIFGYELL
>SEQF1602_02068 hypothetical protein
MNFFDAFALLAERIFWSMWVSIGFALLFNTPRRALWATALLGAIGWSTKFLLIKTLIPDQ
VVIASFVGACVVGFLGMYFAHRVHTPPMVFTIPAVINMIPGKSGYEFMMGLIKIVTITHE
HNQTLETIFETIKLALQTGFITLGLAFGVIAPVLLFNTYSVKDKDLNKFIARKIKRIYKR
ERKTPH
>SEQF1602_02069 hypothetical protein
MELQGRIKLITPIQEYGANGFRKRELIIVTEEQYPQTISLEFTQGNCELLNGYQPGQVVK
VTFDVRGREWTNPQGETKYFNSLVAWRIVNVEAQAQAPVQASTQATPPPPPPAQAPQGGT
TFTAQPAVAPSGNDLEDDGLPF
>SEQF1602_02070 Acetate kinase
MKVLVINGGSSSFKYQLIEMDTETVLAKGLAERIGLEQGKISHEYWENGQKNKVSKEMHF
DNHEVAFKEMAAYLTDEKIGVIHSISEVKYIGHRVVHGGKFTAPERVTPQVMEELRKMIP
LAPLHNPASIIGIEAAQKIFPKETENFVVFDTAFHQTMPEKAFRYAIPNHFYTEDKIRRY
GFHGISHKYVDERTRRHFNNPHLKNITLHLGNGASMAAVDAQGHCIDTSMGFGPNEGLLM
GSRCGDIDSAVVFFLGKKGLSNDEIAEIFNHESGMKGITGSSDARDVEALAEKGDPNGIL
CLDMYAYRVKKYIGAYAAALNGVDTLIFTAGLGENASIIRQLVCEDLEYLGVKIDAEKNK
SLNHPSDIVEIQAPDSKVKIVIVATNEEIQIARDVLSLV
>SEQF1602_02071 hypothetical protein
MKKILFTFSLLVCLLLASCSGNSPKVVAEKFLKAINKADFKEAKKYCDKETAEFIGVLEG
FSKGEKAKPEDIKSFTITKVEEDGDKAKVYYKSEGSDKEESLDLKKVDGKWLVSINKEQG
NKEHGAPGEEGDDHAHPDDADMGDEPHEHEGEPAQDSIPAM
>SEQF1602_02072 hypothetical protein
MNRRIRLFFLCFGILFLFLWGGFRLFFWVDTLQEKKQVTRNSSIIRLTPEQLALLEEGDI
ILRRGYGFFSDIISQKLNDSLFDVTHSAILYRENNKWRVIHSLSSDVSPIDGMQSQSLHD
FLRHSMPEKLLVVRPKKITPEQGKEIVSRAKYYLSLKIPFDHIGTIDEPSKLYCSELIYQ
ILDHDLHLVSFPTEYKKRKEAFYTMRTLYDPQYFEIIINTYPK
>SEQF1602_02073 hypothetical protein
MKKIAFILLITASSFASAQVIDTLKTNVSNEQAINEMKTNLEAQKEALEAKEFAIKQEAA
NRKLAERELKLKERQQKEAERQQKQAEKQQKEAEKLQKKQQKQLEKEQKLKEKQLKQAEK
DAKAAQKRETKKLKVQDKLAKAQIKKNKAQADYDKQDLKLKTELSRGNLSAEKELKLRTK
LLKSKSKLIDAESNVKNLEIELQRLK
>SEQF1602_02074 Putative zinc metalloprotease
METILIKAGQLVLSLSILVILHELGHFIPAKLFKTKVEKFFLFFDIKFALFKKKIGETVY
GIGWLPLGGYVKIAGMIDESMDKEQMAQPAQPWEFRSKPAWQRLIIMIGGVVVNLLLGFF
IYSMIFSVWGKDIFTSKDVPHGYEVSETLKSYGFTDGDIPLKVNGKDLENTFAINKMILT
RHVENITVQKPDGHVVTIAVPDSLGMQIFRNDRSPIPFYKRRTTEIDSVMAGSAAQKAGL
LKGDRLVSINGHPIEFFDQVKGHLTEGENTIEVLRAGQTQSVSITPDKGILGVFAAHFYD
TGSTHRSYSFSEAISEGVSFGYWTLRDYITQFKYIFTKKGASQVGGLGSMAGLFSPQWDW
LHFWEITALLSIILAFMNILPIPALDGGHIVFLLYEMVTGRKPSEKVLEYAQMVGIIIVF
ALLIYANGNDIYRWLTGGK
>SEQF1602_02075 hypothetical protein
MLYNLLNTTKTARFFAIYGMGVLQLLLCRYGILSLEISPTTLLETLLMSFLLLVNLSTIN
LLVRKNQLSEGNLLVPFLWVLLIFFFPKVYQDSSVMLANTCLLLLSSLIIYLRNNTDGRE
IFFNSSVLIFVGSYFFLPSLLWLLLLWAHILIYPSKRLRNMLIPLVTFVLLGILSLAIAL
PMGKVAALVERYYFIPDFSYEAFVHPSYLPLYTIIILNLTLTSWIFWGSYKRYISRFFVG
VVLVGLLGIILFPNKNAVGMVYLTFPTALSLMVLIERIRRVWLKELLLWLLLIASFGIIL
LTSR
>SEQF1602_02076 hypothetical protein
MQRKILPILLLLTFLLVSCRKEDRQRNPYLQEAKFSRTINLRLAEYNRLRIPGTAVLVDN
VGLRGIVVANIGNNFLAWDRACPSQALAECSQMTLESDNLFMLCPCTGVKYNLLNGYPQK
KADTDKEKNTNYPMLNYQVVVQGDLLTISN
>SEQF1602_02077 hypothetical protein
MIYRILISSVLLLVISCSGDIQPKPKAFLRLEYPEPTYDTIKESCPFSFEKNHLSFLNLQ
KGCSMNLDYPQMKATIYITYKPVKDNLTKLLKDAQNFTYEHTIKATNIVEQPYLNEKDKV
YGMFYEVDGNAASQSQFYITDSVNHFITGSIYFKVRPNYDSIYPAALYLKRDIRRIMETT
HWK
>SEQF1602_02078 Magnesium and cobalt efflux protein CorC
MDTDSSISQLLASPTADLIIRAFIFIFLLGCSALISGSETALFSLSNTELEEEEEKGQKT
IVQLLRKPQKLLATILIANNLVNISIVLVFAPLGEFLFGGMNEWVRAIFEVGILTFVILL
CGEILPKIYANRNNRIFARKVAPIIKVLDTLFTPISGIMTLFTTFVNNRLHKSSSISVGQ
LSQALELTSQEDTTQEEHKILSGIVSFGNTDIRAVMHPRIDISAIEESMTYREVLTFIQE
NGYSRVPVYQENIDKITGIIYAKDLLPYLDEEDFDWRKIKRKAFFVPENKKLDDLLTEFQ
QRKIHLAIVVDEYGGTLGVVTLEDIIEEIVGEISDEYDMEDTFYTKIDDRNFLFDGKTSL
KDFYRVLSVEETDQEDFEKVRGESETIAGFLLELIESFPEKKQEIPYKHYIFTIEDIDKK
RIKQLKVTIR
>SEQF1602_02079 Single-stranded DNA-binding protein
MNGTLNKVMLIGRLGSDVKLTYFDKDSCTGQVSLATDESYTDKTTQAKVENTQWHNVVFY
NKMAERVEKYAKKGDLLYVEGRLRTRQYQGQDGVTRYVTEVVALDINFLSPKRSTEGQAT
PITTTATAAQAEPTAAAEAAPTETGGAPF
>SEQF1602_02080 Adenine DNA glycosylase
MKEQTTEIAVLLLTWYAAHKRELPWRGAGNPYYIWLSEVILQQTRVAQGLPYYQRFVEQF
PTVEALAQAPEAQVLKVWQGLGYYSRAKNLQRAAQYITEELQGVFPSTYETLLKLKGVGE
YTASAIASICYNEPKAVVDGNVYRVLSRIFDIDTPINTTEGAKYFKELAQELLDKERAGE
YNQAIMDFGALQCKPQSPDCESCILSAKCLAYHRKKVTQRPVKIAKIKPIHRYFHYCVLK
DSQGNTQLHKREAKDIWQGLYEFPLIEVKENTTEAQVIETIRAQYPHTTYIKKYATEFLH
KLTHQHLHTCFWEVEVAEVLSDGLPIRELVHYPMPALLIKFLKKEKI
>SEQF1602_02081 Phosphatidylserine decarboxylase proenzyme
MFYKPHKEGVKIIFGSTAMVALFLILIDQFVTIEWLRVTLMLVVLAFYILILQFFRNPKR
ETPINPNHIISSVDGKVVVIEEVEENEYFKDKRRMVSVFMSPLNVHVTRYPMSGEVVYSK
YHPGKYLVAWHPKASEENERTTVVVENTQFGKVLYRQIAGALAKRIVNYAKEGDQAVQGE
DAGFIKFGSRVDIYLPLSAKIKVTLGQKVKGGIDIIAEV
>SEQF1602_02082 hypothetical protein
MKKLYLLFLMGGFLGSFQGVAQQLKINQSQQIKDLMEVKKEFSRQEKTYQIQVYNGNVTE
ANEHVKRATSKFPYPSFLVFETPNYKVRMGLFRTRLEAEKALTKVKNTYPAAFVVAPY
>SEQF1602_02083 CTP synthase
MNNTKYIFVTGGVTSSLGKGIIAASLAKLLQAKGYRVTIQKLDPYINIDPGTLNPYEHGE
CYVTEDGAETDLDLGHYERFLNVFTSQANNVTTGRIYQSVIEKERRGEFLGKTVQVIPHI
TNEIKDRIQLLGKSGQYDIVITEIGGTVGDIESLPYIEAVRQLQWELGDNNAIVVHLTLV
PYLAAAGELKTKPTQHSVKTLMESGLKADVLVCRTDRDLPDDLRQKLALFCNVKKEAVIQ
SIDVPTIYDVPNLMLLEGLDKVVLKKLALPDTQAPELTQWNTFLQRHKNPKHRVRIGLVG
KYVELPDAYKSILEAFIHAGAENEVKVEVIMIHSEYLDETNLVDKLSTLDGVLVAPGFGE
RGLEGKIKAIQYVREHNIPFLGICLGMQMAVIEFARHVAGFENAHTAEVNPKAIYKVIDL
MEAQKHITQKGGTMRLGAWDCELLEGSRVYEAYKSKHISERHRHRYEFNSEYRKPLEEAG
LLCSGTNPETGLVEVVEVPTHRWFVGVQYHPEYKSTVAHPHPLFVAFVQAALQYKLEK
>SEQF1602_02084 Membrane protein insertase YidC
MEEKRNNTFSLIGFALMFVVLIYYMYNQKPPQQTTESTNNTTQQSSSQQVATPASTTLPT
DSLGLSKYKETLGAFGFSAALPSAKEGAFTEIENNLIKLQVSNKGGQITNLLVKNQKTYN
GKPVELIKDGNASFSLKFTTNDNRTLETKDLFFSPTLSGNTLSMKLHVSDNQYLEYVYTL
RPDEYMVDFSIRSVGLSQVFNTGVTPELLWKLKARRMEKSVTYEDRYVQAVVQYEDNRDD
KLSAGGEDSEEFKSIKWVDFKQHLFSSFLISDKPLASGKISSKNLATSEGDNVQATKAFA
AEFPIAFTSGELSESLHFFYGPSDYHIFKKYDKEYGLTKAIPLGWGIFGWINKWFVIPVF
DLLSSFMAVGVAIIVLTIIVRILLSPIQYKSYLSQAKMKVLRPEIEEINNKYKGSENAMK
RQQETMALYSKAGVNPLSGCIPALLQMPVFFALFSFFPTAFMLRQKSFMWAEDLSSYDAV
AQLPFSIPFYGNHVSLFPILASVTMLIYMLMTTGQMQQTKQEGMPDMRFMMYLSPIMMLF
FFNNYASGLSLYYFISNLITIFIMLAIKYWIIDEKRIHAKIQENKQKPRKESKFQRKMRE
MMEQAEAQRNAQNKKK
>SEQF1602_02085 Enolase
MNIILDVHARQILDSRGNPTIEVDVITDSGARGRAAVPSGASTGEYEAVELRDGGKEYLG
KGVLKAVENVNDIIAEEIIGMNVFDQNLIDKVLIELDGTPNKSRLGANAILGVSLAVAKA
AAESLGLPLYRYVGGVSANTLPVPMMNIINGGSHSDAPIAFQEFMIMPIKAESFSQALQM
GSEIFHNLKKVLHDRGLSTAVGDEGGFAPTFEGTEDAIETIKKAVEKAGYKFGEEVKIAL
DCASSEFYDNGVYDYTKFEGAKGKKRTSAEQVAYLTELVNKYPIISIEDGMDENDWDGWK
LLTEAIGDRVQLVGDDLFVTNVERLERGIAQGVANSILIKVNQIGTLTETIAAVDMAHRA
GYTSIMSHRSGETEDNTIADLAVALNTRQIKTGSASRSDRMAKYNQLLRIEEELDEVAYY
PQEKAFRVKN
>SEQF1602_02086 N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 1
MKLDILAFGAHPDDVELGCAGTLAKEISLGKTVGIIDLTQGELGTRGSAELRRQEAQEAA
RLLEVKVRENLCFADGFFVNDKEHQIEVIKKIRKYRPEIVICNPFDDRHIDHGKGGKLVS
DACFLSGLRRIETTDEDGSPQQAWRPKVVYHYIQWKDLRPDFVVDITGFLGKKLEAVLAY
RSQFLDEDTKEPQTLINSQNFRDSITYRAQDLGRLINKEYAEGFNVERYIAVKNLSDLI
>SEQF1602_02087 hypothetical protein
MVSLKYIIIIGLIPYLISFFIIKKFANKHRWEYFLILGWFLLQSISSLDLYFIHENFGMD
GITQFSDFEIYIVYSFKILFLEPIHHILFLVALGSLAIKHFKRLSD
>SEQF1602_02088 hypothetical protein
MKLIYLFLFIGSLAWGQNERRQQVYQLQGNVKSLTITQSKLEKAAEALLFDPLDDDQFLL
FDKKGRITELDTYFRGRQPKTIQTWTYDDKNHVSKEVLELVPEKLTQTTSYTYDDKQKKA
SATITSTGFPNKKSKMVISLGDNLLPSEILAYNFEGKLEGKRVLKHSKNGFLAQSLSYDD
KNKLVHSISYEYDDKNRFTKIDNRVNRTYELHFSTKYLYEKGLFPTKYIVTSGKEPSQTF
TLKYKLDSKGNWIEKTYFLDGEAAATIEREITYY
>SEQF1602_02089 hypothetical protein
MNHLFIIFFFLCTLSWGQEDVRLSCQVKGNVKSIDITKEESDEIEGDFLVDSFDYNMSII
LDKKGRVIKLTSYSEKGKPSDIKETTYDNKNRVVKETVLFLPEKITRKISYSYNDKEKKG
TAIAHSSHKSDRRTRREITLNDEGLPIRVIFFDSDGEAFKEISYEYNKNQKLAKSTIYED
GELERQVSYKYDDKGRIIEAKHYYIAFPKGDITYKYVYKDEIYPIEHTAIIGDDDPETLT
FKYKFDSKGNWIEKTYFLDEEAVAIIKRKITYY
>SEQF1602_02090 hypothetical protein
MKSLYLFLITLYSFSSFAQDDNMLPYLRLKGKIESVRIIPYEIKENEDKSIEKNTSIGFL
YDKNTFIRFNKAGKVIEKIDYNNKNEVTRHRKLSYDNKNRCTNEKIYNDKGEMTQEIFIT
YDDKKNESRETDHRRTTICQLDDHDNPVNCMTYNNEGKLIEKCWTTYDKDNKVLEKVYRT
PDNEKKYVFHNEYNADGYHTKITKDDYVDFVDNMKVIYFYKDEKLPYQQSMSANGTLPAY
SELSYQYDKKGNWIQKEVRYNGKLVFLVEAQINYFN
>SEQF1602_02091 Arsenate reductase
MIIYHNPHCSKSRECLAFLKEEDEQPIEIIDYLKNPPSVAQIKELLHKLGIPPIDLVRKK
EVIWKEVGSDSLTDTQIIELLHQYPKLIERPILIQGDKAIIARPLSVAQEWLKLQKK
>SEQF1602_02092 hypothetical protein
MKRIFLVASLLWAGYTASAQVYVSVTGGYAWGVPSTKIGEESINGKESVRFGTFGEGINS
QLRVGYFFNKTWGIDISAGYLYGEDQLVKREISQKNIANTPLTATIDGEVKGRGRAFGAA
LSVIYNFTDNFYGRFGVLTKIGGKTEAIAHSYTTTNQDIPVAALARLGLSLPGLSGLPTS
AVIKQGATIETSYTEDYKGKMPFGTIAAFGYKYNVTEKLAIFAELEYMNIAVKRDYSELR
EFNQTLKATISVAGQNRNVEVPLKSLDGFSNGSYNDVLRGQVYHQRTDYVEEATKEELAN
NSAKKLTEKASYSSLGVNFGVKISF
>SEQF1602_02093 hypothetical protein
MRKRFFLLLFSLPLPVVWGQQQDTIAKRDSIAPTETVYDLEEVLFFGSQPVFRNEEDRKK
YELLRYRVKRVYPYAKLAADKLYRIEKVLDSLPNNRQRKKYTKRVQEDAEARFTEELKKL
SRSQGRILIKLIYRQTGESAYNLVKNLRSGWRAFWYNNTAWFYDLSLKSTYNPEEVEEDF
WIEDILLRAFSSNELEMQPPAIHIDYQAIERKWRKK
>SEQF1602_02094 hypothetical protein
MTQEGTYLVEYLIGEVVFTSSISRAMIFSDVNIALKFKTLLYDRFKIKVSVNTYIY
>SEQF1602_02095 Putative oxidoreductase MhqP
MFYQNTNKEPKKNTDAGVLLLRIVIGGILLFHGFSKLHDISFVEIQLTNNGLPTIWAYGT
YLGELLAPILVILGYRTRFFSMLIAINCLTAIFLVHRSEAFVIDPSTGAWAIENLALFIG
GAITLCLTGGGKYALSYKSSWD
>SEQF1602_02096 CCA-adding enzyme
MNYAAALSDPIFHLISQIAHENNQECFVVGGFVRDLLLSRGQAKDIDIVTLGSGISLAEK
VAAELPNNPKISVFKNFGTAMIKTENIDIEFVGARKESYREDSRKPIVEDGSLSDDQNRR
DFTINALALSLSKDSFGELIDPFHGVDDLQNGLIRTPLEPNVTYSDDPLRMLRAIRFATQ
LNFVIEEKSLQAIADNKERLKIISNERIAEELNKILASPTPSVGFKLLFQTGLLSLILPE
LVALQGVDEKEGQRHKDNFWHTLEVVDNISKHTDDLWLRWAALLHDIGKAPTKRFDKKIG
WTFHGHEFLGGKMVVKIFQRLRLPQNEKMKFVQKMVTMSSRPIIIAQDIVTDSAVRRLLF
DAGDDFEALMTLCEADITTKNPQRYKKYHQNFQIVRQKVVEVEEKDHIRNFQPPISGEDI
MRLFGLSPSREVGQLKEAIKEAILEGIISNSYDDAYPFMIEKAKKMGLSLVADANS
>SEQF1602_02097 hypothetical protein
MKESIKISILSVIIGAIQMILFLPDGYSCIDGKSDIITAIFYDMSIQFCIVLIYSLIFKP
LESSIAKYILLLIVLVFWLYVNRIEFLHREACWSTFLKEEINPVVIYDSIIPCSICIFAF
YIGLNYFQKKKKQKTTPFDKKTNNPLTHLSIIISFLLISCNDSKRDFEVLHTEKVADTYR
YNPDGFIKNNYGKLLIKTISRYDKEGKLKEISWNRANGFLRYTLSELKEDPALLNSFDID
TMYSAEKYIGYIKEKKNDTIFYLSGDKVVIYYPIK
>SEQF1602_02098 hypothetical protein
MLKNNPYSREGEIVAIPLFLADSPKAKPQKEDHNKQFAFARAICEEAGKVLIEVFKQTGS
LDTPMEVIVNSGILMKPLH
>SEQF1602_02099 hypothetical protein
MIQSGKSIKEGDYLLLDTPPFNTLTAPEGLAGFYVSDVTWNKTKEDEEEEEPEEDTDDEV
TILSLIPIKKTKKGFTPLDKEKARNAVWAKLTLNV
>SEQF1602_02100 hypothetical protein
MDKYTNSFNIKVFLNSRIIKADIEVREEKEYNPIIKDLISGRECHLEGLFKIFLMKYKDQ
EGTILYSKSDRLSDAFYKICNKADTHKIKMLIKGCTLGYFMIPKLQNTIKAINLKIGERI
NTENKIVCIFDIEENINNIAPFSQILEYYKKWLLSIKGLPY
>SEQF1602_02101 Putative deoxyribonuclease RhsC
MRWFYSWNANGSLKSVANNDRVHFAFEYDALGRRTAKINLSSKRIKRFLWDGNVPLHEWE
YDLSERPNLSRDKDNLLVYDKEEPVTDNLITWVFDENSFVPAAKLVGDKSYSILTDHLGT
PYEAYDENGEKVWARELDLYGNAIAGDSSFIPFLYQGQYYDEEIGLAYNRFRYYSPESGT
YISQDPIRLAGNNPNFYGYTFDSNTEVDVLGLSCLRAKYDSDVKQLKEIGEFFLAKGFSE
EAVARYLHNKRRALGIYYKNCTPEELRELIYYRNSLKYGDRLGPTYDFLRKSGKTNLEII
ESASRTAGEDLEKLFETISKDLPASGKISLSTMGFI
>SEQF1602_02102 hypothetical protein
MELILLNYENKQTVIFYNIIDNVYGKISSNMRRIGFYDIWEDILFGVVVLNLTIWVFIET
KMVKLDDICNIKNEIINQRTFLLIETTSGNSYTISTTLDLEADYVLESDYYVDGTEYNLG
LYIEKLKLKKDTKELFIKNVSENGLIIS
>SEQF1602_02103 putative deoxyribonuclease RhsB
MLSHSYFYTASMCYFGLEAYDEEGEKVWARELDLYGNAIAGDSSFIPFLYQGQYYDEEIG
LAYNRFRYYSPESGTYISQDPIRLAGNNPNFYGYTFDCNTEVDVWGLDKFLMKFIKSFVL
I
>SEQF1602_02104 hypothetical protein
MKFYNIDINLDPKITGRRNGSFAVEIRKNSFEKDEHKEYFNSFFDSNSNDIKRVRIETFQ
QFDLKNCPNVIYFPMTKSIKKLDFMYYAPYELGIDFLVSKKIVDIISAYKLPIHNKIPVK
IDTFDGNYFLIGFPVWSSKVLDFQKSTFYYQDRDVFSFSNYEDYENFDSEYGDTTKIDLY
LRNKIEYDIISIDEAIFFSEKIVEELKENNATGYRIVDGILNI
>SEQF1602_02105 hypothetical protein
MTDIEKQYLKLVALYKTDKNSAINGMIDIFQEVSESYEHEIYHSIMEWIGLRGNENTLNH
IEHIDLSLYEEENVQILNRLKAKIKERLDNIPNDASC
>SEQF1602_02106 Putative fluoride ion transporter CrcB
MIKEILIIGLGSFVGGALRYVLSVAFSKVGREWAFPIGIMVVNVLGCFLIGLLYSYFKHK
ATTASVLPLLLMTGVLGGFTTFSTFSLETIQLLQQNEYLKTILYVVGSVGLGLTACFWGM
RQF
>SEQF1602_02107 Putative esterase
MQEDLLEQANAIGKNTLLENFEISFIEVGKDYLIAQMPVTEKNCQINGILHGGASAALAE
TVGSMASVLLANPDKQLVLGTDITMNHIRPAALGKTVFAKATLIHKGSTLQHWDIKITDE
DNKLISYGKHTTIIVKKR
>SEQF1602_02108 Isochorismate synthase DhbC
MILSPEDFLQKAKEVAAEGLPFVLFKYPNDTQIHLISQNDKNLYKVKDFTEKGFVIHPFV
GIESFLLRQDNLFSTAFVGEEKKDTLPSPILSPSARVEYQTLFGKALKAIDKGELTKVVL
SRRIAYTKAPKPLLTYFQDLVQAYPTAFCYAFSHPKIGKWVAATPETLVKIEDNQLRTMS
LAGTKPFVEGEKPLWTEKEYREQQVVTDTIIKVLSPYTTDLSTGKIHEVRAGRLWHLCTE
IMAKIAPHTKIKQIVNNLHPTPAVCGFPTEKARQFLLENEGYPREFYAGYCGLVDFKHKN
SLDLFVNLRCTQLTDKEVFVYVGGGVNSGSQEESEWQETENKAQTMLRILQ
>SEQF1602_02109 hypothetical protein
MKTYFYLLFLLSLSLAAQTKDAQKRLYYNPMEGDPAYVMGKYKLKLQGFEESFDVLVTKQ
NMVNFAKQNHFSDTIPKQNPKLKIPHYYLTYYQKNGENHWQNTMIYFLGMKMDGKDVLLI
ATISSVSETPSEEIDTEMLQLVLDRKVPKENYMGGRSFDFLGRKVPLMDECYWTGVNIVR
CPTKGEMNWSLHPTLAEAQQAITLQKRWAMMIPVPENHTMSLLMERDITLFFEGKETRAT
EIIYNEHYQHPILKSHHKDYKLFVYYIATEVRGQAIACVISYYDYNERLADTGLPEFVSQ
FVRLPKSSR
>SEQF1602_02110 hypothetical protein
MNHLSSLILLVFLLVVLVACNSTVEKSQEDNSQELQKSKKDTFERSYFEEQLADSLFLEK
TKKEALLEIEKRFKGKDLDFSYVIEDSDTCYLSVTVRIKKYFEDEAYYAIINTNMQGWEH
IDIYKLGNQAIEHKMFGKDYYSPTDTIFDVNGDGTKDFLVKSYKLSGCCRANNYDIYLSP
AAKKEVVTSHIDLTNPTFYPQEKLIRGVQYGHPGWTGLYKYRWRGEHLDTLEYIYPYPTT
KGRTFIKMHISTDFSYYRDDIKKGTRLPSLPEEYKTVEDLDWFLLYGEGTFGTDF
>SEQF1602_02116 Copper-exporting P-type ATPase A
MTCYHCGNYCDPKHPIVFDDKYFCCQGCQTVYEILSANKLDKYYTYEQTPGARPEEAGEK
YHFLDNPQIVAKLLEFDEGNTQIVSLYIPHIHCSSCIWVLENLQRLHEGVIHALVDFPKK
MVRISYLKDKITLKELVILLSKIGYAPYISLDDYSQKKDKKGQKQLLYKLGVAGFAFGNI
GLLSFPGFFEDNEFWFNRYKDFFRWLMFAFSLPVMFYAATDYFVSAYKGIRNRFLTIDIP
LALGILTMFVRSTYDIISGRGQGFFDSLASLVFLLLIGKFFQQRTYSFLSFERDYKSYFP
IGVTRIEGGREESIQVYDIKEGDRLLIRNEELIPVDAVLIRGVGQIDYSFVTGESKWTEK
NSGDKLFAGGRHKGTAIEIEATKTVSQSYLTQLWSNESFQKNKNEGIKTLTDKISQYFTF
FVLLIAFLTLAFWLFYGTPTEAFNAFTAVLIIACPCALAVSAPFALGNMLRLLGKHRFYL
KDTQAIEQMAQVDTLIFDKTGTITQSNTQEISYEGTSMSAEQLILLKSVLRNSNHPLSRQ
LYDYYNQVGIHALDSYQELIGKGMEATSGTDHIKIGSAKFVADKDNKDETAVYVSINGQL
IGKYTFKNPYRSHIFNVFHELEDKGYTLALLSGDTEVEKAFLQSQLSAKVSLHFNQSPAD
KLHYIEQLQKEGKIVMMLGDGLNDAGALKQAQVGCAVAENSNTFSPACEAILQASEIEKL
PQFLTLSKKTMQVIKISFVLSLLYNCIGTFFAVTGNLEPVVAAILMPISSISIVLFTTLM
TNGLVKKFIK
>SEQF1602_02117 hypothetical protein
MTTNKNYLKKTLQLVLPLLLGLFLCWYAFAQFSTEELALIKEQFLRADYSYLWLSVGMGF
LSHVSRGLRWQYTLASMHYFPKRYNLVLAVFVGYLLNLTIPRSGEVSRALLINRYDKIPF
DKSFGTILTERAIDMCILLLLIAIVFVFQFDLVWHFLESYFTFSYIIVILLVLGLLFVAF
LYWLYRSTTSIAQKIRQLLSGIKEGIFSIVHLKKKWQFVAHTLFIWIMYFLMFYIVFFSM
EQTKDLSLIQVLTAFVIGSFAIVFTNGGLGAYPLFIAKVLLLFGVAETIGTALGWVIWIA
QFLMIILFGGLSFLLLPILNKGNR
>SEQF1602_02118 hypothetical protein
MITPEEIRKKTTQKYLPYLSDIAADTPFAPIEIRGDKTYAKNNFSDFAQQIESLNSQAKD
RKGFGYTVDYKRTRTKYLGEQDIPVSIYFETEQDFLRFLSKEKEVAKFRENIALIISIFP
QLTPWIQKYPKKVVQNETEWTDILKVCSYFKENPHPNCYIRELPIAVHTKFVEQHKGILQ
ELLNILLADTLEVGATHFEQRFHLKDKEPLVRFRILDQDIADAYFQGIDDMAIPISLFNR
LALPVERVWVVENKTSLYTTLAFPAMEKSIAIFGSGYGVAALKEASWLATKKLYYWGDID
AQGFEILSQFRTYFPSVESFLMDEATFEHFYEAYEGTPSSITVELRLTPEEKALYERVKT
ENLRLEQEKIPQDWLLQTLVLITTYL
>SEQF1602_02119 hypothetical protein
MWELFSTNSDTAGFRLQYMEVLNWGTFHKEIVRIAPQGNNSLLTGANASGKSTYIDALLT
LLVPIHNKRFYNQSSGVEKRGDRTEESYVLGYYGNILKEGASSTTTQMLRDKRDTYSIIL
ASFSSTTQQTVTLFQLRWFSGQDLKKSYGIAHRPLEIAKDFPKFDSRGDWKKLLEAKYNY
DKSKRKQVEFFSGPKDYQSAMRSLFGMRSENAFSLFNQMVGVKVLDDLDDFISTHMLDKW
DSEERYEELRTSFFTLTEANDNIEKAKLQVEMLTPICEHITILQQATEQSRELAQLQSES
VYGFAQKYVSLATDEIAEQTAILEEVKQHNVALQDQDEALDTKRLDLEQDIRNDAVGKQI
ETLKKEKKENLLAKEERMRNAEQYNRIVASFELKSDPDEEIFKANKEEAQLLFKKIRSEE
FLQEDNCRKLVNENEEVALQMEALRENIEILRRNKNNISGREAAIRDEILSAVGATKEEI
PFIGELIKVKESEGAWEYAIEKVLHHTALHLVIPPKFYSKVNAYVNTHNLKGRVRYYKYE
QVPPKIFQQPRQEQRLLLDKIEIKPKHPYFLWVEYLIENQHNFVCVEELSEFEQFAEMAL
TPKGLVKYRKGKHEKDDRETTAKRSNYVLGWDNKEKLSELSKELVCLQEIKKKKDTTLKE
LQLKREELRSKQIIIGDLNKQFAKFDTINWQVYALKIQELETAIEQLEQTNNRIKALQEQ
LKKVKEEQAALKITLKEVGKKELVIEQTIAQITEKKQQHQTILATNPEVDIALFVAKYRH
LSELSYANIETHRQAFASALFKQIEENKQLISKKEMEITKAIAKFKNPSAAIIEKFKDWT
ADAYPLPEKIDLVLLTEYQHYLDKLKKDNLPKYEKKFQDYLHETTIHKMGSFATFFDSWA
EEIRENIRQLNESLKEINFNTKPETYIQLVHFQRVSADVSEFKDLLRRARVNINEFSNQE
EGRRLHFEQHIAPFIKRLENETWRKKVLDVRQWFSYKAEESFRETGIKAKTYERMGQLSG
GEKAQLTYTILGSALAYQFGMLKDGMQGNSFRFIAIDEAFKAQDEERAYYLITLCRQLHL
QLLVVTPSDNIHIVENDIAFVHFVSRAKNKTSHLINMPIEQFKAEREKYFQL
>SEQF1602_02120 hypothetical protein
MKKLEEVEQPYSRAIVQLLRGPVDKETGLLWERILTYQTEIQDYIHTIGLELVVRKEEGF
AFVRQLEDEQGNTMGLVRRQSIGFETSVVLVVLRQLLEDFDNNPTDFQSFEKIISHSELK
EEVGLFFQEGYDKVKFLKDIDRYIGNAKDLGFLKVLNSKEDTRYQIHRIIKQKITLDILE
DFKQKLSDYVGTI
>SEQF1602_02121 hypothetical protein
MESPTQQLIDILRTSPSVELLKSKNRVPIITFFIETFTEDHKVLAQEVLFQQLSDFIETQ
HLEEEESEATFEVLFDEKAKHYVRNWLSKGFLTNYQDEQGEVYYELSSHSVKVIDWLWSL
KKEEYIGTESKFSSIFHQLKELVEFTNEDRQERLLLLERRRDALQEQIDKLKRGEEVQVY
EEYQIVPRFNQLTQQAKELLSDFKEVEDNFKEITKEIYQKHSGEQTKDAILEFTFDALDQ
LKNSPQGKSFYAFFEFLVSRQLQEEWEVLIRQLYEALQEKDIPIKDYFLRGMRGHLYHLG
RRVDKANDKMAEKLSRIIRENNATDNQATKHTIKEIKDFLISLSRKQQIPTVSFEIETDV
DIQIPFDRRLTDQKKEQATYQERFENANTTLSDAVQLDKLFSDKIINKELIREHIRKVLQ
ERGQVSLATLINANGGLKKGLTELIAYFAVATEGKYVINNEKMQDIIFDTEHQKRIQFPE
IIISL
>SEQF1602_02122 Aspartate--tRNA ligase
MYRTHTCGELRLSHEKQQVTLSGWVQRIRNKGFMIWVDLRDRYGITQLIFDEERTDKAVF
EQAKTLSREDVIQIQGTVIKREAANTNIPTGEVEILVSALTLLNHSEIPPFTIEDNTDGG
EDLRMKYRYLDIRRTPVRDNLIFRHKVGMIVRNYLSGQGFIEVETPVLIKSTPEGARDFV
VPSRMNPGEFYALPQSPQTFKQLLMVGGLDKYFQIVKCFRDEDLRADRQPEFTQIDCEMS
FVEQEDIIQTFEGLAKHLLKELKGLEFGAFPRMTYAEAMKTYGNDKPDIRFGMKFGELND
IAQHRDFKVFNEAELVVGIAVPGANSYTRKEIDTLVEWMKRPQIGATGLVYVKCNEDGSF
KSSVDKFYNEDDLKAWAERTGAQAGDLICILSGKANKVRGQLSALRMELAERLGLRKPDE
YAPLWVVDFPLLEWSEEEERFFAMHHPFTSPKPEDIPLLDSNPGAVRANAYDLVLNGNEV
GGGSIRIFNQELQAKMFELLGFTPEQAQAQFGFLMNAFKYGAPPHGGLAFGFDRLVALLG
GQETIRDFIAFPKNNSGRDVMIDAPSPIDEAQLKELAIQLAN
>SEQF1602_02123 4,5-DOPA dioxygenase extradiol
MTKKIPALFVGHGNPMNALDEQNPFNQKFAEITQTFDKPKAILCISAHWYSEGLFIMGNP
NPPMMYDFYGFPKALSEVQYPAKGSPELVAQVQELLADTDLKVDPERGFDHGAWAVLKFL
YPKADIPVVQLSLDATKPAQWHADLAKKLAPLRKQGVLILASGDIIHNLRLMNFRYINDL
DAGYDWAFAFRDQINQTITDNNLEALVHFEQFGENAKLSVPTPDHYLPLLYVMALREEDD
EVLIFNDSIVGGSISMTSVLVGGKS
>SEQF1602_02124 hypothetical protein
MLEEIEGFTYRQFIIVSSPNVTIDTEKCIYDQDILPYVIEGTGGRETEDIIECIYLRMIL
ITKLMDASAKYLYKKLYKNLEANPNFRKGFHQGSSMHKNALYDLRTIHKTKRFGLNNPLS
ILTIEEREE
>SEQF1602_02125 Regulator of ribonuclease activity B
MNDNHSPIEIPENWDFYRTSFGETPVSIRLNLALKSIAPIADFPVVVRAIVKMQHPYDNG
FSSQEEFETLADIEDALCDAIESAGAIEVAIVTGGGNREVYSYSKDTETVIKACYKAMEA
FPSYEFKCLSAEDPQWQEYLHTLYPNSVEIHQILNRMVIEQLKEGGDTLEKPREIDHWVY
FGEENEQKAFIELVKSSGFKILSANYNEENNPESRYVLNFSREDHIEHIEEIVSDLIELS
LQFNGYYDGWGCNIITE
>SEQF1602_02126 hypothetical protein
MGYYIFTYGVKTPEIKAVFGSKDEALLQKVKANDIFQNYAEQNQETSQALIDIIKGNPYT
LEEYHYGYAFIGICATLGETLPKTQEIKLGYITEVINETVAEDYDIEIDIETELFPADYA
DPFPLPLIADFPMIDLLDKKRLEHIASLFAKVHKTEDEIEAMLDGDDDEKGFAYEAIMGL
KENIDFCLKNDLDMVVFCH
>SEQF1602_02127 hypothetical protein
MTITDAPNTYNNAIEILYQKGYEVFLLDKDEDYLITQTPLRLLALLLLIDYYGWDWYKIA
VPSHLNELKSY
>SEQF1602_02128 hypothetical protein
MMKISLVITIMCLFSGLMGYGQGMIKPPKWKETELRGEVKSIKIKTALYPMQKQVYPSLK
KIERKPSVVLTDTYFFDKEGIPISFSIDKDVQLSFSYEYNQEDRIIRRISENTALSYQEE
TIYKYDLKNNLIEISTKGKSQEELDKYELTYNAKNQLIERIRTQYKQQDTLRSQHCYLYD
VQGHILEETISNFNPSEDHWKVIQVIRYQYNEKGNVIGQKELNNMGGGVYLPREYCYTYT
YDSQGNYLTQIEYHVYGKRKEKVKVIEREIQYY
>SEQF1602_02129 hypothetical protein
MEEHKYLDDLKEIRQIMRKSTQFLSLSGLSGVLAGIYALIGAGLAFSILEDHYLQQSYVI
LESNTFRKLIGIALGVLVASIVTAYLLSAYKAKRNGETLVNATSKRALYNFALPLLTGGI
LCILLLRNGHYGLLAPMTLIFYGLACVNVSKYTFGDVHYLGITEIVLGLFAVQFSGYGLL
FWVIGFGICHILYGGIMHFKYERNKKESL
>SEQF1602_02130 hypothetical protein
MIEVLKRYIDASNVFRKAKEPHQGAVALYDLLYDLQAKTERTKEEERILTDTYSLLEYHL
SAYETFLRIADPTNYKEKSKLVVLADKAQTHKDTFCIKDIRKSKAKKKQKILKIEDFEKV
EDFESSYEYVLPTRKVVIFGREVEEENFSFFINKDIPLESCLHSINKYLEWLSDAKATLI
NYYNEHCGAYTPEADDNWYNTLEVYSGHLDIGSIGISAHISAGDIFSPDHLLEIDFEGKE
ITHIGWDG
>SEQF1602_02131 hypothetical protein
MKTKFFITTLLFLIGGLCLKAQTNDTDTQKAIATLKEFYKVIYDDNSWKEEQFLKYVSKE
LFNKVFPPSREDNSPEYDPFIQAQDYEAKTLNRSLKITSLGNDRYRVCFLLSDWEKKKTC
VDYQLKKNNKGKYMITNILSDKNFYIEPKKKKN
>SEQF1602_02132 hypothetical protein
MSVLMVNESADFNTLKELLGVTDGNLASHTRALENDEYIAVEKTFIGRKTNTRYRATAKG
RQAFQEHLEALEKMCQLSTSPQEN
>SEQF1602_02133 Inner membrane protein CreD
MDTQRSTFANLLQSNTFRMFLIGTLALLLLIPLSFVKDLVRERKSRQERVVDEIDSKWGS
AIYFYGPILKVPYKVYSDVNRTTFKTSYAYFFPEELKNNSQVQTEVKKRNNYESAVFTAS
MDFTGRYIAPDFSSKGILDEDIAWDKATILIRTTNLSSIKNIVTITLAGKSYPLEPTYDQ
EGEDSYYSWEDTDAMIEIEGEYYGGSRSSHISSLQTGFIPKEELNKPLDFSFSITYDGSK
HIAIAPIGKTTEGTISSNWPNPSFFGHFLPYKKQITPQGFTASWRVLHLNRPFSQQSFGE
LPKINSYAYLVNFLIPVDQYQQNERAVKYGFLVIGMTFLIFFLLQSISKIKIHIFQYAMI
GLALVLFYTLLVSITEHSSFALAYLISSVMTIGLISLYSVAILKNKKFPTFIGISLAALY
GFIYVIIQLENYALLVGSVGLFVILAIVMYASRKIDWNQ
>SEQF1602_02134 hypothetical protein
METALKNIVIKNGIFLGIAMIIFNFTQYTTGVLYTSNTGLSILLWLVGAAMYALFITWGI
QQYKTANNGQLTVVDGLKIGALIGVIAGIFSAIYSVVYTTYLDPNYYEKVVELALEKMAP
LLQRMSEDEVMEFQQGLFEGKPTVISTFIYAIIGSSLGGLILGVIIGLIKKTKNSD
>SEQF1602_02135 5'-nucleotidase SurE
MQKPLILITNDDGITAPGIRTLIQVMTSIGEVVVVAPDAPQSGMGHAITTTSSLFCERVH
TDSGAQVEYRCSGTPVDCVKIARHEILDRTPDLCVSGINHGSNSSINVIYSGTMSAAVEA
GVGGIPAIGFSLLDMNWDADFSQCTDFVRDITLNVLKNKLPHGVVLNVNIPKLKREEIKG
VKVCRQARARWEERFDHRTNPHGRDYYWLTGKFICEDEGTDTDVWALDHGYISVVPVHAD
LTHYPSLEQLNQYPFHEKK
>SEQF1602_02136 hypothetical protein
MRRNKYKEIGIGFLVGLIANALGILLWWLFFAYPTDLVTMLIMAYEQEVLGTIIGLGAIL
NLVAFFGFIRLRHDLRARGVLIATFLSAFVTLVLKFL
>SEQF1602_02137 Adenosine monophosphate-protein transferase SoFic
MQQTKQRLRSELPKIYSQDLLNNLFKNPYTKIEFLEKDLNISKRTAQNYLDMISSIGLLD
KIKVGKSNYYTNENLIKVLKREKN
>SEQF1602_02138 hypothetical protein
MKRLFLAIVALSMSMVAQQKPIFTQGKIQQATVYFTGVDLTHTASANIPKGTSELVIKNV
ANSLSEETIRVLAPSNVTVLSVQFTSRYMQEYEVEKNSPALKRVQDSLTLLEKQLKKLRN
QRYTEEKTISLLDGNNTLKGSQDGIAIGDIPKLMDYYTAKRTELLNSIDVLKEKEEALTT
AIAKLNAKLDVNASQEEKLSNGKIILQLMSPVAQKADFQVSYISNRATWRPFYELRADRL
SAPIHLLYKGQISQSTGVDWKGVKLSLSSGNPNKSNQFPILQAWHLYFGRETYEYTGARN
AAPLGYAKVTTDASLKRADVEKMVLEESSVAEYTTVAENQLNVSFDIDTPYDILSNGKAH
SVSLQELDLKADYKYYTAPRVDKEVYLVAAVEDYSKYNLLSGEANIVFEGLYVGKTYIEP
NQTNETLNVTMGNDRKISVKREKISDKSQTKFISGNKEQIFTYDIILRNNKKEKVDLVLK
DQYPISTDKSMEVELLESSKAIVDDKTHILTWELTLKPNETKTFRLSYKVKYPRDRVIGN
L
>SEQF1602_02139 hypothetical protein
MKYLLPLLLFSCAAPQQMEKKVDTHLLLQGEWTLQTLRGVAPVASIPLPSLQIDLKENRI
SGNGGCNNYFASIEHCSPTALSFSGIGATRMLCLSENIESAYFKALQEVASYKIQENTLL
LFDKQGEEILKMTNTIKPLTHNQS
>SEQF1602_02140 hypothetical protein
MNKIKLTLFVLSAIFMQSCANQSTAKKEEATPQAETTTNKLPNPQLEGQWTILHIKGVKL
VKNTHSIYMKVDLQKKTISGSDSCNNYTGMITTVTDSELVFSPVASTLRLCPEVEYDGAF
HTALQETVSYKIEQDNLHLFNKEGEEVLTFLKKNEK
>SEQF1602_02141 hypothetical protein
MDLSTYYKQHPEERYENIRRMGEILSRVEETLTKAEALLEEWKALQPDFETLVAYYDSPQ
WREDYFDSNDGKIPDEVPQWVLTQDAIFDAIGTEFDLADGYKELIETIDSKKWKE
>SEQF1602_02142 hypothetical protein
MINNIKMDVATYKKLFSEDDAVGWEAMDKSLEALYPHQEPEHYAPNLPASLGGDSYLDGI
SIYHSEYQEPHFHFVTYGFSELYYNEEAAGGDYSGFGFELTFRLKKSGDENVGWAINFLQ
NIAKYVFTSGNYFEPFHVFPANSPIRLEYDTQITAVAFVLDPELGEIDTPHGKVQFLQAV
GITAKELEMLRASFSIEKVEELIRQLEIGNPLLITDLDRK
>SEQF1602_02143 Macrolide export ATP-binding/permease protein MacB
MNLNNLFRIAWRAILLNKTRTLLTMLGIIIGVGSVITMLAIGEGSKKSIKENISKMGTNM
LNIRPGAGMFGGVRNNSDMQSLKLTDYLALKKEAKLLKYVTPVVSGNGQAIVGANNWPTS
IYGVNTEYLPIREWEVEEGAMFGQDELDNLSKVAVIGRTIQKNLFPDGDSPIGQTIRFKN
IPFKIIGILAAKGESNFGQDQDDIIIAPYTTVQKRVLAQTYLQSIVASAINENEAENAVN
EVKKILERTHNIAADQENNFNVFSQQELISTFSSTSEMLTVLLVAIASISLIVGGIGIMN
IMYVSVKERTKEIGLRMAIGAKGKDILAQFLIESVLISITGGVVGVVLGLLATYVVNTFI
GWPVSITFYSIVISFLVCTITGVFFGWYPARKAAELEPITALRYE
>SEQF1602_02144 Cysteine desulfurase IscS
MNLDKKVYLDNAATTPIRPEVKETVIEALSYYGNPSSVHSFGRTAKSLIEKARKNIAKEL
GVSSSEIIFTSGGTEAINMILKGAVRDLGITQIVTSPTEHHAVLNTVHSIENEYGIQVSY
VKLDAKGTPDIEDLNKILSEFLSDEKVLVSLMYVNNEIGNLLSVAKVAEICQKYKAYFHC
DTVQAVGHYPIDLSSLSIDFISASAHKFYGPKGVGFAFIRKDLPIKSFLFGGEQERGRRA
GTECLHNIVGMEEAFLLAYQNLDKERTYIEGLKKYFIERISQEIPLVRFNGQSDNLTESA
YTIVNVSLPIDPQKTDVVMLFLDMRGVACSRGSACQSGSSQGSHVLKAILPEKEREKAHI
RFSFSIFNTREEVNYVIEVLKEFLQ
>SEQF1602_02145 hypothetical protein
MYLCPNILNDMKRTFPFISLLLILLIACNDGNYTVERITFTGSEATSCTRDTTATFLYKT
QGKEALILQFSAGTLKNQVDSITGNIGNNYKLFYRTFDEAPSQSYFCSSPPATSPKVLSQ
IEAQGGTVIIVTRAVRDTVAGVTRYNHLVRIKDLLLTNDNGERLIDQNFNFGSYQTTR
>SEQF1602_02146 hypothetical protein
MKYYLCIAFWLSLLFVGCAPKDKNTPEAVAKDFIIAVNKNEFAKAKQYGDSTVIHRMTQI
EQMFKEYKGEIPENPAIDFQVIQVVPTDEHSAIVTYSLREGESYKQLKVRKIAGQWKVTL
EMQEAMPEEKP
>SEQF1602_02147 TonB-dependent receptor SusC
MKKYFLVLCSLFFCLSLSAQQKYTLSGTVTDASNGEKLLGVNLLIKGTQMGTSTNEYGFY
SLTLPEGEYTLQVEFLGFKTIEEPLHLKGNQHRNYKLQEEGIALDGIEIKAQRTPKADIR
TPQTSVVSVPIETIKKLPVLVGEVDIIKSLQQLPGVSNTGEASSGFNVRGGASDQNLILL
DQATIFNASHLFGFLSIYNADAIRDMKLYKGGMPARYGGRISSVLDVYQKDGNNTQYHAT
GGIGVLSSRLLAEGPIVKDKASFLVGGRASYAHLFLKLTDNKNSAYFYDLNTKLNYKLND
KNSLYLSGYFGRDIFDLAQTIKNSYGNSLVNLRWNHLFSDQLFSNLSLIYSDYYYGLNVD
ISGFKWDSWVRNFNLLYDFKHYLLEKVKLGYGLQATYYDFNPGELTPIGDATIRHKVLPH
KYALETGFYGDIEHKISEHLTLSYGLRWSSFFHLGKRSMNKYLNDEAVVFNPAQRIYERA
TPIGEKEYKRGDLIDVYAHFEPRLSMAYALDDNRSIKASYARMAQYLHLISNTASPTPLD
VWAPSDSYLKPQYSDQFALGYATNLKEDTYSIETEIFYKTVQNRLDYIDGANLIANESIE
REVLPGHTRAYGWELLIRKNTGKFTGWLSYTYSKSEQQTPGRTDQETGINNGNWYATAYD
KPHNFSLTGTYTFNKKWSASAVFTLQSGIPGNFPVGRYKYFDVSISNYSARNAYRLPLYH
RLDVSLSYTPHPERKWKSEWVFGAYNVYNRYNASSIYFRNNKETRQSEAVKLSIFGIVPS
ITYNFTF
>SEQF1602_02148 Glutamine--tRNA ligase
MAEEIKERSNNFIENIIEEDLAGGFSANNLRFRFPPEPNGYLHLGHASSICLNFGLGLRY
NAPVNLRFDDTNPSKEEQEYVDAIRRDVAWLGYKWDKECYASDYFQELYDWAVMLIKKGK
AYVDKQTSEEIAAQKGTPTTAGTESPYRNTSPEENLALFERMKNGEFANGTYVLRAKIDM
ASPNMLMRDPIIYRIMNASHHRTGDKWHIYPMYDWAHGESDYLEQISHSLCTLEFLPHRE
LYDWFLDQVIPTSTLADGKEVVRPKQREFARRNLSHTIVSKRKLLQLVTEKYVAGWDDPR
MPTISGLRRRGYTPEAIRKFADTIGIAKRENLIDVSLLEFCVREDLNKKANRVMGVLDPV
KVIITNYPEGQEEWLEAENNPEVSPMTYRKVPFSRELYIEREDFREEADKKYFRLKLGGE
VRLKNAYIIKAESVVKDNEGNILEIHCTYDPDSRSGSGSEASTRKVKGTLHWVSVPHALT
VEARLYDRLFTVAEPDRQEDSFLNYINPDSLKVITAYVEPSLQTAKAGDIVQFQRLGYFC
VDPDSSLDKLVFNKTVGLKDTWEKVKSEE
>SEQF1602_02149 hypothetical protein
MKLAYRFFYFLLFSCIIASAQDTPLNKELLLELVNAQRNQGCLCGDTYYPAVPSLKWSDK
LTAIAQKHSEEMSVRKQLTHYSKNGADPGKRLSKAGYHWRAYAENIAMGSFQERTVIEGW
LSSPAHCANIMNPHVKEMGIARKGRYWTQVFGSKE
>SEQF1602_02150 hypothetical protein
MKYFFKISFMALAIGLLTIGCSKKGDDEVTPNPKNPSNPTNPSNPSNPPVASSLKFTPEN
PSVEVEKTTTVGIVGTWNTTDKVKIDNEEVATLQGAVQDNKLTVLGKKAGTTKVHILSAD
NKERGSFELTVSPKLLLSFTPEKAVVKEGETTTITFSGVWNATDRVQIVNGEIAQLQGNV
TDNKITLLAKKAGTTKVEIFTQDNRSRGSFEVSVYTTASTLKLPHKNPLPHYRTDITNRE
EYKRLIEERLVAYEKLMLKLENLEKYPLDIYRYRDQDALYQEGIRISRAVKQFYKENKDT
VSDRDLKNTYENLHQYGVCYAEVEIMVRIAEQYRKKYPTHTEIENLIKENFNGEYGNIDG
PNLTDYLNRNMVATYNKIIDIVNTLQ
>SEQF1602_02151 Phosphate regulon transcriptional regulatory protein PhoB
MEEAAPIRILLVDSDIQWLEHRANLLQQVGFEVLTATSAAQALRIAKKAAPEFLLLNIFL
PDTDGVEVCEQLPQMGLPTYPIVVLLAEENQDYALLAGFEAGADDFIYKNLKPKLFIYKL
QALVRCCLSKKEPQHTFVQHDDFSLDPDSYTLLKGGERYVLPKKEFELLSLLLSAPEKLF
TREELALHIWGDAHQAKNRTIDVHIRKIREKIGQNKIKTIKGVGYRLVKNEK
>SEQF1602_02152 Putative esterase
MTRQKEIYNPTSLYESIQLRVRFSETDPLGIVWHGNYIKYFEDAREAFGRKYGISYLDVE
RHGFATPIVKSVCEHKKMVRYGELLEVQAHYMDTTAAKLVFHYLIYNAAKELVCTGETIQ
VFTTLKEGTLSLYNPEFYEQWRKQHL
>SEQF1602_02153 Inner membrane transport permease YbhR
MNKFFASIYKEILLISRDLGGLIILFVMPLVLVITVTLLQDGAFRNISQQQMRILLVDND
HGEVSQHIRMGIEGGHFFSVVTDAQIKGLDEQKAKRLVHQGEYIMAIVLPKHLSADLQAE
VQENVDRILSAFMEEEVHRQPLKEIDPKEVRLYFDPTLSLSYKEVIKTHIDKMMYQVENL
FIYSAFEKELGEDKHLPFPTGRKMITFSEINPTEMTQLPNSVQHNVPAWALFAIFFITIP
LSANIVREKTQGTHIRLLTSPLSYGELLMAKIGVFLLIGLLQFALMVLMGLYIFPLMGLP
LLDITGRMLSLFLVATSATLAAIGLGVLLGTLCQTQEQSAPLGATLTVILAAIGGVWIPV
FAMPSFMQAIARISPMNWGLQAFYEVFLRAGSIASVLPRVGLLLLFFILCMVISIVYDKA
KRNL
>SEQF1602_02154 putative ABC transporter ATP-binding protein YbhF
MSKVIEVVNLYKKYKQSPHFALKDLSFSVEKGEIFGMLGTNGAGKTTLMSILMGEITPTA
GEFSICGLSFKGQANQIRYRIGVVPQEYALYPTLTARENLCYFASLYGLRGKHLQNLVSQ
GLERVALSQVADRKIKHFSGGMKRRINLLAGILHTPEVLFLDEPTVGVDVMSKNIIIDYL
KELNEQGMSILYTSHHMQEAQEFCHRVAILDRGVLLCQGTPKELISQEKVQHLEEVFIRF
TSQELAYE
>SEQF1602_02155 hypothetical protein
MPNQKGALEGLKEVCYVTDNQGNYTTALSEGWEVKDIAIESSMNLLHEQMQKAKELIQAG
KQSPIVYYMARARMDWATLASYMDKWQWIIKRHARPKVFAKLSEKTLKKYAEIFDISVEE
LTNFPSNT
>SEQF1602_02156 hypothetical protein
MMNISILKYLPHRAPMQMVDTITHINDTSIVTEFLIPEDCIFLEEEYFTESGLIENMAQT
CSAIVGQFFFGLEEDTKRVIGYISAIKKAEIFSLPKILHTIRTEATLLSRYDDKGYSICA
MDCGVYHQEKLLAQGQMNLFIKELDV
>SEQF1602_02157 Protease HtpX 
MQYLGIRQQIARNNIKSILFLLAFPLLILVGAYVVLYILSDQDIERTNTQFLSIIPMVLI
GVAIWFFISYFFHTQMIQSATHSRPLERRENMRVYNLTENLCMSVGMTMPKLYIIESDAL
NAFASGINEKTFAVTLTRGIINTLNDEELEGVIAHELTHIRNRDVRLLIVTIVFVGIFAT
IADFAFRMLLNGSMSSSRNRKNDKGGGALVLLIILLVAGAIYFLSILFKLALSRSREYMA
DAGAVELTRNSLALASALKKISGHSTIREVQNDEVKELFIDYKAQGFFSLFATHPPIEKR
IQVLEQY
>SEQF1602_02158 hypothetical protein
MFKIIMFVRKKASLTKEEFIKLWEAHSQKVIKYKEILLIKDYTKTFPFFPTDEKSATQRE
TLPFEFDAMGELWYEYKEDFIQARNTLEGQKALADLREDELKFVDMASSVMWLGTEERIF
DENR
>SEQF1602_02159 hypothetical protein
MTGLIIILAVVAIVVLWYISANNKLVALSNNRENAFADIDVQLKQRHDLIPQLVAAVKGY
MNHESEVLTRITQARSRALAATGVNDKIEAEKELSSAMGAFNVQVEAYPELKANTNFMHL
QEEIADIENKLASVRRYFNSTTKELNTAIQSIPTNIVAGFKHMTPQPFFDLGTEQRKQLD
KAPEISFS
>SEQF1602_02160 Fe(2+) transporter FeoB
MSKNEIKVALIGNPNVGKTSIFNLLTGMNQHVGNYPGVTVDKKVGFCKLSQIINARIYDL
PGTYSTNPNSMDEKVAVSCLLDRDDIDFPDVVVVVADVENLKQNLYLFTQIKDFGIPTIL
AINMADRMKPRGITIDIPALEAALHTRIALVSTRQKTGIEELKELIINYKKLSLETLVDI
ARIDPPFFSSLKEKFPNEELGKLWMVISQNFEVVGALRKMEIQKENIKTEAEIKRMQQRE
TILRYQVINNALKDTYKVTAVGTRALLDKILLHKVWGYVIFMAILLLIFQVIFYVSEYPK
GWIESALGWVGEWLSGILPEGSLTSLLVDGVIPGLTAVVSFVPQIALLFFFISLLEESGY
MSRVVFLMDRIMRPFGLNGKGTIPLISGAACAIPAVMATRTIESWRERLIAILVTPFITC
SARLPIYLIIIKLVIPQGNYFFFDNQAVALFALYMLGVFMAIFSAWLLNKFLVLKHTIKT
HFIIEMPTYKVPLVRNVLLTVYEKSKAFVVNAGKIIFFMTVLIWFLQTHGLSEKYRNAEI
HTEQMAAQYGWDEDQKEHYLLSYRTENSLLGNMGKFVEPVFRPLGYDWKISIAVLGSFAA
RETFVSTLATIYSLGEVDVEEGEAEQRTVITRLQEEMRPDGTPMFNLATGVSILLFFASA
MQCISTFAIVRKETNSWKWAIIQWIFMTGFAYLSAFAAYQILS
>SEQF1602_02161 Fe(2+) transport protein A
MTLTVNQMKRGEKYLIKEIHTEMLPIKLLELGCLPGNKVELVEIAPLGDPYYLIVNDTHL
AIRKEMGQYIEVEIFNTASDE
>SEQF1602_02162 hypothetical protein
MKNYLLRSVVGVQIASFVIVGLLVLITQFINDKVYLYEYEPAQDFLSIVLTPFYILMSNS
QYGNSFFLLLHSLCYFLFFSMVVGNIIGVVWYFIKKKTLKSSPWMKDFLLGEVIFIGLLV
INYLIIYLTNHFSFEIEKDSSLFMFLAAFAGCFPIFLLGRWLWRRGTRLLGGIALAACGI
ALAFVSGISIYTYGQEGEKNWDEYSYENDDYPERDNNSDNEEGEDPEDFLIIEETGDDDE
EEITYNPEKDTKGTYDPFAFKTSQMDYMEWDKPQEYYKWDFNKFNHDFFQKLFHQEQYVV
DLEDIYRQVDRSKASKEAQDKGLYEFTQELGKDSYMLSCFWRHLGTFTLEQMNQNQLLRY
SARARYLLKVYYLDKGNISLYEAVYKVMKDTDNEVTEYGGYDEEQHLKNQLKALLRVYTD
QDRSEELRRDLNNSDLKYTDIRWAYSFWARRYKEKNIPITLRILLDVNKYVKDKYPKEYE
KPVM
>SEQF1602_02163 Alanine--tRNA ligase
MTSQEIRELFLKFFESKGHVIVPSAPMVIKNDPTLMFTNAGMNQFKEFFLGNAKPKQKRV
VDTQKCLRVSGKHNDLEEVGRDTYHHTMFEMLGNWSFGDYFKREAITWAWELLTEVYKIP
KENLYVTVFEGSPEEGVPFDQEAYDIWKERIAEDHILLGNKKDNFWEMGDQGPCGPCSEI
HVDIRSDGEKAKVAGRDLVNNDHPQVIEIWNNVFMEFNRKADGSLEKLPAQNVDTGMGFE
RLCMVLQGKQSNYDTDVFTPLIHKVEEITKTRYTNGIQLTPEQEQINIAIRVISDHIRAV
SFAIADGQLPSNNGAGYVIRRILRRAIRYGFTFLGQKEPFIYKLVETLTKQMGGTFPELE
KEFLLIVSVIKEEEASFLRTLEQGLLMLDVMIQNASDKQLSGSKAFELYDTYGFPKDLTA
LILSERGMTLDEASFEEHLQKQKERSRAAAQVKAGDWVVLRDDEEEEFIGYDTLEAMVRL
VKYRKVESQKDGTLYQLVFNTTPFYPEGGGQVGDRGTLQAANGELIYITDTKKENNLIIH
IAEHLPENLNDPFKAEVHPMGRALAQSNHSATHLLHQALREVLGTHVEQKGSHVSPEALR
FDFSHFAKLTPEELTEVERLVNKRIYEKIPLEEHRNIPIQQALEAGAMALFGEKYGEKVR
MIQFGESRELCGGTHVKNTGDIWFFKIVSEGAVAAGVRRIEAITNAGALKHFLLQEKLLE
EIKGSLKNPQDPIKSITNLQEENARLHKELEQLKREQAKQLKGELKGEFVTISGVQCLTK
RLDLDIATLKDLAFMLGEEVKDAFILFGATQEDGKALLLCYINKELTQSKGLDAGKIVRE
LGKYIQGGGGGQPFFATAGGRKPEGIAEALEKVKTLL
>SEQF1602_02164 hypothetical protein
MQSQYNLYLEKCSDFCYENFYGELSFIKKEALFAAYFLPLLNLSRYPISHQAIQKQLENI
KSDNDYDTYSQKAEELYRETFFNGVFSFSLLQTKEDWDTIGVVQHCFIDEPEQDDLMMEY
TCGSLSLLGFPQELLLDKLKSFFGELGRFEEIDPTTIEAIMSYVTAVSRYHKKNVIGREK
ALDFLKVEVTFMIDVILNEESYISSLPMPTNYAKRYIDIQKENLLSEDFLLRSKYLREEI
LSEIYRIDKPALNNSYTRDALMAFMSIFPFSLEQDGALIKIFITYYTKTFFDKDFLLERL
HYYFSRKLKEQSL
>SEQF1602_02165 Glutamate racemase
MISPIGLFDSGVGGTTIWREVVRQLPWESTLYLADSLNAPYGEKSSEEIIALCEKNTEYL
LDHHSKLIIVACNTATTNAITHLRAKYKVPFIGIEPAIKPAGLYSQTKTIGVLATQSTLK
SAFFANTCQQLLDKGINVLKQEGIGLVPLIEEGKIDTPEMMALLEQYLRPMVAEGMDYLV
LGCTHYPYLTSLISEILPENVRIMDSAQAVAKQTERILSQNNLLAKKEEHVPSHLWLTNK
NAEILQSFAPEGVRVLYEDF
>SEQF1602_02166 hypothetical protein
MLGKKVLARIETLGGDISQVKGTSLREDLSAITFNTPLYQWDDAFDDWSLGEDDEPIYGL
NDFIEAHRELYKEDKDEFRRQLVAHFYSPQNEPVGAQWIGQPFTPFQEGTADYQQWYLHF
SNEEFVDLYQITKLTKELHPNFIHLLASEGYPDGYYIAINDPNPENPTVFSTDHETFFSE
INKEGKLEKFLNNFITPQQLITIVEKELK
>SEQF1602_02167 Modulator of FtsH protease HflK
MSYVPVIFLLFGLFILFSLFFTVKQQTAVSIERFGKFQSIRHSGLQLKIPVIDKIAARIS
LKIQQLDVIVETKTLDDVFVKIKVSVQFVVIKDKVYDAIYKLEYPHDQITSYVFDVVRAE
VPKMKLDDVFVKKDDIAIAVKREVQESMETYGYDIIKTLVTDIDPDAQVKAAMNRINAAE
REKVAAQYEGDAQRILIVEKAKAEAESKRLQGQGIADQRREIARGLVESVDVLNKVGISS
QEASALIVVTQHYDTLQSVGQDTKSNLILLPNSPQAGAEMLNNMIASFAASNQIGEIMRK
ENDKKRE
>SEQF1602_02168 hypothetical protein
MSASSYVVLLKESHGKRLVPIMVGENEAMAIQYNHFKSTAISHPSIYNVMLEILERNELH
ITQVQISEFKEGNFFCHLLCEDEMGTTSYPIRVADGLVMAICANVPIYMVSELVKRYGST
SRGKEDFTETEPEEESTRPASKDELKRYLTAELERLMESSLMEENYEMAAKIQKELDRRK
KI
>SEQF1602_02169 Putative nucleoside permease NupX
MKLIYVFTLLLSPMLGIAQSQGNTIIPSEGMSLESVLRGVLGMCVLLMIAILFSHNRKAI
AWKTVGIGLAIQLLLAFGVLRVAWVRELFELAGRFFLLILDFTRAGSNFLFGNLMDINGI
GYIFVFQILPTIIFFSALTSILFYYGIIQLFTRGLAWVLSKSLKISGAESLSVTGNIFLG
QTEAPLMIKSFLEKMTKSEILLVMIGGMATVAGGVLASYINFLGGNDDALKLEFAKHLLA
ASVMAAPGAVVISKILYPQDEPIPTMYESSHEKYGSNILDVISTGTSEGLKLAANVGAML
LVFVALIAMVNYFLGWVGEITHLNGIISNSSILPYDRFSLEMILGSIFSPIMWLIGVAKE
DMMLVGQLLGIKLAASEFVGYTQLAVLKNPEAPMHLMYQKSVIMSTYLLCGFANFASIGI
QIGGIGSLAPNQRKTLSEFGLKAVLGGTLASLMSATIAGMILG
>SEQF1602_02170 S-ribosylhomocysteine lyase
MERIASFCVDHLKLQRGIYLSRRDVVGQEVITSFDIRMKAPYREPVLGGAEIHTMEHLAA
TWLRNSDWKDKIIYWGPMGCMTGHYLILAGDYTSKDIAPLIIRLFEYMANFEGDIPGASA
VECGNYYNNNLPMAKYEAKKYLDEVLYQLKEENLNYPE
>SEQF1602_02171 putative ABC transporter ATP-binding protein YknY
MGKTIIEIKDLRREFKMGGETLHVLKGIDLNIYEGEFVTIMGPSGSGKSTLLNILGCLDR
PTSGDYILDGISVRNMSKNSLANVRNTKIGFIFQAYNLLARTSAIENVELPLMYNPKISA
KERRDRAIEALKKVGLESRLHHMPSELSGGQQQRVAIARSLVNDPVILLADEATGNLDTR
TSYEVMELFQELNDKGSTIGFVTHEDDIAQFSKRTVVLKDGNIIKDNLIENRFDAKEELR
KIKSGFSE
>SEQF1602_02172 Macrolide export protein MacA
MKKIIKTSIIVLLLAGVSYGAYRFFFTEKPAIIEIQKEKVEKGDVTTEVTATGSVQPVDE
IEVGTQVSGLVSKIYVDYNSQVKKGELLAELDKTNLQENVINAQANYNAALNEVTYYQQN
YERKKNMYDNQIISKADYEQAYYQLHNAKAAVTQRLTMLNQARTNLGYASIYAPIDGIIL
SKEVEVGQTVAATMSAPTLFKIAKDIKKMQVEANVDEADIGQVKVGQRVTFTVDAYPLEE
FQGEVSQVRLSPTTTSNVVTYTVIVDAQNPQEKLKPGLTATIVIYTNELKGVTIVNNKAI
NFSPDLALLAQYYAQKGINVPTPKVERSKGKNKHVWVEQPDGSLSQKAIVIGNNDGINVE
VVSGLSQGEEVVTSLSAMNPTAKTAQGDQNGASPFMPKMRRRDNSKAK
>SEQF1602_02173 Outer membrane protein TolC
MKYKIIFVALLSLPMWAQEKTWSLTDCINYAVTNNISVKKTELSQQTASINLHQAKSNRL
PSVAANASANVNNGSVINQITNDRVNQTTFTNSFGVNASLPLYEGGKLGLQAERTQLVLE
QSELYRKEAQNNITLSVLEAYLQALYQYENITAAKNTARSSEEELAQARKRFENGAIAKI
DLIEIETQNANNQYNIILAQNQYETQVLALKQLLELPIGTDFKIEIIQKEEVSAPIENKE
EIFRQALQHLPNTKVYEKQKEIAQKDIQIAKSGYLPSLTLSAGLNTGYSDRAADKYMEQL
RNNFGETVGLSLNIPIFSRYQNRNNVALAKIAESQAELDRRQAEKDLYTKIETAWHNATT
RQAQEVASKTARDNAKLAYELAQKKHEFGNLTNTELLVSRNTYLNAEQTYLQNKYMVLLY
QQLLNFYQGKEIMINN
>SEQF1602_02174 hypothetical protein
MEQVYIFTLSALFALAIFDLVVGVSNDAVNFLNSAFSSRAARLRTIMIVASIGVGIGAIF
SNGMMEIAKKGIFNPEMFYFEELMVIFATVMLADILLLDFFNTLGLPTSTTISIVFELLG
ASVGVAFVKELKEKDRLLYVIDGVRNYINTDKVGQVIVAIFVSVFIAFVVGSLVQFLTRL
LFTFDFEKRMRYFSGIVGGIALTALSYFLVIKGLSGLSFMHKELLDWIDQNTLLLLGCFF
VGFFILGQVLYWYKVSIWRVVILSGTFALAMAFAGNDLVNFIGVPVAAWDSFQLWEAAGT
PEQSMTMGALRENVQTPQIFLIIAGTLMILTIWFSKKALNVMQTEMKLSQQGGGKERFEA
TGLSRGIVRFSVWVTSMIEALIPKRTLKYIHSRFEKPEEEKSDSIDKPAYDVVRAAINLV
VSSSLIAVGTSLKLPLSTTYVTFMVAMGTSLADRAWGRESAVFRVAGVFNVIGGWFLTAG
AAFVMGLGIAVILFYGEIYGLITMIFLVGYLVVRNAIAYRRKQRKEKEAQKKRFNKEDLI
TISGIMKLSSQNIAGAVQTIDELYREVIDNLAVENHKGLKACKKRAKALTSDIEDLKSDI
YYFIRSIDDSSVTSSKFYILILDYLHSMSNSISFIADTSYTHVDNNHKKLKYNHIRNLKT
ISEKMQQQFQKILEILNVSMYSNSTTQLIKDVSSIKDEISELIEKQIRDIRTTESSPKNT
KLYFSLLLETRVLIRSIINLMTLFKNFKDQFRTMTNEK
>SEQF1602_02175 L-Ala-D/L-Glu epimerase
MKAIFQKHILQFKRPAGTSRGVLTEKPTWLLTIEHDGRFGIGECSPLPGLSIDNIADYER
SKLLWVCQHISLGKEALWDELKSYPSIQFGVEQAFLSLEAQEEGVLFPSAFTQGKEAIPI
NGLIWMGDKEFMQQQIREKLSQGFRCIKMKIGAIDFETEYALLKGIRQQFTSSEIELRVD
ANGAFSPTDALEKLKRLSDLQIHSIEQPIRAGQYEAMVRLCETSPLPIALDEELIGVACP
SRKEEILQWIKPAYIILKPSLIGGYRGSEEWIALAEKENIGWWVTSALEGNIGLSAIAQW
TYTLENPLPQGLGTGSLYTNNFPSSLQVKNGKLWWIK
>SEQF1602_02176 hypothetical protein
MKTNHFLLFILLIALTACDRTERAISQIPMDVKVLRMDSIFFHTPVKELPLIKAKYPLFF
PENTTDEEWAKKQSDSLQKELFSEINKTFGDFSDQKKTIKSIYQHIKYYFPQFTPPKVVT
LTSDVDYSSRVIYADSLLLIGVDNYLGSKHRFYSDMEAYIAQELDKKYLPVDVALSFAEA
IIPSSRNTTFLDAMIHEGKVLYLAHKFLPTVSEEDLLKYTSEKYQWTEENEAQIWRYFIE
NQLLYSTDRKILTRFIDMAPFSKFYLELDNQSPGGVGRYIGLRIVTQYMEKHPDALQKLG
IIPTEELFKEANYKPKK
>SEQF1602_02177 hypothetical protein
MNHTSEIKLQVELDENRIPERLFWEAPDGGIAHQEAKALFLSVWDHKSKEALRIDLWTKD
MPLEEMNIFFYQTFQTMADTFYKATQDQKMTDTMRDFCDYFAEKMNITKK
>SEQF1602_02178 scyllo-inositol 2-dehydrogenase (NAD(+))
MKNKLKVGVLGAGHLGKIHLKLLNQSERYELIGFYDPNKEQAQKVVAEFGYTYFDSIERL
IEAVEVVDIVTPTLSHYECALKAIAAKRNIFIEKPITSTVAEAEEIYRLLEANQLKGQVG
HVERFNPAFQAAKPSIANPMFIEVHRLAEFNPRGTDVSVVLDLMIHDIDVLLSVVDSPVK
HIEASGVAVISKSPDITNARIEFENGCVANLTASRISMKNMRKSRFFQKDAYISVDFLEK
KVEVIHMKDAPEHPSEFDMILQNNEGERKQIYFEYPEVQPTNAILEELETFADAIEHNTT
PVVTFLQGTKALRLAKDIITKIEENFK
>SEQF1602_02179 hypothetical protein
MTIIELIKLIKPIPELFIGIHNVFCLEAFINGWHYRDTEEDVKASVLYTEFCEWLRKRYN
MRGDSRGWANILYYKFETEEKALDEFFVLFNIFYMEKYKTTLW
>SEQF1602_02180 hypothetical protein
MKRKCYFFANDNDYGVFTSFLKEVTTILIDTKPLLINESINPLKNILEAQTKQICLLNTN
IVSLPQYSKEYNNIQGYAHFHPIGRGRIQLLKSTIEKGKFLKNGQLYGFSEDEDSEAWIK
EVFSWIKRHSKKVYRTTLNRNTISEHPEPNYYCFLSASEEFNGEQGKFLTIANDIYCIAK
>SEQF1602_02181 hypothetical protein
MKTLLKKLPYLLILFRFLLAPTILWVAYKAEEPTARLWIVVFIVLGLLSDIFDGIIARYM
GVCTVAMRRMDSQTDLIFWLSVGVACYHLNPTLIAAYRYEIIALFVMEGLCYGVSFWRFG
KETCTHAFLSKLWGVCLLVAFISLIGFGYGGFPLLLAVYWGLFSQLDVILIILLLPKWQN
DIPSSYHAYLLRKGKEIKKHKLFN
>SEQF1602_02182 hypothetical protein
MTIIELIKQIKPFPILFIRKHSIFNLEVFIDGWYYRDEEEDVKADILYTDFYEWLRKRYN
MNDSRGWAHILYYKFETEEKALDEFFVLFNTFYKEKYKTSLW
>SEQF1602_02183 hypothetical protein
MKIYKIRGGNDPIYASIHAQMGQPYEKGEYIKVTWNDYHSKGNGIPDFLYGGYIVCKREI
AKELKQKFESLEIGELEWHKNPKEIVAKNIHRLRWLPKEEVDLVHIYSKINIPILPQSTV
IMSKGNDGKDWIKDYIGEETLFGTKHTPRELGKGIFIDKRELGDFDFFRIEKSTFLLCTE
NVKEYIEKRGFSNVVFLEVGDVIEN
>SEQF1602_02184 hypothetical protein
MLLDKTIRENLDGKYLIIYGESFREGIEYAAEVDIPQIQLRNNTKCNSIDFKELEKIPAL
KVISFVGNTTEIINLDSIYSLKDIQKIYFQQKQKFKIDISKFPNIKHIGAEYWNGLDCFN
KANGLKSIVFSKFSGLDLKQMSPLLNLKVLHIYSSKIQTLEGIELLPIEELFLARNNQLE
DIQAIEKMNYLKNITIEKCAKIRNYNLIENLRNKIKVSVI
>SEQF1602_02185 hypothetical protein
MTSDEFAKNFYLEKLNILKSCFEEQPQYPSAVNAKIKEMALSSIQQEQLKDVIDTLLTDV
FYSVLLGLDGESSIGNTQHTYKIHDEEGNLISDCGELEACAYEYFHEGKYEGCTLAPDSE
SH
>SEQF1602_02186 hypothetical protein
MSYNFSELDTLTDRLINEEIGTYDLPYYIEPLLEGTTLIDLLKAYLNDAITHKNASRIEC
AIILAATLGEEKKLLPQYENLLLEDWHHSHEDLVDVIESYGNSSNVATLQKAFNLSLPYM
EYNHHYSFHRKLLYAILKLAPEQFTSIHKQYIADLKKGIILK
>SEQF1602_02187 hypothetical protein
MNTTLFLVALSGICWTVVYVDAIRIGFRNKTYAIPFWALALNFAWELLCTIIGYQEIGIN
DQMIANIVWLFCDVFILITYFKYGKLYCPIVVQKYFYLNGIVILFISFVVQYAFIREFGL
IMGSSYSAFLQNLLMSILFIGWALDNNRISSQSILIGISKCIGTLAPTILFGMIGSERLG
GANTFLLYIGLMIFVLDIVYITCILLIKRNTKSRTIETS
>SEQF1602_02188 Modification methylase HhaI
MAQMEINKMRLRIFEGFAGYGGASFALRKLKEKYPQFKYEVVGYSEIDKFASSLFDVNHK
GKQGNPIKNWGDITLIDPYELPDFDMFTGGFPCQPFSSAGMMKGEEDPYGRGTLFQHIMR
ICEVKKPKYILMENVKGLKSKKFERTRALMEEMLRDMGYVTNIEDKNEQPLASAMLEPKG
FEFRVF
>SEQF1602_02189 Oxygen-independent coproporphyrinogen III oxidase
MSSLFQKYNVPGPRYTSYPTVPYWEDSSYSYEKWLDSVRTSFTESNSTQGISLYIHLPFC
ESLCTFCGCHKHITKRHEMEDPYIQNVLKEWRLYLAVLPSRPRIKEIHLGGGTPTFFSPE
NLQYLIDQIFEGADRAEGFQFSFEGHPNNTTREHLQRLYDLGFTRVSYGVQDYSPEVQKA
IHRIQPFANVERVTLQAREIGYSSISHDLVFGLPFQKEEDMRYTIDCTNRLRPDRISFYS
YAHVPWVKGTGQRGFDENDLPTPDQKRHLYEIGKQQLLDNGYIEIGMDHFALPSDEMYES
FVRGTLHRNFMGYTASKTQLMIGLGISAISDSWYGFAQNVKTVKEYEEVLSQDRIPVYRG
HILSEEDLILRRHILNLMCQFHTSWEAPQLQFAEAEEVKMRLSEMEKDGLIHILPQGIEV
TDVGKPFVRNICMAFDLRLQRNVPTTRIFSMTI
>SEQF1602_02190 Thioredoxin 1
MALQITDASFEEVVLKSDKPVLVDFWATWCGPCRMLGPVIEEIATEYEGRVVVGKVDVDS
NQEYAAKYGVRNIPTVLVFQNGEVVGRQVGVAPKNTYTEALDSLL
>SEQF1602_02191 Deoxyribose-phosphate aldolase
MDIAKYIDYTLLKATATPANIEKLCKEALEYGFYSVCVNSGYVPLAAEQLKGSKVNVCTV
VGFPLGAMSTQAKLYETSVALSQGAQEIDMVLNVGLFLSGNVAKVLDEIALLKQETGDRV
LKVIIETCYLNDDQKRLASQVCVDAGADFVKTSTGFGTGGATLADVQLIREVVGDRAKIK
ASGGIRDKQTALQYISLGVDRIGASAILV
>SEQF1602_02192 ABC transporter ATP-binding protein NatA
MSDFLLQIENLSKHYGKHTALSEVSLQIPRGSIFGLLGPNGAGKTTLIRILNQIIFPDQG
QVLLEGHPLQPEDISHIGYMPEERGLYKNMTVGEQLLYLGQLKGLSRQRAQERLDFWLKR
LDISHWKGKKLQELSKGMAQKVQFVATVLHEPKLLIFDEVFSGLDPINAEIIKDQVLYLR
EQGSTILFSTHRMESVESLCDHIALLNRSKLLLSGELTAIKRQFQENTYEVGIIPYEGTS
FEEFQRRYTPTAAQFPTIHNEEKWLVALSPTQEVHELLQYLMQLGKITHFNQQIPSVSDI
FIQTIQAGESEE
>SEQF1602_02193 ABC transporter ATP-binding protein NatA
MAVIVENLTKQFAGQTVVDHLSFSLHKGEVTGFLGLNGAGKTTTMKMMTGALEPDQGSVS
VLGYSILTQREQAQKHIGYLPEHNPLYTDMYVKEYLSYVADIYKAPKHRIEESIALTQLE
SHAHKKIHTLSKGYRQRIGLASTLLHDPDVLILDEPTNGLDPQQILEIRQIIRDLGREKV
VLLSSHIMQEIQAVCQRVLILHQGKIILNEPMTALQDKEQTVEVLFDFRVEEQLLRRIPH
VKTVHNNEEFFFTLTFDTEEDMRPKLFDFAMENGLKILQMNHRHTDLEALFTSLTKTK
>SEQF1602_02196 L-threonine ammonia-lyase
MHSLDDFISAREHLAQVLLSTKLIYSPIFSEESGNKVFIKPENLQKTGSFKIRGAYNKIL
KLSPEEKKRGVIASSAGNHAQGVAYAAKKLGIKAVIVMPQSTPLIKVESTRKYGAEVVLY
GDVYDDAYKKAKELEAKEGYVFVHPFNDEDVLEGQGTIALEILEEAPDTDIILVPIGGGG
LISGIACAAKLIKPSIRIIGVEPAGAASALEAIKENKVVELPEANTIADGTAVKRIGETN
FEYIKEYIDEIITISDYELMEAFLLLVEKHKIIAENSGILPMAALKRLHQKNKKVVPVVS
GGNIDVLMISSMINKGLVSRNRIFNFSVSIQDRPGELAKITQIIAQEGANVVKLAHNQFK
NLSRFRDIEVQVTMETNGLAHIEKLTQAFREKNYEISPTK
>SEQF1602_02197 hypothetical protein
MKNWILFLILMVCGKNYAQVPPLVVGYEYIGRNTFHTGITGEIRLDEDKKYAFFGSTGVH
LTGFQGSTRGIFELSAALKYRHTFAGATYTPYAIIPKVGVGTKDIYAYAGYVIPTNAYAS
GDNNPLRRGFAVGININPKVLLILPLALIIGGPLK
>SEQF1602_02198 tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase
MEKVIDETRQGAPLSLEGDAKNTRKLYIESYGCQMNFSDSEIVASILHKVGFNTTEELHE
ADLVLINTCSVREKAEQTIRKRLEQFNAVKRHKPAMKVGVLGCMAERLKHQFLEEEHIVD
LVVGPDAYKDLPNLLQEVDNGRDAVNVLLSRDETYADISPIRLNSNGVTAFVSITRGCDN
MCTFCIVPFTRGRERSRDPHSIIHEIEELWARGFREVTLLGQNVDSYLWYGGGLKKDFEK
ASDIQKVTAVNFAKLLDMVATQFPKMRIRFSTSNPQDMTLDVIDTMAKHHNICKYIHLPV
QSGSNRILKAMNRLHTREEYFALIDGIRERIPECAISQDMITGFPTETEEDHQDTLSLME
YVKYDFGFMFAYSERPGTLAARKIADDVPDEVKKRRLTEIIDLQQKHSLLRTQAQVGKTV
EVLIEGNSKKSDQEWMGRNTQNTVVVFPKEHYKVGDFVNVKITNCTSTTLIGEAVGYSEM
N
>SEQF1602_02199 hypothetical protein
MATKITHPYFGSLDTSKVETLEDDMYDVLWEQEIPYKDSIVWVSFWFSKGNDLLKERLDA
FESFIKKLSLREEQARKVLIQYLKEHPDYFNHFKEKTKRTPDDIETFVSELELDMIDFWY
PQEGEADVDMYFAPYYDEDVETEEVIAVQFALSGEILSIDWDS
>SEQF1602_02200 hypothetical protein
MERNIGKLDKQVRLIFVLISAILGMTKVITNDTIASILGIISIAFIVTILLNFSPLYRLL
GINTYKNKK
>SEQF1602_02201 FeS cluster assembly protein SufB
MAKYTEEELKEELENSEYKYGFYTDIESDTFPKGLNEEVVIALSKKKNEPQWMTDWRVEA
FRIWQAMPEPPHWANIKFETPDFQDIAYYSAPKKKPKLNSLDEVDPQLLETFQKLGISLE
EQKRLTGVEDKPAVAMDVVMDSVSVATTFQKTLAEKGIIFCAISEAIQKHPDLVRKYLGT
VVPKTDNFYAALNSAVFTDGSFCYVPKGVRCPMELSTYFRINQAGTGQFERTLLIVDEGA
YVSYLEGCTAPKRDENQLHAAVVELIAMEGGEIKYSTVQNWFPGDKEGKGGVYNFVTKRA
LAEKNAKISWTQVETGSAITWKYPSVVLKGDNSIGEFYSIAVTNHFQQADTGTKMIHLGN
NTKSTIISKGISAGRSQNSYRGLVKVVPNAKNARNFSQCDSLLMGNNCGAHTFPYIEAKN
PTAQIEHEATTSKIGEDQIFYCNQRGIDTEKAISLIVNGFGKEVLNKLPMEFAVEAQKLL
EISLEGSVG
>SEQF1602_02202 hypothetical protein
MNEFFSGLSNQHFVGELSLGVVFFRLFLAVVFGGLVGFERERKRKPAGFRTYILVCFGAA
IVSMIQDQLRIHIIDFESTHSGLAAVIKTDLGRLGAQVISGIGFLGAGSIIKERGESIAG
MTTAAGIWATGCVGLGIGWGFYNIALVAIVFMLIIMIVLKTVESKIIKKSFVTSLEISYA
QEQDPTQLLETCATLLRKKSISITKIKKNPAHNCFTLSLSSEEISNFSEWVLLLSSQEGI
LSVMEK
>SEQF1602_02203 hypothetical protein
MLSKASSNEETAKIIEEGSPYHLMIVNQVNQVLKSNVSSQELKLDYVLIETDKITFMLAI
SALGKFFSITAMERDKCNIGISRALLYKNKAKFGTMLEDFF
>SEQF1602_02204 hypothetical protein
MTAAKLQQLLDAHCQDMKASMPGFLFYGILSTTDGTMLSKASSNEETAKIIEEGSPYHLM
IINQVNQVLKSNVSSQELKLDYVLIETDKITFMLAISALGKFFSITALERDKCNIGISRA
LLYKCKAEFGTMLDDFF
>SEQF1602_02205 hypothetical protein
MIVNQVNQVLKTNLSSEQLELVETNKITFMLMISALGKFFSITDLDRDKCNIGISRALLY
KCKAEFGTMLDDFF
>SEQF1602_02206 3-hydroxylaminophenol mutase
MLRFDALSEVRQRKPLPVSSCERLSDLFAQNVFHEGAMRERMTREVFESVMNSIRRGTKI
DRHIADQVAMAMREWAISKGATHYTHWFQPLTGGTAEKHDAFFDPISSREAIEHFSGNLL
VQQESDASSFPNGGIRNTFEARGYTAWDPSSPPFVYGDVLCIPTIFIAYTGAALDNKTPL
LKALTAIDKAATQVAQLFDKQVSHVTTTLGCEQEYFLIDKSLVATRPDLLITGRTLLGHQ
AAKGQQLEDHYLGAIPSRVLAYMKELERECLLLGIPVKTRHNEVAPNQFELAPIFSEANR
AVDQNALLMHLMRKVAEKHDFTVFFHEKPFIGVNGSGKHNNWSLSTDTGVNLLSPGKTPM
SNLQFLTFFLCTIRAVHRYEAILRASVASATNDYRLGANEAPPAIISVFIGEQLTKILQT
LIQGGDKEISQKETLNVINKIPDLFIDTTDRNRTSPFAFTGNKFEFRAVGSSANCGKPMM
VLNTIVAKQLSDFKKEVDSLLHSSGKKSLKKEEAILKVLRSYANASKPILFEGDGYSKAW
EEEAAKRGLSNHKTTPQALKENVSETAIALFEEMKVLSRTELLARYDIDLEEYIKTVQIE
ARVLGDIARNHIIPTAVRYQNILIENVQGLKDIFGEGYRELAFEQIDLIQHISEHIKEIH
SKVSLMVETRKKINNLPSVEEKALAYCQEVRPFFDPIRYHCDKLELMIDDELWTLTKYRE
LLFNN
>SEQF1602_02207 NAD kinase
MKIAIYSQKYKVEYHPLLSSIFQELRSHGDTIRVEADLLRRYREQTPLEGVETFHSVEDL
PADTSLMLTIGGDGTILWAMTYIQHLQIPILGINAGRLGFLATISQEEITDMFAKIRAGR
FHTDERSVLQITHTDGRPIAPLNFALNEITVIRQNSTAMITVEAYLNDQYLTSYWADGLI
IATPTGSTGYSLSCGGPVIMPHSKTLALTPIAPHNLNARPLIIPDSTEITLHVSNREGCY
LATYDARSAILPCETSVKISLAPFHLKTIELEGNDFFKTLRNKLLWGEDKRN
>SEQF1602_02208 hypothetical protein
MEALSSLKLSHILFLDIETVPLQPSYEELSPIERSLWEDKTHYIRQEVPAEDYYERAGIW
AEFGKIVCISVGYFVVKNGQRQFRVRSFVGEERDILEDFSYLVNQFFSGREHLLAAHNGK
EFDFPFIARRMLILGLALPQKLQLFGKKPWELGFLDTLDLWKFGDYKHYTSLNLLAYVLG
IPSPKDDITGAEVRAVYYQEQDIARIAQYCQKDTLTVAQILLRMRGEPLLEPEEIHYAT
>SEQF1602_02209 3-(3-hydroxy-phenyl)propionate/3-hydroxycinnamic acid hydroxylase
MKQEQTDVLIIGAGPSGCVSAAYLHKQGVAVRVVEKTRFPRLVVGESLIPRVMDHFEEAG
FLPALEAQKYEVKWGARFIRGEQVCQFDFSKKYSKGWDWTWQVPRADFDNVLAQEVVRQG
VPLAFETEVTNVEFFDGYQLTTVKDKKGETYQIRSKFVIDASGYGRVLPRLLDLNEPSKL
DDHSAIFTHIKEEKVRPEGEEGTLISFDILEREVWLWVIPFSNGNTSVGVVGPTHYINSL
SATGDTAKALRQAIKTSDFYRDRFEKSEFLFPPQKIQSYSCAVKRLYGDGYVLTGNSTEF
LDPVFSSGVAFATESGMLAAKLVKRQLSGEKVDWEKEYTQYMKRGIDVFTSYVREWYTGN
LQTLFFHEPGNEEVKKKICSVLAGYVWDESNVFVKKHATIIKNMAYAIENGLGMQEE
>SEQF1602_02210 hypothetical protein
MIIKGKIIATRSPKVGNHNDLYEIEEVLKEILALLEEAGIEHKGLFLNADAGFDSKSLRE
FLESKEIIANIKPNPRNGEQPDIYFDEELYKNRFKIEQANGWLDGYKGLIMRYEYLDVTW
IGMLLLGFISKFLKKV
>SEQF1602_02211 hypothetical protein
MGKTVKRELKYVWWKRNYFPHIILERPREINEMCKENGITRADDQFYIEDESIYIGKMYI
YLGVVFLVFTSFGAFSRDAFEIPGVFVLVIFFLTGILYIVYHYTHPPKKIILDRLNGIIT
FPGIFYGKPITMPFDKVLPFLKFNGIGASVSLGFCHHKILATSIRIDNTPKSSWSFIVWY
MDKNRPLPPGKVFDPYRKRDYERRKAEGFPEPLYESWISIFEYYDEQFRVRKEQEERQKR
RNKRNNKYK
>SEQF1602_02212 hypothetical protein
MYILANYLIDDEFERYFKNSWLRSDSDVKLYQKALNTPSWSYLHKIYRNRNLLMNSKNKK
LVNPWKNNIHLCYQSFLNLFNKSDLKVIGISRNMDSLFDDDNSIYCCTGGVDEVDIVAFP
EFSDSLKNVDQFDYRIFVQNVVTKSIEEVPKGAISTPILTTENGKWCIKVDICISQWRRY
KYGTAMGVKFIIAYKLQLNQEDFPYTYAGDPKYFIVSVPLHLNYTEHRSNDYKPSVYYSY
EFTAPLKKETVGTINQLINGKLKL
>SEQF1602_02213 hypothetical protein
MKRELKYVWWKRNYFPHIILERPRGKNEMSKSNGITRADDQFYIVDKSLYIGKMYIYFGV
FFLVLTFSLSFSRDANEIPGVFFRVIFFLIGILLIVYQYTHPPQKIILDRLNGIITFPNV
FYGKPITMPFDKVLAALKLNGKNGPVSLGFYHHKILATDIDLDYTPIKSWSFIVWYMDKN
RPLPPGKVFDPYRKRDYERRKAEGFPEPLYESWISIFEYYEYYDEQFQARKEQEERQKRR
NKRNNKYK
>SEQF1602_02214 hypothetical protein
MNHEILREIITTPMPYGKYKGTMIADLPLYYLEWFASQGFPKGKLGMLLATTFEIKTNGL
QEIIDTLKKL
>SEQF1602_02216 hypothetical protein
MKRTIYVFCVAVCALFVMVSCSKSDSNEPKRFDIPAEAKAIIPEGYIAKMNANGMTINEG
INPPNIEGIFATGILEMIYTSLENDSYPVGKEIDSYRFKFYEQKGTKVRTDYINESITAN
DQARGRGTIISGNGNKFTAYLDMDITDLEIKTRDVSVLSGEITPQGIKDFQYGFLKIEKI
GDTSNRMVPEGTIRIWVSQSKLAVKKQNYPRD
>SEQF1602_02217 hypothetical protein
MKRVMHALCAGVFALFALVSCSKSVDNGGYNNGNNQNNNGSTNGNNSKSLNIPVEAKAII
PEETLHQIRAQGMPIYEGTNPPNIEGIYLLDNLRFHYSSDPGEKGFTKGDKAVNYKYRFY
QQNGVKLKSDYRALKFGVNDIATGSGAIISGSGNNFTVFLNHAAHTEGVKNNDIILISGE
ITPEGIKDLLLTLTVTEKEDTNNQIMKVGVYRIFQHEGIARRETLY
>SEQF1602_02218 hypothetical protein
MRKSLVLTVFASFLLWGCYNNQEAMYSKEYQYPPYIRDMQVPTDENRETFGEIKENPFVE
VASQPVSTFSVDVDRAAYSNIRRMIQQGTLPPKDAVRIEEMINYFDYEYPTPDAQTPSPL
RVSYEQAPAPWNAAHQLLCIGLKTKPLDLSQTPPSHLVFLIDISGSMIDYNKLPLLKSSL
KLLLHNLKAQDKVSIVTYASGVRVALEPTSVRELEKIEKVLDGLEAGGATSGEQGIQLAY
EQAHKAFIKGGNNRIILATDGDFNIGINNPNDLKAFIEKQREGGVYLSVLGFGMGNYRDD
MAETLADSGNGNYAYIDNLTEAKKVLVNEFGGTLFTVAKDVKLQIEFNPKYVKQYKLLGY
ENRMLTNEDFTNDKKDAGEVGAGHTITAIYEIVPSEGKVTSSLRYQDSQLNEIGKGNEIA
FLKIRYKDPKETNAASREVVEPLIFNLKKLSETSEDFRFATAVAEFGLLLRDSEYKANAS
YDQVVELAKNAFGKDEEGYRKEFVRLVESAKLMAKNK
>SEQF1602_02219 hypothetical protein
MVFPTAFVEYQGEQWIGWTKGNFLEGGKGAIGYRFRDTFSLSLLADASIYAAFLRKEGKK
AVFFIQHTIVGLQPNFRVGKYLHIPLVIGADLMRMGIYKERKLSTFFTQTFEGAPKQIYS
PALYFSVGIKIMN
>SEQF1602_02220 hypothetical protein
MKNTIFYCNTLSKSKGFDKVYKLFAWLYLLPIFVSAQVSFKTDILGKEGLFREELSLQLP
IHLDSLAKDPYRRISVWTVGGNMVSQQMNPTEGLPYQTMNLSANILHLQPLGTRWSWLTA
VGLGTYTPENRLSSIAIGENVVANGALLFIWHSNQHMQIGGRNACQYPFGISYGFSYCFC
RISRRAVDRMD
>SEQF1602_02221 Putative NAD(P)H nitroreductase
MLSITFMMALVALKGRAQDSDYMTLIKAATQAPSAHNSQPWWFETFDHSIVISPNFEKAL
PAVDSQHRELFISLGCALENLCTKASELHYQTQVSLSEEGVITVELHKSNTVVPDPLAAF
IEKRQTNRSEYQDRRIDPALLQSLIDKVYEGLSPFEGAGMFHVFAKDTPLFERFTQAVLQ
GNTVQMSDPAFKNELLSWIRFNKKHSESTHDGLSYAVLGAPNLPRWVTEPIVRGSLKAKT
QNKTDLKKIQSSSHMVLLTTEGNDIRTWIQTGRTLERFLLLLTQAGIAHAYLNQPCEVPE
INLTLRENFPKENLYPQILLRIGYAKPVAYSKRKDIKEVMLKN
>SEQF1602_02222 hypothetical protein
MNIIELINLIKPRPELFINEHDIFCLNAFLNGWYYRNQEEEVKAYILYKDFYYWLRKKYH
LRDSRGWASILFYKFKTKEKALDAFFELFDIFYQEHISRDFFGKVEWLIITLEDENYNNL
AHLLKEDLKYTTLGTELCMKLRFRLTTILQEKDTYPRAHFSLVEELLGELHEKIAP
>SEQF1602_02223 hypothetical protein
MNLDFLSQYFTEVHFAKGQLITRVGEVENSLYYLSEGIVRFFYYNPTTDKETTVDILFPE
SFCLSYTSFVRREPSLLSIEALKEVTAYKIGREHLDHLIQQQEYLQIKADILEHLLIEKM
QREAQFLLQSPEEIYLNLLEKDPKLIQNIPLKYIASYIGITPQALSRIRKRIF
>SEQF1602_02224 hypothetical protein
MKQALKNILTLSFMWIVSSTTFAQVNILNAKVPSEIGEKTAAQQESDNDVPLPYGYVDDR
DIMWSTTTWELIDLEERANFPLLFPIDTMEIGADRRSLYDVLLRAMKEKRLTETYVDSYF
TEKRTYDDLKYSLSKADTLDAGYEILNQGQPLPPEYIVRTDLTSRDIVQYRIKGLWYFDK
RQGELKYRLLGIAPVAPDVSVLGTDDAQSNLVELFWVWYPSARNILHKARVFNQLNSANR
VSFDHLLNARRFVGVIYKEDNVYGDREIKKYLPDNALYQLLEAERIKQRIRDREQDMWVY
>SEQF1602_02225 hypothetical protein
MAAANSPRQRMINLMYLVFIAMMALNMGKEVLSAFGLMNEKLQTANERYQLTNEAAFAEL
ERKEQEKPEDYKEALEKARQVRELSNEYYAYLSTLKEEVMSQASNKTDYQVMDKSDFLDE
KFFKTDGLKPEGQKFLDEINKYRTQLISLLGTKDEALKKIIEERFSTGENNKVKNREGNT
VGWVQYNYEGFPYIAAVTKFSQLQSDIRQTEQDFYKAMLGEKMKEELSMKHYTTLLEQSR
GAYYANQQFDGAIVLGRKDNSTKPKRVELTLDGRKLSESEVEVVEGKIKLKVNTGNVGEH
KIAGTLYYEQDGQETPVEVAQSFTTIPRPNEAVISADKMNVVYRGVVNPMTISMPGVPDN
QVTASAPGLSRKSGPNYIMKPNVGSAEVTINVTGTIEGQKFSSSKKFRIKDIPKPEGAIL
RTTGAVKLAKANILAGELSVAFNDFDFDLSTKVNSFRILVPGQPSVVVQGSRVSASPAAA
AAVNRAKKGDIIQISEIRYSVSGYSGTPKPATPISIEVL
>SEQF1602_02226 hypothetical protein
MANSSKSSKKIINMVYGLGASVVILGALFKILHWELPLGSIKLGGGTLLAIGLITEAIIF
AISAFEPVDTGYDWSRVFPELEGGEPRQLNFSGNAQLPSRNDQETQVLRESLSEKLDNIL
REAHIDANLMNSLATSIRNFEGAAKNIGPAADAVASTRKYGEELTTAAVQLEALNSLYRI
QLERTELQVNAQEGMVDNLNSLNAQVNSFKEHLRSLNTVYGGMLSAMGGAR
>SEQF1602_02227 Serine/threonine-protein kinase pkn1
MILKLKKVALIVIGYLVVSCGSGNDRGELVGVKGGQWKQPKPYGMTLVPGGAFVMGSSDY
DKAHTEDATTKTVTVSPFYMDDTEITNGEYRQFVNWVRDSIVRRKLAIMAEESGQSAGGE
GIGQYAFLDTDQEKLNAYDKYMYENYGDKDNPEKRKINRKVKLIWDKEKYPDEHYVEVMD
TMYVPIEETYNGRRPLDVDKLVFKYQWMDIEAAARSHKKGRKDFIKEEIVKIYPDTTVWI
KDFNYSYNEPMHNDYFWHYAYSEYPVVGVTWRQAKAFCEWRTLYKNSFQKAKKKKDVNAF
RLPTEAEWEFAARGGLEGATYPWGGPYTVDSKACFMANFKPTRGDYAADNALYTVEAKSY
HPNGYNLYNMAGNVSEWTNTSYDSNSYEYMSSMNPNVNDQKNKRKVIRGGSWKDVAFYTQ
VATRDYEYQDSARSYIGFRTVQSFMGVQRVDTKKGNLTNMR
>SEQF1602_02228 Aerotaxis receptor
MSTPVNKEVAWDKAKTIMSKTDAKGTIEYVNQVFIDVSGYSEGELIGKPHNVIRHPDMPK
TIFKILWDNIQKGINFHAIVKNMAKSGEYYWVITDFDIIRNPSGQIINYMGRRTSVPSQT
IEKYIGPLYQKILQAEQAGGVEAGEKYFEQFLKDQGKDYLTYIEDVILEFK
>SEQF1602_02229 hypothetical protein
MRQIIFTLFLFSFAGGYGQKLLNQSDIEEKKFGMESLFSLYEDKSPLNGAYKISQGNGEY
YEASFSDGKLDGIAKYYDRNGKIMAERSYKNGQLTGVSREYHPNGKVKKEIELTAGIFTG
FYREYTRSGMLWREYFYKNDQMEGSFREFSDGKVVKDLHYKADKPDGEWKEYDEDGKPIE
IEHYKMGKKDGKQWYMRYYDRRSGIKQYITEYYKEDVPVGKWETKLEDGTLRERQEYKPN
GTSVRERYHENGKLRELATFKGDKRHGPYKLYDDLGVLLEDSTYENNYPAHLKTFYPNGQ
VKEENFSKNGKREGKYVLYDERGRTLLKGNYLKDYEDGLWQYYSLKGNLEKEINFKEGSR
EGTYKEYHLSGNPYIIGQYLHNQKEGTWKYFNPEGETMQEITYKNGNQMQVTRYELKDTR
EKTKK
>SEQF1602_02230 hypothetical protein
MTKAFDLHKAIRARLLRFLDEATPEQLALIPEGFHNNILWNIAHCVVTQQLLCYKLAGVQ
PHVSEELINTYRKGTYPDGHIPSQEGIATLRQLLTSTHDQIIEDYQKGVFAGKDYPVYET
SFGYTLHSVEEAILFNNTHEGMHIGTILALRYFV
>SEQF1602_02231 hypothetical protein
MKRILYASQREKYGYKSYFKDKNSVYSYSEKAQEMIKENYDPKNFDEEAVWKLRVRRSAD
>SEQF1602_02232 Regulator of ribonuclease activity B
MNNKNLPQNWDFFMCRIEGAPASIRTNLALIEVAPLEGLSQRLQFCIKMQNPRPDGLSSN
EEYPILCDIEDALGDKAEAIGAILAGVVKSEGFLELWFYTQNAEALAKTCEDALQTFEGY
QSGYNIAEDPEWEDYFDFLYPDEFSYQTMQNRKVLMQLEKNGDKMEVPREIDHFIYFKEA
AQQQAFAKEAEAKGFKVRFNDDEFVEDRKAEGKEYPYMVEATREDSPLDIDDIVWDLLEL
ASPFEGDYDGWGCANVQ
>SEQF1602_02233 hypothetical protein
MNYKTLTTLLAFALCLLACNAQERFTTLPKKNWESLNLHGKVKKLEAVKKMMPNYLPHRY
EGSGTISSTISFNTAGYVQQIKTYDDIQKEVTTANYVYDTQHNLITETVVTLSDQGAPLD
RKTIHYKYNQVGKVIQSDEYINDQYAFKNLYSYDKKGRFSKKNTIPISEKDSLTSQTTYS
YNDKYYDTVTTITYPKGKSTAKVFRYKYDNQNNLIEMEYKIYKKFVKVLSTYNENKDEIS
NKYFSEGEQQSEEIYEYEYDKHHNPIKKTTLTGSRDLHNIETIKYEYYEQ
>SEQF1602_02234 hypothetical protein
MTNLIHTIQQAFSGVTLGNGIGLSEGNAMDDYASAEERTRCRKQDEQTHWHKIPVELLNQ
YYVALCYFAPKGMRFHLPAFLIADLQGLFRFDLVYTFIHLDRYKEQQFSLLNAQQKQAVA
QYLRWICTDPNCHTTADDTTAIEEALLLFWET
>SEQF1602_02235 hypothetical protein
MDATDIKVLLKVGERISFECKKAENNIPKSVWETYSSFANTIGGIIVLGITENIKFAGEA
NHFEITGITNPQKLRKEFFDTLNSNKVNRNILTDSDVEIIDYEGVSLMCITVPQADYRQR
PIYINGNMMNGAFKRNYEGDYHCTEEDVKAMIRDANDSGNDGILIEHYNTDDIDSATLSA
YRNRFRTANPDHIWNDYDDKDFLLNIGAYTKDRNTGREGLTLAGLLLFGKGLSIRERFDN
IRMDYLDYTNLEEESRWSDRLTYDGRWENNLYNFFMRVQSKLISDIKRPFSLKGMEREDD
SLLHKAIREALTNLIIHTDYMLTGVLKVEKYDNRFVFSNPGSLKIPVVDIYEGGHSKARN
PHIQAIFRMIGFGENIGSGFPTILEACKKENWRRPLLSERPDLHLVELTLSMISLISSEC
ETQLLEIYGDDYKEIEKEEQLILATTFSEGIIANNTVQLLLDKNPLEAGKLLYALVAKDM
LLSTNKGRWTTYAINKEYTQGVENSRSKTQGVKRQGVKRQGVKRQGVEKARSNKKEKIIE
RIIAFCQEPHTLQEIAQELGFSDRYKMKRKYINPLLGDVLQMTSVESKNAPTQKYVVINK
>SEQF1602_02236 hypothetical protein
MAISTKLKKRWDVYPTLQEVLTATQNLSVSPFGLTEEGLQDFRGIKLIGERAQVPLRNGY
MWENISKPLHTSLSYADFTGSVWQYFAIEETDDFTPVIDHVIFDESMFQLSAYAICGNGA
TFLSCSFAGCKYKWGEFIGATLKDCRFTQIKKNVRLKFNSCKLLEDCLFSGEIHKALFWY
SNLKNCTFEGLLYDCSFYGAEKTGDLRKGEIIPPEKVDNRMDGVDFSKADIIMCSFQSFC
YLDKVKPSKNNCVFKVTDEFHNYLLTAIESSDSPLKEKLIEYAKLFYAPHTTTPYEVAHP
NNFSFKHLEEAELSQQLYDFVCKAAEATGCRVK
>SEQF1602_02237 General stress protein 14
MRSLKNISFLLFLVGFPLMLFSQSKTYKVFSPASKILVISGHPHLENSNVNKVILKELEK
HFGEQISIRRLDKLYPDYQINIKAEQEAIKNADFIVLQFPFYWYSTPALLKKWIDDVLYD
YFPGNNLSGRFKDKVVIASITIGGSKERYTPPHKTVETYLIPLQETFEIIGAEWELPVYS
FDAVLSNKNLSKTALQHFLELEKRINKNNVILHEPRCW
>SEQF1602_02238 3-oxoacyl-[acyl-carrier-protein] synthase 2
MGDRIVITGVGISSSLGQGLPIHTERLLLGSTGISRIDYIETLHREHIKVGEIKRSNEEL
AASLGIPPINAYSRTSFLGIEALGEALQSAGLSKDEITQIPLVMASSVAGMDITERYFYE
YTTAPELRRYIHTHNIGEVTAQIADYFGIKGMVTSLSTACSSSANAIITGAQLIRSRRAK
RVVVGGADALSKFTINGFNTLMILSDMDCTPFDAHRKGLNLGEAAAFLVLESQEEALEKG
RKIWGVLSGWGNANDAYHQTASSEEGEGAFLAMERALHLSGLAPTDIDYINAHGTATVNN
DLSESRALMRIFGEEVPDFSSTKPFTGHTLAVASAVEAIFSLLAIQEGAVWPNLNWQSPM
PEVPLRPQTTLKRKPIRHVLSNSFGFGGNCSTLIFSKASECSQLGI
>SEQF1602_02239 Acyl carrier protein
MDTLIKELKEKVIEVLNLEEMTPEDIKTDTPLFGAEGLGLDSIDALELIVLLDKEYGIRL
ADPKQGRDIFYSIQTMADYIQKHRTK
>SEQF1602_02240 Murein DD-endopeptidase MepM
MKKKTDLCSPNYVLSHMKRLFQGSILLIGLAALIPSCKREPKTEPQSTVVETPPPPKPVY
EYGFNLLEYNIVKDTLKQGDTFGALLGAQHISAQKVAEIADLSKELIRPKNFRAGQPYAL
VYDKKQPDSLAYFVYQPDLLHFIEIKLRDSLAIRRIDRKVTIVEREGGGYIKNNLIDDVM
KSGMSFAAAYKLSQIFDYTIDFFHLQEDDKFKIIYDERYVDDTINAGLVRVKAAFFEHKG
KPYYAFHFQSDTTKAGGYYDENGNMMKRMFLKSPLDIFRITSHYGMRYHPILHRMKGHFG
TDYAAPTGTPIRATASGTVTQAGYGSGNGNYVKIRHDKTYETQYLHMSKIIARKGQHVSQ
GDVIGLVGSTGLATGPHVCYRFWKNGVQIDPLKEKLPEATPIDGALKPRYMEFVTPLKKQ
LDAVPYANIQTTETTSGSADTPVDTLPTK
>SEQF1602_02241 Bifunctional enzyme CysN/CysC
MNILRFITAGSVDDGKSTLIGRLLYDSKSILADQLEALEQQSKNKNDDGIDLAILTDGLR
AEREQGITIDVAYRYFATDKRKFIIADAPGHIQYTRNMITGASNSDLIILLVDARNGVTE
QTRRHSIIASLLHIPEVVVAVNKMDLVGYDQKVFDNIKKEYEGIAKQLNLKQVHYFPISA
FVGDNIVNTTSAMPWYQGDSLLHFLERVQINSHPYDKPRFQVQYVIRPQTEELHDYRGYA
GQVLSGTYTKGDTLTILPQGVTTSLSRIEVDGKEVEEVQAGTPAVLHISDDIDISRGDYL
VKADSEPHIEQTLEATLCWMDRRELQEGSRYLLQQRARLTKVIVKEIIYKIDVNTLAQDT
ESKSVKLNEIAKVQLKAASPLVYDPFEENPPMGSAILIDETSNATVAGVLINEF
>SEQF1602_02242 Lipoyl synthase
MDTTTTTSVEKTAKPQWLRVKLPTGKKYTELRSLVDKYQLNTICTSGSCPNMGECWGHGT
ATFMILGNICTRSCGFCGVKTGRPDTIDWEEPEKVARSIKLMNITHAVITSVDRDDLKDM
GSIIWAETVKAIRRMNPKTTLETLIPDFQGVERNLNRILAVAPEVISHNMETVRRLTREV
RIQAQYDRSLGVLRYLKENGARRTKSGIMLGLGETEEEVIQTLYDLKEAKVDIVTIGQYL
QPSKKHLPVKQYITPDQFQKYKEIGDSLGFRHFESSALVRSSYKAYKHVE
>SEQF1602_02243 Outer membrane protein 41
MKKNILTLAAILTAAVSANAQETLSGSKFFDNWQVGVKAGGYSPTHHEAFIKSTRATFGA
EIGKQISPAFRLGVEGMAYVRPIDLDNNPEYGNFIDGTNVSLVGTVNLSNLFGGYKEAPR
TFEVEGFAGLGWAHDYIQNIVPGVNKRENADTNHMTAQFGSNLLFNLGQSKAWGVKLSPA
IIYVVDTPAKNSANSLNSLTSFTQLTGGVVYRFKGSNGAHHFTRPSNREELEALNKQLAG
LREDLRGKDGQLSDSQKRIAQLEKELQEARNKKPEVIERTITKSKKTLESVVTYRVGRTN
IESSQLPNVERIATYLKKYPNSKVVIKGYASPEGNLEKNQKLAADRAESVKKILVTRYKI
SSDRIQAEGNGIGDMFSEPDWNRVSISTIVE
>SEQF1602_02244 hypothetical protein
MNRITFFSMAMALVPLAGMAQEQGDAPVVEEKEHFFTLSGQLRPRFEYRNGAYQALQEGE
EPAILVNNRLRLNMDYRFRQDLQLYVSLQQVNIWGQAPQVQVIDRTGGLSVFEAYAALPL
GGGFDLKLGRQQIVLDEDRIFGSLDWHPAGRAHDAVNINWRPVENLYLRSFFAFNQNYLD
GKAATDKINGNVNNPKGQYFTPGQPYQHMEALHAHYAFTPEQQLSFLFANLGLRNDDKAD
YNMQTFGVHYRGRSESLSYGAEAYLQTGKNNTGATKEAYLLAAMVGYKFLPSLSATMGID
YLSGNNTTDSSDKDKVFTPFSGTNHKFYGFMDYYYVSYTPKVGLLNPYISATVKTSEKGN
LSATGHYFRSAGKIDGKTHHLGVEADLVYTHKLQPFASLQVGYSVHKVSGSYNTLRGFSA
TRPWQDWFWCSININPTMLKL
>SEQF1602_02245 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MKRYTVLGGGSWATAIVKILTENLPQITWYMRNEHAIEHIRQYRHNPNYLSSVELHTEKL
HLTSNINEAIEEADYIIFVIPSAFLVQELSKLTLSLKEKVVFSAIKGIVPESGLVVGEHL
IQAYGINPLNVGVITGPCHAEEVALERLSYLTIACEDLLKAEEMASALRCTFIRTKISED
IIGVEYGAMLKNIYAIAAGIAHGLGYGDNFQSVLMSNAIREMERYVDTIHPIARNINQSA
YLGDLLVTGYSAFSRNRLFGSMIGKGYSVRSAFMEMNMVAEGYYAVENAYKINQRQALPA
YTPILNAVYKVLYLHHSARETFQKLTEEMD
>SEQF1602_02246 Efflux pump membrane transporter BepE
MIKSFINRPVLSTVISILIVILGVLGILSLPVSQYPDIAPVTVSVRASYGGANAETVLKA
VVIPLEEQINGVENMDYIVSSASNSGSANITVYFKNGMDPDNAAVLVQNRVSYANAILPA
EVKQAGVTVEKREAGNLMFLTFFSDNPEIDEVFLENYLAINVIPGLKRITGVGDAEEFGG
KNYSMRIWLDPQKLQAYKLNPTEVTAAISSQSLEAAAGTLGQNSGSSYEYTIKYKGKYNK
VSEYENIVLKAMEGGRILRLKDVAKVELDAMGYTSFSESKGRPAIAMGISQTPGANAHAV
VQNIETYLKSIEKTLPEGVTYSINFNVNTFLNAAISKVVSTLLEAFLLVFLVVYLFLQDF
RSTLIPAIAVPVSIVGTFFFLNIFGYSINMLTLFALVLAIGIVVDDAIVVVEAVHSKMEH
TGEKAKPATISAMNEITGAIISITLVMAAVFVPVTFIEGTTGVFYKQFGVTLIVAIFISA
VNALTLSPVLCSLFLKPHGDKEYQNKSWMGKFFHKFNIAFDAATLKYGQTFTFFLRHKWV
TLVLFAVAGAGIYFANNNLQKGFVPNEDQGFVLMDASMIPGASMERVANQLREVSKDLNE
IPGVENFTFVTGNGMLSGAGSNNGMGFFTLKPFEERAKHPDQSIDAIIGKAFAAASKIKD
ARILFFQPPAVSGFGMGAGVSFALLNKSGADVTEINKTTQEFMAALNARPEVQYAQTSFN
TDFPQYQMDINVERAMQSGIAVSTILSTLQNYIGGYYATDFTLYGKQFRVMVQALPEDRK
DVNSLNNLFVKTGTGEMAPISEYVTLNRVFGPQAISRYNLYTSVDISAATNEGYSTGDVV
KAIEEVAAQKLNSNYGIDYTGLTREEQNAGSQTIVIFLLSLIFTYFILSAQYESYILPLS
VLMSLPFGIFGAYLGQWLFGLENNIYFQISLIMLMGLLAKNAILIVEFAVQRRRHGESLS
KAAINAAMARLRPILMTSFAFIVGLLPLVFASGVGAAGNRSVATGAAIGQLIGTFFGLIV
IPVLFVIFQHLQERISGVKHKEEVFVAPTDNY
>SEQF1602_02247 putative oxidoreductase
MTENIKNKVVIITGASSGLGEATALLLATYGAKVVLAARRKERLEKVASQITSQGGEALV
VVADVAIQSDVERIAQETLKRYGRIDVLINNAGIMPQATLDKLKVEEWDKMIDVNVKGVL
YGIAAVLPTMQQQHSGHIINLSSVAGLRVAAGRGTVYSGTKFAVKAISEGLRVEVAKDNI
RVTTLYPGAVESELKYGSSDPEASENIQAFYKAYEIPASSVARAIAYAINEPEEVAINEI
TLRPTRQEF
>SEQF1602_02248 Putative ribosomal N-acetyltransferase YdaF
MITNQYNQPIGEALPNFSVGATPHITLLEGNYCLLEPLSVAKHLDDLSDFYLEASAVMPD
WTYLSIAPAKNKEELHALLTKQEASTDPYFLTIVDKQTRKAVGTLALMRIDPKNRVIEVG
WVNYSPALQRTRMATEAQYLLAKYVFETLQYRRYEWKCDSLNEPSRRAAERLGFVYEGTF
RQAVVYKGRSRDTAWFAMIDKEWEANKRALEQWLSPENFDSQGKQRKSLSTIRQGNIQ
>SEQF1602_02249 hypothetical protein
MTREELIQLGNQIIEETDDDRQEELMERFDRNVPHPEGSSLFFYPENYNARTMDISSYDP
TVEEVVDKCLAYQPII
>SEQF1602_02250 hypothetical protein
MDIEIIKNRKGAQKAVDIPAEVLSLLNEGRIETVNLTEWLAVDHSQLVASVFPALGIDKN
IIEELVCQINQQKKPSTMNTIKLIGALLYEKYANTDLYEPLFKQISTHLSDSVRCYACYL
VALHTEIPLEDKLHKLKSLVADSHFGVREIIWMALRPEMSEHLDFSIGFLSHWAESEEEN
IRRFSTEALRPRGVWCAHIEALKEKPEVYLPILDKLKSDKAKYVQDSVGNWLNDASKTRP
DFVTALCERWERESPTKETKYIVKKALRTIASK
>SEQF1602_02251 hypothetical protein
MNNEVLPTTYLGRELPKEYVNSIENGESFPEWLTMFPHTEYEHSTEIEVWSKEYLLSHTY
SESFCNYAFFTRDDIDFSMLQTRDEDTLTSEELQSAFAIGSVNEGFVFINLHDGSLWIWY
HDMFCEKIAANFSDFQNLLTKESINTEEEE
>SEQF1602_02252 hypothetical protein
MIPNILLQQLENALPKGMQIPEELRKLYQWIEDNGYYSENEGIRYGYLYPQDKLRESWKE
EEREGGTDIAFSVLKNIDREEVLENCYKKHKDEVRRRLLVFAQSGADGSECALWLDDEGH
TQIVHIGSGSGSIMTCILVKNALDFLRLLAIGYDEICWDEDYPLPPNSNKDNTFVYPNTQ
YQEWVQNTFHTTIPKIGLEVVTPHNMNDEPITDPFLKWFLEVTE
>SEQF1602_02253 putative peptidase
MKRLFLTSSFSSVAKLFEDFAGEPVNGKKLAFIPTASLVEKVRFYVDDDRKAFEKLGLII
EELEISTATTEEIATVLERNDYIFISGGNTFYLMQELKKKGADKLLIEQIDNGKLYIGTS
AGSIIASPTIEFVRDMDETKKAPELTDYSGLHLVDFYFLPHYLNFPFKEVTQKIVNDYSQ
KIDLRPISNNQVITVLGNEIKTLEKPKRATKK
>SEQF1602_02254 hypothetical protein
MTTREEIKELNDHLQAFPKAEDIFVKEQPWLKNHFLPLMSIDLAEINPDWAGQKVYMLAP
FEPYEGYIGDNTTEYHNEYTAPNWLAFRLTDDNKFEFLGKEGYFERTAIHHWDFNSEEEE
LFREMADNYEKSKENVAKYGTLVDLHYLEYKGKLNRKTFLEILGGEPQYGNWCSTIEDEE
YPKAFKMNIEDGEEDDEVVFDISYKGNPFYLVAEATAFHWVGAGGYIIMLYEPVSRIVLF
TFDYS
>SEQF1602_02255 hypothetical protein
MQSREEIQELNDHLQAFPKAEDIFVKEQPWLKNHFLPLMSIDLAEINPDWAGQKVYMLCP
FEPYEGYIGDNTTEYHNEYTAPNWLAFRLTDDNKFEFLGKEGYFERTAIHNWDFDSEEEE
EIQEMQKEYEENKANFKKYGALVLNGYADYDGNLNVVNYLDTLGGELQYGNWCSTIENEE
YPKAFKMHIEDGEENDEVVFDISYKGNPFYLVAEARAFYWVGAGDNIIMLYEPVSRIVLF
TFDYS
>SEQF1602_02256 hypothetical protein
MTTREEIQELNDHLQAFPKAEDIFVKEQQWLKNHFLPLMSIDLAEINPDWVGSGGYIICF
MSLLAVLCYSLLIIRKKNRLINIKNTMTTTEEIQELNDHLQAFPKAEDIFVKEQPWLKNH
FLPLMRIDLAEINPDWAGQKVYMLCPFEPYEGYIGDNTTEYHNEYTAPNWLAFRLTDDNK
FEFLGKEGYFERTAIHDWDFNSEEEKEFQKMQKSYEKSKVNFEKYGTLINIFALEYDGKI
EKANYLSRLGGEYSFSNWATSISSGEYPKAFAMKLDREEGLPDDGISITYKGNPFYFIAE
TASYDWYDGGIDGIIMFYEPVSRIVLYTFDFT
>SEQF1602_02257 Outer membrane protein OprM
MNRIIYKGFAVAFVALTLTACAGRKTYERPNVVNEKLFRTDNIPTDSLSSANVSWRNIFT
DATLQGHINKALSNNLDVRVAMQNVASAQAYLKQSKAAFIPTLAAQANYTRATSSINAMG
GVGERTYGNLWDLTGSASWEADIWGKLSAQKRASYASYLATVEAQKAVQSEVVATLATAY
YQLLMLDKQKKVLEQTIDFRQKSLETTKHLKEAGSTTEVATKQIEALVYNAQAQLISIKN
SVWALENTICVLLGEEPHTIERTTLAEQNFPTEFKQGYAAKLLQNRPDVARAELSLRNAF
EMTNVARAAFYPTLTLSARGGFSSTELDTWISAKSIFANFVAGLAQPILNGRQIRTQYEM
RQIEQETALLNFKKVILSAGKEVADAMQNFSNQTEFIELKNKEMKAYQEATDYSKQLFDS
GMVNYLEVITAEVNRLNAELSVAESQFTRMQYGISLYKALGGGWK
>SEQF1602_02258 hypothetical protein
MTRLAIFLFFFTLSTMAQITVSGRVFDEENKPFPKLIVSNGREKVYTDAQGNYTIQAKLF
DILEFSVESEYKGYKMNKQYYFVIKNIPHQKYKVQLDSDVIYKYFVDPYTVSFSFYLDDS
KVEKSNEEAFKERVRNGEFYTYEIRTWDEMPKEIEQISMYNVFVYTQDYYNEHIKNKQK
>SEQF1602_02259 hypothetical protein
MTRITIFLFFFTLSTMAQITVSGRVFDDEKKPYADFPVTNGRDTVRTDSEGRYKIEAKLW
DVIYFYRFEKKSQIYYVGIPYYVLKETPHQSYDAFVGFSSIYECIKGARNPDILFVLDGV
PIKAKDKESFKERLRNGEFFQYSLKEDAIFSDRISDYYDYILYVYTKDYYNEHIKDKEKK
K
>SEQF1602_02260 hypothetical protein
MNRLTIFLFFFTLSTMAQITITGKVTDKEGKPLANITVKTDVIIYTNEEHYAANYVTTDA
NGMYKIQAKQWDTIHFDNMGCYIVFKDTPHQVYNHTMDRLYRNSNIHIEYAYGCGILFIR
NDKIVEEKDREAFKKELRSGQFYKYSVMEKQELFEQYGYLSQYGLVAYTKDYYNEHKKNK
SKKK
>SEQF1602_02261 hypothetical protein
MAQEDKTQKGGIKDIGRIPNEPPLCIIDGKKLSRWSLKTKKLQPDEIAEILLFFREEAKN
IFGNSAKYGALYIITKETLSKAEALIDIPAERKLNRRERHYREIGEFYQTYRLIVVSGKV
TDKEGNPLANIKVRNNDRGTRTFTDSIGNYTIEARRWNAIQPENIEDCYLVVKEAREQSH
NFVQHPPIESRNSDPRASTPSISLKTPCDKLFVLDGLPIEKKEEFLKKIRRKKIEEIIEI
DEQSGVPLYGSLGAYGVIIINTKK
>SEQF1602_02262 Carbonic anhydrase 2
MDTYKTIFENNRQWVERKTGEDKDFFKKLVKEQNPDFLYIGCSDSRVTAEELMGLGPGDV
FVHRNIANVVNTLDMSSTAVIQYAVEHLQVKHIIVCGHYDCGGVKAAMQAKDLGLLNPWL
RTIRDVYRLHQDELDSITSPKERYNRLVELNVEEQCINVAKMACVQEGYLYHQYPIVHGW
VFDIRSGRLIDLEIDFVELMKRIQKVYDLTGEDWNYK
>SEQF1602_02263 Efflux pump periplasmic linker BepF
MNKVLIFVSMLVLTIGCKKGQEQQGAGMGATQKVLPTITVGEQSTTSNLSFPVNIEGVVN
SPVQAKISGYITKVLVDEGQAVRQGQPMFQLETQTLNQSAASAKAQVEVARVEVNRLLPL
VEKNIVSKVQLETAQANLQRAQAAYNEVASNIGFAVVKAPVNGVVGAIQYREGALVTANN
TVLTTVSDVKDVYAYFSMNEKDYLSFLAQAKGATVKEKLANFSEVSLIMANGKEYNHKGK
IQTVTGQIDPTTGSIQIRATFPNPEHLLTNGNSGTILIPQTFDNSLVIPEVAVFEQQGKI
FAYKVEDNTIKQVVVTLKSRADNLVVVESGLKAGDVIIVQGLNGVRTGDKVTPQPVSMDS
IVKAIQPIF
>SEQF1602_02264 Bicyclomycin resistance protein
MKNYNTDVLFILILGLLSMLTPLAIDMYLPSFGAIASDLHVSKERIQTTLALFTLGFALG
QLLWGPLSDSYGRKPTIIVGVIVAAVIALWLTQVGELYHFYILRFLQGFFGSAPAVVAGA
LLRDLFNKEAFSKMMSMIMLVTMIAPLVAPILGGYIADWFHWQAIFYLLTVLGLLAALLV
WLRIPESLPKERRIPLDIIGVLRNYRTVATNRKVLGYIFTNAFSYSGMFCFLTSGSLVYT
GVYGVAPKNFGYFFILNIGVMMIATFLGGRFVGRLGTERILRIGLWIQLIMGVYLAFCAF
FHWGLWPSAIGVALYVGMVSIVSSNANAAVLELFPRTAGTANSLIGMFRFAIGAIIGAIL
ALFSVETEQPMLFAITLCILISVGMYKGLVKSKK
>SEQF1602_02265 hypothetical protein
MNIEKNTLIEMMSELFRKMHHVSPMAAKILSVLVIEGCAEGLTFEYLIERVQASKSTLST
NINFLLDKGLIYYDTKEGKRRKYFKSFPFDKRFSEFLELIRYERDFTLRFRKYIDEQDPQ
HTDRFLERRMKKTGILLDYLGKMESLTEDFLEKLKQEDIREKL
>SEQF1602_02266 hypothetical protein
MQSFLPNMFYYGFPVVLLTTTNEKGNANITPISCTFTLSTHAVMALVKLNKAYENVLVVP
EVVFNLPTASMWEQVDTIAPYTAKNPVPAQKAEKYTFAQDKFAIGGFTPLPSQKVRPPRI
AQCPIQAEAKVTEVIDRNGYVLVELEFVVVHAEDHLVMDGDKINPLAWNPLIYNFKHYYG
LGEHKGVNFALRPQQ
>SEQF1602_02267 Neutral endopeptidase
MKKIYLLASVAFLVACGSQKQSKNDPIEKGLDLSAMDTSVRPQDDFYNFVNGKWAKTAQI
PADKSTWGTFQILRDKTDEQCLAILDELLQKDFPKGSEGQKIKDLYASYLDWNRRNAEGL
KPLGQCFVKIDAIQSLADLQRYLIEVTPQGENPICNWSVSADKKDSQMNAVYLGAFSIGL
SRSYYQKDSEANTKTIAKYQEYVTKVLSMIGEENPAQKAQELVDMERRIAKLIYTNEERR
DPNITYNPLSIKELSSLVKGVNLPVYLSTVGVQTDRVIVPEIRLYKAYDTFLSQENIPLL
KTYLKYQQVSSNLHTLDSALDELSFDFYTRYLKGQQQQRPMNKRALGIINGLLGEAFGKF
YVERYFPAKAKEEMLVLIDYLRRSFAQHIQQVQWMSPQTKEKALAKLNKFGVKVGYPDKW
TDYSRLEIAPASTASYFDNVCSIRAWRYKENLADVGQKVDKSRWRMTPQTINAYYSPMNN
EIVFPAAILQAPFFSFDADPAVNFGGIGAVIGHEMTHGFDDSGAEYDGDGNLKNWWTPQD
KENFKKATKALAAQFDKYEVAKGVFVNGIFTNGENIADLGGVNIAYDALQLYLKEHGKVQ
KISGYTQEERFFISWATVWRGFSTEKHLLNQVKTDPHTPQYIRAYAPLTNVEAWYKAFKV
KTGDKLYRAPQDRVKIW
>SEQF1602_02268 Transcription-repair-coupling factor
MSKELLLSSFLEGKPYHQLSEYIKGKTSCFAENLVGSSLSFVLFDIFKRTGQTLLFVGDD
KEQAAYLLNDLELLLGQEQVLFFPSSYRRPYQTEETDNANVLLRAEVLSQLQQGARVVVS
YSEALFEKVLTRQQLDKNTLTLKRGEHLSLDILNETLFEYQFQRVDFVSEPGEFSVRGGI
VDVFSFSNDTPYRIEFFSDVVESIRTFDVETQLSLQQVSSVVIIPNIESKVAGEQRTSFL
SLLPEETLIFVQDFELFAPKWEKMYQKAQEAFATLKGEIAHLPPEELFCNAQEGLRDFVQ
RYVVRINPHNPQEMEGKGVSFAMRPQPSFNKRFELLIEHFKEKYNEGYTNYICCVSAQQA
QRFLDIFEELHQQVPCELLELSLSEGFTDTANKINCYTDHQILERYHKFNIRNGYAKKQA
ITLKELHQLTIGDYVTHIDHGIGKYAGLQKIDIEGKKQEAIKLIYGDRDVLYVSIHSLHK
ISKYNGKDGAPPRLYKLGSSAWKALKQKTKARVKQIAFNLIQLYAKRREAVGYAFAPDSY
LQKELEASFIYEDTPDQSKATLEVKQDMERARPMDRLVCGDVGFGKTEVAIRAAFKAVDN
GKQVAVLVPTTILAFQHYQTFCERLKELPVRVEYLNRFRTAKEKNQVLADLASGKVDILI
GTHQIVNEKVKYKDLGLLVIDEEQKFGVAVKDKLKTLRENIDVLTLTATPIPRTLQFSLM
AARDLSVITTPPPNRYPIESQIISFNEEVIRDGIAYELQRGGQVFFIHNRVENIKEVAGM
IQRLIPDAKIGIGHGQMEGKQLEEVMLAFINGDYDILVATTIIESGLDVPNANTIFIHNA
QHFGLSDLHQMRGRVGRSNKKAFCYFITPNLSELPEDSRKRMQAIAQFSDLGSGIHIAMK
DLEIRGAGDLLGGEQSGFINDIGFDAYQKILQEAVTELKENEFAELYADEAQQAVYITDT
QLDSDFELLYPDNYINSITERLNLYNELSNLKNEEELSQYEYRLIDRFGALPPQARDLLN
SVRIKWLATQMGIERLVMKQGKMLGYFIADQQSKFYQSGTFQRVLTFVQRNSDKCHLNEK
ETRNGLRLIITFDKITSIDKALRIISGFVE
>SEQF1602_02269 hypothetical protein
MNKVIYLLVVILAFGACHKENKQENQPRDWTCYDSPNEEAVILIDKTLVPEGSLQKFVLY
EENEAKEKIEQKQFTYSQVIKDTIHFTFAILHDMNRVLGKRTINFSLEIPNFEPISMTFS
GEYITVPRCCSIPKVYKAWLNGKEWNPKSGHTYILPKEALQKKNLNSQ
>SEQF1602_02270 hypothetical protein
MNKVIYLLVVILAFGACHKEKKQEDKDIGWRCCSSPNEDAVILIDKTLVPEGSLQKFVLY
EENEAKEKIEQKQFTYSQVIKDTIHFTFAILHDMDRVLGKRTINFSLEIPNFEPISMTFS
GEYITVPRCCSIPQVYKAWLNGKEWDPKSGHTYILPKEALKKKNLNSQ
>SEQF1602_02271 hypothetical protein
MKRIFLLWGVAMTFIACQREGEVLSTTPTPKPTPEGVQQATQNNPNLKWVALTQDYNVSE
EEAKNLVLSFVRETQKVNSTARAVSLEIESIEAVKASNTTMRISQNTSMENDLYIVNFKD
NNGFVLTAADKRVPGIFAYSDRGKWEKSLTNPVQKILYERLLNYIEQSRIIFDKRKDKLV
KEAWEEFTKDFSVKEKENLYKEYFDDKGNLKRVVKRASYQRYHEFDPDNPNDPNCPQGTD
YEVFYNNWELVEETEVLLKTGWAQFGDYNLFTRYRNCSSGQTPVGCVAVAVGQIMAYYKR
PAIFNGRIMHWDQMTTNPIITSLSPQGKEDVQHLLADLGESTYLKMNYKCGSSGASDENA
CETFKKLGYIHATLSDRYDIEKDLLAKRPVYIGGFDKTKENRPRIGHAWVIDGYRKYKAT
SKEVIYIDCMEKIYHDTMYFPLIHHNLGWGMGSNLWYSPKPYYENEKESFGNYPQMDRYP
YDISIINNIY
>SEQF1602_02272 hypothetical protein
MLEIKREYRIFVALKLLLDNLVIFRNLYLQNMQIFKTSVARKVAMALSAFFLILFLVIHL
AVNFMSVLSEGTFNMLSHFMGTNPLIQFAMQPVLLFGVVFHFVMGFVLELQNKRARGNQP
YYSYNGAANASWMSRNMIITGVVVLGFLALHLYDFWAPEMVYKYIDFNEPDETRYYGELI
EKFHDPIRVGIYVFCFVFLCLHLLHGFQSAFQSMGWKDDKRKKFISCLGKWYSFLICGGF
IFVALFHYINSLI
>SEQF1602_02273 Fumarate reductase flavoprotein subunit
MSTLDSKIPEGPLADKWTKYKDHINLVNPANKRNIDIIVVGTGLAGGSAAATLAELGYNV
KAFAYQDSPRRAHSIAAQGGINAAKNYMGDGDSNYRLFYDTVKGGDYRAREANVYRLAEV
SGNIIDQCVAQGVPFARDYGGLLDNRSFGGVLVSRTFYAKGQTGQQLLLGAYAAMNRQIA
RGKIDMYNRHEMMDVVIVDGKARGIIARNMVTGEIERHSAHAVVIASGGYGNVYFLSTNA
MGCNATAAWKIHKKGAFFANPCFTQIHPTCIPRSGDYQSKLTLMSESLRNDGRIWVPKKM
EDAVAIREKRKKPTEIPEEDRDYYLERRYPAFGNLVPRDVASRAAKERCDAGYGVNETGE
AVYLDFASAIERYGKEQCKIHGVEPTKEEVTKRGEKIIEAKYGNLFQMYEKIVAENPYKT
PMMIYPATHYTMGGIWVDYNLMTTVPGLYAIGEANFSDHGANRLGASALMQGLADGYFVL
PYTIGDYLAADIRTGKISTNTPEFDEAERVVKERLAHFINNKGTHSVDYFHKKLGKVMWD
KVGMARNAEGLKQAIKEIREIREEFWRDVKVPGELTGMNVELEKANRVADFLELGELFAK
DALERNESCGGHFREEYQTPEGEALRDDVNYAYVAAWQYTGNPTEVVNTYNPSEEVLHKE
PLVFKDIELKQRSYK
>SEQF1602_02274 Fumarate reductase iron-sulfur subunit
MNMNLTLKIWRQKDAKSKGQMVEYKVTNISDHMSFLEMLDILNEQLIEKGEEPVAFDHDC
REGICGMCSLFINGEAHGPDRGITTCQLHMRMFKDGDTITIEPWRATAFPVIKDLIVDRS
AFERIQQAGGYISVNTSGNTQDANAIPIPKRDADRSMDAAACIGCGACVATCKNSSAMLF
VAAKVSQFALLPQGRVEATERVLNMVNQMEHEGFGNCTNTGACEVECPKGISLENIARLN
REYLKASIQ
>SEQF1602_02275 Anaerobic C4-dicarboxylate transporter DcuB
MNTYILIFEFLFLLGILYIGSRYGGIGLGVISGIGLVIEVFVFRMPPASAPIEVMLIILA
VVTCASILEAAGGLKFMLQVAEKILRKNPKQITFLGPIATYTLTLMLGTGHAVYSIMPII
GDIALKNKIRPERPMAAASVASQLALTASPISAVVTVYLGKGLLDLFHQQGGESLTLINI
LSVTLPATFLGLMAMCFYSLRRGKELEADPEYQRRLQDPIYRDQILNSTKTTLNDFIPQS
SKNAVYIFLSSIVLIVVLALYEDIRTFEVLKEGVTTQMVVPMGVIIQMVMLCFGGIILTT
CKTSVKLVPEGVVFKSGMVACVAIFGIAWMSDTYFTYAMPYFKDGITAMVQAYPWTFIFA
LFAVSIVINSQAATAKMMLPVAITMGLPVPLLIGIMPATYAYFFIPNYPSDIATVNFDPT
GTTKIGKYYFNHSFMVPGLIAVGVSCLVGIGLSQFLIR
>SEQF1602_02276 Sodium, potassium, lithium and rubidium/H(+) antiporter
MVEYFPYLLLLLIVIVGITMLANRIRVAYPILLVFGGLALAFIPKLPTMAIDPNWVLLIF
LPPLLYADSWVLSPKELWKWRRIIFSFAFIVVFITAAVVAWVANMVLPGFSLALGFLFGG
VVGSTDVVSVSAILKFVKVPHRLSTILENESLLNDASSLIVFRFASIVVTTGQFVWYEVA
GSFVWVVLGGIAIGLAVGWLLRAIHKLLPTDANMDIILTYISPYVMYILANAVDASGVLS
VVTGGVYLHYYRNEIFTASTRNKIEAVWDNIVFILNGLAFSLIGLSLPQVLSSFQQEGMA
LSTATYYGLLMAGVIIGVRICCAYAAVVTTQIMKRFIKVADGRRYNNVWIPLLLGWAGMR
GVLSLAVALSIPLTLADGTPFPHRNLILYMTFIVILVTLVLQGLTLPWFIKKVTFPDYDD
HIPDTEAETLIRKDLARVALEYMNDHYKEGITDSFLLQNQKDVWEFQLKTAYCNVTAEVR
DKYIAILRYQREYLSELNKNPRINEQLIRSFERQLNLEEEKWESSE
>SEQF1602_02277 hypothetical protein
MRYLGAYFFCFLLLVGCSSKEEATDQVDYLLSKNPSLLFQIHHKDQFVNQLIHNDFWKNY
FKYYPNQNVQNLLRSLPEDDHIWVAYTHDGVYLSATLEKQDSLSVWKNLSSGKLDSLTVE
NKKWYYITKDKEILISSLKDISFPETPVVRQEAFHKVAKTISGEVPANIFLAQKKNKEFI
GGIFPERIVKHLDGWTAWDIYLEKNTLRMSGSLLRPADSLPQLPIVPSQKNTIETYAVIP
QTAQGISCFSFEEKLVPEEFYFDFQQDISSVTFFDFQRDSMAVLRSSNPEETLRYFTILK
SDTFQGETLHHIEEFSDIQSFFSIFERELQPKYLYRNEENLIFAQNKEALEALINAIQMK
QTLSQGKSFEALQQKSSSQNSFITIENLQEQKDFSAKYASLAQRYAYASLQISPQDEFYQ
LTLTTTADTGGSSTATATSSEERGISERFLITLDKEALTQPVFVTNHRTGQKEVVIQDAD
NQLYLIGNDGKILWKKRLDAPIVGGIHQVDLFQNGFLQMAFNTASSFWILDRNGNVVAPF
PMSYKEKLLPLQVFDYERNREYRFVVCSEKTIRLIDKRGDIVKGFEKSQVPNGLAQTPQH
FRIAGKDFIVFPEKNGTLSILHRNGTVRIPISQKFDFSDNPISTYKDFFCFTTKAGKLFF
VDTNGGVRSESIGEGNFSFDCQRDIKVLLHNNILTINQTKVELPYADYSGAKLHWEDRNP
VISVFDRENSRLYLLNTQGEIYSQFPVFSLSQADVTQDKGKLLLAFLKEKNVLCVSEQ
>SEQF1602_02278 Putative O-methyltransferase
MHFLSEDLENYANTHSQEEPALLRALNRETHLRVLQPRMLSGHLQGRFLSLLSKLIRPKY
ILEIGTFTGYATLCLAEGLAPEGVLHTIEVNEELEEIQNKYFAQSPYREQIVQHFAPALE
VIPTLETGIDIAFIDADKKNYLNYLEAVLPKMSHGGVILSDNVLWSGKVVEPLKESDKHT
QILMEYNQRLATDLRLETVLLPIRDGISIARVK
>SEQF1602_02279 Dipeptidyl-peptidase 7
MRKLIFSLVTSFFLLLPSVIRADEGMWFLMFIKRLNERDMQKKGLQLTAEEIYSINNNSL
KNAIVQFNGGCTASIISPDGLVITNHHCGYGAIAGLSTPEHNYLKDGYWAKDRSQELPPK
SLYVRFFVRMDNVTDRMLSVVNSSMSEKERQDALNREMEKIQKENSEGGKYVVSVRPFFQ
GNEYYYFVYQDFKDVRFVGTPPENVGKFGGDTDNWEWPRHTGDFSVFRVYTDKDGNPAPY
SPNNIPMKAKKYLNVTLKGVQENDFAMILGYPGRTNRWVSSHWVDQQVKYGYPAWVEASK
TAMDAMKAHMDKDKAVRLKYASRYASLANYWKNRQGMIDALTAHKTADLKRAAEKKFAVW
ANKPENKAEYGNVLSDLATYFEKTNQEAANHNYLLLFFRASRIVPQANGYVKQLNTYLNS
SSDQEKQQIRERIAKELDAYYSESYLPAEIDLFADNLKLYADKATDIPQEIAQIKSQYNG
DFRKFAAEVFARSIFTTKENFENFMNNPSSDALQSDPIAQIARVMIDKYYNSQSEALKDG
YEKAFRKYVKGMRDSKVSLILYPDANSTLRLTYGSVKSLPKDKRNHDVKRNYYTTFKTML
EKYKPGDAEFDMPKKFVEMYEKKDFGRYLDKDGTMHVCFLTNNDITGGNSGSPVMNGKGE
LIGLAFDGNIEAMAGDVIFDKKLQRTIVVDIRYVLWCIDTFGGAKHIVDEMTIIQ
>SEQF1602_02280 hypothetical protein
MLFLSINIKKHLKPKFFLVNTLSLQKKFIYLRLEKAEKKWDY
>SEQF1602_02281 hypothetical protein
MGLLDLFKKKKFDETDLKSITYKRYWLDPISTILIPTDWEVSNTDRFLAKSADDRANLTV
MSSEEPIKGEITKDFFEKLKGDFFKEYERDGFTALDETTSNERYISKTFQTYDEVEYHFT
CAKKIDDKAIITELILRHKEPYSLEMRELVDKIGMSIQYVADFTRLFAERLITKNPNVQV
RKTKGLEIEWMLKSEPGQLITSFLDNAYAEYMHRSDFYLSEIIEKYASSILETIPKEKPK
PKPQPQPTAKPQPEKPKQEPPKVITPEPPKEEPIIIATPPPVEKVKEEPKKEEVTAKAEP
IIELSGGIESVAKEPVTPQKPTDKEEIVKEEKEPQNTQEKTQEMPAMKETPESMAKKAEG
PIFPDISKFVPQAKVEEEKTITKEETPIDISESLKDILDVAINLDTTQETPAAMTTPEPI
APAAPIVETPATPVEPPVATVEEPHEEPLMDENATEVVSGNIIIKKEEIFPLVRTTSFIN
DLKRELPDLLYENINSELGVIYLVRNEKVSLTTEDLKNLRLDRLALRSLAVKNLIEQVEV
GVEEEGSRYTIVADGKFEASFLVVSELWSKDNIPVEGTITIGVPSNNVLLITGSGNAADM
NWIRHRVAQAYVESNIPISDKLFEIKGNTLIPLEF
>SEQF1602_02282 hypothetical protein
MKKLFFIFLLIGSSCALWSQEDNGNILLPKNQKNQNPFGGFTFGGNIGASFGDNVWGVSL
SPRIGYKLTDDLELAFSVNYNWQKTSYSQYNFLGLGPAVNYYFFRSAYVHASYQHYFIKQ
KFDRQESYRTEEDALYLGGGYMQPLGGNAYLQMGFSYNVLYKKDKSIFSSGFSPSVGVVI
GL
>SEQF1602_02283 Peptidoglycan O-acetyltransferase
MDFTQMSFWIFFVIIYIGFALVYKRIFIRNLFLFFVSCFFYYKTSGLFVLLLIFSTITDF
YFGKQIDKSENESKRKFFVTLSVVLNLTVLSYFKYAYFFTDTYNTIFHTDHKVFNYLAYW
GNGFSSKGAFSVDEIVLPVGISFYTFQTISYTVDIYRRKLKSLDSILDFGFYVTFFPQLV
AGPIVRAEEFVPQILRPTEITAQDFNRGTYFIFKGLIKKMLFANFIAVEFLDRVFEMPTM
YSGFTNLMALVGYSLQVYGDFAGYTDIAIGLALLMGFELPRNFNSPYKAINTGDFWKRWH
ISLSTWLKDYLYIPLGGNRTGSWASVAIALVFVVVALIGVGNPYFSLIIGFLLLGGTLLA
MKSTRFQHYITTNINLMLTMLLGGLWHGASWKYILWGGINGLGIVFYKLWRKVSPYEHST
HWLAHFWKVFSTFLFIVFVRLYFRGEDMERINQWYGQVWNNMDWASSGQVLWYFREAFLV
MILGYTVHWLPQSLKDKVEQAYYRSDLWVKVLVMVVVAVICYQTFSNDAPAFIYFQF
>SEQF1602_02284 hypothetical protein
MKAICFYFEVHHPEQLRQYHFFDIGKQHDYFDYYLNRTEIEQLARECYLPANNLLLELIA
QYKGRFRVAFSLSGSAIELLELHAPEVIRSFEALAKTGCVEFLCEPYAHSLSSLSNTTTE
FEKDVRRHAQRIEKLFGHAPTAFRNTSLIYSDSIGERIARLGFHTILTEGAKHILGWRNP
NFVHHHPNNDKVKILLKNAKLSDDISLRFSSRDWDEYPLTAEKYARWLKASLQEGDVVNL
FFRYQAFGKYNLASSGIFDFLRYLPQYILDEEQYAFLTPSQVAETFPAKEAIYVPNPISW
TDEERDITSWLGNELQENAFEELFALSPKVENIPDEALHRTYSRLQCSNHFNYMSTKIIS
LEQRLKKVSPYASPYDAYINYMNVLSDFSLEIDKALAKQVKNEVTLQEF
>SEQF1602_02285 Glycogen synthase
MKKIKVLMFGWEFPPHISGGLGTACLGLTKGLAKNEVEVLFVMPKASGDEDAQAARIINA
SEEEMLEDYSLSQDYAEHIKFMEIGSTLRPYLSPEVFASYWEEERTKIQTQEYHNKRLYN
FSGKYGENLLEEVYRYALVAGTIASKYDFDIIHAHDWLTYQAGILAKRISGKPLVVHVHA
TEYDRGGEYNRNSIVYEIEKSGMHQADHVITVSDWTRAIVIEKYGVAPEKVSTVHNAVDF
SDEQLDLPPRALNEKIVTFLGRITLQKGPEYFIEAAAKVHKRLPNVHFVMAGNGDKMTPS
VRRVAQLKLGGHFHFTGFLRGTDVQRMFRYSDVYVMPSVSEPFGISPLEAMRIGVPTIIS
KQSGVSEVLQHAIKVDYWDVDALADAIYGVLAYPKLAQSLQKEGLTEVNALKWEGAAGKL
KSIYQTMIA
>SEQF1602_02286 hypothetical protein
MALSFKQRDLVNLEFALQREFLGTNREGGYLSTTLNFCNTSRYHGLLVVPIDAFKGRNHL
LLSSLDETVVVNDMEFNFAIHEYPDTFFPKGHKYIVSSELNKYYSITYQVAGISLRKDIM
MLHGQPQVLIRYTLLGGADAVQLRLKPFLAFRDIHALSVENTVACTDYEYVSQGIATRLY
EGFPTLYMQLSGEHTYLHDPHWYKHIQYSKDKARGGDYQEDLLVPGYMELTLHKEIPVVF
SASTKEEEVASLPMNFSKAAQQRAPRDSFENCLKYAANQFVIEKLTETRIKAGYPWHLSY
GRNTFISLPGIAIASGNTGLFEQVLSSMQQYQKGGLFPRLISSHAPNEYNADTSLWFFWT
LQQYEHWAKIPPKMLWERYKHTLSSVLEAYRDGRTFPQVHMTENKLIYAQRYHRPLTWMN
GTIQGEPLVERHGYIVEVNALWYNAVSYALTLAQEADDRDFVAQWEAYPAQIAQEFVQTF
WNEHKRYLADWQDEGVQDLSVRPNQIIACALDYSPLKESQKKDIIDLVEDKLLNDRGLRT
LAPDDKRYRGCCEGSMREQEEAIYQGGTHTWLLSFYIESALKLYGKDFVAEAEQLLSHVD
QDIQNYGIGLISEFYDGNPPYVGHGCISQARNTAEIIRSIYLIQCYREGNTKKI
>SEQF1602_02287 hypothetical protein
MKIQYCIFILLVCFTSCKNISSKQGRTMAASVQDSLKDSRYDSIVSFDAHHMYERVKEGK
KYYLHKDSLFVREKDTFYCREYHSYFDTHGNIRGIIFYRKNTEYTDPFMEYWYHDNGQIS
EKIYYFTQKDSIIYDIDTVKCNALHILYDPKGNIIFRGCQGTAASEDINTGMSVGTWYYY
KDGKLVKEEYYHNGSYGKDYIIHFLYKTKYTKEIIVTNNFQLYQNDSVVLYPKKVAGKSS
NKGELFDILTNTKRRKQLKDDQLLLLTKKSAPYEQSSGDYKECRGWSVPEKTIKYVMKHS
KVIDFRELHDMFGVFPCVVEGVLIYKDEPYFYSMNAGGWWELTQGEKYLMMGYYEDDAIK
RGFINGVYDWSKME
>SEQF1602_02288 1,4-alpha-glucan branching enzyme GlgB
MLYDGDTLLLPYKKILLERQLLTLQKAQLLQGSAPCLADSCNSYLYYGLHYTGQEWVLRE
WAPHATAIFLLFEGNNWKKHTDYLFTQVGDENWELRLPKETLSHGMLYKLLVEWYGGGGE
RLPSHTKRAVQDPYSKVFSAQVWQPENPYSWKHLRPKGGEPPLIYEAHIGMSTEQQKVST
FTEFRLFVLPRIANLGYNVLQLMAIQEHPYYGSFGYQVSNFFAVSSRFGTPEELKELIDA
AHGLGIRVILDLVHSHSVSNEAEGLSLFDGTEYQYFHKGSRGKHPAWDSRCFDYGKLSVV
HFLLSNCKFWLEEYHFDGFRFDGVTSMLYYDHGLGKAFTDYSLYFDGNEDNDAYSYLALA
NQLIHQVYGSALTIAEEMSGMPGVAAPIQEGGMGFDYKLSMGIPDYWIKLIKEVPDYKWH
VGDIYYELTNKRQEEKTISYAESHDQALVGDKTIFFRLTDKEIYTGMSVFEQSLIIDRAI
ALHKVIRLVTITTSGGGYLNFMGNEWGHPEWIDFPRMGNCDSYAHARRQWSLVDDPNLKF
KYLNAFDKAMIHFVKESSLLEETPQVQVQDIEKQILVFSRGGYLFVFSFNPTEAFVNYTF
PIYAGKYTYVLNTDNPAFGGQGLINEQTEHFTQYINHQNLISLYIPPRIGLVLKRE
>SEQF1602_02289 Aspartate ammonia-lyase
MKEFRTESDLLGELQVPKEAYYGVQTQRALENFHISTSKMNDYPEFIRAFAFVKLAAAQA
NAALGVIPKEIGAAIEKAAHEIIDGKFHDQFPVDMFQGGAGTSVNMNTNEVIANRALEIL
GFEKGDYVHCYPNDHVNGSQSTNDSYPTAIKLAVFNMNKILVKHVQALADAFRAKGKEFA
DVIKMGRTQLQDAVPMTLGQEFESYAVSMEAEIATLNKTANSLLEINMGGTAIGTGLNAP
HGYAKLCTENLAKATGEAFVLSHDLVEATPDTSAYVFYSSALKKFAVKLSKICNDLRLLA
SGPRAGLSEINLPPMQPGSSIMPGKVNPVIPEVVNQVCFKVIGNDLTVTFAAEAGQLELN
VMEPVICQAIMESIVLFQNAVDTLKDKCVVGITANREVCLNMVKNSIGIVTALNPHIGYK
NSTKIAKEALQTGKAVYDLVLDHGLLSKEKLDEILDPKNMIVAK
>SEQF1602_02290 Peptide methionine sulfoxide reductase MsrA
MEEAIIAAGCFWCTEAIFKRLIGVTQVEVGFTGGSLPEPTYKQVCHGQTGHAEAIRITYD
PKKISYWDILEVFWRAHDPTTRNRQGEDIGEQYRSAIFYLNPEQQQIALKSKELIEQSGI
FSDPIVTEILPATIFYPAKEEYHQNYYENNTDRGYCIFSIAPKINKIHNLFEEKIKPEYQ
NLENENRTQETL
>SEQF1602_02291 hypothetical protein
MKTELKKLYEGDIPTVTMLVGALEEVGITPIVKDPMASAAIAGYGALGGDQQVYVFQDQW
EKASEILSELNLSQE
>SEQF1602_02292 Sugar phosphatase YbiV
MIKLIISDMDGTLLNSNHELPQDFMHVFETLQERGIYFCVASGRQYLSLLSFFAPIKDKM
AFISENGAFVSINGKEVYQNAISPYHIQQVVARYKQFSGMAIGLCGKKATYLLPTTPYAE
EQVNIYHHTVEKVTDLSQIDDTISQITILDPIGAREHSFPAFSSLSQEGLKITISGAYWI
DITNEGVNKGVAVTALQEFLGISPEETMAFGDYLNDLELLKRASYSYAMKNAQEEVKQVA
FYETKDDNNHNGVLKTICEVLKIPLSS
>SEQF1602_02293 hypothetical protein
MHITQKTNYLTMAHDLFISAWITAIITILLTPSLGKRSDLHNTLRVDTPKEVGVYGYTTN
TDTSLPSPRLVSLQHYNDFISFKEKMGYRESRNNYFITNPYGHIGKYQFGKSALKFFGVS
RSDFLNNPSLQENVFYTSLAHNKWKLQHEIDTFAGKHFAGVYVTESGILAAAHLLGANSV
KSFFKSKGKNVLVDANGTTITNYMKSFQNFDLSCVKASKYDGSKING
>SEQF1602_02294 hypothetical protein
MELQPVDSLKIIQDIIRQRKQKYEENGFFLIFWSVLIALSGIVQFVMLATDYYPKYSWIG
WGVLMPLGFFISFFSKMREGIRNRKEQKSTDPLDWLWLVAGLGAISCFCLPYSNWKNYEI
ALLVIYLPFSFVSLAIALHLRISLWIVTSIIGIILTYSVLFLHYGIALPLLCAILACLLF
LTPGIQFYSNYKKQKNVQ
>SEQF1602_02295 hypothetical protein
MFSDLDPILHSQLRLAIVSLLIAEEKADFARIKKITKATSGNISVQIQKLEAVGYISVTK
SFKDNYPNTEISLTHKGLLAFESYVEALKSYIVVNR
>SEQF1602_02296 Arginine--tRNA ligase
MSLQEILLENTIKGISSLYGIAMENVEIQQTRKEFEGDYTLVLFPLLKHIKANPQEIGEK
LGDYLSSHALWEGQPIVSGYNVVKGFLNLSICENYFLHFLHQIAPEKDYGKKPITKDSPA
VIVEYSSPNTNKPLHLGHIRNNLLGFSMAKIIEATGKKVYKTQIINDRGIHICKSMIAWQ
LFGKGETPESTGEKGDKLVGKYYVLFDKAYKEEIAGLISAGKTKEEAEREAPIFLKAQEM
LRLWEQGDPETLALWRQMNQWVYDGFEVTYHNLGVSFDRNYYESETYLLGKDIVQRGLDE
GVFYRKEDGSVWIDLTAEGLDEKLVLRSDGTSVYITQDLGTATKRIEEDFPKVEGMIYTV
GNEQDYHFKVLFLILQKLGYTWAKNLYHLSYGMVELPNGKMKSREGTVVDADDLMEEMVQ
VAQELSQELGKLEGYSDQQKEQLYRVIGLGALKYYILKVDPKKKIAFNPQESIDFQGNTG
PFIQYTYARIQSILRRAETCELPKSVSLHPKEKELIKLLSLFPEVVQNAADTYSPALIAN
YVYDLVKEFNSFYQNVSILGEEDTDKRSLRVHLSRKVGEVIAIGFDLLGIEVPERM
>SEQF1602_02297 hypothetical protein
MKKMFFTIAMALLSVGAFAQTYKNEAKINILNVIVRPSIELGYEYYLDENQSVDAELMFL
DRFSYWHIWSGSKEYKFSTTSFKVGYNYYFNSVNGEGAYINPFLKARFGTFTENKNGVDE
KTKMDAFIIGVGAGYAWVFNDKFVVAPYVNIGRNFSGPVNSRFIAIEPNAGVRLGFRF
>SEQF1602_02298 hypothetical protein
MKKIGLFMALFFTIASYAQDYTQHNKGKIFVFWGGNRGYYTNSDITFKGNDYDFTLSNVE
AVDKPKGWHIDYINPLRMTIPQTNFRIGYYLGDNWTISAGVDHMKYVMVQDQEVNINGYV
GAGTTHDKVYNNEKKKLTEDFLTFEHTDGLNYVLVEGARVDDISSLFGIRNTDIFQVNLT
EGLGFGAVYPKTNTKLLNRERYDEFHVAGVGMHAKAGLHLFLFKHFMMVGELRGGYLNMY
DVRTTQSKSDRAHHDFFFFETMLSVGWIFRI
>SEQF1602_02299 hypothetical protein
MRKLLNNFWVFVARLVLRNRYIFLSIFIGITIFLALQWKYIRMTYSEANMLPKDSPISKE
YDKFLSMFGEEGNLIVIGVEADKITQAGGFNRWNMLAHDLQKFPQVEGVLSLNTIKELYK
DTIHERFATRNFFPQEVSTQGEVDSLFPKLFDKTPVYEGLLYNKDHSTLRMAVSLRKDIV
NTAIRKDFILKDLKPLIENYQKDLGVPIHVSGMPYIRTLSTEIITGEIGFFIIGALLATC
LVLLFFFRSFRAMFISMCTVLIGVMWAFGFLGLFHYEITILTAVIPPLVIVIGVPNCVFL
INRYQQEIHKHGYKAMALQRVITKVGNVTLLTNLTTAAGFATFIITESSILKEFGIVSSI
SIMCLYVISLCVIPIIYSFMPTPKPRHLKHLTKQWIGGLLEGIERIVKKHRFATFSVAVA
LLVASIIGIYRIHISGSVIEDMPKGETFYDDILFFEKEFGGIMPLEITVDTGKKNGVMRP
STLQSMDKLEEYLEDIPEISQPISVVRLVKYARQAFYNGNPEYFALPTAQERAFVLAYVK
NSEGKADMLRSIVDSTGQVARITVFMKDIGTEKMHQIEEAIAKQTEKLFPQEQYKVHLTG
KAYMFTKGTDYLVGNLIQSLLLTIVIIAVMMFYMFRSFKMVIISLIPNLLPLLVTAGVMG
YAGIPLKPSTILVFGIAFGISIDDTIHFLAKYRQELVLHKWKVKRSVYAALQETGISMFY
TSIILLFGFSIFTLSSFGGTKALGGLISTTLFFAMTSNLILLPSLLIALEKSIANKKTLI
EPHIDVLGEDEEE
>SEQF1602_02300 hypothetical protein
MNPYIRSFLKYFLQGVVIIGPLSTTVWIIWSIFYSVDNLVPHISERFPGLVFILVLGGTT
LIGYLGNRFLVGKLLVEGLDYLLEHTPGVKFIYKTIRDVIGSFVGDKQKFSNPVWVKVQE
QPDIWRIGFLTQEDMSAIGLKEMVSVYLPHSYAISGWVIVVHQDYVKPAEGFTAKQAMEF
AVSGGTVGAVSNP
>SEQF1602_02301 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase
MKIGIIGAMESEIQLLREYLGNPAPTHLRRYAFYEGQIGNHQVVVLLSGIGKVSASIGTA
LLIDHFAPELVINTGTAGGLRHSKVFDMVLATEVSYYDVDVTAFGYAIGQQAQMPRSYLP
AEQWFYKVQELVARYTSQLHCAPIVSGDSFVSKKETRQWIETHFPEAVAVEMEAAAIAQT
CYLMDTPFLILRAVSDNAGEGNTISYDTFVEKAAALSAKMNIDFIEHLI
>SEQF1602_02302 Aspartate--ammonia ligase
MSSCRIPQGYNPKYGIMDTERAIKRIKDFFETELSKALNLSRISAPLFVKNSTGLNDNLN
GVERPVSFQMKDAPEDTIEIVHSLAKWKRLALKRYAIGVGEGIYTDMNAIRRDETLDNTH
SIYVDQWDWEKIITKEQRTLAYLEETVRKIYKVFLATEAVITLEYPLLTPFLPREITFIT
SQELEHKYPNLSPNQREQCFAKEKGAIFIMQIGGALLSGEKHDGRAPDYDDWQLNGDLIL
WNPVLESALELSSMGIRVDEVSLMQQLKATNLEERKHLDYHQMLLQGDLPLTIGGGIGQS
RICMFFLQKAHIGEVQASIWTEEILSLCAKHHINLL
>SEQF1602_02303 putative NTE family protein
MKTFGLTLSGGGVRALAHGGMLKALEEHNLRPVVISGTSGGALVGALYASGKTPEEIVDF
FKETPLFKLSMLSLPRMGLINSNKYPALFQKHLSCNTFEELSIPLYIAATNLLNGKAIYF
SKGDLISPMVASSALPPYFSPIKIGEAIYCDGGLLNNFPIEPLKGKCDILIGSFVNPLKE
VNEKELGNPIKFLQRIYNVVMDGSYEKKFKKCDYVFLHELDNIGVLETKLIDKAFDYGYE
KTLSHIALIKSLVEN
>SEQF1602_02304 3-oxoacyl-[acyl-carrier-protein] synthase 3
MNCVYITKANKFLPNTPIDNDLMEAFLGKINEAASRAKRVVLRNNGIQTRYYALDTQGNP
THTNAELTCLAIEGLLDNRFKAEDIEVLSCGTSTPDTLLPSHAAMVHGLLRGSGSVELNS
SAGVCNSGMNALKFGYLSVKAGNSSNAVCTGSERVSTWLRANKYENEIQTLALLEEHPIL
AFKKDFLRFMLSDGAGAFLLENTPLPSQDSLQIMWMEGYSYAHQLEACMYAGGEKQSDGS
LKAWSDYAPEEWLEYSIFAIKQDVKLLNENILVKGAESMLVALKKHDLSAEEITYFLPHI
SSNYFKERLYEELKKVGIDIPLDRWFMNLTKVGNVGSASPYLMLEELFNSGKLQKGDSLL
LSVPESGRFSYSYALLKVV
>SEQF1602_02305 hypothetical protein
MDSMYRIYPQKRYGKTLTILERFAPKGTTILDLGVRNPFSEVMEKEGYIVNNTQGEDLDL
FPEKLADYTGEFVTALEILEHLVNPFEVLQHLPAQRLLVTVPLRLWFASAYRNDNDPRDC
HYHEFEDWQLDMLLEKAGWRIKYREKWTHPVGKLGIRPLLRYFTPRYYAVYAERIIDNEY
QVKKI
>SEQF1602_02306 Glutamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGIVGYIGNKEAYPIIINGLKRLEYRGYDSAGFVVNAGKFISEKTKGKVSDLEEKSAKD
TLSGATFGIGHTRWATHGVPNDVNSHPHFSNSGKLVIVHNGIIENYQPIKQRLLKEGYVF
HSDTDTEVLVNFIEYIKNKKQLPLEEAVRYALNEVVGAYAIAVMEEDHPSKMVVARLGSP
LVIGIGENEFYIASDASPFIEYTQNALYLEDGEMATIELNQEVQVRKIHNNEEVDPTIQE
LKLSIDAIEKGGYEHFMLKEIFEQPQSIQDTMRGRLLEDHTTKISGINNNLKQFLSADRI
VIVACGTSWHAGLVGEYLFEELARIPVEVEYASEFRYRNPVINPSDVVIAISQSGETADT
LAALKLAKERGAFIYGICNVVGSSIARLTDSGTYTHAGPEIGVASTKAFTTQLTVLTLLA
LHLGHKKGTIDHTTYKKLCQNLALVPDLVAKTIEMTKDKVIEIAQEYKDVSNCIYLGRGY
NFPVALEGALKLKEISYIHAEGYPAAEMKHGPIALIDENMPVIFLAPSKGHYEKVVSNAQ
EIKARKGKIIAVVTENDTQMSSLADHTLEIPEVDEIFSPILSVIPLQLLSYHIATMRGCN
VDQPRNLAKSVTVE
>SEQF1602_02308 hypothetical protein
MNLEHIAQISFKLFWIIDIIGGLPIFISLMNRFGKIQTEKAALVSACLMIIFLFAGEAML
RFLDIPLKVFAVAGAFILFIIAVEMILGVSFHKMEEANSISIVPIAFPLLAGPGVLTMIL
SLHSSYSSVDIVISILINVAIAYVVIKHCRRINDWMGQTGIVIANKIAGVILLALSIKMF
ADNWKTIFE
>SEQF1602_02309 Neopullulanase 2
MKVIIYQAFVRLFGNISTDNIPYGTKEENGVGKFSDFTDAALQGIKELGTTHIWLTGVLH
HALVGDYTAIGVAHDNPYLVKGRAGSPYAVKDYYNVNPDLAENPDKRLQEFVALVERIHR
QGMKVIIDIVPNHVARQYHSTSKREGIKDFGEEDDTTVGYRRDNNFYYNVGESFQLPEFS
LGYTPTIPYTSYQEYPAKWTGNSRSSAPALTDWYETVKLNYGVSPEGEKDFDTLPPEFAQ
WDWGAHYAFWRSRVVPNTWIKFKDIVSFWLALGVDGFRYDMAQMVPVEFFSYLNSFIKTQ
KPDSFLMAEIYEEARYREYLQMGKMDALYHKVGLYDTLRDIICYGHSSDRIDFVQEPLRD
IAPRMLHFLENHDEQRIASEGFAGEARYGLPAMTLTAHLSQAAVMLYFGQEVGEPAREHA
GFGAPTRTSIFDYIGVPAHQGWVNGKRYDGGGLTPEQASLRDFYCRLLRLPIKGNFQNIH
RYNREHTSYYNDKVYSFVREEKQRKWIIIVNFSREDTYGFDLQIPPVLRAHWLLSDGVYP
LEDRLYGEKQTQLFTMGGQAHMRVDIAPLESLIFCLEK
>SEQF1602_02310 Superoxide dismutase [Mn/Fe]
MKRFILPGILAAVASCNCPKTAQSAAQETVKQNVAKENWGNPNEVKAQGKFQLSGLAYGY
SDLEPYIDGRTMSIHYSKHYLGYTNNLNKAIAGTALESQTIEEILAGLDLNNKAVRNNAG
GYYNHTLFWEVMTPKKTTPKGALLAQINADFGSLENFKNQFADAAAKQFGSGWAWLVVGQ
DGKLHIGDTPNQDNPLMPNMPIQGTPILALDVWEHAYYLKYQNQRPKVH
>SEQF1602_02311 hypothetical protein
MLPFLTKISLISLLLIGNTYGQREDIWQEQSSSPILRKVEKSKEIFLSSTSWHTCQWVHY
LHGETSASLMKIPKGERPAPSSYLRPNDIAVHLSTFLQGASYIVPEDILDKYGRALVGRP
DNCQFVIPKEQMDCLLEEAKGDVSYIEAALGVPHGHWAGRRLSRIDIPSPENFFLRMPTG
NEAGVNKFWLPGGYLWQGYREAIISQVPQGAYVETRIMINTKINNE
>SEQF1602_02312 FeS cluster assembly protein SufD
MNLKEKWVAAFEAFPHKDDILKDIRKEALSFFVEKGFPHKKVEAWKYTSLSNLQATDYSL
WQPIHNKTTLSPEVLHKYAIADCYQLVFVNGYYCPEMSSKEIVGATISPLLEALHKGGEA
FIKKYFNTNTEKGDIFTALNTAFASEGIYIEVPKGKIVDKPIQLLYFNDRKEITCYQPRN
IIAVGENAQLKVIEVHQNLSDTATAILTNVVTEAFVAKEAFLDYYKLQNDSLTASLIDNT
YISQEANSHASVHTFSFGGTLTRNNLNFYHQGEYLESTLKGLSILKGTQHTDHYTLVNHA
CPNCESHQDYKSIVSDEATNVFNGKIMVEQIAQKTNAYQQNDNILLSDKATVYTKPQLEI
FADDVKCSHGCTVGSLSADSLFYLQTRGIGKKEAAALLTYAFANTVLESVKIPALSEHIN
QIIAEKLGVTVDF
>SEQF1602_02313 hypothetical protein
MLIEKYTETLTNPLLPEAFQFSKRKDIFAINYEHQQIGVCNESEGFSLYTFEKELLWEIN
KPIVGALLAIERQQIWLAQRHDAQHITVWVYDLQGKALASIPMDDEIYDANIELKTLPNN
KVVITFYGGQDGCMSYLLSFENEKLKVAKQLPNDVDFCCMLSEKEAVFTNFYEAELYVMS
YPSLKTLKKHHFSKDWGAIAQPFKGDKILITDMYCNRHYIFDISTLTVEDEIIFKGFEPY
QDEVEEFLVSDIDELHYHNGQLIGGYTEVDSNRNAIYHWLISKLEY
>SEQF1602_02314 putative ATP-dependent transporter SufC
MLIIKNLHAGVDGKEILKGIDLEIKAGEVHAIMGPNGAGKSTLSSVIAGNENFEVTEGDI
LLEGESLLEDAPEERAHKGIFMSFQYPVEIPGISVTNFIKTAINESRKAKGLPDMPAAEL
LKKIREKAALLEINPDFLSRSLNQGFSGGEKKRNEIFQMAMLEPKVAILDETDSGLDIDA
LRIVANGVNKLKNENNAVLVITHYQRLLDYIVPDYVHVLSDGKIVKTGDKNLALELEAKG
YDWLKG
>SEQF1602_02315 hypothetical protein
MEEEEILFVITVADVQHWAEEKLGRRLTYEELQIAKDKLEWGLSEDIDVVYSAIFEEMK
>SEQF1602_02316 hypothetical protein
MTKQEKDFSDLSQKLLTTTDGSEYHELVRKIVKKYGEKMRQETLQTLVRAVKESKITHAR
NFVIARISELVTENDTALAPFFYEMISKGLPYWAFSGLLKVEGDKCYPFLVDYLQKEDNK
ENKGSAIIALAEHSGQPFNNDLPSDPAYWQALPIEKVLEWQTQGYPRKQAHSEFPFLITH
PQTDLEKAMAKIEQALAKERDFWHVKSYQYNRAILEVPEKQVINNIKARWELPAVYLTFL
ERFSPADDAFLKGINLYGANTLIKHQYGYAFSSPDDELFPDWKAHWFVIADKDADPYILD
LSKSDGNDTPIYKAPHGAGQWKWRKVAGSFLEFLEKL
>SEQF1602_02317 hypothetical protein
MIPLANIAETIEELNGEDSWFSINPDYLFIPFGQTGGGDYYCFLYDQNHPKPTPPIALLQ
HDSDEAELLANTLEDFFFYEMLNSVNDIYEGSLVRSEGNFYENITRLLQSHLPYISNEAQ
RQVIQDVYSRKLTDFTRVLPRSTQTYQGLLSDEELEQLLQQHIPITGEKTFVYTTENEIE
STPSRYIDGTLYVRVSPIPAKNDKVYDALKALNWRQNKAVTDRLEYSKKMQLYYNDQYGV
PWEEYILGAFKERIEALRKFPNVTVTFEQANND
>SEQF1602_02318 Sulfoacetaldehyde reductase
MELNRIKGKIAFISGASSGIGKAVAEKLAQMGVNLILCARRAEVLTELKTQLEKEHAIEV
TTLAFDVRNYQEVAKNIQSLPEKWQQIDILINNAGLAIGLQHLHTYAIEDIDQMIDTNIK
GFTYIANNVIPLMIATGKVGTIVNVGSVAGEIAYPNGSIYCATKFAVRALSDAMRIELMD
KNIKVTNVKPGLVETNFSKVRFKGDQQKADNVYKGITPLYAEDIADTIAYIVNLPDKIQI
TDITVTPLHQSDAIHVHKLAN
>SEQF1602_02319 hypothetical protein
MNTLRKELRPDFATAEKLYPLVLKRLEDYEAFWDSQSKDTPEEVFDKEYKAMEQYLSELT
GKDLSNTWLWEWWEGNGIEVFAFDLAMPDPVKHNNLTREDIAAFVRIIIDNEFECENDFQ
EEFMPYMFYAHQYFYKFLELNCPHFDPSVFNTTKDKKGKYHEPTVEEVMEKIWK
>SEQF1602_02320 hypothetical protein
MKNLELKIPPAAVWFICALIMWVLARLLPFGALPHLPVVAMAVAGIGIGISFAGVWSFRK
ARTTINPLEPSQATHFVSKGVYQLSRNPMYVGLACCLLAWAIWLSYLLTWIGIPLFIVYM
TRFQIIP
>SEQF1602_02321 hypothetical protein
MEKYKELFPSTEDYHRYIEQLEKKISTFATSYMSNAKWRKLFTAIIAHKNLIKQCEIYDF
FGYCVNEIAWHKVGNDSALSIQEDYISENITTGEYPTYYREIEYIEFKARWQKAYIGKLV
PPIYETQDLNVIETLLHSIGQFQLLKTEESLRVLGYGN
>SEQF1602_02322 hypothetical protein
MLSFTKDDIEALHQAGITAELHSPQPHLMSLDEVLQNKFALLNDYPQMGFYFIRFPDELI
PMQQQGQHFQCFGKCCYGYFALNAKGNVYLLSTNDDYTDASVVWVNHSLDEFIKSYSWLL
AGVFQLKGSDTSTQEKLFAVLDKVAQQITEAIRELHPELLEEGSLWSQFIYMIEDGWFST
AYHEIFYIREGRRSL
>SEQF1602_02323 hypothetical protein
MVYRIPDESIMHIHNKVGEELIFGHGKDVKKFNIKKALYGYDNTDLEEAENDIIMDIGYE
KFAEYAVCEFYDKMSKDTNKIINTHLNYFSSLSDIDEVIVIGHSYNEIDYPYFKKISESI
SHKATWTLHYFSDKDKVNAERLMSEIKRYGDFVLR
>SEQF1602_02324 hypothetical protein
MKLYIIGNGFDIAHGIPCRYSDFYTYLEKKRCDVLEKMEQYYDVDKGSDLWSDFERNLEE
KICYDSFREIISENVPRLGSDDFRDAEWYDAQIFTEQECDELLGKIRSGFKEWINSLDLN
IIIEV
>SEQF1602_02325 hypothetical protein
MKYYRVLNQSEEPSNTQLNSEHQLSEFRKQAIAMLPYSEAVCNLSKSTGMQLKGAMCLAQ
NIPCFLDIVRQFINNGKKLCPLIELCVNDPIKYIKLDDLIEFSNNYIGIINNTKLYFDID
NGNVLWEYIWEYIRKNQYSNLPSRLKSVFLFNNKKEASEFFKNYRDDRYSICEIKLLSGK
TENFDMNWFTDVPCDITFNDAIKYAESYWGRKQTPQPIIETLHQGLYSW
>SEQF1602_02326 hypothetical protein
MTEAVAKHIKKLHQLEKKGNLEVEHLLKILKTPNKEYITPLQEMIAQYHWQPLNDELIVP
FASWVEAICIYLEEGTKGLSKALYKTKDFFHIVFGVLEELPTEESLPTFLEIAQTFSTNI
TDEQRDFVQKYAYSLCNISHQLKGEKVNKDHHDTFVPILKQIISFGQSKKDEVLMCSATV
CFQAFGDKNDIPYLKALPFTEAYYKSTGKTIAKRIEKKYGN
>SEQF1602_02327 hypothetical protein
MKKKILTYIYLFSYAALLPMIIGGLILMIISFVQHRDMIFNPDTYTKRFVTLDSVIYSTM
KGTPRYPRQAYSNQVNKGKTTIEIVNIEKGTFYNYVQKENDKNYIYIWYKPNEKYAYLAK
KEETIFPVKEYLRDDRNLIIAFLATIILNRALHRYLFKRWWSLPRK
>SEQF1602_02328 hypothetical protein
MTEVVEKYIKKLYNLTSKDCKGFSEAQLLKAEKRLHITLPEEFRAYYLQLGATKSVNQSY
NSLATPQQLYFAGDYLCFCEENQGVVMWAIRKEDLTNPNPPVWGNYGSETDPNWIQETQN
LSDFWLYLAIYNGVMGGLPYNANAMGGWDIENFEVPEQAVAHIEKQYTELTSLSWKGQRT
FTDTDFQIVITLAIHQTTNRATAIFIGSAQQELFDTLLDAMENFGLQWDYTSYDDDDFQE
VSEAELNELKAKGLWTLS
>SEQF1602_02329 hypothetical protein
MASITHPYFGTLDTSIIQEDFDPDVLWEQKVTFQELSDPVEFSLWLAKKEEISKERLDLF
EQFIKHFPERDQQARKALKSYLEQDSEYIDFHIDELELEVPTSIDDFVTAMKINNVGLWY
CISKEEIIVDYMIDPDQSDEILAVRFNLDGSFSSIAWES
>SEQF1602_02330 hypothetical protein
MKLCKQKSWQFETSGVEGEVKLFGVNIFDYQWQETGEYVKVTDPLYHAQRSFCLYKVVIN
GETHSFVAGEFSNMIWGFYLLKY
>SEQF1602_02331 hypothetical protein
MQTEIIWKTTLKNGIYGSLTPPLADPFNLDHFYVTDGWGSKYASMRLHKLSFSTGKEVAN
VLIRNNVRCMYFSTDGQHIFALTDNKIFQLSRETLEVVKKIEKGVPKFSDYVASNDQDTL
ILMNFSGITVTAYNYVEESAKKKRIKGEGCALIAREKAGIYLIASYQNGVIQRYDTTTNK
IELLFKTDSFHSVCRDSKGNWYFHLGQYIPPRSNTTGIKKPLYIIRVLKTDGTQKDYPLG
LPFKKPIQLSEDEQSLFLSNDHNLWKFSLQEERITDTTVISGGEKLIHFFEKQQFLLCVE
ADSDYKKLVGRSLQ
>SEQF1602_02332 RNA 2'-phosphotransferase
MSKEEKHKKESKFLSLVLRHHPEAIGITLDTHGWAEVNMLIKNMKRKFPVFSLKMLEEIV
TTDSKQRYAFSEDNTKIRANQGHSLAVALELQPQTPPEYLYHGTASRFVESILKSGLQKQ
TRQHVHLSIDITTATKVGARHGKPIIFKVNTMAMHQAGYVFYLSANGVWLTNEVPPKFLE
LIVSN
>SEQF1602_02333 hypothetical protein
MYFANTWHKSFNFVITPEEFEAVFSRDDYEFVTGNTLVDMDYISTEKQEIFNAYQQYYEK
ILLREEKYDHKTLWTVEDKMRQSMIDQTKKLIFLEVEGNKKDAVKYKRVRTKEPFMNIDP
FYLLYKKEKNLLSTIYHAPENTFGLKLTYPKTISLADKNDNLRGNYSTEKYPMYAIFEDI
IKQIKKISHKAKMMKGEQLLKPDFWISDKAKEQVGKNYYLQQTGLVFV
>SEQF1602_02334 hypothetical protein
MKTVLLLIFSAITLSGKSQTIQSKLDYCAIFIPDENYENYCIEDYKAHRKAFIKTEKKLL
NDELKIFSHSDCTIIFDNDPKCSVTRDLEKKLKPLENIEIQFNGKSIIIDTTFVELGTKK
MIPYKVKYQKKKKETLMKLTFENVLWTSAGGFHRYDIYLVAKNDQLTVSKIKAFYISKAF
NSYGKEQTEVIYPTK
>SEQF1602_02335 Putative ribosomal N-acetyltransferase YdaF
MKTLHTTRLLLRPWEVSDAQALYIQARNPIIGKRCGWPAHKSVEESREIIQNVLRRPHSF
ALCLSDNTLIGSIGLLLQGESRLSVGKNEAEIGYWLGEDFWGKGYMTEAALQVIHYAFEE
LHLTGLWASVYKENIASQRVIEKCGFCYHHTLEDFLFPLIGERHTSLVYTLQKEYVL
>SEQF1602_02336 hypothetical protein
MKKVFLLYGICLCLFACREQSGKQQQSITILQDGIKTTSAGEVEEKDIWVDPQLVEMMRE
ALQRVDTLYKGEDLTYSYIYSDTLPISETIIKVGKFFDQQPYVMVNSTWEDRLIEVYKIE
QNHTFRKKFSYISSWMEFAKDSIFDVNGDGIKDLSIAWSGTGALNYNPTYIYLFDPKTAT
FSERYEFENADFFPKEQVVRGVETGFSGVVGLYKYKWIGGQWVAQEYIYPDYISNGKYFI
RTQKDGPYPSREDGELLHKIPEEYLVLKDLSWFLMYDTDSELPFLQQTLEERKMEGNK
>SEQF1602_02337 Aminopeptidase N
MKKIVLVALGLLSSGYTFAQTDTSGRGLYRATPDKKTALKHTKLKVDFNFSNQTMGGEEW
LTAAPFFYPTDSLVLDAKAMLIHKVALEEKGKQQPLAYSYKDDLLRIKLPKKYQKGEAYT
VYIKYTAQPEKVANKGNLSISDTKGLYFINPEGKPEGYPRQIWTQGEAESSSCWFPTIDK
PNQKTTQEIEMTVPDSFVTLSNGLLKSSEKKGNLRTDYWVMDKPHAPYLFFMGAGEFAVV
KDTPWHGKVPVEYYVEKDYAPLAKKLFGNTSEMISFFSERFGYDYPWDKYAQIIVRDFVT
GAMENTTAVSHSESAYQSEEALNDQNYWEYIIAHELAHHWFGDLATAESWANLTVNESFA
NYSEYLWIAHKYGKDAADYHLRNNTQQYHQRPDDFKKDLVRFSYISTDDMFDMVSYNKGG
AILHMLRRYLGDEAFFQGVTDYLKTHAYGNGEAHQLRLSFEKISGKDLSWFFNQWYFGYG
NPTVKVEKHYDATKKQLTVKITQLQSEDLYFQFPLDIDIYQDNKPIRHTVWVNARQENAF
TFAVSKAPALVNINPEGVVVMQEQYPKTTKEYLFQIQHAPELKSRLEAISSLETGKGKEV
VLAALQDPYFKIRKAALELLEGYQLTKKDLALVEKIATKDPENLARAAAIWVLNDQEDKR
YTPLYEKALTVPSAAIKNAALNGIARTNPSRAKQFLKKANPADLEGDQLLGLVSVITNHK
MEKYLPSLMPYLVNYPFFEEDEPQRSADFKKAYLWAMSLDNTPLTEQVQQAFKDFTQEEN
DSKTKQTLWKVIDLGIDQKKKLSNTASVKEQIQMLEELKSKIK
>SEQF1602_02338 Putative phospholipase A1
MSCFPLVSAAQTDSLSITGDPLPEVKRSEPADLDKTISKIWELDKEDQRGTFRFLEYKPM
YAIPFRLTDKPIEQPVSLNPNRPVPEHRDYQHVEMKFQVSLKAKIMQDAFGKGDVWVAFT
QQAYWQMYNGKLSRPFREINYEPELIFTYPMNLSAGNFKFKMLGLSINHQSNGKEAAHSR
SWNRIILMGVASWKNSIITARVWRRFSEKSIEDDNPQIEEYIGRSEVTAAIPFRKNVFTL
TVRNNLNFNHNRGHAELSWIYPLSRDLRIMLQASHGYGDSLIDYNYKQTVLGVGFTFLNL
>SEQF1602_02339 hypothetical protein
MKTFFLSLFFFLGGSLIFAQNVLLKGSVGDGKSPLPEATLSVEGQEVHATSDEAGNFQLS
LPKGFYILDIHAKGYRSQRMNIELTDNLTLPTITLQKELMAQGEHTVGNTINLSDEELDD
EEGSPEMISGFLQSSQDLYFRRSSFDFSPVFYRPRGYQSNAATVLVNGVLMNKVETGRPQ
WSNWGGLNDATRSNVITTGVGASEDDFGGVFGSNVMTIAPSELRNGLRISGTTTNRNYFG
RAMVTYNTGTLPSGWGYMVSGSYRGGNGRTWLVPSVEGMVYQSYGISAAVEYKASPYFTT
NLMGIFSYNNRGKSAPLTQEAISLGGRNYNPNWGFQGDHIRNSKMKRISEPLFVLSNTYH
KGDTKIALHLGYQFGQVGDTRIQYVKSQNPDPSYYTNMPTYFYNMYDQETGEGDPFAWDK
AARQIDYFKANKQLNWDALYQTNSHTGGESMFSLNEDIIDTKTLTGNLLATTKIDPNITL
NAGASFQRIGTENFQQINDLLGGQYFLNKSYYSGENYDTPENLRLGEGDKYQYHYKALVQ
RANVFGQLRFKYGRALFYVAGRFQHTDYEREGLFANNAVYNDAKGKSGMKYFNTLSTKAG
LTYSINGRHILQFNTGYFEEAQPLNNIFVNIRNSNSLLPSKLSPETQITADGSYIVRMPY
VKARLTGYVTKFENATEKSYFFTQSRLGDESAGFLTQTMMDVEKLHFGGELGVEVQLHPS
WKASAVVSLNQYTYTNDPILFQSSDKRLVSEPIVSHLKNYHAGQAPEQVYSLGLEYQSQH
YWWVSLTGNLFNNNYIGIAPSLRTENIYLDPNTGSRYTNIDENAVRGLLKQEKLPVLFLM
NASAGKSFRIKGHFLNVFASVNNLLNTQYKTNGFEQARKGDYQSMLKDRKSGYPTFGNKY
FLGYGTTYYLNVTLSL
>SEQF1602_02340 hypothetical protein
MKKIVYFALSLALLSSCSKVSGFDTPDVQQLEKQQQEKANAFNGTRITYAQLRAKVTPSF
TQYTDNDAFEGYVISSDEAGNFYKKVYVQAPDKSGTIAVAIDKKGLYGEYPVGTKVQVRL
KGTTVWYSGRYSTLEVGYGHGKTAGGNTKISNLPSAMYQEVLVSTGEKIGLDQLATTFDN
LSFDKQAQNNKLLIINGVSFENTAIGKTFHVSTNQYNTTYNLTDGAGGTLPFLTSSFAAY
IKDIVPSGRLRITGVLTRYGSSPQFYINSVNDIQKIN
>SEQF1602_02341 hypothetical protein
MKKLFILGIALSLFISCAKEDNAGIPPVNQGQTPQQKDLSILEASTAKASDYVNGKKVKI
HGNIVRDGNRSYFKFSDNTMVLIYAATSVYDALPQEKKTKLSTAGQEITVTGTLKDFTPK
NSTSAVKQIVYESESDLVFGQAGSTTPGEITTLEAATATASDYVVGKKVKLHGTVAEVQG
NKSFFKFSDGTLVQIFTPKFKELSQETNNKLKTVGQEITVTGTFTDFTKNGVTVKEIVYE
SESDLVFGTVSNNPQPQQPTDVLEAATATANDYVAGKDVKIHGTIVRDGNHSYFKFSDNT
MVQIYVVKSVFDLLSQEDKTKFATTGQEVTVTGKFKDFKPKNSTNVVKEIECTSKDNLVF
GAASNNPQPQPQPQPQPQPQPSQGGVFDFEWITDNSTGYGTAVQKTIDGVSLEAIGRTNT
TEGNIDYAINGKGLVLNGYDKGHIKITFPNGVKNFSFDYKAFHTNTKAREIVIREGNTEI
DKVSVAKDAQGTYTKALNKTGQVEITIKGGATSKQFVIDNIKWTN
>SEQF1602_02342 hypothetical protein
MKRLFLLLFAGLFVWGACVREDQTEIPPVDPKEKPTPNPTPTPPVLFTLEAATAKASDYV
VGKKLIVHGFITVKNKRAYFKFSDGTLVQIFTPKFKELSEETSKKLQKEGQEVSVTGTFT
DYTLPKGDVVKEIVYQNETDLVFGEGTPTPEEIPSLEASQISMTDFTAYFDKKVKLHGSI
AEIEGNRSFIKLSDGTLVQVFTHKFKELSEETSKKLKEIGQEVTVIGKFSDYTDKKTQKK
YHQIVYEEEKDLTFGAAPTPQPDPQPQPNPQPQPDPKPQPNPQPDPKPQPKPSPDPNEIV
NLEASNATIADYQEGKKAKIHGKITIKGNFSYFIFKDGTEIQIYGKNYKNLSNEIKDKLK
ITDQELTVTGVFKNHTTKDGKSIREIVYETEADLIFGKTPETKPNPQPNPQPQPDPKPQP
NPQPDPKPSPDPNEIVNLEASNATIADYQEGKKAKIHGKVTIKGNFSYFIFKDGTEIQIY
GKNYANLPEEVKKKLKIADQELTVTGIFKNHTTKDGKSIREIVYETEADLIFGKTPETKP
NPQPNPQPQPDPKPQPKPQPDPKPQPKPSPDPNEIVNLEASNATIADYQEGKKAKIHGKI
APEGNFSYFIFKDGTKIQIYGKNYKTLPEEVKKKLKIADQELTVTGVFKNHRTNSGQVIK
EIVYETEADLIFGKTPETKPNPQPNPQPQPDPKPQPKPQPDPKPNPDPKPNPQPQPSSGV
FDFEWIEKANNGYANHVTKTLNGVTLDATARTDTKEQNQDYAIQGKGLVLDGRRGLITIT
FPEGVKTISFDYKAFLAGNKKREILVSGGGIEDTISVGTDKQTYTKTLNKTGNVEITIKG
NSGSKQFVIDNIKWTR
>SEQF1602_02343 Fructose-bisphosphate aldolase class 1
MKEKIEKMRSGKGFIAALDQSGGSTPKALKLYGIEESAYKNDAEMFDLIHQMRTRIIKSP
AFNENKILGAILFEQTMDNKIDGKYTAEYLWEEKHILPFLKVDKGLLDLDADGVQLMKPI
SNLADLLKRANEHHVFGTKMRSVVKKASKAGIARIVDQQFEIAAQIIAAGLVPIIEPEVD
INIPDKAEAEAILREEILKHLDKLPATSDVMLKLTLPTVADFYKPLVEHPRVVRVVALSG
GYSREKANEILAKNHGVIASFSRALSEGLSAGQSDAEFNKTLAESIEGIYEASIK
>SEQF1602_02344 Branched-chain amino acid transport system 2 carrier protein
MNKKKFLTLTTTGFALFAMFFGAGNLVIPPYIGLKMGAASGAAFVGFFLSGILIPFLAVL
MVSSIGTSFTDLGKRFPAPFVNSLVVLIIVVFGPLVCVPRSGSTTYEVAIESFFPMVGKV
TFGVIFFTITLFLALSRSKLVDIIGRWLTPILFLSLIVLIVEGTINAPKGLTDNGLNFKE
AFTFGFSKGYLTLDVLSGVIFSGLIISAIIQKGYSSERQKREITILSGMIAAGCLVFIYG
GLLYLGATSDVVTTEEVKYIDILKHIAHKGLGNNGAIVISVAVAFACLTTAVAIVSAMGG
IFETLSHGRIPYRWGVWGCTLVSFVLSIQSVDQIILYAGYILDFVYPITIALTLFILLFG
KRVQKKTPYIIGVSFTAVFSAIFVIGNLMESQTLKGIQDSLPLAQYHIEWLLPAFAAFGV
GAIINNK
>SEQF1602_02345 hypothetical protein
MDNIVTKFFVYLLLDYLSLSFMRYSIFLSFLMFIGCLSSPKQQKESFSEKVSDTLVEAKE
QRYFSKNVENELLLEKAMVDALQKIADSFHGEDWEYTYDFDKGEGDTPHIRVDIKVQKYF
EETYYAVIYASDYVNTLVRLYRIDHDAIQEKLSEYFPWMTVPSDTIFDANGDEVKDFALR
FYPSSGCCRRDIYYLYLSPEKKEGQLSYIELINPTFYPKEHLIRGIGYGWPGHVELYKYR
WRGEELDTLEYILPDVATKGKTFLKSRNLYGFTKEKEIRLTKLPEEYQTVIGLDYFLDYT
AEDFNSD
>SEQF1602_02346 hypothetical protein
MRKLLFTLAIMASVGSYAQKFASDHEITEQVFGTEKLYKFRKSGDPLDGHYKVAQGEGAY
YEVTFENGRMNGTYKSYDAQGNLRAEKNFKKGILDGKSVSYNDEGKEKDLRTYKDGKLEG
ISKEYSSNGKLRTELSYKGGKPNGEWKYYDNEGKVRKIESYKEGKLHGKQWQKMTSNRGE
YTATEYYDNDKPTGKWQEIWENGLVLSEKEYKDKGTYTEREFFRNGKMESEVSYKDFKLH
GLRKKYNDAGILVRQDTYDEDKLTNRKYFFGNNGKLREELNYKNDGKEGKYIENNENGTI
KEEGNYKNNFKEGVWKEYTDKGVLHEQSTYVAGNLQGAYKEFYASGKVRQEGNYKDDQKD
GTWKYYDASGKLSAEVIYEKGNRIKTVDYE
>SEQF1602_02347 hypothetical protein
MPVNEEPTLFSRLGDREFWKERDSEDLEKKKEAKYLQDFYENPLIDEQDIALLQPFIKQW
LDFYHLDLHEARLTRTEEHAPINAGEDKESLYYHPFEAADDVGDDLCNLYSPDKMRYVNE
YKGCEISDGKLSFNMDDSQNINLTDRRLRHHTMILFLGSLEVSHDVFWKDNDIFAIVGYS
EATLGEYYIHLFDIKNSLVKRYEILDNGYTPTTYYPSNTIKKAIAKGYKYK
>SEQF1602_02348 Ribosomal protein S12 methylthiotransferase RimO
MHPQTSNNIMRTKSIKQNKINVVTLGCSKNVYDSEVLMGQLKASGKEVVHEDKGNIVVIN
TCGFINNAKEESINTILEYIQKKEEGLVDKVFVMGCLSERYKPDLQKEIPDVDQYFGTTE
LPALLKVLGADYKHELIGERLTTTPKNYAYLKVSEGCDRPCSFCAIPIMRGSHKSTSIEN
LVIEAEKLAKKGVKELILIAQDVTYYGLDLYGERKLADLLRALAKVEGIEWIRIHYAFPT
GFPKDVLTVMKEEPKICKYLDIPLQHIADPILKSMKRGTTKAKTTQLLEDFRKAMPEIAI
RTTLIVGYPNETEEDFEELKEFVRQMRFERLGCFTYSHEENTAAYELEDNIPEEVKQRRA
AEIMEIQSQISWELNQAKVGKTFRCLIDRKEGQYFVGRTEYDSPDVDNEVLIDAAKHYVK
IGDFADILITEATDFDLYGEPVSSKQKAVNGEQKAVSSEQKAVNSEKLV
>SEQF1602_02349 Secretory immunoglobulin A-binding protein EsiB
MRNILLTILLLGSVYTYSQDLDKPIKDTTLHKAKAPNFAQNVEEEHIVKKKLQNSRKESI
TKKKKELQDVEIGCINEKEKELQKADNTFEGGEFEKAFSLYIKYKQELNGEQYNNLGWMY
YFGKGVTIDYKEASYYYQKAAEAGNSDGMFNLGICYYSGKGTPYDAKKGMYWLKEAASEG
SSKSMYQLGLTYYSEGFEKETFYWLKKAIESGYTEREVYYLLARCYYYGKGTSQDYEQAF
FYFRKDIENRNDYTSMNYVGSMYEEGKGVTKDYSQAFYWYKKSADGEDSGGMNYLGELYR
DGKGVAKNSKQAFLLFAKAHKKGNKKATYNLVSYYYMGDVVTKDLELASYLCREACASGI
ERACADIIRLKL
>SEQF1602_02350 ESX secretion system protein EccC
MKSTSFYSTYKPLPSNTKDFDLSLVEDSKFPEAVYVGEFKTIAGETVPALLPLKEVNGLC
FLSHPENAQQIHNCMQTIALRILLSLPPGLCKFTLYDGTNLGANLIALSSLSPKIKGENI
LTDPEELRRALTSIKTDIPNIIQKVLGHRYLGKSLIEYNADANELAKPYHILMIADFPNA
LSKEHCEAIERIVRTGKQAGIFVIMNLDSSYKPSRSYDYAPQALLDIMTTIYQSPNTNDW
YIRNIPYEEYFNSKFYFQLTENFPSDTIDEILDFINNRLTQYKKVEVDILSRLNQSNLWS
RDASAGVEIPIGKVNSVDLQNFVLSLSDGISDTPHHCLIGGATGSGKTVLLHNIICNGAW
FYSPEDLQFILLDYKEGTEFKIYENLPHVRVLSMRSEREYGVSVLEYLYKEIEQRGDLFK
EYNVSNLSKYNTASKHKLPRILVVIDEFQKLLDGNSSTANFVSAALDDIGRRGRSFGINL
ILSTQSLSGVNIHQAMSHLGLRICLKLNSERDCDQLLGSGNHVPFTTITKPGEGIYNARG
GLSEGNLRFQSAYASDSKIQYLINSIKKEVEAHYGTAQPFKRFIYDGEQTASIKNNPMLI
EGDLPVNDKECEIFIGEPTALVTSHTSYKLSRQNGSNVLIVGGDETASLSILSHSIEQAI
KQSDEKAAFYLCDKTNVDSANYGVLQRLTQYPAVNYCEDDSAIEQVITSLYEILEKRKKK
EEQRDRIILVLADLFNVRSMRKSGYNTPTATQSLQTILRDGPAFGIHTLASFKSYSNFSQ
LLDTINTLQDFDIRIELRGGEGHKIFVSNTFDTQKNSPTKQNIGVIQTSANTQLLQKFKV
YSL
>SEQF1602_02351 Chromosome partition protein Smc
MSTYSDYIEYLKHVDNIAKEEIDKQISALNENINTLKSSLAGLQKEKDVQTTELAQLQKK
LASKNDMLNMKAVEIDQHLRKQTELNNTIDSLKEQKEKINTTLEQEKIKLQQKITEIEEK
DLQLLKQKKELDSKFIRLQAEYNELLAKQVSADSSTTILKRDLEALQEKLNLETENTQQL
KTEINNLNRQKEILNQKITQHNNDSAALQKELKRQLEEANNKTKRLREELNKKTDNEQLL
QEEIDNLSEQNKTLYQKIGQNLDDSSKLEKQLDEAYNKIKKLCKEKENLNKKIGEEEQLR
VENNNLNELNKALQERIKKIEKESSDTNSKIKEASTKNTQLKKECRELESSIYSLQLDLE
KQKKSKKNNFFIGLLLGFAALSLLWFISPNLIGTPLDLSSVSPPDLPSANQEQVDIYGYT
EDKALPEDKAKYTGQTKEGVPHGIGTKEFSEGGSDKFVGAFKEGEFYYGVRTLENGKIYI
GPYVNNQANGVGSYQFGDGSRYIGEFKDDAMNGYGIYIDEKGNKTMGEFKNNNLVKPNSY
GN
>SEQF1602_02352 Secretory immunoglobulin A-binding protein EsiB
MEIRCLYILIGFIITLNSTAQDISKPGGIKLSQKEPDKSKEKTSSKADTHIQKTYNTNSS
LYQQELTAEDMFKKGEEYEDTSDYAKAVKWYQKAAEKGHIEAQSALIEIYYEGAKGVPKD
IAEAIKWCRRLAEQGHIEAQFSLGQLYEEGKDVSKDYAEAVKWYRKAAEQGNPMAQSSLA
EMYKNGIGVSKDYTEAVKWYRKAAEQGYAKAQNHLGDLYYLGYGIVSVNYTEAVKWYRKA
AEQGQEQGQFNLGKMYIEGKGVKKDFLEGIKWYKKAAEQGNVNTLIHIGMMYYEGLDGAK
RDYTEAIKWYQKAAEQGYARAQYKVGDMYEKGEGVSKDVAEAIKWYRKAAKQGHEIAKDN
LRRLNETW
>SEQF1602_02353 hypothetical protein
MSIFNSNDYKRGYEDGYTAGFGGKDKDFTSSGMSMKFAIYGGKAIDSYNQGYNEGYKKGI
EDRLSKPKPQTVNIETDNTAKSPVINTKNTKHSKNSYSNHYSTVNTNSEIMASIQQYQVQ
LMKLEEMVSFLNMFKEQMEQNLNGYKARVQQMYETGMPEEVMRRFESDHIPETANLITQI
KMLMDDRIIPYTNTQIEIIRMALERS
>SEQF1602_02354 Aspartate-semialdehyde dehydrogenase
MKVAVVGATGLVGNVMLEVLAERNFPVTELIPVASEKSVGKTISFKGKEYKVVGMNQAIS
LKPDVALFSAGGDTSKEWAPKFAQVGTVVVDNSSAWRMDPTKKLVIPEINAEVLTAEDKI
IANPNCSTIQMLVALAPLRKYGIKRIVVSTYQSITGTGVKAVTQLENEYKGIQGPMAYHY
PIHRNAIPHCDVFEENGYTKEEMKLVRETKKIFGDDSIQVTATAVRIPVVGGHSEAVNVE
FEQEYDLAEVRKLLSHAPGVILQDNTDTNTYPMPIYAHGKDEVFVGRVRRDESQPKTLNL
WVVADNLRKGAATNTIQIAEALIKKGILK
>SEQF1602_02355 hypothetical protein
MKHIFLLLPLFFYINTARAQEIVVGTLSDTIPVDENWIPKEIEGAHYQIEPDLYFTYQKP
KFWDLINKAPRNALNTLKDFVSKPYYPYGIAALGATAALIPADPWLIRESRSLGESMGLN
EAHTYKKLGFLKIVPADVNSALYFIGNGTTFILISGGLATYGLITDDYRAKSTAMQLIES
ILITGVFVQPLKRLTGRESPFITAENGNWHSSWTFAPSFAAYQKHTSNYDAMPSGHLTTA
MAAVTVLAENYKDYKWIKPVSYTALALMSFEMMQSKVHWASDYPIALFMGYLIGKNIAKS
RIETSDYRVKTAQKYHWNLSSSTAWDGTPLYGVALSF
>SEQF1602_02356 Kynurenine formamidase
MNLYQILQEKQWVDLSHQIDEHSPKFPALPALEQKDLFTLKDGFHVQQFSVVGQYGTHID
APIHFVEGGRWLDDIPLKDLLLPLYVIDKSQEVSQNNDYILTREDILAFEAQYGQIVPGA
FVAFRSDWHKRWPSYEQMRNLDDKGVQHTPGWSREALEFLIHERKVKAVGHETLDTDAGV
LAAAKGLVEEYYLLSQDIYQIEVMANLDQCPATDAIISIAYPHWRGATGSPVRAVAIF
>SEQF1602_02357 hypothetical protein
MKKYLLPLLALSFSAIHCTKENEKIVVQEKVTQGSMILSGEGVPSAEKGQTGDYYLDLSS
SALYGPKTKDGWGNSVLNLKGLKGDKGDKGDNGTNGQNGQLGQNGQPGLTPHIGENGNWW
VGNTDLGVKAQGNPGTNGQDGQPGRDGQPGQPGRDGQNGQPGRDGQNGETPRIGDNGNWW
IGNEDTGKPARGAQGPQGNPGTNGQNGQPGRDGQNGETPRIGDNGNWWIGNEDTGKPARG
AQGPQGNPGTNGQNGQPGRDGQNGHTPHIGKNGNWWVGDQDTGKPARGAQGPQGSQGNPG
QQGAQGNPGRDGKPGADGSKILAGNGTPQASDGNIGDYFIDKTAKIFYGPKTASGWPTTG
ISLTGNPVVTEDYQLSPDGKTLVKWLNKKARYIDMNTDPKLSEVEKIADNAFDEMGADNE
LSTIIVGDKVTELGKFTFSKCRNLRRIELPDGLTTIGKGAFDACSNLQYINIPETVTNLG
EQAFTNCTKLKTITIPKGISSFGKRTFFGCSALRTLILENPVGFEINKANMQNAFQGVTL
NVIYVPYGSADDYKNKNKSSYSNYQNIIKSIVIQ
>SEQF1602_02358 Phosphate acetyltransferase
MNTSDATPDTSKKFQNYMVETAKKLQKRIVLPEGEDKRILSAAAKLAEDGLAYLTILGEE
KEVLARVDELGLTWNPERIQIVSPKKNPNYEAYWKKLYEIRKEKGMTEAQAQELMLDVSY
YGTMMVFMGEADGMVSGAVNSTAHTIRPSLQFVKTKKGVKTVSSVFFMILPDRVLVYGDC
AVVPKPTAEQLAEIAITSAESAKAFGIEPKVALLSYSSGTSGSGEDVDKVREATEIVKAQ
RPDLLVEGPIQYDAAVDATVAKQKMPDSPVAGKANVLIFPDLNAGNITYKAVQRETHSIA
IGPMLQGLRKPVNDLSRGATVPDIYNTVLITAIQAGMQE
>SEQF1602_02359 Hercynine oxygenase
MDMQSLKKPMLASLLVAAFLVGCGKKGSDKNTSSATGWKINAKEGGFQYNTNFKEQVTGP
GLVFVEGGTFTMGKVQDDVMHDWNNTPSQQHVQSFYMDETEVTNKMYMEYLDWLKQVFPP
EDKDGHYKNIYLGALPDTLVWRSPLSANETMVSEYLRHPAYAEYPVVGVNWVQATQFSSW
RTNRVNESILEKDGYIQQGSRYQVDAESTFSTDTYLNTPENSYGRKVSEFAGKKATNKDG
NVTYAKQTEGILLPEYRLPTEVEWEYAAKSLNGIREYNSIRGRKKYPWAGRYTRNGKRAE
MGNQMANFKQGQGDYGGLAGWSEDKGDITTKVKTFAPNDFGLYDMAGNVAEWVADVYRPR
VDDELSDFNYYRGNVYTKNKIGEDGKLVVVDAQSITYDTLSNGRIIARNLPGQLAKVAVD
DNETYLRYNFTTADNRNYRDGDRVSSKEYAKLTMDRHSENIDSLTASQRANVSRTMYNSP
NQKILSDGQGGIIKVYDRSNDRTTLIDDEARVIKGGSWRDRAYWIDPAQRRYLPQYSATD
YIGFRCAMSRVGSKAKKGKSSRG
>SEQF1602_02360 hypothetical protein
MKPFITLAIVATVLTSCAGIQVSSDYDSKAPFAQYKTFAFLKEGIDKAEVSDLDKKRILR
SIESRMLEKGYTLSETPDIFVNFFTRERERQDLYQTVGVGWGWGPVWGSTVQVTPTLTEG
ILFIDIIDGKGKDLIWQGKGAGMLSERANKDEQIDKFVSEILKQYPPQQVKKP
>SEQF1602_02361 hypothetical protein
MKKILLASISLLTPFLLSAQIDRDKMPEPTQMPSFTLGEPHVKKLPNGLTLMVVENHKLP
HVSVSLTLDRPPIDETQKPGMYYLTSELMGGGSKNISKEAFVEETDRMGATVYLTVDGGN
TYSLTRYFPRVLELFAEAALHPNFTQAELDKARDKAIASLKAEENSAQSIIYRLNSALTY
GKKHPYGSFYTEESLKSITLSDVSNFYKTYFSPANAYMVVVGDVNTAQVEELVSKYFHGW
WPAKSLQMTTPTPQDVQYTQVNLVDVPTAVQTEISVFNLYPLKMSDKDYFAVRVLNQILG
GDYGSYININLREQHGYTYGARSYMGTNRFTLANFFVSVRVRNEVAAKSVVEILKEIKRI
QTENVSEQKLKEVKGQLVGRFVMSTQYPATIANLAVTRETQKLPMDFYSNYIKNIEAVTV
ADVKRVANKYIKYNNLRFIIVGKSSDFIKELESLKHNGKPLPIFYYDKYANKIK
>SEQF1602_02362 putative zinc protease
MWVTFFYSYKGKFFLKYFFISGKKPNFAVMFLSLSFMKKYILTLNALLLSTGIAMAQKIN
FEEYDLPNGLHVILHQDNSAPVVTTTVMYHVGAKDDLPGKSGFAHFFEHLLFEGTKNIPR
SRWFDIVSAHGGDNNAFTDVDKTYYYETVPSNNLQLALWMESERLLHPVINQIGVDTQKE
VVKEEKREGTDNVPYGKIIYMPVVQNQLFDKHPYKHPTIGSMDDLNSAKLEDFIRYNHRY
YNPNNAVLVVAGDFQKDQAKSWIETYFGPIKNRQAKPVRNYPMDAPITQTKKVTDYDANI
TAPAKVLAWRTPKMTEQDARVMDFIQALLANGESARLYKKMVEEKKEVLQFISYTCNYED
IGILMIAAVAQDAPLEQLTRDMDSEIKRLQTELISEKEYEKLLNSFETSFIANNSDVRGI
AYSLAVDYTFYKDTNLINKELDLYRKVTREDIRRVAKQYLNANQRLEIDYLPEKKSN
>SEQF1602_02363 putative lipoprotein YiaD
MKRIKISLASLALVATVGSVQAQDENSKWAIGFGINAVDIRTPHQFGDFLKDWGGTKDLN
ILPAVTKLSVARYIGAGFSAEIEGSLNKIKEGFDGYSEDKSFWSANLQAKYALRRLFTTE
SGWFDPYIKVGGGYTAYESRFDDKEGGFKALAGGGINFWFTDHLGVNLQTGYHHGFQKNG
TDYFQHSAGIVIKFGSKDTDKDGIPDNKDACPEVPGLKEFNGCPDTDGDGIPDKDDACPQ
VKGPKEFNGCPDTDGDGIPDKDDACPEVAGPKEFNGCPDTDGDGIPDKDDKCPDVAGPAE
NGGCPWPDTDGDGVLDKDDLCPEVAGPASNKGCPEPDEKEQKQLNQYAKTILFDTGKATI
KFQSAEVLNQIINVLKKYPNSRFRIEGHTDSTGKKAKNMILSQNRADAVKVYLIQGGIDA
GRLESQGFGPEKPIASNKNKKGRELNRRVEINLIK
>SEQF1602_02364 L-tyrosine C(3)-methyltransferase
MQGIITLFKDIVMKMSPSVAQQYTQEHLSALQAQRLAHEIAFAPVVFQVSRLMIKFGILQ
LLSDHNKGLTQKQIAEHTSVSEYAVQVLLEASLSIGTVRVSEDRFVLTKAGWFLLNDESV
RINMDFIHEVCYQGLFYMEETLREGRPAGLEVFGQWPTIYEGLSQLPREAQKKWFAFDHH
YSDNSFQEALEIVFSSPVKKLLDVGGNTGRWAMQCVGYNPEVEVTIMDLPQQLGLMREAT
RGKAGADRIKEYPANLLDPKGTFPKGFDVIWMSQFLDCFSQEEVISILRRAAQAMDAHTV
LYILESYWDRQQYETGAYCLTQISLYFSVMANGNSKMYYSQDMIRCVEAAGLEVTQIHDH
LGKGHSIFVCKKK
>SEQF1602_02365 Hydroxypyruvate reductase
MKILHIDSNHPLMIAQLQEAGFENDTDYLSSKAEIEDKIAAYDGIVIRSRFPIDKGFIDK
ASRLKFIARVGAGMENIDTAYAHQRGIALISSPEGNRNAVGNHTLALLLALLNKLKKADQ
EIAQGLWLREENRGYELDSLTVGIIGYGNMGKAFAKKLRGFDCRVLCYDIKEGVGDTCAT
QVPLEVFQKEVDVVSLHTPETPLTLGIVNTTFIEGFAKNFWLINTARGKSVITEDLVSAL
QKGKILGAGLDVLEYEQSSFENFFKGTLPEAFSYLTQANNVILTPHIAGWTIESKTLLSQ
VIVDKIKALGHTHSLPMDDNA
>SEQF1602_02366 Putative membrane protein insertion efficiency factor
MQRKISQLLTYPFILLVRFYQVAISPLKPPTCRFSPTCSTYALEALKKYGLLKGGRLALR
RIMRCHPWGGSGYDPVP
>SEQF1602_02367 hypothetical protein
MKNLFLVTFAWLMMIAIIGSVIYSMLFLGQMYVPHDETFQYFWCCFTAAVLIPAYKGIYY
IHSLWLKMLKEYRESSYREEEVKEIPFFQDVTNKVDQVHPFMQKKEGRIAPREELSETLR
KIRSEANSKLSQLRTEDIANTKKDSHYFVSKYTSEKNILVDTIFEGEQEAVPERVVAEKS
EEVLHPVFSTPISDKEVQEEEHPVEEKPSKAQNLRAVMDTEGKKAPARKPRKQTGKKAGK
GGTQTSKGGTHKKKE
>SEQF1602_02368 hypothetical protein
MKINFFKTQKIRQFSYQPRYYQETEERGGFSIVKHQSRASSFRRQWKEMRQPASIRSHSN
RLVWVIVLVLILILFYFFDFNLSFFLNK
>SEQF1602_02369 DNA mismatch repair protein MutL
MSDIIRLLPDNVANQIAAGEVIQRPASAVKELLENAIDAKATQIKLILKDAGRTLVQVVD
NGIGMSPTDARLAFERHATSKIRVADDLFSLQTKGFRGEALASIAAIAQVEMTTCQEGEE
IGTAITIEGNKITDQYPTVTQKGTSIAMKNLFFNVPARRNFLKSDNVELRHILDEFHRVV
LAHPDIQFSLIHNGVEQFNLPPTSLKKRIVQVFGNRLNEQLVPVEEKTEVVNIHGFISRN
SFKRNKSLQFFMVNHRFIKNRYLHHAVLSAFEGLLREGEQPEYFLYLEIDPKHIDINIHP
TKTEIKFDNDQTIYALLRSAIKHSLGQFHVLPTIDFSLDESQEVPYSYKDKEAQTPTYQV
DRNFNPFKMDNPSTLGGTFSSHRNTPSPQWESLYAGIPSRVNDPFEKEQVVPTLIEHPTE
VKVQTLLYFQKKYIITYLKDKVLFIHVSRAHQRILYERFHKSITQGVSISQSLLFPLEFE
FSPTEIISLQGLIPLLNRVGFLLEIQGNKICFTGLPPMVKESQVEDILHQLLEKEMEDIP
QDELSQKEALVKNLSKSLAVKAGQTLSAEEQEQLVYDLFSCKDSLISPFGKKIYTELSSN
ELENRLQ
>SEQF1602_02370 UDP-N-acetylenolpyruvoylglucosamine reductase
MNIHKNISLQAYNTFGIEQKAALLIEAYDTKDILEALRSYPNLIVLGGGSNILLTQEIQT
PILKIMQKGISVEKETDSHVWIKAQAGEVWSDFVDSCVARGYGGLENLSLIYGTVGAAPV
QNIGAYGVELKDVLSSCEVLDRESGQTMTLLKENCHFGYRDSLFKQQKGRYIILSATFCQ
TKRDHLFKTHYGDIRALLQEKGWGETPELISKVIKEIRLSKLPNPTELGNSGSFFKNPVI
PREQFLSLQERYPTMPHFEISAEEVKVPAAFLIETCELKGFRIDKVGVHHKQPLVLVNFG
GATGEEVLALARHIQKRVLNRFGIQLEMEVNVW
>SEQF1602_02371 putative RNA pseudouridine synthase
MQSSPKKPQGKHSSTKGKRFDSKENTTNQKRKTSSGKENFSSDRKKTTTGREKTPYKKEK
PSYNKEKSAEYSPTTRAPYKRNTPKPNATDQSKGIRLNKYIANAGICARREADRYIAAGN
VEVNGKPMTELGYRVQPTDVVKFDGKNISAEKKEYILLNKPKGFITTTQDEKGRKTVMDL
VAGAAEGNIKPVGRLDRLTTGLLLLTNDGDLMKKLTHPSHGVRKIYHVILDKKLALADFH
KIQEGLTLEDGFIQVDDINFVDGAPHNEIGVKIHSGRNRIVRRIFESLGYVVEKLDRVVF
AGLTKKDLPRGHWRTLTAQEIINLKNLSL
>SEQF1602_02372 hypothetical protein
MNKMKKTLLIGLPLLLLVLGGWIYMRYYFVFAEGVKSGYLNYAVYKGDLFKTYEGKLIQE
GFAKTKTGSGMQSNEFEFSIENKKIFQQLEVNSGKHFELHYREYHNALPWRGNTVYIVDS
IVNMRD
>SEQF1602_02373 Putative TrmH family tRNA/rRNA methyltransferase
MKNTQIFGLRPVIEAIEAGKTIDKIFIQKGLSGTLFTELNTLISQQKLPCSYVPVEKLQR
LTRGNHQGVVALLSPVEFVPLEELVLSTIESGKVPLLLILDHLSDVRNIGAIIRTAECTG
VSGIILPKQGSASIGEDMVKTSAGAIFNIPLCKVDNLIDTIYYLQGSGIKVIGATEKASS
LLYQLNLTEPLAIVMGAEDTGISKGVLKVLDERAKLPIQGEISSLNVSVACGAFLYEVVR
QRLNGQ
>SEQF1602_02374 Zinc transporter ZupT
MVSSIIEYLSSINPVLAALYATLFTWGVTALGAALVFFFKSSNKLVMDGMLGFTGGVMVA
ASVWSLLIPAIDMSGGERFEKVLPAVIGFLGGSLFIYALDRILPHFHPNFKQTEGVKSSW
QRTTLLVLAITLHNIPEGLAVGVLFGGVAAGIPEASIAGAVTLAIGIGLQNFPEGVAVSM
PLRRMGLNRWKSFFYGQLSAIVEPIAGVLGAFAVVFFTPILPYALAFAAGAMIYVVVEET
IPESQQSRNTDISTIGFLIGFVVMMVMDVALG
>SEQF1602_02375 Adenylosuccinate lyase
MSLTAISPIDGRYASKTTALQAYFSEQALIQYRLRVEIEYFIALCELPLPQLMGVDKSIF
PSLRAIYREFSQADALAIKEIERITNHDVKAVEYFLKQQFDRLGLHPYKEFIHFGLTSQD
INNTAIPLSLKEAIENVYLPEIKILIQKIETLAREWKDIPMLARTHGQPASPTRLGKEMK
VFAVRLVEQLQYFSTLKHAAKFGGATGNYNAHKVAYPQIQWRSFGKHFVEDILGLHHSFP
TTQIEHYDHLAALFDLVKRINTILIDFNRDIWTYISMDYFKQRIKEGEVGSSAMPHKVNP
IDFENSEGNLGIANALLEHLSAKLPISRLQRDLTDSTVLRNIGVPFAHTLIATSSTLKGL
DKLILNPDKLHADLQDNWAVVAEAIQTILRREGYPNPYEALKGLTRTNQKINEQTLHDFV
DTLAISDSLKATLKAITPENYTGGDYLDY
>SEQF1602_02376 DNA processing protein DprA
MTEEDILALLALQHTPNIGDITAKKLIAHCGSPAAIYKEKKHKIAHIERIGSTILQHLFD
PIHRVAAEKEWQYIQDNHFSYHTFFDADYPANLKQIIDAPIIFFSRGNIDLKNKKTLSIV
GTRQITTYGKAFCEKFVEELSPLEDLVIISGFAYGVDIAAHKAAMDNGLQTIACLAHGLD
IIYPASHKKYTKEVEAYGGFITEFWHQSSFDRKNFIGRNRIIAGLSDATVVIESALKGGS
LVTADMAFSYDREVFAIPGRADDTYSQGCNKLIKTDKARLITSAADLVYYMGWEVEKKNP
KVITPELFVELTPEEEKVATYLRENGKQTLDDLARECSLPVYKLSNLLFQMEMKGVVRPL
PGKMFVMANKQ
>SEQF1602_02377 hypothetical protein
MKIAEKKKCKEARKALAQKELNDFRASLPMEEKYFSELFHYLEKTLQKTPCDHTLRGITR
FLAEKKVSDPEKVITWLASHGGYCDCEVLYNVEERFDYLEDTFCKAPIELNTIEKNILEK
KKKINELPPEFDFPFSSVSAPWKLSQKEVQGKPEYLLQLGKGFNACIAMLKLDFPKEKLS
EEGYFLSQWKAFTGIKSPKGLEREILEVGTYQYIIVKSKEYTPVIIFVLSKENKRGYLVV
QTELTRYKNDLKEIERLLRG
>SEQF1602_02378 Thymidylate synthase 2
MQAYKDLLNHILTYGHSKDDRTGTGTISVFGYQLRHNLQEGFPLLTTKKIHLKSVIYELL
WFLRGDTNIHYLTEHGVRIWNEWADEQGDLGPVYGAQWRNWNGEGIDQITEVLHTLKTNP
DSRRMVVSAWNPSVMPDTSLSFAENVANNKAALPPCHALFQFYVMEGRLSCQLYQRSADA
FLGVPFNIASYALLTQMMAHVTGLQVGDFVHSFGDLHIYKNHLEQVKLQLSREPRPLPTM
KLNEKVTDLFAFDYSDFILEGYDPYPTIKGKVSV
>SEQF1602_02379 Cystathionine gamma-synthase
MKFETTAIHGIRNTEDPSQKWGSCINMASTFPLNEFGVTQEFEYSRVSNPTRKEFETLIA
KLESGRHGFGFSSGMAATTSLFTIFEKGDHFVFGLDIYGGTFRIMKDVFAKFGLEATYVD
TTNLDNIRKAIRPNTKGIFIETPSNPLLDVTDIRGTVAIAKEHGLLTIVDNTFLSPYLQR
PLELGADIVVHSATKYLSGHNDIIAGAVVVNDDTLAEKISFAQVAIGALISPFDSWLLIR
SIKTLKVRMDYAQSNALKLIEFLQGHPAVEKVYYPTLPSNKGKAIQESQASGAGAVFSFV
MKDEKKVKTFFESLRVALFAVSLGGVETLVTHPSTHTHTEFPEEEKVARGVTQTLVRVAV
GLENIEDLIADFKQALDQ
>SEQF1602_02380 putative S-adenosylmethionine-dependent methyltransferase/MSMEI_2290
MNTENTLNEHQGHWMLAKLGKRVLRPGGRELTEKLIAGLQITPEDDIVEFAPGLGFTANI
ACSYHPKSYTGVDLNQEAASVARKRIKYDKAKIINANAAESTLPDTYADKVYGEAMLTMQ
PLEQKKAIIAEAFRILKSGGYYGIHELGIKPDDVSEEVKEDLFKELSETIRVHARPMTTA
EWTALLEEQGFKIIRVEHNPMLLLERSRIIQDEGWLRMLLITFNLLRFPEIRKRVKKMKA
CFRKYRDNLDAVAIIAQKP
>SEQF1602_02381 hypothetical protein
MKKFKYITMAALAIVSLLSCSKEDDDKPTPPVPPTPPTQLKTVAETKVDTYTVRLQNTSG
TFVMGYNDVTLSVTDASGKEVDLQAATFTPWMEMYKGDGKGGFSKEIMHTHTCPHTALAK
EGNVWKSQVLFQMMTAPSGVWFGTITFRAAGKDYEYKRLDFEVKPQTNKALGTVNRFKLF
SEATPKGQTHLYALVAPESPKVGENEIALGIWKMENLQNFPRVTDWTVEVSVKSKEGTVV
LSTTTLRYERNFYRGKVFYPKAGEYTLSYALKDAQGKTIQPQDNDKKDVSIATTIQF
>SEQF1602_02382 hypothetical protein
MKKAIRGIAILMSFVFLLNTLLSGIYLSYFLVSKRDFVAAYCQNQAQPERHCEGACKFAE
VTKETSDTPLTEKKAIFLPESFFQEIPILIYSKTFLQKVVHSYFYLFSLSQGVGNTLLRP
PQEE
>SEQF1602_02383 Inner membrane transport protein YdhP
MNMKMIRQLFPLAIGGIALGSTEFIPMGLMRTMGGDLHLSDDQVGNFIAAYAIGVVVGAP
TLVGLSTRFQPKKVLIAFMLLFTLFNGLFSLMPTYETLLVSRFCSGLPHGAFFGVGAIVA
KQLAPREKEAMAISVMFGGLTIANLLVIPLFTHLGGVIGWRPVVGMIAALGLVTALCVFF
FLPKVDSQRDMTLWKELQHFFSVPSMLLLVITALGCGGLFSWLSYIEPLMLDYAHLPREQ
MPTVMIVVGIGMVVGNFFGGWLTDKLHLVRASIIVFTSTICVLLIIFFFSDQLWLSWVLT
FVCAIAAMSVGAPLNIMMFRVSPQAQMMGAAFMQAAFNLANTLGAYLGGKPLKYGYTSNY
PALVGATMALVGFLCALFLYRKYARLFK
>SEQF1602_02384 ATP synthase subunit delta
MIHSTKVAKRYAKALLDYAIENQKEELLFGEISSVVEVIHENPDLKALLHSPIVKTEVKQ
RVLQEIFAEHISELQVLFTILFQNKRISDLYAIAREFVEQYNEYKEKIVIHLTTAVEASD
KLKEEFVAKAVALSGKRNISLENKIDPSIIGGFILRINDLQYNASISYKLQAIQEQFKEN
VF
>SEQF1602_02385 ATP synthase subunit b
MNFIHPESLSFWTLIVFVCLLLLLRAFAWKPILKALKEREDSINHALEAADEAKKEMANL
KADNEKLLTEARQEREAILKEAREIKERLISQAKEEAHAEGLKIISQAKATIEGEKKMAI
AEMKEQIASLSLDIAKKVLTKELASEVRQEKLVEDLLNEITIK
>SEQF1602_02386 ATP synthase subunit c
MVLAGIGAGIAALAAGIGIGRIGSSAMEGIARQPEAASKIQGAMIIAAALIEGVALFAVV
VALVAK
>SEQF1602_02387 ATP synthase subunit a
MIQKIISKWLFLSILILPCTSLWASEQASEEEVDFTQVIQHHIADSHEYHLLDWGGTSIT
LPLPIILWTDNGLVTFLSSEFHHDDKGEVIVEKAGQYFARVHGQIYYTDATGNISYSEDH
KVTNARPLDFSITKNVVLLFLIALLMILAFVSVARSYKKNPKAPKGFANLLETLIVFIRD
EVAKPNIGDKKYQRYMPYLLTVFFFILIGNLLGLVPIISGTLTNDIIFTGTLAVVTFLIT
TFSGNSHYWKHIFATPGVPLWLSPIMIPVEVIGMLTKPFSLMIRLFANITAGHIIILSLL
GLIFTFKTVFISPVSVAFSLFISILELLVAFIQAYVFTLLSALFIGGAVAEEHHAEEHH
>SEQF1602_02388 hypothetical protein
MNPATGKVEKKVRVYVEDSKGELKQENGGKQVCAHSVFIYKEYMDVVIPNYFTPNGDGEY
DTWAPLNLASYPHAETIIYDRYGRQIATLNNRQEWDGTYGGEPLPTGDYWYVLRLNEPDD
SRTFKGHFTLYR
>SEQF1602_02389 hypothetical protein
MKSSANGSCGQDVTGFSGGVVQITERPIPAFDANPPANPGIEIVQAGCGAATSYGVTPKQ
SNAQLYLNIKGGTAPYKVEIYEAGNVILTQTVTSTTPPAPYPGPTVYTANATIDLPAKDV
DYTIVVKVTDANGCVLAIPGSFVGTVKTLQKITGATFHRTQQMSCQPTGTEQVTMTVTRT
NGSNTGGYNVYIRKMTGAGAPTEVAGYDSAARTAGTAQIGGTGVGTITFPQIAEESADYE
ITLTDKDTGCTFVVPSGYRVEKAKAPRVNFFVTAGICGDTASPAPGTVGVTFRVEVEGEI
GTGGYTWFVKKSGGTTYGTQTGHGASDQMTVHIPVGDVPQGTAITFETEVTVVGTQCKTA
AQLTATRPQNINAVSKVLRYMTYCNGEAQNDAQIGVTSAPTGGWGAPYQYRVVTDGNAGS
FTDQMTFTVGVGTHYIEVRDSRGCTRKLDSFTFVPYHGPSMQLQAPNAPTATKIPSCVGS
QDGEIKLTGVIGGSVTATTPSPSGSTPTLIEGRLSYELFDATTERSLGRILPDDNPTTRG
TVTFSGLGAGKYFIRITSDMLCADDKVDSQPVTVNDPGTIIARAELTKYPGCNTAGDITV
QIEGRPNMNPTRGTYKVELYDISAGRPGTLVPVTPTITGAYQTGVTAVFAAAVTTPVSSD
RVYYAKVMDNGGGTGACEGESNEVHVAKVNPIDGAIDNDKSVTSLKCYGSSYGKIVVTAT
GGKNDEPYVFTLKRNGSVVPGLSTPNPNAQGVFEGLDASDDYSVEISQAVGVCIPKVVQV
PIKQETKYTVEYEVKQVTCNGDHDGSIEITTTSGQTKLDGTQRKLTYAISPRLDRFLDNG
GKFEGLAPGKYYVIVQDENGCRPNEIKEKGQPTPLGTDIIEFTITEPDPLSVTVRMDTVE
HESCAGSNDGKAYLRVIGGTPLRTVGNDKVYEYSKDGGTTWVEYHSDGNGTLIDGLAPGD
HTIKIRDKNGCQAEATLTIEAGSEVTLKLSEGKYECVNNVIKYVVEASVEPASAALNVRY
LLDGVAHNNTRFELDVDLQTNTTKSYVISVIHKVAGHGECRKDSAPILVAPKTPLKAQAD
KITSVSCHDGADGSFEVVAQGGSGKYEYGLKQADGSYRWQGTNNQFKDLSVGSYTVGVKD
TKYGCIYEVVNTAIIAPTPILITQNSITHVGCKGEANGEIEYVLKGGNPQYSWEVFFENG
ESTSKRGTGEREATPFKIQGLKAGKYLLVVKDAKGCSQKKEFEIIEGVDLKGVITQHYQC
NADISENNKVLVVDGSGPNSDTAAEATYDVYVSVTTPYLVINPSSGGAINRLRYAITTQG
GSPIQRYEFNGTTPTGTDNTHNMYKIAHASLLAQLNAVRPLQEGLNKYELHLYYFNKDNP
AMSDPPLCQEVRELNIEYYPPIKITNQSIANDLNLVKVKVEGGKERYTVYFSGAQYHTGE
EVKAHYVQKVDDVKAGDEVVYYVQKTGL
>SEQF1602_02390 hypothetical protein
MKLFIIVSIILALCILGMAIKIWAKKDGKFSGTCASQNPHLNPEGTPCSFCGRLPEEAEC
RKS
>SEQF1602_02391 NADP-dependent glyceraldehyde-3-phosphate dehydrogenase
MSEFQPIPKAYICNPLQHKTYLINGELREWTGAYDEVYSTISSTEVYAPTLVGSVPHLDK
EQALEALEAAANAFGKGNGLWATMRVRDRIEILERFTEKMKTKRDEVIHLMMWEIGKTIS
ESQKEFDRTIEYIYDTIEEYKKLDRDSAHFQKRDGVYAHIRRGPLGIVLCLGPYNYPLNE
AFALLIPALLMGNTVIYKPPKYGVLLITPLLEIFKECFPKGVINIIFGRGREIATPIMET
GRVDVLALIGNSRSAIALQDKHPHKNRLRLILGLEAKNPAIILPDADIELAVNECVVGAL
TFNGQRCTALKIIYVHNAIKEEFLSKFTERVDALPFGNPWELNVKLTPLPEPDKPQYIQD
LIDDALSKGAKILNKKGGERSENFIFPAVLGPVTPDMRVYQEEQFGPVVPVRFFSDIEEV
RQEIADSHYGQQVSLFGKDIYTLAPLIDNLVNLVCRVNLNSLCQRGPDVFPFTGRKDSAV
GTLSVYDALRSFSIRTFVASKDNPYNNEILENLLKTGISNFVHNDYVL
>SEQF1602_02392 hypothetical protein
MSLNKNSVLGYATLIMILFGLILIGLGIFRYEEVAGWGFATTGAGFLAIAWVFDSLKGRV
>SEQF1602_02393 ECA polysaccharide chain length modulation protein
MSQDIQKDDEIDLLALLQKIVQGKKTIFKCFLVFFVIGVFIAIFSKKEYTATSLVLAQEN
NAAAGGSLSGLASLAGINLSSGSSDLISPKLYTSIAQSIPFLRKMIQARIKVQQSNTPIT
YQEYYQKYDKGNFLDVIQKYTIGLPSLIVDKVTPSEENTPQYTTSEKDTLEVYPLTHEEK
GLFGLLKSQLKITNNDKDNTVSLSFSMEDPVAAAQMLEQAKNYLQETIIEFKTRKAKKQL
EFIQKQYEEAEKSFKEKQIRLAAFQDSNRGLITAVPMTRQSQLQSDYNLAYNLYVELAKQ
YENQKIKVQEDTPAFITIEPVSIPLEKSKPKKGMIIAIWSFLGIVIGIGTIFAKDFMKAM
KNRSAVPAQE
>SEQF1602_02394 Polysialic acid transport protein KpsD
MIRKIVFFLFLSVGISMPISAQIQNLNLDQLSYINVDQLSNEQIQAFWDKVQAQGYSITD
LETAARVKGVPVSQINKLRQRIMTLSSSTNNKKNTTTNKNNTPEQEIFGRTGKEYKRDTL
APAKKSRVFGYDFFQNPKISFSPTINVPTPESYIINTGDELLVEVWGAAESSTTQKVDNQ
GNIILPMAGKVHVGGLNFVEAKAKINSALRKIYAGISAPEGSYSKVYTGVSIANIRTVKV
NIIGEVEAPGTYSLSALSTVINALYASGGPTENGSFRNIEVVRGGKTVAHLDIYSFLLKG
SQEGNINLLDQDVIIVPPYKNQVEVIGFVKREGLYEVKDGEKLTALIDYFGGFKSNAYKD
NLIVERIVGAKREVKEVSLSQAQSFSMQGGDKLLVHRLSDIFHNKLSITGAVYQPGNYAY
SEGMTALDLINRAAGVRDEAYLNRAILFRTIDRVDRQSVNFSLKDILDKKQTIALQPNDS
LHVYGKDSLSIKPMVRIEGAVRKPQKFPFAKGLKAEDLVIMAGGFTENADKTHLQVARQL
NDTNFKTISKVYDITLSEGVPTETIELEPNDIVTVRYQQGYTPQQIVKVEGEVSFPGFYA
ILSKEERISNLIERAGGLAPYAYIEGATLVRKKGKEKDEKTQEKRLNELKKIDKELSIIE
TKNTDEDKDKDKNKDKDTTKTKKVNQEEDTEEEELSEYRVGINLKKIMEHKGSYQDLILK
DGDVLIVPSEKQTVEVKGLVLAPSLVRYEKGKSTRSYINSAGGFSDKAQKKSVYVMYANG
DVKGTNRFLFFKSYPKVAPGAVVIVPEKPEKKGLTTTETVSITTALTTLAILIYNTFK
>SEQF1602_02395 DNA polymerase III subunit alpha
MYLIFDTETTGLPRNYNAPISDSENWPRAVQIAWQLHDEKGALLEHKDFLIIPDGYTIPY
DAERIHGISTELATEQGVSIHKVFEEFEKALSKTQYIVGQNIGFDIHIMGAEFYRYGVST
VLDKLPILDTCSELTAELCKIPGGRAGKFKYPNLTELHEFLFGTPFAEAHNATADVEATA
RCFFELLRRNEGFSSSAISPEAILLIQENHPSPISLWGLKHINLKSASEKLKSKEQRGLS
DSEISENLALLQSAPFAHLHNHSQHSVLQSTASISDLVNAAAKEQMPAVALTDHGNMMGA
FHFTKEVAKYNKEAKAKNARAQEEGNAPTHTLLKPIIGCEFYVCENHLDKTKKDNGYQIV
LLAKNKEGYQNLIKMASIAYTEGFYYVPRIDKEIVQRYKDQVIALSGNLQGEIPSKILNQ
GNRQAEEALLWWKELFQDDFYIELMRHGQEDENRANTVLIELAKKHAIKLVATNNTYYIN
PKDANAHDILLCVKDGEKQATSIGQGRGFRNGLPNEEYYFKSSEQMKELFKDIPEAILSI
QEIIDKITPYELARDILLPKFSIPKEFQVEDDPTGKKGENKYLRHLTYIGAEKRYKELTD
EIRERIDFELSIIEKTGYPGYFLIVEDFITAARNMGVSVGPGRGSAAGSAVAYCLGITNI
DPIAYDLLFERFLNPDRVSMPDIDIDFEDDGRGRVLDYVIGKYGANQVAQISTYGTMAAK
SSIRDTARVLDLPLKDADQIAKLVPNISLKKIFSLPDEELKEKVGSDFPKVTELKKIAQG
HDLAAKTVQQACILEGSVRNTGIHACGVIITPDDITNFVPVMLAKDSDLFVTQFDNSVVE
SAGLLKMDFLGLKTLTILKDAVSLIQKRHNITLDIEEIPLDDVPTYELFQRGETIGIFQY
ESPGMQKHMRELKPTVFGDLIAMNALYRPGPMDYIPSFIHRKHGKEPITYDLADMEEYLK
DTYGITVYQEQVMLLSQKLAGFTKGEADKLRKAMGKKLKDVLAEMKPKFIEGGGKKGHPA
ETLEKIWKDWEAFASYAFNKSHSTCYAWIAYQTAYLKANYPAEFMAAVLSNNMNDIKSIS
FFLSECHRMGIKVLSPDVNESEYKFTVNKEGAIRFGMGAVKGLGKAAVDTIVETRKSGPY
KSVFDMVKRIDLKSANKKAFESLVLAGGFDSFPEVHRAQFFHQEPSENMVFLEKILRYGA
KAQESAKSIQLSLFGDSPETQFPEPKMPKTEEWSPMEKLHREKEVVGIYISGHPLDIFHY
QLKYLCNKEVIELAEGIERFENQEVRFGGIITKIEHKTSKTGKGWGLFTIEDYSGGAEFR
IFGEEYLKFRHFLCENQFVFIKAHISPGYVNKEGIRSAPKMNFTFVDFLENTLSLVRKLQ
IATELKEINKVNIDAFKEFLQEFQGNTPISFLIIGENEKKKIELTLNCPHSKIAISKELF
DWLSASHMPYRINDEDRWLNTLQEEKPTLALDTEIIIEENSEIE
>SEQF1602_02396 60 kDa chaperonin
MAKDIKFDIDARDGLKKGVDALANAVKVTLGPKGRNVIISKSFGAPTVTKDGVTVAKEVE
LPDALENMGAQMVKEVASKTNDLAGDGTTTATVLAQAIVREGLKNVAAGANPMDLKRGID
KSVKAIVNELAKQSQKVGDSIDKIRQVAAISANNDEAVGELIADAFKKVGKEGVITVEEA
KGTDTYVDIVEGMQFDRGYLSPYFVTNSEKMIAELDNPFILLYDKKISTMKDLLPILEPV
AQSGKSLLIIAEDIDGEALATLVVNKLRGALRIAAVKAPGFGDRRKAMLEDIAILTGGTV
IAEERGFTLENATVDMLGRAERVAIDKDNTTIVNGAGKSEEIQARVGQIKAQIEVTTSDY
DKEKLQERLAKLAGGVAVLYVGAPSEVEMKEKKDRVDDALHATRAAVEEGIVAGGGVALL
RARNVLHKIKTENSDEVTGIQIVYRAVEAPLRTIVENAGGEGSVVIAKVLESRNSFGYNA
KTEKYVDMFRAGIIDPKKVTRVALENAASVAGMILTTECSLVDIKEDTPAMPPMGGGMPG
MM
>SEQF1602_02397 hypothetical protein
MFYTLQLNAKLQPFDRHDLEDLIDEFLSEENLGNTSGGGTLMSKEGEIEYCDIEIELNDT
PNIVERLLQKLEEIGVPKGSKLYNEDCSYEVGSLEGLGLYINGTDLPEQVYETCDINIVF
DTISETLKDVLVLTSYHEGNNDTALYFYVKGSFAEAKERIKDFVTSYPLCEKCRIIQIA
>SEQF1602_02398 10 kDa chaperonin 1
MSVKLKPLADRVLIEPAPAETTTASGIIIPDTAQEKPQKGKVVAVGAGTKENPITVKVGN
TVLYGKYAGTELKLEGKTYLIMRENDLLGILE
>SEQF1602_02399 Inorganic triphosphatase
MNFTEIERKFLVENTDFISQSYKSTVIIQAYLNSDPLRTVRVRIKGEKSYLTIKGKSEDG
ISRFEWEKEIPLSEAHALLPLCEPFPIEKTRYEVLVGQSLWEVDVFHGKNQGLILAEIEL
KDTEATFEKPDWIGKEVTAEACYYNSYLSKHPYNEWKSSKNTQKG
>SEQF1602_02400 Nuclease SbcCD subunit C
MLPLYLTIEGIYSYQEKQHIDFSQLTDAGLFGIFGAVGSGKSSILEAITFALYGETERLN
KADKRGYNMMNLKSNRFYIDFEFLNFENKHIRVTRELKRNSKKFEDVRTPIVQFYERVGN
QWIPLEQANPQKLIGLSYENFKRTIIIPQGQFKEFLELGAKDRTEMMKEIFNLQKFDLSD
NIAKLKRENNEQLSFKEGELKGYEEIHEEAIQIQQDKLKVEKDKQKSLETEFDQLKTHYE
HLRSLKSDFELLEQKRKEFAILYSQKKSFDELEKKVNTYEKIEKVFKNLLENKTRLTKEL
QSYTYKKDTDTKKLKEVQEKLINISDNINYLQEAYEKLSETKQMEADLQQILSTFPLQEK
LIEEKGRTIKGTEKIAAVEKELKDKKDYNNTIENEIESLKKQRIDSQLLLEVGNWYEKNH
ALSENKNKQQQKIQGTTAQLEEITHELSLFSLFKEGFVSDFKEKITIERENIEKEKDILR
QKLNQLELQRQLSHYTKELHEGSPCPLCGSSEHPNITHFEDVSTELAATQKAIKILDSQQ
EQLQQSLFQIEKTVDKKQFFEKQIQSEKEIALQIEKEQLAHHDKFIWSEFSKENRAVFDE
KREFASALEQQIETKEALYKKGSKEIEDLQITIEKYKKGLENIFKEIATLEGHIASKKES
LKVYNFEDYKDKDFEFVQKTYQFVTKTNKYIEQTYTSLIEEKNRLAPLQSQYEAQLKGTS
ELLEKWERELLSVEHTLESTLAQEHISLEEVTQILSSPIAIEENRKKIQDFKIHYEVLQE
QIQNLESKFVHVSFDPKAFAEIEKQYTLKGQEVKALHEQCIRIASELERITKALVHKKEL
LKSVTQLRTRNEHIKLLENIFRGQGFVQYISSIYLQQLCQHANVRFQRMTRGQLQLQLGE
NNEFEVIDFLNEGKSRSVKTLSGGQAFQVSLSLALALAESVQSKAKADKNFFFIDEGFGT
QDSEAINIVFETITGLLKDNRIVGIISHVEELKERIPLSLTITKDNERGSIIKGCEG
>SEQF1602_02401 Nuclease SbcCD subunit D
MKILHTADWHLGKRLDRFSRIEEQRAVMEEIVQIANDQKVDMVIVAGDLFDNFTPNTDAV
ELFYKTLKQLSCEGKRPIVAISGNHDSPKLIDAPDPLARECGIFLIGYPNAIVSPIKAET
FEITTSEEGFLEFCFEKYPYPLRILHTPYANEPRLKQELEGDKQVSLSQLLSDKWHFLAN
TYCDSSGVNILTAHLFMQPKNGETLEEPEGERPIRIGNADMIYTDTIPPQIQYTALGHLH
GFKNIGSEENPVVYASSPLSYSFSEAGQQKYVVVVEVTPDQRPSFEKIPLTQGKPLARKS
FDNVPLALEWLRENPNTWVELTLELKEYLKAQERKQLYSTHEGIVFLIPKISWELGKSPS
GELSLQDINFENITPLFESYFKYKNSGIAPNKEILDLFNEVINTPTE
>SEQF1602_02402 hypothetical protein
MAKFNKKKSGGVPPISTASLPDIIFMLLFFFMTVTQTKDGEIKVANDIPTANQVQKLDKK
DPVIYVYAGEPLPMYQEKFGKNAKIQINDVFVDVEQVGTPILKYKEGLQERYKEAFITSL
KIDKHTKMGIIGDLKEQLRDINALKINYITKEGKPSLLND
>SEQF1602_02403 hypothetical protein
MARRSIPEVNAGSMADIAFLLLIFFLVTTDITSNAGIVAKLPPRVPKQEQQEPPINERNL
FVVLVNKNNQLFVEDRLMDIKDLRKAAIEFLDNGGGKGEEACSYCQGQHDPTSSDNPNKA
VISLQNDRETNYETYITVQNELVAAYNELRERERQKLFKEEVPYTEMDAEFNAAKTSEKR
KNELRPKLEKLQELFPKKLVEASVKKDKN
>SEQF1602_02404 hypothetical protein
MHKITRIIALILGVLGLALCGWLMISSDKVKNSLSNFPMNGMFILGYLLLAIGLVVVIFS
ATKNILSSPKSIKKTLLYSGVFLGIMILSYPLSYVLFGTDSKYQWISAGIMATYLLLLIT
LISVIFSVVKKS
>SEQF1602_02405 hypothetical protein
MYSKLTLATLFFINFGVAFAENTNGGVNQSFKEYFIKGGPAYMAPILLCLIIGLAVAIER
IIYLTMATTNTKKLLTNVEDALKNGGTEAAKEVCRNTPGPVASIFYQGLDRVDEGIDIVE
KSVVSYGGVQMGLLEKNISWISLFISIAPMLGFMGTVIGMIQAFEKISLAGGLDASLIAG
DIQVALLTTVFGLIVAMILQVFYNYIVAKVDSIVNDMEDASISLVDLLVSYRK
>SEQF1602_02407 L-asparaginase 1
MTQRTKILLIYTGGTIGMVKDYETGVLKPFRFEKIKERLPELSQLDSDIEHVSFDPPIDS
SDMNISHWERIAQSIEENYQEYDGFVVLHGSDTMGYSASALSFMLENLSKPVIFTGSQLP
IGDLRTDARENLITSIRLASLKENEQPVIKEVCLYFEYKLYRGNRTTKIDAENFQAFDSP
NYPTLAESGVHLKVHDEFLYKRERQEPLRIFTKFDPNVAFLKIFPNITQPILDGILNLPN
LRGVVMETFGSGNAPTCQWFLESIEKAIKKGVVVVNITQCMRGFVLPNKYEAGSHFENIG
VINGKDITSEAAITKLMYLLGKNIDSKSLKIKYEKEAQGEIS
>SEQF1602_02408 hypothetical protein
MTDFSQIRPFHDSEVSEILGYIKDNPTMRQLLHFGFPKLSEEEQIKLLLSCKKIRDFQSR
IMYPIIKNAISKSVTQFSGEGFEYLNPAQAYLFISNHRDIILDTSFLNVLLHENGFKMTA
SAMGSNLVNTPFLLAFAKLNRNFIIHRGLSPRETLEKSQIVSKFIGRCIIEKNRSVWIAQ
REGRTKDGNDRTQQGVIKMLSINCPKEMALMDYFKQLHIVPMAISYELDPTDVLKMPALL
AQHHGVEYIKTEDEDYHNIVQGFVGQKGSVHISLGKPLYEELDEIAAKEEHANKQIQALV
ELLDSKIYAQYKLFSSNYIAYDMLTGIHKFADKYTEKELRQFERRLENRSNSEGNISRTK
FLEMYANPVINKLKL
>SEQF1602_02409 hypothetical protein
MRLLKGRLTMLLKFLSPKRSLIGIFYVTLRYYLT
>SEQF1602_02410 D-aminoacyl-tRNA deacylase
MPAFNFFYTMIIDTHTHLYVEEFDTDYKEVIQRAIDYGVEKFFLPAIDSTYTERMFRLQK
EYPEHMYLMNGLHPCSVKENWQEEIAKVNALVSAHSKDFYAIGEIGIDLYWDKTFLEAQK
EAFALQIRLAKEHHLPIVIHCREAFEETFEVLEKEKSDDLFGIFHCFTGNKEQALRAISF
GLKLGIGGVVTFKNGKIDTFLKEIPLEHLVLETDAPYLAPVPFRGKRNESSYLIYIVKKL
VEIYNISENEIIKRTTNNALEIFKP
>SEQF1602_02411 Fructose-1,6-bisphosphatase class 1
MKEEKSLPTLGEFIIEKQRDFKYSTGELSRLISCIQIASKMVNRAINKAGIANILGAAGN
ENVQGEEQQKLDVIANETFIKSLSQREVVCGIASEENDTFIEIKSGANSELSKYVVLIDP
LDGSSNIDVNVSVGTIFSIYRRITPDGTPVQLEDFLQKGIHQVAAGYIVYGSSTMLVYTT
GKGVNGFTLDPSLGSYYLSHPDMKFPEKGKIYSINEGNYIKFPQGVKDYIKYCQEEKEDR
PYTSRYIGSLVSDFHRNMIKGGIYMYPSTSQSPNGKLRLLYECNPMAFLTEQAGGKASDG
FQRILEIEPSKLHQRTPFFCGSRAMVDTVEAFMRGEKK
>SEQF1602_02412 Ribosomal RNA small subunit methyltransferase I
MGKLYLIPTPIGNLQDITLRALQVLQEVDLILAEDTRNSGKLLQHFKIHVPMLSHHKFNE
HESLNSLIRQLKEGKQMALISDAGTPAIADPGFLLVRACIAENIEVETLPGATAFVPALV
NSGLPNDRFVFEGFLPDKKGRQTRLLKLVEETRTMIFYVSPHKLVKTLMEFTTYFGALRR
ASISRELTKLHEETLRGTLTELSAHFEKHPPKGEFVLILEGKE
>SEQF1602_02413 hypothetical protein
MKEKIQMDIVQTAQKILTNSSYLDNSELLVVELRKLYEDVLVLNFLEKNMPETLKNPSPT
LSEGWADIKAHAPEKEVFFEQKTVEKPISEPKKSLNDQVASKQLQIGLNDRIAFVAHLFD
GNIDEYNKAIGMINNLHTPDECWDFILNKVKPSYNNWQGKEEYEDRFFYIVSKRFG
>SEQF1602_02414 Putative esterase
MNSNFTFEIRTRYGETDQMGVIYYGIYPQYLEVARVEWLRSLGISYKELEALGVMLPVVS
LQINYKRPARYDELLSITLTLRERPTSKITFDYQIFNEEKQLLAEANTTLVFVNKETFKP
IKCPDFILEKIEL
>SEQF1602_02415 Chromosomal replication initiator protein DnaA
MNTDVRNIWENCLSFIKDNVTTDVYDVWFKPIEPVELTSDNTLVIMVPSMFFMEWIEDHY
INLIWSALTKELGARPKLIYNIKMENNPNKTEQATEQLPSSNRKATSMEVLGYKQKPQQS
YNPYVVPGLVEIEEVKVDSQLNPNKNFDTFIEGESNRLARSAGKAITERPGGTSFNPLFI
FGGVGLGKTHLAHAIGNEIQEKHPKKRILYIEAEDFTKQYSVAAKNNNRTDFIHFYQQID
VLIIDNVQFFASKPGTQDVFFQIFNHLHQNGKQLILTSDKAPVDIQDVEQRLLSRFKWGL
SAELQAPDYQMRKRILQAILYRDGVEMSEEIVDYIAQNVKTNIRELEGVNTSLMAEALFN
KKEITLDLAKKAVDKIVKNIKKEITVEYIQEIVSEYFQLSIEELQSKTRKRHVVQARQLA
MFFAKKYTKLSLANIGKSIGKRDHATVLHACKTVDNLNETDKQFRKFLSDLTTKINNR
>SEQF1602_02416 hypothetical protein
MKKIIFFNILIILLCCSCNDNTSKKNSNENTEIQETTIDYKGLVQLLKLECNVSNKEEFY
KLNCQNVRVANEIEEGKNSISEIITVTVGKDSRKIIRKKEPNDLLTSSPFVYLDEENKTY
ILLFPLVGEYNFGWELYCYKDNKIFPLGQRITYWKAEYEESKTTYGDFVKIYRSEGKYIV
AMPKKYISAEDSEYNDYPDYLEGTLVKDKNIYYFEFPYTELPYYKKYMNGDKKGDYEEFL
KNDFATPEDIVITEEGIIQNDSGEMIQFKNITEVINRIQKYKLFTLKKMYLHDLNQDGNK
DIFLVFKNNNDLKSDDDKTLVAPVILLIHQGGDKYKFFHNEKIYPSIEGFFFKRIAFKDN
FFTIELDAEVPDEYTAEKYITFKYSKNKIVLHRFGDITYWWDERKPSNVQATQKDFGEIL
FEDYDPEKINEIIYHK
>SEQF1602_02417 hypothetical protein
MKKILTTITFFIFALAIAQEIKNDLPYISFQDLSDFSESSKEVSRTMIYRSEKLAKIFGL
NNKYFIDGGGQVLYGNVLVSEWVVLKSFSDYTYTNSKQRERLVLITKKENGKEVIKSAVK
VFTTNDYAICQLDKKGHSFGIAIGKYHITNNKEFFEIQHIFSILDNKLKKEPLNKLIYDC
PPPSDYSSSEEPDEYFYGVKGGKKYERYWYDN
>SEQF1602_02418 hypothetical protein
MKNLDTYIEDLLFKHQCVIIPEFGAFVSNRKAAELAADKSFSPPQKELTFNSRLTYNDGL
VAKHISEVERSSYEEAQEYIKSVVTRWKQELSLGQEVRLANIGKFTKGTDNNIIFTSLSK
ENYLTDSFGMSPVTTKEVSKGETGVEVANPIYNDQNNKPGLVENPSVTPEEAAAGKPKPK
MPLPIKYAAVAIVGLSAIGYAVYSLMTNQENPTVVQVEPDPAKVEELVNQEVAKATYVPE
IELTATAIKVTKDPVLVKKRKEELKKQAALEAQREKERQKAQVAGTTDTPSTTTNTTTSE
PTTPKSTNTPRTSSGGGSSSGSTKVSGSFFLIAGAFSSESNAQNRVRQLKNSGYSTAGMV
GQNEKGYYLVAYRGFSTRAQAESYMPEIKNKGLSTWIYPPAK
>SEQF1602_02419 Pyridoxine/pyridoxamine 5'-phosphate oxidase
MEKDLSNLRLVYERGHLLETEVRENPMEQFQQWFLQAQESESEKEPNAMSVATIGLDGFP
KTRVVLLKKFTDEGFIFYTNYNSEKGKAIAANPHVCLSFFWSALERQVIIKGVAEKLARN
LSEGYFESRPRGSQLGSMSSAQSQVVPSRAYLEEQLAALEKEYEGKSLKCPEHWGGFLVR
PHSLEFWQGRPNRLHDRLRYTLEEDYDWKIERLSP
>SEQF1602_02420 hypothetical protein
MSVQPDIKDVISTLYYLRNNSKMNNLKKNDEVGMDMIFDDDEVYKFRLRFLGKEKVDTPL
GEINTLIFRPLVQDGRVFKEQESLTLWISDDENKIPVKIKASLRVGSLVGEIIHYNGLKH
PTVLKKK
>SEQF1602_02421 hypothetical protein
MRKIFLVAILSFMAIPCFSQAESAFQEGEYLKFRVRYGIFNASYASLTLKNKTYQGKTVY
HALGKGETTGLAKLFFKVDDTYESYFDKETGKPYFFNRDIYEGGYTTEAQLPL
>SEQF1602_02422 hypothetical protein
MRRFLFFFFVVNLFLIACGRKELRNDLQQLYLQGEIKQIRTSSYTVLEKFDQIEKKSKTT
ERENTLLTFNEKGNQVEKTLFSPTDKPTRIYTYLYDMKGNRALVNETLDDGTLKKRYIYT
YDDKGNRTEINTYSGDGIFLQKEKRTYDEKQNPLEEDTYNGKGELEQKQINIYDEKGLCI
ESNLYTPSGELKNRYTYSYDENKNMLERKKYDKNGKILANHTYTYSFDKRKNWTQRIEYL
NGKAIYLTEREIEYGVGAKEQRQPVAQMDTAPQKKFNYTVSVKNDWTAQELKGAVKTLRV
RTYNAQNHKQKDNGQNTLTIFSKEGYLTRITYYDKDNIYSYEKKFSYQYNDKGYRREGKM
LINESDYLVSTYDDKGYITGGYLFQNNTQFEQKASYDDSGNMTSYYLGDVEITYIYDKNH
QLIEEKHKNGGDAWDIRYSRGKNGSILEEEIYRKGILDEKKTYIYTFDERGNWTERTQYK
NRTPVEITERVIEYY
>SEQF1602_02423 5,10-methylenetetrahydrofolate reductase
MKVTEHIAKAQGKTLFSFEIVPPKKGNSIEELYKNIEPLLEFKPPFIDVTTSREEFYYKE
HPNGLLEKKLVRMRPGTVGICSAIQHKYNVDTVPHVLCGGFTREETEDLLVDCFYLGIDN
IMALRGDAMKEEKYFRPTKNGNVYALDLVKQINDLRKGIYLHDTLENNTGMDFCIGVAGY
PEKHIEAPSKAFDLEKLKEKVDNGADYVVTQMFFDNKQYFDFVEKARQMGINVPIIPGIK
PISVKRHLNIIPQAFFLDFPEELVKEIEKCKNNNEVKQVGIEWAIAQSKELRQAGVPSLH
YYSMGKSENIIQIISKVF
>SEQF1602_02424 Chaperone protein DnaJ
MSRIVEKYLEYIVAVVIGVITRNIWIAIAVLCLGLLLRLTLFKGRGSNQVNLNPQRALEG
GFNPTDFELNLLSLCALVIKADGTGPTQKELDYVRYKFVSLYGKEKANEIFRAFNQIKQA
EVPVTRICLYIRARTNYEARLSIIHFLFDIASLDGRIKEAEMALLERINKNLNIDSSDFE
SVKAMFRQEKDDDYAILGISKDASEADIKKAYRDMVKKYHPDRINTDDVAIRKGAEEKFK
RIQEAYV
>SEQF1602_02425 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit alpha
MKKIDKKTYLQWYEEMLFWRKFEDKLASAYIQQKVRGFLHLYNGQEAIVAGCMHVIDPKK
DKMITAYRNHVHPIALGVDPRRIMAELFGKGTGTSHGLGGSMHIFSKEHNFFGGHGIVGG
QIALGAGLAFAEKYNETGGVVLTFMGDGATRQGTLHETFNMAMNWKLPVVFICENNHYAM
GTSVERTANHPDIWKLGLGYEMPCEPVDGMNPVSVAEKVYEAVERARRGDGPTFLDIRTY
RYRGHSMSDAQHYRTKEEVEEYKKIDPITQVLDVIKAKKYATDAEIEAIDERVKDLVAEC
EKFANESPFPEKNVMYDVVYEQENYPFLPHKL
>SEQF1602_02426 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MAEIVNMPRLSDTMEEGVVAKWLKKVGDTVKEGDILAEIETDKATMEFESFYSGTLLYIG
LKEGETAPVDTLLAIIGEKGEDISALIGGGAPAPAKEAAPAAPAATAPAAAPAAMPAGVQ
IVTMPRLSDTMTEGTVASWLKKVGDTVKEGDILAEIETDKATMEFESFYAGTLLYVGIKE
GESAPIDSLLAIIGPAGTDVNAVLAAAKGGASAAPAAPATAEAPKAAEAPTAAAAPAAAD
SRVFASPLAKKIAQDKGIDLSQVKGTGENGRIVRKDVEGFTPSAKPATAAAAPAEKSVAP
VSYIPVGEEVTEEVKNSQMRKTIAKRLSESKFTAPHYYLTIEVDMDNAMESRTQINNLPD
TKVSFNDMVVKACAMALRKHPQVNTSWKGDVTVYNKHVHIGVAVAIEDGLVVPVLKFADN
MSLSQIGVLVKDLAGKARNKKLTPAEMEGSTFTVSNLGMFGVEQFTSIINQPNSAILSVG
AIIEKPVVKNGQIVVGHTMKLCLACDHRTIDGATGAQFLQTLKAYIENPVTMLA
>SEQF1602_02427 Dipeptidyl-peptidase 6
MYAICHLSIVPIREESSHKSEQISQLLYGELCFIIKKEDDWCYIRTDFDDYEGWVEARQL
TPMSEAIYEETKKILPRYASDMVDYVQVSDKEYDLLPICIGATVSNAPFIGHLFAGEVQR
KVLRKNIVEIALRYLNAPYLWGGKSPFGIDSAGLVQMVYKLIGIRLQREVSLQYDSIKND
VNSLQEAEVGDLLFFTNNVGRIVHVGILIQPGYLIHAYGKVRVDRIEPEGIYDVDTQKIT
HSLYAIKRILDDDEKKLTK
>SEQF1602_02428 Ribosomal RNA large subunit methyltransferase H
MTIKLLVIGKTDASPLEKLIEEYKKRIGFYVKIDIKIIADLKNVKNISQQEQKSKEGALL
LKEVAENDILVLLDERGKEYTSVEFAQYIQKVLNTGVKQCVFAIGGAYGFSSEVYQRANH
SCALSKMTFSHQMVRLFFVEQLYRAFTILNNEPYHHQ
>SEQF1602_02429 hypothetical protein
MYSKEEAAKLRQEFWISFGKSFPYKWTLYKTGVKNLSFRFYFDTKKAMVCIDIEGSEEER
RECFEKMCSLKGILIEIFPENTYQEHYFLENGKEISRIWVEKSQVSIHNKETWQQTMIFL
HKRMLQIETFWEEYQDFFKEDF
>SEQF1602_02430 Uridine kinase
MLLIGITGGTGCGKTTVVNQIIKELPQGAVSVISQDSYYKDLSHLSFEERTKVNFDHPKS
LDFELLKEHLSQLKAGKTIMQPTYSFVEHNRTPQVVPIAPCSVLIVEGILILSHPDLRDL
FDIKIFVHADSDERLIRRIKRDTTERGRDIQEVLNRYQTTLKPMHQEFIEPTKEYADIII
PNNRHNKVAIDIVKAIVHNRIMHQTQ
>SEQF1602_02431 hypothetical protein
MIDFQFYIKKYAYLIGIVVFAIWMLFFDSNSWLSHRKLNKEIEVLKRQKEFLQKEIVKDR
DIIREINTAEGREKFGRENYYFKKENEDIFIIEYDTIK
>SEQF1602_02432 hypothetical protein
MYENEGENNEIFSKALRAGRRTYFFDIRGTKAGDYYLTITESKKFTHEDGSSHYQKHKIY
LYKEDFNAFREILDEMTSYVFEEKGEEVISEKHQKDFKKNFYAEGREKNDGSSSFTIDDF
EDIK
>SEQF1602_02433 Sodium-dependent dicarboxylate transporter SdcS
MPMNMYITLAILVIASAFFMMGKIRSDLVALSSLLLLVLFGILTPEEALSGFSNTVVVMM
IGLFVVGGAIFQTGLAKMISNKLLKLAGKSELKLFVLVILATSFIGAFVSNTGTVALMLP
IVVSMAMSANINSSRLLMPLAFASSLGGMMTLIGTPPNLIINEELIKHGFSSLTFFSFTP
VGLIALTVGLLYLIPVSKRFLNKTDPHQESKKDGKSLSDLMEEYQLSKDIHLVMIGKNAP
FVGQTLLESHIADKYEVNVTEILRKPSLNSSIFQNPNRELAQASTILHEGDILFVQGDIR
KIEAMAWEKSLSLIEDRFTSQEELMNSQKHGIAEVLITSTSRLVNLPIKKSRFREQFSLN
ILGMQRNESYILKNLKDQRIHSGDILLVQGSWKDIARLNEQQRHLIVLGQPLREASKVTL
THKAPIAGIIMLLMVVSMMFDFIPIQPITAVLVASLLMVFSGALPNVEAAYKTINWESVV
LIAAMLPMALALEKTGASTWVSQMLVGKLGGYSPYILLASIYFTTSLLTMFISNTATAIL
IAPIAMSAATSMGINPLPLLIAVSVGASMCFASPFSTPPNALVMSAGRYTFMDYVKVGLP
LQILMGIVMVLALPLLFPF
>SEQF1602_02434 Phosphomannomutase/phosphoglucomutase
MSLIKSISGIRGTIGGKVDENLTPIDAVKFAAAYGSWLKGQVGKEHVKVVIGRDARISGE
MIQNLVQYTLIGLGIDVVNIGLSTTPTVEVAVPLEKANGGIILTASHNPKEWNALKLLND
KGEFVSDQDGKAILKIAQENDFSFATVDHLGKFNYDDRYIDLHIQKVLALPLVTPEAIQK
KKFRVVVDAVNSTGGIAIPRLLEQLGVEVVKLYCEPNGHFPHNPEPLKEHLGDICKKVVE
EKADFGIVVDPDVDRLAFITDQGEMFGEEYTLVACADYVLSKAKGNVVSNLSSSRALRDI
AQKYGVTYSAAAVGEVNVVTEMKRVEAIIGGEGNGGIIYPELHYGRDALVGVALFLSLLA
ERGGSVQQLRESYPAYFMSKNKIQLTEQINPDQILKAMEQKYAHEQTTTIDGLKIDFADS
WVHLRKSNTEPIIRIYTEAKSQKEADALAQRFIEEMRALI
>SEQF1602_02435 hypothetical protein
MNRHLLLLLLFACSWASKANMAKPTIDGTSHTCLILTNDCSVTHEKIIAEIIKDDKNSFN
DYIIRFRAKYHISSPKEQSMPLLFMASNYLNDQQVFVNGQAISSNSIDQEQDYPFLRKEE
IIDTLQYSDGTPTRYNTYTKYYISYDGKEEEEVTPSDLIYFTAPLKTGENVIEVSYSAFP
TTFLYGFLPPYRFEYNLYPSKFWKTFPEIEVEIHFPKELEFEKSSMEKEEYTVSDQLFKG
KIKDITYGNYYWRFSPKPSWFGRIVLTINPLGFGAILFLVAAGLHIYTIRKKSKWGLWLG
VFLAPLLFYVGLFAAIPFIDWVLGRPSDQGYVFLIAFTYPIFLIFYGIFTFIYYKSQKNK
I
>SEQF1602_02436 hypothetical protein
MPPPVEDTLHPLCKIPKNIASYIKANQDTFTPIDIEKRFSKEFWEYYQIHQGKGCPIICY
GDFNADGQQDAALMVDYKGVGDRTYPDNTPFLAIFHSYETKVEDPVIIYQLDSYKEHNHS
VIYEQPEGIECYIEKGKRNGKDIINLILPEKSGFLIYWNEDTYRYRYVNVLDEIENPFPK
TTLTPEIEKNLYQLLKCGHFSWREGYYQIPDYGCWSQIQQLGMANVILIPRTSAFDTHLA
WEKDHQKEGYIEALENRIESLSLEEIKKHFCAVVFLTNPYYLDYTPYLDSSYNPTYPYYE
ETFLLTNGKWSKEKTYLITKDTDTQIYKQQEKYIDSLSKKYQSKITK
>SEQF1602_02437 hypothetical protein
MNKYLSFLLLIIHTWTSTANMAKTSIDGTFHSSLILTNDCTVSYEKITAQILKNPHKEVL
YKYIILFKIKYKINAPANEAMPLVFMASNYLQDHKIFVNGEELTSIPIDEKQNYPFLRKE
VITDTLQQSNSSVEFHTYTNYYITYDSKEKKKVELSDLIHFIAPLKKGENTIEVSYTAFP
EVLRDDFLPLYDLEYSTYPSKFWKTFPEIEVEIHFPKELEFEQSSMEKEEYRVSDQLFQG
KIKDITYGNHYWRFSPKPSWFGRIVLTINPLGFGAILFLVAAGLHIYTIRKKSKWGLWLG
VFLAPLFFYVGFFAAIPFIEWVLGRSSNQGYVFLIAFTYPIFLIFYGIFTFIYYHLKKSK
GF
>SEQF1602_02438 hypothetical protein
MDRHHILLIIHLISATIWVGGHLILLLGFLPKALKHKNFDFISRFEKTYEPIGMPSLLLL
VVTGIWMAYDLNAPLPSWFSFATGIETVVSLKIIGLLTSICFAISAQTRVLPKLAKGQIK
KLPEMAVHILCVTLIAVTLLILGSTIRNGGFLF
>SEQF1602_02439 Tyrosine recombinase XerC
MIEAFENYLSLEKKYSSHTVTAYLADVQEFAAYLTEVEPTMLLPQVNYSLIRSWIIHLVE
RGITNRSINRKLASLKAYYAFLVRTLAIKASPFVPHIPLKAPKKISIPFSSREIDSVLSQ
PIVEDSYTQMRNKTIIELFYATGMRRAELIDLKISDIDFSQKTVKVLGKRNKERIIPLIH
TVVETLEKYLTLRKGVETNEVFLFLTDKGKKMYPKLVYNIINSYFSTATTKLKKSPHVLR
HSFATHLLDNGADLNAVKELLGHAGLAATQVYTHSSIAELKNQYKNAHPRMTNKEY
>SEQF1602_02440 hypothetical protein
MDKLDLFYDKVIDAEVYLKLDNTTAKENKIVEIKINVPGDSFVVKKQFKSFEEGVDSCVN
PIERFLKKYKETR
>SEQF1602_02441 Nicotinamidase
MNRVLILVDIQNDFITGELPVPDGRAIVDPVNHLISQFDHVIATQDWHPENHFSFFTLHE
GKKAFESIPQGDFLQTLWPPHCVQESKGAEFFPELHTQSINTIFRKGTDPNIDSYSAFFD
NQKLKSTGLDGYLKGLSIEELHFVGLAADYCVYYSMVDALDLGYRVFLHEHCTRAISKEH
FQQQKEELIKHPNFTLLP
>SEQF1602_02442 Beta-monoglucosyldiacylglycerol synthase
MRFGIVIPAHNEGDILALTLDSLLNQHYPAHQIIVVDDNSSDNTAEVLAAYCAKYPQVKQ
LYRSSSAYRLPGAKIVQAFYAGLPLLEQVEVICKFDADLIFPPDYLQKLHQYYIQHPKLG
MCGGVCSIEKQGKWLREELTDKNHLRGALKSYRRECFEDISGLRQAMGWDTVDELLAQYY
GWEVLVDNTLQVKHLRLTASRYNSQAQYMQGGMFYRLRYGMILSFLASAKLAYKKQSFRL
FWDYIKGYFKAKKGKQDFLVTPEEGKWIRAYRWRNIKKKF
>SEQF1602_02443 4-hydroxy-tetrahydrodipicolinate reductase
MKIALLGYGKMGKTIERIALERGHEIVLRVDAPGEYDLSVAQVAIEFSTPQSAFANISKA
LSAGIPTIAGTTGWLENYPKAEALCRAHDTAFLYASNFSIGVNVFFEINKVLAKLMQKYP
QYAIAIEEIHHTQKLDAPSGTAITLAQDIIEQTDKVGWQLGETSEDKIPITAKRIENTPG
THIVTYSSQVDTIEIKHTAHSRDGFALGAVLAAEWIQGKKGVFSMKDVLFEK
>SEQF1602_02444 hypothetical protein
MASVRRLKKNIASVLGELVDTLIIWELVTDKKNEASQAVVEEIYAAYDKYLGQINNPSEN
KGAFYKQLLKNFEEEVNAIVAKINALS
>SEQF1602_02445 hypothetical protein
MQLVFFAYITMKKLFLFLFLAFTSVTFAQQTYKLYVEGEKQWAYRENVLTDFVYAFCTKD
FEAIAKNPMVRDSLKVALLESIYDKMLQSIPTKDKNTQISLFFGERKKGKGRIFFMTFFE
GNLKGKRKDAFFQFLLENNTKEGTFKCDTIVISEGKHRFTYQEPSVKLKTRYQKEVMQEY
EAHALEKNAKKELENYINTRKRWRKMIIVN
>SEQF1602_02446 Ribosomal large subunit pseudouridine synthase D
MADDDLITDDELYEHYSFKAGKGQEPLRVDKFLMNFVENASRNKVQQAAKDGNIFVNGVA
VKANHRVKANDEVKVMFAHPPHEYLLVPEPIPLDIVYEDEELIIINKPAGLVVHPGHGNY
QGTLINGLIYHFQHLPMNSSDRPGLVHRIDKDTSGLLVVAKTEEAMNHLAKQFFNKTSER
EYVALVWGNLAQDEGTIIGHIGRHPKNRLQMTVFPDGSEGKEAITHYKVLERFGYVTIVS
CRLETGRTHQIRAHFTYIGHPLFNDERYGGDKILKGTTSAKYKQFVENCFKILPRQALHA
KTLGVEKPSTGQMLRFDSEIPQDMQQCIEKWRNYLSNREVVND
>SEQF1602_02447 hypothetical protein
MKQFFFRQAKIEDLEAIWPLFLYAKETMRQRGTHQWQDGYPFKETIEQDIVHHYAYVVEE
AGEVIAYVAITRDGEPTYQKIEGAWLNQEPYIVGHRMVVGKKGRGKGLGSFMIREAEKIA
IIHGIRSVRVDTNFDNQVMKHIFEKEGYTYCGIIQVRDGKREAFQKILV
>SEQF1602_02448 3-dehydroquinate synthase
MKYNQIDTGAYTIYFAEEGYKYLADYIKEKKYSKIFVLSDTHTHECCVYTFLQKFPFEVE
IIEVEAGEEYKTLDTCLSLWQTLSDLEADRKSLLINVGGGVVTDMGGFVASTFKRGIDFI
NIPTSLLAMVDASIGGKTGVDLGTLKNQIGVIENPKLLLIDVNYLNTLPKEEFRSGLSEM
FKHGLIQSPPYWEKMRHLSTLTTDDLEEIIYQSVVIKYQVVSEDPKEQGLRKILNFGHTL
GHAIESYALSHREKRLLHGEAVAIGMILAAYISHKVLQFPWDKVEEIKTTLLEYFPQENF
TSQEREAIQQLLKYDKKNAYGRIYFVLLEEIGKPKWDIEVPSSLIEEAFDYYGINH
>SEQF1602_02449 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MVIVILNWNGKHLLEQFLPSVVRYSSGVGLYVIDNASTDGSVLFLQEHYPQIKIVQNAEN
YGYAKGYNEGLKHIPADVYCLINSDVEVTPHWLEAPMHIFAHEPQVSILQPKIKSYKQKN
YFEYAGAAGGYIDKYGFPYCRGRVFDTIEEDIGQYEEQTPIFWASGACFFIKASVFEHLG
GFDEDFFAHQEEIDLCWRAQNEGYKVYYTPLSQIYHLGGATLEQGSTQKVFLNFRNSLFM
LLKNLPKGAWFSTIFLRMVLDGIAGIRFFFQGKPSYTWAILRAHFAFYKYFFYFYHKRKN
PMLKQYYSIKSIAYSYFIKNKKVGY
>SEQF1602_02450 hypothetical protein
MRNILLIFLCICSFLGYAQEETLMRGSVFNTKTNLPLDNVNVLNINQVKGTVTNIKGDFS
IRVAVNDTLHFSYLGFKSIKIRVTQDMIRFPGTRIGMTELAYALEEVVISPYRLTGYLDI
DAKYMPVNTNRQYSISGLDLGYEPRTRDKNKTEEVVTSVLNPAGLLYKAFSSRAKDLRKL
KKMKQSDEIRSMLNGKYDREALAEILGISKDKLEELLRHCNYSKDFIKNSNDLQFLDALT
QCYEEYKLLNKNGEPQNKK
>SEQF1602_02451 hypothetical protein
MKKFFKIFGIIVLVLILLLVCIPFLFKNTIKEKIMEKVNESVNAQISFTDFSLSVFKNFP
NATVELEGLKVINNAPFAGDTLAYVGNFSAKVNLKDILFKGDKDPYKLLGFSLSNAVVNV
HMNEEGKGNFDIAKSTSDTTDEEPNNFSLDLKEYSIENLRFTFRDDTSKMSVILDSLYHK
GKGNFANQVLDLETTTATKVSFASDGTAFLRNNVVTLDAVLGIDLNQQKYTLKDNTLKLN
ALELNFDGFVQLLEDGQLYNLSFKTPKTTFKNFLDLIPAAYTKSIEGVQTTGEFTINGKV
DGKYTPTTIPKLDIRMLSNNASFKYPSLPKSVKNIDIDVKIGNETEKLEDTYVNINRFAF
TIDQDAFSVKALLRNLTKNMLVNADLKGVINLENIQKAYPVKMDLDLKGILKADISTAFD
MASVEKKAYERIQNSGHASLEKFVYSGAGFLQPFHINKAGISFNNAKIELTELDAKTGKT
DFNIKGTLENFYGFTLRNEVLKGNFTLASNHIDVGDFMQTDTPAETPKQDKQEEKPTETK
PTSKTNASIKIPAFLDCSLDAKAKSVLYDKLNLTNVSGKLIIKDEKVSLQNLQTDIFGGK
TAVTGSVSTKGDTSTFSVDLDMNKLNVMESFSQIEMLKKIMPIAKVVEGFFSSKINVKGK
LTPELTPDINSISGSLSAALLDSHLKEASPLVSALDAQFNQLNLSKLNLKDLKANVTFEN
GRVVVKPFAIKWNGSTINVAGTHGFDQTMDYKLTFNVPAKMLGQDASALLAKLTVTEQQK
LGDIPVNVNMGGNFTKPQVSTDMKQVVNNLALQVAKAQANQLTDKVMDKVGKEVTNKITE
KVGGEAVNKATDALGKLIGGKTSATDTTKTTPKEQTKKAVNNLLDGLFKKKNNNEQ
>SEQF1602_02452 hypothetical protein
MIHHLLLIMRSLVFLVILIIAQSCLLNRTHYTGYVCDAATKKPLAGVKVTELESQQYTFT
DEKGFFTLKKMDDIASRLIFEREPYIKDTLSSVLIQHGEHFEFLFKGEQIYLRTIQYMDS
IYNDYEKSLYKSTNPREQILPKDSLIIRGKDTAVVTRLRIYHYPEEQLITKDYIGYYKGE
KPRKNSNYIEKHALRTYFIRQGKLSTETIYFPKKDSLIYDRDTVRCESLFIRYDLEGNIK
EKICEGNFSCPDIAAHTRVGTAFFYKGDKLIQEKYYHNDRREKDYIRHRVYDTMGNYREI
YTNNYELFNNDSLVLSPEEVRRRTKR
>SEQF1602_02453 Protein-L-isoaspartate O-methyltransferase
MKDTVRHQGMRNLLARQLTERKEYPISDEKVLQAIRMIPRHLFLDSIFEEKAYQDIAFPI
GAGQTISRPHTVAFQTELLQVSAGQKVLEIGTGSGYQSAVLVALNVELYTIERQQELFKK
TKLLLDKMGYMPRKMIFGDGYKGYAEQAPYDRILVTAGAPEVPKELLAQLKVGGRLVIPI
GRGAQIMTVFVRLSPTEFSKEEYGTFGFVPMLEDTQVRRKQ
>SEQF1602_02454 Inosine-5'-monophosphate dehydrogenase
MKQRVPVSQIMSKDIVTLSPTQTLYEAEALFKKHHIRHIPVVEGHKLIGVLSLTDLLRIS
FADLSDDEKHVDSVVYDMFTIPQVMAKVPLAISPDTTIKEAAEILAEQTFHALPVTDNGN
LVGMLTTTDLIKYLLEQY
>SEQF1602_02455 Dipeptidyl-peptidase 5
MRKITLILTLFMVYSTFAQQPLTPEKLWELHRVSGIGMTADKNHVLIGVTTPNVKNNSFD
KEYYKLAIKDGKTVSITKEQLELLTEKLNNNKSLKLIHKEVKLTPVLAKDFYKDLDKSSG
KIYQGLDHRHWDKWNEGSYNHVFIENIASGALTDIMQGLPYYCPQEPHGGEEDYIWSPDG
KKVLYVTKAKVGTQYVVSTNTDIYQYDIATKTTTNLTEGMMGYDTNPSFSKEGVLAWLSM
KEDGNEADKNDLYILHNGQKINLTATWDNTVFSYLWSDDGKKIYFIAATNGTQQLFEIEP
FAKNPTVKQLTKGIFDINNIIGQSGDLLVVTRNDMNRAPEIYTVNLKGRKAPLEVKQLSH
INDYLYKNIAKCPVKERTIKTTDGKDMLAWVIYPPDFNPKKKYPTLLYCQGGPQSALTQF
YSFRWNLQLMASQGYIVIAPNRRGMPGHGVEWNAQISGDWGGQVMKDYLAAIDDIAKEPY
VDSNRLGAVGASYGGYSVYNLAGIHNKRFKTFIAHCGVFNTQSMFGTTEETFFNNHEFAG
PYWEKNNALAQKAYTEFNPIEKVAAWDTPILIIHGGKDYRVPEEQGFQAFTAAQLRGIKS
KLLYFPDENHWVLQPQNALLWQRTFFDWLKETLQ
>SEQF1602_02456 Chaperone protein DnaJ
MKKDYYEILGVSKNATAAEIKKAYRKKALEYHPDKNPGDKEAEEKFKEAAQAYEILGDEQ
KRAQYDQYGHAAFEGGAGGGYSTMEDIFRNFGDIFGGHFSGFSGFGGFGGGNSHSYRVKG
GDLRIRVKLNLADIATGTEKKVKVQRKIKAEGATYKSCATCHGHGSIVREVNTMLGRMQT
SSPCPTCGGSGEIIDKRPDGADSQGLKSIEETVSIKIPAGVMEGMQLKVSGKGNEAPGSN
SIPGDLLVLIEEIEHETLKREGENLHLDLYISMPEAVLGTSKDIETATGKVRIKLEEGIQ
SGKILRLKNKGLPNINGYGTGDLLVHVNVWTPKTLTKEQKNFFQKMLEDENFTPNPDKSE
KTFFEKVKDMFS
>SEQF1602_02457 Protein GrpE
MNTGHNHHQGDFHTDDIQDAEFQDAEIIDEIHEQEAPKSHHQATAQDSLDVEIEDETKDE
LPEIIIKKNPEQKSEEKQTEKSNNNQSNNSSEADEAISILEAELHKEKDKFTRLFAEFEN
YKRRTAKERLELLTSAGQDVILSMLPVLDDFDRALVEISKSEDENLLRGVELIHSKFLNT
LRSKGLEQIQVDTGDLFDSDIHEAITQTTAPTEDLRGKVLDVVEKGYKLGDKIIRYPKVV
VGQ
>SEQF1602_02458 hypothetical protein
MFRHQGKKRSAKNNLQIAVVLSFVAGMVNVVGFLFLGRLTTNVTGHFAFFIHDMSIAEFW
KGTIYLFYIVCFLLGSFSSGWLIEEANYHKRQNKYFRPTILECIVLGLVILLNRISLDFP
HEATTFMLLYAMGLQNSFVTKISNATVRTTHLTGLFTDLGIELSQLFYLKRNNYQEQEKK
IKNSIRLRLSIVLFFFLGGFFAGFAFVELGLKLKTLFFAIGILLSGLYYDDLRFRYLTKK
RKHRGHRHHSKQTIPHTR
>SEQF1602_02459 Phenylalanine--tRNA ligase alpha subunit
MINKIKEHIARVEAFATEKKEELEQFRIEYFGKKGLLNDFFAQFKEVPKEEKKDFGQIIN
ELKSKAEAKINELKEKLSGQNVTTQSLNDLTRPAFPIEIGSRHPVSLIKNRIIEVFANIG
FNIAEGPEIEDDWHNFTALNLPEYHPARDMQDTFFIQTRPDILLHTHTSSVEVRYMEQHQ
PPIRIIAPGRVYRNEDISARSHCLFHQIEGLYIDTNVSFADLKQTLLYFTKEMFGKSKIR
LRPSYFPFTEPSAELDIYWGLNNEIDYRITKGTGWLEIMGCGMTDPNVLTNCKIDPQKYS
GFAFGIGLERVAMLLYQIGDIRAFYENDVRFLEQFRSSI
>SEQF1602_02460 Putative sugar phosphate isomerase YwlF
MKIVIGNDHAGTEYKNLILQYLLSKDYQVTNVGADTSQSVDYPDFAHPVGEMIDKGEADW
GIVICGSGNGVAMTVNKHPKVRCALCWNKEIAALARAHNNANVLAIPARFTAAEQALEMV
KTFLETPFEEGRHQRRVEKIQLC
>SEQF1602_02461 Ribonuclease BN
MKLTFLGTGTSQGVPVIGMNTPVAHSRDKRDKRLRTSVLLSWGGVNVAIDCSPDFRQQML
SHKVQHLEAILFTHEHADHTAGLDDIRPFVLKQGDMPIYGLPRVIEQLRIRFAYIFATEN
RYEGAPSVRVTEVDASTPFTLFGQEVIPIAVEHGSLPILGYRIGKLAYITDAKHIQEAEL
SKLYKVDTLVLNALRKAPHPTHLNIAEAMEIVKEVHPRQAFFTHISQTMGFHAKVQKELP
KNVYLAYDKLTIKI
>SEQF1602_02462 Lipid A export ATP-binding/permease protein MsbA
MEIPKGKTVALVGQSGSGKSTIANLIARFYDVDKGSISFDGIDIRDIKIHSLRDLIGIVS
QDSILFNDTITNNLLIGKADASSQEIEEAAKVANAYNFINDLPNKFQTNIGDMGGKLSGG
QKQRLSIARAVLKNPPIMILDEATSALDTESEKLVQNALEKMMLNRTSVVIAHRLSTIQN
ADIIVVMEKGKIIEQGNHTSLMAKNGTYRKLVEMQSFSE
>SEQF1602_02463 Cyclic nucleotide-gated potassium channel
MFWTFRTPSFFIQSKMKKALKEKYELLKEKAFTIIYGRDTVAGKLFDLILLGFILLSVFL
TIFESIKTVDKHIHTLLVILEWMITIFFTIEYILRIICNPKWKRYIFSFYGIIDLISILP
VYLSFFVAESKFLSIIRILRLLRIFRILDLVQFTQQANQLRKALKNSQTKILVFIYFVLV
LSVILGALMYMIEPHDKAFTSIPRSIYWCIVTLTTVGYGDVVPTTTFGQIMASIIMILGY
GIIAVPTGIVTSEYSRFYRKKEEQKPHYSHRTPPTKYSHSHTHGYCRHCGTYPLPDDALY
CHKCGAKQ
>SEQF1602_02464 hypothetical protein
MYPPEIVAPMIAELESVGFESLHSVESVDEAIKRSGTTLVVVNSVCGCAARNARPAVVLS
LKNAKKPDHLVTVFAGFDIEATAQMRDYMLPFPPSSPSIALFKDGELVHMLERHHIEGRV
AEVIAENLVAAYNEFC
>SEQF1602_02465 hypothetical protein
MRKLLFFLLFLPLWAGAQGFDDFEYWGVRAAFTHTNRSHNLGFVGASLNTEYNWVSRSLY
AGVHLGAQNTFTEEGRKQSKMEIVPEIGYEFSLVLLGIGASLNTHAFQPRVGLSFFNIHQ
AYVGYSLPFRQDTVFKGLTFTLVLNLSNAESSNDLRLW
>SEQF1602_02466 Riboflavin biosynthesis protein RibBA
MNQEIKLNTIEEAIEDIKQGKMIIVVDDEDRENEGDFIAAAEKVTPEMINFMTQHGRGLL
CAPLLEKRCKELGLDMMVENNTVLHHTQFTVSIDLKGEGCTTGISVFDRAKTIKALVKPQ
TKPEDFGRPGHIFPLRAKEGGVLRRTGHTEAAVDLARLAGLEPAGILIEILNEDGSMARL
PQLVKVAEKHNLKIISIEDLVAYRMRHDSLIVKKEDFSIDTDYGQFRLRAYEQTTNGQIH
LAFTKGTWAKDEPVLTRIHANFISNDILDLLCKKDNELNRIFQQIDAAGKGAFIVINQGA
YSQNLLHRIQTIKEAQEGKQAPSQVPSSQVKDIGIGAQILIDLGISHMKLLTNSEPSRYI
GMSGYGLEITDYVNY
>SEQF1602_02467 hypothetical protein
MKIERLLFEDKNIIKDFFPFTFTRPSAELRAGILTFSERWQRLLGITQVSYLTADYLQGK
YPYTGVSEEVTLSIYANFLPTPRLLEQLRSLEVGESITYQGRTLAFVGKSITLSSIPPIE
WEEPLVLFEKPTDLFTYNDKAIDFDFKLLTQGRTSAPLSPTNGFLGDKADLFIEEGAKVE
FATLNCQKGKIYIGKDAEVMEGSHLRGPIALCEHATVNMGAKLYGATTIGPYSKVGGEIS
NSVIWGYSNKGHDGFLGNSVLGQWCNLGADTNVSNLKNTYNTIQLWDYQKGGYSSSGLQF
CGVLMGDHSKTAINTQLNSGTTVGVFANLFSAGFPSKYIPNFAWGASADKYRLDEAFAVA
ERVMARRGIAFDQKEQDILQWLFDNQ
>SEQF1602_02468 Succinate semialdehyde dehydrogenase [NAD(P)+] Sad
MINKALTAVSEVENAYHTWKTRPLASRKESIVRIKEKLLAHSEKYAKAITTDMNKPLAQS
LAEVKKCATLCDYYLTHIDDFLRPQPLQSSWTESYVRLDPLGVLLAVMPWNFPFWQVFRV
AIPNLLLGNVLVVKHASNVPTAAALLEEIFLDESLGFPIYKNLSLPSQYVEEIIAHPAIK
GVTLTGSEPAGRSVAQCAGKHLKKSVLELGGSAAFIVCEDADLTKAVITAVNARMQNAGQ
SCIAGKRILVQESIAQSFIEAFTEKVKGLKQGDKYDLNTEIGAMAREDLAIEIEEMVKQS
LAEGATLRCGGKRTGAFYTPTVLTDVTPSMRVFREETFGPVAVISTFRDFEEAIALSNQS
DFGLGVSIFSQNVDFVKSQAPRFDEGAVYINEMLISDPHLPFGGIKNSGYGRELSYFGVW
EFANIKTVVVK
>SEQF1602_02469 hypothetical protein
MIAMGSPKAGNHNDLYEIEEVVLKEILALLEEAAIEHKGLFLNADAGFDSKSLREFLESK
EIIANIKPNPRNGEQPDVYFDEELYKNRFKIEQANGWLDRYKGLIMRYEYLDVTWIGMLL
LGFISKFLKKV
>SEQF1602_02470 hypothetical protein
MITNVLCRKKENNKDYYFNYENPNEKDQALRFGNRMAIDAIEWNYKNKKYEICFQRKEFG
DVLIEKDKIFIQYQTAEASFPAPNNIVIYTPTAEIEKVLTTPILPNGKKGGGFLQINKII
SNKNNFIREFENHLEVWVWEDERSPCIYHYFFNIDTYEFIFRLKSRY
>SEQF1602_02471 hypothetical protein
MQLKLNNGQFISFDQEKMNLCYSHIQDPPCWNIYTSNSKFLKEGFVRDYNAYVLKLEYGK
KYDYPAYRVRTYCNYKDGKYDLSNIADNTVILFPDLETKRKIGFHIYNDNSVDVPYDKFV
TEVTDVWEERTPIKGFKFEEEPILYLKKNSIWLVEH
>SEQF1602_02472 hypothetical protein
MIRIKSLEDYTNYFGVCCRFWKSKEKYHLQTLLDNEILERLQFKKYEDNNLKDKMYKLVS
YEEIDNAYSVFFFVFYKRLKFFVENVIEDDIFILRPLEEAMIFFNDFPKQGYDPIYEIKE
SEVTDVWEERTPIKGFKFEEEPIVYLKKNGVWLVEH
>SEQF1602_02473 hypothetical protein
MSLPYLWNYPFILRNNGRLGILEYVFEKGIFVKPTEGSEIWRIKSDETEELIAIFEKEQE
KFVQIKK
>SEQF1602_02474 hypothetical protein
MLKIKNDFYAKYLDTDGRFWEVKKGIYRIQVEKRKNLLGFKNYDEVELKDKMFIDVSKNK
ISSAYRVRTYCNYKDGKYDLSNIADNTVILFPDLETKRKIGFHIYNDNSVDVPYDKFVTE
VTDVWEERTPIKDFKFEEEPIVYLKKNGVWLVEH
>SEQF1602_02475 hypothetical protein
MATIGRKGDFGYLNDNLLSLQKEKDWLFITEDTSLINKYHFKKYDYYYGLVIKNTKIISA
YSIYYYALYKGLKFFVENVIKNDIFILCPLEEAMIFFNDFPKQGYDPIYEIKESEVTDVW
EERTPIKGFKFEEEPIVYLKKNGVWLVEH
>SEQF1602_02476 hypothetical protein
MDDFLYMMQKHANGFTSGNNGRLGIPEYVFEKGIFVKPTEGSEIWRIKSDGTEELIGVFK
EENNIERFYKIK
>SEQF1602_02477 hypothetical protein
MDIVSINKIYNQYRLEFEDSGNEESIINLLLKQKEWNLLDDDQKLIKRKKYLLDFEKYFI
YNEKRERVFLYENLVFQTYLKIKDSLNIIEADISSFEGFFFRIKSMLFCEKELVNQYESF
KRIGHIPFEIFEPLIEKVKDTQEYKQYRLDELFEEYKKMYQLFLDKPYE
>SEQF1602_02478 hypothetical protein
MMNLEQEIKFLKEQKVPIEEIRLLEILKEEEEWNLLSKKEKQNKRKFAISFLERESHKNI
NIEYEKNIINLYDIGENIIHNTMYTDKIYLKRLCILVNIQQDFIDEMGIKNLYKIRKVDI
NIIENLFKEIKQKDSQEYRSLNLDNYLILFEKVWKNAE
>SEQF1602_02479 hypothetical protein
MKYFTIDESIDLDIIGEYPQVSTTENCVLGSPFSDKRLSFGEIPNKIPYLELEFNKRVKK
QLLILETYTL
>SEQF1602_02480 hypothetical protein
MNGIGLEKYTKLIGKGIHGNHPAYDKYVKTQLDRFNKIGLTPEQANKFLQEELIPDLKEK
IIKAKTQG
>SEQF1602_02481 Prolyl endopeptidase
MINATTQQLKSKTFFVFSKKSRIFVAVLTEILKAVNLIITSMRHFFIPMGCLLALSACKN
NTQPAQTEEMKDFAYPQTKEQVVEDDYFGEKVADPYRWLEDDRSAETEAWVKAQSQFTAD
YLNAIPYRKTIKEQLEKLWNYEKSGAPFVEGDYTYYYRNNGLQDQSVLYRKDKEGKEEVF
LDPNKFAADGTTSLAGINFSKDGSLVCYLISEAGSDWKKAIVLNAKTKEQIGDPIVDVKF
GGGNWRGNEGFYYSSYDKPKGSELSEKTDQNKVYYHKLGTSQKEDVLIFGGTPEEKNRYT
DAFVTDDQRYLVIFGADATSGNKLFIKDLKDPKAPLVTILNDYSSDTSVIDVKGDKLYLF
TNLNAPNGKVVVTDIKTPTPDHWKDLIPETENVLDVITAGGYILAKYTVAALTEVKQYDF
TGKFIRDIKLPSIGVAGGFSAKENQKDTYFWFTNTCTPTSIYKLNLESGETTQYWKPSIN
FNSDEYESKQVFYTSKDGTKVPMTITYKKTTKLDGTAPTLLYGYGGFNAITYPYFGVSTA
IWMNNGGVYATANIRGGGEYGKKWHDAGTKFQKQNVFDDFIAAAEYLIKEKYTSKEKLAI
KGASNGGLLVGAVMTQRPDLMRVALPDVGVMDMLRYHKFTAGAGWAYDYGTSDDSKEMFQ
YLKGYSPIHNVKDGVCYPATMVSTADHDDRVVPAHSFKFAAQLQKKQACKNVPIIIRIET
NAGHGAGTPVSKMIEGYADEQAFSLWNMGYKELPKQ
>SEQF1602_02482 hypothetical protein
MGCLLDFAPWGIVPLPQKSNLYTIMREQAIQILFEIAQGTAQKQGEKTVYPTIRERLAAI
KLLATMEGWNKPQKKTAEKPQQKISTPPAEKEVISSASKEVTTTPKVSRKEEPVVQKQTP
IAEEKQATEMKESPKPKIVPILSQVVIEEDILSPRDRLLDSGGRFLQKDTSFFPTILYRK
GNRQKGSIPKINVYAC
>SEQF1602_02483 Prolyl endopeptidase
MRQFFIPLSCVLVLSACHDKVQKEENTQEAWEQITYPETKKENVEDTYFGEKVIDPYRWL
EDDQSAETEAWVKAQNAVTFGYLHSIPFRDKIKAQAEKLWNHEQLTAPFRVGEYTYYYKN
NGLQNQDVLYRKGKDGKEELFLDPNGFASDGTTSLAEVNFSKDGSLVCYLISEGGSDWRK
AIVMNTQTREQVGDTIVNIKYSGGYWYKNEGFYYCSYDKPKGSELSEKTDQNKLYYHKLG
TPQSSDALIFGGKPEEKNRFVGGYVSNDENYLIIRGEETTSGGKLWIKDLRKPNSPLVNI
LNDYSSDTFVLAIKGEKIYFQTNLNAPNGKIVVADLKDPTPTHWKDLIPETENVITPVVA
GKYILAHYMKDAISEVKQYDFEGKFIREIKLPALGTVTLESAKEEENESYFSFENFYTPS
SIYKLHLEKGDTELYWAPKMDFNPNDFESKQVFYTSKDGTKVPMIITYKKGTPLDGTAPA
TLYGYGGFNISYTPWFAVTYAIWMNNGGVFAVANIRGGGEYGKKWHDAGTKFQKQNVFDD
FIGACEYLIDNKYTSKEKLAIKGGSNGGLLIGAVMTQRPDLIRVALPYVGVMDMLRYHKF
TSGAGWAYDYGTSDDSKEMFEYLKGYSPVHNVKEGTCYPATLIFTGDHDDRVVPAHSFKF
AAQLQSKQSCKNPVFIRIETNAGHGAGTPVSKIIDQTADWQAFALWNMGYKKLPNEK
>SEQF1602_02484 hypothetical protein
MINDMLKLCSLLTAHYSKKISFSLIHIEKKRIFVVFSNTFLLCLNAREKGGGIFISYLKE
>SEQF1602_02485 Peptidoglycan glycosyltransferase MrdB
MLKHLDWISVLLYFALVTIGWVCIYATGYNEHTTNLMDFSQHASKQLFFVCTSVLLILFI
LAIEAQFYENSAEIFYIFAILLLVGVLIFGKTINGAKAWYALGPVTIQPAEFAKTATALL
FAKQLSHIQTDIRRFKDLLNVLVIIVVPCFLIILQPDPGSTLVYGAFIFALNREGMSSSF
VFLMLLFLSVFLSTLKFGMGNTITFFSLLTCIYGYWVKKQKGHIPYKNVSLLVLLCVLTS
FSANFIFYNVFKQHHRDRFSLWLRLENEITDSQTLRQTVAYNTLQAESAISSGGLSGKGF
LEGTLTKGDFVPEQHTDYIFTTLGEEWGFYGTTTVTLLFAILCLRIWYLAENQRCKFYRI
YGYCVAAIFFIHFFINISMVIGIMPTIGIPLPFFSYGGSGLWGFTMLLFIFLRLNMNKEK
H
>SEQF1602_02486 Peptidoglycan D,D-transpeptidase MrdA
MKKIFLPFVICVGTLSILARLFYLQVLEKESRKDSIASDVAIEVSYDYPERGYIYDRNGK
LLVTNQSAYDIMVIPREVKPLDTLEFCNLVGIDIVRFREELDKAKKYSYRKPSVFVSQLS
KEEYAPLQEKLRKFSGFFVQKRLLRHYETYSGANVLGYISEVNDWELKNNPYYLAGEIIG
RQGVEKQYEDFLRGKKGVRYLQKDKFNRVIGSYKNGAYDTLPVAGKSLELTIDDDLQSYG
EILMQCKRGSIVAIEPKSGEILALVSAPSYDPNLLVGRKRSQNYTLLYNDSIAKPLFDRA
LLAEYPPGSTFKPFTALLGLQEGVMTPQSVVSCNGGYHYGNRVMKCHAHASPLDMLHAIA
TSCNAYFAHEYRKIIEKYPTPAQGITAWGNDLRSFGFGEYLGSDFPIGRKGYIPDAAFYN
RHYGENGWRATTNISNGIGQGEVLVTPLQLANALSAIANKGDYYTPHIVRKIDGKTTPFT
QYTEVKHTGVAPQYFDPIIKGMNLSYTGGTSRGTQIDSVNVAAKTGTAENYIRVNGKRMQ
LTDHSIFMAMAPIEDPKIAIVVVVENGYFGARIAGPIASLMIEKYLTKNVKRKDLEKRMI
EKSLEEEYAKPYSGRPFSINQ
>SEQF1602_02487 hypothetical protein
MNRIVDVKYFSKFCTKYKERNRVKYLFFLTFYEAIHKIITL
>SEQF1602_02488 hypothetical protein
MGNVKSVRITTYVALDKGGGKFGKGSVAKGMDNFLISYDKKGNVTDRVAYYTNGKVWYTK
KYVYEGIDIPKEVPEKMVVQPKEKVALEKTEEGFRGKVVYRYDKKGQKTEESSFDSKGTL
LWRYVYRYNNKGHLLEKDNFDTQANLIFRESYRYDTNEKVLEKTITMNNQTAYKCVWQYD
DKGKVVEKEEYFTELITPEKLDKLVIDEINTQGVLWKKIKYSYDNKGNRVEVNVYDAQKK
EAPKYVGGAQQPKKEQPKQPSYDELPNPKLLYTDEHDNLGNLWKKDTYVYDDKGQIIEVK
SVDNEGKPLFRYTYKYDAKGREIERINYDKSNEMIQKTTHLYDLKGHLLERAEYDAYGEL
IQRNTYKYNDKDQIIEQKGHNTNGSLAFLIKFSYNHLGECVESVTTKPKGEQTSKLVQEY
KLDDHNNWIKLTQYAEGKATYITECTIEYYP
>SEQF1602_02489 hypothetical protein
MKQSLLSIAGLVCCAAFAQSIGKENYKKSLNGPVSSICVITYKALDKGGGNYGKGEIEKG
MENFLISYDKKGNMTEKIAYYPNGSVWWTASYIRRERCEKSSSCKKGN
>SEQF1602_02490 hypothetical protein
MYVYDDNGKITQVKSMDNKDKPQFNYVYTYDENGNETSRTTLDKNDKQVQKISYTYDTKG
NVTEMVEHDAQGALAQKETYKYNEKNQKVEQQGDNFNGSLAYTFKYFYNPKGELIETRTF
NPQGDLTSKLTQHFKTDAYKNWVERIQYTDSKGSYITERTIEYHKSN
>SEQF1602_02491 hypothetical protein
MKKIKFPTPYTVLVIVMIFAATLTWLLPSGGYDTLWYDKGKDVFVIQSVDKTQEVPATQE
ALTSRNISITLDKFKEQKIKNPISIPNTYQERKATPQGITEVLFAPIKGIYEAVSLILFV
LFIGGFIGVFNSSGALNQGVGYLAHRFRGKEGILIIVLSTLMALGGTTFGLAEETLAFYP
MLVPIFLAAGYDLLVPLAVIFVSANVGSLASTANPFAVIIASDAAGVDWTSGLTIRAVAL
VLCLVISIVYIIRYAEKVKKNPEKSLVYGTTVPEIYASNTPETTHSLKFSTKIQLFIFAL
TFVVMIVGVSQWEWWFQEMTGLFLVAAIVIAILQRTGEEKFIEHFLTGARDLLGVAFIIG
IARGVSFILNEGQISGTILYYATELVQGMSPMLFLPILMLIFGVLSLFIASSSGMAVLTM
PIMGALATVVGVEGDNVVTAYLFGMGMMALITPTGMTLPSLTMVNVNYNQWLRFAWPLMV
IYAVVLTLLLWIDSGQL
>SEQF1602_02492 Penicillin-binding protein 1A
MGTKKATPSKGVFSRKRLLKYFWGTILVGITAVIFVFLLASWGAFGEMPDFKGLENPETN
FATRIYSSDGKILGKFYFNDNRTAVTYKDLPEHLVNALIATEDERFEDHSGIDMRGTLRA
IVFLGRRGGASTITQQLAKLLFHREGSKKTSERYLQKIKEWIIAIRLERQYTKKEILTMY
FNQYDFNNNADGIRSASRIYFGKEPKDLKIEEGAMLVGMFKNSSLYNPRKNPQGVINRRN
VVLAQMEKNHYLTTKEKDSLQKLPLQLNFNPEGHNEGIATYFREHLRSFMKDWVNKEENL
KPDGSKYDIYSDGLKIYTTIDSRMQAIAEEAVKNHMKNLQKAFFKENNIKNNKTFPFVKL
SKEEIDKLMERAMKNSERWAQMKYLGHSEKEIRDSFYKKTPMQVFSWHGTIDTIMTPYDS
IRYYKAFLRTAIMSMEPQTGHIKAWVGGIDYNNFKYDQVYQGARQVGSAFKPFVYAAAID
QLGYTPCTQIPDVKTCIEAGKFGNGKEWCPHNTNGSYSGKMMTLKAALANSINSITAKLM
DDVGPVPVVKLIKDLGITSNIPELPSIALGSADITLFEMVGAYGAFANQGNYRKPVFITR
IEDKDGRILYEYTPEVRNAINPVKAYTVVKLMEGVTQSGSGARLRTKGADGYNNIYKNVI
TGYPYAFKNPIAGKTGTTQNQSDGWFMGMVPNLVTGVWVGGEDRSVHFKGIQLGQGATMA
LPIWGYYMKKIYENKDLEVSTAPFPIPKDKDGASMISSSDLDCKGNDPVETIGDDSEINF
>SEQF1602_02493 Putative teichuronic acid biosynthesis glycosyltransferase TuaG
MSLKYSLIIPVYNRPEEVKELLETIAAQTFAGDFETIVIEDGSTLSSREVVAEYTSRIAI
TYLEKENSGPGDSRNYGMERASGDYFIILDSDCLLPDHYLESVDEFLGRHYVDCFGGADA
ATEHFTPIQKAINYAMTSLLTTGGIRGNKRAVSKFEPRSFNMGLSRRAFQATGGFGRIHP
GEDPDLTIRLWEKGFETAFVEEAFVYHKRRISWEKYFQQVKKFGQTRAILNRWHPQSRKI
VHWFPTLFLIGFLISLLLLFVGEWGFIFIYIAYFILIFFDSKRINHSSQIGYLSVWAVCL
QFYAYGTGFLGATLRILSSKKSPEELFPKLFFKK
>SEQF1602_02495 hypothetical protein
MKEESDIPLLKSYNKDTTVIETDPFMEKEIEELIRAYAQPQEIIRRLRDVGYSEEEVRQS
YKFQFYCEILKQIQKDKEEEKAELRLSIPFIISLVVFSLFSLAATIGIFFSVYFIFLALP
LWVLTYGFYKLNKLSIIIWGILLLILSILGCIALFSGSGKVFAAFVPVGTALLNYLADLL
KRS
>SEQF1602_02496 hypothetical protein
MKLYRIIFLFWIYNIFAIFQFSWMAGVWFDSEDLMQRSDYEIYKPPLWQYQLYYILFGVY
VVISSLLLYLWQKKIRNTEGGIIVWVLHIIWVLFFILGWMISI
>SEQF1602_02497 hypothetical protein
MPTETLEDTEGILSLIEKYDSLISNIESPISLEEAKVIISIFPEGFFYDLHWDLVRLIES
FLIQNEQQYLEIINQCPSEEWKEVLNTRYINWKKG
>SEQF1602_02498 hypothetical protein
MEKYVLDYSETSYFKGLRILYPYIEEGLLYAQQNNIKDICVWTQGDWTKQNVNFDFLNGK
SFIETFHWLVPMSKKTDVTGIYNLLNLKELRWGFYDLDLSYFKELERLNITYSAKILGWN
SLKKVTHLTIGGVKTQDLSFLEDMDNLEYLRIIKGTFSTIKGVDRCNKLKTIFIQGCNSL
LDIKDTLINNKNIENLLLERCKNVILEGIESLGLKNLSVI
>SEQF1602_02499 hypothetical protein
MIKAGLEIFFTTFPFFIIFLWFWIFKWNKHSSFVGAIIYQYLLIAILFFFDSLPIEFYQE
LEGNQSKLAGVFQGVFHLLLISIAKIFLFISLYKNKEFKLLIIDSILFVLLILFVYLYY
>SEQF1602_02500 hypothetical protein
MYNELLTIENEIVTISDDLDSSYHIGNWAIPPSYYEFCKELGYGLLLELFLTYIPMGKGN
PFCDSLENQNIYLKNILKKYLETPLMMLKNADNYNLIANAEPFMFGENGEIVFWDIRESK
EGEYPIYLANFPVGVYYAGGNFREFIINLTDKDTYKKILTFYEEPLLPKFRPLKMVQ
>SEQF1602_02501 Fumarate hydratase class II
MEYRIEKDTMGEVKVPSDKLWGAQTERSRNNFKIGEPASMPKEVIYGFAYLKKAAAYANC
ELGVLSQEKRDLIAKVCDEILEGKLDDQFPLVIWQTGSGTQSNMNVNEVIANRAQQLAGR
KIGEGEKVLQPNDDVNKSQSSNDTFPTGMHIAAYKMVVEVTLPGLEKLRDTLQKKSEAFK
GVVKIGRTHLMDATPLTLGQEFSGYVSQIEHGIKALKNTLAHLSELALGGTAVGTGINTP
QGYDVLVAKYIAQFTGLPFVTAQNKFEALAAHDAMVESHGALKQIAVSLNKIANDIRLMA
SGPRSGIGEILIPANEPGSSIMPGKVNPTQCEAVTMVAAQVMGNDVAISVGATQGHYELN
VFKPVICANFLQSARLIGDACVSFEEHCASGIEPNYTRIKELVNNSLMLVTALNTKIGYY
KAAEIANTAHKNGTTLREEAIRLGYVTPEEFDAWVRPEDMVGSLKK
>SEQF1602_02502 Elongation factor P
MASTADIKKGLCIRFNHDIYKIIEFLHVKPGKGPAFVRTKLKSVTTGKTIDNTFSAGHKI
DDVRVETRSFQYLYPEGDELVFMNVEDFNQVHIRRDMLDYPDLLKEGEVVMIIFNAEDET
PLSVEMPANVILTVTHVEPGVKGNTATNATKPATVETGATVNVPLFINEGDRIKVETEKG
TYVERMKD
>SEQF1602_02503 Endoribonuclease YbeY
MIHFFYELPFSLPNDEEDFQRWIQLIIASERKKEGDINYIFCNDEYLHKINVDYLQHDTL
TDIITFDYGKDNLLASDIYISIERVRENAQEFGVDFSTELLRVMSHGILHLCGYKDKTPE
QSQQMRQKEEEKMALFLK
>SEQF1602_02504 hypothetical protein
MAKKPTNHLLVIRLSAMGDVAISVPVLMALTQQYPELRLTVLTRPLFAPLFAHLPNTEVF
PIDPKGRHKGLRGLYRLFRELKALGIDKVADLHGVLRTHILRGFFAFSSIPFQQIDKGRK
EKKALTRAKNKVFTPLLPTYLRYAKVFEALDLPIALDRPFFAPKPVLSEPLKELLSNTLN
IGIAPFASHKGKEYPFEKMKEVILSLSQRYPKGKILIFGGGRREKELTATLPTLENVECV
IGRFSFEEELALIAHLSLMIAMDSGNAHLAAMYGVPTLTLWGVTHPYAGFAPYGQPSDYT
LMADREQYPLIPTSVFGNKYPEGYEKSITTISLHNILDKVTSILEK
>SEQF1602_02505 Exodeoxyribonuclease
MKIFSYNVNGIRAAMSKGFTQWLKAADPDVICLQEIKALESQIDLPALEEIGYTYHYFHS
AEKKGYSGVAILSKTAPTQVEVGAGIDYMDREGRILRADYGDLSIMSLYLPSGTNIDRLD
HKLQFMADFQNYINELKKTHPNLIICGDYNICHEAIDIHDPVRNANVSGFLPVERKWLDD
FLKSGFIDSFRFFHKEPHNYSWWSYRANARANNKGWRIDYCLVAQPLENRLLRAAILPEA
KHSDHCPILVEIQ
>SEQF1602_02506 hypothetical protein
MKHIKEGEEHNAPQVHLLKRQKRNRLLLFFSFLLLIGIVFYTIYISESLLPLREALSRDN
YIFYWMILAGCGAEIVAGSMGMGYGVICATILLMMNIDPRAISGSIHASETFTSAAGSIS
HFKLKNMDKELIKRLLVPAIIGTVVGALLLLYLGDEGSRWAKFTKPFIAVYTIVLGVKIL
ANGFRGKVENKEVKTIPLGLFAGFVDAFTGGGWGPLVTSSFIKNGHTPRYVIGVSTFTNF
AITVVSTLIFITVPEAINWRIALGLVIGGVLTAPISALITSKLHTRKIFFIIGSLIIIMG
LTTIYKAIF
>SEQF1602_02507 putative peptidyl-prolyl cis-trans isomerase
MDITKLEEGIYAQIHTAKGDILLRLTYEKTPATVANFVALAEGKMKNSAKPIGVPFYDGL
KFHRVIADFMIQGGCPQGTGTGTPGYRFDDEFHPDLKHDRPGILSMANAGANTNGSQFFI
THRPTPHLDNKHTVFGYVVEGQKVVDTISQNDKIESVKIIRVGKKAEEWDALAAFEKFNA
EKQARIEAEKRKQQEALAQLTEGFEKTASGLYYKITEKGNGKKPKKGDQVAVHYTGMLLD
GKVFDSSLYRGQPLNFAVGIGQVIEGWDEGILLLNEGDKARLVIPSDLAYGSQGAGGVIP
PNAALVFDVELVRVL
>SEQF1602_02508 hypothetical protein
MRNYLLPFLSIIIGTCIVLWLKPNNKNRIKLLLAFSGAFLLGMTVFTLIPEVYHSLLEGE
HSHEDIKNIGLWIIIGILLQIVLEFFSHGAEHGHFHSPAKGLRKQFPWGLFVSLSIHSIL
EGFPLHAHSNMVYGIFIHHLPIAMVLTIFFLDSGIGIKKTIIFLFLFSLMTPIGAFLANT
VPQLVAYHTQMSAIVIGIFLHISSVILFETAEGHKFNYQKLGVIILGFALAFTL
>SEQF1602_02509 Dihydroorotate dehydrogenase (quinone)
MYKSIIRPLLFLFDPEKVHQFTFRWLKFVNKIPFIPALLRARYRLKDKRLEREVFGIKFP
NPVGLAAGLDKNAELFSELSSLGFGFIEIGTVTPKPQPGNPPKRLFRLVEDEGIINRMGF
NNEGVEAIVARLKKNKNVIIGGNIGKNKWTENDKAHEDYLYCFEHLAPYVDYFVVNVSSP
NTPNLRSLQEKEPLQKLLTLLQEANGKLPKSKPILLKIAPDLTDEQLMDIIDIVEQTRIA
GVIATNTTITREGLTSEKKVETGGLSGRPLTQRSTEVIRFLAEKSQHRFPIIGVGGIHTP
EDALEKLRAGASLVQIFTGFIYEGPSLIKRINKAIIKRMKSEE
>SEQF1602_02510 Bifunctional purine biosynthesis protein PurH
MEQKKRIHSALVSVFSKDGLEPIIRKMNQLGISLYSTGGTESFIKSLGVPVIPVEDITQY
PSILGGRVKTLHPKIFGGILNRQDNPTDQEQMASYQIPQIDLVIVDLYPFEQTVASGASQ
QDIIEKIDIGGISLIRAAAKNFNDTLCVSSKEEYPALLQILTEANGETSLSERKSFALRA
FATSSRYDTAIFNYFNSDNTTQLLRVSQDEAQVLRYGENPHQKGIFFGDFEALFTKLHGK
ELSYNNLLDVDAAVNLMSEFADQAPTFAILKHNNTCGIASRPTLLEAYNRALACDPVSAF
GGILIANRPIDKDTAEAINPLFCEVVIAPGYAPEALTILESKKNRILLQQKETSLPTTSL
RSCLNGYLWQDKDLKTDTLADITFVTEKHPDELALEDLLFASKICKHTKSNTIVLVKNKQ
LLASGTGQTSRVDALKQAIEKAKEFNFSLQGAAMASDAFFPFPDCVEIAHKAGITSVIQP
GGSIKDNLSIDYCNEHQVAMVMTGIRHFKH
>SEQF1602_02511 GTP pyrophosphokinase
METEYYTAEESKEIAKRYKDLLRESYQTLSEEDKRLIRKAFDVAVDAHKEQRRKSGEPYI
YHPIAVAKIVAYDIGLDAVSIASALLHDVVEDTPITIEEIAQQFGDTIAKIVKGLTKISD
LSRDTDVSFQAENFRKMLLTLNDDVRVILIKIADRLHNMQTMDAMPTYKQQKIASETLFI
YAPLAHRIGLYNIKTELEDLGLKYTEPEQYYAILSKIEESKEEQLQYIKEFSDTVKAALD
KEKIDYYIKGRPKSIYSIYKKMTSKKIPFEEVYDKFAIRIIYKSSDEEEKFLAWKIYSIV
TDYFRPNPTRLRDWLSSPKSTGYEALHITVVGPKNRWVEVQIRSDRMHEIAEKGYAAHFK
YKHGQQKERGIEQWLNRLQEVLEDSEANAVEFVQEFKMNLYADEIFVFTPNGEIKSLPKG
ATPLDFAFCIHTQVGMHTRGAKVNGKLVPLNYKLRSGEQVEIITAENATPNSNWLDYATT
SKAIAKIKSALKENRKKIAEEGKEILRRKLKQLKINLDEKVTNDMVTYFKTKTSQDIFYQ
MATGEINNQMLKNFVASRSTTSAFFNFFRKKPTTYVAPEKKDQYDMIVFGKDEQVLDYTF
SKCCTPIPGDEIFGYIAVNGGSIKVHKKDCPNALSMFSNYAYRITPAKWVKSTEREYETT
IKIIGVDRKGLAAEITNHITHKGLGMNNIQLMSQGGIFEGEITLLVSNTEALNSLLDSLR
KLNGVEKVFRE
>SEQF1602_02512 hypothetical protein
MEQKINVHWSWFTRIVTILVSLVFARIIWEEFKDFQANSLNRGVLLYVIFFILISVVFAI
NAPISVRLTPQYFELRKLVGRIRIEYTAITHVVRYKPSFWDMRVFGSGGFFGYIGFFQGD
KIGRYSGFFADKNQAFLIRTKRGKLYVFSTEAPDRTVEELKKRIQ
>SEQF1602_02513 Cell wall-associated protease
MICKNPIFYMAFSGLLVACGGTSKIASLPLETLEGKNIPSISEKPNKDDLKTWPHRDLLT
SGYPGISLEKAYNALKGRKAQTVIVGVVDSGVDINHEDLKSIIWTNPKEIPNNGIDDDKN
GYVDDVHGWNFLGEINQENLEYVRILKSGDTKNPDYQRALDKYNKEYQDAQGKVDFYSQI
KERIAQSDALIQAHLGKKEYTLEDLEKINTSSEQLQGAIRGMKYLLSNEVSVKETLEELT
DGIKHFEERLQYGLNKDFSPRKTILKDNPDDINDKYYGNNNVVGPTAEGALHGTHVAGII
AAVRHNNIGIDGVADHVRIMPVRTVPDGDEYDKDVALALRYAIDNGAKVINTSFGKEFSP
HKEWVYDALKYAAQKDVLIVNAAGNDTKNVDVQLTFPDDNIGGKEFTDTMITVGALNYEY
NENLVASFSNYGKNNVDLFSPGVEIYATVPENKYKFLSGTSMAAPEVAGVAALIRAYFPK
LKAREVKQILMESGVTPTVKEVLVGGRGEEQEAQRMPFSSLSKSGKILNAYNAIILAAKR
SK
>SEQF1602_02514 Threonylcarbamoyl-AMP synthase
MEINEIVKETLSFLRSGKVILYPTDTIWGLGCDPYSREGIQRIQAIKQRDIRKSFILLVS
SYQMLQRYVAVSQETLAFLDKQERPTSVIYTQVYDSHLPEAADHSLAFRVVKDPFCKALI
DAFDAPLVSTSANISGEESPKNFSLISEQIKKSVDYIVPYRREEQGAGQPSQLLKIEDNQ
VIFLRK
>SEQF1602_02515 Serine hydroxymethyltransferase
MKRDQRIFDLIQQEKERQLRGIELIASENFVSPEVMEAAGSVLTNKYAEGYPGKRYYGGC
QIVDQVEQLAIDRAKALFGAEYVNVQPHSGSQANASVYAACLSPGDKILGFDLSHGGHLT
HGASVNFSGKLFQPVFYGVEKETGLLNYDKIAEIAHKEKPKMIIAGYSAYSRNIDFKRFR
EIADSVGAFLMADIAHPAGLIAKGLLNDPIPFCHFVTTTTHKTLRGPRGGMIMMGKDFEN
PFGLKTPKGEIRMMSSLIDLSVFPGNQGGPLEHIIAAKAVSFGEALSDAFLLYAVQVQKN
AKKLAQLLLEKNYNIVSGGTDNHLMLIDLRNKNISGKEAEAALVKADITANKNMVPFDDR
SPFVTSGIRLGTAAITTRGLKEADMEVVAGYIDEVINHANDEKLLESIAKKVNEFMHGRP
LFND
>SEQF1602_02517 hypothetical protein
MFHRYIKIALAVLIFAFAIYQFTLGNIGNGIFLILLSLFPILFYFKNEFLLLAFLRLRKQ
DIAGTKKWLDYIKNPETALIPKQRGYYNYLYGIVTSQTNLTQAEKYFKTALKYGLNMSYD
EAMAKLSLAGISMQKRRKREAQEYLTQAKKLDKQNLLKDQIRMMQEQLKKI
>SEQF1602_02518 Sigma factor SigB regulation protein RsbQ
MKNISITFLFFLFISPLLSFGQASFSVQKIGNKGNSILFIPGLACSAEVWQDTVKEFSPN
HTCYLFTMAGFAGTAPVKNPSLDNWAEAIISYVKKEKIKKPIIIGHSLGGMLAMKIAAKE
PKLLQKIVIVDALPALAALSNGDFKVDPNKDCTPIIKEFVGMPKENFQQAQTSSMVYYTE
SKDRIPQIIQWSMDSDRETIGKMVCELSNTDLREEIQHIEVPTLVLLESVFSFSKDKIEQ
QYAKPLKRNLDMRTRDCTSLCTMTLIGISSN
>SEQF1602_02519 Thiosulfate sulfurtransferase GlpE
MKITKILSFTALSLLGGALQAQEKSLATLVNEKDAFLVDVRSEKEFDQGSALNAVNIPVD
KIEKELDQFKGKSNIILFCRAGRRAEAARKLLEKHHIKAINGGTYQQVKTLQKENLMDRL
SYRTDKQTVSVIKNGEGVKQVAVALGKGAILKKHTTDVPAFLVVVKGEIRFLINGQEILL
KALDTYNIPAEIEHELIGVDDENLFILTKSKYFKE
>SEQF1602_02520 UDP-glucose 4-epimerase
MATILVTGGLGFIGSHTTVALQQAGHEVIIIDNLSNASIEVKDRIAKITGRAPIFEQIDL
REKDKVQDFFLRYPNIDGVIHFAASKAVGESVEKPLLYYENNIASLIYLLQELQKRKNTA
FIFSSSCTVYGQADKLPVTEDAPFKQAECPYGNTKQINEEIIRDTCTIAKNIKAISLRYF
NPIGAHASALIGELPNGVPQNLIPYITQTAIGLRESLSVYGDDYPTPDGTCIRDYIHVVD
LAEAHLAALEYILQGKIQGNYEVFNVGTGKGSSVLEVIKAFEKVTGQALPYKIVGRRAGD
VVAAYADTHKVNEVLKWKAKQTLEEALLSAWNWEKKLRNK
>SEQF1602_02521 Small-conductance mechanosensitive channel
MNEKDTYINNLQSFTDKFADKMISYSPNLIGAIILLFVGIWVCRLIRKFVRRIMVRRAVD
ITIQNFVNELLRWVLYIILGLAVIQKVGVPVSSFLGALAAAGVAVGLALQGSLSNFAGGI
MLLILKPFRIGDTIEAKGHIGTVERIGMFYTTIIKFGNEKLMIPNGPLFSDNIINYSESE
TRRDNIIVGIGYGSDLKKAKEILYTLTKNCPTALQDPAPAVFVNELADNSVNFTLRVWSK
TEHYWNTHFYLIEQIKLTFDKEGIEIPFPQRDVHIISK
>SEQF1602_02522 Cell division protein FtsA
MNQKKYIAGIDIGTTKIVAIVGSENQYGKLEILGYGKAKSQGISRGMVGNIGKTIDSIKQ
AVDLAQAKAGVVISEAYVGIAGQHIKSNEASDYITRENADEMISSEDLDALCHCVMSSKN
RYPGEEVIHILPQEYKVDNQEDIHDPVGMVGARLEGTFHIVTGQVAPIKNIQRCVTKSGI
ELKGLTLEPIASSASVLSEAEKDAGVALVDIGGGTTDLAIFKEGYIRYTAVVPFGGNIID
KDIKEGCGVFDKQAEMLKIKFGSALPEYTKENEVINIQVFKGREPQEIQVTNLARIIRCR
MEEIIEAVFNEIKNYGYDQPRKKLIAGIVLTGGGSELKDLPQLVEYITGLPTRIGHPNEH
LANNTPPELSSPIYATAIGLLLDGIEREQNEGQRIDFSHLKDTPQPEVHSHQEPTPLTTP
EVAAPVAIEPTPVVTPKKEEEEEEIVKPEKKTILKTISDKFTDFFKSMD
>SEQF1602_02523 Cell division protein FtsQ
MNFLLKNKYVLLLIKNAFSIDFYLIFIPIFAPYIIWLFLWMNSKRNKIFIILKISCIFLL
PILLQSFSFHRNNNRKIQKIVISRQENTQHIQQAQYITNDAVENLLFSAKNAEEYTLQEI
KINALEKMLAANPMVEHADIYLTIDGVLKIVIKQREPIARMVRGGQFYYMDIQGKRMPLS
DASSARVPLVRGVEEPMWEDAHIILKHIYMDHFLRENIVELSVNKGKFFARLRGANFSVC
LGKSDDINLKFNNLKAFYKKAAKDNFLDRYTEVNLQYYNQVVCTHAHAVVEERNQ
>SEQF1602_02524 UDP-3-O-acylglucosamine N-acyltransferase
MKFPQPYTLEQIATIIGSRYVGDKDFPVLGMNEIHVVEAGDIVFVDHPKYYDKALHSKAT
IVLINKEVPCPEGKALLISEDPFRDFNKLTRFFKPFERATALIAPTAQIGEGTIVQPGAF
VGNHVVIGKNCLIHANVTIYDHCVIGDNVTIHSGTILGADAFYYKKRPEGFDKLLSGGRV
VIGDQVDLGALCTIDRGVTGDTTIKRGTKIDNHVHVGHDTVIGEECLIASQVGIAGCVVI
EDRVTLWGQVGITSGVTIGEKAVILAQSGVSKSLEGNQTYFGSPAEEARKRYKELASVRA
LVERQ
>SEQF1602_02525 hypothetical protein
MKKVLIITYYWAPAGGPGVQRWLKFVKYLRDFGIEPIIYTPQNPTYPMVDAHIADDLPQD
LTLLQTKIWEPYSIASLFSKEKTKKISAGIIPTKKLSWVDKCLLWVRGNLFIPDARVFWV
RPSVKYLSDYITTHGIDTIITTAPPHSVHLIGMHLKEKFPSLRWIADFRDPWTNIGYHSQ
LRLTKKSAEKHLTLERKVLQTADTIIVTSPSTQREFAAKTPKPIVLITNGYDDTFTKEVS
LSPYFLLSHIGSLLSERNPEPLWQVLGEMVRENEAFRKDLRICLAGKVSEEVFASIEKYG
LTSSLEYKGYLSHTEALALQRSSQLLLLLEINHHKTEGIIPGKLFEYMASQRPILALGYS
QWDVKEIISQTQTGITLSVTDTSAIKQALTQYYALYKANQLHTQPTSLGAYHRKALTQKL
SEVILEK
>SEQF1602_02526 hypothetical protein
MKTKWEYFISWLSNLFSSSGRIGRTTYGVSLIICIFLSTLILISILLTQENMSFFILLYI
PIIWLALAQGAKRCHDLGNSGWFQWIPFYYFIMLLKEGDKKTNYYGESPKYRHSQKKTAS
ENSPPSDTDTSTHQKKENSYSKYNKDYRKNYSQKY
>SEQF1602_02527 hypothetical protein
MKAKTISLFIVFFVSIIACSSNEVSETYVYICKGPNSAAYHYNPHCRGLRQCSTDVEKLT
VKEAVEKGRKLCGYED
>SEQF1602_02528 hypothetical protein
MNQTARIEEFFSTFRGGTETLKQYINYQKKFTDGEEAIIEKKKNEIIEKELENYQKNYEE
NKDNPERIKRIQELQNEIDLLTKDKEGEEKILGICKAQRLYDELRWLQGDGEYLIENEGS
FEEDPEKLNISSFTIIQNNTTLVLIYSFFENQLKRLCDILGEKAPIHYCDLKGDATVQCG
KFLTKFCKVESFIFEQIHWQFLDSIRVLRNQIIHNNPHYFSVLTEKVLKNSIDKEYIHKN
LEEIIQTENFLKTEYNNSDYYIRLSDTFLLKVINYMEIFFSDLENYVQKKR
>SEQF1602_02529 hypothetical protein
MAIEIISLNGKSPYIDYKAFEESVHQVLNNTCPNAKIYLFNRFPIPISNIIDIDLLLVII
VPNKKDSYYRINENSLFQNQIIPVKFIDKYIDKELYSSDESDDRVFLTEKGEIDYQNELE
KLKSGIREYLTQIFREENIIDKEEYVYIPFPIIQILSPKYRCVTTNYLLGASFDFHMLDE
YFKKNTQEMYFCSIKKWSQSGAYEVVPFDIEKIVDRISKDSEYGYLTKRKIENIVKQRAN
LSTVEKEIGNKLIIVEGKAGNGKTNRLLTIAYKHYIKGQHILFLSYNRLLVHDINKTFQS
ISNLKKESKVGRVPANTFHSFFFDLCRKTGVIKLEKHKRYKENKKRYEELVNILEKNMPI
ISDILNSLRLTDFDFNKENLKTYFQNRDDLDSVTKDYARDYINSYDRSIEIFIKKKKEYL
ADLLLSVKQDNDGGLFNQDYEKFLRILYKVLNNTSEFYNEYDVRNKKELLETSLNLNNES
NEISFRAFSKHIEDKKNRLPIKYDLIFVDEAQDCYEYEKEILIKLFGEGKIIVANGGEEQ
LIRYPELCDWRKRKAETETGYKETNYIPHKPIIPTKKDPVSTSYRSKEEVIRLCNFFANK
INIEFKLHSLNEEVAPKEYIDRGEIIFDFRRNPEILSIYNQLKEKSSINGYKPYESILIL
ITPEDEQEENSEGVSHKNKTHIYENNYVNTTNIKEKKGSWEYLKLLEDNGYQCYNGTKSK
HLPFDFDDTRIIHYESCRGLETFAVCCFGLDTFFEIKYKEEKAERTLLNKTRYNNQDLTN
EKRKQIYATNWLLMALTRAIDTLYIQIDDKNSDIGKLVCEYIEMNKDNKNIKVYE
>SEQF1602_02530 Pyruvate dehydrogenase [ubiquinone]
MSKNVSDQLVEMLVQAGVKRVYAITGDSLNPVNDAIRRDGRLEWIHVRHEESAAYAASMD
AELNGIGCCMGSSGPGHVHLINGLYDANRSGNPVIAIASTCATHKFGTHWFQETNPFLLF
QDCSKYVYVANTPKQFTTMMQRAIQTAINEKGVAVLGLPGDVAGADQEEVPTATQTFLAK
PVVRPSDSELDKLAAVLNDTKHKKITLYCGHGCQYAVKEVEQLAETLKAPIVASFRGKIF
FDRVDSPYIAGMNGLLGHRSGYDACAESDVLIMLGTDFPYAEFLPKKNTIIQIDERPDII
GRRAKVDYGFAGDVKDTIAALLPKLTPRTEDSFLKKIHKEYVELEKSLDDYAKEKTEVDQ
IDPEYAAKLLDKYAADDAIFTVDTGMNVVWAARFIKGTGKRYLTGSFNHGSMANALPMSI
GAAASSKGRQVVAMCGDGGLSMLLGDLATLMQYQYPVKIFVFNNRSLAMVKLEMEVSGYL
DWQTNMVNPPFDKLAELMNIKGYEVRKMEDLEATVKAAFEHDGPTLVNIYTNRDTLAMPP
HITFEQMKGFATNVIKKIGQGDFAEAKDSIANSMKHLKDIF
>SEQF1602_02531 Nitronate monooxygenase
MQTRITELFNIQYPIIQGGMIWASQWPLVVAVSNAGGLGLLGSGSMSAEELRTQIRQCKA
HTSKPFGVNVPIMYQNSAHTMEVIMEEGVPVVFTSAGNPSLWTAQLQERGIKVVHVVSSS
KFALKAQAAGVDAVVAEGFEAGGHNGKEETTTLVLTPQVCSAVDIPVIAAGGIATGRGMY
ATMALGAEGIQMGSRFIATKEATVHQRFKEEVIKAKEGDTILTLKELSPVRLLKNPFYAQ
IETLYQSREATPEKLRELFGKGRTRMGMFEGNLDEGELEIGQVSSLIHEEKSVEAVFEEI
LTEFEQVRNQMYTLKR
>SEQF1602_02532 ComE operon protein 3
MFGCYSIAYLMESRRARYDSLLLSAFILLLCKPTFLFEVGFQLSYMAVLSIEFFLPYFNR
YIYFENKLLNFFTNIIKVSIAAQIGVFPLSLYYFHQFAGLFLLTNILILPLLGGILAIGI
IVVLLSYRGWVTSGLIYCYDTILHLMNKIIAWVASVEHMVIRDVYFDRILLWLCYLCIIG
GAIYLKIRKITFLYLSLFSLLLMQSYLFYLKYESIHTEQLIVFQQYKKTIIASQVGKQAT
FYLSDTLEIPTKLLQNFHTQQQLQEIHYEPIRNIIPFKNDFLTIIDAPFYLDRSFPTDYI
LLRNSPKIHLEKFLSTIQPKMLIADGSNRPFIVEKWKLTCQKLHIPFHYTKEDGNLSL
